PT J
AU Baud, D
   Van Mieghem, T
   Musso, D
   Truttmann, AC
   Panchaud, A
   Vouga, M
AF Baud, David
   Van Mieghem, Tim
   Musso, Didier
   Truttmann, Anita C.
   Panchaud, Alice
   Vouga, Manon
TI Clinical management of pregnant women exposed to Zika virus
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Baud, David; Vouga, Manon] Univ Lausanne Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Baud, David; Vouga, Manon] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Baud, David; Vouga, Manon] Univ Lausanne Hosp, Lausanne, Switzerland.
   [Van Mieghem, Tim] Univ Hosp Leuven, Div Woman & Child, Dept Obstet & Gynecol, Leuven, Belgium.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
   [Truttmann, Anita C.] Univ Lausanne Hosp, Dept Femme Mere Enfant, Clin Neonatol, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Swiss Teratogen Informat Serv, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland.
   [Panchaud, Alice] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
RP Baud, D (reprint author), Univ Lausanne Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
EM david.baud@chuv.ch
OI panchaud, alice/0000-0001-6086-2401
CR Calvet G., 2016, LANCET INFECT DIS
   Musso D, 2016, LANCET INFECT DIS
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
NR 5
TC 3
Z9 3
U1 22
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2016
VL 16
IS 5
BP 523
EP 523
DI 10.1016/S1473-3099(16)30008-1
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DJ5TL
UT WOS:000374272900015
PM 27056096
ER

PT J
AU Sarmiento-Ospina, A
   Vasquez-Serna, H
   Jimenez-Canizales, CE
   Villamil-Gomez, WE
   Rodriguez-Morales, AJ
AF Sarmiento-Ospina, Andrea
   Vasquez-Serna, Heriberto
   Jimenez-Canizales, Carlos E.
   Villamil-Gomez, Wilmer E.
   Rodriguez-Morales, Alfonso J.
TI Zika virus associated deaths in Colombia
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID ARBOVIRUS THREAT; AMERICA
C1 [Sarmiento-Ospina, Andrea] Secretary Hlth Ibague, Ibague, Tolima, Colombia.
   [Vasquez-Serna, Heriberto; Jimenez-Canizales, Carlos E.] Secretary Hlth Tolima, Ibague, Tolima, Colombia.
   [Jimenez-Canizales, Carlos E.; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Hosp Univ Sincelejo, Infect Dis Res Grp, Sucre, Colombia.
RP Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (reprint author), Hosp Univ Sincelejo, Infect Dis Res Grp, Sucre, Colombia.
EM arodriguezm@utp.edu.co
CR Arzusa-Ortega L, 2016, EMERG INFECT DIS, V22
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   PAHO, 2015, EP AL
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
NR 5
TC 3
Z9 3
U1 11
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2016
VL 16
IS 5
BP 523
EP 524
DI 10.1016/S1473-3099(16)30006-8
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DJ5TL
UT WOS:000374272900016
PM 27068488
ER

PT J
AU Fernandes, LN
   de Paula, MB
   Araujo, AB
   Goncalves, EFB
   Romano, CM
   Natal, D
   Malafronte, RD
   Marrelli, MT
   Levi, JE
AF Fernandes, Licia Natal
   de Paula, Marcia Bicudo
   Araujo, Alessandra Bergamo
   Bertoletti Goncalves, Elisabeth Fernandes
   Romano, Camila Malta
   Natal, Delsio
   Malafronte, Rosely dos Santos
   Marrelli, Mauro Toledo
   Levi, Jose Eduardo
TI Detection of Culex flavivirus and Aedes flavivirus nucleotide sequences
   in mosquitoes from parks in the city of Sao Paulo, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Flavivirus; Mosquitoes; Parks; Polymerase chain reaction
ID WEST-NILE-VIRUS; INSECT-SPECIFIC FLAVIVIRUS; FUSING AGENT VIRUS;
   ALBOPICTUS DIPTERA-CULICIDAE; UNITED-STATES; ZIKA VIRUS; VERTICAL
   TRANSMISSION; YUCATAN PENINSULA; VECTOR COMPETENCE; DENGUE-VIRUS
AB The dengue viruses are widespread in Brazil and are a major public health concern. Other flaviviruses also cause diseases in humans, although on a smaller scale. The city of Sao Paulo is in a highly urbanized area with few green spaces apart from its parks, which are used for recreation and where potential vertebrate hosts and mosquito vectors of pathogenic Flavivirus species can be found. Although this scenario can contribute to the transmission of Flavivirus to humans, little is known about the circulation of members of this genus in these areas. In light of this, the present study sought to identify Flavivirus infection in mosquitoes (Diptera: Culicidae) collected in parks in the city of Sao Paulo. Seven parks in different sectors of the city were selected. Monthly mosquito collections were carried out in each park from March 2011 to February 2012 using aspiration and traps (Shannon and CD C-CO2). Nucleic acids were extracted from the mosquitoes collected and used for reverse-transcriptase and real-time polymerase chain reactions with genus-specific primers targeting a 200-nucleotide region in the Flavivirus NS5 gene. Positive samples were sequenced, and phylogenetic analyses were performed. Culex and Aedes were the most frequent genera of Culicidae collected. Culex flavivirus (CxFV)-related and Aedes flavivirus (AEFV)- related nucleotide sequences were detected in 17 pools of Culex and two pools of Aedes mosquitoes, respectively, among the 818 pools of non-engorged females analyzed. To the best of our knowledge, this is the first report of CxFV and AEFV in the city of Sao Paulo and Latin America, respectively. Both viruses are insect- specific flaviviruses, a group known to replicate only in mosquito cells and induce a cytopathic effect in some situations. Hence, our data suggests that CxFV and AEFV are present in Culex and Aedes mosquitoes, respectively, in parks in the city of Sao Paulo. Even though Flavivirus species of medical importance were not detected, surveillance is recommended in the study areas because of the presence of vertebrates and mosquitoes that could act as amplifying hosts and vectors of flaviviruses, providing the required conditions for circulation of these viruses. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Fernandes, Licia Natal; Malafronte, Rosely dos Santos] Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Protozool, Av Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
   [de Paula, Marcia Bicudo; Natal, Delsio; Marrelli, Mauro Toledo] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Av Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
   [Araujo, Alessandra Bergamo] Prefeitura Sao Paulo, Ctr Controle Zoonoses, Lab Fauna Sinantrop, Rua Santa Eulalia 86, BR-02031020 Sao Paulo, SP, Brazil.
   [Bertoletti Goncalves, Elisabeth Fernandes] Prefeitura Sao Paulo, Dept Parques & Areas Verdes, Ave 4 Centenario, BR-04030090 Sao Paulo, SP, Brazil.
   [Romano, Camila Malta; Levi, Jose Eduardo] Univ Sao Paulo, Inst Med Trop Sao Paulo, Virol Lab, Av Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
   [Levi, Jose Eduardo] Fundacao Prosangue, Hemoctr Sao Paulo, Dept Biol Mol, Av Dr Eneas de Carvalho Aguiar 155, BR-05403000 Sao Paulo, SP, Brazil.
RP Fernandes, LN (reprint author), Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Protozool, Av Dr Eneas de Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil.
EM licianatal@usp.br
RI Fernandes, Licia/F-9619-2016; Romano, Camila/C-8185-2013
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: BIOTA
   Program) [2010/51230-8]
FX We would like to thank Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP: BIOTA Program: Project 2010/51230-8) for providing
   funding. Our thanks also to all the other members of the Department of
   Epidemiology in the Faculty of Public Health, University of Sao Paulo
   (especially Dr. Paulo Roberto Urbinatti and Aristides Fernandes), the
   staff at the Zoonosis Control Center/COVISA/SMS/PMSP (in particular
   Maria Helena Silva Homem de Mello and Renildo Souza Teixeira) and the
   staff at the Department of Parks and Green Spaces, SVMA-Sao Paulo, who
   helped with the field and laboratory work. Finally, we would like to
   thank Almir Robson Ferreira (Institute of Tropical Medicine, University
   of Sao Paulo) for providing the map.
CR Diaz LA, 2008, EMERG INFECT DIS, V14, P689
   [Anonymous], 2012, CHINESE J VIROL
   Blitvich BJ, 2009, J MED ENTOMOL, V46, P934, DOI 10.1603/033.046.0428
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bosch I, 2007, EMERG INFECT DIS, V13, P651
   Burivong P, 2004, VIROLOGY, V329, P261, DOI 10.1016/j.virol.2004.08.032
   Bustamante F. M., 1951, FOLHA MED, V32, P53
   Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324
   Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0
   Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carvalho G.C., 2014, J VECTOR ECOL, V39, P146
   Chen YY, 2013, COMP IMMUNOL MICROB, V36, P387, DOI 10.1016/j.cimid.2013.02.001
   Christophers S. R., 1960, BIONOMICS STRUCTURE
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.079850-0
   Crockett RK, 2012, J MED ENTOMOL, V49, P165, DOI 10.1603/ME11080
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/s0034-89102010005000046
   Travassos da Rosa J.F.T.d.R.A., 1998, OVERVIEW ARBOVIROLOG, P19
   de Castro Gomes A., 1985, Revista de Saude Publica, V19, P190
   Espinoza-Gomez F, 2011, ARCH VIROL, V156, P1263, DOI 10.1007/s00705-011-0967-2
   Farfan-Ale JA, 2010, VECTOR-BORNE ZOONOT, V10, P777, DOI 10.1089/vbz.2009.0196
   Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85
   Figueiredo L. T. M., 2010, Dengue Bulletin, V34, P6
   Figueiredo L. T., 1998, OVERVIEW ARBOVIROLOG, P154
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Figueiredo Regina Maria Pinto de, 2008, Emerg Infect Dis, V14, P667, DOI 10.3201/eid1404.071185
   Forattini O, 2002, CULICIDOLOGIA MED, V2
   Goenaga S, 2014, J MED ENTOMOL, V51, P900
   Grisenti M, 2015, J GEN VIROL, V96, P420, DOI 10.1099/vir.0.069625-0
   Gubler Duane J., 1997, P1
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoshino K., 2009, VIROLOGY, V15, P119
   Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039
   Huanyu Wang, 2012, Virol J, V9, P73, DOI 10.1186/1743-422X-9-73
   Johnson N, 2010, VECTOR-BORNE ZOONOT, V10, P665, DOI 10.1089/vbz.2009.0210
   Kent R. J., 2010, PLOS NEGLECT TROP D, V4, P671
   Kihara Y, 2007, J VIROL METHODS, V146, P372, DOI 10.1016/j.jviromet.2007.07.008
   Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034
   Komar N, 2000, REV SCI TECH OIE, V19, P166
   Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006
   Kuno G, 1998, J VIROL, V72, P73
   Kuwata R., 2015, J MED ENTOMOL, V52, P229
   Laporta GZ, 2006, REV BRAS ENTOMOL, V50, P125, DOI 10.1590/S0085-56262006000100019
   [Anonymous], 2003, EPIDEMIOL SERV SAUDE
   Machado DC, 2012, INTERVIROLOGY, V55, P475, DOI 10.1159/000337166
   Marin M. S., 1995, VIROLOGY, V213, P169
   Mattar S, 2005, EMERG INFECT DIS, V11, P1497
   Medeiros-Sousa AR, 2015, ACTA TROP, V150, P200, DOI 10.1016/j.actatropica.2015.08.002
   Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1
   Melandri V, 2012, MEM I OSWALDO CRUZ, V107, P1073, DOI 10.1590/S0074-02762012000800020
   Montes J, 2005, REV SAUDE PUBL, V39, P578, DOI 10.1590/S0034-89102005000400010
   Figueiredo LTM, 2012, REV SOC BRAS MED TRO, V45, P285, DOI 10.1590/S0037-86822012000300001
   Morals S. A., 2006, REV BRAS ENTOMOL, V50, P413
   Morales-Betoulle ME, 2008, J MED ENTOMOL, V45, P1187, DOI 10.1603/0022-2585(2008)45[1187:CFIFMI]2.0.CO;2
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   NASCI RS, 1981, MOSQ NEWS, V41, P808
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   NATAL D, 1984, REV SAUDE PUBL, V18, P418
   Natal D., 2002, BIOLOGICO, V62, P205
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Ometto T, 2013, T ROY SOC TROP MED H, V107, P723, DOI 10.1093/trstmh/trt081
   Paiva BR, 2006, ACTA TROP, V99, P252, DOI 10.1016/j.actatropica.2006.08.009
   Paula M. B., 2015, BIOTA NEOTROP, V15, P1
   Pauvolid-Correa A, 2011, MEM I OSWALDO CRUZ, V106, P467, DOI 10.1590/S0074-02762011000400014
   Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28
   Pereira LE, 2001, REV SAUDE PUBL, V35, P119, DOI 10.1590/S0034-89102001000200003
   Rizzo F., 2014, PARASITE VECTOR, V26, P395
   Roiz D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-223
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Saiyasombat R, 2010, ARCH VIROL, V155, P983, DOI 10.1007/s00705-010-0665-5
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   Almeida A. F., 2007, FAUN SILV QUEM OND V
   Silverio ED, 2011, REV SOC BRAS MED TRO, V44, P504, DOI 10.1590/S0037-86822011000400020
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   SUNDIN DR, 1988, AM J TROP MED HYG, V38, P428
   Taipe-Lagos CB, 2003, REV SAUDE PUBL, V37, P275, DOI 10.1590/S0034-89102003000300002
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99
   Urbinatti PR, 2001, REV SAUDE PUBL, V35, P461, DOI 10.1590/S0034-89102001000500009
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos P. F., 2005, TRATATO INFECTOLOGIA, P289
   Vasconcelos PFC, 2003, T ROY SOC TROP MED H, V97, P60, DOI 10.1016/S0035-9203(03)90023-X
   Vasconcelos PFC, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Yamanaka A, 2013, INFECT GENET EVOL, V19, P188, DOI 10.1016/j.meegid.2013.07.012
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 97
TC 1
Z9 1
U1 85
U2 88
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAY
PY 2016
VL 157
BP 73
EP 83
DI 10.1016/j.actatropica.2016.01.026
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH4MZ
UT WOS:000372761400009
PM 26829359
ER

PT J
AU Cordeiro, MT
   Pena, LJ
   Brito, CA
   Gil, LH
   Marques, ET
AF Cordeiro, Marli Tenorio
   Pena, Lindomar J.
   Brito, Carlos A.
   Gil, Laura H.
   Marques, Ernesto T.
TI Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates
   with microcephaly in Brazil
SO LANCET
LA English
DT Letter
C1 [Cordeiro, Marli Tenorio; Pena, Lindomar J.; Gil, Laura H.; Marques, Ernesto T.] Fiocruz MS, Dept Virol, Ctr Pesquisas Aggeu Magalhaes CPqAM, BR-50670420 Recife, PE, Brazil.
   [Brito, Carlos A.] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Marques, Ernesto T.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Cordeiro, MT (reprint author), Fiocruz MS, Dept Virol, Ctr Pesquisas Aggeu Magalhaes CPqAM, BR-50670420 Recife, PE, Brazil.
EM marli@cpqam.fiocruz.br
CR Carrolla ID, 2007, TRAVEL MED INFECT DI, V5, P3183
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
NR 4
TC 3
Z9 3
U1 19
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 30
PY 2016
VL 387
IS 10030
BP 1811
EP 1812
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6SS
UT WOS:000375056100017
PM 27103126
ER

PT J
AU Nielsen, KK
   Bygbjerg, IC
AF Nielsen, Karoline Kragelund
   Bygbjerg, Ib Christian
TI Zika virus and hyperglycaemia in pregnancy
SO LANCET
LA English
DT Letter
C1 [Nielsen, Karoline Kragelund; Bygbjerg, Ib Christian] Univ Copenhagen, Dept Publ Hlth, Global Hlth Sect, DK-1014 Copenhagen, Denmark.
RP Nielsen, KK (reprint author), Univ Copenhagen, Dept Publ Hlth, Global Hlth Sect, DK-1014 Copenhagen, Denmark.
EM kani@sund.ku.dk
RI Nielsen, Karoline/E-2228-2016
CR Arteaga J, 2008, REV INVEST CLIN, V60, P107
   Regis C, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.170639, DOI 10.2471/BLT.16.170639]
   LOWY C, 1986, DIABETIC MED, V3, P458
   Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061
   Trujillo J, 2015, DIABETES RES CLIN PR, V108, P288, DOI 10.1016/j.diabres.2015.02.007
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00006-4
NR 7
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 30
PY 2016
VL 387
IS 10030
BP 1812
EP 1812
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6SS
UT WOS:000375056100018
PM 27103128
ER

PT J
AU Grobusch, MP
   Karimi, O
   Schinkel, J
   Codrington, J
   Vreden, SGS
   Vermaat, JS
   Stijnis, C
   Goorhuis, A
AF Grobusch, Martin Peter
   Karimi, Ouafae
   Schinkel, Janke
   Codrington, John
   Vreden, Stephen Gerold S.
   Vermaat, Joost S.
   Stijnis, Cornelis
   Goorhuis, Abraham
TI Uncommon presentation of Zika fever or co-infection? Reply
SO LANCET
LA English
DT Letter
ID VIRUS
C1 [Grobusch, Martin Peter; Karimi, Ouafae; Stijnis, Cornelis; Goorhuis, Abraham] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, NL-1100 DD Amsterdam, Netherlands.
   [Schinkel, Janke] Univ Amsterdam, Acad Med Ctr, Lab Clin Virol, Dept Med Microbiol, NL-1100 DD Amsterdam, Netherlands.
   [Vermaat, Joost S.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, Div Internal Med, NL-1100 DD Amsterdam, Netherlands.
   [Codrington, John] Acad Hosp Paramaribo, Dept Lab, Paramaribo, Surinam.
   [Vreden, Stephen Gerold S.] Acad Hosp Paramaribo, Internal Med & Infect Dis, Paramaribo, Surinam.
RP Grobusch, MP (reprint author), Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, NL-1100 DD Amsterdam, Netherlands.
EM m.p.grobusch@amc.uva.nl
RI Schinkel, Janke/I-3099-2012
OI Schinkel, Janke/0000-0002-1112-0644
CR Breeveld FJV, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-95
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/50140-6736(16)00502-X]
   Van den Bossche D, 2015, EUR J CLIN MICROBIOL, V34, P1361, DOI 10.1007/s10096-015-2359-0
   [Anonymous], 2016, J INFECT PUBLIC HEAL, DOI DOI 10.1016/J.JIPH.2015.12.002
NR 4
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 30
PY 2016
VL 387
IS 10030
BP 1813
EP 1814
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6SS
UT WOS:000375056100020
PM 27203499
ER

PT J
AU Palacios, R
   Poland, GA
   Kalil, J
AF Palacios, Ricardo
   Poland, Gregory A.
   Kalil, Jorge
TI Another emerging arbovirus, another emerging vaccine: Targeting Zika
   virus
SO VACCINE
LA English
DT Editorial Material
ID INFECTION; OUTBREAK; BRAZIL
C1 [Palacios, Ricardo; Kalil, Jorge] Inst Butantan, Ave Vital Brasil 1500, BR-05503900 Sao Paulo, SP, Brazil.
   [Poland, Gregory A.] Mayo Clin, Dept Internal Med, Mayo Vaccine Res Grp, Rochester, MN USA.
   [Kalil, Jorge] Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil.
RP Kalil, J (reprint author), Inst Butantan, Ave Vital Brasil 1500, BR-05503900 Sao Paulo, SP, Brazil.
EM jorge.kalil@butantan.gov.br
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boseley S, 2014, WHO SEVERAL 100 1000
   [Anonymous], MON CAS MICR BRAS
   [Anonymous], 2015, EV SAUD PUBL REL AOS
   [Anonymous], 2015, B EPIDEMIOLOGICO, V46, P1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Direction de la sante, 2015, B SURVEILL SANIT
   Dixit R, 2016, VACCINE
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kwong JC, 2013, LANCET INFECT DIS, V13, P769, DOI 10.1016/S1473-3099(13)70104-X
   Mallet HP, 2015, BISES B INFORM SANIT, P1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Sencer DJ, 2006, EMERG INFECT DIS, V12, P29
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 1
Z9 1
U1 11
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD APR 29
PY 2016
VL 34
IS 20
BP 2291
EP 2293
DI 10.1016/j.vaccine.2016.03.059
PG 3
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DL3AF
UT WOS:000375505900001
PM 27015734
ER

PT J
AU Guo, J
AF Guo, Jia
TI Studies using IPS cells support a possible link between ZIKA and
   microcephaly
SO CELL AND BIOSCIENCE
LA English
DT Article
DE Zika virus; Human neural progenitor cells; Microcephaly
ID VIRUS
AB There is a suspected link between Brazilian babies born with microcephaly and Zika virus (ZIKV) infection. However, little is know about the brain cell targets and the mechanisms that Zika virus may cause microcephaly. A recent report demonstrated that Zika virus infection increases cell death and dysregulates cell-cycle, resulting in attenuated human neural progenitor cells growth. This study fills a major gap and serves as an entry point to establish a mechanistic link between Zika infection and microcephaly.
C1 [Guo, Jia] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.
RP Guo, J (reprint author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.
EM jguo3@gmu.edu
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
NR 6
TC 1
Z9 1
U1 8
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD APR 26
PY 2016
VL 6
AR 28
DI 10.1186/s13578-016-0096-4
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DK2EP
UT WOS:000374727700001
PM 27119012
ER

PT J
AU Dasgupta, S
   Reagan-Steiner, S
   Goodenough, D
   Russell, K
   Tanner, M
   Lewis, L
   Petersen, EE
   Powers, AM
   Kniss, K
   Meaney-Delman, D
   Oduyebo, T
   O'Leary, D
   Chiu, S
   Talley, P
   Hennessey, M
   Hills, S
   Cohn, A
   Gregory, C
AF Dasgupta, Sharoda
   Reagan-Steiner, Sarah
   Goodenough, Dana
   Russell, Kate
   Tanner, Mary
   Lewis, Lillianne
   Petersen, Emily E.
   Powers, Ann M.
   Kniss, Krista
   Meaney-Delman, Dana
   Oduyebo, Titilope
   O'Leary, Dan
   Chiu, Sophia
   Talley, Pamela
   Hennessey, Morgan
   Hills, Susan
   Cohn, Amanda
   Gregory, Christopher
CA Zika Virus Response Epidemiology L
TI Patterns in Zika Virus Testing and Infection, by Report of Symptoms and
   Pregnancy Status - United States, January 3-March 5, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID REPRODUCTIVE AGE; EXPOSURE; WOMEN; BRAIN
C1 [Dasgupta, Sharoda; Russell, Kate; Tanner, Mary; Lewis, Lillianne; Oduyebo, Titilope; Chiu, Sophia; Talley, Pamela; Hennessey, Morgan] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Dasgupta, Sharoda; Tanner, Mary] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Reagan-Steiner, Sarah] CDC, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Goodenough, Dana] CDC, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Russell, Kate; Kniss, Krista] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Lewis, Lillianne] CDC, Natl Ctr Environm Hlth, Div Environm Hazards & Hlth Effects, Atlanta, GA 30333 USA.
   [Petersen, Emily E.; Oduyebo, Titilope] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Powers, Ann M.; Hennessey, Morgan; Hills, Susan] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [O'Leary, Dan] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Chiu, Sophia] NIOSH, Div Surveillance Hazard Evaluat & Field Studies, Washington, DC USA.
   [Talley, Pamela] Minnesota Dept Hlth, Minneapolis, MN 55414 USA.
   [Cohn, Amanda] CDC, Off Director, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Gregory, Christopher] CDC, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA 30333 USA.
RP Reagan-Steiner, S (reprint author), CDC, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
EM sor1@cdc.gov
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   CDC, 2016, AR WITH ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rasmussen SA, 2016, N ENGL J MED
NR 10
TC 1
Z9 1
U1 10
U2 10
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 22
PY 2016
VL 65
IS 15
BP 395
EP 399
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK0WT
UT WOS:000374633600003
PM 27101541
ER

PT J
AU Sirohi, D
   Chen, ZG
   Sun, L
   Klose, T
   Pierson, TC
   Rossmann, MG
   Kuhn, RJ
AF Sirohi, Devika
   Chen, Zhenguo
   Sun, Lei
   Klose, Thomas
   Pierson, Theodore C.
   Rossmann, Michael G.
   Kuhn, Richard J.
TI The 3.8 angstrom resolution cryo-EM structure of Zika virus
SO SCIENCE
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; TRANSMISSION; MATURATION; MICRONESIA;
   INFECTION; COMPLEX; BRAZIL
AB The recent rapid spread of Zika virus and its unexpected linkage to birth defects and an autoimmune neurological syndrome have generated worldwide concern. Zika virus is a flavivirus like the dengue, yellow fever, and West Nile viruses. We present the 3.8 angstrom resolution structure of mature Zika virus, determined by cryo-electron microscopy (cryo-EM). The structure of Zika virus is similar to other known flavivirus structures, except for the similar to 10 amino acids that surround the Asn(154) glycosylation site in each of the 180 envelope glycoproteins that make up the icosahedral shell. The carbohydrate moiety associated with this residue, which is recognizable in the cryo-EM electron density, may function as an attachment site of the virus to host cells. This region varies not only among Zika virus strains but also in other flaviviruses, which suggests that differences in this region may influence virus transmission and disease.
C1 [Sirohi, Devika; Chen, Zhenguo; Sun, Lei; Klose, Thomas; Rossmann, Michael G.; Kuhn, Richard J.] Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.
   [Sirohi, Devika; Chen, Zhenguo; Sun, Lei; Klose, Thomas; Rossmann, Michael G.; Kuhn, Richard J.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
   [Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Rossmann, MG; Kuhn, RJ (reprint author), Purdue Univ, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.; Rossmann, MG; Kuhn, RJ (reprint author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
EM mr@purdue.edu; kuhnr@purdue.edu
FU National Institute of Allergy and Infectious Diseases of the NIH
   [R01AI073755, R01AI076331]; National Institute of Allergy and Infectious
   Diseases
FX We thank X. de Lamballerie (Emergence des Pathologies Virales,
   Aix-Marseille Universite, Marseille, France) and the European Virus
   Archive Goes Global (EVAg) for consenting to the use of the H/PF/2013
   ZIKV strain for this study under a material transfer agreement with
   EVAg's partner, Aix-Marseille Universite, and we thank M. S. Diamond
   (Washington University, St. Louis, MO, USA) for sending the virus. We
   acknowledge E. Frye for help with sequence alignments. We also
   acknowledge the use of the Purdue cryo-EM facility. We are grateful to
   W. Jiang for his jspr program, which was used to perform the anisotropic
   magnification corrections, and Y. Liu for providing help in submitting
   the Protein Data Bank (PDB) coordinates. The work presented in this
   report was funded by the National Institute of Allergy and Infectious
   Diseases of the NIH through grants R01AI073755 and R01AI076331 to M.G.R.
   and R.J.K. T.C.P was supported by the intramural program of the National
   Institute of Allergy and Infectious Diseases. Supporting information for
   this research is provided in the supplementary materials. The atomic
   coordinates and cryo-EM density maps for the mature ZIKV are available
   at the PDB and Electron Microscopy Data Bank under accession codes 5IRE
   and EMD-8116, respectively.
CR Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS ZIK VIR
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Guo F., 2013, METHOD MOL BIOL, V1117, P401
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   World Health Organization, 2016, ZIK STRAT RESP FRAM
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 36
TC 19
Z9 21
U1 29
U2 29
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 22
PY 2016
VL 352
IS 6284
BP 467
EP 470
DI 10.1126/science.aaf5316
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ8RH
UT WOS:000374479700049
PM 27033547
ER

PT J
AU Roze, B
   Najioullah, F
   Signate, A
   Apetse, K
   Brouste, Y
   Gourgoudou, S
   Fagour, L
   Abel, S
   Hochedez, P
   Cesaire, R
   Cabie, A
AF Roze, B.
   Najioullah, F.
   Signate, A.
   Apetse, K.
   Brouste, Y.
   Gourgoudou, S.
   Fagour, L.
   Abel, S.
   Hochedez, P.
   Cesaire, R.
   Cabie, A.
CA Neuro-Zika Working Grp Martinique
TI Zika virus detection in cerebrospinal fluid from two patients with
   encephalopathy, Martinique, February 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID DENGUE
AB We report two cases of encephalopathy (one with seizures, one with electroencephalogram changes) in patients with Zika virus infection. The cases occurred on Martinique in February 2016, during the Zika virus outbreak. Awareness of the various neurological complications of Zika virus infection is needed for patients living in areas affected by Zika virus infections or for travellers to these areas.
C1 [Roze, B.; Abel, S.; Hochedez, P.; Cabie, A.] Univ Hosp Martin, Infect & Trop Dis Dept, Fort De France, France.
   [Najioullah, F.; Fagour, L.; Cesaire, R.] Univ Hosp Martin, Virol Lab, Fort De France, France.
   [Najioullah, F.; Abel, S.; Hochedez, P.; Cabie, A.] Univ Antilles, EA4537, Fort De France, France.
   [Signate, A.] Univ Hosp Martin, Dept Neurol, Fort De France, France.
   [Apetse, K.] Univ Hosp Martin, Electrophysiol Dept, Fort De France, France.
   [Brouste, Y.; Gourgoudou, S.] Univ Hosp Martin, Emergency Dept, Fort De France, France.
   [Cabie, A.] INSERM CIC1424, Fort De France, France.
RP Roze, B (reprint author), Univ Hosp Martin, Infect & Trop Dis Dept, Fort De France, France.
EM benoit.roze@chu-fortdefrance.fr
FU University Hospital of Martinique; Clinical Research Hospital Program
   from the French Ministry of Health [PHRC 2009]
FX This work was sponsored by the University Hospital of Martinique for
   regulatory and ethic submission.; This work was supported by a grant
   from the Clinical Research Hospital Program from the French Ministry of
   Health (PHRC 2009).
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Antilles Guyane CIRE, 2016, CIRE ANTILLES GUYANE, V12, P1
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Mathew S, 2010, J STROKE CEREBROVASC, V19, P253, DOI 10.1016/j.jstrokecerebrovasdis.2009.05.003
   Pan American Health Organization / World Health Organization, 2016, ZIK EP UPD 14 APR 20
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Wasay M, 2015, NEUROLOGY, V84, P421, DOI 10.1212/WNL.0000000000001177
NR 7
TC 0
Z9 0
U1 4
U2 4
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 21
PY 2016
VL 21
IS 16
BP 5
EP 8
AR 30205
DI 10.2807/1560-7917.ES.2016.21.16.30205
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DK3QZ
UT WOS:000374833800002
ER

PT J
AU Huzly, D
   Hanselmann, I
   Schmidt-Chanasit, J
   Panning, M
AF Huzly, D.
   Hanselmann, I.
   Schmidt-Chanasit, J.
   Panning, M.
TI High specificity of a novel Zika virus ELISA in European patients after
   exposure to different flaviviruses
SO EUROSURVEILLANCE
LA English
DT Article
ID REACTIVITY; SEROLOGY
AB The current Zika virus (ZIKV) epidemic in the Americas caused an increase in diagnostic requests in European countries. Here we demonstrate high specificity of the Euroimmun anti-ZIKV IgG and IgM ELISA tests using putative cross-reacting sera of European patients with antibodies against tick-borne encephalitis virus, dengue virus, yellow fever virus and hepatitis C virus. This test may aid in counselling European travellers returning from regions where ZIKV is endemic.
C1 [Huzly, D.; Hanselmann, I.; Panning, M.] Univ Freiburg, Med Ctr, Inst Virol, Freiburg, Germany.
   [Schmidt-Chanasit, J.] Natl Reference Ctr Trop Infect Dis, Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Hamburg, Germany.
   [Schmidt-Chanasit, J.] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
RP Panning, M (reprint author), Univ Freiburg, Med Ctr, Inst Virol, Freiburg, Germany.
EM marcus.panning@uniklinik-freiburg.de
RI Panning, Marcus/I-7889-2016
CR Alidjinou EK, 2016, J CLIN VIROL, V75, P60, DOI 10.1016/j.jcv.2015.11.025
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   European Centre for Disease Prevention and Control (ECDC), ZIK VIR INF FACT SHE
   [Anonymous], ZIK VIR INF SHORT FA
   Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reusken C, 2013, EUROSURVEILLANCE, V18, P2
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Venturi G, 2016, EUROSURVEILLANCE, V21, P30163, DOI [10.2807/1560-7917.ES.2016.21.10.30163, DOI 10.2807/1560-7917.ES.2016.21.10.30163]
   Vorou R, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.10.30161, DOI 10.2807/1560-7917.ES.2016.21.10.30161]
NR 13
TC 5
Z9 5
U1 12
U2 12
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 21
PY 2016
VL 21
IS 16
BP 9
EP 12
AR 30203
DI 10.2807/1560-7917.ES.2016.21.16.30203
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DK3QZ
UT WOS:000374833800003
ER

PT J
AU Mouchtouri, VA
   Hadjichristodoulou, C
AF Mouchtouri, V. A.
   Hadjichristodoulou, C.
TI European Union SHIPSAN ACT Joint Action publishes interim guidance on
   maritime transport and Zika virus disease
SO EUROSURVEILLANCE
LA English
DT News Item
C1 [Mouchtouri, V. A.; Hadjichristodoulou, C.] Univ Thessaly, European Union SHIPSAN ACT Joint Action, Larisa, Greece.
   [Mouchtouri, V. A.; Hadjichristodoulou, C.] Univ Thessaly, Dept Hyg & Epidemiol, Larisa, Greece.
RP Mouchtouri, VA (reprint author), Univ Thessaly, European Union SHIPSAN ACT Joint Action, Larisa, Greece.; Mouchtouri, VA (reprint author), Univ Thessaly, Dept Hyg & Epidemiol, Larisa, Greece.
EM mouchtourib@med.uth.gr
CR European Centre for Disease Prevention and Control (ECDC), ZIK VIR INF
   World Health Organization (WHO), 2016, WHO 2 M IHR EM COMM
   WHO, 2008, INT HLTH REG
NR 3
TC 0
Z9 0
U1 4
U2 4
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 21
PY 2016
VL 21
IS 16
BP 61
EP 61
DI 10.2807/1560-7917.ES.2016.21.16.30207
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DK3QZ
UT WOS:000374833800009
ER

PT J
AU Broutet, N
   Krauer, F
   Riesen, M
   Khalakdina, A
   Almiron, M
   Aldighieri, S
   Espinal, M
   Low, N
   Dye, C
AF Broutet, Nathalie
   Krauer, Fabienne
   Riesen, Maurane
   Khalakdina, Asheena
   Almiron, Maria
   Aldighieri, Sylvain
   Espinal, Marcos
   Low, Nicola
   Dye, Christopher
TI Zika Virus as a Cause of Neurologic Disorders
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
C1 [Broutet, Nathalie; Khalakdina, Asheena; Dye, Christopher] WHO, CH-1211 Geneva, Switzerland.
   [Krauer, Fabienne; Riesen, Maurane; Dye, Christopher] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
   [Almiron, Maria; Aldighieri, Sylvain; Espinal, Marcos] Pan Amer Hlth Org, Washington, DC USA.
RP Broutet, N (reprint author), WHO, CH-1211 Geneva, Switzerland.
CR Cao-Lormeau VM, 2016, LANCET
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204
   Vandenbroucke JP, 2001, ANN INTERN MED, V134, P330
   [Anonymous], 2016, ZIK VIR POT COMPL
NR 5
TC 12
Z9 13
U1 17
U2 17
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 21
PY 2016
VL 374
IS 16
BP 1506
EP 1509
DI 10.1056/NEJMp1602708
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7IA
UT WOS:000374383900003
PM 26959308
ER

PT J
AU Petersen, LR
   Jamieson, DJ
   Powers, AM
   Honein, MA
AF Petersen, Lyle R.
   Jamieson, Denise J.
   Powers, Ann M.
   Honein, Margaret A.
TI Zika Virus
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Review
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; BRAIN DISRUPTION SEQUENCE; UPDATE
   INTERIM GUIDELINES; TREATED HOUSE SCREENS; UNITED-STATES; DENGUE
   VIRUSES; MATERNAL RUBELLA; AEDES-AEGYPTI; PUERTO-RICO; TRANSMISSION
AB IN 1947, A STUDY OF YELLOW FEVER YIELDED THE FIRST ISOLATION OF A NEW virus, from the blood of a sentinel rhesus macaque that had been placed in the Zika Forest of Uganda.(1) Zika virus remained in relative obscurity for nearly 70 years; then, within the span of just 1 year, Zika virus was introduced into Brazil from the Pacific Islands and spread rapidly throughout the Americas.(2) It became the first major infectious disease linked to human birth defects to be discovered in more than half a century and created such global alarm that the World Health Organization (WHO) would declare a Public Health Emergency of International Concern.(3) This review describes the current understanding of the epidemiology, transmission, clinical characteristics, and diagnosis of Zika virus infection, as well as the future outlook with regard to this disease.
C1 [Petersen, Lyle R.; Powers, Ann M.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Ft Collins, CO USA.
   [Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA.
   [Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA USA.
RP Petersen, LR (reprint author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM lxp2@cdc.gov
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Atkinson B HP, 2016, EMERG INFECT DIS
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Besnard M, 2014, EURO SURVEILL, V19
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664
   Den Hollander NS, 2000, ULTRASOUND OBST GYN, V15, P282, DOI 10.1046/j.1469-0705.2000.00092.x
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824., DOI 10.1056/NEJMOA1601824, 10.1056/NEJMoa1601824]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dupont-Rouzeyrol M., 2016, LANCET
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foulon I, 2012, INT J PEDIATR OTORHI, V76, P712, DOI 10.1016/j.ijporl.2012.02.026
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   de Paula Freitas B, 2016, JAMA OPHTHALMOL 0209
   Gabis L, 1997, J PERINAT MED, V25, P213
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gulland A, 2016, BMJ-BRIT MED J, V352, pi657
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [10.1371/journal.pntd.0001477.22389730, DOI 10.1371/JOURNAL.PNTD.0001477.22389730]
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Jouannic JM, 2016, LANCET
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/50140-6736(16)00502-X]
   Korhonen EM, 2016, EURO SURVEILL, V21
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciott RS, 2016, EMERG INFEC IN PRESS
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leibovitz Z, 2015, ULTRASOUND OBSTET GY, V116
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet H-P, 2015, BILAN EPIDEMIE VIRUS
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   Mansuy JMDM, 2016, LANCET INFECT DIS
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Mecharles S., 2016, LANCET
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER E, 1982, LANCET, V2, P781
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x
   Monaghan AJ, 2016, PLOS CURR
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Morens DM, 2010, EMERG INFECT DIS, V16, P1023, DOI 10.3201/eid1606.100453
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   National Birth Defects Prevention Network, 2013, MAJ BIRTH DEF DAT PO
   Oehler E, 2014, EURO SURVEILL, P19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   PECKHAM CS, 1972, ARCH DIS CHILD, V47, P571
   Perkasa A, 2016, EMERG INFEC IN PRESS
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Rasmussen SA, 1990, DYSMORPHOL CLIN GENE, V4, P53
   Reddy UM, 2014, AM J OBSTET GYNECOL, V210, P387, DOI 10.1016/j.ajog.2014.02.028
   Reefhuis J, 2016, EMERG INFEC IN PRESS
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   RORKE LB, 1973, ARCH OTOLARYNGOL, V98, P249
   Roth A., 2014, EURO SURVEILL, V19
   Roze B, 2016, EURO SURVEILL, V21
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Tappe D, 2014, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EURO SURVEILL, V21
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Webster WS, 1998, TERATOLOGY, V58, P13
   WELLER TH, 1962, NEW ENGL J MED, V266, P1233, DOI 10.1056/NEJM196206142662401
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P609
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P154
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P34
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P159
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P242
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P182
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P55
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P211
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P122
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P215
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P59
NR 136
TC 41
Z9 41
U1 56
U2 56
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 21
PY 2016
VL 374
IS 16
BP 1552
EP 1563
DI 10.1056/NEJMra1602113
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7IA
UT WOS:000374383900008
PM 27028561
ER

PT J
AU Carteaux, G
   Maquart, M
   Bedet, A
   Contou, D
   Brugieres, P
   Fourati, S
   de Langavant, LC
   de Broucker, T
   Brun-Buisson, C
   Leparc-Goffart, I
   Dessap, AM
AF Carteaux, Guillaume
   Maquart, Marianne
   Bedet, Alexandre
   Contou, Damien
   Brugieres, Pierre
   Fourati, Slim
   de Langavant, Laurent Cleret
   de Broucker, Thomas
   Brun-Buisson, Christian
   Leparc-Goffart, Isabelle
   Dessap, Armand Mekontso
TI Zika Virus Associated with Meningoencephalitis
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Carteaux, Guillaume; Bedet, Alexandre; Contou, Damien; Brugieres, Pierre; Fourati, Slim; de Langavant, Laurent Cleret; Brun-Buisson, Christian] AP HP, Creteil, France.
   [Maquart, Marianne; Leparc-Goffart, Isabelle] French Armed Forces Biomed Res Inst, Marseille, France.
   [de Broucker, Thomas] Ctr Hosp St Denis, St Denis, France.
   [Dessap, Armand Mekontso] Univ Paris Est Creteil, Creteil, France.
RP Carteaux, G (reprint author), AP HP, Creteil, France.
EM guillaume.carteaux@yahoo.fr
CR Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E, 2014, EURO SURVEILL, P19
   [Anonymous], 2016, LAT ZIK VIR SIT REP
NR 5
TC 16
Z9 17
U1 7
U2 7
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 21
PY 2016
VL 374
IS 16
BP 1595
EP 1597
DI 10.1056/NEJMc1602964
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7IA
UT WOS:000374383900031
PM 26958738
ER

PT J
AU Gyawali, N
   Bradbury, RS
   Taylor-Robinson, AW
AF Gyawali, Narayan
   Bradbury, Richard S.
   Taylor-Robinson, Andrew W.
TI The global spread of Zika virus: is public and media concern justified
   in regions currently unaffected?
SO INFECTIOUS DISEASES OF POVERTY
LA English
DT Article
DE Zika; Flavivirus; Arbovirus; Mosquito; Aedes; Transmission; Vector
   control; Diagnosis; Treatment; Epidemic
ID AEDES-AEGYPTI; TRANSMISSION; MICRONESIA; AUSTRALIA; INDONESIA;
   MOSQUITOS; SINGAPORE; EPIDEMIC; OUTBREAK; VECTOR
AB Background: Zika virus, an Aedes mosquito-borne flavivirus, is fast becoming a worldwide public health concern following its suspected association with over 4000 recent cases of microcephaly among newborn infants in Brazil.
   Discussion: Prior to its emergence in Latin America in 2015-2016, Zika was known to exist at a relatively low prevalence in parts of Africa, Asia and the Pacific islands. An extension of its apparent global dispersion may be enabled by climate conditions suitable to support the population growth of A. aegypti and A. albopictus mosquitoes over an expanding geographical range. In addition, increased globalisation continues to pose a risk for the spread of infection. Further, suspicions of alternative modes of virus transmission (sexual and vertical), if proven, provide a platform for outbreaks in mosquito non-endemic regions as well. Since a vaccine or anti-viral therapy is not yet available, current means of disease prevention involve protection from mosquito bites, excluding pregnant females from travelling to Zika-endemic territories, and practicing safe sex in those countries. Importantly, in countries where Zika is reported as endemic, caution is advised in planning to conceive a baby until such time as the apparent association between infection with the virus and microcephaly is either confirmed or refuted. The question arises as to what advice is appropriate to give in more economically developed countries distant to the current epidemic and in which Zika has not yet been reported.
   Summary: Despite understandable concern among the general public that has been fuelled by the media, in regions where Zika is not present, such as North America, Europe and Australia, at this time any outbreak (initiated by an infected traveler returning from an endemic area) would very probably be contained locally. Since Aedes spp. has very limited spatial dispersal, overlapping high population densities of mosquitoes and humans would be needed to sustain a focus of infection. However, as A. aegypti is distinctly anthropophilic, future control strategies for Zika should be considered in tandem with the continuing threat to human wellbeing that is presented by dengue, yellow fever and Japanese encephalitis, all of which are transmitted by the same vector species.
C1 [Gyawali, Narayan; Bradbury, Richard S.; Taylor-Robinson, Andrew W.] Cent Queensland Univ, Sch Med & Appl Sci, Infect Dis Res Grp, Rockhampton, Qld 4702, Australia.
RP Taylor-Robinson, AW (reprint author), Cent Queensland Univ, Sch Med & Appl Sci, Infect Dis Res Grp, Rockhampton, Qld 4702, Australia.
EM a.taylor-robinson@cqu.edu.au
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   Center for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, 2016, ZIK VIR WHAT CDC IS
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahalingam S, 2016, CONVERSATION
   Marano G, 2015, BLOOD TRANSFUS, V5, P1, DOI DOI 10.2450/2015.0066-15.[
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Muir LE, 1998, AM J TROP MED HYG, V58, P277
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   PAHO/WHO, 2016, ZIK VIR INF
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pierson TC, 2013, FIELDS VIROLOGY, V1, P746
   Siettos CI, 2013, VIRULENCE, V4, P295, DOI 10.4161/viru.24041
   Tappe D, 2014, EURO SURVEILL, V19
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Vogel G, 2016, ZIKA VIRUS YOUR QUES
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   WHO, 2012, HDB INT VECT MAN
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2016, WHO DIRECTOR GEN SUM
   [Anonymous], 2016, TELEGRAPH
NR 45
TC 0
Z9 0
U1 10
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2049-9957
J9 INFECT DIS POVERTY
JI Infect. Dis. Poverty
PD APR 19
PY 2016
VL 5
AR 37
DI 10.1186/s40249-016-0132-y
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DS8MN
UT WOS:000381037600001
PM 27093860
ER

PT J
AU Messina, JP
   Kraemer, MUG
   Brady, OJ
   Pigott, DM
   Shearer, FM
   Weiss, DJ
   Golding, N
   Ruktanonchar, CW
   Gething, PW
   Cohn, E
   Brownstein, JS
   Khan, K
   Tatem, AJ
   Jaenisch, T
   Murray, CJL
   Marinho, F
   Scott, TW
   Hay, SI
AF Messina, Jane P.
   Kraemer, Moritz U. G.
   Brady, Oliver J.
   Pigott, David M.
   Shearer, Freya M.
   Weiss, Daniel J.
   Golding, Nick
   Ruktanonchar, Corrine W.
   Gething, Peter W.
   Cohn, Emily
   Brownstein, John S.
   Khan, Kamran
   Tatem, Andrew J.
   Jaenisch, Thomas
   Murray, Christopher J. L.
   Marinho, Fatima
   Scott, Thomas W.
   Hay, Simon I.
TI Mapping global environmental suitability for Zika virus
SO ELIFE
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; SPECIES DISTRIBUTION MODELS; DENGUE-FEVER;
   HEMORRHAGIC-FEVER; ZOONOTIC NICHE; TRANSMISSION; CLIMATE; SURVIVAL;
   TEMPERATURE; ALBOPICTUS
AB Zika virus was discovered in Uganda in 1947 and is transmitted by Aedes mosquitoes, which also act as vectors for dengue and chikungunya viruses throughout much of the tropical world. In 2007, an outbreak in the Federated States of Micronesia sparked public health concern. In 2013, the virus began to spread across other parts of Oceania and in 2015, a large outbreak in Latin America began in Brazil. Possible associations with microcephaly and Guillain-Barre syndrome observed in this outbreak have raised concerns about continued global spread of Zika virus, prompting its declaration as a Public Health Emergency of International Concern by the World Health Organization. We conducted species distribution modelling to map environmental suitability for Zika. We show a large portion of tropical and sub-tropical regions globally have suitable environmental conditions with over 2.17 billion people inhabiting these areas.
C1 [Messina, Jane P.; Kraemer, Moritz U. G.; Weiss, Daniel J.; Gething, Peter W.] Univ Oxford, Dept Zool, Oxford, England.
   [Brady, Oliver J.; Pigott, David M.; Shearer, Freya M.; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Pigott, David M.; Murray, Christopher J. L.; Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Golding, Nick] Univ Melbourne, Dept BioSci, Parkville, Vic, Australia.
   [Ruktanonchar, Corrine W.; Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, VorldPop Project, Southampton, Hants, England.
   [Cohn, Emily; Brownstein, John S.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA.
   [Khan, Kamran] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Tatem, Andrew J.] Flowminder Fdn, Stockholm, Sweden.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
   [Jaenisch, Thomas] German Ctr Infect Res DZIF, Heidelberg Partner Site, Heidelberg, Germany.
   [Marinho, Fatima] Minist Hlth Brazil, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
RP Messina, JP (reprint author), Univ Oxford, Dept Zool, Oxford, England.; Hay, SI (reprint author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.; Hay, SI (reprint author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
EM jane.messina@zoo.ox.ac.uk; sihay@uw.edu
FU European Commission [21893]; Bill and Melinda Gates Foundation
   [OPP1053338, OPP1119467, OPP1106023, OPP1093011, OPP1081737,
   OPP1068048]; Wellcome Trust [095066]; University of Southampton;
   National Institutes of Health [P01AI098670]; University of Melbourne;
   McKenzie fellowship; Economic and Social Research Council's Doctoral
   Training Centre
FX European Commission 21893 Jane P Messina Moritz UG Kraemer Thomas
   Jaenisch; Bill and Melinda Gates Foundation OPP1053338; OPP1119467;
   OPP1106023; OPP1093011; OPP1081737; OPP1068048 Oliver J Brady David M
   Pigott Daniel J Weiss Thomas W Scott Simon I Hay; Wellcome Trust 095066
   Simon I Hay; University of Southampton Economic and Social Research
   Council's Doctoral Training Centre Corrine W Ruktanonchai; National
   Institutes of Health P01AI098670 Thomas W Scott; University of Melbourne
   McKenzie fellowship Nick Golding
CR Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010
   Arino O., 2008, EUROPEAN SPACE AGENC, V2008, P24
   Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x
   Barrera R, 2006, AM J TROP MED HYG, V74, P290
   Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Lazcano JAB, 2006, REV PANAM SALUD PUBL, V19, P379, DOI 10.1590/S1020-49892006000600003
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Campbell KM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003957
   Chandy S, 2013, INDIAN J MED MICROBI, V31, P283, DOI 10.4103/0255-0857.115640
   Chowell G, 2006, J ENVIRON HEALTH, V68, P40
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Cox J, 2007, AM J TROP MED HYG, V76, P820
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2
   DICK GWA, 1953, BRIT MED BULL, V9, P215
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dom NC, 2013, GEOCARTO INT, V28, P258, DOI 10.1080/10106049.2012.696726
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faria NR, 2016, SCIENCE, V352, DOI [10.1126/science.aaf5036, DOI 10.1126/SCIENCE.AAF5036]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [10.1371/journal.pntd.0002681, DOI 10.1371/JOURNAL.PNTD.0002681]
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7
   Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   International Committee on Taxonomy of Viruses (ICTV), 2014, VIR TAX 2014 REL
   Jones PG, 2000, AGRON J, V92, P445
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MU, 2015, SCI DATA, V2, DOI [DOI 10.1038/SDATA.2015.35, 10.1038/sdata.2015.35]
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103/141662, 10.3201/eid2103.141662]
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lin QH, 2012, 5 INT C IM SIGN PROC, P1043, DOI [10.1109/cisp.2012.6470008, DOI 10.1109/CISP.2012.6470008]
   LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3
   Linard C, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-7
   Linard C, 2013, APPL GEOGR, V44, P23, DOI 10.1016/j.apgeog.2013.07.009
   Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397
   Luz C, 2008, MEM I OSWALDO CRUZ, V103, P214, DOI 10.1590/S0074-02762008000200016
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI [10.1111/1469-0691.12707, DOI 10.1111/1469-0691.12707]
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Messina JP, 2015, T ROY SOC TROP MED H, V109, P503, DOI 10.1093/trstmh/trv050
   Messina JP, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.16
   Messina JP, 2014, SCI DATA, V1, DOI [10.1038/sdata.2014.4, DOI 10.1038/SDATA.2014.4]
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Mylne AQN, 2015, T ROY SOC TROP MED H, V109, P483, DOI 10.1093/trstmh/trv047
   Nelson A., 2008, TRAVEL TIME MAJOR CI
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Pigott DM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003756
   Pigott DM, 2014, ELIFE, V3, DOI 10.7554/eLife.02851
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Pinto E, 2011, INT J ENVIRON HEAL R, V21, P415, DOI 10.1080/09603123.2011.572279
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755
   Sankari T, 2012, INDIAN J MED RES, V136, P649
   Schneider A, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034002
   Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003
   Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   Socio-economic Data andn Applications Center, 2015, GRIDD POP WORLD V4 G
   Sorichetta A., 2015, SCI DATA, V2015, P2, DOI [10.1038/sdata.2015.45, DOI 10.1038/SDATA.2015.45]
   SOTA T, 1992, OECOLOGIA, V90, P353, DOI 10.1007/BF00317691
   Smithburn K., 1954, AM J HYG, V59, P157
   Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280
   Trpis M., 1972, B WHO, V47
   Troyo A, 2009, SINGAPORE J TROP GEO, V30, P265, DOI 10.1111/j.1467-9493.2009.00367.x
   UN, 2014, WORLD URB PROSP 2014
   UNFPA International Confederation of Midwives WHO, 2014, STAT WORLDS MIDW 201
   Wan ZM, 2002, INT GEOSCI REMOTE SE, P3683, DOI [10.1109/igarss.2002.1027290, DOI 10.1109/IGARSS.2002.1027290]
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weiss DJ, 2014, ISPRS J PHOTOGRAMM, V98, P106, DOI 10.1016/j.isprsjprs.2014.10.001
   Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x
   World Health Organisation, 2015, ZIK VIR INF BRAZ COL
   Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354
   WorldPop, 2015, HIGH RES AG STRUCT P
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 1999, WHO COLL CTR REF RES, P143
NR 114
TC 7
Z9 7
U1 9
U2 9
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD APR 19
PY 2016
VL 5
AR e15272
DI 10.7554/eLife.15272
PG 19
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DS0LQ
UT WOS:000380287500001
ER

PT J
AU Bullerdiek, J
   Dotzauer, A
   Bauer, I
AF Bullerdiek, Joern
   Dotzauer, Andreas
   Bauer, Ingrid
TI The mitotic spindle: linking teratogenic effects of Zika virus with
   human genetics?
SO MOLECULAR CYTOGENETICS
LA English
DT Article
DE Zika virus; Microcephaly; Chorioretinopathy; Mechanisms; Syndromes;
   Genetics; Phenocopy
ID NEURONAL DEVELOPMENT; MUTATIONS; INFECTION; EG5; CHORIORETINOPATHY;
   ASSOCIATION; LYMPHEDEMA; CHECKPOINT; BRAZIL; CELLS
AB Background: Recently, an association between Zika virus infection and microcephaly/ocular findings was found to be reasonable e.g. because of the demonstration that the virus was found in the brain of a fetus after presumed maternal infection. Although there is no proof yet for a causal relationship, for an appropriate risk calculation efforts are urgently needed to either establish or disprove this assumption.
   Presentation of the hypothesis: On the basis of inherited syndromes combining microcephaly with ocular findings similar to those associated with Zika infections, we have hypothesized that the impairment of the proper function of the mitotic apparatus is a possible mechanism by which Zika can exert teratogenic effects.
   Testing the hypothesis: A bundle of well-known cytogenetic and molecular-cytogenetic methods (e.g. formation of micronuclei, chromosomal lagging, immunofluorescence of centrosomes) to evaluate proper function, maintenance, and establishment of the mitotic spindle poles can be applied on infected cells. Also, the viral proteins can be tested for their possible interaction with proteins encoded by genes involved in inherited syndromes with microcephaly and ocular findings resembling those in presumed cases of intrauterine ZIKV infection.
   Implications of the hypothesis: Once proved, this hypothesis allows for a targeted approach into mechanisms of possible relevance as e.g. if different strains of the virus are implicated in the teratogenic effects to the same or a different extent.
C1 [Bullerdiek, Joern] Univ Bremen, Ctr Human Genet, Leobener Str ZHG, D-28359 Bremen, Germany.
   [Bullerdiek, Joern] Univ Rostock, Med Ctr, Inst Med Genet, Ernst Heydemann Str 8, D-18057 Rostock, Germany.
   [Dotzauer, Andreas; Bauer, Ingrid] Univ Bremen, Lab Virus Res, Leobener Str UFT 28359, D-28359 Bremen, Germany.
RP Bullerdiek, J (reprint author), Univ Bremen, Ctr Human Genet, Leobener Str ZHG, D-28359 Bremen, Germany.; Bullerdiek, J (reprint author), Univ Rostock, Med Ctr, Inst Med Genet, Ernst Heydemann Str 8, D-18057 Rostock, Germany.
EM bullerd@uni-bremen.de
CR BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   Ferhat L, 1998, J NEUROSCI, V18, P7822
   Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003
   FRYNS JP, 1995, CLIN GENET, V48, P131
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503
   Lecland N, 2014, NAT CELL BIOL, V16, P770, DOI 10.1038/ncb2996
   Liu M, 2014, J PATHOL, V233, P138, DOI 10.1002/path.4333
   Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mirzaa GM, 2014, AM J MED GENET A, V164, P2879, DOI 10.1002/ajmg.a.36707
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018
   Scheidecker S, 2015, AM J HUM GENET, V96, P666, DOI 10.1016/j.ajhg.2015.02.011
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang H, 2016, CELL STEM CELL
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomas JT, 1998, J VIROL, V72, P1131
   Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 23
TC 1
Z9 1
U1 10
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1755-8166
J9 MOL CYTOGENET
JI Mol. Cytogenet.
PD APR 19
PY 2016
VL 9
AR 32
DI 10.1186/s13039-016-0240-1
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA DK2OG
UT WOS:000374753700003
PM 27099632
ER

PT J
AU Barton, MA
   Salvadori, MI
AF Barton, Michelle A.
   Salvadori, Marina I.
TI Zika virus and microcephaly
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT Editorial Material
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; PREGNANT-WOMEN; UNITED-STATES
C1 [Barton, Michelle A.; Salvadori, Marina I.] Univ Western Ontario, Dept Paediat, Div Paediat Infect Dis, London, ON, Canada.
RP Barton, MA (reprint author), Univ Western Ontario, Dept Paediat, Div Paediat Infect Dis, London, ON, Canada.
EM mbartonf@uwo.ca
CR Alarcon A, 2013, J PEDIATR-US, V163, P828, DOI 10.1016/j.jpeds.2013.03.014
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Cauchemez S, 2016, LANCET
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   [Anonymous], DISP RUM ZIK MICR
NR 12
TC 0
Z9 0
U1 15
U2 15
PU CMA-CANADIAN MEDICAL ASSOC
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA
SN 0820-3946
EI 1488-2329
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD APR 19
PY 2016
VL 188
IS 7
BP E118
EP E119
DI 10.1503/cmaj.160179
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK3BQ
UT WOS:000374790500004
PM 27001741
ER

PT J
AU Saiz, JC
   Vazquez-Calvo, A
   Blazquez, AB
   Merino-Ramos, T
   Escribano-Romero, E
   Martin-Acebes, MA
AF Saiz, Juan-Carlos
   Vazquez-Calvo, Angela
   Blazquez, Ana B.
   Merino-Ramos, Teresa
   Escribano-Romero, Estela
   Martin-Acebes, Miguel A.
TI Zika Virus: the Latest Newcomer
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Zika; flavivirus; outbreak; microcephaly; zoonosis
ID WEST-NILE-VIRUS; GUILLAIN-BARRE-SYNDROME; YELLOW-FEVER EPIDEMIC; DENGUE
   VIRUS; FRENCH-POLYNESIA; AEDES-ALBOPICTUS; DECEMBER 2013; 3-DIMENSIONAL
   ARCHITECTURE; ANTIBODY PROPHYLAXIS; ENCEPHALITIS-VIRUS
AB Since the beginning of this century, humanity has been facing a new emerging, or re-emerging, virus threat almost every year: West Nile, Influenza A, avian flu, dengue, Chikungunya, SARS, MERS, Ebola, and now Zika, the latest newcomer. Zika virus (ZIKV), a flavivirus transmitted by Aedes mosquitoes, was identified in 1947 in a sentinel monkey in Uganda, and later on in humans in Nigeria. The virus was mainly confined to the African continent until it was detected in south-east Asia the 1980's, then in the Micronesia in 2007 and, more recently in the Americas in 2014, where it has displayed an explosive spread, as advised by the World Health Organization, which resulted in the infection of hundreds of thousands of people. ZIKV infection was characterized by causing a mild disease presented with fever, headache, rash, arthralgia, and conjunctivitis, with exceptional reports of an association with Guillain Barre syndrome (GBS) and microcephaly. However, since the end of 2015, an increase in the number of GBS associated cases and an astonishing number of microcephaly in fetus and new-borns in Brazil have been related to ZIKV infection, raising serious worldwide public health concerns. Clarifying such worrisome relationships is, thus, a current unavoidable goal. Here, we extensively review what is currently known about ZIKV, from molecular biology, transmission routes, ecology, and epidemiology, to clinical manifestations, pathogenesis, diagnosis, prophylaxis, and public health.
C1 [Saiz, Juan-Carlos; Vazquez-Calvo, Angela; Blazquez, Ana B.; Merino-Ramos, Teresa; Escribano-Romero, Estela; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr Aiimentaria, Dept Biotechnol, Madrid, Spain.
RP Saiz, JC (reprint author), Inst Nacl Invest & Tecnol Agr Aiimentaria, Dept Biotechnol, Madrid, Spain.
EM jcsaiz@inia.es
RI Vazquez-Calvo, Angela/G-8795-2015; Escribano-Romero, Estela/H-1495-2015
OI Vazquez-Calvo, Angela/0000-0003-3172-2762; Escribano-Romero,
   Estela/0000-0002-5036-7607
FU ZIKA-BIO from INIA; MINECO [AGL2014-56518-JIN]; "Formacion de Personal
   Investigador (FPI)" pre-doctoral fellowship from INIA
FX This work was supported by grant ZIKA-BIO from INIA to J-CS, and
   AGL2014-56518-JIN from MINECO to MM-A, AV-C is a recipient of a
   "Contrato de formacion postodoctoral" from MINECO. TM-R is a recipient
   of a "Formacion de Personal Investigador (FPI)" pre-doctoral fellowship
   from INIA.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C., 2014, Genome Announcements, V2, pe00500
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870
   Berthet FX, 1997, J GEN VIROL, V78, P2293
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Blazquez AB, 2015, VIROLOGY, V482, P67, DOI 10.1016/j.virol.2015.03.020
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Dauphin G, 2007, VACCINE, V25, P5563, DOI 10.1016/j.vaccine.2006.12.005
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dominguez-Moreno R, 2014, REV NEUROLOGIA, V58, P4
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I467
   Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. D. M., 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   GOLLINS SW, 1986, J GEN VIROL, V67, P1941, DOI 10.1099/0022-1317-67-9-1941
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P271
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li J, 2006, J GEN VIROL, V87, P613, DOI 10.1099/vir.0.81320-0
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I720
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P113
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Puccioni-Sohler Marzia, 2012, Neurol Int, V4, pe15, DOI 10.4081/ni.2012.e15
   Pupella S, 2013, BLOOD TRANSFUS-ITALY, V11, P563, DOI 10.2450/2013.0077-13
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Roehrig JT, 2001, ANN NY ACAD SCI, V951, P286
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ulbert S, 2014, FUTURE MICROBIOL, V9, P1221, DOI [10.2217/fmb.14.67, 10.2217/FMB.14.67]
   van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc
   Vazquez-Calvo A, 2012, VIRUS RES, V167, P125, DOI 10.1016/j.virusres.2012.05.024
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   VORNDAM V, 1993, J GEN VIROL, V74, P2653, DOI 10.1099/0022-1317-74-12-2653
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Way J H, 1976, J Gen Virol, V30, P123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WINKLER G, 1987, VIROLOGY, V159, P237, DOI 10.1016/0042-6822(87)90460-0
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 156
TC 9
Z9 9
U1 36
U2 36
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 19
PY 2016
VL 7
AR 496
DI 10.3389/fmicb.2016.00496
PG 19
WC Microbiology
SC Microbiology
GA DJ5WJ
UT WOS:000374281200001
PM 27148186
ER

PT J
AU Chen, LH
AF Chen, Lin H.
TI Zika Virus Infection in a Massachusetts Resident After Travel to Costa
   Rica: A Case Report
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Letter
C1 [Chen, Lin H.] Harvard Univ, Sch Med, Mt Auburn Hosp, Cambridge, MA 02138 USA.
   [Chen, Lin H.] GeoSentinel Surveillance Network, Cambridge, MA USA.
RP Chen, LH (reprint author), Harvard Univ, Sch Med, Mt Auburn Hosp, Cambridge, MA 02138 USA.; Chen, LH (reprint author), GeoSentinel Surveillance Network, Cambridge, MA USA.
CR Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P1
NR 5
TC 2
Z9 2
U1 9
U2 9
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD APR 19
PY 2016
VL 164
IS 8
BP 574
EP 576
DI 10.7326/L16-0075
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ5OH
UT WOS:000374257900030
PM 26864175
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Zika Virus May Infect up to 700 000 People in Colombia: Government
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 15
PY 2016
VL 62
IS 8
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DK7EU
UT WOS:000375088500001
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Interim Guidelines for Pregnant Women During a Zika Virus Outbreak
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 15
PY 2016
VL 62
IS 8
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DK7EU
UT WOS:000375088500005
ER

PT J
AU Traynor, K
AF Traynor, Kate
TI Public health officials alarmed at spread of Zika virus
SO AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 15
U2 15
PU AMER SOC HEALTH-SYSTEM PHARMACISTS
PI BETHESDA
PA 7272 WISCONSIN AVE, BETHESDA, MD 20814 USA
SN 1079-2082
EI 1535-2900
J9 AM J HEALTH-SYST PH
JI Am. J. Health-Syst. Pharm.
PD APR 15
PY 2016
VL 73
IS 8
BP 508
EP 509
DI 10.2146/news160023
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DJ5VO
UT WOS:000374278400001
PM 27045056
ER

PT J
AU Baptista, T
   Quaghebeur, G
   Alarcon, A
AF Baptista, Tiago
   Quaghebeur, Gerardine
   Alarcon, Ana
TI Neuroimaging findings of babies with microcephaly and presumed
   congenital Zika virus infection
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [Baptista, Tiago; Quaghebeur, Gerardine] Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford OX3 9DU, England.
   [Alarcon, Ana] Oxford Univ Hosp NHS Fdn Trust, Neonatol Unit, Oxford OX3 9DU, England.
RP Baptista, T (reprint author), Oxford Univ Hosp NHS Fdn Trust, Dept Neuroradiol, Oxford OX3 9DU, England.
EM tiago.baptista@ouh.nhs.uk
CR Doshi P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1847
   Hazin AN, 2016, NEW ENGL J MED, DOI [10.1056/NEJMc1603617, DOI 10.1056/NEJMC1603617]
   Lucey DR, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i781
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Rasmussen SA, 2016, N ENGL J MED
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization-Regional Office for Europe, ZIK VIR VECT RISK SP
NR 8
TC 0
Z9 0
U1 13
U2 13
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 15
PY 2016
VL 353
AR i2194
DI 10.1136/bmj.i2194
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7EV
UT WOS:000374375600012
PM 27083981
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI US agency says Zika virus causes microcephaly
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Doshi P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1847
   Hazin AN, 2016, NEW ENGL J MED, DOI [10.1056/NEJMc1603617, DOI 10.1056/NEJMC1603617]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 4
TC 0
Z9 0
U1 9
U2 9
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 15
PY 2016
VL 353
AR i2167
DI 10.1136/bmj.i2167
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7EV
UT WOS:000374375600008
PM 27083694
ER

PT J
AU Deckard, DT
   Chung, WM
   Brooks, JT
   Smith, JC
   Woldai, S
   Hennessey, M
   Kwit, N
   Mead, P
AF Deckard, D. Trew
   Chung, Wendy M.
   Brooks, John T.
   Smith, Jessica C.
   Woldai, Senait
   Hennessey, Morgan
   Kwit, Natalie
   Mead, Paul
TI Male-to-Male Sexual Transmission of Zika Virus - Texas, January 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
C1 [Deckard, D. Trew] Med Off Steven M Pounders, Dallas, TX USA.
   [Chung, Wendy M.; Smith, Jessica C.; Woldai, Senait] Dallas Cty Hlth & Human Serv, Acute Communicable Dis Epidemiol Div, Dallas, TX 75207 USA.
   [Brooks, John T.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis TB & STD Prevent, Atlanta, GA 30333 USA.
   [Hennessey, Morgan; Kwit, Natalie; Mead, Paul] CDC, Divis Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
   [Hennessey, Morgan; Kwit, Natalie] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
RP Brooks, JT (reprint author), CDC, Div HIV AIDS Prevent, Natl Ctr HIV Hepatitis TB & STD Prevent, Atlanta, GA 30333 USA.
EM zud4@cdc.gov
CR Atkinson BHP, 2016, EMERG INFECT DIS, P22
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 10
TC 13
Z9 13
U1 10
U2 10
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 15
PY 2016
VL 65
IS 14
BP 372
EP 374
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK0WP
UT WOS:000374633200003
PM 27078057
ER

PT J
AU Vasquez, AM
   Sapiano, MRP
   Basavaraju, SV
   Kuehnert, MJ
   Rivera-Garcia, B
AF Vasquez, Amber M.
   Sapiano, Mathew R. P.
   Basavaraju, Sridhar V.
   Kuehnert, Matthew J.
   Rivera-Garcia, Brenda
TI Survey of Blood Collection Centers and Implementation of Guidance for
   Prevention of Transfusion-Transmitted Zika Virus Infection - Puerto
   Rico, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
ID TRANSMISSION; OUTBREAK
C1 [Vasquez, Amber M.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Vasquez, Amber M.; Sapiano, Mathew R. P.; Basavaraju, Sridhar V.; Kuehnert, Matthew J.] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR 00936 USA.
RP Vasquez, AM (reprint author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Vasquez, AM (reprint author), CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM avasquez@cdc.gov
CR Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   CDC, 2016, ZIK VIR TRANSM RISKS
   Chung KW, 2016, TRANSFUSION IN PRESS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Reuters, 2016, REUTERS         0204
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   US Department of Health and Human Services, 2016, HHS SHIPS BLOOD PROD
NR 9
TC 3
Z9 3
U1 16
U2 16
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 15
PY 2016
VL 65
IS 14
BP 375
EP 378
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK0WP
UT WOS:000374633200004
PM 27078190
ER

PT J
AU Faria, NR
   Azevedo, RDD
   Kraemer, MUG
   Souza, R
   Cunha, MS
   Hill, SC
   Theze, J
   Bonsall, MB
   Bowden, TA
   Rissanen, I
   Rocco, IM
   Nogueira, JS
   Maeda, AY
   Vasami, FGD
   Macedo, FLD
   Suzuki, A
   Rodrigues, SG
   Cruz, ACR
   Nunes, BT
   Medeiros, DBD
   Rodrigues, DSG
   Queiroz, ALN
   da Silva, EVP
   Henriques, DF
   da Rosa, EST
   de Oliveira, CS
   Martins, LC
   Vasconcelos, HB
   Casseb, LMN
   Simith, DD
   Messina, JP
   Abade, L
   Loureno, J
   Alcantara, LCJ
   de Lima, MM
   Giovanetti, M
   Hay, SI
   de Oliveira, RS
   Lemos, PD
   de Oliveira, LF
   de Lima, CPS
   da Silva, SP
   de Vasconcelos, JM
   Franco, L
   Cardoso, JF
   Vianez, JLDG
   Mir, D
   Bello, G
   Delatorre, E
   Khan, K
   Creatore, M
   Coelho, GE
   de Oliveira, WK
   Tesh, R
   Pybus, OG
   Nunes, MRT
   Vasconcelos, PFC
AF Faria, Nuno Rodrigues
   da Silva Azevedo, Raimunda do Socorro
   Kraemer, Moritz U. G.
   Souza, Renato
   Cunha, Mariana Sequetin
   Hill, Sarah C.
   Theze, Julien
   Bonsall, Michael B.
   Bowden, Thomas A.
   Rissanen, Ilona
   Rocco, Iray Maria
   Nogueira, Juliana Silva
   Maeda, Adriana Yurika
   da Silva Vasami, Fernanda Giseli
   de Lima Macedo, Fernando Luiz
   Suzuki, Akemi
   Rodrigues, Sueli Guerreiro
   Ribeiro Cruz, Ana Cecilia
   Nunes, Bruno Tardeli
   de Almeida Medeiros, Daniele Barbosa
   Guerreiro Rodrigues, Daniela Sueli
   Nunes Queiroz, Alice Louize
   Pinto da Silva, Eliana Vieira
   Henriques, Daniele Freitas
   Travassos da Rosa, Elisabeth Salbe
   de Oliveira, Consuelo Silva
   Martins, Livia Caricio
   Vasconcelos, Helena Baldez
   Neves Casseb, Livia Medeiros
   Simith, Darlene de Brito
   Messina, Jane P.
   Abade, Leandro
   Loureno, Jose
   Junior Alcantara, Luiz Carlos
   de Lima, Maricelia Maia
   Giovanetti, Marta
   Hay, Simon I.
   de Oliveira, Rodrigo Santos
   Lemos, Poliana da Silva
   de Oliveira, Layanna Freitas
   Silva de Lima, Clayton Pereira
   da Silva, Sandro Patroca
   de Vasconcelos, Janaina Mota
   Franco, Luciano
   Cardoso, Jedson Ferreira
   da Silva Gonalves Vianez-Junior, Joao Lidio
   Mir, Daiana
   Bello, Gonzalo
   Delatorre, Edson
   Khan, Kamran
   Creatore, Marisa
   Coelho, Giovanini Evelim
   de Oliveira, Wanderson Kleber
   Tesh, Robert
   Pybus, Oliver G.
   Nunes, Marcio R. T.
   Vasconcelos, Pedro F. C.
TI Zika virus in the Americas: Early epidemiological and genetic findings
SO SCIENCE
LA English
DT Article
ID FRENCH-POLYNESIA; CHIKUNGUNYA VIRUS; DECEMBER 2013; BRAZIL;
   TRANSMISSION; INFECTION; OUTBREAK; ISLAND; EPIDEMICS; EVOLUTION
AB Brazil has experienced an unprecedented epidemic of Zika virus (ZIKV), with similar to 30,000 cases reported to date. ZIKV was first detected in Brazil in May 2015, and cases of microcephaly potentially associated with ZIKV infection were identified in November 2015. We performed next-generation sequencing to generate seven Brazilian ZIKV genomes sampled from four self-limited cases, one blood donor, one fatal adult case, and one newborn with microcephaly and congenital malformations. Results of phylogenetic and molecular clock analyses show a single introduction of ZIKV into the Americas, which we estimated to have occurred between May and December 2013, more than 12 months before the detection of ZIKV in Brazil. The estimated date of origin coincides with an increase in air passengers to Brazil from ZIKV-endemic areas, as well as with reported outbreaks in the Pacific Islands. ZIKV genomes from Brazil are phylogenetically interspersed with those from other South American and Caribbean countries. Mapping mutations onto existing structural models revealed the context of viral amino acid changes present in the outbreak lineage; however, no shared amino acid changes were found among the three currently available virus genomes from microcephaly cases. Municipality-level incidence data indicate that reports of suspected microcephaly in Brazil best correlate with ZIKV incidence around week 17 of pregnancy, although this correlation does not demonstrate causation. Our genetic description and analysis of ZIKV isolates in Brazil provide a baseline for future studies of the evolution and molecular epidemiology of this emerging virus in the Americas.
C1 [Faria, Nuno Rodrigues; de Oliveira, Rodrigo Santos; Lemos, Poliana da Silva; de Oliveira, Layanna Freitas; Silva de Lima, Clayton Pereira; da Silva, Sandro Patroca; de Vasconcelos, Janaina Mota; Franco, Luciano; Cardoso, Jedson Ferreira; da Silva Gonalves Vianez-Junior, Joao Lidio; Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.
   [Faria, Nuno Rodrigues; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Bonsall, Michael B.; Messina, Jane P.; Abade, Leandro; Loureno, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
   [da Silva Azevedo, Raimunda do Socorro; Rodrigues, Sueli Guerreiro; Ribeiro Cruz, Ana Cecilia; Nunes, Bruno Tardeli; de Almeida Medeiros, Daniele Barbosa; Guerreiro Rodrigues, Daniela Sueli; Nunes Queiroz, Alice Louize; Pinto da Silva, Eliana Vieira; Henriques, Daniele Freitas; Travassos da Rosa, Elisabeth Salbe; de Oliveira, Consuelo Silva; Martins, Livia Caricio; Vasconcelos, Helena Baldez; Neves Casseb, Livia Medeiros; Simith, Darlene de Brito; Vasconcelos, Pedro F. C.] Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.
   [Souza, Renato; Cunha, Mariana Sequetin; Rocco, Iray Maria; Nogueira, Juliana Silva; Maeda, Adriana Yurika; da Silva Vasami, Fernanda Giseli; de Lima Macedo, Fernando Luiz; Suzuki, Akemi] Univ Sao Paulo, Inst Adolfo Lutz, Sao Paulo, Brazil.
   [Bowden, Thomas A.; Rissanen, Ilona; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Messina, Jane P.; Pybus, Oliver G.] Metabiota, San Francisco, CA 94104 USA.
   [Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil.
   [de Lima, Maricelia Maia] Univ Estadual Feira de Santana, Ctr Post Grad Collect Hlth, Dept Hlth, Feira De Santana, BA, Brazil.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.
   [Mir, Daiana; Bello, Gonzalo; Delatorre, Edson] Fiocruz MS, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Creatore, Marisa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Coelho, Giovanini Evelim; de Oliveira, Wanderson Kleber] Brazilian Minist Hlth, Brasilia, DF, Brazil.
   [Tesh, Robert; Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Nunes, MRT (reprint author), Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.; Pybus, OG (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.; Vasconcelos, PFC (reprint author), Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.; Pybus, OG (reprint author), Metabiota, San Francisco, CA 94104 USA.; Nunes, MRT (reprint author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM oliver.pybus@zoo.ox.ac.uk; marcionunesbrasil@yahoo.com.br;
   pedrovasconcelos@iec.pa.gov.br
RI Delatorre, Edson/J-8330-2015; Hay, Simon/F-8967-2015; Oliveira,
   Wanderson/D-7140-2016
OI Delatorre, Edson/0000-0002-5746-0820; Hay, Simon/0000-0002-0611-7272;
   Oliveira, Wanderson/0000-0002-9662-1930
FU European Research Council (ERC) under the European Union
   [614725-PATHPHYLODYN]; ERC under the European Union [268904-DIVERSITY];
   Metabiota; American people through the United States Agency for
   International Development (USAID) Emerging Pandemic Threats
   Program-PREDICT; Wellcome Trust [095066, 102427, 090532/Z/09/Z]; Bill
   and Melinda Gates Foundation [OPP1119467, OPP1093011, OPP1106023,
   OPP1132415]; Evandro Chagas Institute; Brazilian Ministry of Health;
   CNPq (Brazilian National Council for Scientific and Technological
   Development) [302032/2011-8, 200024/2015-9]; National Institute of
   Science and Technology for Viral Hemorrhagic Fevers; U.S. NIH [R24 AT
   120942]; UK Medical Research Council [MR/L009528/1]; CNPq-National
   Agency for Scientific and Technologic Development [573739/2008-0,
   301641/2010-2, 457664/2013-4]
FX We thank X. de Lamballerie and J. Lednicky for permission to include
   their unpublished ZIKV genomes in our analysis. We thank the Death
   Verification Service (SVO); Central Laboratories of Public Health
   (LACEN); and health departments of the Ceara State and Maranhao State,
   Brazil, for collaboration. O.G.P. is supported by the European Research
   Council (ERC) under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 614725-PATHPHYLODYN. J.L. is supported by the
   ERC under the European Union's Seventh Framework Programme
   (FP7/2007-2013)/ERC grant 268904-DIVERSITY. O.G.P. received consulting
   fees from Metabiota between 2015 and 2016. This study is made possible
   in part by the generous support of the American people through the
   United States Agency for International Development (USAID) Emerging
   Pandemic Threats Program-PREDICT. The contents are the responsibility of
   the authors and do not necessarily reflect the views of USAID or the
   U.S. government. S.I.H. is funded by a Senior Research Fellowship from
   the Wellcome Trust (095066) and grants from the Bill and Melinda Gates
   Foundation (OPP1119467, OPP1093011, OPP1106023, and OPP1132415).
   M.R.T.N. is funded as an associated researcher in public health by the
   Evandro Chagas Institute, Brazilian Ministry of Health, and as a
   researcher in scientific productivity by CNPq (Brazilian National
   Council for Scientific and Technological Development) grants
   302032/2011-8 and 200024/2015-9 and is also supported in part by the
   National Institute of Science and Technology for Viral Hemorrhagic
   Fevers. R.T. is funded by grant R24 AT 120942 from the U.S. NIH. S.C.H.
   is supported by a Wellcome Trust grant (102427). T.A.B. and I.R. are
   supported by grants from the UK Medical Research Council (MR/L009528/1)
   and the Wellcome Trust (090532/Z/09/Z). P.F.C.V. is supported by
   CNPq-National Agency for Scientific and Technologic Development (grants
   573739/2008-0, 301641/2010-2, and 457664/2013-4). All samples were
   obtained from persons visiting local clinics or hospitalized by the
   Brazilian Ministry of Health personnel as part of dengue, chikungunya,
   and Zika fever surveillance activities. In these cases, patient consent
   was oral and not recorded. The study was authorized by the Coordination
   of the National Program for Dengue, Chikungunya, and Zika Control
   coordinated by Brazil's Ministry of Health. The data are available at
   DRYAD (DOI: 10.5061/dryad.6kn23). The ZIKV genomes reported in this
   study are deposited in GenBank under accession numbers KU321639,
   KU365777 to KU365780, KU729217, and KU729218.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control (ECDC), 2015, RAP RISK ASS MICR BR
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meyer A. G., 2015, Virus Evolution, V1, pvev006, DOI 10.1093/ve/vev006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   PAHO, 2015, EP AL NEUR SYNDR CON
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878
   Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109
   Pyke A. T., 2014, PLOS CURR, DOI [10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e, DOI 10.1371/CURRENTS.OUTBREAKS.4635A54DBFFBA2156FB2FD76DC49F65E]
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V47
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sorichetta A, 2015, SCI DATA, V2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organization, 2016, ASS INF MICR CONT ZI
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 40
Z9 41
U1 82
U2 82
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 15
PY 2016
VL 352
IS 6283
BP 345
EP 349
DI 10.1126/science.aaf5036
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ1UK
UT WOS:000373990100041
PM 27013429
ER

PT J
AU Guzzetta, G
   Poletti, P
   Montarsi, F
   Baldacchino, F
   Capelli, G
   Rizzoli, A
   Rosa, R
   Merler, S
AF Guzzetta, G.
   Poletti, P.
   Montarsi, F.
   Baldacchino, F.
   Capelli, G.
   Rizzoli, A.
   Rosa, R.
   Merler, S.
TI Assessing the potential risk of Zika virus epidemics in temperate areas
   with established Aedes albopictus populations
SO EUROSURVEILLANCE
LA English
DT Article
ID VECTOR
AB Based on 2015 abundance of Aedes albopictus in nine northern Italian municipalities with temperate continental/oceanicclimate, we estimated the basic reproductive number R-o for Zika virus (ZIKV) to be systematically below the epidemic threshold in most scenarios. Results were sensitive to the value of the probability of mosquito infection after biting a viraemic host. Therefore, further studies are required to improve models and predictions, namely evaluating vector competence and potential non-vector transmissions.
C1 [Guzzetta, G.; Poletti, P.; Merler, S.] Fdn Bruno Kessler, Trento, Italy.
   [Poletti, P.] Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy.
   [Montarsi, F.; Capelli, G.] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy.
   [Baldacchino, F.; Rizzoli, A.; Rosa, R.] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, Trento, Italy.
RP Merler, S (reprint author), Fdn Bruno Kessler, Trento, Italy.
EM merler@fbk.eu
RI Rosa, Roberto/B-8562-2011; Rizzoli, Annapaola/J-2439-2012
OI Rosa, Roberto/0000-0002-8655-2230; Rizzoli,
   Annapaola/0000-0003-3997-6783
FU Autonomous Province of Trento (Italy); Research funds for Grandi
   Progetti, Project LExEM (Laboratory of excellence for epidemiology and
   modelling)
FX We thank for mosquito collection Daniele Arnoldi, Francesca Bussola,
   Charlotte Lapere, Sara Carlin, Graziana Da Rold, Marco Dal Pont, Nicola
   Ferro Milone, Luca Tripepi. We thank Markus Metz and Markus Neteler for
   providing us with LST temperature data. This work was funded by the
   Autonomous Province of Trento (Italy), Research funds for Grandi
   Progetti, Project LExEM (Laboratory of excellence for epidemiology and
   modelling, http://www.lexem.eu).
CR Barnard DR, 2014, ACTA TROP, V136, P58, DOI 10.1016/j.actatropica.2014.04.019
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cao-Lormeau VM, 2016, LANCET
   Cauchemez S, 2016, LANCET
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Funk S, 2016, BIORXIV         0311
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064
   Mallet HP, 2015, B INFORM SANITAIRES, P13
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Metz M, 2014, REMOTE SENS-BASEL, V6, P3822, DOI 10.3390/rs6053822
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   [Anonymous], ZIK VIR VECT RISK SP
NR 20
TC 2
Z9 2
U1 16
U2 16
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 14
PY 2016
VL 21
IS 15
BP 5
EP 10
AR 30199
DI 10.2807/1560-7917.ES.2016.21.15.30199
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DJ6LP
UT WOS:000374325000002
ER

PT J
AU Aragao, MDV
   van der Linden, V
   Brainer-Lima, AM
   Coeli, RR
   Rocha, MA
   da Silva, PS
   de Carvalho, MDCG
   van der Linden, A
   de Holanda, AC
   Valenca, MM
AF Vasco Aragao, Maria de Fatima
   van der Linden, Vanessa
   Brainer-Lima, Alessandra Mertens
   Coeli, Regina Ramos
   Rocha, Maria Angela
   da Silva, Paula Sobral
   Costa Gomes de Carvalho, Maria Durce
   van der Linden, Ana
   de Holanda, Arthur Cesario
   Valenca, Marcelo Moraes
TI Clinical features and neuroimaging (CT and MRI) findings in presumed
   Zika virus related congenital infection and microcephaly: retrospective
   case series study
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID ABNORMALITIES; OUTBREAK; BRAZIL
AB OBJECTIVE
   To report radiological findings observed in computed tomography (CT) and magnetic resonance imaging (MRI) scans of the first cases of congenital infection and microcephaly presumably associated with the Zika virus in the current Brazilian epidemic.
   DESIGN
   Retrospective study with a case series.
   SETTING
   Association for Assistance of Disabled Children (AACD), Pernambuco state, Brazil.
   PARTICIPANTS
   23 children with a diagnosis of congenital infection presumably associated with the Zika virus during the Brazilian microcephaly epidemic.
   MAIN OUTCOME MEASURES
   Types of abnormalities and the radiological pattern of lesions identified on CT and MRI brain scans.
   RESULTS
   Six of the 23 children tested positive for IgM antibodies to Zika virus in cerebrospinal fluid. The other 17 children met the protocol criteria for congenital infection presumably associated with the Zika virus, even without being tested for IgM antibodies to the virus-the test was not yet available on a routine basis. Of the 23 children, 15 underwent CT, seven underwent both CT and MRI, and one underwent MRI. Of the 22 children who underwent CT, all had calcifications in the junction between cortical and subcortical white matter, 21 (95%) had malformations of cortical development, 20 (91%) had a decreased brain volume, 19 (86%) had ventriculomegaly, and 11 (50%) had hypoplasia of the cerebellum or brainstem. Of the eight children who underwent MRI, all had calcifications in the junction between cortical and subcortical white matter, malformations of cortical development occurring predominantly in the frontal lobes, and ventriculomegaly. Seven of the eight (88%) children had enlarged cisterna magna, seven (88%) delayed myelination, and six each (75%) a moderate to severe decrease in brain volume, simplified gyral pattern, and abnormalities of the corpus callosum (38% hypogenesis and 38% hypoplasia). Malformations were symmetrical in 75% of the cases.
   CONCLUSION
   Severe cerebral damage was found on imaging in most of the children in this case series with congenital infection presumably associated with the Zika virus. The features most commonly found were brain calcifications in the junction between cortical and subcortical white matter associated with malformations of cortical development, often with a simplified gyral pattern and predominance of pachygyria or polymicrogyria in the frontal lobes. Additional findings were enlarged cisterna magna, abnormalities of corpus callosum (hypoplasia or hypogenesis), ventriculomegaly, delayed myelination, and hypoplasia of the cerebellum and the brainstem.
C1 [Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Do Leite Recife, PE, Brazil.
   [Vasco Aragao, Maria de Fatima] Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil.
   [van der Linden, Vanessa] Associat Assistance Disabled Children, Recife, PE, Brazil.
   [van der Linden, Vanessa] Barao de Lucena Hosp, Recife, PE, Brazil.
   [Brainer-Lima, Alessandra Mertens] Univ Pernambuco, PROCAPE, Recife, PE, Brazil.
   [Coeli, Regina Ramos; Rocha, Maria Angela; da Silva, Paula Sobral; Costa Gomes de Carvalho, Maria Durce] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [van der Linden, Ana] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
   [de Holanda, Arthur Cesario] Univ Fed Pernambuco, Sch Med, Recife, PE, Brazil.
   [Valenca, Marcelo Moraes] Univ Fed Pernambuco, Neurol & Neurosurg, Recife, PE, Brazil.
RP Aragao, MDV (reprint author), Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Do Leite Recife, PE, Brazil.; Aragao, MDV (reprint author), Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil.
EM vascoaragao@gmail.com
CR Barkovich AJ, 2012, PEDIAT NEUROIMAGING
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   [Anonymous], 2014, EUROSURVEILLANCE, DOI DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bosemani T, 2015, RADIOGRAPHICS, V35, P200, DOI 10.1148/rg.351140038
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centre d'hygiene et de salubrite publique de la Direction de la sante, 2015, B TEL SIT SUIV RES O
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dogan Y, 2011, FETAL DIAGN THER, V30, P141, DOI 10.1159/000330636
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hess CP, 2013, IMAGING OF THE BRAIN, P45
   Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Malinger G, 2003, AJNR AM J NEURORADIO, V24, P28
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Ministerio da Saude (Brazil), CENTR OP EM SAUSD PU
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sze G, 1999, CRANIAL MRI CT, P453
   Tang H, 2016, CELL STEM CELL, V18, P1
   Tavernise S, 2016, NY TIMES
NR 27
TC 12
Z9 12
U1 18
U2 18
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 13
PY 2016
VL 353
AR i1901
DI 10.1136/bmj.i1901
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ7ET
UT WOS:000374375400003
ER

PT J
AU Smith, DW
   Mackenzie, J
AF Smith, David W.
   Mackenzie, John
TI Zika virus and Guillain-Barre syndrome: another viral cause to add to
   the list
SO LANCET
LA English
DT Editorial Material
C1 [Smith, David W.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia.
   [Mackenzie, John] Curtin Univ, Fac Hlth Sci, Bentley, WA, Australia.
RP Smith, DW (reprint author), Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia.
EM david.smith@health.wa.gov.au
CR Cao-Lormeau VM, 2016, LANCET
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   WHO. WHO statement on the first meeting of the International Health Regulations, 2005, EM COMM ZIKA VIR OBS
   World Health Organization, GUILL BARR SYNDR COL
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00006-4
NR 11
TC 7
Z9 7
U1 17
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 9
PY 2016
VL 387
IS 10027
BP 1486
EP 1488
DI 10.1016/S0140-6736(16)00564-X
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI8HH
UT WOS:000373741600005
PM 26948432
ER

PT J
AU Cao-Lormeau, VM
   Blake, A
   Mons, S
   Lastere, S
   Roche, C
   Vanhomwegen, J
   Dub, T
   Baudouin, L
   Teissier, A
   Larre, P
   Vial, AL
   Decam, C
   Choumet, V
   Halstead, SK
   Willison, HJ
   Musset, L
   Manuguerra, JC
   Despres, P
   Fournier, E
   Mallet, HP
   Musso, D
   Fontanet, A
   Neil, J
   Ghawche, F
AF Cao-Lormeau, Van-Mai
   Blake, Alexandre
   Mons, Sandrine
   Lastere, Stephane
   Roche, Claudine
   Vanhomwegen, Jessica
   Dub, Timothee
   Baudouin, Laure
   Teissier, Anita
   Larre, Philippe
   Vial, Anne-Laure
   Decam, Christophe
   Choumet, Valerie
   Halstead, Susan K.
   Willison, Hugh J.
   Musset, Lucile
   Manuguerra, Jean-Claude
   Despres, Philippe
   Fournier, Emmanuel
   Mallet, Henri-Pierre
   Musso, Didier
   Fontanet, Arnaud
   Neil, Jean
   Ghawche, Frederic
TI Guillain-Barre Syndrome outbreak associated with Zika virus infection in
   French Polynesia: a case-control study
SO LANCET
LA English
DT Article
ID CAMPYLOBACTER; CHIKUNGUNYA; INFLUENZA; CRITERIA; DENGUE; MICRONESIA;
   DIAGNOSIS; BRAZIL
AB Background Between October, 2013, and April, 2014, French Polynesia experienced the largest Zika virus outbreak ever described at that time. During the same period, an increase in Guillain-Barre syndrome was reported, suggesting a possible association between Zika virus and Guillain-Barre syndrome. We aimed to assess the role of Zika virus and dengue virus infection in developing Guillain-Barre syndrome.
   Methods In this case-control study, cases were patients with Guillain-Barre syndrome diagnosed at the Centre Hospitalier de Polynesie Francaise (Papeete, Tahiti, French Polynesia) during the outbreak period. Controls were age-matched, sex-matched, and residence-matched patients who presented at the hospital with a non-febrile illness (control group 1; n=98) and age-matched patients with acute Zika virus disease and no neurological symptoms (control group 2; n=70). Virological investigations included RT-PCR for Zika virus, and both microsphere immunofluorescent and seroneutralisation assays for Zika virus and dengue virus. Anti-glycolipid reactivity was studied in patients with Guillain-Barre syndrome using both ELISA and combinatorial microarrays.
   Findings 42 patients were diagnosed with Guillain-Barre syndrome during the study period. 41 (98%) patients with Guillain-Barre syndrome had anti-Zika virus IgM or IgG, and all (100%) had neutralising antibodies against Zika virus compared with 54 (56%) of 98 in control group 1 (p<0.0001). 39 (93%) patients with Guillain-Barre syndrome had Zika virus IgM and 37 (88%) had experienced a transient illness in a median of 6 days (IQR 4-10) before the onset of neurological symptoms, suggesting recent Zika virus infection. Patients with Guillain-Barre syndrome had electrophysiological findings compatible with acute motor axonal neuropathy (AMAN) type, and had rapid evolution of disease (median duration of the installation and plateau phases was 6 [IQR 4-9] and 4 days [3-10], respectively). 12 (29%) patients required respiratory assistance. No patients died. Anti-glycolipid antibody activity was found in 13 (31%) patients, and notably against GA1 in eight (19%) patients, by ELISA and 19 (46%) of 41 by glycoarray at admission. The typical AMAN-associated anti-ganglioside antibodies were rarely present. Past dengue virus history did not differ significantly between patients with Guillain-Barre syndrome and those in the two control groups (95%, 89%, and 83%, respectively).
   Interpretation This is the first study providing evidence for Zika virus infection causing Guillain-Barre syndrome. Because Zika virus is spreading rapidly across the Americas, at risk countries need to prepare for adequate intensive care beds capacity to manage patients with Guillain-Barre syndrome.
C1 [Cao-Lormeau, Van-Mai; Roche, Claudine; Teissier, Anita; Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Tahiti, Fr Polynesia.
   [Blake, Alexandre; Dub, Timothee; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, 25 Rue Docteur Roux, F-75015 Paris, France.
   [Mons, Sandrine; Baudouin, Laure] Ctr Hosp Polynesie Francaise, Serv Reanimat Polyvalente, Tahiti, Fr Polynesia.
   [Lastere, Stephane] Ctr Hosp Polynesie Francaise, Clin Lab, Tahiti, Fr Polynesia.
   [Vanhomwegen, Jessica; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France.
   [Vanhomwegen, Jessica; Choumet, Valerie; Manuguerra, Jean-Claude] Inst Pasteur, Unit Environm & Infect Risks, Paris, France.
   [Larre, Philippe; Ghawche, Frederic] Ctr Hosp Polynesie Francaise, Serv Neurol, Papeete, Tahiti, Fr Polynesia.
   [Vial, Anne-Laure; Mallet, Henri-Pierre] Bur Veille Sanit, Direct Sante, Papeete, Fr Polynesia.
   [Decam, Christophe] Serv Sante Forces Armees, Papeete, Fr Polynesia.
   [Halstead, Susan K.; Willison, Hugh J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Musset, Lucile; Neil, Jean] Grp Hosp Pitie Salpetriere, AP HP, Dept Immunol, Lab Immunochem & Autoimmun, F-75634 Paris, France.
   [Despres, Philippe] Univ Reunion Isl, St Denis, Reunion.
   [Fournier, Emmanuel] Grp Hosp Pitie Salpetriere, AP HP, Dept Neurophysiol, F-75634 Paris, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France.
   [Fontanet, Arnaud] Inst Pasteur, Ctr Global Hlth Res & Educ, Paris, France.
RP Fontanet, A (reprint author), Inst Pasteur, Emerging Dis Epidemiol Unit, 25 Rue Docteur Roux, F-75015 Paris, France.
EM fontanet@pasteur.fr
FU Labex Integrative Biology of Emerging Infectious Diseases; EU; Wellcome
   Trust
FX Labex Integrative Biology of Emerging Infectious Diseases, EU 7th
   framework programme PREDEMICS, and Wellcome Trust.
CR Wim Ang C, 2004, TRENDS IMMUNOL, V25, P261
   Aubry M, 2015, 64 ANN M AM SOC TROP
   Beck C, 2015, BIOMED RES INT, DOI 10.1155/2015/678084
   Cao-Lormeau VM, 2013, EMERG INFECT DIS, V20, P1085, DOI DOI 10.3201/EID2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   [Anonymous], 2014, RAP RISK ASS ZIK VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072
   Gubler DJ, 2007, FIELDS VIROLOGY, P1155
   Hiraga A, 2003, NEUROLOGY, V61, P471
   Ho TW, 1997, NEUROLOGY, V48, P717
   Kokubun N, 2013, CLIN NEUROPHYSIOL, V124, P1671, DOI 10.1016/j.clinph.2013.02.010
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, B INFORM SANITAIRES
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Monos DS, 1997, J INFECT DIS S2, V176, P180
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Neil J, 2012, J NEUROIMMUNOL, V242, P72, DOI 10.1016/j.jneuroim.2011.11.007
   Oehler E., 2014, Eurosurveillance, V19, P20720
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Rinaldi S, 2008, CURR OPIN NEUROL, V21, P540, DOI 10.1097/WCO.0b013e32830b84b7
   Rinaldi S, 2012, METHODS MOL BIOL, V808, P413, DOI 10.1007/978-1-61779-373-8_28
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Willison HJ, 2007, J NEUROCHEM, V103, P143, DOI 10.1111/j.1471-4159.2007.04718.x
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 41
TC 80
Z9 83
U1 48
U2 48
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 9
PY 2016
VL 387
IS 10027
BP 1531
EP 1539
DI 10.1016/S0140-6736(16)00562-6
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI8HH
UT WOS:000373741600029
PM 26948433
ER

PT J
AU Adibi, JJ
   Marques, ETA
   Cartus, A
   Beigi, RH
AF Adibi, Jennifer J.
   Marques, Ernesto T. A., Jr.
   Cartus, Abigail
   Beigi, Richard H.
TI Teratogenic effects of the Zika virus and the role of the placenta
SO LANCET
LA English
DT Article
ID CEREBRAL-CORTEX; HUMAN FETUS; INFECTION; CELLS; PATHOGENESIS;
   ABNORMALITIES; EXOSOMES; STEM
AB The mechanism by which the Zika virus can cause fetal microcephaly is not known. Reports indicate that Zika is able to evade the normal immunoprotective responses of the placenta. Microcephaly has genetic causes, some associated with maternal exposures including radiation, tobacco smoke, alcohol, and viruses. Two hypotheses regarding the role of the placenta are possible: one is that the placenta directly conveys the Zika virus to the early embryo or fetus. Alternatively, the placenta itself might be mounting a response to the exposure; this response might be contributing to or causing the brain defect. This distinction is crucial to the diagnosis of fetuses at risk and the design of therapeutic strategies to prevent Zika-induced teratogenesis.
C1 [Adibi, Jennifer J.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA.
   [Adibi, Jennifer J.; Beigi, Richard H.] Univ Pittsburgh, Dept Obstet & Gynecol & Reprod Sci, Pittsburgh, PA USA.
   [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Marques, Ernesto T. A., Jr.] Oswaldo Cruz Fdn Fiocruz, Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [Cartus, Abigail] Univ Texas Hlth Sci Ctr Houston, Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA.
RP Adibi, JJ (reprint author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15261 USA.
EM adibij@pitt.edu
RI Adibi, Jennifer/I-8077-2016
OI Adibi, Jennifer/0000-0001-6562-8315
CR Adibi JJ, 2015, J CLIN ENDOCR METAB, V100, pE1216, DOI 10.1210/jc.2015-2370
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   Burton GJ, 2001, PLACENTA, V22, pS70, DOI 10.1053/plac.2001.0639
   Calvet G., 2016, LANCET INFECT DIS
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770
   DEKABAN AS, 1968, J NUCL MED, V9, P471
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x
   Gabrielli L, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/j.jcv.2009.09.026
   Garcez PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7474
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   HADEED AJ, 1989, PEDIATRICS, V84, P205
   Halstead SB, 2014, MICROBIOL SPECTR, V2
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   KENNEDY LA, 1984, TERATOLOGY, V29, P363, DOI 10.1002/tera.1420290306
   Leviton A, 2010, EARLY HUM DEV, V86, P515, DOI 10.1016/j.earlhumdev.2010.07.001
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montiel JF, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00022
   MOSTOUFIZADEH M, 1984, ARCH PATHOL LAB MED, V108, P403
   Nascimento EJM, 2014, CRIT REV IMMUNOL, V34, P227
   Pulvers Jeremy N, 2015, Front Cell Neurosci, V9, P92, DOI 10.3389/fncel.2015.00092
   Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x
   Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/ror.0.0040081
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389
   Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446
NR 29
TC 12
Z9 14
U1 20
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 9
PY 2016
VL 387
IS 10027
BP 1587
EP 1590
DI 10.1016/S0140-6736(16)00650-4
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI8HH
UT WOS:000373741600034
PM 26952548
ER

PT J
AU Daniel, KL
AF Daniel, Katherine Lyon
CA CDC Zika Response
TI Vital Signs: Preparing for Local Mosquito-Borne Transmission of Zika
   Virus - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Daniel, Katherine Lyon] CDC Zika Response, Atlanta, GA 30302 USA.
RP Daniel, KL (reprint author), CDC Zika Response, Atlanta, GA 30302 USA.
EM eocjictriage2@cdc.gov
CR Brasil P, N ENGL J MED
   CDC, 2016, ZIK VIR TRANSM RISKS
   CDC, 2016, ZIK VIR
   CDC, 2016, ZIK ACT PLAN ZAP SUM
   Oster AM, MMWR MORB MORTAL WKL
   Petersen EE, MMWR MORB MORTAL WKL
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
NR 7
TC 0
Z9 0
U1 14
U2 14
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 8
PY 2016
VL 65
IS 13
BP 352
EP 352
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DJ3DJ
UT WOS:000374084700004
ER

PT J
AU Nah, K
   Mizumoto, K
   Miyamatsu, Y
   Yasuda, Y
   Kinoshita, R
   Nishiura, H
AF Nah, Kyeongah
   Mizumoto, Kenji
   Miyamatsu, Yuichiro
   Yasuda, Yohei
   Kinoshita, Ryo
   Nishiura, Hiroshi
TI Estimating risks of importation and local transmission of Zika virus
   infection
SO PEERJ
LA English
DT Article
DE Zika virus; Importation; Risk; Mathematical model; Transmission;
   Statistical estimation; Network; Epidemiology
AB Background. An international spread of Zika virus (ZIKV) infection has attracted global attention. ZIKV is conveyed by a mosquito vector, Aedes species, which also acts as the vector species of dengue and chikungunya viruses.
   Methods. Arrival time of ZIKV importation (i.e., the time at which the first imported case was diagnosed) in each imported country was collected from publicly available data sources. Employing a survival analysis model in which the hazard is an inverse function of the effective distance as informed by the airline transportation network data, and using dengue and chikungunya virus transmission data, risks of importation and local transmission were estimated.
   Results. A total of 78 countries with imported case(s) have been identified, with the arrival time ranging from 1 to 44 weeks since the first ZIKV was identified in Brazil, 2015. Whereas the risk of importation was well explained by the airline transportation network data, the risk of local transmission appeared to be best captured by additionally accounting for the presence of dengue and chikungunya viruses.
   Discussion. The risk of importation may be high given continued global travel of mildly infected travelers but, considering that the public health concerns over ZIKV infection stems from microcephaly, it is more important to focus on the risk of local and widespread transmission that could involve pregnant women. The predicted risk of local transmission was frequently seen in tropical and subtropical countries with dengue or chikungunya epidemic experience.
C1 [Nah, Kyeongah; Mizumoto, Kenji; Miyamatsu, Yuichiro; Yasuda, Yohei; Kinoshita, Ryo; Nishiura, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan.
   [Nah, Kyeongah; Miyamatsu, Yuichiro; Kinoshita, Ryo; Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Saitama, Japan.
   [Nah, Kyeongah; Mizumoto, Kenji; Miyamatsu, Yuichiro; Kinoshita, Ryo; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.
   [Mizumoto, Kenji] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.
RP Nishiura, H (reprint author), Univ Tokyo, Grad Sch Med, Tokyo, Japan.; Nishiura, H (reprint author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.; Nishiura, H (reprint author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.
EM nishiurah@gmail.com
FU Japanese Society for the Promotion of Science (JSPS) KAKENHI [26670308,
   26700028, 15K20936]; Japan Agency for Medical Research and Development;
   Japan Science and Technology Agency (JST) CREST program; RISTEX program
   for Science of Science, Technology and Innovation Policy
FX HN received funding support from the Japanese Society for the Promotion
   of Science (JSPS) KAKENHI Grant Numbers 26670308 and 26700028, Japan
   Agency for Medical Research and Development, the Japan Science and
   Technology Agency (JST) CREST program and RISTEX program for Science of
   Science, Technology and Innovation Policy. KM received funding support
   from the Japanese Society for the Promotion of Science (JSPS) KAKENHI
   Grant Number 15K20936. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adelman Zach N, 2016, Trends Parasitol, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Babaniyi OA, 2015, INT J PUBLIC HLTH EP, V4, P110
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bogoch II, 2016, LANCET, V387, P335, DOI [10.1016/S0140-6736(16)00080-5, DOI 10.1016/S0140-6736(16)00080-5]
   Brasil P, 2016, NEW ENGLAND IN PRESS, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOAL1602412]
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention (CDC) USA, 2016, CHIK VIR GEOGR DISTR
   Centers for Disease Control and Prevention (CDC) USA., 2016, DENG HOM
   Contentshare, 2016, OP DAT
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   European Centre for Disease Prevention and Control (ECDC), 2016, COUNTR TERR LOC ZIK
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gengsheng Qin, 2008, Stat Methods Med Res, V17, P207, DOI 10.1177/0962280207087173
   Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X
   Korhonen EM, 2016, EUROSRUVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.2.30107, DOI 10.2807/1560-7915.ES.2016.21.2.30107]
   Kraemer MU, 2015, SCI DATA, V2, DOI [DOI 10.1038/SDATA.2015.35, 10.1038/sdata.2015.35]
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   loos S, 2014, MED MALADIES INFECT, V44, P302
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nah K, 2016, BMC INFECT IN PRESS
   Nishiura H, 2016, EPIDEMICS, DOI [10.1016/j.epidem.2016.03.001, DOI 10.1016/J.EPIDEM.2016.03.001]
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2013, EUROSURVEILLANCE, V19, P20685
   The Walter Reed Biosystematics Unit USA, 2016, AED AFR
   World Health Organization Western Pacific Region (WPRO), 2016, PAC SYNDR SURV REP
   [Anonymous], 2016, CONTROLLING DENGUE O
NR 32
TC 4
Z9 4
U1 24
U2 24
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD APR 5
PY 2016
VL 4
AR e1904
DI 10.7717/peerj.1904
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ4FK
UT WOS:000374160600007
PM 27069825
ER

PT J
AU Birbeck, GL
AF Birbeck, Gretchen L.
TI Zika virus What the neurologist wants to know
SO NEUROLOGY
LA English
DT Editorial Material
ID INTERIM GUIDELINES; FRENCH-POLYNESIA; UNITED-STATES; TRANSMISSION;
   INFECTION
AB Just as Neurology (R) Without Borders launched in late January, news coverage about the Zika virus epidemic in Latin America with Brazil at ground zero began to reach the popular press.(1-4) Photographs of devastated parents and microcephalic, dysmorphic infants have captured the public's attention. Recent articles in the New England Journal of Medicine(5) and Lancet(6-8) among others have outlined some of what is known about the epidemiology of this arbovirus and how we believe it made its way from Africa (identified in 1947) to Southeast Asia (mid-20th century) to Micronesia (2007) to French Polynesia (2014) and most recently to Latin America in 2015.(9</SUP)
C1 [Birbeck, Gretchen L.] Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.
RP Birbeck, GL (reprint author), Univ Rochester, Sch Med & Dent, Rochester, NY 14627 USA.
EM gretchen_birbeck@urmc.rochester.edu
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   CDC, 2016, ZIK VIR
   Crawford A, 2016, SKY NEWS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i467
   [Anonymous], 2014, RAP RISK ASS ZIK VIR
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, N ENGL J MED
   Garcia-Navarro L., 2016, ZIKA VIRUS LIKELY AF
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E, 2014, EURO SURVEILL, P19
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   RSTMH, 2016, ZKA VIR 1 DESCR T
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tetro JA., MICROBES INFECT
   Triunfol M, LANCET INFECT DIS
NR 25
TC 0
Z9 0
U1 34
U2 34
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 5
PY 2016
VL 86
IS 14
BP 1272
EP 1274
DI 10.1212/WNL.0000000000002553
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA DI1YE
UT WOS:000373292100001
PM 26896047
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Vectors for Zika virus may spread further than was previously thought,
   CDC reports
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Centers for Disease Control and Prevention, 2016, EST RANG AED ALB AED
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
NR 2
TC 0
Z9 0
U1 22
U2 22
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 4
PY 2016
VL 353
AR i1914
DI 10.1136/bmj.i1914
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ0LL
UT WOS:000373894800006
PM 27044278
ER

PT J
AU Mecharles, S
   Herrmann, C
   Poullain, P
   Tran, TH
   Deschamps, N
   Mathon, G
   Landais, A
   Breurec, S
   Lannuzel, A
AF Mecharles, Sylvie
   Herrmann, Cecile
   Poullain, Pascale
   Tran, Tuan-Huy
   Deschamps, Nathalie
   Mathon, Gregory
   Landais, Anne
   Breurec, Sebastien
   Lannuzel, Annie
TI Acute myelitis due to Zika virus infection
SO LANCET
LA English
DT Editorial Material
ID NERVOUS-SYSTEM
C1 [Mecharles, Sylvie; Tran, Tuan-Huy; Deschamps, Nathalie; Landais, Anne; Lannuzel, Annie] Ctr Hosp Univ Pointe A Pitre, Serv Neurol, Pointe A Pitre 97159, Guadeloupe.
   [Herrmann, Cecile; Breurec, Sebastien] Ctr Hosp Univ Pointe A Pitre, Lab Microbiol Clin & Environm, Pointe A Pitre 97159, Guadeloupe.
   [Poullain, Pascale; Mathon, Gregory] Ctr Hosp Univ Pointe A Pitre, Serv Radiol, Pointe A Pitre 97159, Guadeloupe.
   [Breurec, Sebastien; Lannuzel, Annie] Univ Antilles, Fac Med, Antilles, Guadeloupe.
   [Breurec, Sebastien] Inst Pasteur Guadeloupe, Unite Sante & Environm, Pointe A Pitre, Guadeloupe.
   [Lannuzel, Annie] Univ Paris 04, INSERM, U1127, CNRS,UMR 7225,Inst Cerveau & Moelle Epiniere,ICM, Paris, France.
RP Lannuzel, A (reprint author), Ctr Hosp Univ Pointe A Pitre, Serv Neurol, Pointe A Pitre 97159, Guadeloupe.
EM annie.lannuzel@chu-guadeloupe.fr
CR Ali M, 2005, AM J NEURORADIOL, V26, P289
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Larik A, 2012, BMJ CASE REP, DOI [10.1136/bcr.12.2011.53783, DOI 10.1136/BCR.12.2011.53783]
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Verma R, 2012, BMJ CASE REP, DOI [10.1136/bcr-2012-007094, DOI 10.1136/BCR-2012-007094]
NR 5
TC 9
Z9 9
U1 16
U2 16
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 2
PY 2016
VL 387
IS 10026
BP 1481
EP 1481
DI 10.1016/S0140-6736(16)00644-9
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI0WH
UT WOS:000373217500036
PM 26946926
ER

PT J
AU Brasil, P
   Sequeira, PC
   Freitas, AD
   Zogbi, HE
   Calvet, GA
   de Souza, RV
   Siqueira, AM
   de Mendonca, MCL
   Nogueira, RMR
   de Filippis, AMB
   Solomon, T
AF Brasil, Patricia
   Sequeira, Patricia Carvalho
   Freitas, Andrea D'Avila
   Zogbi, Heruza Einsfeld
   Calvet, Guilherme Amaral
   de Souza, Rogerio Valls
   Siqueira, Andre Machado
   Lima de Mendonca, Marcos Cesar
   Ribeiro Nogueira, Rita Maria
   Bispo de Filippis, Ana Maria
   Solomon, Tom
TI Guillain-Barre syndrome associated with Zika virus infection
SO LANCET
LA English
DT Editorial Material
ID DENGUE
C1 [Brasil, Patricia; Freitas, Andrea D'Avila; Zogbi, Heruza Einsfeld; Calvet, Guilherme Amaral; de Souza, Rogerio Valls; Siqueira, Andre Machado] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Sequeira, Patricia Carvalho; Lima de Mendonca, Marcos Cesar; Ribeiro Nogueira, Rita Maria] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.
   [Solomon, Tom] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 3BX, Merseyside, England.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
RP Brasil, P (reprint author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
RI Calvet, Guilherme/G-6959-2013
OI Calvet, Guilherme/0000-0002-3545-5238
CR Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
NR 5
TC 10
Z9 10
U1 34
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD APR 2
PY 2016
VL 387
IS 10026
BP 1482
EP 1482
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI0WH
UT WOS:000373217500037
PM 27115821
ER

PT J
AU Kadri, MR
AF Kadri, Michele Rocha
TI Zika Virus in Brazil: A New Challenge for the National Health System and
   Nursing Care
SO INTERNATIONAL JOURNAL OF CHILDBIRTH EDUCATION
LA English
DT Article
DE Zika virus; Brazil
AB The appearance and rapid spread of the ZIKA virus in Brazil and elsewhere in the Americas has received increasing attention. The main vector for the Zika virus is the Aedes aegypti mosquito. There is mounting correlational evidence in support of this link between the Sika virus and microcephaly. The Zika virus epidemic has profound implications for mothers and their children in Brazil. Another issue affected by the ZIKA epidemic is pregnancy planning. Finally, there is the complex discussion of the effectiveness of control measures that are being taken to eliminate the Aedes aegypti mosquitoes. There are still many unanswered questions that will require long-term research efforts to resolve.
C1 [Kadri, Michele Rocha] Fundacao Oswaldo Cruz, Leonidas & Maria Deane Res Ctr, Manaus, Amazonas, Brazil.
RP Kadri, MR (reprint author), Fundacao Oswaldo Cruz, Leonidas & Maria Deane Res Ctr, Manaus, Amazonas, Brazil.
CR Abrasco, NOT TECN MICR DOENC
   Agencia Fiocruz de Noticia, FIOCR DET PRES VIR Z
   Brasil, 2010, PESQ NAC SAN BAS 200
   Brasil, INF EP
   Ligia Formenti, 2015, DIRETOR MINISTERIO S
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
NR 6
TC 0
Z9 0
U1 1
U2 1
PU INT CHILDBIRTH EDUCATION ASSOC
PI RALEIGH
PA 1500 SUNDAY DR, STE 102, RALEIGH, NC 27607 USA
SN 0887-8625
J9 INT J CHILDBIRTH EDU
JI Int. J. Childbirth Educ.
PD APR
PY 2016
VL 31
IS 2
BP 26
EP 28
PG 3
WC Nursing
SC Nursing
GA DV3TC
UT WOS:000382845300007
ER

PT J
AU Yung, CF
   Chong, CY
   Yeo, KT
   Liew, C
   Ng, LC
   Tan, NWH
   Yeo, GSH
   Tee, NWS
   Lin, RTP
   Tan, TC
   Rajadurai, VS
   Chan, JKY
   Thoon, KC
AF Yung, Chee Fu
   Chong, Chia Yin
   Yeo, Kee Thai
   Liew, Christina
   Ng, Lee Ching
   Tan, Natalie W. H.
   Yeo, George S. H.
   Tee, Nancy W. S.
   Lin, Raymond T. P.
   Tan, Thiam Chye
   Rajadurai, Victor S.
   Chan, Jerry K. Y.
   Thoon, Koh Cheng
TI Zika Virus: An Evolving Public Health Threat
SO ANNALS ACADEMY OF MEDICINE SINGAPORE
LA English
DT Editorial Material
ID YELLOW-FEVER; INTERIM GUIDELINES; POTENTIAL VECTOR; UNITED-STATES;
   INFECTION; AEDES; OUTBREAK; UGANDA; MICRONESIA; INDONESIA
C1 [Yung, Chee Fu; Chong, Chia Yin; Tan, Natalie W. H.; Thoon, Koh Cheng] KK Womens & Childrens Hosp, Dept Paediat, Infect Dis Serv, 100 Bukit Timah Rd, Singapore 229899, Singapore.
   [Yeo, Kee Thai; Rajadurai, Victor S.] KK Womens & Childrens Hosp, Dept Neonatol, Singapore, Singapore.
   [Liew, Christina; Ng, Lee Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
   [Ng, Lee Ching] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Yeo, George S. H.] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore.
   [Tee, Nancy W. S.] KK Womens & Childrens Hosp, Dept Pathol & Lab Med, Singapore, Singapore.
   [Lin, Raymond T. P.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.
   [Tan, Thiam Chye] KK Womens & Childrens Hosp, Dept Obstet & Gynaecol, Singapore, Singapore.
   [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore.
RP Yung, CF (reprint author), KK Womens & Childrens Hosp, Dept Paediat, Infect Dis Serv, 100 Bukit Timah Rd, Singapore 229899, Singapore.
EM Yung.Chee.Fu@kkh.com.sg
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2016, LANCET
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Surveillance of Congenital Abnormalies, 2005, INSTR REG SURV CONG
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Ministry of Health Singapore, 2016, 032016 MIN HLTH SING
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira Melo A S, 2016, Ultrasound Obstet Gynecol, V47, P6, DOI 10.1002/uog.15831
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PanAmericanHealth Organization (PAHO), 2015, EP ZIK VIR INF
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yap G, 2016, EPIDEMIOLOGICAL NEWS, V42, P3
NR 29
TC 0
Z9 0
U1 1
U2 1
PU ACAD MEDICINE SINGAPORE
PI REPUBLIC SINGAPORE
PA 142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE
SN 0304-4602
J9 ANN ACAD MED SINGAP
JI Ann. Acad. Med. Singap.
PD APR
PY 2016
VL 45
IS 4
BP 148
EP 151
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1MG
UT WOS:000381246200005
PM 27292005
ER

PT J
AU Yadav, S
   Rawal, G
   Baxi, M
AF Yadav, Sankalp
   Rawal, Gautam
   Baxi, Mudit
TI Zika virus: A pandemic in progress
SO JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE
LA English
DT Article
DE arboviruses; diagnosis; emerging disease; French Polynesia; serum;
   viruses; Zika virus
ID YELLOW-FEVER; TRANSMISSION; OUTBREAK; MICRONESIA; ISOLATIONS; INFECTION;
   VECTOR; STATES; BRAZIL; AEDES
AB The world is facing a number of emerging infections. The latest outbreak of Zika virus infection has only added to the suffering. The WHO declared a state of emergency in the affected countries and has issued alarms worldwide. The paucity of literature leading to lack of clear guidelines is one of the most important factors resulting in a higher number of cases. The absence of clinical vaccine and an antiviral drug may prove to be a really grave situation. The present paper throws some light on this new emerging virus that has been known to man since 1947.
C1 [Yadav, Sankalp] North Delhi Municipal Corp, Dept Med & TB, Chest Clin Moti Nagar, New Delhi, India.
   [Rawal, Gautam] Max Super Specialty Hosp, Resp Intens Care, New Delhi, India.
   [Baxi, Mudit] Sri Aurobindo Med Coll & Postgrad Inst, Dept Orthoped, Indore, Madhya Pradesh, India.
RP Yadav, S (reprint author), North Delhi Municipal Corp, Dept Med & TB, Chest Clin Moti Nagar, New Delhi, India.
EM drsankalpyadav@gmail.com
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, TRAV NOT
   CDC, 2016, CDC HLTH ADV REC MAN
   CDC, 2016, ZIK VIR
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2009, Med Trop (Mars), V69, P339
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 1998, J VIROL, V72, P73
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nasci RS, 2016, CDC HLTH INFORM INT, P94
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Reuters Staff, EL SALV URG PREGN 20
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yadav S, 2015, INT J PHARM CHEM ANA, V2, P46
   Yadav S, 2015, INT J HLTH SCI RES, V5, P368
   Yadav S, 2015, INT J SCI RES REV, V4, P101
   Yadav S, 2015, INT J PHARM CHEM ANA, V2, P139
   Yadav S, 2016, INT J HLTH SCI RES, V6, P364
   Yadav S, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.118.6455
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 47
TC 0
Z9 0
U1 2
U2 2
PU DE GRUYTER OPEN LTD
PI WARSAW
PA BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND
SN 2450-131X
EI 2224-4018
J9 J TRANSL INTERN MED
JI J. TRANSL. INTERN. MED.
PD APR
PY 2016
VL 4
IS 1
SI SI
BP 42
EP 45
DI 10.1515/jtim-2016-0009
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT6XZ
UT WOS:000381629700009
ER

PT J
AU Minassian, ML
AF Laura Minassian, Maria
TI Zika virus: chronicle of an "unexpected'' pandemic
SO REVISTA ARGENTINA DE MICROBIOLOGIA
LA Spanish
DT Editorial Material
C1 [Laura Minassian, Maria] Revista Argentina Microbiol, Buenos Aires, DF, Argentina.
RP Minassian, ML (reprint author), Revista Argentina Microbiol, Buenos Aires, DF, Argentina.
EM marialauraminassian@yahoo.com.ar
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS ZIK VIR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Ministerio de Salud Argentina, 2016, B INT VIG N309 SE19
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Organizacion Panamericana de la Salud/Organizacion Mundial de la Salud, 2016, ACT EP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 12
TC 0
Z9 0
U1 6
U2 6
PU ASOCIACION ARGENTINA MICROBIOLOGIA
PI BUENOS AIRES
PA BULNES 44  PB   B, BUENOS AIRES, 00000, ARGENTINA
SN 0325-7541
EI 1851-7617
J9 REV ARGENT MICROBIOL
JI Rev. Argent. Microbiol.
PD APR-JUN
PY 2016
VL 48
IS 2
BP 97
EP 99
DI 10.1016/j.ram.2016.06.001
PG 3
WC Microbiology
SC Microbiology
GA DR0FC
UT WOS:000379582400001
PM 27377478
ER

PT J
AU Solomon, T
AF Solomon, T.
TI Flavivirus encephalitis and other neurological syndromes (Japanese
   encephalitis, WNV, Tick borne encephalits, Dengue, Zika virus)
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Solomon, T.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England.
NR 0
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2016
VL 45
SU 1
MA 16.001
BP 24
EP 24
DI 10.1016/j.ijid.2016.02.086
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DK4GZ
UT WOS:000374876700046
ER

PT J
AU Tsankova, GS
   Kasimova, Z
   Todorova, TT
   Avdzhiyska, M
   Tsankova, D
AF Tsankova, Gabriela S.
   Kasimova, Zekie
   Todorova, Tatina T.
   Avdzhiyska, Milena
   Tsankova, Dajna
TI OUTBREAK OF ZIKA VIRUS DISEASE AND ITS COMPLICATIONS
SO JOURNAL OF IMAB
LA English
DT Article
DE Zika virus; Pregnancy; Microcephaly; Guillain-Barre syndrome
ID INTERIM GUIDELINES; UNITED-STATES; BRAZIL; TRANSMISSION; INFECTION
AB Zika virus (ZIKV) is an arbovirus from Flaviviridae family, genus Flavivirus. Like most of the viruses which belong to the Flavivirus genus, it replicates in and is transmitted by mosquitoes. Unlike other arbovirus infections including dengue and chikungunya, Zika virus causes a relatively mild disease. The most common symptoms of ZIKV are mild fever, arthralgia, myalgia, headache, asthenia, abdominal pain, oedema, lymphadenopathy, retro-orbital pain, conjunctivitis, and cutaneous maculopapular rash, which last for several days to a week. Although 80% of the cases with ZIKV are asymptomatic, severe complications such as microcephalia and GBS may be observed. This explains why ZIKV is more dangerous that it was thought to be and why it rapidly evolves in unexpected challenge for the international and national public health authorities.
C1 [Tsankova, Gabriela S.; Todorova, Tatina T.] Med Univ Varna, Fac Pharm, Dept Preclin & Clin Sci, 3 Bregalniza Str, Varna 9002, Bulgaria.
   [Kasimova, Zekie; Avdzhiyska, Milena; Tsankova, Dajna] Med Univ Varna, Varna, Bulgaria.
RP Tsankova, GS (reprint author), Med Univ Varna, Fac Pharm, Dept Preclin & Clin Sci, 3 Bregalniza Str, Varna 9002, Bulgaria.
EM gabriela_sc@abv.bg
CR Besnard M, 2014, EURO SURVEILL, V19
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS ZIK VIR
   Faye O, 2013, VIROL J, V10, P311, DOI DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V2016, P55
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI [10.1016/S1473-3099(16)30015-9, 10.1056/NEJMoa1602412]
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, 2016, ZIK VIR MICR GUILL B, P1
   World Health Organization, 2016, PREGN MAN CONT ZIK V
NR 23
TC 0
Z9 0
U1 9
U2 9
PU GOSPODIN ILIEV PEYTCHINSKI, ED & PUB
PI PLEVEN
PA DROUJBA BL 116, PLEVEN, 5806, BULGARIA
SN 1312-773X
J9 J IMAB
JI J. IMAB
PD APR-JUN
PY 2016
VL 22
IS 2
BP 1136
EP 1138
DI 10.5272/jimab.2016222.1136
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP6EU
UT WOS:000378590500007
ER

PT J
AU Sahiner, F
AF Sahiner, Fatih
TI Global Spread of Zika Virus Epidemic: Current Knowledges and
   Uncertainties
SO MIKROBIYOLOJI BULTENI
LA Turkish
DT Review
DE Zika virus; outbreak; epidemiology; infection; diagnosis
ID OF-THE-LITERATURE; FRENCH-POLYNESIA; DECEMBER 2013; INTERIM GUIDELINES;
   UNITED-STATES; YELLOW-FEVER; INFECTION; TRANSMISSION; BRAZIL; TURKEY
AB Zika virus (ZIKV) is an enveloped RNA virus that belongs to the Flaviviridae family. Although more than 60 years have passed since the discovery and first reported human cases of the virus, only a small number (< 10) of cases had been encountered in the literature until the last 10 years. Zika virus was known as a virus which caused sporadic infections and was confined to Africa and Asia along a narrow equatorial line. In 2007, howev r, the first major outbreak of ZIKV occurred in Yap Island (Micronesia), and so it was reported for the first time outside of Africa and Asia. Between the years of 2007 and 2014, ZIKV spreaded to island groups located in Southeast Asia and the Pacific Ocean, and in 2015-2016, it has spread to South and Central America and the Caribbean. Today, travel-related imported cases is still been reported in Europe, North America, and other countries in the Far East. According to the data from the World Health Organization and the Centers for Disease Control and Prevention, as of March 2016, ZIKV infections have already spread locally in more than 30 countries, and travel alerts have been issued for the countries where the virus is present. Zika virus infections are generally asymptomatic or may present with a moderate clinical picture (e.g. acute onset of fever, maculopapular rash, arthralgia, and nonpurulent conjunctivitis). Although no deaths were attributed to ZIKV infection over the past 60 years, as of November 2015, it has been suggested that three deaths in Brazil, including the death of a newborn with microcephaly, may be attributed to ZIKV infection. In addition, concurrent with outbreaks in 2013 in French Polynesia and in 2015 in Brazil, there have been significant rises reported in the incidence of some autoimmune and neurodevelopmental disorders, including Guillain-Barre syndrome and microcephaly; these reports have caused considerable international concern. There are many points that are still unclear about ZIKV, including: (1) intrauterine transmission risk, frequency, and effects of the infection on fetal development; (2) the probability of perinatal transmission and if so the possible risks; (3) association with autoimmune and neurological diseases, and presence of long-term sequelae risks after infection; (4) possible routes of transmission other than mosquito bites, such as sexual contact, blood transfusion, and other body fluids (saliva, semen, or urine); (5) presence of reservoir(s) and different mosquito vectors; (6) diagnostic difficulties including cross reactivity in serological tests and standardization of testing procedures; (7) severity of the infection in immunocompromised patients; and (8) the potential effectiveness of antiviral therapy or preventive vaccines. In this review, updated information and recommendations regarding ZIKV outbreaks and risks, and the epidemiology, diagnosis and characteristics of ZIKV infections, are summarized in light of the most recent literature.
C1 [Sahiner, Fatih] Gulhane Mil Med Acad, Dept Med Microbiol, Ankara, Turkey.
RP Sahiner, F (reprint author), GATA Tibbi Mikrobiyol Anabilim Dali, Tibbi Virol Bilim Dali, TR-06018 Ankara, Turkey.
EM fsvirol@gmail.com
CR Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Caglayik DY, 2012, MIKROBIYOL BUL, V46, P122
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Centers for Disease Control and Prevention, ZIK VIR
   [Anonymous], 2016, MEM REV DIAGN TEST Z
   Center for Disease Control and Prevention, 2016, AR WITH ZIK
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US
   Chastel C, 2012, Bull Soc Pathol Exot, V105, P251, DOI 10.1007/s13149-012-0255-8
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ergunay K, 2010, MIKROBIYOL BUL, V44, P415
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF OUTBR BR
   European Centre for Disease Prevention and Control, COUNTR LOC ZIK TRANS
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   The International Committee on Taxonomy of Viruses, 7 INT COMM TAX VIR
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Klinik Mikrobiyoloji Uzmanlik Dernegi, ZIK VIR
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Oter K, 2013, VECTOR-BORNE ZOONOT, V13, P753, DOI 10.1089/vbz.2012.1093
   The Pan American Health Organization/World Health Organization, 2015, EP AL ZIK VIR INF
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pyke AT, 2014, PLOS CURR, V2014, P6
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapshak P, 2015, GLOBAL VIROLOGY, P477
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Uyar Y, 2013, MIKROBIYOL BUL, V47, P173
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   vLanciotti RS, 2008, EMERG INFECT DIS, V14, P1232
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WHO, 2016, ZIK SIT REP
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 64
TC 0
Z9 0
U1 12
U2 12
PU ANKARA MICROBIOLOGY SOC
PI ANKARA
PA HACETLEPE UNIV FACULTY MEDICINE DEPT MICROBIOLOGY, 06100 ANKARA, TURKEY
SN 0374-9096
J9 MIKROBIYOL BUL
JI Mikrobiyol. Bul.
PD APR
PY 2016
VL 50
IS 2
BP 333
EP 351
DI 10.5578/mb.24167
PG 19
WC Microbiology
SC Microbiology
GA DP0MN
UT WOS:000378184000019
PM 27175508
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Information tools and prevention about the virus Zika
SO ACTUALITES PHARMACEUTIQUES
LA French
DT Editorial Material
CR Haut Conseil de la sante publique, 2016, AV REL TRANSM VIR ZI
NR 1
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 0515-3700
J9 ACTUAL PHARMACEUT
JI Actual. Pharm.
PD APR
PY 2016
VL 55
IS 555
BP 6
EP 6
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DO3SU
UT WOS:000377702600008
ER

PT J
AU Borchardt, RA
AF Borchardt, Roy A.
TI Zika virus: A rapidly emerging infectious disease
SO JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS
LA English
DT Article
DE Zika virus; arbovirus; flavivirus; microcephaly; pregnancy; infection
ID OUTBREAK; STATES
AB Zika virus is a flavivirus transmitted to humans via the bite of infected mosquitoes. A recent outbreak in Brazil has spread to several surrounding countries, and the virus also has been reported in the United States. The virus is associated with microcephaly among newborns whose mothers were infected. Because no vaccine or treatment is available, efforts have focused on preventing mosquito bites and advising pregnant women and women trying to get pregnant to avoid active areas of Zika virus transmission. Clinicians should understand the infection, its diagnosis and testing, and monitor pregnant women for travel history to outbreak regions and for the presence of clinical symptoms. Patient education on preventive measures offers the best option to avoid Zika virus infection.
C1 [Borchardt, Roy A.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Adv Practice Providers, Houston, TX 77030 USA.
RP Borchardt, RA (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Adv Practice Providers, Houston, TX 77030 USA.
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci A.S., 2016, N ENGL J MED
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi306, DOI DOI 10.1136/BMJ.I306
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Oster AM, 2016, MMWR EARLY RELEASE, V65
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
NR 12
TC 1
Z9 2
U1 21
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1547-1896
EI 0893-7400
J9 JAAPA-J AM ACAD PHYS
JI JAAPA-J. Am. Acad. Physician Assist.
PD APR
PY 2016
VL 29
IS 4
BP 48
EP 50
DI 10.1097/01.JAA.0000481413.11539.b1
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO6FZ
UT WOS:000377880000017
PM 26953673
ER

PT J
AU Nunez, CA
   Gonzalez, CR
   Obreque, V
   Riquelme, B
   Reyes, C
   Rojas, M
AF Andrea Nunez, Claudia
   Raul Gonzalez, Christian
   Obreque, Victor
   Riquelme, Brenda
   Reyes, Carolina
   Rojas, Mabel
TI Molecular characterization of Aedes aegypti (L.) (Diptera: Culicidae) of
   Easter Island based on analysis of the mitochondrial ND4 gene
SO REVISTA BRASILEIRA DE ENTOMOLOGIA
LA English
DT Article
DE Dengue; Haplotypes; Rapa Nui
ID CHILE
AB Aedes aegypti mosquitoes are the main vector of viruses Dengue, Zika and Chikungunya. Shortly after the first report of the dengue vector Ae. aegypti in Easter Island (Rapa Nui) in late 2000, the first disease outbreak dengue occurred. Viral serotyping during the 2002 outbreak revealed a close relationship withPacific DENV-1 genotype IV viruses, supporting the idea that the virus most likely originated in Tahiti. Mitochondrial NADH dehydrogenase subunit 4 (ND4) DNA sequences generated from 68 specimens of Ae. aegypti from Easter Island reporting a unique finding of a single maternal lineage of Ae. aegypti on Easter Island. (C) 2016 Sociedade Brasileira de Entomologia. Published by Elsevier Editora Ltda.
C1 [Andrea Nunez, Claudia; Obreque, Victor; Rojas, Mabel] Univ Iberoamericana Ciencias & Tecnol, Ctr Biotechnol, Santiago, Chile.
   [Raul Gonzalez, Christian; Reyes, Carolina] Inst Salud Publ Chile, Sect Parasitol, Lab Med Entomol, Santiago, Chile.
   [Raul Gonzalez, Christian] Univ Metropolitana Ciencias Educ, Inst Entomol, Santiago, Chile.
   [Riquelme, Brenda] Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Alameda 340, Santiago, Chile.
RP Nunez, CA (reprint author), Univ Iberoamericana Ciencias & Tecnol, Ctr Biotechnol, Santiago, Chile.
EM claudia.nunez@uibero.cl
CR Bandelt H., 1999, MOL BIOL EVOL, V16, P31
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Brown J.E., 2013, EVOLUTION, V68, P514
   Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Hall T. A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X
   Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   OLEA M. PILAR, 2003, Rev. chil. infectol., V20, P129, DOI 10.4067/S0716-10182003000200008
   Perret C, 2003, EMERG INFECT DIS, V9, P1465
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Urdaneta-Marquez L, 2008, AM J TROP MED HYG, V78, P479
NR 13
TC 0
Z9 0
U1 7
U2 7
PU SOC BRASILEIRA ENTOMOLOGIA
PI CURITIBA
PA CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL
SN 0085-5626
EI 1806-9665
J9 REV BRAS ENTOMOL
JI Rev. Bras. Entomol.
PD APR-JUN
PY 2016
VL 60
IS 2
BP 186
EP 187
DI 10.1016/j.rbe.2016.03.001
PG 2
WC Entomology
SC Entomology
GA DO6II
UT WOS:000377886200011
ER

PT J
AU Ladner, JT
   Kuhn, JH
   Palacios, G
AF Ladner, J. T.
   Kuhn, J. H.
   Palacios, G.
TI Standard finishing categories for high-throughput sequencing of viral
   genomes
SO REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
LA English
DT Article
DE Data curation; Genome assembly; High-throughput sequencing; Medical
   countermeasure development; Molecular epidemiology; Population genomics;
   Virus
ID EBOLA-VIRUS; DIVERSITY; EVOLUTION; DISCOVERY; VARIANTS; SURVEILLANCE;
   CORONAVIRUS; POPULATION; EMERGENCE; EPIDEMIC
AB Viral genome sequencing has become the cornerstone of almost all aspects of virology. In particular, high-throughput, next-generation viral genome sequencing has become an integral part of molecular epidemiological investigations into outbreaks of viral disease, such as the recent outbreaks of Middle Eastern respiratory syndrome, Ebola virus disease and Zika virus infection. Multiple institutes have acquired the expertise and necessary infrastructure to perform such investigations, as evidenced by the accumulation of thousands of novel viral sequences over progressively shorter time periods. The authors recently proposed a nomenclature comprised of five high-throughput sequencing standard categories to describe the quality of determined viral genome sequences. These five categories (standard draft, high quality, coding complete, complete and finished) cover all levels of viral genome finishing and can be applied to sequences determined by any technology platform or assembly technique.
C1 [Ladner, J. T.; Palacios, G.] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA.
   [Kuhn, J. H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD USA.
RP Palacios, G (reprint author), US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Frederick, MD 21702 USA.
EM gustavo.f.palacios.ctr@mail.mil
RI Palacios, Gustavo/I-7773-2015
OI Palacios, Gustavo/0000-0001-5062-1938
FU Defense Threat Reduction Agency [1881290]; Battelle Memorial Institute's
   prime contract; US National Institute of Allergy and Infectious Diseases
   [HHSN272200700016I]
FX This work was partly funded by Defense Threat Reduction Agency Project
   No. 1881290 and by Battelle Memorial Institute's prime contract with the
   US National Institute of Allergy and Infectious Diseases under Contract
   No. HHSN272200700016I. A subcontractor who performed this work is JHK,
   an employee of Tunnell Government Services. The authors thank Laura
   Bollinger for editing this manuscript.
CR Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13
   Brister JR, 2010, VIRUSES-BASEL, V2, P2258, DOI 10.3390/v2102258
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614
   Chan JFW, 2013, J FORMOS MED ASSOC, V112, P372, DOI 10.1016/j.jfma.2013.05.010
   Chow CET, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00265
   Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404
   Domingo E, 2006, CURR TOP MICROBIOL, V299, P51
   Fancello L, 2012, VIROLOGY, V434, P162, DOI 10.1016/j.virol.2012.09.025
   Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139
   Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   King AMQ., 2012, VIRUS TAXONOMY CLASS
   Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771
   Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038
   Kugelman J. R., 2014, EMERG INFECT DIS, V21, P1135
   Kuhn JH, 2014, VIRUSES-BASEL, V6, P3663, DOI 10.3390/v6093663
   Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0
   Labonte JM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00315
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14
   Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93
   Lipkin WI, 2013, NAT REV MICROBIOL, V11, P133, DOI 10.1038/nrmicro2949
   Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417
   Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053
   Palacios G, 2011, J VIROL, V85, P3811, DOI 10.1128/JVI.02275-10
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Perez-Ruiz M, 2012, EMERG INFECT DIS, V18, P855, DOI 10.3201/eid1805.111646
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-6-405, 10.1186/gb-2013-14-7-405]
   Sanchez AB, 2006, VIROLOGY, V350, P370, DOI 10.1016/j.virol.2006.01.012
   Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Suttle C, 2005, ENVIRON MICROBIOL, V7, P481, DOI 10.1111/j.1462-2920.2005.803_11.x
   Suttle CA, 2013, GENOME, V56, P542, DOI 10.1139/gen-2013-0152
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478
   Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Webster JP, 2016, EVOL APPL, V9, P313, DOI 10.1111/eva.12341
   Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869
   Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354
NR 42
TC 0
Z9 0
U1 4
U2 4
PU OFFICE INT EPIZOOTIES
PI PARIS
PA 12 RUE DE PRONY, 75017 PARIS, FRANCE
SN 0253-1933
J9 REV SCI TECH OIE
JI Rev. Sci. Tech. Off. Int. Epizoot.
PD APR
PY 2016
VL 35
IS 1
BP 43
EP 52
DI 10.20506/rst.35.1.2416
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA DO8EA
UT WOS:000378014200004
PM 27217167
ER

PT J
AU Jouannic, JM
   Huissoud, C
AF Jouannic, J. -M.
   Huissoud, C.
TI Zika virus and pregnancy
SO GYNECOLOGIE OBSTETRIQUE & FERTILITE
LA French
DT Editorial Material
DE Zika virus; Fetal infection; Brain anomalies; Ultrasound; Prenatal
ID INFECTION
C1 [Jouannic, J. -M.] Hop Trousseau, AP HP, Serv Med Foetale, Federat Francaise Ctr Pluridisciplinaires Diagnos, 26 Ave Dr Arnold Netter, F-75012 Paris, France.
   [Huissoud, C.] HCL, Serv Gynecol Obstet, Matern Croix Rousse, 103 Grande Rue Croix Rousse, F-69004 Lyon, France.
RP Jouannic, JM (reprint author), Hop Trousseau, AP HP, Serv Med Foetale, Federat Francaise Ctr Pluridisciplinaires Diagnos, 26 Ave Dr Arnold Netter, F-75012 Paris, France.
EM jean-marie.jouannic@aphp.fr
CR Besnard M, 2014, EURO SURVEILL, V19
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang H, 2016, STEM CELLS, DOI DOI 10.1016/J.STEM.2016.02.016
NR 7
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1297-9589
EI 1769-6682
J9 GYNECOL OBSTET FERTI
JI Gynecol. Obstet. Fertil.
PD APR
PY 2016
VL 44
IS 4
BP 193
EP 194
DI 10.1016/j.gyobfe.2016.03.006
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DM0SF
UT WOS:000376055400001
PM 27053037
ER

PT J
AU Salinas, S
   Foulongne, V
   Loustalot, F
   Fournier-Wirth, C
   Moles, JP
   Briant, L
   Nagot, N
   Van de Perre, P
   Simonin, Y
AF Salinas, Sara
   Foulongne, Vincent
   Loustalot, Fabien
   Fournier-Wirth, Chantal
   Moles, Jean-Pierre
   Briant, Laurence
   Nagot, Nicolas
   Van de Perre, Philippe
   Simonin, Yannick
TI Zika virus An emerging threat
SO M S-MEDECINE SCIENCES
LA French
DT Review
ID FRENCH-POLYNESIA; TRANSMISSION; INFECTION; BRAZIL; OUTBREAK; MICRONESIA;
   PREGNANCY; GENOME; STATES; CELLS
C1 [Salinas, Sara; Foulongne, Vincent; Loustalot, Fabien; Fournier-Wirth, Chantal; Moles, Jean-Pierre; Nagot, Nicolas; Van de Perre, Philippe; Simonin, Yannick] Univ Montpellier, INSERM, UMR 1058, Etablissement Francais Sang Pathogenesis & Contr, 60 Rue Navacelles, F-34394 Montpellier 5, France.
   [Foulongne, Vincent; Nagot, Nicolas; Van de Perre, Philippe] CHU Montpellier, Dept Bacteriol Virol, Montpellier, France.
   [Fournier-Wirth, Chantal] Etablissement Francais Sang, Parc Euromed, F-34184 Montpellier 4, France.
   [Briant, Laurence] Univ Montpellier, CNRS, CPBS, FRE3689, 1919 Route Mende, F-34293 Montpellier 5, France.
   [Simonin, Yannick] Univ Montpellier, 4 Blvd Henri IV, F-34967 Montpellier 2, France.
RP Simonin, Y (reprint author), Univ Montpellier, INSERM, UMR 1058, Etablissement Francais Sang Pathogenesis & Contr, 60 Rue Navacelles, F-34394 Montpellier 5, France.; Simonin, Y (reprint author), Univ Montpellier, 4 Blvd Henri IV, F-34967 Montpellier 2, France.
EM sara.salinas@inserm.fr; yannick.simonin@umontpellier.fr
RI Salinas, Sara/O-1856-2013
OI Salinas, Sara/0000-0003-4492-2093
CR Baronti C, 2014, GENOME ANNOUNC, V2
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EURO SURVEILL, V19
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   BVS CHPF, 2015, NOT INV AUT MALF CER
   Cao-Lormeau VM, 2016, LANCET
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Consigny PH, 2006, M S-MED SCI, V22, P444
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de MCR, 2016, J CLIN VIROL, V77, P69
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M., 2016, LANCET
   ECDC, 2016, RAP RISK ASS
   ECDC, 2015, RAP RISK ASS
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Flamand M, 2002, M S-MED SCI, V18, P816, DOI 10.1051/medsci/20021889816
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin Patrick, 2008, PLoS Med, V5, pe60, DOI 10.1371/journal.pmed.0050060
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grard G, 2014, PLOS NEGLECT TROP D, V8, P1
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haut Conseil de la Sante Publique, 1995, PRIS CHARG MED PERS
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2011, M S-MED SCI, V27, P375, DOI 10.1051/medsci/2011274012
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Maria AT, 2016, EURO SURVEILL, V2
   Martines R, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6506E1ER
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108
   Roth A, 2012, EUROSURVEILLANCE, V19, P20929
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   World Health Organization, 2015, EP AL
   Wong Pei-Sze Jeslyn, 2013, PLoS Neglected Tropical Diseases, V7, P1
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 55
TC 0
Z9 0
U1 4
U2 4
PU EDP SCIENCES S A
PI LES ULIS CEDEX A
PA 17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A,
   FRANCE
SN 0767-0974
J9 M S-MED SCI
JI M S-Med. Sci.
PD APR
PY 2016
VL 32
IS 4
BP 378
EP 386
DI 10.1051/medsci/20163204016
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DM1YQ
UT WOS:000376143200006
PM 27137695
ER

PT J
AU Rios-Gonzalez, CM
   Escobar-Salinas, JS
AF Miguel Rios-Gonzalez, Carlos
   Sebastian Escobar-Salinas, Jorge
TI Pregnancy and Zika virus infection: an emerging problem in Paraguayan
   public health
SO PEDIATRIA-ASUNCION
LA Spanish
DT Editorial Material
C1 [Miguel Rios-Gonzalez, Carlos; Sebastian Escobar-Salinas, Jorge] Univ Nacl Caaguazu, Fac Ciencias Med, Coronel Oviedo, Paraguay.
RP Rios-Gonzalez, CM (reprint author), Univ Nacl Caaguazu, Fac Ciencias Med, Coronel Oviedo, Paraguay.
EM carlosmigue_rios@live.com
CR British Broadcasting Corporation (BBC) News, 2016, BRIT BROADCASTI 0205
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio de Salud Publica y Bienestar Social, 2016, INF PREN MIN SAL CON
   Ministerio de Salud Publica y Bienestar Social, 2015, FIEBR ZIK BOL EP, V46, P7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization, 2015, EP AL NEUR SYNDR CON
NR 11
TC 0
Z9 0
U1 5
U2 5
PU SOC PARAGUAYA PEDIATRIA
PI ASUNCION
PA MCAL ESTIGARRIBIA 1764, C RCA FRANCESA, ASUNCION, 00000, PARAGUAY
SN 1683-979X
EI 1683-9803
J9 PEDIATRIA-ASUNCION
JI Pediatria-Asuncion
PD APR
PY 2016
VL 43
IS 1
BP 77
EP 78
PG 2
WC Pediatrics
SC Pediatrics
GA DM0HW
UT WOS:000376025500010
ER

PT J
AU Bell, BP
   Boyle, CA
   Petersen, LR
AF Bell, Beth P.
   Boyle, Coleen A.
   Petersen, Lyle R.
TI Preventing Zika Virus Infections in Pregnant Women: An Urgent Public
   Health Priority
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID BRAZIL
C1 [Bell, Beth P.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
   [Boyle, Coleen A.] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Petersen, Lyle R.] CDC, Div Vector Borne Dis, Ft Collins, CO USA.
RP Bell, BP (reprint author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd,Mailstop C12, Atlanta, GA 30329 USA.
EM bbell@cdc.gov
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EPID AM POT
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Martin J. L. S., 2010, American Journal of Tropical Medicine and Hygiene, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martines R, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6506E1ER
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J., 2016, N ENGL J MED
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Plotkin SA, 2008, VACCINES, P735
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   [Anonymous], 2016, ZIK VIR MICR GUILL B
NR 14
TC 0
Z9 0
U1 8
U2 18
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2016
VL 106
IS 4
BP 589
EP 590
DI 10.2105/AJPH.2016.303124
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL8SY
UT WOS:000375913000008
PM 26959253
ER

PT J
AU Miranda, DD
   Martelli, CMT
   Ximenes, RAD
   Araujo, TVB
   Rocha, MAW
   Ramos, RCF
   Dhalia, R
   Franca, RFD
   Marques, ETD
   Rodrigues, LC
AF Miranda-Filho, Democrito de Barros
   Turchi Martelli, Celina Maria
   de Alencar Ximenes, Ricardo Arraes
   Barreto Araujo, Thalia Velho
   Wanderley Rocha, Maria Angela
   Ferreira Ramos, Regina Coeli
   Dhalia, Rafael
   de Oliveira Franca, Rafael Freitas
   de Azevedo Marques Junior, Ernesto Torres
   Rodrigues, Laura Cunha
TI Initial Description of the Presumed Congenital Zika Syndrome
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID VIRUS; INFECTIONS; BRAZIL
AB Objectives. To provide an initial description of the congenital syndrome presumably associated with infection by Zika virus compared with other syndromes including congenital infections of established etiologies.
   Methods. We provide an overview of a published case series of 35 cases, a clinical series of 104 cases, and published and unpublished reports of clinical and laboratory findings describing cases diagnosed since the beginning of the epidemic of microcephaly in Brazil.
   Results. About 60% to 70% of mothers report rash during pregnancy; mainly in the first trimester. Principal features are microcephaly, facial disproportionality, cutis girata, hypertonia/spasticity, hyperreflexia, and irritability; abnormal neuroimages include calcifications, ventriculomegaly, and lissencephaly. Hearing and visual abnormalities may be present.
   Conclusions. Preliminary data suggest that severe congenital abnormalities are linked to Zika virus infection. Cases have severe abnormalities, and although sharing many characteristics with congenital abnormalities associated with other viral infections, abnormalities presumably linked to the Zika virus may have distinguishing characteristics. These severe neurologic abnormalities may result in marked mental retardation and motor disabilities for many surviving offspring.
   Policy Implications. Affected nations need to prepare to provide complex and costly multidisciplinary care that children diagnosed with this new congenital syndrome will require.
C1 [Miranda-Filho, Democrito de Barros; de Alencar Ximenes, Ricardo Arraes; Wanderley Rocha, Maria Angela; Ferreira Ramos, Regina Coeli] Univ Pernambuco, Recife, PE, Brazil.
   [Turchi Martelli, Celina Maria; Dhalia, Rafael; de Oliveira Franca, Rafael Freitas; de Azevedo Marques Junior, Ernesto Torres] Fiocruz MS, Oswaldo Cruz Fdn, Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [de Alencar Ximenes, Ricardo Arraes; Barreto Araujo, Thalia Velho] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, London WC1, England.
RP Miranda, DD (reprint author), Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
EM demofilho@gmail.com
FU Brazilian Ministry of Health, Pernambuco State Health Department
   (SES-PE); Pan American Health Organization; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq [306489/2010-4,
   308311/2009-4, 308590/2013-9]
FX We thank the support of the Brazilian Ministry of Health, Pernambuco
   State Health Department (SES-PE) and Pan American Health Organization.
   The authors received partial support from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq (scholarship
   306489/2010-4 to C. M. T. M., 308311/2009-4 to R. A. A. X.,
   308590/2013-9 to D. B. M. F.).
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brazilian Ministry of Health, 10 BRAZ MIN HLTH
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 8
TC 11
Z9 13
U1 10
U2 10
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2016
VL 106
IS 4
BP 598
EP 600
DI 10.2105/AJPH.2016.303115
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL8SY
UT WOS:000375913000013
ER

PT J
AU Teixeira, MG
   Costa, MDN
   de Oliveira, WK
   Nunes, ML
   Rodrigues, LC
AF Teixeira, Maria G.
   Costa, Maria da Conceicao N.
   de Oliveira, Wanderson K.
   Nunes, Marilia Lavocat
   Rodrigues, Laura C.
TI The Epidemic of Zika Virus-Related Microcephaly in Brazil: Detection,
   Control, Etiology, and Future Scenarios
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID INFECTION; OUTBREAK
AB We describe the epidemic of microcephaly in Brazil, its detection and attempts to control it, the suspected causal link with Zika virus infection during pregnancy, and possible scenarios for the future. In October 2015, in Pernambuco, Brazil, an increase in the number of newborns with microcephaly was reported. Mothers of the affected newborns reported rashes during pregnancy and no exposure to other potentially teratogenic agents. Women delivering in October would have been in the first trimester of pregnancy during the peak of a Zika epidemic in March. By the end of 2015, 4180 cases of suspected microcephaly had been reported. Zika spread to other American countries and, in February 2016, the World Health Organization declared the Zika epidemic a public health emergency of international concern. This unprecedented situation underscores the urgent need to establish the evidence of congenital infection risk by gestational week and accrue knowledge. There is an urgent call for a Zika vaccine, better diagnostic tests, effective treatment, and improved mosquito-control methods.
C1 [Teixeira, Maria G.; Costa, Maria da Conceicao N.] Univ Fed Bahia, Inst Saude Coletiva, Salvador, BA, Brazil.
   [de Oliveira, Wanderson K.; Nunes, Marilia Lavocat] Minist Hlth, Brasilia, DF, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
RP Rodrigues, LC (reprint author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM laura.rodrigues@lshtm.ac.uk
CR Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOL, V46, P1
   Brasil MdSd, 2015, B EPIDEMIOL, V46, P1
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOL
   Brasil Ministerio da Saude, 2015, PREV COMB DENG CHIK
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2016, TRAV HLTH NOT AL LEV
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Mlakar J., 2016, N ENGL J MED
   Oehler E., 2014, EUROSURVEILLANCE, V19, P9
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887
   Pan American Health Organization World Health Organization, 2015, CONG AN 2 LEAD CAUS
   Pan American Health Organization, 2015, EP LOG AL NEUR SYNDR
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   PARSONSON IM, 1977, INFECT IMMUN, V15, P254
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stein R, BIG ZIKA VIRUS OUTBR
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7
   Ventura CV, 2016, LANCET, V387, P228
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, 2015, CONGENITAL ANOMALIES
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
NR 28
TC 8
Z9 9
U1 27
U2 42
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2016
VL 106
IS 4
BP 601
EP 605
DI 10.2105/AJPH.2016.303113
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL8SY
UT WOS:000375913000014
PM 26959259
ER

PT J
AU Paixao, ES
   Barreto, F
   Teixeira, MD
   Costa, MDN
   Rodrigues, LC
AF Paixao, Enny S.
   Barreto, Florisneide
   Teixeira, Maria da Gloria
   Costa, Maria da Conceicao N.
   Rodrigues, Laura C.
TI History, Epidemiology, and Clinical Manifestations of Zika: A Systematic
   Review
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Review
ID VIRUS-INFECTION; FRENCH-POLYNESIA; POTENTIAL VECTOR; DENGUE VIRUSES;
   DECEMBER 2013; TRANSMISSION; AEDES; BRAZIL; OUTBREAK; CHIKUNGUNYA
AB Objectives. To describe salient epidemiological characteristics of Zika virus outbreaks across the world and to examine the clinical presentations, complications, and atypical manifestations related to their occurrence in recent history.
   Methods. We conducted a systematic review of the literature by searching through MEDLINE, Embase, and Global Health Library, as well as the epidemiological bulletins and alerts from the World Health Organization, the Pan American Health Organization, and the European Centre for Disease Prevention and Control over the period 1954 to 2016.
   Results. The search yielded 547 records. We retained 333 for further analysis, to which we added 11 epidemiological bulletins from various sources. Of these, we systematically reviewed 52 articles and reports, revealing some epidemiological features and patterns of spread of the Zika virus worldwide, as well as pathological outcomes suspected to be linked to Zika outbreaks. Neurologic disorders among zika patients were similar in Brazil and French Polynesia but a causal link is not established. Incidence of zika infection in pregnant women is not known. In Brazil, during the zika outbreak the incidence of microcephaly increased more than 20 times. Among 35 infants with microcephaly, born from women suspected to have Zika infection during pregnancy in northeast Brazil, 74% of the mothers reported rash during the first and second trimester.
   Conclusions. On February 1, 2016, The World Health Organization declared the ongoing Zika crisis an emergency and that, although not yet scientifically proven, the link between the virus and growing numbers of microcephaly cases was "strongly suspected." However, the causal relationship between zika and microcephaly is not universally accepted.
   Public Health Implications. The current situation with regard to Zika is not encouraging, because there is no vaccine, no treatment, and no good serological test, and vector control remains a challenge.
C1 [Paixao, Enny S.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, London WC1, England.
   [Barreto, Florisneide; Teixeira, Maria da Gloria; Costa, Maria da Conceicao N.] Univ Fed Bahia, Inst Saude Coletiva, Salvador, BA, Brazil.
RP Paixao, ES (reprint author), 21 Woodside Pk Ave,Flat 25, London N12 8AQ, England.
EM enny.cruz@lshtm.ac.uk
FU National Council for Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico) [205427/2014-6]
FX This study was supported by the National Council for Scientific and
   Technological Development (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico; process 205427/2014-6).
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   [Anonymous], 2016, LANCET
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Butler D, NATURE NEWS
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2015, SYMPT DIAGN TREATM
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2011, AM J TROP MED HYG S1, V85, P183
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hearn PT, 2014, AM J TROP MED HYG S1, V91, P62
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Karen BB, 2014, IDCASES, P95
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuno G, 1998, J VIROL, V72, P73
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malet H, EPIDEMIOLOGICAL STAT
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Ministry of Health of Brazil Secretary of Surveillance in Health, EPIDEMIOLOGICAL B
   Ministry of Health of Brazil Secretary of Health of the State of Bahia, 2015, B EPIDEMIOL, P11
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, EP AL NEUR SYNDR CON
   Pan American Health Organization, 2015, EP AL ZIK VIR INF
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   PELLISSIER AIME, 1954, BULL SOC PATHOL EXOT, V47, P223
   Pyke AT, 2014, PLOS CURR, V6
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Solbrig MV, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0550-4
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas SM, 2014, INT J ENV RES PUB HE, V11, P3360, DOI 10.3390/ijerph110303360
   Tognarelli J, 2015, ARCH VIROL
   Villamil-Gomez W E, 2016, J INFECT PUBLIC HLTH, DOI S1876-0341(15)00221-X
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   World Health Organization Regional Office for the Western Pacific Region, PAC SYNDR SURV REP M
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 74
TC 10
Z9 11
U1 35
U2 44
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2016
VL 106
IS 4
BP 606
EP 612
DI 10.2105/AJPH.2016.303112
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL8SY
UT WOS:000375913000015
PM 26959260
ER

PT J
AU Lucey, DR
AF Lucey, Daniel R.
TI WILL ZIKA VIRUS AND MICROCEPHALY EPIDEMICS EMERGE AFTER EBOLA IN WEST
   AFRICA? THE NEED FOR PROSPECTIVE STUDIES NOW
SO HEALTH SECURITY
LA English
DT Editorial Material
C1 [Lucey, Daniel R.] Georgetown Univ, Sch Med, Med, Washington, DC USA.
   [Lucey, Daniel R.] Georgetown Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA.
RP Lucey, DR (reprint author), Georgetown Univ Hosp, Med Ctr, Div Infect Dis, Dept Med, 3800 Reservoir Rd NW, Washington, DC 20057 USA.
EM DRL23@Georgetown.edu
CR Garcez PP, 2016, PEERJ PREPRINTS, V4
   Tang H, 2016, CELL STEM CELL, V18, P1
   World Health Organization, 2016, ZIK VIR RISK ASS WHO
   World Health Organization, 2016, WHO STAT 2 M IHR EM
NR 4
TC 1
Z9 1
U1 5
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD APR
PY 2016
VL 14
IS 2
BP 53
EP 54
DI 10.1089/hs.2016.0033
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK1FJ
UT WOS:000374657600005
PM 26986702
ER

PT J
AU Perret, C
AF Perret, Cecilia
TI Zika virus, guilty or innocent?
SO REVISTA CHILENA DE INFECTOLOGIA
LA Spanish
DT Editorial Material
ID INFECTION; BRAZIL
C1 [Perret, Cecilia] Pontificia Univ Catolica Chile, Escuela Med, Santiago, Chile.
RP Perret, C (reprint author), Pontificia Univ Catolica Chile, Escuela Med, Santiago, Chile.
EM cperret@med.puc.cl
CR Brasil P, 2016, N ENGL J MED
   Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Oehler E, 2014, EURO SURVEILL, P19
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2015, ARCH VIROL, V161, P665, DOI DOI 10.1007/S00705-015-2695-5.EPUB
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 0
Z9 0
U1 1
U2 1
PU SOC CHILENA INFECTOLOGIA
PI PROVIDENCIA
PA BERNARDA MORIN 488, 2 PISO, PROVIDENCIA, SANTIAGO 00000, CHILE
SN 0716-1018
EI 0717-6341
J9 REV CHIL INFECTOL
JI Rev. Chil. Infectol.
PD APR
PY 2016
VL 33
IS 2
BP 187
EP 188
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DL2WJ
UT WOS:000375495600008
ER

PT J
AU Higgs, S
   Vanlandingham, DL
AF Higgs, S.
   Vanlandingham, D. L.
TI Search and one will find: Zika virus everywhere
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Editorial Material
DE Aedes aegypti; Epidemic; Microcephaly; Transmission; Zika virus
C1 [Higgs, S.] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
   Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
RP Higgs, S (reprint author), Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
EM shiggs@ksu.edu
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Higgs S, 2015, T ROY SOC TROP MED H, V109, P543, DOI 10.1093/trstmh/trv061
   MacNamara FN., 1952, ANN REPORT VIRUS RES
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Tang H, 2016, CELL STEM CELL, V18, P1
NR 11
TC 0
Z9 0
U1 8
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD APR
PY 2016
VL 110
IS 4
BP 207
EP 208
DI 10.1093/trstmh/trw020
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DJ9ZV
UT WOS:000374573000001
PM 27076507
ER

PT J
AU Liu, SQ
   Zhang, B
AF Liu, Si-Qing
   Zhang, Bo
TI Zika virus: a flavivirus caused pandemics in Latin America
SO VIROLOGICA SINICA
LA English
DT Editorial Material
ID MICRONESIA
C1 [Liu, Si-Qing; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
RP Zhang, B (reprint author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
EM zhangbo@wh.iov.cn
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hennessey M, 2016, MORB MORTAL WKLY REP, V65
   Kuno G, 1998, J VIROL, V72, P73
   Lamb RA, 2001, FIELDS VIROLOGY
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Schuler-Faccini L, 2016, MORB MORTAL WKLY REP, P65
   Shinohara K, 2016, J TRAVEL MED, V23
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Van-Mai C-L, 2013, EMERG INFECT DIS, V20, P1084
   World Health Organization, 2016, ZIK SIT REP ZIK POT
NR 18
TC 0
Z9 0
U1 10
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2016
VL 31
IS 2
BP 101
EP 102
DI 10.1007/s12250-016-3738-0
PG 2
WC Virology
SC Virology
GA DL3NF
UT WOS:000375539800001
PM 26965108
ER

PT J
AU Wang, ZY
   Wang, PG
   An, J
AF Wang, Zhaoyang
   Wang, Peigang
   An, Jing
TI Zika virus and Zika fever
SO VIROLOGICA SINICA
LA English
DT Review
DE Zika virus; Zika fever; Zika host interaction; microcephaly; neuronal
   disorder
ID ASIAN LINEAGE; AMERICA; INFECTION; OUTBREAK; MICRONESIA; SPREADS;
   STATES; CELLS
AB An emerging mosquito-borne arbovirus named Zika virus (ZIKV), of the family Flaviviridae and genus Flavivirus, is becoming a global health threat. ZIKV infection was long neglected due to its sporadic nature and mild symptoms. However, recently, with its rapid spread from Asia to the Americas, affecting more than 30 countries, accumulating evidences have demonstrated a close association between infant microcephaly and Zika infection in pregnant women. Here, we reviewed the virological, epidemiological, and clinical essentials of ZIKV infection.
C1 [Wang, Zhaoyang; Wang, Peigang; An, Jing] Chinese Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China.
RP Wang, PG; An, J (reprint author), Chinese Capital Med Univ, Sch Basic Med Sci, Dept Microbiol, Beijing 100069, Peoples R China.
EM pgwang@ccmu.edu.cn; anjing@ccmu.edu.cn
FU National Natural Science Foundations of China [81471957, 81271839,
   81372935, 81301435, 81401676]
FX This work was supported by the National Natural Science Foundations of
   China (81471957, 81271839, 81372935, 81301435, and 81401676).
CR Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EURO SURVEILL, V19
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cunha MS, 2016, GENOME ANNOUNC, V4, DOI DOI 10.1128/GENOMEA.00032-16
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de MCR, 2016, J CLIN VIROL, V77, P69
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Franchini M, 2015, BLOOD TRANSFUS, V1
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2015, BLOOD TRANSFUS, V14, P95
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 47
TC 1
Z9 1
U1 13
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2016
VL 31
IS 2
BP 103
EP 109
DI 10.1007/s12250-016-3780-y
PG 7
WC Virology
SC Virology
GA DL3NF
UT WOS:000375539800002
PM 27129450
ER

PT J
AU Shen, S
   Shi, JM
   Wang, J
   Tang, S
   Wang, HL
   Hu, ZH
   Deng, F
AF Shen, Shu
   Shi, Junming
   Wang, Jun
   Tang, Shuang
   Wang, Hualin
   Hu, Zhihong
   Deng, Fei
TI Phylogenetic analysis revealed the central roles of two African
   countries in the evolution and worldwide spread of Zika virus
SO VIROLOGICA SINICA
LA English
DT Article
DE Flaviviridae; Zika virus (ZIKV); phylogenetic analysis; lineages;
   recombination; migration
ID MOSQUITO-BORNE DISEASE; INFECTION; ARBOVIRUSES; INDONESIA; CHIKUNGUNYA;
   MICRONESIA; PACIFIC; DENGUE; TRAVEL; GABON
AB Recent outbreaks of Zika virus (ZIKV) infections in Oceania's islands and the Americas were characterized by high numbers of cases and the spread of the virus to new areas. To better understand the origin of ZIKV, its epidemic history was reviewed. Although the available records and information are limited, two major genetic lineages of ZIKV were identified in previous studies. However, in this study, three lineages were identified based on a phylogenetic analysis of all virus sequences from GenBank, including those of the envelope protein (E) and non-structural protein 5 (NS5) coding regions. The spatial and temporal distributions of the three identified ZIKV lineages and the recombination events and mechanisms underlying their divergence and evolution were further elaborated. The potential migration pathway of ZIKV was also characterized. Our findings revealed the central roles of two African countries, Senegal and Cote d'Ivoire, in ZIKV evolution and genotypic divergence. Furthermore, our results suggested that the outbreaks in Asia and the Pacific islands originated from Africa. The results provide insights into the geographic origins of ZIKV outbreaks and the spread of the virus, and also contribute to a better understanding of ZIKV evolution, which is important for the prevention and control of ZIKV infections.
C1 [Shen, Shu; Shi, Junming; Wang, Jun; Tang, Shuang; Wang, Hualin; Hu, Zhihong; Deng, Fei] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
RP Deng, F (reprint author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
EM df@wh.iov.cn
FU Science and Technology Basic Work Program from the Ministry of Science
   and Technology of China [2013FY113500]
FX This work was supported by the Science and Technology Basic Work Program
   (2013FY113500) from the Ministry of Science and Technology of China.
CR Alera MT, 2012, EMERG INFECT DIS, V21, P722
   ASAHINA S, 1970, JPN J MED SCI BIOL, V23, P255
   Baronti C, 2014, GENOME ANNOUNC, P2
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kindhauser MK, 2016, B WHO
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2014, EURO SURVEILL, P19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Roth A., 2014, EURO SURVEILL, V19
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2014, ARCH VIROL, V161, P665
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2014, GLOB BRIEF VECT BORN
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 49
TC 4
Z9 4
U1 10
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2016
VL 31
IS 2
BP 118
EP 130
DI 10.1007/s12250-016-3774-9
PG 13
WC Virology
SC Virology
GA DL3NF
UT WOS:000375539800004
PM 27129451
ER

PT J
AU Deng, CL
   Liu, SQ
   Zhang, QY
   Xu, MY
   Zhang, HL
   Gu, DY
   Shi, L
   He, JA
   Xiao, GF
   Zhang, B
AF Deng, Chenglin
   Liu, Siqing
   Zhang, Qiuyan
   Xu, Mingyue
   Zhang, Honglei
   Gu, Dayong
   Shi, Lei
   He, Jian'an
   Xiao, Gengfu
   Zhang, Bo
TI Isolation and characterization of Zika virus imported to China using
   C6/36 mosquito cells
SO VIROLOGICA SINICA
LA English
DT Letter
C1 [Deng, Chenglin; Liu, Siqing; Zhang, Qiuyan; Xu, Mingyue; Zhang, Honglei; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
   [Zhang, Qiuyan; Xu, Mingyue; Zhang, Honglei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Gu, Dayong; Shi, Lei; He, Jian'an] Shenzhen Entry Exit Inspect & Quarantine Bur, Cent Lab Hlth Quarantine, Shenzhen Travel Healthcare Ctr, Shenzhen 518033, Peoples R China.
   [Xiao, Gengfu] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
RP Zhang, B (reprint author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
EM zhangbo@wh.iov.cn
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P1
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Gubler DJ, 2007, FIELDS VIROLOGY, P1154
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Li J, 2016, EMERG INFECT DIS, DOI [10.3201/eld2206.160273, DOI 10.3201/ELD2206.160273]
   Liu S-Q, 2016, VIROL SIN, V31, P1
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
NR 9
TC 1
Z9 1
U1 5
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD APR
PY 2016
VL 31
IS 2
BP 176
EP 179
DI 10.1007/s12250-016-3778-5
PG 4
WC Virology
SC Virology
GA DL3NF
UT WOS:000375539800010
PM 27105638
ER

PT J
AU Flores, MS
   Burgess, TH
   Rajnik, M
AF Flores, Michelle S.
   Burgess, Timothy H.
   Rajnik, Michael
TI Zika virus: A primer for clinicians
SO CLEVELAND CLINIC JOURNAL OF MEDICINE
LA English
DT Review
ID INTERIM GUIDELINES; UNITED-STATES; SEXUAL TRANSMISSION; PREGNANT-WOMEN;
   INFECTION; BRAZIL; MICRONESIA; OUTBREAK; BRAIN; CHILD
AB The ongoing outbreak of Zika virus infection that began in South America and Central America in 2014 is worrisome because of associations with fetal microcephaly and with Guillain-Barre syndrome. Here we summarize what has happened and what is known so far. As the outbreak continues to evolve, we urge clinicians to watch for updates at cdc.gov.
C1 [Flores, Michelle S.; Rajnik, Michael] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA.
   [Burgess, Timothy H.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.
   [Burgess, Timothy H.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.
RP Rajnik, M (reprint author), Uniformed Serv Univ Hlth Sci, Dept Pediat, F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
EM michael.rajnik@usuhs.edu
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atkinson B HP, 2016, EMERG INFECT DIS
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, CHIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, ZIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, CLIN GUID DENG VIR
   Centers for Disease Control and Prevention, UPD DIAGN TEST ZIK C
   Centers for Disease Control and Prevention, ZIK VIR TRANSM RISKS
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, EP UPD COMPL POT LIN
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V347, P601
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fleming-Dutra K, 2016, MMWR-MORBID MORTAL W, V65, P1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR EARLY RELEASE
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 1998, J VIROL, V72, P73
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marano G, 2015, BLOOD TRANSFUS, V5, P1, DOI DOI 10.2450/2015.0066-15.[
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization/World Health Organization, 2015, ZIK VIR INF
   Pan American Health Organization/World Health Organization, 2015, EP AL
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Regan DM, 2016, ASS B, V16
   Rice CM, 1996, FIELDS VIROLOGY, P961
   Rubin EJ, 2016, N ENGL J MED
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith J, 2016, HLTH ADVISORY SEXUAL
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tognarelli J, 2015, REPORT OUTBREAK ZIKA
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, ZIK VIR FACT SHEET
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 60
TC 0
Z9 0
U1 6
U2 6
PU CLEVELAND CLINIC
PI CLEVELAND
PA 9500 EUCLID AVE, CLEVELAND, OH 44106 USA
SN 0891-1150
EI 1939-2869
J9 CLEV CLIN J MED
JI Clevel. Clin. J. Med.
PD APR
PY 2016
VL 83
IS 4
BP 1
EP 10
DI 10.3949/ccjm.83a.16027
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK3TV
UT WOS:000374841200001
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Epidemiologye Zika-Virus and Neurologye
SO FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
LA German
DT Editorial Material
NR 0
TC 0
Z9 0
U1 1
U2 1
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0720-4299
EI 1439-3522
J9 FORTSCHR NEUROL PSYC
JI Forschritte Neurol. Psychiatr.
PD APR
PY 2016
VL 84
IS 4
BP 190
EP 191
DI 10.1055/s-0042-104923
PG 2
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DK3UN
UT WOS:000374843000010
ER

PT J
AU Zumla, A
   Goodfellow, I
   Kasolo, F
   Ntoumi, F
   Buchy, P
   Bates, M
   Azhar, EI
   Cotten, M
   Petersen, E
AF Zumla, Alimuddin
   Goodfellow, Ian
   Kasolo, Francis
   Ntoumi, Francine
   Buchy, Philippe
   Bates, Matthew
   Azhar, Esam I.
   Cotten, Matthew
   Petersen, Eskild
TI Zika virus outbreak and the case for building effective and sustainable
   rapid diagnostics laboratory capacity globally
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
DE Zika virus; Emerging pathogens; laboratory; diagnostics; surveillance;
   public health
ID SUB-SAHARAN AFRICA; RESPIRATORY SYNDROME; CORONAVIRUS; INFECTIONS; CARE
C1 [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] UCLHosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
   [Goodfellow, Ian] Univ Cambridge, Addenbrookes Hosp, Div Virol, Dept Pathol, Hills Rd, Cambridge CB2 2QQ, England.
   [Goodfellow, Ian] Univ Makeni, Sch Publ Hlth, Makeni, Sierra Leone.
   [Kasolo, Francis] WHO AFRO, Country & Inter Country Support, Off Reg Director, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Fdn Congolaise Rech Med, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Univ Marien Ngouabi, Brazzaville, Rep Congo.
   [Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
   [Buchy, Philippe] GlaxoSmithKline Vaccines, R&D Asia Pacific, Gateway West, Singapore.
   [Bates, Matthew] Univ Teaching Hosp, UNZA UCLMS Res & Training Project, Lusaka, Zambia.
   [Azhar, Esam I.] King Abdulaziz Univ, Special Infect Agents Unit, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.
   [Azhar, Esam I.] King Abdulaziz Univ, Fac Appl Med Sci, Med Lab Technol Dept, Jeddah 21413, Saudi Arabia.
   [Cotten, Matthew] Wellcome Trust Sanger Inst, Cambridge, England.
   [Petersen, Eskild] Univ Aarhus, DK-8000 Aarhus C, Denmark.
   [Petersen, Eskild] Royal Hosp, Muscat, Oman.
RP Petersen, E (reprint author), Univ Aarhus, DK-8000 Aarhus C, Denmark.; Petersen, E (reprint author), Royal Hosp, Muscat, Oman.
EM a.i.zumla@gmail.com; ig299@cam.ac.uk; kasolof@who.int;
   fntoumi@fcrm-congo.com; philippe.x.buchy@gsk.com;
   matthew.bates@ucl.ac.uk; eazhar@kau.edu.sa; mc13@sanger.ac.uk;
   eskildp@dadlnet.dk
OI Zumla, Alimuddin/0000-0002-5111-5735
CR Bates M, 2016, EXPERT REV MOL DIAGN, V17, P1
   CDC, 1999, MMWR-MORBID MORTAL W, V48, P265
   Christofferson RC, 2016, AM J TROP MED HYG
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   ECDC, MOSQ MAPS
   Goodfellow I, 2015, EUROSURVEILLANCE, V20
   Heymann DL, 2016, LANCET
   Mikanatha NM, 2013, INFECTIOUS DISEASE SURVEILLANCE, 2ND EDITION, P1, DOI 10.1002/9781118543504
   Mathis Margaux, 2015, Wkly Epidemiol Rec, V90, P238
   McNerney R, 2015, INT J INFECT DIS, V32, P81, DOI 10.1016/j.ijid.2015.01.012
   Ndihokubwayo JB, 2015, STRENGTHENING PUBLIC
   PAHO, 2015, CUM ZIK SUSP CONF CA
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363
   TenoRes study group, 2016, LANCET INFECT DIS
   Tuite N, 2014, J ANTIMICROB CHEMOTH, V69, P1729, DOI 10.1093/jac/dku083
   Waggoner J. J., 2016, J CLIN MICROBIOL
   World Health Organization, 2016, ZIK STRAT RESP FRAM
   WHO, 2016, PROT HUM FUT HLTH CR
   Zaki AM, 2013, NEW ENGL J MED, V369, P394
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zumla A, 2016, NAT REV DRUG DISCOV
   Zumla A, 2014, LANCET INFECT DIS, V14, P1123, DOI 10.1016/S1473-3099(14)70827-8
   Zumla A, 2013, LANCET RESP MED, V1, P284, DOI 10.1016/S2213-2600(13)70099-7
   Zumla A, 2015, INT J INFECT DIS, V37, P77, DOI 10.1016/j.ijid.2015.06.020
   Zumla A, 2015, INT J INFECT DIS, V32, P46, DOI 10.1016/j.ijid.2014.12.039
NR 26
TC 1
Z9 1
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2016
VL 45
BP 92
EP 94
DI 10.1016/j.ijid.2016.02.1007
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DK4HE
UT WOS:000374877300017
PM 26952389
ER

PT J
AU Nishiura, H
   Kinoshita, R
   Mizumoto, K
   Yasuda, Y
   Nah, K
AF Nishiura, Hiroshi
   Kinoshita, Ryo
   Mizumoto, Kenji
   Yasuda, Yohei
   Nah, Kyeongah
TI Transmission potential of Zika virus infection in the South Pacific
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Epidemic; Basic reproduction number; Statistical estimation;
   Transmissibility
ID EPIDEMICS; DENGUE; STATES
AB Objectives: Zika virus has spread internationally through countries in the South Pacific and Americas. The present study aimed to estimate the basic reproduction number, R-0, of Zika virus infection as a measurement of the transmission potential, reanalyzing past epidemic data from the South Pacific.
   Methods: Incidence data from two epidemics, one on Yap Island, Federal State of Micronesia in 2007 and the other in French Polynesia in 2013-2014, were reanalyzed. R-0 of Zika virus infection was estimated from the early exponential growth rate of these two epidemics.
   Results: The maximum likelihood estimate (MLE) of R-0 for the Yap Island epidemic was in the order of 4.3-5.8 with broad uncertainty bounds due to the small sample size of confirmed and probable cases. The MLE of R-0 for French Polynesia based on syndromic data ranged from 1.8 to 2.0 with narrow uncertainty bounds.
   Conclusions: The transmissibility of Zika virus infection appears to be comparable to those of dengue and chikungunya viruses. Considering that Aedes species are a shared vector, this finding indicates that Zika virus replication within the vector is perhaps comparable to dengue and chikungunya. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Nishiura, Hiroshi; Kinoshita, Ryo; Mizumoto, Kenji; Yasuda, Yohei; Nah, Kyeongah] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7, Sapporo, Hokkaido 0608638, Japan.
   [Nishiura, Hiroshi; Kinoshita, Ryo; Nah, Kyeongah] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan.
   [Nishiura, Hiroshi; Kinoshita, Ryo; Mizumoto, Kenji; Nah, Kyeongah] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.
   [Mizumoto, Kenji] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1130033, Japan.
RP Nishiura, H (reprint author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7, Sapporo, Hokkaido 0608638, Japan.; Nishiura, H (reprint author), Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan.; Nishiura, H (reprint author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.
EM nishiurah@gmail.com
FU Japanese Society for the Promotion of Science (JSPS) KAKENHI [26670308,
   26700028]; Japan Agency for Medical Research and Development; Japan
   Science and Technology Agency (JST) CREST program; RISTEX program for
   Science of Science, Technology and Innovation Policy
FX HN received funding support from the Japanese Society for the Promotion
   of Science (JSPS) KAKENHI (grant numbers 26670308 and 26700028), Japan
   Agency for Medical Research and Development, the Japan Science and
   Technology Agency (JST) CREST program, and RISTEX program for Science of
   Science, Technology and Innovation Policy. The funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Imai N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003719
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Keyfitz N., 1968, INTRO MATH POPULATIO
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Majumder MS, 2016, B WHO IN PRESS
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nishiura H, 2010, J R SOC INTERFACE, V7, P297, DOI 10.1098/rsif.2009.0153
   Perkins TA, 2015, PLOS CURR, P7
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
NR 20
TC 7
Z9 7
U1 8
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2016
VL 45
BP 95
EP 97
DI 10.1016/j.ijid.2016.02.017
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DK4HE
UT WOS:000374877300018
PM 26923081
ER

PT J
AU Chen, HL
   Tang, RB
AF Chen, Hui-Lan
   Tang, Ren-Bin
TI Why Zika virus infection has become a public health concern?
SO JOURNAL OF THE CHINESE MEDICAL ASSOCIATION
LA English
DT Review
DE microcephaly; transmission; Zika virus
ID INTERIM GUIDELINES; UNITED-STATES; PREGNANT-WOMEN; OUTBREAK
AB Prior to 2015, Zika Virus (ZIKV) outbreaks had occurred in areas of Africa, Southeast Asia, and the Pacific Islands. Although a causal relationship between Zika infection during pregnancy and microcephaly is strongly suspected, such a connection has not yet been scientifically proven. In May 2015, the outbreak of ZIKV infection in Brazil led to reports of syndrome and pregnant women giving birth to babies with birth defects and poor pregnancy outcomes; the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed ZIKV infection in Brazil. Currently, ZIKV outbreaks are ongoing and it will be difficult to predict how the virus will spread over time. ZIKV is transmitted to humans primarily through the bite of infected mosquitos, Aedes aegypti and Aedes albopictus. These mosquitoes are the principle vectors of dengue, and ZIKV disease generally is reported to include symptoms associated with acute febrile illnesses that clinically resembles dengue fever. The laboratory diagnosis can be performed by using reverse-transcriptase polymerase chain reaction (RT-PCR) on serum, viral nucleic acid and virus-specific immunoglobulin M. There is currently no vaccine and antiviral treatment available for ZIKV infection, and the only way to prevent congenital ZIKV infection is to prevent maternal infection. In February 2016, the Taiwan Centers for Disease Control (Taiwan CDC) activated ZIKV as a Category V Notifiable Infectious Disease similar to Ebola virus disease and MERS. Copyright (C) 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC.
C1 [Chen, Hui-Lan] Keelung Hosp, Dept Pediat, Minist Hlth & Welf, Keelung, Taiwan.
   [Tang, Ren-Bin] Cheng Hsin Gen Hosp, Div Pediat, 45 Cheng Hsin St, Taipei 112, Taiwan.
RP Tang, RB (reprint author), Cheng Hsin Gen Hosp, Div Pediat, 45 Cheng Hsin St, Taipei 112, Taiwan.
EM ch9406@chgh.org.com.tw
CR Bagla P, HUFFINGTON POST
   Centers for Disease Control R.O.C (Taiwan), 2016, ZIK OUTBR PERS LAT A
   Centers for Disease Control R.O.C (Taiwan), 2016, PEOPL RET ZIK AFF CO
   Centers for Disease Control and Prevention, CDC NEWS ROOM ZIKA V
   Centers for Disease Control and Prevention, ZIK VIR HLTH CAR PRO
   Centers for Disease Control and Prevention, ZIK VIR TRANSM
   Center for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, BIRTH DEF FACTS MICR
   Centers for Disease Control and Prevention, ZIK VIR FACT SHEETS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, EP UPD OUTBR ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gulland A., 2016, BMJ-BRIT MED J, V352, pi595, DOI DOI 10.1136/BMJ.I595
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P1
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Maron DF, 2015, SCI AM HLTH     1230
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministry of Health New Zealand, ZIK VIR
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   World Health Organization, ZIK SIT REP ZIK POT
   World Health Organization, WHO IMM VACC BIOL DE
   World Health Organization, WHODENGUE SEV DENG
NR 32
TC 2
Z9 2
U1 28
U2 28
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1726-4901
EI 1728-7731
J9 J CHIN MED ASSOC
JI J. Chin. Med. Assoc.
PD APR
PY 2016
VL 79
IS 4
BP 174
EP 178
DI 10.1016/j.jcma.2016.03.001
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK3GA
UT WOS:000374803900003
PM 27052792
ER

PT J
AU Huang, LM
AF Huang, Li-Min
TI How can we deal with Zika virus infection?
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
ID OUTBREAK
C1 [Huang, Li-Min] Natl Taiwan Univ, Dept Pediat, Childrens Hosp, 8 Chung Shan South Rd, Taipei, Taiwan.
RP Huang, LM (reprint author), Natl Taiwan Univ, Dept Pediat, Childrens Hosp, 8 Chung Shan South Rd, Taipei, Taiwan.
EM lmhuang@ntu.edu.tw
OI Huang, Li-Min/0000-0002-9291-260X
CR Chang SC, 2015, J FORMOS MED ASSOC, V114, P1025, DOI 10.1016/j.jfma.2015.10.006
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, 2016, ZIK SIT REP NEUR SYN
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Wong SSY, 2015, J FORMOS MED ASSOC, V114, P384, DOI 10.1016/j.jfma.2015.01.012
NR 9
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD APR
PY 2016
VL 115
IS 4
BP 221
EP 222
DI 10.1016/j.jfma.2016.03.001
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6MY
UT WOS:000375039400001
PM 27013108
ER

PT J
AU Huang, ASE
   Shu, PY
   Yang, CH
AF Huang, Angela Song-En
   Shu, Pei-Yun
   Yang, Chin-Hui
TI A new reportable disease is born: Taiwan Centers for Disease Control's
   response to emerging Zika virus infection
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
ID OUTBREAK; TRANSMISSION; STATES
AB Zika virus infection, usually a mild disease transmitted through the bite of Aedes mosquitos, has been reported to be possibly associated with microcephaly and neurologic complications. Taiwan's first imported case of Zika virus infection was found through fever screening at airport entry in January 2016. No virus was isolated from patient's blood taken during acute illness; however, PCR products showed that the virus was of Asian lineage closely related to virus from Cambodia. To prevent Zika virus from spreading in Taiwan, the Taiwan Centers for Disease Control has strengthened efforts in quarantine and surveillance, increased Zika virus infection diagnostic capacity, implemented healthcare system preparedness plans, and enhanced vector control program through community mobilization and education. Besides the first imported case, no additional cases of Zika virus infection have been identified. Furthermore, no significant increase in the number of microcephaly or Guillain-Barre Syndrome has been observed in Taiwan. To date, there have been no autochthonous transmissions of Zika virus infection. Copyright (C) 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC.
C1 [Huang, Angela Song-En; Yang, Chin-Hui] Taiwan Ctr Dis Control, Div Acute Infect Dis, Taipei, Taiwan.
   [Shu, Pei-Yun] Taiwan Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan.
RP Yang, CH (reprint author), 6 Linsen South Rd, Taipei 10050, Taiwan.
EM inf@cdc.gov.tw
CR Brazil Ministry of Health, 2015, MIN DIV B EP MICR
   Calvet G., 2016, LANCET INFE IN PRESS
   Chang SC, 2015, J FORMOS MED ASSOC, V114, P1025, DOI 10.1016/j.jfma.2015.10.006
   Centre D'Hygiene et de Salubrite Publique, 2014, SURV DENG ZIK POL FR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Shinohara K, ZIKA FEVER IMPORTED
   Worl Health Organization (WHO), 2016, GUILL BARR SYNDR
NR 12
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD APR
PY 2016
VL 115
IS 4
BP 223
EP 225
DI 10.1016/j.jfma.2016.03.002
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6MY
UT WOS:000375039400002
PM 27013110
ER

PT J
AU Wong, SSY
   Poon, RWS
   Wong, SCY
AF Wong, Samson Sai-Yin
   Poon, Rosana Wing-Shan
   Wong, Sally Cheuk-Ying
TI Zika virus infection-the next wave after dengue?
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Review
DE Zika virus; Flavivirus; Aedes; travel medicine; congenital abnormalities
ID WEST-NILE-VIRUS; MOSQUITOS DIPTERA-CULICIDAE; YELLOW-FEVER; INSECT
   REPELLENTS; AEDES-ALBOPICTUS; CHIKUNGUNYA VIRUS; UNITED-STATES;
   FEDERATED STATES; FRENCH-POLYNESIA; PHYLOGENETIC-RELATIONSHIPS
AB Zika virus was initially discovered in east Africa about 70 years ago and remained a neglected arboviral disease in Africa and Southeast Asia. The virus first came into the limelight in 2007 when it caused an outbreak in Micronesia. In the ensuing decade, it spread widely in other Pacific islands, after which its incursion into Brazil in 2015 led to a widespread epidemic in Latin America. In most infected patients the disease is relatively benign. Serious complications include Guillain-Barre syndrome and congenital infection which may lead to microcephaly and maculopathy. Aedes mosquitoes are the main vectors, in particular, Ae. aegypti. Ae. albopictus is another potential vector. Since the competent mosquito vectors are highly prevalent in most tropical and subtropical countries, introduction of the virus to these areas could readily result in endemic transmission of the disease. The priorities of control include reinforcing education of travellers to and residents of endemic areas, preventing further local transmission by vectors, and an integrated vector management programme. The container habitats of Ae. aegypti and Ae. albopictus means engagement of the community and citizens is of utmost importance to the success of vector control. Copyright (C) 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC.
C1 [Wong, Samson Sai-Yin] Univ Hong Kong, Dept Microbiol, Res Ctr Infect & Immunol, Fac Med, Hong Kong, Hong Kong, Peoples R China.
   [Poon, Rosana Wing-Shan; Wong, Sally Cheuk-Ying] Queen Mary Hosp, Dept Microbiol, LG-1 Block K,102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
RP Wong, SSY (reprint author), Queen Mary Hosp, Dept Microbiol, LG-1 Block K,102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM samsonsy@hku.hk
CR Advisory Committee on Dangerous Pathogens, 2013, APPR LIST BIOL AG
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Antwi FB, 2008, REGUL TOXICOL PHARM, V51, P31, DOI 10.1016/j.yrtph.2008.03.002
   Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001
   Atkinson B., 2016, EMERG INFEC IN PRESS
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bordignon J, 2007, J MED VIROL, V79, P1506, DOI 10.1002/jmv.20958
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Briassoulis G, 2001, HUM EXP TOXICOL, V20, P8, DOI 10.1191/096032701676731093
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carroll I Dale, 2008, Travel Med Infect Dis, V6, P259, DOI 10.1016/j.tmaid.2008.04.005
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Centers for Disease Control and Prevention (CDC), ZIK VIR DIS US 2015
   Centers for Disease Control and Prevention, 2009, BIOSAFETY MICROBIOLO
   Chang SC, 2015, J FORMOS MED ASSOC, V114, P1025, DOI 10.1016/j.jfma.2015.10.006
   Chaves-Carballo E, 2005, MIL MED, V170, P881
   Chen TH, 2015, J FORMOS MED ASSOC, V114, P546, DOI 10.1016/j.jfma.2014.12.002
   Chung SJ, 2015, AM J TROP MED HYG, V92, P367, DOI 10.4269/ajtmh.14-0247
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Crook KR, 2014, VIROLOGY, V458, P172, DOI 10.1016/j.virol.2014.04.036
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Duvallet G, 2011, PARASITE, V18, P93
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Faull KJ, 2015, J VECTOR ECOL, V40, P292, DOI 10.1111/jvec.12167
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fibriansah G, 2016, ANTIVIRAL R IN PRESS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaunt MW, 2001, J GEN VIROL, V82, P1867
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Goodyer LI, 2010, J TRAVEL MED, V17, P182, DOI 10.1111/j.1708-8305.2010.00402.x
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler DJ, 2007, FIELDS VIROLOGY, P1154
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Idrees Sobia, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P232, DOI 10.1016/S2221-1691(13)60057-X
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Kakumani PK, 2015, BIOCHEM J, V471, P89, DOI 10.1042/BJ20150445
   Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59
   Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005
   KAWANO H, 1993, J VIROL, V67, P6567
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Kumar JS, 2011, J MED VIROL, V83, P1063, DOI 10.1002/jmv.22097
   Kuno G, 1998, J VIROL, V72, P73
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103/141662, 10.3201/eid2103.141662]
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leiby DA, 2004, TRANSFUS MED REV, V18, P293, DOI 10.1016/j.tmrv.2004.07.001
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Kim Lien PT, 2011, ASIAN PAC J TROP MED, V8, P543
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1102
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marcondes CB, 2015, REV SOC BRA IN PRESS
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McGready R, 2001, AM J TROP MED HYG, V65, P285
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Melian EB, 2013, J GEN VIROL, V94, P308, DOI 10.1099/vir.0.047076-0
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J ME IN PRESS
   Mogi M, 1996, J MED ENTOMOL, V33, P438
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Montgomery SP, 2006, TRANSFUSION, V46, P2038, DOI 10.1111/j.1537-2995.2006.01030.x
   MUKWAYA L G, 1974, Acta Tropica, V31, P165
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nasci RS, 2016, CDC HLTH INFORM INT
   Nordin JD, 2013, J TRAVEL MED, V20, P368, DOI 10.1111/jtm.12070
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Onyett H, 2014, PAED CHILD HEALT-CAN, V19, P326
   Osimitz TG, 2010, REGUL TOXICOL PHARM, V56, P93, DOI 10.1016/j.yrtph.2009.09.004
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization, 2016, CUM ZIK CONF SUSP CA
   Pan American Health Organization, ZIK EP AL UPD
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Public Health England, GUID MAL PREV TRAV U
   Ratnam I, 2013, J TRAVEL MED, V20, P384, DOI 10.1111/jtm.12052
   Reed W, 1902, J HYG-CAMBRIDGE, V2, P101
   Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rothan HA, 2013, TROP BIOMED, V30, P681
   Rothan HA, 2014, ARCH VIROL, V159, P711, DOI 10.1007/s00705-013-1880-7
   Royal College of Obstetricians and Gynaecologists, 2016, INT CLIN GUID ZIK VI
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Savage HM, 2015, AM J TROP MED HYG, V92, P429, DOI 10.4269/ajtmh.14-0374
   Savage HM, 1998, AM J TROP MED HYG, V58, P519
   Saxena D, 2013, J CLIN VIROL, V58, P528, DOI 10.1016/j.jcv.2013.08.033
   [Anonymous], INDIA CO SAYS THEY H
   SELIM S, 1995, FUND APPL TOXICOL, V25, P95, DOI 10.1006/faat.1995.1043
   Shi PY, 2014, CELL HOST MICROBE, V16, P269, DOI 10.1016/j.chom.2014.08.011
   Shinohara K, 2016, J TRAVEL MED, V23
   Farias KJS, 2013, SCI WORLD J, DOI 10.1155/2013/282734
   Farias KJS, 2014, MICROBIOL IMMUNOL, V58, P318, DOI 10.1111/1348-0421.12154
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sissoko D, 2010, TROP MED INT HEALTH, V15, P600, DOI 10.1111/j.1365-3156.2010.02485.x
   Stanley E., 2009, Morbidity and Mortality Weekly Report, V58, P1263
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Sudakin DL, 2010, HAYES' HANDBOOK OF PESTICIDE TOXICOLOGY, VOLS 1 AND 2, 3RD EDITION, P2111, DOI 10.1016/B978-0-12-374367-1.00098-7
   Taiwan National Infectious Disease Statistics System, STAT DENG FEV NAT IN
   Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, MED MICROBI IN PRESS
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   TENENBEIN M, 1987, JAMA-J AM MED ASSOC, V258, P1509, DOI 10.1001/jama.258.11.1509
   Tognarelli J, 2015, ARCH VIROL IN PRESS
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Tomashek KM, 2011, TRANSFUSION, V51, P1654, DOI 10.1111/j.1537-2995.2011.03269.x
   TravelHealthPro National Travel Health Network and Centre, ZIK VIR UPD ADV TRAV
   Trongtokit Y, 2005, PHYTOTHER RES, V19, P303, DOI 10.1002/ptr.1637
   Vasani R, 2015, PEDIAT DERM IN PRESS
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Way J H, 1976, J Gen Virol, V30, P123
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   WHO, 2012, GLOB STRAT DENG PREV
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P69
   WHO, 2016, ZIK SIT REP
   World Health Organization, 2016, DIS OUTBREAK NE 0208
   World Health Organization, YELL FEV VACC REQ RE
   Wiles D, 2014, J ANAL TOXICOL, V38, P696, DOI 10.1093/jat/bku082
   Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004
   Witting-Bissinger BE, 2008, J MED ENTOMOL, V45, P891, DOI 10.1603/0022-2585(2008)45[891:NARBIA]2.0.CO;2
   WOLFE MS, 1982, LANCET, V2, P1306
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wong SSY, 2015, J FORMOS MED ASSOC, V114, P384, DOI 10.1016/j.jfma.2015.01.012
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang SL, 2006, VIROLOGY, V353, P35, DOI 10.1016/j.virol.2006.05.025
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
NR 182
TC 3
Z9 4
U1 13
U2 13
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD APR
PY 2016
VL 115
IS 4
BP 226
EP 242
DI 10.1016/j.jfma.2016.02.002
PG 17
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK6MY
UT WOS:000375039400003
PM 26965962
ER

PT J
AU Watrin, L
   Ghawche, F
   Larre, P
   Neau, JP
   Mathis, S
   Fournier, E
AF Watrin, Louise
   Ghawche, Frederic
   Larre, Philippe
   Neau, Jean-Philippe
   Mathis, Stephane
   Fournier, Emmanuel
TI Guillain-Barre Syndrome (42 Cases) Occurring During a Zika Virus
   Outbreak in French Polynesia
SO MEDICINE
LA English
DT Article
ID INFECTION; MICRONESIA; EXPERIENCE; DIAGNOSIS; PATTERNS; CRITERIA;
   DENGUE; ISLAND
AB Zika virus (transmitted by mosquitoes) reached French Polynesia for the first time in 2013, leading to an epidemic affecting 10% of the total population. So far, it has not been known to induce any neurological complications, but, a few weeks after the outbreak, an unexpectedly high number of 42 patients presented with Guillain-Barre syndrome.We report the clinical and electrophysiological characteristics of this series. Males predominated with a sex ratio of 2.82 (mean age: 46). All patients (except 2) were native Polynesian. At admission, 55% were able to walk unaided against 38% at nadir, 24% had swallowing troubles (nadir: 45%), 74% had motor weakness of the limbs (nadir: 86%) and deep tendon reflexes were diminished or not found in the vast majority of patients. Mean duration of the progressive phase and of the plateau phase was respectively 7 and 9 days. Thirty-eight percent of the patients were admitted in intensive care unit and 10 patients underwent tracheotomy. Nerve electrophysiological studies at admission showed marked distal motor conduction alterations, which had almost completely disappeared at the 4th month; this pattern was more suggestive of acute motor axonal neuropathy (AMAN) than of acute inflammatory demyelinating polyneuropathy (AIDP). Lumbar puncture showed elevated proteins in 90% of the cases, with cell count always inferior to 50/L.This epidemic raises several questions, such as the potential existence of interactions between Zika virus and Polynesian HLA system and/or the consequences of several recombination events of this virus. This situation should call for increased vigilance, especially in countries where Aedes mosquitoes are present.
C1 [Watrin, Louise; Neau, Jean-Philippe; Mathis, Stephane] Univ Poitiers, Ctr Hosp, Dept Neurol, Rue Mil, Poitiers, France.
   [Ghawche, Frederic; Larre, Philippe] French Polynesia Hosp Ctr, Dept Neurol, Papeete, Tahiti, Fr Polynesia.
   [Fournier, Emmanuel] La Pitie Salpetriere Univ Hop Ctr, Grp Hosp Pitie Salpetriere, AP HP, Dept Clin Neurophysiol, Bd Hop, Paris, France.
RP Mathis, S (reprint author), Univ Poitiers, Ctr Hosp, Dept Neurol, Rue Mil, Poitiers, France.
EM stephane.mathis@chu-poitiers.fr
CR Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737
   Baronti C, 2014, GENOME ANNOUNC
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, ZIK VIR DIS EP POT A
   ECDC, 2014, RAP ASS ZIK INF OUTB, DOI http://ecdc.europa.eu/en/publications/Publications/zika-virus-rapid-risk-assessment-23-february-2016.pdf
   Edinur HA, 2013, HUM IMMUNOL, V74, P1119, DOI 10.1016/j.humimm.2013.06.011
   Enfissi A, 2016, LANCET
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Fournier E., 2008, EXAMEN ELECTROMYOGRA, P858
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P984
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Isose S, 2009, J PERIPHER NERV SYST, V14, P151, DOI 10.1111/j.1529-8027.2009.00226.x
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jin PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131374
   Kimura J., 2005, PERIPHERAL NEUROPATH, P899
   Kokubun N, 2013, J NEUROL SCI, V326, P111, DOI 10.1016/j.jns.2013.01.015
   Kuwabara S, 2002, J NEUROL NEUROSUR PS, V72, P37, DOI 10.1136/jnnp.72.1.37
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oehler Erwan, 2012, Presse Med, V41, pe547, DOI 10.1016/j.lpm.2012.03.010
   Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Schmidt-Chanasit J, 2013, EUROSURVEILLANCE, P19
   Sejvar James J, 2011, Curr Infect Dis Rep, V13, P387, DOI 10.1007/s11908-011-0194-8
   Shahani BT, 1979, ACTA NEUROL SCAND  S, V73, P118
   Thorsby E, 2012, PHILOS T R SOC B, V367, P812, DOI 10.1098/rstb.2011.0319
   Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025
   Uncini A, 2013, CLIN NEUROPHYSIOL, V124, P212, DOI 10.1016/j.clinph.2012.05.024
   Verity C, 2014, ARCH DIS CHILD, V99, P532, DOI 10.1136/archdischild-2013-304475
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yap State Department of Health Services, 2007, PLAQ ZIK VIR, DOI https://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&vedOahUKEwjzpuD5jNnLAhVI1BoKHWmkBowQFggcMAA&url=http%3A%2F%2Fwww.invs.sante.fr%2Fcontent%2Fdownload%2F83617%2F305876%2Fversion%2F10%2Ffile%2FZika%2B2014%2Bnote%2B-%2Bpolynesie%2Bet%2Bmicronesie-revue%2BSI%2BVf2.pdf&usg=AFQjCNEQs7PF9YuwE1aXvHAPH6yFGSHsA&bvm=bv.117604692,d.ZWU&cad=rja.
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 41
TC 4
Z9 4
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD APR
PY 2016
VL 95
IS 14
AR e3257
DI 10.1097/MD.0000000000003257
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK9NI
UT WOS:000375257000050
PM 27057874
ER

PT J
AU Sadovsky, Y
   Clifton, VL
   Knofler, M
AF Sadovsky, Yoel
   Clifton, Vicki L.
   Knoefler, Martin
TI Editorial: ZIKA virus and placenta
SO PLACENTA
LA English
DT Editorial Material
RI Clifton, Vicki/A-1445-2012
OI Clifton, Vicki/0000-0002-4892-6748
NR 0
TC 2
Z9 2
U1 5
U2 5
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD APR
PY 2016
VL 40
BP A1
EP A1
DI 10.1016/j.placenta.2016.03.008
PG 1
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA DJ7WJ
UT WOS:000374423600001
PM 27016785
ER

PT J
AU Aliota, MT
   Caine, EA
   Walker, EC
   Larkin, KE
   Camacho, E
   Osorio, JE
AF Aliota, Matthew T.
   Caine, Elizabeth A.
   Walker, Emma C.
   Larkin, Katrina E.
   Camacho, Erwin
   Osorio, Jorge E.
TI Characterization of Lethal Zika Virus Infection in AG129 Mice
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUS; MOUSE MODEL; T-CELLS; INTERFERON; PROTECTION; AEDES;
   RESPONSES; REPLICATION; MICRONESIA; ISOLATIONS
AB Background
   Mosquito-borne Zika virus (ZIKV) typically causes a mild and self-limiting illness known as Zika fever, which often is accompanied by maculopapular rash, headache, and myalgia. During the current outbreak in South America, ZIKV infection during pregnancy has been hypothesized to cause microcephaly and other diseases. The detection of ZIKV in fetal brain tissue supports this hypothesis. Because human infections with ZIKV historically have remained sporadic and, until recently, have been limited to small-scale epidemics, neither the disease caused by ZIKV nor the molecular determinants of virulence and/or pathogenicity have been well characterized. Here, we describe a small animal model for wild-type ZIKV of the Asian lineage.
   Methodology/Principal Findings
   Using mice deficient in interferon alpha/beta and (sic) receptors (AG129 mice), we report that these animals were highly susceptible to ZIKV infection and disease, succumbing within seven to eight days. Rapid viremic dissemination was observed in visceral organs and brain; but only was associated with severe pathologies in the brain and muscle. Finally, these results were consistent across challenge routes, age of mice, and inoculum doses. These data represent a mouse model for ZIKV that is not dependent on adapting ZIKV to intracerebral passage in mice.
   Conclusions/Significance
   Foot pad injection of AG129 mice with ZIKV represents a biologically relevant model for studying ZIKV infection and disease development following wild-type virus inoculation without the requirement for adaptation of the virus or intracerebral delivery of the virus. This newly developed Zika disease model can be exploited to identify determinants of ZIKV virulence and reveal molecular mechanisms that control the virus-host interaction, providing a framework for rational design of acute phase therapeutics and for vaccine efficacy testing.
C1 [Aliota, Matthew T.; Caine, Elizabeth A.; Walker, Emma C.; Larkin, Katrina E.; Camacho, Erwin; Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
RP Osorio, JE (reprint author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM jorge.osorio@wisc.edu
FU National Institutes of Health (NIH) [AI117413-01]; University of
   Wisconsin-Madison Microbes in Health and Disease predoctoral fellowship
   NIH [T32AI055397]
FX This project was partially funded by National Institutes of Health (NIH)
   Grant #AI117413-01 (to JEO and MTA). EAC is supported by the University
   of Wisconsin-Madison Microbes in Health and Disease predoctoral
   fellowship NIH T32AI055397. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bourne N, 2007, J VIROL, V81, P9100, DOI 10.1128/JVI.00316-07
   Caine EA, 2015, VIRUSES-BASEL, V7, P5919, DOI 10.3390/v7112916
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   [Anonymous], 2015, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.H6983
   [Anonymous], 2015, RAPID RISK ASSESSMEN
   Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lobigs M, 2003, J GEN VIROL, V84, P567, DOI 10.1099/vir.0.18654-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Partidos CD, 2011, VACCINE, V29, P3067, DOI 10.1016/j.vaccine.2011.01.076
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Way J H, 1976, J Gen Virol, V30, P123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zompi S, 2012, J IMMUNOL, V188, P404, DOI 10.4049/jimmunol.1102124
NR 41
TC 12
Z9 12
U1 19
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004682
DI 10.1371/journal.pntd.0004682
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700087
PM 27093158
ER

PT J
AU Brasil, P
   Calvet, GA
   Siqueira, AM
   Wakimoto, M
   de Sequeira, PC
   Nobre, A
   Quintana, MDB
   de Mendonca, MCL
   Lupi, O
   de Souza, RV
   Romero, C
   Zogbi, H
   Bressan, CD
   Alves, SS
   Lourenco-de-Oliveira, R
   Nogueira, RMR
   Carvalho, MS
   de Filippis, AMB
   Jaenisch, T
AF Brasil, Patricia
   Calvet, Guilherme Amaral
   Siqueira, Andre Machado
   Wakimoto, Mayumi
   de Sequeira, Patricia Carvalho
   Nobre, Aline
   Borges Quintana, Marcel de Souza
   Lima de Mendonca, Marco Cesar
   Lupi, Otilia
   de Souza, Rogerio Valls
   Romero, Carolina
   Zogbi, Heruza
   Bressan, Clarisse da Silveira
   Alves, Simone Sampaio
   Lourenco-de-Oliveira, Ricardo
   Ribeiro Nogueira, Rita Maria
   Carvalho, Marilia Sa
   Bispo de Filippis, Ana Maria
   Jaenisch, Thomas
TI Zika Virus Outbreak in Rio de Janeiro, Brazil: Clinical
   Characterization, Epidemiological and Virological Aspects
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUSES; TRANSMISSION; CHIKUNGUNYA; EPIDEMICS; STATE
AB Background
   In 2015, Brazil was faced with the cocirculation of three arboviruses of major public health importance. The emergence of Zika virus (ZIKV) presents new challenges to both clinicians and public health authorities. Overlapping clinical features between diseases caused by ZIKV, Dengue (DENV) and Chikungunya (CHIKV) and the lack of validated serological assays for ZIKV make accurate diagnosis difficult.
   Methodology/Principal Findings
   The outpatient service for acute febrile illnesses in Fiocruz initiated a syndromic clinical observational study in 2007 to capture unusual presentations of DENV infections. In January 2015, an increase of cases with exanthematic disease was observed. Trained physicians evaluated the patients using a detailed case report form that included clinical assessment and laboratory investigations. The laboratory diagnostic algorithm included assays for detection of ZIKV, CHIKV and DENV. 364 suspected cases of Zika virus disease were identified based on clinical criteria between January and July 2015. Of these, 262 (71.9%) were tested and 119 (45.4%) were confirmed by the detection of ZIKV RNA. All of the samples with sequence information available clustered within the Asian genotype.
   Conclusions / Significance
   This is the first report of a ZIKV outbreak in the state of Rio de Janeiro, based on a large number of suspected (n = 364) and laboratory confirmed cases (n = 119). We were able to demonstrate that ZIKV was circulating in Rio de Janeiro as early as January 2015. The peak of the outbreak was documented in May/June 2015. More than half of the patients reported headache, arthralgia, myalgia, non-purulent conjunctivitis, and lower back pain, consistent with the case definition of suspected ZIKV disease issued by the Pan American Health Organization (PAHO). However, fever, when present, was low-intensity and short-termed. In our opinion, pruritus, the second most common clinical sign presented by the confirmed cases, should be added to the PAHO case definition, while fever could be given less emphasis. The emergence of ZIKV as a new pathogen for Brazil in 2015 underscores the need for clinical vigilance and strong epidemiological and laboratory surveillance.
C1 [Brasil, Patricia; Calvet, Guilherme Amaral; Siqueira, Andre Machado; Wakimoto, Mayumi; Lupi, Otilia; de Souza, Rogerio Valls; Romero, Carolina; Zogbi, Heruza; Bressan, Clarisse da Silveira] Oswaldo Cruz Fdn Fiocruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [de Sequeira, Patricia Carvalho; Lima de Mendonca, Marco Cesar; Alves, Simone Sampaio; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Oswaldo Cruz Fdn Fiocruz, Flavivirus Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Nobre, Aline; Carvalho, Marilia Sa] Oswaldo Cruz Fdn Fiocruz, Sci Computat Program, Rio De Janeiro, Brazil.
   [Borges Quintana, Marcel de Souza] Oswaldo Cruz Fdn Fiocruz, Clin Res Platform, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Lourenco-de-Oliveira, Ricardo] Oswaldo Cruz Fdn Fiocruz, Mosquito Transmitters Hematozoans Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
   [Jaenisch, Thomas] German Ctr Infect Dis Res, Heidelberg, Germany.
RP Brasil, P (reprint author), Oswaldo Cruz Fdn Fiocruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq
   [484735/2013-6, 402135/2011-3]; Fundacao de Amparo a Pesquisa no Estado
   do Rio de Janeiro-FAPERJ [E- 26/010.001558/2014]; European Commission
   [FP7-21803 IDAMS]
FX We thank the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico - CNPq (grant no. 484735/2013-6 and 402135/2011-3), the
   Fundacao de Amparo a Pesquisa no Estado do Rio de Janeiro-FAPERJ (grant
   no. E- 26/010.001558/2014) and the European Commission, grant FP7-21803
   IDAMS (http://www.idams.eu), for having funded the study. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Araujo Helena R. C., 2015, Insects, V6, P576, DOI 10.3390/insects6020576
   Besnard M, 2014, INCREASE CEREBRAL CO
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Codeco CT, 2009, MEM I OSWALDO CRUZ, V104, P614, DOI 10.1590/S0074-02762009000400014
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fares RCG, 2015, BIOMED RES INT, DOI 10.1155/2015/321873
   Favaro EA, 2013, REV SAUDE PUBL, V47, P588, DOI 10.1590/S0034-8910.2013047004506
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   [Anonymous], 2014, EURO SURVEILLANCE B
   Pan American Health Organization/World Health Organization (PAHO/WHO), 2015, EP AL NEUR SYNDR CON
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   R Core Team, 2015, R LANG ENV STAT COMP
   SCHATZMAYR H G, 1986, Memorias do Instituto Oswaldo Cruz, V81, P245
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 12
Z9 12
U1 13
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004636
DI 10.1371/journal.pntd.0004636
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700064
PM 27070912
ER

PT J
AU Lednicky, J
   De Rochars, VMB
   El Badry, M
   Loeb, J
   Telisma, T
   Chavannes, S
   Anilis, G
   Cella, E
   Ciccozzi, M
   Rashid, M
   Okech, B
   Salemi, M
   Morris, JG
AF Lednicky, John
   De Rochars, Valery Madsen Beau
   El Badry, Maha
   Loeb, Julia
   Telisma, Taina
   Chavannes, Sonese
   Anilis, Gina
   Cella, Eleonora
   Ciccozzi, Massimo
   Rashid, Mohammed
   Okech, Bernard
   Salemi, Marco
   Morris, J. Glenn, Jr.
TI Zika Virus Outbreak in Haiti in 2014: Molecular and Clinical Data
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SEQUENCE ALIGNMENT; CHIKUNGUNYA; DENGUE; BRAZIL; ASSAY
AB Background
   Zika virus (ZIKV), first isolated in Uganda in 1947, is currently spreading rapidly through South America and the Caribbean. In Brazil, infection has been linked with microcephaly and other serious complications, leading to declaration of a public health emergency of international concern; however, there currently are only limited data on the virus (and its possible sources and manifestations) in the Caribbean.
   Methods
   From May, 2014-February, 2015, in conjunction with studies of chikungunya (CHIKV) and dengue (DENV) virus infections, blood samples were collected from children in the Gressier/Leogane region of Haiti who presented to a school clinic with undifferentiated febrile illness. Samples were initially screened by RT-PCR for CHIKV and DENV, with samples negative in these assays further screened by viral culture.
   Findings
   Of 177 samples screened, three were positive for ZIKV, confirmed by viral sequencing; DENV-1 was also identified in culture from one of the three positive case patients. Patients were from two different schools and 3 different towns, with all three cases occurring within a single week, consistent with the occurrence of an outbreak in the region. Phylogenetic analysis of known full genome viral sequences demonstrated a close relationship with ZIKV from Brazil; additional analysis of the NS5 gene, for which more sequences are currently available, showed the Haitian strains clustering within a monophyletic clade distinct from Brazilian, Puerto Rican and Guatemalan sequences, with all part of a larger clade including isolates from Easter Island. Phylogeography also clarified that at least three major African sub-lineages exist, and confirmed that the South American epidemic is most likely to have originated from an initial ZIKV introduction from French Polynesia into Easter Island, and then to the remainder of the Americas.
   Conclusions
   ZIKV epidemics in South America, as well as in Africa, show complex dissemination patterns. The virus appears to have been circulating in Haiti prior to the first reported cases in Brazil. Factors contributing to transmission and the possible linkage of this early Haitian outbreak with microcephaly remain to be determined.
C1 [Lednicky, John; De Rochars, Valery Madsen Beau; El Badry, Maha; Loeb, Julia; Telisma, Taina; Chavannes, Sonese; Anilis, Gina; Cella, Eleonora; Rashid, Mohammed; Okech, Bernard; Salemi, Marco; Morris, J. Glenn, Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Lednicky, John; El Badry, Maha; Loeb, Julia; Okech, Bernard] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.
   [De Rochars, Valery Madsen Beau] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA.
   [Telisma, Taina; Chavannes, Sonese; Anilis, Gina] Christianville Fdn Sch Clin, Gressier, Haiti.
   [Cella, Eleonora; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Sci, Gainesville, FL USA.
   [Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Reference Ctr Phylogeny, Mol Epidemiol & Microbial Evolut FEMEM Epidemiol, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA.
RP Morris, JG (reprint author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.; Morris, JG (reprint author), Univ Florida, Coll Med, Dept Med, Gainesville, FL USA.
EM jgmorris@epi.ufl.edu
RI Cella, Eleonora/J-9961-2016; CICCOZZI, MASSIMO/C-6484-2016
OI Cella, Eleonora/0000-0002-7870-9744; CICCOZZI,
   MASSIMO/0000-0003-3866-9239
FU University of Florida
FX The authors received no funding outside of the University of Florida for
   the work described. Funding was from an internal University of Florida
   pilot grant fund. Funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET
   De Rochars VEMB, 2015, AM J TROP MED HYG, V92, P752, DOI 10.4269/ajtmh.14-0059
   Kleber de Oliveira W, 2016, MMWR MORB MORTAL WKL
   Driggers R.W., 2016, N ENGL J MED
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P236
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Hall T. A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764
   Lanciotti RS L.A., 2016, EMERG INFECT DIS
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Tang H, 2016, CELL STEM CELL, V18, P1
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
NR 28
TC 6
Z9 6
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2016
VL 10
IS 4
AR e0004687
DI 10.1371/journal.pntd.0004687
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DL1FC
UT WOS:000375376700089
PM 27111294
ER

PT J
AU Bachiller-Luque, P
   Gonzalez, MDG
   Alvarez-Manzanares, J
   Vazquez, A
   De Ory, F
   Farinas, MPSS
AF Bachiller-Luque, Pablo
   Dominguez-Gil Gonzalez, Marta
   Alvarez-Manzanares, Jesus
   Vazquez, Ana
   De Ory, Fernando
   Sanchez-Seco Farinas, M. Paz
TI First case of imported Zika virus infection in Spain
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Article
DE Zika virus; Flavivirus; Aedes mosquitoes; Arbovirus; Vector-borne
   diseases
AB We report a case of Zika virus (ZIKV) infection in a patient with diarrhea, fever, synovitis, non-purulent conjunctivitis, and with discreet retro-orbital pain, after returning from Colombia in January 2016. The patient referred several mosquito bites. Presence of ZIKV was detected by PCR (polymerase chain reaction) in plasma. Rapid microbiological diagnosis of ZIKV infection is needed in European countries with circulation of its vector, in order to avoid autochthonous circulation. The recent association of ZIKV infection with abortion and microcephaly, and a Guillain-Barre syndrome highlights the need for laboratory differentiation of ZIKV from other virus infection. Women with potential risk for Zika virus infection who are pregnant or planning to become pregnant must mention that fact during prenatal visits in order to be evaluated and properly monitored. (C) 2016 Elsevier Espafia, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
C1 [Bachiller-Luque, Pablo] Univ Hosp Rio Hortega, Internal Med, Valladolid, Spain.
   [Dominguez-Gil Gonzalez, Marta] Univ Hosp Rio Hortega, Microbiol, Valladolid, Spain.
   [Alvarez-Manzanares, Jesus] Univ Hosp Rio Hortega, Emergency, Valladolid, Spain.
   [Vazquez, Ana; De Ory, Fernando; Sanchez-Seco Farinas, M. Paz] Inst Salud Carlos III, Natl Ctr Microbiol, Virol Area Arbovirus & Imported Viral Dis, Madrid, Spain.
RP Bachiller-Luque, P (reprint author), Univ Hosp Rio Hortega, Internal Med, Valladolid, Spain.
EM pbachiller@gmail.com
RI Vazquez, Ana/H-4911-2013
OI Vazquez, Ana/0000-0002-9872-3316
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Centers for Disease Control and Prevention, EM PREP RESP REC MAN
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, RAP RISK ASS ZIK VIR
   Fauci A.S., 2016, N ENGL J MED
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministerio da Saude (Brazil), 2015, MON CAS DENG FEBR CH, V46
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez WE, 2016, J INFECT PU IN PRESS
NR 12
TC 5
Z9 5
U1 12
U2 12
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD APR
PY 2016
VL 34
IS 4
BP 243
EP 246
DI 10.1016/j.eimc.2016.02.012
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DK2BM
UT WOS:000374719600007
PM 26994814
ER

PT J
AU de Salazar, PM
   Suy, A
   Sanchez-Montalva, A
   Rodo, C
   Salvador, F
   Molina, I
AF Martinez de Salazar, Pablo
   Suy, Anna
   Sanchez-Montalva, Adrian
   Rodo, Carlota
   Salvador, Fernando
   Molina, Israel
TI Zika fever
SO ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
LA English
DT Review
DE Zika virus; Microencephaly; Flavivirus
ID AEDES-AEGYPTI POPULATIONS; BORNE VIRAL-INFECTIONS; VIRUS-INFECTION;
   INSECTICIDE RESISTANCE; FRENCH-POLYNESIA; POTENTIAL VECTOR;
   YELLOW-FEVER; BRAZIL; TRANSMISSION; NIGERIA
AB Zika fever is an arboviral systemic disease that has recently become a public health challenge of global concern after its spread through the Americas. This review highlights the current understanding on Zika virus epidemiology, its routes of transmission, clinical manifestations, diagnostic tests, and the current management, prevention and control strategies. It also delves the association between zika infection and complications, such as microencephaly or Guillem-Barre syndrome. (C) 2016 Elsevier Espafia, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
C1 [Martinez de Salazar, Pablo] Vall dHebron Univ Hosp, Dept Microbiol, PROSICS Barcelona, Barcelona, Spain.
   [Martinez de Salazar, Pablo] IS Global, Barcelona, Spain.
   [Martinez de Salazar, Pablo] Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
   [Suy, Anna; Rodo, Carlota] Vall dHebron Univ Hosp, Dept Obstet & Gynaecol, Maternal Fetal Med Unit, Barcelona, Spain.
   [Sanchez-Montalva, Adrian; Salvador, Fernando; Molina, Israel] Vall dHebron Univ Hosp, PROSICS Barcelona, Dept Infect Dis, Barcelona, Spain.
RP de Salazar, PM (reprint author), Vall dHebron Univ Hosp, Dept Microbiol, PROSICS Barcelona, Barcelona, Spain.; de Salazar, PM (reprint author), IS Global, Barcelona, Spain.; de Salazar, PM (reprint author), Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
EM pmartinezdesalazar@gmail.com
OI Molina Romero, Israel/0000-0001-6642-7515
CR The American Congress of Obstetricians and Gynecologists, PRACT ADV INT GUID C
   Baronti C, 2014, GENOME ANNOUNCE, V2
   Besnard M, 2014, EURO SURV B EUR MALA, V19
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Institut de Veille Sanitaire (InVS), 2014, B HEBD INT 5 11 MARS
   Korhonen EM, 2016, EURO SURV B EUR MALA, V21
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D, 2014, EURO SURV B EUR MALA, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, ZIK VIR INF
   Pyke AT, 2014, PLOS CURR, V2014, P6
   Roth A, 2014, EURO SURV B EUR MALA, V19
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, 2014, EURO SURV B EUR MALA, V19
   Tognarelli J, 2015, ARCH VIROL
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez W E, 2016, J INFECT PUBLIC HLTH, DOI S1876-0341(15)00221-X
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zammarchi L, 2015, EURO SURV B EUR MALA, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 66
TC 4
Z9 4
U1 18
U2 18
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0213-005X
EI 1578-1852
J9 ENFERM INFEC MICR CL
JI Enferm. Infec. Microbiol. Clin.
PD APR
PY 2016
VL 34
IS 4
BP 247
EP 252
DI 10.1016/j.eimc.2016.02.016
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DK2BM
UT WOS:000374719600008
ER

PT J
AU Alvarado-Socarras, JL
   Rodriguez-Morales, AJ
AF Alvarado-Socarras, J. L.
   Rodriguez-Morales, A. J.
TI Etiological agents of microcephaly: implications for diagnosis during
   the current Zika virus epidemic
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Letter
ID INFECTION
C1 [Alvarado-Socarras, J. L.] Fdn Cardiovasc Colombia, Dept Pediat, Neonatal Unit, Floridablanca, Santander, Colombia.
   [Alvarado-Socarras, J. L.; Rodriguez-Morales, A. J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Rodriguez-Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (reprint author), OLFIS, Bucaramanga, Santander, Colombia.; Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
CR Eyaid W, 2012, NEUROSCIENCES, V17, P248
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
NR 5
TC 0
Z9 0
U1 11
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD APR
PY 2016
VL 47
IS 4
BP 525
EP +
DI 10.1002/uog.15885
PG 2
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA DJ0SY
UT WOS:000373915900024
PM 26947268
ER

PT J
AU Papageorghiou, AT
   Thilaganathan, B
   Bilardo, CM
   Ngu, A
   Malinger, G
   Herrera, M
   Salomon, LJ
   Riley, LE
   Copel, JA
AF Papageorghiou, A. T.
   Thilaganathan, B.
   Bilardo, C. M.
   Ngu, A.
   Malinger, G.
   Herrera, M.
   Salomon, L. J.
   Riley, L. E.
   Copel, J. A.
TI ISUOG Interim Guidance on ultrasound for Zika virus infection in
   pregnancy: information for healthcare professionals
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Editorial Material
ID HEAD CIRCUMFERENCE; GUIDELINES; BRAZIL; BRAIN
C1 [Papageorghiou, A. T.; Thilaganathan, B.] St Georges Univ Fdn Hosp NHS Trust, Fetal Med Unit, London, England.
   [Papageorghiou, A. T.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Bilardo, C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet, Groningen, Netherlands.
   [Ngu, A.] East Melbourne Ultrasound, East Melbourne, Vic, Australia.
   [Malinger, G.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lis Matern Hosp,Div Ultrasound Obstet & Gynecol, IL-69978 Tel Aviv, Israel.
   [Herrera, M.] Colombian Univ Clin, Colsanitas Clin, Maternal Fetal Med Dept, Bogota, Colombia.
   [Salomon, L. J.] Univ Paris 05, Necker Enfants Malades Hosp, AP HP, Dept Obstet & Maternal Fetal Med, Paris, France.
   [Riley, L. E.] Massachusetts Gen Hosp, Obstet & Gynecol, Boston, MA 02114 USA.
   [Copel, J. A.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA.
RP Papageorghiou, AT (reprint author), St Georges Univ Fdn Hosp NHS Trust, Fetal Med Unit, London, England.; Papageorghiou, AT (reprint author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.
CR Deloison B, 2012, PRENATAL DIAG, V32, P869, DOI 10.1002/pd.3923
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Leibovitz Z, 2015, ULTRASOUND OBST GYN, DOI [10.1002/uog.15801., DOI 10.1002/UOG.15801]
   Malinger G, 2003, AM J NEURORADIOL, V24, P28
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Royal College of Obstetricians & Gynaecologists, INT RCOG RCM PHE HPS
   Salomon L J, 2013, Ultrasound Obstet Gynecol, V41, P102, DOI 10.1002/uog.12342
   Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, WHO CHILD GROWTH STA
   World Health Organization, ASS INF MICR CONT ZI
   World Health Organization, PREGN MAN CONT ZIK V
NR 17
TC 2
Z9 3
U1 7
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD APR
PY 2016
VL 47
IS 4
BP 530
EP 532
DI 10.1002/uog.15896
PG 3
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA DJ0SY
UT WOS:000373915900027
PM 26969966
ER

PT J
AU Carod-Artal, FJ
AF Carod-Artal, Francisco J.
TI Epidemiology and neurological complications of infection by the Zika
   virus: a new emerging neurotropic virus
SO REVISTA DE NEUROLOGIA
LA Spanish
DT Article
DE Epidemic outbreak; Flavivirus; Guillain-Barre; Microcephalia; Zika
   virus; Zika virus disease
ID UNITED-STATES; INTERIM GUIDELINES; PREGNANT-WOMEN; SOUTH-PACIFIC;
   OUTBREAK; TRANSMISSION; NIGERIA; BRAZIL; ARBOVIRUSES; MICRONESIA
AB Introduction. The current epidemic outbreak due to Zika virus began in 2015 and since then it has been reported in 31 countries and territories in America. The epidemiological and clinical aspects related to infection by Zika virus are reviewed.
   Development. Since 2007, 55 countries in America, Asia, Africa and Oceania have detected local transmission of the virus. This epidemic has affected almost 1.5 million people in Brazil. 80% of the cases are asymptomatic. The symptoms of Zika virus disease include fever, maculopapular rash, arthralgia and non-purulent conjunctivitis. The symptoms are usually self-limiting and last one week. An increase in the incidence of cases of microcephaly, retinal lesions and Guillain-Barre syndrome associated with the Zika virus has been reported. Zika-associated Guillain-Barre syndrome in Polynesia is a pure motor axonal variant. The RNA of the Zika virus has been identified in samples of brain tissue, placenta and amniotic liquid of children with microcephaly and in the still-born infants of women infected by Zika during pregnancy. The reverse transcription polymerase chain reaction test is recommended to detect viral RNA, and serological tests (IgM ELISA and neutralising antibodies) should be conducted to confirm infection by Zika. The differential diagnosis includes infection by the dengue and chikungunya viruses.
   Conclusions. Knowledge about the pathogenic mechanisms involved in infection due to Zika virus and its long-term consequences in adults and newborn infants is still limited.
C1 [Carod-Artal, Francisco J.] Raigmore Hosp, Serv Neurol, Inverness IV2 3UJ, Scotland.
RP Carod-Artal, FJ (reprint author), Raigmore Hosp, Old Perth Rd, Inverness IV2 3UJ, Scotland.
EM javier.carodartal@nhs.net
CR Atkinson B, 2016, EMERG INFECT DIS, DOI [10.3201/eid225.160107, DOI 10.3201/EID225.160107]
   Besnard M, 2014, EURO SURVEILL, V19
   Blog da Saude (Ministerio da Saude; Brazil), 2015, PROT VIG MICR VIR ZI
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, N ENGL J MED
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET
   Carod-Artal FJ, 2015, REV NEUROLOGIA, V60, P267
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cunha MS, GENOME ANNOUNC, V206
   Prazeres J, 2016, JAMA OPHTHALMOL 0209
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   [Anonymous], ZIK VIR EP AM POT AS
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyurech D, 2016, SWISS MED WEEKLY, P14296
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jampol LM, 2016, JAMA OPHTHALMOL 0209
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Carod-Artal FJ, 2015, EXPERT REV ANTI-INFE, V13, P1185, DOI 10.1586/14787210.2015.1079128
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JMDM, 2016, LANCET INFECT DIS
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Mecharles S., 2016, LANCET
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EURO SURVEILL, P19
   Oliveira Melo A S, 2016, Ultrasound Obstet Gynecol, V47, P6, DOI 10.1002/uog.15831
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Oster AM, 2015, MMWR-MORBID MORTAL W, V65, P120
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pyke AT, 2014, PLOS CURR, V2014, P6
   Reyna-Villasmil E, 2016, MED CLIN BARC
   Roth A., 2014, EURO SURVEILL, V19
   Rowland A, 2016, J ASIST REPROD  0305
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2014, EURO SURVEILL, V19
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Traveller's Health, 2016, CDC ISS INT TRAV GUI
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization, 2016, BREASTF CONT ZIK VIR
   World Health Organization, 2016, ID MAN GUILL BARR SY
   World Health Organization, ZIK SIT REP 10 MARCH
   World Health Organization, 2016, PREGN MAN CONT ZIK V
NR 72
TC 6
Z9 7
U1 36
U2 36
PU REVISTA DE NEUROLOGIA
PI BARCELONA
PA C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN
SN 0210-0010
EI 1576-6578
J9 REV NEUROLOGIA
JI Rev. Neurologia
PD APR 1
PY 2016
VL 62
IS 7
BP 317
EP 328
PG 12
WC Clinical Neurology
SC Neurosciences & Neurology
GA DJ3LW
UT WOS:000374107800005
PM 26988170
ER

PT J
AU Deng, YQ
   Zhao, H
   Li, XF
   Zhang, NN
   Liu, ZY
   Jiang, T
   Gu, DY
   Shi, L
   He, JA
   Wang, HJ
   Sun, ZZ
   Ye, Q
   Xie, DY
   Cao, WC
   Qin, CF
AF Deng, Yong-Qiang
   Zhao, Hui
   Li, Xiao-Feng
   Zhang, Na-Na
   Liu, Zhong-Yu
   Jiang, Tao
   Gu, Da-Yong
   Shi, Lei
   He, Jian-An
   Wang, Hong-Jiang
   Sun, Zhao-Zeng
   Ye, Qing
   Xie, Dong-Yang
   Cao, Wu-Chun
   Qin, Cheng-Feng
TI Isolation, identification and genomic characterization of the Asian
   lineage Zika virus imported to China
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Letter
ID AMERICA
C1 [Deng, Yong-Qiang; Zhao, Hui; Li, Xiao-Feng; Liu, Zhong-Yu; Jiang, Tao; Wang, Hong-Jiang; Ye, Qing; Cao, Wu-Chun; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zhang, Na-Na; Qin, Cheng-Feng] Guangxi Med Univ, Grad Sch, Xining 530021, Peoples R China.
   [Gu, Da-Yong; Shi, Lei; He, Jian-An] Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen Travel Healthcare Ctr, Cent Lab Hlth Quarantine, Shenzhen 518033, Peoples R China.
   [Sun, Zhao-Zeng] Acad Mil Med Sci, Lab Anim Ctr, Beijing 100071, Peoples R China.
   [Xie, Dong-Yang; Qin, Cheng-Feng] Anhui Med Univ, Grad Sch, Hefei 230032, Peoples R China.
RP Cao, WC; Qin, CF (reprint author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Qin, CF (reprint author), Guangxi Med Univ, Grad Sch, Xining 530021, Peoples R China.; Qin, CF (reprint author), Anhui Med Univ, Grad Sch, Hefei 230032, Peoples R China.
EM caowc@bmi.ac.cn; qincf@bmi.ac.cn
OI Qin, Cheng-Feng/0000-0002-0632-2807
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Li X.F., 2016, SCI CHINA L IN PRESS, V59
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
NR 9
TC 7
Z9 7
U1 5
U2 5
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD APR
PY 2016
VL 59
IS 4
BP 428
EP 430
DI 10.1007/s11427-016-5043-4
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DJ3JQ
UT WOS:000374101500015
PM 26993654
ER

PT J
AU Li, XF
   Han, JF
   Shi, PY
   Qin, CF
AF Li, Xiao-Feng
   Han, Jian-Feng
   Shi, Pei-Yong
   Qin, Cheng-Feng
TI Zika virus: a new threat from mosquitoes
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Editorial Material
ID OUTBREAK; DENGUE; BRAZIL; CHINA
C1 [Li, Xiao-Feng; Han, Jian-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.
   [Li, Xiao-Feng; Han, Jian-Feng; Qin, Cheng-Feng] State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Phamarcol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Qin, CF (reprint author), Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.; Qin, CF (reprint author), State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Shi, PY (reprint author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Phamarcol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.gov; qincf@bmi.ac.cn
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci A.S., 2016, N ENGL J MED
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Pan American Health Organization, 2016, UPD NEUR SYNDR CONG
   Qin CF, 2014, SCI CHINA LIFE SCI, V57, P1230, DOI 10.1007/s11427-014-4783-2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Zhao H, 2014, SCI CHINA LIFE SCI, V57, P1149, DOI 10.1007/s11427-014-4782-3
NR 12
TC 3
Z9 3
U1 15
U2 15
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD APR
PY 2016
VL 59
IS 4
BP 440
EP 442
DI 10.1007/s11427-016-5020-y
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DJ3JQ
UT WOS:000374101500020
PM 26944581
ER

PT J
AU Hurlburt, A
   Brooks, J
   Money, D
   Patrick, D
AF Hurlburt, Andrew
   Brooks, James
   Money, Deborah
   Patrick, David
TI Zika virus: A summary
SO BRITISH COLUMBIA MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [Hurlburt, Andrew] Univ British Columbia, Internal Med, Vancouver, BC, Canada.
   [Brooks, James; Money, Deborah] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada.
   [Patrick, David] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
RP Hurlburt, A (reprint author), Univ British Columbia, Internal Med, Vancouver, BC, Canada.
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Brazil Ministry of Health, PUBL HLTH EM OP CTR
   Calvet G., 2016, LANCET INFECT DIS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, ZIK VIR INF FACT SHE
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EURO SURVEILL, P19
   Pan American Health Organization/World Health Organization, EP AL NEUR SYNDR CON
   Pan American Health Organization/World Health Organization, EP UPD NEUR SYNDR CO
   Public Health Agency of Canada, LAB TEST REC ZIK VIR
   Public Health Agency of Canada, INS BIT PREV
   Public Health Agency of Canada, 2016, RAP RISK ASS RISK ZI
   Public Health Agency of Canada, CAN REC PREV TREATM
   Vancouver Coastal Health, COMM MED NEWSL ZIK V
NR 22
TC 0
Z9 0
U1 16
U2 16
PU BRITISH COLUMBIA MEDICAL ASSOCIATION
PI VANCOUVER
PA 115-1665 W BROADWAY, VANCOUVER, BC V6J 5A4, CANADA
SN 0007-0556
J9 B C MED J
JI B. C. Med. J.
PD APR
PY 2016
VL 58
IS 3
BP 158
EP 161
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI5ZC
UT WOS:000373578000023
ER

PT J
AU Duchin, JS
AF Duchin, Jeffrey S.
TI US Public Health Preparedness for Zika and Other Threats Remains
   Vulnerable
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Editorial Material
DE Zika; emergency preparedness; public health; foundational capacities;
   emerging infection
AB The unanticipated global outbreak of Zika virus infection is the most current but certainly not the last emerging infectious disease challenge to confront the US public heath system. Despite a number of such threats in recent years, significant gaps remain in core areas of public health system readiness. Stable, sustained investments are required to establish a solid foundation for achieving necessary national public health emergency preparedness and response capacity. (Disaster Med Public Health Preparedness. 2016;10:298-299)
C1 [Duchin, Jeffrey S.] Publ Hlth Seattle & King Cty, Communicable Dis Epidemiol & Immunizat Sect, Seattle, WA USA.
   [Duchin, Jeffrey S.] Univ Washington, Sch Med, Med, Seattle, WA USA.
   [Duchin, Jeffrey S.] Univ Washington, Sch Publ Hlth, Med, Seattle, WA 98195 USA.
   [Duchin, Jeffrey S.] Infect Dis Soc Amer, Publ Hlth Comm, Arlington, VA USA.
RP Duchin, JS (reprint author), Publ Hlth Seattle & King Cty, Communicable Dis Epidemiol & Immunizat Sect, Seattle, WA USA.
EM jeff.duchin@kingcounty.gov
CR Centers for Disease Control and Prevention, 2013, 2013 2014 NAT SNAPSH
   Himmelstein, 2016, AM J PUBLIC HEALTH, V106, P56
   National Association of County and City Health Officials, 2015, IMP PUBL HLTH EM PRE
   National Association of County and City Health Officials, 2015, CHANG PUBL HLTH LAND
   Trust for Americas Health, 2016, PUBL HLTH EM PREP CO
NR 5
TC 1
Z9 1
U1 14
U2 14
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD APR
PY 2016
VL 10
IS 2
BP 298
EP 299
DI 10.1017/dmp.2016.26
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DI7ZC
UT WOS:000373719500022
PM 26952646
ER

PT J
AU Frank, C
   Faber, M
   Stark, K
AF Frank, Christina
   Faber, Mirko
   Stark, Klaus
TI Causal or not: applying the Bradford Hill aspects of evidence to the
   association between Zika virus and microcephaly
SO EMBO MOLECULAR MEDICINE
LA English
DT Editorial Material
ID INFECTION; BRAZIL
C1 [Frank, Christina; Faber, Mirko; Stark, Klaus] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.
RP Frank, C (reprint author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.
EM frankc@rki.de
OI Frank, Christina/0000-0001-6776-8450
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   HILL AB, 1965, P ROY SOC MED, V58, P295
   KATZ RG, 1968, CLIN PEDIATR, V7, P323, DOI 10.1177/000992286800700607
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 10
TC 3
Z9 3
U1 12
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD APR
PY 2016
VL 8
IS 4
BP 305
EP 307
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DI7XK
UT WOS:000373715100001
PM 26976611
ER

PT J
AU Kline, MW
   Schutze, GE
AF Kline, Mark W.
   Schutze, Gordon E.
TI What Pediatricians and Other Clinicians Should Know About Zika Virus
SO JAMA PEDIATRICS
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES; INFECTION
C1 [Kline, Mark W.; Schutze, Gordon E.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, 6621 Fannin St,Ste A150,MC1150, Houston, TX 77030 USA.
RP Kline, MW (reprint author), Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, 6621 Fannin St,Ste A150,MC1150, Houston, TX 77030 USA.
EM mkline@bcm.edu
CR Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Martines RB, 2015, MMWR MORB MORTAL WKL, DOI 10.15585/mmwr.mm6506e1er
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
NR 7
TC 1
Z9 1
U1 4
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD APR
PY 2016
VL 170
IS 4
BP 309
EP 310
DI 10.1001/jamapediatrics.2016.0429
PG 2
WC Pediatrics
SC Pediatrics
GA DI3EI
UT WOS:000373380800003
PM 26893150
ER

PT J
AU Rowland, A
   Washington, CI
   Sheffield, JS
   Pardo-Villamizar, CA
   Segars, JH
AF Rowland, Ayresleigh
   Washington, Chantel I.
   Sheffield, Jeanne S.
   Pardo-Villamizar, Carlos A.
   Segars, James H.
TI Zika virus infection in semen: a call to action and research
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Editorial Material
ID TRANSMISSION
C1 [Rowland, Ayresleigh] Johns Hopkins Univ, Sch Med, 733 North Broadway, Baltimore, MD 21205 USA.
   [Washington, Chantel I.; Segars, James H.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 720 Rutland Ave,Room 624 Ross Bldg, Baltimore, MD 21205 USA.
   [Sheffield, Jeanne S.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, 600 North Wolfe St,Phipps Bldg,Room 203, Baltimore, MD 21287 USA.
   [Pardo-Villamizar, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, David H Koch Canc Res Bldg 2,1550 Orleans St, Baltimore, MD 21287 USA.
RP Segars, JH (reprint author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Sci & Womens Hlth Res, 720 Rutland Ave,Room 624 Ross Bldg, Baltimore, MD 21205 USA.
EM jsegars2@jhmi.edu
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Centers for Disease Control and Prevention, 2015, SURV CONTR AED AEG A
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hynes NA, 2016, J HOPKINS POC IT ABX
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
NR 11
TC 4
Z9 4
U1 16
U2 16
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD APR
PY 2016
VL 33
IS 4
BP 435
EP 437
DI 10.1007/s10815-016-0684-6
PG 3
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA DI5XG
UT WOS:000373573200002
PM 26945753
ER

PT J
AU Burd, I
   Griffin, D
AF Burd, Irina
   Griffin, Diane
TI The chasm between public health and reproductive research: what history
   tells us about Zika virus
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Article
DE Zika; Mother-to-child transmission; Sexual transmission virus in seminal
   fluid
ID DIARRHEA VIRUS; INFECTION; LESIONS; CALVES
AB Zika transmission from mother to fetus and its possible sexual transmission have become a media focus in the past months as a major public health concern. While mother-to-fetus transmission, fetal neurologic manifestations or sexual transmission have never been documented for this virus before, other viruses that belong to the same family are very well known to reproductive health workers, clinicians, and researchers. As a member of Flaviviridae family, including hepatitis C and bovine viral diarrhea virus (BVDV), Zika's pathogenesis may have some parallels with these infections which may pose future questions for public health and research. Vertical transmission of hepatitis C virus from mother to child is known to occur in up to 10 % of pregnancies. BVDV, a member of Pestivirus genus of Flaviviridae family is not known to be transmitted to humans but is known for its vertical transmission in cattle. BVDV infection at different stages of gestation may lead to a spectrum of adverse pregnancy outcomes, including pregnancy loss and neurologic manifestations (including deformations such as hydrocephalus and microcephaly) in the offspring. Similar to hepatitis C, which is a virus of Hepacivirus genus, BVDV is capable of persistent infection, meaning that virus may stay in mother and future generations of calves may be infected as well, which may, in turn, result in persistence of infection in offspring. Would this be a case with Zika virus? Along with mother-to-fetus transmission, sexual transmission is a concerning implication for Zika virus. Would woman become a persistent career or male be able to persistently carry virus with its sperm is yet unknown; yet, there is a concern for the reservoir of infection. Animal models of the disease are urgently needed not only to demonstrate the mother-to-fetus transmission and confirm the fetal neurologic manifestations but also to address the effects of virus on life-long host's immunity and reproductive health. Along those lines, women desiring pregnancies who are identified to travel, have a partner traveling to, or living in the areas of Zika infections should be encouraged to have a preconception consultation with maternal-fetal medicine.
C1 [Burd, Irina] Johns Hopkins Sch Med, Integrated Res Ctr Fetal Med, Dept Gynecol & Obstet, 600 N Wolfe St,Phipps 228, Baltimore, MD 21287 USA.
   [Burd, Irina] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21287 USA.
   [Griffin, Diane] Johns Hopkins Sch Publ Hlth, Mol Biol & Immunol, Baltimore, MD USA.
RP Burd, I (reprint author), Johns Hopkins Sch Med, Integrated Res Ctr Fetal Med, Dept Gynecol & Obstet, 600 N Wolfe St,Phipps 228, Baltimore, MD 21287 USA.; Burd, I (reprint author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21287 USA.
EM iburd@jhmi.edu
CR Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   BADMAN RT, 1981, AUST VET J, V57, P306, DOI 10.1111/j.1751-0813.1981.tb05831.x
   HEWICKERTRAUTWEIN M, 1995, J VET MED B, V42, P65
   Lanyon SR, 2014, VET J, V199, P201, DOI 10.1016/j.tvjl.2013.07.024
   Peterhans E, 2013, BIOLOGICALS, V41, P39, DOI 10.1016/j.biologicals.2012.07.006
NR 5
TC 1
Z9 2
U1 18
U2 21
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD APR
PY 2016
VL 33
IS 4
BP 439
EP 440
DI 10.1007/s10815-016-0687-3
PG 2
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA DI5XG
UT WOS:000373573200003
PM 26943916
ER

PT J
AU Chang, C
   Ortiz, K
   Ansari, A
   Gershwin, ME
AF Chang, Christopher
   Ortiz, Kristina
   Ansari, Aftab
   Gershwin, M. Eric
TI The Zika outbreak of the 21st century
SO JOURNAL OF AUTOIMMUNITY
LA English
DT Article
DE Guillain-Barre; Mosquitoes; Zika fever; Pandemic; Arborvirus; Sexual
   transmission; Aedes aegypti; Autophagy; Centrosome; Dengue;
   Glycosylation
ID POLYMERASE-CHAIN-REACTION; WEST NILE VIRUS; YELLOW-FEVER; POTENTIAL
   VECTOR; ARBOVIRUS THREAT; FRENCH-POLYNESIA; MOSQUITO VECTOR;
   AEDES-AEGYPTI; INFECTION; TRANSMISSION
AB The Zika virus outbreak has captivated the attention of the global audience and information has spread rapidly and wildly through the internet and other media channels. This virus was first identified in 1947, when it was isolated from a sentinel rhesus monkey placed by British scientists working at the Yellow Fever Research Laboratory located in the Zika forest area of Uganda, hence its name, and is transmitted primarily by the mosquito vector, Aedes aegypti. The fact that the rhesus macaque is an Asian species being placed in an African forest brings to mind the possibility of rapid adaptation of the virus from an African to Asian species, an issue that has not been considered. Whether such adaptation has played any role in acquiring pathogenicity due to cross species transmission remains to be identified. The first human infection was described in Nigeria in 1954, with only scattered reports of about a dozen human infections identified over a 50-year period. It was not until 2007 that Zika virus raised its ugly head with infections noted in three-quarters of the population on the tiny island of Yap located between the Philippines and Papua New Guinea in the western Pacific Ocean, followed by a major outbreak in French Polynesia in 2013. The virus remained confined to a narrow equatorial band in Africa and Asia until 2014 when it began to spread eastward, first toward Oceania and then to South America. Since then, millions of infected individuals have been identified in Brazil, Colombia, Venezuela, including 25 additional countries in the Americas. While the symptoms associated with Zika virus infection are generally mild, consisting of fever, maculopapular rash, arthralgia and conjunctivitis, there have been reports of more severe reactions that are associated with neurological complications. In pregnant women, fetal neurological complications include brain damage and microcephaly, while in adults there have been several cases of virus-associated Guillain-Barre syndrome. The virus was until recently believed to only be transmitted via mosquitoes. But when the Zika virus was isolated from the semen specimens from a patient in Texas, this provided the basis for the recent report of possible sexual transmission of the Zika virus. Due to the neurological complications, various vectors for infection as well as the rapid spread throughout the globe, it has prompted the World Health Organization to issue a global health emergency. Various governmental organizations have recommended that pregnant women do not travel to countries where the virus is epidemic, and within the countries affected by the virus, recommendations were provided for women of childbearing age to delay pregnancy. The overall public health impact of these above findings highlights the need for a rapid but specific diagnostic test for blood banks worldwide to identify those infected and for the counseling of women who are pregnant or contemplating pregnancy. As of this date, there are neither commercially licensed diagnostic tests nor a vaccine. Because cross reactivity of the Zika virus with dengue and Chikungunya virus is common, it may pose difficulty in being able to quickly develop such tests and vaccines. So far the most effective public health measures include controlling the mosquito populations via insecticides and preventing humans from direct exposure to mosquitoes. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Chang, Christopher; Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, 451 Hlth Sci Dr,Suite 6510, Davis, CA 95616 USA.
   [Ortiz, Kristina; Ansari, Aftab] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA USA.
RP Gershwin, ME (reprint author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, 451 Hlth Sci Dr,Suite 6510, Davis, CA 95616 USA.
EM megershwin@ucdavis.edu
CR Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033
   Alera M.T., 2015, EMERG INFECT DIS, P722
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barboza P, 2008, MED MALADIES INFECT, V38, P513, DOI 10.1016/j.medmal.2008.06.011
   Baronti C., 2013, GENOME ANNOUNC, P2
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, P19
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   Bogoch II, 2016, LANCET, V387, P335
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V.M., 2013, EMERG INFECT DIS, V2014, P1085, DOI DOI 10.3201/EID2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Choumet V., 2015, REV SCI TECH, V34, P67
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M., 2015, EMERG INFECT DIS, P381
   Dyer O., 2016, BMJ-BRIT MED J, V352, pi467
   Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Francis MM, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.1136/BJSPORTS-2014-094015
   Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008
   Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x
   Gatherer D., 2015, J GEN VIROL
   Gautret P, 2015, TRAVEL MED INFECT DI
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulland A., 2016, BMJ-BRIT MED J, V352, pi753
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Heang V., 2010, EMERG INFECT DIS, P349
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V2016, P55
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Kelser E.A., 2015, MICROBES INFECT
   Kerkar N, 2016, J AUTOIMMUN, V66, P17, DOI 10.1016/j.jaut.2015.08.017
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   Korhonen E.M., 2016, EUROSURVEILLANCE, P21
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, P19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti R.S., 2007, EMERG INFECT DIS, V2008, P1232
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   loos S, 2014, MED MALADIES INFECT, V44, P302
   Lucey DR, 2016, JAMA
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Martinez-Pulgarin DF, 2015, TRAVEL MED INFECT DI
   Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi306, DOI DOI 10.1136/BMJ.I306
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McMinn PC, 1997, J GEN VIROL, V78, P2711
   MILLER BR, 1991, AM J TROP MED HYG, V45, P399
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   O'Dowd A., 2016, BMJ-BRIT MED J, V352, pi692
   Oehler E., 2013, EUROSURVEILLANCE, P19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Onken J., 2016, ONCOTARGET
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Paz S., 2016, LANCET
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen E.E., 2016, MMWR-MORBID MORTAL W, P30
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   Pyke A.T., 2014, PLOS CURR, P6
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roth A, 2014, EUROSURVEILLANCE, V19
   Sabogal-Roman J.A., 2015, TRAVEL MED INFECT DI
   Salvador F. S., 2015, TRAVEL MED INFECT DI
   Shinohara K, 2016, J TRAVEL MED, P23
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Staples J.E., 2016, MMWR-MORBID MORTAL W, V2016, P63
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D., 2015, MED MICROBIOL IMMUNO
   Tappe D., 2015, EMERG INFECT DIS, P911
   Tappe D., 2014, EUROSURVEILLANCE, P19
   Tetro JA, 2016, MICROBES INFECT
   Thiel H, 2005, VIRUS TAXONOMY, P981
   Tognarelli J., 2015, ARCH VIROL      1126
   Torjesen I, 2016, BMJ-BRIT MED J, V352, pi500
   Valero N, 2015, INVEST CLIN, V56, P241
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez W E, 2016, J INFECT PUBLIC HLTH, DOI S1876-0341(15)00221-X
   Waehre T., 2014, EMERG INFECT DIS, P1412
   Wang LF, 2015, J INTERN MED, V278, P369, DOI 10.1111/joim.12395
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2016, LANCET GLOB HLT 0201
   Zammarchi L., 2015, EUROSURVEILLANCE, P20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P609
NR 136
TC 9
Z9 10
U1 72
U2 85
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0896-8411
EI 1095-9157
J9 J AUTOIMMUN
JI J. Autoimmun.
PD APR
PY 2016
VL 68
BP 1
EP 13
DI 10.1016/j.jaut.2016.02.006
PG 13
WC Immunology
SC Immunology
GA DI5NP
UT WOS:000373546200001
PM 26925496
ER

PT J
AU Sampathkumar, P
   Sanchez, JL
AF Sampathkumar, Priya
   Sanchez, Joyce L.
TI Zika Virus in the Americas: A Review for Clinicians
SO MAYO CLINIC PROCEEDINGS
LA English
DT Review
ID WEST NILE VIRUS; UNITED-STATES; SEXUAL TRANSMISSION; INTERIM GUIDELINES;
   FRENCH-POLYNESIA; BRAZIL; MICRONESIA; PREVENTION; INFECTION; OUTBREAK
AB Zika virus has recently emerged as a new public health threat. An arthropod-borne virus named after the Zika forest in Uganda, it was first discovered in 1947. The virus caused only sporadic cases of Zika infection in Africa and Southeast Asia until 2007, when the first large outbreak occurred in the Yap State in the Federated States of Micronesia. Another outbreak in French Polynesia in 2013 was notable for being associated temporally with an increase in cases of Guillain-Barre syndrome. In 2015, the virus was first reported in Brazil and since then has spread explosively through several additional countries in South and Central America and the Caribbean. Simultaneously, several of these countries have seen a dramatic increase in the incidence of infants born with microcephaly. The rapid spread of Zika virus through the Americas, together with the association of infection with microcephaly and Guillain-Barre syndrome, has resulted in the World Health Organization declaring a public health emergency. Zika virus has the potential to spread to new areas where the Aedes mosquito vector is present and therefore presents a risk to the United States. This concise review describes the clinical features of Zika virus infection and provides advice for clinicians on counseling travelers and others about the disease. (C) 2016 Mayo Foundation for Medical Education and Research
C1 [Sampathkumar, Priya; Sanchez, Joyce L.] Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USA.
RP Sampathkumar, P (reprint author), Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USA.
EM sampathkumar.priya@mayo.edu
CR Besnard M, 2014, EURO SURVEILL, V19
   Boadle A, 2016, REUTERS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention (CDC), TRAV NOT
   Centers for Disease Control and Prevention, ZIK VIR AR ZIK
   Centers for Disease Control and Prevention, ZIK VIR DIAGN TEST
   Centers for Disease Control and Prevention, INSTR SUBM DIAGN SPE
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Fleming-Dutra KE, MMWR MORB MORTAL WKL
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR MORB MORTAL WKL
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2015, MMWR-MORBID MORTAL W, V64, P929, DOI 10.15585/mmwr.mm6434a1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFEC IN PRESS, V21, P552
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2013, EURO SURVEILL, V19
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization/World Health Organization, 2016, GEOGR DISTR CONF CAS
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   [Anonymous], 2016, REP PHYS CROP SPRAYE
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Romero S, 2016, NY TIMES, pA10
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Sampathkumar P, 2003, MAYO CLIN PROC, V78, P1137
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wulifan JK, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-015-0281-3
NR 38
TC 0
Z9 0
U1 32
U2 32
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD APR
PY 2016
VL 91
IS 4
BP 514
EP 521
DI 10.1016/j.mayocp.2016.02.017
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI4TG
UT WOS:000373491600016
PM 27046524
ER

PT J
AU Diniz, SG
AF Diniz, Simone Grilo
TI Zika virus and pregnancy: A perspective from Brazil
SO MIDWIFERY
LA English
DT Editorial Material
C1 [Diniz, Simone Grilo] Univ Sao Paulo, Dept Maternal & Child Hlth, Sch Publ Hlth, Ave Dr Arnaldo 715 Sala 203, BR-01246904 Sao Paulo, SP, Brazil.
RP Diniz, SG (reprint author), Univ Sao Paulo, Dept Maternal & Child Hlth, Sch Publ Hlth, Ave Dr Arnaldo 715 Sala 203, BR-01246904 Sao Paulo, SP, Brazil.
EM sidiniz@usp.br
CR Brazil Ministry of Health, 2016, PUBL HLTH EM OP CTR
   Brazilian Public Health Association (ABRASCO), TECHN NOT MICR VECT
   Centers for Disease Control and Prevention, EFF DIS PREGN WOM EN
   Soares de Araujo J. S., 2016, B WHO UNPUB
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Ximenes MdFFd, 2015, REV SOC BRASILEIRA M
   Public Health England, MOSQ BIT AV TRAV
   [Anonymous], GUID ZIK VIR
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 10
TC 0
Z9 0
U1 13
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0266-6138
EI 1532-3099
J9 MIDWIFERY
JI Midwifery
PD APR
PY 2016
VL 35
BP 22
EP 23
DI 10.1016/j.midw.2016.02.011
PG 2
WC Nursing
SC Nursing
GA DI4QO
UT WOS:000373484600005
PM 27060396
ER

PT J
AU Todd, B
AF Todd, Betsy
TI Zika Virus: An Unfolding Epidemic
SO AMERICAN JOURNAL OF NURSING
LA English
DT Editorial Material
AB What we know now about this emerging global threat.
CR Calvet G., 2016, LANCET INFECT DIS
   Centers for Disease Control and Prevention, 2015, ZIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, 2015, ZIK VIR TRANSM
   Centers for Disease Control and Prevention, 2016, ZIK VIR QUEST ANSW
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIAGN TEST
   Centers for Disease Control and Prevention, 2015, CHIK VIR SURV CONTR
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2015, EP AL ZIK VIR INF
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, EM MICR
NR 12
TC 0
Z9 0
U1 26
U2 26
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0002-936X
EI 1538-7488
J9 AM J NURS
JI Am. J. Nurs.
PD APR
PY 2016
VL 116
IS 4
BP 59
EP 60
DI 10.1097/01.NAJ.0000482140.35295.57
PG 2
WC Nursing
SC Nursing
GA DH5HS
UT WOS:000372817800004
PM 27011140
ER

PT J
AU Trilla, A
   Vilella, A
AF Trilla, Antoni
   Vilella, Anna
TI The Zika virus out of America
SO MEDICINA CLINICA
LA Spanish
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES; TRANSMISSION; OUTBREAK; DENGUE
C1 [Trilla, Antoni; Vilella, Anna] Univ Barcelona, Dept Salud Publ, Serv Med Prevent & Epidemiol, Inst Salud Global Barcelona ISGlobal,Hosp Clin, Barcelona, Spain.
RP Trilla, A (reprint author), Univ Barcelona, Dept Salud Publ, Serv Med Prevent & Epidemiol, Inst Salud Global Barcelona ISGlobal,Hosp Clin, Barcelona, Spain.
EM atrilla@clinic.cat
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Chen LH, 2016, ANN INTERN MED
   Centro de Coordinacion de Alertas y Emergencias Sanitarias, 2016, EV RAP RIESG TRANSM
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS ZIK VIR
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gomes C, 2016, LANCET
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Subdireccio General de Vigilancia i Resposta a Emergencies de Salut Publica, 2016, PROT PREL ACT DAV CA
   Yakob L, 2016, LANCET GLOB HLTH
   [Anonymous], 2016, NATURE, V530, P5
NR 22
TC 0
Z9 0
U1 18
U2 18
PU ELSEVIER DOYMA SL
PI BARCELONA
PA TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN
SN 0025-7753
EI 1578-8989
J9 MED CLIN-BARCELONA
JI Med. Clin.
PD APR 1
PY 2016
VL 146
IS 7
BP 308
EP 310
DI 10.1016/j.medcli.2016.02.004
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH5TL
UT WOS:000372854700005
PM 26947169
ER

PT J
AU Reyna-Villasmil, E
   Lopez-Sanchez, G
   Santos-Bolivar, J
AF Reyna-Villasmil, Eduardo
   Lopez-Sanchez, Geraldine
   Santos-Bolivar, Joel
TI Guillain-Barre syndrome due to Zika virus during pregnancy
SO MEDICINA CLINICA
LA Spanish
DT Letter
C1 [Reyna-Villasmil, Eduardo; Santos-Bolivar, Joel] Hosp Cent Dr Urquinaona, Serv Ginecol & Obstet, Maracaibo, Estado Zulia, Venezuela.
   [Lopez-Sanchez, Geraldine] Hosp Cent Dr Urquinaona, Med Interna Serv, Maracaibo, Estado Zulia, Venezuela.
RP Reyna-Villasmil, E (reprint author), Hosp Cent Dr Urquinaona, Serv Ginecol & Obstet, Maracaibo, Estado Zulia, Venezuela.
EM sippenbauch@gmail.com
CR Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Chan LYS, 2004, ACTA OBSTET GYN SCAN, V83, P319, DOI 10.1111/j.0001-6349.2004.0473.x
   Heang V, 2012, MERG INFECT DIS, V18, P349
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
NR 5
TC 1
Z9 1
U1 17
U2 17
PU ELSEVIER DOYMA SL
PI BARCELONA
PA TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN
SN 0025-7753
EI 1578-8989
J9 MED CLIN-BARCELONA
JI Med. Clin.
PD APR 1
PY 2016
VL 146
IS 7
BP 331
EP 332
DI 10.1016/j.medcli.2016.02.002
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH5TL
UT WOS:000372854700010
PM 26947168
ER

PT J
AU Roure, S
   de Ory, F
   Matas, L
AF Roure, Silvia
   de Ory, Fernando
   Matas, Lurdes
TI Infection imported virus Zika in an area settled by Aedes albopictus
SO MEDICINA CLINICA
LA Spanish
DT Letter
C1 [Roure, Silvia] Unidad Salud Int PROSICS Metropolitana Norte, Santa Coloma De Gramenet, Spain.
   [Roure, Silvia] Hosp Badalona Germans Trias & Pujol, Med Interna Serv, Unidad Enfermedades Infecciosas, Badalona, Spain.
   [de Ory, Fernando] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.
   [Matas, Lurdes] Hosp Badalona Germans Trias & Pujol, Serv Microbiol Clin, Badalona, Spain.
RP Roure, S (reprint author), Unidad Salud Int PROSICS Metropolitana Norte, Santa Coloma De Gramenet, Spain.; Roure, S (reprint author), Hosp Badalona Germans Trias & Pujol, Med Interna Serv, Unidad Enfermedades Infecciosas, Badalona, Spain.
EM sroura.mn.ics@gencat.cat
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
NR 4
TC 0
Z9 0
U1 17
U2 17
PU ELSEVIER DOYMA SL
PI BARCELONA
PA TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN
SN 0025-7753
EI 1578-8989
J9 MED CLIN-BARCELONA
JI Med. Clin.
PD APR 1
PY 2016
VL 146
IS 7
BP 332
EP 333
DI 10.1016/j.medcli.2016.02.003
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH5TL
UT WOS:000372854700011
PM 26947167
ER

PT J
AU Tepper, NK
   Goldberg, HI
   Bernal, MIV
   Rivera, B
   Frey, MT
   Malave, C
   Renquist, CM
   Bracero, NJ
   Dominguez, KL
   Sanchez, RE
   Shapiro-Mendoza, CK
   Rodriguez, BRC
   Simeone, RM
   Pesik, NT
   Barfield, WD
   Ko, JY
   Galang, RR
   Perez-Padilla, J
   Polen, KND
   Honein, MA
   Rasmussen, SA
   Jamieson, DJ
AF Tepper, Naomi K.
   Goldberg, Howard I.
   Bernal, Manuel I. Vargas
   Rivera, Brenda
   Frey, Meghan T.
   Malave, Claritsa
   Renquist, Christina M.
   Bracero, Nabal Jose
   Dominguez, Kenneth L.
   Sanchez, Ramon E.
   Shapiro-Mendoza, Carrie K.
   Rodriguez, Blanca R. Cuevas
   Simeone, Regina M.
   Pesik, Nicki T.
   Barfield, Wanda D.
   Ko, Jean Y.
   Galang, Romeo R.
   Perez-Padilla, Janice
   Polen, Kara N. D.
   Honein, Margaret A.
   Rasmussen, Sonja A.
   Jamieson, Denise J.
TI Estimating Contraceptive Needs and Increasing Access to Contraception in
   Response to the Zika Virus Disease Outbreak - Puerto Rico, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNINTENDED PREGNANCIES; NO-COST
C1 [Tepper, Naomi K.; Goldberg, Howard I.; Shapiro-Mendoza, Carrie K.; Barfield, Wanda D.; Ko, Jean Y.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Bernal, Manuel I. Vargas; Rivera, Brenda] Puerto Rico Dept Hlth, Mayaguez, PR USA.
   [Frey, Meghan T.; Renquist, Christina M.; Simeone, Regina M.; Polen, Kara N. D.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Malave, Claritsa] Off Reg Operat, Hlth Resources & Serv Adm, Rockville, MD 20857 USA.
   [Bracero, Nabal Jose] Univ Puerto Rico, Mayaguez, PR USA.
   [Bracero, Nabal Jose] Amer Coll Obstetricians & Gynecologists, Puerto Rico Sect, Washington, DC 20024 USA.
   [Dominguez, Kenneth L.; Galang, Romeo R.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Sanchez, Ramon E.] Univ Puerto Rico, Family Planning Program Title X Clin Preven, Mayaguez, PR USA.
   [Rodriguez, Blanca R. Cuevas] PROFAMILIAS, Santiago, Chile.
   [Pesik, Nicki T.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Galang, Romeo R.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Perez-Padilla, Janice] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Tepper, NK (reprint author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM zikamch@cdc.gov
CR Bensyl DM, 2002, MMWR SURVEILL SUMM, V54
   Brasil P, 2016, N ENGL J MED
   Daniels K, 2015, NATL HLTH STAT REPOR
   Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416
   Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x
   Hamilton BE, 2015, NATL VITAL STAT REP, V64, P1
   Meaney-Delman D, 2016, OBSTET GYNECOL
   Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [http://10.1097/AOG.0b013e318273eb56, 10.1097/AOG.0b013e318273eb56]
   Secura GM, 2014, NEW ENGL J MED, V371, P1316, DOI 10.1056/NEJMoa1400506
NR 9
TC 4
Z9 4
U1 14
U2 14
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 1
PY 2016
VL 65
IS 12
BP 311
EP 314
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH8IO
UT WOS:000373036900003
PM 27031817
ER

PT J
AU Petersen, EE
   Polen, KND
   Meaney-Delman, D
   Ellington, SR
   Oduyebo, T
   Cohn, A
   Oster, AM
   Russell, K
   Kawwass, JF
   Karwowski, MP
   Powers, AM
   Bertolli, J
   Brooks, JT
   Kissin, D
   Villanueva, J
   Munoz-Jordan, J
   Kuehnert, M
   Olson, CK
   Honein, MA
   Rivera, M
   Jamieson, DJ
   Rasmussen, SA
AF Petersen, Emily E.
   Polen, Kara N. D.
   Meaney-Delman, Dana
   Ellington, Sascha R.
   Oduyebo, Titilope
   Cohn, Amanda
   Oster, Alexandra M.
   Russell, Kate
   Kawwass, Jennifer F.
   Karwowski, Mateusz P.
   Powers, Ann M.
   Bertolli, Jeanne
   Brooks, John T.
   Kissin, Dmitry
   Villanueva, Julie
   Munoz-Jordan, Jorge
   Kuehnert, Matthew
   Olson, Christine K.
   Honein, Margaret A.
   Rivera, Maria
   Jamieson, Denise J.
   Rasmussen, Sonja A.
TI Update: Interim Guidance for Health Care Providers Caring for Women of
   Reproductive Age with Possible Zika Virus Exposure - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID SEXUAL TRANSMISSION; INFECTION; SEMEN; MICRONESIA; GUIDELINES;
   TRAVELERS; HIV-1
C1 [Petersen, Emily E.; Ellington, Sascha R.; Oduyebo, Titilope; Kawwass, Jennifer F.; Kissin, Dmitry; Olson, Christine K.; Rivera, Maria; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Polen, Kara N. D.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Off Director, Atlanta, GA 30333 USA.
   [Oduyebo, Titilope; Russell, Kate; Karwowski, Mateusz P.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Cohn, Amanda] CDC, Off Director, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Oster, Alexandra M.; Bertolli, Jeanne; Brooks, John T.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Influenza Div, NCIRD, Atlanta, GA 30333 USA.
   [Kawwass, Jennifer F.] Emory Univ, Div Reprod Endocrinol & Infertil, Dept Gynecol & Obstet, Sch Med, Atlanta, GA 30322 USA.
   [Karwowski, Mateusz P.] CDC, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.
   [Powers, Ann M.; Munoz-Jordan, Jorge] CDC, Div Vector Borne Dis, NCEZID, Atlanta, GA 30333 USA.
   [Villanueva, Julie] CDC, Div Preparedness & Emerging Infect, NCEZID, Atlanta, GA 30333 USA.
   [Kuehnert, Matthew] CDC, Div Healthcare Qual Promot, NCEZID, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Petersen, EE (reprint author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM ZikaMCH@cdc.gov
CR Atkinson B, DETECTION ZIKA VIRUS
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Bearcroft WGC, 1956, T R SOC TROP MED HYG, V50, P438, DOI 10.1016/0035-9203(56)90090-6
   Brasil P, 2016, N ENGL J MED
   Bujan L, 2002, FERTIL STERIL, V78, P1321, DOI 10.1016/S0015-0282(02)04344-3
   Calvet G, LANCET INFECT DIS
   Cauchemez M, LANCET
   CDC, 2015, CONTRACEPTION
   CDC, 2015, ZIK VIR DIS US 2015
   CDC, 2016, ALL COUNTR TERR ACT
   CDC, 2016, UPD DIAGN TEST ZIK C
   Daiminger A, 2005, BJOG-INT J OBSTET GY, V112, P166, DOI 10.1111/j.1471-0528.2004.00328.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ENDERS G, 1988, LANCET, V1, P1445
   Food and Drug Administration, 2016, DON SCREEN REC RED R
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasci RS, 2016, CDC HLTH INF INT 201
   Nunoue T, 2002, PEDIATR INFECT DIS J, V21, P1133, DOI 10.1097/01.inf.0000040714.21336.84
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pasquier C, 2003, J MED VIROL, V69, P344, DOI 10.1002/jmv.10295
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   Practice Committee of American Society for Reproductive M Practice Committee of Society for Assisted Reproductive T, 2013, FERTIL STERIL, V99, P47
   Revello MG, 2002, J INFECT DIS, V186, P553, DOI 10.1086/341831
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 35
TC 17
Z9 19
U1 10
U2 10
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 1
PY 2016
VL 65
IS 12
BP 315
EP 322
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH8IO
UT WOS:000373036900004
PM 27031943
ER

PT J
AU Oster, AM
   Russell, K
   Stryker, JE
   Friedman, A
   Kachur, RE
   Petersen, EE
   Jamieson, DJ
   Cohn, AC
   Brooks, JT
AF Oster, Alexandra M.
   Russell, Kate
   Stryker, Jo Ellen
   Friedman, Allison
   Kachur, Rachel E.
   Petersen, Emily E.
   Jamieson, Denise J.
   Cohn, Amanda C.
   Brooks, John T.
TI Update: Interim Guidance for Prevention of Sexual Transmission of Zika
   Virus - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Oster, Alexandra M.; Stryker, Jo Ellen; Brooks, John T.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Epidem Intelligence Serv, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Friedman, Allison; Kachur, Rachel E.] CDC, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Petersen, Emily E.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Cohn, Amanda C.] CDC, Off Director, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
RP Oster, AM (reprint author), CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
EM AOster@cdc.gov
CR Atkinson B HP, 2016, EMERG INFECT DIS
   CDC, 2015, CONTRACEPTION
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen E.E., 2016, MMWR MORB MORTAL WKL
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 10
TC 8
Z9 10
U1 12
U2 12
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD APR 1
PY 2016
VL 65
IS 12
BP 323
EP 325
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH8IO
UT WOS:000373036900005
PM 27032078
ER

PT J
AU Meaney-Delman, D
   Rasmussen, SA
   Staples, JE
   Oduyebo, T
   Ellington, SR
   Petersen, EE
   Fischer, M
   Jamieson, DJ
AF Meaney-Delman, Dana
   Rasmussen, Sonja A.
   Staples, J. Erin
   Oduyebo, Titilope
   Ellington, Sascha R.
   Petersen, Emily E.
   Fischer, Marc
   Jamieson, Denise J.
TI Zika Virus and Pregnancy What Obstetric Health Care Providers Need to
   Know
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Editorial Material
ID FRENCH-POLYNESIA; PERINATAL TRANSMISSION; UNITED-STATES; FEBRUARY 2014;
   INFECTION; BRAZIL; OUTBREAK; BRAIN; WOMEN; MICRONESIA
AB Zika virus is a flavivirus transmitted by Aedes (Stegomyia) species of mosquitoes. In May 2015, the World Health Organization confirmed the first local transmission of Zika virus in the Americas in Brazil. The virus has spread rapidly to other countries in the Americas; as of January 29, 2016, local transmission has been detected in at least 22 countries or territories, including the Commonwealth of Puerto Rico and the U.S. Virgin Islands. Zika virus can infect pregnant women in all three trimesters. Although pregnant women do not appear to be more susceptible to or more severely affected by Zika virus infection, maternal-fetal transmission has been documented. Several pieces of evidence suggest that maternal Zika virus infection is associated with adverse neonatal outcomes, most notably microcephaly. Because of the number of countries and territories with local Zika virus transmission, it is likely that obstetric health care providers will care for pregnant women who live in or have traveled to an area of local Zika virus transmission. We review information on Zika virus, its clinical presentation, modes of transmission, laboratory testing, effects during pregnancy, and methods of prevention to assist obstetric health care providers in caring for pregnant women considering travel or with a history of travel to areas with ongoing Zika virus transmission and pregnant women residing in areas with ongoing Zika virus transmission.
C1 [Meaney-Delman, Dana; Rasmussen, Sonja A.; Staples, J. Erin; Oduyebo, Titilope; Ellington, Sascha R.; Petersen, Emily E.; Fischer, Marc; Jamieson, Denise J.] Ctr Dis Control & Prevent, Atlanta, GA 30345 USA.
RP Meaney-Delman, D (reprint author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd,Mailstop C12, Atlanta, GA 30345 USA.
EM Vmo0@cdc.gov
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, FACTS MICR
   Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P1135
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Environmental Protection Agency, REP TREAT CLOTH
   European Centre for Disease Control and Prevention, 2016, RAP RISK ASS ZIK VIR
   Fiorcruz-Parana Carlos Chagas Institute, 2016, INV FIORCR PAR INTR
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Getachew D, 2015, INTERDISCIP PERSPECT, V2015
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hashmi Madiha, 2015, Indian J Crit Care Med, V19, P678, DOI 10.4103/0972-5229.169353
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leibovitz Z, 2015, ULTRASOUND OBSTET GY
   Martines RB, 2016, MMWR MORB MORTAL WKL
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR MORB MORTAL WKL
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR MORB MORTAL WKL
   Pan American Health Organization, 2015, ZIK VIR ZIKV SURV LA
   Pan American Health Organization World Health Organization, 2016, EP UPD NEU SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900
   Reddy UM, 2014, OBSTET GYNECOL, V123, P1070, DOI 10.1097/AOG.0000000000000245
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tocchio S, 2015, SEMIN PERINATOL, V39, P73, DOI 10.1053/j.semperi.2015.01.002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
NR 45
TC 3
Z9 4
U1 29
U2 40
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD APR
PY 2016
VL 127
IS 4
BP 642
EP 648
DI 10.1097/AOG.0000000000001378
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DH4YF
UT WOS:000372791000004
PM 26889662
ER

PT J
AU Rathore, MH
AF Rathore, Mobeen H.
TI Zika Virus-Pediatricians Be Aware
SO PEDIATRICS IN REVIEW
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES
C1 [Rathore, Mobeen H.] Univ Florida, Ctr HIV AIDS Res, Gainesville, FL 32611 USA.
RP Rathore, MH (reprint author), Univ Florida, Ctr HIV AIDS Res, Gainesville, FL 32611 USA.
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2015, EP UPD OUTBR ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
NR 6
TC 0
Z9 0
U1 7
U2 7
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0191-9601
EI 1526-3347
J9 PEDIATR REV
JI Pediatr. Rev.
PD APR
PY 2016
VL 37
IS 4
BP 133
EP 134
PG 2
WC Pediatrics
SC Pediatrics
GA DI2RP
UT WOS:000373346100001
PM 27037098
ER

PT J
AU Solomon, T
   Baylis, M
   Brown, D
AF Solomon, Tom
   Baylis, Matthew
   Brown, David
TI Zika virus and neurological disease-approaches to the unknown
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID BRAZIL; INFECTION; ENCEPHALITIS
C1 [Solomon, Tom; Baylis, Matthew] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
   [Solomon, Tom; Baylis, Matthew; Brown, David] Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Brown, David] Oswaldo Cruz Inst Fiocruz, Influenza Lab, Rio De Janeiro, Brazil.
   [Brown, David] Publ Hlth England, Virus Reference Dept, Natl Infect Serv, London, England.
RP Solomon, T (reprint author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.; Solomon, T (reprint author), Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.; Solomon, T (reprint author), Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
EM tsolomon@liv.ac.uk
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 11
TC 3
Z9 3
U1 36
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD APR
PY 2016
VL 16
IS 4
BP 402
EP 404
DI 10.1016/S1473-3099(16)00125-0
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DH0CH
UT WOS:000372449600015
PM 26923117
ER

PT J
AU Mansuy, JM
   Dutertre, M
   Mengelle, C
   Fourcade, C
   Marchou, B
   Delobel, P
   Izopet, J
   Martin-Blondel, G
AF Mansuy, Jean Michel
   Dutertre, Marine
   Mengelle, Catherine
   Fourcade, Camille
   Marchou, Bruno
   Delobel, Pierre
   Izopet, Jacques
   Martin-Blondel, Guillaume
TI Zika virus: high infectious viral load in semen, a new sexually
   transmitted pathogen?
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION
C1 [Mansuy, Jean Michel; Mengelle, Catherine; Izopet, Jacques] Ctr Hosp & Univ, Virol Lab, Inst Federatif Biol, F-31059 Toulouse, France.
   [Dutertre, Marine; Fourcade, Camille; Marchou, Bruno; Delobel, Pierre; Martin-Blondel, Guillaume] Ctr Hosp & Univ, Serv Malad Infect & Trop, F-31059 Toulouse, France.
   [Dutertre, Marine; Marchou, Bruno; Delobel, Pierre; Izopet, Jacques; Martin-Blondel, Guillaume] Ctr Physiopathol Toulouse Purpan, CNRS, UMR 5282, INSERM,U1043, Toulouse, France.
RP Mansuy, JM (reprint author), Ctr Hosp & Univ, Virol Lab, Inst Federatif Biol, F-31059 Toulouse, France.
EM mansuy.jm@chu-toulouse.fr
RI Delobel, Pierre/K-3166-2014
OI Delobel, Pierre/0000-0002-2874-3581
CR Deen GF, 2015, NEW ENGL J MED, V14, DOI [10.1056/NEJMoa1511410, DOI 10.1056/NEJMOA1511410, 10.1056/NEJMoa1511410.]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Roa M, 2016, LANCET
NR 5
TC 31
Z9 32
U1 22
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD APR
PY 2016
VL 16
IS 4
BP 405
EP 405
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DH0CH
UT WOS:000372449600016
PM 26949027
ER

PT J
AU Stratton, SJ
AF Stratton, Samuel J.
TI Zika Virus Association with Microcephaly: The Power for Population
   Statistics to Identify Public Health Emergencies
SO PREHOSPITAL AND DISASTER MEDICINE
LA English
DT Editorial Material
CR Aschengrau A, 2008, ESSENTIALS EPIDEMIOL, P41
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 2
TC 0
Z9 0
U1 16
U2 16
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1049-023X
EI 1945-1938
J9 PREHOSPITAL DISASTER
JI Prehospital Disaster Med.
PD APR
PY 2016
VL 31
IS 2
BP 119
EP 120
DI 10.1017/S1049023X16000170
PG 2
WC Emergency Medicine
SC Emergency Medicine
GA DG8RX
UT WOS:000372352400005
PM 26940218
ER

PT J
AU Maron, DF
AF Maron, Dina Fine
TI Travels with Zika The mosquito-borne virus migrates to the US from
   diverse nations
SO SCIENTIFIC AMERICAN
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 11
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0036-8733
J9 SCI AM
JI Sci.Am.
PD APR
PY 2016
VL 314
IS 4
BP 84
EP 84
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH0NX
UT WOS:000372482000033
PM 27082204
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika virus: a little less speculation, a little more action
SO LANCET NEUROLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 17
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD APR
PY 2016
VL 15
IS 4
BP 343
EP 343
DI 10.1016/S1474-4422(16)00074-0
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA DG3MP
UT WOS:000371974000001
ER

PT J
AU Shakir, R
AF Shakir, Raad
TI Neurological expertise is essential for Zika virus infection
SO LANCET NEUROLOGY
LA English
DT Letter
ID GUILLAIN-BARRE-SYNDROME
C1 [Shakir, Raad] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, London W6 8RF, England.
RP Shakir, R (reprint author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, London W6 8RF, England.
EM r.shakir@imperial.ac.uk
CR Hughes RAC, 2003, NEUROLOGY, V61, P736
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pritchard J, 2008, POSTGRAD MED J, V84, P532, DOI 10.1136/jnnp.2006.097709
   UK Department of Health, 2011, CLIN GUID IMM US
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   [Anonymous], 2016, LANCET, V387, P96
NR 7
TC 2
Z9 2
U1 7
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1474-4422
EI 1474-4465
J9 LANCET NEUROL
JI Lancet Neurol.
PD APR
PY 2016
VL 15
IS 4
BP 353
EP 354
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA DG3MP
UT WOS:000371974000011
PM 26922438
ER

PT J
AU Fry, DE
AF Fry, Donald E.
TI Zika Virus Infection and Surgery
SO SURGICAL INFECTIONS
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES; TRANSMISSION
CR Calvet G., 2016, LANCET INFECT DIS
   Fry DE, 2010, J AM COLL SURGEONS, V211, P546, DOI 10.1016/j.jamcollsurg.2010.06.389
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EUROSURVEILLANCE, pii
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Waggoner JJ, 2016, J CLIN MICROBIOL, pii
NR 8
TC 1
Z9 1
U1 17
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-2964
EI 1557-8674
J9 SURG INFECT
JI Surg. Infect.
PD APR 1
PY 2016
VL 17
IS 2
BP 123
EP 123
DI 10.1089/sur.2016.29004.df
PG 1
WC Infectious Diseases; Surgery
SC Infectious Diseases; Surgery
GA DG6FL
UT WOS:000372178200001
PM 26978530
ER

PT J
AU Campos, RD
   Cirne-Santos, C
   Meira, GLS
   Santos, LLR
   de Meneses, MD
   Friedrich, J
   Jansen, S
   Ribeiro, MS
   Cruz, IC
   Schmidt-Chanasit, J
   Ferreira, DF
AF Campos, Renata de M.
   Cirne-Santos, Claudio
   Meira, Guilherme L. S.
   Santos, Luana L. R.
   de Meneses, Marcelo D.
   Friedrich, Johannes
   Jansen, Stephanie
   Ribeiro, Mario S.
   da Cruz, Igor C.
   Schmidt-Chanasit, Jonas
   Ferreira, Davis F.
TI Prolonged detection of Zika virus RNA in urine samples during the
   ongoing Zika virus epidemic in Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Letter
ID INFECTION; TRAVEL
C1 [Campos, Renata de M.; Cirne-Santos, Claudio; Meira, Guilherme L. S.; Santos, Luana L. R.; de Meneses, Marcelo D.; Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   [de Meneses, Marcelo D.; Ribeiro, Mario S.; da Cruz, Igor C.] Noel Nutels Cent Lab LACEN, Rio De Janeiro, Brazil.
   [Friedrich, Johannes; Jansen, Stephanie] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Ribeiro, Mario S.] Univ Fed Rio de Janeiro, Inst Publ Hlth, BR-21941 Rio De Janeiro, Brazil.
   [Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, Bochum, Germany.
RP Ferreira, DF (reprint author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Bloco 1,Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
EM davisf@micro.ufrj.br
CR Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Tappe D, 2014, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 8
TC 9
Z9 9
U1 24
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD APR
PY 2016
VL 77
BP 69
EP 70
DI 10.1016/j.jcv.2016.02.009
PG 2
WC Virology
SC Virology
GA DG0WR
UT WOS:000371787100014
ER

PT J
AU Mor, G
AF Mor, Gil
TI Placental Inflammatory Response to Zika Virus may Affect Fetal Brain
   Development
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Editorial Material
ID EBOLA HEMORRHAGIC-FEVER; IMMUNE-SYSTEM; PREGNANCY; DISEASE
C1 [Mor, Gil] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.
RP Mor, G (reprint author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Reprod Sci, 333 Cedar St,LSOG 305A, New Haven, CT 06520 USA.
EM gil.mor@yale.edu
CR Burton Graham J, 2015, Am J Obstet Gynecol, V213, pS6, DOI 10.1016/j.ajog.2015.07.050
   Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308
   Cardenas I, 2010, AM J REPROD IMMUNOL, V61, P397
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Cheslack-Postava K, 2013, NEUROTOXICOL TERATOL, V38, P1, DOI 10.1016/j.ntt.2013.04.001
   Fowden AL, 2015, PLACENTA, V36, pS50, DOI 10.1016/j.placenta.2014.11.018
   Gluckman PD, 2002, ENDOCRINE, V19, P81, DOI 10.1385/ENDO:19:1:81
   Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x
   Jackson P, 2012, MUTAT RES-GEN TOX EN, V745, P73, DOI 10.1016/j.mrgentox.2011.09.018
   Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902
   Jamieson DJ, 2014, OBSTET GYNECOL, V124, P1005, DOI 10.1097/AOG.0000000000000533
   Lee Jungun, 2015, Asian Pac J Cancer Prev, V16, P3029
   Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289
   Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x
   Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Sobrian SK, 1997, ENVIRON RES, V73, P227, DOI 10.1006/enrs.1997.3734
NR 18
TC 6
Z9 7
U1 20
U2 87
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD APR
PY 2016
VL 75
IS 4
BP 421
EP 422
DI 10.1111/aji.12505
PG 2
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA DF7IR
UT WOS:000371531900001
PM 26892436
ER

PT J
AU Drosten, C
AF Drosten, C.
TI Zika virus and congenital malformations in perspective
SO EUROSURVEILLANCE
LA English
DT Editorial Material
C1 [Drosten, C.] Univ Bonn, Inst Virol, Bonn, Germany.
   [Drosten, C.] Deutsch Zentrum Infekt Forsch, Bonn, Germany.
RP Drosten, C (reprint author), Univ Bonn, Inst Virol, Bonn, Germany.; Drosten, C (reprint author), Deutsch Zentrum Infekt Forsch, Bonn, Germany.
EM drosten@virology-bonn.de
CR Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, N ENGL J MED
   Cauchemez S, 2016, LANCET
   Regis C, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.170639, DOI 10.2471/BLT.16.170639]
   Kindhauser MK, 2016, B WHO UNPUB
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Pan American Health Organization (PAHO) / World Health Organization Regional Office for the Americas (WHO), 2016, EP AL INCR MICR NE B
   Pan American Health Organization / World Health Organization, 2016, ZIK EP UPD 09 MARCH
   Rocha HAL, 2016, B WORLD HLTH O UNPUB, DOI [10.2471/BLT.16.171215, DOI 10.2471/BLT.16.171215]
   The Bulletin of the World Health Organization (WHO), 2016, B WHO
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
NR 12
TC 0
Z9 0
U1 6
U2 6
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 31
PY 2016
VL 21
IS 13
BP 2
EP 4
AR 30182
DI 10.2807/1560-7917.ES.2016.21.13.30182
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DI1PS
UT WOS:000373268600001
ER

PT J
AU Besnard, M
   Eyrolle-Guignot, D
   Guillemette-Artur, P
   Lastere, S
   Bost-Bezeaud, F
   Marcelis, L
   Abadie, V
   Garel, C
   Moutard, M
   Jouannic, J
   Rozenberg, F
   Leparc-Goffart, I
   Mallet, H
AF Besnard, M.
   Eyrolle-Guignot, D.
   Guillemette-Artur, P.
   Lastere, S.
   Bost-Bezeaud, F.
   Marcelis, L.
   Abadie, V.
   Garel, C.
   Moutard, M.
   Jouannic, J.
   Rozenberg, F.
   Leparc-Goffart, I.
   Mallet, H.
TI Congenital cerebral malformations and dysfunction in fetuses and
   newborns following the 2013 to 2014 Zika virus epidemic in French
   Polynesia
SO EUROSURVEILLANCE
LA English
DT Article
ID ROBIN,PIERRE SEQUENCE; INFECTION; BRAIN; PREGNANCY; BRAZIL
AB We detected an unusual increase in congenital cerebral malformations and dysfunction in fetuses and newborns in French Polynesia, following an epidemic of Zika virus (ZIKV), from October 2013 to March 2014. A retrospective review identified 19 cases, including eight with major brain lesions and severe microcephaly, six with severe cerebral lesions without microcephaly and five with brainstem dysfunction without visible malformations. Imaging revealed profound neurological lesions (septal and callosal disruption, ventriculomegaly, abnormal neuronal migration, cerebellar hypoplasia, occipital pseudocysts, brain calcifications). Amniotic fluid was drawn from seven cases at gestation weeks 20 to 29. ZIKV RNA was detected by RT-PCR and infectious ZIKV isolates were obtained in four of five microcephalic, but not in two non-microcephalic cases with severe brain lesions. Medical termination of pregnancy was performed in eleven cases; two cases with brainstem dysfunction died in the first months of life; six cases are alive, with severe neurological impairment. The results show that four of seven tested fetuses with major neurological injuries were infected with ZIKV in utero. For other non-microcephalic, congenital abnormalities we were not able to prove or exclude ZIKV infection retrospectively. The unusual occurrence of brain malformations or dysfunction without microcephaly following a ZIKV outbreak needs further studies.
C1 [Besnard, M.] CHPF, Serv Reanimat Neonatale, Pirae, Fr Polynesia.
   [Eyrolle-Guignot, D.] CHPF, Serv Obstet, Pirae, Fr Polynesia.
   [Guillemette-Artur, P.] CHPF, Serv Radiol, Pirae, Fr Polynesia.
   [Lastere, S.] CHPF, Med Biol Lab, Pirae, Fr Polynesia.
   [Bost-Bezeaud, F.] CHPF, Lab Anat Pathol, Pirae, Fr Polynesia.
   [Marcelis, L.; Mallet, H.] Direct Sante, Bur Veille Sanit, Papeete, Fr Polynesia.
   [Abadie, V.] Hop Necker Enfants Malad, AP HP, Serv Pediat Gen, Paris, France.
   [Garel, C.] Hop Armand Trousseau, AP HP, Serv Radiol, Paris, France.
   [Moutard, M.] Hop Armand Trousseau, AP HP, Serv Neuropediat, Paris, France.
   [Jouannic, J.] Hop Armand Trousseau, AP HP, Serv Med Foetale, Paris, France.
   [Rozenberg, F.] Hop Cochin, AP HP, Serv Virol, 27 Rue Faubourg St Jacques, F-75674 Paris, France.
   [Leparc-Goffart, I.] IRBA, Ctr Natl Reference Arbovirus, Marseille, France.
RP Besnard, M (reprint author), CHPF, Serv Reanimat Neonatale, Pirae, Fr Polynesia.
EM mbesnard@nohao.net
CR Abadie V, 2002, EUR J PEDIATR, V161, P275, DOI 10.1007/s00431-002-0936-6
   Abadie V, 2013, HAND CLINIC, V113, P1539, DOI 10.1016/B978-0-444-59565-2.00024-1
   Association des Utilisateurs de Dossiers Informatises en Pediatrie, HEAD CIRC CHARTS
   Besnard M, INCREASE CEREBRAL CO
   European Centre for Disease Prevention and Control (ECDC), 2015, RAP RISK ASS MICR BR
   Esteban H, 2015, ULTRASOUND OBST GYN, V46, P678, DOI 10.1002/uog.14820
   Haute Autorite de Sante ( HAS), 2007, SUIV OR FEMM ENC FON
   Holder-Espinasse M, 2001, J PEDIATR-US, V139, P588, DOI 10.1067/mpd.2001.117784
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kucharski AJ, 2016, TRANSMISSION DYNAMIC, P7, DOI [10. 1101/ 038588, DOI 10.1101/038588]
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   PAHO/WHO - Pan American Health Organization/World Health Organization, 2015, EP AL INCR MICR NE B
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x
   World Health Organisation, 2016, INT STAT CLASS DIS R
NR 19
TC 6
Z9 6
U1 6
U2 6
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 31
PY 2016
VL 21
IS 13
BP 22
EP 30
AR 30181
DI 10.2807/1560-7917.ES.2016.21.13.30181
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DI1PS
UT WOS:000373268600004
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Couples at risk from exposure to Zika virus should consider delaying
   pregnancy, says CDC
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Oster AM, 2016, MMWR MORB MORTAL WKL
   Petersen E.E., 2016, MMWR MORB MORTAL WKL
NR 2
TC 0
Z9 0
U1 6
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 30
PY 2016
VL 352
AR i1813
DI 10.1136/bmj.i1813
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI4TO
UT WOS:000373492400019
PM 27029872
ER

PT J
AU Armstrong, P
   Hennessey, M
   Adams, M
   Cherry, C
   Chiu, S
   Harrist, A
   Kwit, N
   Lewis, L
   McGuire, DO
   Oduyebo, T
   Russell, K
   Talley, P
   Tanner, M
   Williams, C
AF Armstrong, Paige
   Hennessey, Morgan
   Adams, Monica
   Cherry, Cara
   Chiu, Sophia
   Harrist, Alexia
   Kwit, Natalie
   Lewis, Lillianne
   McGuire, Dana Olzenak
   Oduyebo, Titilope
   Russell, Kate
   Talley, Pamela
   Tanner, Mary
   Williams, Charnetta
CA Zika Virus Response Epidemiology
TI Travel-Associated Zika Virus Disease Cases Among US Residents - United
   States, January 2015-February 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UPDATE INTERIM GUIDELINES; INFECTION
C1 [Armstrong, Paige; Hennessey, Morgan; Adams, Monica; Cherry, Cara; Chiu, Sophia; Harrist, Alexia; Kwit, Natalie; Lewis, Lillianne; McGuire, Dana Olzenak; Oduyebo, Titilope; Russell, Kate; Talley, Pamela; Tanner, Mary; Williams, Charnetta] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
RP Armstrong, P (reprint author), Care of Fischer M, Zika Virus Response Epidemiol & Lab Team, New York, NY USA.
EM mfischer@cdc.gov
CR Cao-Lormeau VM, 2016, LANCET
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
NR 10
TC 7
Z9 7
U1 4
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 25
PY 2016
VL 65
IS 11
BP 286
EP 289
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH4CS
UT WOS:000372733700005
PM 27023833
ER

PT J
AU Olson, CK
   Iwamoto, M
   Perkins, KM
   Polen, KND
   Hageman, J
   Meaney-Delman, D
   Igbinosa, II
   Khan, S
   Honein, MA
   Bell, M
   Rasmussen, SA
   Jamieson, DJ
AF Olson, Christine K.
   Iwamoto, Martha
   Perkins, Kiran M.
   Polen, Kara N. D.
   Hageman, Jeffrey
   Meaney-Delman, Dana
   Igbinosa, Irogue I.
   Khan, Sumaiya
   Honein, Margaret A.
   Bell, Michael
   Rasmussen, Sonja A.
   Jamieson, Denise J.
TI Preventing Transmission of Zika Virus in Labor and Delivery Settings
   Through Implementation of Standard Precautions - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Olson, Christine K.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Iwamoto, Martha] CDC, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Perkins, Kiran M.; Hageman, Jeffrey; Bell, Michael] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Polen, Kara N. D.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Off Director, Atlanta, GA 30333 USA.
   [Igbinosa, Irogue I.] CDC, Ctr Surveillance Epidemiol & Lab Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Khan, Sumaiya] CDC, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Ctr Surveillance Epidemiol & Lab Serv, Div Publ Hlth Informat Disseminat, Atlanta, GA 30333 USA.
RP Olson, CK (reprint author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM zikamch@cdc.gov
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Brasil P, 2016, NEW ENGL J MED
   Cao-Lormeau V M, 2016, LANCET
   Gammon J, 2008, J CLIN NURS, V17, P157, DOI 10.1111/j.1365-2702.2006.01852.x
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   KOURI DL, 1993, AM J OBSTET GYNECOL, V169, P312
   Likis FE, 2015, MANAGEMENT POSTPARTU
   Mischke C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009573.pub2
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Sandlin AT, 2014, ARCH GYNECOL OBSTET, V289, P967, DOI 10.1007/s00404-013-3087-2
   Siegel JD, 2007 GUIDELINE ISOLA
NR 11
TC 4
Z9 4
U1 10
U2 10
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 25
PY 2016
VL 65
IS 11
BP 290
EP 292
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DH4CS
UT WOS:000372733700006
PM 27010422
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI WHO's Chan warns over spread of Zika virus beyond Latin America
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 4
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 24
PY 2016
VL 352
AR i1739
DI 10.1136/bmj.i1739
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH8LN
UT WOS:000373044800017
PM 27012725
ER

PT J
AU Rafiei, N
   Hajkowicz, K
   Redmond, A
   Taylor, C
AF Rafiei, Nastaran
   Hajkowicz, Krispin
   Redmond, Andrew
   Taylor, Carmel
TI First report of Zika virus infection in a returned traveller from the
   Solomon Islands
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT Editorial Material
C1 [Rafiei, Nastaran; Hajkowicz, Krispin; Redmond, Andrew] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia.
   [Taylor, Carmel] Queensland Hlth Forens & Sci Serv, Brisbane, Qld, Australia.
RP Rafiei, N (reprint author), Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia.
EM nastaran.rafiei@uqconnect.edu.au
NR 0
TC 1
Z9 1
U1 1
U2 1
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD MAR 21
PY 2016
VL 204
IS 5
BP 186
EP 186
DI 10.5694/mja15.01275
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK0SB
UT WOS:000374621400014
PM 26985845
ER

PT J
AU Anaya, JM
   Ramirez-Santana, C
   Salgado-Castaneda, I
   Chang, C
   Ansari, A
   Gershwin, ME
AF Anaya, Juan-Manuel
   Ramirez-Santana, Carolina
   Salgado-Castaneda, Ignacio
   Chang, Christopher
   Ansari, Aftab
   Gershwin, M. Eric
TI Zika virus and neurologic autoimmunity: the putative role of
   gangliosides
SO BMC MEDICINE
LA English
DT Article
DE Autoimmunity; Gangliosides; Guillain-Barre syndrome; Microcephaly; Zika
   virus
ID GUILLAIN-BARRE-SYNDROME; NERVOUS-SYSTEM; ANTIBODIES; INFECTION
AB An increasing number of severe neurological complications associated with Zika virus (ZIKV), chiefly Guillain-Barre syndrome (GBS) and primary microcephaly, have led the World Health Organization to declare a global health emergency. Molecular mimicry between glycolipids and surface molecules of infectious agents explain most of the cases of GBS preceded by infection, while a direct toxicity of ZIKV on neural cells has been raised as the main mechanism by which ZIKV induces microcephaly. Gangliosides are crucial in brain development, and their expression correlates with neurogenesis, synaptogenesis, synaptic transmission, and cell proliferation. Targeting the autoimmune response to gangliosides may represent an underexploited opportunity to examine the increased incidence of neurological complications related to ZIKV infection.
C1 [Anaya, Juan-Manuel; Ramirez-Santana, Carolina] Univ Rosario, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.
   [Salgado-Castaneda, Ignacio] Hosp Cent Policia, Serv Neurol, Bogota, Colombia.
   [Chang, Christopher; Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.
   [Ansari, Aftab] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
RP Anaya, JM (reprint author), Univ Rosario, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.
EM anayajm@gmail.com
RI Ramirez-Santana, Carolina/J-2363-2016; Anaya, Juan-Manuel/J-1960-2016
OI Ramirez-Santana, Carolina/0000-0003-2137-4899; Anaya,
   Juan-Manuel/0000-0002-6444-1249
CR Anaya JM, 2013, AUTOIMMUNITY
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cao-Lormeau VM, 2016, LANCET
   Chang C, 2016, J AUTOIMMUN, DOI [10.1016/j.jaut.2016.02.006, DOI 10.1016/J.JAUT.2016.02.006]
   Christofferson RC, 2016, AM J TROP MED HYG
   Dalakas MC, 2015, BBA-MOL BASIS DIS, V1852, P658, DOI 10.1016/j.bbadis.2014.06.013
   Denman AM, 2004, AUTOIMMUN REV, V3, P355, DOI 10.1016/j.autrev.2004.03.001
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ghiulai RM, 2014, GLYCOCONJUGATE J, V31, P231, DOI 10.1007/s10719-014-9517-y
   Kivity S, 2014, J AUTOIMMUN, V51, P17, DOI 10.1016/j.jaut.2014.02.008
   Kolter T., 2012, ISRN BIOCH, V2012, DOI DOI 10.5402/2012/506160
   Kostovic I, 2003, GUIDANCE CUES DEV BR
   Lardone RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19901
   Lazear HM, 2016, J VIROL
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D, 2016, LANCET INFECT DIS
   Nahmias AJ, 2006, CLIN DEV IMMUNOL, V13, P167, DOI 10.1080/17402520600801745
   Tang H, 2016, CELL STEM CELL
   Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   [Anonymous], 2016, WKLY EPIDEMIOL REC, V91, P73
NR 24
TC 3
Z9 3
U1 21
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD MAR 21
PY 2016
VL 14
AR 49
DI 10.1186/s12916-016-0601-y
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI0GI
UT WOS:000373173200001
PM 27001187
ER

PT J
AU Cetron, M
AF Cetron, Martin
TI Revision to CDC's Zika Travel Notices: Minimal Likelihood for
   Mosquito-Borne Zika Virus Transmission at Elevations Above 2,000 Meters
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
C1 [Cetron, Martin] CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Cetron, M (reprint author), CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM MCetron@cdc.gov
CR Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Danielson J. J., 2011, GLOBAL MULTIRESOLUTI
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   GARNHAM PCC, 1945, BRIT MED J, V2, P45
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Messina JP, 2014, SCI DATA, V1, DOI [10.1038/sdata.2014.4, DOI 10.1038/SDATA.2014.4]
   Pan American Health Organization, 2015, EP AL ZIK VIR INF 20
NR 9
TC 2
Z9 4
U1 5
U2 10
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 18
PY 2016
VL 65
IS 10
BP 267
EP 268
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DG5SX
UT WOS:000372140000004
PM 26985965
ER

PT J
AU Zhu, Z
   Chan, JFW
   Tee, KM
   Choi, GKY
   Lau, SKP
   Woo, PCY
   Tse, H
   Yuen, KY
AF Zhu, Zheng
   Chan, Jasper Fuk-Woo
   Tee, Kah-Meng
   Choi, Garnet Kwan-Yue
   Lau, Susanna Kar-Pui
   Woo, Patrick Chiu-Yat
   Tse, Herman
   Yuen, Kwok-Yung
TI Comparative genomic analysis of pre-epidemic and epidemic Zika virus
   strains for virological factors potentially associated with the rapidly
   expanding epidemic
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE arbovirus; flavivirus; genome; microcephaly; mosquito; mutation; virus;
   Zika
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; NONSTRUCTURAL PROTEIN NS1;
   AMINO-ACID SUBSTITUTION; DENGUE VIRUS; CAPSID PROTEIN;
   SUBCELLULAR-LOCALIZATION; NUCLEAR-LOCALIZATION; CORE PROTEIN; NS4B
   PROTEIN
AB Less than 20 sporadic cases of human Zika virus (ZIKV) infection were reported in Africa and Asia before 2007, but large outbreaks involving up to 73% of the populations on the Pacific islands have started since 2007, and spread to the Americas in 2014. Moreover, the clinical manifestation of ZIKV infection has apparently changed, as evident by increasing reports of neurological complications, such as Guillain-Barre syndrome in adults and congenital anomalies in neonates. We comprehensively compared the genome sequences of pre-epidemic and epidemic ZIKV strains with complete genome or complete polyprotein sequences available in GenBank. Besides the reported phylogenetic clustering of the epidemic strains with the Asian lineage, we found that the topology of phylogenetic tree of all coding regions is the same except that of the non-structural 2B (NS2B) coding region. This finding was confirmed by bootscan analysis and multiple sequence alignment, which suggested the presence of a fragment of genetic recombination at NS2B with that of Spondweni virus. Moreover, the representative epidemic strain possesses one large bulge of nine bases instead of an external loop on the first stem-loop structure at the 3'-untranslated region just distal to the stop codon of the NS5 in the 1947 pre-epidemic prototype strain. Fifteen amino acid substitutions are found in the epidemic strains when compared with the pre-epidemic strains. As mutations in other flaviviruses can be associated with changes in virulence, replication efficiency, antigenic epitopes and host tropism, further studies would be important to ascertain the biological significance of these genomic changes.
C1 [Zhu, Zheng; Chan, Jasper Fuk-Woo; Tee, Kah-Meng; Lau, Susanna Kar-Pui; Woo, Patrick Chiu-Yat; Tse, Herman; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Lau, Susanna Kar-Pui; Woo, Patrick Chiu-Yat; Tse, Herman; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Choi, Garnet Kwan-Yue; Lau, Susanna Kar-Pui; Woo, Patrick Chiu-Yat; Tse, Herman; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Lau, Susanna Kar-Pui; Woo, Patrick Chiu-Yat; Tse, Herman; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.
RP Chan, JFW (reprint author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW (reprint author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW (reprint author), Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW (reprint author), Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; kyyuen@hku.hk
FU Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Disease of the Department of Health, the Food and Health
   Bureau, Hong Kong Special Administrative Region, China; Key Laboratory
   of Medical Molecular Virology, Fudan University; Croucher Senior Medical
   Research Fellowship; Strategic Research Theme Fund, The University of
   Hong Kong; Mr Larry Chi-Kin Yung and Hui Hoy & Chow Sin Lan Charity Fund
   Limited
FX We thank James Cai (Department of Veterinary Integrative Biosciences,
   Texas A&M University) and Yu-Mei Wen (Key Laboratory of Medical
   Molecular Virology, Fudan University) for facilitation of the study. The
   study was partly supported by the Consultancy Service for Enhancing
   Laboratory Surveillance of Emerging Infectious Disease of the Department
   of Health, the Food and Health Bureau, Hong Kong Special Administrative
   Region, China; the Key Laboratory of Medical Molecular Virology, Fudan
   University; the Croucher Senior Medical Research Fellowship; and the
   Strategic Research Theme Fund, The University of Hong Kong; and by the
   donations of Mr Larry Chi-Kin Yung and Hui Hoy & Chow Sin Lan Charity
   Fund Limited. The funding sources had no role in study design; data
   collection, analysis or interpretation; or writing of the report. Jasper
   Fuk-Woo Chan and Kwok-Yung Yuen had full access to all the data in the
   study and had final responsibility for the decision to submit for
   publication.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   AMBERG SM, 1994, J VIROL, V68, P3794
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Blackwell JL, 1997, J VIROL, V71, P6433
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Freire CCM, 2015, BIORXIV
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Jia F, 2016, VIROLOGY, V490, P109, DOI 10.1016/j.virol.2016.01.001
   Lau SKP, 2011, J VIROL, V85, P11325, DOI 10.1128/JVI.05512-11
   Lin HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100130
   Lin YJ, 2005, J VIROL, V79, P8535, DOI 10.1128/JVI.79.13.8535-8544.2005
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Muylaert IR, 1997, J VIROL, V71, P291
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Roth A, 2012, EUROSURVEILLANCE, V19, P20929
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tognarelli J, 2016, ARCH VIROL, V151, P665
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Wang SH, 2004, J GEN VIROL, V85, P2307, DOI 10.1099/vir.0.80067-0
   Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007
   Wicker JA, 2012, VIROLOGY, V426, P22, DOI 10.1016/j.virol.2011.11.022
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zhang Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-138
   Zumla A, 2016, NAT REV DRUG DISCOV, DOI [10.1038/nrd.2015.37., DOI 10.1038/NRD.2015.37]
NR 59
TC 3
Z9 3
U1 17
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAR 16
PY 2016
VL 5
AR e22
DI 10.1038/emi.2016.48
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DJ0IO
UT WOS:000373885900001
PM 26980239
ER

PT J
AU Nabel, GJ
   Zerhouni, EA
AF Nabel, Gary J.
   Zerhouni, Elias A.
TI Once and future epidemics: Zika virus emerging
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Editorial Material
ID AMERICA
C1 [Nabel, Gary J.] Sanofi, Global Res & Dev R&D, 640 Mem Dr, Cambridge, MA 02139 USA.
   [Zerhouni, Elias A.] Sanofi, Global R&D, F-75008 Paris, France.
RP Nabel, GJ (reprint author), Sanofi, Global Res & Dev R&D, 640 Mem Dr, Cambridge, MA 02139 USA.
EM gary.nabel@sanofi.com
CR Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Marcondes C. B., 2015, REV SOC BRAS MED TRO, V22
   Rubin E. J., 2016, N ENGL J MED, V10
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   The World Bank, 2013, PAND RISK ON HLTH
NR 7
TC 0
Z9 0
U1 13
U2 18
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD MAR 16
PY 2016
VL 8
IS 330
AR 330ed2
DI 10.1126/scitranslmed.aaf4548
PG 3
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA DG4YS
UT WOS:000372079700001
PM 27089202
ER

PT J
AU MacFadden, DR
   Bogoch, II
AF MacFadden, Derek R.
   Bogoch, Isaac I.
TI Zika virus infection
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT Editorial Material
C1 [MacFadden, Derek R.; Bogoch, Isaac I.] Univ Toronto, Div Infect Dis, Toronto, ON, Canada.
   [MacFadden, Derek R.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
RP MacFadden, DR (reprint author), Univ Toronto, Div Infect Dis, Toronto, ON, Canada.; MacFadden, DR (reprint author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
EM derek.macfadden@mail.utoronto.ca
CR [Anonymous], 2016, LANCET
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
NR 3
TC 0
Z9 1
U1 16
U2 27
PU CMA-CANADIAN MEDICAL ASSOC
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA
SN 0820-3946
EI 1488-2329
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD MAR 15
PY 2016
VL 188
IS 5
BP 367
EP 367
DI 10.1503/cmaj.151486
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG1NS
UT WOS:000371835400003
PM 26858352
ER

PT J
AU Dupont-Rouzeyrol, M
   Biron, A
   O'Connor, O
   Huguon, E
   Descloux, E
AF Dupont-Rouzeyrol, Myrielle
   Biron, Antoine
   O'Connor, Olivia
   Huguon, Emilie
   Descloux, Elodie
TI Infectious Zika viral particles in breastmilk
SO LANCET
LA English
DT Letter
ID VIRUS; TRANSMISSION
C1 [Dupont-Rouzeyrol, Myrielle; Biron, Antoine; O'Connor, Olivia] Reseau Int Inst Pasteur, Inst Pasteur Nouvelle Caledonie, Noumea, New Caledonia.
   [Huguon, Emilie; Descloux, Elodie] Ctr Hosp Terr, Noumea, New Caledonia.
RP Dupont-Rouzeyrol, M (reprint author), Reseau Int Inst Pasteur, Inst Pasteur Nouvelle Caledonie, Noumea, New Caledonia.
EM mdupont@pasteur.nc
CR Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ognjan A, 2002, JAMA-J AM MED ASSOC, V288, P1976
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   World Health Organization, 2015, EP AL NEUR SYNDR CON
NR 6
TC 14
Z9 14
U1 10
U2 48
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 12
PY 2016
VL 387
IS 10023
BP 1051
EP 1051
DI 10.1016/S0140-6736(16)00624-3
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG0SD
UT WOS:000371775000017
PM 26944028
ER

PT J
AU Jouannic, JM
   Friszer, S
   Leparc-Goffart, I
   Garel, C
   Eyrolle-Guignot, D
AF Jouannic, Jean-Marie
   Friszer, Stephanie
   Leparc-Goffart, Isabelle
   Garel, Catherine
   Eyrolle-Guignot, Dominique
TI Zika virus infection in French Polynesia
SO LANCET
LA English
DT Letter
C1 [Jouannic, Jean-Marie; Friszer, Stephanie] Univ Paris 06, Hop Armand Trousseau, AP HP, Serv Med Foetale, Paris, France.
   [Garel, Catherine] Univ Paris 06, Hop Armand Trousseau, AP HP, Serv Radiol Pediat, Paris, France.
   [Leparc-Goffart, Isabelle] Hop Instruct Armees Laveran, Ctr Natl Reference Arbovirus, Inst Rech Biomed Armees, Serv Biol, Marseille, France.
   [Eyrolle-Guignot, Dominique] Ctr Hosp Terr, Serv Gynecol Obstetr, Mamao, Papeete, Fr Polynesia.
RP Jouannic, JM (reprint author), Univ Paris 06, Hop Armand Trousseau, AP HP, Serv Med Foetale, Paris, France.
EM jean-marie.jouannic@aphp.fr
CR European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   WHO, 2005, WHO STAT 1 M INT HLT
NR 5
TC 8
Z9 8
U1 8
U2 36
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 12
PY 2016
VL 387
IS 10023
BP 1051
EP 1052
DI 10.1016/S0140-6736(16)00625-5
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG0SD
UT WOS:000371775000018
PM 26944027
ER

PT J
AU de Oliveira, WK
   Cortez-Escalante, J
   De Oliveira, WTGH
   do Carmo, GMI
   Henriques, CMP
   Coelho, GE
   de Franca, GVA
AF de Oliveira, Wanderson Kleber
   Cortez-Escalante, Juan
   Goncalves Holanda De Oliveira, Wanessa Tenorio
   Ikeda do Carmo, Greice Madeleine
   Pessanha Henriques, Claudio Maierovitch
   Coelho, Giovanini Evelim
   Araujo de Franca, Giovanny Vinicius
TI Increase in Reported Prevalence of Microcephaly in Infants Born to Women
   Living in Areas with Confirmed Zika Virus Transmission During the First
   Trimester of Pregnancy - Brazil, 2015
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [de Oliveira, Wanderson Kleber; Goncalves Holanda De Oliveira, Wanessa Tenorio; Ikeda do Carmo, Greice Madeleine; Pessanha Henriques, Claudio Maierovitch; Coelho, Giovanini Evelim; Araujo de Franca, Giovanny Vinicius] Minist Hlth, Brasilia, DF, Brazil.
   [Cortez-Escalante, Juan] Pan Amer Hlth Org, Sao Paulo, Brazil.
RP de Franca, GVA (reprint author), Minist Hlth, Brasilia, DF, Brazil.
EM giovanny.franca@saude.gov.br
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gibbons L, 2012, AM J OBSTET GYNECOL, V206, P331, DOI DOI 10.1016/J.AJ0G.2012.02.026
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nazer J, 2011, REV MED CHILE, V139, P72, DOI [/S0034-98872011000100010, 10.4067/S0034-98872011000100010]
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 13
Z9 14
U1 24
U2 50
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 11
PY 2016
VL 65
IS 9
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF9QR
UT WOS:000371696600005
ER

PT J
AU Barzon, L
   Pacenti, M
   Berto, A
   Sinigaglia, A
   Franchin, E
   Lavezzo, E
   Brugnaro, P
   Palu, G
AF Barzon, L.
   Pacenti, M.
   Berto, A.
   Sinigaglia, A.
   Franchin, E.
   Lavezzo, E.
   Brugnaro, P.
   Palu, G.
TI Isolation of infectious Zika virus from saliva and prolonged viral RNA
   shedding in a traveller returning from the Dominican Republic to Italy,
   January 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID WEST NILE VIRUS; RT-PCR ASSAY; FRENCH-POLYNESIA; TRANSMISSION;
   CHIKUNGUNYA; DENGUE; URINE; OUTBREAK; REGION; MICRONESIA
AB We report the isolation of infectious Zika virus (ZIKV) in cell culture from the saliva of a patient who developed a febrile illness after returning from the Dominican Republic to Italy, in January 2016. The patient had prolonged shedding of viral RNA in saliva and urine, at higher load than in blood, for up to 29 days after symptom onset. Sequencing of ZIKV genome showed relatedness with strains from Latin America.
C1 [Barzon, L.; Berto, A.; Franchin, E.; Lavezzo, E.; Palu, G.] Univ Padua, Dept Mol Med, Padua, Italy.
   [Barzon, L.; Pacenti, M.; Franchin, E.; Palu, G.] Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
   [Sinigaglia, A.] Veneto Inst Oncol IOV IRCCS, Padua, Italy.
   [Brugnaro, P.] Venice City Hosp SS Giovanni & Paolo, Dept Infect Dis, Venice, Italy.
RP Barzon, L (reprint author), Univ Padua, Dept Mol Med, Padua, Italy.; Barzon, L (reprint author), Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
EM luisa.barzon@unipd.it
CR Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Barzon L, 2012, CLIN MICROBIOL INFEC, V18, pE541, DOI 10.1111/1469-0691.12001
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Calvet G., 2016, LANCET INFECT DIS
   Campos R. de M., 2016, Journal of Clinical Virology, V77, P69
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET
   Centers for Disease Control and Prevention (CDC), 2016, HAN PRIOR PROF MED P
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupount-Rouzeyrol M, 2016, LANCET
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Gobbi F, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-60
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   World Health Organization, 2016, WKLY EPIDEMIOL REC, V91, P73
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
NR 37
TC 7
Z9 7
U1 19
U2 27
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 10
PY 2016
VL 21
IS 10
BP 2
EP 6
AR 30159
DI 10.2807/1560-7917.ES.2016.21.10.30159
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA DG6LL
UT WOS:000372195800001
ER

PT J
AU Vorou, R
AF Vorou, R.
TI Letter to the editor: diagnostic challenges to be considered regarding
   Zika virus in the context of the presence of the vector Aedes albopictus
   in Europe
SO EUROSURVEILLANCE
LA English
DT Letter
C1 [Vorou, R.] Hellen Ctr Dis Control & Prevent, Unit Strateg Dev & Policy, Athens, Greece.
RP Vorou, R (reprint author), Hellen Ctr Dis Control & Prevent, Unit Strateg Dev & Policy, Athens, Greece.
EM vorou@keelpno.gr
CR Boukraa S, 2015, J VECTOR ECOL, V40, P398, DOI 10.1111/jvec.12180
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calzolari M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140915
   CDC, 2016, REV DIAGN TEST ZIK C
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rubin EJ, 2016, N ENGL J MED
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
NR 11
TC 0
Z9 0
U1 9
U2 11
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 10
PY 2016
VL 21
IS 10
BP 27
EP 28
AR 30161
DI 10.2807/1560-7917.ES.2016.21.10.30161
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DG6LL
UT WOS:000372195800005
ER

PT J
AU Venturi, G
   Zammarchi, L
   Fortuna, C
   Remoli, ME
   Benedetti, E
   Fiorentini, C
   Trotta, M
   Rizzo, C
   Mantella, A
   Rezza, G
   Bartoloni, A
AF Venturi, G.
   Zammarchi, L.
   Fortuna, C.
   Remoli, M. E.
   Benedetti, E.
   Fiorentini, C.
   Trotta, M.
   Rizzo, C.
   Mantella, A.
   Rezza, G.
   Bartoloni, A.
TI Authors' reply: diagnostic challenges to be considered regarding Zika
   virus in the context of the presence of the vector Aedes albopictus in
   Europe
SO EUROSURVEILLANCE
LA English
DT Letter
C1 [Venturi, G.; Fortuna, C.; Remoli, M. E.; Benedetti, E.; Fiorentini, C.; Rezza, G.] Ist Super Sanita, Dept Infect Parasit & Immune Mediate Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Zammarchi, L.; Mantella, A.; Bartoloni, A.] Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.
   [Zammarchi, L.; Trotta, M.; Bartoloni, A.] Azienda Osped Univ Caeggi, SOD Malattie Infett & Trop, Florence, Italy.
   [Rizzo, C.] Ist Super Sanita, Natl Ctr Epidemiol & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy.
RP Bartoloni, A (reprint author), Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.; Bartoloni, A (reprint author), Azienda Osped Univ Caeggi, SOD Malattie Infett & Trop, Florence, Italy.
EM alessandro.bartoloni@unifi.it
RI VENTURI, GIULIETTA/O-8123-2015; Remoli, Maria Elena/O-9447-2015;
   FORTUNA, CLAUDIA/O-9446-2015; 
OI VENTURI, GIULIETTA/0000-0002-9078-8350; Remoli, Maria
   Elena/0000-0003-3565-383X; Rizzo, Caterina/0000-0002-5583-7508
CR Chancey C, 2015, BIOMED RES INT, V2015
   European Centre for Disease Prevention and Control (ECDC), 2016, FACTSH HLTH PROF
   Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3
   Ministero della salute, 2015, DIR GEN PREV SAN UFF
   Olsen SJ, 2015, EMERG INFECT DIS, V21, P280, DOI 10.3201/eid2102.140291
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vorou R, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.10.30161, DOI 10.2807/1560-7917.ES.2016.21.10.30161]
NR 7
TC 1
Z9 1
U1 2
U2 4
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 10
PY 2016
VL 21
IS 10
BP 29
EP 30
DI 10.2807/1560-7917.ES.2016.21.10.30163
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DG6LL
UT WOS:000372195800006
ER

PT J
AU Kirk, EP
AF Kirk, Edwin P.
TI Zika virus: accurate terminology matters
SO NATURE
LA English
DT Letter
C1 [Kirk, Edwin P.] Sydney Childrens Hosp, Randwick, NSW, Australia.
   [Kirk, Edwin P.] Univ New S Wales, Randwick, NSW, Australia.
   [Kirk, Edwin P.] SEALS Labs, Randwick, NSW, Australia.
RP Kirk, EP (reprint author), Sydney Childrens Hosp, Randwick, NSW, Australia.; Kirk, EP (reprint author), Univ New S Wales, Randwick, NSW, Australia.; Kirk, EP (reprint author), SEALS Labs, Randwick, NSW, Australia.
EM edwin.kirk@health.nsw.gov.au
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   MERLOB P, 1988, J MED GENET, V25, P750, DOI 10.1136/jmg.25.11.750
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 3
TC 0
Z9 0
U1 11
U2 26
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 10
PY 2016
VL 531
IS 7593
BP 173
EP 173
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF9EZ
UT WOS:000371665100021
PM 26961646
ER

PT J
AU Scheuermann, RH
AF Scheuermann, Richard H.
CA Viral Genome Annotation Stand Work
TI Zika virus: designate standardized names
SO NATURE
LA English
DT Letter
C1 [Scheuermann, Richard H.] J Craig Venter Inst, La Jolla, CA USA.
RP Scheuermann, RH (reprint author), J Craig Venter Inst, La Jolla, CA USA.
EM rscheuermann@jcvi.org
NR 0
TC 0
Z9 0
U1 8
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 10
PY 2016
VL 531
IS 7593
BP 173
EP 173
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF9EZ
UT WOS:000371665100020
PM 26961650
ER

PT J
AU Mlakar, J
   Korva, M
   Tul, N
   Popovic, M
   Poljsak-Prijatelj, M
   Mraz, J
   Kolenc, M
   Rus, KR
   Vipotnik, TV
   Vodusek, VF
   Vizjak, A
   Pizem, J
   Petrovec, M
   Zupanc, TA
AF Mlakar, Jernej
   Korva, Misa
   Tul, Natasa
   Popovic, Mara
   Poljsak-Prijatelj, Mateja
   Mraz, Jerica
   Kolenc, Marko
   Rus, Katarina Resman
   Vipotnik, Tina Vesnaver
   Vodusek, Vesna Fabjan
   Vizjak, Alenka
   Pizem, Joze
   Petrovec, Miroslav
   Zupanc, Tatjana Avsic
TI Zika Virus Associated with Microcephaly
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID MICRONESIA; BRAIN; PCR
AB A widespread epidemic of Zika virus (ZIKV) infection was reported in 2015 in South and Central America and the Caribbean. A major concern associated with this infection is the apparent increased incidence of microcephaly in fetuses born to mothers infected with ZIKV. In this report, we describe the case of an expectant mother who had a febrile illness with rash at the end of the first trimester of pregnancy while she was living in Brazil. Ultrasonography performed at 29 weeks of gestation revealed microcephaly with calcifications in the fetal brain and placenta. After the mother requested termination of the pregnancy, a fetal autopsy was performed. Micrencephaly (an abnormally small brain) was observed, with almost complete agyria, hydrocephalus, and multifocal dystrophic calcifications in the cortex and subcortical white matter, with associated cortical displacement and mild focal inflammation. ZIKV was found in the fetal brain tissue on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, with consistent findings on electron microscopy. The complete genome of ZIKV was recovered from the fetal brain.
C1 [Mlakar, Jernej; Popovic, Mara; Mraz, Jerica; Vizjak, Alenka; Pizem, Joze] Univ Ljubljana, Inst Pathol, Fac Med, Ljubljana, Slovenia.
   [Korva, Misa; Poljsak-Prijatelj, Mateja; Kolenc, Marko; Rus, Katarina Resman; Petrovec, Miroslav; Zupanc, Tatjana Avsic] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Zaloska 4, Ljubljana 1000, Slovenia.
   [Tul, Natasa; Vodusek, Vesna Fabjan] Univ Med Ctr Ljubljana, Dept Perinatol, Div Gynecol & Obstet, Ljubljana, Slovenia.
   [Vipotnik, Tina Vesnaver] Univ Med Ctr Ljubljana, Inst Radiol, Ljubljana, Slovenia.
RP Zupanc, TA (reprint author), Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Zaloska 4, Ljubljana 1000, Slovenia.
EM tatjana.avsic@mf.uni-ij.si
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Goldsmith CS, 2013, EMERG INFECT DIS, V19, P886, DOI 10.3201/eid1906.130173
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Macdonald EM, 2014, INT J PEDIAT, V2014, DOI DOI 10.1155/2014/291846
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
NR 19
TC 164
Z9 181
U1 135
U2 204
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 10
PY 2016
VL 374
IS 10
BP 951
EP 958
DI 10.1056/NEJMoa1600651
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF9DH
UT WOS:000371660000008
PM 26862926
ER

PT J
AU Rubin, EJ
   Greene, MF
   Baden, LR
AF Rubin, Eric J.
   Greene, Michael F.
   Baden, Lindsey R.
TI Zika Virus and Microcephaly
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID INFECTION
C1 [Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.
   [Greene, Michael F.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA.
RP Rubin, EJ (reprint author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Koch R., 1891, 10 VERH INT MED C BE, V1, P35
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 7
TC 14
Z9 17
U1 13
U2 40
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAR 10
PY 2016
VL 374
IS 10
BP 984
EP 985
DI 10.1056/NEJMe1601862
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF9DH
UT WOS:000371660000015
PM 26862812
ER

PT J
AU Ai, JW
   Zhang, Y
   Zhang, WH
AF Ai, Jing-Wen
   Zhang, Ying
   Zhang, Wenhong
TI Zika virus outbreak: 'a perfect storm'
SO EMERGING MICROBES & INFECTIONS
LA English
DT News Item
C1 [Ai, Jing-Wen; Zhang, Ying; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China.
   [Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.
   [Zhang, Wenhong] Fudan Univ, Shanghai Med Coll, MOH, Shanghai 200032, Peoples R China.
   [Zhang, Wenhong] Fudan Univ, Shanghai Med Coll, MOE Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
RP Zhang, WH (reprint author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China.; Zhang, WH (reprint author), Fudan Univ, Shanghai Med Coll, MOH, Shanghai 200032, Peoples R China.; Zhang, WH (reprint author), Fudan Univ, Shanghai Med Coll, MOE Key Lab Med Mol Virol, Shanghai 200032, Peoples R China.
EM zhangwenhong@fudan.edu.cn
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Miakar J, 2016, NEW ENGL J MED, V2016, DOI [10.1056/NEJMoa1600651, DOI 10.1056/NEJMOA1600651]
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization/World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2015, 2014 NUMB REP CAS DE
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, 2015 NUM REP CAS DEN
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2015, EPIDEMIOLOGICAL ALER
   Pyke AT, 2014, PLOS CURR, V2014, P6
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
NR 18
TC 2
Z9 2
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAR 9
PY 2016
VL 5
AR e21
DI 10.1038/emi.2016.42
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DJ0IV
UT WOS:000373886600002
PM 26956448
ER

PT J
AU Swannell, C
AF Swannell, Cate
TI New evidence suggests Zika virus can cross placental barrier
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 6
U2 7
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD MAR 7
PY 2016
VL 204
IS 4
BP 140
EP 140
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH4QF
UT WOS:000372769800004
ER

PT J
AU Barreto, ML
   Barral-Netto, M
   Stabeli, R
   Almeida, N
   Vasconcelos, PFC
   Teixeira, M
   Buss, P
   Gadelha, PE
AF Barreto, Mauricio L.
   Barral-Netto, Manoel
   Stabeli, Rodrigo
   Almeida-Filho, Naomar
   Vasconcelos, Pedro F. C.
   Teixeira, Mauro
   Buss, Paulo
   Gadelha, Paulo E.
TI Zika virus and microcephaly in Brazil: a scientific agenda
SO LANCET
LA English
DT Editorial Material
C1 [Barreto, Mauricio L.; Barral-Netto, Manoel] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Buss, Paulo] Fundacao Oswaldo Cruz, Ctr Int Relat Hlth, Rio De Janeiro, Brazil.
   [Stabeli, Rodrigo; Gadelha, Paulo E.] Fundacao Oswaldo Cruz, Off Presidency, Rio De Janeiro, Brazil.
   [Almeida-Filho, Naomar] Univ Fed Sul Bahia, Itabuna, Brazil.
   [Vasconcelos, Pedro F. C.] Inst Evandro Chagas, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Brazil.
   [Teixeira, Mauro] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
RP Barreto, ML (reprint author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
EM mauricio.barreto@bahia.fiocruz.br
CR Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Regis C, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.170639, DOI 10.2471/BLT.16.170639]
   do Azevedo RS, 2015, REV SAUDE PUBL, V49, P58
   Horton R, 2016, LANCET, V387, P520, DOI 10.1016/S0140-6736(16)00229-4
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675
   Lederberg Joshua, 1992, EMERGING INFECT MICR
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude Brazil, 2015, 1813 MIN SAUD
   Ministerio da Saude Brazil, 2016, 11 MIN SAUD
   Mlakar J, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1600651, DOI 10.1056/NEJM0A1600651]
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 12
TC 7
Z9 9
U1 19
U2 44
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 5
PY 2016
VL 387
IS 10022
BP 919
EP 921
DI 10.1016/S0140-6736(16)00545-6
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF8XP
UT WOS:000371644200005
PM 26921913
ER

PT J
AU Karimi, O
   Goorhuis, A
   Schinkel, J
   Codrington, J
   Vreden, SGS
   Vermaat, JS
   Stijnis, C
   Grobusch, MP
AF Karimi, Ouafae
   Goorhuis, Abraham
   Schinkel, Janke
   Codrington, John
   Vreden, Stephen Gerold S.
   Vermaat, Joost S.
   Stijnis, Cornelis
   Grobusch, Martin Peter
TI Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus
   infection
SO LANCET
LA English
DT Letter
C1 [Karimi, Ouafae; Goorhuis, Abraham; Stijnis, Cornelis; Grobusch, Martin Peter] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis, NL-1100 DD Amsterdam, Netherlands.
   [Vermaat, Joost S.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1100 DD Amsterdam, Netherlands.
   [Schinkel, Janke] Univ Amsterdam, Acad Med Ctr, Div Internal Med, NL-1100 DD Amsterdam, Netherlands.
   [Schinkel, Janke] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Clin Virol, NL-1100 DD Amsterdam, Netherlands.
   [Codrington, John] Acad Hosp Paramaribo, Dept Lab, Paramaribo, Surinam.
   [Vreden, Stephen Gerold S.] Acad Hosp Paramaribo, Internal Med & Infect Dis, Paramaribo, Surinam.
RP Grobusch, MP (reprint author), Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis, NL-1100 DD Amsterdam, Netherlands.
EM m.p.grobusch@amc.uva.nl
RI Schinkel, Janke/I-3099-2012
OI Schinkel, Janke/0000-0002-1112-0644
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Overbosch FW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-493
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 5
TC 5
Z9 5
U1 2
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAR 5
PY 2016
VL 387
IS 10022
BP 939
EP 940
DI 10.1016/50140-6736(16)00502-X
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF8XP
UT WOS:000371644200017
PM 26906627
ER

PT J
AU Meaney-Delman, D
   Hills, SL
   Williams, C
   Galang, RR
   Iyengar, P
   Hennenfent, AK
   Rabe, IB
   Panella, A
   Oduyebo, T
   Honein, MA
   Zaki, S
   Lindsey, N
   Lehman, JA
   Kwit, N
   Bertolli, J
   Ellington, S
   Igbinosa, I
   Minta, AA
   Petersen, EE
   Mead, P
   Rasmussen, SA
   Jamieson, DJ
AF Meaney-Delman, Dana
   Hills, Susan L.
   Williams, Charnetta
   Galang, Romeo R.
   Iyengar, Preetha
   Hennenfent, Andrew K.
   Rabe, Ingrid B.
   Panella, Amanda
   Oduyebo, Titilope
   Honein, Margaret A.
   Zaki, Sherif
   Lindsey, Nicole
   Lehman, Jennifer A.
   Kwit, Natalie
   Bertolli, Jeanne
   Ellington, Sascha
   Igbinosa, Irogue
   Minta, Anna A.
   Petersen, Emily E.
   Mead, Paul
   Rasmussen, Sonja A.
   Jamieson, Denise J.
TI Zika Virus Infection Among US Pregnant Travelers - August 2015-February
   2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES; INTERIM GUIDELINES; WOMEN
C1 [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Hills, Susan L.; Rabe, Ingrid B.; Panella, Amanda; Lindsey, Nicole; Lehman, Jennifer A.; Mead, Paul] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Williams, Charnetta; Galang, Romeo R.; Oduyebo, Titilope; Kwit, Natalie; Minta, Anna A.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Williams, Charnetta; Galang, Romeo R.; Bertolli, Jeanne] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Iyengar, Preetha] District Columbia Dept Hlth, Washington, DC USA.
   [Hennenfent, Andrew K.] CDC, CSTE Appl Epidemiol Fellowship, Dist Columbia Dept Hlth, Atlanta, GA 30333 USA.
   [Oduyebo, Titilope; Ellington, Sascha; Petersen, Emily E.; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Zaki, Sherif] CDC, Div High Consequence Pathogens, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Igbinosa, Irogue] CDC, Div Sci Educ & Dev, Atlanta, GA 30333 USA.
   [Minta, Anna A.] CDC, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Meaney-Delman, D (reprint author), CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM ZikaMCH@cdc.gov
CR CHATURVEDI UC, 1980, J INFECT DIS, V141, P712
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2009, AM J PUBLIC HEALTH, V99, pS248, DOI 10.2105/AJPH.2008.152900
   Roth A, 2012, EUROSURVEILLANCE, V19, P20929
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401
NR 13
TC 14
Z9 17
U1 6
U2 16
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 4
PY 2016
VL 65
IS 8
BP 211
EP 214
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF4UC
UT WOS:000371345500004
PM 26938703
ER

PT J
AU Hills, SL
   Russell, K
   Hennessey, M
   Williams, C
   Oster, AM
   Fischer, M
   Mead, P
AF Hills, Susan L.
   Russell, Kate
   Hennessey, Morgan
   Williams, Charnetta
   Oster, Alexandra M.
   Fischer, Marc
   Mead, Paul
TI Transmission of Zika Virus Through Sexual Contact with Travelers to
   Areas of Ongoing Transmission - Continental United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID INTERIM GUIDELINES
C1 [Hills, Susan L.; Hennessey, Morgan; Fischer, Marc; Mead, Paul] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Russell, Kate; Hennessey, Morgan; Williams, Charnetta] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Williams, Charnetta] CDC, Div Sexually Transmitted Dis Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Oster, Alexandra M.] CDC, Div HIV AIDS Prevent, NCHHSTP, Atlanta, GA 30333 USA.
RP Mead, P (reprint author), CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM pmead@cdc.gov
CR Atkinson BHP, 2016, EMERG INFECT DIS, P22
   Council of State and Territorial Epidemiologists, 2015, 2015 NAT SURV CAS DE
   Dallas County Health and Human Services, 2016, DCHHS REP 1 ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Meaney-Delman D, 2016, MMWR MORB MORTAL WKL, V65
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, COUNTR TERR AUT ZIK
NR 9
TC 40
Z9 40
U1 18
U2 31
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAR 4
PY 2016
VL 65
IS 8
BP 215
EP 216
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF4UC
UT WOS:000371345500005
PM 26937739
ER

PT J
AU Rodriguez-Morales, AJ
   Bandeira, AC
   Franco-Paredes, C
AF Rodriguez-Morales, Alfonso J.
   Bandeira, Antonio Carlos
   Franco-Paredes, Carlos
TI The expanding spectrum of modes of transmission of Zika virus: a global
   concern
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Editorial Material
ID LATIN-AMERICA; INFECTION; THREAT; BRAZIL
C1 [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Bandeira, Antonio Carlos] Hosp Alianca, Salvador, BA, Brazil.
   [Bandeira, Antonio Carlos] Fac Ciencias & Tecnol, Sch Med, Salvador, BA, Brazil.
   [Franco-Paredes, Carlos] Phoebe Putney Mem Hosp, Albany, GA USA.
   [Franco-Paredes, Carlos] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico.
RP Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM ajrodriguezmmd@gmail.com
CR Barry A, 2016, EMERG INFECT DIS, DOI [10.3201/eid2205.160107, DOI 10.3201/EID2205.160107]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Marano G, 2015, BLOOD TRANSFUS, DOI [10.2450/2015.0066-15, DOI 10.2450/2015.0066-15]
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodrguez-Morales Alfonso J., 2016, Infect., V20, P59, DOI 10.1016/j.infect.2016.02.001
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 20
TC 5
Z9 5
U1 9
U2 33
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD MAR 3
PY 2016
VL 15
AR 13
DI 10.1186/s12941-016-0128-2
PG 2
WC Microbiology
SC Microbiology
GA DF6IZ
UT WOS:000371460400001
PM 26939897
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI Zika virus may be linked to several birth defects, expert warns
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 8
U2 22
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 3
PY 2016
VL 352
AR i1322
DI 10.1136/bmj.i1322
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG0LO
UT WOS:000371756700016
PM 26940642
ER

PT J
AU Roze, B
   Najioullah, F
   Ferge, J
   Apetse, K
   Brouste, Y
   Cesaire, R
   Fagour, C
   Fagour, L
   Hochedez, P
   Jeannin, S
   Joux, J
   Mehdaoui, H
   Valentino, R
   Signate, A
   Cabie, A
AF Roze, B.
   Najioullah, F.
   Ferge, J.
   Apetse, K.
   Brouste, Y.
   Cesaire, R.
   Fagour, C.
   Fagour, L.
   Hochedez, P.
   Jeannin, S.
   Joux, J.
   Mehdaoui, H.
   Valentino, R.
   Signate, A.
   Cabie, A.
CA GBS Zika Working Grp
TI Zika virus detection in urine from patients with Guillain-Barre syndrome
   on Martinique, January 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID DENGUE VIRUS
C1 [Roze, B.; Hochedez, P.; Cabie, A.] Univ Hosp Martinique, Infect & Trop Dis Unit, Fort De France, France.
   [Najioullah, F.; Cesaire, R.; Fagour, L.] Univ Hosp Martinique, Virol Lab, Fort De France, France.
   [Najioullah, F.; Cesaire, R.; Hochedez, P.; Cabie, A.] Univ Antilles, EA4537, Fort De France, France.
   [Ferge, J.; Mehdaoui, H.; Valentino, R.] Univ Hosp Martinique, Intens Care Unit, Fort De France, France.
   [Apetse, K.] Univ Hosp Martinique, Electrophysiol Dept, Fort De France, France.
   [Brouste, Y.] Univ Hosp Martinique, Emergency Dept, Fort De France, France.
   [Fagour, C.] Univ Hosp Martinique, Diabetol Dept, Fort De France, France.
   [Jeannin, S.; Joux, J.; Signate, A.] Univ Hosp Martinique, Dept Neurol, Fort De France, France.
   [Cabie, A.] INSERM CIC1428, Fort De France, France.
RP Roze, B (reprint author), Univ Hosp Martinique, Infect & Trop Dis Unit, Fort De France, France.
EM benoit.roze@chu-fortdefrance.fr
CR Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Cao-Lormeau VM, 2016, LANCET
   ECDC, 2015, ZIK VIR EP AM POT AS
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   L'Azou M, 2015, AM J TROP MED HYG, V92, P1137, DOI 10.4269/ajtmh.14-0211
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Najioullah F, 2011, DIAGN MICR INFEC DIS, V69, P172, DOI 10.1016/j.diagmicrobio.2010.09.021
   Oehler E., 2014, Eurosurveillance, V19, P20720
   [Anonymous], 2016, CIRE ANTILLES GUYANE, V1, P1
   [Anonymous], 2016, CIRE ANTILLES GUYANE, V4, P1
NR 11
TC 8
Z9 8
U1 9
U2 21
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 3
PY 2016
VL 21
IS 9
BP 8
EP 11
DI 10.2807/1560-7917.ES.2016.21.9.30154
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DF6QN
UT WOS:000371480800002
ER

PT J
AU Idris, FM
AF Idris, Fauziah Mohamad
TI Zika - A Pandemic in Progress?
SO MALAYSIAN JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE Zika virus; Aedes; arboviruses; countermeasures; pandemic
ID AEDES-ALBOPICTUS; VIRUS-INFECTION; FRENCH-POLYNESIA; FEBRUARY 2014;
   TRANSMISSION; OUTBREAK; SPREAD; THREAT; BRAZIL
AB The emerging threat of Zika virus outbreak with associated neurological abnormalities needs to be assessed in perspective in terms of its ability to cause a pandemic. This article attempts to throw some light on the issue.
C1 [Idris, Fauziah Mohamad] Univ Sains Malaysia, Dept Med Microbiol & Parasitol, Sch Med Sci, Kubang Kerian 16150, Kelantan, Malaysia.
RP Idris, FM (reprint author), Univ Sains Malaysia, Dept Med Microbiol & Parasitol, Sch Med Sci, Kubang Kerian 16150, Kelantan, Malaysia.
EM fauziahmi@usm.my
CR Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Den Hollander NS, 2000, ULTRASOUND OBST GYN, V15, P282, DOI 10.1046/j.1469-0705.2000.00092.x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oyston P, 2012, J MED MICROBIOL, V61, P889, DOI 10.1099/jmm.0.039180-0
   Pan American Health Organization (PAHO), 2015, NEUR SYNDR CONG MALF
   Receveur M, 2010, EUROSURVEILLANCE, V15, P7
   Roth A, 2012, EUROSURVEILLANCE, V19, P20929
   Sato H, 2010, EURO SURVEILL, V15
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tomba GS, 2008, MATH BIOSCI, V214, P70, DOI 10.1016/j.mbs.2008.02.009
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
NR 30
TC 0
Z9 0
U1 0
U2 0
PU UNIV SAINS MALAYSIA, SCH MEDICAL SCIENCES
PI KELANTAN
PA HEALTH CAMPUS, 16150 KUBANG KERIAN, KELANTAN, 00000, MALAYSIA
SN 1394-195X
EI 2180-4303
J9 MALAYS J MED SCI
JI Malays. J. Med. Sci.
PD MAR-APR
PY 2016
VL 23
IS 2
BP 70
EP 72
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DR4LN
UT WOS:000379873200010
ER

PT J
AU Goeijenbier, M
   Slobbe, L
   van der Eijk, A
   Melo, MD
   Koopmans, MPG
   Reusken, CBEM
AF Goeijenbier, M.
   Slobbe, L.
   van der Eijk, A.
   Melo, M. de Mendonca
   Koopmans, M. P. G.
   Reusken, C. B. E. M.
TI Zika virus and the current outbreak: an overview
SO NETHERLANDS JOURNAL OF MEDICINE
LA English
DT Review
DE Zika virus; microcephaly; flavivirus; Aedes; outbreak; Americas
ID AEDES-ALBOPICTUS; INFECTION; AMERICA; BRAZIL; TRANSMISSION; ARBOVIRUSES;
   MICRONESIA; THREAT; VECTOR; ISLAND
AB Zika virus (ZIKV), a mosquito-borne flavivirus closely related to yellow fever virus and dengue virus, is currently causing a large outbreak in the Americas. Historically, ZIKV infection was considered a sporadic, relatively mild disease characterised by fever, maculopapular rash, conjunctivitis and often arthralgia. However, current observational studies suggest that ZIKV may cause more severe neurological sequelae such as Guillain-Barre syndrome, and birth defects, mainly microcephaly, in babies of whom the mother was infected with ZIKV during pregnancy. This article provides a clinically focussed overview of ZIKV, with emphasis on the current outbreak, clinical manifestations, diagnostic tools and caveats.
C1 [Goeijenbier, M.; van der Eijk, A.; Koopmans, M. P. G.; Reusken, C. B. E. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Goeijenbier, M.; Slobbe, L.; Melo, M. de Mendonca] Havenziekenhuis, Dept Infect Dis, Rotterdam, Netherlands.
   [Goeijenbier, M.; Slobbe, L.; Melo, M. de Mendonca] Inst Trop Dis, Rotterdam, Netherlands.
RP Reusken, CBEM (reprint author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
CR Andrew KI, 2011, CLIN MED RES, V4, P33
   Atkinson B, 2016, EMERG INFECT DIS, P22
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Beltrame A, 2007, EMERG INFECT DIS, V13, P1264
   Besnard M, 2014, EUROSURVEILLANCE, P19
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, ZIK VIR WHAT CLIN NE
   Charrel R, 2016, B WHO
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003580
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, EP UPD OUTBR ZIK VIR
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/50140-6736(16)00502-X]
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kmietowicz Z, 2016, BMJ-BRIT MED J, V352, P1649
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67
   Loshaj-Shala A, 2015, J NEUROIMMUNOL, V289, P168, DOI 10.1016/j.jneuroim.2015.11.005
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Reusken C, 2016, STATE KNOWLEDGE ZIKA
   Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, P23
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, 2009, DENG HAEM FEV DIAGN
   [Anonymous], 2016, WHO SIT REP NEUR SYN
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 46
TC 1
Z9 1
U1 7
U2 7
PU VAN ZUIDEN COMMUNICATIONS
PI ALPHEN AAN DE RIJN
PA HENRY DUNANTWEG 40A, 2402 NR ALPHEN AAN DE RIJN, NETHERLANDS
SN 0300-2977
EI 1872-9061
J9 NETH J MED
JI Neth. J. Med.
PD MAR
PY 2016
VL 74
IS 3
BP 104
EP 109
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP0AN
UT WOS:000378150100002
PM 27020989
ER

PT J
AU Simoes, R
   Buzzini, R
   Bernardo, W
   Cardoso, F
   Salomao, A
   Cerri, G
AF Simoes, Ricardo
   Buzzini, Renata
   Bernardo, Wanderley
   Cardoso, Florentino
   Salomao, Antonio
   Cerri, Giovanni
TI Zika virus infection and pregnancy
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES; INFANTS; BRAZIL; ASSAY
C1 [Simoes, Ricardo; Salomao, Antonio] Federacao Brasileira Assoc Ginecol & Obstet Febra, Sao Paulo, Brazil.
   [Simoes, Ricardo; Buzzini, Renata; Bernardo, Wanderley; Cardoso, Florentino; Cerri, Giovanni] Assoc Med Brasileira, Guidelines Project, Sao Paulo, SP, Brazil.
RP Simoes, R (reprint author), Federacao Brasileira Assoc Ginecol & Obstet Febra, Sao Paulo, Brazil.; Simoes, R (reprint author), Assoc Med Brasileira, Guidelines Project, Sao Paulo, SP, Brazil.
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brazilian Ministry of Health, MIN SAUD INV 3 852 C
   Calvet G, 2016, LANCET INFECT DIS, V3099, pS1473
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, REC MAN REP ZIK VIR
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, MON CAS MICR BRAS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   EUROCAT European Surveillance of Congenital Anomalies, 2015, PREV TABL
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Mlakar J., 2016, N ENGL J MED
   Monitoramento dos casos de microcefalia no Brasil, MONITORAMENTO CASOS
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   [Anonymous], LEV EV GRAD REC
   Pan American Health Organization, 2015, INCR MICR NE BRAZ EP
   Pan American Health Organization (PAHO), 2015, NEUR SYNDR CONG MALF
   Rubin EJ, 2016, N ENGL J MED
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yoshikawa Hiroo, 2015, Brain Nerve, V67, P1305, DOI 10.11477/mf.1416200300
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 30
TC 0
Z9 0
U1 3
U2 3
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD MAR-APR
PY 2016
VL 62
IS 2
BP 108
EP 115
DI 10.1590/1806-9282.62.02.108
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP1RF
UT WOS:000378266400002
PM 27167538
ER

PT J
AU van Vuren, PJ
   Weyer, J
   Kemp, A
   Dermaux-Msimang, V
   McCarthy, K
   Blumberg, L
   Paweska, J
AF van Vuren, Petrus Jansen
   Weyer, Jacqueline
   Kemp, Alan
   Dermaux-Msimang, Veerle
   McCarthy, Kerrigan
   Blumberg, Lucille
   Paweska, Janusz
TI Is South Africa at risk for Zika virus disease?
SO SAMJ SOUTH AFRICAN MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [van Vuren, Petrus Jansen; Weyer, Jacqueline; Kemp, Alan; Dermaux-Msimang, Veerle; Paweska, Janusz] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Emerging & Zoonot Dis, Johannesburg, South Africa.
   [McCarthy, Kerrigan; Blumberg, Lucille] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa.
RP Paweska, J (reprint author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Emerging & Zoonot Dis, Johannesburg, South Africa.
EM januszp@nicd.ac.za
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P20751
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faun AS, 2016, NEW ENGL J MED
   Gatherer D., 2015, J GEN VIROL
   Kuno G, 1998, J VIROL, V72, P73
   Masse D, 2014, EUROSURVEILLANCE, V19, P20761
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Msimang V, 2013, NATL I COMMUNICABLE, V11, P08
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 12
TC 0
Z9 1
U1 3
U2 3
PU SA MEDICAL ASSOC
PI PRETORIA
PA BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3,
   PRETORIA, 0002, SOUTH AFRICA
SN 0256-9574
EI 2078-5135
J9 SAMJ S AFR MED J
JI SAMJ S. Afr. Med. J.
PD MAR
PY 2016
VL 106
IS 3
BP 232
EP 233
DI 10.7196/SAMJ.2016.v106i3.10615
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL9NK
UT WOS:000375969800008
PM 26915933
ER

PT J
AU Bricaire, F
AF Bricaire, Francois
TI ZIKA Virus: another new epidemic ...
SO PRESSE MEDICALE
LA French
DT Editorial Material
C1 [Bricaire, Francois] Grp Hosp Pitie Salpetriere, Serv Malad Infect & Trop, 43-87 Blvd Hop, F-75013 Paris, France.
RP Bricaire, F (reprint author), Grp Hosp Pitie Salpetriere, Serv Malad Infect & Trop, 43-87 Blvd Hop, F-75013 Paris, France.
EM francois.bricaire@psl.aphp.fr
CR Andres M, 2015, SEX TRANSM INFECT, V91, P359
   Bel Martin, 2008, RESEAU OCEANIEN SURV
   Brian D, 2011, EMERG INFECT DIS, V17, P880
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   HCSP, 2016, COLL AV RAPP
   Lavinia Schuler-Faccini M, 2016, MMWR-MORBID MORTAL W, V65, P59
   Tetro JA, 2016, MICROBES INFECT
NR 7
TC 0
Z9 0
U1 1
U2 1
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0755-4982
EI 2213-0276
J9 PRESSE MED
JI Presse Med.
PD MAR
PY 2016
VL 45
IS 3
BP 281
EP 283
DI 10.1016/j.lpm.2016.03.001
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL7CX
UT WOS:000375798300003
PM 27055374
ER

PT J
AU Maestre, AM
   Caplivski, D
   Fernandez-Sesma, A
AF Maestre, Ana M.
   Caplivski, Daniel
   Fernandez-Sesma, Ana
TI Zika Virus: More Questions Than Answers
SO EBIOMEDICINE
LA English
DT Editorial Material
ID UNITED-STATES; INFECTION; TRAVELERS
C1 [Maestre, Ana M.; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Caplivski, Daniel; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA.
RP Fernandez-Sesma, A (reprint author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Marrs C., 2016, AM J PERINATOL
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   [Anonymous], 2016, ZIK VIR MICR GUILL B
NR 10
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD MAR
PY 2016
VL 5
BP 2
EP 3
DI 10.1016/j.ebiom.2016.03.014
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK7AW
UT WOS:000375078200002
PM 27077095
ER

PT J
AU Petersen, E
   Wilson, ME
   Touch, S
   McCloskey, B
   Mwaba, P
   Bates, M
   Dar, O
   Mattes, F
   Kidd, M
   Ippolito, G
   Azhar, EI
   Zumla, A
AF Petersen, Eskild
   Wilson, Mary E.
   Touch, Sok
   McCloskey, Brian
   Mwaba, Peter
   Bates, Matthew
   Dar, Osman
   Mattes, Frank
   Kidd, Mike
   Ippolito, Giuseppe
   Azhar, Esam I.
   Zumla, Alimuddin
TI Rapid Spread of Zika Virus in The Americas - Implications for Public
   Health Preparedness for Mass Gatherings at the 2016 Brazil Olympic Games
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Arboviruses; Mass Gatherings; Sporting events; Olympics; Zika virus;
   Brazil
ID FIFA WORLD CUP; CHIKUNGUNYA VIRUS; INTERIM GUIDELINES; A226V MUTATION;
   UNITED-STATES; TRANSMISSION; INFECTION; OUTBREAK; DENGUE; SURVEILLANCE
AB Mass gatherings at major international sporting events put millions of international travelers and local host-country residents at risk of acquiring infectious diseases, including locally endemic infectious diseases. The mosquito-borne Zika virus (ZIKV) has recently aroused global attention due to its rapid spread since its first detection in May 2015 in Brazil to 22 other countries and other territories in the Americas. The ZIKV outbreak in Brazil, has also been associated with a significant rise in the number of babies born with microcephaly and neurological disorders, and has been declared a 'Global Emergency by the World Health Organization. This explosive spread of ZIKV in Brazil poses challenges for public health preparedness and surveillance for the Olympics and Paralympics which are due to be held in Rio De Janeiro in August, 2016. We review the epidemiology and clinical features of the current ZIKV outbreak in Brazil, highlight knowledge gaps, and review the public health implications of the current ZIKV outbreak in the Americas. We highlight the urgent need for a coordinated collaborative response for prevention and spread of infectious diseases with epidemic potential at mass gatherings events. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Petersen, Eskild] Royal Hosp, Muscat, Oman.
   [Petersen, Eskild] Aarhus Univ, Insititute Clin Med, Aarhus, Denmark.
   [Wilson, Mary E.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA.
   [Wilson, Mary E.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [Touch, Sok] Minist Hlth, Dept Communicable Dis Control, Phnom Penh, Cambodia.
   [McCloskey, Brian; Dar, Osman] Publ Hlth England, Global Hlth Dept, London, England.
   [Mwaba, Peter; Bates, Matthew] Univ Teaching Hosp, UNZA UCLMS Project, Lusaka, Zambia.
   [Mwaba, Peter; Bates, Matthew] Minist Hlth, Lusaka, Zambia.
   [Mattes, Frank; Kidd, Mike] Univ Coll London Hosp NHS Fdn Trust, Dept Virol, London, England.
   [Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
   [Azhar, Esam I.; Zumla, Alimuddin] King Abdulaziz Univ, King Fahd Med Res Ctr, Special Infect Agents Unit, Jeddah 21413, Saudi Arabia.
   [Azhar, Esam I.; Zumla, Alimuddin] King Abdulaziz Univ, Fac Appl Med Sci, Med Lab Technol Dept, Jeddah 21413, Saudi Arabia.
   [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
RP Petersen, E (reprint author), Royal Hosp, Muscat, Oman.; Petersen, E (reprint author), Aarhus Univ, Insititute Clin Med, Aarhus, Denmark.
EM eskildp@dadlnet.dk
OI Zumla, Alimuddin/0000-0002-5111-5735
CR Aguiar M, 2015, LANCET INFECT DIS, V15, P765, DOI 10.1016/S1473-3099(15)00073-0
   Al-Tawfiq JA, 2014, LANCET INFECT DIS, V14, P992, DOI 10.1016/S1473-3099(14)70840-0
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Baronti C, 2014, GENOME ANNOUNC, V2
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   [Anonymous], 2016, LANCET
   Bordi L, 2011, NEW MICROBIOL, V34, P87
   Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925
   Brazilian Ministry of Health, 2016, WEEKL EP UPD SUSP MI
   Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CDC, 2016, ZIK VIR DIAGN TEST
   CDC, INF VECT CONTR PROGR
   Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P973
   Centers for Disease Control and Prevention (CDC), 2016, INT GUID PREGN WOM Z
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR BR
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control Epidemiological update, EP UPD OUTBR ZIK VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallego V, 2014, TRAVEL MED INFECT DI, V12, P208, DOI 10.1016/j.tmaid.2014.04.004
   Gatherer D., 2015, J GEN VIROL
   Gautret P, 2015, TRAVEL MED INFECT DI
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude (Brazil), 2015, MICR MIN SAUD DIV B
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   NaTHNaC, ZIK VIR UPD ADV PREG
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, 2016, NEUR SYNDR CONG MALF
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2010, TRANSFUS MED REV, V24, P15, DOI 10.1016/j.tmrv.2009.09.002
   Roth A, 2012, EUROSURVEILLANCE, V19, P20929
   Salvador F. S., 2015, TRAVEL MED INFECT DI
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Tognarelli J, 2015, ARCH VIROL
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organization, 2016, ZIK VIR
   Wilson ME, 2014, CLIN INFECT DIS, V58, P1347, DOI 10.1093/cid/ciu122
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 61
TC 31
Z9 35
U1 38
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAR
PY 2016
VL 44
BP 11
EP 15
DI 10.1016/j.ijid.2016.02.001
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA DK4FV
UT WOS:000374873500004
PM 26854199
ER

PT J
AU de Oliveira, CS
   Vasconcelos, PFD
AF de Oliveira, Consuelo Silva
   da Costa Vasconcelos, Pedro Fernando
TI Microcephaly and Zika virus
SO JORNAL DE PEDIATRIA
LA English
DT Editorial Material
ID BRAZIL; TRANSMISSION; INFECTION; BRAIN
C1 [de Oliveira, Consuelo Silva; da Costa Vasconcelos, Pedro Fernando] MS, SVS, IEC, Sect Arbovirol & Hemorrhag Fevers, Ananindeua, PA, Brazil.
   [de Oliveira, Consuelo Silva; da Costa Vasconcelos, Pedro Fernando] Univ Estado Para, Belem, Para, Brazil.
   [da Costa Vasconcelos, Pedro Fernando] OPAS, Collaborating Ctr, WHO, Res & Reference Arbovirus, Brasilia, DF, Brazil.
RP de Oliveira, CS (reprint author), MS, SVS, IEC, Sect Arbovirol & Hemorrhag Fevers, Ananindeua, PA, Brazil.; de Oliveira, CS (reprint author), Univ Estado Para, Belem, Para, Brazil.
EM consuelooliveira@iec.pa.gov.br
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Charrel R, 2016, B WHO
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kindhauser MK, 2016, B WHO UNPUB
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Pan American Health Organization (PAHO) World Health Organization (WHO), 2016, PROV REM ZIK VIR INF
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 19
TC 1
Z9 1
U1 8
U2 8
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD MAR-APR
PY 2016
VL 92
IS 2
BP 103
EP 105
DI 10.1016/j.jped.2016.02.003
PG 3
WC Pediatrics
SC Pediatrics
GA DK3QR
UT WOS:000374833000001
PM 27036749
ER

PT J
AU Pessoa, R
   Patriota, JV
   de Souza, MD
   Felix, AC
   Mamede, N
   Sanabani, SS
AF Pessoa, Rodrigo
   Patriota, Joao Veras
   de Souza, Maria de Lourdes
   Felix, Alvina Clara
   Mamede, Nubia
   Sanabani, Sabri S.
TI Investigation Into an Outbreak of Dengue-like Illness in Pernambuco,
   Brazil, Revealed a Cocirculation of Zika, Chikungunya, and Dengue Virus
   Type 1
SO MEDICINE
LA English
DT Article
ID REVERSE-TRANSCRIPTASE PCR; MAXIMUM-LIKELIHOOD; INFECTION; TRANSMISSION;
   SEROTYPES; MOSQUITOS; FEVER
AB In April 2015, an outbreak of dengue-like illness occurred in Tuparetama, a small city in the northeast region of Brazil; this outbreak was characterized by its fast expansion. An investigation was initiated to identify the viral etiologies and advise the health authorities on implementing control measures to contain the outbreak. This is the first report of this outbreak in the northeast, even though a few cases were documented earlier in a neighboring city.
   Plasma samples were obtained from 77 suspected dengue patients attending the main hospital in the city. Laboratory assays, such as real-time reverse transcription polymerase chain reaction, virus cDNA sequencing, and enzyme-linked immunosorbent assay, were employed to identify the infecting virus and molecular phylogenetic analysis was performed to define the circulating viral genotypes.
   RNA of Zika virus (ZIKV) and Dengue virus (DENV) or IgM antibodies (Abs) to DENV or chikungunya (CHIKV) were detected in 40 of the 77 plasma samples (51.9%). DENV was found in 9 patients (11.7%), ZIKV was found in 31 patients (40.2%), CHIKV in 1 patient (1.3%), and coinfection of DENV and ZIKV was detected in 2 patients (2.6%). The phylogenetic analysis of 2 available partial DENV and 14 ZIKV sequences revealed the identities of genotype 1 and the Asiatic lineage, respectively.
   Consistent with recent reports from the same region, our results showed that the ongoing outbreak is caused by ZIKV, DENV, and CHIKV. This emphasizes the need for a routine and differential diagnosis of arboviruses in patients with dengue-like illness. Coordinated efforts are necessary to contain the outbreak. Continued surveillance will be important to assess the effectiveness of current and future prevention strategies.
C1 [Pessoa, Rodrigo; Sanabani, Sabri S.] Univ Sao Paulo, Sch Med, Hosp Clin HC, Dept Pathol,Clin Lab, LIM 52 Av Dr Eneas Carvalho Aguiar,470-2nd Andar, BR-05403000 Sao Paulo, Brazil.
   [Patriota, Joao Veras; de Souza, Maria de Lourdes; Felix, Alvina Clara; Mamede, Nubia] Municipal Hosp Tuparetama, Tuparetama, PE, Brazil.
   [Sanabani, Sabri S.] Sao Paulo Inst Trop Med, Dept Virol, Sao Paulo, Brazil.
RP Sanabani, SS (reprint author), Univ Sao Paulo, Fac Med, Inst Med Trop Sao Paulo, LIM 52 Av Dr Eneas Carvalho Aguiar,470-2nd Andar, BR-05403000 Sao Paulo, SP, Brazil.
EM sabyem_63@yahoo.com
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/24596-2]
FX This work was partially supported by grants 2014/24596-2 from the
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.
CR Baronti C, 2014, GENOME ANNOUNC, P2
   Besnard M, 2014, EURO SURVEILL, V19
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Calvet GA, 2015, BRAZIL J CLIN VIROL, V74, P1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Felix AC, 2012, CLIN VACCINE IMMUNOL, V19, P1972, DOI 10.1128/CVI.00535-12
   Figueiredo L T, 1990, Bull Pan Am Health Organ, V24, P217
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall T. A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X
   Harris E, 1998, J CLIN MICROBIOL, V36, P2634
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EURO SURVEILL, P19
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Roth A., 2014, EURO SURVEILL, V19
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tappe D, 2014, EURO SURVEILL, V19
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Tognarelli J, 2015, ARCH VIROL, V161, P665, DOI DOI 10.1007/S00705-015-2695-5.EPUB
   Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253
   WHO Library Cataloguing in Publication Data, 2009, WHO LIB CAT PUBL DAT
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 41
TC 4
Z9 4
U1 5
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD MAR
PY 2016
VL 95
IS 12
AR UNSP e3201
DI 10.1097/MD.0000000000003201
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DK9ND
UT WOS:000375256400059
PM 27015222
ER

PT J
AU Araujo, LM
   Ferreira, MLB
   Nascimento, OJM
AF Araujo, Lucas Masiero
   Brito Ferreira, Maria Lucia
   Nascimento, Osvaldo J. M.
TI Guillain-Barre syndrome associated with the Zika virus outbreak in
   Brazil
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE Guillain-Barre syndrome; GBS; Zika virus; Zika virus infection outbreak;
   neurological complications
ID TRANSMISSION; INFECTION; DENGUE
AB Zika virus (ZIKV) is now considered an emerging flavivirosis, with a first large outbreak registered in the Yap Islands in 2007. In 2013, a new outbreak was reported in the French Polynesia, with associated cases of neurological complications including Guillain-Barre syndrome (GBS). The incidence of GBS has increased in Brazil since 2015, what is speculated to be secondary to the ZIKV infection outbreak. The gold-standard test for detection of acute ZIKV infection is the polymerase-chain reaction technique, an essay largely unavailable in Brazil. The diagnosis of GBS is feasible even in resource-limited areas using the criteria proposed by the GBS Classification Group, which is based solely on clinical grounds. Further understanding on the relationship of ZIKV with neurological complications is a research urgency.
C1 [Araujo, Lucas Masiero; Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Dept Med Interna Neurol, Rio De Janeiro, RJ, Brazil.
   [Brito Ferreira, Maria Lucia] Hosp Restauracao, Div Neurol, Recife, PE, Brazil.
RP Nascimento, OJM (reprint author), Rua Siqueira Campos 53-1204, BR-22031071 Rio De Janeiro, RJ, Brazil.
EM osvaldo_nascimento@hotmail.com
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Christo PP, 2015, ARQ NEURO-PSIQUIAT, V73, P641, DOI 10.1590/0004-282X20150108
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kuno G, 1998, J VIROL, V72, P3, DOI [10.1099/0022-1317-81-9-2339, DOI 10.1099/0022-1317-81-9-2339]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Ministerio da Saude (BR) Secretaria de Vigilancia em Saude, 2015, PROT SURV RESP OCC M
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 8
Z9 8
U1 11
U2 13
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2016
VL 74
IS 3
BP 253
EP 255
DI 10.1590/0004-282X20160035
PG 3
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DJ4QJ
UT WOS:000374191900013
PM 27050856
ER

PT J
AU Burke, RM
   Pandya, P
   Nastouli, E
   Gothard, P
AF Burke, Rachael M.
   Pandya, Pranav
   Nastouli, Eleni
   Gothard, Philip
TI Zika virus infection during pregnancy: what, where, and why?
SO BRITISH JOURNAL OF GENERAL PRACTICE
LA English
DT Editorial Material
C1 [Burke, Rachael M.; Gothard, Philip] Hosp Trop Dis, London, England.
   [Pandya, Pranav] Univ Coll London Hosp, Fetal Med, London, England.
   [Nastouli, Eleni] Univ Coll London Hosp, Virol, London, England.
RP Gothard, P (reprint author), Univ Coll London Hosp Fdn Trust, Hosp Trop Dis, Infect Div, 2nd Floor Maple House,149 Tottenham Court Rd, London W1T 7BN, England.
EM philip.gothard@nhs.net
CR Brazilian Ministry of Health, 2016, INF EP NO 10 SEM EP
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, COUNTR LOC ZIK TRANS
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS
   HPA, 2016, GUID VIR RASH PREGN
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   RCGP, 2016, ZIK VIR INF GUID PRI
   Royal College of Obstetricians and Gynaecologists, 2016, INT RCOG RCM F HPS C
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   WHO, 2016, DIR GEN SUMM OUTC EM
NR 11
TC 3
Z9 3
U1 2
U2 10
PU ROYAL COLL GENERAL PRACTITIONERS
PI LONDON
PA 14 PRINCES GATE, HYDE PARK, LONDON SW7 1PU, ENGLAND
SN 0960-1643
EI 1478-5242
J9 BRIT J GEN PRACT
JI Br. J. Gen. Pract.
PD MAR
PY 2016
VL 66
IS 644
BP 122
EP 123
DI 10.3399/bjgp16X683917
PG 2
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA DJ3LM
UT WOS:000374106700017
PM 26917636
ER

PT J
AU Villamil-Gomez, WE
   Mendoza-Guete, A
   Villalobos, E
   Gonzalez-Arismendy, E
   Uribe-Garcia, AM
   Castellanos, JE
   Rodriguez-Morales, AJ
AF Villamil-Gomez, Wilmer E.
   Mendoza-Guete, Anibal
   Villalobos, Elvira
   Gonzalez-Arismendy, Edgardo
   Maria Uribe-Garcia, Ana
   Eduardo Castellanos, Jaime
   Rodriguez-Morales, Alfonso J.
TI Diagnosis, management and follow-up of pregnant women with Zika virus
   infection: A preliminary report of the ZIKERNCOL cohort study on
   Sincelejo, Colombia
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika; Pregnancy; Epidemiology; Colombia; Latin America
ID LATIN-AMERICA; THREAT
C1 [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Univ Cartagena, Programa Doctorado Med Trop, Cartagena, Barranquilla, Colombia.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Pan Amer Assoc Infect Dis, Comm Travel Med, Quito, Ecuador.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Asociac Colombiana Infectol, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
   [Mendoza-Guete, Anibal; Villalobos, Elvira] Hosp Univ Sincelejo, Dept Gynecol, Sincelejo, Sucre, Colombia.
   [Gonzalez-Arismendy, Edgardo; Maria Uribe-Garcia, Ana] Clin Santa Maria, Dept Gynecol, Sincelejo, Sucre, Colombia.
   [Eduardo Castellanos, Jaime] Univ El Bosque, Grp Virol, Bogota, DC, Colombia.
   [Rodriguez-Morales, Alfonso J.] Int Soc Chemotherapy, Working Grp Zoonoses, Aberdeen, Scotland.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Incubator & Grp, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Fac Hlth Sci, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
CR de Paula Freitas B, 2016, OCULAR FINDINGS INFA
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V2016, P122
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Schuler-Faccini L, 2015, MMWR-MORBID MORTAL W, V2016, P59, DOI DOI 10.15585/MMWR.MM6503E2
NR 7
TC 3
Z9 5
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAR-APR
PY 2016
VL 14
IS 2
BP 155
EP 158
DI 10.1016/j.tmaid.2016.02.004
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DI9YH
UT WOS:000373858100013
PM 26960750
ER

PT J
AU Taylor, KA
   Paterson, BJ
AF Taylor, Kathryn A.
   Paterson, Beverley J.
TI Zika virus from a Pacific perspective: What are the risks to
   Australians?
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Travel medicine; Vector-bome disease; Flavivirus; Zika virus infection
C1 [Taylor, Kathryn A.; Paterson, Beverley J.] Hunter New England Local Hlth Dist, Hunter New England Populat Hlth Unit, Sydney, NSW, Australia.
   [Taylor, Kathryn A.] Univ Adelaide, Sch Populat Hlth, Adelaide, SA 5005, Australia.
   [Paterson, Beverley J.] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia.
RP Taylor, KA (reprint author), Hunter New England Local Hlth Dist, Hunter New England Populat Hlth Unit, Sydney, NSW, Australia.
EM kathryn.taylor1@hnehealth.nsw.gov.au
CR Australian Bureau of Statistics, 2015, 3401 0 OV ARR DEP
   Australian Department of Foreign Affairs and Trade's Smartraveller advisory service, 2016, TRAV ADV
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Roth A., 2014, EURO SURVEILL, V19
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
NR 5
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAR-APR
PY 2016
VL 14
IS 2
BP 159
EP 161
DI 10.1016/j.tmaid.2016.03.006
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DI9YH
UT WOS:000373858100014
PM 27016009
ER

PT J
AU Lazic, S
AF Lazic, Srdjan
TI Another emerging pathogen - Zika virus
SO VOJNOSANITETSKI PREGLED
LA English
DT Editorial Material
ID TRANSMISSION
C1 [Lazic, Srdjan] Mil Med Acad, Inst Epidemiol, Crnotravska 17, Belgrade 11000, Serbia.
RP Lazic, S (reprint author), Mil Med Acad, Inst Epidemiol, Crnotravska 17, Belgrade 11000, Serbia.
EM drlazics@gmail.com
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF FACTSH H
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR BR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 1998, J VIROL, V72, P73
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EURO SURVEILL, V19
NR 11
TC 0
Z9 0
U1 1
U2 1
PU MILITARY MEDICAL ACAD-INI
PI BELGRADE
PA CRNOTRAVSKA 17, PO BOX 33-35, BELGRADE, 11040, SERBIA
SN 0042-8450
J9 VOJNOSANIT PREGL
JI Vojnosanit. Pregl.
PD MAR
PY 2016
VL 73
IS 3
BP 225
EP 227
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ1MK
UT WOS:000373966700002
PM 27295904
ER

PT J
AU Franchini, M
   Velati, C
AF Franchini, Massimo
   Velati, Claudio
TI Blood safety and zoonotic emerging pathogens: now it's the turn of Zika
   virus!
SO BLOOD TRANSFUSION
LA English
DT Editorial Material
C1 [Franchini, Massimo] Carlo Poma Hosp, Dept Haematol & Transfus Med, Str Lago Pablo 10, I-46100 Mantua, Italy.
   [Velati, Claudio] Bologna Metropolitan Area, Transfus Med & Immunohaematol Dept, Bologna, Italy.
   [Velati, Claudio] Emilia Romagna Reg Blood Ctr, Bologna, Italy.
RP Franchini, M (reprint author), Carlo Poma Hosp, Dept Haematol & Transfus Med, Str Lago Pablo 10, I-46100 Mantua, Italy.
EM massimo.franchini@aopoma.it
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Kuno G, 1998, J VIROL, V72, P73
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   loos S, 2014, MED MALADIES INFECT, V44, P302
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Ministero della Salute, 2015, SURV HUM CAS CHIK DE
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Pan American Health Organization/World Health Organization, 2015, EP AL ZIK VIR INF
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Pupella S, 2014, BLOOD TRANSFUS-ITALY, V12, P626, DOI 10.2450/2014.0110-14
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
NR 13
TC 2
Z9 3
U1 1
U2 1
PU SIMITI SERVIZI SRL
PI MILAN
PA VIA DESIDERIO 21, MILAN, 20131, ITALY
SN 1723-2007
J9 BLOOD TRANSFUS-ITALY
JI Blood Transf.
PD MAR
PY 2016
VL 14
IS 2
BP 93
EP 94
DI 10.2450/2015.0187-15
PG 2
WC Hematology
SC Hematology
GA DI5EE
UT WOS:000373520900002
PM 26674809
ER

PT J
AU Marano, G
   Pupella, S
   Vaglio, S
   Liumbruno, GM
   Grazzini, G
AF Marano, Giuseppe
   Pupella, Simonetta
   Vaglio, Stefania
   Liumbruno, Giancarlo M.
   Grazzini, Giuliano
TI Zika virus and the never-ending story of emerging pathogens and
   Transfusion Medicine
SO BLOOD TRANSFUSION
LA English
DT Review
ID WEST NILE VIRUS; FRENCH-POLYNESIA; FEBRUARY 2014; BLOOD SYSTEM;
   TRANSMISSION; THREAT; CHIKUNGUNYA; SAFETY; DENGUE; INFECTIONS
AB In the last few years, the transfusion medicine community has been paying special attention to emerging vector-borne diseases transmitted by arboviruses. Zika virus is the latest of these pathogens and is responsible for major outbreaks in Africa, Asia and, more recently, in previously infection-naive territories of the Pacific area. Many issues regarding this emerging pathogen remain unclear and require further investigation. National health authorities have adopted different prevention strategies. The aim of this review article is to discuss the currently available, though limited, information and the potential impact of this virus on transfusion medicine.
C1 [Marano, Giuseppe; Pupella, Simonetta; Vaglio, Stefania; Liumbruno, Giancarlo M.; Grazzini, Giuliano] Natl Inst Hlth, Italian Natl Blood Ctr, Rome, Italy.
   [Vaglio, Stefania] Univ Roma La Sapienza, Fac Med & Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
RP Liumbruno, GM (reprint author), Italian Natl Blood Ctr, Via Giano della Bella 27, I-00162 Rome, Italy.
EM giancarlo@liumbruno.it
CR Auckland Regional Public Health Service ADHB, DENG FEV ZIK CHIK
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barontti C., 2013, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00500-14, DOI 10.1128/GENOMEA.00500-14]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brouard C, 2005, TRANSFUSION, V48, P1333
   de Mendoza C, 2012, AIDS REV, V14, P279
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grazzini G, 2008, BLOOD TRANSFUS-ITALY, V6, P235, DOI 10.2450/2008.0065-08
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V10, P1347
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Katz LM, 2014, CURR OPIN HEMATOL, V21, P509, DOI 10.1097/MOH.0000000000000089
   Lanciotti RS, 2007, EMERG INFECT DIS, V10, P1232
   Laperche S, 2015, PRESSE MED, V44, P189, DOI 10.1016/j.lpm.2014.06.034
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paty MC, 2013, TRANSFUS CLIN BIOL, V20, P165, DOI 10.1016/j.tracli.2013.03.008
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Petersen LR, 2010, TRANSFUS MED REV, V24, P15, DOI 10.1016/j.tmrv.2009.09.002
   Picker SM, 2013, BLOOD TRANSFUS-ITALY, V11, P343, DOI 10.2450/2013.0218-12
   Pupella S, 2013, BLOOD TRANSFUS-ITALY, V11, P563, DOI 10.2450/2013.0077-13
   Pupella S, 2014, BLOOD TRANSFUS-ITALY, V12, P626, DOI 10.2450/2014.0110-14
   Pyke AT, 2014, PLOS CURR, V2014, P6
   Roth A, 2012, EUROSURVEILLANCE, V19, P20929
   Stramer SL, 2014, ISBT SCI SER, V9, P30
   Stramer SL, 2009, TRANSFUSION S, V49, P67
   Stramer SL, 2009, TRANSFUSION S, V49, P59
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tappe D, 2013, EUROSURVEILLANCE, V19, P20685
   Teo D, 2009, TRANSFUSION MED, V19, P66, DOI 10.1111/j.1365-3148.2009.00916.x
   Thiel J-H, 2005, VIRUS TAXONOMY, P981
   Waehre T, 2013, EMERG INFECT DIS, V20, P1412
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 46
TC 10
Z9 13
U1 9
U2 14
PU SIMITI SERVIZI SRL
PI MILAN
PA VIA DESIDERIO 21, MILAN, 20131, ITALY
SN 1723-2007
J9 BLOOD TRANSFUS-ITALY
JI Blood Transf.
PD MAR
PY 2016
VL 14
IS 2
BP 95
EP 100
DI 10.2450/2015.0066-15
PG 6
WC Hematology
SC Hematology
GA DI5EE
UT WOS:000373520900003
PM 26674815
ER

PT J
AU Paixao, ES
   Rodrigues, LC
AF Paixao, Enny S.
   Rodrigues, Laura C.
TI What we need to know about Zika virus
SO BRITISH JOURNAL OF HOSPITAL MEDICINE
LA English
DT Editorial Material
C1 [Paixao, Enny S.; Rodrigues, Laura C.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis, Keppel St, London WC1E 7HT, England.
RP Paixao, ES (reprint author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis, Keppel St, London WC1E 7HT, England.
EM enny.cruz@lshtm.ac.uk
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Malet H, 2015, EPIDEMIOLOGICAL STAT
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
NR 8
TC 0
Z9 0
U1 3
U2 5
PU MA HEALTHCARE LTD
PI LONDON
PA ST JUDES CHURCH, DULWICH ROAD, LONDON SE24 0PB, ENGLAND
SN 1750-8460
EI 1759-7390
J9 BRIT J HOSP MED
JI Br. J. Hosp. Med.
PD MAR
PY 2016
VL 77
IS 3
BP 124
EP 125
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI5QS
UT WOS:000373554300001
PM 26961437
ER

PT J
AU Al-Qahtani, AA
   Nazir, N
   Al-Anazi, MR
   Rubino, S
   Al-Ahdal, MN
AF Al-Qahtani, Ahmed A.
   Nazir, Nyla
   Al-Anazi, Mashael R.
   Rubino, Salvatore
   Al-Ahdal, Mohammed N.
TI Zika virus: a new pandemic threat
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Review
DE Zika virus; Flavivirus; microcephaly; mosquito; Aedes
ID SEXUAL TRANSMISSION; INFECTION; BRAZIL; ISOLATIONS; OUTBREAK; AMERICA;
   STATES
AB Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae family and is related to dengue, Chikungunya, West Nile, yellow fever, and Japanese encephalitis viruses. ZIKV was first discovered in Uganda in 1947. Different species of mosquito from the Aedes genus, mainly A. aegypti and A. albopictus are the vectors responsible for ZIKV infection in humans. It is also reported that ZIKV is transmitted congenitally, sexually, and through blood donation. Until recently, ZIKV outbreaks were sporadic and self-limiting. The first large epidemic was reported from Yap Island in 2007 followed by an outbreak of Zika fever in French Polynesia in 2013. Brazil is the epicenter of the current ZIKV epidemic which is rapidly spreading across the Americas. ZIKV infection remained relatively less studied in view of its low case numbers, and low clinical impact relative to other arboviruses. However, all this is set to change with its rapid spread in the Western hemisphere and suspected complications particularly microcephaly in newborn babies with ZIKV infected mothers. ZIKV is expected to substantially add to both short-term and long-term economic burden of the effected countries. Due to the large number of people travelling across the borders and some reported cases of transmission of ZIKV via contaminated blood, screening and identification of asymptomatic infected individuals are important.
C1 [Al-Qahtani, Ahmed A.; Nazir, Nyla; Al-Anazi, Mashael R.; Rubino, Salvatore; Al-Ahdal, Mohammed N.] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Res Ctr, Riyadh 11211, Saudi Arabia.
   [Al-Qahtani, Ahmed A.; Al-Ahdal, Mohammed N.] Alfaisal Univ, Sch Med, Dept Microbiol & Immunol, Riyadh, Saudi Arabia.
   [Rubino, Salvatore; Al-Ahdal, Mohammed N.] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.
RP Al-Ahdal, MN (reprint author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Res Ctr, Riyadh 11211, Saudi Arabia.
EM ahdal@kfshrc.edu.sa
FU Research Center administration at King Faisal Specialist Hospital and
   Research Center (KFSHRC)
FX The support of the Research Center administration at King Faisal
   Specialist Hospital and Research Center (KFSHRC) is highly appreciated.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brasil P, 2016, ZIKA VIRUS INFECT PR
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317
   Centers for Disease Control and Prevention (CDC), 2016, CDC 24 7 SAV LIV PRO
   Dallas County Health and Human Services (HHS), 2016, HHS PUBL HLTH PREP U
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK OUTBR AM PAC
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EMBO MOL MED
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Kelvin AA, 2016, J INFECT DEV COUNTR, V10, P113, DOI 10.3855/jidc.8248
   Kuno G, 1998, J VIROL, V72, P73
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2014, POTENTIAL ZIKA VIRUS, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Omer SB, 2016, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2016.2237, DOI 10.1001/JAMA.2016.2237.[]
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Specialized Information Services (SIS), 2016, SIS DIS INF MAN RES
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI [10.1097/NEN.0000000000000038, 10.1097/NEN.0000000000000036]
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization (WHO), 2016, WHO PROGR EM PREP RE
   World Health Organization (WHO), 2016, WHO MED CTR
   World Health Organization (WHO), 2016, WHO PROGR EM 2016
   World Health Organization (WHO), 2016, WHO FATC SHEETS MED
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2016, BBC NEWS
   [Anonymous], 2016, MEDSCAPE NEWS PERSPE
   [Anonymous], 2016, CBC NEWS
NR 49
TC 2
Z9 2
U1 18
U2 18
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD MAR
PY 2016
VL 10
IS 3
BP 201
EP 207
DI 10.3855/jidc.8350
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DI4BW
UT WOS:000373446200001
PM 27031450
ER

PT J
AU Hajra, A
   Bandyopadhyay, D
   Hajra, SK
AF Hajra, Adrija
   Bandyopadhyay, Dhrubajyoti
   Hajra, Shyamal Kumar
TI Zika Virus: A Global Threat to Humanity: A Comprehensive Review and
   Current Developments
SO NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES
LA English
DT Review
DE Aedes mosquitoes; microcephaly; pregnancy; Zika virus (ZIKV)
ID INTERIM GUIDELINES; UNITED-STATES; INFECTION; BRAZIL; TRANSMISSION;
   OUTBREAK; CELLS
AB At present, one of greatest concerns of medical personnel is Zika virus (ZIKV). Though it has been reported for quite a long time, its rapid emergence, new modes of transmission, and more importantly, the congenital anomalies associated with it have made the situation worse. It was first detected in 1947. After that, this infection was found in the countries of Africa as well as Asia. At present, interestingly it has been reported from Brazil. Microcephaly and intracranial calcification have been postulated to be related to maternal infection with this virus. Though it is asymptomatic in maximum number of cases, the serious complications of the infection should be prevented at the earliest. No specific treatment and vaccine are available till now. But research continues and hopefully, success is not far off. The right information about this infection should reach patients as well as physicians. It will prevent unnecessary panic. In August, Brazil is going to organize the Olympic and Paralympic Games and all eyes are now focused on this. In this review article, the authors have tried to focus on the important points about this infection. The data were gathered after searching for relevant articles published in PubMed, the World Health Organization's (WHO) website, Centers for Disease Control and Prevention's (CDC) website, and some other related websites on the Internet.
C1 [Hajra, Adrija] IPGMER, Dept Internal Med, Kolkata, W Bengal, India.
   [Hajra, Shyamal Kumar] NMB Diagnost, Hooghly, W Bengal, India.
   [Bandyopadhyay, Dhrubajyoti] Lady Hardinge Med Coll & Hosp, Dept Accid & Emergency, New Delhi, India.
RP Hajra, A (reprint author), IPGMER, Dept Internal Med, Kolkata, W Bengal, India.
EM adrija847@gmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Cook J, 2016, BBC NEWS
   Dallas County Health and Human Services, DCHHS REP 1 ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR, DOI [10.1001/jamaophthalmol.2016.0284, DOI 10.1001/JAMAOPHTHALMOL.2016.0284]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Gallagher J, 2016, ZIKA OUTBREAK WHAT Y
   Gatherer D., 2015, J GEN VIROL
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jampol LM, 2016, JAMA OPHTHALMOL, P1
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   O'Dowd A, 2016, BMJ-BRIT MED J, V352, pi875
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization (PAHO) World Health Organization (WHO), PAHO STAT ZIK VIR TR
   Parry L., EL NINO IS BLAME ZIK
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pollackjan A., 2016, NEW WEAPON FIGHT ZIK
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sexton DJ, 2016, ZIKA VIRUS INFECT
   Siddiqi Z, 2016, REUTERS         0203
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tognarelli J, 2014, ARCH VIROL
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 34
TC 3
Z9 3
U1 35
U2 35
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 2250-1541
EI 1947-2714
J9 N AM J MED SCI
JI N. Am. J. Med. Sci.
PD MAR
PY 2016
VL 8
IS 3
DI 10.4103/1947-2714.179112
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI4RS
UT WOS:000373487600001
PM 27114968
ER

PT J
AU Chouin-Carneiro, T
   Vega-Rua, A
   Vazeille, M
   Yebakima, A
   Girod, R
   Goindin, D
   Dupont-Rouzeyrol, M
   Lourenco-de-Oliveira, R
   Failloux, AB
AF Chouin-Carneiro, Thais
   Vega-Rua, Anubis
   Vazeille, Marie
   Yebakima, Andre
   Girod, Romain
   Goindin, Daniella
   Dupont-Rouzeyrol, Myrielle
   Lourenco-de-Oliveira, Ricardo
   Failloux, Anna-Bella
TI Differential Susceptibilities of Aedes aegypti and Aedes albopictus from
   the Americas to Zika Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHIKUNGUNYA VIRUS; YELLOW-FEVER; INDIAN-OCEAN; MOSQUITOS; DENGUE;
   INFECTION; SEROTYPE-2; OUTBREAK; VECTOR; TEMPERATURE
AB Background
   Since the major outbreak in 2007 in the Yap Island, Zika virus (ZIKV) causing dengue-like syndromes has affected multiple islands of the South Pacific region. In May 2015, the virus was detected in Brazil and then spread through South and Central America. In December 2015, ZIKV was detected in French Guiana and Martinique. The aim of the study was to evaluate the vector competence of the mosquito spp. Aedes aegypti and Aedes albopictus from the Caribbean (Martinique, Guadeloupe), North America (southern United States), South America (Brazil, French Guiana) for the currently circulating Asian genotype of ZIKV isolated from a patient in April 2014 in New Caledonia.
   Methodology/Principal Findings
   Mosquitoes were orally exposed to an Asian genotype of ZIKV (NC-2014-5132). Upon exposure, engorged mosquitoes were maintained at 28 degrees+/-1 degrees C, a 16h: 8h light: dark cycle and 80% humidity. 25-30 mosquitoes were processed at 4, 7 and 14 days post-infection (dpi). Mosquito bodies (thorax and abdomen), heads and saliva were analyzed to measure infection, dissemination and transmission, respectively. High infection but lower disseminated infection and transmission rates were observed for both Ae. aegypti and Ae. albopictus. Ae. aegypti populations from Guadeloupe and French Guiana exhibited a higher dissemination of ZIKV than the other Ae. aegypti populations examined. Transmission of ZIKV was observed in both mosquito species at 14 dpi but at a low level.
   Conclusions/Significance
   This study suggests that although susceptible to infection, Ae. aegypti and Ae. albopictus were unexpectedly low competent vectors for ZIKV. This may suggest that other factors such as the large naive population for ZIKV and the high densities of human-biting mosquitoes contribute to the rapid spread of ZIKV during the current outbreak.
C1 [Chouin-Carneiro, Thais; Lourenco-de-Oliveira, Ricardo] Inst Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil.
   [Vega-Rua, Anubis; Vazeille, Marie; Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors, Paris, France.
   [Yebakima, Andre] Collectivite Territoriale Martin, Ctr Demousticat, Fort De France, Martinique.
   [Girod, Romain] Inst Pasteur French Guiana, Unit Med Entomol, Cayenne, French Guiana.
   [Goindin, Daniella] Inst Pasteur Guadeloupe, Lab Med Entomol Environm & Hlth, Les Abymes, Guadeloupe.
   [Dupont-Rouzeyrol, Myrielle] Inst Pasteur New Caledonia, Dengue & Arboviruses Res & Expertise Unit, Noumea, New Caledonia.
   [Vega-Rua, Anubis] Inst Pasteur Guadeloupe, Lab Med Entomol Environm & Hlth, Les Abymes, Guadeloupe.
RP Failloux, AB (reprint author), Inst Pasteur, Arboviruses & Insect Vectors, Paris, France.
EM anna-bella.failloux@pasteur.fr
FU Institut Pasteur, the French Government's Investissement d'Avenir
   program, Laboratoire d'Excellence "Integrative Biology of Emerging
   Infectious Diseases" [ANR-10-LABX-62-IBEID]
FX This study was funded by the Institut Pasteur, the French Government's
   Investissement d'Avenir program, Laboratoire d'Excellence "Integrative
   Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Arias-Goeta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057548
   Baronti C, 2014, GENOME ANNOUNC, P2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2014, EMERG INFECT DIS, V21, P381, DOI DOI 10.3201/EID2102.141553
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McElroy KL, 2008, VECTOR-BORNE ZOONOT, V8, P675, DOI 10.1089/vbz.2007.0269
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   Oehler E, 2014, EURO SURVEILL, P19
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   TESH RB, 1976, AM J TROP MED HYG, V25, P326
   Tognarelli J, 2015, ARCH VIROL
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   TURELL MJ, 1988, AM J TROP MED HYG, V39, P597
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vega-Rua A, 2015, VIRUSES-BASEL, V7, P5902, DOI 10.3390/v7112917
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 44
TC 25
Z9 26
U1 40
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2016
VL 10
IS 3
AR e0004543
DI 10.1371/journal.pntd.0004543
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DI1RF
UT WOS:000373272500062
PM 26938868
ER

PT J
AU Malone, RW
   Homan, J
   Callahan, MV
   Glasspool-Malone, J
   Damodaran, L
   Schneider, AD
   Zimler, R
   Talton, J
   Cobb, RR
   Ruzic, I
   Smith-Gagen, J
   Janies, D
   Wilson, J
AF Malone, Robert W.
   Homan, Jane
   Callahan, Michael V.
   Glasspool-Malone, Jill
   Damodaran, Lambodhar
   Schneider, Adriano De Bernardi
   Zimler, Rebecca
   Talton, James
   Cobb, Ronald R.
   Ruzic, Ivan
   Smith-Gagen, Julie
   Janies, Daniel
   Wilson, James
CA Zika Response Working Grp
TI Zika Virus: Medical Countermeasure Development Challenges
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; WEST-NILE-VIRUS; DENGUE VIRUS; YELLOW-FEVER;
   TRANSPLACENTAL TRANSFER; SEXUAL TRANSMISSION; HOST SUSCEPTIBILITY;
   INFECTION; ANTIBODIES; BRAZIL
AB Introduction
   Reports of high rates of primary microcephaly and Guillain-Barre syndrome associated with Zika virus infection in French Polynesia and Brazil have raised concerns that the virus circulating in these regions is a rapidly developing neuropathic, teratogenic, emerging infectious public health threat. There are no licensed medical countermeasures (vaccines, therapies or preventive drugs) available for Zika virus infection and disease. The Pan American Health Organization (PAHO) predicts that Zika virus will continue to spread and eventually reach all countries and territories in the Americas with endemic Aedes mosquitoes. This paper reviews the status of the Zika virus outbreak, including medical countermeasure options, with a focus on how the epidemiology, insect vectors, neuropathology, virology and immunology inform options and strategies available for medical countermeasure development and deployment.
   Methods
   Multiple information sources were employed to support the review. These included publically available literature, patents, official communications, English and Lusophone lay press. Online surveys were distributed to physicians in the US, Mexico and Argentina and responses analyzed. Computational epitope analysis as well as infectious disease outbreak modeling and forecasting were implemented. Field observations in Brazil were compiled and interviews conducted with public health officials.
C1 [Malone, Robert W.; Glasspool-Malone, Jill] RW Malone MD LLC, Scottsville, VA USA.
   [Malone, Robert W.; Glasspool-Malone, Jill] Harvard Univ, Sch Med, Global Clin Scholars Res Training Program, Class 2016, Boston, MA USA.
   [Homan, Jane] ioGenetics, Madison, WI USA.
   [Callahan, Michael V.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.
   [Damodaran, Lambodhar; Schneider, Adriano De Bernardi; Janies, Daniel] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.
   [Zimler, Rebecca] Univ Florida, Florida Med Entomol Lab, Dept Entomol & Nematol, Vero Beach, FL USA.
   [Talton, James; Cobb, Ronald R.] NANO ADM Adv Dev & Mfg Ctr, Nanotherapeut, Alachua, FL USA.
   [Ruzic, Ivan] Analyt Outcomes, Washington Crossing, PA USA.
   [Smith-Gagen, Julie] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA.
   [Wilson, James] Univ Nevada, Nevada Ctr Infect Dis Forecasting, Reno, NV 89557 USA.
RP Malone, RW (reprint author), RW Malone MD LLC, Scottsville, VA USA.; Malone, RW (reprint author), Harvard Univ, Sch Med, Global Clin Scholars Res Training Program, Class 2016, Boston, MA USA.
EM RWMaloneMD@gmail.com
FU US Army Contracting Command - APG, Natick Contracting Division,
   Department of Defense [W911QY-13-C-0010]; UNC Research Opportunities
   Initiative grant; NC State University; UNC-Chapel Hill
FX The authors received no specific funding support for this publication.
   The NANO-ADM has been funded in whole or in part with Federal funds from
   the US Army Contracting Command - APG, Natick Contracting Division,
   Department of Defense under Contract No. W911QY-13-C-0010. Research
   reported in this publication was supported by a UNC Research
   Opportunities Initiative grant to UNC Charlotte, NC State University,
   and UNC-Chapel Hill. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   American Association of Blood Banks, 2016, 1603 AM ASS BLOOD BA
   Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22
   Atkinson B HP, 2016, EMERG INFECT DIS
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bank TW, 2015, DAT BIRTH RAT CRUD O
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EURO SURVEILL, V19
   Bodie NM, INVENTOR METHODS TRE
   Brault AC, 2009, VET RES, V40, DOI 10.1051/vetres/2009026
   Bremel Robert D, 2010, Immunome Res, V6, P8, DOI 10.1186/1745-7580-6-8
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Centers for Disease Control and Prevention, 2016, FACTS MICR CTR DIS C
   CDCP, 2016, ZIK VIR DIAGN TEST
   Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P1135
   Centers for Disease Control and Prevention, 2015, ZIK VIR HLTH CAR PRO
   Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EBC Ageencia Brasil, 2016, ZIK VIR CAN CROSS PL
   Ekanayake C. D., 2014, Ceylon Medical Journal, V59, P145, DOI 10.4038/cmj.v59i4.7871
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Estarque Thays, 2016, FIOCR EST ZIK VIR PO
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAPID RISK ASSESSMEN
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF OUTBR BR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Prazeres J, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALM0L.2016.0267]
   Geraque E, 2015, FOLHA DE S PAULO
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler D, 2007, FIELDS VIROLOGY, P1153
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hall RA, 2007, CURR OPIN MOL THER, V9, P498
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   Halstead SB, 2014, MICROBIOLOGY SPECTRU, V2, DOI [10.1128/microbiolspec.AID-0022-2014, DOI 10.1128/MICROBIOLSPEC.AID-0022-2014]
   Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   He L, 2015, J NEUROSCI, V35, P6770, DOI 10.1523/JNEUROSCI.4926-14.2015
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hughes RAC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008630.pub2
   Hughes RAC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub6
   Instituto Butantan, 2016, ZIK VIR BOT POD VAC
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Janies DA, 2011, CLADISTICS, V27, P61, DOI 10.1111/j.1096-0031.2010.00314.x
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MU, 2015, SCI DATA, V2, DOI [DOI 10.1038/SDATA.2015.35, 10.1038/sdata.2015.35]
   Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS L.A., 2016, EMERG INFECT DIS
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/j.jcv.2014.02.009, 10.1016/J.JCV.2014.02.009]
   Lucas RM, 2005, B WORLD HEALTH ORGAN, V83, P792
   Ludwig G, 1986, J WILDLIFE DIS, V3, P326
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050483
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude, 2015, MIN INV AUM CAS MICR
   Ministerio da Saude (Brazil), 2016, NOV B MICR AP 3174
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nosten Francois, 2006, Curr Drug Saf, V1, P1, DOI 10.2174/157488606775252584
   Oehler E, 2014, EURO SURVEILL, P19
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Okia N O, 1971, East Afr Med J, V48, P725
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization WHO, 2016, DESCR CURR EP TRENDS
   Pan American Health Organization WHO, 2015, EP AL NEUR SYNDR CON
   Partlow J, 2016, WASHINGTON POST
   Perret C, 2005, J INFECTION, V51, P287, DOI 10.1016/j.jinf.2004.10.003
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2002, ANN INTERN MED, V137, P173
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pradier S, 2012, REV SCI TECH OIE, V31, P829
   Qiao SX, 2013, AUTOPHAGY, V9, P2087, DOI 10.4161/auto.26506
   Rocha MSG, 2004, ARQ NEURO-PSIQUIAT, V62, P33, DOI 10.1590/S0004-282X2004000100006
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Sanofi-Pasteur, 2015, DENGVAXIA WORLDS 1 D
   Saude. Pd, 2015, FED GOV ALL US 500 M
   Saude, 2016, DILM AJ POP COMB ZIK
   Sautto G, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/838491, DOI 10.1155/2013/838491]
   SCHLESINGER JJ, 1983, VIROLOGY, V125, P8, DOI 10.1016/0042-6822(83)90059-4
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sciascia S, 2015, THROMB HAEMOSTASIS, V115, DOI [10.1160/TH15-06-0491, DOI 10.1160/TH15-06-0491]
   SELLERS RF, 1980, J HYG-CAMBRIDGE, V85, P65
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   Sternberg S., 2016, US NEWS WORLD REPORT
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   US Centers for Disease Control and Prevention, 2016, COUNTR HAV CURR EV Z
   US Food and Drug Administration, 2016, GUID IND REC DON SCR
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Doorn PA, 2010, J CLIN IMMUNOL, V30, pS74, DOI 10.1007/s10875-010-9407-4
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wang LF, 2015, J INTERF CYTOK RES, V35, P143, DOI 10.1089/jir.2014.0038
   Wang S, 2014, PROTEINS, V82, P2620, DOI 10.1002/prot.24626
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
   World Health Organisation, 2016, ZIK VIR DIS INT CAS
   WHO, 2016, ZIK SIT REP
   World Health Organization, 2015, ZIK VIR INF SUR 2015
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zientara Stephan, 2014, Reprod Fertil Dev, V27, P63, DOI 10.1071/RD14367
   Zilbermintz L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13476
   [Anonymous], 2002, WASHINGTON TIMES
   [Anonymous], 2016, NY TIMES
   [Anonymous], 2016, GUARDIAN
   [Anonymous], 2016, CIDRAP NEWS
NR 135
TC 5
Z9 5
U1 24
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2016
VL 10
IS 3
AR e0004530
DI 10.1371/journal.pntd.0004530
PG 26
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DI1RF
UT WOS:000373272500053
PM 26934531
ER

PT J
AU Passi, GR
AF Passi, Gouri Rao
TI ZIKA VIRUS VACCINE FROM INDIA
SO INDIAN PEDIATRICS
LA English
DT News Item
EM gouripassi@hotmail.com
NR 0
TC 0
Z9 0
U1 7
U2 7
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-6061
EI 0974-7559
J9 INDIAN PEDIATR
JI Indian Pediatrics
PD MAR
PY 2016
VL 53
IS 3
BP 267
EP 267
PG 1
WC Pediatrics
SC Pediatrics
GA DH1MN
UT WOS:000372548600028
ER

PT J
AU Kelser, EA
AF Kelser, Erin Archer
TI Meet dengue's cousin, Zika
SO MICROBES AND INFECTION
LA English
DT Editorial Material
ID VIRUS OUTBREAK; MICRONESIA
C1 [Kelser, Erin Archer] POB 254, Norwalk, OH 44857 USA.
RP Kelser, EA (reprint author), POB 254, Norwalk, OH 44857 USA.
EM erinkelserus@gmail.com
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, CLIN GUID DENG VIR
   Centers for Disease Control and Prevention, 2015, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, FRENCH POLYNESI 0214
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF FACTSH H
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oehler E, 2014, EURO SURVEILL, P19
   Simon O, 2013, JOURN SCI IPNC 21 NO
   World Health Organization, 2015, ZIK VIR INF SUR
   World Health Organization, 2015, W PAC REG WPRO ZIK V
   World Health Organization, 2015, ZIK VIR INF
   World Health Organization and Pan American Health Organization, 2015, EP AL INCR MICR NE B
   World Health Organization and Pan American Health Organization, 2015, ZIK VIR SURV AM INT
   World Health Organization and Special Programme for Research and Training in Tropical Diseases, 2009, DENG GUID DIAGN TREA
NR 21
TC 6
Z9 6
U1 5
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAR
PY 2016
VL 18
IS 3
BP 163
EP 166
DI 10.1016/j.micinf.2015.12.003
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DH0PK
UT WOS:000372485900001
PM 26706817
ER

PT J
AU Tetro, JA
AF Tetro, Jason A.
TI Zika and microcephaly: causation, correlation, or coincidence?
SO MICROBES AND INFECTION
LA English
DT Letter
ID VIRUS-INFECTION; AUTOPHAGY; UVRAG
C1 [Tetro, Jason A.] 130 Rosedale Valley Rd,Suite 103, Toronto, ON M4W 1P9, Canada.
RP Tetro, JA (reprint author), 130 Rosedale Valley Rd,Suite 103, Toronto, ON M4W 1P9, Canada.
EM jason@jasontetro.com
CR Agencia Saude, 2015, MICROCEFALIA MIN SAU
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dreux M, 2010, CELL CYCLE, V9, P1295
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107
   Paisley JE, 2006, PEDIATRICS, V117, P814, DOI 10.1542/peds.2005-1187
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Zhao Z, 2012, DEV CELL, V22, P1001, DOI 10.1016/j.devcel.2011.12.027
NR 14
TC 16
Z9 17
U1 16
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAR
PY 2016
VL 18
IS 3
BP 167
EP 168
DI 10.1016/j.micinf.2015.12.010
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DH0PK
UT WOS:000372485900002
PM 26774330
ER

PT J
AU Carneiro, LAM
   Travassos, LH
AF Carneiro, Leticia A. M.
   Travassos, Leonardo H.
TI Autophagy and viral diseases transmitted by Aedes aegypti and Aedes
   albopictus
SO MICROBES AND INFECTION
LA English
DT Editorial Material
DE Autophagy; Dengue virus; Chikungynya virus; Zika virus; Aedes aegypti
ID DENGUE VIRUS; REPLICATION; INFECTION; CELLS
AB Despite a long battle that was started by Oswaldo Cruz more than a century ago, in 1903, Brazil still struggles to fight Aedes aegypti and Aedes albopictus, the mosquito vectors of dengue virus (DENV), Chikungynya virus (CHIKV) and Zika virus (ZIKV). Dengue fever has been a serious public health problem in Brazil for decades, with recurrent epidemic outbreaks occurring during summers. In 2015, until November, 1,534,932 possible cases were reported to the Ministry of Healthv [1]. More recently, the less studied CHIKV and ZIKV have gained attention because of a dramatic increase in their incidence (around 400% for CHIKV) and the association of ZIKV infection with a 11-fold increase in the number of cases of microcephaly from 2014 to 2015 in northeast Brazil (1761 cases until December 2015) [1]. The symptoms of these three infections are very similar, which complicates the diagnosis. These include fever, headache, nausea, fatigue, and joint pain. In some cases, DENV infection develops into dengue hemorrhagic fever, a life threatening condition characterized by bleeding and decreases in platelet numbers in the blood. As for CHIKV, the most important complication is joint pain, which can last for months. (C) 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Carneiro, Leticia A. M.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
   [Travassos, Leonardo H.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Carneiro, LAM (reprint author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.; Travassos, LH (reprint author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
EM leticiac@micro.ufrj.br; leo.travassos@biof.ufrj.br
CR Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880
   [Anonymous], B EP
   Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
NR 11
TC 4
Z9 4
U1 12
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAR
PY 2016
VL 18
IS 3
BP 169
EP 171
DI 10.1016/j.micinf.2015.12.006
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DH0PK
UT WOS:000372485900003
PM 26774331
ER

PT J
AU Shan, C
   Xie, XP
   Barrett, ADT
   Garcia-Blanco, MA
   Tesh, RB
   Vasconcelos, PFD
   Vasilakis, N
   Weaver, SC
   Shi, PY
AF Shan, Chao
   Xie, Xuping
   Barrett, Alan D. T.
   Garcia-Blanco, Mariano A.
   Tesh, Robert B.
   da Costa Vasconcelos, Pedro Fernando
   Vasilakis, Nikos
   Weaver, Scott C.
   Shi, Pei-Yong
TI Zika Virus: Diagnosis, Therapeutics, and Vaccine
SO ACS INFECTIOUS DISEASES
LA English
DT Editorial Material
ID DENGUE VIRUS; DISCOVERY
AB The current explosive epidemic of Zika virus in South and Central America, as well as the Caribbean, poses a global public health emergency. Here we comment on the challenges on development of better diagnosis and potential therapeutics and vaccine for Zika virus.
C1 [Shan, Chao; Xie, Xuping; Garcia-Blanco, Mariano A.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shan, Chao; Xie, Xuping; Garcia-Blanco, Mariano A.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.
   [Shan, Chao; Xie, Xuping; Garcia-Blanco, Mariano A.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.; Tesh, Robert B.; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.; Tesh, Robert B.; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Tesh, Robert B.; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas SVS MS, Ananindeua, Para, Brazil.
   [da Costa Vasconcelos, Pedro Fernando] Univ Estado Para, Belem, Para, Brazil.
RP Shi, PY (reprint author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (reprint author), Univ Texas Med Branch, Dept Phamarcol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (reprint author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Weaver, Scott/D-6490-2011
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   [Anonymous], 2016, LANCET, V387, P96, DOI [10.1016/S0140-6736(16)00014-3, DOI 10.1016/S0140-6736(16)00014-3]
NR 11
TC 2
Z9 2
U1 22
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD MAR
PY 2016
VL 2
IS 3
BP 170
EP 172
DI 10.1021/acsinfecdis.6b00030
PG 3
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA DG6RF
UT WOS:000372213100001
PM 27623030
ER

PT J
AU Scully, C
   Robinson, A
AF Scully, C.
   Robinson, A.
TI Check before you travel: Zika virus - another emerging global health
   threat
SO BRITISH DENTAL JOURNAL
LA English
DT Article
ID INFECTION; INFANTS; STATES
AB We now know that mosquitoes can transmit arboviruses such as the Zika virus (ZIKV) which is pandemic in Latin America. In order to avoid infection it is advised to avoid mosquitoes, but ZIKV can also be transmitted through blood donation, perinatally and sexually and has been detected in urine and saliva. Prevention against mosquito bites (particularly daytime bites) is best offered by avoiding mosquitoes and bites. To prevent the risk of transmission of ZIKV, standard infection control of all recent travellers to Zika affected areas should be conducted during dental care. This article will discuss how healthcare workers could contract diseases especially whilst working in the tropics or subtropics due to disease vectors such as mosquitoes and suggests prevention measures for this group.
C1 [Scully, C.] UCL, London WC1E 6BT, England.
   [Robinson, A.] Natl Univ Singapore, Fac Dent, Singapore 117548, Singapore.
RP Scully, C (reprint author), UCL, London WC1E 6BT, England.
EM crispian.scully@ucl.ac.uk
CR Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   CDC, TRAV HLTH NOT
   Regis C, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.170639, DOI 10.2471/BLT.16.170639]
   Dallas County Department of Health and Human Services, 2016, HLTH ADV SEX TRANSM
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   [Anonymous], 2016, PHYS ALERT ULTRASOUN
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P1
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tognarelli J, 2015, ARCH VIROL
   Van Herck K, 2004, J TRAVEL MED, V11, P3
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, ZIK SIT REP
NR 26
TC 1
Z9 1
U1 9
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0007-0610
EI 1476-5373
J9 BRIT DENT J
JI Br. Dent. J.
PD MAR
PY 2016
VL 220
IS 5
BP 265
EP 267
DI 10.1038/sj.bdj.2016.182
PG 3
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DG2LT
UT WOS:000371899400017
PM 26964604
ER

PT J
AU Roiz, D
   Duperier, S
   Roussel, M
   Bousses, P
   Fontenille, D
   Simard, F
   Paupy, C
AF Roiz, David
   Duperier, Sandy
   Roussel, Marion
   Bousses, Philippe
   Fontenille, Didier
   Simard, Frederic
   Paupy, Christophe
TI Trapping the Tiger: Efficacy of the Novel BG-Sentinel 2 With Several
   Attractants and Carbon Dioxide for Collecting Aedes albopictus (Diptera:
   Culicidae) in Southern France
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes albopictus; mosquito trapping; BG-Sentinel; trap; attractant
ID FAY-PRINCE TRAPS; WEST NILE VIRUS; MOSQUITO VECTORS; LACTIC-ACID;
   1-OCTEN-3-OL; AEGYPTI; FIELD; SURVEILLANCE; POPULATIONS; VIRGINIA
AB Targeted trapping of mosquito disease vectors plays an important role in the surveillance and control of mosquito-borne diseases. The Asian tiger mosquito, Aedes albopictus (Skuse), is an invasive species, which is spreading throughout the world, and is a potential vector of 24 arboviruses, particularly efficient in the transmission of chikungunya, dengue, and zika viruses. Using a 4 x 4 Latin square design, we assessed the efficacy of the new BG-Sentinel 2 mosquito trap using the attractants BG-lure and (R)-1-octen-3-ol cartridge, alone or in combination, and with and without carbon dioxide, for the field collection of Ae. albopictus mosquitoes.
   We found a synergistic effect of attractant and carbon dioxide that significantly increased twofold to fivefold the capture rate of Ae. albopictus. In combination with carbon dioxide, BG-lure cartridge is more effective than (R)-1-octen-3-ol in attracting females, while a combination of both attractants and carbon dioxide is the most effective for capturing males. In the absence of carbon dioxide, BG-lure cartridge alone did not increase the capture of males or females when compared with an unbaited trap. However, the synergistic effect of carbon dioxide and BG-lure makes this the most efficient combination in attracting Ae. albopictus.
C1 [Roiz, David; Duperier, Sandy; Bousses, Philippe; Fontenille, Didier; Simard, Frederic; Paupy, Christophe] Univ Montpellier, MIVEGEC, Inst Rech Dev, UMR,IRD224,CNRS5290, BP 64501, F-34394 Montpellier, France.
   [Roussel, Marion] Univ Lyon 1, CNRS, UMR5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France.
   [Fontenille, Didier] Inst Pasteur Cambodge, Phnom Penh, Cambodia.
RP Roiz, D (reprint author), Univ Montpellier, MIVEGEC, Inst Rech Dev, UMR,IRD224,CNRS5290, BP 64501, F-34394 Montpellier, France.
EM davidroiz@gmail.com; sduperier@yahoo.fr; marion.roussel1@gmail.com;
   philippe.bousses@ird.fr; dfontenille@pasteur-kh.org;
   frederic.simard@ird.fr; christophe.paupy@ird.fr
RI SIMARD, Frederic/J-9489-2016; Roiz, David/F-2082-2011
OI SIMARD, Frederic/0000-0002-2871-5329; Roiz, David/0000-0002-5819-3648
FU Biogents AG (Regensbourg, Germany); ERA-Net BiodivERsA project
   CG-INVAMOFECT [ANR-13-EBID-0007-01, FWF I-1434, DFG KL2087/6-1]
FX This work was funded by Biogents AG (Regensbourg, Germany) and by the
   ERA-Net BiodivERsA project CG-INVAMOFECT with national funders
   ANR-13-EBID-0007-01 France, FWF I-1434 Austria, and DFG KL2087/6-1
   Germany as part of the 2012-2013 BiodivERsA call for research proposals.
   Our thanks to Madame Dainot for her hospitality during this study, and
   to Rene Auguste and Greg Lambert from the Mediterranean EID for help
   with field localization.
CR Bhalala HV, 2010, J AM MOSQUITO CONTR, V26, P226, DOI 10.2987/09-5942.1
   Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032
   Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008
   Canyon DV, 1997, J AM MOSQUITO CONTR, V13, P66
   Cilek JE, 2011, J AM MOSQUITO CONTR, V27, P393, DOI 10.2987/11-6151.1
   Cook JI, 2011, B ENTOMOL RES, V101, P541, DOI 10.1017/S0007485311000162
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8
   Drago A, 2012, J VECTOR ECOL, V37, P117, DOI 10.1111/j.1948-7134.2012.00208.x
   Facchinelli L, 2007, MED VET ENTOMOL, V21, P183, DOI 10.1111/j.1365-2915.2007.00680.x
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51
   HALL DR, 1984, INSECT SCI APPL, V5, P335
   Jourdain F, 2015, TRANSFUS CLIN BIOL, V22, P101, DOI 10.1016/j.tracli.2015.06.001
   Kawada H, 2007, J MED ENTOMOL, V44, P427, DOI 10.1603/0022-2585(2007)44[427:CLSOTR]2.0.CO;2
   Kline DL, 2007, MED VET ENTOMOL, V21, P323
   Kline DL, 2007, J AM MOSQUITO CONTR, V23, P241, DOI 10.2987/8756-971X(2007)23[241:STAMTT]2.0.CO;2
   Kline DL, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/11-6200R.1
   KLINE DL, 1991, J AM MOSQUITO CONTR, V7, P165
   KLINE DL, 1990, MED VET ENTOMOL, V4, P383, DOI 10.1111/j.1365-2915.1990.tb00455.x
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lindgren E, 2012, SCIENCE, V336, P418, DOI 10.1126/science.1215735
   Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1
   Munoz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039549
   Owino EA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-451
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pitts RJ, 2014, ACTA TROP, V132, pS26, DOI 10.1016/j.actatropica.2013.09.005
   Pombi M, 2014, ITALY PARASIT VECTOR, V7, P580
   Qualls WA, 2007, J AM MOSQUITO CONTR, V23, P131, DOI 10.2987/8756-971X(2007)23[131:EOTMMP]2.0.CO;2
   Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   Roiz D, 2012, J VECTOR ECOL, V37, P20, DOI 10.1111/j.1948-7134.2012.00196.x
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Roiz D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-333
   Russell RC, 2004, J VECTOR ECOL, V29, P309
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9
   Shone SM, 2003, J AM MOSQUITO CONTR, V19, P445
   Shone SM, 2006, J MED ENTOMOL, V43, P151, DOI 10.1603/0022-2585(2006)043[0151:TTOMVI]2.0.CO;2
   Silver JB, 2008, MOSQUITO ECOLOGY FIE
   Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P641, DOI 10.2987/8756-971X(2006)22[641:LAFAOS]2.0.CO;2
   Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x
NR 43
TC 2
Z9 2
U1 11
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2016
VL 53
IS 2
BP 460
EP 465
DI 10.1093/jme/tjv184
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DG2PA
UT WOS:000371908500025
PM 26581402
ER

PT J
AU Castellanos, JE
AF Castellanos, Jaime E.
TI Zika, evidence of defeat in the battle against Aedes aegypti
SO BIOMEDICA
LA Spanish
DT Editorial Material
ID VIRUS; BRAZIL; TRANSMISSION
C1 [Castellanos, Jaime E.] Univ El Bosque, Grp Virol, Bogota, DC, Colombia.
RP Castellanos, JE (reprint author), Univ El Bosque, Grp Virol, Bogota, DC, Colombia.
EM castellanosjaime@unbosque.edu.co
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Atkinson B HP, 2016, EMERG INFECT DIS
   Ministerio da Saude Brasil, MIN SAUD B EP
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187
   European Centre for Disease Prevention and Control, RAP RISK ASS ZIK VIR
   Instituto Nacional de Salud, 2016, DIR VIG AN IESG
   Kindhauser MK, 2016, B WHO
   Mattar S, 2015, REV MVZ CORDOBA, V20, P4511
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organisations, NEUR SYNDR CONG MALF
   Santacoloma L, 2012, BIOMEDICA, V32, P333, DOI [10.1590/S0120-41572012000300004, 10.7705/biomedica.v32i3.680]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Villamil-Gomez W E, 2016, J INFECT PUBLIC HLTH, DOI S1876-0341(15)00221-X
   World Health Organization, ZIK VIR MICR GUILL B
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 0
Z9 0
U1 5
U2 11
PU INST NACIONAL SALUD
PI BOGOTA D C
PA AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C,
   00000, COLOMBIA
SN 0120-4157
J9 BIOMEDICA
JI Biomedica
PD MAR
PY 2016
VL 36
IS 1
BP 5
EP 9
PG 5
WC Tropical Medicine
SC Tropical Medicine
GA DF7GG
UT WOS:000371525400001
PM 27622433
ER

PT J
AU Stein, RA
AF Stein, R. A.
TI Zika: where it has been, where it is going, and how to stop it
SO INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
LA English
DT Editorial Material
ID EBOLA HEMORRHAGIC-FEVER; AEDES-ALBOPICTUS; FRENCH-POLYNESIA; FRUIT BATS;
   REPRODUCTIVE HEALTH; VIRUS TRANSMISSION; FEBRUARY 2014; OUTBREAK;
   AMERICA; INFECTION
C1 [Stein, R. A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA.
   [Stein, R. A.] CUNY, La Guardia Community Coll, Dept Nat Sci, Queens, NY USA.
RP Stein, RA (reprint author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA.; Stein, RA (reprint author), CUNY, La Guardia Community Coll, Dept Nat Sci, Queens, NY USA.
EM richardastein@gmail.com
CR Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bongaarts J, 2009, PHILOS T R SOC B, V364, P2985, DOI 10.1098/rstb.2009.0137
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Pozo KC, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-11
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Decat P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-31
   Devaux C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S1-O8
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddad Lisa B, 2009, Rev Obstet Gynecol, V2, P122
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hayman DTS, 2012, EMERG INFECT DIS, V18, P1207, DOI 10.3201/eid1807.111654
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Herskovitz J, 1 US ZIKA VIRUS TRAN
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Olival KJ, 2013, EMERG INFECT DIS, V19, P270, DOI 10.3201/eid1902.120524
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rosenberg R, 2015, CELL MOL LIFE SCI, V72, P1115, DOI 10.1007/s00018-014-1785-y
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tsetsarkin KA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-376
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 1978, B WHO
NR 54
TC 1
Z9 2
U1 17
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1368-5031
EI 1742-1241
J9 INT J CLIN PRACT
JI Int. J. Clin. Pract.
PD MAR
PY 2016
VL 70
IS 3
BP 182
EP 185
DI 10.1111/ijcp.12792
PG 4
WC Medicine, General & Internal; Pharmacology & Pharmacy
SC General & Internal Medicine; Pharmacology & Pharmacy
GA DF6QO
UT WOS:000371480900002
PM 26918507
ER

PT J
AU Lee, J
AF Lee, Jacob
TI Zika Virus Infection: New Threat in Global Health
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Editorial Material
ID FRENCH-POLYNESIA; OUTBREAK; TRANSMISSION; STATES
C1 [Lee, Jacob] Hallym Univ, Coll Med, Div Infect Dis, Seoul, South Korea.
RP Lee, J (reprint author), Hallym Univ, Kangnam Sacred Hosp, Coll Med, Div Infect Dis, 1 Singil Ro, Seoul 07441, South Korea.
EM litjacob@chol.com
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Korean Center for Disease Control and Prevention, 2016, ZIK VIR DIS
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E., 2014, Eurosurveillance, V19, P20720
   PAHO/WHO, 2016, COUNTR TERR AUT TRAN
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 13
TC 0
Z9 1
U1 11
U2 22
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD MAR
PY 2016
VL 31
IS 3
BP 331
EP 332
DI 10.3346/jkms.2016.31.3.331
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG2LN
UT WOS:000371898700001
PM 26955231
ER

PT J
AU Waltz, E
AF Waltz, Emily
TI GM mosquitoes fire first salvo against Zika virus
SO NATURE BIOTECHNOLOGY
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 19
U2 49
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD MAR
PY 2016
VL 34
IS 3
BP 221
EP 222
DI 10.1038/nbt0316-221
PG 2
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DG1CJ
UT WOS:000371802600006
PM 26963535
ER

PT J
AU Hennessey, M
   Fischer, M
   Staples, JE
AF Hennessey, M.
   Fischer, M.
   Staples, J. E.
TI Zika Virus Spreads to New Areas - Region of the Americas, May
   2015-January 2016
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Reprint
ID MICRONESIA
C1 [Hennessey, M.; Fischer, M.; Staples, J. E.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Atlanta, GA 30333 USA.
RP Fischer, M (reprint author), CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Atlanta, GA 30333 USA.
EM mfischer@cdc.gov
CR CDC, 2015, CHIK VIR CLIN EV DIS
   CDC, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nasci RS, 2015, CDC HLTH INFORM INT
   Pan American Health Organization, 2016, ZIK VIR INF
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   WHO, 2009, DENG GUID DIAGN TREA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 1
Z9 1
U1 25
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD MAR
PY 2016
VL 16
IS 3
BP 1031
EP 1034
DI 10.1111/ajt.13743
PG 4
WC Surgery; Transplantation
SC Surgery; Transplantation
GA DF3JQ
UT WOS:000371240500036
PM 26914735
ER

PT J
AU Hennigan, T
AF Hennigan, Tom
TI ZIKA VIRUS Brazil struggles to cope with Zika epidemic
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
EM hennigantom@gmail.com
CR Monteiro MFG, 2015, REPROD CLIM, V30, P11
NR 1
TC 0
Z9 0
U1 4
U2 13
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 1
PY 2016
VL 352
AR i1226
DI 10.1136/bmj.i1226
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG0LJ
UT WOS:000371756000008
PM 26931360
ER

PT J
AU Wise, J
AF Wise, Jacqui
TI Study links Zika virus to Guillain-Barre syndrome
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
NR 1
TC 0
Z9 0
U1 2
U2 20
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 1
PY 2016
VL 352
AR i1242
DI 10.1136/bmj.i1242
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG0LJ
UT WOS:000371756000010
PM 26932976
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI A modest proposal
SO NATURE MEDICINE
LA English
DT Editorial Material
AB Amid heightened concerns about the Zika virus outbreak in parts of the Western Hemisphere, it is worth remembering that the most extreme countermeasures are not necessarily the only ones worth trying. We must engage in calculated and diverse responses that will ensure sustainable outcomes for this and other outbreaks.
NR 0
TC 0
Z9 0
U1 2
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD MAR
PY 2016
VL 22
IS 3
BP 219
EP 219
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DF6DC
UT WOS:000371445100001
ER

PT J
AU Becker, R
AF Becker, Rachel
TI Missing link: Animal models to investigate whether Zika causes birth
   defects
SO NATURE MEDICINE
LA English
DT News Item
ID VIRUS; TRANSMISSION; BRAZIL
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Johnson AJ, 1999, J VIROL, V73, P783
   LaMonica BE, 2012, CURR OPIN NEUROBIOL, V22, P747, DOI 10.1016/j.conb.2012.03.006
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   loos S, 2014, MED MALADIES INFECT, V44, P302
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Oliveira Melo A S, 2016, Ultrasound Obstet Gynecol, V47, P6, DOI 10.1002/uog.15831
   Gomes Victora C., 2016, LANCET
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 5
Z9 5
U1 8
U2 24
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD MAR
PY 2016
VL 22
IS 3
BP 225
EP 227
PG 3
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DF6DC
UT WOS:000371445100004
PM 26937612
ER

PT J
AU Tognarelli, J
   Ulloa, S
   Villagra, E
   Lagos, J
   Aguayo, C
   Fasce, R
   Parra, B
   Mora, J
   Becerra, N
   Lagos, N
   Vera, L
   Olivares, B
   Vilches, M
   Fernandez, J
AF Tognarelli, J.
   Ulloa, S.
   Villagra, E.
   Lagos, J.
   Aguayo, C.
   Fasce, R.
   Parra, B.
   Mora, J.
   Becerra, N.
   Lagos, N.
   Vera, L.
   Olivares, B.
   Vilches, M.
   Fernandez, J.
TI A report on the outbreak of Zika virus on Easter Island, South Pacific,
   2014
SO ARCHIVES OF VIROLOGY
LA English
DT Article
DE Zika virus; Easter Island; Outbreak; South Pacific; ZIKV
ID FRENCH-POLYNESIA; CHILE; MICRONESIA
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus circulating in Asia and Africa. In 2013, a large outbreak was reported on the archipelago of French Polynesia. In this study, we report the detection and molecular characterization of Zika virus for the first time in Chile from an outbreak among the inhabitants of Easter Island. A total of 89 samples from patients suspected of having ZIKV infection were collected between the period from January to May, 2014. Molecular diagnosis of the virus was performed by RT-PCR followed by the sequencing of the region containing the NS5 gene. A comparison of the viral nucleic acid sequence with those of other strains of ZIKA virus was performed using the MEGA software. Fifty-one samples were found positive for ZIKV by RT-PCR analysis. Further analysis of the NS5 gene revealed that the ZIKV strains identified in Easter Island were most closely related to those found in French Polynesia (99.8 to 99.9 % nt and 100 % aa sequence identity). These results strongly suggest that the transmission pathway leading to the introduction of Zika virus on Easter Island has its origin in French Polynesia.
C1 [Tognarelli, J.; Ulloa, S.; Lagos, J.; Aguayo, C.; Parra, B.; Olivares, B.; Fernandez, J.] Publ Hlth Inst Chile, Subdept Mol Genet, Santiago, Chile.
   [Villagra, E.; Mora, J.; Becerra, N.; Lagos, N.; Vera, L.; Vilches, M.] Publ Hlth Inst Chile, Emergent & Hepat Virus Lab, Santiago, Chile.
   [Fasce, R.] Publ Hlth Inst Chile, Subdept Virol, Santiago, Chile.
RP Fernandez, J (reprint author), Publ Hlth Inst Chile, Subdept Mol Genet, Santiago, Chile.
EM jfernand@ispch.cl
FU Public Health Institute
FX We thank Maria Ibanez Aravena, Mauro Arancibia and Liliana Ramos from
   the Subdepartment of Molecular Genetics of the Public Health Institute
   for excellent technical assistance. This study was supported by the
   Public Health Institute.
CR Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Caceres C, 2008, ARCH VIROL, V153, P1967, DOI 10.1007/s00705-008-0200-0
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez J, 2011, ARCH VIROL, V156, P1865, DOI 10.1007/s00705-011-1049-1
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kuno G, 1998, J VIROL, V72, P73
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Perret C, 2003, EMERG INFECT DIS, V9, P1465
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
NR 14
TC 24
Z9 26
U1 9
U2 36
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD MAR
PY 2016
VL 161
IS 3
BP 665
EP 668
DI 10.1007/s00705-015-2695-5
PG 4
WC Virology
SC Virology
GA DF0SR
UT WOS:000371049800018
PM 26611910
ER

PT J
AU Yakob, L
   Walker, T
AF Yakob, Laith
   Walker, Thomas
TI Zika virus outbreak in the Americas: the need for novel mosquito control
   methods
SO LANCET GLOBAL HEALTH
LA English
DT Editorial Material
ID AEDES-AEGYPTI POPULATIONS; WOLBACHIA; DENGUE
C1 [Yakob, Laith; Walker, Thomas] Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.
RP Yakob, L (reprint author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.
EM laith.yakob@lshtm.ac.uk
OI Yakob, Laith/0000-0001-8639-4511
CR Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   ECDC, 2015, MICR BRAZ POT LINK Z
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Phuc HK, 2007, BMC BIOL, V5, P1
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
NR 9
TC 12
Z9 17
U1 14
U2 109
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD MAR
PY 2016
VL 4
IS 3
BP E148
EP E149
DI 10.1016/S2214-109X(16)00048-6
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DE5ML
UT WOS:000370675000007
PM 26848089
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika virus in the dock
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 3
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2016
VL 16
IS 3
BP 265
EP 265
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DE4FQ
UT WOS:000370585000001
ER

PT J
AU Ayres, CFJ
AF Ayres, Constancia F. J.
TI Identification of Zika virus vectors and implications for control
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID TRANSMISSION
C1 [Ayres, Constancia F. J.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Campus UFPE,Cidade Univ, Recife, PE, Brazil.
RP Ayres, CFJ (reprint author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Campus UFPE,Cidade Univ, Recife, PE, Brazil.
EM tans@cpqam.fiocruz.br
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. D. M., 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Li MI, 2012, PLOS NEG TROP DIS, V6, P1
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 13
Z9 15
U1 11
U2 82
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2016
VL 16
IS 3
BP 278
EP 279
DI 10.1016/S1473-3099(16)00073-6
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DE4FQ
UT WOS:000370585000011
PM 26852727
ER

PT J
AU Reisch, MS
AF Reisch, Marc S.
TI Containing the Zika virus
SO CHEMICAL & ENGINEERING NEWS
LA English
DT Article
AB For most people who catch it, the Zika virus isn't so bad. Symptoms include achy joints, a rash, headache, and a slight fever. After a few days, the symptoms are gone. But for pregnant women, Zika is a horror. The virus is the suspect behind an epidemic of more than 4,000 cases of children born in Brazil in the past year with abnormally small heads and brains, a rare condition known as microcephaly.
NR 0
TC 0
Z9 0
U1 2
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD FEB 29
PY 2016
VL 94
IS 9
BP 29
EP 30
PG 2
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DE9VZ
UT WOS:000370988800045
ER

PT J
AU Roa, M
AF Roa, Monica
TI Zika virus outbreak: reproductive health and rights in Latin America
SO LANCET
LA English
DT Letter
C1 [Roa, Monica] Womens Link Worldwide, Madrid, Spain.
RP Roa, M (reprint author), Womens Link Worldwide, Madrid, Spain.
EM m.roa@womenslinkworldwide.org
CR Amnesty International, SALV TOT AB BAN SENT
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
NR 2
TC 7
Z9 9
U1 6
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 27
PY 2016
VL 387
IS 10021
BP 843
EP 843
DI 10.1016/S0140-6736(16)00331-7
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE9RA
UT WOS:000370974400017
PM 26880123
ER

PT J
AU Vouga, M
   Musso, D
   Van Mieghem, T
   Baud, D
AF Vouga, Manon
   Musso, Didier
   Van Mieghem, Tim
   Baud, David
TI CDC guidelines for pregnant women during the Zika virus outbreak
SO LANCET
LA English
DT Letter
C1 [Vouga, Manon; Baud, David] CHU Vaudois, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne Hosp, Lausanne, Switzerland.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
   [Van Mieghem, Tim] Univ Hosp Leuven, Div Woman & Child, Dept Obstet & Gynecol, Leuven, Belgium.
RP Baud, D (reprint author), CHU Vaudois, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.; Baud, D (reprint author), Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.; Baud, D (reprint author), Univ Lausanne Hosp, Lausanne, Switzerland.
EM david.baud@chuv.ch
CR American Congress of Obstetricians and Gynecologists, 2015, OBSTET GYNECOL, P1510, DOI DOI 10.1097/01.AOG.0000466430.19823.53
   Benoist G, 2013, FETAL DIAGN THER, V33, P203, DOI 10.1159/000342752
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P1
   TABOR A, 1986, LANCET, V1, P1287
NR 5
TC 7
Z9 7
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 27
PY 2016
VL 387
IS 10021
BP 843
EP 844
DI 10.1016/S0140-6736(16)00383-4
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE9RA
UT WOS:000370974400018
PM 26898855
ER

PT J
AU Zika, RM
AF Zika, Roa M.
TI Zika virus outbreak: reproductive health and rights in Latin America
   (vol 387, pg 843, 2016)
SO LANCET
LA English
DT Correction
CR Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
NR 1
TC 0
Z9 0
U1 7
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 27
PY 2016
VL 387
IS 10021
BP 848
EP 848
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE9RA
UT WOS:000370974400026
ER

PT J
AU Fleming-Dutra, KE
   Nelson, JM
   Fischer, M
   Staples, JE
   Karwowski, MP
   Mead, P
   Villanueva, J
   Renquist, CM
   Minta, AA
   Jamieson, DJ
   Honein, MA
   Moore, CA
   Rasmussen, SA
AF Fleming-Dutra, Katherine E.
   Nelson, Jennifer M.
   Fischer, Marc
   Staples, J. Erin
   Karwowski, Mateusz P.
   Mead, Paul
   Villanueva, Julie
   Renquist, Christina M.
   Minta, Anna A.
   Jamieson, Denise J.
   Honein, Margaret A.
   Moore, Cynthia A.
   Rasmussen, Sonja A.
TI Update: Interim Guidelines for Health Care Providers Caring for Infants
   and Children with Possible Zika Virus Infection - United States,
   February 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID TRANSMISSION; INDONESIA; OUTCOMES; DENGUE; FEVER
C1 [Fleming-Dutra, Katherine E.] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Nelson, Jennifer M.; Karwowski, Mateusz P.; Minta, Anna A.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Nelson, Jennifer M.] CDC, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis & Hlth Promot, Atlanta, GA 30333 USA.
   [Fischer, Marc; Staples, J. Erin; Mead, Paul] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Karwowski, Mateusz P.] CDC, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.
   [Villanueva, Julie] CDC, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Renquist, Christina M.; Honein, Margaret A.; Moore, Cynthia A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Minta, Anna A.] CDC, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Fleming-Dutra, KE (reprint author), CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM eocbirthdef@cdc.gov
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   HURWITZ ES, 1987, JAMA-J AM MED ASSOC, V257, P1905, DOI 10.1001/jama.257.14.1905
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Minsterio de Saude, 2015, PROT VIG RESP OC MIC
   Mlakar J., 2016, N ENGL J MED
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   SCHERER WF, 1980, AM J TROP MED HYG, V29, P1359
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852
   Tomashek KM, 2016, DENGUE
   University of Calgary, WELC FENT PRET GROWT
   World Health Organization, WHO CHILD GROWTH STA
NR 29
TC 10
Z9 10
U1 7
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD FEB 26
PY 2016
VL 65
IS 7
BP 182
EP 187
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF4UB
UT WOS:000371345300004
PM 26914500
ER

PT J
AU Ahmad, SSY
   Amin, TN
   Ustianowski, A
AF Ahmad, Shazaad S. Y.
   Amin, Tejal N.
   Ustianowski, Andrew
TI PRACTICE POINTER Zika virus: management of infection and risk
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID SEXUAL TRANSMISSION; INTERIM GUIDELINES; UNITED-STATES
C1 [Ahmad, Shazaad S. Y.; Ustianowski, Andrew] Pennine Acute Hosp Trust, North Manchester Gen Hosp, Northwest Reg Infect Dis Unit, Manchester M8 5RB, Lancs, England.
   [Ahmad, Shazaad S. Y.] Cent Manchester Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Royal Infirm, Virol Dept, Manchester M13 9WL, Lancs, England.
   [Amin, Tejal N.] Univ Coll London Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, London, England.
RP Ustianowski, A (reprint author), Pennine Acute Hosp Trust, North Manchester Gen Hosp, Northwest Reg Infect Dis Unit, Manchester M8 5RB, Lancs, England.
EM Andrew.Ustianowski@pat.nhs.uk
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Australian Government Department of Health, 2016, ZIK VIR INF CLIN PUB
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P14, DOI [10.2807/1560-7917.ES2014.19.14, DOI 10.2807/1560-7917.ES2014.19.14]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Royal College of Obstetricians and Gynaecologists Royal College of Midwives Public Health England, 2016, INT RCOG RCM PHE HPS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 15
TC 3
Z9 4
U1 8
U2 15
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 26
PY 2016
VL 352
AR i1062
DI 10.1136/bmj.i1062
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF1RM
UT WOS:000371116900004
PM 26920038
ER

PT J
AU Basarab, M
   Bowman, C
   Aarons, EJ
   Cropley, I
AF Basarab, Marina
   Bowman, Conor
   Aarons, Emma J.
   Cropley, Ian
TI Zika virus
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
ID FRENCH-POLYNESIA; FEBRUARY 2014; TRANSMISSION; OUTBREAK; INFECTION;
   SINGAPORE; AMERICA; VECTOR; BRAZIL; FEVER
C1 [Basarab, Marina; Bowman, Conor; Cropley, Ian] Royal Free London NHS Fdn Trust, Dept Infect Dis, London NW3 2QG, England.
   [Aarons, Emma J.] Publ Hlth England, Rare & Imported Pathogens Lab, Porton Down, England.
RP Cropley, I (reprint author), Royal Free London NHS Fdn Trust, Dept Infect Dis, London NW3 2QG, England.
EM iancropley@nhs.net
CR Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, REV DIAGN TEST ZIK C
   Charrel RN, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171207, DOI 10.2471/BLT.16.171207]
   Symmes Cobb J, COLOMBIAS FORECAST Z
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Da Saude M., 2015, SITUACAO CONFIRMACAO
   Regis C, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.170639, DOI 10.2471/BLT.16.170639]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, COUNTR TERR LOC ZIK
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. D. M., 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [10.1371/journal.pntd.0002681.24516683, DOI 10.1371/JOURNAL.PNTD.0002681.24516683]
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [10.1371/journal.pntd.0001477.22389730, DOI 10.1371/JOURNAL.PNTD.0001477.22389730]
   Haddow AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jan C, 1978, B SOC PATHOL EXOT, V71, P140
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2015, BISES B INFORM SANIT
   Marchette NJ, 1969, AM J TROP MED HYG, V18, P411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1600651.26862926, DOI 10.1056/NEJMOA1600651.26862926]
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scotland HP, NHS NAT SERV SCOTL F
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smithburn KC, 1954, NEUTRALISING ANTIBOD
   Stanczyk NM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h99
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2014, ARCH VIROL, V2015
   World Health Organization, DIS OUTBR NEWS ZIK V
   World Health Organization, ZIK VIR NEWS UPD
   World Health Organization, 2016, EM COMM ZIK VIR OBS
   World Health Organization, DIS OUTBR NEWS GUILL
   World Health Organization, 2016, ZIK SIT REP WHO
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 58
TC 6
Z9 8
U1 13
U2 45
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 26
PY 2016
VL 352
AR i1049
DI 10.1136/bmj.i1049
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF1RM
UT WOS:000371116900003
PM 26921241
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI US health officials investigate sexually transmitted Zika virus
   infections
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1086
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
NR 2
TC 0
Z9 0
U1 5
U2 15
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 26
PY 2016
VL 352
AR i1180
DI 10.1136/bmj.i1180
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF1RM
UT WOS:000371116900005
PM 26921165
ER

PT J
AU Venturi, G
   Zammarchi, L
   Fortuna, C
   Remoli, ME
   Benedetti, E
   Fiorentini, C
   Trotta, M
   Rizzo, C
   Mantella, A
   Rezza, G
   Bartoloni, A
AF Venturi, G.
   Zammarchi, L.
   Fortuna, C.
   Remoli, M. E.
   Benedetti, E.
   Fiorentini, C.
   Trotta, M.
   Rizzo, C.
   Mantella, A.
   Rezza, G.
   Bartoloni, A.
TI An autochthonous case of Zika due to possible sexual transmission,
   Florence, Italy, 2014
SO EUROSURVEILLANCE
LA English
DT Article
ID FRENCH-POLYNESIA; VIRUS; AMERICA; VECTOR; DENGUE
C1 [Venturi, G.; Fortuna, C.; Remoli, M. E.; Benedetti, E.; Fiorentini, C.; Rezza, G.] Ist Super Sanita, Dept Infect Parasit & Immune Mediate Dis, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Zammarchi, L.; Mantella, A.; Bartoloni, A.] Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.
   [Zammarchi, L.; Trotta, M.; Bartoloni, A.] Azienda Osped Univ Caeggi, SOD Malattie Infett & Trop, Florence, Italy.
   [Rizzo, C.] Ist Super Sanita, Natl Ctr Epidemiol & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy.
RP Bartoloni, A (reprint author), Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.; Bartoloni, A (reprint author), Azienda Osped Univ Caeggi, SOD Malattie Infett & Trop, Florence, Italy.
EM alessandro.bartoloni@unifi.it
RI VENTURI, GIULIETTA/O-8123-2015; Remoli, Maria Elena/O-9447-2015;
   FORTUNA, CLAUDIA/O-9446-2015; 
OI VENTURI, GIULIETTA/0000-0002-9078-8350; Remoli, Maria
   Elena/0000-0003-3565-383X; Rizzo, Caterina/0000-0002-5583-7508
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Charrel RN, BULL WORLD HEALTH OR
   Center for Infectious Disease Research and Policy (CIDRAP), 2016, BRAZIL CONFIRMS BLOO
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIKA VIRUS INFECTION
   [Anonymous], 2015, RAPID RISK ASSESSMEN
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Ministero della salute. Direzione Generale della Prevenzione Sanitaria Ufficio V Malattie Infettive e Profilassi Internazionale ex-DGPREV, 2015, CIRCOLARE
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I875
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Venturi G, 2006, J VIROL METHODS, V134, P136, DOI 10.1016/j.jviromet.2005.12.010
   World Health Organization, 2016, WHO DIRECTOR GENERAL
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 18
Z9 18
U1 11
U2 15
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 25
PY 2016
VL 21
IS 8
BP 2
EP 5
DI 10.2807/1560-7917.ES.2016.21.8.30148
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DF1IF
UT WOS:000371092400001
ER

PT J
AU Howard, CR
AF Howard, Colin R.
TI Aedes mosquitoes and Zika virus infection: an A to Z of emergence?
SO EMERGING MICROBES & INFECTIONS
LA English
DT Editorial Material
C1 [Howard, Colin R.] Univ Birmingham, Coll Med & Dent, Birmingham B15 2TT, W Midlands, England.
RP Howard, CR (reprint author), Univ Birmingham, Coll Med & Dent, Birmingham B15 2TT, W Midlands, England.
EM c.r.howard@bham.ac.uk
CR Bonn D, 2006, LANCET INFECT DIS, V6, P543, DOI 10.1016/S1473-3099(06)70559-X
   Dayan GH, 2013, VIRUSES-BASEL, V5, P3048, DOI 10.3390/v5123048
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Schoepp RJ, 2014, EMERG INFECT DIS, V20, P1176, DOI 10.3201/eid2007.131265
NR 9
TC 1
Z9 1
U1 20
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD FEB 24
PY 2016
VL 5
AR e16
DI 10.1038/emi.2016.37
PG 2
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DE8XQ
UT WOS:000370920400003
PM 26905027
ER

PT J
AU Brodwall, K
AF Brodwall, Kristoffer
TI Infection rates of the Zika Virus
SO TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING
LA Norwegian
DT Editorial Material
C1 [Brodwall, Kristoffer] Univ Bergen, Inst Global Helse & Samfunnsmed, N-5020 Bergen, Norway.
RP Brodwall, K (reprint author), Univ Bergen, Inst Global Helse & Samfunnsmed, N-5020 Bergen, Norway.
EM kristoffer.brodwall@gmail.com
RI Brodwall, Kristoffer/L-4995-2016
CR Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
NR 3
TC 0
Z9 0
U1 5
U2 5
PU NORWEGIAN MEDICAL ASSOC
PI OSLO
PA AKERSGATA 2, PO BOX 1152, OSLO, 0107, NORWAY
SN 0029-2001
EI 0807-7096
J9 TIDSSKR NORSKE LAEGE
JI Tidsskr. Nor. Laegeforen.
PD FEB 23
PY 2016
VL 136
IS 4
BP 307
EP 307
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF3JI
UT WOS:000371239700016
ER

PT J
AU Heymann, DL
   Hodgson, A
   Sall, AA
   Freedman, DO
   Staples, JE
   Althabe, F
   Baruah, K
   Mahmud, G
   Kandun, N
   Vasconcelos, PFC
   Bino, S
   Menon, KU
AF Heymann, David L.
   Hodgson, Abraham
   Sall, Amadou Alpha
   Freedman, David O.
   Staples, J. Erin
   Althabe, Fernando
   Baruah, Kalpana
   Mahmud, Ghazala
   Kandun, Nyoman
   Vasconcelos, Pedro F. C.
   Bino, Silvia
   Menon, K. U.
TI Zika virus and microcephaly: why is this situation a PHEIC?
SO LANCET
LA English
DT Editorial Material
C1 [Heymann, David L.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England.
   [Heymann, David L.] Royal Inst Int Affairs, Ctr Global Hlth Secur, Chatham House, London SW1Y 4LE, England.
   [Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana.
   [Hodgson, Abraham] Senegal Inst Pasteur Dakar, WHO Collaborating Ctr Arboviruses & Viral Haemorr, Dakar, Senegal.
   [Freedman, David O.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA.
   [Staples, J. Erin] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Althabe, Fernando] Inst Clin Effectiveness & Hlth Policy, Dept Maternal & Child Hlth Res, Buenos Aires, DF, Argentina.
   [Baruah, Kalpana] Govt India, Minist Hlth & Family Welf, Natl Vector Borne Dis Control Programme, New Delhi, India.
   [Mahmud, Ghazala] Quaid I Azam Univ, Quaid I Azam Post Grad Med Coll, Fac Med, Pakistan Inst Med Sci, Islamabad, Pakistan.
   [Kandun, Nyoman] Minist Hlth, Field Epidemiol Training Program, Jakarta, Indonesia.
   [Vasconcelos, Pedro F. C.] Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Brazil.
   [Bino, Silvia] Inst Publ Hlth, Control Infect Dis Dept, Tirana, Albania.
   [Menon, K. U.] Minist Commun & Informat, Singapore, Singapore.
RP Heymann, DL (reprint author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England.; Heymann, DL (reprint author), Royal Inst Int Affairs, Ctr Global Hlth Secur, Chatham House, London SW1Y 4LE, England.
EM david.heymann@phe.gov.uk
CR Brender N, 2014, GLOBAL RISK GOVERNAN, P21
   Centers for Disease Control and Prevention, 2016, SURV CONTR AED AEG A
   Center for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, 2015, CONG RUB SYNDR RUB E
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2004, EMERG INFECT DIS, V10, P173
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization, 2015, EP UPD ZIK VIR INF
   The PLOS Medicine Editors, 2016, PLOS MED, V13
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4
   Weinhold B, 2009, ENVIRON HEALTH PERSP, V117, pA440
   Whitty CJM, 2015, LANCET, V386, P1797, DOI 10.1016/S0140-6736(15)00758-8
   WHO, 2016, CONGENITAL ANOMALIES
   World Health Organization, 2016, ZIK VIR
   WHO. WHO statement on the first meeting of the International Health Regulations, 2005, WHO 1 M INT HLTH REG
NR 17
TC 36
Z9 37
U1 12
U2 51
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 20
PY 2016
VL 387
IS 10020
BP 719
EP 721
DI 10.1016/S0140-6736(16)00320-2
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE1WU
UT WOS:000370418000004
PM 26876373
ER

PT J
AU Paz, S
   Semenza, JC
AF Paz, Shlomit
   Semenza, Jan C.
TI El Nino and climate change-contributing factors in the dispersal of Zika
   virus in the Americas?
SO LANCET
LA English
DT Letter
C1 [Paz, Shlomit] Univ Haifa, Dept Geog & Environm Studies, IL-3498838 Haifa, Israel.
   [Semenza, Jan C.] Stockholm Environm Inst, Stockholm, Sweden.
RP Paz, S (reprint author), Univ Haifa, Dept Geog & Environm Studies, IL-3498838 Haifa, Israel.
EM shlomit@geo.haifa.ac.il
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   ECDC [European Centre for Disease Prevention and Control], 2015, EP UPD OUTBR ZIK VIR
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   National Oceanic and Atmospheric Administration, GLOB AN ANN 2015
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378
   US National Oceanic and Atmospheric Administration (NOAA) National Centers for Environmental Information, 2015, LAND OC TEMP PERC SE
   US National Oceanic and Atmospheric Administration (NOAA) National Centers for Environmental Information, LAND ONL PREC AN SEP
NR 7
TC 11
Z9 12
U1 13
U2 30
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 20
PY 2016
VL 387
IS 10020
BP 745
EP 745
DI 10.1016/S0140-6736(16)00256-7
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE1WU
UT WOS:000370418000021
PM 26850984
ER

PT J
AU Thomas, DL
   Sharp, TM
   Torres, J
   Armstrong, PA
   Munoz-Jordan, J
   Ryff, KR
   Martinez-Quinones, A
   Arias-Berrios, J
   Mayshack, M
   Garayalde, GJ
   Saavedra, S
   Luciano, CA
   Valencia-Prado, M
   Waterman, S
   Rivera-Garcia, B
AF Thomas, Dana L.
   Sharp, Tyler M.
   Torres, Jomil
   Armstrong, Paige A.
   Munoz-Jordan, Jorge
   Ryff, Kyle R.
   Martinez-Quinones, Alma
   Arias-Berrios, Jose
   Mayshack, Marrielle
   Garayalde, Glenn J.
   Saavedra, Sonia
   Luciano, Carlos A.
   Valencia-Prado, Miguel
   Waterman, Steve
   Rivera-Garcia, Brenda
TI Local Transmission of Zika Virus - Puerto Rico, November 23,
   2015-January 28, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID STATES
C1 [Thomas, Dana L.; Torres, Jomil; Ryff, Kyle R.; Mayshack, Marrielle; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol, San Juan, PR USA.
   [Thomas, Dana L.] CDC, Off Publ Hlth Preparedness & Response, Div State Lab Readiness, Atlanta, GA 30333 USA.
   [Sharp, Tyler M.; Munoz-Jordan, Jorge; Waterman, Steve] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Atlanta, GA 30333 USA.
   [Armstrong, Paige A.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Martinez-Quinones, Alma; Valencia-Prado, Miguel] Puerto Rico Dept Hlth, Puerto Rico Birth Defects Surveillance & Prevent, San Juan, PR USA.
   [Arias-Berrios, Jose; Luciano, Carlos A.] Univ Puerto Rico, Sch Med, Dept Neurol, San Juan, PR USA.
   [Mayshack, Marrielle] CDC, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
   [Garayalde, Glenn J.; Saavedra, Sonia] Vet Affairs Caribbean Healthcare Syst, San Juan, PR USA.
RP Thomas, DL (reprint author), Puerto Rico Dept Hlth, Off Epidemiol, San Juan, PR USA.; Thomas, DL (reprint author), CDC, Off Publ Hlth Preparedness & Response, Div State Lab Readiness, Atlanta, GA 30333 USA.
EM Zika@salud.gov.pr
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Noyd DH, 2015, P R HEALTH SCI J, V34, P65
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 11
TC 13
Z9 17
U1 4
U2 11
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD FEB 19
PY 2016
VL 65
IS 6
BP 154
EP 158
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF4TY
UT WOS:000371345000004
PM 26890470
ER

PT J
AU Martines, RB
   Bhatnagar, J
   Keating, MK
   Silva-Flannery, L
   Muehlenbachs, A
   Gary, J
   Goldsmith, C
   Hale, G
   Ritter, J
   Rollin, D
   Shieh, WJ
   Luz, KG
   Ramos, AMDO
   Davi, HPF
   de Oliveria, WK
   Lanciotti, R
   Lambert, A
   Zaki, S
AF Martines, Roosecelis Brasil
   Bhatnagar, Julu
   Keating, M. Kelly
   Silva-Flannery, Luciana
   Muehlenbachs, Atis
   Gary, Joy
   Goldsmith, Cynthia
   Hale, Gillian
   Ritter, Jana
   Rollin, Dominique
   Shieh, Wun-Ju
   Luz, Kleber G.
   de Oliveira Ramos, Ana Maria
   Freire Davi, Helaine Pompeia
   de Oliveria, Wanderson Kleber
   Lanciotti, Robert
   Lambert, Amy
   Zaki, Sherif
TI Evidence of Zika Virus Infection in Brain and Placental Tissues from Two
   Congenitally Infected Newborns and Two Fetal Losses - Brazil, 2015
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Martines, Roosecelis Brasil; Bhatnagar, Julu; Keating, M. Kelly; Silva-Flannery, Luciana; Muehlenbachs, Atis; Gary, Joy; Goldsmith, Cynthia; Hale, Gillian; Ritter, Jana; Rollin, Dominique; Shieh, Wun-Ju; Zaki, Sherif] CDC, Infectious Dis Pathol Branch, Div High Consequence Pathogens & Pathol, NCEZID, Atlanta, GA 30333 USA.
   [Luz, Kleber G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, BR-59072970 Natal, RN, Brazil.
   [de Oliveira Ramos, Ana Maria] Univ Fed Rio Grande do Norte, Dept Pathol, BR-59072970 Natal, RN, Brazil.
   [Freire Davi, Helaine Pompeia] Serv Ascertaining Death State Rio Grande do Nort, Natal, RN, Brazil.
   [de Oliveria, Wanderson Kleber] Minist Hlth, Sao Paulo, Brazil.
   [Lanciotti, Robert; Lambert, Amy] CDC, Arboviral Dis Branch, Div Vector Borne Dis, NCEZID, Atlanta, GA 30333 USA.
RP Martines, RB (reprint author), CDC, Infectious Dis Pathol Branch, Div High Consequence Pathogens & Pathol, NCEZID, Atlanta, GA 30333 USA.
EM RBrasilMartines@cdc.gov
CR Bhatnagar J, 2012, AM J TROP MED HYG, V86, P335, DOI 10.4269/ajtmh.2012.11-0346
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115
   Victoria CG, 2016, LANCET
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 5
TC 72
Z9 72
U1 22
U2 35
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD FEB 19
PY 2016
VL 65
IS 6
BP 159
EP 160
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF4TY
UT WOS:000371345000005
PM 26890059
ER

PT J
AU Fauci, AS
   Morens, DM
AF Fauci, Anthony S.
   Morens, David M.
TI Zika Virus in the Americas - Yet Another Arbovirus Threat
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
C1 [Fauci, Anthony S.; Morens, David M.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Fauci, AS (reprint author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z, DOI DOI 10.1056/NEJMP1600297
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Pierson TC, 2014, FIELDS VIROLOGY, V1, P746
NR 5
TC 90
Z9 97
U1 17
U2 31
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD FEB 18
PY 2016
VL 374
IS 7
BP 601
EP 604
DI 10.1056/NEJMp1600297
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DD9ER
UT WOS:000370229000003
PM 26761185
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI WHO sets out $56m Zika virus response plan
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR World Health Organization, ZIK STRAT RESP FRAM
NR 1
TC 0
Z9 0
U1 1
U2 9
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 18
PY 2016
VL 352
AR i1042
DI 10.1136/bmj.i1042
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE6FB
UT WOS:000370728000003
PM 26893468
ER

PT J
AU Erickson, B
AF Erickson, Britt
TI PUBLIC HEALTH Obama requests $1.8 billion in emergency funds to combat
   Zika virus
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 3
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD FEB 15
PY 2016
VL 94
IS 7
BP 7
EP 7
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DE1PA
UT WOS:000370397700010
ER

PT J
AU Elachola, H
   Gozzer, E
   Zhuo, JT
   Memish, ZA
AF Elachola, Habida
   Gozzer, Ernesto
   Zhuo, Jiatong
   Memish, Ziad A.
TI A crucial time for public health preparedness: Zika virus and the 2016
   Olympics, Umrah, and Hajj
SO LANCET
LA English
DT Editorial Material
ID PANDEMIC H1N1; TRANSMISSION
C1 [Gozzer, Ernesto] Inst Nacl Salud, Lima, Peru.
   [Zhuo, Jiatong] Guangxi Ctr Dis Control & Prevent, Guangxi, Peoples R China.
   [Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh 11514, Saudi Arabia.
RP Memish, ZA (reprint author), Minist Hlth, Riyadh, Saudi Arabia.; Memish, ZA (reprint author), Alfaisal Univ, Coll Med, Riyadh 11514, Saudi Arabia.
EM zmemish@yahoo.com
CR Al-Tawfiq JA, 2014, INT J INFECT DIS, V27, P26, DOI 10.1016/j.ijid.2014.07.001
   Alhaeli A, 2016, J INFECT PUBLIC HEAL, V9, P117, DOI 10.1016/j.jiph.2015.05.006
   Aziz Al Thabiany, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P849, DOI 10.1016/S2221-1691(12)60242-1
   Bitar D, 2009, EUROSURVEILLANCE, V14
   Brazil Ministry of Health, 2015, B EP, V47
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Ebrahim SH, 2009, SCIENCE, V326, P938, DOI 10.1126/science.1183210
   Fantz A, 2016, OLYMPICS WILL INSPEC
   Memish ZA, 2010, J ROY SOC MED, V103, P386, DOI 10.1258/jrsm.2010.100263
   Ministry of Health Kingdom of Saudi Arabia, 2016, HAJJ 1436 HLTH REG
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   WHO, 2016, WHO DIR GEN BRIEFS E
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 15
TC 8
Z9 10
U1 11
U2 72
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 13
PY 2016
VL 387
IS 10019
BP 630
EP 632
DI 10.1016/S0140-6736(16)00274-9
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DD3QH
UT WOS:000369837100009
PM 26864962
ER

PT J
AU Oster, AM
   Brooks, JT
   Stryker, JE
   Kachur, RE
   Mead, P
   Pesik, NT
   Petersen, LR
AF Oster, Alexandra M.
   Brooks, John T.
   Stryker, Jo Ellen
   Kachur, Rachel E.
   Mead, Paul
   Pesik, Nicki T.
   Petersen, Lyle R.
TI Interim Guidelines for Prevention of Sexual Transmission of Zika Virus -
   United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Oster, Alexandra M.; Brooks, John T.; Stryker, Jo Ellen] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Kachur, Rachel E.] CDC, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Mead, Paul; Petersen, Lyle R.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Pesik, Nicki T.] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Brooks, JT (reprint author), CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
EM zud4@cdc.gov
CR CDC, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR MORB MORTAL WKL, V65
NR 8
TC 39
Z9 45
U1 11
U2 27
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD FEB 12
PY 2016
VL 65
IS 5
BP 120
EP 121
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DE2OO
UT WOS:000370466800005
PM 26866485
ER

PT J
AU Oduyebo, T
   Petersen, EE
   Rasmussen, SA
   Mead, PS
   Meaney-Delman, D
   Renquist, CM
   Ellington, SR
   Fischer, M
   Staples, JE
   Powers, AM
   Villanueva, J
   Galang, RR
   Dieke, A
   Munoz, JL
   Honein, MA
   Jamieson, DJ
AF Oduyebo, Titilope
   Petersen, Emily E.
   Rasmussen, Sonja A.
   Mead, Paul S.
   Meaney-Delman, Dana
   Renquist, Christina M.
   Ellington, Sascha R.
   Fischer, Marc
   Staples, J. Erin
   Powers, Ann M.
   Villanueva, Julie
   Galang, Romeo R.
   Dieke, Ada
   Munoz, Jorge L.
   Honein, Margaret A.
   Jamieson, Denise J.
TI Update: Interim Guidelines for Health Care Providers Caring for Pregnant
   Women and Women of Reproductive Age with Possible Zika Virus Exposure -
   United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID INFECTION; ANTIBODY
C1 [Oduyebo, Titilope; Galang, Romeo R.; Dieke, Ada] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Oduyebo, Titilope; Petersen, Emily E.; Ellington, Sascha R.; Dieke, Ada; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
   [Mead, Paul S.; Fischer, Marc; Staples, J. Erin; Powers, Ann M.; Villanueva, Julie; Munoz, Jorge L.] CDC, Arboviral Dis Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Renquist, Christina M.; Honein, Margaret A.] CDC, Div Birth Defects & Dev Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Galang, Romeo R.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
RP Jamieson, DJ (reprint author), CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM eocbirthdef@cdc.gov
CR American Academy of Pediatrics and American College of Obstetricians and Gynecologists, 2012, GUID PER CAR
   American Congress of Obstetricians and Gynecologists, 2015, OBSTET GYNECOL, P1510, DOI DOI 10.1097/01.AOG.0000466430.19823.53
   Babaliche Prakash, 2015, J Assoc Physicians India, V63, P38
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   CDC, 2009, DENG VIR
   CDC, 2014, REPR LIF PLAN TOOL H
   CDC Centers for Disease Control and Prevention, 2015, CHIK VIR
   CDC, 2015, W NIL VIR INS REP US
   CDC, 2015, ZIK VIR
   Division of Reproductive Health, 2013, MMWR RECOMM REP, V62
   Division of Vector-Borne Diseases, 2016, ARB DIS DENG BRANCH
   Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gibney KB, 2012, AM J TROP MED HYG, V87, P1112, DOI 10.4269/ajtmh.2012.12-0182
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Oster AM, 2016, MMWR MORB MORTAL WKL, V65
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Picone O, 2004, PRENATAL DIAG, V24, P1001, DOI 10.1002/pd.942
   Rasmussen SA, 2011, AM J OBSTET GYNECOL, V204, pS13, DOI 10.1016/j.ajog.2011.01.048
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   WHO, 2009, DENG GUID DIAGN TREA
NR 25
TC 37
Z9 37
U1 9
U2 15
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD FEB 12
PY 2016
VL 65
IS 5
BP 122
EP 127
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DE2OO
UT WOS:000370466800006
PM 26866840
ER

PT J
AU Maria, AT
   Maquart, M
   Makinson, A
   Flusin, O
   Segondy, M
   Leparc-Goffart, I
   Le Moing, V
   Foulongne, V
AF Maria, A. T.
   Maquart, M.
   Makinson, A.
   Flusin, O.
   Segondy, M.
   Leparc-Goffart, I.
   Le Moing, V.
   Foulongne, V.
TI Zika virus infections in three travellers returning from South America
   and the Caribbean respectively, to Montpellier, France, December 2015 to
   January 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID ALBOPICTUS
AB We report three unrelated cases of Zika virus infection in patients returning from Martinique, Brazil and Colombia respectively, to Montpellier, France. They developed symptoms compatible with a mosquito-borne disease, and serological and molecular investigations indicated a recent Zika virus infection. Considering the recent warning for the likely teratogenicity of Zika virus and the presence of competent mosquito vectors in southern France, these cases highlight the need for awareness of physicians and laboratories in Europe.
C1 [Maria, A. T.; Makinson, A.; Le Moing, V.] Montpellier Univ Hosp, Dept Infect Dis & Trop Med, Montpellier, France.
   [Maria, A. T.; Makinson, A.; Segondy, M.; Le Moing, V.; Foulongne, V.] Univ Montpellier, F-34059 Montpellier, France.
   [Maquart, M.; Flusin, O.; Leparc-Goffart, I.] Inst Rech Biomed Armees, Ctr Natl Reference Arbovirus, Marseille, France.
   [Segondy, M.; Foulongne, V.] Montpellier Univ Hosp, Virol Lab, Montpellier, France.
   [Segondy, M.; Foulongne, V.] INSERM, U1058, Pathogenesis & Control Chron Infect, Montpellier, France.
RP Foulongne, V (reprint author), Univ Montpellier, F-34059 Montpellier, France.; Foulongne, V (reprint author), Montpellier Univ Hosp, Virol Lab, Montpellier, France.; Foulongne, V (reprint author), INSERM, U1058, Pathogenesis & Control Chron Infect, Montpellier, France.
EM v-foulongne@chu-montpellier.fr
OI FLUSIN, Olivier/0000-0003-0126-9581
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   ECDC, 2015, COMM DIS THREATS REP
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Institut National de Veille Sanitaire (INVS), 2015, SURVEILLANCE SANITAI
   Marano G, 2015, BLOOD TRANSFUS, V5, P1, DOI DOI 10.2450/2015.0066-15.[
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Ministerio Da Saude (Brazil), 2015, MONITORAMENTO DOS CA
   PAHO, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
NR 14
TC 5
Z9 5
U1 5
U2 7
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 11
PY 2016
VL 21
IS 6
BP 2
EP 5
DI 10.2807/1560-7917.ES.2016.21.6.30131
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DE0RR
UT WOS:000370332500001
ER

PT J
CA Eurosurveillance Editorial Team
TI European Commission Horizon 2020 programme call for vaccine development
   research into malaria and neglected infectious diseases, including Zika
   virus
SO EUROSURVEILLANCE
LA English
DT News Item
C1 [Eurosurveillance Editorial Team] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
RP European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
CR European Commission, COMM CARL MOED EUR C
   European Commission, 2015, OFF J EUR UNION C, V399
   World Health Organization (WHO), 2016, NEGL TROP DIS
NR 3
TC 0
Z9 0
U1 5
U2 13
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 11
PY 2016
VL 21
IS 6
BP 19
EP 19
DI 10.2807/1560-7917.ES.2016.21.6.30132
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DE0RR
UT WOS:000370332500005
ER

PT J
AU O'Dowd, A
AF O'Dowd, Adrian
TI UK records four cases of Zika virus in past six weeks
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
NR 1
TC 0
Z9 0
U1 1
U2 21
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 11
PY 2016
VL 352
AR i875
DI 10.1136/bmj.i875
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE1JT
UT WOS:000370383900013
PM 26868672
ER

PT J
AU Kruger, RP
AF Kruger, Robert P.
TI Zika Virus on the Move
SO CELL
LA English
DT Editorial Material
ID POPULATIONS; WOLBACHIA; DENGUE
CR Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci A.S., 2016, N ENGL J MED
   Freire CCM, 2015, BIORXIV
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
NR 8
TC 1
Z9 1
U1 17
U2 86
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD FEB 11
PY 2016
VL 164
IS 4
BP 585
EP 587
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DD5XN
UT WOS:000369998300001
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Severe eye damage in infants with microcephaly is presumed to be due to
   Zika virus
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Goldstein DA, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0284, DOI 10.1001/JAMA0PHTHALM0L.2016.0284]
NR 2
TC 3
Z9 4
U1 25
U2 66
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 10
PY 2016
VL 352
AR i855
DI 10.1136/bmj.i855
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE1JN
UT WOS:000370383300017
PM 26864344
ER

PT J
AU Gyurech, D
   Schilling, J
   Schmidt-Chanasit, J
   Cassinotti, P
   Kaeppeli, F
   Dobec, M
AF Gyurech, Danielle
   Schilling, Julian
   Schmidt-Chanasit, Jonas
   Cassinotti, Pascal
   Kaeppeli, Franz
   Dobec, Marinko
TI False positive dengue NS1 antigen test in a traveller with an acute Zika
   virus infection imported into Switzerland
SO SWISS MEDICAL WEEKLY
LA English
DT Article
DE Zika virus; dengue virus; false positive NS1 antigen; traveller
ID EPIDEMIC; ANTIBODY; IGM
AB We report the first case of an acute Zika virus infection imported into Switzerland by a traveller returning from Canoa Quebrada, Ceara state, in the north-eastern part of Brazil. Due to a false positive dengue virus NS1 antigen test, IgG-antibody seroconversion and a suggestive clinical picture, an acute dengue fever was initially considered. However, because of lack of specific IgM-antibodies, stationary IgG-antibody titre and a negative dengue virus PCR test result, a dengue virus infection was excluded and a cross-reaction with other, causative flaviviruses was postulated. Based on recent reports of Zika fever cases in the north-eastern parts of Brazil, an acute Zika virus infection was suspected. Because of a lack of commercially available Zika virus diagnostic tests, the case was confirmed in the WHO reference laboratory. As the clinical presentation of Zika virus infection can be confused with dengue fever and chikungunya fever, and because of possible public health implications, all patients returning from affected areas should be additionally tested for Zika virus. This case illustrates the urgent medical need for a broadly available assay capable of differentiating Zika from Dengue infections.
C1 [Gyurech, Danielle; Schilling, Julian] Travel Clin, Zurich, Switzerland.
   [Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, World Hlth Org Collaborating Ctr Arbovirus & Haem, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Hamburg Lubeck Borstel, Hamburg, Germany.
   [Cassinotti, Pascal; Kaeppeli, Franz; Dobec, Marinko] Med Lab Dr F Kaeppeli, Med, Wolfbachstr 17, Zurich, Switzerland.
RP Dobec, M (reprint author), Med Lab Dr F Kaeppeli, Med, Wolfbachstr 17, Zurich, Switzerland.
EM dobec@medica.ch
CR Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Chung SJ, 2015, AM J TROP MED HYG, V92, P367, DOI 10.4269/ajtmh.14-0247
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministerio da Saude, NOT IMPR CONF ZIK VI
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Epidemiological Alert, 2015, EP AL NEUR SYNDR CON, V12, P1
   Pierson T.C., 2013, FIELDS VIROLOGY, P747
   Sanchez-Vargas LA, 2014, DIAGN MICR INFEC DIS, V78, P368, DOI 10.1016/j.diagmicrobio.2013.12.019
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Vickers IE, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0164-9
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 15
TC 11
Z9 11
U1 4
U2 12
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
EI 1424-3997
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD FEB 9
PY 2016
VL 146
AR w14296
DI 10.4414/smw.2016.14296
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DF3OL
UT WOS:000371254100003
PM 26859285
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI CDC updates Zika virus guidance to protect pregnant women
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, DOI [10.15585/mmwr.mm6505e2er, DOI 10.15585/MMWR.MM6505E2ER]
   Oster AM, 2016, MMWR-MORBID MORTAL W, DOI [10.15585/mmwr.mm6505e1er, DOI 10.15585/MMWR.MM6505E1ER]
NR 3
TC 0
Z9 1
U1 1
U2 22
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 9
PY 2016
VL 352
AR i786
DI 10.1136/bmj.i786
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE1IR
UT WOS:000370381000013
PM 26858259
ER

PT J
AU Kampango, A
   Abilio, AP
AF Kampango, Ayubo
   Abilio, Ana Paula
TI The Asian tiger hunts in Maputo city-the first confirmed report of Aedes
   (Stegomyia) albopictus (Skuse, 1895) in Mozambique
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes albopictus; New record; Dengue; Chikungunya; Maputo City;
   Mozambique
ID DIPTERA-CULICIDAE; AE.-ALBOPICTUS; AFRICA; MOSQUITOS; AEGYPTI; VECTOR;
   FEVER
AB Background: Increasing evidence suggests that dengue fever is endemic in Mozambique. Larvae of both the Afrotropical vector Aedes aegypti and its subspecies, Ae. aegypti formosus, have been reported from three provinces in Mozambique, two of which recently experienced dengue outbreaks. Despite reports of the invasive Oriental vector Ae. albopictus on the islands in the Mozambique Channel and nearby Indian Ocean, the species has not yet been reported in Mozambique.
   Findings: Four host-seeking female mosquitoes, collected biting the authors in an urban neighbourhood of Maputo City in the late afternoon of 6 December, 2015, are herein morphologically confirmed as Ae. albopictus.
   Conclusion: This is the first report confirming the occurrence in Mozambique of Ae. albopictus, an invasive species and an important vector of human arboviruses. In view of its potential role as a vector of dengue, Chikungunya and Zika viruses, studies are urgently needed to assess the geographical expansion and relative abundance of these important vectors to better understand the potential transmission impact of arboviruses that are efficiently transmitted and globally spread by these vectors.
C1 [Kampango, Ayubo; Abilio, Ana Paula] INS, Entomol Lab, Av Eduardo Mondlane Allende 1008,CP 246, Maputo, Mozambique.
RP Kampango, A (reprint author), INS, Entomol Lab, Av Eduardo Mondlane Allende 1008,CP 246, Maputo, Mozambique.
EM akampango@gmail.com
CR Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Cancrini G, 2003, VET PARASITOL, V118, P195, DOI 10.1016/j.vetpar.2003.10.011
   Christopher S.R., 1960, AEDES AEGYPTI L YELL
   CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107
   Depoortere E, 2006, EUROSURVEILLANCE, V11
   Girod R, 2004, PARASITE, V11, P74
   GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280
   Gubler DJ, 2003, LANCET INFECT DIS, V3, P751, DOI 10.1016/S1473-3099(03)00826-0
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gudo ES, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004146
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Higa Yukiko, 2015, Tropical Medicine and Health, V43, P107, DOI 10.2149/tmh.2014-29
   Huang Y.-M., 1979, Contributions of the American Entomological Institute, V15, P1
   HUANG Y-M, 1972, Contributions of the American Entomological Institute, V9, P1
   Huang YM, 2004, ZOOTAXA, P1
   Johnson BW, 2002, T ROY SOC TROP MED H, V96, P611, DOI 10.1016/S0035-9203(02)90326-3
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Jupp PG, 1993, J AM MOSQUITO CONTR, V8, P321
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Madon MB, 2002, J VECTOR ECOL, V27, P149
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   MATTINGLY P. F., 1958, ANN TROP MED AND PARASITOL, V52, P5
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   [Anonymous], 2005, CENTRAL AFRICA J MED
   Sylla M, 2004, PLOS NEGLECT TROP D, V3, pe408
   World Health Organisation, 2014, DENG FEV OUTBR MOZ T
   WORTH C. BROOKE, 1960, AN INST MED TROP, V17, P231
NR 31
TC 1
Z9 2
U1 8
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 9
PY 2016
VL 9
AR 76
DI 10.1186/s13071-016-1361-4
PG 4
WC Parasitology
SC Parasitology
GA DD6GN
UT WOS:000370022800001
PM 26856329
ER

PT J
AU Lucey, DR
AF Lucey, Daniel R.
TI Time for global action on Zika virus epidemic
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [Lucey, Daniel R.] Georgetown Univ, Med Ctr, Dept Med, Infect Dis, Washington, DC 20007 USA.
RP Lucey, DR (reprint author), Georgetown Univ, Med Ctr, Dept Med, Infect Dis, Washington, DC 20007 USA.
CR Centers for Disease Control and Prevention, ZIK VIR
   European Centre for Disease Prevention and Control, ZIK VIR INF
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Pan American Health Organization, ZIK VIR
   Public Health England, HLTH PROT GUID ZIK V
   Public Health England, ZIK VIR INF GUID PRI
NR 6
TC 2
Z9 3
U1 23
U2 23
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 8
PY 2016
VL 352
AR i781
DI 10.1136/bmj.i781
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE1IH
UT WOS:000370380000011
PM 26856896
ER

PT J
AU Samarasekera, U
   Triunfol, M
AF Samarasekera, Udani
   Triunfol, Marcia
TI Concern over Zika virus grips the world
SO LANCET
LA English
DT Editorial Material
NR 0
TC 16
Z9 19
U1 5
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD FEB 6
PY 2016
VL 387
IS 10018
BP 521
EP 524
DI 10.1016/S0140-6736(16)00257-9
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DD3PV
UT WOS:000369835800016
PM 26852261
ER

PT J
CA Eurosurveillance Editorial Team
TI Resources and latest news about Zika virus disease available from ECDC
SO EUROSURVEILLANCE
LA English
DT News Item
C1 [Eurosurveillance Editorial Team] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
CR European Centre for Disease Prevention and Control (ECDC), 2016, COMM DIS THREAT REP
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR INF
   European Centre for Disease Prevention and Control (ECDC), 2016, EP UPD OUTBR ZIK VIR
   World Health Organization (WHO), 2016, 1 M INT HLTH REG 200
NR 4
TC 0
Z9 0
U1 2
U2 21
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 4
PY 2016
VL 21
IS 5
BP 32
EP 32
AR 30128
DI 10.2807/1560-7917.ES.2016.21.5.30128
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DD6JA
UT WOS:000370029300005
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Zika virus was transmitted by sexual contact in Texas, health officials
   report
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
ID TRANSMISSION
CR Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Public Health England, 2016, EPIDEMIOLOGY    0204
NR 5
TC 16
Z9 18
U1 7
U2 48
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 4
PY 2016
VL 352
AR i720
DI 10.1136/bmj.i720
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DD4RU
UT WOS:000369911100014
PM 26848011
ER

PT J
AU Butler, D
AF Butler, Declan
TI ZIKA VIRUS Microcephaly surge in doubt
SO NATURE
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 74
U2 95
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD FEB 4
PY 2016
VL 530
IS 7588
BP 12
EP 13
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC6BK
UT WOS:000369304500005
ER

PT J
AU O'Dowd, A
AF O'Dowd, Adrian
TI UK is safe from Zika virus and is helping towards a vaccine, MPs hear
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
NR 1
TC 0
Z9 0
U1 6
U2 16
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 3
PY 2016
VL 352
AR i692
DI 10.1136/bmj.i692
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DD2QN
UT WOS:000369767400012
PM 26842604
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI Zika virus is a global public health emergency, declares WHO
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Gulland A., 2016, BMJ-BRIT MED J, V352, pi595, DOI DOI 10.1136/BMJ.I595
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi306, DOI DOI 10.1136/BMJ.I306
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Torjesen I, 2016, BMJ-BRIT MED J, V352, pi500
NR 6
TC 10
Z9 13
U1 3
U2 27
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 2
PY 2016
VL 352
AR i657
DI 10.1136/bmj.i657
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DD2QK
UT WOS:000369767100019
PM 26839247
ER

PT J
AU Kmietowicz, Z
AF Kmietowicz, Zosia
TI Questions your patients may have about Zika virus
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
CR Centers for Disease Control and Prevention (CDC), 2016, INT GUID PREGN WOM Z
   Gulland A, 2016, BMJ-BRIT MED J, V352, pi657
   Public Health England National Travel Health Network and Centre, 2016, ZIK VIR TRAV ADV PRE
   Royal College of Obstetricians and Gynaecologists, 2016, INT ALG ASS PREGN WO
   Travel Health Pro, 2016, ZIK VIR UPD ADV TRAV
NR 5
TC 0
Z9 0
U1 2
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD FEB 2
PY 2016
VL 352
AR i649
DI 10.1136/bmj.i649
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DD2QK
UT WOS:000369767100017
PM 26839177
ER

PT J
AU Brown, C
AF Brown, Carolyn
TI Zika virus outbreaks in Asia and South America
SO CANADIAN MEDICAL ASSOCIATION JOURNAL
LA English
DT News Item
NR 0
TC 3
Z9 3
U1 15
U2 41
PU CMA-CANADIAN MEDICAL ASSOC
PI OTTAWA
PA 1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA
SN 0820-3946
EI 1488-2329
J9 CAN MED ASSOC J
JI Can. Med. Assoc. J.
PD FEB 2
PY 2016
VL 188
IS 2
BP E34
EP E34
DI 10.1503/cmaj.109-5212
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DC6IX
UT WOS:000369324500006
PM 26696621
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI WHO Declares Zika Virus a Global Health Emergency
SO US PHARMACIST
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU JOBSON PUBLISHING LLC
PI NEW YORK
PA 100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678 USA
SN 0148-4818
EI 2331-3501
J9 US PHARM
JI US Pharm.
PD FEB
PY 2016
VL 41
IS 2
BP 8
EP 8
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DN0KF
UT WOS:000376752100005
ER

PT J
AU Higgs, S
AF Higgs, Stephen
TI Zika Virus: Emergence and Emergency
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Editorial Material
ID TRANSMISSION
C1 [Higgs, Stephen] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
   [Higgs, Stephen] Kansas State Univ, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.
   [Higgs, Stephen] Kansas State Univ, Biosecur, Manhattan, KS 66506 USA.
   [Higgs, Stephen] Amer Soc Trop Med & Hyg, Manhattan, KS USA.
RP Higgs, S (reprint author), Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.; Higgs, S (reprint author), Kansas State Univ, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.; Higgs, S (reprint author), Kansas State Univ, Biosecur, Manhattan, KS 66506 USA.; Higgs, S (reprint author), Amer Soc Trop Med & Hyg, Manhattan, KS USA.
EM shiggs@bri.ksu.edu
CR Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
NR 9
TC 5
Z9 5
U1 2
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD FEB
PY 2016
VL 16
IS 2
BP 75
EP 76
DI 10.1089/vbz.2016.29001.hig
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DK9QQ
UT WOS:000375266700001
PM 26824625
ER

PT J
AU Simkiss, D
AF Simkiss, D.
TI Zika Virus
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Editorial Material
C1 [Simkiss, D.] Univ Warwick, Coventry CV4 7AL, W Midlands, England.
RP Simkiss, D (reprint author), Univ Warwick, Coventry CV4 7AL, W Midlands, England.
CR Centers for Disease Control and Prevention, ZIK VIR
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization, ZIK VIR INF
NR 3
TC 0
Z9 0
U1 2
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD FEB
PY 2016
VL 62
IS 1
BP 1
EP 2
DI 10.1093/tropej/fmw006
PG 2
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA DJ5FH
UT WOS:000374231700001
PM 26895850
ER

PT J
AU Kelvin, AA
   Banner, D
   Pamplona, L
   Alencar, C
   Rubino, S
   Heukelbach, J
AF Kelvin, Alyson A.
   Banner, David
   Pamplona, Luciano
   Alencar, Carlos
   Rubino, Salvatore
   Heukelbach, Jorg
TI ZIKATracker: A mobile App for reporting cases of ZIKV worldwide
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Zika virus; Mobile App; Zika Tracker; Flavivirus; Chikungunya; Dengue
   virus; mosquito
ID VIRUS OUTBREAK; STATES
AB We have developed a mobile App called ZIKATracker (zikatracker.net) to voluntarily be used to report ZIKV cases on a public or private level. As the Zika virus (ZIKV) infection zones are rapidly expanding across South, Central, and North America, and reports have emerged linking ZIKV infection with developmental defects and neurological sequelae, reporting the movement and sequelae of ZIKV is essential. ZIKATracker is a multi-lingual App (English, French, Spanish, and Portuguese) freely available to anyone worldwide wishing to report a suspected or confirmed case of Zika virus and related symptoms. Knowledge gained from the use of this App will help direct the implementation of mosquito control measures in needed areas, bring aid to those affected by the Zika virus, and understand the movement and sequelae of ZIKV as it spreads through communities and across continents.
C1 [Kelvin, Alyson A.] IDR, Princess Margret Canc Res Tower,101 Coll St,9-314, Toronto, ON M5G 1L7, Canada.
   [Banner, David] Univ Hlth Network, Expt Therapeut, Toronto, ON, Canada.
   [Pamplona, Luciano; Alencar, Carlos; Heukelbach, Jorg] Univ Fed Ceara, Sch Med, Dept Community Hlth, Fortaleza, Ceara, Brazil.
   [Rubino, Salvatore] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.
   [Rubino, Salvatore] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.
   [Heukelbach, Jorg] James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld 4811, Australia.
   [Heukelbach, Jorg] James Cook Univ, Div Trop Hlth & Med, Coll Publ Hlth Med & Vet Sci, Townsville, Qld 4811, Australia.
RP Kelvin, AA (reprint author), IDR, Princess Margret Canc Res Tower,101 Coll St,9-314, Toronto, ON M5G 1L7, Canada.
EM akelvinphd@jidc.org
CR Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   [Anonymous], 2014, RAP RISK ASS ZIK VIR
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pan American Health Organization/World Health Organization, 2016, EP UPD NEUR SYND CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
NR 11
TC 2
Z9 2
U1 4
U2 4
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD FEB
PY 2016
VL 10
IS 2
BP 113
EP 115
DI 10.3855/jidc.8248
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DI4AV
UT WOS:000373443300001
PM 26927449
ER

PT J
AU Heukelbach, J
   Alencar, CH
   Kelvin, AA
   de Oliveira, WK
   Cavalcanti, LPD
AF Heukelbach, Jorg
   Alencar, Carlos Henrique
   Kelvin, Alyson Ann
   de Oliveira, Wanderson Kleber
   de Goes Cavalcanti, Luciano Pamplona
TI Zika virus outbreak in Brazil
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Zika virus; Flavivirus; Chikungunya; Dengue virus; Brazil; microcephaly
ID DENGUE VIRUSES; TRANSMISSION; CHIKUNGUNYA; INFECTION
AB Zika virus (ZIKV) infection is spreading rapidly within the Americas after originating from an outbreak in Brazil. We describe the current ZIKV infection epidemic in Brazil and the neurological symptoms arising. First cases of an acute exanthematic disease were reported in Brazil's Northeast region at the end of 2014. In March 2015, autochthonous ZIKV was determined to be the causative agent of the exanthematic disease. As cases of neurological syndromes in regions where ZIKV, dengue and/or Chikungunya viruses co-circulate were reported, ZIKV was also identified in the cerebrospinal fluid of patients with acute neurological syndromes and previous exanthematic disease. By the end of September 2015, an increasing number of infants with small head circumference or microcephaly were noted in Brazil's Northeast which was estimated to be 29 cases between August and October. ZIKV was identified in blood and tissue samples of a newborn and in mothers who had given birth to infants with microcephaly and ophthalmological anomalies. In 2015, there were an estimated 440,000-1,300,000 Zika cases in Brazil. There have been 4,783 suspected cases of microcephaly, most of them in the Northeast of Brazil associated with 76 deaths. The Ministry of Health is intensifying control measures against the mosquito Aedes aegypti and implemented intensive surveillance actions. Further studies are needed to confirm the suspected association between ZIKV infection and microcephaly; to identify antiviral, immunotherapy, or prophylactic vaccine; to introduce diagnostic ELISA testing. Clinical and epidemiological studies must be performed to describe viral dynamics and expansion of the outbreak.
C1 [Heukelbach, Jorg; Alencar, Carlos Henrique; de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Sch Med, Dept Community Hlth, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, CE, Brazil.
   [Heukelbach, Jorg] James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld 4811, Australia.
   [Heukelbach, Jorg] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld 4811, Australia.
   [Kelvin, Alyson Ann] IDR, Toronto, ON, Canada.
   [de Oliveira, Wanderson Kleber] Minist Saude Brasil, Coordenacao Geral Vigilancia & Resposta Emergenci, Brasilia, DF, Brazil.
RP Heukelbach, J (reprint author), Univ Fed Ceara, Sch Med, Dept Community Hlth, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, CE, Brazil.
EM heukelbach@web.de
RI Cavalcanti, Luciano/N-4391-2015
OI Cavalcanti, Luciano/0000-0002-3440-1182
CR Aracaju, 2015, SAUD AR ESCL BOAT EP
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V-M, 2014, EMERG INFEC DIS, V20, P2
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Caxias, 2015, SECR SAUD AD PROV SU
   CDC, 2016, UPD DIAGN TEST ZIK C
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ECDC European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude-Brasil, 2016, SAUD INV 3 670 CAS S
   Ministerio da Saude-Brasil, 2015, PROT AT SAUD RESP OC, V2015
   Ministerio da Saude-Brasil, 2015, MIN SAUD CONF REL EN
   Ministerio da Saude-Brasil, 2015, PROT VIG RESP OC MIC
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PAHO WHO, 2016, EP UPD NEUR SYNDR CO
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Schuler-Faccini L, 2016, MMWR MORB MORT WKLY, P65
   Secretaria Estadual de Saude de Pernambuco. Secretaria Executiva de Vigilancia em Saude, 2015, PROT CLIN EP INV CAS
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 11
Z9 13
U1 18
U2 22
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD FEB
PY 2016
VL 10
IS 2
BP 116
EP 120
DI 10.3855/jidc.8217
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA DI4AV
UT WOS:000373443300002
PM 26927450
ER

PT J
AU Sarno, M
   Sacramento, GA
   Khouri, R
   do Rosario, MS
   Costa, F
   Archanjo, G
   Santos, LA
   Nery, N
   Vasilakis, N
   Ko, AI
   de Almeida, ARP
AF Sarno, Manoel
   Sacramento, Gielson A.
   Khouri, Ricardo
   do Rosario, Mateus S.
   Costa, Federico
   Archanjo, Gracinda
   Santos, Luciane A.
   Nery, Nivison, Jr.
   Vasilakis, Nikos
   Ko, Albert I.
   de Almeida, Antonio R. P.
TI Zika Virus Infection and Stillbirths: A Case of Hydrops Fetalis,
   Hydranencephaly and Fetal Demise
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OUTBREAK; BRAZIL
AB Background
   The rapid spread of Zika virus in the Americas and current outbreak of microcephaly in Brazil has raised attention to the possible deleterious effects that the virus may have on fetuses.
   Methodology/Principal Findings
   We report a case of a 20-year-old pregnant woman who was referred to our service after a large Zika virus outbreak in the city of Salvador, Brazil with an ultrasound examination that showed intrauterine growth retardation of the fetus at the 18th gestational week. Ultrasound examinations in the 2nd and 3rd trimesters demonstrated severe microcephaly, hydranencephaly, intracranial calcifications and destructive lesions of posterior fossa, in addition to hydrothorax, ascites and subcutaneous edema. An induced labor was performed at the 32nd gestational week due to fetal demise and delivered a female fetus. ZIKV-specific real-time polymerase chain reaction amplification products were obtained from extracts of cerebral cortex, medulla oblongata and cerebrospinal and amniotic fluid, while extracts of heart, lung, liver, vitreous body of the eye and placenta did not yield detectable products.
   Conclusions/Significance
   This case report provides evidence that in addition to microcephaly, there may be a link between Zika virus infection and hydrops fetalis and fetal demise. Given the recent spread of the virus, systematic investigation of spontaneous abortions and stillbirths may be warranted to evaluate the risk that ZIKV infection imparts on these outcomes.
C1 [Sarno, Manoel; do Rosario, Mateus S.; Archanjo, Gracinda; de Almeida, Antonio R. P.] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Sarno, Manoel; Costa, Federico; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Sarno, Manoel; Costa, Federico; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Sacramento, Gielson A.; Khouri, Ricardo; Costa, Federico; Santos, Luciane A.; Nery, Nivison, Jr.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Ko, AI (reprint author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.; Ko, AI (reprint author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
EM albert.ko@yale.edu
RI Ko, Albert/P-2343-2015
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brazil Ministry of Health, 2016, 11 BRAZ MIN HLTH
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Paula Freitas B, 2016, JAMA-J AM MED ASSOC, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci A, 2016, ZIKA VIRUS AM YET AN
   Martines R, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6506E1ER
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J., 2016, N ENGL J MED
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 11
TC 36
Z9 37
U1 29
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2016
VL 10
IS 2
AR e0004517
DI 10.1371/journal.pntd.0004517
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DH1TH
UT WOS:000372567300081
PM 26914330
ER

PT J
AU Gatherer, D
   Kohl, A
AF Gatherer, Derek
   Kohl, Alain
TI Zika virus: a previously slow pandemic spreads rapidly through the
   Americas
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Review
ID FRENCH-POLYNESIA; FEBRUARY 2014; TRANSMISSION; INFECTION; OUTBREAK;
   BRAZIL; MICRONESIA; MOSQUITOS; EPIDEMIC; NIGERIA
AB Zika virus (family Flaviviridae) is an emerging arbovirus. Spread by Aedes mosquitoes, it was first discovered in Uganda in 1947, and later in humans elsewhere in sub-Saharan Africa, arriving in south-east Asia at latest by the mid-twentieth century. In the twenty-first century, it spread across the Pacific islands reaching South America around 2014. Since then it has spread rapidly northwards reaching Mexico in November 2015. Its clinical profile is that of a dengue-like febrile illness, but associations with Guillain-Barre syndrome and microcephaly have appeared recently. The final geographical range and ultimate clinical impact of Zika virus are still a matter for speculation.
C1 [Gatherer, Derek] Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster LA1 4YW, England.
   [Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
RP Gatherer, D (reprint author), Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster LA1 4YW, England.
EM d.gatherer@lancaster.ac.uk
FU UK Medical Research Council [MC_UU_12014/8, MR/N017552/1]
FX A. K. is funded is by the UK Medical Research Council (MC_UU_12014/8 and
   MR/N017552/1).
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ECDC, 2015, ZIK VIR EP AM POT AS
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pyke A.T., 2014, PLOS CURR, P6
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tognarelli J, 2015, ARCH VIROL
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 30
Z9 32
U1 27
U2 37
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD FEB
PY 2016
VL 97
BP 269
EP 273
DI 10.1099/jgv.0.000381
PN 2
PG 5
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA DG4ST
UT WOS:000372063600001
PM 26684466
ER

PT J
AU Derrien, E
AF Derrien, Elisa
TI Virology Cases of Zika virus in Guyana and Martinique
SO ACTUALITES PHARMACEUTIQUES
LA French
DT News Item
NR 0
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 0515-3700
J9 ACTUAL PHARMACEUT
JI Actual. Pharm.
PD FEB
PY 2016
VL 55
IS 553
BP 8
EP 8
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DD0QG
UT WOS:000369623900008
ER

PT J
AU Passi, GR
AF Passi, Gouri Rao
TI THE ZIKA VIRUS AND CONGENITAL MICROCEPHALY
SO INDIAN PEDIATRICS
LA English
DT News Item
EM gouripassi@hotmail.com
NR 0
TC 0
Z9 0
U1 6
U2 7
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-6061
EI 0974-7559
J9 INDIAN PEDIATR
JI Indian Pediatrics
PD FEB
PY 2016
VL 53
IS 2
BP 177
EP 177
PG 1
WC Pediatrics
SC Pediatrics
GA DF1LL
UT WOS:000371101200029
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Infectious Diseases Zika-Virus-Outbreak in Latin America Pregnant women
   should not travel in high Risk Areas!
SO PADIATRIE UND PADOLOGIE
LA German
DT Editorial Material
NR 0
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0030-9338
EI 1613-7558
J9 PADIATR PADOL
JI Padiatr. Padol.
PD FEB
PY 2016
VL 51
IS 1
BP 42
EP 42
DI 10.1007/s00608-016-0341-4
PG 1
WC Pediatrics
SC Pediatrics
GA DE8DG
UT WOS:000370865400015
ER

PT J
AU Cofre, F
AF Cofre, Fernanda
TI Zika virus intrauterine infection causes fetal brain abnormality and
   microcephaly: tip of the iceberg?
SO REVISTA CHILENA DE INFECTOLOGIA
LA Spanish
DT Editorial Material
C1 [Cofre, Fernanda] Hosp Roberto del Rio, CCIN, Santiago, Chile.
RP Cofre, F (reprint author), Hosp Roberto del Rio, CCIN, Santiago, Chile.
EM fcofre@yahoo.com
NR 0
TC 0
Z9 0
U1 10
U2 16
PU SOC CHILENA INFECTOLOGIA
PI PROVIDENCIA
PA BERNARDA MORIN 488, 2 PISO, PROVIDENCIA, SANTIAGO 00000, CHILE
SN 0716-1018
EI 0717-6341
J9 REV CHIL INFECTOL
JI Rev. Chil. Infectol.
PD FEB
PY 2016
VL 33
IS 1
BP 96
EP 96
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DE5NT
UT WOS:000370678400021
PM 26965888
ER

PT J
AU Ruiz-Moreno, D
AF Ruiz-Moreno, Diego
TI Assessing Chikungunya risk in a metropolitan area of Argentina through
   satellite images and mathematical models
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Chikungunya; Aedes albopictus; Argentina; Epidemiological modeling;
   Habitat availability; remote sensing
ID AEDES-ALBOPICTUS; TRANSFORMATION EQUATIONS; REUNION ISLAND;
   UNITED-STATES; VIRUS; EPIDEMIC; AEGYPTI; DENGUE; REEMERGENCE; MOSQUITO
AB Background: Chikungunya fever is a viral disease that recently invaded the American continent. In America, it is transmitted mainly by the mosquito Aedes aegypti, but Aedes albopictus is the main vector in other regions of the world. This work estimates the risk of disease emergence and the corresponding population at risk for the case of a naive population in the metropolitan area of Buenos Aires, the capital city of Argentina.
   Methods: A classic metapopulation epidemiological model, that considers human and mosquito populations, was extended in order to include different environmental signals. First, the vital rates of the mosquitoes were affected by local temperature. Second, habitat availability estimated from satellite images was used to determine the carrying capacity for local mosquito populations. Disease invasion was proposed to occur at different moments of the year. For each scenario, Monte Carlo simulations were used to estimate the risk of disease invasion and the population at risk.
   Results: The risk of a Chikungunya outbreak displays strong temporal (seasonal) patterns as well as spatial variability at the level of neighborhoods in the study area. According to the model, Summer and Fall display high risk for a Chikungunya invasion. The population at risk displays less variation over the year underlying the importance of preventive actions.
   Conclusions: The ability of mapping habitat quality for vector-borne diseases allows developing risk analysis at scales that are easily manageable for public health officers. For this location, the correlation of disease risk with the season of the year and the habitat availability could provide information to develop efficient control strategies. This also underlines the importance of involving the whole community when developing control measures for Chikungunya fever and other recently invading vector-borne diseases such as Zika fever.
C1 [Ruiz-Moreno, Diego] Univ Nacl Arturo Jauretche, Inst Ciencias Sociales & Adm, Grp Ecol Computac, Buenos Aires, DF, Argentina.
RP Ruiz-Moreno, D (reprint author), Univ Nacl Arturo Jauretche, Inst Ciencias Sociales & Adm, Grp Ecol Computac, Buenos Aires, DF, Argentina.
EM diego.ruizmoreno.phd@gmail.com
FU ISPRS WG VI/5; National Space Organization; National Applied Research
   Laboratories (NARLabs-NSPO); Chinese Taipei Society of Photogrammetry
   and Remote Sensing; Center for Space and Remote Sensing Research
   (CSRSR), National Central University (NCU) of Taiwan
FX Remote sensed images were obtained thanks to the "Research Announcement:
   Free FORMOSAT-2 Satellite Imagery" sponsored by ISPRS WG VI/5, the
   National Space Organization, National Applied Research Laboratories
   (NARLabs-NSPO) and jointly supported by the Chinese Taipei Society of
   Photogrammetry and Remote Sensing and the Center for Space and Remote
   Sensing Research (CSRSR), National Central University (NCU) of Taiwan.
   No other institutional support was provided. I would like to thank both
   reviewers for their insightful comments on the paper.
CR AbuBakar S, 2007, EMERG INFECT DIS, V13, P147
   Adams B, 2009, PLOS ONE, V4, pe6763
   Ahola T, 2015, VECTOR-BORNE ZOONOT, V15, P250, DOI 10.1089/vbz.2014.1681
   Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   Bacchiega JD, 2015, E P 36 IAHR WORLD C, P1
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Boucau S., 2013, EUROSURVEILLANCE, V19, P1
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Charrel RN, 2008, LANCET INFECT DIS, V8, P5, DOI 10.1016/S1473-3099(07)70296-7
   Chuang TW, 2011, J MED ENTOMOL, V48, P669, DOI 10.1603/ME10246
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   Fernandez Z, 2003, REV SAUDE PUBL, V37, P285, DOI 10.1590/S0034-89102003000300004
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018
   GILOTRA SK, 1967, AM J EPIDEMIOL, V86, P379
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   KEIRANS JE, 1968, MOSQ NEWS, V28, P338
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Kumar CVMN, 2010, ASIAN PAC J TROP MED, V3, P860, DOI 10.1016/S1995-7645(10)60207-6
   Kumar CVMN, 2010, INDIAN J VIROL, V21, P8, DOI 10.1007/s13337-010-0012-1
   Lal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031883
   Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x
   Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013
   Leparc-Goffart I, 2014, LANCET, V383, P3
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   Moore CG, 1997, EMERG INFECT DIS, V3, P329
   Moreno-Cid JA, 2010, VACCINE, V29, P77, DOI 10.1016/j.vaccine.2010.10.011
   [Anonymous], 2015, QGIS GEOGR INF SYST
   Paganin F, 2006, PRESSE MED, V35, P641, DOI 10.1016/S0755-4982(06)74657-7
   Pan American Health Organization, 2014, CHIKV SURV AM DET LA
   Perkins TA, 2015, PLOS CURR OUTBREAKS, V2015, P1
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rossi Gustavo C., 2003, Entomologia y Vectores, V10, P469
   Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918
   Sam IC, 2015, VECTOR-BORNE ZOONOT, V15, P223, DOI 10.1089/vbz.2014.1680
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P5
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580
   Zeng ZY, 2007, INT J REMOTE SENS, V28, P4125
   Zeng ZY, 2007, INT J REMOTE SENS, V28, P4095
NR 50
TC 0
Z9 0
U1 14
U2 27
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD FEB 1
PY 2016
VL 16
AR 49
DI 10.1186/s12879-016-1348-y
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA DC6WS
UT WOS:000369360900001
PM 26830024
ER

PT J
AU Wikan, N
   Suputtamongkol, Y
   Yoksan, S
   Smith, DR
   Auewarakul, P
AF Wikan, Nitwara
   Suputtamongkol, Yupin
   Yoksan, Sutee
   Smith, Duncan R.
   Auewarakul, Prasert
TI Immunological evidence of Zika virus transmission in Thailand
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Emerging infectious diseases; Serosurvey; Thailand; Zika virus
ID DENGUE VIRUS; INFECTION; AEDES; CHIKUNGUNYA; ANTIBODIES; ISOLATIONS;
   INDONESIA; EPIDEMIC; TRAVEL
AB Objective: To identify immunological evidence of Zika virus transmission in Thailand. Methods: To undertake a preliminary serosurvey of possible exposure to Zika virus, 21 serum samples from cohort of acute undifferentiated fever patients were examined for immunoreactivity to Zika, Dengue, Japanese encephalitis and Chikungunya envelope antigens by Western blot analysis. Results: Twenty of the 21 serum samples showed immunoreactivity to at least one of the antigens, with seven samples showing immunoreactivity to all antigens. Of particular note, two serum samples showed immunoreactivity only to Zika envelope antigen, with no immunoreactivity to other envelope antigens. Conclusions: This study presents the first evidence of Zika virus transmission in Thailand, although as yet the relationship between transmission and possible cases of Zika fever in Thailand requires further investigation.
C1 [Wikan, Nitwara; Yoksan, Sutee; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Bangkok 10700, Thailand.
   [Suputtamongkol, Yupin; Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand.
RP Smith, DR (reprint author), Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamonthol Sai 4, Nakhon Pathom 73170, Thailand.
EM duncan_r_smith@hotmail.com
RI Smith, Duncan /C-6891-2011
OI Smith, Duncan /0000-0002-6592-9852
FU Mahidol University; Thailand Research Fund [RTA5780009, IRG5780009];
   Mahidol University Post-Doctoral Fellowship
FX This work was supported by Mahidol University and the Thailand Research
   Fund (RTA5780009 and IRG5780009). NW is supported by a Mahidol
   University Post-Doctoral Fellowship.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830
   Khamim K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003396
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nitatpattana N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-183
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olsen SJ, 2010, INT J INFECT DIS, V14, pE888, DOI 10.1016/j.ijid.2010.03.022
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PONGPAIROJ S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P647
   Pulmanausahakuls R, 2011, INT J INFECT DIS, V15, P671, DOI [10.1016/j.ijid.2011.06.002, DOI 10.1016/J.IJID.2011.06.002]
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sithisarn P, 2003, J MED VIROL, V71, P532, DOI 10.1002/jmv.10520
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thipmontree W, 2014, INT J ENV RES PUB HE, V11, P8542, DOI 10.3390/ijerph110808542
   Thongtan T, 2010, MICROBES INFECT, V12, P37, DOI 10.1016/j.micinf.2009.09.013
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Wikan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031102
   Zammarchi I., 2015, J CLIN VIROL, V63, P32
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 32
TC 7
Z9 7
U1 12
U2 158
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD FEB
PY 2016
VL 9
IS 2
BP 136
EP 139
DI 10.1016/j.apjtm.2016.01.017
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DB4FQ
UT WOS:000368469300007
PM 26919943
ER

PT J
AU Hennessey, M
   Fischer, M
   Staples, JE
AF Hennessey, Morgan
   Fischer, Marc
   Staples, J. Erin
TI Zika Virus Spreads to New Areas - Region of the Americas, May
   2015-January 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID MICRONESIA
C1 [Hennessey, Morgan; Fischer, Marc; Staples, J. Erin] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Atlanta, GA 30333 USA.
RP Fischer, M (reprint author), CDC, Natl Ctr Emerging & Zoonot Infect Dis, Div Vector Borne Dis, Atlanta, GA 30333 USA.
EM mfischer@cdc.gov
CR CDC, 2015, CHIK VIR CLIN EV DIS
   CDC, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Nasci RS, 2016, CDC HLTH INFORM INT
   Pan American Health Organization, 2016, ZIK VIR INF
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   WHO, 2009, DENG GUID DIAGN TREA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 38
Z9 41
U1 3
U2 71
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JAN 29
PY 2016
VL 65
IS 3
BP 55
EP 58
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DC3KX
UT WOS:000369119300004
PM 26820163
ER

PT J
AU Schuler-Faccini, L
   Ribeiro, EM
   Feitosa, IML
   Horovitz, DDG
   Cavalcanti, DP
   Pessoa, A
   Doriqui, MJR
   Neri, JI
   Neto, JMD
   Wanderley, HYC
   Cernach, M
   El-Husny, AS
   Pone, MVS
   Serao, CLC
   Sanseverino, MTV
AF Schuler-Faccini, Lavinia
   Ribeiro, Erlane M.
   Feitosa, Ian M. L.
   Horovitz, Dafne D. G.
   Cavalcanti, Denise P.
   Pessoa, Andre
   Doriqui, Maria Juliana R.
   Neri, Joao Ivanildo
   de Pina Neto, Joao Monteiro
   Wanderley, Hector Y. C.
   Cernach, Mirlene
   El-Husny, Antonette S.
   Pone, Marcos V. S.
   Serao, Cassio L. C.
   Sanseverino, Maria Teresa V.
CA Brazilian Med Genet Soc Zika Embry
TI Possible Association Between Zika Virus Infection and Microcephaly -
   Brazil, 2015
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, BR-90046900 Porto Alegre, RS, Brazil.
   [Ribeiro, Erlane M.; Pessoa, Andre] Hosp Infantil Albert Sabin, Fortaleza, CE, Brazil.
   [Feitosa, Ian M. L.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Horovitz, Dafne D. G.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Cavalcanti, Denise P.] Univ Estadual Campinas, Sao Paulo, Brazil.
   [Doriqui, Maria Juliana R.] Hosp Infantil Juvencio Mattos, Maranhao, Brazil.
   [Neri, Joao Ivanildo] Univ Potiguar, Rio Grande Do Norte, Brazil.
   [de Pina Neto, Joao Monteiro] Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil.
   [Wanderley, Hector Y. C.] Secretaria Estado Saude Espirito Santo, Sao Paulo, Brazil.
   [Cernach, Mirlene] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [El-Husny, Antonette S.] Ctr Univ Estado Para, Belem, Para, Brazil.
   [Serao, Cassio L. C.] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
   [Sanseverino, Maria Teresa V.] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
RP Schuler-Faccini, L (reprint author), Univ Fed Rio Grande do Sul, BR-90046900 Porto Alegre, RS, Brazil.
EM lavinia.faccini@ufrgs.br
RI SCHULER-FACCINI, LAVINIA/K-2927-2016
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC, 2016, REC MAN REP ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   EUROCAT European Surveillance of Congenital Anomalies, 2015, PREV TABL
   Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159
   Hennessey M, 2016, MMWR MORB MORTAL WKL, V65
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Pan American Health Organization, 2015, EP AL INCR MICR NE B
   Pan American Health Organization (PAHO), 2015, NEUR SYNDR CONG MALF
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
NR 10
TC 132
Z9 148
U1 78
U2 229
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JAN 29
PY 2016
VL 65
IS 3
BP 59
EP 62
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DC3KX
UT WOS:000369119300005
PM 26820244
ER

PT J
AU Staples, JE
   Dziuban, EJ
   Fischer, M
   Cragan, JD
   Rasmussen, SA
   Cannon, MJ
   Frey, MT
   Renquist, CM
   Lanciotti, RS
   Munoz, JL
   Powers, AM
   Honein, MA
   Moore, CA
AF Staples, J. Erin
   Dziuban, Eric J.
   Fischer, Marc
   Cragan, Janet D.
   Rasmussen, Sonja A.
   Cannon, Michael J.
   Frey, Meghan T.
   Renquist, Christina M.
   Lanciotti, Robert S.
   Munoz, Jorge L.
   Powers, Ann M.
   Honein, Margaret A.
   Moore, Cynthia A.
TI Interim Guidelines for the Evaluation and Testing of Infants with
   Possible Congenital Zika Virus Infection - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID MICRONESIA
C1 [Staples, J. Erin; Fischer, Marc; Lanciotti, Robert S.; Munoz, Jorge L.; Powers, Ann M.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Dziuban, Eric J.] CDC, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Cragan, Janet D.; Cannon, Michael J.; Frey, Meghan T.; Renquist, Christina M.; Honein, Margaret A.; Moore, Cynthia A.] CDC, Div Birth Defects & Dev Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Moore, CA (reprint author), CDC, Div Birth Defects & Dev Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM ZikaMCH@cdc.gov
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   CDC, 2016, TRAV NOT
   CDC, 2016, ZIK VIR
   CDC, 2015, DEV DIS
   CDC, 2015, CHIK VIR SURV CONTR
   Dahle A J, 2000, J Am Acad Audiol, V11, P283
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Nasci RS, 2016, CDC HLTH INFORM INT, P94
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P1
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, 2006, WHO CHILD GROWTH STA
NR 18
TC 40
Z9 48
U1 7
U2 41
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JAN 29
PY 2016
VL 65
IS 3
BP 63
EP 67
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DC3KX
UT WOS:000369119300006
PM 26820387
ER

PT J
AU Sow, A
   Loucoubar, C
   Diallo, D
   Faye, O
   Ndiaye, Y
   Senghor, CS
   Dia, AT
   Faye, O
   Weaver, SC
   Diallo, M
   Malvy, D
   Sall, AA
AF Sow, Abdourahmane
   Loucoubar, Cheikh
   Diallo, Diawo
   Faye, Oumar
   Ndiaye, Youssoupha
   Senghor, Cheikh Saadibou
   Dia, Anta Tal
   Faye, Ousmane
   Weaver, Scott C.
   Diallo, Mawlouth
   Malvy, Denis
   Sall, Amadou Alpha
TI Concurrent malaria and arbovirus infections in Kedougou, southeastern
   Senegal
SO MALARIA JOURNAL
LA English
DT Article
DE Arbovirus; Malaria; Co-infection; Kedougou
ID ACUTE FEBRILE ILLNESSES; PLASMODIUM-FALCIPARUM; ANOPHELES-ARABIENSIS;
   FRENCH-GUIANA; DENGUE VIRUS; FEVER; TRANSMISSION; COINFECTION; DISTRICT;
   CHILDREN
AB Background: Malaria is one of the leading causes of acute febrile illness (AFI) in Africa. With the advent of malaria rapid diagnostic tests, misdiagnosis and co-morbidity with other diseases has been highlighted by an increasing number of studies. Although arboviral infections and malaria are both vector-borne diseases and often have an overlapping geographic distribution in sub-Saharan Africa, information about their incidence rates and concurrent infections is scarce.
   Methods: From July 2009 to March 2013 patients from seven healthcare facilities of the Kedougou region presenting with AFI were enrolled and tested for malaria and arboviral infections, i.e., yellow fever (YFV), West Nile (WNV), dengue (DENV), chikungunya (CHIKV), Crimean Congo haemorrhagic fever (CCHFV), Zika (ZIKV), and Rift Valley fever viruses (RVFV). Malaria parasite infections were investigated using thick blood smear (TBS) and rapid diagnostics tests (RDT) while arbovirus infections were tested by IgM antibody detection (ELISA) and RT-PCR assays. Data analysis of single or concurrent malaria and arbovirus was performed using R software.
   Results: A total of 13,845 patients, including 7387 with malaria and 41 with acute arbovirus infections (12 YFV, nine ZIKV, 16 CHIKV, three DENV, and one RVFV) were enrolled. Among the arbovirus-infected patients, 48.7 % (20/41) were co-infected with malaria parasites at the following frequencies: CHIKV 18.7 % (3/16), YFV 58.3 % (7/12), ZIKV 88.9 % (8/9), DENV 33.3 % (1/3), and RVF 100 % (1/1). Fever >= 40 degrees C was the only sign or symptom significantly associated with dual malaria parasite/arbovirus infection.
   Conclusions: Concurrent malaria parasite and arbovirus infections were detected in the Kedougou region from 2009 to 2013 and need to be further documented, including among asymptomatic individuals, to assess its epidemiological and clinical impact.
C1 [Sow, Abdourahmane; Loucoubar, Cheikh; Faye, Oumar; Faye, Ousmane; Sall, Amadou Alpha] Inst Pasteur, Arbovirus & Viral Hemorrhag Fevers Unit, 36 Ave Pasteur,BP 220, Dakar, Senegal.
   [Diallo, Diawo; Diallo, Mawlouth] Inst Pasteur, Med Entomol Unit, 36 Ave Pasteur,BP 220, Dakar, Senegal.
   [Ndiaye, Youssoupha] Saraya Hlth Dist, Saraya, Senegal.
   [Senghor, Cheikh Saadibou] Kedougou Hlth Dist, Kedougou, Senegal.
   [Sow, Abdourahmane; Dia, Anta Tal] Univ Cheikh Anta Diop, ISED, Dakar, Senegal.
   [Weaver, Scott C.] Univ Texas Med Branch, Ctr Trop Dis, Inst Human Infect & Immun, Dept Pathol, Galveston, TX 77555 USA.
   [Sow, Abdourahmane; Malvy, Denis] Univ Bordeaux, ISPED, Ctr Rech, INSERM,Epidemiol Biostat U897, Bordeaux, France.
RP Sall, AA (reprint author), Inst Pasteur, Arbovirus & Viral Hemorrhag Fevers Unit, 36 Ave Pasteur,BP 220, Dakar, Senegal.
EM asall@pasteur.sn
RI Weaver, Scott/D-6490-2011
FU National Institutes of Health (NIH) [AI1069145]
FX The authors thank the population, healthcare workers and medical
   authorities in Kedougou region for their support and cooperation in
   conducting this study, and Linsey Yeager for editorial assistance. The
   research was supported by the National Institutes of Health (NIH) Grant
   Number AI1069145.
CR Abbasi A, 2009, JCPSP-J COLL PHYSICI, V19, P25, DOI 01.2009/JCPSP.2529
   Agence nationale de la demographie et de la Statistique (Service regional de Kedougou), 2012, RAPP ANN
   Ali Nadir, 2006, J Coll Physicians Surg Pak, V16, P340
   Arya CS, 2005, DENGUE B, V29, P208
   Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Carme B, 2009, EMERG INFECT DIS, V15, P668, DOI 10.3201/eid1504.080891
   Charrel RN, 2005, EMERG INFECT DIS, V11, P1153
   Deresinski S, 1802, EMERG INFECT DIS, V2006, P12
   Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Epelboin L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-142
   [Anonymous], 1983, 41 FAO
   Le Port A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-193
   Mohapatra MK, 2012, J VECTOR DIS, V49, P262
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Mourembou G, 2015, AM J TROP MED HYG, V92, P926, DOI 10.4269/ajtmh.14-0699
   Mushtaq MB, 2013, CASE REP MED, V2013, DOI 10.1155/2013/520181
   Mwangangi JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-114
   Nabeth P, 2004, EMERG INFECT DIS, V10, P2143
   Niang M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0808-y
   [Anonymous], 2009, RAPP ANN
   R Development Core Team, 2008, R LANG ENV STAT COMP
   ROBIN Y, 1980, ANN INST PASTEUR VIR, V131, P149, DOI 10.1016/0769-2617(80)90029-5
   SALUZZO JF, 1989, RES VIROLOGY, V140, P155, DOI 10.1016/S0923-2516(89)80093-7
   Vdos Santana S, 2010, REV SOC BRAS MED TRO, V43, P508
   Senn N, 2011, AM J TROP MED HYG, V85, P132, DOI 10.4269/ajtmh.2011.10-0482
   [Anonymous], 2007, STAT STAT SOFTW REL
   Thangaratham PS, 2006, JPN J INFECT DIS, V59, P211
   Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419
   Traore LM, 1996, J MED ENTOMOL, V33, P760
   Ward DI, 2006, AM J TROP MED HYG, V75, P182
   Weidmann M, 2010, J CLIN VIROL, V48, P187, DOI 10.1016/j.jcv.2010.04.013
   WHO, 2010, WHO GUID TREATM MAL, P210
   WHO, WHO WORD MAL REP 201
   Wu SJ, 2008, AM J TROP MED HYG, V79, P505
   [Anonymous], 2004, ORG MOND SANT UTILIS, P19
NR 36
TC 4
Z9 4
U1 12
U2 29
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD JAN 28
PY 2016
VL 15
AR 47
DI 10.1186/s12936-016-1100-5
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DB8LA
UT WOS:000368767000004
PM 26821709
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI Sixty seconds on . . . Zika virus
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Torjesen I, 2016, BMJ-BRIT MED J, V352, pi500
NR 1
TC 2
Z9 2
U1 25
U2 25
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JAN 26
PY 2016
VL 352
AR i467
DI 10.1136/bmj.i467
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DC6EQ
UT WOS:000369313000011
PM 26812929
ER

PT J
AU Torjesen, I
AF Torjesen, Ingrid
TI Zika virus outbreaks prompt warnings to pregnant women
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
OI Khan, Yawar/0000-0003-1964-591X
CR Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   O'Dowd A, 2016, BMJ-BRIT MED J, V352, pi455
NR 2
TC 0
Z9 0
U1 2
U2 39
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JAN 26
PY 2016
VL 352
AR i500
DI 10.1136/bmj.i500
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DC6EQ
UT WOS:000369313000013
PM 26813766
ER

PT J
AU Bogoch, II
   Brady, OJ
   Kraemer, MUG
   German, M
   Creatore, MI
   Kulkarni, MA
   Brownstein, JS
   Mekaru, SR
   Hay, SI
   Groot, E
   Watts, A
   Khan, K
AF Bogoch, Isaac I.
   Brady, Oliver J.
   Kraemer, Moritz U. G.
   German, Matthew
   Creatore, Marisa I.
   Kulkarni, Manisha A.
   Brownstein, John S.
   Mekaru, Sumiko R.
   Hay, Simon I.
   Groot, Emily
   Watts, Alexander
   Khan, Kamran
TI Anticipating the international spread of Zika virus from Brazil
SO LANCET
LA English
DT Letter
C1 [Bogoch, Isaac I.; Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada.
   [Creatore, Marisa I.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England.
   [German, Matthew; Creatore, Marisa I.; Watts, Alexander; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada.
   [Kulkarni, Manisha A.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.
   [Brownstein, John S.; Mekaru, Sumiko R.] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA USA.
   [Brady, Oliver J.; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Hay, Simon I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
RP Khan, K (reprint author), Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
EM khank@smh.ca
RI Hay, Simon/F-8967-2015; 
OI Hay, Simon/0000-0002-0611-7272; Brady, Oliver/0000-0002-3235-2129
CR Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 5
TC 49
Z9 54
U1 16
U2 207
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 23
PY 2016
VL 387
IS 10016
BP 335
EP 336
DI 10.1016/S0140-6736(16)00080-5
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DB4XI
UT WOS:000368516500019
PM 26777915
ER

PT J
AU Petersen, EE
   Staples, JE
   Meaney-Delman, D
   Fischer, M
   Ellington, SR
   Callaghan, WM
   Jamieson, DJ
AF Petersen, Emily E.
   Staples, J. Erin
   Meaney-Delman, Dana
   Fischer, Marc
   Ellington, Sascha R.
   Callaghan, William M.
   Jamieson, Denise J.
TI Interim Guidelines for Pregnant Women During a Zika Virus Outbreak -
   United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
C1 [Petersen, Emily E.; Ellington, Sascha R.; Callaghan, William M.; Jamieson, Denise J.] CDC, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA 30333 USA.
   [Staples, J. Erin; Fischer, Marc] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Arboviral Dis Branch, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Off Director, Atlanta, GA 30333 USA.
RP Jamieson, DJ (reprint author), CDC, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA 30333 USA.
EM djj0@cdc.gov
CR Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636
   American Academy of Pediatrics The American College of Obstetricians and Gynecologists, 2012, GUID PER CAR
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   CDC, 2015, CHIK VIR CLIN EV DIS
   CDC, 2015, ZIK VIR HLTH CAR PRO
   CDC, 2015, ZIK VIR PREV
   CDC, 2016, CDC HLTH ADV REC MAN
   CDC, 2015, WEST NIL VIR INS REP
   CDC, 2016, ZIK VIR
   CDC, 2016, TRAV HLTH CDC ISS IN
   CDC, 2013, TRAV HLTH AV BUG BIT
   CDC, 2015, TRAV HLTH PROT MOS T
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Rasmussen SA, 2011, AM J OBSTET GYNECOL, V204, pS13, DOI 10.1016/j.ajog.2011.01.048
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   WHO, 2009, DENG GUID DIAGN TREA
NR 21
TC 69
Z9 76
U1 14
U2 41
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JAN 22
PY 2016
VL 65
IS 2
BP 30
EP 33
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DF4TS
UT WOS:000371344400004
PM 26796813
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika virus prompts travel alert
SO SCIENCE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 4
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JAN 22
PY 2016
VL 351
IS 6271
BP 321
EP 321
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DB3VH
UT WOS:000368440500005
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI Jamaica advises women to avoid pregnancy as Zika virus approaches
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi306, DOI DOI 10.1136/BMJ.I306
NR 2
TC 0
Z9 1
U1 6
U2 17
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JAN 21
PY 2016
VL 352
AR i383
DI 10.1136/bmj.i383
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DC4ZU
UT WOS:000369230300009
PM 26796917
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Zika virus outbreak prompts US to issue travel alert to pregnant women
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
NR 2
TC 0
Z9 1
U1 2
U2 20
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JAN 18
PY 2016
VL 352
AR i306
DI 10.1136/bmj.i306
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DC4ZM
UT WOS:000369229500011
PM 26783242
ER

PT J
AU Enfissi, A
   Codrington, J
   Roosblad, J
   Kazanji, M
   Rousset, D
AF Enfissi, Antoine
   Codrington, John
   Roosblad, Jimmy
   Kazanji, Mirdad
   Rousset, Dominique
TI Zika virus genome from the Americas
SO LANCET
LA English
DT Letter
C1 [Enfissi, Antoine; Kazanji, Mirdad; Rousset, Dominique] Inst Pasteur, Lab Virol, Cayenne, French Guiana.
   [Codrington, John; Roosblad, Jimmy] Lab Acad Ziekenhuis, Paramaribo, Surinam.
RP Rousset, D (reprint author), Inst Pasteur, Lab Virol, Cayenne, French Guiana.
EM drousset@pasteur-cayenne.fr
CR Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   ECDC, ZIK VIR EP AM POT AS
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oehler E, 2014, EURO SURVEILL, P19
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 6
TC 45
Z9 52
U1 13
U2 146
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 16
PY 2016
VL 387
IS 10015
BP 227
EP 228
DI 10.1016/S0140-6736(16)00003-9
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DA9LQ
UT WOS:000368130700027
PM 26775124
ER

PT J
AU Ventura, CV
   Maia, M
   Bravo-Filho, V
   Gois, AL
   Belfort, R
AF Ventura, Camila V.
   Maia, Mauricio
   Bravo-Filho, Vasco
   Gois, Adriana L.
   Belfort, Rubens, Jr.
TI Zika virus in Brazil and macular atrophy in a child with microcephaly
SO LANCET
LA English
DT Letter
C1 [Ventura, Camila V.; Bravo-Filho, Vasco; Gois, Adriana L.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Bravo-Filho, Vasco; Gois, Adriana L.] HOPE Eye Hosp, Recife, PE, Brazil.
RP Belfort, R (reprint author), Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
EM clinbelf@uol.com.br
CR Brazil Ministry of Health, MIN SAUD CONF REL EN
   Brazil Ministry of Health, MICR MIN HLTH REL EP
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
   World Health Organization, EP AL NEUR SYNDR CON
NR 5
TC 78
Z9 83
U1 22
U2 159
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 16
PY 2016
VL 387
IS 10015
BP 228
EP 228
DI 10.1016/S0140-6736(16)00006-4
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DA9LQ
UT WOS:000368130700028
PM 26775125
ER

PT J
AU Korhonen, EM
   Huhtamo, E
   Smura, T
   Kallio-Kokko, H
   Raassina, M
   Vapalahti, O
AF Korhonen, E. M.
   Huhtamo, E.
   Smura, T.
   Kallio-Kokko, H.
   Raassina, M.
   Vapalahti, O.
TI Zika virus infection in a traveller returning from the Maldives, June
   2015
SO EUROSURVEILLANCE
LA English
DT Article
ID TRANSMISSION; INDONESIA; MICRONESIA; OUTBREAK; DENGUE; URINE
AB We report a Zika virus (ZIKV) infection in a patient with fever and rash after returning to Finland from Maldives, June 2015. The patient had dengue virus (DENV) IgG and IgM antibodies but pan-flavivirus RT-PCR and subsequent sequencing showed presence of ZIKV RNA in urine. Recent association of ZIKV with microcephaly highlights the need for laboratory differentiation of ZIKV from DENV infection and the circulation of ZIKV in areas outside its currently known distribution range.
C1 [Korhonen, E. M.; Huhtamo, E.; Smura, T.; Kallio-Kokko, H.; Vapalahti, O.] Univ Helsinki, Dept Virol, Medicum, Fac Med, Helsinki, Finland.
   [Kallio-Kokko, H.; Vapalahti, O.] Helsinki Univ Cent Hosp Lab HUSLAB, Dept Virol & Immunol, Helsinki, Finland.
   [Raassina, M.] Honkaharju Hosp, South Karelia Social & Hlth Care Dist, Imatra, Finland.
   [Vapalahti, O.] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.
RP Korhonen, EM (reprint author), Univ Helsinki, Dept Virol, Medicum, Fac Med, Helsinki, Finland.
EM essi.m.korhonen@helsinki.fi
RI Smura, Teemu/C-4063-2016
FU Helsinki University Hospital Funds [TYH 2014251]; Academy of Finland;
   Sigrid Juselius Foundation
FX Authors thank Minna Ulmanen and Kirsti Raiha for technical assistance.
   We acknowledge CSC - IT Center for Science Ltd. (Espoo, Finland) for the
   allocation of computational resources. We thank Helsinki University
   Hospital Funds (TYH 2014251), Academy of Finland and Sigrid Juselius
   Foundation for financial support.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, ZIK VIR EP AM POT AS
   Erra EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065900
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Duvignaud A, 2016, ZIKA VIRUS AM 01 FRA
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Moureau G, 2010, VECTOR-BORNE ZOONOT, V10, P195, DOI 10.1089/vbz.2008.0216
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Shinohara K., 2014, ZIKA VIRUS JAPAN EX
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2015, ARCH VIROL
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P609
NR 33
TC 12
Z9 12
U1 5
U2 62
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 14
PY 2016
VL 21
IS 2
BP 2
EP 5
DI 10.2807/1560-7917.ES.2016.21.2.30107
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DB4UN
UT WOS:000368509200001
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI First US case of Zika virus infection is identified in Texas
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
NR 1
TC 18
Z9 18
U1 2
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JAN 13
PY 2016
VL 352
AR i212
DI 10.1136/bmj.i212
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DB2YL
UT WOS:000368376500014
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika virus: a new global threat for 2016
SO LANCET
LA English
DT Editorial Material
NR 0
TC 5
Z9 5
U1 5
U2 32
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JAN 9
PY 2016
VL 387
IS 10014
BP 96
EP 96
DI 10.1016/S0140-6736(16)00006-4
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DA8LF
UT WOS:000368055500004
ER

PT J
AU Thiagarajan, P
AF Thiagarajan, Prakash
TI Zika Virus in pregnancy and infancy - What do the paediatricians need to
   know?
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Meeting Abstract
C1 [Thiagarajan, Prakash] Nobles Isle Man Hosp, Div Womens & Childrens Hlth, Neonatal Unit, Douglas, Man, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PY 2016
VL 38
SU 1
MA 340
BP S64
EP S64
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DW6CC
UT WOS:000383733000241
ER

PT J
AU Squires, RC
   Konings, F
AF Squires, Raynal C.
   Konings, Frank
CA WHO Regional Off Western Pacific
   Zika Incident Management Team
TI Preparedness for Zika virus testing in the World Health Organization
   Western Pacific Region
SO WESTERN PACIFIC SURVEILLANCE AND RESPONSE
LA English
DT Article
AB On 1 February 2016, the World Health Organization (WHO) declared that clusters of microcephaly cases and other neurological disorders occurring in Zika virus (ZIKV)-affected areas constituted a public health emergency of international concern. Increased surveillance of the virus, including the requirement for laboratory confirmation of infection, was recommended. The WHO Regional Office for the Western Pacific therefore initiated a rapid survey among national-level public health laboratories in 19 countries and areas to determine regional capacity for ZIKV detection. The survey indicated that 16/19 (84%) countries had capacity for molecular detection of ZIKV while others facilitated testing through referral. These results suggest that robust laboratory capacity is in place to support ZIKV surveillance in the Western Pacific Region.
C1 [Squires, Raynal C.; Konings, Frank] WHO Reg Off Western Pacific, Emerging Dis Surveillance & Response Unit, Div Hlth Secur & Emergencies, Manila, Philippines.
RP Konings, F (reprint author), WHO Reg Off Western Pacific, Emerging Dis Surveillance & Response Unit, Div Hlth Secur & Emergencies, Manila, Philippines.
EM koningsf@wpro.who.int
CR Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   [Anonymous], 2015, COUNTR TERR CHIK CAS
   [Anonymous], 2016, MEM REV DIAGN TEST Z
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675
   Mallet H-P, 2014, B VEILLE SANITAIRE, V2, P9
   Pok KY, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/WPSAR.2015.6.1.017, 10.5365/wpsar.2015.6.1.017]
   Soh LT, 2016, W PACIFIC SURVEILLAN
   Squires Raynal C, 2014, Western Pac Surveill Response J, V5, P40, DOI 10.5365/WPSAR.2014.5.3.001
   [Anonymous], 2016, LAB TEST ZIK VIR INF
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   [Anonymous], 2016, WHO W PAC REG COUNTR
   [Anonymous], 2016, ZIK VIR ZIKV SURV AM
   World Health Organization Regional Office for the Americas, 2014, EP AL
NR 14
TC 0
Z9 0
U1 0
U2 0
PU WORLD HEALTH ORGANIZATION, REGIONAL OFFICE WESTERN PACIFIC
PI MANILA
PA PO BOX 2932, MANILA, 1000, PHILIPPINES
SN 2094-7321
EI 2094-7313
J9 WEST PAC SURVEILL RE
JI West. Pa. Surveill. Response
PD JAN-MAR
PY 2016
VL 7
IS 1
BP 44
EP 47
DI 10.5365/wpsar.2016.7.1.007
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DV9KN
UT WOS:000383259400011
ER

PT J
AU Silveira, ELV
AF Silveira, Eduardo L. V.
TI The importance of B cells in the development of preventive and
   therapeutical approaches against Dengue, Zika and Chikungunya viral
   infections
SO BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Editorial Material
ID YELLOW-FEVER 17D; VIRUS-INFECTION; PLASMABLAST RESPONSES;
   MONOCLONAL-ANTIBODIES; VACCINE; HUMANS; TRANSMISSION; CHILDREN; ANTIGEN;
   VECTOR
C1 [Silveira, Eduardo L. V.] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
RP Silveira, ELV (reprint author), Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
CR Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411
   Clapham HE, 2016, J INFECT DIS, V213, P1428, DOI 10.1093/infdis/jiv759
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DUDLEY D., 2016, BIORXIV
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   LAZEAR H.M., 2016, J VIROL IN PRESS
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nogueira RT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-127
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Silveira ELV, 2015, J IMMUNOL METHODS, V416, P69, DOI 10.1016/j.jim.2014.11.003
   SILVEIRA E.L.V., 2015, SM VACCINE VACCIN, V1, P1001
   Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009
   Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 34
TC 0
Z9 0
U1 1
U2 1
PU UNIV SAO PAULO, CONJUNTO QUIMICAS
PI SAO PAULO
PA SERVICO PUBLICACOES E CIRCULACAO, CAIXA POSTAL 66083, SAO PAULO, 00000,
   BRAZIL
SN 1984-8250
EI 2175-9790
J9 BRAZ J PHARM SCI
JI Braz. J. Pharm. Sci.
PD JAN-MAR
PY 2016
VL 52
IS 1
BP V
EP VIII
DI 10.1590/S1984-82502016000100001
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DV8CE
UT WOS:000383164300001
ER

PT J
AU Cipriano, R
   Monteiro, CC
AF Cipriano, Rosangela
   Monteiro, Carolina Cipriano
TI A report about Zika virus in Brazil
SO REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO
LA English
DT Article
DE Zika Virus
AB Zika virus, a Flavivirus first isolated in Africa, has spread to many countries worldwide including Brazil. In this country, seven months after the World Football Cup, the occurrence of an epidemic was recorded, subsequently associated to cases of microcephaly and Guillain-Barre syndrome. The virus is transmitted by mosquitoes of the Aedes genus, often following a bite from an infected vector. The febrile disease is self-limited and there is no specific treatment. Few months after this outbreak in Brazil, the authorities acknowledged the association between the Zika virus and the occurrence of Guillain-Barre syndrome and microcephaly in newborns, corresponding to fetal cerebral malformation or brain lesions. This finding is a worldwide alert for the strengthening of preventive measures, restricted to preventing insect bites and caring for the environment.
C1 [Cipriano, Rosangela] Univ Fed Maranhao, Maranhao, Brazil.
   [Monteiro, Carolina Cipriano] Univ Estado Rio De Janeiro, Rio De Janeiro, RJ, Brazil.
RP Cipriano, R (reprint author), Univ Fed Maranhao, Maranhao, Brazil.
EM rosacipriano91@gmail.com
CR Ana-Belen Blazquez, 2014, FRONTIERS MICROBIOLO, DOI 10.3389/fmlcb.2014.00266
   Barontti C., 2013, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00500-14, DOI 10.1128/GENOMEA.00500-14]
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Buathong R, 2014, DETECTION ZIKA VIRUS, P2012, DOI 10.4269/ajtmh.15-0022
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Foy BD, EMERG INFECT DIS, V17, P880
   Ministerio da Saude (BR). Portal Brasil, 2015, MIN SAUD PUBL
   Ministerio da Saude (BR), DENG CHIK ZIK EX LAB
   Ministerio da Saude (BR), 2015, PROT VIG RESP OC MIC
   Ministerio da Saude (BR), INF EP 08 SEM EP SE
   Ministerio da Saude (BR), 2015, MIN SAUD B EP, V46
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622
   Nasci Roger S., 2016, YELLOW BOOK HLTH INF
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sullivan Nicolaides Pathology, 2016, ARB REP WEEK 2 END 9
   SVS/MS. NOTA A IMPRENSA, 2015, NOTA IMPRENSA CONF Z
NR 19
TC 0
Z9 0
U1 2
U2 2
PU UNIV SANTA CRUZ DO SUL
PI SANTA CRUZ DO SUL
PA AV INDEPENDENCIA, 2293, BAIRRO UNIVERSITARIO, SANTA CRUZ DO SUL,
   96815-900, BRAZIL
SN 2238-3360
J9 REV EPIDEMIOL CONTRO
JI Rev. Epidemiol. Control. Infecc.
PY 2016
VL 6
IS 1
BP 37
EP 40
DI 10.17058/reci.v6i1.6959
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DV3SP
UT WOS:000382844000008
ER

PT J
AU Ganczak, M
   Brodowska, A
AF Ganczak, Maria
   Brodowska, Agnieszka
TI Zika virus intrauterine infections from the obstetrician's perspective
SO GINEKOLOGIA POLSKA
LA English
DT Review
DE diagnosis; pregnancy; infection; prevention; clinical manifestation;
   Zika virus
AB Zika virus (ZIKAV) infections could potentially occur in Poland due to international travel made by its nationals to regions where the Aedes mosquito is active. A causal relationship between prenatal ZIKAV infection and microcephaly and other serious brain anomalies has been found due to the time association between the infection in pregnancy and a presence of congenital nervous system malformations, together with the detectable pathogen in amniotic fluid and fetus's tissues. Two ZIKAV infection cases of pregnant women who were diagnosed with fetal microcephaly in the state of Paraiba, Brazil, later described in Ultrasound Obstetrics and Gynecology by Oliveira Mello et al. are discussed, in the context of the possible introduction of ZIKAV into Poland and the role the obstetrician should play in the detection and rapid reaction to potential threats. According to recommendations of international agencies for disease control and prevention, Polish obstetricians who take care of pregnant women and of those planning to become pregnant in the nearest future, and declaring travels to areas of the Aedes mosquito activity, should advise their patients to consider postponing travel or if they must travel, to take necessary precautionary measures to avoid mosquito bites. Pregnant women who have travelled to areas with ZIKAV transmission, or whose male partners had travelled to such areas and returned in the period of their female partner's pregnancy, should be monitored appropriately in the context of congenital abnormalities, including microcephaly.
C1 [Ganczak, Maria] Pomeranian Med Univ, Dept Epidemiol & Management, Zolnierska St 48, PL-71210 Szczecin, Poland.
   [Brodowska, Agnieszka] Pomeranian Med Univ, Dept Gynecol & Urogynecol, Szczecin, Poland.
RP Ganczak, M (reprint author), Pomeranian Med Univ, Dept Epidemiol & Management, Zolnierska St 48, PL-71210 Szczecin, Poland.
EM mganczak@pum.edu.pl
CR Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
NR 1
TC 0
Z9 0
U1 1
U2 1
PU VIA MEDICA
PI GDANSK
PA UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND
SN 0017-0011
J9 GINEKOL POL
JI Ginekol. Pol.
PY 2016
VL 87
IS 7
BP 538
EP 539
DI 10.5603/GP.2016.0040
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DU3MX
UT WOS:000382116600012
PM 27504949
ER

PT J
AU Ramharack, P
   Soliman, MES
AF Ramharack, Pritika
   Soliman, Mahmoud E. S.
TI Zika virus drug targets: a missing link in drug design and discovery - a
   route map to fill the gap
SO RSC ADVANCES
LA English
DT Review
ID REPLICATION; INHIBITORS; OUTBREAK; IDENTIFICATION; PRINCIPLES; BINDING
AB Zika virus is an emerging virus that has been defined by the World Health Organization as a serious global biological-threat. Zika virus is an arbovirus from the flavivirus genus that is linked to microcephaly after prenatal transmission from the infected mother and most recently Guillain-Barre Syndrome. The need for innovative research methods is urgent due to the ambiguity surrounding Zika virus. The lack of experimental data regarding potential drug targets, strategies for design and drug resistance has prompted us to provide a comprehensive framework with structured theoretical and technical guidelines on potential drug targets, modeling and design of inhibitors against the virus, thus assisting and encouraging scientists from different research domains to fill the gap in this research area. We have also presented a 3D homology model of the ideal Zika viral target, the non-structural protein 5, identified the active binding sites of each domain of the protein and found potential compounds that may act as inhibitors. This report will be immensely beneficial toward the design of Zika virus drug inhibitors.
C1 [Ramharack, Pritika; Soliman, Mahmoud E. S.] Univ KwaZulu Natal, Sch Hlth Sci, Mol Modeling & Drug Design Res Grp, Westville Campus, ZA-4001 Durban, South Africa.
RP Soliman, MES (reprint author), Univ KwaZulu Natal, Sch Hlth Sci, Mol Modeling & Drug Design Res Grp, Westville Campus, ZA-4001 Durban, South Africa.
EM soliman@ukzn.ac.za
FU College of Health Sciences, UKZN; National Research Foundation
FX The authors acknowledge the College of Health Sciences, UKZN, and the
   National Research Foundation for their financial support.
CR Agnihotri Shefali, 2012, Bioinformation, V8, P123
   Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002
   Bamborough P, 1996, CURR OPIN STRUC BIOL, V6, P236, DOI 10.1016/S0959-440X(96)80081-9
   Barba-Spaeth G., 2016, NATURE, P1
   Basarab M., 2016, BMJ-BRIT MED J, V1049, pi1049
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bhakat S, 2014, EUR J MED CHEM, V87, P677, DOI 10.1016/j.ejmech.2014.10.010
   Calvet G., 2016, LANCET INFECT DIS, V3099, P1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Charrel R. N., 2016, B WORLD HEALTH ORGAN, P1
   Chen L. H., 2016, ANN INTERN MED, P1
   Chetty S, 2015, MED CHEM RES, V24, P2055, DOI 10.1007/s00044-014-1279-3
   Chibueze E. C., 2016, B WORLD HEALTH ORGAN, P1
   Courageot MP, 2000, J VIROL, V74, P564
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Delvecchio R., 2016, BIOCHEM
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins S., 2016, F1000RESEARCH, V5, P275
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Eswar N., 2006, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]
   Eyer L., 2016, J INFECT DIS, V27, P1
   Fathi SMS, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/1472-6807-14-18
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281
   Hirsch AJ, 2010, FUTURE MICROBIOL, V5, P303, DOI [10.2217/fmb.09.121, 10.2217/FMB.09.121]
   Honarparvar B, 2014, CHEM REV, V114, P493, DOI 10.1021/cr300314q
   Hooft RWW, 1997, COMPUT APPL BIOSCI, V13, P425
   Huang BD, 2009, OMICS, V13, P325, DOI 10.1089/omi.2009.0045
   Huang HJ, 2010, J TAIWAN INST CHEM E, V41, P623, DOI 10.1016/j.jtice.2010.03.017
   Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x
   Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+
   Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumalo HM, 2016, CELL MOL BIOENG, V9, P175, DOI 10.1007/s12195-015-0421-8
   Larocca R. A., 2016, NATURE, P1
   Liao CZ, 2011, FUTURE MED CHEM, V3, P1057, DOI [10.4155/fmc.11.63, 10.4155/FMC.11.63]
   Lionta E, 2014, CURR TOP MED CHEM, V14, P1923, DOI 10.2174/1568026614666140929124445
   Lissauer D., 2016, INT J GYNECOL OBSTET, P1258
   Maharaj Y, 2013, CHEM BIOL DRUG DES, V82, P205, DOI 10.1111/cbdd.12152
   Mahfuz M., 2014, INDIAN J PHARM BIOL, V2, P44
   Mahfuz M., 2015, NAT SCI, V1, P37
   Malone R. W., 2016, PLOS NEGLECTED TROP, V10, P1
   Mandal S, 2009, EUR J PHARMACOL, V625, P90, DOI 10.1016/j.ejphar.2009.06.065
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moonsamy S., 2014, J RECEPT SIG TRANSD, V9893, P1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Noppakunmongkolchai W, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0494-6
   Oliveira Melo A S, 2016, Ultrasound Obstet Gynecol, V47, P6, DOI 10.1002/uog.15831
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Plourde A. R., 2016, EMERG INFECT DIS, V22, P1
   Ramesh M., 2015, APPL BIOCHEM BIOTECH, P1
   Reddy AS, 2007, CURR PROTEIN PEPT SC, V8, P329
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Singh R. K., 2016, VET Q, V2176, P1
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336
   Somarowthu S, 2011, BIOPOLYMERS, V95, P390, DOI 10.1002/bip.21589
   Song CM, 2009, BRIEF BIOINFORM, V10, P579, DOI 10.1093/bib/bbp023
   Song H., 2016, NAT STRUCT MOL BIOL, P1
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   Tambunan Usman Sumo Friend, 2014, Bioinformation, V10, P23, DOI 10.6026/97320630010023
   Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P1, DOI DOI 10.1002/0471250953.BI0203S00
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Turmel J. M., 2016, LANCET, V6736, P30775
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   Weltman J. K., 2016, J MED MICROBIOL DIAG, V5, P1
   WHO, 2016, SYNDROME, P1
   Youn S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-339
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 84
TC 0
Z9 0
U1 6
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 73
BP 68719
EP 68731
DI 10.1039/c6ra12142j
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA DT5HJ
UT WOS:000381512600021
ER

PT J
AU Govindarajan, M
   Rajeswary, M
   Benelli, G
AF Govindarajan, Marimuthu
   Rajeswary, Mohan
   Benelli, Giovanni
TI delta-Cadinene, Calarene and delta-4-Carene from Kadsura heteroclita
   Essential Oil as Novel Larvicides Against Malaria, Dengue and Filariasis
   Mosquitoes
SO COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
LA English
DT Article
DE Arbovirus; biosafety; Anopheles stephensi; Aedes aegypti; Culex
   quinquefasciatus; mosquito vectors
ID SUBPICTUS DIPTERA-CULICIDAE; PIPIENS-MOLESTUS DIPTERA;
   SITOPHILUS-GRANARIUS L.; CHEMICAL-COMPOSITION; CULEX-TRITAENIORHYNCHUS;
   MAJOR CONSTITUENTS; AEDES-ALBOPICTUS; TOXICITY; ANOPHELES; VECTORS
AB Mosquitoes (Diptera: Culicidae) are major vectors of extremely dangerous pathogens and parasites. Malaria, dengue fever, yellow fever, filariasis, schistosomiasis, Japanese encephalitis and Zika virus represent important public health challenges. Mosquito control is being problematic due to the development of strains resistant to synthetic mosquitocides currently marketed and concerns for the environment and human health. Plant species employed in traditional Asian medicine may be alternative sources of newer and effective mosquitocides. Here we evaluated the larvicid al potential of the essential oil (EO) extracted from the Kadsura heteroclita leaves. Furthermore, we identified its main EO chemical constituents (delta-Cadinene, Calarene and delta-4-Carene) and we tested them on larvae of Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus. The chemical composition of the EO was analyzed by gas chromatography-mass spectroscopy. GC-MS showed that the essential oil of K. heteroclita contained 33 compounds. Main chemical constituents were delta-Cadinene (18.3%), Calarene (14.8%) and delta-4-Carene (12.5%). The EO was toxic on An. stephensi, Ae. aegypti and Cx. quinquefasciatus larvae, LC50 were 102.86, 111.79 and 121.97 mu g/mL. delta-Cadinene, Calarene and delta-4-Carene appeared highly effective against An. stephensi (LC50 = 8.23, 12.34 and 16.37 mu g/mL, respectively) followed by Ae. aegypti (LC50 = 9.03, 13.33 and 17.91 mu g/mL), and Cx. quinquefasciatus (LC50 = 9.86, 14.49 and 19.50 mu g/mL). Overall, this study adds basic information to develop effective larvicides against malaria, dengue and filariasis mosquitoes.
C1 [Govindarajan, Marimuthu; Rajeswary, Mohan] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (reprint author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; g.benelli@sssup.it
CR Abbassy MA, 2009, ENTOMOL EXP APPL, V131, P225, DOI 10.1111/j.1570-7458.2009.00854.x
   Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   Araujo ECC, 2003, J AGR FOOD CHEM, V51, P3760, DOI 10.1021/jf0211074s
   Azizullah A, 2014, PARASITOL RES, V113, P4321, DOI 10.1007/s00436-014-4175-3
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Calmasur O, 2006, J PLANT DIS PROTECT, V113, P37
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   CHEN DF, 1992, PHYTOCHEMISTRY, V31, P629, DOI 10.1016/0031-9422(92)90049-V
   Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152
   Farnsworth N.R., 1977, NATURAL PRODUCTS PLA
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   FISHER PR, 1991, FEMS MICROBIOL LETT, V77, P117
   Frederich M, 2002, CURR MED CHEM, V9, P1435
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Govindarajan M, 2013, PARASITOL RES, V112, P3713, DOI 10.1007/s00436-013-3557-2
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P106, DOI 10.1016/S1995-7645(11)60047-3
   Jang YS, 2005, J AGR FOOD CHEM, V53, P7892, DOI 10.1021/jf051127g
   Jang YS, 2005, J AM MOSQUITO CONTR, V21, P400, DOI 10.2987/8756-971X(2006)21[400:MLAOAC]2.0.CO;2
   KANGOURI K, 1989, PLANTA MED, P297
   Knio KM, 2008, BIORESOURCE TECHNOL, V99, P763, DOI 10.1016/j.biortech.2007.01.026
   Kordali S, 2006, IND CROP PROD, V23, P162, DOI 10.1016/j.indcrop.2005.05.005
   Kuo YH, 1997, J ORG CHEM, V62, P3242, DOI 10.1021/jo9622542
   Lee CH, 2009, J FOOD PROTECT, V72, P1686
   [ LI Xiaoguang], 2007, [. , Journal of Jinan University], V28, P108
   [ Li Xiaoguang], 2002, [, Chinese Journal of Medicinal Chemistry], V12, P89
   Lucia A, 2009, BIORESOURCE TECHNOL, V100, P6083, DOI 10.1016/j.biortech.2009.02.075
   Mehlhorn H, 2005, PARASITOL RES, V95, P363, DOI 10.1007/s00436-004-1297-z
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Nie ZL, 2005, ANN MO BOT GARD, V92, P275
   Opletal L, 2004, J CHROMATOGR B, V812, P357, DOI 10.1016/j.jchromb.2004.07.040
   Pancharoen C., 2002, J MED ASS THAI, V85, P25
   Park IK, 2008, J ECON ENTOMOL, V101, P139, DOI 10.1603/0022-0493(2008)101[139:TOPEOA]2.0.CO;2
   Pavela R, 2013, IND CROP PROD, V43, P33, DOI 10.1016/j.indcrop.2012.06.044
   Pavela R, 2014, PLANT PROTECT SCI, V50, P36
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pu JX, 2008, PHYTOCHEMISTRY, V69, P1266, DOI 10.1016/j.phytochem.2007.11.019
   Rai R.K., 1993, CHEM ENV RES, V2, P267
   RAJASEKARIAH GR, 1991, ANN TROP MED PARASIT, V85, P663
   Senthilkumar A., 2012, Asian Pacific Journal of Tropical Disease, V2, P324
   Song W. Z., 1982, TRADITIONAL CHINESE, V13, P40
   Tiwary Mohini, 2007, Journal of Vector Borne Diseases, V44, P198
   Traboulsi AF, 2005, PEST MANAG SCI, V61, P597, DOI 10.1002/ps.1017
   Traboulsi AF, 2002, PEST MANAG SCI, V58, P491, DOI 10.1002/ps.486
   Wang W, 2006, PLANTA MED, V72, P450, DOI 10.1055/s-2005-916263
   World Health Organization, HODCOWHD20141 WHO
   World Health Organization, 2005, WHOCDSWHOPESGCDPP13
   YANG XW, 1992, CHEM PHARM BULL, V40, P1510
   Zahran HEM, 2011, J ASIA-PAC ENTOMOL, V14, P46, DOI 10.1016/j.aspen.2010.11.013
NR 58
TC 0
Z9 0
U1 1
U2 1
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1386-2073
EI 1875-5402
J9 COMB CHEM HIGH T SCR
JI Comb. Chem. High Throughput Screen
PY 2016
VL 19
IS 7
BP 565
EP 571
DI 10.2174/1381612822666160531163144
PG 7
WC Biochemical Research Methods; Chemistry, Applied; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA DS2ES
UT WOS:000380565100005
PM 27151483
ER

PT J
AU Lima-Camara, TN
AF Lima-Camara, Tamara Nunes
TI Emerging arboviruses and public health challenges in Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Editorial Material
DE Arbovirus Infections, epidemiology; Communicable Diseases, Emerging,
   prevention & control; Insect Vectors; Public Health
ID WEST-NILE-VIRUS; ZIKA VIRUS; AEDES-ALBOPICTUS; DENGUE VIRUSES;
   CLIMATE-CHANGE; CHIKUNGUNYA; OUTBREAK; DISEASES; EPIDEMIOLOGY;
   SURVEILLANCE
AB Environmental modification by anthropogenic actions, disordered urban growth, globalization of international exchange and climate change are some factors that help the emergence and dissemination of human infectious diseases transmitted by vectors. This review discusses the recent entry of three arboviruses in Brazil: Chikungunya, West Nile, and Zika virus, focusing on the challenges for the Country's public health. The Brazilian population is exposed to infections caused by these three arboviruses widely distributed on the national territory and associated with humans. Without effective vaccine and specific treatment, the maintainance and integration of a continuos entomological and epidemiological surveillance are important so we can set methods to control and prevent these arboviruses in the Country.
C1 [Lima-Camara, Tamara Nunes] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Av Doutor Arnaldo,715 Cerqueira Cesar, BR-01246904 Sao Paulo, SP, Brazil.
RP Lima-Camara, TN (reprint author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Av Doutor Arnaldo,715 Cerqueira Cesar, BR-01246904 Sao Paulo, SP, Brazil.
EM limacamara@usp.br
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2014/05016-5]
FX Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Process
   2014/05016-5 - Research Grant - Regular).
CR Aagaard-Hansen J, 2010, TROP MED INT HEALTH, V15, P1281, DOI 10.1111/j.1365-3156.2010.02629.x
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chancey C, 2015, BIOMED RES INT, V2015
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Epstein PR, 2000, SCI AM, V283, P50
   Fauci AS, 2012, NEW ENGL J MED, V366, P454, DOI 10.1056/NEJMra1108296
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   [Anonymous], 2014, REV PAN-AMAZ SAUDE, DOI DOI 10.5123/S2176-62232014000300007
   McMichael AJ, 2008, SOCIAL ECOLOGY OF INFECTIOUS DISEASES, P378, DOI 10.1016/B978-012370466-5.50019-4
   Meason B, 2014, HEALTH HUM RIGHTS, V16, P105
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Murray KO, 2011, EPIDEMIOL INFECT, V139, P807, DOI 10.1017/S0950268811000185
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Norris DE, 2004, ECOHEALTH, V1, P19, DOI 10.1007/s10393-004-0008-7
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Ometto T, 2013, T ROY SOC TROP MED H, V107, P723, DOI 10.1093/trstmh/trt081
   Pauvolid-Correa A, 2011, MEM I OSWALDO CRUZ, V106, P467, DOI 10.1590/S0074-02762011000400014
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Wermelinger ED, 2014, CAD SAUDE PUBLICA, V30, P2259, DOI 10.1590/0102-311XPE021114
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 32
TC 0
Z9 0
U1 2
U2 2
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2016
VL 50
AR 36
DI 10.1590/S1518-8787.2016050006791
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS4CC
UT WOS:000380728000039
ER

PT J
AU Nandy, A
   Dey, S
   Basak, SC
   Bielinska-Waz, D
   Waz, P
AF Nandy, Ashesh
   Dey, Sumanta
   Basak, Subhash C.
   Bielinska-Waz, Dorota
   Waz, Piotr
TI Characterizing the Zika Virus Genome - A Bioinformatics Study
SO Current Computer-Aided Drug Design
LA English
DT Article
DE Zika virus; Zika virus phylogeny; Zika virus characterization; African
   and Asian-American clades; 2D graphical representation; amino acid
   changes; cladewise transition-transversion ratios; Zika sequence
   descriptors
ID DNA-SEQUENCES; GRAPHICAL REPRESENTATION; DESCRIPTORS; EVOLUTION;
   OUTBREAK; HEALTH; BRAZIL
AB Background: The recent epidemic of Zika virus infections in South and Latin America have raised serious concern on its ramifications for the population in the Americas and spread of the virus worldwide. The Zika virus disease is a relatively new phenomenon for which sufficient and comprehensive data and investigative reports have not been available to date.
   Objective: To carry out a bioinformatics study of the available Zika virus genomic sequences to characterize the virus.
   Method: 2D graphical representation method is used for visual rendering and compute sequence parameters and descriptors of the African and Asian-American groups of the Zika viruses to characterize the sequences. We also used MEGA5.2 and other software to compute various biological properties of interest like phylogenetic relationships, transition-transversion ratios, amino acid usage, codon usage bias and hydropathy index of the Zika genomes and virions.
   Results: The phylogenetic relationships show that the African and Asian-American Zika virus genomes are grouped in two clades. The 2D plots of typical genomes of these types also show dramatic differences indicating that the gene sequences at the 5'-end coding regions for the structural proteins are rather strongly conserved. Among other characteristics, the transition/transversion ratio matrices for the sequences in each of the two clades show that analogous to the dengue virus, the transition rates are about 10 to 15 times the transversion rates.
   Conclusion: These findings are important for computer-assisted approaches towards surveillance of emerging Zika virus strains as well as in the design of drugs and vaccines to combat the growth and spread of the Zika virus.
C1 [Nandy, Ashesh; Dey, Sumanta; Basak, Subhash C.] Ctr Interdisciplinary Res & Educ, 404B Jodhpur Pk, Kolkata 700068, India.
   [Basak, Subhash C.] Univ Minnesota Duluth, Nat Resources Res Inst, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
   [Basak, Subhash C.] Univ Minnesota Duluth, Dept Chem & Biochem, 5013 Miller Trunk Highway, Duluth, MN 55811 USA.
   [Bielinska-Waz, Dorota] Med Univ Gdansk, Dept Radiol Informat & Stat, Tuwima 15, PL-80210 Gdansk, Poland.
   [Waz, Piotr] Med Univ Gdansk, Dept Nucl Med, Tuwima 15, PL-80210 Gdansk, Poland.
RP Nandy, A (reprint author), Ctr Interdisciplinary Res & Educ, 404B Jodhpur Pk, Kolkata 700068, India.
EM anandy43@yahoo.com
CR Basak S.C., 2016, CURR COMP A IN PRESS
   BBC, ZIK VIR TRIGG PREGN
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bielinska-Waz D, 2007, CHEM PHYS LETT, V443, P408, DOI 10.1016/j.cplett.2007.06.088
   Bielinska-Waz D, 2007, CHEM PHYS LETT, V442, P140, DOI 10.1016/j.cplett.2007.05.050
   BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101
   Dey S., 2015, SCIFORUM MOL2NET B
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Horton R, 2016, LANCET, V387, P633, DOI 10.1016/S0140-6736(16)00268-3
   The Intergovernmental Panel on Climate Change, 2007, 4 IPCC, P403
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Nandy A, 1996, COMPUT APPL BIOSCI, V12, P55
   NANDY A, 1994, CURR SCI INDIA, V66, P309
   Nandy A, 2003, CHEM PHYS LETT, V368, P102, DOI 10.1016/S0009-2614(02)01830-4
   Nandy A, 2006, ARKIVOC, P211
   Nandy A, 2015, CURR COMPUT-AID DRUG, V11, P110, DOI 10.2174/1573409911666150722122034
   Raychaudhury C, 1999, J CHEM INF COMP SCI, V39, P243, DOI 10.1021/ci980077v
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10
   Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
NR 27
TC 1
Z9 1
U1 6
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4099
EI 1875-6697
J9 CURR COMPUT-AID DRUG
JI Curr. Comput.-Aided Drug Des.
PY 2016
VL 12
IS 2
BP 87
EP 97
DI 10.2174/1573409912666160401115812
PG 11
WC Chemistry, Medicinal; Computer Science, Interdisciplinary Applications
SC Pharmacology & Pharmacy; Computer Science
GA DS2ET
UT WOS:000380565600002
PM 27032927
ER

PT J
AU Roy, P
AF Roy, Pritam
TI Zika virus disease causes microcephaly
SO NATIONAL MEDICAL JOURNAL OF INDIA
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ALL INDIA INST MEDICAL SCIENCES
PI NEW DELHI
PA ANSARI NAGAR, NEW DELHI 110 029, INDIA
SN 0970-258X
J9 NATL MED J INDIA
JI Natl. Med. J. India
PD JAN-FEB
PY 2016
VL 29
IS 1
BP 57
EP 57
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS1XW
UT WOS:000380419500016
ER

PT J
AU Freitas, ARR
   Angerami, RN
   von Zuben, APB
   Donalisio, MR
AF Ribas Freitas, Andre Ricardo
   Angerami, Rodrigo Nogueira
   Bruno von Zuben, Andrea Paula
   Donalisio, Maria Rita
TI INTRODUCTION AND TRANSMISSION OF ZIKA VIRUS IN BRAZIL: NEW CHALLENGES
   FOR THE AMERICAS
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Letter
ID CHIKUNGUNYA; OUTBREAK
C1 [Ribas Freitas, Andre Ricardo] Fac Med Sao Leopoldo Mandic, Dept Med Social, Campinas, SP, Brazil.
   [Angerami, Rodrigo Nogueira] Univ Estadual Campinas, UNICAMP, Dept Infectol, Hosp Clin, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo; Angerami, Rodrigo Nogueira; Bruno von Zuben, Andrea Paula] Dept Vigilancia Saude, Municipio De Campinas, SP, Brazil.
   [Donalisio, Maria Rita] Univ Estadual Campinas, UNICAMP, Fac Ciencias Med, Dept Saude Colet, Rua Tessalia Vieir de Camargo 126, BR-13083997 Campinas, SP, Brazil.
RP Donalisio, MR (reprint author), Univ Estadual Campinas, UNICAMP, Fac Ciencias Med, Dept Saude Colet, Rua Tessalia Vieir de Camargo 126, BR-13083997 Campinas, SP, Brazil.
EM arrfreitas2010@gmail.com; rodrigo.angerami@gmail.com;
   andreabrunovonzuben@gmail.com; rita.donalisio@gmail.com
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   ProMED-mail, ZIK VIR BRAS 19 SIND
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roth A., 2014, EURO SURVEILL, V19
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I O CRUZ, V4, P569
NR 11
TC 0
Z9 0
U1 2
U2 2
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2016
VL 58
AR 24
DI 10.1590/S1678-9946201658024
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA DS3JX
UT WOS:000380680200012
ER

PT J
AU Villa, R
AF Villa, R.
TI Zika, or the burden of uncertainty
SO CLINICA TERAPEUTICA
LA English
DT Editorial Material
DE Zika virus; microcephaly; public health; risk communication
AB In the first phases of an infectious outbreak, health authorities have to face the challenge of communicating uncertainty. Just when the attention of the public is at the top, information about what is going on is usually still missing. This is the case of Zika crisis in Latin America, where an association with microcephaly in newborns and neurological complications have been described, but not yet confirmed. Despite this, and even if the risk would be mainly limited to pregnant women, Zika threat is perceived by the general public as greater than others, such as those from dengue or flu.
   Some peculiarities of this outbreak explain such a gap between real and perceived risk.
   Nevertheless, in such a situation, WHO and other health authorities have the duty to act out of an abundance of caution, aware of the lose-lose game they are going through: if they raise alarm, and this subsided, they could be accused to fuel people's fears because of economic interests, as it happened in 2009 A(H1N1) pandemic; if they underestimate the threat, they could find themselves in front of a global tragedy.
C1 [Villa, R.] Zadig, ASSET Project, Milan, Italy.
RP Villa, R (reprint author), Zadig, ASSET Project, Milan, Italy.
EM villa@zadig.it
CR Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Peiris M, 2003, LANCET, V361, P1319
   Sandman Peter, 1989, EFFECTIVE RISK COMMU
   Widdowson MA, 2014, LANCET INFECT DIS, V14, P670, DOI 10.1016/S1473-3099(14)70835-7
   [Anonymous], 2016, US TODAY
NR 5
TC 0
Z9 0
U1 4
U2 4
PU SOC EDITRICE UNIV
PI ROME
PA VIA G B MORGAGNI 1, ROME, 10061, ITALY
SN 0009-9074
EI 1972-6007
J9 CLIN TER
JI Clin. Ter.
PD JAN-FEB
PY 2016
VL 167
IS 1
BP 7
EP 9
DI 10.7417/CT.2016.1907
PG 3
WC Medicine, General & Internal; Pharmacology & Pharmacy
SC General & Internal Medicine; Pharmacology & Pharmacy
GA DR3ZZ
UT WOS:000379842500001
PM 26980631
ER

PT J
AU Hafiz, MY
   Mahmood, SU
   Shoaib, M
   Yusuf, FH
AF Hafiz, Muhammad Yusuf
   Mahmood, Syed Uzair
   Shoaib, Maria
   Yusuf, Farah Hafiz
TI Concern over Zika virus outbreak: another alarming global threat
SO INFECTION AND DRUG RESISTANCE
LA English
DT Article
DE Zika virus; global spread; teratogenic; neurological anomalies; public
   health emergency
ID TRAVELERS
AB Zika virus, as highlighted by the World Health Organization in February 2016, has emerged as a public health emergency of international concern. Zika virus is enveloped and icosahedral, and has a nonsegmented, single-stranded, positive-sense RNA genome. It belongs to Flaviviridae family. Aedes aegypticus mosquito is the known vector. Transmission is anthroponotic (human to vector to human) during outbreaks, or occurs perinatally in utero, sexually, and via transfusion of infected blood. Zika virus is turning out to be a major public health concern. Not only has it shown dramatic teratogenic association and caused serious neurological concerns but it has also spread around the globe. Countries that have not yet been affected by Zika virus should adopt proper preventive methods to limit its spread in the population.
C1 [Hafiz, Muhammad Yusuf; Shoaib, Maria; Yusuf, Farah Hafiz] Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan.
   [Mahmood, Syed Uzair] Jinnah Sindh Med Univ, Sindh Med Coll, Karachi, Pakistan.
RP Hafiz, MY (reprint author), 246 CP Berar Soc, Flat 8,2nd Floor, Karachi 75600, Pakistan.
EM m.yusufhafiz17@gmail.com
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Calvet G, LANCET INFECT DIS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Talan J., 2016, NEUROL TODAY, V16, P1
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 13
TC 0
Z9 0
U1 1
U2 1
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6973
J9 INFECT DRUG RESIST
JI Infect. Drug Resistance
PY 2016
VL 9
DI 10.2147/IDR.S108057
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DR0WR
UT WOS:000379628100001
PM 27418843
ER

PT J
AU Silva, ACSE
   Moreira, JM
   Romanelli, RMC
   Teixeira, AL
AF Simoes e Silva, Ana Cristina
   Moreira, Janaina Matos
   Romanelli, Roberta Maia Castro
   Teixeira, Antonio Lucio
TI Zika virus challenges for neuropsychiatry
SO NEUROPSYCHIATRIC DISEASE AND TREATMENT
LA English
DT Review
DE Zika virus; microcephaly; Guillain-Barre syndrome; neurodevelopmental
   disorders
ID GUILLAIN-BARRE-SYNDROME; NEUROLOGICAL COMPLICATIONS; FRENCH-POLYNESIA;
   INFECTION; BRAZIL; TRANSMISSION; OUTBREAK; BRAIN; EPIDEMIOLOGY;
   PATHOGENESIS
AB Before 2007, Zika virus (ZIKV) was generally considered as an arbovirus of low clinical relevance, causing a mild self-limiting febrile illness in tropical Africa and Southeast Asia. Currently, a large, ongoing outbreak of ZIKV that started in Brazil in 2015 is spreading across the Americas. Virus infection during pregnancy has been potentially linked to congenital malformations, including microcephaly. In addition to congenital malformations, a temporal association between ZIKV infection and an increase in cases of Guillain-Barre syndrome is currently being observed in several countries. The mechanisms underlying these neurological complications are still unknown. Emerging evidence, mainly from in vitro studies, suggests that ZIKV may have direct effects on neuronal cells. The aim of this study was to critically review the literature available regarding the neurobiology of ZIKV and its potential neuropsychiatric manifestations.
C1 [Simoes e Silva, Ana Cristina; Moreira, Janaina Matos; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Interdisciplinary Lab Med Invest, Belo Horizonte, MG, Brazil.
   [Simoes e Silva, Ana Cristina; Moreira, Janaina Matos; Romanelli, Roberta Maia Castro] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Teixeira, Antonio Lucio] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Psychiat & Behav Sci, Neuropsychiat Program, 1941 East Rd, Houston, TX 77054 USA.
RP Teixeira, AL (reprint author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Psychiat & Behav Sci, Neuropsychiat Program, 1941 East Rd, Houston, TX 77054 USA.
EM antonio.l.teixeira@uth.tmc.edu
FU FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais,
   Brazil)
FX This study was partially supported by FAPEMIG (Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais, Brazil).
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2013, EUROSURVEILLANCE, V2016, P21, DOI [10.2807/1560-7917.ES.2016.21.13.30181, DOI 10.2807/1560-7917]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brazil. Ministerio da Saude, 2016, PROT VIG OC MICR E O
   Brazil, 2015, B EPIDEMIOLOGICO
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P2924
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Center for Disease Control, 2015, ZIK AND PREGN
   Soares de Araujo JS, 2016, B WHO
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, V134, P529, DOI DOI 10.1001/JAMA0PHTHALM0L.2016.0267
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Ferreira MLB, 2016, AM AC NEUR ANN M
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hazin Adriano N, 2016, N Engl J Med, V374, P2193, DOI 10.1056/NEJMc1603617
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Johansson MA, 2016, N ENGL J MED
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malinger Gustavo, 2003, Reprod Biol Endocrinol, V1, P110, DOI 10.1186/1477-7827-1-110
   Mallet HP, 2015, B INFORM SANITAIRES
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de Vigilancia das Doencas Transmissiveis, 2016, PROT VIG RESP OC MIC
   Brazil, 2016, B EP MON CAS DENG FE
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Pan American Health Organization/World Health Organization (PAHO/WHO) 1 December, 2015, NEUR SYNDR CONG MALF
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simmins Jr CH, 2016, B WHO
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Venturi G, 2016, EURO SURVEILL, V21
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Way J H, 1976, J Gen Virol, V30, P123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   World Health Organization, ZIK VIR DIS YELL FEV
   World Health Organization, 2016, ASS INF MICR CONT ZI
   WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, P217
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 83
TC 0
Z9 0
U1 7
U2 7
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2021
J9 NEUROPSYCH DIS TREAT
JI Neuropsychiatr. Dis. Treat.
PY 2016
VL 12
BP 1747
EP 1760
DI 10.2147/NDT.S113037
PG 14
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DR1PE
UT WOS:000379676600001
ER

PT J
AU Govindarajan, M
   Benelli, G
AF Govindarajan, Marimuthu
   Benelli, Giovanni
TI One-pot green synthesis of silver nanocrystals using Hymenodictyon
   orixense: a cheap and effective tool against malaria, chikungunya and
   Japanese encephalitis mosquito vectors?
SO RSC ADVANCES
LA English
DT Article
ID LEAF EXTRACT; ANOPHELES-STEPHENSI; AEDES-AEGYPTI;
   CULEX-QUINQUEFASCIATUS; ANTIBACTERIAL ACTIVITY; VETERINARY IMPORTANCE;
   DIPTERA-CULICIDAE; ESSENTIAL OILS; NANOPARTICLES; BIOSYNTHESIS
AB Mosquitoes are important vectors of malaria, dengue, Zika virus and many other parasites and pathogens of public health relevance. Recently, the green nanosynthesis of mosquitocides relying on plant compounds as reducing and stabilizing agents has received growing interest, due to the absence of toxic chemicals and high-energy input. In this research, Hymenodictyon orixense-mediated synthesis of silver nanoparticles (AgNPs) was conducted to control larval populations of the malaria vector Anopheles subpictus, the chikungunya vector Aedes albopictus and the Japanese encephalitis vector Culex tritaeniorhynchus. AgNPs were characterized using UV-visible spectrophotometry, FTIR spectroscopy, EDX and XRD analyses, AFM, SEM and TEM. AgNPs were toxic towards all the mosquito vectors, LC50 values ranged from 17.10 mu g ml(-1) to 20.08 mu g ml(-1). Notably, AgNPs were safer to the non-target mosquito predator Diplonychus indicus (LC50 = 833 mu g ml(-1)). Overall, H. orixense-fabricated AgNPs can be considered for the development of novel and safer control tools against mosquito vectors of medical and veterinary importance.
C1 [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (reprint author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; g.benelli@sssup.it
CR Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3
   Ankamwar B, 2005, SYNTH REACT INORG ME, V35, P19, DOI 10.1081/SIM-200047527
   Anyaele OO, 2003, AFR J BIOMED RES, V6, P49
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chitra G., 2014, PARASITOL RES, V114, P1407
   DEO P G, 1988, International Pest Control, V30, P118
   Finney D.J., 1971, PROBIT ANAL
   Ghani A, 2003, MED PLANTS BANGLADES
   Govindarajan M, 2016, PARASITOL RES MG, V8, P99, DOI 10.1007/978-3-319-25292-6_7
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Jayaseelan C, 2012, PARASITOL RES, V111, P921, DOI 10.1007/s00436-011-2473-6
   Klempner MS, 2007, NEW ENGL J MED, V356, P2567, DOI 10.1056/NEJMp078081
   [Anonymous], 2014, J PARASITOL RES
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Oberdorster G, 2005, FIBRE TOXICOL, V2, P8, DOI DOI 10.1186/1743-8977-2-8
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Mehrotra BN, 1993, COMPENDIUM INDIAN ME
   Raut RW, 2010, NANO-MICRO LETT, V2, P106, DOI 10.5101/nml.v2i2.p106-113
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Saxena A, 2010, DIG J NANOMATER BIOS, V5, P427
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shankar S. S., 2004, NANOTECHNOL APPL, V1, P69
   Shanmugam N., 2014, APPL NANOSCI, V4, P881, DOI DOI 10.1007/S13204-013-0271-4
   Singh BP, 2010, J ENVIRON QUAL, V39, P1
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Swe N. N., 2008, J MYANMAR ACAD ARTS, V6, P193
   Thirunavokkarasu M., 2013, SPECTROCHIM ACTA A, V116
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   WHO, 2005, WHOCDSWHOPESGCDPP200
   Zaheer Z, 2013, COLLOID SURFACE B, V108, P90, DOI 10.1016/j.colsurfb.2013.02.023
   Zargar M, 2011, MOLECULES, V6, P6667
NR 46
TC 1
Z9 1
U1 1
U2 1
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 64
BP 59021
EP 59029
DI 10.1039/c6ra10228j
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA DQ6XQ
UT WOS:000379350100021
ER

PT J
AU Siqueira, WL
   Moffa, EB
   Mussi, MCM
   Machado, MADM
AF Siqueira, Walter Luiz
   Moffa, Eduardo Buozi
   Martins Mussi, Maria Carolina
   de Andrade Moreira Machado, Maria Aparecida
TI Zika virus infection spread through saliva - a truth or myth?
SO BRAZILIAN ORAL RESEARCH
LA English
DT Article
DE Saliva; Zika Virus; Microcephaly; Pediatric Dentistry; Infection;
   Pediatrics
ID HEPATITIS-C VIRUS; DENGUE VIRUS; TRANSMISSION; URINE
AB In this Point-of-view article we highlighted some features related to saliva and virus infection, in special for zika virus. In addition, we pointed out the potential oral problems caused by a microcephaly originated by a zika virus infection. In the end the, we demonstrated the importance of a more comprehensive exploration of saliva and their components as a fluid for diagnostic and therapeutic approaches on oral and systemic diseases.
C1 [Siqueira, Walter Luiz; Moffa, Eduardo Buozi] Univ Western Ontario, Schulich Sch Med & Dent, Dept Dent & Biochem, London, ON, Canada.
   [Martins Mussi, Maria Carolina] Univ Sao Paulo, Sch Dent, Dept Oral Pathol, Sao Paulo, SP, Brazil.
   [de Andrade Moreira Machado, Maria Aparecida] Univ Sao Paulo, Bauru Dent Sch, Dept Pediat Dent Orthodont & Publ Hlth, Bauru, SP, Brazil.
RP Siqueira, WL (reprint author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Dent & Biochem, London, ON, Canada.
EM walter.siqueira@uwo.ca
RI Machado, Maria Aparecida/D-8224-2012
FU Canadian Institutes of Health Research CIHR [106657, 97577]; Canada
   Foundation for Innovation [25116]; CIHR [113166]
FX Supported by The Canadian Institutes of Health Research CIHR grants
   #106657, #97577, and Canada Foundation for Innovation grant #25116. WLS
   is recipient of a CIHR New Investigator Award grant#113166.
CR ARCHIBALD DW, 1986, BLOOD, V67, P831
   Baron S, 1999, ARCH INTERN MED, V159, P303, DOI 10.1001/archinte.159.3.303
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Blicharz TM, 2008, CLIN CHEM, V54, P1473, DOI 10.1373/clinchem.2008.105320
   Blicharz TM, 2009, ANAL CHEM, V81, P2106, DOI 10.1021/ac802181j
   Bolscher JGM, 2002, EUR J ORAL SCI, V110, P149, DOI 10.1034/j.1600-0722.2002.11175.x
   Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112
   Ferreiro MC, 2005, ORAL DIS, V11, P230, DOI 10.1111/j.1601-0825.2005.01076.x
   Hermida M, 2002, J VIROL METHODS, V101, P29, DOI 10.1016/S0166-0934(01)00417-7
   Lee YH, 2009, AM J DENT, V22, P241
   Liuzzi G, 1996, AIDS, V10, pF51
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Morava E, 2008, EUR J HUM GENET, V16, P28, DOI 10.1038/sj.ejhg.5201947
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Siqueira WL, 2011, PROTEOM CLIN APPL, V5, P575, DOI 10.1002/prca.201100046
   White MR, 2009, ORAL MICROBIOL IMMUN, V24, P18, DOI 10.1111/j.1399-302X.2008.00468.x
NR 17
TC 1
Z9 1
U1 5
U2 6
PU SOCIEDADE BRASILEIRA DE PESQUISA ODONTOLOGICA
PI SAO PAULO
PA CIDADE UNIV, AV PROF LINEU PRESTES, ARMANDO SALLE OLIVEIRA, AVENIDA
   LINEU PRESTES, 2227, CP 8216, SAO PAULO, SP 05508-900, BRAZIL
SN 1806-8324
EI 1678-8079
J9 BRAZ ORAL RES
JI Braz. Oral Res.
PY 2016
VL 30
IS 1
AR e46
DI 10.1590/1807-3107BOR-2016.vol30.0046
PG 3
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DP9DM
UT WOS:000378796900004
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus infection spread through saliva
SO BRAZILIAN ORAL RESEARCH
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surin Rajabhat Univ, Bangkok, Thailand.
RP Wiwanitkit, V (reprint author), Surin Rajabhat Univ, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Wiwanitkit S., 2015, Journal of Acute Disease, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2009, J INFECT DEV COUNTR, V4, P51, DOI DOI 10.3855/JIDC.145
   Wiwanitkit V, 2006, LUNG, V184, P373, DOI 10.1007/s00408-006-0021-4
NR 5
TC 0
Z9 0
U1 4
U2 4
PU SOCIEDADE BRASILEIRA DE PESQUISA ODONTOLOGICA
PI SAO PAULO
PA CIDADE UNIV, AV PROF LINEU PRESTES, ARMANDO SALLE OLIVEIRA, AVENIDA
   LINEU PRESTES, 2227, CP 8216, SAO PAULO, SP 05508-900, BRAZIL
SN 1806-8324
EI 1678-8079
J9 BRAZ ORAL RES
JI Braz. Oral Res.
PY 2016
VL 30
IS 1
AR e76
DI 10.1590/1807-3107BOR-2016.vol30.0076
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DP9DM
UT WOS:000378796900022
ER

PT J
AU Korzeniewski, K
   Juszczak, D
   Zwolinska, E
AF Korzeniewski, Krzysztof
   Juszczak, Dariusz
   Zwolinska, Ewa
TI Zika - another threat on the epidemiological map of the world
SO INTERNATIONAL MARITIME HEALTH
LA English
DT Review
DE Zika virus; epidemiology; clinical symptoms; prevention
ID SEXUAL TRANSMISSION; INTERIM GUIDELINES; UNITED-STATES; VIRUS; OUTBREAK;
   AMERICA
AB Zika fever is an acute infectious disease caused by the Zika virus (ZIKV) of the Flaviviridae family and Flavivirus genus. It is transmitted by day-time active Aedes mosquitoes, and potentially by sexual contacts, blood transfusion, and from mother to foetus (resulting in microcephaly in a child). ZIKV was first isolated from a macaque monkey in the Zika forest in Uganda in 1947. The first case of the Zika fever in a human was recorded in Nigeria in 1954. Until 2007 only 14 cases of the disease were confirmed worldwide. In 2007, there was an outbreak of the Zika fever in Micronesia (Yap Island) with an estimated 5,000 cases. Between 2013 and 2015 a further outbreak of the disease occurred in the Pacific islands: in French Polynesia, New Caledonia, Cook Islands, Easter Island, and Solomon Islands. In 2015, the Zika fever spread to Brazil and more than 20 other countries in the South and Central America. Until March 2016, an estimated 1.6 million autochthonous cases of Zika have been reported globally, with approximately 1.5 million cases recorded in Brazil. Typically, 80% of Zika infections are asymptomatic. The most common symptoms of the disease include fever, maculopapular rash, muscle and joint pain, conjunctivitis. Zika fever can be diagnosed on the basis of clinical signs (it must be differentiated from dengue, chikungunya), ZIKV identification is also possible by the application of polymerase chain reaction in acutely ill patients and the detection of specific IgM and IgG antibodies to ZIKV. Until today, there is no effective antiviral treatment or an effective vaccine against Zika fever (in case of an infection only symptomatic treatment is applied). In August 2016 in Rio de Janeiro (Brazil) Summer Olympic Games will take place, attracting thousands of athletes and spectators. The fight against the Zika fever and the race against time have gained momentum.
C1 [Korzeniewski, Krzysztof] Mil Inst Med, Dept Epidemiol & Trop Med, Ul Grudzinskiego 1, PL-81103 Warsaw, Poland.
   [Juszczak, Dariusz] Commander 7th Navy Hosp, Gdansk, Poland.
   [Zwolinska, Ewa] Holy Family Matern Hosp, Warsaw, Poland.
RP Korzeniewski, K (reprint author), Mil Inst Med, Dept Epidemiol & Trop Med, Ul Grudzinskiego 1, PL-81103 Warsaw, Poland.
EM kktropmed@wp.pl
CR Barker A, 2016, ABC NEWS
   Cao-Lormeau V.M., 2013, EMERG INFECT DIS, V2014, P1085, DOI DOI 10.3201/EID2006.140138
   Centers for Disease Control and Prevention, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015
   CDC, 2016, REV DIAGN TEST ZIK C
   Chen LH, 2016, ANN INTERN MED
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i467
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, MOSQ MAPS
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcia E., 2016, Weekly Epidemiological Record, V91, P73
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Hayes BE, 2009, EMERG INFECT DIS, V15, P1347
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kraemer MU, 2015, SCI DATA, V2, DOI [DOI 10.1038/SDATA.2015.35, 10.1038/sdata.2015.35]
   Kuno G, 1998, J VIROL, V72, P73
   Lanciotti R.S., 2007, EMERG INFECT DIS, V2008, P1232
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines R, 2015, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, WHO ZIK SIT REP FEBR
   Pan American Health Organization. World Health Organization Regional Office for the Americas, GUID REP ZIKV
   ProMED-mail, 2016, ZIK VIR AM AS
   ProMED-mail, 2016, ZIK VIR WHO DECL PUB
   Rajagopalan M, 2016, REUTERS
   Schuler-Faccini L, 2015, MMWR-MORBID MORTAL W, V2016, P59, DOI DOI 10.15585/MMWR.MM6503E2
   Shinohara K, 2016, J TRAVEL MED, V23
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2013, EURO SURVEILL, P19
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization, 2016, ZIK VIR FACT SHEET
   World Health Organization, 2016, MICR BRAZ
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   [Anonymous], 2016, US TODAY
NR 45
TC 1
Z9 1
U1 8
U2 8
PU VIA MEDICA
PI GDANSK
PA UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND
SN 1641-9251
EI 2081-3252
J9 INT MARIT HEALTH
JI Int. Marit. Health
PY 2016
VL 67
IS 1
BP 31
EP 37
DI 10.5603/IMH.2016.0007
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP0ED
UT WOS:000378160100007
PM 27029927
ER

PT J
AU Cassone, A
AF Cassone, Antonio
TI Zika, more reasons for concern
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Editorial Material
ID SEXUAL TRANSMISSION; VIRUS
C1 [Cassone, Antonio] Univ Perugia, Polo Innovaz Genom Genet & Biol, I-06100 Perugia, Italy.
RP Cassone, A (reprint author), Univ Perugia, Polo Innovaz Genom Genet & Biol, I-06100 Perugia, Italy.
EM a.cassone@pologgb.com
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cassone A, 2015, PATHOG GLOB HEALTH, V109, P43, DOI 10.1179/2047772415Z.000000000253
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Tang H, 2016, CELL STEM CELL
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 10
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2016
VL 110
IS 2
BP 37
EP 38
DI 10.1080/20477724.2016.1182803
PG 2
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA DO9SZ
UT WOS:000378128500001
PM 27241952
ER

PT J
AU Tsiodras, S
   Pervanidou, D
   Papadopoulou, E
   Kavatha, D
   Baka, A
   Koliopoulos, G
   Badieritakis, E
   Michaelakis, A
   Gavana, E
   Patsoula, E
   Tsimpos, I
   Gioksari, T
   Kyriazopoulou, E
   Vakali, A
   Pavli, A
   Maltezou, HC
   Georgakopoulou, T
   Hadjichristodoulou, C
   Kremastinou, J
   Papa, A
AF Tsiodras, Sotirios
   Pervanidou, Danai
   Papadopoulou, Elpida
   Kavatha, Dimitra
   Baka, Agoritsa
   Koliopoulos, George
   Badieritakis, Evangelos
   Michaelakis, Antonios
   Gavana, Elpida
   Patsoula, Eleni
   Tsimpos, Ioannis
   Gioksari, Thalia
   Kyriazopoulou, Evdoxia
   Vakali, Annita
   Pavli, Androula
   Maltezou, Helena C.
   Georgakopoulou, Theano
   Hadjichristodoulou, Christos
   Kremastinou, Jenny
   Papa, Anna
TI Imported Chikungunya fever case in Greece in June 2014 and public health
   response
SO PATHOGENS AND GLOBAL HEALTH
LA English
DT Article
DE Public Health; Vector-borne diseases; Arboviruses; Medical entomology;
   Viral infection; Alphaviruses
ID ZIKA VIRUS-INFECTIONS; AEDES-ALBOPICTUS; DIPTERA-CULICIDAE;
   SOUTH-AMERICA; INDIAN-OCEAN; TRAVELERS; FRANCE; EUROPE; SPREAD; DENGUE
AB We report about the first imported case of Chikungunya fever in Greece in a Greek traveler returning from the Dominican Republic and the associated public health response. We investigated the case and performed focused epidemiological and entomological investigation in all areas the patient visited during the infectious period, to identify the targeted interventions needed. Entomological investigation revealed the occurrence of the competent vector Aedes albopictus (Diptera: Culicidae) in the environment surrounding the hospital where the patient was admitted and in her workplace. All captured mosquitoes tested negative for Chikungunya virus. We further conducted clinical and laboratory examination of the patient's co-travelers, gave advice on appropriate personal preventive measures against mosquito bites to the patient and co-travelers and on vector control, and raised awareness among health professionals throughout Greece. The risk of introduction and local transmission of Chikungunya and other arboviruses in Greece and other European countries is present, as the competent vector exists in many parts of Europe. Public health professionals, travel medicine specialists and clinicians should maintain awareness regarding this possibility of importation of arbovirus cases in order to provide the appropriate advice, seek the prompt diagnosis, and implement appropriate interventions. Mobilization of various stakeholders will lead to enhanced epidemiological and entomological surveillance that will allow for improved risk assessment in each area.
C1 [Tsiodras, Sotirios; Kavatha, Dimitra; Tsimpos, Ioannis; Gioksari, Thalia; Kyriazopoulou, Evdoxia] Univ Athens, Sch Med, Attikon Univ Hosp, Dept Internal Med 4, GR-11527 Athens, Greece.
   [Tsiodras, Sotirios; Pervanidou, Danai; Baka, Agoritsa; Vakali, Annita; Pavli, Androula; Maltezou, Helena C.; Georgakopoulou, Theano; Hadjichristodoulou, Christos; Kremastinou, Jenny] Hellen Ctr Dis Control & Prevent, Athens, Greece.
   [Papadopoulou, Elpida; Gavana, Elpida; Papa, Anna] Aristotle Univ Thessaloniki, Natl Reference Ctr Arboviruses & Hemorrhag Fever, Sch Med, Dept Microbiol A, GR-54006 Thessaloniki, Greece.
   [Koliopoulos, George; Badieritakis, Evangelos; Michaelakis, Antonios] Benaki Phytopathol Inst, Athens, Greece.
   [Patsoula, Eleni] Natl Sch Publ Hlth, Dept Parasitol Entomol & Trop Dis, Athens, Greece.
   [Hadjichristodoulou, Christos] Univ Thessaly, Dept Hyg & Epidemiol, Larisa, Greece.
RP Tsiodras, S (reprint author), Univ Athens, Sch Med, Attikon Univ Hosp, Dept Internal Med 4, GR-11527 Athens, Greece.
EM tsiodras@med.uoa.gr
FU HCDCP, Ministry of Health; project LIFE CONOPS - European Commission
   [LIFE12 ENV/GR/000466]
FX The National Reference Centre for Arboviruses and Hemorrhagic Fever
   Viruses is financially supported by the HCDCP, Ministry of Health. The
   Department of Parasitology, Entomology and Tropical Diseases of the
   National School of Public Health is financially supported by HCDCP,
   Ministry of Health, through a memorandum of collaboration between
   NSPH-HCDCP. The entomological investigation was supported from the
   project LIFE CONOPS (LIFE12 ENV/GR/000466) which is funded by the
   European Commission in the framework of the programme LIFE + Environment
   Policy and Governance.
CR Angelini R, 2007, EUROSURVEILLANCE, V12, P3260
   Angelini R., 2007, EUROSURVEILLANCE, V12, P3313
   Becker N, 2010, MOSQUITOES THEIR CON, P577
   Bonn D, 2006, LANCET INFECT DIS, V6, P543, DOI 10.1016/S1473-3099(06)70559-X
   Bottieau E, 2009, EUROSURVEILLANCE, V14, P2
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cassadou S., 2013, EUROSURVEILLANCE, V19, P20752
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15
   CDC, HAS CHIK VIR BEEN FO
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Depoortere E., 2006, EURO SURVEILL, V11
   European Centre for Disease Prevention and Control (ECDC), 2012, GUID SURV INV MOSQ E
   Giatropoulos A.K., 2012, Hellenic Plant Protection Journal, V5, P49
   Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096
   Giatropoulos A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127762
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Higgs S, 2006, VECTOR-BORNE ZOONOT, V6, P115, DOI 10.1089/vbz.2006.6.115
   Hochedez P, 2007, EURO SURVEILL, V12, P42
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   Krastinova E, 2006, EURO SURVEILL, V11
   Kurkela S, 2012, J CLIN VIROL, V54, P289, DOI 10.1016/j.jcv.2012.02.027
   Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Menard A, 2015, TRAVEL MED INFECT DI, V13, P94, DOI 10.1016/j.tmaid.2014.12.009
   Noel H, 2014, EUROSURVEILLANCE, V19, P2
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10
   Pfeffer M., 2010, EURO SURVEILL, V15
   Pistone T, 2009, J TRAVEL MED, V16, P286, DOI 10.1111/j.1708-8305.2008.00294.x
   Pistone T, 2009, TRAVEL MED INFECT DI, V7, P52, DOI 10.1016/j.tmaid.2008.10.001
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Receveur M, 2010, EUROSURVEILLANCE, V15, P7
   Requena-Mendez A, 2014, EUROSURVEILLANCE, V19, P5
   Samanidou-Voyadjoglou A., 2005, European Mosquito Bulletin, V19, P10
   Samanidou-Voyadjoglou A., 1998, 4 INT C DIPT 6 13 SE, P194
   Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Tappe D, 2013, EUROSURVEILLANCE, V19, P20685
   Van Bortel W, EURO SURVEILL
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Villamil-Gomez WE, 2016, J INFECT PUBL HLTH, V1
   [Anonymous], CHIK FRANC DIS OUTBR
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2006, WEEKLY EPIDEMIOL REC, V81, P106
NR 48
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2047-7724
EI 2047-7732
J9 PATHOG GLOB HEALTH
JI Pathog. Glob. Health
PY 2016
VL 110
IS 2
BP 68
EP 73
DI 10.1080/20477724.2016.1176311
PG 6
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA DO9SZ
UT WOS:000378128500005
PM 27159571
ER

PT J
AU Slavov, SN
   Otaguiri, KK
   Kashima, S
   Covas, DT
AF Slavov, S. N.
   Otaguiri, K. K.
   Kashima, S.
   Covas, D. T.
TI Overview of Zika virus (ZIKV) infection in regards to the Brazilian
   epidemic
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Zika virus; ZIKV; Transmission; Epidemiology; Congenital infection;
   Brazil
ID GUILLAIN-BARRE-SYNDROME; SEROLOGICAL SURVEY; TRANSMISSION; AEDES;
   ARBOVIRUSES; INFLUENZA; MOSQUITOS; VECTOR; GABON; MICRONESIA
AB Zika virus (ZIKV), a mosquito-borne flavivirus, belongs to the Flaviviridae family, genus Flavivirus. ZIKV was initially isolated in 1947 from a sentinel monkey in the Zika forest, Uganda. Little clinical importance was attributed to ZIKV, once only few symptomatic cases were reported in some African and Southeast Asiatic countries. This situation changed in 2007, when a large outbreak was registered on the Yap Island, Micronesia, caused by the Asian ZIKV lineage. Between 2013 and 2014, ZIKV spread explosively and caused many outbreaks in different islands of the Southern Pacific Ocean and in 2015 autochthonous transmission was reported in Brazil. Currently, Brazil is the country with the highest number of ZIKV-positive cases in Latin America. Moreover, for the first time after the discovery of ZIKV, the Brazilian scientists are studying the possibility for the virus to cause severe congenital infection related to microcephaly and serious birth defects due to the time-spatial coincidence of the alarming increase of newborns with microcephaly and the Brazilian ZIKV epidemic. The present review summarizes recent information for ZIKV epidemiology, clinical picture, transmission, diagnosis and the consequences of this emerging virus in Brazil.
C1 [Slavov, S. N.; Otaguiri, K. K.; Kashima, S.; Covas, D. T.] Univ Sao Paulo, Fac Med Ribeirao Preto, Hemoctr Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Slavov, S. N.; Covas, D. T.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
   [Otaguiri, K. K.; Kashima, S.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin Toxicol & Bromatol, Ribeirao Preto, SP, Brazil.
RP Slavov, SN (reprint author), Univ Sao Paulo, Fac Med Ribeirao Preto, Hemoctr Ribeirao Preto, Ribeirao Preto, SP, Brazil.; Slavov, SN (reprint author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
EM svetoslav.slavov@hemocentro.fmrp.usp.br
FU Fundacao de Amparo e Pesquisa do Estado de Sao Paulo-FAPESP, Brazil
   [2009/16623-1]; CTC [1998/14. 247-6]; INCTC [2008/57.877-3]; Conselho
   Nacional do Desenvolvimento Cientifico e Tecnologico, Brazil (INCTC)
   [573.754/2008-0]
FX We are grateful to Sandra Navarro Bresciani for the artwork. We are also
   grateful to the funding agencies Fundacao de Amparo e Pesquisa do Estado
   de Sao Paulo-FAPESP, Brazil (#2009/16623-1, CTC-#1998/14. 247-6 and
   INCTC-#2008/57.877-3), and the Conselho Nacional do Desenvolvimento
   Cientifico e Tecnologico, Brazil (INCTC-#573.754/2008-0).
CR Ali M, 2005, AM J NEURORADIOL, V26, P289
   Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Campos R. de M., 2016, Journal of Clinical Virology, V77, P69
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, GUILLAIN BARRE SYNDR, DOI [10.1016/S0140-6736(16)00562-6, DOI 10.1016/S0140-6736(16)00562-6]
   Chan JF, 2016, J INFECT
   Chippaux A, 1981, Med Trop (Mars), V41, P53
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Costa F, 2016, IDEAS OPINIONS EMERG
   Coulombier D, 2015, RAPID RISK ASSESMENT
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, COMM DIS THREAT REP
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, P1
   Garcia E., 2016, Weekly Epidemiological Record, V91, P73
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larik A, 2012, BMJ CASE REP, V2012
   Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Marrs C., 2016, AM J PERINATOL
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Mecharles S., 2016, LANCET
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Pyke AT, 2014, PLOS CURR, V6
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EURO SURVEILL, V19
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verma R, 2012, BMJ CASE REP, V2012
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 66
TC 0
Z9 0
U1 10
U2 10
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2016
VL 49
IS 5
AR e5420
DI 10.1590/1414-431X20165420
PG 11
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA DM9KF
UT WOS:000376684000010
PM 27143174
ER

PT J
AU Kantor, IN
AF Kantor, Isabel N.
TI Dengue, Zika and Chikungunya
SO MEDICINA-BUENOS AIRES
LA Spanish
DT Article
DE arbovirus; chikungunya; zika; dengue; Argentina
ID BUENOS-AIRES; INDIGENOUS DENGUE; VIRUS; ARGENTINA; TRANSMISSION;
   COLOMBIA; OUTBREAK; FEVER; RISK; CITY
AB Arboviruses are transmitted by arthropods, including those responsible for the current pandemic: alphavirus (Chikungunya) and flaviviruses (dengue and Zika). Its importance increased in the Americas over the past 20 years. The main vectors are Aedes aegypti and A. albopictus. Dengue infection provides long lasting immunity against the specific serotype and temporary to the other three. Subsequent infection by another serotype determines more serious disease. There is a registered vaccine for dengue, Dengvaxia (Sanofi Pasteur). Other two (Butantan and Takeda) are in Phase III in 2016. Zika infection is usually asymptomatic or occurs with rash, conjunctivitis and not very high fever. There is no vaccine or specific treatment. It can be transmitted by parental, sexual and via blood transfusion. It has been associated with microcephaly. Chikungunya causes prolonged joint pain and persistent immune response. Two candidate vaccines are in Phase II. Dengue direct diagnosis is performed by virus isolation, RT-PCR and ELISA for NS1 antigen detection; indirect methods are ELISA-IgM (cross-reacting with other flavivirus), MAC-ELISA, and plaque neutralization. Zika is diagnosed by RT-PCR and virus isolation. Serological diagnosis cross-reacts with other flavivirus. For CHIKV culture, RT-PCR, MAC-ELISA and plaque neutralization are used. Against Aedes organophosphate larvicides (temephos), organophosphorus insecticides (malathion and fenitrothion) and pyrethroids (permethrin and deltamethrin) are usually employed. Resistance has been described to all these products. Vegetable derivatives are less expensive and biodegradable, including citronella oil, which microencapsulated can be preserved from evaporation.
C1 [Kantor, Isabel N.] Med Buenos Aires, Com Redacc, RA-1427 Buenos Aires, DF, Argentina.
RP Kantor, IN (reprint author), Med Buenos Aires, Combatientes Malvinas 3150, RA-1427 Buenos Aires, DF, Argentina.
EM isabel.kantor@gmail.com
CR Aviles G, 2000, MEDICINA-BUENOS AIRE, V60, P875
   Carbajo AE, 2004, MEDICINA-BUENOS AIRE, V64, P231
   Carbajo AE, 2015, MEM I OSWALDO CRUZ, V110, P259, DOI 10.1590/0074-02760150005
   CDC, 2016, ARB CAT
   CDC, 2016, YELL FEV VACC
   Conde M, 2015, BIOMEDICA, V35, P43, DOI [10.1590/S0120-41572015000100007, 10.7705/biomedica.v35i1.2367]
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Rowland Jones SL, 2016, T R SOC MED HYG, V110, P85
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mareze VA, 2016, APPL MICROBIOL BIOT, V100, P125, DOI 10.1007/s00253-015-6973-7
   Martines R, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6506E1ER
   Min. Salud, 2016, B INT VIG 296 SE5
   Min Salud. Dir. Epid, 2016, CIRC VIR ZIK REG INC
   Min Salud SNVS, 2016, VIG EP ARG
   Ruiz Moreno D, 2016, BMC INFECT DIS, V16, P49
   Natiello M, 2008, EMERG INFECT DIS, V14, P1498, DOI 10.3201/eid1409.080143
   OMS, 2016, ENF VIR ZIK
   [OMS OPS], 2016, DENG AM
   [OMS OPS], 2016, SIT OPS DENG
   Gimenez JO, 2015, J MED ENTOMOL, V52, P879, DOI 10.1093/jme/tjv107
   Parra-Henao G, 2012, BIOMEDICA, V32, P252, DOI 10.1590/S0120-41572012000300013
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760
   Precioso AR, 2015, VACCINE, V33, P7121, DOI 10.1016/j.vaccine.2015.09.105
   Schwameis M, 2015, HUM VACCIN IMMU 1110
   Seijo A, 2001, MEDICINA-BUENOS AIRE, V61, P137
   Seijo A, 2014, MEDICINA-BUENOS AIRE, V74, P476
   Seijo A, 2009, MEDICINA-BUENOS AIRE, V69, P593
   Solomon B, 2012, EUR J PHARM BIOPHARM, V80, P61, DOI 10.1016/j.ejpb.2011.08.003
   Miro Specos MM, 2016, FIJACION CICLODEXTRI
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Wardrop NA, 2016, T ROY SOC TROP MED H, V110, P87, DOI 10.1093/trstmh/trv115
   Orellano PW, 2016, VACCINE, V34, P616, DOI 10.1016/j.vaccine.2015.12.040
   WHO, 2016, QUEST ANSW DENG VACC
NR 35
TC 0
Z9 1
U1 8
U2 8
PU MEDICINA (BUENOS AIRES)
PI BUENOS AIRES
PA DONATO ALVAREZ 3150, 1427 BUENOS AIRES, ARGENTINA
SN 0025-7680
EI 1669-9106
J9 MEDICINA-BUENOS AIRE
JI Med.-Buenos Aires
PY 2016
VL 76
IS 2
BP 93
EP 97
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6NZ
UT WOS:000376471000006
PM 26942903
ER

PT J
AU Lopes, MH
   Miyaji, KT
   Infante, V
AF Lopes, Marta Heloisa
   Miyaji, Karina Takesaki
   Infante, Vanessa
TI Zika virus
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Article
ID DENGUE VIRUSES; INFECTION; BRAZIL; TRANSMISSION; OUTBREAK; CHIKUNGUNYA;
   TRAVEL
C1 [Lopes, Marta Heloisa; Miyaji, Karina Takesaki; Infante, Vanessa] Univ Sao Paulo FMUSP, Fac Med, Dept Infect & Parasit Dis, Sao Paulo, SP, Brazil.
RP Lopes, MH (reprint author), FMUSP, Dept Infect & Parasit Dis, Av Dr Eneas Carvalho Aguiar 470,Predio 1,Sala 102, BR-05403000 Sao Paulo, SP, Brazil.
EM mahlopes@usp.br
CR Besnard M, 2014, EURO SURVEILL, V19
   Brasil. Ministerio da Saude, 2015, PROT AT SAUD RESP OC
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Diseases Control and Prevention, 2015, ZIK VIR TRANSM
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR FR
   Fauci A.S., 2016, N ENGL J MED
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire CCM, 2015, BIORXIV
   International Society for Infectious Diseases, 2015, MICR BRAS 10 VAR EST
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Ministerio da Saude, 2016, MIN SAUD AT NUM CAS
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Roth A., 2014, EURO SURVEILL, V19
   Salvador F. S., 2015, TRAVEL MED INFECT DI
   Secretaria de Estado da Saude - Coordenadoria de Controle de Doencas - Centro de Vigilancia Epidemiologica - Instituto Adolfo Lutz, 2015, 01 SECR EST SAUD COO
   Secretaria de Vigilancia em Saude - Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46, P46
   Secretaria de Vigilancia em Saude - Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46
   Tappe D, 2014, EURO SURVEILL, V19
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WHO, 2015, DIS OUTBREAK NEWS
   Zammarchi L, 2015, EURO SURVEILL, V20
   [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P609
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00006-4
NR 32
TC 1
Z9 1
U1 10
U2 10
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD JAN-FEB
PY 2016
VL 62
IS 1
BP 4
EP 9
DI 10.1590/1806-9282.62.01.4
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6TU
UT WOS:000376486200002
PM 27008481
ER

PT J
AU Massad, E
   Tan, SH
   Khan, K
   Wilder-Smith, A
AF Massad, Eduardo
   Tan, Ser-Han
   Khan, Kamran
   Wilder-Smith, Annelies
TI Estimated Zika virus importations to Europe by travellers from Brazil
SO GLOBAL HEALTH ACTION
LA English
DT Article
DE Zika virus; travel; importations; Brazil; Europe
ID DENGUE HEMORRHAGIC-FEVER; TRANSMISSION; OUTBREAK; AREAS; RISK
AB Background: Given the interconnectivity of Brazil with the rest of the world, Zika virus (ZIKV) infections have the potential to spread rapidly around the world via viremic travellers. The extent of spread depends on the travel volume and the endemicity in the exporting country. In the absence of reliable surveillance data, we did mathematical modelling to estimate the number of importations of ZIKV from Brazil into Europe.
   Design: We applied a previously developed mathematical model on importations of dengue to estimate the number of ZIKV importations into Europe, based on the travel volume, the probability of being infected at the time of travel, the population size of Brazil, and the estimated incidence of ZIKV infections.
   Results: Our model estimated between 508 and 1,778 imported infections into Europe in 2016, of which we would expect between 116 and 355 symptomatic Zika infections; with the highest number of importations being into France, Portugal and Italy.
   Conclusions: Our model identified high-risk countries in Europe. Such data can assist policymakers and public health professionals in estimating the extent of importations in order to prepare for the scale up of laboratory diagnostic assays and estimate the occurrence of Guillain-Barre Syndrome, potential sexual transmission, and infants with congenital ZIKV syndrome.
C1 [Massad, Eduardo] Univ Sao Paolo, Dept Med, Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London WC1, England.
   [Tan, Ser-Han] Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Bergheimer Str 58, D-69115 Heidelberg, Germany.
   [Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, SE-90185 Umea, Sweden.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
RP Wilder-Smith, A (reprint author), Lee Kong Chian Sch Med, 11 Mandalay Rd, Singapore 308232, Singapore.
EM anneliesws@gmail.com
FU European Commission 7th framework, under Dengue Tools consortium
   [282589]
FX This work was partially funded for AWS and EM through the European
   Commission 7th framework, under the Dengue Tools consortium (Grant No.
   282589). The funders played no role in the study design, data
   collection, analysis, or preparation of the manuscript.
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cavalcanti LPD, 2010, REV SOC BRAS MED TRO, V43, P355, DOI 10.1590/S0037-86822010000400003
   ECDC, 2016, EP SIT ZIK OUTBR EUR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcia E., 2016, Weekly Epidemiological Record, V91, P73
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Helmerson JL, 2016, EBIOMEDICINE
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   Venturi G, 2016, EURO SURVEILL, V21
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   [Anonymous], 2016, ZIK VIR SIT REP
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6
   Wilder-Smith Annelies, 2015, BMC Med, V13, P133, DOI 10.1186/s12916-015-0363-y
   [Anonymous], LANCET INFECT DIS, V387, P719
NR 30
TC 2
Z9 2
U1 5
U2 5
PU CO-ACTION PUBLISHING
PI JARFALLA
PA RIPVAGEN 7, JARFALLA, SE-175 64, SWEDEN
SN 1654-9880
J9 GLOBAL HEALTH ACTION
JI Glob. Health Action
PY 2016
VL 9
BP 1
EP 7
AR 31669
DI 10.3402/gha.v9.31669
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM0ZZ
UT WOS:000376076100001
PM 27193266
ER

PT J
AU Tjan, R
AF Tjan, Richard
TI Global emergence of Zika virus
SO UNIVERSA MEDICINA
LA English
DT Editorial Material
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
NR 7
TC 0
Z9 0
U1 0
U2 0
PU TRISAKTI UNIV, FAC MEDICINE
PI WEST JAKARTA
PA JALAN KYAI TAPA NO 1 GROGOL, WEST JAKARTA, 00000, INDONESIA
SN 1907-3062
EI 2407-2230
J9 UNIVERSA MED
JI Universa Med.
PD JAN-APR
PY 2016
VL 35
IS 1
BP 1
EP 2
DI 10.18051/UnivMed.2016.v35.001
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM2FL
UT WOS:000376162300001
ER

PT J
AU Arredondo-Garcia, JL
   Mendez-Herrera, A
   Medina-Cortina, H
AF Arredondo-Garcia, J. L.
   Mendez-Herrera, A.
   Medina-Cortina, H.
TI Arbovirus in Latin America
SO ACTA PEDIATRICA DE MEXICO
LA Spanish
DT Article
DE Dengue; zika; chikungunya; arbovirus; Aedes
ID ZIKA VIRUS; DENGUE VIRUS; CHIKUNGUNYA VIRUS; AEDES-AEGYPTI; INFECTION;
   TRANSMISSION; CHILDREN; BRAZIL; MANIFESTATIONS; EPIDEMIOLOGY
AB Diseases produced by arboviruses are a major worldwide problem due to the fact that the surveillance and prevention of them implies the surveillance of vectors, which makes it very difficult to control them, and almost impossible to avoid their expansion to any tropical or subtropical country, and even some temperate regions. Globally, dengue is the most common arboviral disease, with 40% of the world population living in areas with dengue virus transmission. Of the estimated 390 million infections and 100 million cases annually, a small proportion of these cases progress to severe dengue. Approximately one in 2,000 dengue cases result in death. However, the case-fatality rate of patients with severe dengue can be reduced from almost 10% to less than 0.1% by the timing and quality of clinical care that patients receive. This, coupled with the recent and quick spread of Chikungunya virus and the outbreak of Zika virus in Latin American countries including Mexico, makes it necessary the medical update and review of bibliography concerning the prevention, control and management of arboviral-caused diseases. Therefore we present a review of the most recent literature on arboviral diseases in Latin America.
C1 [Arredondo-Garcia, J. L.] Inst Nacl Pediat, Invest Med, Insurgentes Sur 3700-C, Ciudad De Mexico 04530, DF, Mexico.
   [Mendez-Herrera, A.; Medina-Cortina, H.] Inst Nacl Pediat, Unidad Apoyo Invest Clin, Ciudad De Mexico 04530, DF, Mexico.
RP Arredondo-Garcia, JL (reprint author), Inst Nacl Pediat, Invest Med, Insurgentes Sur 3700-C, Ciudad De Mexico 04530, DF, Mexico.
EM joselag@unam.mx
CR Aggarwal A, 2015, J PEDIATR NEUROSCI, V10, P76, DOI 10.4103/1817-1745.154362
   Angel RMd, 2013, PLOS PATHOG, V9
   Arroyo-Avila M, 2015, P R HEALTH SCI J, V34, P71
   Babaliche Prakash, 2015, J Assoc Physicians India, V63, P38
   Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   Besnard M, 2014, EURO SURVEILL, V19
   Bhatia MS, 2015, J CLIN DIAGN RES, V9, pVC01
   Brisola-Marcondes C, 2015, REV SOC BRAS MED TRO
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carter JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139899
   Division of Vector-Borne Diseases, 2014, VECT BORN THREATS WH
   Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Courderc T, 2015, ANTIVIR RES, V121, P120
   Curtis Z, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003999
   Da Silva Voorham J. M., 2014, NED TIJDSCHR GENEES, V158, pA7946
   de Souza LJ, 2013, BRAZ J INFECT DIS, V17, P27, DOI 10.1016/j.bjid.2012.08.020
   Prazeres J, 2016, JAMA OPHTALMOL, DOI [10.1001/jamaophthal-mol.2016.0267, DOI 10.1001/JAMAOPHTHAL-MOL.2016.0267]
   Fajardo-Dolci German, 2012, Rev Med Inst Mex Seguro Soc, V50, P631
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gulland A., 2016, BMJ-BRIT MED J, V352, pi595, DOI DOI 10.1136/BMJ.I595
   Guy B, 2015, NATURE REV, V14, P45, DOI DOI 10.1038/NRMICRO.2015.2
   Halstead SB, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0004101, DOI 10.1371/JOURNAL.PNTD.0004101]
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Henry R, 2014, EMERG INFECT DIS, V20, P1090
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Holmes EC, 1998, BRIT MED BULL, V54, P533
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jampol LM, 2016, JAMA OPHTALMOL, DOI [10.1001/jamaophthal-mol.2016.0284, DOI 10.1001/JAMAOPHTHAL-MOL.2016.0284]
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kurukularatne C, 2011, ANN ACAD MED SINGAP, V40, P539
   Lam S, 2015, MABS-AUSTIN, V7, P1178, DOI 10.1080/19420862.2015.1083664
   Libraty DH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004267
   Markedian SK, 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/834371, DOI 10.1155/2015/834371]
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez-Sanchez Abisai, 2015, Rev Med Inst Mex Seguro Soc, V53, P200
   Medeiros DN, 2015, PEDIATR EMERG CARE, V31, P11
   Mlakar J, 2016, NEW ENGL J MED, DOI [10.1056/NEJ-Moa1600651, DOI 10.1056/NEJ-M0A1600651]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Napolea-Pego P, 2008, J HUM RETROVIROL, V1, P00018, DOI 10.15406/jhvrv.2014.01.00018
   Navarrete-Espinosa Joel, 2006, Rev Med Inst Mex Seguro Soc, V44, P347
   Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415
   Oliveira Melo A S, 2016, Ultrasound Obstet Gynecol, V47, P6, DOI 10.1002/uog.15831
   Organizacion Panamericana de la Salud, 2011, PREP RESP ANT EV INT, V1, P1
   Pan American Heatlh Organization, 2015, NUMB REP CAS CHIK AM
   Pan American Health Organization, 2015, NUMB REP CAS DENG SE
   Parkash O, 2015, VIRUSES-BASEL, V7, P5410, DOI 10.3390/v7102877
   Picollo-Oliveira JF, 2015, CLIN KIDNEY J, V8, P681
   Rattanaburee T, 2015, ANTIVIR RES, V124, P83, DOI 10.1016/j.antiviral.2015.10.005
   Ribera A, 2012, MED TROP MARS, V72, P83
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0004199, DOI 10.1371/JOURNAL.PNTD.0004199.ECOLLECTION]
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   Schwameis M, 2015, HUM VACCIN IMMUNOTHE, V10
   COFEPRIS, 2015, COFEPRIS MEX APR PRI
   Subsecretaria de prevencion y promocion de la salud, SUBS PREV PROM SAL L
   Comite Nacional para la Vigilancia Epidemiologica, 2015, INF VIR ZIK SINDR NE
   Comite Nacional para la Vigilancia Epidemiologica, 2015, SIT EP INF VIR ZIK A
   Direccion General de Epidemiologia, 2016, B EPIDEMIOLOGICO, V6, P35
   [Anonymous], 2015, DIR GEN EP PAN EP GI
   Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Thirion-Icaza J, 2010, MOSQUITO AEDES AEGYP
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Unnikrishnan Rahul, 2015, J Family Med Prim Care, V4, P369, DOI 10.4103/2249-4863.161323
   Uribarren-Berrueta T, 2015, DENGUE FIEBRE CHIKUN
   van den Hurk AF, 2010, VECTOR-BORNE ZOONOT, V10, P489, DOI 10.1089/vbz.2009.0106
   Vasilakis N, 2008, AM J TROP MED HYG, V79, P128
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013
   Villegas-Trejo A, 2011, SALUD PUBLICA MEXICO, V53, P141, DOI 10.1590/s0036-36342011000200007
   Whitehorn J, 2015, CLIN INFECT DIS
   World Health Organization, 1967, WHO TECHN REP SER, V369, P1
   Wongsa Adisorn, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P123
   Zambrano B, 2015, J PEDIAT INFECT DIS, V3, P181
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang F, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003488.pub3
NR 81
TC 0
Z9 0
U1 7
U2 7
PU INST NAC PEDIATRIA
PI MEXICO D F
PA AVE INSURGENTES SUR NO 3700-C, COL INSURGENTES CUICUILCO, MEXICO D F,
   04530, MEXICO
SN 0186-2391
EI 2395-8235
J9 ACTA PEDIATR MEX
JI Acta Pediatr. Mex.
PY 2016
VL 37
IS 2
BP 111
EP 131
PG 21
WC Pediatrics
SC Pediatrics
GA DL0EP
UT WOS:000375305400008
ER

PT J
AU Omura, Y
   Lu, D
   Jones, MK
   Nihrane, A
   Duvvi, H
   Yapor, D
   Shimotsuura, Y
   Ohki, M
AF Omura, Yoshiaki
   Lu, Dominic
   Jones, Marilyn K.
   Nihrane, Abdallah
   Duvvi, Harsha
   Yapor, Dario
   Shimotsuura, Yasuhiro
   Ohki, Motomu
TI Optimal Dose of Vitamin D-3 400 IU for Average Adults has A Significant
   Anti-Cancer Effect, While Widely Used 2000 IU or Higher Promotes Cancer:
   Marked Reduction of Taurine & 1 alpha, 25(OH)(2)D-3 Was Found In Various
   Cancer Tissues and Oral Intake of Optimal Dose of Taurine 175mg for
   Average Adults, Rather Than 500mg, Was Found to Be A New Potentially
   Safe and More Effective Method of Cancer Treatment
SO ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH
LA English
DT Article
DE Taurine; Vitamin D-3; cholesterol; 1 alpha, 25(OH)(2)Vitamin D-3(=1
   alpha, 25(OH)(2)D-3); Oncogene C-fosAb2; Integrin alpha(5)beta(1);
   8-OH-dG; HPV-16; CMV; Zika Virus; Acetylcholine; ANP (Atrial Natriuretic
   Peptide); DHEA; Cilantro; omega 3 fish oil
ID BREAST-CANCER; ASBESTOS; CHRYSOTILE; DIAGNOSIS; DHEA; ETC.
AB During the past 10 years, the author had found that the optimal dose of Vitamin D-3 400 I.U. has safe & effective anticancer effects, while commonly used 2000 similar to 5000 I.U. of Vit. D-3 often creates a 2 similar to 3 time increase in cancer markers. We examined the concentration of Taurine in normal internal organs and in cancer using Bi-Digital O-Ring Test. We found that Taurine levels in normal tissue are 4 similar to 6ng. But, the amount of Taurine of average normal value of 5.0 similar to 5.25ng was strikingly reduced to 0.0025 similar to 0.0028ng in this study of several examples in adenocarcinomas of the esophagus, stomach, pancreas, colon, prostate, and lung, as well as breast cancer. The lowest Taurine levels of 0.0002 similar to 0.0005ng were found in so called Zika virus infected babies from Brazil with microcephaly. While Vitamin D-3 receptor stimulant 1 alpha, 25 (OH)(2)D-3 in normal tissues was 0.45 similar to 0.53ng, they were reduced to 0.0025 similar to 0.006ng in cancers (1/100th similar to 1/200th of normal value), particularly in various adenocarcinomas. All of these adenocarcinomas had about 1500ng HPV-16 viral infection. In 500 breast cancers, about 97% had HPV-16. The optimal dose of Taurine for average adult has been found to be about 175mg, rather than the widely used 500mg. In addition, since Taurine is markedly reduced to close to 1/1000th similar to 1/2000th of its normal value in these cancer tissues, we examined the effect of the optimal dose of Taurine on cancer patients. Optimal dose of Taurine produced a very significant decrease in cancer-associated parameters, such as Oncogene C-fosAb2 & Integrin alpha(5)beta(1) being reduced to less than 1/1,000th, and 8-OH-dG (which increases in the presence of DNA mutation) reduced to less than 1/10th. The optimal dose of Taurine 175mg for average adult various cancer patient 3 times a day alone provide beneficial effects with very significant anti-cancer effects with strikingly increased urinary excretion of bacteria, viruses, & funguses, asbestos, toxic metals & other toxic substances. However, optimal doses of Taurine combined with optimal individualized doses of omega 3 fish oil [EPA 180mg & DHA 120mg] & special cilantro tablet 3 times/day without creating harmful drug interactions among them including other essential drugs, is often extremely safe, more effective, economical & non-invasive new treatment for various cancer patients.
C1 [Omura, Yoshiaki] New York Med Coll, Dept Family & Community Med, Valhalla, NY 10595 USA.
   [Omura, Yoshiaki] Heart Dis Res Fdn, Med Res, Brooklyn, NY USA.
   [Omura, Yoshiaki] Int Coll Acupuncture & Electrotherapeut, New York, NY USA.
   [Lu, Dominic] Univ Penn, Oral Med, Philadelphia, PA 19104 USA.
   [Lu, Dominic] Amer Soc Advancement Anesthesia & Sedat Dent, Chicago, IL USA.
   [Lu, Dominic; Jones, Marilyn K.; Yapor, Dario] Int Coll Acupuncture & Electrotherapeut, Holist Dent, New York, NY USA.
   [Jones, Marilyn K.] Holist Dent Ctr Houston, Houston, TX USA.
   [Jones, Marilyn K.] Univ Houston, Chem, Houston, TX 77004 USA.
   [Nihrane, Abdallah; Duvvi, Harsha; Shimotsuura, Yasuhiro] Int Coll Acupuncture & Electrotherapeut, Integrat Med, New York, NY USA.
   [Nihrane, Abdallah] Mt Sinai Sch Med, Dept Med, New York, NY USA.
   [Nihrane, Abdallah] NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Duvvi, Harsha] New York Med Coll, Dept Family & Community Med & Neurologist, Valhalla, NY 10595 USA.
   [Shimotsuura, Yasuhiro] Japan Bidigital O Ring Test Assoc, Tokyo, Japan.
   [Shimotsuura, Yasuhiro; Ohki, Motomu] ORT Life Sci Res Inst, Kurume, Fukuoka, Japan.
RP Omura, Y (reprint author), 800 Riverside Dr 8-I, New York, NY 10032 USA.
EM icaet@yahoo.com
CR Brons C, 2004, EUR J CLIN NUTR, V58, P1239, DOI 10.1038/sj.ejcn.1601955
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101
   Omura Y., 2008, FUTURE MED RING TEST
   Mayo Clinic, DRUGS S VIT D DOS
   Omura Y., 2014, ACUPUNCTURE ELECTRO, V39, P344
   Omura Y., 2008, BIDIGITAL RING TEST
   Omura Y, 2005, ACUPUNCTURE ELECTRO, V30, P219
   Omura Y., 2014, PROMOTION HLTH LOGET
   Omura Y., 2005, ILLUSTRATED PRACTICE
   Omura Y, 1986, ILLUSTRATED PRACTICE
   Omura Y, 1983, ACUPUNTURA MANUAL
   Omura Y., 2012, DETECT DIS HUMAN FAC
   Omura Y., ACUPUNCTURE ELECTROT
   Omura Y., 2005, ACUPUNTURA MANUAL BA
   Omura Y., 2009, LIFE REVOLUTION LOGE
   Omura Y, PRACTICA TESTE ANEL
   Omura Y, 2013, ACUPUNCTURE ELECTRO, V38, P37
   Omura Y, 2014, ACUPUNCTURE ELECTRO, V39, P135, DOI 10.3727/036012914X14054537750463
   Omura Y, 2015, ACUPUNCTURE ELECTRO, V40, P157, DOI 10.3727/036012915X14473562232941
   Omura Y, 2013, ACUPUNCTURE ELECTRO, V38, P211, DOI 10.3727/036012913X13831832269324
   Omura Y, 2012, ADVANCING MEDICINE WITH FOOD AND NUTRIENTS, 2ND EDITION, P777
   REDDY BS, 1993, CANCER RES, V53, P3493
   Robsahm TE, 2004, CANCER CAUSE CONTROL, V15, P149, DOI 10.1023/B:CACO.0000019494.34403.09
   Saransaari P., P W PHARM SOC, V50, P8
   [Anonymous], 1998, GUEST SPEAK 8 ANN C, V23, P229
   Omura Y, 1993, US Patent, Patent No. [5,188,107, 5188107]
NR 26
TC 1
Z9 1
U1 4
U2 4
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0360-1293
EI 2167-9010
J9 ACUPUNCTURE ELECTRO
JI Acupunct. Electro-Ther. Res.
PY 2016
VL 41
IS 1
BP 39
EP 60
DI 10.3727/036012916X14597946741564
PG 22
WC Integrative & Complementary Medicine; Neurosciences
SC Integrative & Complementary Medicine; Neurosciences & Neurology
GA DK3PX
UT WOS:000374830700003
PM 27244952
ER

PT J
AU de Souza, WV
   de Araujo, TVB
   Albuquerque, MDPM
   Braga, MC
   Ximenes, RAD
   Miranda, DD
   Bezerra, LCA
   Dimech, GS
   de Carvalho, PI
   de Assuncao, RS
   Santos, RH
   de Oliveira, WK
   Rodrigues, LC
   Martelli, CMT
AF de Souza, Wayner Vieira
   Barreto de Araujo, Thalia Velho
   Militao Albuquerque, Maria de Fatima P.
   Braga, Maria Cynthia
   de Alencar Ximenes, Ricardo Arraes
   Miranda-Filho, Democrito de Barros
   Albuquerque Bezerra, Luciana Caroline
   Dimech, George Santiago
   de Carvalho, Patricia Ismael
   de Assuncao, Romildo Siqueira
   Santos, Roselene Hans
   de Oliveira, Wanderson Kleber
   Rodrigues, Laura Cunha
   Turchi Martelli, Celina Maria
TI Microcephaly in Pernambuco State, Brazil: epidemiological
   characteristics and evaluation of the diagnostic accuracy of cutoff
   points for reporting suspected cases
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Microcephaly; Zika Virus Infection; Epidemiological Surveillance; Data
   Accuracy
AB The increase in the number of reported cases of microcephaly in Pernambuco State, and Northeast Brazil, characterized an epidemic that led the Brazilian Ministry of Health to declare a national public health emergency. The Brazilian Ministry of Health initially defined suspected cases as newborns with gestational age (GA) >= 37 weeks and head circumference (HC) <= 33cm, but in December 2015 this cutoff was lowered to 32cm. The current study aimed to estimate the accuracy, sensitivity, and specificity of different cutoff points for HC, using ROC curves, with the Fenton and Intergrowth (2014) curves as the gold standard. The study described cases reported in Pernambuco from August 8 to November 28, 2015, according to sex and GA categories. The Fenton and Intergrowth methods provide HC growth curves according to GA and sex, and microcephaly is defined as a newborn with HC below the 3rd percentile in these distributions. Of the 684 reported cases, 599 were term or post-term neonates. For these, the analyses with ROC curves show that according to the Fenton criterion the cutoff point with the largest area under the ROC curve, with sensitivity greater than specificity, is 32cm for both sexes. Using the Intergrowth method and following the same criteria, the cutoff points are 32cm and 31.5cm for males and females, respectively. The cutoff point identified by the Fenton method (32cm) coincided with the Brazilian Ministry of Health recommendation. Adopting Intergrowth as the standard, the choice would be 32cm for males and 31.5cm for females. The study identified the need to conduct critical and on-going analyses to evaluate cutoff points, including other characteristics for microcephaly case definition.
C1 [de Souza, Wayner Vieira; Militao Albuquerque, Maria de Fatima P.; Braga, Maria Cynthia; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, BR-50670420 Recife, PE, Brazil.
   [Barreto de Araujo, Thalia Velho; de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Miranda-Filho, Democrito de Barros] Univ Pernambuco, Recife, PE, Brazil.
   [Albuquerque Bezerra, Luciana Caroline; Dimech, George Santiago; de Carvalho, Patricia Ismael; de Assuncao, Romildo Siqueira; Santos, Roselene Hans] Secretaria Estadual Saude Pernambuco, Secretaria Execut Vigilancia Saude, Recife, PE, Brazil.
   [de Oliveira, Wanderson Kleber] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Rodrigues, Laura Cunha] Univ London, London Sch Hyg & Trop Med, London, England.
RP de Souza, WV (reprint author), Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Saude Colet, Ave Moraes Rego S-N, BR-50670420 Recife, PE, Brazil.
EM wayner@cpqam.fiocruz.br
FU Brazilian Ministry of Health; Pernambuco State Health Secretariat
   (SES-PE); Pan American Health Organization; National Council for
   Scientific and Technological Development - CNPq [306489/2010-4,
   308311/2009-4, 308590/2013-9, 301779/2009-0, 304174/2014-9,
   306222/2013-2]
FX The authors wish to acknowledge the support of the Brazilian Ministry of
   Health, the Pernambuco State Health Secretariat (SES-PE), and the Pan
   American Health Organization. The authors received partial support from
   the National Council for Scientific and Technological Development - CNPq
   (grants 306489/2010-4 for C.M.T.M., 308311/2009-4 for R.A.A.X.,
   308590/2013-9 for D.B.M.F., 301779/2009-0 for M.F.P.M.A., 304174/2014-9
   for M.C.B., and 306222/2013-2 for W.V.S.). We also wish to thank Dr.
   Enrique Vazquez (Pan American Health Organization, Brasilia, Brazil) for
   his attentive reading of the manuscript and important suggestions.
CR Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Ministerio da Saude, MIN SAUD CONF REL EN
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   [Ministerio da Saude Secretaria de Vigilancia em Saude], 2015, PROC PREL SER AD VIG
   [Secretaria Estadual de Saude Secretaria Executiva de Vigilancia em Saude], 2015, PROT CLIN EP INV CAS
   [Secretaria Estadual de Saude Secretaria Executiva de Vigilancia em Saude], 2015, 4315 SECR EX VIG SAU
   Sene A, 2015, DIARIO PERNAMBUCO
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
NR 10
TC 0
Z9 0
U1 8
U2 8
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JAN
PY 2016
VL 32
IS 4
AR e00017216
DI 10.1590/0102-311X00017216
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DK7CJ
UT WOS:000375082200005
ER

PT J
AU Shinohara, K
   Kutsuna, S
   Takasaki, T
   Moi, ML
   Ikeda, M
   Kotaki, A
   Yamamoto, K
   Fujiya, Y
   Mawatari, M
   Takeshita, N
   Hayakawa, K
   Kanagawa, S
   Kato, Y
   Ohmagari, N
AF Shinohara, Koh
   Kutsuna, Satoshi
   Takasaki, Tomohiko
   Moi, Meng Ling
   Ikeda, Makiko
   Kotaki, Akira
   Yamamoto, Kei
   Fujiya, Yoshihiro
   Mawatari, Momoko
   Takeshita, Nozomi
   Hayakawa, Kayoko
   Kanagawa, Shuzo
   Kato, Yasuyuki
   Ohmagari, Norio
TI Zika fever imported from Thailand to Japan, and diagnosed by PCR in the
   urine
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Zika fever; Mosquito-borne disease; Flaviviridae
ID VIRUS-INFECTION; MICRONESIA
AB In July 2014, a Japanese traveller returning from Thailand was investigated for fever, headache, rash and conjunctivitis. Zika virus RNA was detected in his urine sample by real-time reverse transcription polymerase chain reaction. Serological tests showed cross reactivity of IgM against the dengue virus. Zika fever could be misdiagnosed or missed and should be considered in febrile patients with a rash, especially those returning from Thailand.
C1 [Shinohara, Koh; Kutsuna, Satoshi; Yamamoto, Kei; Fujiya, Yoshihiro; Mawatari, Momoko; Takeshita, Nozomi; Hayakawa, Kayoko; Kanagawa, Shuzo; Kato, Yasuyuki; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo 1628655, Japan.
   [Takasaki, Tomohiko; Moi, Meng Ling; Ikeda, Makiko; Kotaki, Akira] Natl Inst Infect Dis, Dept Virol, Shinjuku Ku, Tokyo, Japan.
RP Kutsuna, S (reprint author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.
EM sonare.since1192@gmail.com
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haynes EB, 2009, EMERG INFECT DIS, V15, P1347
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oehler E, 2014, EURO SURVEILL, P19
   Tappe D, 2014, EURO SURVEILL, V19
   Wsshre T, 2014, EMERG INFECT DIS, V20, P1412
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 13
TC 12
Z9 12
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD JAN
PY 2016
VL 23
IS 1
DI 10.1093/jtm/tav011
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DJ6EB
UT WOS:000374301700013
ER

PT J
AU Barreiro, P
AF Barreiro, Pablo
TI Evolving RNA Virus Pandemics: HIV, HCV, Ebola, Dengue, Chikunguya, and
   now Zika!
SO AIDS REVIEWS
LA English
DT News Item
C1 [Barreiro, Pablo] La Paz Univ Hosp, Infect Dis & Trop Med, Madrid, Spain.
RP Barreiro, P (reprint author), La Paz Univ Hosp, Infect Dis & Trop Med, Madrid, Spain.
CR Centers for Disease Control and Prevention, 2016, ZIK AND PREGN
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Lucey DR, 2016, JAMA
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
NR 4
TC 2
Z9 3
U1 7
U2 7
PU PERMANYER PUBL
PI BARCELONA
PA MALLORCA, 310, BARCELONA, 00000, SPAIN
SN 1139-6121
EI 1698-6997
J9 AIDS REV
JI Aids Rev.
PD JAN-MAR
PY 2016
VL 18
IS 1
BP 54
EP 55
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DJ0BR
UT WOS:000373866900006
PM 27028271
ER

PT J
AU Ribeiro, GS
   Kitron, U
AF Ribeiro, Guilherme Sousa
   Kitron, Uriel
TI Zika virus pandemic: a human and public health crisis
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
ID OUTBREAK; BRAZIL
C1 [Ribeiro, Guilherme Sousa; Kitron, Uriel] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Ribeiro, Guilherme Sousa] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
RP Ribeiro, GS (reprint author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Pan American Health Organization/World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Roth A, 2014, EURO SURVEILL 2014, V19
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 2
Z9 2
U1 5
U2 6
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2016
VL 49
IS 1
BP 1
EP 3
DI 10.1590/0037-8682-0036-2016
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH5RA
UT WOS:000372848300001
PM 27163559
ER

PT J
AU Marcondes, CB
   Ximenes, MDFD
AF Marcondes, Carlos Brisola
   Freire de Melo Ximenes, Maria de Fatima
TI Zika virus in Brazil and the danger of infestation by Aedes (Stegomyia)
   mosquitoes
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Aedes aegypti; Aedes albopictus; Arbovirus; Stegomyia; Culicidae
ID HOST-FEEDING PATTERNS; WEST-NILE-VIRUS; DIPTERA-CULICIDAE; CHIKUNGUNYA
   VIRUS; YELLOW-FEVER; WYEOMYIA-MITCHELLII; VECTOR COMPETENCE; POTENTIAL
   VECTOR; PUBLIC-HEALTH; 1ST REPORT
AB Zika virus, already widely distributed in Africa and Asia, was recently reported in two Northeastern Brazilian: State of Bahia and State of Rio Grande do Norte, and one Southeastern: State of Sao Paulo. This finding adds a potentially noxious virus to a list of several other viruses that are widely transmitted by Aedes (Stegomyia) aegypti and Aedes (Stegomyia) albopictus in Brazil. The pathology and epidemiology, including the distribution and vectors associated with Zika virus, are reviewed. This review is focused on viruses transmitted by Aedes (Stegomyia) mosquitoes, including dengue, Chikungunya, Zika, Mayaro, and yellow fever virus, to emphasize the risks of occurrence for these arboviruses in Brazil and neighboring countries. Other species of Aedes (Stegomyia) are discussed, emphasizing their involvement in arbovirus transmission and the possibility of adaptation to environments modified by human activities and introduction in Brazil.
C1 [Marcondes, Carlos Brisola] Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil.
   [Freire de Melo Ximenes, Maria de Fatima] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
RP Marcondes, CB (reprint author), Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil.
EM cbrisolamarcondes@gmail.com
CR AITKEN THG, 1959, AM J TROP MED HYG, V8, P41
   Alencar CHM, 2008, REV APS, V11, P459
   Armistead JS, 2012, J MED ENTOMOL, V49, P1318, DOI 10.1603/ME11261
   Besnard M, 2014, EUROSURVEILLANCE, P19
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Boechat B, 2015, PORTAL EXTRA GLOBO
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Cha Go Woon, 2013, Osong Public Health Res Perspect, V4, P170, DOI 10.1016/j.phrp.2013.04.008
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   Christophers R, 1962, AEDES AEGYPTI L YELL
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   Degallier N, 2003, REV SAUDE PUBL, V37, P386, DOI [10.1590/S0034-89102003000300019, 10.1590/s0034-89102003000300019]
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Empresa Brasil de Comunicacao S/A - EBC Agencia Brasil, 2015, 1 CAS ZIK VIR CONF E
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaffi gan TV, 2015, SYSTEMATIC CATALOG C
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Gomes AC, 2008, EPIDEMIOL SERV SAUDE, V17, P71
   Granwehr BP, 2004, LANCET INFECT DIS, V4, P547, DOI 10.1016/S1473-3099(04)01128-4
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johnson BW, 2002, T ROY SOC TROP MED H, V96, P611, DOI 10.1016/S0035-9203(02)90326-3
   Joshi V, 2006, J MED ENTOMOL, V43, P330, DOI 10.1603/0022-2585(2006)043[0330:IOSSAT]2.0.CO;2
   Juliano AS, 2005, ECOL LETT, V8, P558
   Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59
   Kek K, 2014, J MED ENTOMOL, V51, P880
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lenharo M, 2015, DETECCAO ZIKA LIQUID
   Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marcondes CB, 2007, TRENDS PARASITOL, V23, P302, DOI 10.1016/j.pt.2007.04.011
   Marie J, 2013, J MED ENTOMOL, V50, P37, DOI 10.1603/ME12170
   Marques CCA, 1998, OVERVIEW ARBOVIROLOG, P248
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI [10.1590/S0034-89102003000400013, 10.1590/s0034-89102003000400013]
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Melandri V, 2012, MEM I OSWALDO CRUZ, V107, P1073, DOI 10.1590/S0074-02762012000800020
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Ministerio da Saude, 2015, MIN SAUD DIV NOV DAD
   MIYAGI I, 1985, Mosquito Systematics, V17, P133
   Montarsi F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-292
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Muller GA, 2010, ENTOMOL NEWS, V121, P102, DOI 10.3157/021.121.0102
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NASCI RS, 1989, J AM MOSQUITO CONTR, V5, P416
   Obara MT, 2012, EPIDEMIOL SERV SAUDE, V21, P457
   Oehler E, 2014, EUROSURVEILLANCE, P19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Ortiz DI, 2008, J MED ENTOMOL, V45, P1117, DOI 10.1603/0022-2585(2008)45[1117:SOAADC]2.0.CO;2
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Portal da Saude - Ministerio da Saude, 2015, CONF ZIK VIR BRAS
   Reinart John F., 2009, European Mosquito Bulletin, V27, P10
   REINERT J F, 1975, Mosquito Systematics, V7, P105
   Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x
   Reis JG, 2015, CTR ESTADUAL VIGILAN
   RIBEIRO JMC, 1988, J MED ENTOMOL, V25, P431
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Roth A, 2014, EUROSURVEILLANCE, V19
   Rozendaal J. A., 1997, VECTOR CONTROL METHO
   Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025
   Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x
   SHROYER DA, 1981, MOSQ NEWS, V41, P805
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Thome RCA, 2010, MATH BIOSCI, V223, P12, DOI 10.1016/j.mbs.2009.08.009
   TRPIS M, 1972, B WORLD HEALTH ORGAN, V47, P77
   Van der Stuyft P, 1999, LANCET, V353, P1558, DOI 10.1016/S0140-6736(99)03291-2
   Vasconcelos Pedro Fernando da Costa, 2003, Rev. Soc. Bras. Med. Trop., V36, P275, DOI 10.1590/S0037-86822003000200012
   Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P72
   Vasconcelos PFC, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   World Health Organization, 1985, PREV CONTR YELL FEV
   WHO/TDR, 2009, DENG GUID DIAGN TREA
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2015, FOLHA SAO PAULO
NR 87
TC 11
Z9 12
U1 25
U2 27
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2016
VL 49
IS 1
BP 4
EP 10
DI 10.1590/0037-8682-0220-2015
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH5RA
UT WOS:000372848300002
PM 26689277
ER

PT J
AU Sahiner, F
   Sig, AK
   Savasci, U
   Tekin, K
AF Sahiner, Fatih
   Sig, Ali Korhan
   Savasci, Umit
   Tekin, Kemal
TI Zika virus infections in pregnancy: epidemics and case management
SO CUKUROVA MEDICAL JOURNAL
LA Turkish
DT Review
DE Zika virus; Pregnancy; epidemic; microcephaly
ID INTERIM GUIDELINES; UNITED-STATES; TRANSMISSION; AMERICA; BRAZIL
AB Zika virus is an RNA virus belonging to the Flaviviridae family, and is primarily transmitted by Aedes mosquitoes. Only a small number of cases had been described until 2007 when the first major Zika virus outbreak occurred on Yap Island, Micronesia. Approximately 80% of people infected with Zika virus do not exhibit any symptoms. Symptomatic infections are generally moderate and characterized by acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis. The virus has recently attracted a broad interest due to the emerging cases of microcephaly that are possibly associated with mothers infected by the Zika virus during pregnancy, and the regional increases in the incidence of Guillain-Barre syndrome during the epidemic periods. Although the relationship between Zika virus infection and these abnormalities is not obviously understood yet, Zika virus testing is recommended for infants with microcephaly or intracranial calcifications whose mothers were potentially infected with the Zika virus during pregnancy. Every day, new reports are being published about the outbreaks associated with this virus; nevertheless, no new cases of this virus have been reported in Turkey. Despite this, we cannot currently exclude the possibility of the encounter with the virus because of the presence of Aedes mosquitoes, which are responsible for the spread of the virus, are prevalent in Turkey, and an increasing number of travel-related cases are being reported from different countries. In the light of the current knowledge on this virus, this review aims to discuss the course of Zika virus infections in detail, especially congenital infection, and presenting current information about the case management and preventive measures.
C1 [Sahiner, Fatih; Sig, Ali Korhan; Tekin, Kemal] Gulhane Askeri Tip Akad, Tibbi Mikrobiyol Anabilim Dali, Ankara, Turkey.
   [Savasci, Umit] Gulhane Askeri Tip Akad, Kan Egitim Merkezi & Kan Bankasi Mudurlugu, Ankara, Turkey.
RP Sahiner, F (reprint author), Gulhane Askeri Tip Akad, Tibbi Mikrobiyol Anabilim Dali, Ankara, Turkey.
EM fsvirol@gmail.com
CR Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   CDC, 2016, ZIK VIR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   [Anonymous], COUNTR LOC ZIK TRANS
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EURO SURVEILL, V19
   [Anonymous], ZIK VIR
   Oehler E, 2013, EURO SURVEILL, V19
   Pan American Health Organization (PAHO), 2015, EP AL ZIK VIR INF
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   [Anonymous], 2016, ZIK VIR
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   [Anonymous], 2006, NEUR SYNDR CONG AN
   World Health Organization, 2006, WHO CHILD GROWTH STA
NR 25
TC 0
Z9 0
U1 10
U2 10
PU CUKUROVA UNIV, FAC MEDICINE
PI ADANA
PA YAYIN VE DOKUMENTASYON KURULU, BALCALI, ADANA, 01330, TURKEY
SN 0250-5150
J9 CUKUROVA MED J
JI Cukurova Med. J.
PY 2016
VL 41
IS 1
BP 143
EP 151
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DH9PS
UT WOS:000373128700023
ER

PT J
AU Calvez, E
   Guillaumot, L
   Millet, L
   Marie, J
   Bossin, H
   Rama, V
   Faamoe, A
   Kilama, S
   Teurlai, M
   Mathieu-Daude, F
   Dupont-Rouzeyrol, M
AF Calvez, Elodie
   Guillaumot, Laurent
   Millet, Laurent
   Marie, Jerome
   Bossin, Herve
   Rama, Vineshwaran
   Faamoe, Akata
   Kilama, Sosiasi
   Teurlai, Magali
   Mathieu-Daude, Francoise
   Dupont-Rouzeyrol, Myrielle
TI Genetic Diversity and Phylogeny of Aedes aegypti, the Main Arbovirus
   Vector in the Pacific
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DNA POLYMORPHISM; POPULATION-GENETICS; STATISTICAL TESTS; CHIKUNGUNYA
   VIRUS; FRENCH-POLYNESIA; MOSQUITO VECTOR; WESTERN PACIFIC; DENGUE
   VIRUSES; YELLOW-FEVER; SOFTWARE
AB Background
   The Pacific region is an area unique in the world, composed of thousands of islands with differing climates and environments. The spreading and establishment of the mosquito Aedes aegypti in these islands might be linked to human migration. Ae. aegypti is the major vector of arboviruses (dengue, chikungunya and Zika viruses) in the region. The intense circulation of these viruses in the Pacific during the last decade led to an increase of vector control measures by local health authorities. The aim of this study is to analyze the genetic relationships among Ae. aegypti populations in this region.
   Methodology/Principal Finding
   We studied the genetic variability and population genetics of 270 Ae. aegypti, sampled from 9 locations in New Caledonia, Fiji, Tonga and French Polynesia by analyzing nine microsatellites and two mitochondrial DNA regions (CO1 and ND4). Microsatellite markers revealed heterogeneity in the genetic structure between the western, central and eastern Pacific island countries. The microsatellite markers indicate a statistically moderate differentiation (FST = 0.136; P < = 0.001) in relation to island isolation. A high degree of mixed ancestry can be observed in the most important towns (e.g. Noumea, Suva and Papeete) compared with the most isolated islands (e.g. Ouvea and Vaitahu). Phylogenetic analysis indicated that most of samples are related to Asian and American specimens.
   Conclusions/Significance
   Our results suggest a link between human migrations in the Pacific region and the origin of Ae. aegypti populations. The genetic pattern observed might be linked to the island isolation and to the different environmental conditions or ecosystems.
C1 [Calvez, Elodie; Dupont-Rouzeyrol, Myrielle] Reseau Int Inst Pasteur, Inst Pasteur Nouvelle Caladonie, URE Dengue & Autres Arboviroses, Noumea, New Caledonia.
   [Guillaumot, Laurent; Kilama, Sosiasi] Reseau Int Inst Pasteur, Inst Pasteur Nouvelle Caladonie, URE Entomol Med, Noumea, New Caledonia.
   [Millet, Laurent] Inst Rech Dev, ENTROPIE, UMR 9220, Noumea, New Caledonia.
   [Marie, Jerome; Bossin, Herve] Inst Louis Malarde, Pole Malad Infect & Emergentes, Papeete, Tahiti, Fr Polynesia.
   [Rama, Vineshwaran] Minist Hlth, Suva, Fiji.
   [Faamoe, Akata] Minist Hlth, Nukualofa, Tonga.
   [Teurlai, Magali] Reseau Int Inst Pasteur, Inst Pasteur Nouvelle Caledonie, URE Epidemiol Malad Infect, Noumea, New Caledonia.
   [Mathieu-Daude, Francoise] Inst Rech Dev, MIVEGEC, UMR IRD 224,CNRS 5290, UM1,UM2, Noumea, New Caledonia.
RP Calvez, E (reprint author), Reseau Int Inst Pasteur, Inst Pasteur Nouvelle Caladonie, URE Dengue & Autres Arboviroses, Noumea, New Caledonia.
EM ecalvez@pasteur.nc
FU "Agence Francaise pour le Developpement" through Pacific Fund
   [CZT102701R/no 1162, CNC194801X/no 1272, UO0209CSOLD988/no1439];
   Government of New Caledonia [CS123007063/no1162]
FX This work was funded by the "Agence Francaise pour le Developpement"
   through the Pacific Fund (CZT102701R/no 1162, CNC194801X/no 1272,
   UO0209CSOLD988/no1439) and by the Government of New Caledonia
   (CS123007063/no1162). Recipient for both grants: LG. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37
   Belkhir K, 1996, 5000 CNRS UMR
   Belkin J. N., 1962, MOSQUITOES S PACIFIC, V1
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Cao-Lormeau V-M, LANCET, V384, P1571
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   CHOW CY, 1967, B WORLD HEALTH ORGAN, V36, P544
   Chungue E., 1998, Pacific Health Dialog, V5, P154
   Costa-da-Silva AL, 2005, MEM I OSWALDO CRUZ, V100, P639, DOI 10.1590/S0074-02762005000600007
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Dupont-Rouzeyrol M, 2014, EMERG INFECT DIS, V21, P381, DOI DOI 10.3201/EID2102.141553
   Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7
   ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2005, EVOL BIOINFORM, V1, P47
   Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y
   Failloux AB, 1995, J AM MOSQUITO CONTR, V11, P457
   Fluxus Technology ltd, 2004, NETWORK 4 6 1 3
   FU YX, 1993, GENETICS, V133, P693
   Fu YX, 1997, GENETICS, V147, P915
   Goudet J, 1995, J HERED, V86, P485
   Guillaumot L, 2012, PARASITE VECTOR, V5, P1756
   Guillaumot L, 2013, ENTOMOLOGICAL SURVEY
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   Hall T. A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X
   Hlaing T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-11
   Horwood Paul, 2013, Western Pac Surveill Response J, V4, P8, DOI 10.5365/WPSAR.2013.4.2.003
   HUERRE M, 1995, MED MALADIES INFECT, V25, P688, DOI 10.1016/S0399-077X(05)80880-7
   IRD, 2012, ATL NOUV CAL
   ISEE, 2014, BIL EC SOC 2014 ECH
   Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13
   Kopelman NM, 2015, MOL ECOL RESOUR, V12, P1755
   Kuno G, 2007, REV MED VIROL, V17, P327, DOI 10.1002/rmv.545
   LAILLE M, 1990, B SOC PATHOL EXOT, V83, P394
   Lambrechts L, 2009, BMC EVOL BIOL, V9, P1471
   Lardeux F, 2002, ANN TROP MED PARASIT, V96, pS105, DOI 10.1179/000349802125002455
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lovin DD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-590
   Marcombe S, 2013, PLOS ONE, V8
   Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167
   Nhan TX, 2014, EMERG INFECT DIS, V20, P1773, DOI 10.3201/eid2010.141060
   ORSTOM, 1993, ATL POL FRANC
   Paduan KD, 2008, J MED ENTOMOL, V45, P59, DOI 10.1603/0022-2585(2008)45[59:MDPAHI]2.0.CO;2
   Paupy C, 2000, ESPACE POPULATION SO, V62, P217
   Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001
   Paupy C, 2012, INFECT GENET EVOL, V12, P1260, DOI 10.1016/j.meegid.2012.04.012
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Perrier X, 2003, GENETIC DIVERSITY CU, P43
   PERRY WJ, 1950, AM J TROP MED, V30, P103
   Powell JR, 2013, MEM I O CRUZ, V1, P11
   Pritchard JK, 2000, GENETICS, V155, P945
   Rageau J, 1958, 117 CPS
   Raju A. K., 2003, Dengue Bulletin, V27, P149
   Rallu J-L, 1989, FRANCE PACIFIQUE, V76, P45, DOI [10.3406/outre.1989.2742, DOI 10.3406/OUTRE.1989.2742]
   Rallu J-L, 1994, ESPACE POPULATION SO, P201, DOI [10.3406/espos.1994.1640, DOI 10.3406/ESPOS.1994.1640]
   RAO N P, 1987, Heredity, V59, P253
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   ROSEN L, 1954, AM J TROP MED HYG, V3, P878
   Roth A, 2012, EUROSURVEILLANCE, V19, P20929
   Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359
   Shineberg D., 1967, THEY CAME SANDALWOOD
   Singh Narendra, 2005, Pac Health Dialog, V12, P111
   Slotman MA, 2007, MOL ECOL NOTES, V7, P168, DOI 10.1111/j.1471-8286.2006.01533.x
   Tabachnick Walter J., 1994, Advances in Disease Vector Research, V10, P93
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   TAJIMA F, 1989, GENETICS, V123, P597
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   [Anonymous], 1986, SURV NZDOLA ATL S PA
NR 69
TC 6
Z9 6
U1 14
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2016
VL 10
IS 1
AR e0004374
DI 10.1371/journal.pntd.0004374
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DH1SR
UT WOS:000372565700068
PM 26799213
ER

PT J
AU Basak, SC
   Nandy, A
AF Basak, Subhash C.
   Nandy, Ashesh
TI Computer-Assisted Approaches as Decision Support Systems in the Overall
   Strategy of Combating Emerging Diseases: Some Comments Regarding Drug
   Design, Vaccinomics, and Genomic Surveillance of the Zika Virus
SO CURRENT COMPUTER-AIDED DRUG DESIGN
LA English
DT Editorial Material
ID MATHEMATICAL DESCRIPTORS
C1 [Basak, Subhash C.] Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55811 USA.
   [Basak, Subhash C.] Univ Minnesota, Dept Chem & Biochem, Duluth, MN 55811 USA.
   [Nandy, Ashesh] Ctr Interdisciplinary Res & Educ, Jodhpur Pk, Kolkata 700068, India.
RP Basak, SC (reprint author), Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55811 USA.; Basak, SC (reprint author), Univ Minnesota, Dept Chem & Biochem, Duluth, MN 55811 USA.; Nandy, A (reprint author), Ctr Interdisciplinary Res & Educ, Jodhpur Pk, Kolkata 700068, India.
EM sbasak@nrri.umn.edu; anandy43@yahoo.com
CR Basak SC, 2010, SAR QSAR ENVIRON RES, V21, P103, DOI 10.1080/10629360903568614
   Basak SC, 2015, CURR COMPUT-AID DRUG, V11, P197, DOI 10.2174/157340991103151124190920
   Basak SC, 2010, CURR COMPUT-AID DRUG, V6, P240
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Ghattoni R., 2015, ECANCERMEDICALSCIENC, V9, P526
   Ghosh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040749
   Ghosh A, 2009, J CHEM INF MODEL, V49, P2627, DOI 10.1021/ci9001662
   Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277
   Lajiness M., 1990, COMPUTATIONAL CHEM G, P299
   Liao B, 2006, CHEM PHYS LETT, V421, P313, DOI 10.1016/j.cplett.2006.01.030
   Moisa A.A., 2012, SYNTHETIC PEPTIDE VA, P201
   Nandy A., 2015, ADV MATH CHEM APPL, V2, P96
   Nandy A, 2014, CURR COMPUT-AID DRUG, V10, P283
   Nandy A, 2006, ARKIVOC, P211
   Nandy A, 2015, CURR COMPUT-AID DRUG, V11, P110, DOI 10.2174/1573409911666150722122034
   National Institute of Allergy and Infectious Diseases, ZIK VIR
   Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078
   Pharmaceutical Research and Manufacturers of America, BIOPH RES IND PROF 2
   Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
NR 20
TC 0
Z9 0
U1 10
U2 10
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4099
EI 1875-6697
J9 CURR COMPUT-AID DRUG
JI Curr. Comput.-Aided Drug Des.
PY 2016
VL 12
IS 1
BP 2
EP 4
DI 10.2174/1573409912999160315115502
PG 3
WC Chemistry, Medicinal; Computer Science, Interdisciplinary Applications
SC Pharmacology & Pharmacy; Computer Science
GA DH1NG
UT WOS:000372550900001
PM 26975308
ER

PT J
AU Sikka, V
   Chattu, VK
   Popli, RK
   Galwankar, SC
   Kelkar, D
   Sawicki, SG
   Stawicki, SP
   Papadimos, TJ
AF Sikka, Veronica
   Chattu, Vijay Kumar
   Popli, Raaj K.
   Galwankar, Sagar C.
   Kelkar, Dhanashree
   Sawicki, Stanley G.
   Stawicki, Stanislaw P.
   Papadimos, Thomas J.
TI The emergence of zika virus as a global health security threat: A review
   and a consensus statement of the INDUSEM Joint working Group (JWG)
SO JOURNAL OF GLOBAL INFECTIOUS DISEASES
LA English
DT Review
DE Arbovirus; Flavivirus; Global health security; Public health emergency
   of international concern; Public health; Viral vector control; Zika
   virus
ID YELLOW-FEVER VIRUS; FRENCH-POLYNESIA; DENGUE VIRUS; GEOGRAPHIC
   EXPANSION; DEVELOPING-WORLD; VECTOR CONTROL; BIRTH-DEFECTS;
   AEDES-AEGYPTI; NOVEMBER 2013; WEST-NILE
AB The Zika virus (ZIKV), first discovered in 1947, has emerged as a global public health threat over the last decade, with the accelerated geographic spread of the virus noted during the last 5 years. The World Health Organization (WHO) predicts that millions of cases of ZIKV are likely to occur in the Americas during the next 12 months. These projections, in conjunction with suspected Zika-associated increase in newborn microcephaly cases, prompted WHO to declare public health emergency of international concern. ZIKV-associated illness is characterized by an incubation period of 3-12 days. Most patients remain asymptomatic (i.e., similar to 80%) after contracting the virus. When symptomatic, clinical presentation is usually mild and consists of a self-limiting febrile illness that lasts approximately 2-7 days. Among common clinical manifestations are fever, arthralgia, conjunctivitis, myalgia, headache, and maculopapular rash. Hospitalization and complication rates are low, with fatalities being extremely rare. Newborn microcephaly, the most devastating and insidious complication associated with the ZIKV, has been described in the offspring of women who became infected while pregnant. Much remains to be elucidated about the timing of ZIKV infection in the context of the temporal progression of pregnancy, the corresponding in utero fetal development stage(s), and the risk of microcephaly. Without further knowledge of the pathophysiology involved, the true risk of ZIKV to the unborn remains difficult to quantify and remediate. Accurate, portable, and inexpensive point-of-care testing is required to better identify cases and manage the current and future outbreaks of ZIKV, including optimization of preventive approaches and the identification of more effective risk reduction strategies. In addition, much more work needs to be done to produce an effective vaccine. Given the rapid geographic spread of ZIKV in recent years, a coordinated local, regional, and global effort is needed to generate sufficient resources and political traction to effectively halt and contain further expansion of the current outbreak.
C1 [Sikka, Veronica] Vet Affairs Med Ctr, Dept Emergency Med, Orlando, FL USA.
   [Popli, Raaj K.] Digest Dis Consultants Cent Florida, Altamonte Springs, FL USA.
   [Galwankar, Sagar C.; Kelkar, Dhanashree] Univ Florida, Dept Emergency Med, Jacksonville, FL USA.
   [Sawicki, Stanley G.] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.
   [Papadimos, Thomas J.] Ohio State Univ, Coll Med, Dept Anesthesiol, Columbus, OH 43210 USA.
   [Stawicki, Stanislaw P.] St Lukes Univ Hlth Network, Dept Res & Innovat, Bethlehem, PA USA.
   [Chattu, Vijay Kumar] Univ W Indies, Inst Int Relat, St Augustine, Trinid & Tobago.
RP Stawicki, SP (reprint author), St Lukes Univ Hlth Network, Dept Res & Innovat, Bethlehem, PA USA.
EM stanislaw.stawicki@sluhn.org
CR Abd El Wahed A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129682
   Adams AP, 2013, AM J TROP MED HYG, V88, P455, DOI 10.4269/ajtmh.12-0110
   Alphey L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003909
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Baba MM, 2014, FUTURE VIROL, V9, P595, DOI 10.2217/FVL.14.33
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bogoch II, 2016, LANCET
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brinton M, 1989, CLIN MOL ASPECTS NEU, P69
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cancian N, 2016, STUDY CONFIRMS ZIKA
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carnec X, 2015, J VIROL, V90, P92
   CDC, 2016, CDC HLTH ADV REC MAN
   [Anonymous], 2016, ZIKA VIR
   Cha AE, 2016, ZIKA VIRUS SPREADING
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.1053-10555.2004
   Curtis Z, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003999
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dwibedi B, 2010, VECTOR-BORNE ZOONOT, V10, P347, DOI 10.1089/vbz.2008.0190
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   EICHHORN MM, 1971, SCIENCE, V173, P710, DOI 10.1126/science.173.3998.710-a
   Eliminate_ Dengue_ Program, 2016, EL DENG PROGR WOLB
   Enfissi A, 2016, LANCET
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European_Centre_for_Disease_Prevention_and_Control, 2015, RAP RISK AS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   FALGOUT B, 1989, J VIROL, V63, P1852
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fox M., 2016, COULD WE HAVE ZIKA V
   Francis MM, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.1136/BJSPORTS-2014-094015
   Gabrieli P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0535-7
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Grenoble R, 2016, WHO DECLARES PUBLIC
   GUBLER DJ, 1994, AM J TROP MED HYG, V50, P50
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hardy TA, 2011, CURR ALLERGY ASTHM R, V11, P197, DOI 10.1007/s11882-011-0190-y
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Jamieson DJ, 2011, AM J OBSTET GYNECOL, V204, pS1, DOI 10.1016/j.ajog.2011.04.010
   Kalra Sarathi, 2014, J Glob Infect Dis, V6, P164, DOI 10.4103/0974-777X.145247
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 1998, J VIROL, V72, P73
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   LaMotte S., 2016, ZIKA HAS BEEN SEXUAL
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Lindenbach BD, 2013, FIELDS VIROLOGY
   Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Martel F, 2016, ZIKA 4000 MICROCEPHA
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi306, DOI DOI 10.1136/BMJ.I306
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McKay B, 2016, TEXAS WOMAN DIAGNOSE
   McNeil Jr DG, 2016, HAWAII BABY BRAIN DA
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MENSER MA, 1974, MED J AUSTRALIA, V1, P123
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   MORRIS AC, 1989, MED VET ENTOMOL, V3, P1, DOI 10.1111/j.1365-2915.1989.tb00467.x
   Muench H, 1934, J AM STAT ASSOC, V29, P25, DOI 10.2307/2278457
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nickel R, 2016, RACE ZIKA VACCINE GA
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oxitec_ Ltd, 2016, AED AEG OX513A
   [Anonymous], 2016, PAHO WHO PAHO STAT Z
   [Anonymous], 2015, PAHO WHO EP AL ZIK V
   [Anonymous], 2015, PAHO WHO NEUR SYNDR
   PAHO/WHO PAHO Activities on Zika Prevention and Control, 2016, PAHO WHO PAHO ACT ZI
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Phillips D, 2016, BRAZIL MAY HAVE FEWE
   Pierson T.C., 2013, FIELDS VIROLOGY, P747
   Ramamurthy M, 2013, S RAMACHANDRA J MED, V68, P22
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reuters & Al Jazeera, 2016, REUTERS AL JAZEERA
   Romero S, 2016, RES WEIGH RISKS ZIKA
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schapiro R, 2016, ZIKA VIRUS VACCINE C
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Singer PA, 2003, BRIT MED J, V327, P1342, DOI 10.1136/bmj.327.7427.1342
   Stawicki Stanislaw P, 2014, Int J Crit Illn Inj Sci, V4, P200, DOI 10.4103/2229-5151.141398
   Tami A, 2016, TRAVEL MED IN PRESS
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Weaver S, 2006, QUASISPECIES CONCEPT, P285
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   [Anonymous], 2016, REUT SPREAD ZIK VIR
   WHO, 2009, DENG GUOD DIAGN TREA
   Wojda TR, 2015, J GLOB INFECT DIS, V7, P127, DOI 10.4103/0974-777X.170495
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2014, WHO STAT 1 M IHR EM
   [Anonymous], 2016, REUTERS
NR 113
TC 9
Z9 10
U1 14
U2 42
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0974-777X
EI 0974-8245
J9 J GLOB INFECT DIS
JI J. Glob. Insect. Dis.
PD JAN-MAR
PY 2016
VL 8
IS 1
BP 3
EP 15
DI 10.4103/0974-777X.176140
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA DF0OH
UT WOS:000371038000002
PM 27013839
ER

PT J
AU Gautret, P
   Simon, F
AF Gautret, Philippe
   Simon, Fabrice
TI Dengue, chikungunya and Zika and mass gatherings: What happened in
   Brazil, 2014
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
ID FIFA WORLD CUP; VIRUS; TRANSMISSION; VISITORS; OUTLOOK; RISKS
C1 [Gautret, Philippe; Simon, Fabrice] Laveran Mil Teaching Hosp, Dept Infect Dis & Trop Med, Marseille, France.
RP Gautret, P (reprint author), Hop Instruct Arme Laveran, Serv Pathol Infectieuse & Trop, BP 60149, F-13384 Marseille 13, France.
EM philippe.gautret@club-internet.fr
CR Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8
   Aguiar M, 2015, LANCET INFECT DIS, V15, P765, DOI 10.1016/S1473-3099(15)00073-0
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Gallego V, 2014, TRAVEL MED INFECT DI, V12, P208, DOI 10.1016/j.tmaid.2014.04.004
   Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Massad E, 2014, LANCET INFECT DIS, V14, P552, DOI 10.1016/S1473-3099(14)70807-2
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   van Panhuis WG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003063
   Wilson ME, 2014, TRAVEL MED INFECT DI, V12, P205, DOI 10.1016/j.tmaid.2014.04.001
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 4
Z9 5
U1 4
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2016
VL 14
IS 1
BP 7
EP 8
DI 10.1016/j.tmaid.2015.12.004
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DE6DA
UT WOS:000370722500003
PM 26778293
ER

PT J
AU Goorhuis, A
   von Eije, KJ
   Douma, RA
   Rijnberg, N
   van Vugt, M
   Stijnis, C
   Grobusch, MP
AF Goorhuis, Abraham
   von Eije, Karin J.
   Douma, Renee A.
   Rijnberg, Noor
   van Vugt, Michele
   Stijnis, Cornelis
   Grobusch, Martin P.
TI Zika virus and the risk of imported infection in returned travelers:
   Implications for clinical care
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Travel; Microcephaly; Sexual transmission; Case series
ID TRANSMISSION
AB Since late 2015, an unprecedented outbreak of Zika virus is spreading quickly across Southern America. The large size of the current outbreak in The Americas will also result in an increase in Zika virus infections among travelers returning from endemic areas.
   We report five cases of imported Zika virus infection to The Netherlands. Although the clinical course is usually mild, establishing the diagnosis is important, mainly because of the association with congenital microcephaly and the possibility of sexual transmission. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Goorhuis, Abraham; Douma, Renee A.; Rijnberg, Noor; van Vugt, Michele; Stijnis, Cornelis; Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, Meibergdreef 9,POB 22660, NL-1100 AZ Amsterdam, Netherlands.
   [von Eije, Karin J.] Univ Amsterdam, Acad Med Ctr, Lab Clin Virol, Dept Med Microbiol,Ctr Infect & Immun Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
RP Goorhuis, A (reprint author), Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Dept Infect Dis,Div Internal Med, Meibergdreef 9,POB 22660, NL-1100 AZ Amsterdam, Netherlands.
EM a.goorhuis@amc.uva.nl
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P2075
   European Centre for Disease Prevention and Control (ECDC), 2015, RAP RISK ASS MICR BR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pan American Health Organization (PAHO), ZIK VIR INF
   Tognarelli J, 2015, ARCH VIROL
NR 8
TC 6
Z9 6
U1 10
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2016
VL 14
IS 1
BP 13
EP 15
DI 10.1016/j.tmaid.2016.01.008
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DE6DA
UT WOS:000370722500006
PM 26872416
ER

PT J
AU Ginier, M
   Neumayr, A
   Gunther, S
   Schmidt-Chanasit, J
   Blum, J
AF Ginier, Mylene
   Neumayr, Andreas
   Guenther, Stephan
   Schmidt-Chanasit, Jonas
   Blum, Johannes
TI Zika without symptoms in returning travellers: What are the
   implications?
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Flavivirus infection; Travel medicine
ID ALBOPICTUS DIPTERA-CULICIDAE; VIRUS; DENGUE; CHIKUNGUNYA; TRANSMISSION;
   FRANCE; ABUNDANCE; FLORIDA; STATES
AB Against the background of the emergence and rapid spread of Zika virus (ZIKV) in the Americas, we report the case of an afebrile ZIKV infection in a traveller returning from Central America to highlight relevant clinical and diagnostic aspects. ZIKV should be considered in the differential diagnosis of patients with clinical symptoms suggestive of dengue or chikungunya fever. Given the frequent subfebril and afebrile manifestations of ZIKV infections, we propose abstaining from the term "Zika fever (ZF)" in favour of "Zika virus disease (ZVD)". Owing to its unspecific clinical presentation and cross-reactivity in serological assays, ZVD may easily be missed or misdiagnosed as dengue fever. Until conclusive data on the currently suspected link between ZIKV infection in pregnancy and foetal microcephaly become available, pregnant women and women who are trying to become pregnant should be advised against travelling to regions with ongoing ZIKV transmission. In addition, male travellers returning from regions with ongoing transmission should be informed of the potential risk of sexual transmission until conclusive data on the significance of this mode of transmission become available. Although probably low and seasonally restricted, there is a risk of ZIKV importation to Aedes mosquito-infested regions in temperate climates (including regions of North America and Europe) with consecutive autochthonous transmission. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Ginier, Mylene] Univ Lausanne, CH-1015 Lausanne, Switzerland.
   [Ginier, Mylene; Neumayr, Andreas; Blum, Johannes] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Neumayr, Andreas] Univ Basel, CH-4003 Basel, Switzerland.
   [Guenther, Stephan; Schmidt-Chanasit, Jonas] WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Guenther, Stephan; Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site, Hamburg, Germany.
RP Neumayr, A (reprint author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
EM andreas.neumayr@unibas.ch
CR Angelini R, 2007, Euro Surveill, V12
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   [Anonymous], 2016, LANCET
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096
   Goorhuis A., 2015, PROMED MAIL POST ZIK
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Kutsuna S, 2013, EUROSURVEILLANCE, V19, P20683
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization, 2015, EP AL ZIK VIR INF
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Schmidt-Chanasit J, 2010, EUROSURVEILLANCE, V15, P2
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Zitko T, 2014, J MED ENTOMOL, V51, P760, DOI 10.1603/ME13071
NR 29
TC 6
Z9 6
U1 15
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2016
VL 14
IS 1
BP 16
EP 20
DI 10.1016/j.tmaid.2016.01.012
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DE6DA
UT WOS:000370722500007
PM 26876061
ER

PT J
AU Salvador, FS
   Fujita, DM
AF Salvador, Felipe Scassi
   Fujita, Dennis Minoru
TI Entry routes for Zika virus in Brazil after 2014 world cup: New
   possibilities
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika virus; Brazil; Travelers; World cup
C1 [Salvador, Felipe Scassi; Fujita, Dennis Minoru] Univ Sao Paulo, Inst Med Trop Sao Paulo, BR-09500900 Sao Paulo, Brazil.
RP Fujita, DM (reprint author), Av Dr Eneas Carvalho Aguiar,470 1 Aandar, BR-05403000 Sao Paulo, Brazil.
EM dmfujita@usp.br
CR Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2015, B EPIDEMIOLOGICO, V46
   Pan American Health Organization (PAHO), 2015, EP AL ZIK VIR INF
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 4
TC 14
Z9 15
U1 7
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JAN-FEB
PY 2016
VL 14
IS 1
BP 49
EP 51
DI 10.1016/j.tmaid.2015.10.004
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DE6DA
UT WOS:000370722500013
PM 26627575
ER

PT J
AU Ventura, CV
   Maia, M
   Ventura, BV
   Van Der Linden, V
   Araujo, EB
   Ramos, RC
   Rocha, MAW
   Carvalho, MDCG
   Belfort, R
   Ventura, LO
AF Ventura, Camila V.
   Maia, Mauricio
   Ventura, Bruna V.
   Van Der Linden, Vanessa
   Araujo, Eveline B.
   Ramos, Regina C.
   Rocha, Maria Angela W.
   Carvalho, Maria Durce C. G.
   Belfort, Rubens, Jr.
   Ventura, Liana O.
TI Ophthalmological findings in infants with microcephaly and presumable
   intra-uterus Zika virus infection
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Microcephaly; Zika virus; Ocular findings; Vertical transmission; Retina
ID EYE
AB Purpose: In 2015, a twenty-fold increase in the prevalence of microcephaly in Brazil was reported, and the Ministry of Health associated this abnormal prevalence with the maternal-fetal Zika virus (ZIKV) transmission.
   Methods: We assessed the ophthalmological findings of ten mothers and their infants that had been clinically diagnosed with ZIKV-related microcephaly and presented ocular abnormalities, born from May to December 2015.
   Results: Seven mothers (70.0%) referred symptoms during pregnancy (malaise, rash and arthralgia), of which six (85.7%) were in the first trimester. At the time of exam, no ophthalmological abnormalities were identified in the mothers and they did not report ocular symptoms during pregnancy. Serology was negative in all infants for Toxoplasmosis, Rubella, Cytomegalovirus, Syphilis and Human Immunodeficiency Viruses. Ocular findings included macular alterations (gross pigment mottling and/or chorioretinal atrophy) in fifteen eyes (75.0%), and optic nerve abnormalities (hypoplasia with double-ring sign, pallor, and/or increased cup-to-disk ratio) in nine eyes (45.0%).
   Conclusions: Patients presented normal anterior segment and important macular and optic nerve abnormalities. Further studies will assess the visual significance of these alterations.
C1 [Ventura, Camila V.; Ventura, Bruna V.; Araujo, Eveline B.; Ventura, Liana O.] FAV, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Bruna V.; Araujo, Eveline B.; Ventura, Liana O.] Hosp Olhos Pernambuco HOPE, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Ventura, Bruna V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo UNIFESP, EPM, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil.
   [Van Der Linden, Vanessa] Hosp Barao de Lucena, Recife, PE, Brazil.
   [Ramos, Regina C.; Rocha, Maria Angela W.; Carvalho, Maria Durce C. G.] HUOC, Recife, PE, Brazil.
RP Belfort, R (reprint author), Escola Paulista Med, Dept Oftalmol, Rua Botucatu 831, BR-04023062 Sao Paulo, SP, Brazil.
EM clinbelf@uol.com.br
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brasil, 2015, PROT VIG RESP OC MIC, P1
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias (COES), 2015, INF EP SEM EP, V47
   GORDON RA, 1985, ARCH OPHTHALMOL-CHIC, V103, P785
   Kaur Savleen, 2013, Oman J Ophthalmol, V6, P77, DOI 10.4103/0974-620X.116622
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Ventura CV, 2015, LANCET
NR 9
TC 34
Z9 39
U1 56
U2 115
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2016
VL 79
IS 1
BP 1
EP 3
DI 10.5935/0004-2749.20160002
PG 3
WC Ophthalmology
SC Ophthalmology
GA DD1BS
UT WOS:000369656700002
PM 26840156
ER

PT J
AU Fontes, BM
AF Fontes, Bruno M.
TI Zika virus-related hypertensive iridocyclitis
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Letter
C1 [Fontes, Bruno M.] Ctr Microcirurgia & Diagnost, Rio De Janeiro, RJ, Brazil.
   [Fontes, Bruno M.] Ave Ataulfo de Paiva 135-1418, BR-22440032 Rio De Janeiro, RJ, Brazil.
RP Fontes, BM (reprint author), Ave Ataulfo de Paiva 135-1418, BR-22440032 Rio De Janeiro, RJ, Brazil.
EM fontesbrunom@gmail.com
CR Dyer O., BMJ             1223, V351, ph6983
   Fauci A.S., 2016, N ENGL J MED
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Triunfol M., 2015, LANCET INFECT DIS
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P609
NR 6
TC 5
Z9 6
U1 3
U2 17
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD JAN-FEB
PY 2016
VL 79
IS 1
BP 63
EP 63
DI 10.5935/0004-2749.20160020
PG 1
WC Ophthalmology
SC Ophthalmology
GA DD1BS
UT WOS:000369656700020
PM 26840174
ER

PT J
AU Aubry, M
   Richard, V
   Green, J
   Broult, J
   Musso, D
AF Aubry, Maite
   Richard, Vaea
   Green, Jennifer
   Broult, Julien
   Musso, Didier
TI Inactivation of Zika virus in plasma with amotosalen and ultraviolet A
   illumination
SO TRANSFUSION
LA English
DT Article
ID WEST-NILE-VIRUS; TRANSFUSION-ASSOCIATED TRANSMISSION; PATHOGEN
   INACTIVATION; PHOTOCHEMICAL INACTIVATION; BLOOD-TRANSFUSION;
   UNITED-STATES; FEVER; INFECTION; PLATELET; EPIDEMIC
AB BACKGROUNDZika virus (ZIKV) is an arthropod-borne virus (arbovirus) transmitted by mosquitoes. The potential for ZIKV transmission through blood transfusion was demonstrated during the ZIKV outbreak that occurred in French Polynesia from October 2013 to April 2014. Pathogen inactivation of blood products is a proactive strategy that provides the potential to reduce transfusion-transmitted diseases. Inactivation of arboviruses by amotosalen and ultraviolet A (UVA) illumination was previously demonstrated for chikungunya, West Nile, and dengue viruses. We report here the efficiency of this process for ZIKV inactivation of human plasma.
   STUDY DESIGN AND METHODSPlasma units were spiked with ZIKV. Viral titers and RNA loads were measured in plasma before and after amotosalen and UVA photochemical treatment.
   RESULTSThe mean ZIKV titers and RNA loads in plasma before inactivation were respectively 6.57 log TCID50/mL and 10.25 log copies/mL. After inactivation, the mean ZIKV RNA loads was 9.51 log copies/mL, but cell cultures inoculated with inactivated plasma did not result in infected cells and did not produce any replicative virus after one passage, nor detectable viral RNA from the second passage.
   CONCLUSIONIn this study we demonstrate that amotosalen combined with UVA light inactivates ZIKV in fresh-frozen plasma. This inactivation process is of particular interest to prevent plasma transfusion-transmitted ZIKV infections in areas such as French Polynesia, where several arboviruses are cocirculating.
C1 [Aubry, Maite; Richard, Vaea; Musso, Didier] Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, Fr Polynesia.
   [Green, Jennifer] Cerus Corp, Concord, CA USA.
   [Broult, Julien] Hop Taaone, Ctr Transfus Sanguine Polynesie Francaise, Tahiti, Fr Polynesia.
RP Aubry, M (reprint author), Inst Louis Malarde, POB 30, Papeete, Tahiti, Fr Polynesia.
EM maubry@ilm.pf
FU Cerus Corporation
FX This study was partially funded by Cerus Corporation.
CR Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005
   Besnard M, 2014, EUROSURVEILLANCE, P19
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Bruchmuller I, 2005, TRANSFUSION, V45, P1464, DOI 10.1111/j.1537-2995.2005.00553.x
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Campos GS, 2015, EMERG INFECT DIS, P21
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Centers for Disease Control and Prevention (CDC), 2003, MMWR-MORBID MORTAL W, V52, P769
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   Corten L, 2011, 3 INT M EM DIS SURV
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupuis K, 2012, TRANSFUSION, V52, P2012
   Epstein JS, 2003, TRANSFUSION, V43, P1347, DOI 10.1046/j.1537-2995.2003.00584.x
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   Kelly S, 2013, MMWR-MORBID MORTAL W, V62, P622
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lin L, 1997, TRANSFUSION, V37, P423, DOI 10.1046/j.1537-2995.1997.37497265344.x
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Meny GM, 2011, BLOOD, V117, P5778, DOI 10.1182/blood-2011-02-335901
   Montgomery SP, 2006, TRANSFUSION, V46, P2038, DOI 10.1111/j.1537-2995.2006.01030.x
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Oehler E, 2014, EURO SURVEILL, P19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Roth A, 2014, EUROSURVEILLANCE, V19, P41
   Sagripanti JL, 2011, PHOTOCHEM PHOTOBIOL, V87, P1369, DOI 10.1111/j.1751-1097.2011.00998.x
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh Y, 2006, TRANSFUSION, V46, P1168, DOI 10.1111/j.1537-2995.2006.00867.x
   Stramer SL, 2009, TRANSFUSION S2, V43, P1
   Stramer SL, 2014, ISBT SCI SER, V9, P30
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan LK, 2013, ADV INFECT DIS, V3, P1
NR 48
TC 13
Z9 14
U1 16
U2 89
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JAN
PY 2016
VL 56
IS 1
BP 33
EP 40
DI 10.1111/trf.13271
PG 8
WC Hematology
SC Hematology
GA DA6YJ
UT WOS:000367951500005
PM 26283013
ER

PT J
AU Melo, ASO
   Malinger, G
   Ximenes, R
   Szejnfeld, PO
   Sampaio, SA
   de Filippis, AMB
AF Melo, A. S. Oliveira
   Malinger, G.
   Ximenes, R.
   Szejnfeld, P. O.
   Sampaio, S. Alves
   de Filippis, A. M. Bispo
TI Zika virus intrauterine infection causes fetal brain abnormality and
   microcephaly: tip of the iceberg?
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Editorial Material
C1 [Melo, A. S. Oliveira] ISEA, Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Brazil.
   [Malinger, G.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Div Ultrasound Obstet & Gynecol,Lis Matern Hosp, IL-69978 Tel Aviv, Israel.
   [Ximenes, R.] Centrus Fetal Med, Fetal Med Fdn Latinamer FMFLA, Campinas, SP, Brazil.
   [Szejnfeld, P. O.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Diagnost Imagem DDI UNIFESP, FIDI Fundacao Inst Ensino & Pesquisa Diagnost Ima, Sao Paulo, Brazil.
   [Sampaio, S. Alves; de Filippis, A. M. Bispo] Inst Oswaldo Cruz FIOCRUZ, Lab Flavivirus, Rio De Janeiro, Brazil.
RP Malinger, G (reprint author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Div Ultrasound Obstet & Gynecol,Lis Matern Hosp, IL-69978 Tel Aviv, Israel.
EM gmalinger@gmail.com
CR Besnard M, 2014, EURO SURVEILL, V19
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P1135
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V8, P1232
NR 7
TC 74
Z9 82
U1 27
U2 229
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD JAN
PY 2016
VL 47
IS 1
BP 6
EP 7
DI 10.1002/uog.15831
PG 2
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA DA3TE
UT WOS:000367721000002
ER

PT J
AU Calvet, GA
   Filippis, AMB
   Mendonca, MCL
   Sequeira, PC
   Siqueira, AM
   Veloso, VG
   Nogueira, RM
   Brasil, P
AF Calvet, Guilherme A.
   Filippis, Ana Maria B.
   Mendonca, Marcos Cesar L.
   Sequeira, Patricia C.
   Siqueira, Andre M.
   Veloso, Valdilea G.
   Nogueira, Rita M.
   Brasil, Patricia
TI First detection of autochthonous Zika virus transmission in a
   HIV-infected patient in Rio de Janeiro, Brazil
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika; ZIKV; Arbovirus; HIV; Brazil
ID DENGUE VIRUSES; CHIKUNGUNYA; EXPANSION; FEVER
AB Since May 2015, Brazil's Ministry of Health has reported autochthonous transmission of Zika virus (ZIKV) in some states of the country. Simultaneous circulation of Dengue, Chikungunya and ZIKV in the country hinder both the diagnosis and the therapeutic approach of patients seeking care with acute febrile illnesses especially in patients with comorbidities. The association between HIV infection and endemic diseases has been described especially in tropical regions with varying levels of complications, although there has been no report of ZIKV in HIV-infected patients. We report the first autochthonous case of laboratory confirmed ZIKV infection in a HIV-infected patient in Rio de Janeiro, Brazil. He evolved with only mild symptoms and recovered well without major laboratory abnormalities. Phylogenetic analysis of the ZIKV detected in the patient sera clustered within the Asian clade. To the best of our knowledge, this is the first time that Zika virus co-infection is reported in a HIV-infected patient. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Calvet, Guilherme A.; Siqueira, Andre M.; Brasil, Patricia] Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, BR-21045360 Rio De Janeiro, Brazil.
   [Filippis, Ana Maria B.; Mendonca, Marcos Cesar L.; Sequeira, Patricia C.; Nogueira, Rita M.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Flavivirus Lab, BR-21045360 Rio De Janeiro, Brazil.
   [Veloso, Valdilea G.] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, STD AIDS Clin Res Lab, BR-21045360 Rio De Janeiro, Brazil.
RP Calvet, GA (reprint author), Fundacao Oswaldo Cruz, Lab Pesquisa Clin Doencas Febris Agudas, Inst Nacl Infect Evandro Chagas, Ave Brasil 4365, BR-21045360 Rio De Janeiro, Brazil.
EM guilherme.calvet@ini.fiocruz.br; abispo@ioc.fiocruz.br;
   marcosclm@ioc.fiocruz.br; patricia@ioc.fiocruz.br;
   andre.siqueira@ioc.fiocruz.br; valdiled.veloso@gmail.com;
   rita@ioc.fiocruz.br; patricia.brasil@ini.fiocruz.br
RI Calvet, Guilherme/G-6959-2013; 
OI Calvet, Guilherme/0000-0002-3545-5238; Siqueira,
   Andre/0000-0003-2208-0294
FU FAPERJ (Research Foundation of the State of Rio de Janeiro)
   [E-26/010.001558/2014]; Fiocruz
FX FAPERJ (Research Foundation of the State of Rio de
   Janeiro)[E-26/010.001558/2014] and Fiocruz.
CR Bressan C.S., 2010, THESIS
   Collao X, 2010, AM J TROP MED HYG, V82, P505, DOI [10.4269/ajtmh.2010.09-0435, 10.4269/ajtmh.2010/09-0435]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   McLinden JH, 2008, J INFECT DIS, V198, P860, DOI 10.1086/591254
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Secretaria de Vigilancia em Saude Ministerio da Saude, ZIK SIT EP DAD
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Watt G, 2003, CLIN INFECT DIS, V36, P1067, DOI 10.1086/374600
NR 17
TC 15
Z9 16
U1 14
U2 103
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JAN
PY 2016
VL 74
BP 1
EP 3
DI 10.1016/j.jcv.2015.11.014
PG 3
WC Virology
SC Virology
GA CZ9BC
UT WOS:000367391800001
PM 26615388
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI Zika virus spreads across Americas as concerns mount over birth defects
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Brazil Ministry of Health, MON CAS MICR BRAS
   Brazil Ministry of Health, 2015, NOT MED PER CEF DIAG
   Pan American Health Organization (PAHO), 2015, NEUR SYNDR CONG MALF
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
NR 4
TC 25
Z9 26
U1 12
U2 129
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD DEC 23
PY 2015
VL 351
AR h6983
DI 10.1136/bmj.h6983
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA CZ7QI
UT WOS:000367294200011
PM 26698165
ER

PT J
AU Aubry, M
   Finke, J
   Teissier, A
   Roche, C
   Broult, J
   Paulous, S
   Despres, P
   Cao-Lormeau, VM
   Musso, D
AF Aubry, Maite
   Finke, Jerome
   Teissier, Anita
   Roche, Claudine
   Broult, Julien
   Paulous, Sylvie
   Despres, Philippe
   Cao-Lormeau, Van-Mai
   Musso, Didier
TI Seroprevalence of arboviruses among blood donors in French Polynesia,
   2011-2013
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE French Polynesia; Seroprevalence; Blood donors; Arboviruses; Dengue;
   Pacific
AB Objectives: French Polynesia is a high epidemic/endemic area for arthropod-borne viruses (arboviruses). We recently reported the silent circulation of Ross River virus and absence of active transmission of chikungunya virus (CHIKV) among blood donors sampled before the emergence of Zika virus (ZIKV) and CHIKV in French Polynesia. In this study, the prevalence of the four serotypes of dengue virus (DENV) and the occurrence of circulation of other arboviruses were investigated in blood donors in French Polynesia.
   Methods: Serum samples from 593 blood donors collected between July 2011 and October 2013 were tested by ELISA for the presence of immunoglobulin G antibodies against each of the four DENV serotypes, ZIKV, Japanese encephalitis virus (JEV), and West Nile virus (WNV).
   Results: It was found that 80.3%, 0.8%, 1.3%, and 1.5% of blood donors were seropositive for at least one DENV serotype, ZIKV, JEV, and WNV, respectively.
   Conclusions: These results corroborate the expected high transmission of DENV and conversely suggest that no active circulation of ZIKV, JEV, and WNV occurred in French Polynesia before 2011. Information provided by this study may be useful for public health authorities to improve surveillance and implement strategies to prevent the transmission of arboviruses. (C) 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Aubry, Maite; Teissier, Anita; Roche, Claudine; Cao-Lormeau, Van-Mai; Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete 98713, Tahiti, Fr Polynesia.
   [Finke, Jerome] Hsch Emden Leer, Emden, Germany.
   [Broult, Julien] Hop Taaone, Ctr Transfus Sanguine Polynesie Francaise, Papeete, Tahiti, Fr Polynesia.
   [Paulous, Sylvie; Despres, Philippe] Inst Pasteur, Unite Hepacivirus & Immun Innee, Paris, France.
   [Despres, Philippe] Univ Reunion, UMR PIMIT 12T, St Clotilde, Reunion.
RP Aubry, M (reprint author), Inst Louis Malarde, Unit Emerging Infect Dis, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM maubry@ilm.pf
FU  [7331/MSS/DSP]
FX We are grateful to Jerome Viallon from the Institut Louis Malarde,
   French Polynesia, for technical support. We also thank Philippe Buchy
   from the Institut Pasteur in Cambodia for providing JEV-positive control
   serum. This study was supported by the "Contrat de projets 2012-2014''
   (Convention No. 7331/MSS/DSP, 08/31/2012).
CR Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Beck C, 2015, BIOMED RES INT, DOI 10.1155/2015/678084
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   CHUNGUE E, 1989, T ROY SOC TROP MED H, V83, P708, DOI 10.1016/0035-9203(89)90404-5
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Marie J, 2013, J MED ENTOMOL, V50, P37, DOI 10.1603/ME12170
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Singh Narendra, 2005, Pac Health Dialog, V12, P111
NR 10
TC 20
Z9 22
U1 10
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2015
VL 41
BP 11
EP 12
DI 10.1016/j.ijid.2015.10.005
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DA8FI
UT WOS:000368040100004
PM 26482390
ER

PT J
AU Cardoso, CW
   Paploski, IAD
   Kikuti, M
   Rodrigues, MS
   Silva, MMO
   Campos, GS
   Sardi, SI
   Kitron, U
   Reis, MG
   Ribeiro, GS
AF Cardoso, Cristiane W.
   Paploski, Igor A. D.
   Kikuti, Mariana
   Rodrigues, Moreno S.
   Silva, Monaise M. O.
   Campos, Gubio S.
   Sardi, Silvia I.
   Kitron, Uriel
   Reis, Mitermayer G.
   Ribeiro, Guilherme S.
TI Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and
   Dengue Viruses, Salvador, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID MICRONESIA; EPIDEMIC
C1 [Cardoso, Cristiane W.] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Paploski, Igor A. D.; Kikuti, Mariana; Rodrigues, Moreno S.; Silva, Monaise M. O.; Kitron, Uriel; Reis, Mitermayer G.; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Paploski, Igor A. D.; Kikuti, Mariana; Campos, Gubio S.; Sardi, Silvia I.; Reis, Mitermayer G.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (reprint author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Paploski, Igor/D-7015-2014
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Zammarchi L, 2015, EURO SURVEIL, V20
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 43
Z9 45
U1 17
U2 135
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2015
VL 21
IS 12
BP 2274
EP 2276
DI 10.3201/eid2112.151167
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CX1MT
UT WOS:000365461000048
PM 26584464
ER

PT J
AU Diagne, CT
   Diallo, D
   Faye, O
   Ba, Y
   Faye, O
   Gaye, A
   Dia, I
   Faye, O
   Weaver, SC
   Sall, AA
   Diallo, M
AF Diagne, Cheikh Tidiane
   Diallo, Diawo
   Faye, Oumar
   Ba, Yamar
   Faye, Ousmane
   Gaye, Alioune
   Dia, Ibrahima
   Faye, Ousmane
   Weaver, Scott C.
   Sall, Amadou Alpha
   Diallo, Mawlouth
TI Potential of selected Senegalese Aedes spp. mosquitoes (Diptera:
   Culicidae) to transmit Zika virus
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Aedes; Arboviruses; Oral infection; Senegal; Vector competence; West
   Africa; Zika virus
ID EQUINE ENCEPHALITIS-VIRUS; YELLOW-FEVER; SOUTHEASTERN SENEGAL;
   GEOGRAPHIC STRAINS; CHIKUNGUNYA VIRUS; ARBOVIRUSES; SUSCEPTIBILITY;
   AEGYPTI; VECTOR; ALBOPICTUS
AB Background: Zika virus (ZIKV; genus Flavivirus, family Flaviviridae) is an emerging virus of medical importance maintained in a zoonotic cycle between arboreal Aedes spp. mosquitoes and nonhuman primates in African and Asian forests. Serological evidence and virus isolations have demonstrated widespread distribution of the virus in Senegal. Several mosquito species have been found naturally infected by ZIKV but little is known about their vector competence.
   Methods: We assessed the vector competence of Ae. aegypti from Kedougou and Dakar, Ae. unilineatus, Ae. vittatus and Ae. luteocephalus from Kedougou in Senegal for 6 ZIKV strains using experimental oral infection. Fully engorged female mosquitoes were maintained in an environmental chamber set at 27 +/- 1 degrees C and 80 +/- 5 % Relative humidity. At day 5, 10 and 15 days post infection (dpi), individual mosquito saliva, legs/wings and bodies were tested for the presence of ZIKV genome using real time RT-PCR to estimate the infection, dissemination, and transmission rates.
   Results: All the species tested were infected by all viral strains but only Ae. vittatus and Ae. luteocephalus were potentially capable of transmitting ZIKV after 15 dpi with 20 and 50 % of mosquitoes, respectively, delivering epidemic (HD 78788) and prototype (MR 766) ZIKV strains in saliva.
   Conclusion: All the species tested here were susceptible to oral infection of ZIKV but only a low proportion of Ae. vittatus and Ae. luteocephalus had the viral genome in their saliva and thus the potential to transmit the virus. Further investigations are needed on the vector competence of other species associated with ZIKV for better understanding of the ecology and epidemiology of this virus in Senegal.
C1 [Diagne, Cheikh Tidiane; Diallo, Diawo; Ba, Yamar; Gaye, Alioune; Dia, Ibrahima; Diallo, Mawlouth] Inst Pasteur, Unite Entomol Med, Dakar, Senegal.
   [Faye, Oumar; Faye, Ousmane; Sall, Amadou Alpha] Inst Pasteur, Unite Arbovirus & Virus Fievres Hemorrag, Dakar, Senegal.
   [Diagne, Cheikh Tidiane; Faye, Ousmane] Univ Cheikh Anta Diop, Lab Ecol Vectorielle & Parasitaire, Dept Biol Anim, Dakar, Senegal.
   [Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol & Microbiol & Immunol, Galveston, TX 77555 USA.
RP Diagne, CT (reprint author), Inst Pasteur, Unite Entomol Med, 36 Ave Pasteur,BP 220, Dakar, Senegal.
EM ctdiagne@pasteur.sn
RI Weaver, Scott/D-6490-2011
FU US National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health [R01AI069145]
FX This work was supported by grant from the US National Institute of
   Allergy and Infectious Diseases [Grant R01AI069145] of the National
   Institutes of Health. The authors gratefully thank Amadou Thiaw, Abdou
   K. Bodian for their technical assistance during fieldwork and mosquito
   rearing.
CR Adam F, 2013, CRORA
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1
   Berge TO, 1975, INT CATALOG ARBOVIRU
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Nikolay B, 2012, AM J TROP MED HYG, V86, P993
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chen RB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003591
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P446, DOI 10.1016/0035-9203(83)90108-6
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   Diagne CT, 2014, AM J TROP MED HYG, V91, P635, DOI 10.4269/ajtmh.13-0627
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2014, AM J TROP MED HYG, V90, P1003, DOI 10.4269/ajtmh.13-0404
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fall G, 2014, AM J TROP MED HYG, V90, P747, DOI 10.4269/ajtmh.13-0405
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2014, EMERG INFECT DIS, V20, P456, DOI 10.3201/eid2003.121885
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Karabatsos N., 1985, INT CATALOGUE ARBOVI
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith DR, 2006, EMERG INFECT DIS, V12, P1190
   Smith DR, 2005, AM J TROP MED HYG, V73, P33
   TESH RB, 1976, AM J TROP MED HYG, V25, P326
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 38
TC 24
Z9 24
U1 13
U2 112
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 2
PY 2015
VL 15
AR 492
DI 10.1186/s12879-015-1231-2
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA CV5AU
UT WOS:000364278400001
PM 26527535
ER

PT J
AU Galindo-Fraga, A
   Ochoa-Hein, E
   Sifuentes-Osornio, J
   Ruiz-Palacios, GM
AF Galindo-Fraga, Arturo
   Ochoa-Hein, Eric
   Sifuentes-Osornio, Jose
   Ruiz-Palacios, Guillermo M.
TI ZIKA VIRUS: A NEW EPIDEMIC ON OUR DOORSTEP
SO REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL
   INVESTIGATION
LA English
DT Article
DE Zika; Microcephaly; Aedes albopictus; Mexico
ID TRANSMISSION; BRAZIL
AB Zika virus, a flavivirus transmitted to humans by mosquitoes of the genus Aedes, was first described in humans as isolated cases in Africa. Outbreaks have been reported outside that region since 2007, followed by its gradual introduction to different geographical areas. In 2015, Zika virus was detected in Brazil, from where it is rapidly expanding in the continent; the first case in Mexico was detected in October 2015. Initially deemed as a cause of mild illness, confirmation of microcephaly cases associated with this infection in Brazil have resulted in the World Health Organization declaration of Zika virus infection as a Public Health Emergency of International Concern. The US Centers for Disease Control and Prevention issued travel alerts for countries with declared cases. The vector is widely distributed in Mexico and control measures are the most effective means for prevention, not only of Zika virus, but also dengue and chikungunya.
C1 [Galindo-Fraga, Arturo; Ochoa-Hein, Eric] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hosp Epidemiol & Hlth Care Qual Control, Vasco de Quiroga 15,Col Secc 16, Mexico City 14000, DF, Mexico.
   [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico.
   [Ruiz-Palacios, Guillermo M.] Secretaria Salud Mexico, Inst Nacl Salud & Hosp Alta Especialidad, Comis Coordinadora, Mexico City, DF, Mexico.
RP Galindo-Fraga, A (reprint author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hosp Epidemiol & Hlth Care Qual Control, Vasco de Quiroga 15,Col Secc 16, Mexico City 14000, DF, Mexico.
EM arturo.galindof@incmnsz.mx
CR Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   loos S, 2014, MED MALADIES INFECT, V44, P302
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pech-May A, 2016, ACTA TROP, V157, P30, DOI 10.1016/j.actatropica.2016.01.021
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Salud Mexico, 2015, LIN EST VIG EP DIAGN
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 11
TC 2
Z9 2
U1 14
U2 14
PU INST NACIONAL NUTRICION
PI MEXICO
PA VASCO DE QUIROZA 15, COLONIA SECCION XVI, TLALPAN, MEXICO 14000 D F,
   MEXICO
SN 2385-3956
J9 REV INVEST CLIN
JI Rev. Investig. Clin.
PD NOV-DEC
PY 2015
VL 67
IS 6
BP 329
EP 332
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI1FA
UT WOS:000373240800001
ER

PT J
AU Brito, C
AF Brito, Carlos
TI Zika Virus: A New Chapter in the History of Medicine
SO ACTA MEDICA PORTUGUESA
LA English
DT Editorial Material
DE Aedes; Arboviruses; Flavivirus; Flaviviridae Infections
ID BRAZIL
C1 [Brito, Carlos] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Brito, C (reprint author), Univ Fed Pernambuco, Recife, PE, Brazil.
EM cbritoc@gmail.com
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Pan American Health Organization/World Health Organization (PAHO/WHO), 2015, EP AL NEUR SYNDR CON
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 4
TC 5
Z9 6
U1 7
U2 42
PU ORDEM MEDICOS
PI LISBON
PA AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL
SN 1646-0758
J9 ACTA MEDICA PORT
JI Acta Medica Port.
PD NOV-DEC
PY 2015
VL 28
IS 6
BP 679
EP 680
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DB5AZ
UT WOS:000368526700001
PM 26849748
ER

PT J
AU Pinto, VL
   Luz, K
   Parreira, R
   Ferrinho, P
AF Pinto Junior, Vitor Laerte
   Luz, Kleber
   Parreira, Ricardo
   Ferrinho, Paulo
TI Zika Virus: A Review to Clinicians
SO ACTA MEDICA PORTUGUESA
LA Portuguese
DT Article
DE Aedes; Arboviruses; Flavivirus; Flaviviridae Infections
ID SEROLOGIC SURVEY; HUMAN-POPULATION; INFECTIONS; AEDES; ARBOVIRUSES;
   NIGERIA; STATE; TRANSMISSION; MICRONESIA; ISOLATIONS
AB Zika virus is a flavivirus related to Dengue virus, yellow fever virus and West Nile virus. It is considered an emerging arbovirus transmitted by mosquitos of the genus Aedes. Its first description took place in 1947 in the Zika Forest in Uganda, isolated on Rhesus monkey used as bait to study the yellow fever virus. Sporadic cases have been detected in African countries and at the end of the 70's in Indonesia. In 2007, epidemics were described in Micronesia and other islands in the Pacific Ocean and more recently in Brazil. Clinical picture is characterized as a 'dengue-like' syndrome, with abrupt onset of fever and an early onset evanescent rash, often pruritic. Occasionally the disease has been associated with Guillain-Barre syndrome. Nevertheless, until now deaths and complications caused by the disease were not reported. The diagnosis can be performed by PCR or by IgG and IgM antibodies detection. The rapid spread of the virus and its epidemic potential are especially problematic in countries where there are the circulation of other arboviruses which imposes difficulties in the differential diagnosis and healthcare burden. Control measures are the same recommended for dengue and chikungunya which are based in health education and vector control.
C1 [Pinto Junior, Vitor Laerte] Fiocruz MS, Dept Epidemiol & Vigilancia Saude, Brasilia, DF, Brazil.
   [Pinto Junior, Vitor Laerte; Parreira, Ricardo; Ferrinho, Paulo] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, P-1200 Lisbon, Portugal.
   [Luz, Kleber] Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande do Norte, Dept Doencas Infecciosas, BR-59072970 Natal, RN, Brazil.
RP Pinto, VL (reprint author), Fiocruz MS, Dept Epidemiol & Vigilancia Saude, Brasilia, DF, Brazil.
EM vitorlaerte@gmail.com
CR Ansar V, 2015, PRIMARY CARE, V42, P189, DOI 10.1016/j.pop.2015.01.001
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Besnard M, 2014, EUROSURVEILLANCE, P19
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chippaux A, 1981, Med Trop (Mars), V41, P53
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, RAP RISK ASS ZIK VIR
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nelwan Erni J, 2014, Acta Med Indones, V46, P339
   Oehler E, 2013, EURO SURVEILL, V19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Zammarchi L., 2015, EUROSURVEILLANCE, P20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 51
TC 3
Z9 4
U1 10
U2 77
PU ORDEM MEDICOS
PI LISBON
PA AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL
SN 1646-0758
J9 ACTA MEDICA PORT
JI Acta Medica Port.
PD NOV-DEC
PY 2015
VL 28
IS 6
BP 760
EP 765
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DB5AZ
UT WOS:000368526700015
PM 26849762
ER

PT J
AU Macesic, N
   Abbott, IJ
   Johnson, DF
AF Macesic, Nenad
   Abbott, Iain J.
   Johnson, Douglas F.
TI Fever and Rash in a Husband and Wife Returning From the Cook Islands
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
ID ZIKA VIRUS; DENGUE; CHIKUNGUNYA; INFECTIONS
C1 [Macesic, Nenad; Johnson, Douglas F.] Austin Hosp, Dept Infect Dis, Melbourne, Vic 3084, Australia.
   [Abbott, Iain J.] Austin Hosp, Victorian Infect Dis Reference Lab, Melbourne, Vic 3084, Australia.
   [Johnson, Douglas F.] Austin Hosp, Dept Gen Med, Melbourne, Vic 3084, Australia.
RP Macesic, N (reprint author), Austin Hosp, 145 Studley Rd, Heidelberg, Vic 3084, Australia.
EM nenadmacesic@yahoo.com.au
CR Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Roth A, 2014, EUROSURVEILLANCE, V19
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
NR 13
TC 1
Z9 1
U1 17
U2 22
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2015
VL 61
IS 9
BP 1445
EP +
DI 10.1093/cid/civ401
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CT6XI
UT WOS:000362956000015
PM 26453655
ER

PT J
AU Kleinman, S
AF Kleinman, Steven
TI Pathogen inactivation: emerging indications
SO CURRENT OPINION IN HEMATOLOGY
LA English
DT Review
DE blood safety; emerging infectious agents; pathogen inactivation;
   pathogen reduction; transfusion-transmitted infection
ID WEST-NILE-VIRUS; TRANSFUSION-TRANSMITTED DENGUE; CHIKUNGUNYA VIRUS;
   BLOOD-TRANSFUSION; PLATELET COMPONENTS; UNITED-STATES; PHOTOCHEMICAL
   INACTIVATION; ESTIMATED RISK; EPIDEMIC; REDUCTION
AB Purpose of reviewTo review data about transfusion-transmitted infections so as to assess potential safety benefits of applying pathogen inactivation technology to platelets.Recent findingsResidual bacterial risk still exists. Multiple arbovirus epidemics continue to occur and challenge blood safety policy makers in nonendemic developed countries. There is new documentation of transfusion transmission of dengue and Ross River viruses, and new or increased concern about chikungunya and Zika viruses. Pathogen inactivation has been shown to inactivate almost all bacterial species and several epidemic arboviruses that pose a transfusion transmission risk. The two available platelet pathogen inactivation technologies show different levels of pathogen inactivation as measured by in-vitro infectivity assays; the clinical significance of this finding is not known.SummaryPathogen inactivation can mitigate infectious risk and should do so more completely than other interventions such as donor questioning, donor/component recall, or donor testing. However, pathogen inactivation increases the cost of the pathogen-reduced blood component, which is a significant obstacle in the current healthcare environment. This may inhibit the ability to move forward with an effective new paradigm for blood safety that fulfills the implicit public trust in the blood system.
C1 [Kleinman, Steven] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.
RP Kleinman, S (reprint author), Univ British Columbia, 1281 Rockcrest Ave, Victoria, BC V9A 4W4, Canada.
EM skleinman@shaw.ca
FU Cerus Corporation, manufacturer of the Intercept System
FX Paid consultant for Cerus Corporation, manufacturer of the Intercept
   System.
CR Alter HJ, 2008, TRANSFUS MED REV, V22, P97, DOI 10.1016/j.tmrv.2008.01.001
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Appassakij H, 2014, TRANSFUSION, V54, P1945, DOI 10.1111/trf.12575
   Aubry M, 2015, VOX SANG S1, V109, P189
   Benjamin RJ, 2014, TRANSFUS MED REV, V28, P61, DOI 10.1016/j.tmrv.2014.01.001
   Benjamin RJ, 2014, ISBT SCI SER, V9, P124
   Biggerstaff BJ, 2002, TRANSFUSION, V42, P1019, DOI 10.1046/j.1537-2995.2002.00167.x
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Centers for Disease Control and Prevention, CHIK VIR 2014 PROV D
   Center for Biologics Evaluation and Research Food and Drug Administration, 2014, GUID IND BA IN PRESS
   Chuang WW, 2008, HONG KONG MED J, V14, P170
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Dupuis K, 2012, TRANSFUSION, V52, P2012
   Dupuis K, 2014, VOX SANG, V107, P126
   [Anonymous], 2014, RAP RISK ASS ZIK VIR
   Faddy H, 2012, VOX SANG, V103, P191
   Faddy HM, 2015, TRANSFUSION, V55, P824, DOI 10.1111/trf.12899
   Farrugia A, 2015, TRANSFUSION, V55, P224, DOI 10.1111/trf.12933
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Girona-Llobera E, 2014, TRANSFUSION, V54, P158, DOI 10.1111/trf.12232
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Kleinman S, 2013, TRANSFUSION, V53, P1603, DOI 10.1111/j.1537-2995.2012.03928.x
   Kwon SY, 2014, VOX SANG, V107, P254, DOI 10.1111/vox.12158
   Lafeuillade B, 2015, TRANSFUSION, V55, P636, DOI 10.1111/trf.12883
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Levi JE, 2015, TRANSFUSION, V55, P961, DOI 10.1111/trf.12944
   Lieshout-Krikke RW, 2015, TRANSFUSION, V55, P79, DOI 10.1111/trf.12783
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Lozano M, 2015, TRANSFUSION, V55, P690, DOI 10.1111/trf.12996
   Marano G, 2015, BLOOD TRANSFUS
   McCullough J, 2015, TRANSFUSION
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Oh HB, 2015, TRANSFUSION, V55, P1655, DOI 10.1111/trf.13054
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Petersen LR, 2014, TRANSFUSION, V54, P1911, DOI 10.1111/trf.12790
   Peterson LR, 2012, TRANSFUSION, V52, P1647
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   Roth A, 2014, EUROSURVEILLANCE, V19
   Sabino EC, 2015, J INFECT DIS
   Schmidt M, 2015, TRANSFUSION
   Snyder EL, 2015, NEW ENGL J MED, V372, P1882, DOI 10.1056/NEJMp1500154
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan LK, 2013, ADV INFECT DIS, V3, P1
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   Tsetsarkin KA, 2013, AM J TROP MED HYG, V88, P1163, DOI 10.4269/ajtmh.12-0603
   Vanlandingham DL, 2013, TRANSFUSION, V53, P284, DOI 10.1111/j.1537-2995.2012.03717.x
NR 50
TC 6
Z9 6
U1 5
U2 33
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1065-6251
EI 1531-7048
J9 CURR OPIN HEMATOL
JI Curr. Opin. Hematol.
PD NOV
PY 2015
VL 22
IS 6
BP 547
EP 553
DI 10.1097/MOH.0000000000000186
PG 7
WC Hematology
SC Hematology
GA CT2OI
UT WOS:000362641700014
PM 26390164
ER

PT J
AU Campos, GS
   Bandeira, AC
   Sardi, SI
AF Campos, Gubio S.
   Bandeira, Antonio C.
   Sardi, Silvia I.
TI Zika Virus Outbreak, Bahia, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Campos, Gubio S.; Sardi, Silvia I.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Bandeira, Antonio C.] Hosp Alianca, Salvador, BA, Brazil.
RP Sardi, SI (reprint author), Univ Fed Bahia, Inst Ciencias Saude, Virol Lab, Av Reitor Miguel Calmon,S-N 40110-100 Vale Canela, Salvador, BA, Brazil.
EM sissardi@yahoo.com.br
CR Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chowdhury P, 2014, COMP IMMUNOL MICROB, V37, P39, DOI 10.1016/j.cimid.2013.10.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2014, EMERG INFECT DIS, V21, P381, DOI DOI 10.3201/EID2102.141553
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
NR 10
TC 116
Z9 121
U1 31
U2 175
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2015
VL 21
IS 10
BP 1885
EP 1886
DI 10.3201/eid2110.150847
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CS5ZY
UT WOS:000362158000038
PM 26401719
ER

PT J
AU Musso, D
AF Musso, Didier
TI Zika Virus Transmission from French Polynesia to Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID DENGUE
C1 Inst Louis Malarde, Papeete 98713, Tahiti, Fr Polynesia.
RP Musso, D (reprint author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR Campos GS, 2016, EMERG INFECT DIS
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Schwan K, 2014, PROMEDMAIL      0309
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 5
TC 52
Z9 56
U1 11
U2 111
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2015
VL 21
IS 10
BP 1887
EP 1887
DI 10.3201/eid2110.151125
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CS5ZY
UT WOS:000362158000039
PM 26403318
ER

PT J
AU Valero, N
AF Valero, Nereida
TI Zika virus: Another emerging arbovirus in Venezuela?
SO INVESTIGACION CLINICA
LA Spanish
DT Editorial Material
CR Besnard M, 2014, EUR COMMUN DIS B, V19
   Carvajal A, INFECCION VRUS ZIKA
   Deilgat M, 2014, CCDR, V40, P1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 6
TC 1
Z9 1
U1 3
U2 6
PU INST INVESTIGACION CLINICA
PI MARACAIBO
PA APARTADO 23, MARACAIBO 4001-A, VENEZUELA
SN 0535-5133
J9 INVEST CLIN
JI Invest. Clin.
PD SEP
PY 2015
VL 56
IS 3
BP 241
EP 242
PG 2
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DL0WG
UT WOS:000375352700001
PM 26710538
ER

PT J
AU Nhan, TX
   Musso, D
AF Nhan, Tu-Xuan
   Musso, Didier
TI Emergence of Zika virus
SO VIROLOGIE
LA French
DT Review
DE Zika virus; ZIKV; arbovirus; emerging; French Polynesia
ID FRENCH-POLYNESIA; CHIKUNGUNYA VIRUS; AEDES-ALBOPICTUS; POTENTIAL VECTOR;
   FEBRUARY 2014; YELLOW-FEVER; TRANSMISSION; DENGUE; INFECTIONS; OUTBREAK
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) of the family Flaviviridae, genus Flavivirus, transmitted by the bite of infected mosquitoes. ZIKV was first isolated from a non-human primate in 1947, ZIKV infections in humans were sporadic during 60 years before emerging in the Pacific in 2007 and 2013 and in Brazil in 2015. Due to a non-specific clinical presentation, Zika fever can be misdiagnosed with other arboviruses such as dengue and chikungunya. ZIKV infections were associated with mild illness before the large French Polynesia outbreak in 2013-2014 in which severe neurological complications were reported. Routine laboratory diagnosis of Zika fever relies on the detection of specific ZIKV RNA by PCR. Serological diagnosis is complicated due to cross reactivity with other flaviviruses. ZIKV adapted to an urban cycle involving humans and domestic mosquito vectors that are widely distributed, such as Aedes aegypti and Ae. albopictus. This adaptation highlights the potential for ZIKV to emerge in tropical, intertropical and also temperate areas.
C1 [Nhan, Tu-Xuan; Musso, Didier] Inst Louis Malarde, Lab Anal Biol Med, Papeete 98713, Tahiti, Fr Polynesia.
   [Musso, Didier] Inst Louis Malarde, Pole Rech & Veille Malad Infectieuses Emergentes, Papeete 98713, Tahiti, Fr Polynesia.
RP Nhan, TX (reprint author), Inst Louis Malarde, Lab Anal Biol Med, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM tnhan@ilm.pf
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   [Anonymous], 2014, RAP RISK ASS ZIK VIR
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, PLOS NEGL TROP DIS, V201
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Haut conseil de la Sante publique (HCSP), 2015, MEDICAL CARE OF PATI
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2013, EUROSURVEILLANCE, V19, P20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nhan T X, 2015, Clin Microbiol Infect, V21, pe47, DOI 10.1016/j.cmi.2015.02.018
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization, 2015, EP AL ZIK VIR INF
   Pyke A.T., 2014, PLOS CURR, P6
   Secretarait of the Pacific Community (SPC), 2015, EP EM DIS AL PAC REG
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 51
TC 5
Z9 5
U1 27
U2 280
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1267-8694
J9 VIROLOGIE
JI Virologie
PD SEP-OCT
PY 2015
VL 19
IS 5
BP 225
EP 235
DI 10.1684/vir.2015.0622
PG 11
WC Virology
SC Virology
GA CW9OF
UT WOS:000365327400006
ER

PT J
AU Andries, AC
   Duong, V
   Ly, S
   Cappelle, J
   Kim, KS
   Try, PL
   Ros, S
   Ong, S
   Huy, R
   Horwood, P
   Flamand, M
   Sakuntabhai, A
   Tarantola, A
   Buchy, P
AF Andries, Anne-Claire
   Duong, Veasna
   Ly, Sowath
   Cappelle, Julien
   Kim, Kim Srorn
   Try, Patrich Lorn
   Ros, Sopheaktra
   Ong, Sivuth
   Huy, Rekol
   Horwood, Paul
   Flamand, Marie
   Sakuntabhai, Anavaj
   Tarantola, Arnaud
   Buchy, Philippe
TI Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LINKED-IMMUNOSORBENT-ASSAY; WEST NILE VIRUS; PROTEIN NS1; NONSTRUCTURAL
   PROTEIN-1; ACUTE INFECTION; HEPATITIS-A; BLOOD SPOTS; ZIKA VIRUS;
   ANTIBODIES; ANTIGEN
AB Background
   Dengue laboratory diagnosis is essentially based on detection of the virus, its components or antibodies directed against the virus in blood samples. Blood, however, may be difficult to draw in some patients, especially in children, and sampling during outbreak investigations or epidemiological studies may face logistical challenges or limited compliance to invasive procedures from subjects. The aim of this study was to assess the possibility of using saliva and urine samples instead of blood for dengue diagnosis.
   Methodology/Principal Findings
   Serial plasma, urine and saliva samples were collected at several time-points between the day of admission to hospital until three months after the onset of fever in children with confirmed dengue disease. Quantitative RT-PCR, NS1 antigen capture and ELISA serology for anti-DENV antibody (IgG, IgM and IgA) detection were performed in parallel on the three body fluids. RT-PCR and NS1 tests demonstrated an overall sensitivity of 85.4%/63.4%, 41.6%/14.5% and 39%/28.3%, in plasma, urine and saliva specimens, respectively. When urine and saliva samples were collected at the same time-points and tested concurrently, the diagnostic sensitivity of RNA and NS1 detection assays was 69.1% and 34.4%, respectively. IgG/IgA detection assays had an overall sensitivity of 54.4%/37.4%, 38.5%/26.8% and 52.9%/28.6% in plasma, urine and saliva specimens, respectively. IgM were detected in 38.1% and 36% of the plasma and saliva samples but never in urine.
   Conclusions
   Although the performances of the different diagnostic methods were not as good in saliva and urine as in plasma specimens, the results obtained by qRT-PCR and by anti-DENV antibody ELISA could well justify the use of these two body fluids to detect dengue infection in situations when the collection of blood specimens is not possible.
C1 [Andries, Anne-Claire; Duong, Veasna; Ros, Sopheaktra; Ong, Sivuth; Horwood, Paul; Buchy, Philippe] Inst Pasteur Cambodia, Virol Unit, Phnom Penh, Cambodia.
   [Ly, Sowath; Cappelle, Julien; Tarantola, Arnaud] Inst Pasteur Cambodia, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia.
   [Cappelle, Julien] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite AGIRs, Montpellier, France.
   [Kim, Kim Srorn; Try, Patrich Lorn] Kampong Cham Prov Hosp, Dept Pediat, Kampong Cham, Cambodia.
   [Huy, Rekol] Minist Hlth, Ctr Natl Malariol, Phnom Penh, Cambodia.
   [Flamand, Marie] Inst Pasteur, Struct Virol Unit, Paris, France.
   [Flamand, Marie] Inst Pasteur, CNRS UMR 3569, Paris, France.
   [Sakuntabhai, Anavaj] Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France.
   [Sakuntabhai, Anavaj] CNRS, Unite Rech Associee, Paris, France.
   [Buchy, Philippe] GlaxoSmithKline Vaccines, Vaccine Value & Hlth Sci, Singapore, Singapore.
RP Andries, AC (reprint author), Inst Pasteur Cambodia, Virol Unit, Phnom Penh, Cambodia.
EM buchyphilippe@hotmail.com
RI Tarantola, Arnaud/D-2149-2015
OI Tarantola, Arnaud/0000-0002-6946-7958
FU European Union [282 378]
FX The research leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007/2011) under Grant
   Agreement no282 378. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.2.376-381.2002
   Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   Anders KL, 2012, AM J TROP MED HYG, V87, P165, DOI 10.4269/ajtmh.2012.11-0713
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Bakoush O, 2001, NEPHROL DIAL TRANSPL, V16, P1357, DOI 10.1093/ndt/16.7.1357
   Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Balmaseda A, 2008, J CLIN VIROL, V43, P287, DOI 10.1016/j.jcv.2008.07.016
   Banavar SR, 2014, J CLIN DIAGN RES, V8, P229, DOI DOI 10.7860/JCDR/2014/7521.4169
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Buchy Philippe, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P178
   Chakravarti A, 2007, CURR MICROBIOL, V55, P461, DOI 10.1007/s00284-007-9040-5
   Chau Tran Nguyen Bich, 2010, PLoS Negl Trop Dis, V4, pe657, DOI 10.1371/journal.pntd.0000657
   Chuansumrit A, 2011, DIAGN MICR INFEC DIS, V71, P467, DOI 10.1016/j.diagmicrobio.2011.08.020
   Cuzzubbo AJ, 1998, J CLIN MICROBIOL, V36, P3737
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Elsana S, 1998, J MED VIROL, V55, P24
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   FRERICHS RR, 1994, AIDS, V8, P885, DOI 10.1097/00002030-199407000-00004
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Hijmans R.J., 2014, SPECIES DISTRIBUTION
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hue Kien Duong Thi, 2011, J Virol Methods, V177, P168, DOI 10.1016/j.jviromet.2011.08.002
   Jaenisch T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002320
   Jarman RG, 2011, AM J TROP MED HYG, V84, P218, DOI 10.4269/ajtmh.2011.09-0798
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Joshi MS, 2002, CLIN DIAGN LAB IMMUN, V9, P840, DOI 10.1128/CDLI.9.4.840-845.2002
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lizarraga Karlo J, 2014, J Nephropathol, V3, P57, DOI 10.12860/jnp.2014.13
   Luo W, 2013, J CLIN VIROL, V58, pE113, DOI 10.1016/j.jcv.2013.08.017
   Ma XZ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-56
   Menon MC, 2012, INT J NEPHROL, V2012, DOI DOI 10.1155/2012/749010
   Michishige Fumiko, 2006, J Med Invest, V53, P140, DOI 10.2152/jmi.53.140
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415
   NUMATA N, 1993, J MED VIROL, V41, P120, DOI 10.1002/jmv.1890410207
   Papa A, 2014, J MED VIROL, V86, P2142, DOI 10.1002/jmv.23949
   PARRY JV, 1987, LANCET, V2, P72
   Patidar Kalpana A, 2011, J Oral Sci, V53, P97
   PERRY KR, 1992, J MED VIROL, V38, P265, DOI 10.1002/jmv.1890380407
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Ridgeway G., 2013, GEN BOOSTED REGRESSI
   Saito Y, 2015, JPN J INFECT DIS, DOI [10.7883/yoken.JJID.2014.441, DOI 10.7883/Y0KEN.JJID.2014.441]
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Special Programme for Research and Training in Tropical Diseases World Health Organization, 2009, DENG GUID DIAGN TREA
   Talarmin A, 1998, J CLIN MICROBIOL, V36, P1189
   Terada K, 2000, PEDIATR INFECT DIS J, V19, P104, DOI 10.1097/00006454-200002000-00003
   Thomas L, 2010, AM J TROP MED HYG, V83, P696, DOI [10.4269/ajtmh.2010.10-0138, 10.1269/ajtmh.2010.10-0138]
   Toblli JE, 2012, INT J NEPHROL, V2012
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Vazquez S, 2007, INT J INFECT DIS, V11, P256, DOI 10.1016/j.ijid.2006.05.005
   Vong S, 2006, PLOS NEGLECT TROP D, V4, pe903, DOI DOI 10.1371/J0URNAL.PNTD.0000903
   World Health Organization-European Union supported DSG, 1997, DENG HAEM FEV DIAGN
   Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754
   Yap G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001046
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053
   Zhang Y, 2015, LAB CHIP, V15, P1465, DOI 10.1039/c4lc01127a
NR 64
TC 4
Z9 4
U1 13
U2 57
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2015
VL 9
IS 9
AR e0004100
DI 10.1371/journal.pntd.0004100
PG 30
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CT7YI
UT WOS:000363031200066
PM 26406240
ER

PT J
AU Summers, DJ
   Acosta, RW
   Acosta, AM
AF Summers, Dyan J.
   Acosta, Rebecca Wolfe
   Acosta, Alberto M.
TI Zika Virus in an American Recreational Traveler
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
ID TRANSMISSION
AB We report the case of a 48-year-old American traveler who presented to our clinic with diffuse rash, malaise, fatigue, fever, arthralgia, low back pain, and bilateral exudative conjunctivitis. The patient had an extensive vaccination and travel history: most notable for prior receipt of yellow fever vaccine; extensive travel or residence in areas endemic for dengue, chikungunya, and West Nile virus; and recent travel to French Polynesia. Clinical and laboratory findings were consistent with Zika virus (ZIKV) infection. Our report highlights the need to include ZIKV in the differential diagnosis, especially in febrile patients with a rash returning from endemic areas.
C1 [Summers, Dyan J.; Acosta, Rebecca Wolfe; Acosta, Alberto M.] Travelers Med Serv New York, New York, NY 10022 USA.
   [Summers, Dyan J.] Columbia Univ, Sch Nursing, New York, NY USA.
   [Acosta, Alberto M.] Weill Cornell Med Coll, Dept Med, New York, NY USA.
   [Acosta, Alberto M.] New York Presbyterian Hosp, New York, NY USA.
RP Summers, DJ (reprint author), Travelers Med Serv New York, 595 Madison Ave,Suite 1200, New York, NY 10022 USA.
EM dsummers@travelersmedical.com
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kutsuna S, 2014, EURO SURVEILL, P19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EURO SURVEILL, V19
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
NR 15
TC 14
Z9 17
U1 4
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD SEP-OCT
PY 2015
VL 22
IS 5
BP 338
EP 340
DI 10.1111/jtm.12208
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA CQ7EU
UT WOS:000360766600008
PM 25996909
ER

PT J
AU Hamel, R
   Dejarnac, O
   Wichit, S
   Ekchariyawat, P
   Neyret, A
   Luplertlop, N
   Perera-Lecoin, M
   Surasombatpattana, P
   Talignani, L
   Thomas, F
   Cao-Lormeau, V
   Choumet, V
   Briant, L
   Despres, P
   Amara, A
   Yssel, H
   Misse, D
AF Hamel, Rodolphe
   Dejarnac, Ophelie
   Wichit, Sineewanlaya
   Ekchariyawat, Peeraya
   Neyret, Aymeric
   Luplertlop, Natthanej
   Perera-Lecoin, Manuel
   Surasombatpattana, Pornapat
   Talignani, Loic
   Thomas, Frederic
   Cao-Lormeau, Van-Mai
   Choumet, Valerie
   Briant, Laurence
   Despres, Philippe
   Amara, Ali
   Yssel, Hans
   Misse, Dorothee
TI Biology of Zika Virus Infection in Human Skin Cells
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID HUMAN DENDRITIC CELLS; WEST-NILE-VIRUS; DENGUE-VIRUS; HEPARAN-SULFATE;
   ENCEPHALITIS-VIRUS; IMMUNE-RESPONSES; AEDES-ALBOPICTUS; I INTERFERON;
   AUTOPHAGY; REPLICATION
AB Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae family, which includes dengue, West Nile, yellow fever, and Japanese encephalitis viruses, that causes a mosquito-borne disease transmitted by the Aedes genus, with recent outbreaks in the South Pacific. Here we examine the importance of human skin in the entry of ZIKV and its contribution to the induction of antiviral immune responses. We show that human dermal fibroblasts, epidermal keratinocytes, and immature dendritic cells are permissive to the most recent ZIKV isolate, responsible for the epidemic in French Polynesia. Several entry and/or adhesion factors, including DC-SIGN, AXL, Tyro3, and, to a lesser extent, TIM-1, permitted ZIKV entry, with a major role for the TAM receptor AXL. The ZIKV permissiveness of human skin fibroblasts was confirmed by the use of a neutralizing antibody and specific RNA silencing. ZIKV induced the transcription of Toll-like receptor 3 (TLR3), RIG-I, and MDA5, as well as several interferon-stimulated genes, including OAS2, ISG15, and MX1, characterized by strongly enhanced beta interferon gene expression. ZIKV was found to be sensitive to the antiviral effects of both type I and type II interferons. Finally, infection of skin fibroblasts resulted in the formation of autophagosomes, whose presence was associated with enhanced viral replication, as shown by the use of Torin 1, a chemical inducer of autophagy, and the specific autophagy inhibitor 3-methyladenine. The results presented herein permit us to gain further insight into the biology of ZIKV and to devise strategies aiming to interfere with the pathology caused by this emerging flavivirus.
   IMPORTANCE
   Zika virus (ZIKV) is an arbovirus belonging to the Flaviviridae family. Vector-mediated transmission of ZIKV is initiated when a blood-feeding female Aedes mosquito injects the virus into the skin of its mammalian host, followed by infection of permissive cells via specific receptors. Indeed, skin immune cells, including dermal fibroblasts, epidermal keratinocytes, and immature dendritic cells, were all found to be permissive to ZIKV infection. The results also show a major role for the phosphatidylserine receptor AXL as a ZIKV entry receptor and for cellular autophagy in enhancing ZIKV replication in permissive cells. ZIKV replication leads to activation of an antiviral innate immune response and the production of type I interferons in infected cells. Taken together, these results provide the first general insights into the interaction between ZIKV and its mammalian host.
C1 [Hamel, Rodolphe; Wichit, Sineewanlaya; Ekchariyawat, Peeraya; Perera-Lecoin, Manuel; Talignani, Loic; Thomas, Frederic; Misse, Dorothee] UM, Lab MIVEGEC, UMR 224, IRD,CNRS, Montpellier, France.
   [Dejarnac, Ophelie; Amara, Ali] INSERM, U944, Lab Pathol & Virol Mol, Paris, France.
   [Neyret, Aymeric; Briant, Laurence] UM, Ctr Etud Agents Pathogenes & Biotechnol Sante, CNRS, UMR 5236, Montpellier, France.
   [Luplertlop, Natthanej] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.
   [Surasombatpattana, Pornapat] Prince Songkla Univ, Dept Pathol, Hat Yai, Thailand.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete, Tahiti, Fr Polynesia.
   [Choumet, Valerie] Inst Pasteur, Environm & Infect Risks Unit, Paris, France.
   [Despres, Philippe] Inst Pasteur, Dept Infect & Epidemiol, Paris, France.
   [Despres, Philippe] Univ La Reunion, CNRS 9192, GIP CYROI, UMR,PIMIT I2T Team,INSERM,U1187,IRD 249, St Clotilde, Reunion.
   [Yssel, Hans] Univ Paris 06, Hop La Pitie Salpetriere, APHP, Ctr Immunol & Malad Infect,INSERM,U1135,Sorbonne, Paris, France.
RP Misse, D (reprint author), UM, Lab MIVEGEC, UMR 224, IRD,CNRS, Montpellier, France.
EM dorothee.misse@ird.fr
RI Yssel, Hans/C-6406-2009; MISSE, DOROTHEE/A-7590-2012
OI Yssel, Hans/0000-0001-7454-1836; 
FU Agence Nationale de la Recherche [ANR-12-BSV3-0004-01,
   ANR-14-CE14-0029]; Infectiopole Sud foundation
FX This work was supported by grants from the Agence Nationale de la
   Recherche (grants ANR-12-BSV3-0004-01 and ANR-14-CE14-0029).
   Sineewanlaya Wichit was supported by a fellowship from the Infectiopole
   Sud foundation.
CR Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bourne N, 2007, J VIROL, V81, P9100, DOI 10.1128/JVI.00316-07
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P446, DOI 10.1016/0035-9203(83)90108-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kuno G, 1998, J VIROL, V72, P73
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006
   Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paladino P, 2006, J IMMUNOL, V177, P8008
   Panyasrivanit M, 2011, VIROLOGY, V418, P74, DOI 10.1016/j.virol.2011.07.010
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Proost P, 2003, EUR J IMMUNOL, V33, P3146, DOI 10.1002/eji.200324136
   Pyke AT, 2014, PLOS CURR, V2, P6, DOI DOI 10.1371/CURRENTS
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Talloczy Z, 2006, AUTOPHAGY, V2, P24
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
NR 64
TC 74
Z9 77
U1 75
U2 279
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2015
VL 89
IS 17
BP 8880
EP 8896
DI 10.1128/JVI.00354-15
PG 17
WC Virology
SC Virology
GA CQ6GZ
UT WOS:000360703900020
PM 26085147
ER

PT J
AU Choumet, V
   Despres, P
AF Choumet, V.
   Despres, Ph.
TI Dengue and other flavivirus infections
SO REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
LA English
DT Article
DE Arbovirus; Dengue; Flavivirus; Vaccines; Vector transmission; Virus
   diagnosis; Yellow fever; Zika fever
ID YELLOW-FEVER; HEMORRHAGIC-FEVER; VIRUSES; PATHOGENESIS; CHALLENGES;
   DIAGNOSIS
AB Flaviviruses are responsible for yellow fever, Zika fever and dengue, all of which are major human diseases found in tropical regions of the globe. They are zoonoses with a transmission cycle that involves primates as reservoirs' and mosquitoes of the genus Aedes as vectors. The recent upsurge of urban epidemics of yellow fever, Zika fever and dengue has involved human-to-human transmission with mosquitoes as the vector. This paper is primarily concerned with dengue, which has become the pre-eminent arbovirosis in terms of public health.
C1 [Choumet, V.] Inst Pasteur, Flavivirus Host Mol Interact Unit, World Hlth Org Collaborating Ctr Arbovirus & Vira, World Org Anim Hlth OIE Collaborating Ctr Rift Va, F-75724 Paris, France.
   [Despres, Ph.] Univ Reun Isl, UMR PIMIT, Team Immunopathol Infect Dis Trop, INSERM,U1187,CNRS 9192, St Clotilde 97491, Reunion.
   [Despres, Ph.] IRD 249, Technol Platform CYROI, St Clotilde, Reunion.
RP Despres, P (reprint author), Univ Reun Isl, UMR PIMIT, Team Immunopathol Infect Dis Trop, INSERM,U1187,CNRS 9192, 2 Rue Maxime Riviere, St Clotilde 97491, Reunion.
EM philippe.despres@univ-reunion.ft
CR Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Chanama S, 2004, J CLIN VIROL, V31, P185, DOI 10.1016/j.jcv.2004.03.005
   Cottin P, 2013, EXPERT REV VACCINES, V12, P1351, DOI 10.1586/14760584.2013.836320
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Herrero LJ, 2013, PHARMACOL THERAPEUT, V137, P266, DOI 10.1016/j.pharmthera.2012.10.007
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Kong YY, 2006, J VIROL METHODS, V138, P123, DOI 10.1016/j.jviromet.2006.08.003
   KUNO G, 1991, J VIROL METHODS, V33, P101, DOI 10.1016/0166-0934(91)90011-N
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   Slatko BE, 2014, MOL BIOCHEM PARASIT, V195, P88, DOI 10.1016/j.molbiopara.2014.07.004
   Special Programme for Research and Training in Tropical Diseases World Health Organization, 2009, DENG GUID DIAGN TREA
   Tangy F, 2014, J INFECT DIS, V209, P318, DOI 10.1093/infdis/jit551
   Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Yauch LE, 2014, ADV VIRUS RES, V88, P315, DOI 10.1016/B978-0-12-800098-4.00007-6
NR 25
TC 2
Z9 3
U1 6
U2 56
PU OFFICE INT EPIZOOTIES
PI PARIS
PA 12 RUE DE PRONY, 75017 PARIS, FRANCE
SN 0253-1933
J9 REV SCI TECH OIE
JI Rev. Sci. Tech. Off. Int. Epizoot.
PD AUG
PY 2015
VL 34
IS 2
BP 473
EP 478
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA CS8BP
UT WOS:000362311000014
PM 26601449
ER

PT J
AU Buathong, R
   Hermann, L
   Thaisomboonsuk, B
   Rutvisuttinunt, W
   Klungthong, C
   Chinnawirotpisan, P
   Manasatienkij, W
   Nisalak, A
   Fernandez, S
   Yoon, IK
   Akrasewi, P
   Plipat, T
AF Buathong, Rome
   Hermann, Laura
   Thaisomboonsuk, Butsaya
   Rutvisuttinunt, Wiriya
   Klungthong, Chonticha
   Chinnawirotpisan, Piyawan
   Manasatienkij, Wudtichai
   Nisalak, Ananda
   Fernandez, Stefan
   Yoon, In-Kyu
   Akrasewi, Passakorn
   Plipat, Tanarak
TI Detection of Zika Virus Infection in Thailand, 2012-2014
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID MICRONESIA
AB Zika virus (ZIKV) is an emerging mosquito-borne pathogen with reported cases in Africa, Asia, and large outbreaks in the Pacific. No autochthonous ZIKV infections have been confirmed in Thailand. However, there have been several cases reported in travelers returning from Thailand. Here we report seven cases of acute ZIKV infection in Thai residents across the country confirmed by molecular or serological testing including sequence data. These endemic cases, combined with previous reports in travelers, provide evidence that ZIKV is widespread throughout Thailand.
C1 [Buathong, Rome; Akrasewi, Passakorn; Plipat, Tanarak] Minist Publ Hlth, Dept Dis Control, Bur Epidemiol, Nonthaburi, Thailand.
   [Hermann, Laura; Thaisomboonsuk, Butsaya; Rutvisuttinunt, Wiriya; Klungthong, Chonticha; Chinnawirotpisan, Piyawan; Manasatienkij, Wudtichai; Nisalak, Ananda; Fernandez, Stefan; Yoon, In-Kyu] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand.
   Univ Toronto, Dept Med, Toronto, ON, Canada.
RP Hermann, L (reprint author), Armed Forces Res Inst Med Sci, Dept Virol, 315-6 Rajvithi Rd, Bangkok 10400, Thailand.
EM romebua@health2.moph.go.th; laura.hermann@afrims.org;
   butsayat@afrims.org; wiriyar@afrims.org; chontichak@afrims.org;
   piyawanc@afrims.org; wudtichaim@afrims.org; anandan.ca@afrims.org;
   stefan.fernandez@afrims.org; inkyu.yoon@afrims.org;
   pasakorn.sewi@gmail.com; kepidem@gmail.com
FU Canadian Institutes of Health Research
FX Laura Hermann was supported by a Canadian Institutes of Health Research
   Fellowship.
CR Baronti C, 2014, GENOME ANNOUNC, V2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   KUNO G, 1991, J VIROL METHODS, V33, P101, DOI 10.1016/0166-0934(91)90011-N
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   loos S, 2014, MED MALADIES INFECT, V44, P302
   Mallet H-P, 2014, PROMED
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Porter Kevin R., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P408
   Shinohara K, 2014, PROMED
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
NR 20
TC 39
Z9 44
U1 7
U2 41
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD AUG
PY 2015
VL 93
IS 2
BP 380
EP 383
DI 10.4269/ajtmh.15-0022
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CO7GK
UT WOS:000359327400034
PM 26101272
ER

PT J
AU Patino-Barbosa, AM
   Medina, I
   Gil-Restrepo, AF
   Rodriguez-Morales, AJ
AF Patino-Barbosa, Andres M.
   Medina, Ivonne
   Felipe Gil-Restrepo, Andres
   Rodriguez-Morales, Alfonso J.
TI Zika: another sexually transmitted infection?
SO SEXUALLY TRANSMITTED INFECTIONS
LA English
DT Letter
ID VIRUS; TRANSMISSION
C1 [Patino-Barbosa, Andres M.; Medina, Ivonne; Felipe Gil-Restrepo, Andres; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res & Incubator Grp, Pereira 660003, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res & Incubator Grp, Pereira 660003, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
CR [Anonymous], 2014, EUROSURVEILLANCE, DOI DOI 10.2807/1560-7917.ES2014.19.13.20751
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   [Anonymous], 2014, EUROSURVEILLANCE
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
NR 8
TC 13
Z9 14
U1 13
U2 60
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1368-4973
EI 1472-3263
J9 SEX TRANSM INFECT
JI Sex. Transm. Infect.
PD AUG
PY 2015
VL 91
IS 5
BP 359
EP 359
DI 10.1136/sextrans-2015-052189
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA CN7DQ
UT WOS:000358594600015
PM 26113729
ER

PT J
AU Musso, D
   Cao-Lormeau, V
   Gubler, DJ
AF Musso, Didier
   Cao-Lormeau, Van Mai
   Gubler, Duane J.
TI Zika virus: following the path of dengue and chikungunya?
SO LANCET
LA English
DT Letter
C1 [Musso, Didier; Cao-Lormeau, Van Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
   [Gubler, Duane J.] Duke NUS Grad Sch Med, Program Emerging Infect Dis, Singapore, Singapore.
   [Gubler, Duane J.] Partnership Dengue Control, Lyon, France.
RP Musso, D (reprint author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nhan T, 2015, CLIN MICROBIOL INFEC, DOI [10.1016/j.cmi.2015.02.018, DOI 10.1016/J.CMI.2015.02.018]
   Pan American Health Organization, 2015, EP AL ZIK VIR
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 7
TC 75
Z9 81
U1 20
U2 112
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 18
PY 2015
VL 386
IS 9990
BP 243
EP 244
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA CN1XI
UT WOS:000358213700020
PM 26194519
ER

PT J
AU Khongwichit, S
   Libsittikul, S
   Yoksan, S
   Auewarakul, P
   Suputtamongkol, Y
   Smith, DR
AF Khongwichit, Sarawut
   Libsittikul, Sirikwan
   Yoksan, Sutee
   Auewarakul, Prasert
   Suputtamongkol, Yupin
   Smith, Duncan R.
TI Retrospective screening of acute undifferentiated fever serum samples
   with universal flavivirus primers
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE fever; dengue; serum; flavivirus; phylogeny; RT-PCR
ID ZIKA VIRUS-INFECTION; DENGUE INFECTIONS; THAILAND; TRANSMISSION;
   ENCEPHALITIS
AB Introduction: Fever is a common symptom of many tropical diseases and in many cases the etiologic agent remains unidentified as a consequence of either the etiologic agent not being part of routine diagnostic screening or as a consequence of false negatives on standard diagnostic tests.
   Methodology: This study screened a well characterized panel of 274 serum samples collected on day of admission from adult patients with acute undifferentiated fever admitted to a hospital in Nakhon Ratchasima, Thailand by RT-PCR using pan-flavivirus degenerate primers.
   Results: Subsequent clinical diagnosis was achieved for 38 of the patients, and included 19 cases of dengue fever. RT-PCR screening identified seven positive samples (2.5%) which were revealed by sequence analysis to be dengue virus 1 (2 cases), dengue virus 2 (2 cases) and dengue virus 3 (3 cases). Only 5 out of 19 (26%) serum samples from patients subsequently diagnosed with dengue were positive, but 2 samples which clinically remained undiagnosed were shown to be positive for dengue virus. Sequence analysis suggested that the dengue virus 3 cases occurred as a result of importation of a strain of dengue from India or China. No other flaviviruses were identified.
   Conclusions: No evidence was found of other flaviviruses besides dengue circulating in this population. Despite improved diagnostic tests, cases of dengue are still evading correct diagnosis.
C1 [Khongwichit, Sarawut; Libsittikul, Sirikwan; Yoksan, Sutee; Smith, Duncan R.] Mahidol Univ, Siriraj Hosp, Inst Mol Biosci, Bangkok 10700, Thailand.
   [Yoksan, Sutee; Auewarakul, Prasert; Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand.
   [Auewarakul, Prasert; Suputtamongkol, Yupin] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand.
RP Smith, DR (reprint author), Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamonthol Sai 4, Nakhon Pathom 73170, Thailand.
EM duncan_r_smith@hotmail.com
RI Smith, Duncan /C-6891-2011
OI Smith, Duncan /0000-0002-6592-9852
FU Thailand Research Fund [RTA5780009, IRG5780009]; Office of the Higher
   Education Commission; Mahidol University under the National Research
   Universities Initiative; Mahidol University; TRF; Mahidol University
   (Thai Royal Golden Jubilee) PhD Scholarship
FX This work was supported by grants from the Office of the Higher
   Education Commission and Mahidol University under the National Research
   Universities Initiative, the Thailand Research Fund (RTA5780009 and
   IRG5780009) and Mahidol University. S.K is supported by a TRF and
   Mahidol University (Thai Royal Golden Jubilee) PhD Scholarship. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Campbell KM, 2013, AM J TROP MED HYG, V89, P1066, DOI 10.4269/ajtmh.13-0321
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376
   O'Guinn ML, 2013, AM J TROP MED HYG, V89, P1023, DOI 10.4269/ajtmh.13-0160
   Olsen SJ, 2010, INT J INFECT DIS, V14, pE888, DOI 10.1016/j.ijid.2010.03.022
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Puttikhunt C, 2011, J CLIN VIROL, V50, P314, DOI 10.1016/j.jcv.2011.01.001
   Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001990
   Sasmono RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103815
   Schweitzer BK, 2009, LABMEDICINE, V40, P493, DOI 10.1309/LM5YWS85NJPCWESW
   Suttinont C, 2006, ANN TROP MED PARASIT, V100, P363, DOI [10.1197/136485906X112158, 10.1179/136485906X112158]
   Tappe D, 2014, 1 CASE LAB CONFIRMED, V19
   Thipmontree W, 2014, INT J ENV RES PUB HE, V11, P8542, DOI 10.3390/ijerph110808542
   Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
NR 20
TC 0
Z9 0
U1 7
U2 25
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD JUL
PY 2015
VL 9
IS 7
BP 760
EP 764
DI 10.3855/jidc.5866
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA CR3QU
UT WOS:000361248800011
PM 26230127
ER

PT J
AU Musso, D
   Roche, C
   Nhan, TX
   Robin, E
   Teissier, A
   Cao-Lormeau, V
AF Musso, Didier
   Roche, Claudine
   Tu-Xuan Nhan
   Robin, Emilie
   Teissier, Anita
   Cao-Lormeau, Van-Mai
TI Detection of Zika virus in saliva
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika; ZIKV; PCR; Saliva; French Polynesia; Arbovirus
ID REVERSE-TRANSCRIPTASE PCR; URINE; MICRONESIA; INFECTION; GENOME
AB Background: During the largest Zika virus (ZIKV) outbreak ever reported that occurred from October 2013 to March 2014 in French Polynesia, we observed that several patients presenting the symptoms of acute phase Zika fever were tested negative in blood by ZIKV real-time PCR (RT-PCR).
   Objectives: As we have previously detected ZIKV RNA in the saliva of a young child, we investigated the use of saliva as an alternative sample for routine ZIKV RNA detection.
   Study design: Over a 6 month period, 1,067 samples collected from 855 patients presenting symptoms of Zika fever (saliva only, blood only or both samples) were tested using a specific ZIKV RT-PCR. A medical questionnaire was available for most of the patients.
   Results: ZIKV was more frequently detected in saliva compared to blood. For the 182 patients with both samples collected, tests were positive for 35 (19.2%) in saliva while negative in blood and tests were positive for 16 (8.8%) in blood while negative in saliva; the difference in mean days after symptoms onset and the percentage of the main symptoms of Zika fever for patients only positive in saliva or in blood was not significant.
   Conclusion: The use of saliva sample increased the rate of molecular detection of ZIKV at the acute phase of the disease but did not enlarge the window of detection of ZIKV RNA. Saliva was of particular interest when blood was difficult to collect (children and neonates especially). (C) 2015 Elsevier B.V. All rights reserved.
C1 [Musso, Didier; Tu-Xuan Nhan; Robin, Emilie] Inst Louis Malarde, Med Biol Lab, Tahiti, Fr Polynesia.
   [Musso, Didier; Roche, Claudine; Teissier, Anita; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, Fr Polynesia.
RP Musso, D (reprint author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf; croche@ilm.pf; tnhan@ilm.pf; e.grange@cht.nc;
   ateissier@ilm.pf; mlormeau@ilm.pf
CR Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Besnard M, 2014, EURO SURVEILL, V19
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler J.D., 2007, FIELD VIROLOGY, VFifth, P1155
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   Poloni TR, 2010, VIROL J, P7
NR 15
TC 78
Z9 89
U1 39
U2 138
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JUL
PY 2015
VL 68
BP 53
EP 55
DI 10.1016/j.jcv.2015.04.021
PG 3
WC Virology
SC Virology
GA CK3FF
UT WOS:000356101300011
PM 26071336
ER

PT J
AU Zammarchi, L
   Tappe, D
   Fortuna, C
   Remoli, ME
   Gunther, S
   Venturi, G
   Bartoloni, A
   Schmidt-Chanasit, J
AF Zammarchi, L.
   Tappe, D.
   Fortuna, C.
   Remoli, M. E.
   Guenther, S.
   Venturi, G.
   Bartoloni, A.
   Schmidt-Chanasit, J.
TI Zika virus infection in a traveller returning to Europe from Brazil,
   March 2015
SO EUROSURVEILLANCE
LA English
DT Article
ID CHIKUNGUNYA VIRUS; OUTBREAK
AB We report a case of laboratory-confirmed Zika virus infection imported into Europe from the Americas. The patient developed fever, rash, and oedema of hands and feet after returning to Italy from Brazil in late March 2015. The case highlights that, together with chikungunya virus and dengue virus, three major arboviruses are now co-circulating in Brazil. These arboviruses represent a burden for the healthcare systems in Brazil and other countries where competent mosquito vectors are present.
C1 [Zammarchi, L.; Bartoloni, A.] Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.
   [Tappe, D.; Guenther, S.; Schmidt-Chanasit, J.] Natl Reference Ctr Trop Infect Dis, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Fortuna, C.; Remoli, M. E.; Venturi, G.] Ist Super Sanita, Dept Infect Parasit & Immune Mediate Dis, I-00161 Rome, Italy.
RP Zammarchi, L (reprint author), Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.
EM alessandro.bartoloni@unifi.it
RI VENTURI, GIULIETTA/O-8123-2015; FORTUNA, CLAUDIA/O-9446-2015; Remoli,
   Maria Elena/O-9447-2015
OI VENTURI, GIULIETTA/0000-0002-9078-8350; Remoli, Maria
   Elena/0000-0003-3565-383X
CR Centers for Disease Control and Prevention (CDC), 2015, TRAV HLTH ZIK BRAZ
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kutsuna S, 2013, EUROSURVEILLANCE, V19, P20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization,World Health Organization, 2013, NUMB REP CAS CHIK FE
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   World Health Organization, 2012, GLOB STRAT DENG CONT
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 17
TC 0
Z9 0
U1 3
U2 19
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 11
PY 2015
VL 20
IS 23
BP 14
EP 16
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA CK4CS
UT WOS:000356168200004
ER

PT J
AU Rodriguez-Morales, AJ
AF Rodriguez-Morales, Alfonso J.
TI Zika: the new arbovirus threat for Latin America
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Editorial Material
DE Zika; arbovirus; emerging; Latin America
ID FRENCH-POLYNESIA; FEBRUARY 2014; VIRUS; TRANSMISSION; CHIKUNGUNYA;
   OUTBREAK
C1 Univ Tecnol Pereira, Pereira 660003, Colombia.
RP Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Pereira 660003, Colombia.
EM arodriguez@jidc.org
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Clouet-Huerta D, 2014, REV CHIL INFECTOL, V31, P761, DOI 10.4067/S0716-10182014000600022
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2014, EMERG INFECT DIS, V21, P381, DOI DOI 10.3201/EID2102.141553
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Rodriguez-Morales AJ, 2015, ARCH MED IN PRESS, V11
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
NR 16
TC 28
Z9 32
U1 4
U2 61
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD JUN
PY 2015
VL 9
IS 6
SI SI
BP 684
EP 685
DI 10.3855/jidc.7230
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA CQ8MI
UT WOS:000360861500025
PM 26142684
ER

PT J
AU Zanluca, C
   de Melo, VCA
   Mosimann, ALP
   dos Santos, GIV
   dos Santos, CND
   Luz, K
AF Zanluca, Camila
   Andrade de Melo, Vanessa Campos
   Pamplona Mosimann, Ana Luiza
   Viana dos Santos, Glauco Igor
   Duarte dos Santos, Claudia Nunes
   Luz, Kleber
TI First report of autochthonous transmission of Zika virus in Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; "dengue-like syndrome"; Brazil
ID CHIKUNGUNYA-VIRUS; FRENCH-POLYNESIA; DENGUE VIRUSES; PACIFIC
AB In the early 2015, several cases of patients presenting symptoms of mild fever, rash, conjunctivitis and arthralgia were reported in the northeastern Brazil. Although all patients lived in a dengue endemic area, molecular and serological diagnosis for dengue resulted negative. Chikungunya virus infection was also discarded. Subsequently, Zika virus (ZIKV) was detected by reverse transcription-polymerase chain reaction from the sera of eight patients and the result was confirmed by DNA sequencing. Phylogenetic analysis suggests that the ZIKV identified belongs to the Asian clade. This is the first report of ZIKV infection in Brazil.
C1 [Zanluca, Camila; Pamplona Mosimann, Ana Luiza; Duarte dos Santos, Claudia Nunes] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
   [Andrade de Melo, Vanessa Campos; Viana dos Santos, Glauco Igor] Secretaria Estadual Saude Rio Grande Norte, Natal, RN, Brazil.
   [Luz, Kleber] Univ Fed Rio Grande do Norte, Inst Med Trop, BR-59072970 Natal, RN, Brazil.
RP dos Santos, CND (reprint author), Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
EM clsantos@fiocruz.br; klebergluz@gmail.com
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pierson TC, 2013, FIELDS VIROLOGY, V2, P747
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
NR 17
TC 137
Z9 153
U1 71
U2 162
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2015
VL 110
IS 4
BP 569
EP 572
DI 10.1590/0074-02760150192
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CL0DT
UT WOS:000356610000017
PM 26061233
ER

PT J
AU Mattar, S
   Gonzalez, M
AF Mattar, Salim, V
   Gonzalez T, Marco
TI Now is the time for the Zika virus
SO REVISTA MVZ CORDOBA
LA English
DT Editorial Material
ID DENGUE
CR Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
NR 4
TC 1
Z9 2
U1 2
U2 37
PU UNIV CORDOBA
PI MONTERIA
PA FAC MEDICINA VETERINARIA Y ZOOTECNIA, KM 26, VIA CIENEGA DE ORO,
   APARTADO AEREO NO 354, MONTERIA, 00000, COLOMBIA
SN 0122-0268
J9 REV MVZ CORDOBA
JI Rev. MVZ Cordoba
PD MAY-AUG
PY 2015
VL 20
IS 2
BP 4511
EP 4512
PG 2
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA CW0YH
UT WOS:000364715700001
ER

PT J
AU Tappe, D
   Nachtigall, S
   Kapaun, A
   Schnitzler, P
   Gunther, S
   Schmidt-Chanasit, J
AF Tappe, Dennis
   Nachtigall, Stephan
   Kapaun, Annette
   Schnitzler, Paul
   Guenther, Stephan
   Schmidt-Chanasit, Jonas
TI Acute Zika Virus Infection after Travel to Malaysian Borneo, September
   2014
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID ORANGUTANS; INDONESIA
C1 [Tappe, Dennis; Guenther, Stephan; Schmidt-Chanasit, Jonas] World Hlth Org Collaborating Ctr Arbovirus & Haem, Bernhard Nocht Inst Trop Med World, D-20359 Hamburg, Germany.
   [Nachtigall, Stephan; Kapaun, Annette] Univ Med Ctr Heidelberg, Heidelberg, Germany.
   [Schnitzler, Paul] Heidelberg Univ, D-69115 Heidelberg, Germany.
   [Guenther, Stephan; Schmidt-Chanasit, Jonas] German Ctr Infect Res, Heidelberg, Germany.
RP Schmidt-Chanasit, J (reprint author), World Hlth Org Collaborating Ctr Arbovirus & Haem, Bernhard Nocht Inst Trop Med World, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
EM jonassi@gmx.de
CR Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
NR 10
TC 28
Z9 29
U1 5
U2 20
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2015
VL 21
IS 5
BP 911
EP 913
DI 10.3201/eid2105.141960
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CG9BW
UT WOS:000353610400038
PM 25898277
ER

PT J
AU Leung, GHY
   Baird, RW
   Druce, J
   Anstey, NM
AF Leung, Grace H. Y.
   Baird, Robert W.
   Druce, Julian
   Anstey, Nicholas M.
TI ZIKA VIRUS INFECTION IN AUSTRALIA FOLLOWING A MONKEY BITE IN INDONESIA
SO SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Article
DE Zika virus; monkey bite; traveller
ID DENGUE VIRUS; TRANSMISSION; ARBOVIRUSES; VECTOR
AB A traveller returning to Australia developed Zika virus infection, with fever, rash and conjunctivitis, with onset five days after a monkey bite in Bali, Indonesia. Flavivirus RNA detected on PCR from a nasopharyngeal swab was sequenced and identified as Zika virus. Although mosquito-borne transmission is also possible, we propose the bite as a plausible route of transmission. The literature for non-vector transmissions of Zika virus and other flaviviruses is reviewed.
C1 [Leung, Grace H. Y.; Baird, Robert W.; Anstey, Nicholas M.] Royal Darwin Hosp, Darwin, NT, Australia.
   [Druce, Julian] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.
   [Anstey, Nicholas M.] Menzies Sch Hlth Res, Darwin, NT, Australia.
   [Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia.
RP Leung, GHY (reprint author), Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia.
EM gracehyleung@gmail.com
FU NHMRC
FX We thank Amy Crowe and Kevin Freeman for their assistance. NA is
   supported by a NHMRC Practitioner Fellowship.
CR Besnard M, 2014, EURO SURVEILL, V19
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Cohen JI, 2002, CLIN INFECT DIS, V35, P1191, DOI 10.1086/344754
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grard G, 2007, PLOS NEGLECT TROP D, V8, pe2681, DOI DOI 10.1371/J0URNAL.PNTD.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kuno G, 2001, ACTA VIROL, V45, P139
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Poloni TR, 2010, VIROL J, V27, P22
   Pyke AT, 2014, PLOS CURR, V2, P6, DOI DOI 10.1371/CURRENTS
   Roth A, 2014, EUROSURVEILLANCE, V19, P41
   Wheatley B. P., 1999, SACRED MONKEYS BALI
NR 22
TC 25
Z9 26
U1 9
U2 41
PU SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION
PI BANGKOK
PA SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND
SN 0125-1562
J9 SE ASIAN J TROP MED
JI Southeast Asian J. Trop. Med. Public Health
PD MAY
PY 2015
VL 46
IS 3
BP 460
EP 464
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Tropical Medicine
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Tropical Medicine
GA CH6HR
UT WOS:000354137700009
PM 26521519
ER

PT J
AU Keighley, CL
   Saunderson, RB
   Kok, J
   Dwyer, DE
AF Keighley, Caitlin L.
   Saunderson, Rebecca B.
   Kok, Jen
   Dwyer, Dominic E.
TI Viral exanthems
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE exanthem; Gianotti-Crosti syndrome; rash; viral infection; virus
ID EBOLA HEMORRHAGIC-FEVER; HUMAN PARVOVIRUS B19; EPSTEIN-BARR-VIRUS;
   MOUTH-DISEASE; COXSACKIEVIRUS A6; ATYPICAL HAND; SKIN MANIFESTATIONS;
   CHIKUNGUNYA VIRUS; PRIMARY INFECTION; RUBELLA OUTBREAK
AB Purpose of review
   Determining the viral cause of a rash presents significant diagnostic challenges. We review contemporary literature on viral exanthems and suggest a structured approach to aid diagnosis.
   Recent findings
   Strains responsible for, and the clinical presentation of, enteroviral infections have diverged from classic descriptions. The causative relationship between antibiotic administration and rash in Epstein-Barr virus infection has been recently questioned. Major measles virus outbreaks have recently occurred in Europe and the USA. The largest Ebola virus outbreak in West Africa has resulted in importation of the virus to other countries and secondary local transmission. Autochthonous transmission of Chikungunya virus has occurred in nonendemic areas, including Europe, the Caribbean and Americas. Zika virus has re-emerged in the Pacific with local transmission from imported cases. Climate change, global warming and spillover of zoonotic viruses are contributing to the emergence and spread of viral diseases.
   Summary
   Important clues to the diagnosis of viral exanthems include their distribution and morphology, geographic location and potential exposure to vector-borne or blood-borne viruses. Diagnosis is commonly made via serology, nucleic acid tests or, rarely, viral culture. Skin biopsy is not usually required. In general, viral exanthems are self-limiting and treatment is supportive.
C1 [Keighley, Caitlin L.; Saunderson, Rebecca B.; Kok, Jen; Dwyer, Dominic E.] Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Lab Serv, Pathol West, Westmead, NSW 2145, Australia.
   [Keighley, Caitlin L.] Univ Sydney, Dept Med, Westmead, NSW 2145, Australia.
   [Kok, Jen; Dwyer, Dominic E.] Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW, Australia.
   [Kok, Jen; Dwyer, Dominic E.] Univ Sydney, Westmead Hosp, Ctr Res Excellence Crit Infect, Westmead, NSW 2145, Australia.
RP Keighley, CL (reprint author), Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Lab Serv, Pathol West, Westmead, NSW 2145, Australia.
EM ckei1332@usyd.edu.au
CR Al-Shukri I, 2013, LANCET, V382, P1856, DOI 10.1016/S0140-6736(13)62074-7
   Albarino CG, 2014, EMERG INFECT DIS, V20, P211, DOI 10.3201/eid2002.131620
   Biao D, 2014, VIROL J, V11, P157
   Biesbroeck L, 2013, DERMATOL THER, V26, P433, DOI 10.1111/dth.12107
   Blauvelt A, 2001, J INVEST DERM SYMP P, V6, P197, DOI 10.1046/j.0022-202x.2001.00040.x
   Budavari JM, 2007, INT J DERMATOL, V46, P706, DOI 10.1111/j.1365-4632.2007.03141.x
   Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Caseris M, 2014, CLIN MICROBIOL INFEC, V20, pO242, DOI 10.1111/1469-0691.12384
   CDC, 2014, MEASL CAS OUTBR
   Chovel-Sella A, 2013, PEDIATRICS, V131, pE1424, DOI 10.1542/peds.2012-1575
   Chusri Sarunyou, 2014, Am J Trop Med Hyg, V90, P410, DOI 10.4269/ajtmh.12-0681
   de Moraes JC, 2011, J INFECT DIS, V204, pS627, DOI 10.1093/infdis/jir490
   Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247
   Di Lernia V, 2013, INT J DERMATOL, V52, P1177, DOI 10.1111/j.1365-4632.2012.05855.x
   Dore Amanda, 2004, Australas J Dermatol, V45, P125, DOI 10.1111/j.1440-0960.2004.00062.x
   Drago F, 2012, J AM ACAD DERMATOL, V67, P1282, DOI 10.1016/j.jaad.2012.04.014
   Feder HM, 2014, LANCET INFECT DIS, V14, P83, DOI 10.1016/S1473-3099(13)70264-0
   Gershon AA, 2013, CLIN MICROBIOL REV, V26, P728, DOI 10.1128/CMR.00052-13
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805
   Halsey ES, 2014, AM J TROP MED HYG, V90, P449, DOI 10.4269/ajtmh.13-0544
   Harada T, 2002, ANGIOLOGY, V53, P727, DOI 10.1177/000331970205300615
   Hashimoto H, 2011, J CLIN VIROL, V52, P269, DOI 10.1016/j.jcv.2011.08.004
   Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002
   Hocqueloux L, 2013, CLIN INFECT DIS, V57, P1661, DOI 10.1093/cid/cit553
   Hongyan Gu, 2014, Pediatr Infect Dis J, V33, P1302, DOI 10.1097/INF.0000000000000467
   Horsley E, 2014, J PAEDIATR CHILD H, V50, P525, DOI 10.1111/jpc.12625
   Huang WC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-209
   Hubiche T, 2014, PEDIATR INFECT DIS J, V33, pE92, DOI 10.1097/INF.0000000000000120
   Hueston L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065197
   Ishida T, 2014, ALLERGY, V69, P798, DOI 10.1111/all.12410
   Iwasaki Eisuke, 2013, Nihon Shokakibyo Gakkai Zasshi, V110, P1657
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kaley J, 2013, J CUTAN PATHOL, V40, P226, DOI 10.1111/cup.12039
   Kappus Matthew R, 2013, Gastroenterol Hepatol (N Y), V9, P123
   Katta R, 2002, DERMATOL CLIN, V20, P333, DOI 10.1016/S0733-8635(01)00013-4
   Konig AL, 2001, TRANSFUSION, V41, P488, DOI 10.1046/j.1537-2995.2001.41040488.x
   Koul PA, 2013, CASE REPORTS, V1
   Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13
   Kutsuna S, 2014, EURO SURVEILL, P19
   Lamunu M, 2004, INT J INFECT DIS, V8, P27, DOI 10.1016/j.ijid.2003.04.001
   Lott JP, 2013, J AM ACAD DERMATOL, V69, P736, DOI 10.1016/j.jaad.2013.07.024
   Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073
   Mage V, 2014, J AM ACAD DERMATOL, V71, P62, DOI 10.1016/j.jaad.2014.02.044
   Mathes EF, 2013, PEDIATRICS, V132, pE149, DOI 10.1542/peds.2012-3175
   McIntyre Mary G., 2012, Morbidity and Mortality Weekly Report, V61, P213
   Messedi E, 2014, J CLIN VIROL, V61, P248, DOI 10.1016/j.jcv.2014.07.003
   Miguelez A, 2014, INT J DERMATOL, V53, P3583
   Molina-Ruiz AM, 2015, AM J DERMATOPATH, V37, P1, DOI 10.1097/DAD.0000000000000203
   Molina-Ruiz AM, 2015, AM J DERMATOPATH, V37, P93, DOI 10.1097/DAD.0000000000000200
   Montes M, 2013, EMERG INFECT DIS, V19, P676, DOI 10.3201/eid1904.121589
   Mowatt Lizette, 2014, Infect Dis Ther, V3, P63, DOI 10.1007/s40121-014-0043-9
   Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Outhred AC, 2012, NEUROVIRAL INFECT GE
   Outhred AC, 2011, EXPERT REV ANTI-INFE, V9, P545, DOI [10.1586/eri.11.34, 10.1586/ERI.11.34]
   Paller A. S., 2011, HURWITZ CLIN PEDIAT
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Prevention ECFD Team CEHCUEE, 2014, CONT SEAS CIRC ENT D, P19
   Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666
   Puenpa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098888
   Robin S, 2010, EUR J PEDIATR, V169, P67, DOI 10.1007/s00431-009-0986-0
   Rosenberg M, 2010, CAN MED ASSOC J, V182, pE146, DOI 10.1503/cmaj.091678
   Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006
   Roth A., 2014, EURO SURVEILL, V19
   Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Singh MP, 2014, J MED VIROL, V87, P344
   Smith DW, 2011, TRAVEL MED INFECT DI, V9, P113, DOI 10.1016/j.tmaid.2010.05.005
   Sparrer KMJ, 2014, GENOME ANNOUNCEMENTS, V2
   Stojkovic-Filipovic J, 2014, G ITAL DERMATOL VENE
   Stone JH, 2013, NEW ENGL J MED, V368, P1239, DOI 10.1056/NEJMcpc1210260
   Tabak F, 2012, ANN DERMATOL, V24, P420, DOI 10.5021/ad.2012.24.4.420
   Tanaka-Taya K, 2004, J MED VIROL, V73, P465, DOI 10.1002/jmv.20113
   Ujiie Mugen, 2014, Lancet, V383, P1460, DOI 10.1016/S0140-6736(14)60712-1
   Weston Kathryn M, 2006, Commun Dis Intell Q Rep, V30, P358
   World Health Organisation, 2005, WHO HDB INT MAN CHIL
   Wiwanitkit Somsri, 2014, Indian J Dermatol, V59, P529, DOI 10.4103/0019-5154.139899
   Wyplosz B, 2008, CLIN INFECT DIS, V47, P684, DOI 10.1086/590942
   Xu H, 2013, VACCINE, V32, P85, DOI 10.1016/j.vaccine.2013.10.070
   Yermalovich MA, 2012, J MED VIROL, V84, P973, DOI 10.1002/jmv.23294
   Zenner D, 2012, J INFECT DEV COUNTR, V6, P271, DOI 10.3855/jidc.1756
   Zhou HT, 2014, INT J INFECT DIS, V28, P123, DOI 10.1016/j.ijid.2014.05.032
   Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923
   [Anonymous], 2011, WEEKLY EPIDEMIOLOGIC
NR 86
TC 8
Z9 8
U1 11
U2 51
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD APR
PY 2015
VL 28
IS 2
BP 139
EP 150
DI 10.1097/QCO.0000000000000145
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA CE9EW
UT WOS:000352147700004
PM 25706914
ER

PT J
AU Alera, MT
   Hermann, L
   Tac-An, IA
   Klungthong, C
   Rutvisuttinunt, W
   Manasatienkij, W
   Villa, D
   Thaisomboonsuk, B
   Velasco, JM
   Chinnawirotpisan, P
   Lago, CB
   Roque, VG
   Macareo, LR
   Srikiatkhachorn, A
   Fernandez, S
   Yoon, IK
AF Alera, Maria Theresa
   Hermann, Laura
   Tac-An, Ilya A.
   Klungthong, Chonticha
   Rutvisuttinunt, Wiriya
   Manasatienkij, Wudtichai
   Villa, Daisy
   Thaisomboonsuk, Butsaya
   Velasco, John Mark
   Chinnawirotpisan, Piyawan
   Lago, Catherine B.
   Roque, Vito G., Jr.
   Macareo, Louis R.
   Srikiatkhachorn, Anon
   Fernandez, Stefan
   Yoon, In-Kyu
TI Zika Virus Infection, Philippines, 2012
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRAVEL
C1 [Alera, Maria Theresa; Velasco, John Mark; Lago, Catherine B.] Armed Forces Res Inst Med Sci, Philippines AFRIMS, Cebu, Philippines.
   [Hermann, Laura] Univ Toronto, Toronto, ON, Canada.
   [Hermann, Laura; Klungthong, Chonticha; Rutvisuttinunt, Wiriya; Manasatienkij, Wudtichai; Thaisomboonsuk, Butsaya; Chinnawirotpisan, Piyawan; Macareo, Louis R.; Fernandez, Stefan; Yoon, In-Kyu] AFRIMS, Bangkok, Thailand.
   [Roque, Vito G., Jr.] Dept Hlth, Manila, Philippines.
   [Srikiatkhachorn, Anon] Univ Massachusetts, Sch Med, Worcester, MA USA.
RP Hermann, L (reprint author), USAMC AFRIMS, APO, AP 96546 USA.
EM laura.hermann@afrims.org
CR Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fonseca K, 2014, AM J TROP MED HYG
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
NR 10
TC 22
Z9 23
U1 6
U2 38
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2015
VL 21
IS 4
BP 722
EP 724
DI 10.3201/eid2104.141707
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CE2NK
UT WOS:000351652100035
PM 25811410
ER

PT J
AU Ngoagouni, C
   Kamgang, B
   Nakoune, E
   Paupy, C
   Kazanji, M
AF Ngoagouni, Carine
   Kamgang, Basile
   Nakoune, Emmanuel
   Paupy, Chistophe
   Kazanji, Mirdad
TI Invasion of Aedes albopictus (Diptera: Culicidae) into central Africa:
   what consequences for emerging diseases?
SO PARASITES & VECTORS
LA English
DT Review
DE Aedes albopictus; Aedes aegypti; Invasive species; Arboviruses; Public
   health; Central Africa
ID BLOOD-FEEDING BEHAVIOR; CHIKUNGUNYA-VIRUS; AE.-ALBOPICTUS; 1ST RECORD;
   DIROFILARIA-REPENS; ZIKA VIRUS; AEGYPTI; DENGUE; MOSQUITO; VECTOR
AB Aedes albopictus, a mosquito native to Asia, has invaded all five continents during the past three decades. It was reported in central Africa in the 2000s, first in Cameroon, and, since then, has colonised almost all countries of the region. The species, originally considered a secondary vector of dengue viruses, has been showed to play a major role in transmission of chikungunya virus in numerous countries, including in the central African region. We review the current spread of Ae. albopictus in central Africa, its larval ecology and its impact on indigenous species such as Ae. aegypti. We explore the potential of Ae. albopictus to affect the epidemiology of emerging or re-emerging arboviruses and discuss the conventional means for its control, while emphasizing the importance of data on its susceptibility to insecticides to cope with potential outbreaks.
C1 [Ngoagouni, Carine; Kamgang, Basile; Nakoune, Emmanuel; Kazanji, Mirdad] Inst Pasteur, Bangui, Cent Afr Republ.
   [Paupy, Chistophe] CIRMF, Franceville, Gabon.
   [Paupy, Chistophe] CNRS IRD UM1 UM2, IRD, UMR 224 5290, Lab Malad Infect & Vecteurs Ecol Genet Evol & Con, Montpellier, France.
RP Kazanji, M (reprint author), Inst Pasteur, Bangui, Cent Afr Republ.
EM mirdad.kazanji@pasteur.fr
FU Institut Pasteur of Bangui and the International Network of Pasteur
   Institutes (Actions Concertees Inter-Pasteuriennes) ACIP [A12-12]
FX This review was supported by Institut Pasteur of Bangui and the
   International Network of Pasteur Institutes (Actions Concertees
   Inter-Pasteuriennes) ACIP no A12-12.
CR Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356
   Bagny L., 2009, Bulletin de la Societe de Pathologie Exotique, V102, P193
   Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204
   Bagny L, 2009, J MED ENTOMOL, V46, P1541, DOI 10.1603/033.046.0644
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Cancrini G, 2003, VET PARASITOL, V118, P195, DOI 10.1016/j.vetpar.2003.10.011
   Cancrini G, 2003, MED VET ENTOMOL, V17, P448, DOI 10.1111/j.1365-2915.2003.00463.x
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chen CD, 2006, TROP BIOMED, V23, P224
   Coffinet T, 2007, J AM MOSQUITO CONTR, V23, P471, DOI 10.2987/5636.1
   CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Diallo M, 2010, TROP MED INT HEALTH, V15, P1185, DOI 10.1111/j.1365-3156.2010.02594.x
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   Fontenille D, 2001, EMERG INFECT DIS, V7, P1066
   GONZALEZ JP, 1989, RES VIROLOGY, V140, P319, DOI 10.1016/S0923-2516(89)80112-8
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hawley W A, 1988, J Am Mosq Control Assoc Suppl, V1, P1
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Kamgang B, 2010, MED VET ENTOMOL, V24, P132, DOI 10.1111/j.1365-2915.2010.00869.x
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57
   Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kelvin AA, 2011, J INFECT DEV COUNTR, V5, P441, DOI 10.3855/jidc.2171
   Lockwood J.L., 2008, INVASION ECOLOGY
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   MATHIOT CC, 1988, B SOC PATHOL EXOT, V81, P396
   MEUNIER DMY, 1987, B SOC PATHOL EXOT, V80, P51
   Mombouli JV, 2013, EMERG INFECT DIS, V19, P1542, DOI 10.3201/eid1909.130451
   Pages F, 2007, PLOS ONE, V4, pe4691
   Pampiglione S, 2001, HISTOPATHOLOGY, V38, P344, DOI 10.1046/j.1365-2559.2001.01099.x
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Raharimalala FN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-56
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   SALUZZO JF, 1980, B SOC PATHOL EXOT, V73, P390
   SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101
   Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241
   Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Toto JC, 2003, MED VET ENTOMOL, V17, P343, DOI 10.1046/j.1365-2915.2003.00447.x
   Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   Vu Sinh Nam, 2005, Am J Trop Med Hyg, V72, P67
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WHO, 1997, HLTH ENV SUST DEV 5, P1
NR 57
TC 6
Z9 6
U1 9
U2 44
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 31
PY 2015
VL 8
AR 191
DI 10.1186/s13071-015-0808-3
PG 7
WC Parasitology
SC Parasitology
GA CE5TX
UT WOS:000351899700001
PM 25885461
ER

PT J
AU Derraik, JG
   Slaney, D
AF Derraik, Jose G.
   Slaney, David
TI Notes on Zika virus - an emerging pathogen now present in the South
   Pacific
SO AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID NEW-ZEALAND; VECTOR; ARBOVIRUSES; MICRONESIA; INFECTION; MOSQUITOS;
   CULICIDAE; DISEASES; DIPTERA; THREAT
C1 [Derraik, Jose G.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand.
   [Slaney, David] Univ S Australia, Barbara Hardy Inst, Adelaide, SA 5001, Australia.
RP Derraik, JG (reprint author), Univ Auckland, Liggins Inst, Private Bag 92019, Auckland 1, New Zealand.
EM j.derraik@auckland.ac.nz
CR Besnard M, 2014, EURO SURVEILL, V19
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Derraik JGB, 2004, AUST NZ J PUBL HEAL, V28, P27, DOI 10.1111/j.1467-842X.2004.tb00628.x
   Derraik JGB, 2007, ECOHEALTH, V4, P72, DOI 10.1007/s10393-006-0080-2
   Derraik Jose G B, 2005, N Z Med J, V118, pU1670
   Derraik JGB, 2010, AM J TROP MED HYG, V83, P755, DOI 10.4269/ajtmh.2010.10-0123
   Derraik Jose G B, 2009, N Z Med J, V122, P7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   European Commission, 2014, COMM DIS THREATS REP, P1
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaffigan TV, 2014, SYSTEMATIC CATALOG C
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Horwood Paul, 2013, Western Pac Surveill Response J, V4, P8, DOI 10.5365/WPSAR.2013.4.2.003
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kutsuna S, 2013, EUROSURVEILLANCE, V19, P20683
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, ppii=
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MAGUIRE T, 1994, NEW ZEAL MED J, V107, P448
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Ministerio de Salud de Chile, 2014, DEP EP DIV PLAN SAN
   Musso D, 2014, EURO SURVEILL, V19
   Nicholson J, 2014, J MED ENTOMOL, V51, P661, DOI 10.1603/ME13204
   Oehler E, 2014, EURO SURVEILL, P19
   Oehler E, 2014, EUROSURVEILLANCE, V19, p:
   ProMED- mail, 2014, BROOKLINE
   Pyke AT, 2014, PLOS CURRENTS, V2014, P6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Pyke AT, 2014, PLOS CURRENTS, V6, ppii, DOI [doi: 10.1371/ currents. outbre aks. 4635a54dbffba2156fb2fd76dc49f65e., DOI 10.1371/CURRENTS.0UTBRE]
   Tappe D, 2014, EUROSURVEILLANCE, V19, ppii=
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   van den Hurk AF, 2003, J MED ENTOMOL, V40, P82, DOI 10.1603/0022-2585-40.1.82
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 39
TC 9
Z9 9
U1 2
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1326-0200
EI 1753-6405
J9 AUST NZ J PUBL HEAL
JI Aust. N. Z. Publ. Health
PD FEB
PY 2015
VL 39
IS 1
BP 5
EP 7
DI 10.1111/1753-6405.12302
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CB0HT
UT WOS:000349307300002
PM 25559142
ER

PT J
AU Musso, D
   Roche, C
   Robin, E
   Nhan, T
   Teissier, A
   Cao-Lormeau, V
AF Musso, Didier
   Roche, Claudine
   Robin, Emilie
   Tuxuan Nhan
   Teissier, Anita
   Cao-Lormeau, Van-Mai
TI Potential Sexual Transmission of Zika Virus
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; URINE
AB In December 2013, during a Zika virus (ZIKV) outbreak in French Polynesia, a patient in Tahiti sought treatment for hematospermia, and ZIKV was isolated from his semen. ZIKV transmission by sexual intercourse has been previously suspected. This observation supports the possibility that ZIKV could be transmitted sexually.
C1 [Musso, Didier; Roche, Claudine; Robin, Emilie; Tuxuan Nhan; Teissier, Anita; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete 98713, Tahiti, Fr Polynesia.
RP Musso, D (reprint author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Habu A, 1977, Uirusu, V27, P21
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   MUSSO D, 2014, CLIN MICOBIOL INFECT
   Oehler E, 2014, EUROSURVEILLANCE, V19
   Stefanovic KB, 2009, AM FAM PHYSICIAN, V80, P1421
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320
NR 15
TC 157
Z9 173
U1 94
U2 211
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2015
VL 21
IS 2
BP 359
EP 361
DI 10.3201/eid2102.141363
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AZ8WC
UT WOS:000348491400030
PM 25625872
ER

PT J
AU Dupont-Rouzeyrol, M
   O'Connor, O
   Calvez, E
   Daures, M
   John, M
   Grangeon, JP
   Gourinat, AC
AF Dupont-Rouzeyrol, Myrielle
   O'Connor, Olivia
   Calvez, Elodie
   Daures, Maguy
   John, Michele
   Grangeon, Jean-Paul
   Gourinat, Ann-Claire
TI Co-infection with Zika and Dengue Viruses in 2 Patients, New Caledonia,
   2014
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID SOUTH-PACIFIC
C1 [Dupont-Rouzeyrol, Myrielle; O'Connor, Olivia; Calvez, Elodie; Gourinat, Ann-Claire] Inst Pasteur, Noumea, New Caledonia.
   [Daures, Maguy; John, Michele; Grangeon, Jean-Paul] Direct Affaires Sanit & Sociales, Noumea, New Caledonia.
RP Dupont-Rouzeyrol, M (reprint author), Inst Pasteur Nouvelle Caledonie, Unite Rech & Expertise Dengue & Autres Arbovirose, 9-11 Ave Paul Doumer,BP 61, Noumea 98845, New Caledonia.
EM mdupont@pasteur.nc
CR Baronti C, 2014, GENOME ANNOUNC, P2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   *DIR AFF SAN SOC N, 2014, SIT SAN NOUV CAL DEN
   Dupont-Rouzeyrol M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-61
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004
   WHO, 2009, DENG GUID DIAGN TREA
NR 10
TC 50
Z9 51
U1 9
U2 40
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2015
VL 21
IS 2
BP 381
EP 382
DI 10.3201/eid2102.141553
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AZ8WC
UT WOS:000348491400039
PM 25625687
ER

PT J
AU Zammarchi, L
   Stella, G
   Mantella, A
   Bartolozzi, D
   Tappe, D
   Gunther, S
   Oestereich, L
   Cadar, D
   Munoz-Fontela, C
   Bartoloni, A
   Schmidt-Chanasit, J
AF Zammarchi, Lorenzo
   Stella, Giulia
   Mantella, Antonia
   Bartolozzi, Dario
   Tappe, Dennis
   Guenther, Stephan
   Oestereich, Lisa
   Cadar, Daniel
   Munoz-Fontela, Cesar
   Bartoloni, Alessandro
   Schmidt-Chanasit, Jonas
TI Zika virus infections imported to Italy: Clinical, immunological and
   virological findings, and public health implications
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika; Dengue; Immunity; Italy; Polynesia; Travel
ID YELLOW-FEVER; CHIKUNGUNYA; MOSQUITOS; OUTBREAK; DENGUE; VECTOR; FRANCE
AB We report the first two cases of laboratory confirmed Zika virus (ZIKV) infections imported into Italy from French Polynesia. Both patients presented with low grade fever, malaise, conjunctivitis, myalgia, arthralgia, ankle oedema, and axillary and inguinal lymphadenopathy. One patient showed leukopenia with relative monocytosis and thrombocytopenia.
   The diagnosis was based on ZIKV seroconversion in both cases and on ZIKV RNA detection in one patient from acute serum sample. Sera from both patients exhibited cross-reactivity with dengue virus antigens. Our immunological analysis demonstrated that recovery from ZIKV infection is associated with restoration of normal numbers of immune cells in the periphery as well as with normal function of antigen-presenting cells. ZIKV is an emerging arbovirus, which has recently spread extensively in tourist destinations on several West Pacific islands. Returning viremic travelers may ignite autochthonous infections in countries like Italy, which are infested by Aedes albopictus, a suitable vector for ZIKV. The role of clinicians is crucial and includes early diagnosis and timely notification of public health authorities in order to quickly implement adequate focal vector control measurements. (C) 2014 Elsevier B.V. All rights reserved.
EM lorenzo.zammarchi@unifi.it; guilia.stella44@gmail.com;
   antoniamantella@libero.it; bartolozzid@aou.careggi.toscana.it;
   tappe@bnitm.de; guenther@bnitm.de; oestereich@bnitm.de; cadar@bnitm.de;
   alessandro.bartoloni@unifi.it; jonassi@gmx.de
FU Leibniz Gemeinschaft
FX Dr Cesar Munoz-Fontela is supported by Leibniz Gemeinschaft. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Besnard M., 2014, EUROSURVEILLANCE, V19
   Charrel RN, 2008, LANCET INFECT DIS, V8, P5, DOI 10.1016/S1473-3099(07)70296-7
   Charrel R.N., 2008, EUROSURVEILLANCE, V13
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gjenero-Margan I., 2011, EUROSURVEILLANCE, V16
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V., 2010, EMERG INFECT DIS, V18, P349, DOI DOI 10.3201/EID1802.111224
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Ministero della Salute, 2014, SORV CAS UM MAL TRAS
   Ministero della Salute Dipartimento della Sanita Pubblica e dell'Innovazione, 2012, 12922P MIN SAL DIP S
   Musso D, 2014, EUROSURVEILLANCE, V19
   Oehler E., 2014, EUROSURVEILLANCE, V19
   Pesaro Antonio Eduardo, 2007, Arq. Bras. Cardiol., V89, pe12, DOI 10.1590/S0066-782X2007001400015
   Puzelli S., 2013, EUROSURVEILLANCE, V18
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   La Ruche G., 2010, EUROSURVEILLANCE, V15, P19676
   Schmidt-Chanasit J., 2010, EUROSURVEILLANCE, V15
   Tappe D., 2014, EUROSURVEILLANCE, V19
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 28
TC 45
Z9 48
U1 10
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD FEB
PY 2015
VL 63
BP 32
EP 35
DI 10.1016/j.jcv.2014.12.005
PG 4
WC Virology
SC Virology
GA AZ2BT
UT WOS:000348040300006
PM 25600600
ER

PT J
AU Morales, AJR
AF Rodriguez Morales, Alfonso J.
TI Aedes: an efficient vector of old and new arboviruses (dengue,
   Chikungunya and Zika) in the Americas
SO REVISTA DEL CUERPO MEDICO DEL HOSPITAL NACIONAL ALMANZOR AGUINAGA ASENJO
LA Spanish
DT Editorial Material
ID VIRUS; BRAZIL
C1 [Rodriguez Morales, Alfonso J.] Grp Invest Salud Publ & Infecc, Bucaramanga, Santander, Colombia.
   [Rodriguez Morales, Alfonso J.] Univ Tecnol Pereira, Fac Ciencias Salud, Comuna Univ, Pereira, Risaralda, Colombia.
RP Morales, AJR (reprint author), Univ Tecnol Pereira, Fac Ciencias Salud, Dept Med Comunitaria, Comuna Univ, Pereira 660003, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardona-Ospina JA, 2015, J CLIN VIROL
   Cardona-Ospina JA, 2015, J INFECT PUBLIC HLTH
   Clouet-Huerta D, 2014, REV CHIL INFECTOL, V31, P761, DOI 10.4067/S0716-10182014000600022
   Culquichicon-Sanchez CG, 2015, REV CHILENA IN PRESS, V32
   Bedoya-Arias JE, 2015, J INFECT DEV COUNTR, V9, P330, DOI 10.3855/jidc.6445
   Galan Rodas E, 2015, REV PERU MED EXP SAL, V32, P397
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Maguia-Vargas Ciro, 2015, Rev Med Hered, V26, P55
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, RHEUMATOL INT
   Rodriguez-Morales AJ, 2015, ONE HLTH NEWSLETTER, V8, P7
   Rodriguez-Morales AJ, 2015, ARCH MED, V11
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 19
TC 0
Z9 0
U1 0
U2 0
PU HOSPITAL NACL ALMANZOR AGUINAGA ASENJO, ASOC CUERPO MEDICO
PI CHICLAYO
PA PLAZA SEGURIDAD SOCIAL S-N, CHICLAYO, 00000, PERU
SN 2225-5109
EI 2227-4731
J9 REV CUERPO MED HOSP
JI Rev. Cuerpo Med. Hosp. Nac. Almanzor Aguinaga Asenjo
PY 2015
VL 8
IS 2
BP 50
EP 52
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV3UI
UT WOS:000382848800001
ER

PT J
AU Babaniyi, OA
   Mwaba, P
   Mulenga, D
   Monze, M
   Songolo, P
   Mazaba-Liwewe, ML
   Mweene-Ndumba, I
   Masaninga, F
   Chizema, E
   Eshetu-Shibeshi, M
   Malama, C
   Rudatsikira, E
   Siziya, S
AF Babaniyi, Olusegun A.
   Mwaba, Peter
   Mulenga, David
   Monze, Mwaka
   Songolo, Peter
   Mazaba-Liwewe, Mazyanga L.
   Mweene-Ndumba, Idah
   Masaninga, Freddie
   Chizema, Elizabeth
   Eshetu-Shibeshi, Messeret
   Malama, Costantine
   Rudatsikira, Emmanuel
   Siziya, Seter
TI Risk Assessment for Yellow Fever in Western and North-Western Provinces
   of Zambia
SO JOURNAL OF GLOBAL INFECTIOUS DISEASES
LA English
DT Article
DE Prevalence; Western and North-Western provinces; yellow fever; Zambia
AB Background: North-Western and Western provinces of Zambia were reclassified as low-risk areas for yellow fever (YF). However, the current potential for YF transmission in these areas is unclear. Aims: To determine the current potential risk of YF infection. Setting and Design: A cross sectional study was conducted in North-Western and Western provinces of Zambia. Materials and Methods: Samples were tested for both YF virus-specific IgG and IgM antibodies by the ELISA and YF virus confirmation was done using Plaque Reduction Neutralization Test. The samples were also tested for IgG and IgM antibodies against other flaviviruses. Results: Out of the 3625 respondents who participated in the survey, 46.7% were males and 9.4% were aged less than 5 years. Overall, 58.1% of the participants slept under an impregnated insecticide-treated net and 20.6% reported indoor residual spraying of insecticides. A total of 616 (17.0%) samples were presumptive YF positive. The prevalence for YF was 0.3% for long-term infection and 0.2% for recent YF infection. None of the YF confirmed cases had received YF vaccine. Prevalence rates for other flaviviruses were 149 (4.1%) for Dengue, 370 (10.2%) for West Nile and 217 (6.0%) for Zika. Conclusion: There is evidence of past and recent infection of YF in both provinces. Hence, they are at a low risk for YF infection. Yellow fever vaccination should be included in the EPI program in the two provinces and strengthen surveillance with laboratory confirmation.
C1 [Babaniyi, Olusegun A.] WHO, Zambia Country Off, Lusaka, Zambia.
   [Mwaba, Peter] Minist Home Affairs, Permanent Secretary Off, Lusaka, Zambia.
   [Mulenga, David; Siziya, Seter] Copperbelt Univ, Sch Med, Dept Clin Sci, Ndola, Zambia.
   [Monze, Mwaka; Mazaba-Liwewe, Mazyanga L.; Mweene-Ndumba, Idah] Univ Teaching Hosp, Dept Pathol & Microbiol, Lusaka, Zambia.
   [Songolo, Peter] WHO, Dept Dis Prevent & Control, Lusaka, Zambia.
   [Mazaba-Liwewe, Mazyanga L.; Mweene-Ndumba, Idah] WHO, Dept Immunizat Vaccines & Emergencies, Lusaka, Zambia.
   [Masaninga, Freddie] WHO, Dept Malaria, Lusaka, Zambia.
   [Chizema, Elizabeth; Malama, Costantine] Minist Hlth, Dept Publ Hlth Surveillance & Res, Lusaka, Zambia.
   [Eshetu-Shibeshi, Messeret] World Hlth Org, Dept Intercountry Support Team, Harare, Zimbabwe.
   [Rudatsikira, Emmanuel] Andrews Univ, Deans Off, Sch Hlth Profess, Berrien Springs, MI 49104 USA.
   [Siziya, Seter] Univ Lusaka, Sch Hlth Sci, Dept Publ Hlth, Lusaka, Zambia.
RP Babaniyi, OA (reprint author), WHO, Zambia Country Off, Lusaka, Zambia.
EM agbagba@yahoo.com
CR Aregheore EM, COUNTRY PASTURE FORA
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   BONNEL P H, 1954, Bull World Health Organ, V11, P325
   Central Statistical Office, 2012, 2010 CENS POP HOUS N
   Diallo M., 2013, Journal of Public Health and Epidemiology, V5, P291
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   MAHAFFY AF, 1946, T ROY SOC TROP MED H, V40, P57, DOI 10.1016/0035-9203(46)90062-4
   MOH CSO PATH MACEPA CDC WHO, 2012, ZAMB NAT MAL IND SUR
   MONATH TP, 1984, AM J TROP MED HYG, V33, P151
   ROBINSON G G, 1950, East Afr Med J, V27, P284
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   WHO, 2004, WHOIVB0408
NR 12
TC 2
Z9 2
U1 6
U2 12
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0974-777X
EI 0974-8245
J9 J GLOB INFECT DIS
JI J. Glob. Insect. Dis.
PD JAN-MAR
PY 2015
VL 7
IS 1
BP 11
EP 17
DI 10.4103/0974-777X.150884
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DE1KM
UT WOS:000370385900004
PM 25722614
ER

PT J
AU Wilson, ME
   Chen, LH
AF Wilson, Mary Elizabeth
   Chen, Lin H.
TI Dengue: Update on Epidemiology
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Article
DE Dengue; Epidemiology; Epidemic; Hemorrhagic fever; Travel; Chikungunya;
   Mosquito; Vector; Emerging infection; Co-infection; Disease burden;
   Mapping; Climate change; Aedesaegypti; Aedesalbopictus Seroptyes; Zika
   virus; Surveillance; Transmission; Models; Forecasting outbreaks; Air
   travel
ID RIO-DE-JANEIRO; VIRUS TRANSMISSION; KEY-WEST; METEOROLOGICAL FACTORS;
   QUERY DATA; WORLD CUP; BRAZIL; SURVEILLANCE; TRAVELERS; OUTBREAKS
AB The epidemiology of dengue fever has undergone major shifts in recent decades. The global distribution has expanded to include more geographic areas. The intensity of transmission and the severity of infections have increased in areas where infection was already endemic. Multiple studies provide a clearer picture of the epidemiology and allow mapping of its distribution and change over time. Despite major efforts to control transmission, competent vectors now infest most tropical and subtropical regions; Aedes albopictus, also a competent vector, is able to survive in temperate areas, placing parts of Europe and North America at risk for local transmission. Many research teams in dengue-endemic areas are working to identify key local weather, vector, and other variables that would allow prediction of a likely epidemic early enough to permit interventions to avert it or blunt its impact.
C1 [Wilson, Mary Elizabeth] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Wilson, Mary Elizabeth] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA.
   [Wilson, Mary Elizabeth] Global Hlth Sci, San Francisco, CA 94158 USA.
   [Chen, Lin H.] Harvard Univ, Sch Med, Travel Med Ctr, Mt Auburn Hosp, Cambridge, MA 02138 USA.
RP Wilson, ME (reprint author), Global Hlth Sci, 550 16th St,Mission Hall,Box 1224, San Francisco, CA 94158 USA.
EM mewilson@hsph.harvard.edu
FU Shoreland Inc; GSK; Elsevier Publishing; Wiley Publishing
FX Mary Wilson has no conflicts of interest. Lin Chen reports personal fees
   from Shoreland Inc, another from GSK, and personal fees from Elsevier
   Publishing, another from Wiley Publishing, outside the submitted work.
CR Amarasinghe A, 2012, T ROY SOC TROP MED H, V106, P1, DOI 10.1016/j.trstmh.2011.08.014
   Muhammad Azami NA, 2011, BMC RES NOTES, V4, P216, DOI DOI 10.1186/1756-0500-4-216
   Aziz AT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-258
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bin G, 2012, AM J TROP MED HYG, V86, P1072, DOI [10.4269/ajtmh.2012.11-0723, DOI 10.4269/AJTMH.2012.11-0723]
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Buczak AL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-124
   Chacon-Duque JC, 2014, INFECT GENET EVOL, V27, P89, DOI 10.1016/j.meegid.2014.07.003
   Campbell KM, 2013, AM J TROP MED HYG, V89, P1066, DOI 10.4269/ajtmh.13-0321
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Caron M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078030
   CDC, 2013, MMWR, V62
   Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Domingo C, 2011, J TRAVEL MED, V18, P183, DOI 10.1111/j.1708-8305.2011.00501.x
   Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X
   Eastin MD, 2014, AM J TROP MED HYG, V91, P598, DOI 10.4269/ajtmh.13-0303
   European Centre for Disease Prevention and Control [ECDC], VBORN MAPS MOSQ
   Fan J, 2014, EPIDEMIOL INFECT, V142, P634, DOI 10.1017/S0950268813001519
   Faye O, 2014, EMERG INFECT DIS, V20, P456, DOI 10.3201/eid2003.121885
   Ferguson NM, 2014, P NATL ACAD SCI USA, V111, P9370, DOI 10.1073/pnas.1407648111
   Gjenero-Margan I, 2011, EURO SURVEILL, P16
   Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713
   Gomes AF, 2012, CAD SAUDE PUBLICA, V28, P2189, DOI 10.1590/S0102-311X2012001100018
   Hoen AG, 2012, EMERG INFECT DIS, V18, P1147, DOI [10.3201/eid1807.120055, 10.3201/eid1808.120055]
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Jaenisch T, 2014, EMERG INFECT DIS
   JMGd A' j, 2012, PLOS NEGLECT TROP D, V6, pe1784, DOI [10.1371/journal.pntd.0001784, DOI 10.1371/JOURNAL.PNTD.0001784]
   Koo C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-275
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Marchand E., 2013, EURO SURVEILL, V201
   Massad E, 2011, INT J ENV HLTH RES
   Massad E, 2014, LANCET INFECT DIS
   Massad E, 2013, EPIDEMIOL INFECT, V141, P412, DOI 10.1017/S0950268812000507
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Munoz-Jordan JL, 2013, EMERG INFECT DIS, V19, P652, DOI 10.3201/eid1904.121295
   Musso D, 2014, EUROSURVEILLANCE, V19
   Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI [10.3201/eid2008.140333, 10.3201/eid2008.130333]
   Nguyet Minh Nguyen, 2013, Proc Natl Acad Sci U S A, V110, P9072, DOI 10.1073/pnas.1303395110
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Parreira R., 2014, EURO SURVEILL, V19
   Punzel M, 2014, EMERG INFECT DIS, V20
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Ratnam I, 2012, EUR J CLIN MICROBIOL, V31, P1203, DOI 10.1007/s10096-011-1429-1
   Ratnam I, 2013, J TRAVEL MED, V20, P384, DOI 10.1111/jtm.12052
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rocklov J, 2014, SCAND J INFECT DIS
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Sanchez-Vegas C, 2013, J TRAVEL MED, V20, P352, DOI 10.1111/jtm.12057
   Schaffner F, 2014, LANCET INFECT DIS
   Schmidt-Chanasit J, 2013, EURO SURVEILL, V19
   Schwartz E., 2013, EURO SURVEILL, V18
   Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775
   Shin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074582
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sousa CA, 2012, EURO SURVEILL, V17
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Streit JA, 2011, EMERG INFECT DIS
   Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203
   Taulung LA, 2013, MMWR-MORBID MORTAL W, V62, P570
   Teixeira MG, 2000, PLOS NEGLECT TROP D, V7, pe2520, DOI [DOI 10.1371/JOURNAL.PNTD.0002520, 10.1371/journal.pntd.0002520]
   Teoh BT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-213
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   van Panhuis WG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003063
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Wilder-Smith A., 2014, EURO SURVEILL, P19
   Williams M, 2014, AM J TROP MED HYG, V91, P611, DOI 10.4269/ajtmh.13-0600
   Wilson ME, 2014, CLIN INFECT DIS, V58, P1347, DOI 10.1093/cid/ciu122
   Xu HY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002805
   Yang F, 2014, EPIDEMIOL INFECT, V142, P225, DOI 10.1017/S0950268813000897
NR 79
TC 8
Z9 8
U1 11
U2 52
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD JAN
PY 2015
VL 17
IS 1
AR 457
DI 10.1007/s11908-014-0457-2
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA CC0VD
UT WOS:000350054800008
PM 25475383
ER

PT J
AU Althouse, BM
   Hanley, KA
   Diallo, M
   Sall, AA
   Ba, Y
   Faye, O
   Diallo, D
   Watts, DM
   Weaver, SC
   Cummings, DAT
AF Althouse, Benjamin M.
   Hanley, Kathryn A.
   Diallo, Mawlouth
   Sall, Amadou A.
   Ba, Yamar
   Faye, Ousmane
   Diallo, Diawo
   Watts, Douglas M.
   Weaver, Scott C.
   Cummings, Derek A. T.
TI Impact of Climate and Mosquito Vector Abundance on Sylvatic Arbovirus
   Circulation Dynamics in Senegal
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID YELLOW-FEVER VIRUS; AEDES-AEGYPTI; DENGUE VIRUS; WEST-AFRICA;
   TEMPERATURE; TRANSMISSION; SUSCEPTIBILITY; CYCLES; POPULATIONS;
   CHIKUNGUNYA
AB Sylvatic arboviruses have been isolated in Senegal over the last 50 years. The ecological drivers of the pattern and frequency of virus infection in these species are largely unknown. We used time series analysis and Bayesian hierarchical count modeling on a long-term arbovirus dataset to test associations between mosquito abundance, weather variables, and the frequency of isolation of dengue, yellow fever, chikungunya, and Zika viruses. We found little correlation between mosquito abundance and viral isolations. Rainfall was a negative predictor of dengue virus (DENV) isolation but a positive predictor of Zika virus isolation. Temperature was a positive predictor of yellow fever virus (YFV) isolations but a negative predictor of DENV isolations. We found slight interference between viruses, with DENV negatively associated with concurrent YFV isolation and YFV negatively associated with concurrent isolation of chikungunya virus. These findings begin to characterize some of the ecological associations of sylvatic arboviruses with each other and climate and mosquito abundance.
C1 [Althouse, Benjamin M.] Santa Fe Inst, Santa Fe, NM 87501 USA.
   [Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Diallo, Mawlouth; Sall, Amadou A.; Ba, Yamar; Faye, Ousmane; Diallo, Diawo] Inst Pasteur, Dakar, Senegal.
   [Watts, Douglas M.] Univ Texas El Paso, Off Res & Sponsored Projects, El Paso, TX 79968 USA.
   [Watts, Douglas M.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Watts, Douglas M.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Cummings, Derek A. T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
RP Althouse, BM (reprint author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.
EM althouse@santafe.edu; khanley@nmsu.edu; diallo@pasteur.sn;
   asall@pasteur.sn; yba@pasteur.sn; fayeo@orange.sn; diawod@yahoo.com;
   dwatts2@utep.edu; sweaver@utmb.edu; dcumming@jhsph.edu
RI Weaver, Scott/D-6490-2011
FU National Institutes of Health [AI069145]; US National Institutes of
   Health National Institute of General Medical Sciences Models of
   Infectious Disease Agent Study (MIDAS) [1U54GM088491-0109]; National
   Science Foundation Graduate Research Fellowship [DGE-0707427]; Omidyar
   Postdoctoral Fellowship Program; Burroughs Wellcome Fund
FX This work was funded by National Institutes of Health Grant AI069145 (to
   K.A.H, S.C.W., and D.A.T.C.) as well as US National Institutes of Health
   National Institute of General Medical Sciences Models of Infectious
   Disease Agent Study (MIDAS) Grant 1U54GM088491-0109 (to D.A.T.C.).
   B.M.A. acknowledges National Science Foundation Graduate Research
   Fellowship Grant DGE-0707427 and the Omidyar Postdoctoral Fellowship
   Program. D.A.T.C. holds a Career Award at the Scientific Interface from
   the Burroughs Wellcome Fund.
CR Althouse BM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001928
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2
   Cardosa J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000423
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chatfield C., 2004, ANAL TIME SERIES INT
   Cook S, 2005, J MED ENTOMOL, V42, P19, DOI 10.1603/0022-2585(2005)042[0019:MMFMIO]2.0.CO;2
   CORNET M, 1978, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V16, P315
   Davis NC, 1932, AM J HYG, V16, P163
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Diallo M, 2005, AM J TROP MED HYG, V73, P445
   Diallo M, 1999, AM J TROP MED HYG, V60, P281
   Diallo M, 2003, EMERG INFECT DIS, V9, P362
   Diallo M, 2008, T ROY SOC TROP MED H, V102, P493, DOI 10.1016/j.trstmh.2008.02.010
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Hill J., 2006, DATA ANAL USING REGR
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Inoue S, 2003, J MED PRIMATOL, V32, P89, DOI 10.1034/j.1600-0684.2003.00015.x
   Jupp PG, 2002, T ROY SOC TROP MED H, V96, P493, DOI 10.1016/S0035-9203(02)90417-7
   KURANE I, 1991, J VIROL, V65, P1823
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Service M. W., 1993, MOSQUITO ECOLOGY FIE
   Sylla M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000408
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vasilakis N, 2008, EMERG INFECT DIS, V14, P502, DOI 10.3201/eid1403.070843
   Ripley B. D., 2002, MODERN APPL STAT S
   Vittinghoff E, 2011, REGRESSION METHODS B
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143
   Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034
   ZELLER HG, 1992, RES VIROLOGY, V143, P101, DOI 10.1016/S0923-2516(06)80088-9
NR 38
TC 8
Z9 8
U1 3
U2 30
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JAN
PY 2015
VL 92
IS 1
BP 88
EP 97
DI 10.4269/ajtmh.13-0617
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA AZ4GU
UT WOS:000348180600020
PM 25404071
ER

PT J
AU Gourinat, AC
   O'Connor, O
   Calvez, E
   Goarant, C
   Dupont-Rouzeyrol, M
AF Gourinat, Ann-Claire
   O'Connor, Olivia
   Calvez, Elodie
   Goarant, Cyrille
   Dupont-Rouzeyrol, Myrielle
TI Detection of Zika Virus in Urine
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MICRONESIA; ISOLATIONS; INFECTION; VECTOR; AEDES
AB We describe the kinetics of Zika virus (ZIKV) detection in serum and urine samples of 6 patients. Urine samples were positive for ZIKV >10 days after onset of disease, which was a notably longer period than for serum samples. This finding supports the conclusion that urine samples are useful for diagnosis of ZIKV infections.
C1 [O'Connor, Olivia; Calvez, Elodie; Goarant, Cyrille; Dupont-Rouzeyrol, Myrielle] Inst Pasteur, Noumea 98845, New Caledonia.
   [Gourinat, Ann-Claire] Inst Pasteur, Serol Immunol & Mol Biol Unit, Noumea 98845, New Caledonia.
RP Dupont-Rouzeyrol, M (reprint author), Inst Pasteur, 9-11 Ave Paul Doumer,BP 61, Noumea 98845, New Caledonia.
EM mdupont@pasteur.nc
OI Goarant, Cyrille/0000-0002-0690-9464
CR Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Kuno G, 1998, J VIROL, V72, P73
   KUTSUNA S, 2013, EUROSURVEILLANCE, P19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oehler E, 2014, EUROSURVEILLANCE, P19
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   2014, HEALTH SITUATION IN
NR 15
TC 90
Z9 103
U1 52
U2 115
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2015
VL 21
IS 1
BP 84
EP 86
DI 10.3201/eid2101.140894
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AY3SW
UT WOS:000347503700012
PM 25530324
ER

PT J
AU Barbaud, A
AF Barbaud, A.
TI What's new in clinical dermatology?
SO ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
LA French
DT Article
DE Chronic urticaria; Cutaneous adverse drug reactions; Demodicosis;
   Hidradenitis suppurativa; Methylisothiazolinone; Parvovirus; Pemphigoid;
   Psoriasis; Urticaria
ID NEUTROPHILIC URTICARIAL DERMATOSIS; ALLERGIC CONTACT-DERMATITIS;
   SMALL-FIBER NEUROPATHIES; WET WIPES; VIRUS-INFECTION; RISK-FACTORS;
   HEPATITIS-C; BABY WIPES; METHYLISOTHIAZOLINONE; PSORIASIS
AB Dermatoses have been better characterized as hypochromic vitiligo in subjects with dark skin or the acquired racquet nails associated with hyperparathyroidism. The innate immunity has a central role in the new classification of auto inflammatory diseases, neutrophilic dernnatoses, neutrophilic urticaria or pseudo-neutrophilic urticaria. Comorbidities have been studied e.g. cardiovascular co morbidities for psoriasis, IBD associated with hidradenitis suppurativa or neurological disorders associated with pemphigoid. Bullous pemphigoid could be renamed as cutaneous pemphigoid, it can be induced by drugs especially gliptins. Genetic predispositions are analyzed in auto inflammatory diseases, psoriasis (HLA), drug eruptions (HLA or cytokines). Telaprevir often induces rashes, which can be severe but other treatments against hepatitis C as interferon can also induce debilitating rashes, some eligible for drug tolerance induction. European guidelines for the definition, classification, diagnosis of chronic spontaneous urticaria have been published. Severe cutaneous adverse drug reactions may be associated with severe systemic symptoms such as organ involvement in AGEP or the occurrence of a shock in DRESS. Allover Europe, there is now an epidemic of contact allergies to nnethylisothiazolinone (MIT), contained in cosmetics, wet wipes but also in paints. MIT should be tested at 2.000 ppm in water, included in the standard series for patch tests. Its role has to be evoked in any case localized on the face or hand, airborne or generalized eczema. Among infectious diseases, skin manifestations due to Parvovirus have been specified, a febrile rash can be related to dengue infection or to Zika virus. (C) 2014 Elsevier Masson SAS. All rights reserved.
C1 Ctr Hosp Univ Nancy, Hop Brabois, Dept Dermatol & Allergol, F-54500 Vandoeuvre Les Nancy, France.
RP Barbaud, A (reprint author), Ctr Hosp Univ Nancy, Hop Brabois, Dept Dermatol & Allergol, Batiment Specialites Med, F-54500 Vandoeuvre Les Nancy, France.
EM a.barbaud@chu-nancy.fr
CR Admani S, 2014, PEDIATR DERMATOL, V31, P350, DOI 10.1111/pde.12328
   Aerts O, 2014, J EUR ACAD DERMATOL, DOI [10.1111/jdv.12598, DOI 10.1111/JDV.12598]
   Aerts O, 2014, CONTACT DERMATITIS, V71, P41, DOI 10.1111/cod.12249
   Alfirevic A, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010891, DOI 10.1002/14651858.CD010891]
   Attaway Amy, 2014, J Dermatol Case Rep, V8, P24, DOI 10.3315/jdcr.2014.1166
   Bakker CV, 2013, JAMA DERMATOL, V149, P950, DOI 10.1001/jamadermatol.2013.756
   Baran R, 2014, J EUR ACAD DERMATOL, V28, P257, DOI 10.1111/jdv.12187
   Barbaud A, 2014, J EUR ACAD DERMATOL, V28, P491, DOI 10.1111/jdv.12130
   Belani H, 2013, JAMA DERMATOL, V149, P453, DOI 10.1001/jamadermatol.2013.2705
   Bene J, 2015, FUND CLIN PHARMACOL, V29, P112, DOI 10.1111/fcp.12083
   Bernardeschi C, 2016, J EUR ACAD DERMATOL, V30, P143, DOI 10.1111/jdv.12635
   Borradori L, 2014, JAMA DERMATOL, V150, P459, DOI 10.1001/jamadermatol.2014.51
   Brick KE, 2014, J AM ACAD DERMATOL, V71, P1191, DOI 10.1016/j.jaad.2014.07.052
   Bruze M, 2014, CONTACT DERMATITIS, V71, P35, DOI 10.1111/cod.12240
   Cahill JL, 2014, MED J AUSTRALIA, V200, P208, DOI 10.5694/mja13.10946
   Cai SCS, 2014, BRIT J DERMATOL, V170, P1319, DOI 10.1111/bjd.12806
   Casas-de-la-Asuncion E, 2014, Actas Dermosifiliogr, V105, P860, DOI 10.1016/j.ad.2014.04.013
   Castelain M, 2014, EUR J DERMATOL, V24, P15
   Chang MW, 2014, PEDIATRICS, V133, pE434, DOI 10.1542/peds.2013-1453
   Chen W, 2014, BRIT J DERMATOL, V170, P1219, DOI 10.1111/bjd.12850
   Chung SD, 2014, J EUR ACAD DERMATOL, V28, P558, DOI 10.1111/jdv.12132
   CICCARELLI F, 2013, CURR MED CHEM, V21, P261
   Crowley JJ, 2014, BRIT J DERMATOL, V171, P1561, DOI 10.1111/bjd.13122
   Dubourg G, 2014, EUR J CLIN MICROBIOL, V33, P1449, DOI 10.1007/s10096-014-2090-2
   Ekman AK, 2014, BRIT J DERMATOL, V171, P1517, DOI 10.1111/bjd.13178
   Ezzedine K, 2015, BRIT J DERMATOL, V172, P716, DOI 10.1111/bjd.13423
   Fichel F, 2014, JAMA DERMATOL, V150, P25, DOI 10.1001/jamadermatol.2013.5757
   Friis UF, 2014, CONTACT DERMATITIS, V71, P65, DOI 10.1111/cod.12235
   Gelot P, 2012, ANN DERMATOL VENER, V139, P287, DOI 10.1016/j.annder.2012.01.025
   Gisondi P, 2008, ANN RHEUM DIS, V67, P26, DOI 10.1136/ard.2007.075101
   Gold DA, 2014, J AM ACAD DERMATOL, V70, P699, DOI 10.1016/j.jaad.2013.11.014
   Gonul M, 2014, J CUTAN MED SURG, V18, P65, DOI 10.2310/7750.2013.13051
   Hartig I, 2014, JCR-J CLIN RHEUMATOL, V20, P96, DOI 10.1097/RHU.0000000000000078
   Hosteing S, 2014, CONTACT DERMATITIS, V70, P262, DOI 10.1111/cod.12207
   Hotz C, 2013, BRIT J DERMATOL, V169, P1223, DOI 10.1111/bjd.12502
   Ingram JR, 2014, BRIT J DERMATOL, V171, P1422, DOI 10.1111/bjd.13163
   Isaksson M, 2015, ACTA DERM-VENEREOL, V95, P31, DOI 10.2340/00015555-1844
   Kieffer C, 2009, MEDICINE, V88, P23, DOI 10.1097/MD.0b013e3181943f5e
   Kimmoun A, 2013, SHOCK, V40, P387, DOI 10.1097/SHK.0000000000000041
   Lallas A, 2014, J EUR ACAD DERMATOL, V28, P609, DOI 10.1111/jdv.12146
   Lammintausta K, 2014, CONTACT DERMATITIS, V70, P184, DOI 10.1111/cod.12186
   Langenbruch A, 2014, BRIT J DERMATOL, V171, P1123, DOI 10.1111/bjd.13272
   Lee JY, 2014, J DERMATOL, V41, P343, DOI 10.1111/1346-8138.12406
   Levender MM, 2014, BRIT J DERMATOL, V170, P1189, DOI 10.1111/bjd.12771
   Leysen J, 2014, CONTACT DERMATITIS, V70, P323, DOI 10.1111/cod.12208
   Li ZX, 2014, J CLIN VIROL, V60, P190, DOI 10.1016/j.jcv.2014.04.012
   Lynde CW, 2014, J AM ACAD DERMATOL, V71, P141, DOI 10.1016/j.jaad.2013.12.036
   Madsen JT, 2014, CONTACT DERMATITIS, V70, P183, DOI 10.1111/cod.12191
   Mage V, 2014, J AM ACAD DERMATOL, V71, P62, DOI 10.1016/j.jaad.2014.02.044
   Miller IM, 2013, J AM ACAD DERMATOL, V69, P1014, DOI 10.1016/j.jaad.2013.06.053
   Misery L, 2014, J EUR ACAD DERMATOL, V28, P825, DOI 10.1111/jdv.12274
   Misery L, 2014, EUR J DERMATOL, V24, P147, DOI 10.1684/ejd.2013.2189
   Patel AN, 2014, BRIT J DERMATOL, V170, P1200, DOI 10.1111/bjd.12823
   Picard D, 2014, BRIT J DERMATOL, V171, P580, DOI 10.1111/bjd.13155
   Pistone G, 2014, BR J DERMATOL
   Poreaux C, 2014, CLIN EXP ALLERGY, V44, P756, DOI 10.1111/cea.12217
   Prat L, 2014, CLIN DERMATOL, V32, P376, DOI 10.1016/j.clindermatol.2013.11.004
   Schmidt T, 2014, BRIT J DERMATOL, V171, P212, DOI 10.1111/bjd.12936
   Stavropoulos PG, 2014, J EUR ACAD DERMATOL, V28, P1133, DOI 10.1111/jdv.12366
   Taghipour K, 2014, J EUR ACAD DERMATOL, V28, P569, DOI 10.1111/jdv.12136
   Tani N, 2015, BRIT J DERMATOL, V172, P120, DOI 10.1111/bjd.13374
   Teixeira VB, 2014, AN BRAS DERMATOL, V89, P274, DOI 10.1590/abd1806-4841.20142516
   van der Voort EAM, 2014, J AM ACAD DERMATOL, V70, P517, DOI 10.1016/j.jaad.2013.10.044
   van der Zee HH, 2014, BRIT J DERMATOL, V171, P673, DOI 10.1111/bjd.13002
   Vandevenne A, 2014, CONTACT DERMATITIS, V71, P111, DOI 10.1111/cod.12253
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wechwithan S, 2014, REGUL TOXICOL PHARM, V70, P407, DOI 10.1016/j.yrtph.2014.06.007
   Yousefi M, 2013, J EUR ACAD DERMATOL, V27, P1498, DOI 10.1111/jdv.12033
   Zhang H, 2014, BIOMED RES INT, V2014
   Zhao YE, 2014, J EUR ACAD DERMATOL, V28, P355, DOI 10.1111/jdv.12256
   Zuberbier T, 2014, ALLERGY, V69, pe1
NR 71
TC 0
Z9 0
U1 4
U2 7
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0151-9638
EI 2214-5451
J9 ANN DERMATOL VENER
JI Ann. Dermatol. Venereol.
PD DEC
PY 2014
VL 141
SU 4
BP S597
EP S609
PG 13
WC Dermatology
SC Dermatology
GA CP1AE
UT WOS:000359607400001
PM 25539751
ER

PT J
AU Berthet, N
   Nakoune, E
   Kamgang, B
   Selekon, B
   Descorps-Declere, S
   Gessain, A
   Manuguerra, JC
   Kazanji, M
AF Berthet, Nicolas
   Nakoune, Emmanuel
   Kamgang, Basile
   Selekon, Benjamin
   Descorps-Declere, Stephane
   Gessain, Antoine
   Manuguerra, Jean-Claude
   Kazanji, Mirdad
TI Molecular Characterization of Three Zika Flaviviruses Obtained from
   Sylvatic Mosquitoes in the Central African Republic
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Central Africa; Aedes africanus; Zika virus; Genomic characterization;
   Aedes opok
ID AEDES-ALBOPICTUS; YELLOW-FEVER; VIRUS; ARBOVIRUSES; TRANSMISSION;
   PATTERNS; GABON
AB Zika virus (ZIKV) is an emerging pathogen belonging to the Spondweni serocomplex within the genus Flavivirus. It has been isolated from several mosquito species. Two lineages of ZIKV have been defined by polyprotein homology. Using high-throughput sequencing, we obtained and characterized three complete genomes of ZIKV isolated between 1976 and 1980 in the Central African Republic. The three viruses were isolated from two species of mosquito, Aedes africanus and Ae. opok. Two sequences from Ae. africanus had 99.9% nucleotide sequence identity and 100% amino acid identity, whereas the complete genome obtained from Ae. opok had 98.3% nucleotide identity and 99.4% amino acid identity with the other two genomes. Phylogenetic analysis based on the amino acid sequence of the polyprotein showed that the three ZIKV strains clustered together but diverged from all other ZIKV strains. Our molecular data suggest that a different subtype of West African ZIKV strains circulated in Aedes species in Central Africa.
C1 [Berthet, Nicolas; Nakoune, Emmanuel; Kamgang, Basile; Selekon, Benjamin; Kazanji, Mirdad] Inst Pasteur, Dept Virol, Bangui, Cent Afr Republ.
   [Berthet, Nicolas; Gessain, Antoine] Inst Pasteur, Paris, France.
   [Berthet, Nicolas; Gessain, Antoine] CNRS, Paris, France.
   [Descorps-Declere, Stephane] Inst Pasteur, Plate Forme Bioanal Genom, Paris, France.
   [Manuguerra, Jean-Claude] Inst Pasteur, Unite Rech & Expertise Environm & Risques Infect, Paris, France.
RP Kazanji, M (reprint author), Inst Pasteur, Dept Virol, BP 923, Bangui, Cent Afr Republ.
EM mirdad.kazanji@pasteur.fr
RI Berthet, Nicolas/J-9373-2012
FU Programme Transversal de Recherche CEVACAR - Institut Pasteur (Paris,
   France) [385]
FX This study was supported by the Programme Transversal de Recherche
   CEVACAR No. 385 financed by the Institut Pasteur (Paris, France). The
   funder had no role in study design, data analysis, or preparation of the
   manuscript.
CR Adam F, 2005, CRORA DATABASE
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Musso D, 2014, EURO SURVEILL, V19
   NATHNAC, 2014, ZIK VIR OUTBR
   Ngoagouni C, 2012, PARASITE VECTOR, V16, P175
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
NR 25
TC 21
Z9 21
U1 9
U2 54
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD DEC 1
PY 2014
VL 14
IS 12
BP 862
EP 865
DI 10.1089/vbz.2014.1607
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA AW6AJ
UT WOS:000346351600005
PM 25514122
ER

PT J
AU Fonseca, K
   Meatherall, B
   Zarra, D
   Drebot, M
   MacDonald, J
   Pabbaraju, K
   Wong, S
   Webster, P
   Lindsay, R
   Tellier, R
AF Fonseca, Kevin
   Meatherall, Bonnie
   Zarra, Danielle
   Drebot, Michael
   MacDonald, Judy
   Pabbaraju, Kanti
   Wong, Sallene
   Webster, Patricia
   Lindsay, Robbin
   Tellier, Raymond
TI Case Report: First Case of Zika Virus Infection in a Returning Canadian
   Traveler
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RT-PCR; MICRONESIA; DENGUE
AB A woman who recently traveled to Thailand came to a local emergency department with a fever and papular rash. She was tested for measles, malaria, and dengue. Positive finding for IgM antibody against dengue and a failure to seroconvert for IgG against dengue for multiple blood samples suggested an alternate flavivirus etiology. Amplification of a conserved region of the non-structural protein 5 gene of the genus Flavivirus yielded a polymerase chain reaction product with a matching sequence of 99% identity with Zika virus. A urine sample and a nasopharygeal swab specimen obtained for the measles investigation were also positive for this virus by reverse transcription polymerase chain reaction. Subsequently, the urine sample yielded a Zika virus isolate in cell culture. This case report describes a number of novel clinical and laboratory findings, the first documentation of this virus in Canada, and the second documentation from this region in Thailand.
C1 [Fonseca, Kevin; Zarra, Danielle; Pabbaraju, Kanti; Wong, Sallene; Tellier, Raymond] Prov Lab Publ Hlth, Calgary, AB, Canada.
   [Meatherall, Bonnie; MacDonald, Judy; Webster, Patricia] Alberta Hlth Serv, Calgary, AB, Canada.
   [Drebot, Michael; Lindsay, Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Fonseca, Kevin; Meatherall, Bonnie; MacDonald, Judy; Tellier, Raymond] Univ Calgary, Calgary, AB, Canada.
   Univ Manitoba, Winnipeg, MB, Canada.
RP Fonseca, K (reprint author), Prov Lab Publ Hlth, 3030 Hosp Dr NW, Calgary, AB, Canada.
EM kevin.fonseca@albertahealthservices.ca; blmeathe@ucalgary.ca;
   danielle.zarra@albertahealthservices.ca; mike.drebot@phac-aspc.gc.ca;
   judy.macdonald@albertahealthservices.ca;
   kanti.pabbaraju2@albertahealthservices.ca;
   sallene.wong@albertahealthservices.ca;
   patricia.webster@albertahealthservices.ca;
   robbin.lindsay@phac-aspc.gc.ca; raymond.tellier@albertahealthservices.ca
CR Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   [Anonymous], 2014, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lertanekawattana Sujet, 2013, Southeast Asian J Trop Med Public Health, V44, P780
   Musso D, 2014, EURO SURVEILL, V19
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   ProMed-mail, 2013, PROMED MAIL     0529
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
NR 17
TC 40
Z9 43
U1 2
U2 32
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2014
VL 91
IS 5
BP 1035
EP 1038
DI 10.4269/ajtmh.14-0151
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA AS7PO
UT WOS:000344447800031
PM 25294619
ER

PT J
AU Cao-Lormeau, VM
AF Cao-Lormeau, Van-Mai
TI Zika Virus, French Polynesia, South Pacific, 2013 Response
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID MICRONESIA
C1 Inst Louis Malarde, Papeete 98713, Tahiti, Fr Polynesia.
RP Cao-Lormeau, V (reprint author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM mlormeau@ilm.pf
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1961
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
NR 4
TC 0
Z9 0
U1 7
U2 20
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2014
VL 20
IS 11
BP 1960
EP 1960
DI 10.3201/eid2011.141380
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AS0KO
UT WOS:000343966300043
PM 25513658
ER

PT J
AU Hancock, WT
   Marfel, M
   Bel, M
AF Hancock, W. Thane
   Marfel, Maria
   Bel, Martin
TI Zika Virus, French Polynesia, South Pacific, 2013
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Hancock, W. Thane; Marfel, Maria; Bel, Martin] Yap State Dept Hlth Serv, Colonia 96943, Yap, Micronesia.
RP Hancock, WT (reprint author), Yap State Dept Hlth Serv, EpiNet, POB 148, Colonia 96943, Yap, Micronesia.
EM thane@fsmhealth.fm
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
NR 2
TC 10
Z9 10
U1 7
U2 23
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2014
VL 20
IS 11
BP 1960
EP 1960
DI 10.3201/eid2011.141253
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AS0KO
UT WOS:000343966300042
PM 25341051
ER

PT J
AU Roth, A
   Mercier, A
   Lepers, C
   Hoy, D
   Duituturaga, S
   Benyon, E
   Guillaumot, L
   Souares, Y
AF Roth, A.
   Mercier, A.
   Lepers, C.
   Hoy, D.
   Duituturaga, S.
   Benyon, E.
   Guillaumot, L.
   Souares, Y.
TI Concurrent outbreaks of dengue, chikungunya and Zika virus infections -
   an unprecedented epidemic wave of mosquito-borne viruses in the Pacific
   2012-2014
SO EUROSURVEILLANCE
LA English
DT Article
ID SOUTH-PACIFIC; FEDERATED STATES; REUNION ISLAND; NEW-CALEDONIA;
   SURVEILLANCE; MICRONESIA; COUNTRIES
AB Since January 2012, the Pacific Region has experienced 28 new documented outbreaks and circulation of dengue, chikungunya and Zika virus. These mosquito-borne disease epidemics seem to become more frequent and diverse, and it is likely that this is only the early stages of a wave that will continue for several years. Improved surveillance and response measures are needed to mitigate the already heavy burden on island health systems and limit further spread to other parts of the world.
C1 [Roth, A.; Mercier, A.; Lepers, C.; Hoy, D.; Duituturaga, S.; Benyon, E.; Souares, Y.] Secretariat Pacific Commun, Noumea, New Caledonia.
   [Guillaumot, L.] Inst Pasteur Nouvelle Caledonie, Noumea, New Caledonia.
RP Roth, A (reprint author), Secretariat Pacific Commun, Noumea, New Caledonia.
EM adamr@spc.int
CR *BUR VEILL SAN, BULLETIN DE SURVEILL
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   *CDCP, 2013, MMWR MORBIDITY AND M, V62, P570
   Chretien JP, 2007, LANCET, V370, P1805, DOI 10.1016/S0140-6736(07)61752-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Dupont-Rouzeyrol M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-61
   DUPONTROUZEYROL M, 2014, ANNUAL REPORT 2013, P24
   *ECDC, 2014, FRENCH POLYNESIA
   Guillaumot L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-247
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   JONES J, 2011, EUROSURVEILL, V16
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kool JL, 2012, GLOB PUBLIC HEALTH, V7, P670, DOI 10.1080/17441692.2012.699536
   Kuehn BM, 2014, JAMA-J AM MED ASSOC, V311, P1189, DOI 10.1001/jama.2014.2272
   LAGACHERIE P, 2012, MED TROP MARS, V72
   Lau CL, 2013, EPIDEMIOL INFECT, V141, P2328, DOI 10.1017/S0950268813000058
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Morens D. M., 1996, Pacific Health Dialog, V3, P240
   Musso D, 2014, CLIN MICROBIOL INFEC
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nhan TX, 2014, EMERG INFECT DIS, V20, P1773, DOI 10.3201/eid2010.141060
   OEHLER E, 2014, EUROSURVEILL, V19
   *PPHSN, 2014, THE PACIFIC OUTBREAK
   *QUEENSL GOV, QUEENSLAND NOTIFIABL
   Renault P, 2012, MED MALADIES INFECT, V42, P93, DOI 10.1016/j.medmal.2011.12.002
   ROTH A, 2014, EMERGING INFECT DIS, V20
   Singh Narendra, 2005, Pac Health Dialog, V12, P111
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   *STAT DEV DIV, 2013, LES POPULATIONS DU P
   *STIT ENV SCIENC R, DENGUE WEEKLY UPDATE
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   *WHO, 2014, WEEKLY PACIFIC SYNDR
NR 34
TC 32
Z9 33
U1 7
U2 45
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD OCT 16
PY 2014
VL 19
IS 41
BP 2
EP 9
AR UNSP 20929
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA AR7MW
UT WOS:000343764800001
ER

PT J
AU Diallo, D
   Sall, AA
   Diagne, CT
   Faye, O
   Faye, O
   Ba, Y
   Hanley, KA
   Buenemann, M
   Weaver, SC
   Diallo, M
AF Diallo, Diawo
   Sall, Amadou A.
   Diagne, Cheikh T.
   Faye, Oumar
   Faye, Ousmane
   Ba, Yamar
   Hanley, Kathryn A.
   Buenemann, Michaela
   Weaver, Scott C.
   Diallo, Mawlouth
TI Zika Virus Emergence in Mosquitoes in Southeastern Senegal, 2011
SO PLOS ONE
LA English
DT Article
ID YELLOW-FEVER VIRUS; CHIKUNGUNYA VIRUS; AEDES; TRANSMISSION; ISOLATIONS;
   CULICIDAE; DIPTERA; VECTOR; AMPLIFICATION; SURVEILLANCE
AB Background: Zika virus (ZIKV; genus Flavivirus, family Flaviviridae) is maintained in a zoonotic cycle between arboreal Aedes spp. mosquitoes and nonhuman primates in African and Asian forests. Spillover into humans has been documented in both regions and the virus is currently responsible for a large outbreak in French Polynesia. ZIKV amplifications are frequent in southeastern Senegal but little is known about their seasonal and spatial dynamics. The aim of this paper is to describe the spatio-temporal patterns of the 2011 ZIKV amplification in southeastern Senegal.
   Methodology/Findings: Mosquitoes were collected monthly from April to December 2011 except during July. Each evening from 18: 00 to 21: 00 hrs landing collections were performed by teams of 3 persons working simultaneously in forest (canopy and ground), savannah, agriculture, village (indoor and outdoor) and barren land cover sites. Mosquitoes were tested for virus infection by virus isolation and RT-PCR. ZIKV was detected in 31 of the 1,700 mosquito pools (11,247 mosquitoes) tested: Ae. furcifer (5), Ae. luteocephalus (5), Ae. africanus (5), Ae. vittatus (3), Ae. taylori, Ae. dalzieli, Ae. hirsutus and Ae. metallicus (2 each) and Ae. aegypti, Ae. unilinaetus, Ma. uniformis, Cx. perfuscus and An. coustani (1 pool each) collected in June (3), September (10), October (11), November (6) and December (1). ZIKV was detected from mosquitoes collected in all land cover classes except indoor locations within villages. The virus was detected in only one of the ten villages investigated.
   Conclusions/Significance: This ZIKV amplification was widespread in the Kedougou area, involved several mosquito species as probable vectors, and encompassed all investigated land cover classes except indoor locations within villages. Aedes furcifer males and Aedes vittatus were found infected within a village, thus these species are probably involved in the transmission of Zika virus to humans in this environment.
C1 [Diallo, Diawo; Diagne, Cheikh T.; Ba, Yamar; Diallo, Mawlouth] Inst Pasteur, Unite Entomol Med, Dakar, Senegal.
   [Sall, Amadou A.; Faye, Oumar; Faye, Ousmane] Inst Pasteur, Unite Arbovirus & Virus Fievres Hemorrag, Dakar, Senegal.
   [Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Buenemann, Michaela] New Mexico State Univ, Dept Geog, Las Cruces, NM 88003 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Diallo, D (reprint author), Inst Pasteur, Unite Entomol Med, Dakar, Senegal.
EM ddiallo@pasteur.sn
RI Weaver, Scott/D-6490-2011
FU National Center for Research Resources [5P20RR016480-12]; National
   Institutes of Health [AI069145]
FX This study was supported by grants from the National Center for Research
   Resources (5P20RR016480-12) and the National Institutes of Health
   (AI069145). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Adam F, CTR COLLBAORATEUR OM
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Cornet M, 1979, ENTOMOL MED PARASITO, V17, P47
   Cornet M., 1979, ENTOMOL MED PARASITO, V17, P149
   Cornet M, 1973, ENTOMOL MED PARASIT, V11, P175
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P446, DOI 10.1016/0035-9203(83)90108-6
   DIAGNE N, 1994, B SOC PATHOL EXOT, V87, P267
   Diallo D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-286
   Diallo D, 2013, T ROY SOC TROP MED H, V107, P200, DOI 10.1093/trstmh/trs095
   Diallo D, 2014, AM J TROP MED HYG, V90, P1003, DOI 10.4269/ajtmh.13-0404
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 2003, EMERG INFECT DIS, V9, P362
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2009, Med Trop (Mars), V69, P339
   Edwards F, 1941, MOSQUITOES ETHIPIAN
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferrara L, 1984, ENTOMOL MED PARASITO, V22, P95
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HUANG YM, 1986, J MED ENTOMOL, V23, P196
   Huang Y-M, 1981, PICTORIAL KEY IDENTI
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Jupp PG, 1997, MOSQUITOES SO AFRIC
   Kuno G, 1998, J VIROL, V72, P73
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Rickenbach A, 1969, Bull. Soc. Path. exot., V62, P266
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tewari SC, 2004, TROP MED INT HEALTH, V9, P499, DOI 10.1111/j.1365-3156.2004.01103.x
   TraoreLamizana M, 1996, J MED ENTOMOL, V33, P760
   TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P623
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
NR 43
TC 30
Z9 32
U1 14
U2 46
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 13
PY 2014
VL 9
IS 10
AR e109442
DI 10.1371/journal.pone.0109442
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ9WZ
UT WOS:000343210300050
PM 25310102
ER

PT J
AU Musso, D
   Nilles, EJ
   Cao-Lormeau, VM
AF Musso, D.
   Nilles, E. J.
   Cao-Lormeau, V. -M.
TI Rapid spread of emerging Zika virus in the Pacific area
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
C1 [Musso, D.; Cao-Lormeau, V. -M.] Inst Louis Malarde Papeete, Tahiti, Fr Polynesia.
   [Nilles, E. J.] World Hlth Org, Suva, Fiji.
RP Musso, D (reprint author), Inst Louis Malarde Papeete, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
OI Nilles, Eric/0000-0001-7044-5257
CR Besnard M, 2014, EURO SURVEILL, V19
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Musso D, 2014, EURO SURVEILL, V19
   Oehler E, 2013, EURO SURVEILL, V19
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
NR 9
TC 44
Z9 47
U1 10
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD OCT
PY 2014
VL 20
IS 10
BP O595
EP O596
DI 10.1111/1469-0691.12707
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA AU8DE
UT WOS:000345825900002
PM 24909208
ER

PT J
AU Ledermann, JP
   Guillaumot, L
   Yug, L
   Saweyog, SC
   Tided, M
   Machieng, P
   Pretrick, M
   Marfel, M
   Griggs, A
   Bel, M
   Duffy, MR
   Hancock, WT
   Ho-Chen, T
   Powers, AM
AF Ledermann, Jeremy P.
   Guillaumot, Laurent
   Yug, Lawrence
   Saweyog, Steven C.
   Tided, Mary
   Machieng, Paul
   Pretrick, Moses
   Marfel, Maria
   Griggs, Anne
   Bel, Martin
   Duffy, Mark R.
   Hancock, W. Thane
   Tai Ho-Chen
   Powers, Ann M.
TI Aedes hensilli as a Potential Vector of Chikungunya and Zika Viruses
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MOSQUITO-BORNE INFECTIONS; FEDERATED STATES; YAP STATE; DENGUE-FEVER;
   EPIDEMIC; MICRONESIA; OUTBREAK; NIGERIA; ALBOPICTUS; STRAINS
AB An epidemic of Zika virus (ZIKV) illness that occurred in July 2007 on Yap Island in the Federated States of Micronesia prompted entomological studies to identify both the primary vector(s) involved in transmission and the ecological parameters contributing to the outbreak. Larval and pupal surveys were performed to identify the major containers serving as oviposition habitat for the likely vector(s). Adult mosquitoes were also collected by backpack aspiration, light trap, and gravid traps at select sites around the capital city. The predominant species found on the island was Aedes (Stegomyia) hensilli. No virus isolates were obtained from the adult field material collected, nor did any of the immature mosquitoes that were allowed to emerge to adulthood contain viable virus or nucleic acid. Therefore, laboratory studies of the probable vector, Ae. hensilli, were undertaken to determine the likelihood of this species serving as a vector for Zika virus and other arboviruses. Infection rates of up to 86%, 62%, and 20% and dissemination rates of 23%, 80%, and 17% for Zika, chikungunya, and dengue-2 viruses respectively, were found supporting the possibility that this species served as a vector during the Zika outbreak and that it could play a role in transmitting other medically important arboviruses.
C1 [Ledermann, Jeremy P.; Griggs, Anne; Duffy, Mark R.; Powers, Ann M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
   [Guillaumot, Laurent] Inst Pasteur Nouvelle Caledonie, URE Entomol Med, Noumea, New Caledonia.
   [Yug, Lawrence; Tided, Mary] Dept Hlth Serv, Div Publ Hlth, Environm Hlth Serv, Ponape, Micronesia.
   [Saweyog, Steven C.; Machieng, Paul] Dept Hlth & Social Affairs, Natl Food Safety Program, Ponape, Micronesia.
   [Pretrick, Moses] Dept Hlth Educ & Social Affairs, Ponape, Micronesia.
   [Marfel, Maria; Bel, Martin; Hancock, W. Thane] Waab Community Hlth Ctr, Yap, Micronesia.
   [Tai Ho-Chen] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Field Assignments Branch, Atlanta, GA USA.
RP Ledermann, JP (reprint author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
EM APowers@cdc.gov
FU United States Government, Dept. of Health and Human Services, Centers
   for Disease Control and Prevention
FX This study was funded by the United States Government, Dept. of Health
   and Human Services, Centers for Disease Control and Prevention. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Ashford DA, 2003, AM J TROP MED HYG, V69, P135
   BARNES WJS, 1974, AM J TROP MED HYG, V23, P495
   Bohart RM, 1956, INSECTS MICRONESIA D
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   FILIPE AR, 1973, B WORLD HEALTH ORGAN, V49, P37
   Gaffigan TV, 2013, SYSTMATIC CATALOG CU
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler DG, 2001, FIELDS VIROLOGY, P1152
   Gubler DJ, 1988, ARBOVIRUSES EPIDEMIO, VII, P223
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Karabatsos N., 1985, INT CATALOG ARBOVIRU
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Linnen JM, 2008, TRANSFUSION, V48, P1355, DOI 10.1111/j.1537-2995.2008.01772.x
   MACKERRAS IM, 1946, T ROY SOC TROP MED H, V40, P295, DOI 10.1016/0035-9203(46)90070-3
   MAGUIRE T, 1974, J HYG-CAMBRIDGE, V73, P263
   MAGUIRE T, 1971, J HYG-CAMB, V69, P287
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Mossel EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060427
   Myles KM, 2006, J VIROL, V80, P4992, DOI 10.1128/JVI.80.10.4992-4997.2006
   Nukui Y, 2006, EMERG INFECT DIS, V12, P343
   Partidos CD, 2011, VACCINE, V29, P3067, DOI 10.1016/j.vaccine.2011.01.076
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   ROSEN L, 1954, AM J TROP MED HYG, V3, P878
   ROSEN L, 1985, AM J TROP MED HYG, V34, P603
   Rueda LM, 2004, ZOOTAXA, V589, P60
   Sang RC, 2008, AM J TROP MED HYG, V78, P77
   Savage HM, 1998, AM J TROP MED HYG, V58, P519
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh Narendra, 2005, Pac Health Dialog, V12, P111
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   STEINLY BA, 1991, J AM MOSQUITO CONTR, V7, P649
   Taulung LA, 2013, MMWR-MORBID MORTAL W, V62, P570
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   TURELL MJ, 1992, J MED ENTOMOL, V29, P49
   WATERMAN SH, 1989, CLIN DERMATOL, V7, P117, DOI 10.1016/0738-081X(89)90034-5
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
NR 50
TC 31
Z9 33
U1 15
U2 51
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2014
VL 8
IS 10
AR e3188
DI 10.1371/journal.pntd.0003188
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AS9WJ
UT WOS:000344589000015
PM 25299181
ER

PT J
AU Waehre, T
   Maagard, A
   Tappe, D
   Cadar, D
   Schmidt-Chanasit, J
AF Waehre, Torgun
   Maagard, Anne
   Tappe, Dennis
   Cadar, Daniel
   Schmidt-Chanasit, Jonas
TI Zika Virus Infection after Travel to Tahiti, December 2013
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Waehre, Torgun; Maagard, Anne] Oslo Univ Hosp, Oslo, Norway.
   [Tappe, Dennis; Cadar, Daniel; Schmidt-Chanasit, Jonas] WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, D-20359 Hamburg, Germany.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res, Hamburg, Germany.
RP Schmidt-Chanasit, J (reprint author), WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
EM jonassi@gmx.de
CR European Centre for Disease Prevention and Control, 2014, ZIK VIR PAC
   Fonseca K., 2013, ZIKA VIRUS CANADA EX
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kutsuna S, 2014, EURO SURVEILL, P19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Schwan K., 2014, ZIKA VIRUS PACIFIC
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2009, MED MICROBIOL IMMUN, V198, P271, DOI 10.1007/s00430-009-0122-9
NR 10
TC 24
Z9 25
U1 3
U2 12
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2014
VL 20
IS 8
BP 1412
EP 1414
DI 10.3201/eid2008.140302
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AM4ZF
UT WOS:000339864000036
ER

PT J
AU Voelker, R
AF Voelker, Rebecca
TI Zika Virus Strikes French Polynesia
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
OI Khan, Yawar/0000-0003-1964-591X
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
NR 1
TC 0
Z9 0
U1 2
U2 12
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD JUL 23
PY 2014
VL 312
IS 4
BP 329
EP 329
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA AL6QN
UT WOS:000339257800011
ER

PT J
AU Ioos, S
   Mallet, HP
   Goffart, IL
   Gauthier, V
   Cardoso, T
   Herida, M
AF Ioos, S.
   Mallet, H. -P.
   Goffart, I. Leparc
   Gauthier, V.
   Cardoso, T.
   Herida, M.
TI Current Zika virus epidemiology and recent epidemics
SO MEDECINE ET MALADIES INFECTIEUSES
LA English
DT Review
DE Zika virus; Aedes; Arbovirus; Yap; French Polynesia
ID ARBOVIRUSES; INFECTION; INDONESIA
AB The Zika virus (ZIKV) is a mosquito-borne flavivirus (Aedes), similar to other arboviruses, first identified in Uganda in 1947. Few human cases were reported until 2007, when a Zika outbreak occurred in Yap, Micronesia, even though ZIKV activity had been reported in Africa and in Asia through virological surveillance and entomological studies. French Polynesia has recorded a large outbreak since October 2013. A great number of cases and some with neurological and autoimmune complications have been reported in a context of concurrent circulation of dengue viruses. The clinical presentation is a "dengue-like syndrome". Until the epidemic in French Polynesia, no severe ZIKV disease had been described so far. The diagnosis is confirmed by viral genome detection by genomic amplification (RT-PCR) and viral isolation. These two large outbreaks occurred in a previously unaffected area in less than a decade. They should raise awareness as to the potential for ZIKV to spread especially since this emergent disease is not well known and that some questions remain on potential reservoirs and transmission modes as well as on clinical presentations and complications. ZIKV has the potential to spread to new areas where the Aedes mosquito vector is present and could be a risk for Southern Europe. Strategies for the prevention and control of ZIKV disease should include the use of insect repellent and mosquito vector eradication. (C) 2014 Elsevier Masson SAS. All rights reserved.
C1 [Ioos, S.; Gauthier, V.; Cardoso, T.; Herida, M.] Inst Veille Sanit, Dept Coordinat Alertes & Reg, F-94415 St Maurice, France.
   [Mallet, H. -P.] Bur Veille Sanit, Direct Sante, Papeete, Fr Polynesia.
   [Goffart, I. Leparc] IRBA, Ctr Natl Reference Arbovirus, Marseille, France.
RP Ioos, S (reprint author), Inst Veille Sanit, Dept Coordinat Alertes & Reg, 12 Rue Val Osne, F-94415 St Maurice, France.
EM s.ioos@invs.sante.fr
CR DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Dass Nouvelle Caledonie, 2014, DASS NOUVELLE CALEDO
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy, 2009, NEW ENGL J MED, V360, P24
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Grard G, 2007, PLOS NEGLECT TROP D, V8, pe2681, DOI DOI 10.1371/J0URNAL.PNTD.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Institut national de sante publique de Norvege, 2014, NOT INF DEST PROF SA
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2013, EUROSURVEILLANCE, V19, P20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Ministere de la sante chilien, 2014, NOT ZIK
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   [Anonymous], 2013, NOT INF DEST PROF SA
   [Anonymous], 2000, YAP CENSUS
NR 20
TC 84
Z9 102
U1 62
U2 216
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0399-077X
J9 MED MALADIES INFECT
JI Med. Mal. Infect.
PD JUL
PY 2014
VL 44
IS 7
BP 302
EP 307
DI 10.1016/j.medmal.2014.04.008
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA AO2BN
UT WOS:000341120600003
PM 25001879
ER

PT J
AU Blazquez, AB
   Escribano-Romero, E
   Merino-Ramos, T
   Saiz, JC
   Martin-Acebes, MA
AF Blazquez, Ana-Belen
   Escribano-Romero, Estela
   Merino-Ramos, Teresa
   Saiz, Juan-Carlos
   Martin-Acebes, Miguel A.
TI Stress responses in flavivirus-infected cells: activation of unfolded
   protein response and autophagy
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE flavivirus; unfolded protein response; autophagy; dengue virus; West
   Nile virus; endoplasmic reticulum stress; virus replication
ID HEPATITIS-C VIRUS; ENDOPLASMIC-RETICULUM STRESS; DENGUE VIRUS;
   3-DIMENSIONAL ARCHITECTURE; REPLICATION SITES; IN-VITRO; PATHWAY;
   INDUCTION; IMMUNITY; INNATE
AB The Flavivirus is a genus of RNA viruses that includes multiple long known human, animal, and zoonotic pathogens such as Dengue virus, yellow fever virus, West Nile virus, or Japanese encephalitis virus, as well as other less known viruses that represent potential threats for human and animal health such as Usutu or Zika viruses. Flavivirus replication is based on endoplasmic reticulum-derived structures. Membrane remodeling and accumulation of viral factors induce endoplasmic reticulum stress that results in activation of a cellular signaling response termed unfolded protein response (UPR), which can be modulated by the viruses for their own benefit. Concomitant with the activation of the UPR, an upregulation of the autophagic pathway in cells infected with different flaviviruses has also been described. This review addresses the current knowledge of the relationship between endoplasmic reticulum stress, UPR, and autophagy in flavivirus-infected cells and the growing evidences for an involvement of these cellular pathways in the replication and pathogenesis of these viruses.
C1 [Blazquez, Ana-Belen; Escribano-Romero, Estela; Merino-Ramos, Teresa; Saiz, Juan-Carlos; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotecnol, Madrid, Spain.
   [Martin-Acebes, Miguel A.] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Dept Virol & Microbiol, Madrid 28049, Spain.
RP Martin-Acebes, MA (reprint author), Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Biol Mol Severo Ochoa, Dept Virol & Microbiol, Nicolas Cabrera 1,Campus Cantoblanco UAM, Madrid 28049, Spain.
EM mamartin@cbm.csic.es
RI Martin-Acebes, Miguel/L-2258-2014; Blazquez, Ana /G-9791-2015;
   Escribano-Romero, Estela/H-1495-2015
OI Martin-Acebes, Miguel/0000-0001-6015-3613; Blazquez, Ana
   /0000-0002-0847-0977; Escribano-Romero, Estela/0000-0002-5036-7607
FU Spanish' Research Council (CSIC) [RTA 00036-2011]; INIA
FX We thank Dr. Andreas Meyerhans for critical reading of the manuscript.
   This work was supported by grant RTA 00036-2011. Miguel A. Martin-Acebes
   is a recipient of a "Junta de Ampliacion de Estudios (JAE)"
   post-doctoral fellowship from the Spanish' Research Council (CSIC).
   Teresa Merino-Ramos is a recipient of a "Formacion de Personal
   investigador (FPI)" pre-doctoral fellowship from INIA.
CR Ambrose RL, 2013, J VIROL, V87, P2206, DOI 10.1128/JVI.02097-12
   Ambrose RL, 2013, FUTURE VIROL, V8, P1095
   Ambrose R. L., 2010, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Beatman E, 2012, VIROLOGY, V433, P262, DOI 10.1016/j.virol.2012.08.016
   Blazquez AB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002509
   Cao SS, 2013, EXPERT OPIN THER TAR, V17, P437, DOI 10.1517/14728222.2013.756471
   Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje
   Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003
   Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016
   Dreux M, 2011, VIRUSES-BASEL, V3, P1342, DOI 10.3390/v3081342
   Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.1073/pnas.0907344106
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052909
   Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474
   Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151
   Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630
   Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696
   Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1
   Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001
   Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039
   Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200
   Liu CY, 2003, J CELL SCI, V116, P1861, DOI 10.1242/jcs.00408
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   McLean J. E., 2012, J BIOL CHEM, V286, P22147, DOI [10.1074/jbc.M110.192500, DOI 10.1074/JBC.M110.192500]
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mohl BP, 2012, J VIROL, V86, P10724, DOI 10.1128/JVI.01667-12
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Orvedahl A, 2008, CELL MICROBIOL, V10, P1747, DOI 10.1111/j.1462-5822.2008.01175.x
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Pei JJ, 2014, AUTOPHAGY, V10, P93, DOI 10.4161/auto.26843
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Scherbik SV, 2010, J VIROL, V84, P8721, DOI 10.1128/JVI.00144-10
   Shinohara Y, 2013, BIOCHEM BIOPH RES CO, V432, P326, DOI 10.1016/j.bbrc.2013.01.103
   Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866
   Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464
   Sir D, 2008, AUTOPHAGY, V4, P830
   Suh DH, 2012, ANN NY ACAD SCI, V1271, P20, DOI 10.1111/j.1749-6632.2012.06739.x
   Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200
   Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004
   Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Yu C, 2013, VIRUS RES, V178, P471, DOI 10.1016/j.virusres.2013.10.012
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zheng Y, 2005, J MICROBIOL, V43, P529
NR 63
TC 20
Z9 22
U1 16
U2 58
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 3
PY 2014
VL 5
AR 266
DI 10.3389/fmicb.2014.00266
PG 7
WC Microbiology
SC Microbiology
GA AJ2XD
UT WOS:000337527400001
PM 24917859
ER

PT J
AU Cao-Lormeau, VM
   Roche, C
   Teissier, A
   Robin, E
   Berry, AL
   Mallet, HP
   Sall, AA
   Musso, D
AF Cao-Lormeau, Van-Mai
   Roche, Claudine
   Teissier, Anita
   Robin, Emilie
   Berry, Anne-Laure
   Mallet, Henri-Pierre
   Sall, Amadou Alpha
   Musso, Didier
TI Zika Virus, French Polynesia, South Pacific, 2013
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID MICRONESIA; ISLAND
C1 [Cao-Lormeau, Van-Mai; Roche, Claudine; Teissier, Anita; Robin, Emilie; Musso, Didier] Inst Louis Malarde, Papeete 98713, Tahiti, Fr Polynesia.
   [Berry, Anne-Laure; Mallet, Henri-Pierre] Direct Sante, Dakar, Senegal.
   [Sall, Amadou Alpha] Inst Pasteur, Dakar, Senegal.
RP Cao-Lormeau, VM (reprint author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM mlormeau@ilm.pf
CR Aubry M, 2012, J CLIN VIROL, V55, P23, DOI 10.1016/j.jcv.2012.05.010
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
NR 10
TC 101
Z9 111
U1 12
U2 62
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2014
VL 20
IS 6
BP 1085
EP 1086
DI 10.3201/eid2006.140138
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AI0SZ
UT WOS:000336561600039
PM 24856001
ER

PT J
AU Musso, D
   Nhan, T
   Robin, E
   Roche, C
   Bierlaire, D
   Zisou, K
   Yan, AS
   Cao-Lormeau, VM
   Broult, J
AF Musso, D.
   Nhan, T.
   Robin, E.
   Roche, C.
   Bierlaire, D.
   Zisou, K.
   Yan, A. Shan
   Cao-Lormeau, V. M.
   Broult, J.
TI Potential for Zika virus transmission through blood transfusion
   demonstrated during an outbreak in French Polynesia, November 2013 to
   February 2014
SO EUROSURVEILLANCE
LA English
DT Article
ID WEST-NILE-VIRUS; AEDES-ALBOPICTUS; EPIDEMIC; MICRONESIA; THREAT; DENGUE;
   STATES; ISLAND
C1 [Musso, D.; Nhan, T.; Robin, E.; Roche, C.; Zisou, K.; Yan, A. Shan; Cao-Lormeau, V. M.] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
   [Bierlaire, D.; Broult, J.] Ctr Hosp Taaone, Tahiti, Fr Polynesia.
RP Musso, D (reprint author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Cao- Lormeau VM, 2014, EMERG INFEC IN PRESS
   Direction des Affaires Sanitaires et Sociales de Nouvelle Caledonie (DASS- NC), 2014, EP ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2014, ZIK VIR INF OUTBR FR
   Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Kutsuna S, 2014, EURO SURVEILL, P19
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tappe D, 2013, EURO SURVEILL, P19
   Tomashek KM, 2011, TRANSFUSION, V51, P1654, DOI 10.1111/j.1537-2995.2011.03269.x
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 23
TC 55
Z9 61
U1 7
U2 31
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 10
PY 2014
VL 19
IS 14
BP 6
EP 8
AR 20761
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA AE9SQ
UT WOS:000334350200002
ER

PT J
AU Besnard, M
   Lastere, S
   Teissier, A
   Cao-Lormeau, VM
   Musso, D
AF Besnard, M.
   Lastere, S.
   Teissier, A.
   Cao-Lormeau, V. M.
   Musso, D.
TI Evidence of perinatal transmission of Zika virus, French Polynesia,
   December 2013 and February 2014
SO EUROSURVEILLANCE
LA English
DT Article
ID VERTICAL TRANSMISSION; DENGUE; MICRONESIA; PREGNANCY; OUTCOMES
AB A Zika virus (ZIKAV) outbreak started in October 2013 in French Polynesia, South Pacific. We describe here the clinical and laboratory features of two mothers and their newborns who had ZIKAV infection as confirmed by ZIKAV RT-PCR performed on serum collected within four days post-delivery in date. The infants' infection most probably occurred by transplacental transmission or during delivery. Attention should be paid to ZIKAV-infected pregnant women and their newborns, as data on the impact on them are limited.
C1 [Besnard, M.; Lastere, S.] Hop Taaone, Ctr Hosp Polynesie Francaise, Tahiti, Fr Polynesia.
   [Teissier, A.; Cao-Lormeau, V. M.; Musso, D.] Inst Louis Malarde, Tahiti, Fr Polynesia.
RP Besnard, M (reprint author), Hop Taaone, Ctr Hosp Polynesie Francaise, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Cao- Lormeau VM, 2014, EMERG INFEC IN PRESS
   Centers for Disease Control Prevention, 2002, MMWR-MORBID MORTAL W, V51, P877
   Direction des Affaires Sanitaires et Sociales de Nouvelle Caledonie (DASS- NC), 2014, EP ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2014, ZIK VIR INF OUTBR FR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin Patrick, 2008, PLoS Med, V5, pe60, DOI 10.1371/journal.pmed.0050060
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kirya BG, 1977, T R SOC TROP MED HYG, V71, P254
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kutsuna S, 2014, EURO SURVEILL, V19
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Stewart RD, 2013, CASE REP INFECT DIS, V2013
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
NR 21
TC 67
Z9 72
U1 15
U2 64
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD APR 3
PY 2014
VL 19
IS 13
BP 13
EP 16
AR 20751
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA AE5LD
UT WOS:000334029600004
ER

PT J
AU Faye, O
   Freire, CCDM
   Faye, O
   de Oliveira, JV
   Zanotto, PMDA
   Diallo, M
   Sall, AA
AF Faye, O.
   Freire, C. C. D. M.
   Faye, O.
   de Oliveira, J. V.
   Zanotto, P. M. D. A.
   Diallo, M.
   Sall, A. A.
TI Molecular evolution of Zika virus during its emergence in the 20th
   century
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Faye, O.; Faye, O.; Diallo, M.; Sall, A. A.] Inst Pasteur, Dakar, Senegal.
   [Freire, C. C. D. M.] Biomed Sci Inst ICB II, Dept Microbiol, Lab Mol Evolut & Bioinformat LEMB, Sao Paulo, Brazil.
   [de Oliveira, J. V.; Zanotto, P. M. D. A.] Univ Sao Paulo, Biomed Sci Inst ICB II, Lab Mol Evolut & Bioinformat LEMB, Dept Microbiol, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2014
VL 21
SU 1
MA Pre.004
BP 2
EP 3
DI 10.1016/j.ijid.2014.03.411
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA V43TP
UT WOS:000209704000005
ER

PT J
AU Oehler, E
   Watrin, L
   Larre, P
   Leparc-Goffart, I
   Lastere, S
   Valour, F
   Baudouin, L
   Mallet, HP
   Musso, D
   Ghawche, F
AF Oehler, E.
   Watrin, L.
   Larre, P.
   Leparc-Goffart, I.
   Lastere, S.
   Valour, F.
   Baudouin, L.
   Mallet, H. P.
   Musso, D.
   Ghawche, F.
TI Zika virus infection complicated by Guillain-Barre syndrome - case
   report, French Polynesia, December 2013
SO EUROSURVEILLANCE
LA English
DT Article
ID DENGUE VIRUS; AEDES; MICRONESIA; ALBOPICTUS; SINGAPORE; FEVER; STATE;
   PCR
AB Zika fever, considered as an emerging disease of arbo-viral origin, because of its expanding geographic area, is known as a benign infection usually presenting as an influenza-like illness with cutaneous rash. So far, Zika virus infection has never led to hospitalisation. We describe the first case of Guillain-Barre syndrome (GBS) occurring immediately after a Zika virus infection, during the current Zika and type 1 and 3 dengue fever co-epidemics in French Polynesia.
   We report on a French Polynesian patient presenting a Zika virus (ZIKA) infection complicated by Guillain-Barre syndrome GBS).
C1 [Oehler, E.; Valour, F.] French Polynesia Hosp Ctr, Dept Internal Med, Pirae, Tahiti, Fr Polynesia.
   [Watrin, L.; Larre, P.; Ghawche, F.] French Polynesia Hosp Ctr, Dept Neurol, Pirae, Tahiti, Fr Polynesia.
   [Leparc-Goffart, I.] Inst Rech Biomed Armees, Natl Reference Lab Arboviruses, Marseille, France.
   [Lastere, S.] French Polynesia Hosp Ctr, Virol Lab, Pirae, Tahiti, Fr Polynesia.
   [Baudouin, L.] French Polynesia Hosp Ctr, Intens Care Unit, Pirae, Tahiti, Fr Polynesia.
   [Mallet, H. P.] Bur Veille Sanitaire, Intens Care Unit, Papeete, Tahiti, Fr Polynesia.
   [Musso, D.] Louis Mallarde Inst, Papeete, Tahiti, Fr Polynesia.
RP Oehler, E (reprint author), French Polynesia Hosp Ctr, Dept Internal Med, Pirae, Tahiti, Fr Polynesia.
EM erwan.oehler@cht.pf
CR Adam F, 2005, FLAVIVIRUS ZIKA 606
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fokam E B, 2010, East Afr Med J, V87, P262
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hardy TA, 2011, CURR ALLERGY ASTHM R, V11, P197, DOI 10.1007/s11882-011-0190-y
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kutsuna S, 2014, EURO SURVEILL, P19
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Oehler E, 2011, Med Trop (Mars), V71, P203
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 20
TC 7
Z9 8
U1 7
U2 40
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 6
PY 2014
VL 19
IS 9
BP 4
EP 6
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA AD0OM
UT WOS:000332933900002
ER

PT J
AU Grard, G
   Caron, M
   Mombo, IM
   Nkoghe, D
   Ondo, SM
   Jiolle, D
   Fontenille, D
   Paupy, C
   Leroy, EM
AF Grard, Gilda
   Caron, Melanie
   Mombo, Illich Manfred
   Nkoghe, Dieudonne
   Ondo, Statiana Mboui
   Jiolle, Davy
   Fontenille, Didier
   Paupy, Christophe
   Leroy, Eric Maurice
TI Zika Virus in Gabon (Central Africa)-2007: A New Threat from Aedes
   albopictus?
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHIKUNGUNYA VIRUS; MAXIMUM-LIKELIHOOD; MOSQUITO; ARBOVIRUSES;
   INFECTIONS; OUTBREAK; AEGYPTI; VECTOR; DENGUE; FLAVIVIRUSES
AB Background Chikungunya and dengue viruses emerged in Gabon in 2007, with large outbreaks primarily affecting the capital Libreville and several northern towns. Both viruses subsequently spread to the south-east of the country, with new outbreaks occurring in 2010. The mosquito species Aedes albopictus, that was known as a secondary vector for both viruses, recently invaded the country and was the primary vector involved in the Gabonese outbreaks. We conducted a retrospective study of human sera and mosquitoes collected in Gabon from 2007 to 2010, in order to identify other circulating arboviruses.
   Methodology/Principal Findings Sample collections, including 4312 sera from patients presenting with painful febrile disease, and 4665 mosquitoes belonging to 9 species, split into 247 pools (including 137 pools of Aedes albopictus), were screened with molecular biology methods. Five human sera and two Aedes albopictus pools, all sampled in an urban setting during the 2007 outbreak, were positive for the flavivirus Zika (ZIKV). The ratio of Aedes albopictus pools positive for ZIKV was similar to that positive for dengue virus during the concomitant dengue outbreak suggesting similar mosquito infection rates and, presumably, underlying a human ZIKV outbreak. ZIKV sequences from the envelope and NS3 genes were amplified from a human serum sample. Phylogenetic analysis placed the Gabonese ZIKV at a basal position in the African lineage, pointing to ancestral genetic diversification and spread.
   Conclusions/Significance We provide the first direct evidence of human ZIKV infections in Gabon, and its first occurrence in the Asian tiger mosquito, Aedes albopictus. These data reveal an unusual natural life cycle for this virus, occurring in an urban environment, and potentially representing a new emerging threat due to this novel association with a highly invasive vector whose geographic range is still expanding across the globe.
   Author Summary Not previously considered an important human arboviral pathogen, the epidemic capacity of Zika virus (ZIKV, a dengue-related flavivirus) was revealed by the Micronesia outbreak in 2007, which affected about 5000 persons. Widely distributed throughout tropical areas of Asia and Africa, ZIKV is transmitted by a broad range of mosquito species, most of which are sylvatic or rural, Aedes aegypti, an anthropophilic and urban species, being considered the main ZIKV epidemic vector. In a context of emerging arbovirus infections (chikungunya (CHIKV) and dengue (DENV)) in Gabon since 2007, we conducted a retrospective study to detect other, related viruses. In samples collected during the concurrent CHIKV/DENV outbreaks that occurred in the capital city in 2007, we detected ZIKV in both humans and mosquitoes, and notably the Asian mosquito Aedes albopictus that recently invaded the country and was the main vector responsible for these outbreaks. We found that the Gabonese ZIKV strain belonged to the African lineage, and phylogenetic analysis suggested ancestral diversification and spread rather than recent introduction. These findings, showing for the first time epidemic ZIKV activity in an urban environment in Central Africa and the presence of ZIKV in the invasive mosquito Aedes albopictus, raise the possibility of a new emerging threat to human health.
C1 [Grard, Gilda; Caron, Melanie; Mombo, Illich Manfred; Nkoghe, Dieudonne; Ondo, Statiana Mboui; Leroy, Eric Maurice] Ctr Int Rech Med Franceville, UMVE, Franceville, Gabon.
   [Caron, Melanie; Mombo, Illich Manfred; Jiolle, Davy; Fontenille, Didier; Paupy, Christophe; Leroy, Eric Maurice] Univ Montpellier I, MIVEGEC, Inst Rech Dev IRD 224, CNRS 5290, Montpellier, France.
   [Caron, Melanie; Mombo, Illich Manfred; Jiolle, Davy; Fontenille, Didier; Paupy, Christophe; Leroy, Eric Maurice] Univ Montpellier 2, MIVEGEC, Inst Rech Dev IRD 224, CNRS 5290, Montpellier, France.
   [Nkoghe, Dieudonne] Minist Sante Publ, Libreville, Gabon.
   [Jiolle, Davy; Paupy, Christophe] CIRMF, URES, Franceville, Gabon.
RP Grard, G (reprint author), Ctr Int Rech Med Franceville, UMVE, BP 769, Franceville, Gabon.
EM gildagrard@gmail.com
RI LEROY, Eric/I-4347-2016
OI LEROY, Eric/0000-0003-0022-0890
FU CIRMF; Gabonese Government; Total Gabon; French Foreign Ministry;
   Fondation Christophe et Rodolphe Merieux; Institut de France; Institut
   de recherches pour le developpement (IRD); Metabiota
FX This work was supported by CIRMF, which is funded by the Gabonese
   Government, Total Gabon and the French Foreign Ministry. It was also
   partially financed by grants from Fondation Christophe et Rodolphe
   Merieux, Institut de France, Institut de recherches pour le
   developpement (IRD), and Metabiota. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adam F, 2005, CRORA DATABASE
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Cornet M, 1979, CAHIERS ORSTOM EMP, P47
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Powers AM, 2000, J GEN VIROL, V81, P471
   Promed-Mail, 2013, SUBJ PRO EDR ZIK VIR
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 45
TC 62
Z9 66
U1 26
U2 83
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2014
VL 8
IS 2
AR e2681
DI 10.1371/journal.pntd.0002681
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AB8CK
UT WOS:000332017500017
PM 24516683
ER

PT J
AU Kutsuna, S
   Kato, Y
   Takasaki, T
   Moi, ML
   Kotaki, A
   Uemura, H
   Matono, T
   Fujiya, Y
   Mawatari, M
   Takeshita, N
   Hayakawa, K
   Kanagawa, S
   Ohmagari, N
AF Kutsuna, S.
   Kato, Y.
   Takasaki, T.
   Moi, M. L.
   Kotaki, A.
   Uemura, H.
   Matono, T.
   Fujiya, Y.
   Mawatari, M.
   Takeshita, N.
   Hayakawa, K.
   Kanagawa, S.
   Ohmagari, N.
TI Two cases of Zika fever imported from French Polynesia to Japan,
   December 2013 to January 2014
SO EUROSURVEILLANCE
LA English
DT Article
ID VIRUS-INFECTION; MICRONESIA
C1 [Kutsuna, S.; Kato, Y.; Uemura, H.; Matono, T.; Fujiya, Y.; Mawatari, M.; Takeshita, N.; Hayakawa, K.; Kanagawa, S.; Ohmagari, N.] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.
   [Takasaki, T.; Moi, M. L.; Kotaki, A.] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Tokyo, Japan.
RP Kutsuna, S (reprint author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.
EM sonare.since1192@gmail.com
FU Research on Emerging and Re-emerging Infectious Diseases by the Ministry
   of Health, Labor and Welfare, Japan [H24-shinkou-ippan-013,
   H23-shinkou-ippan-010]
FX This work was supported by funding from Research on Emerging and
   Re-emerging Infectious Diseases by the Ministry of Health, Labor and
   Welfare, Japan (H24-shinkou-ippan-013, H23-shinkou-ippan-010).
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Institut de Veille Sanitaire (InVS), 2013, B HEBD INT 30 OCT 5, V424
   Kuno G, 1998, J VIROL, V72, P73
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   ProMED-mail, 2013, ZIK VIR CAN EXTH
   ProMED-mail, 2014, ZIK VIR FRENCH POL
   ProMED-mail, 2014, ZIK VIR NEW CAL
   [Anonymous], ZIK DENG EP
   Tappe D, 2014, EURO SURVEILL, V19
NR 15
TC 11
Z9 12
U1 1
U2 7
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 30
PY 2014
VL 19
IS 4
BP 8
EP 11
AR 20683
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA AA5KJ
UT WOS:000331136700002
ER

PT J
AU Tappe, D
   Rissland, J
   Gabriel, M
   Emmerich, P
   Guenther, S
   Held, G
   Smola, S
   Schmidt-Chanasit, J
AF Tappe, D.
   Rissland, J.
   Gabriel, M.
   Emmerich, P.
   Guenther, S.
   Held, G.
   Smola, S.
   Schmidt-Chanasit, J.
TI First case of laboratory-confirmed Zika virus infection imported into
   Europe, November 2013
SO EUROSURVEILLANCE
LA English
DT Article
ID MICRONESIA; AEDES
C1 [Tappe, D.; Gabriel, M.; Emmerich, P.; Guenther, S.; Schmidt-Chanasit, J.] WHO, Collaborating Ctr Arbovirus & Haemorrhag Fever Re, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Rissland, J.; Smola, S.] Univ Saarland, Med Ctr, Inst Virol, Homburg, Germany.
   [Held, G.] Univ Saarland, Med Ctr, Homburg, Germany.
   [Schmidt-Chanasit, J.] German Ctr Infect Res DZIF, Hamburg, Germany.
RP Tappe, D (reprint author), WHO, Collaborating Ctr Arbovirus & Haemorrhag Fever Re, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
EM jonassi@gmx.de
CR Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   FRANK C, 2013, EURO SURVEILL, V18
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kutsuna S, 2014, EURO SURVEILL, P19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LARUCHE G, 2010, EUROSURVEILLANCE, V15
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   PROMEDMAIL, NUMBER
   Schmidt-Chanasit J, 2010, EUROSURVEILLANCE, V15, P2
   Schmidt-Chanasit J, 2014, EURO SURVEILL, V19
   Tappe D, 2009, MED MICROBIOL IMMUN, V198, P271, DOI 10.1007/s00430-009-0122-9
NR 19
TC 30
Z9 31
U1 4
U2 15
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JAN 30
PY 2014
VL 19
IS 4
BP 12
EP 15
AR 20685
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA AA5KJ
UT WOS:000331136700003
ER

PT J
AU Faye, O
   Freire, CCM
   Iamarino, A
   Faye, O
   de Oliveira, JVC
   Diallo, M
   Zanotto, PMA
   Sall, AA
AF Faye, Oumar
   Freire, Caio C. M.
   Iamarino, Atila
   Faye, Ousmane
   de Oliveira, Juliana Velasco C.
   Diallo, Mawlouth
   Zanotto, Paolo M. A.
   Sall, Amadou Alpha
TI Molecular Evolution of Zika Virus during Its Emergence in the 20th
   Century
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUS; SEQUENCE ALIGNMENT; RECOMBINANT SEQUENCES; PHYLOGENETIC
   ANALYSIS; ENVELOPE PROTEINS; GENUS FLAVIVIRUS; MOSAIC STRUCTURE;
   YELLOW-FEVER; MISSING DATA; RNA VIRUSES
AB Zika virus (ZIKV) is a mosquito-borne flavivirus first isolated in Uganda in 1947. Although entomological and virologic surveillance have reported ZIKV enzootic activity in diverse countries of Africa and Asia, few human cases were reported until 2007, when a Zika fever epidemic took place in Micronesia. In the context of West Africa, the WHO Collaborating Centre for Arboviruses and Hemorrhagic Fever at Institut Pasteur of Dakar (http://www.pasteur.fr/recherche/banques/CRORA/) reports the periodic circulation of ZIKV since 1968. Despite several reports on ZIKV, the genetic relationships among viral strains from West Africa remain poorly understood. To evaluate the viral spread and its molecular epidemiology, we investigated 37 ZIKV isolates collected from 1968 to 2002 in six localities in Senegal and Cote d'Ivoire. In addition, we included strains from six other countries. Our results suggested that these two countries in West Africa experienced at least two independent introductions of ZIKV during the 20th century, and that apparently these viral lineages were not restricted by mosquito vector species. Moreover, we present evidence that ZIKV has possibly undergone recombination in nature and that a loss of the N154 glycosylation site in the envelope protein was a possible adaptive response to the Aedes dalzieli vector.
C1 [Faye, Oumar; Faye, Ousmane; Diallo, Mawlouth; Sall, Amadou Alpha] Inst Pasteur, Dakar, Senegal.
   [Freire, Caio C. M.; Iamarino, Atila; de Oliveira, Juliana Velasco C.; Zanotto, Paolo M. A.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.
RP Faye, O (reprint author), Inst Pasteur, Dakar, Senegal.
EM asall@pasteur.sn
OI Iamarino, Atila/0000-0003-3904-0248
FU Institute Pasteur of Dakar in Senegal, FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo, Brazil) [00/04205-6, 08/17013-6,
   10/19341-4]; CAPES [12/04818-5]; FAPESP; CNPq-PQ grant; NIH
   [R01-AI069145]
FX This study was made possible by the Institute Pasteur of Dakar in
   Senegal, FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo,
   Brazil) projects #00/04205-6 (VGDN program), #08/17013-6 and
   #10/19341-4. CCMF has a CAPES studentship, AI (project #12/04818-5) and
   JVCdO received FAPESP scholarships and PMAZ holds a CNPq-PQ grant.
   Funding was also provided by NIH grant R01-AI069145. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481
   BLAND JM, 1995, BRIT MED J, V310, P170
   Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771
   Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874
   Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chambers TJ, 1998, J GEN VIROL, V79, P2375
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diallo M, 1999, AM J TROP MED HYG, V60, P281
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaunt MW, 2001, J GEN VIROL, V82, P1867
   Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Gupta R., 2002, PAC S BIOCOMPUT, V7, P310, DOI DOI 10.1142/9789812799623_
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151
   Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Nagarajan N, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1232
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056
   Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s0023901-0034-9
   Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698
   Robin Y, 1978, B SOC PATHOL EXOT, V68, P249
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Schierup MH, 2000, GENETICS, V156, P879
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITH JM, 1992, J MOL EVOL, V34, P126
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Suchard MA, 2001, MOL BIOL EVOL, V18, P1001
   Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Westesson O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000318
   Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330
   Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
   Zwickl DJ, 2006, GENETIC ALGORITHM AP
NR 75
TC 49
Z9 49
U1 49
U2 168
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2014
VL 8
IS 1
AR e2636
DI 10.1371/journal.pntd.0002636
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AJ8SI
UT WOS:000337977300032
PM 24421913
ER

PT J
AU Kaddumukasa, MA
   Mutebi, JP
   Lutwama, JJ
   Masembe, C
   Akol, AM
AF Kaddumukasa, M. A.
   Mutebi, J. -P.
   Lutwama, J. J.
   Masembe, C.
   Akol, A. M.
TI Mosquitoes of Zika Forest, Uganda: Species Composition and Relative
   Abundance
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Zika forest; Uganda; mosquito species composition; arbovirus vector
ID ONYONG-NYONG FEVER; SOUTH-CENTRAL UGANDA; YELLOW-FEVER; EPIDEMIC; VIRUS;
   EMERGENCE; DIPTERA; MONKEYS; ABSENCE
AB Mosquito collections were conducted in Zika Forest near Entebbe, Uganda, from July 2009 through June 2010 using CO2-baited light traps, ovitraps, and human-baited catches. In total, 163,790 adult mosquitoes belonging to 12 genera and 58 species were captured. Of these, 22 species (38%) were captured in Zika Forest for the first time. All the new records found in the forest in this study had previously been captured in other regions of Uganda, implying that they are native to the country and do not represent new introductions. More than 20 species previously collected in Zika Forest were not detected in our collections, and this may suggest a change in the mosquito fauna during the past 40 yr or variation in species composition from year to year. Arboviruses of public health importance have previously been isolated from >50% of the 58 mosquito species captured in Zika Forest, which suggests a high potential for transmission and maintenance of a wide range of arboviruses in Zika Forest.
C1 [Kaddumukasa, M. A.; Masembe, C.; Akol, A. M.] Makerere Univ, Dept Biol Sci, Coll Nat Sci, Kampala, Uganda.
   [Kaddumukasa, M. A.; Lutwama, J. J.] Uganda Virus Res Inst, Dept Arbovirol, Entebbe, Uganda.
   [Mutebi, J. -P.] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO 80521 USA.
RP Akol, AM (reprint author), Makerere Univ, Dept Biol Sci, Coll Nat Sci, POB 7062, Kampala, Uganda.
EM aakol@sci.mak.ac.ug
FU Uganda Virus Research Institute; Department of Biological Sciences,
   Makerere University; UVRIE; CDC; Organization for Women in Science for
   the Developing World (OWSDW)
FX We thank F. Ssenfuka, T. Muwawu, J.-F. Lwanga, J. Mugga, and S. Wakaalo
   for their assistance in the field and in the laboratory. We thank R.
   Kading and M. Crabtree of the Centers for Disease Control and Prevention
   (CDC) and the entomology team at Kenya Medical Research Institute
   (KEMRI), Nairobi, for their assistance with mosquito identification. We
   thank the Uganda Virus Research Institute and the Department of
   Biological Sciences, Makerere University, for financial assistance. This
   research was partly funded by in part by UVRIE, the CDC and by a grant
   from the Organization for Women in Science for the Developing World
   (OWSDW) formerly TWOWS to M. Kaddumukasa.
CR Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x
   Corbet P. S., 1961, Transactions of the Royal Entomological Society of London, V113, P356
   Corbet P. S., 1964, J ANIM ECOL, P141
   De Meillon B., 1947, ANOPHELINI ETHIOPIAN
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Edwards F. W., 1941, BRIT MUSEUM NATURAL, VIII
   Gillett J, 1972, COMMON AFRICAN MOSQU
   Gillies MT, 1987, ANOPHELINAE AFRICA S
   Goma L.K.H., 1964, 24 HOUR AIR SAMPLING
   GOMA LKH, 1965, B ENTOMOL RES, V56, P17
   HADDOW A. J., 1964, BULL ENTOMOL RES, V55, P589
   Haddow A. J., 1965, Transactions of the Royal Entomological Society of London, V117, P215
   HADDOW AJ, 1974, B ENTOMOL RES, V64, P45
   Haddow A. J., 1963, ENTOMOLOGY FIELD STU
   HADDOW AJ, 1946, B ENTOMOL RES, V37, P57
   HADDOW AJ, 1945, B ENTOMOL RES, V36, P33
   HADDOW AJ, 1948, B ENTOMOL RES, V39, P185
   Haddow A. J., 1968, T R ENTOMOL SOC LOND, V120, P212
   Haddow A. J., 1965, ENTOMOLOGICAL STUD 1
   HADDOW AJ, 1954, B ENTOMOL RES, V45, P199
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMMER O., 2001, PALAEONTOL ELECTRON, V4, P1, DOI DOI 10.1016/J.BCP.2008.05.025
   Jupp PG, 1996, MOSQUITOES SO AFRICA
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Kiwanuka N, 1999, CLIN INFECT DIS, V29, P1243, DOI 10.1086/313462
   Knight KL, 1977, CATALOG MOSQUITOES W
   Koh LP, 2007, J APPL ECOL, V44, P703, DOI 10.1111/j.1365-2664.2007.01324.x
   Lanciotti RS, 1998, VIROLOGY, V252, P258, DOI 10.1006/viro.1998.9437
   Lutwama JJ, 1999, AM J TROP MED HYG, V61, P158
   Lutwama Julius Julian, 2000, Insect Science and its Application, V20, P51
   MONATH TPC, 1972, ARCH GES VIRUSFORSCH, V38, P125, DOI 10.1007/BF01249661
   Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023
   R Development Core Team, 2010, R LANG ENV STAT COMP
   Rwaguma EB, 1997, EMERG INFECT DIS, V3, P77
   Sanders EJ, 1999, J INFECT DIS, V180, P1436, DOI 10.1086/315073
   SAWYER W. A., 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P397, DOI 10.1016/S0035-9203(36)90055-X
   SIMPSON DIH, 1965, T ROY SOC TROP MED H, V59, P449, DOI 10.1016/0035-9203(65)90065-9
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   Smithburn K. C., 1946, AM J TROP MED HYG, V1, P189
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WILLIAMS MC, 1964, ANN TROP MED PARASIT, V58, P367
   Williams M. C., 1964, STUDIES MOSQUITOES D
   Woodall JP, 1964, P E AFR ACAD, V2, P141
NR 45
TC 3
Z9 3
U1 7
U2 23
PU ENTOMOLOGICAL SOC AMER
PI LANHAM
PA 10001 DEREKWOOD LANE, STE 100, LANHAM, MD 20706-4876 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2014
VL 51
IS 1
BP 104
EP 113
DI 10.1603/ME12269
PG 10
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA 291CF
UT WOS:000329804600012
PM 24605459
ER

PT J
AU Faye, O
   Faye, O
   Diallo, D
   Diallo, M
   Weidmann, M
   Sall, AA
AF Faye, Oumar
   Faye, Ousmane
   Diallo, Diawo
   Diallo, Mawlouth
   Weidmann, Manfred
   Sall, Amadou Alpha
TI Quantitative real-time PCR detection of Zika virus and evaluation with
   field-caught Mosquitoes
SO VIROLOGY JOURNAL
LA English
DT Article
ID YELLOW-FEVER; SOUTHEASTERN SENEGAL; FEDERATED STATES; RAPID DETECTION;
   YAP STATE; MICRONESIA; ASSAY; INFECTIONS; FLAVIVIRUS; EXPRESSION
AB Background: Zika virus (ZIKV), a mosquito borne flavivirus is a pathogen affecting humans in Asia and Africa. ZIKV infection diagnosis relies on serology-which is challenging due to cross-reactions with other flaviviruses and/or absence or low titer of IgM and IgG antibodies at early phase of infection-virus isolation, which is labor intensive, time consuming and requires appropriate containment. Therefore, real-time RT-PCR (rRT-PCR) is an appealing option as a rapid, sensitive and specific method for detection of ZIKV in the early stage of infection. So far, only one rRT-PCR assay has been described in the context of the outbreak in Micronesia in 2007. In this study, we described a one step rRT-PCR for ZIKV which can detect a wider genetic diversity of ZIKV isolates from Asia and Africa.
   Results: The NS5 protein coding regions of African ZIKV isolates were sequenced and aligned with representative flaviviruses sequences from GenBank to design primers and probe from conserved regions. The analytical sensitivity of the assay was evaluated to be 32 genome-equivalents and 0.05 plaque forming unit (pfu). The assay was shown to detect 37 ZIKV isolates covering a wide geographic in Africa and Asia over 36 years but none of the 31 other flaviviruses tested showing high analytical specificity. The rRT-PCR could be performed in less than 3 hours. This method was used successfully to detect ZIKV strains from field-caught mosquitoes.
   Conclusion: We have developed a rapid, sensitive and specific rRT - PCR for detection of ZIKV. This assay is a useful tool for detection of ZIKV infection in regions where a number of other clinically indistinguishable arboviruses like dengue or chikungunya co-circulate. Further studies are needed to validate this assay in clinical positive samples collected during acute ZIKV infection.
C1 [Faye, Oumar; Faye, Ousmane; Sall, Amadou Alpha] Inst Pasteur, Unite Arbovirus & Virus Fievres Hemorrag, Dakar, Senegal.
   [Diallo, Diawo; Diallo, Mawlouth] Unite Entomol Med 36, Dakar, Senegal.
   [Weidmann, Manfred] Univ Med Ctr Gottingen, Dept Virol, Gottingen, Germany.
RP Sall, AA (reprint author), Inst Pasteur, Unite Arbovirus & Virus Fievres Hemorrag, 36,Ave Pasteur,BP 220, Dakar, Senegal.
EM asall@pasteur.sn
RI Weidmann, Manfred/G-1817-2015; 
OI Weidmann, Manfred/0000-0002-7063-7491
FU Arbovirus Unit of Pasteur Institute in Dakar; National Institutes of
   Health (NIH) [5R01A1069145]
FX The authors thank Lang Girault for providing ZIKV strains. This work was
   supported by Arbovirus Unit of Pasteur Institute in Dakar and the
   National Institutes of Health (NIH), Grant Number 5R01A1069145.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   CORNET M, 1978, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V16, P315
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Digoutte JP, 1980, MED TROP, V40, P5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P5
   Haddow A, 2012, PLOS NEGLECT TROP D, V6, P1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066
   Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Robert V, 1986, B SOC PATHOL EXOT, V86, P90
   Savage HM, 1998, AM J TROP MED HYG, V58, P519
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Tolstrup N, 2003, NUCLEIC ACIDS RES, V31, P3758, DOI 10.1093/nar/gkg580
   Weidmann M, 2004, J CLIN VIROL, V30, P94, DOI 10.1016/j.jcv.2003.09.004
   Weidmann M, 2010, J CLIN VIROL, V48, P187, DOI 10.1016/j.jcv.2010.04.013
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wu SJ, 2008, AM J TROP MED HYG, V79, P505
NR 34
TC 36
Z9 37
U1 15
U2 93
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD OCT 22
PY 2013
VL 10
AR 311
DI 10.1186/1743-422X-10-311
PG 8
WC Virology
SC Virology
GA 264KL
UT WOS:000327875800001
PM 24148652
ER

PT J
AU Kwong, JC
   Druce, JD
   Leder, K
AF Kwong, Jason C.
   Druce, Julian D.
   Leder, Karin
TI Case Report: Zika Virus Infection Acquired During Brief Travel to
   Indonesia
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID MICRONESIA
AB Zika virus infection closely resembles dengue fever. It is possible that many cases are misdiagnosed or missed. We report a case of Zika virus infection in an Australian traveler who returned from Indonesia with fever and rash. Further case identification is required to determine the evolving epidemiology of this disease.
C1 [Kwong, Jason C.; Leder, Karin] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia.
   [Druce, Julian D.] Victorian Infect Dis Reference Lab, North Melbourne, Vic, Australia.
RP Kwong, JC (reprint author), Royal Melbourne Hosp, Victorian Infect Dis Serv, Grattan St, Parkville, Vic 3050, Australia.
EM kwongj@gmail.com; julian.druce@mh.org.au; karin.leder@monash.edu
OI Leder, Karin/0000-0003-1368-1039; Kwong, Jason/0000-0002-6298-7942
FU Pfizer; GlaxoSmithKline; Sanofi Pasteur
FX Jason C. Kwong has received financial assistance from Pfizer to attend
   an international conference. Karin Leder has received funding from
   GlaxoSmithKline for a study on hepatitis B, and financial assistance
   from GlaxoSmithKline and Sanofi Pasteur to attend international
   conferences.
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
NR 9
TC 44
Z9 46
U1 9
U2 22
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD SEP
PY 2013
VL 89
IS 3
BP 516
EP 517
DI 10.4269/ajtmh.13-0029
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 240XB
UT WOS:000326129900020
PM 23878182
ER

PT J
AU Wong, PSJ
   Li, MZI
   Chong, CS
   Ng, LC
   Tan, CH
AF Wong, Pei-Sze Jeslyn
   Li, Mei-zhi Irene
   Chong, Chee-Seng
   Ng, Lee-Ching
   Tan, Cheong-Huat
TI Aedes (Stegomyia) albopictus (Skuse): A Potential Vector of Zika Virus
   in Singapore
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID YELLOW-FEVER; CHIKUNGUNYA; MICRONESIA; STATE
AB Background: Zika virus (ZIKV) is a little known arbovirus until it caused a major outbreak in the Pacific Island of Yap in 2007. Although the virus has a wide geographic distribution, most of the known vectors are sylvatic Aedes mosquitoes from Africa where the virus was first isolated. Presently, Ae. aegypti is the only known vector to transmit the virus outside the African continent, though Ae. albopictus has long been a suspected vector. Currently, Ae. albopictus has been shown capable of transmitting more than 20 arboviruses and its notoriety as an important vector came to light during the recent chikungunya pandemic. The vulnerability of Singapore to emerging infectious arboviruses has stimulated our interest to determine the competence of local Ae. albopictus to transmit ZIKV.
   Methodology/Principal Findings: To determine the competence of Ae. albopictus to ZIKV, we orally infected local mosquito strains to a Ugandan strain virus. Fully engorged mosquitoes were maintained in an environmental chamber set at 29 degrees C and 80-85% RH. Twelve mosquitoes were then sampled daily from day one to seven and on day 10 and 14 post infection (pi). Zika virus titre in the midgut and salivary glands of each mosquito were determined using tissue culture infectious dose(50) assay, while transmissibility of the virus was determined by detecting viral antigen in the mosquito saliva by qRT-PCR. High dissemination and transmission rate of ZIKV were observed. By day 7-pi, all mosquitoes have disseminated infection and 73% of these mosquitoes have ZIKV in their saliva. By day 10-pi, all mosquitoes were potentially infectious.
   Conclusions/Significance: The study highlighted the potential of Ae. albopictus to transmit ZIKV and the possibility that the virus could be established locally. Nonetheless, the threat of ZIKV can be mitigated by existing dengue and chikungunya control program being implemented in Singapore.
C1 [Wong, Pei-Sze Jeslyn; Li, Mei-zhi Irene; Chong, Chee-Seng; Ng, Lee-Ching; Tan, Cheong-Huat] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
   [Ng, Lee-Ching] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.
RP Wong, PSJ (reprint author), Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
EM tan_cheong_huat@nea.gov.sg
FU Ministry of Environment and Water Resources
FX The study was funded by the Ministry of Environment and Water Resources.
   The funders had no role in study design, data collection and analysis,
   decision to publish or preparation of the manuscript.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Caminade C, J R SOC INTERFACE, V9, P2708
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Gasperi G, PLOS NEGL TROP DIS, V6, pe1836
   Guillaumot L, PARASIT VECTORS, V5, P247
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hawley W A, 1988, J Am Mosq Control Assoc Suppl, V1, P1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V., 2010, EMERG INFECT DIS, V18, P349, DOI DOI 10.3201/EID1802.111224
   Higgs S, 1997, VIRAL EXPRESSION SYS, P459
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li M, 2012, MATER MANUF PROCESS, V27, P26, DOI 10.1080/10426914.2011.551904
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012
   Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
NR 31
TC 64
Z9 71
U1 17
U2 45
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2013
VL 7
IS 8
AR e2348
DI 10.1371/journal.pntd.0002348
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 211WE
UT WOS:000323941500015
PM 23936579
ER

PT J
AU Balm, MND
   Lee, CK
   Lee, HK
   Chiu, L
   Koay, ESC
   Tang, JW
AF Balm, Michelle N. D.
   Lee, Chun Kiat
   Lee, Hong Kai
   Chiu, Lily
   Koay, Evelyn S. C.
   Tang, Julian W.
TI A diagnostic polymerase chain reaction assay for Zika virus
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE febrile illness; arthralgia; dengue; Chikungunya; surveillance
ID FEVER; CHIKUNGUNYA; MICRONESIA; INFECTIONS; DISEASE; DENGUE; STATE;
   ASIA; PCR
AB Zika virus (ZIKV) is a mosquito-borne flavivirus. Infection results in a dengue-like illness with fever, headache, malaise, and a maculopapular rash. Nearly all cases are mild and self-limiting but in 2007, a large outbreak of ZIKV was reported from the island of Yap (in Micronesia, northwest of Indonesia). Singapore is already endemic for dengue, and its impact on public health and economic burden is significant. Other dengue-like infections (e.g., Chikungunya virus) are present. Yet only 10% of reported dengue cases have laboratory confirmation. The identification and control of other dengue-like, mosquito-transmitted infections is thus important for the health of Singapore's population, as well as its economy. Given that ZIKV shares the same Aedes mosquito vector with both dengue and Chikungunya, it is possible that this virus is present in Singapore and causing some of the mild dengue-like illness. A specific and sensitive one-step, reverse transcription polymerase chain reaction (RT-PCR) with an internal control (IC) was designed and tested on 88 archived samples of dengue-negative, Chikungunya-negative sera from patients presenting to our hospital with a dengue-like illness, to determine the presence of ZIKV in Singapore. The assay was specific for detection of ZIKV and displayed a lower limit of detection (LoD) of 140 copies viral RNA/reaction when tested on synthetic RNA standards prepared using pooled negative patient plasma. Of the 88 samples tested, none were positive for ZIKV RNA, however, the vast majority of these were from patients admitted to hospital and further study may be warranted in community-based environments. J. Med. Virol. 84:1501-1505, 2012. (c) 2012 Wiley Periodicals, Inc.
C1 [Balm, Michelle N. D.; Tang, Julian W.] Natl Univ Singapore Hosp, Dept Lab Med, Div Microbiol, Singapore 119074, Singapore.
   [Lee, Chun Kiat; Lee, Hong Kai; Chiu, Lily; Koay, Evelyn S. C.; Tang, Julian W.] Natl Univ Singapore Hosp, Mol Diag Ctr, Dept Lab Med, Singapore 119074, Singapore.
   [Koay, Evelyn S. C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore.
RP Tang, JW (reprint author), Natl Univ Singapore Hosp, Dept Lab Med, Div Microbiol, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.
EM jwtang49@hotmail.com
OI Lee, Chun Kiat/0000-0002-6065-0000
FU Clinician Scientists Unit, Yong Loo Lin School of Medicine, National
   University of Singapore
FX Grant sponsor: Clinician Scientists Unit, Yong Loo Lin School of
   Medicine, National University of Singapore.
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   RAO TR, 1971, B WORLD HEALTH ORGAN, V44, P585
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 17
TC 32
Z9 34
U1 12
U2 65
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
J9 J MED VIROL
JI J. Med. Virol.
PD SEP
PY 2012
VL 84
IS 9
BP 1501
EP 1505
DI 10.1002/jmv.23241
PG 5
WC Virology
SC Virology
GA 977IA
UT WOS:000306648800023
PM 22825831
ER

PT J
AU Li, MI
   Wong, PSJ
   Ng, LC
   Tan, CH
AF Li, MeiZhi Irene
   Wong, Pei Sze Jeslyn
   Ng, Lee Ching
   Tan, Cheong Huat
TI Oral Susceptibility of Singapore Aedes (Stegomyia) aegypti (Linnaeus) to
   Zika Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; CULEX-PIPIENS-QUINQUEFASCIATUS; DENGUE-2 VIRUS;
   GEOGRAPHIC STRAINS; DIPTERA-CULICIDAE; VECTOR COMPETENCE; YELLOW-FEVER;
   INFECTION; MOSQUITOS; TRANSMISSION
AB Background: Zika virus (ZIKV) is a little known flavivirus that caused a major outbreak in 2007, in the South-western Pacific Island of Yap. It causes dengue-like syndromes but with milder symptoms. In Africa, where it was first isolated, ZIKV is mainly transmitted by sylvatic Aedes mosquitoes. The virus has also been isolated from Ae. aegypti and it is considered to be the vector involved in the urban transmission of the virus. Transmission of the virus by an African strain of Ae. aegypti has also been demonstrated under laboratory conditions. The aim of the present study is to describe the oral susceptibility of a Singapore strain of Ae. aegypti to ZIKV, under conditions that simulate local climate.
   Methodology/Principal Findings: To assess the receptivity of Singapore's Ae. aegypti to the virus, we orally exposed a local mosquito strain to a Ugandan strain of ZIKV. Upon exposure, fully engorged mosquitoes were maintained in an environmental chamber set at 29 degrees C and 70-75% RH. Eight mosquitoes were then sampled daily from day 1 to day 7, and subsequently on days 10 and 14 post exposure (pe). The virus titer of the midgut and salivary glands of each mosquito were determined using a tissue culture infectious dose(50) (TCID50) assay. High midgut infection and salivary gland dissemination rates were observed. By day 5 after the infectious blood meal, ZIKV was found in the salivary glands of more than half of the mosquitoes tested (62%); and by day 10, all mosquitoes were potentially infective.
   Conclusions/Significance: This study showed that Singapore's urban Ae. aegypti are susceptible and are potentially capable of transmitting ZIKV. The virus could be established in Singapore should it be introduced. Nevertheless, Singapore's current dengue control strategy is applicable to control ZIKV.
C1 [Li, MeiZhi Irene; Wong, Pei Sze Jeslyn; Ng, Lee Ching; Tan, Cheong Huat] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
RP Li, MI (reprint author), Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
EM tan_cheong_huat@nea.gov.sg
FU Ministry of Environment and Water Resources
FX The Ministry of Environment and Water Resources provided funding for the
   study. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Bhatt PN, 1960, P HAFFK I DIAM S, P57
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007
   Corena MD, 2005, J EXP BIOL, V208, P3263, DOI 10.1242/jeb.01739
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P446, DOI 10.1016/0035-9203(83)90108-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Girard YA, 2004, VECTOR-BORNE ZOONOT, V4, P109, DOI 10.1089/1530366041210729
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P146
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318
   GUIRAKHOO F, 1993, VIROLOGY, V194, P219, DOI 10.1006/viro.1993.1252
   Gushulak BD, 2010, CMAJ, V183, pE952
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Higgs S, 1997, VIRAL EXPRESSION SYS, P459
   Knox TB, 2003, J MED ENTOMOL, V40, P950, DOI 10.1603/0022-2585-40.6.950
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee KS, 2011, INFECT GENET EVOL, V12, P77, DOI DOI 10.1016/J.MEEGID.2011.10.012
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Moudy RM, 2011, AM J TROP MED HYG, V85, P374, DOI 10.4269/ajtmh.2011.10-0697
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365
   Ng LC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-305
   Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Powers AM, 2009, FUTURE VIROL, V4, P391, DOI 10.2217/FVL.09.19
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Setbon M, 2009, Emerg Health Threats J, V2, pe6, DOI 10.3134/ehtj.09.006
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smartt CT, 2009, AM J TROP MED HYG, V81, P258
   Smith DR, 2007, AM J TROP MED HYG, V77, P176
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   Sumanochitrapon W, 1998, AM J TROP MED HYG, V58, P283
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P383, DOI 10.1089/vbz.2010.0022
   Vaidyanathan R, 2007, VECTOR-BORNE ZOONOT, V7, P193, DOI 10.1089/vbz.2006.0589
   Vanlandingham DL, 2004, AM J TROP MED HYG, V71, P120
   Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Zhang MC, 2010, AM J TROP MED HYG, V83, P700, DOI 10.4269/ajtmh.2010.10-0193
NR 57
TC 37
Z9 38
U1 16
U2 50
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2012
VL 6
IS 8
AR e1792
DI 10.1371/journal.pntd.0001792
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 001YS
UT WOS:000308497100028
PM 22953014
ER

PT J
AU Haddow, AD
   Schuh, AJ
   Yasuda, CY
   Kasper, MR
   Heang, V
   Huy, R
   Guzman, H
   Tesh, RB
   Weaver, SC
AF Haddow, Andrew D.
   Schuh, Amy J.
   Yasuda, Chadwick Y.
   Kasper, Matthew R.
   Heang, Vireak
   Huy, Rekol
   Guzman, Hilda
   Tesh, Robert B.
   Weaver, Scott C.
TI Genetic Characterization of Zika Virus Strains: Geographic Expansion of
   the Asian Lineage
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID YELLOW-FEVER EPIDEMIC; SEROLOGICAL SURVEY; ARBOVIRUSES; NIGERIA; UGANDA;
   INFECTIONS; ANTIBODIES; TRANSMISSION; MICRONESIA; MOSQUITOES
AB Background: Zika virus (ZIKV) is a mosquito-borne flavivirus distributed throughout much of Africa and Asia. Infection with the virus may cause acute febrile illness that clinically resembles dengue fever. A recent study indicated the existence of three geographically distinct viral lineages; however this analysis utilized only a single viral gene. Although ZIKV has been known to circulate in both Africa and Asia since at least the 1950s, little is known about the genetic relationships between geographically distinct virus strains. Moreover, the geographic origin of the strains responsible for the epidemic that occurred on Yap Island, Federated States of Micronesia in 2007, and a 2010 pediatric case in Cambodia, has not been determined.
   Methodology/Principal Findings: To elucidate the genetic relationships of geographically distinct ZIKV strains and the origin of the strains responsible for the 2007 outbreak on Yap Island and a 2010 Cambodian pediatric case of ZIKV infection, the nucleotide sequences of the open reading frame of five isolates from Cambodia, Malaysia, Nigeria, Uganda, and Senegal collected between 1947 and 2010 were determined. Phylogenetic analyses of these and previously published ZIKV sequences revealed the existence of two main virus lineages (African and Asian) and that the strain responsible for the Yap epidemic and the Cambodian case most likely originated in Southeast Asia. Examination of the nucleotide and amino acid sequence alignments revealed the loss of a potential glycosylation site in some of the virus strains, which may correlate with the passage history of the virus.
   Conclusions/Significance: The basal position of the ZIKV strain isolated in Malaysia in 1966 suggests that the recent outbreak in Micronesia was initiated by a strain from Southeast Asia. Because ZIKV infection in humans produces an illness clinically similar to dengue fever and many other tropical infectious diseases, it is likely greatly misdiagnosed and underreported.
C1 [Haddow, Andrew D.; Schuh, Amy J.; Guzman, Hilda; Tesh, Robert B.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Trop Dis, Dept Pathol, Galveston, TX 77555 USA.
   [Yasuda, Chadwick Y.; Kasper, Matthew R.; Heang, Vireak] US Naval Med Res Unit, Phnom Penh, Cambodia.
   [Huy, Rekol] Natl Dengue Control Program, Phnom Penh, Cambodia.
RP Haddow, AD (reprint author), Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Trop Dis, Dept Pathol, Galveston, TX 77555 USA.
EM adhaddow@gmail.com
RI Weaver, Scott/D-6490-2011; Valle, Ruben/A-7512-2013
FU National Institutes of Health (NIH) [AI069145,
   HHSN272201000040I/HHSN27200004/D04, A1007536, AI60549]; American Society
   of Tropical Medicine and Hygiene; United States Department of Defense
   Global Emerging Infections Surveillance and Response System
FX This study was supported by National Institutes of Health (NIH) grant
   AI069145 (to SCW) and NIH contract HHSN272201000040I/HHSN27200004/D04
   (to RBT). ADH was supported by NIH T-32 training grant A1007536 and a
   Robert E. Shope International Fellowship in Infectious Diseases from the
   American Society of Tropical Medicine and Hygiene. AJS was supported by
   NIH T-32 training grant AI60549. CYY, MRK, VH, and RH were funded by the
   United States Department of Defense Global Emerging Infections
   Surveillance and Response System. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   ASAHINA S, 1970, JPN J MED SCI BIOL, V23, P255
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   CAREY DE, 1972, B WORLD HEALTH ORGAN, V46, P645
   Chambers TJ, 1998, J GEN VIROL, V79, P2375
   Curry DP, 1939, P NEW JERS MOSQ EXT, V26, P36
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Felsenstein, 1989, CLADISTICS, V5, P164
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fokam E, 2010, E AFR MED J, V6, P262
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Grard G, J GEN VIROL, V91, P87
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   Henderson BE, 1967, VIRUS RES I ANN REPO, P29
   Institut Pasteur de Dakar, 1999, WHO COLL CTR REF RES
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   McCoy OR, 1964, DENGUE, P29
   McCrae AW, 1970, VIRUS RES I ANN REPO, P20
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Theiler M, 1973, ARTHROPOD BORNE VIRU
   Thiel J-H, 2005, VIRUS TAXONOMY, P981
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
NR 57
TC 59
Z9 62
U1 32
U2 114
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1935-2727
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2012
VL 6
IS 2
AR e1477
DI 10.1371/journal.pntd.0001477
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 901FX
UT WOS:000300949200009
PM 22389730
ER

PT J
AU Heang, V
   Yasuda, CY
   Sovann, L
   Haddow, AD
   da Rosa, APT
   Tesh, RB
   Kasper, MR
AF Heang, Vireak
   Yasuda, Chadwick Y.
   Sovann, Ly
   Haddow, Andrew D.
   da Rosa, Amelia P. Travassos
   Tesh, Robert B.
   Kasper, Matthew R.
TI Zika Virus Infection, Cambodia, 2010
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID FEVER
C1 [Heang, Vireak; Yasuda, Chadwick Y.] US Naval Med Res Unit 2, Phnom Penh, Cambodia.
   [Sovann, Ly] Minist Hlth, Phnom Penh, Cambodia.
   [Haddow, Andrew D.; da Rosa, Amelia P. Travassos; Tesh, Robert B.] Univ Texas Med Branch, Galveston, TX USA.
   [Kasper, Matthew R.] US Naval Med Res Unit 2, Jakarta, Indonesia.
RP Kasper, MR (reprint author), US Embassy Lima, NAMRU 6,Unit 3230,13ox 46, Dpo, AA 34031 USA.
EM matthew.kasper@med.navy.mil
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Reynes JM, 2003, J CLIN MICROBIOL, V41, P3864, DOI 10.1128/JCM.41.8.3864-3867.2003
   Santhosh SR, 2007, J VIROL METHODS, V143, P73, DOI 10.1016/j.jviromet.2007.02.011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
NR 10
TC 52
Z9 56
U1 4
U2 34
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2012
VL 18
IS 2
BP 349
EP 351
DI 10.3201/eid1802.111224
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 889MU
UT WOS:000300078600035
PM 22305269
ER

PT J
AU Foy, BD
   Kobylinski, KC
   Foy, JLC
   Blitvich, BJ
   da Rosa, AT
   Haddow, AD
   Lanciotti, RS
   Tesh, RB
AF Foy, Brian D.
   Kobylinski, Kevin C.
   Foy, Joy L. Chilson
   Blitvich, Bradley J.
   da Rosa, Amelia Travassos
   Haddow, Andrew D.
   Lanciotti, Robert S.
   Tesh, Robert B.
TI Probable Non-Vector-borne Transmission of Zika Virus, Colorado, USA
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MICRONESIA; HAMSTERS; FEVER
AB Clinical and serologic evidence indicate that 2 American scientists contracted Zika virus infections while working in Senegal in 2008. One of the scientists transmitted this arbovirus to his wife after his return home. Direct contact is implicated as the transmission route, most likely as a sexually transmitted infection.
C1 [Foy, Brian D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Foy, Joy L. Chilson] Poudre Valley Hosp, Ft Collins, CO USA.
   [Blitvich, Bradley J.] Iowa State Univ, Ames, IA USA.
   [da Rosa, Amelia Travassos; Haddow, Andrew D.; Tesh, Robert B.] Univ Texas Med Branch, Galveston, TX USA.
   [Lanciotti, Robert S.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RP Foy, BD (reprint author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
EM brian.foy@colostate.edu
FU US National Institutes of Allergy and Infectious Diseases [AI079528,
   N01-AI-25489]
FX This study was supported by grant AI079528 and contract N01-AI-25489
   from the US National Institutes of Allergy and Infectious Diseases.
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   DAVIS JW, 1974, INFECT IMMUN, V10, P328
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Habu A, 1977, Uirusu, V27, P21
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LUBY JP, 1980, AM J TROP MED HYG, V29, P265
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tonry JH, 2005, AM J TROP MED HYG, V72, P320
NR 15
TC 161
Z9 172
U1 59
U2 140
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2011
VL 17
IS 5
BP 880
EP 882
DI 10.3201/eid1705.101939
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 760AB
UT WOS:000290291900020
PM 21529401
ER

PT J
AU Weissenbock, H
   Hubalek, Z
   Bakonyi, T
   Nowotny, N
AF Weissenboeck, H.
   Hubalek, Z.
   Bakonyi, T.
   Nowotny, N.
TI Zoonotic mosquito-borne flaviviruses: Worldwide presence of agents with
   proven pathogenicity and potential candidates of future emerging
   diseases
SO VETERINARY MICROBIOLOGY
LA English
DT Review
DE Flaviviruses; Mosquito-borne flaviviruses; Zoonoses
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; MURRAY VALLEY
   ENCEPHALITIS; USUTU-VIRUS; INFECTIOUS-DISEASES; CENTRAL-EUROPE; WILD
   BIRDS; EMERGENCE; VIRULENCE; AUSTRIA
AB An update on the mosquito-borne flavivirus species including certain subtypes, as listed in the Eighth Report of the International Committee on Taxonomy of Viruses, is given. Special emphasis is placed on viruses which have been shown to cause diseases in animals, and viruses for which no pathogenicity has been proven yet. Several recent examples (Usutu virus and lineage-2 West Nile virus in central Europe, Zika virus in Micronesia) have shown that sources providing information on such scientifically largely neglected viruses are valuable tools for scientists and public health officials having to deal with such disease emergences. Furthermore the effects of global warming will lead to introduction of competent mosquito vectors into temperate climate zones and will increase efficiency of viral replication in less competent vector species. This, facilitated by rising global travel and trade activities, will facilitate introduction and permanent establishment of mosquitoborne viruses, some of which may become of public health or veterinary concern, into novel environments, e.g. industrialized countries worldwide. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Weissenboeck, H.] Univ Vet Med, Dept Pathobiol, Inst Pathol & Forens Vet Med, Vienna, Austria.
   [Hubalek, Z.] Acad Sci, Inst Vertebrate Biol, Med Zool Lab, Valtice, Czech Republic.
   [Bakonyi, T.] Szent Istvan Univ, Fac Vet Sci, Dept Microbiol & Infect Dis, Budapest, Hungary.
   [Bakonyi, T.; Nowotny, N.] Univ Vet Med, Dept Pathobiol, Zoonoses & Emerging Infect Grp, Vienna, Austria.
RP Weissenbock, H (reprint author), Univ Vet Med, Dept Pathobiol, Inst Pathol & Forens Vet Med, Vienna, Austria.
EM Herbert.Weissenboeck@vetmeduni.ac.at
RI ASCR, IVB/A-9883-2011; Hubalek, Zdenek/G-1111-2014
OI Hubalek, Zdenek/0000-0003-4732-0987
CR ADAM F, 2005, VIRUS DAFRIQUE BASE
   ANDERSON CR, 1955, AM J TROP MED HYG, V4, P662
   Bakonyi T, 2006, EMERG INFECT DIS, V12, P618
   Bakonyi Tamas, 2004, Virology, V328, P301, DOI 10.1016/j.virol.2004.08.005
   Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Chvala S, 2007, VET MICROBIOL, V122, P237, DOI 10.1016/j.vetmic.2007.01.029
   Endy TP, 2002, CURR TOP MICROBIOL, V267, P11
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Fontela P, 2007, J POWER SOURCES, V169, P184, DOI 10.1016/j.jpowsour.2007.01.056
   FULOP LD, 1995, J GEN VIROL, V76, P2317, DOI 10.1099/0022-1317-76-9-2317
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler Duane J., 1997, P1
   Guy J.S., 2008, DIS POULTRY, P414
   Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hofle U, 2008, VET MICROBIOL, V129, P171, DOI 10.1016/j.vetmic.2007.11.006
   Hubalek Z, 2003, EMERG INFECT DIS, V9, P403
   Hubalek Z, 2008, VIRAL IMMUNOL, V21, P247, DOI 10.1089/vim.2007.0111
   Hurrelbrink RJ, 2003, ADV VIRUS RES, V60, P1, DOI 10.1016/S0065-3527(03)60001-1
   Karabatsos N, 1985, INT CATALOGUE ARBOVI
   Komar Nicholas, 2003, Adv Virus Res, V61, P185
   Kono Y, 2000, AM J TROP MED HYG, V63, P94
   Koopmans M, 2007, ECOL CONT VECTOR-BOR, V1, P123
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee E, 2000, J VIROL, V74, P8867, DOI 10.1128/JVI.74.19.8867-8875.2000
   Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Linke S, 2007, AM J TROP MED HYG, V77, P358
   Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P1
   MACKENZIE JS, 1995, VET MICROBIOL, V46, P79, DOI 10.1016/0378-1135(95)00074-K
   May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0
   McMinn PC, 1997, J GEN VIROL, V78, P2711
   Meister T, 2008, VET MICROBIOL, V127, P237, DOI 10.1016/j.vetmic.2007.08.023
   MORSE SS, 1995, EMERG INFECT DIS, V1, P7
   Murgue B, 2002, CURR TOP MICROBIOL, V267, P195
   Nisbet DJ, 2005, J GEN VIROL, V86, P121, DOI 10.1099/vir.0.80381-0
   OMILABU SA, 1989, MICROBIOS, V60, P53
   Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1
   Shope Robert E, 2003, Adv Virus Res, V61, P373, DOI 10.1016/S0065-3527(03)61009-2
   Swanepoel R., 2004, Infectious diseases of livestock. Volume Two, P987
   THEILER M, 1973, ARTHROPOD BORNE VIRU, P147
   Thiel H, 2005, VIRUS TAXONOMY, P981
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652
   *WHO, 2008, ZOON VET PUBL HLTH
   Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007
   Yamada M, 2004, VET PATHOL, V41, P62, DOI 10.1354/vp.41-1-62
NR 54
TC 67
Z9 68
U1 27
U2 122
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD JAN 27
PY 2010
VL 140
IS 3-4
SI SI
BP 271
EP 280
DI 10.1016/j.vetmic.2009.08.025
PG 10
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA 561OD
UT WOS:000274986400010
PM 19762169
ER

PT J
AU Hayes, EB
AF Hayes, Edward B.
TI Zika Virus Outside Africa
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID YELLOW-FEVER; SEROLOGICAL SURVEY; ARBOVIRUSES; INFECTIONS; NIGERIA;
   MICRONESIA; ANTIBODIES; SOUTHEAST; INDONESIA; HUMANS
AB Zika virus (ZIKV) is a flavivirus related to yellow fever, dengue, West Nile, and Japanese encephalitis viruses. In 2007 ZIKV caused an outbreak of relatively mild disease characterized by rash, arthralgia, and conjunctivitis on Yap Island in the southwestern Pacific Ocean. This was the first time that ZIKV was detected outside of Africa and Asia. The history, transmission dynamics, virology, and clinical manifestations of ZIKV disease are discussed, along with the possibility for diagnostic confusion between ZIKV illness and dengue. The emergence of ZIKV outside of its previously known geographic range should prompt awareness of the potential for ZIKV to spread to other Pacific islands and the Americas.
C1 Barcelona Ctr Int Hlth Res, Barcelona 08037, Spain.
RP Hayes, EB (reprint author), Barcelona Ctr Int Hlth Res, Rosello 132, Barcelona 08037, Spain.
EM ned.hayes@cresib.cat
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kuno G, 1998, J VIROL, V72, P73
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Petersen LR, 2004, NEW ENGL J MED, V351, P2257, DOI 10.1056/NEJMp048261
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
NR 28
TC 153
Z9 166
U1 63
U2 186
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2009
VL 15
IS 9
BP 1347
EP 1350
DI 10.3201/eid1509.090442
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 490NK
UT WOS:000269507500002
PM 19788800
ER

PT J
AU Mackenzie, JS
   Williams, DT
AF Mackenzie, J. S.
   Williams, D. T.
TI The Zoonotic Flaviviruses of Southern, South-Eastern and Eastern Asia,
   and Australasia: The Potential for Emergent Viruses
SO ZOONOSES AND PUBLIC HEALTH
LA English
DT Review
DE Flavivirus; zoonotic; evolution; emergence; spread
ID JAPANESE ENCEPHALITIS-VIRUS; TICK-BORNE ENCEPHALITIS; WEST-NILE-VIRUS;
   ARBOVIRUS INFECTIONS; GENUS FLAVIVIRUS; ZIKA VIRUS;
   GENETIC-CHARACTERIZATION; NORTH-QUEENSLAND; KUNJIN-VIRUS; USUTU-VIRUS
AB P>The genus Flaviviridae comprises about 70 members, of which about 30 are found in southern, south-eastern and eastern Asia and Australasia. These include major pathogens such as Japanese encephalitis (JE), West Nile (WN), Murray Valley encephalitis (MVE), tick-borne encephalitis, Kyasanur Forest disease virus, and the dengue viruses. Other members are known to be associated with mild febrile disease in humans, or with no known disease. In addition, novel flaviviruses continue to be discovered, as demonstrated recently by New Mapoon virus in Australia, Sitiawan virus in Malaysia, and ThCAr virus in Thailand. About 19 of these viruses are mosquito-borne, six are tick-borne, and four have no known vector and represent isolates from rodents or bats. Evidence from phylogenetic studies suggest that JE, MVE and Alfuy viruses probably emerged in the Malaya-Indonesian region from an African progenitor virus, possibly a virus related to Usutu virus. WN virus, however, is believed to have emerged in Africa, and then dispersed through avian migration. Evidence suggests that there are at least seven genetic lineages of WN virus, of which lineage 1b spread to Australasia as Kunjin virus, lineages 1a and 5 spread to India, and lineage 6 spread to Malaysia. Indeed, flaviviruses have a propensity to spread and emerge in new geographic areas, and they represent a potential source for new disease emergence. Many of the factors associated with disease emergence are present in the region, such as changes in land use and deforestation, increasing population movement, urbanization, and increasing trade. Furthermore, because of their ecology and dependence on climate, there is a strong likelihood that global warming may significantly increase the potential for disease emergence and/or spread.
C1 [Mackenzie, J. S.; Williams, D. T.] Curtin Univ Technol, Australian Biosecur Cooperat Res Ctr Emerging Inf, Div Hlth Sci, Perth, WA 6845, Australia.
RP Mackenzie, JS (reprint author), Curtin Univ Technol, Australian Biosecur CRC, GPO Box U1987, Perth, WA 6845, Australia.
EM j.mackenzie@curtin.edu.au; d.williams@curtin.edu.au
RI Williams, David/H-6750-2013
CR AASKOV JG, 1993, T ROY SOC TROP MED H, V87, P452, DOI 10.1016/0035-9203(93)90032-L
   Ali A, 1997, MICROBIOL IMMUNOL, V41, P241
   Ando K., 1952, KITASATO ARCH EXP ME, V24, P49
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P225
   Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07
   BANCROFT WH, 1976, AM J TROP MED HYG, V25, P500
   Banerjee K, 1996, INDIAN J MED RES, V103, P177
   Berthet FX, 1997, J GEN VIROL, V78, P2293
   Billoir F, 2000, J GEN VIROL, V81, P781
   BLITVICH BJ, 2008, ANIM HLTH RES REV MA, V19, P1
   Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0
   BOUGHTON CR, 1986, MED J AUSTRALIA, V145, P90
   BOWEN ETW, 1970, ANN TROP MED PARASIT, V64, P263
   Broom Annette K., 2002, Vector Borne and Zoonotic Diseases, V2, P87, DOI 10.1089/153036602321131887
   Burke DS, 1988, ARBOVIRUSES EPIDEMIO, V3, P63
   Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Charrel RN, 2001, BIOCHEM BIOPH RES CO, V287, P455, DOI 10.1006/bbrc.2001.5610
   CHEN WR, 1990, J GEN VIROL, V71, P2915, DOI 10.1099/0022-1317-71-12-2915
   CHEN WR, 1992, AM J TROP MED HYG, V47, P61
   COELEN RJ, 1988, J GEN VIROL, V69, P1903, DOI 10.1099/0022-1317-69-8-1903
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Danielova V, 1991, MODERN ACAROLOGY, V2, P7
   DANIELS PW, 2002, EMERGING VIRAL DIS S, P249
   de Lamballerie X, 2002, J GEN VIROL, V83, P2443
   De Silva AM, 1999, AM J TROP MED HYG, V60, P300
   DEZANOTTO PM, 1996, P NATL ACAD SCI USA, V93, P548
   Dhanda V, 1997, INDIAN J MED RES, V106, P4
   DOHERTY RL, 1963, AUST J EXP BIOL MED, V41, P17, DOI 10.1038/icb.1963.2
   DOHERTY RL, 1964, AUST J EXP BIOL MED, V41, P149
   DOHERTY RL, 1971, T ROY SOC TROP MED H, V65, P504, DOI 10.1016/0035-9203(71)90161-1
   Ellis PM, 2000, VET CLIN N AM-EQUINE, V16, P565
   ENDY TP, 2002, CURR TOP MICROBIOL, V267, P12
   Gaunt MW, 2001, J GEN VIROL, V82, P1867
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   [Anonymous], 2004, ARCH VIROL         S
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015
   Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Hall RA, 2002, CURR TOP MICROBIOL, V267, P253
   HALL RA, 1991, IMMUNOL CELL BIOL, V69, P47, DOI 10.1038/icb.1991.7
   Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1
   Hanna JN, 1996, MED J AUSTRALIA, V165, P256
   Hanna JN, 1999, MED J AUSTRALIA, V170, P533
   HAWKES RA, 1985, MED J AUSTRALIA, V143, P555
   HAWKES RA, 1993, MED J AUSTRALIA, V159, P159
   Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039
   HUMPHERYSMITH I, 1991, EPIDEMIOL INFECT, V107, P435
   IGARASHI A, 1994, MICROBIOL IMMUNOL, V38, P827
   Jia XY, 1999, LANCET, V354, P1971, DOI 10.1016/S0140-6736(99)05384-2
   Johansen CA, 2000, AM J TROP MED HYG, V62, P631
   Johansen CA, 2007, VIRUS GENES, V35, P147, DOI 10.1007/s11262-007-0091-2
   JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608
   Karabatsos N, 1985, INT CATALOGUE ARBOVI
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73
   Kohl I, 1996, EUR J EPIDEMIOL, V12, P373
   Kono Y, 2000, AM J TROP MED HYG, V63, P94
   Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2006, AM J TROP MED HYG, V75, P1165
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   LEAKE CJ, 1986, T ROY SOC TROP MED H, V80, P831, DOI 10.1016/0035-9203(86)90397-4
   [Anonymous], 2004, ARCH VIROL         S
   MACDONALD J, 2001, ARBOVIRUS RES AUSTR, V8, P225
   Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P49
   Mackenzie JS, 2000, ACIAR P, P48
   MACKENZIE JS, 1998, WATER RESOURCES HLTH, P108
   Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P1
   MACKENZIE JS, 2007, PERSPECT MED VIROL, V16, P201
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Monath TP, 1988, ARBOVIRUSES EPIDEMIO, P151
   May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MORGAN IR, 1985, J WILDLIFE DIS, V21, P193
   Nisbet D.J., 2001, Arbovirus Research in Australia, V8, P263
   Nisbet DJ, 2005, J GEN VIROL, V86, P121, DOI 10.1099/vir.0.80381-0
   Nuttall PA, 2003, ADV VIRUS RES, V60, P233, DOI 10.1016/S0065-3527(03)60007-2
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Pandey Basu Dev, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P161
   Pattnaik P, 2006, REV MED VIROL, V16, P151, DOI 10.1002/rmv.495
   PLATT GS, 1975, ANN TROP MED PARASIT, V69, P65
   Poidinger M, 1996, VIROLOGY, V218, P417, DOI 10.1006/viro.1996.0213
   Poidinger M, 2000, VIRUS RES, V68, P7, DOI 10.1016/S0168-1702(00)00143-X
   Ritchie SA, 1997, AM J TROP MED HYG, V56, P80
   Rizzoli A, 2007, VECTOR-BORNE ZOONOT, V7, P411, DOI 10.1089/vbz.2006.0626
   Rodrigues FM, 1988, B NAT I VIROL PUNE, V6, P3
   RUDNICK ALBERT, 1965, J MED ENTOMOL, V2, P203
   Russell R. C., 1995, Review of Medical and Veterinary Entomology, V83, P141
   SALAUN JJ, 1974, ANN INST PASTEUR MIC, VA125, P485
   Scherret JH, 2002, CURR TOP MICROBIOL, V267, P373
   Scherret JH, 2001, EMERG INFECT DIS, V7, P697
   SIMPSON DIH, 1970, ANN TROP MED PARASIT, V64, P137
   SMITH CEG, 1956, NATURE, V178, P581
   Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003
   SOMAN RS, 1977, INDIAN J MED RES, V66, P709
   Spencer J D, 2001, Commun Dis Intell Q Rep, V25, P33
   STGEORGE TD, 1977, AUST J EXP BIOL MED, V55, P493
   STGEORGE TD, 1985, AM J TROP MED HYG, V34, P406
   Suzuki Y, 2007, GENES GENET SYST, V82, P187, DOI 10.1266/ggs.82.187
   Tajima S, 2005, VIROLOGY, V332, P38, DOI 10.1016/j.virol.2004.06.052
   TAKASHIMA I, 1988, AM J TROP MED HYG, V38, P420
   Takashima I, 1997, J CLIN MICROBIOL, V35, P1943
   Takeda T, 1998, J MED ENTOMOL, V35, P227
   Takeda T, 1999, AM J TROP MED HYG, V60, P287
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Thakare J. P., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P801
   Thiel HJ, 2005, VIRUS TAXONOMY, P979
   Tsai Y. B., 2000, EARTHQUAKE ENG ENG S, V2, P1
   Uchil PD, 2001, AM J TROP MED HYG, V65, P242
   UMENAI T, 1985, B WORLD HEALTH ORGAN, V63, P625
   VARELASWESLEY I, 1982, AM J TROP MED HYG, V31, P1273
   VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197
   VENUGOPAL K, 1992, VIROLOGY, V190, P515, DOI 10.1016/0042-6822(92)91245-P
   WALLACE HG, 1977, MOSQ NEWS, V37, P35
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Woodroofe GM, 1971, J CURTIN SCH MED RES, P90
   Zaki AM, 1997, T ROY SOC TROP MED H, V91, P179, DOI 10.1016/S0035-9203(97)90215-7
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
   ZANOTTO PMD, 1995, VIROLOGY, V210, P152
NR 125
TC 73
Z9 77
U1 28
U2 120
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1863-1959
J9 ZOONOSES PUBLIC HLTH
JI Zoonoses Public Health
PD AUG
PY 2009
VL 56
IS 6-7
BP 338
EP 356
DI 10.1111/j.1863-2378.2008.01208.x
PG 19
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Veterinary Sciences
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Veterinary Sciences
GA 469GH
UT WOS:000267883500010
PM 19486319
ER

PT J
AU Powers, AM
AF Powers, Ann M.
TI Overview of emerging arboviruses
SO FUTURE VIROLOGY
LA English
DT Review
DE alphavirus; arbovirus; emergence; epidemics; flavivirus; viral evolution
ID WEST-NILE-VIRUS; EPIDEMIC CHIKUNGUNYA VIRUS; ACUTE FLACCID PARALYSIS;
   ZIKA VIRUS; AEDES-ALBOPICTUS; REUNION-ISLAND; UNITED-STATES;
   PHYLOGENETIC ANALYSIS; FEDERATED STATES; GENOME SEQUENCES
AB Numerous arboviral outbreaks during the past decade have demonstrated that arthropod-borne pathogens continue to be significant public and animal health threats. These outbreaks have occurred globally and have not been limited to tropical or developing countries, as people and goods can be moved anywhere in the world within days. Several examples of recent outbreaks have been described, including how they were identified, tracked and the resulting outcomes from these events. Fortunately, scientific research, including advances in rapid detection of this diverse group of pathogens, has also been progressing. While arboviruses are likely to continually emerge and re-emerge, improved scientific technologies and approaches will hopefully make each future epidemic less likely to occur.
C1 Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Infect Dis, Ft Collins, CO 80521 USA.
RP Powers, AM (reprint author), Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Infect Dis, Ft Collins, CO 80521 USA.
EM apowers@cdc.gov
CR Autorino GL, 2002, EMERG INFECT DIS, V8, P1372
   BALANCA G, 2009, VECTOR BORNE ZOONOTI
   Beasley DWC, 2004, ARCH VIROL, P35
   Beltrame A, 2007, EMERG INFECT DIS, V13, P1264
   Blitvich Bradley J., 2008, Animal Health Research Reviews, V9, P71, DOI 10.1017/S1466252307001430
   Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   *CDC, 2008, W NIL VIR MAPS DAT
   Chhabra M, 2008, INDIAN J MED MICROBI, V26, P5
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405
   Cruz L, 2005, AM J TROP MED HYG, V72, P612
   Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022
   DERANITZ CM, 1965, INDIAN J MED RES, V53, P756
   Diallo M, 1999, AM J TROP MED HYG, V60, P281
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupuis AP, 2003, EMERG INFECT DIS, V9, P860
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Estrada-Franco JG, 2003, EMERG INFECT DIS, V9, P1604
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Feng QH, 2009, J CLIN MICROBIOL, V47, P547, DOI 10.1128/JCM.01707-08
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Giladi M, 2001, EMERG INFECT DIS, V7, P659
   GILOTRA SK, 1967, AM J EPIDEMIOL, V86, P379
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Grinev A, 2008, J VIROL METHODS, V154, P27, DOI 10.1016/j.jviromet.2008.09.015
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P1022
   HARRISON VR, 1967, J IMMUNOL, V98, P979
   Hindson BJ, 2008, J CLIN MICROBIOL, V46, P1081, DOI 10.1128/JCM.01740-07
   Horejsh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni015
   Hull R, 2008, DIAGN MICR INFEC DIS, V62, P272, DOI 10.1016/j.diagmicrobio.2008.07.004
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   JUPP PG, 1981, T ROY SOC TROP MED H, V75, P15, DOI 10.1016/0035-9203(81)90005-5
   JUPP PG, 1990, J AM MOSQUITO CONTR, V6, P415
   Kalantri SP, 2006, NATL MED J INDIA, V19, P315
   Karabatsos N., 1985, INT CATALOGUE ARBOVI, P1147
   Kraftcheck D J, 2003, Can Commun Dis Rep, V29, P189
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Krisztalovics K., 2008, EURO SURVEILL, V13
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013
   LeGuenno B, 1996, LANCET, V348, P1315
   Lvov DK, 2000, EMERG INFECT DIS, V6, P373
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maiti C R, 1978, J Indian Med Assoc, V70, P256
   Malkinson M, 2002, EMERG INFECT DIS, V8, P392
   MANGIAFICO JA, 1971, AM J TROP MED HYG, V20, P642
   MARCHETTE N J, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P317
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Morales-Betoulle ME, 2006, EMERG INFECT DIS, V12, P1038
   MOURYA DT, 1987, INDIAN J MED RES, V86, P269
   Murgue B, 2001, ANN NY ACAD SCI, V951, P117
   Murgue B, 2001, EMERG INFECT DIS, V7, P692
   Murgue B, 2002, CURR TOP MICROBIOL, V267, P195
   MYERS RM, 1965, INDIAN J MED RES, V53, P694
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954
   Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0
   OBEYESEKERE I, 1972, BRIT HEART J, V34, P821
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PADBIDRI VS, 1979, J HYG EPID MICROB IM, V23, P445
   *PAHO, 2009, UPD SIT YELL FEV AM
   Paquet C, 2006, EUROSURVEILLANCE, V11
   Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168
   Platonov AE, 2001, EMERG INFECT DIS, V7, P128
   Platonov AE, 2008, PARASITOL RES, V103, pS45, DOI 10.1007/s00436-008-1050-0
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   *PUBL HLTH AG CAN, 2002, W NIL VIR MON HUM SU
   Putonti C, 2006, FEBS J, V273, P398, DOI 10.1111/j.1742-4658.2005.05074.x
   Quirin R, 2004, EMERG INFECT DIS, V10, P706
   Rao T., 1966, SCI CULTURE, V32, P215
   RAO TR, 1964, INDIAN J MED RES, V52, P719
   Ravi V, 2006, Indian J Med Microbiol, V24, P83
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   REUBEN R, 1967, INDIAN J MED RES, V55, P1
   Rezza G, 2009, EUR J PUBLIC HEALTH, V19, P236, DOI 10.1093/eurpub/ckn135
   Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5
   Rossini G, 2008, EURO SURVEILL, V13
   Saad M, 2005, J INFECTION, V51, P120, DOI 10.1016/j.jinf.2004.10.005
   Sang RC, 2008, AM J TROP MED HYG, V78, P77
   Santhosh SR, 2007, J CLIN VIROL, V39, P188, DOI 10.1016/j.jcp.2007.04.015
   Savage HM, 1998, AM J TROP MED HYG, V58, P519
   Saxena S., 2006, EUROSURVEILLANCE, V11
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021
   Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788
   Seneviratne SL, 2007, BJOG-INT J OBSTET GY, V114, P781, DOI 10.1111/j.1471-0528.2007.01321.x
   Seneviratne SL, 2006, BRIT MED J, V333, P1220, DOI 10.1136/bmj.39051.725729.3A
   Sergon K, 2007, AM J TROP MED HYG, V76, P1189
   Sergon K, 2008, AM J TROP MED HYG, V78, P333
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   Soon Y Y, 2007, Med J Malaysia, V62, P214
   STAPLES JE, 2009, CLIN INFEC IN PRESS
   TESH RB, 1976, AM J TROP MED HYG, V25, P326
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Valerio L., 2008, Parassitologia (Rome), V50, P103
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163
   Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580
   [Anonymous], 2008, WKLY EPIDEMIOL REC, V83, P105
   2006, MORB MORTAL WKLY REP, V55, P150
   1999, MORB MORTAL WKLY REP, V48, P845
   2008, DISASTERS PREPAREDNE, V109, P4
   [Anonymous], 2008, LANCET, V371, P786
NR 115
TC 5
Z9 5
U1 8
U2 43
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
J9 FUTURE VIROL
JI Future Virol.
PD JUL
PY 2009
VL 4
IS 4
BP 391
EP 401
DI 10.2217/FVL.09.19
PG 11
WC Virology
SC Virology
GA 472HA
UT WOS:000268120000014
ER

PT J
AU Duffy, MR
   Chen, TH
   Hancock, WT
   Powers, AM
   Kool, JL
   Lanciotti, RS
   Pretrick, M
   Marfel, M
   Holzbauer, S
   Dubray, C
   Guillaumot, L
   Griggs, A
   Bel, M
   Lambert, AJ
   Laven, J
   Kosoy, O
   Panella, A
   Biggerstaff, BJ
   Fischer, M
   Hayes, EB
AF Duffy, Mark R.
   Chen, Tai-Ho
   Hancock, W. Thane
   Powers, Ann M.
   Kool, Jacob L.
   Lanciotti, Robert S.
   Pretrick, Moses
   Marfel, Maria
   Holzbauer, Stacey
   Dubray, Christine
   Guillaumot, Laurent
   Griggs, Anne
   Bel, Martin
   Lambert, Amy J.
   Laven, Janeen
   Kosoy, Olga
   Panella, Amanda
   Biggerstaff, Brad J.
   Fischer, Marc
   Hayes, Edward B.
TI Zika Virus Outbreak on Yap Island, Federated States of Micronesia
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID WEST-NILE-VIRUS; POLYMERASE-CHAIN-REACTION; ORIGINAL ANTIGENIC SIN;
   YELLOW-FEVER; INFECTIONS; NIGERIA; EPIDEMIC; ANTIBODIES; DENGUE;
   ENCEPHALITIS
AB BACKGROUND
   In 2007, physicians on Yap Island reported an outbreak of illness characterized by rash, conjunctivitis, and arthralgia. Although serum from some patients had IgM antibody against dengue virus, the illness seemed clinically distinct from previously detected dengue. Subsequent testing with the use of consensus primers detected Zika virus RNA in the serum of the patients but no dengue virus or other arboviral RNA. No previous outbreaks and only 14 cases of Zika virus disease have been previously documented.
   METHODS
   We obtained serum samples from patients and interviewed patients for information on clinical signs and symptoms. Zika virus disease was confirmed by a finding of Zika virus RNA or a specific neutralizing antibody response to Zika virus in the serum. Patients with IgM antibody against Zika virus who had a potentially cross-reactive neutralizing-antibody response were classified as having probable Zika virus disease. We conducted a household survey to estimate the proportion of Yap residents with IgM antibody against Zika virus and to identify possible mosquito vectors of Zika virus.
   RESULTS
   We identified 49 confirmed and 59 probable cases of Zika virus disease. The patients resided in 9 of the 10 municipalities on Yap. Rash, fever, arthralgia, and conjunctivitis were common symptoms. No hospitalizations, hemorrhagic manifestations, or deaths due to Zika virus were reported. We estimated that 73% (95% confidence interval, 68 to 77) of Yap residents 3 years of age or older had been recently infected with Zika virus. Aedes hensilli was the predominant mosquito species identified.
   CONCLUSIONS
   This outbreak of Zika virus illness in Micronesia represents transmission of Zika virus outside Africa and Asia. Although most patients had mild illness, clinicians and public health officials should be aware of the risk of further expansion of Zika virus transmission.
C1 [Fischer, Marc] CDC, Div Vector Borne Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Arboviral Dis Branch, Ft Collins, CO 80521 USA.
   [Chen, Tai-Ho; Holzbauer, Stacey; Dubray, Christine] CDC, Epidem Intelligence Serv Field Assignments Branch, Atlanta, GA 30333 USA.
   [Hancock, W. Thane; Bel, Martin] Waab Community Hlth Ctr, Yap, Micronesia.
   [Marfel, Maria] Yap State Dept Hlth Serv, Yap, Micronesia.
   [Kool, Jacob L.] WHO, Off S Pacific, Suva, Fiji.
   [Pretrick, Moses] Dept Hlth Educ & Social Affairs, Ponape, Micronesia.
   [Guillaumot, Laurent] Inst Pasteur, Noumea, New Caledonia.
RP Fischer, M (reprint author), CDC, Div Vector Borne Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Arboviral Dis Branch, 3150 Rampart Rd, Ft Collins, CO 80521 USA.
EM mfischer@cdc.gov
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Durand Mark A, 2005, Pac Health Dialog, V12, P99
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Gubler DG, 2001, FIELDS VIROLOGY, P1152
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154
   INOUYE S, 1984, MICROBIOL IMMUNOL, V28, P569
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Nasci RS, 2002, J AM MOSQUITO CONTR, V18, P294
   NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Powers AM, 2000, J GEN VIROL, V81, P471
   Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376
   Sarndal C.E., 1992, MODEL ASSISTED SURVE, VSpringer-Verlag
   Sarndal CE, 2005, WILEY SER SURV METH, P1
   Savage HM, 1998, AM J TROP MED HYG, V58, P519
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
NR 36
TC 314
Z9 343
U1 149
U2 312
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUN 11
PY 2009
VL 360
IS 24
BP 2536
EP 2543
DI 10.1056/NEJMoa0805715
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 456BS
UT WOS:000266813800008
PM 19516034
ER

PT J
AU Pillet, S
AF Pillet, S.
TI Infection with Zika virus: recent epidemic in the Islands of Yap
   (Micronesia)
SO VIROLOGIE
LA French
DT News Item
C1 CHU St Etienne, Fac Med Jacques Lisfranc, Lab Bacteriol Virol, St Etienne, France.
RP Pillet, S (reprint author), CHU St Etienne, Fac Med Jacques Lisfranc, Lab Bacteriol Virol, St Etienne, France.
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
NR 1
TC 0
Z9 0
U1 3
U2 11
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1267-8694
J9 VIROLOGIE
JI Virologie
PD MAY-JUN
PY 2009
VL 13
IS 3
BP 183
EP 184
PG 2
WC Virology
SC Virology
GA 497RF
UT WOS:000270077800009
ER

PT J
AU Oumar, F
   Ousmane, F
   Anne, D
   Mady, N
   Mawlouth, D
   Alpha, SA
AF Oumar, Faye
   Ousmane, Faye
   Anne, Dupressoir
   Mady, Ndiaye
   Mawlouth, Diallo
   Alpha, Sall Amadou
TI PHYLOGENETIC ANALYSIS OF WEST AFRICAN ZIKA VIRUS USING SEQUENCES OF
   PARTS OF E, NSS AND NS5/3 ' NC
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Oumar, Faye; Ousmane, Faye; Mawlouth, Diallo; Alpha, Sall Amadou] Inst Pasteur, Dakar, Senegal.
   [Anne, Dupressoir] Inst Gustave Roussy, Paris, France.
   [Mady, Ndiaye] Univ Cheikh Anta Diop Dakar, Dakar, Senegal.
NR 0
TC 0
Z9 0
U1 5
U2 13
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
MA 832
BP 245
EP 246
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644601197
ER

PT J
AU Oumar, F
   Ousmane, F
   Anne, D
   Manfred, W
   Mady, N
   Alpha, SA
AF Oumar, Faye
   Ousmane, Faye
   Anne, Dupressoir
   Manfred, Weidmann
   Mady, Ndiaye
   Alpha, Sall Amadou
TI ONE STEP RT-PCR FOR DETECTION OF ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Oumar, Faye; Ousmane, Faye; Alpha, Sall Amadou] Inst Pasteur, Dakar, Senegal.
   [Anne, Dupressoir] CNRS, Inst Gustave Roussy, UMR 8122, Paris, France.
   [Manfred, Weidmann] Univ Gottingen, Inst Virol, Gottingen, Germany.
   [Mady, Ndiaye] Univ Cheikh Anta Diop, Dakar, Senegal.
NR 0
TC 0
Z9 0
U1 8
U2 9
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
SU S
MA 912
BP 268
EP 269
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644601277
ER

PT J
AU Oumar, F
AF Oumar, Faye
TI ONE STEP RT-PCR FOR DETECTION OF ZIKA VIRUS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Oumar, Faye] Inst Pasteur, Dakar, Senegal.
NR 0
TC 0
Z9 0
U1 12
U2 12
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
SU S
MA 911
BP 268
EP 268
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644601276
ER

PT J
AU Barboza, P
   Tarantola, A
   Lassel, L
   Mollet, T
   Quatresous, I
   Paquet, C
AF Barboza, P.
   Tarantola, A.
   Lassel, L.
   Mollet, T.
   Quatresous, I.
   Paquet, C.
TI Emerging viral infections in South East Asia and the Pacific region
SO MEDECINE ET MALADIES INFECTIEUSES
LA French
DT Review
DE Arboviruses; Emerging infections; Alphavirus; Flavivirus; Henipavirus
ID AUSTRALIAN BAT LYSSAVIRUS; ROSS RIVER VIRUS; JAPANESE
   ENCEPHALITIS-VIRUS; MURRAY-VALLEY ENCEPHALITIS; BARMAH FOREST VIRUS;
   NIPAH VIRUS; ZIKA VIRUS; EPIDEMIC POLYARTHRITIS; CHIKUNGUNYA VIRUSES;
   WESTERN PACIFIC
AB The epidemiology of several viral diseases underwent profound changes in South-East Asia and Oceania over the past decades. This was due to several factors. including the geographical distribution of vectors and the viruses they transmit: increasing traveling and trade: increasing ecological and demographic pressure. We reviewed the Current state of knowledge based oil published sources and available epidemiological data. The review was limited to potentially emerging viruses ill Southeast Asia and the Pacific reported in human cases. Dengue, Chikungunya, and Japanese Encephalitis viruses have recurred on a yearly, basis with a steady increase in these regions. Ross River and Barmah viruses now appear regularly in Australia. in all increasing number of cases. Nipah virus strikes regularly with limited but deadly epidemies in Southeast Asia. Finally, infections by lyssaviruses. Kunjin, Murray Valley, or Zika Viruses were also reviewed. (C) 2008 Elsevier Masson SAS. Tous droits reserves.
C1 [Barboza, P.; Tarantola, A.; Lassel, L.; Mollet, T.; Quatresous, I.; Paquet, C.] Inst Veille Sanit, Dept Int & Trop, F-94415 St Maurice, France.
RP Barboza, P (reprint author), Inst Veille Sanit, Dept Int & Trop, 12 Rue Val Osne, F-94415 St Maurice, France.
EM p.barboza@invs.sante.fr
RI Tarantola, Arnaud/D-2149-2015
OI Tarantola, Arnaud/0000-0002-6946-7958
CR AASKOV JG, 1981, AM J TROP MED HYG, V30, P1053
   AbuBakar S, 2004, EMERG INFECT DIS, V10, P2228
   Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0
   Ashford DA, 2003, AM J TROP MED HYG, V69, P135
   *AUSTR GOV AUSTR I, AUSTR HLTH 2006
   *AUSTR GOV DEP HLT, ROSS RIV VIR INF FAC
   Bi P, 2003, VECTOR-BORNE ZOONOT, V3, P111, DOI 10.1089/153036603768395807
   BISWAS K, 2007, COMMUNICABLE NEWSLET, V4, P4
   Brisse S, 2007, NEW ENGL J MED, V356, P2650
   Broom AK, 2003, AM J TROP MED HYG, V69, P277
   Broom Annette K, 2005, Commun Dis Intell Q Rep, V29, P65
   Broom Annette K, 2002, Commun Dis Intell Q Rep, V26, P428
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172
   BURNET FM, 1952, AM J PUBLIC HLTH NAT, V42, P1519
   Chadha MS, 2006, EMERG INFECT DIS, V12, P235
   CHASTEL CLAUDE, 1964, BULL SOC PATHOL EXOTIQUE, V57, P65
   Chua KB, 2007, P NATL ACAD SCI USA, V104, P11424, DOI 10.1073/pnas.0701372104
   Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3
   Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x
   *DEP PRIM IND FISH, HENDR VIR EQ MORB EM
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DIWAN AR, 1952, T R SOC TROP MED HYG, V46, P509
   *ECDC, ZIK VIR OUTBR MICR D
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Enserink M, 2000, SCIENCE, V289, P518, DOI 10.1126/science.289.5479.518
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   FAGBAMI AH, 1977, TROP GEOGR MED, V29, P87
   FAURAN P, 1984, AM J TROP MED HYG, V33, P1228
   FAURAN P, 1984, B SOC PATHOL EXOT, V77, P628
   Flexman JP, 1998, MED J AUSTRALIA, V169, P159
   GARD G, 1970, J VIROL, V6, P100
   Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701
   Guyatt KJ, 2003, J GEN VIROL, V84, P485, DOI 10.1099/vir.0.18652-0
   Hall RA, 2001, ANN NY ACAD SCI, V951, P153
   Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hanna JN, 2000, MED J AUSTRALIA, V172, P597
   Harit AK, 2006, INDIAN J MED RES, V123, P553
   Harvey Lara, 2004, N S W Public Health Bull, V15, P199
   Hemmerter S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-100
   Hsu KC, 2004, BIOL BLOOD MARROW TR, V10, P7, DOI 10.1016/j.bbmt.2003.12.013
   *I VEILL SAN DEP I, 2007, DENG AS SUD EST 25 J
   Johansen CA, 2000, AM J TROP MED HYG, V62, P631
   Jupp PG, 1988, ARBOVIRUSES EPIDEMIO, VII, P137
   Kirkland PD, 2001, AUST VET J, V79, P199, DOI 10.1111/j.1751-0813.2001.tb14580.x
   Kit Lam Sai, 2002, Asia Pac J Public Health, V14, P6
   Lam K., 2005, Hong Kong Medical Journal, V11, P182
   Lam SK, 2002, CLIN INFECT DIS, V34, pS48, DOI 10.1086/338818
   LAWRENCE J, 2005, EURO SURVEILL, V10
   Lehle C, 2007, EMERG INFECT DIS, V13, P159, DOI DOI 10.3201/EID1301.060791
   Liu Conan, 2006, Commun Dis Intell Q Rep, V30, P411
   Luby SP, 2006, EMERG INFECT DIS, V12, P1888
   Mackenzie J S, 1998, Commun Dis Intell, V22, P93
   Mackenzie JS, 2001, EMERG INFECT DIS, V7, P497
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   McCall BJ, 2000, EMERG INFECT DIS, V6, P259
   McCormack JG, 2002, MED J AUSTRALIA, V177, P45
   MING CK, 1974, J TROP MED HYG, V77, P260
   MITCHELL CJ, 1993, AM J TROP MED HYG, V48, P585
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MULLBACHER A, 1986, J GEN VIROL, V67, P295, DOI 10.1099/0022-1317-67-2-295
   MYERS RM, 1965, INDIAN J MED RES, V53, P694
   OBEYESEKERE I, 1972, BRIT HEART J, V34, P821
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887
   PAUL WS, 1993, J INFECT DIS, V167, P1053
   Porter KR, 2005, AM J TROP MED HYG, V72, P60
   Powers AM, 2000, J GEN VIROL, V81, P471
   Pritchard LI, 2006, ARCH VIROL, V151, P229, DOI 10.1007/s00705-005-0644-4
   Prociv P, 2007, MED J AUSTRALIA, V186, P325
   *PROM MAIL, ZIK VIR OUTBR MICR Y
   REUBEN R, 1967, INDIAN J MED RES, V55, P1
   Reynolds J, 2005, J PEDIAT OPHTH STRAB, V42, P7
   ROSEN L, 1981, AM J TROP MED HYG, V30, P1294
   Rulli NE, 2007, ANN NY ACAD SCI, V1102, P96, DOI 10.1196/annals.1408.007
   Scherret JH, 2001, EMERG INFECT DIS, V7, P697
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Sendow I, 2006, EMERG INFECT DIS, V12, P711
   SISSOKO D, 2007, EV MAN ART CHIK ENTR
   Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263
   *STAT GOV VICT DEP, 2005, BLUEB GUID CONTR INF
   Tan KS, 2000, NEUROL J SE ASIA, V5, P69
   TESH RB, 1981, T ROY SOC TROP MED H, V75, P426, DOI 10.1016/0035-9203(81)90112-7
   TIPAYAMONGKHOLG.M, 2007, CHANGE WORST EPIDEMI
   Warrilow D, 2002, VIROLOGY, V297, P109, DOI 10.1006/viro.2002.1417
   Warrilow D, 2003, EMERG INFECT DIS, V9, P262
   WATTS DM, 2007, TROPICAL INFECT DIS
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P325
   World Health Organization (WHO), 2007, SCI WORK GROUP M DEN
   *WHO, 2005, BIR M JAP ENC WHO SE
   *WHO, 2007, JAP ENC
   Williams DT, 2001, AM J TROP MED HYG, V65, P379
   Yaiw KC, 2007, J INFECT DIS, V196, P884, DOI 10.1086/520817
   *YAP STAT DEP HLTH, 2007, ZIK VIR INF CLIN OTH
   Yob J M, 2001, Emerg Infect Dis, V7, P439
   [Anonymous], 1991, LANCET, V337, P948
   1999, CAN COMMUN DIS REP, V25, P108
   1969, CALIF MED, V111, P461
   2001, N S W PUBLIC HLTH B, V12, P14
   2002, N S W PUBLIC HLTH B, V13, P170
   2007, VS SURV ACT FORM EM
NR 103
TC 7
Z9 7
U1 6
U2 23
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0399-077X
J9 MED MALADIES INFECT
JI Med. Mal. Infect.
PD OCT
PY 2008
VL 38
IS 10
BP 513
EP 523
DI 10.1016/j.medmal.2008.06.011
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA 373OA
UT WOS:000260980100002
PM 18771865
ER

PT J
AU Faye, O
   Faye, O
   Dupressoir, A
   Weidmann, M
   Ndiaye, M
   Sall, AA
AF Faye, Oumar
   Faye, Ousmane
   Dupressoir, Anne
   Weidmann, Manfred
   Ndiaye, Mady
   Sall, Amadou Alpha
TI One-step RT-PCR for detection of Zika virus
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; detection; diagnosis; RT-PCR
ID POLYMERASE CHAIN-REACTION; YELLOW-FEVER; IDENTIFICATION; SEQUENCES
AB Background: Zika virus (ZIKV) is an emerging mosquito-borne flavivirus circulating in Asia and Africa. Human infection induces an influenza-like syndrome that is associated with retro-orbital pain, oedema, lymphadenopathy, or diarrhea. Diagnosis of Zika fever requires virus isolation and serology, which are time consuming or cross-reactive.
   Objective: To develop a one-step RT-PCR assay to detect ZIKV in human serum.
   Study design: An assay targeting the envelope protein coding region was designed and evaluated for its specificity, detection limit, repeatability, and capacity to detect ZIKV isolates collected over a 40-year period from various African countries and hosts.
   Results: The assay's detection limit and repeatability were respectively 7.7 pfu/reaction and 100% in serum and L-15 medium; none of 19 other flaviviruses tested were detected.
   Conclusions: The assay is rapid, sensitive, and specific to detect ZIKV in cell culture or serum, but needs to be validated for diagnosis using clinical samples. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Faye, Oumar; Faye, Ousmane; Dupressoir, Anne; Sall, Amadou Alpha] Inst Pasteur, Dakar, Senegal.
   [Dupressoir, Anne] Inst Gustave Roussy, CNRS, UMR8122, Villejuif, France.
   [Weidmann, Manfred] Univ Gottingen, Inst Virol, D-37075 Gottingen, Germany.
   [Faye, Oumar; Ndiaye, Mady] Univ Cheikh Anta Diop Dakar, Dakar, Senegal.
RP Sall, AA (reprint author), Inst Pasteur, 36 Ave Pasteur,BP 220, Dakar, Senegal.
EM asall@pasteur.sn
RI Weidmann, Manfred/G-1817-2015; 
OI Weidmann, Manfred/0000-0002-7063-7491
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BEARCROFT WG, 1956, T ROY SOC TROP MED H, V50, P48
   BEL M, 2007, 200707132252 PROM
   Brown T M, 1994, Clin Diagn Virol, V2, P41, DOI 10.1016/0928-0197(94)90034-5
   DICK GW, 1952, T ROY SOC TROP MED H, V46, P506
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   KILBOURN AM, 2003, J WILDLIFE DIS, V39
   Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MONDET B, 2007, 200707022108 PROM
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MORITA K, 1991, J CLIN MICROBIOL, V29, P2107
   NATHAN DW, 2001, AM J TROP MED HYG, V65, P310
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   Robert V, 1986, B SOC PATHOL EXOT, V86, P90
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
NR 24
TC 46
Z9 48
U1 17
U2 61
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2008
VL 43
IS 1
BP 96
EP 101
DI 10.1016/j.jcv.2008.05.005
PG 6
WC Virology
SC Virology
GA 356DA
UT WOS:000259757700017
PM 18674965
ER

PT J
AU Ellis, BR
   Barrett, ADT
AF Ellis, Brett R.
   Barrett, Alan D. T.
TI The enigma of yellow fever in East Africa
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
ID CENTRAL UGANDA 1964; TICK AMBLYOMMA-VARIEGATUM; 1ST RECORDED OUTBREAK;
   AEDES-AEGYPTI; SEROLOGICAL SURVEY; CHIKUNGUNYA VIRUS; BATS CHIROPTERA;
   INDIAN-OCEAN; ZIKA FOREST; ARBOVIRUSES
AB Despite a safe and effective vaccine, there are approximately 200 000 cases, including 30 000 deaths, due to yellow fever virus (YFV) each year, of which 90% are in Africa. The natural history of YFV has been well described, especially in West Africa, but in East Africa yellow fever (YF) remains characterised by unpredictable focal periodicity and a precarious potential for large epidemics. Recent outbreaks of YF in Kenya (1992-1993) and Sudan (2003 and 2005) are important because each of these outbreaks have involved the re-emergence of a YFV genotype (East Africa) that remained undetected for nearly 40 years and was previously unconfirmed in a clinically apparent outbreak. In addition, unlike West Africa and South America, YF has vet to emerge in urban areas of East Africa and be vectored by Aedes (Stegomyia) aegypti. This is a Significant public health concern in a region where the majority of the population remains unvaccinated. This review describes historical findings, highlights a number of disease indicators, and provides clarification regarding the natural history, recent emergence and future risk of YF in East Africa. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Ellis, Brett R.] Tulane Univ, Dept Trop Med, New Orleans, LA 70118 USA.
   [Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Ctr Biodefense & Emerging Infect Dis, Inst Human Infect & Immun, Galveston, TX USA.
RP Ellis, BR (reprint author), Univ Hawaii, JA Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, 651 Ilalo St,BSB 3rd Floor,Off Suite 320, Honolulu, HI 96813 USA.
EM brellis@hawaii.edu
FU Tulane University Department of Tropical Medicine; CDC Cooperative
   Agreement [T01/CCT622308-02]
FX Supported by Tulane University Department of Tropical Medicine and CDC
   Cooperative Agreement: T01/CCT622308-02. We also thank Dr Rosemary Sang,
   Kenya Medical Research Institute and the Institute of Primate Research -
   National Museums Kenya for their support and assistance.
CR ADAM F, 2006, I PASTEUR DAKAR
   ANDRAL L, 1968, B WORLD HEALTH ORGAN, V38, P855
   ARDOIN P, 1976, TROP GEOGR MED, V28, P309
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   BAUER JOHANNES S., 1928, AMER JOUR TROP MED, V8, P261
   BEATY BJ, 1980, AM J TROP MED HYG, V29, P125
   Chippaux A, 1970, Bull Soc Pathol Exot Filiales, V63, P173
   Chippaux-Hyppolite C, 1965, Bull Soc Pathol Exot Filiales, V58, P812
   CORDELLIER R, 1991, B WORLD HEALTH ORGAN, V69, P73
   CORNET JP, 1982, B SOC PATHOL EXOT, V75, P136
   COURTOIS G., 1960, ANN SOC BEIGE MED TROP, V40, P29
   Despommier D, 2006, ECOHEALTH, V3, P281, DOI 10.1007/s10393-006-0063-3
   Diallo M, 2005, AM J TROP MED HYG, V73, P445
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P47, DOI 10.1016/0035-9203(52)90003-5
   Ellis BR, 2007, VECTOR-BORNE ZOONOT, V7, P129, DOI 10.1089/vbz.2006.0561
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   FINDLAY G. M., 1941, ANN TROP MED AND PARASITOL, V35, P121
   Findlay G.M., 1937, T R SOC TROP MED HYG, V31, P103, DOI 10.1016/S0035-9203(37)90107-X
   FINDLAY GM, 1936, T ROY SOC TROP MED H, V29, P419, DOI 10.1016/S0035-9203(36)90058-5
   Fontenille D, 1997, T ROY SOC TROP MED H, V91, P533, DOI 10.1016/S0035-9203(97)90013-4
   GARNHAM PCC, 1946, B ENTOMOL RES, V36, P473
   GERMAIN M, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P125
   Germain M., 1981, Medecine Tropicale, V41, P31
   GERMAIN M, 1979, CR ACAD SCI D NAT, V289, P635
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   GILLETT JD, 1950, ANN TROP MED PARASIT, V44, P342
   GOULD LH, 2005, T R SOC TROP MED HYG
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   HADDOW A. J., 1964, TRANS ROY SOC TROP MED HYG, V58, P521, DOI 10.1016/0035-9203(64)90109-9
   HADDOW AJ, 1965, T ROY SOC TROP MED H, V59, P436, DOI 10.1016/0035-9203(65)90062-3
   HADDOW AJ, 1961, E AFR VIRUS RES I RE, V11, P16
   HADDOW AJ, 1951, T ROY SOC TROP MED H, V45, P189, DOI 10.1016/S0035-9203(51)90901-7
   HADDOW AJ, 1952, ANN TROP MED PARASIT, V46, P135
   HADDOW AJ, 1946, AM J TROP MED HYG, V26, P261
   HADDOW AJ, 1969, PROC R SOC EDIN B-BI, V70, P191
   HENDERSON BE, 1968, E AFR VIRUS RES I RE, V18, P48
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P787
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   HERVE J-P, 1977, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V15, P271
   HEWITT TF, 1958, REP VIRUS RES I E AF, V8, P11
   HUANG Y-M, 1990, Contributions of the American Entomological Institute, V26, P1
   HUANG YM, 1986, J MED ENTOMOL, V23, P196
   Hughes T. P., 1943, TRANS ROY SOC TROP MED AND HYG, V36, P339, DOI 10.1016/S0035-9203(43)90059-8
   Jupp PG, 2002, T ROY SOC TROP MED H, V96, P493, DOI 10.1016/S0035-9203(02)90417-7
   Ker A., 1995, FARMING SYSTEMS AFRI
   Kirk R., 1941, ANN TROP MED AND PARASITOL, V35, P67
   KIRK R, 1953, ANN TROP MED PARASIT, V47, P225
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   LAEMMERT HW, 1945, AM J TROP MED, V25, P231
   Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151
   LEBRUN AJ, 1963, AM J TROP MED HYG, V12, P398
   LEWIS D. J., 1942, ANN TROP MED AND PARASITOL, V36, P34
   LIEGEOIS P, 1948, Ann Soc Belg Med Trop (1920), V28, P247
   LUMSDEN WHR, 1954, REP E AFR VIRUS RES, V4, P5
   LUMSDEN WHR, 1955, REP E AFR VIRUS RES, V5, P8
   LUMSDEN WHR, 1951, T ROY SOC TROP MED H, V45, P53, DOI 10.1016/S0035-9203(51)90544-5
   MACCALLUM FO, 1937, T R SOC TROP MED HYG, V31, P199, DOI 10.1016/S0035-9203(37)90038-5
   MAHAFFY A. F., 1942, TRANS ROY SOC TROP MED AND HYG, V36, P9, DOI 10.1016/S0035-9203(42)90051-8
   MAHAFFY A. F., 1941, ANN TROP MED AND PARASITOL, V35, P141
   MAHAFFY AF, 1949, T ROY SOC TROP MED H, V42, P511, DOI 10.1016/0035-9203(49)90062-0
   MAHAFFY AF, 1946, T ROY SOC TROP MED H, V40, P57, DOI 10.1016/0035-9203(46)90062-4
   MATHIOT CC, 1988, B SOC PATHOL EXOT, V81, P396
   MATHIOT CC, 1990, T ROY SOC TROP MED H, V84, P732, DOI 10.1016/0035-9203(90)90168-E
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Metselaar D, 1970, East Afr Med J, V47, P130
   MONATH TP, 1991, AM J TROP MED HYG, V45, P1
   MONATH TP, 1993, AM J TROP MED HYG, V48, P274
   MONATH TP, 1994, SEMIN VIROL, V5, P133, DOI 10.1006/smvy.1994.1014
   Mutebi JP, 2002, MICROBES INFECT, V4, P1459, DOI 10.1016/S1286-4579(02)00028-X
   Mutebi JP, 2004, J VIROL, V78, P9652, DOI 10.1128/JVI.78.18.9652-9665.2004
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Nassar Elza Da S., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P337
   Onyango Clayton O, 2004, Emerg Infect Dis, V10, P1063
   OSTERRIETH PAUL M., 1961, ANN SOC BELGE MED TROP, V41, P63
   PANTHIER R, 1958, ANN SOC BELG MED TR, V42, P65
   PHILIP CORNELIUS B., 1930, AMER JOUR TROP MED, V10, P1
   PHILIP CORNELIUS B., 1929, AMER JOUR TROP MED, V9, P267
   PINTO MR, 1973, B WORLD HEALTH ORGAN, V49, P31
   *PROMEDMAIL, 2005, YELL FEV SUD KORD
   Reiter P, 1998, AM J TROP MED HYG, V59, P650
   Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rosen L., 1981, Medecine Tropicale, V41, P23
   ROSS R W, 1953, East Afr Med J, V30, P1
   ROSS RW, 1950, ANN TROP MED PARASIT, V44, P351
   Salaun J.J., 1981, Medecine Tropicale, V41, P45
   SALUZZO J-F, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P19
   Sanders EJ, 1998, AM J TROP MED HYG, V59, P644
   Sanders EJ, 1996, EMERG INFECT DIS, V2, P236
   Sang R C, 2001, East Afr Med J, V78, P655
   SATTI MH, 1966, J TROP MED HYG, V69, P36
   SAWYER W. A., 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P397, DOI 10.1016/S0035-9203(36)90055-X
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   SEMPALA SDK, 1973, AM J TROP MED HYG, V22, P263
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P879
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P873
   Service M. W., 1982, Bulletin of the Society of Vector Ecologists, V7, P1
   SIMPSON DIH, 1968, ANN TROP MED PARASIT, V62, P422
   SIMPSON DIH, 1968, ANN TROP MED PARASIT, V62, P432
   SIMPSON DIH, 1965, T ROY SOC TROP MED H, V59, P449, DOI 10.1016/0035-9203(65)90065-9
   SMITHBURN KC, 1949, AM J TROP MED, V29, P389
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74
   Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638
   SUREAU P, 1977, B SOC PATHOL EXOT, V70, P131
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219
   TAYLOR R M, 1955, Bull World Health Organ, V12, P711
   Taylor RM, 1951, YELLOW FEVER, P427
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   TRPIS M, 1975, B ENTOMOL RES, V65, P199
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   TUKEI PM, 1974, E AFR VIRUS RES I RE, P2
   TULLOCH JA, 1965, T ROY SOC TROP MED H, V59, P441, DOI 10.1016/0035-9203(65)90063-5
   VAINIO J, 1998, WHOEPIGEN9811, P1
   Wang H, 1997, J GEN VIROL, V78, P1349
   WATTS DM, 1994, J TROP MED HYG, V97, P228
   *WHO, 1972, WKLY EPIDEMIOL REC, V47, P229
   *WHO, 1960, WHO CHRON, V14, P155
   *WHO, 1958, WHO CHRON, V12, P91
   *WHO, 1972, WKLY EPIDEMIOL REC, V47, P88
   *WHO, 1979, WKLY EPIDEMIOL REC, V41, P314
   *WHO, 2005, WKLY EPIDEM REC, V80, P417
   WHO, 2000, WHO TECHN REP SER, P1
   *WHO, 1967, WHO CHRON, V21, P393
   World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P105
   WILLIAMS MC, 1965, T ROY SOC TROP MED H, V59, P444, DOI 10.1016/0035-9203(65)90064-7
   WOODALL JP, 1968, ANN TROP MED PARASIT, V62, P522
   Woods CW, 2002, EMERG INFECT DIS, V8, P138
   Zeller HG, 1998, B SOC PATHOL EXOT, V91, P56
   2008, WKLY EPIDEMIOL REC, V83, P17
NR 133
TC 27
Z9 28
U1 1
U2 27
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1052-9276
J9 REV MED VIROL
JI Rev. Med. Virol.
PD SEP-OCT
PY 2008
VL 18
IS 5
BP 331
EP 346
DI 10.1002/rmv.584
PG 16
WC Virology
SC Virology
GA 350CH
UT WOS:000259329600005
PM 18615782
ER

PT J
AU Lanciotti, RS
   Kosoy, OL
   Laven, JJ
   Velez, JO
   Lambert, AJ
   Johnson, AJ
   Stanfield, SM
   Duffy, MR
AF Lanciotti, Robert S.
   Kosoy, Olga L.
   Laven, Janeen J.
   Velez, Jason O.
   Lambert, Amy J.
   Johnson, Alison J.
   Stanfield, Stephanie M.
   Duffy, Mark R.
TI Genetic and serologic properties of zika virus associated with an
   epidemic, Yap State, Micronesia, 2007
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; INFECTIONS; NIGERIA; DENGUE; AEDES; RNA
AB Zika virus (ZIKV) is a mosquito-borne flavivirus first isolated in Uganda from a sentinel monkey in 1947. Mosquito and sentinel animal surveillance studies have demonstrated that ZIKV is endemic to Africa and Southeast Asia, yet reported human cases are rare with < 10 cases reported in the literature. In June 2007, an epidemic of fever and rash associated with ZIKV was detected in Yap State, Federated States of Micronesia. We report the genetic and serologic properties of the ZIKV associated with this epidemic.
C1 [Lanciotti, Robert S.] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Diagnost & Reference Lab, Ft Collins, CO 80521 USA.
RP Lanciotti, RS (reprint author), Ctr Dis Control & Prevent, Arbovirus Dis Branch, Diagnost & Reference Lab, 3150 Rampart Rd,CSU Foothills Campus, Ft Collins, CO 80521 USA.
EM rsl2@cdc.gov
CR ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Berthet FX, 1997, J GEN VIROL, V78, P2293
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154
   Johnson AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P566, DOI 10.1128/CDLI.12.5.566-574.2005
   JOHNSON C, 2000, SE ASIA RES, V8, P31
   Kuno G, 1998, J VIROL, V72, P73
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   *PROMED, 2007, ZIK VIR OUTBR MICR Y
   Shi PY, 2001, J CLIN MICROBIOL, V39, P1264, DOI 10.1128/JCM.39.4.1264-1271.2001
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Wang WK, 2000, J CLIN MICROBIOL, V38, P3306
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
NR 21
TC 185
Z9 197
U1 58
U2 163
PU CENTER DISEASE CONTROL
PI ATLANTA
PA ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2008
VL 14
IS 8
BP 1232
EP 1239
DI 10.3201/eid1408.080287
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 334JA
UT WOS:000258216900007
PM 18680646
ER

PT J
AU Kuno, G
   Chang, GJJ
AF Kuno, G.
   Chang, G.-J. J.
TI Full-length sequencing and genomic characterization of Bagaza, Kedougou,
   and Zika viruses
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID CYCLIZATION SEQUENCES; UNTRANSLATED REGION; FLAVIVIRUS; REPLICATION;
   RNA; GLYCOSYLATION; ENCEPHALITIS; PROTEINS
AB Many members of the genus Flavivirus are the agents of important diseases of humans, livestock, and wildlife. Currently, no complete genome sequence is available for the three African viruses, Bagaza, Zika, and Kedougou viruses, each representing a distinct virus subgroup according to the latest virus classification. In this study, we obtained a complete genome sequence of each of those three viruses and characterized the open reading frames (ORFs) with respect to gene sizes, cleavage sites, potential glycosylation sites, distribution of cysteine residues, and unique motifs. The sequences of the three viruses were then scanned across the entire length of the ORF against available sequences of other African flaviviruses and selected reference viruses for genetic relatedness. The data collectively indicated that Kedougou virus was close to dengue viruses but nonetheless distinct, while Bagaza virus shared genetic relatedness with West Nile virus in several genomic regions. In the non-coding regions, it was found that a particular organizational pattern of conserved sequences in the 3' terminal region generally correlated with the current virus grouping.
C1 Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Ft Collins, CO 80522 USA.
RP Kuno, G (reprint author), Ctr Dis Control & Prevent, Arbovirus Dis Branch, Div Vector Borne Infect Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, POB 2087, Ft Collins, CO 80522 USA.
EM gokl@cdc.gov; gxc7@cdc.gov
CR Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Barnard B.J., 1950, ONDERSTEPOORT J VET, V47, P89
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chang G.-J, 1997, P175
   Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000
   Fauquet C., 2005, VIRUS TAXONOMY CLASS
   Felsenstein J., 1995, PHYLIP VERSION 3 57C
   FU JL, 1992, VIROLOGY, V188, P953, DOI 10.1016/0042-6822(92)90560-C
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Hall T, 2001, BIOEDIT
   Karabatsos N, 1985, INT CATALOGUE ARBOVI
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73
   Li J, 2006, J GEN VIROL, V87, P613, DOI 10.1099/vir.0.81320-0
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R
   PIERRE V, 1994, RES VIROLOGY, V145, P179
   Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194
   RAY S, 1999, SIMPLOT
   Rice CM, 1990, SEMIN VIROL, V1, P357
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   VORNDAM V, 1993, J GEN VIROL, V74, P2653, DOI 10.1099/0022-1317-74-12-2653
   WINKLER G, 1987, VIROLOGY, V159, P237, DOI 10.1016/0042-6822(87)90460-0
   ZHAO B, 1986, VIROLOGY, V155, P77, DOI 10.1016/0042-6822(86)90169-8
   Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11
NR 27
TC 76
Z9 84
U1 19
U2 84
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
J9 ARCH VIROL
JI Arch. Virol.
PY 2007
VL 152
IS 4
BP 687
EP 696
DI 10.1007/s00705-006-0903-z
PG 10
WC Virology
SC Virology
GA 164BY
UT WOS:000246208800003
PM 17195954
ER

PT J
AU Huang, YM
AF Huang, YM
TI The subgenus Stegomyia of Aedes in the afrotropical region with keys to
   the species (Diptera : Culicidae)
SO ZOOTAXA
LA English
DT Review
DE mosquitoes; Stegomyia; characteristic; systematics; medical
   significance; identification; new species; Afrotropical Region
ID YELLOW-FEVER; LECTOTYPE DESIGNATION; CHIKUNGUNYA VIRUS; IVORY-COAST;
   ZIKA VIRUS; AFRICA; ALBOPICTUS; UGANDA; TRANSMISSION; ASSIGNMENT
AB The subgenus Stegomyia Theobald of the genus Aedes Meigen in the Afrotropical Region is characterized. Eleven species groups are recognized and diagnosed. The taxonomy, distribution, bionomics and medical importance of the species of the region are discussed and summarized. Keys and illustrations are provided for the identification of the 11 species groups and 59 species and subspecies known to occur in this region. Information on the present status of the species of the African Stegomyia is summarized. Six new species: Aedes ealaensis, ethiopiensis, gandaensis, hogsbackensis, mpusiensis and sampi are recognized. Aedes blacklocki Evans is restored to specific status. One subspecies, denderensis Wolfs is elevated to specific status.
C1 Smithsonian Inst, Dept Entomol, Washington, DC 20013 USA.
RP Huang, YM (reprint author), Smithsonian Inst, Dept Entomol, MRC-534,POB 37012, Washington, DC 20013 USA.
EM huang.yiau-min@nmnh.si.edu
CR BANG YH, 1983, J MED ENTOMOL, V20, P128
   BANG YH, 1979, WHO VECTOR BIOL CONT, V725, P1
   BAUDON D, 1984, LANCET          0707, P42
   BAUER JOHANNES S., 1928, AMER JOUR TROP MED, V8, P261
   Belkin J, 1962, MOSQUITOES S PACIFIC
   CHIPPAUX A, 1975, CR ACAD SCI D NAT, V281, P79
   CHWATT LJ, 1949, NATURE, V163, P808, DOI 10.1038/163808a0
   CORDELLIER R, 1977, CAHIERS OFFICE RECHE, V33, P1
   CORNEL AJ, 1991, J AM MOSQUITO CONTR, V7, P107
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   CORNET M, 1978, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V16, P227
   CORNET M, 1974, CAHIERS OFFICE RECHE, V11, P175
   de MEILLON BOTHA, 1947, JOUR ENT SOC SO AFRICA, V10, P110
   de MEILLON BOTHA, 1944, JOUR ENT SOC SO AFRICA, V7, P38
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Edwards F. W., 1917, Bulletin of Entomological Research London, V7
   Edwards F.W., 1932, GENERA INSECTORUM
   Edwards FW, 1941, MOSQUITOES ETHIOPIAN
   Edwards FW., 1912, B ENTOMOL RES, V3, P1
   Enderlein G., 1923, Wiener Entomologische Zeitung, V40, P25
   Evans A. M., 1925, Annals of Tropical Medicine and Parasitology, V19, P119
   Fontenille D, 2001, EMERG INFECT DIS, V7, P1066
   GERMAIN M, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P125
   GERMAIN M, 1982, B I PASTEUR, V80, P315
   GERMAIN M, 1978, PAPER I PASTEUR BANG, P81
   GERMAIN M, 1980, AM J TROP MED HYG, V29, P929
   GERMAIN M, 1972, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V10, P291
   GERMAIN M, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P101
   GERMAIN M, 1975, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V13, P41
   GILLETT JD, 1953, ANN TROP MED PARASIT, V47, P367
   HADDOW A. J., 1961, BULL ENTOMOL RES, V52, P317
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218
   HADDOW AJ, 1949, B ENTOMOL RES, V40, P169
   HADDOW AJ, 1961, E AFRICA VIRUS RES I, P16
   HADDOW AJ, 1947, B ENTOMOL RES, V37, P301
   HADDOW AJ, 1945, B ENTOMOL RES, V36, P33
   HADDOW AJ, 1947, T ROY SOC TROP MED H, V40, P677, DOI 10.1016/0035-9203(47)90026-6
   HADDOW AJ, 1968, ROYAL SOC EDINBURG B, V70, P191
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMON J, 1971, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V9, P3
   HARBACH R E, 1981, Mosquito Systematics, V13, P201
   Harbach R. E., 1980, TAXONOMISTS GLOSSARY
   Hopkins GHE, 1952, MOSQUITOES ETHIOPIAN, VI
   Huang D. P., 1977, Journal of Food Safety, V1, P1, DOI 10.1111/j.1745-4565.1977.tb00254.x
   Huang Y.-M., 1979, Contributions of the American Entomological Institute, V15, P1
   HUANG Y-M, 1972, Contributions of the American Entomological Institute, V9, P1
   HUANG Y-M, 1990, Contributions of the American Entomological Institute, V26, P1
   HUANG Y-M, 1974, Mosquito Systematics, V6, P27
   HUANG Y-M, 1979, Mosquito Systematics, V11, P221
   HUANG Y-M, 1988, Mosquito Systematics, V20, P1
   HUANG Y-M, 1981, Mosquito Systematics, V13, P92
   Huang Yiau-Min, 1997, Contributions of the American Entomological Institute, V29, P1
   HUANG YM, 1986, J MED ENTOMOL, V23, P196
   Huang YM, 2002, CTR INSECT SYSTEMATI, V19, P1
   HUANG YM, 1974, P ENTOMOL SOC WASH, V76, P208
   HUANG YM, 1972, P ENTOMOL SOC WASH, V74, P253
   Huang YM, 2001, P ENTOMOL SOC WASH, V103, P1
   Jupp PG, 1988, ARBOVIRUSES EPIDEMIO, VII, P137
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   KNIGHT KENNETH L., 1949, JOUR WASHINGTON ACAD SCI, V39, P20
   LEESON HS, 1948, B ENTOMOL RES, V39, P221
   LUDLOW CS, 1908, THESIS G WASHINGTON
   LUDLOW CS, 2005, CAN ENTOMOL, V37, P94
   LUMSDEN WHR, 1951, B ENTOMOL RES, V42, P317
   MacGregor M. E., 1924, Bulletin of Entomological Research London, V14, P409
   MAHAFFY A. F., 1942, TRANS ROY SOC TROP MED AND HYG, V36, P9, DOI 10.1016/S0035-9203(42)90051-8
   MARKS E. N., 1954, Bulletin of the British Museum (Natural History), B. Entomology, V3, P349
   MATTINGLY P. F., 1952, Bulletin of the British Museum (Natural History), B. Entomology, V2, P235
   Mattingly P. F., 1953, Revue de Zoologie et de Botanique Africaines, V47, P311
   MATTINGLY P. F., 1956, BULL BRIT MUS [NAT HIST] ENT, V4, P89
   MATTINGLY P. F., 1953, BULL BRIT MUS [NAT HIST] ENT, V3, P1
   Mattingly PF, 1962, B ZOOLOGICAL NOMENCL, V19, P208
   Mattingly P. F., 1965, CULICINE MOSQUITOE 6
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4
   MONDET B, 1993, ANN SOC ENTOMOL FR, V29, P261
   Muspratt J., 1954, Journal of the Entomological Society of Southern Africa, V16, P83
   MUSPRATT J., 1956, MEM ENT SOC SOUTHERN AFRICA, V4, P1
   Pajot F.-X., 1972, Cahiers Off Rech Sci Tech Outre - Mer, V10, P111
   Philip CB, 1930, SCIENCE, V71, P614, DOI 10.1126/science.71.1850.614
   PHILIP CORNELIUS B., 1929, AMER JOUR TROP MED, V9, P267
   RIBEIRO H, 1973, Anais do Instituto de Higiene e Medicina Tropical, V1, P107
   RICKENBACH A, 1971, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V9, P285
   SALUZZO JF, 1980, B SOC PATHOL EXOT, V73, P390
   SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P873
   SERVICE M W, 1976, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V14, P259
   SMITHBURN KC, 1948, BRIT J EXP PATHOL, V29, P107
   SMITHBURN KC, 1946, AM J TROP MED, V26, P261
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74
   Theobald FV, 1910, MONOGRAPH CULICIDAE, V5
   Theobald FV, 1906, REPORT WELLCOME TRUS, V2, P67
   Theobald FV., 1901, J TROPICAL MED, V4, P229
   THEOBALD FV, 1901, MONOGRAPH CULCIDAE M, V1
   THEOBALD FV, 1901, MOSQUITOES THEY LIVE, P235
   THEOBALD FV, 1901, MEMOIRES LIVERPOOL S, V4, P1
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   WEINBREN M P, 1957, S Afr Med J, V31, P951
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, 1978, WEEKLY EPIDEMIOLOGIC, V53, P345
   WOLFS J, 1949, REV ZOOLOGIE BOT AFR, V42, P190
   WORTH C. BROOKE, 1960, AN INST MED TROP, V17, P231
NR 102
TC 17
Z9 17
U1 3
U2 16
PU MAGNOLIA PRESS
PI AUCKLAND
PA PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND
SN 1175-5326
EI 1175-5334
J9 ZOOTAXA
JI Zootaxa
PD OCT 27
PY 2004
IS 700
BP 1
EP 120
PG 120
WC Zoology
SC Zoology
GA 877TK
UT WOS:000225593900001
ER

PT J
AU Kilbourn, AM
   Karesh, WB
   Wolfe, ND
   Bosi, EJ
   Cook, RA
   Andau, M
AF Kilbourn, AM
   Karesh, WB
   Wolfe, ND
   Bosi, EJ
   Cook, RA
   Andau, M
TI Health evaluation of free-ranging and semi-captive orangutans (Pongo
   pygmaeus pygmaeus) in Sabah, Malaysia
SO JOURNAL OF WILDLIFE DISEASES
LA English
DT Article
DE adenovirus; arbovirus; conservation; demographics; orangutan;
   Plasmodium; rotavirus; wildlife; zoonosis
ID VIRAL-INFECTIONS; PRIMATES; MALARIA
AB Baseline data on health of free-ranging wildlife is essential to evaluate impacts of habitat transformation and wildlife translocation, rehabilitation, and reintroduction programs. Health information on many species, especially great apes, is extremely limited. Between 1996 and 1998, 84 free-ranging orangutans captured for translocation, underwent a complete health evaluation. Analogous data were gathered from 60 semi-captive orangutans in Malaysia. Baseline hematology and serology; vitamin, mineral and pesticide levels; and results of health evaluations, including physical examination, provide a baseline for future monitoring. Free-ranging and semicaptive orangutans shared exposure to 11 of 47 viruses. The semi-captive orangutans had significantly higher prevalence of antibodies to adenovirus (P<0.0005) and rota (SA 11) virus (P<0.008). More free-ranging than semi-captive animals had antibodies to Japanese encephalitis virus (P<0.08) and foamy virus (P=0.05). Exposure to parainfluenza and langat viruses was detected exclusively in semi-captive animals and exposure to sinbis virus was only found in free-ranging orangutans. There was evidence of exposure to respiratory syncytial virus, coxsackie virus, dengue virus, and zika virus in both groups. Ebstein-Barr virus was ubiquitous in both groups. Prevalence of antibodies against mumps virus changed from 0% in 1996 to 45% in 1998. No antibodies were detected to many important zoonotic viral pathogens, including herpesvirus and hepatitis virus. Prevalence of Balantidium coli and Plasmodium pitheci infections and exposure to mycobacterium was higher in the semi-captive animals. Differences in exposure to pathogens between the groups may be due to environmental factors including differences in exposures to other species, habitat quality, nutritional status, and other potential stressors. Differences in health parameters between captive and free-ranging orangutans need to be considered when planning conservation areas, translocation procedures, and rehabilitation protocols. Because survival of the orangutan is linked to animal and ecosystem health, results of this study will assist wildlife conservation programs by providing baseline health information.
C1 Wildlife Conservat Soc, Field Vet Studies, Bronx, NY 10460 USA.
   Wildlife Dept Sabah, Sandakan 90009, Sabah, Malaysia.
   Johns Hopkins Sch Hyg & Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD 21217 USA.
RP Karesh, WB (reprint author), Wildlife Conservat Soc, Field Vet Studies, 2300 So Blvd, Bronx, NY 10460 USA.
CR Andau Patrick Mahedi, 1994, Oryx, V28, P263
   ANDAU PM, 1994, P INT C OR NEGL AP
   Colborn T, 1997, OUR STOLEN FUTURE
   Cox-Singh J, 1997, INT J PARASITOL, V27, P1575, DOI 10.1016/S0020-7519(97)00147-1
   DIERENFELD ES, 1993, J WILDLIFE DIS, V29, P98
   DOBSON AP, 1986, TRENDS ECOL EVOL, V1, P11, DOI 10.1016/0169-5347(86)90060-1
   DUNCAN JR, 1994, VET LAB MED, P132
   Goh KT, 1999, LANCET, V354, P1355, DOI 10.1016/S0140-6736(99)02853-6
   HAHN C, 2001, CDC MORBIDITY MORTAL, V50, P21
   HEBERLING RL, 1986, J CLIN MICROBIOL, V23, P109
   Hennekens CH, 1987, EPIDEMIOLOGY MED
   *INT SPEC INF SYST, 1997, PHYS DAT
   KALTER SS, 1971, BACTERIOL REV, V35, P310
   KALTER SS, 1967, AM J EPIDEMIOL, V86, P552
   Kalter SS, 1997, LAB ANIM SCI, V47, P461
   Kilbourn AM, 1997, P AM ASS ZOO VET, P301
   Kilbourn AM, 2001, J WILDLIFE DIS, V37, P65
   Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6
   MARCHETTE N, 1994, HDB ZOONOSES, P275
   PRICE HA, 1986, B ENVIRON CONTAM TOX, V37, P1
   REINHARD KR, 1963, DIS TRANSMITTED ANIM, P624
   Robertson JMY, 2001, ORYX, V35, P26, DOI 10.1046/j.1365-3008.2001.00149.x
   Singh B, 1996, T ROY SOC TROP MED H, V90, P519, DOI 10.1016/S0035-9203(96)90302-8
   SPIELMAN A, 1990, TROPICAL GEOGRAPHIC
   STOWE HD, 1985, AM J VET RES, V46, P561
   TESH RB, 1975, AM J TROP MED HYG, V24, P664
   TSAI T, 1994, HDB ZOONOSES B, P4
   Warren KS, 1999, J VIROL, V73, P7860
   Warren KS, 1998, J MED PRIMATOL, V27, P33
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wolfheim JH, 1983, PRIMATES WORLD DISTR
   Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7
   1999, EPIDEMIC ENCEPHALITI
   2000, MORBIDITY MORTALITY, V49, P816
   1998, DIS OUTBREAK REPORTS
   1998, DENGUE DENGUE HAEMOR
NR 36
TC 37
Z9 41
U1 5
U2 43
PU WILDLIFE DISEASE ASSN, INC
PI LAWRENCE
PA 810 EAST 10TH ST, LAWRENCE, KS 66044-8897 USA
SN 0090-3558
J9 J WILDLIFE DIS
JI J. Wildl. Dis.
PD JAN
PY 2003
VL 39
IS 1
BP 73
EP 83
PG 11
WC Veterinary Sciences
SC Veterinary Sciences
GA 661FL
UT WOS:000181880500008
PM 12685070
ER

PT J
AU Akoua-Koffi, C
   Diarrassouba, S
   Benie, VB
   Ngbichi, JM
   Bozoua, T
   Bosson, A
   Akran, V
   Carnevale, P
   Ehouman, A
AF Akoua-Koffi, C
   Diarrassouba, S
   Benie, VB
   Ngbichi, JM
   Bozoua, T
   Bosson, A
   Akran, V
   Carnevale, P
   Ehouman, A
TI Inquiry into a fatal case of yellow fever in Cote d'lvoire in 1999
SO BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE
LA French
DT Article
DE yellow fever; dengue; inquiry; Zika virus; Cote d'Ivoire; (Ivory Coast);
   Sub-Saharan Africa
ID DIVOIRE
AB Cote d'Ivoire is an endemic country for yellow fever but no case was officially notified in recent years. In July 1999, however one fatal case was reported, A German citizen was infected in the national park of Comoe, in the north eastern area of the country, In order to evaluate the extent of amaril virus circulation and the risk for local people, a virological entomological and epidemiological investigation logical investigation was carried out by the ministry of health, the OCCGE, the Cote d'Ivoire Pasteur Institute (IPCI) and the World Health Organisation in the area where the fatal case had been staying. 18 suspected and 24 confirmed mosquito catchers were identified by interview and a blood specimen was collected from each of them. In addition, 159 batches of mosquitoes from which 94 batches of potential vectors were collected; among the suspected cases, 22% were immunised against yellow fever Serological and virological analyses were made at IPCI and the Paris Pasteur Institute by ELISA technique and isolation on cells cultures and newborn mice. All the suspicious sera and 87,5% of the catchers were positive for IgG anti-amaril virus. One catchers serum was positive for IgM anti-amaril virus. 11 suspected sera were positive for IgG anti-dengue virus with 1 positive for IgM. 1 strain of amaril virus and 3 strains of Zika virus were isolated from mosquitoes at IPCI and confirmed by CRORA in Dakar These results indicated that there is a yellow fever and dengue virus are prevalent among the human and vector populations in the study area. Preventive measures must be adopted to protect human beings at risk for amaril infection.
C1 Inst Pasteur Cote Ivorie, Abidjan, Cote Ivoire.
   Inst Pierre Richet, OCCGE, Abidjan, Cote Ivoire.
   Inst Natl Hyg Publ, Abidjan, Cote Ivoire.
   Direct Sante Communautaire, Abidjan, Cote Ivoire.
RP Akoua-Koffi, C (reprint author), Inst Pasteur Cote Ivorie, Abidjan, Cote Ivoire.
CR BRES PLJ, 1986, B WORLD HEALTH ORGAN, V64, P775
   CHIPPAUX A, 1975, CR ACAD SCI D NAT, V281, P79
   CORDELLIER R, 1983, CAH ORSTOM SER ENT M
   Cordellier R, 1982, Med Trop (Mars), V42, P269
   Digoutte J.-P., 1995, EXOTIC VIRAL INFECT, P67
   Durand JP, 2000, EMERG INFECT DIS, V6, P83
   LHUILLIER M, 1983, ANN INST PASTEUR VIR, V134, P349, DOI 10.1016/S0769-2617(83)80008-2
   LHUILLIER M, 1985, B WORLD HEALTH ORGAN, V63, P527
   NOGUEIRA RMR, 1992, REV I MED TROP, V34, P447
   *OMS, 1986, PREV CONTR YELL FEV
   *OMS, 1971, REL EPID HEBD, V49, P493
   *OMS, 1996, REL EPID HEBD, V71, P313
   Teichmann D, 1999, LANCET, V354, P1608, DOI 10.1016/S0140-6736(99)09233-8
   TOMORI O, 1994, 4 SIVA YAM COT TVOIR, P107
   1986, REPARTITION CONNUE A
NR 15
TC 30
Z9 31
U1 2
U2 11
PU S P E
PI PARIS
PA 25 RUE DU DOCTEUR ROUX, 75015 PARIS, FRANCE
SN 0037-9085
J9 B SOC PATHOL EXOT
JI Bull. Soc. Pathol. Exot.
PD AUG
PY 2001
VL 94
IS 3
BP 227
EP 230
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Pathology; Tropical Medicine
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Pathology; Tropical Medicine
GA 479JP
UT WOS:000171401500001
PM 11681215
ER

PT J
AU Wolfe, ND
   Kilbourn, AM
   Karesh, WB
   Rahman, HA
   Bosi, EJ
   Cropp, BC
   Andau, M
   Spielman, A
   Gubler, DJ
AF Wolfe, ND
   Kilbourn, AM
   Karesh, WB
   Rahman, HA
   Bosi, EJ
   Cropp, BC
   Andau, M
   Spielman, A
   Gubler, DJ
TI Sylvatic transmission of arboviruses among Bornean orangutans
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DENGUE VIRUSES; POPULATIONS
AB Wild populations of nonhuman primates live in regions of sylvatic arbovirus transmission. To assess the status of arbovirus transmission in Bornean forests and the susceptibility of wild orangutans to arboviral infection, blood samples of wild orangutans. semi-captive orangutans, and humans were examined. Samples were tested by plaque reduction neutralization test for antibodies to viruses representing three families (Flaviviridae, Alphaviridae, and Bunyaviridae), including dengue-2, Japanese encephalitis, Zika, Langat, Tembusu, Sindbis, Chikungunya, and Batai viruses. Both wild and semi-captive orangutan groups as well as local human populations showed serologic evidence of arbovirus infection. The presence of neutralizing antibodies among wild orangutans strongly suggests the existence of sylvatic cycles for dengue, Japanese encephalitis, and sindbis viruses in North Borneo. The present study demonstrates that orangutans are susceptible to arboviral infections in the wild, although the impact of arboviral infections on this endangered ape remain unknown.
C1 Wildlife Conservat Soc, Field Vet Program, Bronx, NY 10460 USA.
   Dept Hlth, Kota Kinabalu 88814, Sabah, Malaysia.
   Sabah Wildlife Dept, Kota Kinabalu 88100, Sabah, Malaysia.
   Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Vector Borne Dis, Ft Collins, CO 80522 USA.
   Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
RP Wolfe, ND (reprint author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, 624 N Broadway,Hampton House 210, Baltimore, MD 21205 USA.
CR Andau Patrick Mahedi, 1994, Oryx, V28, P263
   BOWEN ETW, 1975, T ROY SOC TROP MED H, V69, P182, DOI 10.1016/0035-9203(75)90151-0
   Brack M., 1987, AGENTS TRANSMISSIBLE
   BURKE DS, 1988, ARBOVIRUSES EPIDEMIO, V2, P63
   DAVIES CR, 1991, FUNCT ECOL, V5, P655, DOI 10.2307/2389485
   De Silva AM, 1999, AM J TROP MED HYG, V60, P300
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   Fleagle JG, 1996, J HUM EVOL, V30, P489, DOI 10.1006/jhev.1996.0039
   FREELAND W J, 1976, Biotropica, V8, P12, DOI 10.2307/2387816
   FREELAND WJ, 1979, ECOLOGY, V60, P719, DOI 10.2307/1936609
   GULBER DJ, 1997, DENGUE DENGUE HEMORR, P1
   Hanna JN, 1996, MED J AUSTRALIA, V165, P256
   Jupp PG, 1988, ARBOVIRUSES EPIDEMIO, VII, P137
   KANAMITSU M, 1979, AM J TROP MED HYG, V28, P351
   KARABASTOS N, 1985, INT CATALOGUE ARBOVI
   Karesh William B., 1995, Oryx, V29, P244
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   Mackenzie JS, 1999, EMERG INFECT DIS, V5, P1
   MacKinnon J., 1993, FIELD GUIDE BIRDS BO
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4
   McIntosh B M, 1970, S Afr J Med Sci, V35, P65
   Monath TP, 1989, ARBOVIRUSES EPIDEMIO, V5, P139
   PAVRI K, 1989, REV INFECT DIS, V11, pS854
   Payne J, 1985, FIELD GUIDE MAMMALS
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108
   RUDNICK ALBERT, 1965, J MED ENTOMOL, V2, P203
   Scott T. W., 1988, ARBOVIRUSES EPIDEMIO, V1, P257
   SIMPSON DIH, 1970, ANN TROP MED PARASIT, V64, P137
   SIMPSON DIH, 1970, T ROY SOC TROP MED H, V64, P503, DOI 10.1016/0035-9203(70)90070-2
   TESH RB, 1975, AM J TROP MED HYG, V24, P664
   Whitmore TC, 1990, TROPICAL RAIN FOREST
   Wolfe ND, 1998, EMERG INFECT DIS, V4, P149
   YUWONO J, 1984, Southeast Asian Journal of Tropical Medicine and Public Health, V15, P194
NR 37
TC 65
Z9 67
U1 8
U2 34
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAY-JUN
PY 2001
VL 64
IS 5-6
BP 310
EP 316
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 453NH
UT WOS:000169921600017
PM 11463123
ER

PT J
AU Baba, SS
   Fagbami, AH
   Ojeh, CK
AF Baba, SS
   Fagbami, AH
   Ojeh, CK
TI Preliminary studies on the use of solid-phase immunosorbent techniques
   for the rapid detection of Wesselsbron virus (WSLV) IgM by
   haemagglutination-inhibition
SO COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES
LA English
DT Article
DE Wesselsbron virus IgM; HI-antibodies; solid-phase; immunosorbent
   technique; human sera; Nigeria
ID CROSS-NEUTRALIZATION; YELLOW-FEVER; NIGERIA; FLAVIVIRUSES
AB Serum samples from 446 randomly selected persons belonging to different age groups and locations in Nigeria were tested for the presence of WSLV IgM using the flavivirus haemagglutination-inhibition (HI) test adopted to the solid-phase immunosorbent technique (SPIT). 61 (14%) persons had IgM to WSLV only, while 9 (2%) persons had heterologous IgM to WSLV and two other flaviviruses, namely yellow fever and Uganda S viruses. There was a high prevalence of IgM in people of younger age groups than those in older groups. The majority of the IgM positive sera (67 (96%) of the 70 positive sera reacted to high titres (greater than or equal to 1:80). With the conventional HI tests, 314 (70%) of the total sera tested had HI antibodies to one or more flaviviruses (yellow fever, West Nile, Potiskum, Zika and Uganda S) out of which 305/314 (97%) had antibodies to 3 or more flaviviruses used in the tests. Although SPIT may not be as sensitive as the conventional HI test, it was found to be more specific and could be adopted for the detection of early WSLV infections in flavivirus hyperendemic environments. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Univ Maiduguri, Fac Med Vet, Dept Vet Microbiol & Parasitol, Maiduguri, Nigeria.
   Univ Ibadan, Fac Med Vet, Dept Vet Microbiol & Parasitol, Ibadan, Nigeria.
RP Baba, SS (reprint author), Univ Maiduguri, Fac Med Vet, Dept Vet Microbiol & Parasitol, PMB 1069, Maiduguri, Nigeria.
CR BABA SS, 1991, THESIS U IBADAN IBAD, P1
   BABA SS, 1993, VET MICROBIOL, V34, P311, DOI 10.1016/0378-1135(93)90056-D
   BABA SS, 1990, PREV VET MED, V10, P97, DOI 10.1016/0167-5877(90)90055-M
   BABA SS, 1995, MICROBIOLOGICA, V18, P151
   BABA SS, 1989, ACTA VIROL, V33, P8186
   BABA SS, 1993, 9 INT C VIR GLASG SC, P149
   BUXTON A, 1977, ANIMAL MICROBIOLOGY, V2, P648
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   *CDCP DEP PHHS, 1986, ARTHR BORN VIR INF E, P3
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110
   HEYMANN C S, 1958, S Afr Med J, V32, P543
   *I PAST, 1989, RAPP ANN, P90
   JUSTINES GH, 1969, HLTH LAB SCI AM PUB, V1, P46
   KEMP GE, 1973, AM J VET RES, V34, P707
   KOKERNOT R. H., 1960, S AFRICAN MED JOUR, V34, P871
   KRECH U, 1979, J GEN VIROL, V44, P281, DOI 10.1099/0022-1317-44-2-281
   LHUILLIER M, 1983, ANN INST PASTEUR VIR, V134, P349, DOI 10.1016/S0769-2617(83)80008-2
   MONATH TP, 1984, AM J TROP MED HYG, V33, P151
   MORVAN J, 1990, Archives de l'Institut Pasteur de Madagascar, V57, P183
   Olaleye O D, 1989, Rev Elev Med Vet Pays Trop, V42, P321
   OMILABU SA, 1990, COMP IMMUNOL MICROB, V13, P95, DOI 10.1016/0147-9571(90)90521-T
   PRICE PC, 1977, THESIS U BERN SWITZE
   *ROCK FDN VIR LAB, 1960, 1960 ANN REP
   SMITHBURN K. C, 1957, S AFRICAN JOUR MED SCI, V22, P113
   SOLIMAN AK, 1988, J CLIN MICROBIOL, V26, P1913
   SWANEPOEL R, 1989, ARBOVIRUSES EPIDEMIO, V1
   SWANEPOEL R, 1994, INFECT DIS LIVESTOCK, V1, P663
   THEILER M, 1973, ARTHROPOD BORNE VIRU, P174
   TIKASINGH E. S., 1966, AMER J TROP MED HYG, V15, P219
   TOMORI O, 1981, AM J TROP MED HYG, V30, P855
   TRENT DW, 1977, J VIROL, V22, P608
   WEISS K. E., 1956, ONDERSTEPOORT JOUR VET RES, V27, P183
   WHO, 1986, PREV CONTR YELL FEV
NR 35
TC 5
Z9 5
U1 7
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0147-9571
J9 COMP IMMUNOL MICROB
JI Comp. Immunol. Microbiol. Infect. Dis.
PD JAN
PY 1999
VL 22
IS 1
BP 71
EP 79
DI 10.1016/S0147-9571(98)00003-4
PG 9
WC Immunology; Microbiology; Veterinary Sciences
SC Immunology; Microbiology; Veterinary Sciences
GA 131PJ
UT WOS:000076584200007
PM 10099030
ER

PT J
AU Rodier, GR
   Gubler, DJ
   Cope, SE
   Cropp, CB
   Soliman, AK
   Polycarpe, D
   Abdourhaman, MA
   Parra, JP
   Maslin, J
   Arthur, RR
AF Rodier, GR
   Gubler, DJ
   Cope, SE
   Cropp, CB
   Soliman, AK
   Polycarpe, D
   Abdourhaman, MA
   Parra, JP
   Maslin, J
   Arthur, RR
TI Epidemic dengue 2 in the city of Djibouti 1991-1992
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE dengue 2; Djibouti
ID ORIGINAL ANTIGENIC SIN; SEROLOGICAL EVIDENCE; INFECTIONS; FEVER;
   ANTIBODIES; VIRUSES
AB From October 1991 to February 1992, an outbreak of acute fever (in which thick blood films were negative for malaria) spread rapidly in the city of Djibouti, Djibouti Republic, affecting all age groups and both nationals and foreigners. The estimated number of cases was 12000. The clinical features were consistent with a non-haemorrhagic dengue-like illness. Serum samples from 91 patients were analysed serologically for flavivirus infection (dengue 1-4, West Nile, yellow fever, Zika, Banzi, and Uganda-S), and virus isolation was attempted. Twelve strains of dengue 2 virus were isolated. Dengue infection was confirmed by a 4-fold or greater rise in immunoglobulin (Ig) G antibody in paired serum specimens, the presence of IgM antibody, or isolation of the virus. Overall, 46 of the suspected cases (51%) were confirmed virologically or had serological evidence of a recent flavivirus infection. Statistical analysis showed that the presence of a rash was the best predictor of flavivirus seropositivity. In November 1992, Aedes aegypti was widespread and abundant in several districts of Djibouti city. A serological study of serum samples collected from Djiboutian military personnel 5 months before the epidemic showed that only 15/177 (8.5%) had flavivirus antibodies. These findings, together with a negative serosurvey for dengue serotypes 1-4 and yellow fever virus performed in 1987, support the conclusion that dengue 2 virus has only recently been introduced to Djibouti.
C1 USN,MED RES UNIT 3,CAIRO,EGYPT.
   UNIV MARYLAND,SCH MED,BALTIMORE,MD 21201.
   CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV VECTOR BORNE INFECT DIS,FT COLLINS,CO 80522.
   JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,BALTIMORE,MD.
CR BANCROFT WH, 1981, INFECT IMMUN, V31, P698
   BOTROS BAM, 1989, J MED VIROL, V29, P79, DOI 10.1002/jmv.1890290202
   BURKE DS, 1982, J CLIN MICROBIOL, V15, P1034
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   GALLO D, 1981, J CLIN MICROBIOL, V13, P631
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158
   GUBLER DJ, 1986, AM J TROP MED HYG, V35, P12780
   Gubler DJ, 1988, ARBOVIRUSES EPIDEMIO, VII, P223
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154
   HAYES CG, 1988, ARBOVIRUSES EPIDEMIO, V5, P59
   HYAMS KC, 1986, AM J TROP MED HYG, V35, P8600
   INNIS BL, 1989, AM J TROP MED HYG, V40, P416
   INOUYE S, 1984, MICROBIOL IMMUNOL, V28, P569
   JOHNSON BK, 1982, KLANCET, V1, P208
   KUNO G, 1993, T ROY SOC TROP MED H, V87, P103, DOI 10.1016/0035-9203(93)90444-U
   LAURENT A, 1990, CATALOGUE CMMENTE OI
   MORRILL JC, 1991, J TROP MED HYG, V94, P166
   MOUCHET KJ, 1971, B WORLD HEALTH ORGAN, V45, P383
   RODHAIN F, 1975, TROP GEOGR MED, V27, P307
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
   SALAH S, 1988, ANN INST PASTEUR VIR, V139, P439, DOI 10.1016/S0769-2617(88)80079-0
   SALEH AS, 1985, LANCET, V1, P211
   SCHERER WF, 1972, AM J TROP MED HYG, V27, P590
   SCOTT R, 1972, INFECT IMMUN, V6, P227
   Welch G., 1988, SANDGROUSE, V10, P26
   WESTAWAY EG, 1968, NATURE, V219, P78, DOI 10.1038/219078a0
NR 26
TC 22
Z9 22
U1 6
U2 12
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON, ENGLAND W1N 4EY
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY-JUN
PY 1996
VL 90
IS 3
BP 237
EP 240
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA UT794
UT WOS:A1996UT79400009
PM 8758061
ER

PT J
AU PIERRE, V
   DROUET, MT
   DEUBEL, V
AF PIERRE, V
   DROUET, MT
   DEUBEL, V
TI IDENTIFICATION OF MOSQUITO-BORNE FLAVIVIRUS SEQUENCES USING UNIVERSAL
   PRIMERS AND REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION
SO RESEARCH IN VIROLOGY
LA English
DT Article
DE FLAVIVIRUS; SEQUENCING; PCR; RT, VIRUS IDENTIFICATION; EPIDEMIOLOGY
ID COMPLETE NUCLEOTIDE-SEQUENCE; JAPANESE ENCEPHALITIS-VIRUS;
   AMINO-ACID-SEQUENCE; DENGUE VIRUSES; NONSTRUCTURAL PROTEINS; GENOME RNA;
   RAPID DETECTION; TYPE-2; AMPLIFICATION; EXPRESSION
AB A reverse transcription/polymerase chain reaction (RT/PCR) protocol for the rapid detection and identification of flaviviruses was developed using a set of universal oligonucleotide primers. These primers correspond to sequences in the 3' non-coding region and in the NS5 gene which are highly conserved among the mosquito-borne flaviviruses. The sequences of the resulting amplified products were analysed for dengue 1, dengue 2, dengue 3, dengue 4, Japanese encephalitis, West Nile, yellow fever and Zika viruses, and compared with the published sequences of other flaviviruses. The 291-297 nucleotides corresponding to the C-terminus of NS5 gene showed 56 to 76 % similarity, whereas the 3' non-coding region (190 to 421 nucleotides) showed only 20 to 36 % similarity. Genetic classification of the Zika virus supported its traditional serelogical grouping. Recombinant plasmids containing the flavivirus sequences were used in a nucleic acid hybridization test to identify the RT/PCR products derived from viral RNA extracted from experimentally infected mosquitoes. The plasmids were dotted on a strip of nitrocellulose membrane and incubated with the RT/PCR product labelled with digoxigenin during the PCR step. This is a valuable method for the rapid and specific identification of mosquito-borne flaviviruses in biological specimens and for subsequent sequence analysis.
C1 INST PASTEUR,UNITE ARBOVIRUS & VIRUS FIEVRES HEMORRAG,F-75724 PARIS 15,FRANCE.
CR AIHARA S, 1991, VIRUS GENES, V5, P95, DOI 10.1007/BF00571925
   BLOK J, 1992, VIROLOGY, V187, P573, DOI 10.1016/0042-6822(92)90460-7
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CASTLE E, 1986, VIROLOGY, V149, P10, DOI 10.1016/0042-6822(86)90082-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   DEUBEL V, 1993, ARCH VIROL, V129, P197, DOI 10.1007/BF01316895
   DEUBEL V, 1988, VIROLOGY, V165, P234, DOI 10.1016/0042-6822(88)90677-0
   DEUBEL V, 1990, J VIROL METHODS, V30, P41, DOI 10.1016/0166-0934(90)90042-E
   ELDADAH ZA, 1991, J MED VIROL, V33, P260, DOI 10.1002/jmv.1890330410
   FU JL, 1992, VIROLOGY, V188, P953, DOI 10.1016/0042-6822(92)90560-C
   GUBLER DJ, 1985, AM J TROP MED HYG, V34, P170
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   HAHN YS, 1988, VIROLOGY, V162, P167, DOI 10.1016/0042-6822(88)90406-0
   Hashimoto H, 1988, Virus Genes, V1, P305, DOI 10.1007/BF00572709
   HENCHAL EA, 1991, AM J TROP MED HYG, V45, P418
   HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7
   HOWE DK, 1992, J VIROL METHODS, V36, P101, DOI 10.1016/0166-0934(92)90161-6
   IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7
   KUNO G, 1985, AM J TROP MED HYG, V26, P533
   LAILLE M, 1991, J MED VIROL, V34, P51, DOI 10.1002/jmv.1890340109
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   LEE E, 1992, J VIROL METHODS, V37, P275, DOI 10.1016/0166-0934(92)90029-D
   LEWIS JG, 1992, J VIROL METHODS, V38, P11, DOI 10.1016/0166-0934(92)90165-A
   MACKOW E, 1987, VIROLOGY, V159, P217, DOI 10.1016/0042-6822(87)90458-2
   MANDL CW, 1989, VIROLOGY, V173, P291, DOI 10.1016/0042-6822(89)90246-8
   Maniatis T., 1982, MOL CLONING
   Monath T., 1990, VIROLOGY, P763
   MORITA K, 1991, J CLIN MICROBIOL, V29, P2107
   NITAYAPHAN S, 1990, VIROLOGY, V177, P541, DOI 10.1016/0042-6822(90)90519-W
   Osatomi K, 1988, Virus Genes, V2, P99, DOI 10.1007/BF00569739
   OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R
   PLETNEV AG, 1990, VIROLOGY, V174, P250, DOI 10.1016/0042-6822(90)90073-Z
   PORTER KR, 1993, AM J TROP MED HYG, V48, P440
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   ROSEN L, 1974, AM J TROP MED HYG, V23, P1153
   Sneath PHA, 1973, NUMERICAL TAXONOMY P
   SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   TARDIEUX I, 1990, RES VIROLOGY, V141, P455, DOI 10.1016/0923-2516(90)90046-L
   TOLOU H, 1992, B I PASTEUR, V90, P11
   TRENT DW, 1992, FRONTIER VIROLOGY, V1, P356
   WENGLER G, 1986, J GEN VIROL, V67, P1183, DOI 10.1099/0022-1317-67-6-1183
   WILBUR NJ, 1983, P NATL ACAD SCI USA, V80, P5463
NR 46
TC 73
Z9 75
U1 22
U2 51
PU EDITIONS SCIENTIFIQUES ELSEVIER
PI PARIS CEDEX 15
PA 141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE
SN 0923-2516
J9 RES VIROLOGY
JI Res. Virol.
PD MAR-APR
PY 1994
VL 145
IS 2
BP 93
EP 104
DI 10.1016/S0923-2516(07)80011-2
PG 12
WC Virology
SC Virology
GA NJ134
UT WOS:A1994NJ13400004
PM 7520190
ER

PT J
AU MONLUN, E
   ZELLER, H
   LEGUENNO, B
   TRAORELAMIZANA, M
   HERVY, JP
   ADAM, F
   FERRARA, L
   FONTENILLE, D
   SYLLA, R
   MONDO, M
   DIGOUTTE, JP
AF MONLUN, E
   ZELLER, H
   LEGUENNO, B
   TRAORELAMIZANA, M
   HERVY, JP
   ADAM, F
   FERRARA, L
   FONTENILLE, D
   SYLLA, R
   MONDO, M
   DIGOUTTE, JP
TI ARBOVIRUS AFFECTING HUMANS IN SOUTHEASTERN SENEGAL - SURVEILLANCE IN
   HUMANS AND MOSQUITOS (1988-1991)
SO BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE
LA English
DT Article
DE ARBOVIRUS; IGM; ELISA; MOSQUITO; EPIDEMIOLOGY; SENEGAL
AB A study about the circulation of arboviruses of medical interest in southeastern Senegal was conducted from 1988 to 1991, during and around the periods of transmission. Specific IgM antibodies were detected by ELISA test in human sera, as a sign of a recent infection within 2 to 5 months. The comparison of the serological IgM results from human surveys in different villages, and the isolations of arboviruses from mosquitoes during the same period of time permitted a rapid and global evaluation of the circulation of these viruses.
   A low level of yellow fever virus activity was detected both in humans and mosquitoes in 1988 to 1990. A dengue 2 epizootic occurred in 1989-1990. Dengue 2 virus was isolated from humans and mosquitoes in 1990. Some dengue 2 outbreak may occur in the upcoming years. A Zika virus epizootic outbreak was observed each year. A human strain was isolated in 1990. The other flaviviruses (West-Nile, Kedougou, Wesselsbron), Chikungunya virus, Rift Valley Fever virus and Crimean-Congo Hemorrhagic Fever virus did not seem to present a major public health concern in southeastern Senegal.
RP MONLUN, E (reprint author), INST PASTEUR,BP 220,DAKAR,SENEGAMBIA.
RI FONTENILLE, didier/G-4091-2013
NR 0
TC 46
Z9 47
U1 6
U2 17
PU MASSON EDITEUR
PI PARIS 06
PA 120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE
SN 0037-9085
J9 B SOC PATHOL EXOT
JI Bull. Soc. Pathol. Exot.
PY 1993
VL 86
IS 1
BP 21
EP 28
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Pathology; Tropical Medicine
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Pathology; Tropical Medicine
GA LC801
UT WOS:A1993LC80100006
PM 8099299
ER

PT J
AU MILLER, BR
   MITCHELL, CJ
AF MILLER, BR
   MITCHELL, CJ
TI GENETIC SELECTION OF A FLAVIVIRUS-REFRACTORY STRAIN OF THE YELLOW-FEVER
   MOSQUITO AEDES-AEGYPTI
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DENGUE VIRUSES; ORAL INFECTION; EPIDEMIC; NIGERIA
AB Two inbred (isofemale) Aedes aegypti mosquito lines were derived that manifested a resistant or susceptible phenotype following ingestion of yellow fever virus; lack of virus movement from the midgut defined the resistant phenotype. Other flaviviruses, including dengue 1-4, Uganda S, and Zika, viruses behaved in a similar fashion in the two mosquito lines. Crosses between the two lines produced progeny that were of intermediate susceptibility, indicating codominance; F2 backcrosses to the parents yielded results consistent with a major controlling genetic locus and provide evidence of a second locus capable of modulating the phenotype of the major gene. The rapid selection necessary to fix the susceptible and refractory phenotypes support the hypothesis of a single major controlling locus. Viral movement across the midgut is likely to be governed by a single major gene and modifying minor genes or a group of closely linked genes. These inbred mosquito lines will be useful in discovering the molecular basis for flavivirus resistance in Ae. aegypti.
RP MILLER, BR (reprint author), CTR DIS CONTROL,DIV VECTOR BORNE INFECT DIS,MED ENTOMOL ECOL BRANCH,POB 2087,FT COLLINS,CO 80522, USA.
CR BALLINGERCRABTREE ME, 1990, J GEN VIROL, V71, P2115, DOI 10.1099/0022-1317-71-9-2115
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   COCKBURN AF, 1990, HDB NATURAL PESTICID, V4, P227
   COLLINS FH, 1986, SCIENCE, V234, P610
   DECOCK KM, 1988, LANCET, V1, P630
   GROOT H, 1980, AM J TROP MED HYG, V29, P330
   GUBLER DJ, 1982, RECENT DEV GENETICS, P326
   HANDLER AM, 1991, ANNU REV ENTOMOL, V36, P159
   Hardy JL, 1988, ARBOVIRUSES EPIDEMIO, V1, P87
   HOUK EJ, 1990, VIRUS RES, V17, P105, DOI 10.1016/0168-1702(90)90072-J
   KUBERSKI TT, 1977, AM J TROP MED HYG, V26, P533
   MILLER BR, 1987, T ROY SOC TROP MED H, V81, P1011, DOI 10.1016/0035-9203(87)90381-6
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   MILLER BR, 1986, AM J TROP MED HYG, V35, P1302
   MILLER BR, 1988, ACTA VIROL, V32, P227
   MONATH TP, 1987, REV INFECT DIS, V9, P165
   NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X
   OBROCHTA DA, 1990, B ENTOMOL RES, V80, P241
   ROMANS P, 1991, J MED ENTOMOL, V28, P147
   ROSEN L, 1974, AM J TROP MED HYG, V23, P1153
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Tabachnick W.J., 1982, P413
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219
   TABACHNICK WJ, IN PRESS AM J TROP M
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053
   WALLIS GP, 1985, AM J TROP MED HYG, V34, P1225
   YOUNG ND, 1988, GENETICS, V120, P579
NR 28
TC 76
Z9 80
U1 23
U2 45
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DRIVE SUITE 130, MCLEAN, VA 22101
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 1991
VL 45
IS 4
BP 399
EP 407
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GN354
UT WOS:A1991GN35400001
PM 1659238
ER

PT J
AU BUCKLEY, A
   GOULD, EA
AF BUCKLEY, A
   GOULD, EA
TI DETECTION OF VIRUS-SPECIFIC ANTIGEN IN THE NUCLEI OR NUCLEOLI OF CELLS
   INFECTED WITH ZIKA OR LANGAT VIRUS
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
C1 UNIV LONDON LONDON SCH HYG & TROP MED,WINCHES FARM FIELD STN,ARBOVIRUS RES UNIT,395 HATFIELD RD,ST ALBINS AL4 0XQ,HERTS,ENGLAND.
CR BELL D, 1974, NATURE, V248, P505, DOI 10.1038/248505a0
   Brinton M, 1986, TOGAVIRIDAE FLAVIVIR, P327
   CARDIFF RD, 1973, INFECTION IMMUNITY, V8, P1017
   CARDIFF RD, 1976, INFECT IMMUN, V13, P1699
   GOULD EA, 1983, INFECT IMMUN, V41, P774
   GOULD EA, 1985, J GEN VIROL, V66, P1369, DOI 10.1099/0022-1317-66-7-1369
   GOULD EA, 1985, J VIROL METHODS, V11, P41, DOI 10.1016/0166-0934(85)90123-5
   MURPHY FA, 1980, ST LOUIS ENCEPHALITI, P65
   PFEFFERKORN ER, 1974, COMPREHENSIVE VIROLO, V3, P171
   TIKHOMIROVA TI, 1968, ACTA VIROL, V12, P529
   VARMA MGR, 1973, T ROYAL SOC TROPICAL, V68, P374
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   Westaway E, 1980, TOGAVIRUSES, P531
   YASUZUMI G, 1965, J ULTRA MOL STRUCT R, V12, P317, DOI 10.1016/S0022-5320(65)80102-2
NR 14
TC 30
Z9 30
U1 4
U2 23
PU SOC GENERAL MICROBIOLOGY
PI READING
PA HARVEST HOUSE 62 LONDON ROAD, READING, BERKS, ENGLAND RG1 5AS
SN 0022-1317
J9 J GEN VIROL
JI J. Gen. Virol.
PD AUG
PY 1988
VL 69
BP 1913
EP 1920
DI 10.1099/0022-1317-69-8-1913
PN 8
PG 8
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA P5466
UT WOS:A1988P546600015
PM 2841406
ER

PT J
AU MCCRAE, AWR
   KIRYA, BG
AF MCCRAE, AWR
   KIRYA, BG
TI YELLOW-FEVER AND ZIKA VIRUS EPIZOOTICS AND ENZOOTICS IN UGANDA
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
C1 E AFRICAN VIRUS RES INST,ENTEBBE,UGANDA.
   UGANDA VIRUS RES INST,ENTEBBE,UGANDA.
CR AITKEN THG, 1979, AM J TROP MED HYG, V28, P119
   BANG YH, 1979, WHOVBC79725 ARB RES
   BEATY BJ, 1980, AM J TROP MED HYG, V29, P125
   BRES P, 1964, ANN I PASTEUR PARIS, V107, P34
   BUXTON AP, 1952, J ANIM ECOL, V21, P25, DOI 10.2307/1908
   CASEY HL, 1965, PUBLIC HLTH MONOGR, V74, P31
   CAUSEY OR, 1969, 1969 IB ARB LAB ANN
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   CORBET PS, 1964, J ANIM ECOL, V33, P141, DOI 10.2307/2354
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   CORNET M, 1979, MED MALADIES INFECT, V9, P63, DOI 10.1016/S0399-077X(79)80024-4
   COZ J, 1976, CR ACAD SCI D NAT, V283, P109
   DICK GWA, 1952, T ROYAL SOC TROPICAL, V46, P135
   DUTARY BE, 1981, T ROY SOC TROP MED H, V75, P128, DOI 10.1016/0035-9203(81)90036-5
   Germain M., 1981, Medecine Tropicale, V41, P31
   GERMAIN M, 1979, CR ACAD SCI D NAT, V289, P635
   GILLETT J. D., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P269, DOI 10.1016/0035-9203(58)90086-5
   GILLETT JD, 1950, ANN TROP MED PARASIT, V44, P342
   Haddow A. J., 1965, Transactions of the Royal Entomological Society of London, V117, P215
   HADDOW AJ, 1965, T ROY SOC TROP MED H, V59, P436, DOI 10.1016/0035-9203(65)90062-3
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218
   HADDOW AJ, 1951, T ROY SOC TROP MED H, V45, P189, DOI 10.1016/S0035-9203(51)90901-7
   HADDOW AJ, 1947, T ROY SOC TROP MED H, V40, P677, DOI 10.1016/0035-9203(47)90026-6
   HADDOW AJ, 1963, 13 E AFR VIR RES I R, P24
   Haddow AJ., 1968, P R SOC EDIN B, V70, P191
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HADDOW AJ, 1961, 196061 EAST AFR VIR, P16
   HENDERSON BE, 1969, 1968 EAST AFR VIR RE, P48
   HENDERSON BE, 1975, E AFRICAN J MED RES, V2, P206
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110
   HUANG Y-M, 1979, Mosquito Systematics, V11, P221
   JUPP PG, 1981, T ROY SOC TROP MED H, V75, P15, DOI 10.1016/0035-9203(81)90005-5
   KIRYA BG, 1971, 20 E AFR VIR RES I R, P19
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   KIRYA BG, 1972, WHOVIR727
   KIRYA PG, 1970, 19 E AFR VIR RES I R, P25
   LULE M, 1975, 1973 E AFR VIR RES I, P6
   LUMSDEN WHR, 1955, 5 E AFR VIR RES I RE, P16
   LUMSDEN WHR, 1956, 6 E AFR VIR RES I RE, P9
   MCCRAE AWR, 1969, 18 E AFR VIR RES I R, P93
   MCCRAE AWR, 1970, 19 E AFR VIR RES I R, P23
   MCCRAE AWR, 1976, B ENTOMOL RES, V66, P587
   MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4
   MUKWAYA LG, 1969, 18 E AFR VIR RES I R, P86
   PAJOT F-X, 1977, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V15, P73
   PORTERFIELD JS, 1960, VIROLOGY, V11, P765, DOI 10.1016/0042-6822(60)90119-7
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035
   Salaun J.J., 1981, Medecine Tropicale, V41, P45
   SAMPALA SDK, 1970, 19 E AFR VIR RES I R, P31
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P879
   SIMPSON DIH, 1965, T ROY SOC TROP MED H, V59, P449, DOI 10.1016/0035-9203(65)90065-9
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74
   SPIELMAN A, 1975, ANN NY ACAD SCI, V266, P115, DOI 10.1111/j.1749-6632.1975.tb35092.x
   WILLIAMS MC, 1965, T ROY SOC TROP MED H, V59, P444, DOI 10.1016/0035-9203(65)90064-7
NR 57
TC 53
Z9 56
U1 10
U2 30
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON, ENGLAND W1N 4EY
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PY 1982
VL 76
IS 4
BP 552
EP 562
DI 10.1016/0035-9203(82)90161-4
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA PE413
UT WOS:A1982PE41300026
PM 6304948
ER

PT J
AU OLSON, JG
   KSIAZEK, TG
   SUHANDIMAN
   TRIWIBOWO
AF OLSON, JG
   KSIAZEK, TG
   SUHANDIMAN
   TRIWIBOWO
TI ZIKA VIRUS, A CAUSE OF FEVER IN CENTRAL JAVA, INDONESIA
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
C1 GAJAH MADA UNIV,YOGYAKARTA,INDONESIA.
RP OLSON, JG (reprint author), USN,MED RES UNIT 2,JAKARTA DETACHMENT,APO,SAN FRANCISCO,CA 96356, USA.
CR Berge TO, 1975, INT CATALOG ARBOVIRU
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, ROYAL SOC TROPICAL M, V47, P13
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   KSIAZEK TG, 1977, AM J TROP MED HYG, V26, P815
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Saroso J. S., 1978, Asian Journal of Infectious Diseases, V2, P7
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SULZER CR, 1975, J CLIN MICROBIOL, V2, P218
   SUNARTO J, 1979, American Journal of Tropical Medicine and Hygiene, V28, P717
NR 20
TC 78
Z9 82
U1 10
U2 30
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON, ENGLAND W1N 4EY
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PY 1981
VL 75
IS 3
BP 389
EP 393
DI 10.1016/0035-9203(81)90100-0
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LW338
UT WOS:A1981LW33800012
PM 6275577
ER

PT J
AU FAGBAMI, AH
AF FAGBAMI, AH
TI ZIKA VIRUS-INFECTIONS IN NIGERIA - VIROLOGICAL AND SEROEPIDEMIOLOGICAL
   INVESTIGATIONS IN OYO STATE
SO JOURNAL OF HYGIENE
LA English
DT Article
RP FAGBAMI, AH (reprint author), UNIV IBADAN,VIRUS RES LAB,IBADAN,NIGERIA.
CR BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   CAREY DE, 1972, B WORLD HEALTH ORGAN, V46, P645
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DOWNS W G, 1975, Bulletin of the New York Academy of Medicine, V51, P984
   FABIYI A, 1962, AM J TROP MED HYG, V11, P817
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   Fagbami A H, 1976, Niger Med J, V6, P38
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   GUYER B, 1972, ANN TROP MED PARASIT, V66, P243
   HALDANE JBS, 1960, NATURE, V187, P879, DOI 10.1038/187879a0
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110
   LEE VH, 1969, STUDIES ARTHROPOD HO, P100
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MONATH TP, 1974, T ROY SOC TROP MED H, V68, P30, DOI 10.1016/0035-9203(74)90248-X
   MONATH TP, 1973, B WHO, V48, P123
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SOUTHAM CM, 1956, J INFECT DIS, V99, P155
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WEINBREN MP, 1958, REPORT E AFR RES I, V8, P38
NR 24
TC 60
Z9 66
U1 3
U2 27
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 40 WEST 20TH STREET, NEW YORK, NY 10011-4211
SN 0950-2688
J9 J HYG-CAMBRIDGE
PY 1979
VL 83
IS 2
BP 213
EP 219
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HR954
UT WOS:A1979HR95400003
PM 489960
ER

PT J
AU KIRYA, BG
   MUKWAYA, LG
   SEMPALA, SDK
AF KIRYA, BG
   MUKWAYA, LG
   SEMPALA, SDK
TI YELLOW-FEVER EPIZOOTIC IN ZIKA FOREST, UGANDA, DURING 1972 .1. VIRUS
   ISOLATION AND SENTINEL MONKEYS
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
C1 MAKERERE UNIV,SCH MED,DEPT MED MICROBIOL,KAMPALA,UGANDA.
   E AFRICAN VIRUS RES INST,ENTEBBE,UGANDA.
CR BUXTON AP, 1952, J ANIM ECOL, V21, P25, DOI 10.2307/1908
   CASEY HL, 1965, 74 PUBL HLTH MON, P31
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   COBERT PS, 1963, B ENTOMOLOGICAL RESE, V54, P213
   HADDOW A. J., 1964, BULL ENTOMOL RES, V55, P589
   HADDOW AJ, 1965, T ROY SOC TROP MED H, V59, P436, DOI 10.1016/0035-9203(65)90062-3
   Haddow AJ., 1968, P R SOC EDIN B, V70, P191
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   PORTERFIELD JS, 1960, VIROLOGY, V11, P765, DOI 10.1016/0042-6822(60)90119-7
   SAWYER W. A., 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P397, DOI 10.1016/S0035-9203(36)90055-X
   Stokes A, 1928, J AMER MED ASSOC, V90, P253
   STRODE GK, 1951, YELLOW FEVER, P5
NR 12
TC 12
Z9 12
U1 6
U2 13
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON, ENGLAND W1N 4EY
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PY 1977
VL 71
IS 3
BP 254
EP 260
DI 10.1016/0035-9203(77)90020-7
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP974
UT WOS:A1977DP97400014
PM 407675
ER

PT J
AU FILIPE, AR
   MARTINS, CMV
   ROCHA, H
AF FILIPE, AR
   MARTINS, CMV
   ROCHA, H
TI LABORATORY INFECTION WITH ZIKA VIRUS AFTER VACCINATION AGAINST
   YELLOW-FEVER
SO ARCHIV FUR DIE GESAMTE VIRUSFORSCHUNG
LA English
DT Article
C1 FAC VET LOURENCO MARQUES,LOURENCO MARQUES,MOZAMBIQUE.
   INST HIGIENE & MED TROP,ARBOVIRUS LAB,RUA JUNQUEIRA 96,LISBON,PORTUGAL.
CR BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   CASALS J, 1959, 6TH P INT C TROP MED, V5, P34
   CASALS J, 1961, B WORLD HEALTH ORGAN, V24, P723
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   FILIPE AR, TO BE PUBLISHED
   HAMMON WM, 1964, DIAGNOSTIC PROCEDURE
   Karber G., 1931, ARCH EXP PATHOL PH, V162, P480
   SCHLESINGER RW, 1956, J IMMUNOL, V77, P352
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P843
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SIMPSON DIH, 1972, BRIT MED BULL, V28, P10
   WISSEMAN CL, 1962, AM J TROP MED HYG, V11, P550
   1971, 479 ORG MOND SANT SE
NR 13
TC 34
Z9 37
U1 5
U2 14
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA
SN 0003-9012
J9 ARCH GES VIRUSFORSCH
PY 1973
VL 43
IS 4
BP 315
EP 319
DI 10.1007/BF01556147
PG 5
WC Virology
SC Virology
GA S3110
UT WOS:A1973S311000004
PM 4799154
ER

PT J
AU BELL, TM
   FIELD, EJ
   NARANG, HK
AF BELL, TM
   FIELD, EJ
   NARANG, HK
TI ZIKA VIRUS INFECTION OF CENTRAL NERVOUS SYSTEM OF MICE
SO ARCHIV FUR DIE GESAMTE VIRUSFORSCHUNG
LA English
DT Article
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V34, P158
   BLINZINGER K, 1970, DTSCH Z NERVENHEILKD, V197, P18
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   FILSHIE BK, 1968, VIROLOGY, V34, P435, DOI 10.1016/0042-6822(68)90063-9
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   OTA Z, 1965, VIROLOGY, V25, P372, DOI 10.1016/0042-6822(65)90057-7
   OYANAGI S, 1969, ACTA NEUROPATHOL, V13, P169
   PARKER JR, 1967, ARCH GES VIRUSFORSCH, V20, P469, DOI 10.1007/BF01275229
   PEAT A, 1970, ARCH GES VIRUSFORSCH, V31, P230, DOI 10.1007/BF01253757
   ROOK GAW, 1970, BRIT MED J, V4, P210
   WEINBREN MP, 1964, T ROY SOC TROP MED H, V52, P263
   WILLIAMS MC, 1965, REP E AFR VIRUS RES, V14, P42
   Woodall JP, 1964, P E AFR ACAD, V2, P141
   YASUZUMI G, 1964, J ULTRA MOL STRUCT R, V11, P213, DOI 10.1016/S0022-5320(64)90029-2
   ZLOTNIK I, 1968, BRIT J EXP PATHOL, V49, P555
NR 16
TC 63
Z9 63
U1 19
U2 52
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA
SN 0003-9012
J9 ARCH GES VIRUSFORSCH
PY 1971
VL 35
IS 2-3
BP 183
EP &
DI 10.1007/BF01249709
PG 0
WC Virology
SC Virology
GA L0931
UT WOS:A1971L093100006
PM 5002906
ER

PT J
AU MARCHETTE, NJ
   GARCIA, R
   RUDNICK, A
AF MARCHETTE, NJ
   GARCIA, R
   RUDNICK, A
TI ISOLATION OF ZIKA VIRUS FROM AEDES AEGYPTI MOSQUITOES IN MALAYSIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   CUTCHINS E, 1960, J IMMUNOL, V85, P275
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Miller LC, 1944, P SOC EXP BIOL MED, V57, P261
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   SEVER JL, 1962, J IMMUNOL, V88, P320
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
NR 17
TC 89
Z9 96
U1 12
U2 38
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 1969
VL 18
IS 3
BP 411
EP +
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA D2371
UT WOS:A1969D237100014
PM 4976739
ER

PT J
AU HADDOW, AJ
   WILLIAMS, MC
   WOODALL, JP
   SIMPSON, DIH
   GOMA, LKH
AF HADDOW, AJ
   WILLIAMS, MC
   WOODALL, JP
   SIMPSON, DIH
   GOMA, LKH
TI 12 ISOLATIONS OF ZIKA VIRUS FROM AEDES ( STEGOMYIA ) AFRICANUS (
   THEOBALD ) TAKEN IN AND ABOVE A UGANDA FOREST
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
CR Allee WC, 1926, ECOLOGY, V7, P445, DOI 10.2307/1931171
   Bugher JC, 1944, AM J HYG, V39, P16
   BURKITT D, 1962, POSTGRAD MED J, V38, P71
   BUXTON AP, 1952, J ANIM ECOL, V21, P25, DOI 10.2307/1908
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   CORBET PHILIP S., 1962, BULL ENTOMOL RES, V53, P409
   CORBET PS, 1964, J ANIM ECOL, V33, P141, DOI 10.2307/2354
   CORBET PS, 1962, 12 E AFR VIR RES I R, P49
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   HADDOW A. J., 1961, BULL ENTOMOL RES, V52, P317
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218
   HADDOW AJ, 1951, T ROY SOC TROP MED H, V45, P189, DOI 10.1016/S0035-9203(51)90901-7
   HADDOW AJ, 1947, B ENTOMOL RES, V37, P301
   HADDOW AJ, 1945, B ENTOMOL RES, V36, P33
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P271
   HADDOW AJ, 1960, T R ENT SOC LOND, V113, P249
   HADDOW AJ, 1954, B ENTOMOL RES, V45, P199
   HADDOW AJ, 1961, 196061 EAST AFR VIR, P16
   Harris W. V., 1942, Bulletin of Entomological Research London, V33, P181
   Hingston R. W. G., 1932, NATURALIST GUIANA FO
   HOCKING B., 1953, TRANS ROY ENT SOC LONDON, V104, P223
   JOHNSON CG, 1953, DISCOVERY, V14, P19
   KNIGHT EM, 1961, 1960 1961 E AFR VIR, P17
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P103
   LUMSDEN WH, 1961, ANN TROP MED PARASIT, V55, P389
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MAHAFFY A. F., 1942, TRANS ROY SOC TROP MED AND HYG, V36, P9, DOI 10.1016/S0035-9203(42)90051-8
   MATTINGLY PF, 1949, B ENTOMOL RES, V40, P149
   McCLELLAND G.A.H., 1960, ANN TROP MED AND PARASITOL, V54, P300
   PORTERFIELD JS, 1960, VIROLOGY, V11, P765, DOI 10.1016/0042-6822(60)90119-7
   SIMPSON DR, IN PRESS
   SMITHBURN K. C., 1959, S AFRICAN MED JOUR, V33, P959
   SMITHBURN K. C, 1957, S AFRICAN JOUR MED SCI, V22, P113
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1940, AMER J TROP MED, V21, P75
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74
   Stone A, 1959, SYNOPTIC CATALOG MOS
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wellington W. G., 1945, CANADIAN ENT, V77, P21
   WILLIAMS M. C., 1963, Bulletin of Entomological Research, V54, P407
   WILLIAMS M. C. B. WEITZ, 1958, ANN TROP MED AND PARASITOL, V52, P186
   WILLIAMS MC, 1964, 13 EAST AFR VIR RES, P17
NR 45
TC 66
Z9 70
U1 7
U2 18
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA DISTRIBUTION AND SALES, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PY 1964
VL 31
IS 1
BP 57
EP &
PG 0
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 60882
UT WOS:A19646088200007
PM 14230895
ER

PT J
AU MACNAMARA, FN
AF MACNAMARA, FN
TI ZIKA VIRUS - A REPORT ON 3 CASES OF HUMAN INFECTION DURING AN EPIDEMIC
   OF JAUNDICE IN NIGERIA
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
CR DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   GLEDHILL A W, 1952, Lancet, V2, P509
   MACNAMARA FN, 1952, 1951 52 VIR RES I AN
   PELISSIER A, 1949, B SOC PATH EXOT, V42, P197
   PELISSIER A, 1952, B SOC PATH EXOT, V45, P304
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   TAYLOR RM, 1952, J IMMUNOL, V68, P473
NR 10
TC 75
Z9 76
U1 13
U2 27
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON W1N 4EY, ENGLAND
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PY 1954
VL 48
IS 2
BP 139
EP 145
DI 10.1016/0035-9203(54)90006-1
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA XT994
UT WOS:A1954XT99400006
PM 13157159
ER

PT J
AU REAGAN, RL
   BRUECKNER, AL
AF REAGAN, RL
   BRUECKNER, AL
TI COMPARISON BY ELECTRON MICROSCOPY OF THE NTAYA AND ZIKA VIRUSES
SO TEXAS REPORTS ON BIOLOGY AND MEDICINE
LA English
DT Article
CR REAGAN RL, 1951, P SOC EXP BIOL MED, V78, P630
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130
   WILLIAMS RC, 1946, J APPL PHYS, V17, P23, DOI 10.1063/1.1707630
NR 3
TC 2
Z9 2
U1 10
U2 18
PU UNIV TEXAS
PI GALVESTON
PA MEDICAL BRANCH, GALVESTON, TX 77550
SN 0040-4675
J9 TEX REP BIOL MED
PY 1953
VL 11
IS 2
BP 347
EP 351
PG 5
WC Medicine, Research & Experimental; Multidisciplinary Sciences
SC Research & Experimental Medicine; Science & Technology - Other Topics
GA XS072
UT WOS:A1953XS07200016
PM 13077401
ER

PT J
AU DICK, GWA
AF DICK, GWA
TI EPIDEMIOLOGICAL NOTES ON SOME VIRUSES ISOLATED IN UGANDA (YELLOW FEVER,
   RIFT VALLEY FEVER, BWAMBA FEVER, WEST NILE, MENGO, SEMLIKI FOREST,
   BUNYAMWERA, NTAYA, UGANDA-S AND ZIKA VIRUSES)
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
CR BIELING R, 1950, T AUSTRIAN SOC MICRO
   CARMICHAEL J, 1952, T ROY SOC TROP MED H, V46, P385, DOI 10.1016/0035-9203(52)90057-6
   Daubney R, 1933, E AFR MED J, V10, P2
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   DICK G. W. A., 1948, BRIT JOUR EXPTL PATH, V29, P547
   DICK G W A, 1948, Lancet, V2, P286
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   DICK GWA, 1949, J IMMUNOL, V62, P311
   DICK GWA, 1949, J IMMUNOL, V62, P375
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P449, DOI 10.1016/0035-9203(52)90062-X
   DICK GWA, 1952, AM J HYG, V55, P140
   DICK GWA, 1947, T ROY SOC TROP MED H, V41, P295, DOI 10.1016/S0035-9203(47)90068-0
   DICK GWA, 1948, BRIT J EXP PATHOL, V29, P559
   DICK GWA, 1952, J HYG-CAMBRIDGE, V50, P376
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1951, E AFR MED J, V27, P403
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P47, DOI 10.1016/0035-9203(52)90003-5
   DICK GWA, 1950, ANN TROP MED PARASIT, V44, P319
   FREED I, 1951, S Afr Med J, V25, P930
   GARD S, 1951, P SOC EXP BIOL MED, V76, P68
   GARNHAM PCC, 1931, J PATH BACT, V34, P545
   GEAR JAMES, 1951, S AFRICAN MED JOUR, V25, P908
   GILLETT JD, 1951, ANN TROP MED PARASIT, V45, P110
   GLEDHILL A W, 1952, Lancet, V2, P509
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218
   HADDOW AJ, 1949, B ENTOMOL RES, V40, P169
   HADDOW AJ, 1951, T ROY SOC TROP MED H, V45, P189, DOI 10.1016/S0035-9203(51)90901-7
   HADDOW AJ, 1952, ANN TROP MED PARASIT, V45, P110
   HADDOW AJ, 1950, ANN TROP MED PARASIT, V44, P238
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P271
   HADDOW AJ, 1947, T ROY SOC TROP MED H, V40, P677, DOI 10.1016/0035-9203(47)90026-6
   HAHN RG, 1951, AM J HYG, V54, P50
   HELWIG FC, 1945, SCIENCE, V102, P31, DOI 10.1126/science.102.2637.31
   HORGAN ES, 1951, 1950 VIR RES I ANN R
   HORGAN ES, 1952, 1951 VIR RES I ANN R
   JOUBERT J D S, 1951, S Afr Med J, V25, P890
   JUNGBLUT CLAUS W., 1950, ARCH PEDIATRICS, V67, P519
   JUNGEBLUT CL. W., 1952, ARCH GES VIRUSFORSCH, V4, P568, DOI 10.1007/BF01242024
   Jungeblut CW, 1943, AM J PUBLIC HEALTH N, V33, P169, DOI 10.2105/AJPH.33.2.169
   JUNGEBLUT CW, 1951, P SOC EXP BIOL MED, V77, P672
   Jungeblut CW, 1940, J EXP MED, V72, P407, DOI 10.1084/jem.72.4.407
   KERR JA, 1952, J IMMUNOL, V68, P461
   Kirk R., 1941, ANN TROP MED AND PARASITOL, V35, P67
   KOCH F, 1950, Z Kinderheilkd, V68, P328, DOI 10.1007/BF00438575
   Laemmert H. W., 1944, AMER JOUR TROP MED, V24, P71
   Lennette Edwin H., 1943, AMER JOUR TROP MED, V23, P481
   LUMSDEN WHR, 1951, T ROY SOC TROP MED H, V45, P53, DOI 10.1016/S0035-9203(51)90544-5
   MACCALLUM FO, 1937, T R SOC TROP MED HYG, V31, P199, DOI 10.1016/S0035-9203(37)90038-5
   MACNAMARA F, 1952, 1951 ANN REP VIR RES
   MAHAFFY A. F., 1942, TRANS ROY SOC TROP MED AND HYG, V36, P9, DOI 10.1016/S0035-9203(42)90051-8
   MAHAFFY AF, 1946, T ROY SOC TROP MED H, V40, P57, DOI 10.1016/0035-9203(46)90062-4
   MELNICK JL, 1951, P SOC EXP BIOL MED, V77, P661
   MUNDEL B., 1951, S AFRICAN MED JOUR, V25, P797
   OLITSKY PK, 1949, P SOC EXP BIOL MED, V71, P719
   Philip CB, 1943, P SOC EXP BIOL MED, V53, P49
   POWELL HM, 1948, P SOC EXP BIOL MED, V68, P80
   ROCAGARCIA M, 1952, CITED INDIRECTLY
   SABIN AB, 1944, CITED INDIRECTLY
   SABIN AB, 1947, P SOC EXP BIOL MED, V64, P385
   SABIN AB, VIRAL RICKETTSIAL IN, P451
   SAWYER W. A., 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P397, DOI 10.1016/S0035-9203(36)90055-X
   Sawyer WA, 1937, AM J TROP MED, V17, P137
   SHRIRE L, 1951, S AFRICAN MEDICAL J, V25, P926
   SMADEL JE, 1947, J CLIN INVEST, V26, P1197
   SMITH E. C., 1940, TRANS ROY SOC TROP MED AND HYG, V34, P97, DOI 10.1016/S0035-9203(40)90093-1
   SMITHBURN K. C, 1941, AMER JOUR TROP MED, V21, P75
   SMITHBURN K. C., 1949, AMER JOUR TROP MED, V29, P414
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   SMITHBURN KC, 1946, AM J TROP MED, V26, P189
   Smithburn KC, 1942, J IMMUNOL, V44, P9
   SMITHBURN KC, 1949, AM J TROP MED, V29, P389
   SMITHBURN KC, 1948, BRIT J EXP PATHOL, V29, P107
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   SMITHBURN KC, 1949, BRIT J EXP PATHOL, V30, P35
   Smithburn KC, 1944, J IMMUNOL, V49, P141
   SMITHBURN KC, 1949, BRIT J EXP PATHOL, V30, P1
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P182
   SMITHBURN KC, 1949, J IMMUNOL, V62, P213
   SMITHBURN KC, 1946, AM J TROP MED, V26, P261
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130
   SMITHBURN KC, 1952, ANN TROP MED PARASIT, V46, P61
   SMITHBURN KC, 1945, J IMMUNOL, V51, P173
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74
   SOUTHAM CM, 1951, AM J TROP MED, V31, P724
   THEILER MAX, 1933, ANN TROP MED AND PARASITOL [LIVERPOOL], V27, P57
   VIVELL O, 1952, Z IMMUN FORSCH, V109, P274
   VIVELL O., 1952, ZEITSCHR IMMUNITATSFORSCH, V109, P527
   VIVELL O, 1952, ARCH GES VIRUSFORSCH, V4, P568
   WADDELL MB, 1948, AM J TROP MED, V28, P87
   WARREN J, 1949, P SOC EXP BIOL MED, V71, P376
   WARREN J, 1949, J IMMUNOL, V62, P387
   WATSON J. M., 1950, UGANDA JOUR, V14, P53
   1947, 1946 INT HLTH DIV AN, P119
NR 93
TC 32
Z9 33
U1 8
U2 27
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON W1N 4EY, ENGLAND
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PY 1953
VL 47
IS 1
BP 13
EP 43
DI 10.1016/0035-9203(53)90021-2
PG 31
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA XT987
UT WOS:A1953XT98700021
PM 13077697
ER

PT J
AU DICK, GWA
   KITCHEN, SF
   HADDOW, AJ
AF DICK, GWA
   KITCHEN, SF
   HADDOW, AJ
TI ZIKA VIRUS .1. ISOLATIONS AND SEROLOGICAL SPECIFICITY
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
CR BUXTON AP, IN PRESS OBSERVATION
   DICK G. W. A., 1948, BRIT JOUR EXPTL PATH, V29, P547
   DICK GWA, 1949, J IMMUNOL, V62, P375
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, IN PRESS UGANDA S VI
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218
   HADDOW AJ, 1947, B ENTOMOL RES, V37, P301
   MAHAFFY A. F., 1942, TRANS ROY SOC TROP MED AND HYG, V36, P9, DOI 10.1016/S0035-9203(42)90051-8
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   SMITHBURN KC, 1946, AM J TROP MED, V26, P189
   SMITHBURN KC, 1948, BRIT J EXP PATHOL, V29, P107
   Smithburn KC, 1944, J IMMUNOL, V49, P141
   SMITHBURN KC, 1946, AM J TROP MED, V26, P261
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74
   THEILER MAX, 1933, ANN TROP MED AND PARASITOL [LIVERPOOL], V27, P57
   WARREN J, 1949, J IMMUNOL, V62, P387
NR 17
TC 235
Z9 255
U1 74
U2 210
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON W1N 4EY, ENGLAND
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PY 1952
VL 46
IS 5
BP 509
EP 520
DI 10.1016/0035-9203(52)90042-4
PG 12
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA XT985
UT WOS:A1952XT98500007
PM 12995440
ER

PT J
AU DICK, GWA
AF DICK, GWA
TI ZIKA VIRUS .2. PATHOGENICITY AND PHYSICAL PROPERTIES
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, IN PRESS HISTOPATHOL
   Elford WJ, 1935, J PATHOL BACTERIOL, V40, P135, DOI 10.1002/path.1700400111
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218
   HADDOW AJ, 1948, UNPUB ANN REPORT YEL
   MAHAFFY A. F., 1942, TRANS ROY SOC TROP MED AND HYG, V36, P9, DOI 10.1016/S0035-9203(42)90051-8
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74
NR 8
TC 84
Z9 93
U1 22
U2 72
PU ROYAL SOC TROPICAL MEDICINE
PI LONDON
PA MANSON HOUSE 26 PORTLAND PLACE, LONDON W1N 4EY, ENGLAND
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PY 1952
VL 46
IS 5
BP 521
EP 534
DI 10.1016/0035-9203(52)90043-6
PG 14
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA XT985
UT WOS:A1952XT98500008
PM 12995441
ER

VR 1.0
PT J
AU Calvo, EP
   Sanchez-Quete, F
   Duran, S
   Sandoval, I
   Castellanos, JE
AF Calvo, Eliana P.
   Sanchez-Quete, Fernando
   Duran, Sandra
   Sandoval, Isabel
   Castellanos, Jaime E.
TI Easy and inexpensive molecular detection of dengue, chikungunya and zika
   viruses in febrile patients
SO ACTA TROPICA
LA English
DT Article
DE Arbovirus; Chikungunya; Dengue; Zika; Detection; Nested PCR
ID POLYMERASE CHAIN-REACTION; RT-PCR ASSAY; CLINICAL-SAMPLES; RAPID
   DETECTION; REUNION ISLAND; INFECTION; AMERICA; STEP; QUANTIFICATION;
   PERFORMANCE
AB Dengue (DENV), chikungunya (CHIKV) and zika (ZIKV) are arthropod-borne viruses (arboviruses) sharing a common vector, the mosquito Aedes aegypti. At initial stages, patients infected with these viruses have similar clinical manifestations, however, the outcomes and clinical management of these diseases are different, for this reason early and accurate identification of the causative virus is necessary. This paper reports the development of a rapid and specific nested-PCR for detection of DENV, CHIKV and ZIKV infection in the same sample. A set of six outer primers targeting the C-preM, E1, and E gene respectively was used in a multiplex one-step RT-PCR assay, followed by the second round of amplification with specific inner primers for each virus. The specificity of the present assay was validated with positive and negative serum samples for viruses and supernatants of infected cells. The assay was tested using clinical samples from febrile patients. In these samples, we detected mono and dual infections and a case of triple co-infection DENV-CHIKV-ZIKV. This assay might be a useful and an inexpensive tool for detection of these infections in regions where these arboviruses co-circulate. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Calvo, Eliana P.; Sanchez-Quete, Fernando; Duran, Sandra; Sandoval, Isabel; Castellanos, Jaime E.] Univ El Bosque, Lab Virol, Ave Cra 9 131 A-02,Edificio D, Bogota, DC, Colombia.
   [Sanchez-Quete, Fernando; Castellanos, Jaime E.] Univ Nacl Colombia, Grp Patogenesis Infecciosa, Bogota, Colombia.
RP Calvo, EP (reprint author), Univ El Bosque, Lab Virol, Ave Cra 9 131 A-02,Edificio D, Bogota, DC, Colombia.
EM calvoeliana@unbosque.edu.co
FU Vicerrectoria de investigaciones, Universidad El Bosque; Colciencias
   [360-2011]; Programa Red de Investigacion Multidisciplinaria para la
   prevencion y control de Enfermedades Transmitidas por Vectores
FX Vicerrectoria de investigaciones, Universidad El Bosque. Colciencias
   360-2011. Programa Red de Investigacion Multidisciplinaria para la
   prevencion y control de Enfermedades Transmitidas por Vectores.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvo E. P., 2016, BIOMEDICA S1, V36
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317
   Castellanos J. E., 2014, REV FAC MED UNAL, V62, P455
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Dash PK, 2008, DIAGN MICR INFEC DIS, V62, P52, DOI 10.1016/j.diagmicrobio.2008.05.002
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Ummul Haninah A., 2010, TROP BIOMED, V27, P611
   Hennessey M, 2015, MMWR-MORBID MORTAL W, P65
   Ho PS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-13
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   Magalhaes BML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003239
   Mishra B, 2011, DIAGN MICR INFEC DIS, V71, P118, DOI 10.1016/j.diagmicrobio.2011.06.020
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moyen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115938
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   PAHO, 2016, EPIDEMIOLOGICAL WEEK
   PAHO, 2014, SEMANA EPIDEMIOLOGIC
   PAHO, 2016, SEMANA EPIDEMIOLOGIC
   Pan American Health Organization/World Health Organization (PAHO/WHO), 2015, EP AL NEUR SYNDR CON
   Panning M, 2009, J CLIN MICROBIOL, V47, P3014, DOI 10.1128/JCM.01024-09
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Ridde V, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0120-2
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   [Anonymous], 2016, SEMANA EPIDEMIOLOGIC
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   WHO, 2009, DENG GUID DIAGN TREA
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
NR 49
TC 0
Z9 0
U1 34
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2016
VL 163
BP 32
EP 37
DI 10.1016/j.actatropica.2016.07.021
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DW3FO
UT WOS:000383527700007
PM 27477452
ER

PT J
AU Calvet, GA
   dos Santos, FB
   Sequeira, PC
AF Calvet, Guilherme Amaral
   dos Santos, Flavia Barreto
   Sequeira, Patricia Carvalho
TI Zika virus infection: epidemiology, clinical manifestations and
   diagnosis
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE Guillain-Barre syndrome; microcephaly; sexual transmission; Zika virus
ID RT-PCR; FLAVIVIRUSES; MOSQUITOS; PRIMERS
AB Purpose of reviewZika virus (ZIKV) is an arbovirus previously believed to cause only a mild and self-limiting illness. Recently, it has emerged as a new public health threat that caused a large outbreak in French Polynesia in 2013-2014 and since 2015 an explosive outbreak in Brazil, with an increase in severe congenital malformations (microcephaly) and neurological complications, mainly Guillain-Barre syndrome (GBS). Since then, it has spread through the Americas. On 1 February 2016, the WHO declared the ZIKV epidemic in Brazil a Public Health Emergency of International Concern. We reviewed the epidemiology of ZIKV infection, clinical presentations and diagnosis. We highlighted the clinical features and nonvector borne transmission of the virus.Recent findingsAssociation between ZIKV infection and severe foetal outcomes, including microcephaly and other birth defects; increased rate of GBS and other neurological complications due to the ongoing ZIKV outbreak; increased evidence to date of ZIKV being the only arbovirus linked to sexual transmission; the challenge of ZIKV diagnosis; and the need for a specific point-of care test in epidemic scenarios.SummaryThe findings illustrate the emergence of a viral disease with the identification of new associated disorders, new modes of transmission, including maternal-foetal and sexual transmission.
C1 [Calvet, Guilherme Amaral] Fundacao Oswaldo Cruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [dos Santos, Flavia Barreto; Sequeira, Patricia Carvalho] Fundacao Oswaldo Cruz, Flavivirus Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Calvet, GA (reprint author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Ave Brasil 4365, BR-21045360 Rio De Janeiro, Brazil.
EM guilherme.calvet@ini.fiocruz.br
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi720
   Meiyu Fang, 1997, Microbiology and Immunology, V41, P209
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
NR 21
TC 0
Z9 0
U1 36
U2 36
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD OCT
PY 2016
VL 29
IS 5
BP 459
EP 466
DI 10.1097/QCO.0000000000000301
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DW8QC
UT WOS:000383919600005
PM 27496713
ER

PT J
AU Fernandez-Salas, I
   Diaz-Gonzalez, EE
   Lopez-Gatell, H
   Alpuche-Aranda, C
AF Fernandez-Salas, Ildefonso
   Diaz-Gonzalez, Esteban E.
   Lopez-Gatell, Hugo
   Alpuche-Aranda, Celia
TI Chikugunya and zika virus dissemination in the Americas: different
   arboviruses reflecting the same spreading routes and poor vector-control
   policies
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE chikungunya; emergence; transcontinental movement; zika
ID CHIKUNGUNYA CHRONIC ARTHRALGIA; AEDES-AEGYPTI; PHYLOGENETIC ANALYSIS;
   WESTERN-HEMISPHERE; DENGUE VIRUSES; UNITED-STATES; 1ST REPORT;
   TRANSMISSION; BRAZIL; INFECTIONS
AB Purpose of reviewThis review gathers the most recent investigations about chikungunya and zika viruses in America and would help in creating new research approaches.Recent findingsClinical descriptions of chikungunya fever have been performed in the American outbreak observing that fever, polyarthalgia, myalgia and rash are the most common symptoms in the acute phase, while chronic arthralgia has persisted in 37-90% of small cohorts. The Asian origin of American strains of chikungunya virus (CHIKV) and zika virus (ZIKV) evidences a dissemination route in common and both are being transmitted by Aedes aegypti. Regarding zika fever, the association of congenital malformations with previous ZIKV exposure of pregnant women and potential sexual transmission of ZIKV are the most important discoveries in the New World.SummaryMassive outbreaks of chikungunya fever in 2014 and then followed by zika fever epidemics of lower magnitude in the next year throughout the American continent have their origins in Asia but may have used Pacific Islands as a path of dissemination. Reports of chronic arthralgia have been little described in the continent and more research is needed to measure the economic and health impact in patients who contracted CHIKV before. On the contrary, zika is menacing newborns' health because of its link with congenital microcephaly and sexual health by prolonged presence of viral particles in semen and urine.
C1 [Fernandez-Salas, Ildefonso] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, 19 Poniente S-N Entre 4 Norte & 6 Norte, Tapachula 30700, Chiapas, Mexico.
   [Diaz-Gonzalez, Esteban E.] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico.
   [Diaz-Gonzalez, Esteban E.] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolas De Los Garza, Nuevo Leon, Mexico.
   [Lopez-Gatell, Hugo; Alpuche-Aranda, Celia] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.
RP Fernandez-Salas, I (reprint author), Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, 19 Poniente S-N Entre 4 Norte & 6 Norte, Tapachula 30700, Chiapas, Mexico.
EM ildefonso.fernandez@insp.mx
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carter D, 2014, AM J NURS, V114, P18
   Cassadou S, 2014, EUROSURVEILLANCE, V19, P6
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15
   Centro Nacional de Programas Preventivos y Control de Enfermedades, 2014, DECL EM EP EE 2 2014
   Cigarroa-Toledo N, 2016, EMERG INFECT DIS, V22, P1804, DOI 10.3201/eid2210.152087
   Comision Nacional para la Vigilancia Epidemiologica, 2015, INF VIR ZIK SINDR NE
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI [10.4269/ajtmh.15-0450, 10.4269/ajtmh15-0450]
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Espinosa N., 2016, OPEN J MED MICROBIOL, V6, P23
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214
   Guerbois Mathilde, J INFECT DIS, DOI [10.1093/infdis/jiw302, DOI 10.1093/INFDIS/JIW302]
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kautz TF, 2015, EMERG INFECT DIS, V21, P2070, DOI 10.3201/eid2111.150546
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Khan K, 2014, PLOS CURR, V6, P6, DOI DOI 10.1371/CURRENTS.OUTBREAKS.2134A0A7BF37FD8D388181539FEA2DA5
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Lindsey NP, 2015, AM J TROP MED HYG, V92, P82, DOI 10.4269/ajtmh.14-0442
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan AJ, 2016, PLOS CURR
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Morosini FC, 2016, BRAZILIAN APPROACH S
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Noel H, 2014, EUROSURVEILLANCE, V19, P2
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Pan American Health Organization, 2016, CHIK STAT DAT
   Pan American Health Organization, 2015, CUM ZIK SUSP CONF CA
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10
   PEERS RR, 1972, CAN J MICROBIOL, V18, P741
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinnock FH, 2012, CARIBBEAN MARITIME T
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Requena-Mendez A, 2014, EUROSURVEILLANCE, V19, P5
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001
   Rodriguez-Morales AJ, 2016, CLIN RHEUMATOL, V35, P831, DOI 10.1007/s10067-015-3041-8
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Servicio Metereologico Nacional, 2016, SERV MET NAC REP AN
   Sistema IBGE de Recuperacao Automatica, EM INT SEX 2 CONT PA
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Vergara Y, 2016, TVN NOTICIAS
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeana C, 2016, TRAVEL MED INFECT DI, V14, P21, DOI 10.1016/j.tmaid.2016.01.009
NR 75
TC 0
Z9 0
U1 7
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD OCT
PY 2016
VL 29
IS 5
BP 467
EP 475
DI 10.1097/QCO.0000000000000304
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DW8QC
UT WOS:000383919600006
PM 27472289
ER

PT J
AU Makhluf, H
   Kim, K
   Shresta, S
AF Makhluf, Huda
   Kim, Kenneth
   Shresta, Sujan
TI Novel strategies for discovering inhibitors of Dengue and Zika fever
SO EXPERT OPINION ON DRUG DISCOVERY
LA English
DT Editorial Material
DE Dengue virus; Zika virus and antivirals
ID VIRUS-INFECTION; MOUSE MODELS; INFLUENZA; THERAPY; HIV
C1 [Makhluf, Huda; Kim, Kenneth; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Ctr Infect Dis, La Jolla, CA USA.
   [Makhluf, Huda] Natl Univ, Dept Math & Nat Sci, La Jolla, CA USA.
RP Makhluf, H (reprint author), Natl Univ, 11255 North Torrey Pines Rd, La Jolla, CA 92037 USA.
EM hmakhluf@nu.edu
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burel JG, 2016, TRENDS IMMUNOL, V37, P53, DOI 10.1016/j.it.2015.11.006
   De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010
   Deligny C, 2014, J CLIN VIROL, V61, P442, DOI 10.1016/j.jcv.2014.08.011
   Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017
   Pheng S, 2013, ANTIVIR RES, V100, P500, DOI [10.1016/j.antivira1.2013.09.013, DOI 10.1016/J.ANTIVIRA1.2013.09.013]
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15
   Suzuki Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005357
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tang WW, 2015, CURR OPIN VIROL, V13, P61, DOI 10.1016/j.coviro.2015.04.007
   Warfield KL, 2015, VIRUSES-BASEL, V7, P2404, DOI 10.3390/v7052404
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Wyles DL, 2013, J INFECT DIS, V207, pS33, DOI 10.1093/infdis/jis761
NR 14
TC 0
Z9 0
U1 10
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1746-0441
EI 1746-045X
J9 EXPERT OPIN DRUG DIS
JI Expert. Opin. Drug Discov.
PD OCT
PY 2016
VL 11
IS 10
BP 921
EP 923
DI 10.1080/17460441.2016.1212013
PG 3
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DW8VQ
UT WOS:000383934000002
PM 27401601
ER

PT J
AU Cinnamon, J
   Jones, SK
   Adger, WN
AF Cinnamon, Jonathan
   Jones, Sarah K.
   Adger, W. Neil
TI Evidence and future potential of mobile phone data for disease disaster
   management
SO GEOFORUM
LA English
DT Article
DE Mobile phone; Call detail records; SMS; Disaster; Disease; Big data
ID BIG DATA; SURVEILLANT ASSEMBLAGE; POPULATION; CRISIS; MALARIA; TRAVEL;
   TOOL; SMS
AB Global health threats such as the recent Ebola and Zika virus outbreaks require rapid and robust responses to prevent, reduce and recover from disease dispersion. As part of broader big data and digital humanitarianism discourses, there is an emerging interest in data produced through mobile phone communications for enhancing the data environment in such circumstances. This paper assembles user perspectives and critically examines existing evidence and future potential of mobile phone data derived from call detail records (CDRs) and two-way short message service (SMS) platforms, for managing and responding to humanitarian disasters caused by communicable disease outbreaks. We undertake a scoping review of relevant literature and in-depth interviews with key informants to ascertain the: (i) information that can be gathered from CDRs or SMS data; (ii) phase(s) in the disease disaster management cycle when mobile data may be useful; (iii) value added over conventional approaches to data collection and transfer; (iv) barriers and enablers to use of mobile data in disaster contexts; and (v) the social and ethical challenges. Based on this evidence we develop a typology of mobile phone data sources, types, and end-uses, and a decision-tree for mobile data use, designed to enable effective use of mobile data for disease disaster management. We show that mobile data holds great potential for improving the quality, quantity and timing of selected information required for disaster management, but that testing and evaluation of the benefits, constraints and limitations of mobile data use in a wider range of mobile-user and disaster contexts is needed to fully understand its utility, validity, and limitations. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Cinnamon, Jonathan; Adger, W. Neil] Univ Exeter, Dept Geog, Coll Life & Environm Sci, Exeter, Devon, England.
   [Jones, Sarah K.] Kings Coll London, Dept Geog, London WC2R 2LS, England.
RP Cinnamon, J (reprint author), Univ Exeter, Dept Geog, Amory Bldg,Rennes Dr, Exeter EX4 4RJ, Devon, England.
EM j.cinnamon@exeter.ac.uk
FU UK Department for International Development (DFID); Natural Environment
   Research Council (NERC); Economic and Social Research Council (ESRC)
FX A portion of this research was funded as part of the Science for
   Humanitarian Emergencies and Resilience (SHEAR) programme, by the UK
   Department for International Development (DFID), the Natural Environment
   Research Council (NERC) and the Economic and Social Research Council
   (ESRC). Thank you to the interview participants for sharing their
   practical insight and perspectives, and to the four reviewers for
   suggestions that improved the manuscript.
CR Ahas R, 2015, INT J GEOGR INF SCI, V29, P2017, DOI 10.1080/13658816.2015.1063151
   Ahas R, 2014, J URBAN TECHNOL, V21, P1, DOI 10.1080/10630732.2014.913420
   Alexander D.E., 2002, PRINCIPLES EMERGENCY
   Anderson C., 2008, WIRED, V16, P16
   Anderson M., 2014, GUARDIAN
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Asiimwe C, 2011, AM J TROP MED HYG, V85, P26, DOI 10.4269/ajtmh.2011.10-0528
   Asokan G V, 2015, J Epidemiol Glob Health, V5, P311, DOI 10.1016/j.jegh.2015.02.001
   Aubrecht C, 2015, NAT HAZARDS, P1
   Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923
   Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083
   Bharti N, 2015, INT HEALTH, V7, P90, DOI 10.1093/inthealth/ihv003
   Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878
   Buckee CO, 2013, TRAVEL MED INFECT DI, V11, P15, DOI 10.1016/j.tmaid.2012.12.003
   Bums R., 2015, GEOJOURNAL, V80, P477
   Burns R, 2014, GEOFORUM, V53, P51, DOI 10.1016/j.geoforum.2014.02.002
   Buscher M., 2014, INT J INF SYST CRISI, V6
   Buscher M., 2013, P 10 INT ISCRAM C BA
   Cecaj A, 2016, J AMB INTEL HUM COMP, V7, P83, DOI 10.1007/s12652-015-0303-x
   Chandler C, 2015, LANCET, V385, P1275, DOI 10.1016/S0140-6736(14)62382-5
   Cinnamon J., 2013, GEOJOURNAL, V78, P657, DOI [DOI 10.1007/S10708-012-9458-6, 10.1007/s10708-012-9458-6]
   Crawford K, 2015, GEOJOURNAL, V80, P491, DOI 10.1007/s10708-014-9597-z
   Center for Global Development, 2014, DEL DAT REV SUBS AFR
   Custers B., 2016, INT DATA PRIVACY LAW
   de Montjoye Y.A., 2014, ISS TECHNOL INNO NOV, P1
   Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111
   Douglass RW, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0040-6
   Doyle J, 2014, J URBAN TECHNOL, V21, P109, DOI 10.1080/10630732.2014.888904
   Fadiya S.O., 2014, PROCEDIA ENG, V78, P88
   FCS, 2012, UK STAND CDRS
   Gao S, 2013, T GIS, V17, P463, DOI 10.1111/tgis.12042
   Gilpin L., 2014, ALGORITHM DETECTED E
   Goodchild MF, 2010, INT J DIGIT EARTH, V3, P231, DOI 10.1080/17538941003759255
   Griffin G.F., 2014, GEOMATICA, V68, P265
   GSMA, 2015, MOB EC 2015
   GSMA, 2013, COD COND GUID US SMS
   GSMA, 2014, GSMA GUID PROT PRIV
   Haggerty KD, 2000, BRIT J SOCIOL, V51, P605
   Hern A., 2014, GUARDIAN
   Hey A.J., 2009, 4 PARADIGM DATA INTE
   Higgins A., 2014, FIGHTING EBOLA LIBER
   Jacobsen K., 2014, CHRISTIAN SCI MONITO
   Jarv O, 2014, TRANSPORT RES C-EMER, V38, P122, DOI 10.1016/j.trc.2013.11.003
   Kennedy H., 2015, BIG DATA SOC, V2
   Kitchin R, 2014, BIG DATA SOC, V1, P1, DOI DOI 10.1177/2053951714528481
   Kitchin Rob, 2013, DIALOGUES HUMAN GEOG, V3, P262, DOI [DOI 10.1177/2043820613513388, 10.1177/2043820613513388]
   Kitchin Rob, 2014, GEOJOURNAL, V79, P1, DOI DOI 10.1007/S10708-013-9516-8
   Koch T., 2016, CAN GEOGR
   Leszczynski A, 2015, ENVIRON PLANN D, V33, P965, DOI 10.1177/0263775815595814
   Lydersen K., 2014, HALT EBOLAS SPREAD
   Lyon D., 2007, SURVEILLANCE STUDIES
   Lyon D., 2003, SURVEILLANCE SOCIAL
   Macharia K, 2015, AFRICA IS BIG DATA S
   Madianou M., 2015, INT J COMMUN, V9, P19
   MapAction, 2016, GETT HELP ITS NEED M
   Mayer J., 2014, METAPHONE SENSITIVIT
   McDonald S.M., 2016, EBOLA BIG DATA DISAS
   Meier P., 2015, DIGITAL HUMANITARIAN
   Miller HJ, 2010, J REGIONAL SCI, V50, P181, DOI 10.1111/j.1467-9787.2009.00641.x
   Miller HJ, 2015, GEOJOURNAL, V80, P449, DOI 10.1007/s10708-014-9602-6
   Muah S., 2014, TECH SECTOR CAN HELP
   Mushayi W., 2015, MAKING SCH SAFER SIE
   O'Donovan J, 2015, LANCET GLOB HEALTH, V3, pE22, DOI 10.1016/S2214-109X(14)70357-2
   Oliver N., 2013, GUARDIAN
   Pew Research Center,, 2015, CELL PHON AFR COMM L
   Pu C., 2013, BIG DAT DIS MAN JST
   Revere Debra, 2014, BMC Res Notes, V7, P514, DOI 10.1186/1756-0500-7-514
   Roche Stephane, 2013, GEOJOURNAL, V78, P21, DOI DOI 10.1007/S10708-011-9423-9
   Scepanovic S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124160
   Shacklett M., 2015, FIGHTING EBOLA HOLIS
   Shanley LA, 2013, PHOTOGRAMM ENG REM S, V79, P865
   Shelton T, 2014, GEOFORUM, V52, P167, DOI 10.1016/j.geoforum.2014.01.006
   Tatem AJ, 2014, INT HEALTH, V6, P5, DOI 10.1093/inthealth/ihu006
   Tatem AJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-52
   Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287
   Taylor L., 2015, ENV PLANN D
   Taylor L, 2015, GEOFORUM, V64, P229, DOI 10.1016/j.geoforum.2015.07.002
   Thatcher J., 2016, ENV PLANN D
   Thompson S., 2006, International Journal of Emergency Management, V3, P250, DOI 10.1504/IJEM.2006.011295
   Townsend A.M., 2013, SMART CITIES BIG DAT
   Tracey L.E., 2015, EURO SURVEILL, V20
   Trad Mohamad-Ali, 2015, F1000Res, V4, P43, DOI 10.12688/f1000research.6105.1
   UN International Strategy for Disaster Reduction, 2009, UNISDR TERM DIS RISK
   Vasilescu L., 2008, MANAGE MARKET, P43
   Vayena E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003904
   Voigt S, 2007, IEEE T GEOSCI REMOTE, V45, P1520, DOI 10.1109/TGRS.2007.895830
   Wesolowski A, 2014, PLOS CURR, V2014, P6
   Wesolowski A., 2014, SCI REP, V4
   Whitford HM, 2012, J AM MED INFORM ASSN, V19, P744, DOI 10.1136/amiajnl-2011-000785
   Wood DM, 2013, GEOFORUM, V49, P317, DOI 10.1016/j.geoforum.2013.07.001
   Xu Y, 2016, ANN AM ASSOC GEOGR, V106, P489, DOI 10.1080/00045608.2015.1120147
   Yang CH, 2009, B WORLD HEALTH ORGAN, V87, P619, DOI 10.2471/BLT.08.060905
   Young SD, 2015, PREV MED, V70, P17, DOI 10.1016/j.ypmed.2014.11.002
   Zhao Z., 2016, INT J GEOGR INF SCI, P1
   Zhong SR, 2016, ANN AM ASSOC GEOGR, V106, P480, DOI 10.1080/00045608.2015.1113113
   Zook M., 2010, World Medical and Health Policy, V2, P7, DOI 10.2202/1948-4682.1069
   Zoomers A, 2016, GEOFORUM, V69, P147, DOI 10.1016/j.geoforum.2015.11.017
   Zwitter A., 2014, BIG DATA SOC, V1, P1
   [Anonymous], 2014, GUARDIAN
   [Anonymous], 2014, ECONOMIST
NR 100
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0016-7185
EI 1872-9398
J9 GEOFORUM
JI Geoforum
PD OCT
PY 2016
VL 75
BP 253
EP 264
DI 10.1016/j.geoforum.2016.07.019
PG 12
WC Geography
SC Geography
GA DW8ZJ
UT WOS:000383943700027
ER

PT J
AU Gadea, G
   Bos, S
   Krejbich-Trotot, P
   Clain, E
   Viranaicken, W
   El-Kalamouni, C
   Mavingui, P
   Despres, P
AF Gadea, Gilles
   Bos, Sandra
   Krejbich-Trotot, Pascale
   Clain, Elodie
   Viranaicken, Wildriss
   El-Kalamouni, Chaker
   Mavingui, Patrick
   Despres, Philippe
TI A robust method for the rapid generation of recombinant Zika virus
   expressing the GFP reporter gene
SO VIROLOGY
LA English
DT Article
DE Arbovirus; Emerging disease; Flavivirus; Zika virus; Molecular clones;
   Recombinant virus; GFP reporter
ID WEST-NILE-VIRUS; DENGUE VIRUS; RNA VIRUSES; CHIKUNGUNYA; LUCIFERASE;
   EMERGENCE; SYSTEMS; PROTEIN
AB Zika virus (ZIKV) infection is a major public health problem with severe human congenital and neurological anomalies. The screening of anti-ZIKV compounds and neutralizing antibodies needs reliable and rapid virus-based assays. Here, we described a convenient method leading to the rapid production of molecular clones of ZIKV. To generate a molecular clone of ZIKV strain MR766(NIID), the viral genome was directly assembled into Vero cells after introduction of four overlapping synthetic fragments that cover the full-length genomic RNA sequence. Such strategy has allowed the production of a recombinant ZIKV expressing the GFP reporter gene that is stable over two culturing rounds on Vero cells. Our data demonstrate that the ZIKV reporter virus is a very reliable GFP-based tool for analyzing viral growth and measuring the neutralizing antibody as well as rapid screening of antiviral effect of different classes of inhibitors. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Gadea, Gilles; Bos, Sandra; Krejbich-Trotot, Pascale; Clain, Elodie; Viranaicken, Wildriss; El-Kalamouni, Chaker; Mavingui, Patrick; Despres, Philippe] Univ La Reunion, CNRS UMR 9192, Plateforme Technol CYROI,INSERM U1187, IRD UMR 249,Unite Mixte Proc Infectieux Insulaire, F-97490 St Clotilde, Reunion.
RP Despres, P (reprint author), Univ La Reunion, CNRS UMR 9192, Plateforme Technol CYROI,INSERM U1187, IRD UMR 249,Unite Mixte Proc Infectieux Insulaire, F-97490 St Clotilde, Reunion.
EM philippe.despres@univ-reunion.fr
FU grant ZIKAVAx from the INSERM-transfert, France; grant DIRED from the
   Conseil General de La Reunion, France
FX We are grateful to ML. Gougeon, M. de Wispelaere, M. Roche, and E.
   Frumence, for helpful discussion and assistance during the course of
   this work. This research was supported in part by the grant ZIKAVAx from
   the INSERM-transfert, France. EC is supported by a grant DIRED from the
   Conseil General de La Reunion, France.
CR Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Brehin AC, 2008, VIROLOGY, V371, P185, DOI 10.1016/j.virol.2007.09.028
   Cao-Lormeau M., 2016, LANCET
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   de Wispelaere M, 2015, J VIROL, V89, P5862, DOI [10.1128/JVI.00358-15, 10.1128/JVI.00358]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gatherer D., 2015, J GEN VIROL
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Mertens E, 2010, VIROLOGY, V399, P176, DOI 10.1016/j.virol.2009.12.036
   Musso D., 2016, CLIN MICROBIOL REV
   Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Quick K. M., 2016, CELL HOST MICROBE
   Ren LZ, 2016, APPL BIOCHEM BIOTECH, V178, P1567, DOI 10.1007/s12010-015-1968-5
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Shan C., 2016, CELL HOST MICROBE, V0
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhang PT, 2016, VIRUS RES, V211, P17, DOI 10.1016/j.virusres.2015.09.015
   Zmurko J., 2016, PLOS NEGLECT TROP D
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 24
TC 0
Z9 0
U1 8
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD OCT
PY 2016
VL 497
BP 157
EP 162
DI 10.1016/j.virol.2016.07.015
PG 6
WC Virology
SC Virology
GA DW8RC
UT WOS:000383922200016
PM 27471954
ER

PT J
AU Gostin, LO
   Hodge, JG
AF Gostin, Lawrence O.
   Hodge, James G., Jr.
TI Zika virus and global health security
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.
   [Hodge, James G., Jr.] Arizona State Univ, Sandra Day OConnor Coll Law, Phoenix, AZ USA.
RP Gostin, LO (reprint author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.
EM gostin@law.georgetown.edu
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Belson K, 2016, NY TIMES
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Hodge JG, 2016, US NEWS WORLD REP
   Lewis JT, 2016, WALL STREET J
   Pan American Health Organization, REG ZIK EP UPD AM
   Perking TA, 2016, NAT MICROBIOL, V1, P16126
   Pestano AV, 2016, POLL 88 PERCENT AM N
   Tavernise S, 2016, NY TIMES
   Whitefield M, 2016, MIAMI HERALD
   WHO, WHO DIR GEN ADDR HIG
   WHO, ZIK RESP FUND
   WHO, CONT FUND EM INC ALL
   World Bank, WORLD BANK PROV 150
   World Bank Group, SHORT TERM EC COSTS
   Zagorskey JL, 2016, SCI AM
   [Anonymous], 2016, BBC NEWS
NR 17
TC 0
Z9 0
U1 48
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1099
EP 1100
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000014
PM 27676336
ER

PT J
AU Yakob, L
   Kucharski, A
   Hue, S
   Edmunds, WJ
AF Yakob, Laith
   Kucharski, Adam
   Hue, Stephane
   Edmunds, W. John
TI Low risk of a sexually-transmitted Zika virus outbreak
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID EPIDEMIC AREA; APRIL 2016; TRANSMISSION; SEMEN
C1 [Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect & Trop Dis, London WC1E 7HT, England.
   [Kucharski, Adam; Hue, Stephane; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.
RP Yakob, L (reprint author), London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect & Trop Dis, London WC1E 7HT, England.
EM laith.yakob@lshtm.ac.uk
CR D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   ECDC, 2016, HLTH TOP ZIK VIR INF
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0
   Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
NR 12
TC 0
Z9 0
U1 24
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1100
EP 1102
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000015
PM 27676337
ER

PT J
AU Mansuy, JM
   Suberbielle, E
   Chapuy-Regaud, S
   Mengelle, C
   Bujan, L
   Marchou, B
   Delobel, P
   Gonzalez-Dunia, D
   Malnou, CE
   Izopet, J
   Martin-Blondel, G
AF Mansuy, Jean Michel
   Suberbielle, Elsa
   Chapuy-Regaud, Sabine
   Mengelle, Catherine
   Bujan, Louis
   Marchou, Bruno
   Delobel, Pierre
   Gonzalez-Dunia, Daniel
   Malnou, Cecile E.
   Izopet, Jacques
   Martin-Blondel, Guillaume
TI Zika virus in semen and spermatozoa
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Mansuy, Jean Michel; Chapuy-Regaud, Sabine; Mengelle, Catherine; Izopet, Jacques] CHU Toulouse, Lab Virol, Inst Federatif Biol, F-31059 Toulouse, France.
   [Suberbielle, Elsa; Chapuy-Regaud, Sabine; Delobel, Pierre; Gonzalez-Dunia, Daniel; Malnou, Cecile E.; Izopet, Jacques; Martin-Blondel, Guillaume] Univ Toulouse, CNRS, INSERM, Ctr Physiopathol Toulouse Purpan,UPS, Toulouse, France.
   [Marchou, Bruno; Delobel, Pierre; Martin-Blondel, Guillaume] CHU Toulouse, Serv Malad Infect & Trop, Toulouse, France.
   [Bujan, Louis] Univ Toulouse, Human Fertil Res Grp, CECOS, Ctr Hosp Univ Paule de Viguier,UPS, Toulouse, France.
RP Mansuy, JM (reprint author), CHU Toulouse, Lab Virol, Inst Federatif Biol, F-31059 Toulouse, France.
EM mansuy.jm@chu-toulouse.fr
CR Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sow MS, 2016, J INFECT DIS, DOI [10.1093/infdis/jiw078, DOI 10.1093/INFDIS/JIW078]
NR 5
TC 0
Z9 0
U1 13
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1106
EP 1107
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000019
PM 27676340
ER

PT J
AU Arsuaga, M
   Bujalance, SG
   Diaz-Menendez, M
   Vazquez, A
   Arribas, JR
AF Arsuaga, Marta
   Garcia Bujalance, Silvia
   Diaz-Menendez, Marta
   Vazquez, Ana
   Arribas, Jose R.
TI Probable sexual transmission of Zika virus from a vasectomised man
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Arsuaga, Marta; Diaz-Menendez, Marta; Arribas, Jose R.] Hosp Univ La Paz IdiPAZ, Dept Internal Med, Madrid 28046, Spain.
   [Garcia Bujalance, Silvia] Hosp Univ La Paz IdiPAZ, Dept Microbiol, Madrid 28046, Spain.
   [Arribas, Jose R.] Hosp Univ La Paz IdiPAZ, Infect Dis Unit, Madrid 28046, Spain.
   [Vazquez, Ana] Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Arbovirus & Imported Viral Dis, Madrid, Spain.
RP Arribas, JR (reprint author), Hosp Univ La Paz IdiPAZ, Dept Internal Med, Madrid 28046, Spain.; Arribas, JR (reprint author), Hosp Univ La Paz IdiPAZ, Infect Dis Unit, Madrid 28046, Spain.
EM joser.arribas@salud.madrid.org
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
NR 3
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1107
EP 1107
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000020
PM 27676342
ER

PT J
AU Purpura, LJ
   Choi, MJ
   Rollin, PE
AF Purpura, Lawrence J.
   Choi, Mary J.
   Rollin, Pierre E.
TI Zika virus in semen: lessons from Ebola
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Purpura, Lawrence J.; Choi, Mary J.; Rollin, Pierre E.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.
RP Purpura, LJ (reprint author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.
EM yxp0@cdc.gov
CR Brooks John T, 2016, MMWR Morb Mortal Wkly Rep, V65, P745, DOI 10.15585/mmwr.mm6529e2
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Soka MJ, 2016, LANCET GLOBAL HLTH
   World Health Organization, 2016, INT ADV SEX TRANSM E
NR 7
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1107
EP 1108
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000021
PM 27676341
ER

PT J
AU Musso, D
   Baud, D
   Freedman, DO
AF Musso, Didier
   Baud, David
   Freedman, David O.
TI Should testing of donors be restricted to active Zika virus areas?
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti 98713, Fr Polynesia.
   [Baud, David] Univ Lausanne Hosp, Maternofetal & Obstet Res Unit, Dept Femme Mere Enfant, Matern, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne Hosp, Lausanne, Switzerland.
   [Freedman, David O.] Univ Alabama Birmingham, Div Infect Dis, William C Gorgas Ctr Geog Med, Birmingham, AL USA.
RP Musso, D (reprint author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti 98713, Fr Polynesia.
EM dmusso@ilm.pf
CR Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Meltzer Eyal, 2016, Emerg Infect Dis, V22, P1521, DOI 10.3201/eid2208.160480
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rafiei N, 2016, MED J AUST, V204, P186
   WHO, 2016, SIT REP ZIK VIR MICR
NR 5
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1108
EP 1109
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000022
PM 27676343
ER

PT J
AU Levy-Blitchtein, S
   del Valle-Mendoza, J
AF Levy-Blitchtein, Saul
   del Valle-Mendoza, Juana
TI Zika virus is arriving at the American continent
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Arbovirosis; Dengue virus; Chikungunya; Aedes aegypti
ID INFECTION; SPREADS
AB Zika virus is the last arbovirosis arriving at the American continent and it is able to produce severe complications due to its neurotropism, such as microcephaly and it is also associated with Guillain-Barre syndrome (GBS). Presence of Aedes aegypti in many regions of Peru makes it easier to spread and it could be present in population, not being detected because there is a lack of rapid diagnosis methods. It is important to make a quick, effective and combined response to this new threat.
C1 [Levy-Blitchtein, Saul; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas UPC, Sch Med, Fac Hlth Sci, Lima, Peru.
   [Levy-Blitchtein, Saul; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas UPC, Fac Hlth Sci, Res Ctr & Innovat, Lima, Peru.
   [del Valle-Mendoza, Juana] Inst Invest Nutr, Lima, Peru.
   [Levy-Blitchtein, Saul] Univ Peruana Ciencias Aplicadas UPC, Av Primavera 2390, Lima, Peru.
RP del Valle-Mendoza, J (reprint author), Univ Peruana Ciencias Aplicadas UPC, Av Primavera 2390, Lima, Peru.
EM jdelvall@upc.edu.pc
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, ZIK VIR HLTH CAR PRO
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Kindhauser MK, 2016, B WHO
   Leiva G Nlida, 2004, Rev. per. med. exp. salud publica, V21, P157
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Pan American Health Organization, ZIK VIR INF
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Peru Ministerio de Salud, 2011, APR EXP LECC APR PRE
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Yez Pamela, 2013, Rev. per. med. exp. salud publica, V30, P246
NR 26
TC 0
Z9 0
U1 33
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD OCT
PY 2016
VL 9
IS 10
BP 997
EP 999
DI 10.1016/j.apjtm.2016.07.030
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DV4LA
UT WOS:000382895900016
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Estimated number of local transmission cases of Zika virus infection
   imported from Brazil to France
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Letter
DE Zika virus; Infection; Importation; Transmission
AB The Zika virus infection becomes the present public health threat and the control of this disease needs international collaboration. An important problem is the international travel that promotes the importation of Zika virus disease to the new setting. The local transmission of the imported infection is the big problem. Based on the available data on published articles, in this letter, the authors estimated the number of local transmission cases, by both mosquito borne and sexually transmitted modes, of Zika virus infection imported from Brazil to France.
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Wiwanitkit, S (reprint author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Gao Daozhou, 2016, Sci Rep, V6, P28070, DOI 10.1038/srep28070
   Maria AT, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917]
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Wiwanitkit Somsri, 2016, Asian Pac J Trop Med, V9, P513, DOI 10.1016/j.apjtm.2016.03.036
NR 6
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD OCT
PY 2016
VL 9
IS 10
BP 1000
EP 1000
DI 10.1016/j.apjtm.2016.07.032
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DV4LA
UT WOS:000382895900017
ER

PT J
AU Haque, U
   Ball, JD
   Zhang, WY
   Khan, MMH
   Trevino, JA
AF Haque, Ubydul
   Ball, Jacob D.
   Zhang, Wenyi
   Khan, Md. Mobarak Hossain
   Trevino C, Jesus A.
TI Clinical and spatial features of Zika virus in Mexico
SO ACTA TROPICA
LA English
DT Article
ID UNITED-STATES; TRAVEL; AGE
AB Background: Zika virus (ZIKV) is an emerging arbovirus transmitted to humans by Aedes mosquitoes, the same vectors that transmit dengue virus and chikungunya. Recent work has suggested that prior infection with dengue could lead to more severe clinical disease in ZIKV patients. Here, we describe the spatial distribution of and clinical symptoms experienced by ZIKV cases in Mexico.
   Methods: We performed Fisher's Exact test and Pearson's Chi-Square tests on data from Mexico's national surveillance system on the demographic and clinical characteristics of ZIKV patients (N=84), and then a multivariate logistic regression analysis to determine demographic risk factors for patients presenting with at least 9 symptoms. We also mapped the cases to describe the spatial distribution of ZIKV in Mexico.
   Results: Results from the multivariate logistic regression analysis indicate that, controlling for all covariates, sex (male) is a significant protective factor in reporting a high number of symptoms (OR = 0.36, 95% CI: 0.14, 0.92), and that a one-year increase in age is associated with a 4% increase in odds of having at least 9 symptoms (95% CI: 1.00, 1.08). Spatial analysis revealed more than 50% cases reported within 50 km of railways.
   Conclusion: We found that sex and age are both significant risk factors for ZIKV infection severity, using number of reported symptoms as a proxy. The presence of cases along railways indicates that transportation networks within Mexico may be relevant for the national and international spread of the disease. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Haque, Ubydul] Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   [Haque, Ubydul; Ball, Jacob D.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Ball, Jacob D.] Univ Florida, Dept Epidemiol, Gainesville, FL USA.
   [Zhang, Wenyi] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.
   [Khan, Md. Mobarak Hossain] King Faisal Univ, Dept Publ Hlth, Al Hufuf, Al Ahsa, Saudi Arabia.
   [Trevino C, Jesus A.] Univ Autonoma Nuevo Leon, San Nicolas De Los Garza, Nuevo Leon, Mexico.
RP Trevino, JA (reprint author), Univ Autonoma Nuevo Leon, San Nicolas De Los Garza, Nuevo Leon, Mexico.
EM jtrevino41@hotmail.com
FU Emerging Pathogens Institute at the University of Florida; College of
   Liberal Arts and Sciences, as part of the University of Florida
   Pre-eminence Initiative; King Faisal University; SMART Scholarship
   Program; US Assistant Secretary of Defense for Research and Education,
   National Defense Education Program (NDEP)/BA-1, Basic Research
   [Defense-Wide/PE0601120D8Z]
FX Ubydul Hague was supported in part by the Emerging Pathogens Institute
   at the University of Florida and the College of Liberal Arts and
   Sciences, as part of the University of Florida Pre-eminence Initiative.
   Md. Mobarak Hossain Khan was supported by King Faisal University. Jacob
   D. Ball was supported by the SMART Scholarship Program, which is funded
   by the US Assistant Secretary of Defense for Research and Education,
   Defense-Wide/PE0601120D8Z National Defense Education Program
   (NDEP)/BA-1, Basic Research. The authors appreciate the constructive
   comments of Maria Eugenia Jimenez Corona, from the General Directorate
   of Epidemiology, Ministry of Health, Mexico.
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Jimenez Corona M.E., 2016, PLOS CURRENTS OUTBRE
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Direccion General de Epidemiologia, 2016, SECR SAL LIN EST VIG
   Egger JR, 2007, EMERG INFECT DIS, V13, P924
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Jenkins Nash, 2016, 1 3 DEATHS COLOMBIA
   Karimi Faith, 2016, 3 DEATHS LINKED ZIKA
   Kindhauser MK, 2016, B WHO
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan A.J., 2016, PLOS CURR, V8
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Paul L. M., 2016, DENGUE VIRUS ANTIBOD
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rodriguez-Morales A.J., 2016, B WHO
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Secretaria de Salud, 2016, MEX ZIK UPD MEX 2016
NR 18
TC 0
Z9 0
U1 80
U2 80
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD OCT
PY 2016
VL 162
BP 5
EP 10
DI 10.1016/j.actatropica.2016.06.010
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DT9RS
UT WOS:000381840600002
PM 27311388
ER

PT J
AU Murugan, K
   Anitha, J
   Dinesh, D
   Suresh, U
   Rajaganesh, R
   Chandramohan, B
   Subramaniam, J
   Paulpandi, M
   Vadivalagan, C
   Amuthavalli, P
   Wang, L
   Hwang, JS
   Wei, H
   Alsalhi, MS
   Devanesan, S
   Kumar, S
   Pugazhendy, K
   Higuchi, A
   Nicoletti, M
   Benelli, G
AF Murugan, Kadarkarai
   Anitha, Jaganathan
   Dinesh, Devakumar
   Suresh, Udaiyan
   Rajaganesh, Rajapandian
   Chandramohan, Balamurugan
   Subramaniam, Jayapal
   Paulpandi, Manickam
   Vadivalagan, Chitravel
   Amuthavalli, Pandiyan
   Wang, Lan
   Hwang, Jiang-Shiou
   Wei, Hui
   Alsalhi, Mohamad Saleh
   Devanesan, Sandhanasamy
   Kumar, Suresh
   Pugazhendy, Kannaiyan
   Higuchi, Akon
   Nicoletti, Marcello
   Benelli, Giovanni
TI Fabrication of nano-mosquitocides using chitosan from crab shells:
   Impact on non-target organisms in the aquatic environment
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Anopheles stephensi; biosafety; Culicidae; Danio rerio; Non-target
   effects; Plasmodium
ID SYNTHESIZED SILVER NANOPARTICLES; VECTOR AEDES-AEGYPTI; BORNE DISEASES;
   MEDIATED SYNTHESIS; DIPTERA-CULICIDAE; DENGUE VECTOR; ZIKA VIRUS;
   ANTIBACTERIAL PROPERTIES; VETERINARY IMPORTANCE; PREDATION EFFICIENCY
AB Mosquitoes are arthropods of huge medical and veterinary relevance, since they vector pathogens and parasites of public health importance, including malaria, dengue and Zika virus. Currently, nano technology is considered a potential eco-friendly approach in mosquito control research. We proposed a novel method of biofabrication of silver nanopartides (AgNP) using chitosan (Ch) from crab shells. Ch-AgNP nanocomposite was characterized by UV-vis spectroscopy, FTIR, SEM, EDX and XRD. Ch-AgNP were tested against larvae and pupae of the malaria vector Anopheles stephensi obtaining LC50 ranging from 3.18 ppm (I) to 6.54 ppm (pupae). The antibacterial properties of Ch-AgNP were proved against Bacillus subtilis, Kiebsiella pneumoniae and Salmonella typhi, while no growth inhibition was reported in assays conducted on Proteus vulgaris. Concerning non-target effects, in standard laboratory considtions the predation efficiency of Danio rerio zebrafishes was 68.8% and 61.6% against I and II instar larvae of A. stephensi, respectively. In a Ch-AgNP-contaminated environment, fish predation was boosted to 89.5% and 77.3%, respectively. Quantitative analysis of antioxidant enzymes SOD, CAT and 120 from hepatopancreas of fresh water crabs Parateiphusa hydmdromous exposed for 16 clays to a Ch-AgNP-contaminated aquatic environment were conducted. Notably, deleterious effects of Ch-AgNP contaminating aquatic enviroment on the non-target crab P. hydrodromous were observed, particularly when doses higher than 8-10 ppm are tested. Overall, this research highlights the potential of Ch-AGNP for the development of newer control tools against young instar populations of malaria mosquitoes, also highlighting some risks concerned the employ of nanopartides in aquatic environments. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Murugan, Kadarkarai; Anitha, Jaganathan; Dinesh, Devakumar; Suresh, Udaiyan; Rajaganesh, Rajapandian; Chandramohan, Balamurugan; Subramaniam, Jayapal; Paulpandi, Manickam; Vadivalagan, Chitravel; Amuthavalli, Pandiyan] Bharathiar Univ, Sch Life Sci, Dept Zool, Coimbatore 641046, Tamil Nadu, India.
   [Murugan, Kadarkarai] Thiruvalluvar Univ, Dept Biotechnol, Vellore 632115, Tamil Nadu, India.
   [Wang, Lan] Shanxi Univ, Sch Life Sci & Technol, Taiyuan 030006, Peoples R China.
   [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan.
   [Wei, Hui] Fujian Acad Agr Sci, Inst Plant Protect, Fuzhou 350013, Fujian, Peoples R China.
   [Alsalhi, Mohamad Saleh; Devanesan, Sandhanasamy] King Saud Univ, Dept Phys & Astron, Res Chair Laser Diag Canc, Riyadh, Saudi Arabia.
   [Kumar, Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Fac Med & Hlth Sci, Seri Kembangan, Malaysia.
   [Pugazhendy, Kannaiyan] Annamalai Univ, Dept Zool, Annamalainagar 608002, Tamil Nadu, India.
   [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, 300 Jhongli, Taoyuan 32001, Taiwan.
   [Nicoletti, Marcello] Sapienza Univ Rome, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Vale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
RP Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013
FU King Saud University, through the Vice Deanship of Research Chairs;
   PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX Prof. K. Kannan and three anonymous reviewers improved an earlier
   version of the manuscript. The authors would like to thank the financial
   support rendered by King Saud University, through the Vice Deanship of
   Research Chairs. G. Benelli is supported by PROAPI (PRAF 2015) and
   University of Pisa, Department of Agriculture, Food and Environment
   (Grant ID: COFIN2015_22). Funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aebi H., 1974, METHOD ENZYMAT AN, P671
   Ali SW, 2011, CARBOHYD POLYM, V83, P438, DOI 10.1016/j.carbpol.2010.08.004
   Wazed Ali S., 2001, CARBOHYD POLYM, V83, P438
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Benelli G., 2015, PARASITOL RES
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli Giovanni, 2016, Asian Pacific Journal of Tropical Biomedicine, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Benelli Giovanni, 2016, Asian Pacific Journal of Tropical Biomedicine, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, PARASITOL RES, V115, P2545, DOI 10.1007/s00436-016-5095-1
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Bittelli M, 2001, AGR FOREST METEOROL, V107, P167, DOI 10.1016/S0168-1923(00)00242-2
   BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Buege J A, 1978, Methods Enzymol, V52, P302
   Cahu TB, 2012, PROCESS BIOCHEM, V47, P570, DOI 10.1016/j.procbio.2011.12.012
   Casals P, 2002, P 10 IUPAC INT C CHE, V1, P228
   Chen P, 2007, RADIAT PHYS CHEM, V76, P1165, DOI 10.1016/j.radphyschem.2006.11.012
   Company R, 2004, MAR ENVIRON RES, V58, P377, DOI 10.1016/j.marenvres.2004.03.083
   Deduve C, 1985, TISSUE BIOCH J, V60, P604
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Ruas CBG, 2008, ECOTOX ENVIRON SAFE, V71, P86, DOI 10.1016/j.ecoenv.2007.08.018
   Gibson R., 1979, Oceanography and Marine Biology an Annual Review, V17, P285
   Govindan S., 2012, APPL NANOSCI, V2, P299, DOI DOI 10.1007/S13204-012-0109-5
   Govindarajan M., 2016, J CLUST SCI
   Govindarajan M., 2016, ENZYM MICROB TECHNOL
   Govindarajan M, 2016, PARASITOL RES, V115, P2685, DOI 10.1007/s00436-016-5038-x
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI [10.1016/j.rvsc.2015.11.011, 10.1016/j.rvsc.2016.05.017]
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Harris V.C, 2010, PLOS PATHOG, V6
   Howard A.F.B., 2007, STUDY BMC PUBL HLTH, V7, P7
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Kalimuthu K, 2014, HYDROBIOLOGIA, V741, P113, DOI 10.1007/s10750-013-1745-9
   [Anonymous], 2007, CHIN J OCEANOL LIMN, DOI 10.1007/S00343-007-0221-7
   Lamarque G, 2005, BIOMACROMOLECULES, V6, P131, DOI 10.1021/bm0496357
   Lee YG, 2009, PROTEIN EXPRES PURIF, V65, P244, DOI 10.1016/j.pep.2008.12.004
   Lertsutthiwong P., 2002, J METALS MAT MINERAL, V12, P11
   Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1
   MacFarlane G., 2007, ARCH ENV CONTAM TOXI, V51, P584
   Govindarajan Marimuthu, 2016, Journal of Asia-Pacific Entomology, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan Marimuthu, 2016, Journal of Asia-Pacific Entomology, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Mukherjee P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075103
   Murugadoss A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/01/015603
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   [Anonymous], 1985, J CARBOHYDR POLYM
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Pavasovic M, 2004, AQUACULTURE, V242, P641, DOI 10.1016/j.aquaculture.2004.08.036
   Pavela R., 2015, PARASITOL RES
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pugazhendy K., 2015, INT J ADV RES BIOL S, V2, P183
   Rai R, 2011, SCI MICROBIAL PATHOG, P197
   Reinecke AJ, 2003, WATER AIR SOIL POLL, V145, P395, DOI 10.1023/A:1023602121272
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Rueda LM, 2008, HYDROBIOLOGIA, V595, P477, DOI 10.1007/s10750-007-9037-x
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Said S.M., 2011, AZ J PHARM SCI, V43, P123
   [Anonymous], 2012, INT RES J BIOL SCI
   Sanpui P, 2008, INT J FOOD MICROBIOL, V124, P142, DOI 10.1016/j.ijfoodmicro.2008.03.004
   Saraswathy G, 2001, B MATER SCI, V24, P415, DOI 10.1007/BF02708641
   Sastry K.V., 2004, NAT S BIOD BIOT ENV, V75
   [Anonymous], 2003, BLOCH ECOTOXICOL ENV, DOI DOI 10.1016/S0147-6513(03)00009-5
   Schuwerack PMM, 2001, ECOTOXICOLOGY, V10, P159, DOI 10.1023/A:1016689810391
   Sereemaspun A, 2008, INT J PHARMACEUT, V4, P492, DOI DOI 10.3923/IJP.2008.492.495
   Shahverdi AR, 2007, PROCESS BIOCHEM, V42, P919, DOI 10.1016/j.procbio.2007.02.005
   SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005
   Shwetha V., 2012, INT J CURR PHARM RES, V4
   Kappus, 1985, OXIDATIVE STRESS, P273
   SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413
   Singh A, 2010, DIG J NANOMATER BIOS, V5, P483
   SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7
   Soenen SJ, 2015, CHEM REV, V115, P2109, DOI 10.1021/cr400714j
   Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x
   Sreenivasan R. S., 2011, INT J BIOL MED RES, V2, P784
   Stuart B.H., 2002, POLYM ANAL
   Subramaniam J., 2016, ENV SCI POLL RES
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Tankhiwale R, 2010, J APPL POLYM SCI, V115, P1894, DOI 10.1002/app.31168
   Ting D., 2005, DYEING FINISHING, V14, P12
   Trang S.T., 2015, INT J CARB CHEM, DOI 101155/2015/706259
   Trung TS, 2006, BIORESOURCE TECHNOL, V97, P659, DOI 10.1016/j.biortech.2005.03.023
   Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.econenv.2005.03.013
   Xia W. S., 2003, J CHIN I FOOD SCI TE, V3, P77
   Yilmaz S, 2006, TOXICOLOGY, V218, P164, DOI 10.1016/j.tox.2005.10.015
   Zhang M, 2003, J BIOACT COMPAT POL, V18, P391, DOI 10.1177/088391103039019
NR 100
TC 1
Z9 1
U1 103
U2 103
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD OCT
PY 2016
VL 132
BP 318
EP 328
DI 10.1016/j.ecoenv.2016.06.021
PG 11
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DS6BR
UT WOS:000380867200039
PM 27344400
ER

PT J
AU Marston, HD
   Lurie, N
   Borio, LL
   Fauci, AS
AF Marston, Hilary D.
   Lurie, Nicole
   Borio, Luciana L.
   Fauci, Anthony S.
TI Considerations for Developing a Zika Virus Vaccine
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID INFECTION
C1 [Marston, Hilary D.; Fauci, Anthony S.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Borio, Luciana L.] US FDA, Off Commissioner, Silver Spring, MD USA.
   [Lurie, Nicole] US Dept HHS, Off Assistant Secretary Preparedness & Response, Washington, DC 20201 USA.
RP Marston, HD (reprint author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
CR Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Miller FG, 2001, CLIN INFECT DIS, V33, P1028, DOI 10.1086/322664
NR 4
TC 0
Z9 0
U1 7
U2 7
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 29
PY 2016
VL 375
IS 13
BP 1209
EP 1212
DI 10.1056/NEJMp1607762
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX3HU
UT WOS:000384265000001
PM 27682031
ER

PT J
AU Lyon, J
AF Lyon, Jeff
TI Zika: Worse Than Thalidomide?
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
ID INFLUENZA; VIRUS
CR Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Parboosing R, 2013, JAMA PSYCHIAT, V70, P677, DOI 10.1001/jamapsychiatry.2013.896
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 5
TC 0
Z9 0
U1 1
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD SEP 27
PY 2016
VL 316
IS 12
BP 1246
EP 1248
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW9EW
UT WOS:000383959800002
PM 27556748
ER

PT J
AU Londono-Renteria, B
   Troupin, A
   Colpitts, TM
AF Londono-Renteria, Berlin
   Troupin, Andrea
   Colpitts, Tonya M.
TI Arbovirosis and potential transmission blocking vaccines
SO PARASITES & VECTORS
LA English
DT Review
DE Transmission blocking vaccines; Arbovirus; Arthropod; Vectors
ID WEST-NILE-VIRUS; TICK-BORNE DISEASES; RIFT-VALLEY FEVER;
   ANTIBODY-DEPENDENT ENHANCEMENT; PHLEBOTOMINE SAND FLIES; LONE STAR TICK;
   AEDES-AEGYPTI; BOOPHILUS-MICROPLUS; UNITED-STATES; INSECTICIDE
   RESISTANCE
AB Infectious diseases caused by arboviruses (viruses transmitted by arthropods) are undergoing unprecedented epidemic activity and geographic expansion. With the recent introduction of West Nile virus (1999), chikungunya virus (2013) and Zika virus (2015) to the Americas, stopping or even preventing the expansion of viruses into susceptible populations is an increasing concern. With a few exceptions, available vaccines protecting against arboviral infections are nonexistent and current disease prevention relies on vector control interventions. However, due to the emergence of and rapidly spreading insecticide resistance, different disease control methods are needed. A feasible method of reducing emerging tropical diseases is the implementation of vaccines that prevent or decrease viral infection in the vector. These vaccines are designated 'transmission blocking vaccines', or TBVs. Here, we summarize previous TBV work, discuss current research on arboviral TBVs and present several promising TBV candidates.
C1 [Londono-Renteria, Berlin; Troupin, Andrea; Colpitts, Tonya M.] Univ South Carolina, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.
RP Londono-Renteria, B (reprint author), Univ South Carolina, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.
EM blondono@uscmed.sc.edu
CR Alkan C, 2013, ANTIVIR RES, V100, P54, DOI 10.1016/j.antiviral.2013.07.005
   Allan SA, 2009, J AM MOSQUITO CONTR, V25, P338, DOI 10.2987/09-5854.1
   Amaro F, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0407-0
   Aubry P, 2011, TRANSBOUND EMERG DIS, V58, P1, DOI 10.1111/j.1865-1682.2010.01173.x
   Ba Y, 2012, J AM MOSQUITO CONTR, V28, P170, DOI 10.2987/12-5725.1
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Baly A, 2016, TROP MED INT HEALTH, V21, P597, DOI 10.1111/tmi.12693
   Barre N, 2010, REV SCI TECH OIE, V29, P149
   Barrera R, 2010, J MED ENTOMOL, V47, P1185, DOI 10.1603/ME10038
   Bates PA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0712-x
   Beck-Johnson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079276
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Bergmann-Leitner Elke S, 2014, Vaccines (Basel), V2, P252, DOI 10.3390/vaccines2020252
   Bergsman LD, 2016, MATH BIOSCI ENG, V13, P401, DOI 10.3934/mbe.2015009
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   BLOCH H, 1993, AM J DIS CHILD, V147, P772
   Busch JD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-188
   [Anonymous], 2012, CDC NEWSR CDC REL FI
   Chambers TJ, 2003, ADV VIRUS RES, V60, pxiii
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   COMER JA, 1991, J MED ENTOMOL, V28, P289
   CONNAT JL, 1991, PARASITOL RES, V77, P452, DOI 10.1007/BF00931644
   Cooper CL, 2012, CURR OPIN INFECT DIS, V25, P26, DOI 10.1097/QCO.0b013e32834ef56c
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Coutinho-Abreu IV, 2010, MEM I OSWALDO CRUZ, V105, P1, DOI 10.1590/S0074-02762010000100001
   Coutinho-Abreu IV, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000901
   CUPP EW, 1991, VET CLIN N AM-SMALL, V21, P1
   Danforth ME, 2016, J MED ENTOMOL, V53, P681, DOI 10.1093/jme/tjw013
   DAROSA APAT, 1984, AM J TROP MED HYG, V33, P999
   Day JF, 2015, J MED ENTOMOL, V52, P743, DOI 10.1093/jme/tjv076
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   De La Fuente J, 2000, ANN NY ACAD SCI, V916, P617
   de la Fuente J, 1998, VACCINE, V16, P366, DOI 10.1016/S0264-410X(97)00208-9
   De la Fuente J, 2006, PARASITE IMMUNOL, V28, P275, DOI 10.1111/j.1365-3024.2006.00828.x
   de la Fuente J, 2010, VACCINE, V28, P1786, DOI 10.1016/j.vaccine.2009.12.007
   de la Fuente Jose, 2003, Expert Rev Vaccines, V2, P583
   de Leon AAP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00195
   Delpeyroux F, 2013, M S-MED SCI, V29, P1034, DOI 10.1051/medsci/20132911021
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   DeWeerdt S, 2012, NATURE, V484, pS24, DOI 10.1038/484S24a
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002
   Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104
   Djouaka R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1723-y
   Ebel GD, 2004, AM J TROP MED HYG, V71, P268
   Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Flicek Barbara Fouts, 2007, Crit Care Nurs Clin North Am, V19, P27, DOI 10.1016/j.ccell.2006.11.001
   Fontenille D, 1998, EMERG INFECT DIS, V4, P289
   Franta Z, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-119
   Gardner AM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-9
   Gholam BIA, 1999, CAN MED ASSOC J, V161, P1419
   GOLDFIELD M, 1973, AM J TROP MED HYG, V22, P78
   Gomes-Solecki M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00136
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gujarati TP, 2014, J MATH BIOL, V69, P1773, DOI 10.1007/s00285-013-0749-4
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Hahn MB, 2015, AM J TROP MED HYG, V92, P1013, DOI 10.4269/ajtmh.14-0737
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Halstead SB, 2007, LANCET, V369, P1410, DOI 10.1016/S0140-6736(07)60645-X
   Havlikova S, 2009, INT J PARASITOL, V39, P1485, DOI 10.1016/j.ijpara.2009.05.005
   Hermance ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155889
   Hernandez-Jover M, 2013, PREV VET MED, V109, P186, DOI 10.1016/j.prevetmed.2012.09.018
   Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI [10.1586/eri.09.118, 10.1586/ERI.09.118]
   Hill CA, 2005, NAT REV MICROBIOL, V3, P262, DOI 10.1038/nrmicro1101
   Imam I Z, 1978, J Egypt Public Health Assoc, V53, P205
   Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   Jonsson NN, 2001, AUST VET J, V79, P826, DOI 10.1111/j.1751-0813.2001.tb10929.x
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kaslow DC, 1997, INT J PARASITOL, V27, P183, DOI 10.1016/S0020-7519(96)00148-8
   KAY BH, 1994, AM J TROP MED HYG, V50, P87
   Kean Joy, 2015, Insects, V6, P236, DOI 10.3390/insects6010236
   Khetarpal N, 2016, J IMMUNOL RES, DOI 10.1155/2016/6803098
   KOCH HG, 1981, J MED ENTOMOL, V18, P93
   Kosoy OI, 2015, EMERG INFECT DIS, V21, P760, DOI 10.3201/eid2105.150150
   Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258
   Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015
   Labuda M, 2006, PLOS PATHOG, V2, P251, DOI 10.1371/journal.ppat.0020027
   Lai AA, 2001, P NATL ACAD SCI USA, V98, P5228, DOI 10.1073/pnas.091447398
   LAMONTAGNE JR, 1983, REV INFECT DIS, V5, P723
   Leger E, 2013, EXP APPL ACAROL, V59, P219, DOI 10.1007/s10493-012-9615-0
   Leitner WW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004107
   Lew-Tabor AE, 2016, TICKS TICK-BORNE DIS, V7, P573, DOI 10.1016/j.ttbdis.2015.12.012
   Li YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18848
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Liu XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002566
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Londono-Renteria B, 2016, METHODS MOL BIOL, V1435, P1, DOI 10.1007/978-1-4939-3670-0_1
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8
   Matuschewski K, 2007, FEBS J, V274, P4680, DOI 10.1111/j.1742-4658.2007.05998.x
   Mbaeyi C, 2015, MMWR-MORBID MORTAL W, V64, P1166, DOI 10.15585/mmwr.mm6441a2
   MCBEAN AM, 1984, REV INFECT DIS, V6, pS552
   Medlock JM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0751-3
   Merino O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00030
   Miller RS, 2013, PREV VET MED, V110, P119, DOI 10.1016/j.prevetmed.2012.11.021
   Miller MA SJ, 2006, DIS MORTALITY SUBSAH
   Moreno A, 2015, CURR OPIN IMMUNOL, V35, P98, DOI 10.1016/j.coi.2015.06.008
   MORENS DM, 1987, MICROB PATHOGENESIS, V3, P231, DOI 10.1016/0882-4010(87)90056-8
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Neelakanta G, 2015, ARCH IMMUNOL THER EX, V63, P169, DOI 10.1007/s00005-014-0324-8
   Nijhof AM, 2007, INT J PARASITOL, V37, P653, DOI 10.1016/j.ijpara.2006.11.005
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Ocampo CB, 2014, ACTA TROP, V132, P15, DOI 10.1016/j.actatropica.2013.12.019
   Odongo D, 2007, VACCINE, V25, P1287, DOI 10.1016/j.vaccine.2006.09.085
   Ogden NH, 2016, TRENDS PARASITOL, V32, P646, DOI 10.1016/j.pt.2016.04.015
   Paingankar MS, 2010, ARCH VIROL, V155, P1453, DOI 10.1007/s00705-010-0728-7
   Parish LA, 2011, J PROTEOME RES, V10, P5150, DOI 10.1021/pr2006268
   Pasquale AD, 2015, VACCINES, V3, P320, DOI DOI 10.3390/VACCINES3020320
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117
   Prommalikit Olarn, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P29
   Puerta JM, 2015, J MED ENTOMOL, V52, P1309, DOI 10.1093/jme/tjv129
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Qian F, 2007, VACCINE, V25, P3923, DOI 10.1016/j.vaccine.2007.02.073
   Ratovonjato J, 2011, VECTOR-BORNE ZOONOT, V11, P753, DOI 10.1089/vbz.2010.0031
   Reeves WK, 2008, J AM MOSQUITO CONTR, V24, P444, DOI 10.2987/5745.1
   Riedel Stefan, 2005, Proc (Bayl Univ Med Cent), V18, P21
   Robles-Murguia M, 2014, MEM I OSWALDO CRUZ, V109, P1064, DOI 10.1590/0074-0276140382
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Savage HM, 2016, J MED ENTOMOL
   Schuijt TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015926
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Seufi AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-65
   Shimp RL, 2013, VACCINE, V31, P2954, DOI 10.1016/j.vaccine.2013.04.034
   SIAM AL, 1980, BRIT J OPHTHALMOL, V64, P366, DOI 10.1136/bjo.64.5.366
   Sojka D., 2014, ENCY PARASITOLOGY, P1
   Sokhna C, 2013, CLIN MICROBIOL INFEC, V19, P902, DOI 10.1111/1469-0691.12314
   Sprong H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-77
   Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038
   Tham HW, 2014, VIRUSES-BASEL, V6, P5028, DOI 10.3390/v6125028
   Tonteri E, 2015, EURO SURVEILL, V20, P646
   Toole MJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0594-6
   Trimnell AR, 2005, VACCINE, V23, P4329, DOI 10.1016/j.vaccine.2005.03.041
   Troupin A, 2016, METHODS MOL BIOL, V1435, P15, DOI 10.1007/978-1-4939-3670-0_2
   Valle MR, 2004, EXP APPL ACAROL, V34, P375, DOI 10.1007/s10493-004-1389-6
   van der Meulen KM, 2005, ARCH VIROL, V150, P637, DOI 10.1007/s00705-004-0463-z
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Walsh B, 2016, HEALTH AFFAIR, V35, P356, DOI [10.1377/hlthaff.2015.1019, 10.1377/hlthaff.2015.10]
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143
   Whiten SR, 2016, J MED ENTOMOL, V53, P139, DOI 10.1093/jme/tjv159
   Whitty CJM, 2015, INT HEALTH, V7, P302, DOI 10.1093/inthealth/ihv049
   Wieten RW, 2016, J INFECTION, V72, P713, DOI 10.1016/j.jinf.2016.02.017
   Willadsen P, 1999, PARASITOL TODAY, V15, P258, DOI 10.1016/S0169-4758(99)01472-6
   Willadsen P, 2004, PARASITOLOGY, V129, pS367, DOI 10.1017/S0031182003004657
   WILLADSEN P, 1989, J IMMUNOL, V143, P1346
   Winkelmann ER, 2016, F1000RESEARCH, V5
   WORK TH, 1955, AM J TROP MED HYG, V4, P872
   [Anonymous], 2016, ESTIMATED RANGE AEDE
NR 158
TC 0
Z9 0
U1 4
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD SEP 23
PY 2016
VL 9
AR 516
DI 10.1186/s13071-016-1802-0
PG 11
WC Parasitology
SC Parasitology
GA DW7TC
UT WOS:000383853600002
ER

PT J
AU Mains, JW
   Brelsfoard, CL
   Rose, RI
   Dobson, SL
AF Mains, James W.
   Brelsfoard, Corey L.
   Rose, Robert I.
   Dobson, Stephen L.
TI Female Adult Aedes albopictus Suppression by Wolbachia-Infected Male
   Mosquitoes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CYTOPLASMIC INCOMPATIBILITY; DIPTERA-CULICIDAE; RELEASE; ESTABLISHMENT;
   PERFORMANCE; POPULATION; DISPERSAL; INSECTS; BIOLOGY; STRAIN
AB Dengue, chikungunya and zika viruses are pathogens with an increasing global impact. In the absence of an approved vaccine or therapy, their management relies on controlling the mosquito vectors. But traditional controls are inadequate, and the range of invasive species such as Aedes albopictus (Asian Tiger Mosquito) is expanding. Genetically modified mosquitoes are being tested, but their use has encountered regulatory barriers and public opposition in some countries. Wolbachia bacteria can cause a form of conditional sterility, which can provide an alternative to genetic modification or irradiation. It is unknown however, whether openly released, artificially infected male Ae. albopictus can competitively mate and sterilize females at a level adequate to suppress a field population. Also, the unintended establishment of Wolbachia at the introduction site could result from horizontal transmission or inadvertent female release. In 2014, an Experimental Use Permit from the United States Environmental Protection Agency approved a pilot field trial in Lexington, Kentucky, USA. Here, we present data showing localized reduction of both egg hatch and adult female numbers. The artificial Wolbachia type was not observed to establish in the field. The results are discussed in relation to the applied use of Wolbachia-infected males as a biopesticide to suppress field populations of Ae. albopictus.
C1 [Mains, James W.; Brelsfoard, Corey L.; Dobson, Stephen L.] MosquitoMate Inc, 2520 Regency Rd, Lexington, KY 40503 USA.
   [Rose, Robert I.] 8322 Sharon Dr, Frederick, MD 21704 USA.
   [Dobson, Stephen L.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.
RP Dobson, SL (reprint author), MosquitoMate Inc, 2520 Regency Rd, Lexington, KY 40503 USA.; Dobson, SL (reprint author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.
EM sdobson@mosquitomate.com
FU National Institutes of Health [AI-098179]; Kentucky Cabinet for Economic
   Development [KSTC-184-512-12-142, KSTC-184-512-14-198]
FX We thank Katherine Evans, Jeannie Haak and Karen Dobson for technical
   assistance. This work was supported by grants from the National
   Institutes of Health [AI-098179] and the Kentucky Cabinet for Economic
   Development [KSTC-184-512-12-142, KSTC-184-512-14-198].
CR Achee NL, 2015, VECTOR-BORNE ZOONOT, V15, P89, DOI 10.1089/vbz.2014.1628
   Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834
   Aultman KS, 2000, SCIENCE, V288, P2321, DOI 10.1126/science.288.5475.2321
   Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154
   Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254
   Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813
   Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Roiz D, 2016, J MED ENTOMOL, V53, P460, DOI 10.1093/jme/tjv184
   Sanogo YO, 2004, INSECT MOL BIOL, V13, P365, DOI 10.1111/j.0962-1075.2004.00498.x
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Unlu I, 2014, J AM MOSQUITO CONTR, V30, P122, DOI 10.2987/14-6401.1
   Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
NR 25
TC 0
Z9 0
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 23
PY 2016
VL 6
AR 33846
DI 10.1038/srep33846
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DX0HX
UT WOS:000384043500001
ER

PT J
AU Oliveira, DBL
   Almeida, FJ
   Durigon, EL
AF Oliveira, Danielle B. L.
   Almeida, Flavia J.
   Durigon, Edison L.
TI Prolonged Shedding of Zika Virus Associated with Congenital Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Oliveira, Danielle B. L.; Durigon, Edison L.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Almeida, Flavia J.] Irmandade Santa Casa de Misericordia Sao Paulo, Sao Paulo, Brazil.
RP Durigon, EL (reprint author), Univ Sao Paulo, Sao Paulo, Brazil.
EM eldurigo@usp.br
CR D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
NR 5
TC 0
Z9 0
U1 4
U2 4
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 22
PY 2016
VL 375
IS 12
BP 1202
EP 1204
DI 10.1056/NEJMc1607583
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW3JE
UT WOS:000383537100034
PM 27653589
ER

PT J
AU Coloma, J
   Jain, R
   Rajashankar, KR
   Garcia-Sastre, A
   Aggarwal, AK
AF Coloma, Javier
   Jain, Rinku
   Rajashankar, Kanagalaghatta R.
   Garcia-Sastre, Adolfo
   Aggarwal, Aneel K.
TI Structures of NS5 Methyltransferase from Zika Virus
SO CELL REPORTS
LA English
DT Article
ID CRYSTAL-STRUCTURE; RNA CAP; FLAVIVIRUS; METHYLATION; DOMAIN;
   RECOGNITION; INHIBITION; VALIDATION
AB The Zika virus (ZIKV) poses a major public health emergency. To aid in the development of antivirals, we present two high-resolution crystal structures of the ZIKV NS5 methyltransferase: one bound to S-adenosylmethionine (SAM) and the other bound to SAM and 7-methyl guanosine diphosphate (7-MeGpp). We identify features of ZIKV NS5 methyltransferase that lend to structure-based antiviral drug discovery. Specifically, SAM analogs with functionalities on the Cb atom of the methionine portion of the molecules that occupy the RNA binding tunnel may provide better specificity relative to human RNA methyltransferases.
C1 [Coloma, Javier; Jain, Rinku; Aggarwal, Aneel K.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.
   [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.
   [Rajashankar, Kanagalaghatta R.] Adv Photon Source, NE CAT, Argonne, IL 60439 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA.
RP Aggarwal, AK (reprint author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.
EM aneel.aggarwal@mssm.edu
FU National Institute of General Medical Sciences (NIGMS) from the NIH [P41
   GM103403]; National Cancer Institute [ACB-12002]; NIGMS [AGM-12006];
   NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science by Argonne
   National Laboratory [DE-AC02-06CH11357]; NIH [U19AI118610]
FX We thank Jian Jin for helpful discussions. This work is based upon
   research conducted at the Northeastern Collaborative Access Team (NECAT)
   and GM/CA@APS beamlines at the Argonne National Laboratory. The NECAT
   beamlines are funded by the National Institute of General Medical
   Sciences (NIGMS) from the NIH (P41 GM103403). The GM/CA@APS beamlines
   have been funded in whole or in part with funds from the National Cancer
   Institute (ACB-12002) and NIGMS (AGM-12006). The Pilatus 6M detector on
   24-ID-C beam line is funded by an NIH-ORIP HEI grant (S10 RR029205).
   This research used resources of the Advanced Photon Source, a US
   Department of Energy (DOE) Office of Science User Facility operated for
   the DOE Office of Science by Argonne National Laboratory under contract
   no. DE-AC02-06CH11357. A.G.-S. is partly supported by NIH grant
   U19AI118610.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200
   Bollati M, 2009, J MOL BIOL, V385, P140, DOI 10.1016/j.jmb.2008.10.028
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Kaniskan HU, 2015, ACS CHEM BIOL, V10, P40, DOI 10.1021/cb500785t
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Luo MK, 2012, ACS CHEM BIOL, V7, P443, DOI 10.1021/cb200519y
   [Anonymous], 1997, ENZYMOLOGY, DOI DOI 10.1016/S0076-6879
   Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   Wu H, 2008, PROTEINS, V72, P519, DOI 10.1002/prot.22065
   Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 29
TC 0
Z9 0
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD SEP 20
PY 2016
VL 16
IS 12
BP 3097
EP 3102
DI 10.1016/j.celrep.2016.08.091
PG 6
WC Cell Biology
SC Cell Biology
GA DW8DQ
UT WOS:000383884200002
PM 27633330
ER

PT J
AU Miner, JJ
   Sene, A
   Richner, JM
   Smith, AM
   Santeford, A
   Ban, N
   Weger-Lucarelli, J
   Manzella, F
   Ruckert, C
   Govero, J
   Noguchi, KK
   Ebel, GD
   Diamond, MS
   Apte, RS
AF Miner, Jonathan J.
   Sene, Abdoulaye
   Richner, Justin M.
   Smith, Amber M.
   Santeford, Andrea
   Ban, Norimitsu
   Weger-Lucarelli, James
   Manzella, Francesca
   Rueuckert, Claudia
   Govero, Jennifer
   Noguchi, Kevin K.
   Ebel, Gregory D.
   Diamond, Michael S.
   Apte, Rajendra S.
TI Zika Virus Infection in Mice Causes Panuveitis with Shedding of Virus in
   Tears
SO CELL REPORTS
LA English
DT Article
ID HEPATITIS-C VIRUS; EBOLA-VIRUS; TRANSMISSION; RECEPTORS; CELLS;
   ALPHA/BETA; RESPONSES
AB Zika virus (ZIKV) is an emerging flavivirus that causes congenital abnormalities and Guillain-Barre syndrome. ZIKV infection also results in severe eye disease characterized by optic neuritis, chorioretinal atrophy, and blindness in newborns and conjunctivitis and uveitis in adults. We evaluated ZIKV infection of the eye by using recently developed mouse models of pathogenesis. ZIKV-inoculated mice developed conjunctivitis, panuveitis, and infection of the cornea, iris, optic nerve, and ganglion and bipolar cells in the retina. This phenotype was independent of the entry receptors Axl or Mertk, given that Axl(-/-), Mertk(-/-), and Axl(-/-) Mertk(-/-) double knockout mice sustained levels of infection similar to those of control animals. We also detected abundant viral RNA in tears, suggesting that virus might be secreted from lacrimal glands or shed from the cornea. This model provides a foundation for studying ZIK-Vinduced ocular disease, defining mechanisms of viral persistence, and developing therapeutic approaches for viral infections of the eye.
C1 [Miner, Jonathan J.; Richner, Justin M.; Smith, Amber M.; Govero, Jennifer; Diamond, Michael S.; Apte, Rajendra S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Sene, Abdoulaye; Santeford, Andrea; Ban, Norimitsu; Apte, Rajendra S.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.
   [Weger-Lucarelli, James; Rueuckert, Claudia; Ebel, Gregory D.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Manzella, Francesca; Noguchi, Kevin K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Apte, Rajendra S.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.
RP Miner, JJ; Diamond, MS; Apte, RS (reprint author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Apte, RS (reprint author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.; Apte, RS (reprint author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.
EM miner@wustl.edu; diamond@borcim.wustl.edu; apte@vision.wustl.edu
FU NIH [R01 AI073755, R01 AI101400, R01 AI104972, R01 EY019287, P30
   EY02687, R01 AI067380]; Research to Prevent Blindness; Schulak Family
   Gift Fund for Retinal Research; Jeffrey Fort Innovation Fund;
   Rheumatology Research Foundation Scientist Development Award;
   Intellectual and Developmental Disabilities Research Center at
   Washington University [NIH/NICHD U54 HD087011]; Moderna; Sanofi;
   Visterra
FX This study was supported by grants from the NIH (R01 AI073755, R01
   AI101400, and R01 AI104972 [to M.S.D.], R01 EY019287 [to R.S.A.], P30
   EY02687 [Vision Core Grant], and R01 AI067380 [to G.D.E.]). R.S.A. also
   was supported by a Physician-Scientist Award from Research to Prevent
   Blindness, the Schulak Family Gift Fund for Retinal Research, and the
   Jeffrey Fort Innovation Fund. J.J.M. was supported by a Rheumatology
   Research Foundation Scientist Development Award. K.N. was supported by
   the Intellectual and Developmental Disabilities Research Center at
   Washington University (NIH/NICHD U54 HD087011). Additional funding comes
   from an unrestricted grant to the Department of Ophthalmology and Visual
   Sciences of Washington University School of Medicine from Research to
   Prevent Blindness. M.S.D. is a consultant for Inbios, Visterra, Sanofi,
   and Takeda Pharmaceuticals, is on the Scientific Advisory Boards of
   Moderna and OraGene, and is a recipient of research grants from Moderna,
   Sanofi, and Visterra.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Baronti C., 2014, GENOME ANNOUNC, V2, P2, DOI DOI 10.1128/GENOMEA.00500-14
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Chong EM, 2004, AM J OPHTHALMOL, V138, P474, DOI 10.1016/j.ajo.2004.04.027
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Derbent M, 2004, AM J MED GENET A, V128A, P232, DOI 10.1002/ajmg.a.30109
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hershberger VS, 2003, OPHTHALMOLOGY, V110, P1732, DOI 10.1016/S0161-6420(03)00720-6
   HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284
   Kaiser PK, 2003, AM J OPHTHALMOL, V136, P928, DOI 10.1016/S0002-9394(03)00866-3
   Kuchtey RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P1648, DOI 10.1001/archopht.121.11.1648
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee HM, 2001, CORNEA, V20, P37, DOI 10.1097/00003226-200101000-00007
   Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Miranda Homero Augusto de 2nd, 2016, Ophthalmology, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sakala IG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005342
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   Tugwell BD, 2005, ANN INTERN MED, V143, P648
   Valverde P, 2004, EXP EYE RES, V78, P27, DOI 10.1016/j.exer.2003.10.002
   VANDENBROEK MF, 1995, J VIROL, V69, P4792
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
NR 42
TC 0
Z9 0
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD SEP 20
PY 2016
VL 16
IS 12
BP 3208
EP 3218
DI 10.1016/j.celrep.2016.08.079
PG 11
WC Cell Biology
SC Cell Biology
GA DW8DQ
UT WOS:000383884200013
PM 27612415
ER

PT J
AU Brent, C
   Dunn, A
   Savage, H
   Faraji, A
   Rubin, M
   Risk, I
   Garcia, W
   Cortese, M
   Novosad, S
   Krow-Lucal, ER
   Crain, J
   Hill, M
   Atkinson, A
   Peterson, D
   Christensen, K
   Dimond, M
   Staples, JE
   Nakashima, A
AF Brent, Carolyn
   Dunn, Angela
   Savage, Harry
   Faraji, Ary
   Rubin, Mike
   Risk, Ilene
   Garcia, Wendy
   Cortese, Margaret
   Novosad, Shannon
   Krow-Lucal, Elisabeth Raquel
   Crain, Jacqueline
   Hill, Mary
   Atkinson, Annette
   Peterson, Dallin
   Christensen, Kimberly
   Dimond, Melissa
   Staples, J. Erin
   Nakashima, Allyn
TI Preliminary Findings from an Investigation of Zika Virus Infection in a
   Patient with No Known Risk Factors - Utah, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Brent, Carolyn; Risk, Ilene; Hill, Mary] Salt Lake Cty Hlth Dept, Salt Lake City, UT 84190 USA.
   [Brent, Carolyn; Crain, Jacqueline] CDC, Publ Hlth Associates Program Off, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
   [Dunn, Angela; Crain, Jacqueline; Peterson, Dallin; Dimond, Melissa; Nakashima, Allyn] Utah Dept Hlth, Salt Lake City, UT USA.
   [Savage, Harry; Krow-Lucal, Elisabeth Raquel; Staples, J. Erin] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Faraji, Ary] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT USA.
   [Rubin, Mike] Univ Utah Hosp, Salt Lake City, UT USA.
   [Garcia, Wendy] Davis Cty Hlth Dept, Clearfield, UT USA.
   [Cortese, Margaret] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Novosad, Shannon] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Atkinson, Annette; Christensen, Kimberly] Utah Publ Hlth Lab, Taylorsville, UT USA.
RP Brent, C (reprint author), Salt Lake Cty Hlth Dept, Salt Lake City, UT 84190 USA.; Brent, C (reprint author), CDC, Publ Hlth Associates Program Off, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
EM cbrent@slco.org
CR CDC, 2016, ZIK VIR TRANSM RISKS
   CDC, 2007, 2007 GUID IS PREC PR
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
NR 3
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 16
PY 2016
VL 65
IS 36
BP 981
EP 982
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DW1EP
UT WOS:000383386100009
PM 27631467
ER

PT J
AU Walker, WL
   Lindsey, NP
   Lehman, JA
   Krow-Lucal, ER
   Rabe, IB
   Hills, SL
   Martin, SW
   Fischer, M
   Staples, JE
AF Walker, William L.
   Lindsey, Nicole P.
   Lehman, Jennifer A.
   Krow-Lucal, Elisabeth R.
   Rabe, Ingrid B.
   Hills, Susan L.
   Martin, Stacey W.
   Fischer, Marc
   Staples, J. Erin
TI Zika Virus Disease Cases-50 States and the District of Columbia, January
   1-July 31, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES
C1 [Walker, William L.; Krow-Lucal, Elisabeth R.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Walker, William L.; Lindsey, Nicole P.; Lehman, Jennifer A.; Krow-Lucal, Elisabeth R.; Rabe, Ingrid B.; Hills, Susan L.; Martin, Stacey W.; Fischer, Marc; Staples, J. Erin] CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Staples, JE (reprint author), CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM auv1@cdc.gov
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Brent C, 2016, MMWR MORB M IN PRESS
   Brooks John T, 2016, MMWR Morb Mortal Wkly Rep, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Food and Drug Administration, 2016, REV REC RED RISK ZIK
   Frieden TR, 2016, JAMA
   Hennessey Morgan J, 2016, Am J Trop Med Hyg, V95, P212, DOI 10.4269/ajtmh.16-0049
   Oduyebo Titilope, 2016, MMWR Morb Mortal Wkly Rep, V65, P739, DOI 10.15585/mmwr.mm6529e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
NR 10
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 16
PY 2016
VL 65
IS 36
BP 983
EP 986
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DW1EP
UT WOS:000383386100010
PM 27631604
ER

PT J
AU Mayor, S
AF Mayor, Susan
TI Preliminary results from case- control study confirm Zika virus causes
   microcephaly
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Araujo TV, 2016, LANCET INFECT DIS, DOI [10.1016/S1473-3099(16)30318-8, DOI 10.1016/S1473-3099(16)30318-8]
NR 1
TC 0
Z9 0
U1 10
U2 10
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD SEP 16
PY 2016
VL 354
DI 10.1136/bmj.i5031
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW3OJ
UT WOS:000383550600011
ER

PT J
AU Gupta, AK
   Kaur, K
   Rajput, A
   Dhanda, SK
   Sehgal, M
   Khan, MS
   Monga, I
   Dar, SA
   Singh, S
   Nagpal, G
   Usmani, SS
   Thakur, A
   Kaur, G
   Sharma, S
   Bhardwaj, A
   Qureshi, A
   Raghava, GPS
   Kumar, M
AF Gupta, Amit Kumar
   Kaur, Karambir
   Rajput, Akanksha
   Dhanda, Sandeep Kumar
   Sehgal, Manika
   Khan, Md. Shoaib
   Monga, Isha
   Dar, Showkat Ahmad
   Singh, Sandeep
   Nagpal, Gandharva
   Usmani, Salman Sadullah
   Thakur, Anamika
   Kaur, Gazaldeep
   Sharma, Shivangi
   Bhardwaj, Aman
   Qureshi, Abid
   Raghava, Gajendra Pal Singh
   Kumar, Manoj
TI ZikaVR: An Integrated Zika Virus Resource for Genomics, Proteomics,
   Phylogenetic and Therapeutic Analysis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HEPATITIS-C VIRUS; VACCINE DEVELOPMENT; ANTIVIRAL PEPTIDES;
   BINDING-SITES; EBOLA-VIRUS; PREDICTION; GLYCOSYLATION; RNA; SEQUENCE;
   ARBOVIRUSES
AB Current Zika virus (ZIKV) outbreaks that spread in several areas of Africa, Southeast Asia, and in pacific islands is declared as a global health emergency by World Health Organization (WHO). It causes Zika fever and illness ranging from severe autoimmune to neurological complications in humans. To facilitate research on this virus, we have developed an integrative multi-omics platform; ZikaVR (http://bioinfo.imtech.res.in/manojk/zikavr/), dedicated to the ZIKV genomic, proteomic and therapeutic knowledge. It comprises of whole genome sequences, their respective functional information regarding proteins, genes, and structural content. Additionally, it also delivers sophisticated analysis such as whole-genome alignments, conservation and variation, CpG islands, codon context, usage bias and phylogenetic inferences at whole genome and proteome level with user-friendly visual environment. Further, glycosylation sites and molecular diagnostic primers were also analyzed. Most importantly, we also proposed potential therapeutically imperative constituents namely vaccine epitopes, siRNAs, miRNAs, sgRNAs and repurposing drug candidates.
C1 [Gupta, Amit Kumar; Kaur, Karambir; Rajput, Akanksha; Dhanda, Sandeep Kumar; Sehgal, Manika; Khan, Md. Shoaib; Monga, Isha; Dar, Showkat Ahmad; Singh, Sandeep; Nagpal, Gandharva; Usmani, Salman Sadullah; Thakur, Anamika; Kaur, Gazaldeep; Sharma, Shivangi; Bhardwaj, Aman; Qureshi, Abid; Raghava, Gajendra Pal Singh; Kumar, Manoj] CSIR, Inst Microbial Technol, Bioinformat Ctr, Sect 39A, Chandigarh 160036, India.
RP Kumar, M (reprint author), CSIR, Inst Microbial Technol, Bioinformat Ctr, Sect 39A, Chandigarh 160036, India.
EM manojk@imtech.res.in
RI Raghava, Gajendra/B-1717-2009
FU Council of Scientific and Industrial Research, India [BSC0121];
   Department of Biotechnology, Government of India [GAP0001]
FX Financial support for this work is provided by Council of Scientific and
   Industrial Research, India (BSC0121) and Department of Biotechnology,
   Government of India (GAP0001). Open access charges by: CSIR-Institute of
   Microbial Technology, Chandigarh, India.
CR Ahmed F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023443
   Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632
   Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-276
   Behura SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043111
   Ben-Yedidia T, 2007, EXPERT REV VACCINES, V6, P939, DOI 10.1586/14760584.6.6.939
   Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005
   Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771
   Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castresana J, 2000, MOL BIOL EVOL, V17, P540
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chambers TJ, 1998, J GEN VIROL, V79, P2375
   Chaudhary K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20678
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Crotty S, 2002, J MOL MED-JMM, V80, P86, DOI 10.1007/s00109-001-0308-0
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dar SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20031
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   Dhanda SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/263952
   Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30
   Dhanda SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep24782
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I630
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565
   Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1
   Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843
   Goto Y, 2014, INT J ONCOL, V45, P344, DOI 10.3892/ijo.2014.2438
   Gupta R., 2002, PAC S BIOCOMPUT, V322, P310
   Haasnoot J, 2003, J BIOMED SCI, V10, P607, DOI 10.1159/000073526
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151
   Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050
   [Anonymous], 2015, DATABASE OXFORD 0627, DOI DOI 10.1093/DATABASE/BAV055
   Khan MS, 2016, EPIGENOMICS-UK, V8, P67, DOI 10.2217/epi.15.95
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73
   Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438
   Koshy R, 1996, TRENDS BIOTECHNOL, V14, P364, DOI 10.1016/0167-7799(96)10049-4
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039
   Kumar G. A., 2015, SCI REP, V5, P12522, DOI [10.1038/srep12522, DOI 10.1038/SREP12522]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li X, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00033
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Moriel DG, 2008, HUM VACCINES, V4, P184
   Moura G, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r28
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Oyarzun P, 2016, HUM VACC IMMUNOTHER, V12, P763, DOI 10.1080/21645515.2015.1094595
   Ozcan G, 2015, ADV DRUG DELIVER REV, V87, P108, DOI 10.1016/j.addr.2015.01.007
   PEREZPEREZ MJ, 1992, J MED CHEM, V35, P2988, DOI 10.1021/jm00094a009
   Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112
   Qureshi A., 2014, DATABASE-OXFORD, DOI [10.1093/database/bau103, DOI 10.1093/DATABASE/BAU103]
   Qureshi A, 2014, NUCLEIC ACIDS RES, V42, pD1147, DOI 10.1093/nar/gkt1191
   Qureshi A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-305
   Rajput A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120066
   Rajput A, 2016, NUCLEIC ACIDS RES, V44, pD634, DOI 10.1093/nar/gkv1076
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9
   Shawan M. M. A. K., 2014, INDIAN J PHARM BIOL, V2, P44
   Shawan M. M. A. K., 2015, NAT SCI, V13, P37
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236
   Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108
   Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216
   Sintchenko V, 2010, INFECTIOUS DISEASE INFORMATICS, P1, DOI 10.1007/978-1-4419-1327-2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438
   Sullivan CS, 2007, METHOD ENZYMOL, V427, P3, DOI 10.1016/S0076-6879(07)27001-6
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450
   Thakur N, 2012, NUCLEIC ACIDS RES, V40, pD230, DOI 10.1093/nar/gkr1147
   The RTS, 2015, LANCET, V386, P31, DOI DOI 10.1016/S0140-6736(15)60721-8
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023
   Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151
   Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003
   Webb Benjamin, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0506s47
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yoon H, 2015, BIOINFORMATICS, V31, P1472, DOI 10.1093/bioinformatics/btu832
NR 109
TC 0
Z9 0
U1 9
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 16
PY 2016
VL 6
AR 32713
DI 10.1038/srep32713
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DW0JW
UT WOS:000383327700001
PM 27633273
ER

PT J
AU Culjat, M
   Darling, SE
   Nerurkar, VR
   Ching, N
   Kumar, M
   Min, SK
   Wong, R
   Grant, L
   Melish, ME
AF Culjat, Marko
   Darling, Stephen E.
   Nerurkar, Vivek R.
   Ching, Natascha
   Kumar, Mukesh
   Min, Sarah K.
   Wong, Rupa
   Grant, Leon
   Melish, Marian E.
TI Clinical and Imaging Findings in an Infant With Zika Embryopathy
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; microcephaly; MRI; fetal brain disruption sequence;
   ultrasound
ID BRAIN DISRUPTION SEQUENCE; VIRUS-INFECTION; INTERIM GUIDELINES;
   UNITED-STATES; OUTBREAK; MICRONESIA; ISLAND
AB Recent Zika virus (ZIKV) outbreaks have been associated with an increased incidence of neonatal microcephaly. Subsequently, tropism for the brain was established in human fetal brain tissue. We present the first congenital ZIKV infection in the United States, confirmed by high ZIKV immunoglobulin M antibody titers in serum and cerebrospinal fluid. The phenotypic characteristics of the patient fall within fetal brain disruption sequence, suggesting impaired brain development in the second half of gestation. Brain imaging revealed an almost agyric brain with diffuse parenchymal calcifications, hydrocephalus ex vacuo, and cerebellar hypoplasia. Ophthalmologic examination revealed macular pigment stippling and optic nerve atrophy. Liver, lungs, heart, and bone marrow were not affected. The patient had progressive neurologic deterioration in the first month of life. The discovery of ZIKV infection in human fetal brain tissue along with serologic confirmation proves the vertical transmission of ZIKV. Therefore, ZIKV has joined the group of congenital infections.
C1 [Culjat, Marko; Ching, Natascha; Min, Sarah K.; Grant, Leon] Univ Hawaii Manoa, John A Burns Sch Med, Dept Pediat, Kapiolani Med Ctr Women & Children, Honolulu, HI 96822 USA.
   [Darling, Stephen E.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Radiol, Kapiolani Med Ctr Women & Children, Honolulu, HI 96822 USA.
   [Nerurkar, Vivek R.; Kumar, Mukesh] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.
   [Wong, Rupa; Melish, Marian E.] John A Burns Sch Med, Kapiolani Med Ctr Women & Children, Honolulu, HI USA.
   [Melish, Marian E.] John A Burns Sch Med, Dept Pediat, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI USA.
RP Melish, ME (reprint author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Pediat, Honolulu, HI 96826 USA.
EM mmelish@hawaii.edu
FU Centers of Biomedical Research Excellence, National Institute of General
   Medical Sciences, National Institutes of Health [P30GM114737]
FX V. R. N. and M. K. are partly supported by the Centers of Biomedical
   Research Excellence, National Institute of General Medical Sciences,
   National Institutes of Health (grant number P30GM114737).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Besnard M, 2014, EUROSURVEILLANCE, P19
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burton GJ, 2001, PLACENTA, V22, pS70, DOI 10.1053/plac.2001.0639
   Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Fatima Vasco Aragao M, 2016, BMJ-BRIT MED J, V353, pi1901, DOI 10.1136/ bmj. i1901
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824., DOI 10.1056/NEJMOA1601824, 10.1056/NEJMoa1601824]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pan American Health Organization/World Health Organization, 2016, EP UPD NEUR SYNDR CO, P1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SMITH DW, 1973, J PEDIATR-US, V83, P374, DOI 10.1016/S0022-3476(73)80258-6
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang H, 2016, CELL STEM CELL, V18, P1
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
NR 34
TC 1
Z9 1
U1 3
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD SEP 15
PY 2016
VL 65
IS 6
BP 805
EP 811
DI 10.1093/cid/ciw324
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DW7UK
UT WOS:000383857500017
PM 27193747
ER

PT J
AU Dourado, ME
   Ferreira, LC
   Freire-Neto, FP
   Jeronimo, SMB
AF Dourado Junior, Mario Emilio
   Ferreira, Leonardo Capistrano
   Freire-Neto, Francisco Paulo
   Jeronimo, Selma M. B.
TI No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barre
   Syndrome in a Brazilian population
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Article
DE Guillain-Barre Syndrome; FCGR; Polymorphism; Genetics
ID FC-RECEPTOR POLYMORPHISMS; ZIKA VIRUS OUTBREAK; CAMPYLOBACTER-JEJUNI;
   ANTIGANGLIOSIDE ANTIBODIES; INFECTION; IIA; SUSCEPTIBILITY;
   POLYNEUROPATHY; IMMUNOGLOBULIN; SEVERITY
AB The pathogenesis of Guillain-Barre Syndrome (GBS) is not entirely understood, but includes infection-induced aberrant immune responses. Genetic polymorphisms in Fc gamma receptor genes (FCGR) have been associated with GBS. We assessed whether polymorphisms rs1801274 in FCGR2A and rs396991 in FCGR3A were associated with GBS in a Brazilian population. We genotyped 141 GBS cases and 364 healthy controls from Brazil for both polymorphisms. The FCGR genotypes and alleles frequencies did not differ significantly between GBS and controls. In addition, there was no genetic association with either severity or clinical outcomes. We conclude that these FCGR polymorphisms are not associated with susceptibility to Guillain-Barre Syndrome in this Brazilian population. (C) 2016 Published by Elsevier B.V.
C1 [Dourado Junior, Mario Emilio] Univ Fed Rio Grande do Norte, Dept Integrat Med, Natal, RN, Brazil.
   [Dourado Junior, Mario Emilio; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Postgrad Program, Natal, RN, Brazil.
   [Ferreira, Leonardo Capistrano; Freire-Neto, Francisco Paulo; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
RP Jeronimo, SMB (reprint author), Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Dept Biochem, Natal, RN, Brazil.
EM smbj@cb.ufrn.br
FU Brazilian Research Council (CNPq) [482017/2009-0]
FX We thank John Donelson, PhD (University of Iowa, Iowa City, IA, USA) and
   Cleni M Marzocchi-Machado, PhD (FCFRP-USP, Ribeirao Preto, Brazil) for
   their helpful revision of this manuscript. This study was supported by a
   grant 482017/2009-0 from the Brazilian Research Council (CNPq).
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Vigato-Ferreira ICC, 2014, AUTOIMMUNITY, V47, P451, DOI 10.3109/08916934.2014.921809
   Dalakas MC, 1998, NEUROLOGY, V51, pS2
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Dourado ME, 2003, ACTA NEUROL SCAND, V108, P102, DOI 10.1034/j.1600-0404.2003.00103.x
   Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x
   FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201
   Gillis C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00254
   Godschalk PCR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-32
   GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390
   He L, 2015, J NEUROSCI, V35, P6770, DOI 10.1523/JNEUROSCI.4926-14.2015
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   HUGHES RAC, 1978, LANCET, V2, P750
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Kuwano ST, 2000, TRANSFUSION, V40, P1388, DOI 10.1046/j.1537-2995.2000.40111388.x
   McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610
   Moriya H., 2014, BIOMED REP, V2, P265
   Nachamkin I, 2008, J INFECT DIS, V198, P226, DOI 10.1086/589624
   Odaka M, 2001, J NEUROL NEUROSUR PS, V70, P50, DOI 10.1136/jnnp.70.1.50
   Rodrigues F.N., 2016, PLOS CURR, V8
   SALMON JE, 1990, J CLIN INVEST, V85, P1287, DOI 10.1172/JCI114566
   SALMON JE, 1995, J CLIN INVEST, V95, P2877, DOI 10.1172/JCI117994
   Sheikh KA, 1998, NEUROLOGY, V51, P371
   Sinha S, 2010, ACTA NEUROL SCAND, V122, P21, DOI 10.1111/j.1600-0404.2009.01229.x
   Siqueira JF, 2011, J ENDODONT, V37, P1345, DOI 10.1016/j.joen.2011.06.025
   Siqueira JF, 2009, J ENDODONT, V35, P1186, DOI 10.1016/j.joen.2009.05.006
   Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007
   Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856
   van der Pol WL, 2000, NEUROLOGY, V54, P1661
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Sorge NM, 2003, ANN NEUROL, V53, P570, DOI 10.1002/ana.10503
   van Sorge NM, 2005, J NEUROIMMUNOL, V162, P157, DOI 10.1016/j.jneuroim.2005.01.016
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   Vedeler CA, 2000, NEUROLOGY, V55, P705
   YUKI N, 1990, NEUROLOGY, V40, P1900
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zhang G., 2014, PLOS ONE, V11
NR 40
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD SEP 15
PY 2016
VL 298
BP 160
EP 164
DI 10.1016/j.jneuroim.2016.07.020
PG 5
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA DW8WQ
UT WOS:000383936600023
PM 27609290
ER

PT J
AU Motta, IJF
   Spencer, BR
   Ferreira, OC
AF Motta, Iara J. F.
   Spencer, Bryan R.
   Ferreira, Orlando C., Jr.
TI Evidence for Transmission of Zika Virus by Platelet Transfusion
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID FRENCH-POLYNESIA; FEBRUARY 2014
C1 [Motta, Iara J. F.] Inst Nacl Canc Jose Alencar Gomes da Silva, Rio De Janeiro, Brazil.
   [Spencer, Bryan R.] Amer Red Cross, Massachusetts Reg, Dedham, MA USA.
   [Ferreira, Orlando C., Jr.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RP Ferreira, OC (reprint author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
EM orlandocfj@gmail.com
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
NR 5
TC 0
Z9 0
U1 6
U2 6
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 15
PY 2016
VL 375
IS 11
BP 1101
EP 1103
DI 10.1056/NEJMc1607262
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV6ZG
UT WOS:000383085000030
PM 27532622
ER

PT J
AU Morris, JK
   Rankin, J
   Garne, E
   Loane, M
   Greenlees, R
   Addor, MC
   Arriola, L
   Barisic, I
   Bergman, JEH
   Csaky-Szunyogh, M
   Dias, C
   Draper, ES
   Gatt, M
   Khoshnood, B
   Klungsoyr, K
   Kurinczuk, JJ
   Lynch, C
   McDonnell, R
   Nelen, V
   Neville, AJ
   O'Mahony, MT
   Pierini, A
   Randrianaivo, H
   Rissmann, A
   Tucker, D
   Verellen-Dumoulin, C
   de Walle, HEK
   Wellesley, D
   Wiesel, A
   Dolk, H
AF Morris, Joan K.
   Rankin, Judith
   Garne, Ester
   Loane, Maria
   Greenlees, Ruth
   Addor, Marie-Claude
   Arriola, Larraitz
   Barisic, Ingeborg
   Bergman, Jorieke E. H.
   Csaky-Szunyogh, Melinda
   Dias, Carlos
   Draper, Elizabeth S.
   Gatt, Miriam
   Khoshnood, Babak
   Klungsoyr, Kari
   Kurinczuk, Jennifer J.
   Lynch, Catherine
   McDonnell, Robert
   Nelen, Vera
   Neville, Amanda J.
   O'Mahony, Mary T.
   Pierini, Anna
   Randrianaivo, Hanitra
   Rissmann, Anke
   Tucker, David
   Verellen-Dumoulin, Christine
   de Walle, Hermien E. K.
   Wellesley, Diana
   Wiesel, Awi
   Dolk, Helen
TI Prevalence of microcephaly in Europe: population based study
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID ZIKA VIRUS-INFECTION; CONGENITAL-ANOMALIES
AB OBJECTIVES
   To provide contemporary estimates of the prevalence of microcephaly in Europe, determine if the diagnosis of microcephaly is consistent across Europe, and evaluate whether changes in prevalence would be detected using the current European surveillance performed by EUROCAT (the European Surveillance of Congenital Anomalies).
   DESIGN
   Questionnaire and population based observational study.
   SETTING
   24 EUROCAT registries covering 570 000 births annually in 15 countries.
   PARTICIPANTS
   Cases of microcephaly not associated with a genetic condition among live births, fetal deaths from 20 weeks' gestation, and terminations of pregnancy for fetal anomaly at any gestation.
   MAIN OUTCOME MEASURES
   Prevalence of microcephaly (1 Jan 2003-31 Dec 2012) analysed with random effects Poisson regression models to account for heterogeneity across registries.
   RESULTS
   16 registries responded to the questionnaire, of which 44% (7/16) used the EUROCAT definition of microcephaly (a reduction in the size of the brain with a skull circumference more than 3 SD below the mean for sex, age, and ethnic origin), 19% (3/16) used a 2 SD cut off, 31% (5/16) were reliant on the criteria used by individual clinicians, and one changed criteria between 2003 and 2012. Prevalence of microcephaly in Europe was 1.53 (95% confidence interval 1.16 to 1.96) per 10 000 births, with registries varying from 0.4 (0.2 to 0.7) to 4.3 (3.6 to 5.0) per 10 000 (X-2= 338, df= 23, I-2=93%). Registries with a 3 SD cut off reported a prevalence of 1.74 per 10 000 (0.86 to 2.93) compared with those with the less stringent 2 SD cut off of 1.21 per 10 000 (0.21 to 2.93). The prevalence of microcephaly would need to increase in one year by over 35% in Europe or by over 300% in a single registry to reach statistical significance (P<0.01).
   CONCLUSIONS
   EUROCAT could detect increases in the prevalence of microcephaly from the Zika virus of a similar magnitude to those observed in Brazil. Because of the rarity of microcephaly and discrepant diagnostic criteria, however, the smaller increases expected in Europe would probably not be detected. Clear diagnostic criteria for microcephaly must be adopted across Europe.
C1 [Morris, Joan K.] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England.
   [Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.
   [Garne, Ester] Hosp Lillebaelt, Dept Paediat, Kolding, Denmark.
   [Loane, Maria; Greenlees, Ruth; Dolk, Helen] Univ Ulster, Newtownabbey, Antrim, North Ireland.
   [Addor, Marie-Claude] Div Med Genet, Lausanne, Switzerland.
   [Arriola, Larraitz] CIBER Epidemiol & Salud Publ CIBERESP, Basque Govt, Inst BIODonostia, Publ Hlth Div Gipuzkoa, Madrid, Spain.
   [Barisic, Ingeborg] Univ Zagreb, Childrens Hosp Zagreb, Sch Med, Zagreb, Croatia.
   [Bergman, Jorieke E. H.; de Walle, Hermien E. K.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.
   [Csaky-Szunyogh, Melinda] Hungarian Congenital Abnormal Registry, Natl Publ Hlth & Med Officer Serv, Budapest, Hungary.
   [Dias, Carlos] Ctr Estudos & Registo AC, Lisbon, Portugal.
   [Draper, Elizabeth S.] Univ Leicester, Leicester, Leics, England.
   [Gatt, Miriam] Dept Hlth Informat & Res, Guardamangia, Malta.
   [Khoshnood, Babak] INSERM, Paris, France.
   [Klungsoyr, Kari] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
   [Klungsoyr, Kari] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway.
   [Kurinczuk, Jennifer J.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England.
   [Lynch, Catherine] Hlth Serv Execut, Kilkenny, Ireland.
   [McDonnell, Robert] Hlth Serv Execut, Dublin, Ireland.
   [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium.
   [Neville, Amanda J.] Univ Ferrara, Ctr Clin & Epidemiol Res, IMER Registry, Ferrara, Italy.
   [Neville, Amanda J.] Azienda Osped Univ Ferrara, Ferrara, Italy.
   [O'Mahony, Mary T.] Hlth Serv Execut, Cork, Ireland.
   [Pierini, Anna] CNR Inst Clin Physiol, Pisa, Italy.
   [Randrianaivo, Hanitra] Registre Malformat Congenitales Reunion, St Pierre, Reunion.
   [Rissmann, Anke] Univ Magdeburg, Fac Med, Malformat Monitoring Ctr Saxony Anhalt, Magdeburg, Germany.
   [Tucker, David] Publ Hlth Wales, Swansea, W Glam, Wales.
   [Verellen-Dumoulin, Christine] Inst Pathol & Genet, Charleroi, Belgium.
   [Wellesley, Diana] Univ Southampton, Southampton, Hants, England.
   [Wellesley, Diana] Wessex Clin Genet Serv, Southampton, Hants, England.
   [Wiesel, Awi] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Birth Registry Mainz Model, Mainz, Germany.
RP Morris, JK (reprint author), Queen Mary Univ London, Wolfson Inst Prevent Med, London, England.
EM j.k.morris@qmul.ac.uk
FU European Union [2008-13]
FX This study was funded by the European Union in the framework of the
   Health Programme (2008-13). The funders had no role in the study design;
   in the collection, analysis, and interpretation of data; in the writing
   of the report; and in the decision to submit the article for
   publication. Researchers were independent of the funders.
CR Bhide P, 2016, B WORLD HEALTH ORGAN, V23, DOI [10.2471/BLT.16.172080, DOI 10.2471/BLT.16.172080]
   Boyd PA, 2011, BIRTH DEFECTS RES A, V91, pS2, DOI 10.1002/bdra.20780
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   EUROCAT, 2015, EUROCAT STAT MON REP
   EUROCAT, 2014, EUROCAT STAT MON PRO
   Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157
   Loane M, 2011, BIRTH DEFECTS RES A, V91, pS23, DOI 10.1002/bdra.20779
   Lopez-Camelo JS, 2015, ECLAMC FINAL DOCUMEN
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   National Birth Defects Prevention Network, 2013, BIRTH DEFECTS RES A, V97, pS1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Springett A, 2015, AM J MED GENET A, V167, P3062, DOI 10.1002/ajmg.a.37355
   Teljeur C, 2015, EUR J EPIDEMIOL, V30, P1165, DOI 10.1007/s10654-015-0044-3
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   World Health Organization, 2007, WHO CHILD GROWTH STA
   Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854
NR 19
TC 1
Z9 1
U1 3
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD SEP 13
PY 2016
VL 354
AR i4721
DI 10.1136/bmj.i4721
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW3NG
UT WOS:000383547700006
PM 27623840
ER

PT J
AU Vythilingam, I
   Sam, JIC
   Chan, YF
   Khaw, LT
   Sulaiman, WYW
AF Vythilingam, Indra
   Sam, Jamal I-C.
   Chan, Yoke F.
   Khaw, Loke T.
   Sulaiman, Wan Y. Wan
TI New Paradigms for Virus Detection, Surveillance and Control of Zika
   Virus Vectors in the Settings of Southeast Asia
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; vectors; diagnostic tools; new paradigms; control
ID AEDES STEGOMYIA AEGYPTI; WATER STORAGE CONTAINERS;
   CLUSTER-RANDOMIZED-TRIAL; DENGUE VECTORS; FIELD-EVALUATION; DESICCATED
   MOSQUITOS; DIPTERA-CULICIDAE; NS1 ANTIGEN; INSECTICIDE; SINGAPORE
AB Zika virus (ZIKV) has now become a global public health concern. The vectors for ZIKV are Aedes aegypti and A. albopictus. Both these mosquitoes are predominant in Southeast Asia and are also responsible for the spread of other arboviral diseases like dengue virus and chikungunya virus. The incidence of dengue has been increasing over the years and this is of concern to public health workers. Simple laboratory tools for the detection of ZIKV is also lacking. In the absence of drugs and vaccine for these arboviral diseases, vector control is the main option for surveillance and control. Aedes larval surveys have been the hallmark of dengue control along with larviciding and fogging when cases are reported. However, we need new paradigms and options for control of these vectors. The current situation in Southeast Asia clearly proves that effective strategies for vector control need to be proactive and not reactive. This will be the way forward to control epidemics of these diseases inclusive of ZIKV until a vaccine becomes available.
C1 [Vythilingam, Indra; Khaw, Loke T.; Sulaiman, Wan Y. Wan] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.
   [Sam, Jamal I-C.; Chan, Yoke F.] Univ Malaya, Fac Med, Dept Microbiol, Kuala Lumpur, Malaysia.
RP Vythilingam, I (reprint author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.
EM indrav@um.edu.my
FU University of Malaya [E000013-20001]
FX JS and YC received funding from the University of Malaya (HIR grant
   E000013-20001).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Aumentado C, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/WPSAR.2015.6.3.HYN_018, 10.5365/wpsar.2015.6.3.HYN_018]
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bishop-Lilly KA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000878
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Caragata Eric P, 2016, Trends Parasitol, V32, P207, DOI 10.1016/j.pt.2015.10.011
   CDCP, 2016, ZIK VIR DIAGN TEST
   Chadee DD, 2010, J VECTOR ECOL, V35, P395, DOI 10.1111/j.1948-7134.2010.00098.x
   Chang Moh Seng, 2011, Western Pac Surveill Response J, V2, P9, DOI 10.5365/WPSAR.2010.1.1.012
   Chao DY, 2015, J VECTOR DIS, V52, P134
   CHEONG WH, 1967, B WORLD HEALTH ORGAN, V36, P586
   Cheong WH, 1986, BULLETIN, V23, P155
   Chung YK, 2001, MED VET ENTOMOL, V15, P321, DOI 10.1046/j.0269-283x.2001.00311.x
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Dash AP, 2013, J VECTOR DIS, V50, P77
   de Resende MC, 2013, MEM I OSWALDO CRUZ, V108, P1024, DOI 10.1590/0074-0276130128
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gama RA, 2007, NEOTROP ENTOMOL, V36, P294, DOI 10.1590/S1519-566X2007000200018
   Grard G, 2007, PLOS NEGLECT TROP D, V8, pe2681, DOI DOI 10.1371/J0URNAL.PNTD.0002681
   Gretchen V., 2016, TOP MOSQUITO SUSPECT
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V., 2010, EMERG INFECT DIS, V18, P349, DOI DOI 10.3201/EID1802.111224
   Ho T., 1980, MED J MALAYSIA, V24, P409
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001
   Hugo LE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002669
   Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Invest J., 2008, P 6 INT C URB PESTS
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675
   Kittayapong P, 2012, PATHOG GLOB HEALTH, V106, P446, DOI 10.1179/2047773212Y.0000000059
   Koou SY, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0471-0
   Koou SY, 2014, J MED ENTOMOL, V51, P170, DOI 10.1603/ME13113
   Kroeger A, 2006, BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lau SM, 2015, TROP MED INT HEALTH, V20, P1271, DOI 10.1111/tmi.12555
   Lazaro A, 2015, TROP MED INT HEALTH, V20, P685, DOI 10.1111/tmi.12485
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   Lee HL, 1997, J VECTOR ECOL, V22, P146
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Meagher RJ, 2016, TRENDS MOL MED, V22, P529, DOI 10.1016/j.molmed.2016.05.009
   de Santos EMM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-195
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305
   Mudin R. N., 2015, INT MED J MALAYSIA, V14, P05
   Muller DA, 2012, J VIROL METHODS, V183, P90, DOI 10.1016/j.jviromet.2012.03.033
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Oo TT, 2011, TROP BIOMED, V28, P302
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887
   PANT CP, 1973, J MED ENTOMOL, V10, P219
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2
   Ponlawat A, 2013, SE ASIAN J TROP MED, V44, P167
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1230-6
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Saiful A. N., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P315, DOI 10.1016/S2221-1691(12)60031-8
   Sam J I C, 2016, Med J Malaysia, V71, P66
   Samuel PP, 2006, INDIAN J MED RES, V123, P615
   Seng Chang Moh, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P822
   Seng CM, 2008, J VECTOR ECOL, V33, P139, DOI 10.3376/1081-1710(2008)33[139:CUOTLF]2.0.CO;2
   Sommerfeld J, 2012, PATHOG GLOB HEALTH, V106, P428, DOI 10.1179/2047773212Y.0000000055
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sulaiman S, 2000, J VECTOR ECOL, V25, P94
   Sulaiman S, 2002, J VECTOR ECOL, V27, P230
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
   Tanrang Y., 2004, TROP BIOMED, V21, P57
   Tappe D, 2013, EUROSURVEILLANCE, V19, P20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tewari SC, 1999, T ROY SOC TROP MED H, V93, P525, DOI 10.1016/S0035-9203(99)90365-6
   Thenmozhi V, 2005, TROP MED INT HEALTH, V10, P187, DOI 10.1111/j.1365-3156.2004.01360.x
   Tozan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108017
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Tsunoda T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-6
   Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477
   Vythilingam I, 2005, J AM MOSQUITO CONTR, V21, P296, DOI 10.2987/8756-971X(2005)21[296:LAFEOT]2.0.CO;2
   VYTHILINGAM I, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P102
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wan-Norafikah O, 2010, J ASIA-PAC ENTOMOL, V13, P175, DOI 10.1016/j.aspen.2010.03.003
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   WHO, 2012, GLOB STRAT DENG PREV
   World Health Organization, 2016, SAUDI MED J, V37, P471
   World Health Organization, 2016, EM US ASS LIST EUAL, P2
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zuharah WF, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev115
NR 123
TC 0
Z9 0
U1 18
U2 18
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 13
PY 2016
VL 7
AR 1452
DI 10.3389/fmicb.2016.01452
PG 9
WC Microbiology
SC Microbiology
GA DV5KY
UT WOS:000382967300001
PM 27679623
ER

PT J
AU Abbink, P
   Larocca, RA
   De La Barrera, RA
   Bricault, CA
   Moseley, ET
   Boyd, M
   Kirilova, M
   Li, ZF
   Ng'ang'a, D
   Nanayakkara, O
   Nityanandam, R
   Mercado, NB
   Borducchi, EN
   Agarwal, A
   Brinkman, AL
   Cabral, C
   Chandrashekar, A
   Giglio, PB
   Jetton, D
   Jimenez, J
   Lee, BC
   Mojta, S
   Molloy, K
   Shetty, M
   Neubauer, GH
   Stephenson, KE
   Peron, JPS
   Zanotto, PMD
   Misamore, J
   Finneyfrock, B
   Lewis, MG
   Alter, G
   Modjarrad, K
   Jarman, RG
   Eckels, KH
   Michael, NL
   Thomas, SJ
   Barouch, DH
AF Abbink, Peter
   Larocca, Rafael A.
   De La Barrera, Rafael A.
   Bricault, Christine A.
   Moseley, Edward T.
   Boyd, Michael
   Kirilova, Marinela
   Li, Zhenfeng
   Ng'ang'a, David
   Nanayakkara, Ovini
   Nityanandam, Ramya
   Mercado, Noe B.
   Borducchi, Erica N.
   Agarwal, Arshi
   Brinkman, Amanda L.
   Cabral, Crystal
   Chandrashekar, Abishek
   Giglio, Patricia B.
   Jetton, David
   Jimenez, Jessica
   Lee, Benjamin C.
   Mojta, Shanell
   Molloy, Katherine
   Shetty, Mayuri
   Neubauer, George H.
   Stephenson, Kathryn E.
   Peron, Jean Pierre S.
   Zanotto, Paolo M. de A.
   Misamore, Johnathan
   Finneyfrock, Brad
   Lewis, Mark G.
   Alter, Galit
   Modjarrad, Kayvon
   Jarman, Richard G.
   Eckels, Kenneth H.
   Michael, Nelson L.
   Thomas, Stephen J.
   Barouch, Dan H.
TI Protective efficacy of multiple vaccine platforms against Zika virus
   challenge in rhesus monkeys
SO SCIENCE
LA English
DT Article
ID JAPANESE ENCEPHALITIS; INFECTION; MICE; ANTIBODIES; ORGANOIDS
AB Zika virus (ZIKV) is responsible for a major ongoing epidemic in the Americas and has been causally associated with fetal microcephaly. The development of a safe and effective ZIKV vaccine is therefore an urgent global health priority. Here we demonstrate that three different vaccine platforms protect against ZIKV challenge in rhesus monkeys. A purified inactivated virus vaccine induced ZIKV-specific neutralizing antibodies and completely protected monkeys against ZIKV strains from both Brazil and Puerto Rico. Purified immunoglobulin from vaccinated monkeys also conferred passive protection in adoptive transfer studies. A plasmid DNA vaccine and a single-shot recombinant rhesus adenovirus serotype 52 vector vaccine, both expressing ZIKV premembrane and envelope, also elicited neutralizing antibodies and completely protected monkeys against ZIKV challenge. These data support the rapid clinical development of ZIKV vaccines for humans.
C1 [Abbink, Peter; Larocca, Rafael A.; Bricault, Christine A.; Moseley, Edward T.; Boyd, Michael; Kirilova, Marinela; Li, Zhenfeng; Ng'ang'a, David; Nanayakkara, Ovini; Nityanandam, Ramya; Mercado, Noe B.; Borducchi, Erica N.; Agarwal, Arshi; Brinkman, Amanda L.; Cabral, Crystal; Chandrashekar, Abishek; Giglio, Patricia B.; Jetton, David; Jimenez, Jessica; Lee, Benjamin C.; Mojta, Shanell; Molloy, Katherine; Shetty, Mayuri; Neubauer, George H.; Stephenson, Kathryn E.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [De La Barrera, Rafael A.; Modjarrad, Kayvon; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [Peron, Jean Pierre S.; Zanotto, Paolo M. de A.] Univ Sao Paulo, BR-05508000 Sao Paulo, Brazil.
   [Misamore, Johnathan; Finneyfrock, Brad; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA.
   [Alter, Galit; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
   [Modjarrad, Kayvon] Henry M Jackson Fdn, Bethesda, MD 20817 USA.
RP Barouch, DH (reprint author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (reprint author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
FU U.S. Military Research and Materiel Command; U.S. Military HIV Research
   Program; Henry M. Jackson Foundation [W81XWH-11-2-0174]; National
   Institutes of Health [AI095985, AI096040, AI100663, AI124377]; Ragon
   Institute of MGH; MIT; Harvard; Sao Paulo Research Foundation (FAPESP)
   [2011/18703-2, 2014/17766-9]
FX We thank J. Mascola, B. Graham, H. Marston, P. Vasconcelos, N. Collins,
   R. Olson, K. Kabra, C. Springer, G. Ballarini, N. Botero, K. Chandrika,
   G. Donofrio, M. Robb, D. Weiss, A. Cook, J. Campbell, S. Hetzel, U.
   Reimer, H. Wenschuh, T. Suscovich, C. Linde, R. Lu, L. Peter, J. Le
   Suer, P. Gandhi, M. Iampietro, K. Visitsunthorn, A. Badamchi-Zadeh, L.
   Maxfield, and F. Stephens for generous advice, assistance, and reagents.
   The data from this study are tabulated in the main paper and in the
   supplementary materials. P. A., R. A. L., D. H. B., R. G. J., K.H.E.,
   and S. J. T. are co-inventors on pending patent applications related to
   ZIKV vaccines, antigens, and vectors, and licensure discussions with
   industry partners are currently ongoing. P. A. and D. H. B. are
   cofounders and equity holders in AVVI Biotech. ZIKV challenge stocks and
   vaccine constructs are available with appropriate material transfer
   agreements. We acknowledge support from the U.S. Military Research and
   Materiel Command and the U.S. Military HIV Research Program through its
   cooperative agreement with the Henry M. Jackson Foundation
   (W81XWH-11-2-0174); the National Institutes of Health (grants AI095985,
   AI096040, AI100663, and AI124377); the Ragon Institute of MGH, MIT, and
   Harvard; and the Sao Paulo Research Foundation (FAPESP; grants
   2011/18703-2 and 2014/17766-9). The views expressed in this manuscript
   are those of the authors and do not represent the official views of the
   Department of the Army or the Department of Defense.
CR Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Demicheli V., 2009, COCHRANE DB SYST REV, V2009
   Demicheli V., 2000, COCHRANE DB SYST REV, V2000
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2005.07.002
   Johansson MA, 2016, NEW ENGL J MED, V375
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819
   MASON RA, 1973, APPL MICROBIOL, V25, P539
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Stephenson KE, 2015, J IMMUNOL METHODS, V416, P105, DOI 10.1016/j.jim.2014.11.006
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 30
TC 1
Z9 1
U1 44
U2 44
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD SEP 9
PY 2016
VL 353
IS 6304
BP 1129
EP 1132
DI 10.1126/science.aah6157
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV0RN
UT WOS:000382626800047
PM 27492477
ER

PT J
AU van der Eijk, AA
   van Genderen, PJ
   Verdijk, RM
   Reusken, CB
   Mogling, R
   van Kampen, JJA
   Widagdo, W
   Aron, GI
   GeurtsvanKessel, CH
   Pas, SD
   Raj, VS
   Haagmans, BL
   Koopmans, MPG
AF van der Eijk, Annemiek A.
   van Genderen, Perry J.
   Verdijk, Rob M.
   Reusken, Chantal B.
   Mogling, Ramona
   van Kampen, Jeroen J. A.
   Widagdo, Widagdo
   Aron, Georgina I.
   GeurtsvanKessel, Corine H.
   Pas, Suzan D.
   Raj, V. Stalin
   Haagmans, Bart L.
   Koopmans, Marion P. G.
TI Miscarriage Associated with Zika Virus Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [van der Eijk, Annemiek A.; Verdijk, Rob M.; Reusken, Chantal B.; Mogling, Ramona; van Kampen, Jeroen J. A.; Widagdo, Widagdo; Aron, Georgina I.; GeurtsvanKessel, Corine H.; Pas, Suzan D.; Raj, V. Stalin; Haagmans, Bart L.; Koopmans, Marion P. G.] Erasmus MC, Rotterdam, Netherlands.
   [van Genderen, Perry J.] Harbour Hosp, Rotterdam, Netherlands.
RP van der Eijk, AA (reprint author), Erasmus MC, Rotterdam, Netherlands.
EM a.vandereijk@erasmusmc.nl
CR Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
NR 3
TC 0
Z9 0
U1 12
U2 12
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 8
PY 2016
VL 375
IS 10
BP 1002
EP 1004
DI 10.1056/NEJMc1605898
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU9IG
UT WOS:000382529500024
PM 27463941
ER

PT J
AU Guo, XX
   Li, CX
   Deng, YQ
   Xing, D
   Liu, QM
   Wu, Q
   Sun, AJ
   Dong, YD
   Cao, WC
   Qin, CF
   Zhao, TY
AF Guo, Xiao-xia
   Li, Chun-xiao
   Deng, Yong-qiang
   Xing, Dan
   Liu, Qin-mei
   Wu, Qun
   Sun, Ai-juan
   Dong, Yan-de
   Cao, Wu-chun
   Qin, Cheng-feng
   Zhao, Tong-yan
TI Culex pipiens quinquefasciatus: a potential vector to transmit Zika
   virus
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE Culex pipiens quinquefasciatus; transmission; vector competence; Zika
   virus (ZIKV)
ID JAPANESE ENCEPHALITIS-VIRUS; AEDES-AEGYPTI MOSQUITOS; CHINA;
   CHIKUNGUNYA; ISOLATIONS; ALBOPICTUS; CULICIDAE; SINGAPORE; OUTBREAK;
   DIPTERA
AB Zika virus (ZIKV) has become a threat to global health since the outbreak in Brazil in 2015. Although ZIKV is generally considered an Aedes-transmitted pathogen, new evidence has shown that parts of the virus closely resemble Culex-transmitted viruses. Therefore, it is important to evaluate the competence of Culex species for ZIKV to understand their potential as vectors. In this study, female Culex pipiens quinquefasciatus were orally exposed to ZIKV. Mosquito midguts, salivary glands and ovaries were tested for ZIKV to measure infection and dissemination at 2, 4, 6, 8, 12, 16 and 18 days post exposure (pe). In addition, saliva was collected from mosquitoes after infection and infant mice were bitten by infected mosquitoes to measure the transmission ability of Cx. p. quinquefasciatus. The results showed that the peak time of virus appearance in the salivary glands was day 8 pe, with 90% infection rate and an estimated virus titer of 3.92 +/- 0.49 lg RNA copies/mL. Eight of the nine infant mice had positive brains after being bitten by infected mosquitoes, which meant that Cx. p. quinquefasciatus could be infected with and transmit ZIKV following oral infection. These laboratory results clearly demonstrate the potential role of Cx. p. quinquefasciatus as a vector of ZIKV in China. Because there are quite different vector management strategies required to control Aedes (Stegomyia) species and Cx. p. quinquefasciatus, an integrated approach may be required should a Zika epidemic occur.
C1 [Guo, Xiao-xia; Li, Chun-xiao; Xing, Dan; Liu, Qin-mei; Wu, Qun; Sun, Ai-juan; Dong, Yan-de; Zhao, Tong-yan] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Vector Biol & Control, Beijing 100071, Peoples R China.
   [Deng, Yong-qiang; Qin, Cheng-feng] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
   [Cao, Wu-chun] Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Epidemiol, Beijing 100071, Peoples R China.
RP Zhao, TY (reprint author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Vector Biol & Control, Beijing 100071, Peoples R China.; Qin, CF (reprint author), Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
EM qincf@bmi.ac.cn; tongyanzhao@126.com
FU Infective Diseases Prevention and Cure Project of China
   [2012ZX10004219]; National Key Technology Support Program
   [2014BAI13B01]; National Key Research and Development Project of China
   [2016YFD0500304]; Zika Prevention and Control Project of China
FX This work was funded by grants from the Infective Diseases Prevention
   and Cure Project of China (NO 2012ZX10004219), the National Key
   Technology Support Program (NO 2014BAI13B01), the National Key Research
   and Development Project of China (NO 2016YFD0500304) and the Zika
   Prevention and Control Project of China.
CR Azmi SA, 2015, J VECTOR DIS, V52, P252
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   [Anonymous], 2014, ZHONGGUO MEIJIESHENG
   Jiang SF, 2010, J MED ENTOMOL, V47, P788, DOI 10.1603/ME08292
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 1998, J VIROL, V72, P73
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Lu BL, 1997, FAUNA SINICA INSECT, P401
   Lu BL, 1999, MOSQUITO INTEGRATED
   Lu RZ, 2016, CHIN J VECTOR BIOL C, V27, P107
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Samuel PP, 2004, J MED ENTOMOL, V41, P442, DOI 10.1603/0022-2585-41.3.442
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123
   van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510
   [Anonymous], 2015, ZHONGGUO MEIJIESHENG
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao TongYan, 1995, Entomologia Sinica, V2, P1
NR 38
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 7
PY 2016
VL 5
AR e102
DI 10.1038/emi.2016.102
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DW1LG
UT WOS:000383404100001
PM 27599470
ER

PT J
AU Yin, YX
   Xu, Y
   Su, L
   Zhu, X
   Chen, MX
   Zhu, WJ
   Xia, HM
   Huang, X
   Gong, ST
AF Yin, Yingxian
   Xu, Yi
   Su, Ling
   Zhu, Xun
   Chen, Minxia
   Zhu, Weijin
   Xia, Huimin
   Huang, Xi
   Gong, Sitang
TI Epidemiologic investigation of a family cluster of imported ZIKV cases
   in Guangdong, China: probable human-to-human transmission
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE arbovirus; flavivirus; molecular epidemiology; Guangdong; Zika virus
ID VIRUS; ALBOPICTUS; INFECTION; MOSQUITOS; OUTBREAK; VECTOR; PCR
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that can potentially threaten South China. A Chinese family of four returning from Venezuela to China was found to be positive for ZIKV when the youngest son's fever was first detected at an airport immigration inspection. They were isolated temporarily in a local hospital in Enping city, Guangdong province, where their clinical data were recorded and urine and saliva were collected to isolate ZIKV and to obtain viral sequences. All of them except the mother presented mild symptoms of rash and fever. Envelope gene sequences from the father, daughter and son were completely identical. Phylogenetic analysis demonstrated that this strain is similar to several imported strains reported in recent months, which are all clustered into a group isolated from 2015 ZIKA outbreaks in Brazil. Together with the climatic features in Venezuela, New York and Guangdong in February, it can be concluded that our subjects are imported cases from Venezuela. With the same viral sequence being shared between family members, neither direct human-to-human nor vector transmission can be ruled out in this study, but the former seems more likely. Although our subjects had mild illness, epidemiologists and public health officials should be aware of the risk of further expansion of ZIKV transmission by local competent vectors.
C1 [Yin, Yingxian; Su, Ling] Guangzhou Med Univ, Guangzhou Inst Pediat, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
   [Xu, Yi; Chen, Minxia; Zhu, Weijin] Guangzhou Med Univ, Dept Infect Dis, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
   [Zhu, Xun; Huang, Xi] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510080, Guangdong, Peoples R China.
   [Xia, Huimin] Guangzhou Med Univ, Dept Pediat Surg, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
   [Gong, Sitang] Guangzhou Med Univ, Dept Gastroenterol, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
RP Gong, ST (reprint author), Guangzhou Med Univ, Dept Gastroenterol, Guangzhou Women & Childrens Med Ctr, Guangzhou 510623, Guangdong, Peoples R China.
EM sitanggong@foxmail.com
FU Science and Technology Program of Guangzhou, China [2014Y2-00197]
FX We thank Dr De Wu (Guangdong Provincial Center for Disease Control and
   Prevention, China) for helpful discussions on Zika virus isolation. This
   work was supported by a grant (2014Y2-00197) from the Science and
   Technology Program of Guangzhou, China.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Kosasih H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004390
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li J., 2016, EMERG INFECT DIS, V22, P22, DOI DOI 10.3201/EID2206.160273
   Liuzzi Giuseppina, 2016, New Microbiol, V39, P83
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Meltzer E, 2016, AM J MED
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Pyke AT, 2016, SCI REP-UK, V6, DOI 10.1038/srep22356
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shakir R, 2016, LANCET NEUROL, V15, P353, DOI 10.1016/S1474-4422(16)00072-7
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 38
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 7
PY 2016
VL 5
AR e100
DI 10.1038/emi.2016.100
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DW1LG
UT WOS:000383404100002
PM 27599469
ER

PT J
AU Zumla, A
   Alagaili, AN
   Cotten, M
   Azhar, EI
AF Zumla, Alimuddin
   Alagaili, Abdulaziz N.
   Cotten, Matthew
   Azhar, Esam I.
TI Infectious diseases epidemic threats and mass gatherings: refocusing
   global attention on the continuing spread of the Middle East Respiratory
   syndrome coronavirus (MERS-CoV)
SO BMC MEDICINE
LA English
DT Article
DE MERS-CoV; Mass gathering; Hajj; Infectious diseases; Epidemic
   transmission; Control
ID SAUDI-ARABIA; PUBLIC-HEALTH; SOUTH-KOREA; SURVEILLANCE; OUTBREAK;
   EMERGENCE; GAMES; EBOLA
AB Media and World Health Organization (WHO) attention on Zika virus transmission at the 2016 Rio Olympic Games and the 2015 Ebola virus outbreak in West Africa diverted the attention of global public health authorities from other lethal infectious diseases with epidemic potential. Mass gatherings such as the annual Hajj pilgrimage hosted by Kingdom of Saudi Arabia attract huge crowds from all continents, creating high-risk conditions for the rapid global spread of infectious diseases. The highly lethal Middle Eastern respiratory syndrome coronavirus (MERS-CoV) remains in the WHO list of top emerging diseases likely to cause major epidemics. The 2015 MERS-CoV outbreak in South Korea, in which 184 MERS cases including 33 deaths occurred in 2 months, that was imported from the Middle East by a South Korean businessman was a wake-up call for the global community to refocus attention on MERS-CoV and other emerging and re-emerging infectious diseases with epidemic potential. The international donor community and Middle Eastern countries should make available resources for, and make a serious commitment to, taking forward a "One Health" global network for proactive surveillance, rapid detection, and prevention of MERS-CoV and other epidemic infectious diseases threats.
C1 [Zumla, Alimuddin] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
   [Alagaili, Abdulaziz N.] King Saud Univ, Coll Sci, Dept Zool, KSU Mammals Res Chair, Riyadh, Saudi Arabia.
   [Cotten, Matthew] Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
   [Azhar, Esam I.] King Abdulaziz Univ, King Fahd Med Res Ctr, Special Infect Agents Unit, Jeddah, Saudi Arabia.
   [Azhar, Esam I.] King Abdulaziz Univ, Fac Appl Med Sci, Med Lab Technol Dept, Jeddah, Saudi Arabia.
RP Zumla, A (reprint author), UCL, Div Infect & Immun, London, England.; Zumla, A (reprint author), UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.
EM a.zumla@ucl.ac.uk
CR Arabi YM, 2016, LANCET RESP MED, V4, P93, DOI 10.1016/S2213-2600(16)00007-2
   Al Arabiya, SAUDI ARABIA BANS HA
   Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   CDC, 2016, MIDDL E RESP SYNDR M
   Cho SY, 2016, LANCET
   Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7
   Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176
   Hastings DL, 2016, EMERG INFECT DIS, V22, P794, DOI 10.3201/eid2205.151797
   Hui DS, 2015, LANCET RESP MED, V3, P509, DOI 10.1016/S2213-2600(15)00238-6
   Hui DS, 2014, J INFECT DIS, V209, P173, DOI 10.1093/infdis/jit591
   Hui DS, 2016, LANCET
   Mayer LW, 2002, J INFECT DIS, V185, P1596, DOI 10.1086/340414
   McCloskey B, 2014, LANCET INFECT DIS, V14, P1001, DOI 10.1016/S1473-3099(14)70846-1
   McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9
   Memish ZA, 2014, CLIN MICROBIOL INFEC, V20, P469, DOI 10.1111/1469-0691.12562
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0
   Memish ZA, 2014, INT J INFECT DIS, V23, P63, DOI 10.1016/j.ijid.2014.03.1372
   Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen E, 2015, INT J INFECT DIS, V36, P54, DOI 10.1016/j.ijid.2015.06.004
   PHE, MERS COV PUBL HLTH I
   Reusken CBEM, 2016, CURR OPIN VIROL, V16, P55, DOI 10.1016/j.coviro.2016.01.004
   Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3
   WHO, WHO DIR GEN SUMM OUT
   WHO MERS-CoV Research Group, 2013, PLOS CURR, V5
   WHO, MIDD E RESP SYNDR CO
   WHO, SEV AC RESP SYNDR SA
   WHO, 2016, ROADM RES PROD DEV M
   WHO, 2016, WHO PUBL LIST TOP EM
   WHO, MIDDL E RESP SYNDR C
   WHO, WORLD TRAV ADV MERS
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zumla A, 2015, LANCET RESP MED, V3, P100, DOI 10.1016/S2213-2600(14)70316-9
   Zumla Alimuddin, 2016, Int J Infect Dis, V47, P5, DOI 10.1016/j.ijid.2016.06.012
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
   Zumla A, 2015, INT J INFECT DIS, V37, P77, DOI 10.1016/j.ijid.2015.06.020
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 39
TC 0
Z9 0
U1 7
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD SEP 7
PY 2016
VL 14
AR 132
DI 10.1186/s12916-016-0686-3
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV2FO
UT WOS:000382736400001
PM 27604081
ER

PT J
AU Saiz, JC
   Blazquez, AB
   De Oya, NJ
   Merino-Ramos, T
   Martin-Acebes, MA
   Escribano-Romero, E
   Vazquez-Calvo, A
AF Saiz, Juan-Carlos
   Blazquez, Ana B.
   De Oya, Nereida Jimenez
   Merino-Ramos, Teresa
   Martin-Acebes, Miguel A.
   Escribano-Romero, Estela
   Vazquez-Calvo, Angela
TI Response: Commentary: Zika Virus: the Latest Newcomer
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Editorial Material
DE Zika virus (ZIKV); Guillain-Barre syndrome; Flavivirus; surveillance;
   communicable diseases
C1 [Saiz, Juan-Carlos; Blazquez, Ana B.; De Oya, Nereida Jimenez; Merino-Ramos, Teresa; Martin-Acebes, Miguel A.; Escribano-Romero, Estela; Vazquez-Calvo, Angela] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain.
RP Saiz, JC (reprint author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain.
EM jcsaiz@inia.es
CR Blazquez A. B., WORLD J VIR IN PRESS
   Craig AT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01028
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sejvar JJ, 2004, NEUROLOGY, V63, P206
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Winner J. B., 2001, MOL PATHOL, V54, P381, DOI [10.1136/mp.54.6.381, DOI 10.1136/MP.54.6.381]
NR 11
TC 0
Z9 0
U1 8
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 7
PY 2016
VL 7
AR 1398
DI 10.3389/fmicb.2016.01398
PG 2
WC Microbiology
SC Microbiology
GA DU9GO
UT WOS:000382524700002
PM 27656170
ER

PT J
AU Onorati, M
   Li, Z
   Liu, FC
   Sousa, AMM
   Nakagawa, N
   Li, MF
   Dell'Anno, MT
   Gulden, FO
   Pochareddy, S
   Tebbenkamp, ATN
   Han, WQ
   Pletikos, M
   Gao, TLY
   Zhu, Y
   Bichsel, C
   Varela, L
   Szigeti-Buck, K
   Lisgo, S
   Zhang, YL
   Testen, A
   Gao, XB
   Mlakar, J
   Popovic, M
   Flamand, M
   Strittmatter, SM
   Kaczmarek, LK
   Anton, ES
   Horvath, TL
   Lindenbach, BD
   Sestan, N
AF Onorati, Marco
   Li, Zhen
   Liu, Fuchen
   Sousa, Andre M. M.
   Nakagawa, Naoki
   Li, Mingfeng
   Dell'Anno, Maria Teresa
   Gulden, Forrest O.
   Pochareddy, Sirisha
   Tebbenkamp, Andrew T. N.
   Han, Wenqi
   Pletikos, Mihovil
   Gao, Tianliuyun
   Zhu, Ying
   Bichsel, Candace
   Varela, Luis
   Szigeti-Buck, Klara
   Lisgo, Steven
   Zhang, Yalan
   Testen, Anze
   Gao, Xiao-Bing
   Mlakar, Jernej
   Popovic, Mara
   Flamand, Marie
   Strittmatter, Stephen M.
   Kaczmarek, Leonard K.
   Anton, E. S.
   Horvath, Tamas L.
   Lindenbach, Brett D.
   Sestan, Nenad
TI Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human
   Neuroepithelial Stem Cells and Radial Glia
SO CELL REPORTS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; BINDING KINASE 1; HUMAN BRAIN; NEURAL
   PROGENITORS; INNATE IMMUNITY; LONG-TERM; INFECTION; MICE; ORGANOIDS;
   ADAPTER
AB The mechanisms underlying Zika virus (ZIKV)-related microcephaly and other neurodevelopment defects remain poorly understood. Here, we describe the derivation and characterization, including singlecell RNA-seq, of neocortical and spinal cord neuroepithelial stem (NES) cells to model early human neurodevelopment and ZIKV-related neuropathogenesis. By analyzing human NES cells, organotypic fetal brain slices, and a ZIKV-infected micrencephalic brain, we show that ZIKV infects both neocortical and spinal NES cells as well as their fetal homolog, radial glial cells (RGCs), causing disrupted mitoses, supernumerary centrosomes, structural disorganization, and cell death. ZIKV infection of NES cells and RGCs causes centrosomal depletion and mitochondrial sequestration of phospho-TBK1 during mitosis. We also found that nucleoside analogs inhibit ZIKV replication in NES cells, protecting them from ZIKV-induced pTBK1 relocalization and cell death. We established a model system of human neural stem cells to reveal cellular and molecular mechanisms underlying neurodevelopmental defects associated with ZIKV infection and its potential treatment.
C1 [Onorati, Marco; Li, Zhen; Liu, Fuchen; Sousa, Andre M. M.; Li, Mingfeng; Gulden, Forrest O.; Pochareddy, Sirisha; Tebbenkamp, Andrew T. N.; Han, Wenqi; Pletikos, Mihovil; Gao, Tianliuyun; Zhu, Ying; Bichsel, Candace; Horvath, Tamas L.; Sestan, Nenad] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.
   [Onorati, Marco; Li, Zhen; Liu, Fuchen; Sousa, Andre M. M.; Li, Mingfeng; Gulden, Forrest O.; Pochareddy, Sirisha; Tebbenkamp, Andrew T. N.; Han, Wenqi; Pletikos, Mihovil; Gao, Tianliuyun; Zhu, Ying; Bichsel, Candace; Horvath, Tamas L.; Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA.
   [Nakagawa, Naoki; Testen, Anze; Anton, E. S.] Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.
   [Nakagawa, Naoki; Testen, Anze; Anton, E. S.] Univ N Carolina, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.
   [Dell'Anno, Maria Teresa; Strittmatter, Stephen M.; Sestan, Nenad] Yale Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, Dept Neurol, New Haven, CT 06510 USA.
   [Dell'Anno, Maria Teresa; Strittmatter, Stephen M.; Sestan, Nenad] Yale Sch Med, Dept Neurosci, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA.
   [Varela, Luis; Szigeti-Buck, Klara; Gao, Xiao-Bing; Horvath, Tamas L.; Sestan, Nenad] Yale Sch Med, Sect Comparat Med, New Haven, CT 06510 USA.
   [Lisgo, Steven] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Zhang, Yalan; Kaczmarek, Leonard K.] Yale Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.
   [Mlakar, Jernej; Popovic, Mara] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana 1000, Slovenia.
   [Flamand, Marie] Inst Pasteur, Dept Virol, F-75724 Paris 15, France.
   [Kaczmarek, Leonard K.] Yale Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.
   [Horvath, Tamas L.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.
   [Horvath, Tamas L.] Yale Sch Med, Yale Program Integrat Cell Signaling & Neurobiol, New Haven, CT 06510 USA.
   [Lindenbach, Brett D.] Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA.
   [Sestan, Nenad] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.
   [Sestan, Nenad] Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.
RP Horvath, TL; Sestan, N (reprint author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.; Sestan, N (reprint author), Yale Sch Med, Cellular Neurosci Neurodegenerat & Repair Program, Dept Neurol, New Haven, CT 06510 USA.; Sestan, N (reprint author), Yale Sch Med, Dept Neurosci, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA.; Horvath, TL; Sestan, N (reprint author), Yale Sch Med, Sect Comparat Med, New Haven, CT 06510 USA.; Horvath, TL (reprint author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.; Horvath, TL (reprint author), Yale Sch Med, Yale Program Integrat Cell Signaling & Neurobiol, New Haven, CT 06510 USA.; Lindenbach, BD (reprint author), Yale Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA.; Sestan, N (reprint author), Yale Sch Med, Dept Genet, New Haven, CT 06510 USA.; Sestan, N (reprint author), Yale Sch Med, Dept Psychiat, New Haven, CT 06510 USA.
EM tamas.horvath@yale.edu; brett.lindenbach@yale.edu; nenad.sestan@yale.edu
FU NIH [NS076503, MH103339, MH105972, MH106934, MH060929, NS080388,
   AG034924, AG047270, DC01919, AI120113, AI089826, HD0008836]; Simons
   Foundation [SFARI 307705]; Connecticut Innovations' Regenerative
   Medicine Research Fund [15-RMA-YALE-31]; Joint MRC/Wellcome Trust
   [099175/Z/12/Z]; Kavli Foundation; Falk Medical Research Trust
FX We thank Carolyn Hain for assistance with tissue acquisition and
   processing and Brian G. Rash for technical advice. We also thank
   Angeliki Louvi and Flora Vaccarino for sharing equipment and providing
   reagents and tissue samples. We thank Alain Kohl (MRC Glasgow) for
   providing us with the Brazilian ZIKV strain PE243, Scott Terhune
   (Medical College of Wisconsin) and Felicia Goodrum (University of
   Arizona) for supplying HCMV-GFP, and Avinash Phadke (Achillion
   Pharmaceuticals) for supplying samples of Sofosbuvir and
   2'-C-methyladenosine. We also thank the other members of our
   laboratories for their comments. This work was supported by grants
   NS076503, MH103339, MH105972, MH106934, MH060929, NS080388, AG034924,
   AG047270, DC01919, AI120113, and AI089826 from the NIH, SFARI 307705
   from the Simons Foundation, and 15-RMA-YALE-31 from Connecticut
   Innovations' Regenerative Medicine Research Fund. The Laboratory of
   Developmental Biology at the University of Washington, Seattle, and
   Human Developmental Biology Resource were supported by NIH award number
   HD0008836 and the Joint MRC/Wellcome Trust grant 099175/Z/12/Z,
   respectively. Additional support was provided by the Kavli Foundation
   and the Falk Medical Research Trust.
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066
   Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112
   Diaz AL, 2009, CLIN PERINATOL, V36, P503, DOI 10.1016/j.clp.2009.06.008
   Edri R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7500
   Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208
   Eyer Ludek, 2016, J Infect Dis, V214, P707, DOI 10.1093/infdis/jiw226
   Farlik M, 2012, MOL CELL BIOL, V32, P1032, DOI 10.1128/MCB.06021-11
   FINE JD, 1985, J AM ACAD DERMATOL, V12, P697
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Helgason E, 2013, FEBS LETT, V587, P1230, DOI 10.1016/j.febslet.2013.01.059
   Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523
   Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106
   KRUMLAUF R, 1993, J NEUROBIOL, V24, P1328, DOI 10.1002/neu.480241006
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Marin-Padilla M, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00038
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOLLGARD K, 1986, NEUROPATH APPL NEURO, V12, P337, DOI 10.1111/j.1365-2990.1986.tb00146.x
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Ning YJ, 2014, J MOL CELL BIOL, V6, DOI 10.1093/jmcb/mju015
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Onorati M, 2011, CELL MOL LIFE SCI, V68, P1769, DOI 10.1007/s00018-010-0548-7
   Onorati M, 2014, NAT NEUROSCI, V17, P1804, DOI 10.1038/nn.3860
   Pattabhi S, 2016, J VIROL, V90, P2372, DOI 10.1128/JVI.02202-15
   Pillai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10072
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082
   Roberts MR, 2000, J NEUROSCI, V20, P2295
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008
   Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003168
   Tailor J, 2013, J NEUROSCI, V33, P12407, DOI 10.1523/JNEUROSCI.0130-13.2013
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 64
TC 0
Z9 0
U1 3
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD SEP 6
PY 2016
VL 16
IS 10
BP 2576
EP 2592
DI 10.1016/j.celrep.2016.08.038
PG 17
WC Cell Biology
SC Cell Biology
GA DW8CH
UT WOS:000383880400005
PM 27568284
ER

PT J
AU Swannell, C
AF Swannell, Cate
TI Zika virus tentacles reach further
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD SEP 5
PY 2016
VL 205
IS 5
BP 197
EP 197
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX0FQ
UT WOS:000384037600003
ER

PT J
AU Cristina, J
   Fajardo, A
   Sonora, M
   Moratorio, G
   Musto, H
AF Cristina, Juan
   Fajardo, Alvaro
   Sonora, Martin
   Moratorio, Gonzalo
   Musto, Hector
TI A detailed comparative analysis of codon usage bias in Zika virus
SO VIRUS RESEARCH
LA English
DT Article
DE Zika; Codon usage; Codon bias; Evolution
ID ADAPTATION INDEX; BRAZIL; DEOPTIMIZATION; TRANSMISSION; EVOLUTION;
   INFECTION; SELECTION; REGION
AB Zika virus (ZIKV) is a member of the family Flaviviridae and its genome consists of a single-stranded positive sense RNA molecule with 10,794 nucleotides. Clinical manifestations of disease caused by ZIKV infection range from asymptomatic cases to an influenza-like syndrome. There is an increasing concern about the possible relation among microcephaly and ZIKV infection. To get insight into the relation of codon usage among viruses and their hosts is extremely important to understand virus survival, fitness, evasion from host's immune system and evolution. In this study, we performed a comprehensive analysis of codon usage and composition of ZIKV. The overall codon usage among ZIKV strains is similar and slightly biased. Different codon preferences in ZIKV genes in relation to codon usage of human, Aedes aegypti and Aedes albopictus genes were found. Most of the highly frequent codons are A-ending, which strongly suggests that mutational bias is the main force shaping codon usage in this virus. G+C compositional constraint as well as dinucleotide composition also influence the codon usage of ZIKV. The results of these studies suggest that the emergence of ZIKV outside Africa, in the Pacific and the Americas may also be reflected in ZIKV codon usage. No significant differences were found in codon usage among strains isolated from microcephaly cases and the rest of strains from the Asian cluster enrolled in these studies. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Cristina, Juan; Fajardo, Alvaro; Sonora, Martin; Moratorio, Gonzalo] Univ La Republ, Fac Ciencias, Ctr Invest Nucl, Mol Virol Lab, Igua 4225, Montevideo 11400, Uruguay.
   [Moratorio, Gonzalo] Inst Pasteur, CNRS UMR 3569, Viral Populat & Pathogenesis Lab, Paris, France.
   [Musto, Hector] Univ La Republ, Fac Ciencias, Inst Biol, Lab Org & Evoluc Genoma, Igua 4225, Montevideo 11400, Uruguay.
RP Cristina, J (reprint author), Univ La Republ, Fac Ciencias, Ctr Invest Nucl, Mol Virol Lab, Igua 4225, Montevideo 11400, Uruguay.
EM cristina@cin.edu.uy
FU Agencia Nacional de Investigacion e Innovacion (ANII)
   [PE_ALI_2009_1_1603]; FondoMariaVinas; PEDECIBA, Uruguay; Fondo Clemente
   Estable [2007_722]; Comision Sectorial de Investigacion Cientifica
   (CSIC), Universidad de la Republica, Uruguay
FX Authors acknowledge support by Agencia Nacional de Investigacion e
   Innovacion (ANII) through project PE_ALI_2009_1_1603, FondoMariaVinas
   and PEDECIBA, Uruguay. We also thank the support of Fondo Clemente
   Estable, 2007_722 to HM. We acknowledge Comision Sectorial de
   Investigacion Cientifica (CSIC), Universidad de la Republica, Uruguay,
   for support through Grupos I+D program.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006
   Butler D., 2016, NATURE, V530, P13
   Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cristina J, 2015, VIRUS RES, V196, P87, DOI 10.1016/j.virusres.2014.11.005
   Dorn A, 2008, CURR OPIN MOL THER, V10, P10
   Driggers R.W., 2016, NEW ENGL J MED
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Faye O., 2014, PLOS NEGLECT TROP D, V8
   Greenacre M. J., 1984, THEORY APPL CORRES A
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hu JS, 2011, INFECT GENET EVOL, V11, P2098, DOI 10.1016/j.meegid.2011.08.025
   Costafreda MI, 2014, J VIROL, V88, P5029, DOI 10.1128/JVI.00087-14
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lobo F. P., 2009, PLOS ONE, V20
   Ma JJ, 2013, J ANIM VET ADV, V12, P88
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Novembre JA, 2002, MOL BIOL EVOL, V19, P1390
   Puigbo P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-65
   Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305
   SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   Tsai CT, 2007, VIRUS RES, V126, P196, DOI 10.1016/j.virusres.2007.03.001
   Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0
   Wessa P., 2012, FREE STAT SOFTWARE O
   Wong E. H., 2010, BMC EVOL BIOL, V19, P253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 42
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD SEP 2
PY 2016
VL 223
BP 147
EP 152
DI 10.1016/j.virusres.2016.06.022
PG 6
WC Virology
SC Virology
GA DW7JI
UT WOS:000383826600019
PM 27449601
ER

PT J
AU Dirlikov, E
   Major, CG
   Mayshack, M
   Medina, N
   Matos, D
   Ryff, KR
   Torres-Aponte, J
   Alkis, R
   Munoz-Jordan, J
   Colon-Sanchez, C
   Salinas, JL
   Pastula, DM
   Garcia, M
   Segarra, MO
   Malave, G
   Thomas, DL
   Rodriguez-Vega, GM
   Luciano, CA
   Sejvar, J
   Sharp, TM
   Rivera-Garcia, B
AF Dirlikov, Emilio
   Major, Chelsea G.
   Mayshack, Marrielle
   Medina, Nicole
   Matos, Desiree
   Ryff, Kyle R.
   Torres-Aponte, Jomil
   Alkis, Rebecca
   Munoz-Jordan, Jorge
   Colon-Sanchez, Candimar
   Salinas, Jorge L.
   Pastula, Daniel M.
   Garcia, Myriam
   Segarra, Marangely Olivero
   Malave, Graciela
   Thomas, Dana L.
   Rodriguez-Vega, Gloria M.
   Luciano, Carlos A.
   Sejvar, James
   Sharp, Tyler M.
   Rivera-Garcia, Brenda
TI Guillain-Barre Syndrome During Ongoing Zika Virus Transmission - Puerto
   Rico, January 1-July 31, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Dirlikov, Emilio; Mayshack, Marrielle; Ryff, Kyle R.; Torres-Aponte, Jomil; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR 00927 USA.
   [Dirlikov, Emilio; Salinas, Jorge L.] CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Major, Chelsea G.; Medina, Nicole; Matos, Desiree; Munoz-Jordan, Jorge; Colon-Sanchez, Candimar; Pastula, Daniel M.; Sharp, Tyler M.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Major, Chelsea G.; Mayshack, Marrielle] CDC, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
   [Alkis, Rebecca] Emory Univ, Atlanta, GA 30322 USA.
   [Pastula, Daniel M.] Univ Colorado, Dept Neurol, Denver, CO 80202 USA.
   [Pastula, Daniel M.] Univ Colorado, Div Infect Dis, Denver, CO 80202 USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Biol & Chem Emergencies Lab, Off Publ Hlth Preparedness & Response, San Juan, PR USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Publ Hlth Lab, San Juan, PR USA.
   [Thomas, Dana L.] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Rodriguez-Vega, Gloria M.] HIMA San Pablo, Caguas, PR USA.
   [Luciano, Carlos A.] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Sejvar, James] CDC, Off Infect Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Dirlikov, E (reprint author), Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR 00927 USA.; Dirlikov, E (reprint author), CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
EM GBS@salud.pr.gov
CR Adams Laura, 2016, MMWR Morb Mortal Wkly Rep, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Siu R, 2016, NEUROLOGY
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 10
TC 0
Z9 0
U1 4
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 2
PY 2016
VL 65
IS 34
BP 910
EP 914
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DV4NQ
UT WOS:000382902700006
PM 27584942
ER

PT J
AU Brooks, RB
   Carlos, MP
   Myers, RA
   White, MG
   Bobo-Lenoci, T
   Aplan, D
   Blythe, D
   Feldman, KA
AF Brooks, Richard B.
   Carlos, Maria Paz
   Myers, Robert A.
   White, Mary Grace
   Bobo-Lenoci, Tanya
   Aplan, Debra
   Blythe, David
   Feldman, Katherine A.
TI Likely Sexual Transmission of Zika Virus from a Man with No Symptoms of
   Infection - Maryland, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; EPIDEMIC
C1 [Brooks, Richard B.] CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Brooks, Richard B.; Blythe, David; Feldman, Katherine A.] Maryland Dept Hlth & Mental Hyg, Prevent & Hlth Promot Adm, Baltimore, MD 21201 USA.
   [Carlos, Maria Paz; Myers, Robert A.] Maryland Dept Hlth & Mental Hyg, Labs Adm, Baltimore, MD 21201 USA.
   [White, Mary Grace; Bobo-Lenoci, Tanya] Baltimore City Dept Hlth, Baltimore, MD USA.
   [Aplan, Debra] Montgomery Cty Dept Hlth & Human Serv, Rockville, MD USA.
RP Brooks, RB (reprint author), CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.; Brooks, RB (reprint author), Maryland Dept Hlth & Mental Hyg, Prevent & Hlth Promot Adm, Baltimore, MD 21201 USA.
EM richard.brooks@maryland.gov
CR Brooks John T, 2016, MMWR Morb Mortal Wkly Rep, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
NR 6
TC 0
Z9 0
U1 3
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 2
PY 2016
VL 65
IS 34
BP 915
EP 916
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DV4NQ
UT WOS:000382902700007
PM 27585037
ER

PT J
AU Leal, MC
   Muniz, LF
   Ferreira, TSA
   Santos, CM
   Almeida, LC
   Van der Linden, V
   Ramos, RCF
   Rodrigues, LC
   Neto, SSC
AF Leal, Mariana C.
   Muniz, Lilian F.
   Ferreira, Tamires S. A.
   Santos, Cristiane M.
   Almeida, Luciana C.
   Van der Linden, Vanessa
   Ramos, Regina C. F.
   Rodrigues, Laura C.
   Caldas Neto, Silvio S.
TI Hearing Loss in Infants with Microcephaly and Evidence of Congenital
   Zika Virus Infection - Brazil, November 2015-May 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Leal, Mariana C.; Ferreira, Tamires S. A.; Santos, Cristiane M.] Hosp Agamenon Magalhaes, Recife, PE, Brazil.
   [Leal, Mariana C.; Muniz, Lilian F.; Almeida, Luciana C.; Caldas Neto, Silvio S.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Van der Linden, Vanessa] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [Van der Linden, Vanessa] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [Ramos, Regina C. F.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, London, England.
RP Leal, MC (reprint author), Hosp Agamenon Magalhaes, Recife, PE, Brazil.; Leal, MC (reprint author), Univ Fed Pernambuco, Recife, PE, Brazil.
EM marianacleal@hotmail.com
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI 10.32032/eid2206.160062
   de Fatima Vasco Aragao M, 2016, BMJ-BRIT MED J, p[353, i1901]
   Brazilian Ministry of Health, PROT MON RESP MICR O
   Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Goderis J, 2014, PEDIATRICS, V134, P972, DOI 10.1542/peds.2014-1173
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 10
TC 0
Z9 0
U1 13
U2 13
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 2
PY 2016
VL 65
IS 34
BP 917
EP 919
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DV4NQ
UT WOS:000382902700008
PM 27585248
ER

PT J
AU Barreira, AA
   Marques, W
   Marreco, A
   Aquino-Cruz, C
   Esposito, D
   Klein, T
   Jacobs, BC
   Hughes, RAC
   Cornblath, DR
   van Doorn, P
   Gorson, KC
   Hartung, HP
   Willison, HJ
   Kusunoki, S
   Fonseca, B
AF Barreira, A. A.
   Marques, W., Jr.
   Marreco, A.
   Aquino-Cruz, C.
   Esposito, D.
   Klein, T.
   Jacobs, B. C.
   Hughes, R. A. C.
   Cornblath, D. R.
   van Doorn, P.
   Gorson, K. C.
   Hartung, H-P
   Willison, H. J.
   Kusunoki, S.
   Fonseca, B.
TI GUILLAIN-BARRE SYNDROME RELATED TO ZIKA VIRUS INFECTION IN BRAZIL
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Barreira, A. A.] Univ Sao Paulo, Med Sch Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Marques, W., Jr.; Marreco, A.; Aquino-Cruz, C.; Esposito, D.; Klein, T.; Fonseca, B.] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Marques, W., Jr.; Marreco, A.; Aquino-Cruz, C.; Esposito, D.; Klein, T.; Fonseca, B.] Univ Sao Paulo, Univ Hosp Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Jacobs, B. C.; van Doorn, P.] Erasmus MC, Rotterdam, Netherlands.
   [Hughes, R. A. C.] UCL, Inst Neurol, London, England.
   [Cornblath, D. R.] Johns Hopkins Univ, Baltimore, MD USA.
   [Gorson, K. C.] Tufts Univ, Sch Med, Boston, MA 02111 USA.
   [Hartung, H-P] Univ Dusseldorf, Dusseldorf, Germany.
   [Willison, H. J.] Univ Glasgow, Glasgow, Lanark, Scotland.
   [Kusunoki, S.] Univ Sch Med, Osaka, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 162
EP 162
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200020
ER

PT J
AU Ferreira, ACAF
   Cruz, LCH
   Santos, PP
   Fontes, CAP
   Neves, DG
   Cavaliere, MG
   Prado, HIP
   Herculano, FGN
   Silva, IRF
   Nascimento, OJM
AF Ferreira, A. C. A. F.
   Cruz Jr, L. C. H.
   Santos, P. P.
   Fontes, C. A. P.
   Neves, D. G.
   Cavaliere, M. G.
   Prado, H. I. P.
   Herculano, F. G. N.
   Silva, I. R. F.
   Nascimento, O. J. M.
TI MRI FINDINGS OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM IN PATIENTS
   WITH ZIKA VIRUS INFECTION
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Ferreira, A. C. A. F.; Santos, P. P.; Fontes, C. A. P.; Neves, D. G.; Cavaliere, M. G.; Prado, H. I. P.; Herculano, F. G. N.; Silva, I. R. F.; Nascimento, O. J. M.] Univ Fed Fluminense, Rio De Janeiro, Brazil.
   [Cruz Jr, L. C. H.] Hosp Amer, CDPI, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 173
EP 173
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200049
ER

PT J
AU Ferreira, MLB
   Brito, PFR
   Albuquerque, LBB
   Coutinho, MCR
   Moreira, AJP
   Machado, MIM
AF Ferreira, M. L. B.
   Brito, P. F. R.
   Albuquerque, L. B. B.
   Coutinho, M. C. R.
   Moreira, A. J. P.
   Machado, M. I. M.
TI GUILLAIN-BARRE SYNDROME ASSOCIATED TO ZIKA VIRUS OUTBREAK IN RECIFE,
   NORTHEAST BRAZIL
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Ferreira, M. L. B.; Moreira, A. J. P.; Machado, M. I. M.] Hosp Restauracao, Recife, PE, Brazil.
   [Brito, P. F. R.] Fac Pernambucana Saude, Med, Recife, PE, Brazil.
   [Albuquerque, L. B. B.] Univ Fed Pernambuco, Fac Med, Recife, PE, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 173
EP 173
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200050
ER

PT J
AU Santos, PP
   Nogueira, CB
   Cruz, LCH
   Vianna, FSL
   Ferreira, ACA
   Carvalho, ML
   Filho, PFM
   Matta, AP
   Silva, IRF
   Nascimento, OJM
AF Santos, P. P.
   Nogueira, C. B.
   Cruz Jr, L. C. H.
   Vianna, F. S. L.
   Ferreira, A. C. A.
   Carvalho, M. L.
   Filho, P. F. M.
   Matta, A. P.
   Silva, I. R. F.
   Nascimento, O. J. M.
TI CNS AND PNS FINDINGS DURING THE ZIKA VIRUS OUTBREAK
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Santos, P. P.; Nogueira, C. B.; Vianna, F. S. L.; Ferreira, A. C. A.; Carvalho, M. L.; Filho, P. F. M.; Matta, A. P.; Silva, I. R. F.; Nascimento, O. J. M.] Univ Fed Fluminense, Rio De Janeiro, Brazil.
   [Cruz Jr, L. C. H.] Hosp Amer, CDPI, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 207
EP 207
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200142
ER

PT J
AU Silva, IRF
   Araujo, LM
   Santos, PP
   Ferreira, ACA
   Almeida, IM
   Pagliarini, LFD
   Magalhaes, TN
   Pupe, CCB
   Guedes, V
   Costa, HVM
   Nascimento, OJM
AF Silva, I. R. F.
   Araujo, L. M.
   Santos, P. P.
   Ferreira, A. C. A.
   Almeida, I. M.
   Pagliarini, L. F. D.
   Magalhaes, T. N.
   Pupe, C. C. B.
   Guedes, V
   Costa, H. V. M.
   Nascimento, O. J. M.
TI INCREASED INCIDENCE OF GBS CASES DURING ZIKA EPIDEMIC IN BRAZIL: A
   POPULATION STUDY ZIKA VIRUS OUTBREAK
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Silva, I. R. F.; Araujo, L. M.; Santos, P. P.; Ferreira, A. C. A.; Almeida, I. M.; Pagliarini, L. F. D.; Magalhaes, T. N.; Pupe, C. C. B.; Guedes, V; Costa, H. V. M.; Nascimento, O. J. M.] Univ Fed Fluminense, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 211
EP 211
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200155
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Association Between Zika Virus and Microcephaly in French Polynesia,
   2013-2015: A Retrospective Study EDITORIAL COMMENT
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD SEP
PY 2016
VL 71
IS 9
BP 512
EP 514
DI 10.1097/01.ogx.0000491260.72445.aa
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DW9RT
UT WOS:000384000500005
ER

PT J
AU Dorit, RL
AF Dorit, Robert L.
TI Zika Goes Viral While the Zika virus has its moment, few people are
   discussing the problems underlying the worldwide increase in emerging
   infectious diseases
SO AMERICAN SCIENTIST
LA English
DT Editorial Material
C1 [Dorit, Robert L.] Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.
RP Dorit, RL (reprint author), Ford Hall 114,100 Green St, Northampton, MA 01063 USA.
EM rdorit@smith.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SIGMA XI-SCI RES SOC
PI RES TRIANGLE PK
PA PO BOX 13975, RES TRIANGLE PK, NC 27709 USA
SN 0003-0996
EI 1545-2786
J9 AM SCI
JI Am. Scientist
PD SEP-OCT
PY 2016
VL 104
IS 5
BP 274
EP 277
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT4JU
UT WOS:000381446800013
ER

PT J
AU Leandro, CG
AF Leandro, Carol Gois
TI Nutritional status and gross motor function in children with cerebral
   palsy, and implications for Zika virus infection
SO DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
LA English
DT Editorial Material
ID BIRTH-WEIGHT; PERFORMANCE
AB This commentary is on the original article by Herrera-Anaya etal. on pages 936-941 of this issue.
C1 [Leandro, Carol Gois] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Recife, PE, Brazil.
RP Leandro, CG (reprint author), Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Recife, PE, Brazil.
CR Herrera-Anaya E, 2016, DEV MED CHILD NEUROL, V58, P936, DOI 10.1111/dmcn.13108
   Moura-Dos-Santos M, 2013, AM J HUM BIOL, V25, P58, DOI 10.1002/ajhb.22341
   Moura-Dos-Santos MA, 2015, DEV MED CHILD NEUROL, V57, P470, DOI 10.1111/dmcn.12664
   Penagini F, 2015, NUTRIENTS, V7, P9400, DOI 10.3390/nu7115469
   Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100
NR 5
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0012-1622
EI 1469-8749
J9 DEV MED CHILD NEUROL
JI Dev. Med. Child Neurol.
PD SEP
PY 2016
VL 58
IS 9
BP 893
EP 894
DI 10.1111/dmcn.13134
PG 2
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA DV3VJ
UT WOS:000382852000004
PM 27060691
ER

PT J
AU Madrid, L
   Varo, R
   Sitoe, A
   Bassat, Q
AF Madrid, Lola
   Varo, Rosauro
   Sitoe, Antonio
   Bassat, Quique
TI Congenital and perinatally-acquired infections in resource-constrained
   settings
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE TORCH; congenital infections; congenital toxoplasmosis; rubella;
   cytomegalovirus; neonatal herpes; congenital syphilis; hepatitis B;
   congenital varicella syndrome; parvovirus B19
ID HERPES-SIMPLEX-VIRUS; HEPATITIS-B-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS;
   PARVOVIRUS B19 INFECTION; VARICELLA-ZOSTER-VIRUS;
   CYTOMEGALOVIRUS-INFECTION; PREGNANT-WOMEN; CHAGAS-DISEASE; ZIKA VIRUS;
   TYPE-2 INFECTION
AB Introduction: Congenital and perinatal infections are a leading cause of neonatal and infant morbidity and mortality. Maternal screening, vaccines or treatment where available, constitute effective prevention strategies to reduce the burden of these diseases. Data on the burden of congenital and perinatal infections are very limited for low and middle-income regions.Areas covered: This review aims to summarize the burden of congenital and perinatal infections and the main challenges for their control in resource-limited settings. Articles were identified through the main electronic databases and cover the period 1971-2016.Expert commentary: Estimates from low and middle-income countries indicate that the burden of congenital infections may be higher in these regions than in industrialized countries. As preventive and curative strategies are available to tackle some of these infections, efforts at the international and national levels must be made to implement those and thus reduce their burden in resource-limited countries.
C1 [Madrid, Lola; Varo, Rosauro; Sitoe, Antonio; Bassat, Quique] CISM, Rua 12, Maputo 1929, Mozambique.
   [Madrid, Lola; Varo, Rosauro; Bassat, Quique] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.
RP Madrid, L (reprint author), CISM, Rua 12, Maputo 1929, Mozambique.
EM lola.madrid@isglobal.org
CR Adler SP, 1996, PEDIATR INFECT DIS J, V15, P240, DOI 10.1097/00006454-199603000-00013
   Adler SP, 2013, BRIT MED BULL, V107, P57, DOI 10.1093/bmb/ldt023
   Anderson KB, 2016, ANN INTERN MED
   Andrus JK, 2011, VACCINE, V29, pD91, DOI 10.1016/j.vaccine.2011.04.059
   Ansbro EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127728
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Baquero-Artigao F, 2009, AN PEDIATR, V71, P535, DOI 10.1016/j.anpedi.2009.07.029
   Baquero-Artigao F, 2013, AN PEDIAT BARC, V79
   Basnayake SK, 2016, J VIRAL HEPATITIS, V23, P545, DOI 10.1111/jvh.12519
   BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366
   Benova L, 2014, CLIN INFECT DIS, V59, P765, DOI 10.1093/cid/ciu447
   Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204
   Best JM, 2007, SEMIN FETAL NEONAT M, V12, P182, DOI 10.1016/j.siny.2007.01.017
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bollen LJM, 2008, AIDS, V22, P1169, DOI 10.1097/QAD.0b013e3282fec42a
   BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007
   Botelho CAO, 2008, REV PATOL TROP, V37, P341
   Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Brown Zane, 2004, Herpes, V11 Suppl 3, p175A
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Candotti D, 2007, J GEN VIROL, V88, P2686, DOI 10.1099/vir.0.83102-0
   Carlier Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001250
   Carlier Y, 2015, MEM I OSWALDO CRUZ, V110, P363, DOI 10.1590/0074-02760140405
   (CDC) CfDCaP, 2009, MMWR-MORBID MORTAL W, V2014, P983
   Chang MH, 2007, SEMIN FETAL NEONAT M, V12, P160, DOI 10.1016/j.siny.2007.01.013
   Chotun N, 2015, VACCINE, V33, P4618, DOI 10.1016/j.vaccine.2015.06.076
   Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Cortina-Borja M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000351
   Cowan FA, 2008, AIDS, V22, P193
   Cutts FT, 1997, B WORLD HEALTH ORGAN, V75, P55
   Dabbagh AJ, 2013, MMWR-MORBID MORTAL W, V62, P983
   de Haan TR, 2008, BJOG-INT J OBSTET GY, V115, P76, DOI 10.1111/j.1471-0528.2007.01555.x
   De Paschale M, 2014, TROP MED INT HEALTH, V19, P743, DOI 10.1111/tmi.12296
   Del Pizzo J, 2011, PEDIATR REV, V32, P537, DOI 10.1542/pir.32-12-537
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765
   Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832
   Duryea EL, 2010, PEDIATR INFECT DIS J, V29, P915, DOI 10.1097/INF.0b013e3181e0ce05
   El-Magrahe H, 2010, J INFECT DEV COUNTR, V4, P168
   El-Shabrawi MH, 2013, WORLD J GASTROENTERO, V19, P7880, DOI 10.3748/wjg.v19.i44.7880
   FAIRLEY CK, 1995, LANCET, V346, P1335, DOI 10.1016/S0140-6736(95)92346-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FORDJONES EL, 1995, PEDIATR INFECT DIS J, V14, P638, DOI 10.1097/00006454-199507000-00028
   Franco Elisabetta, 2012, World J Hepatol, V4, P74, DOI 10.4254/wjh.v4.i3.74
   Gentile Ivan, 2014, Int J Womens Health, V6, P605, DOI 10.2147/IJWH.S51138
   Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277
   Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053
   Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733
   Gous NM, 2016, JAIDS-J ACQ IMM DEF, V71, pE34, DOI 10.1097/QAI.0000000000000872
   Grant G, 2014, GLOBAL RUBELLA UPDAT
   GRATACOS E, 1995, J INFECT DIS, V171, P1360
   Guibert G, 2009, CLIN INFECT DIS, V48, P1516, DOI 10.1086/598934
   Gulaid LA, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17390
   Gumbo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114870
   Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012
   Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4
   Jhaveri Ravi, 2014, J Pediatric Infect Dis Soc, V3 Suppl 1, pS13, DOI 10.1093/jpids/piu045
   Jones JL, 2014, AM J TROP MED HYG, V90, P1135, DOI 10.4269/ajtmh.14-0013
   Kamb ML, 2010, OBSTET GYNECOL INT, V2010, P1, DOI DOI 10.1155/2010/312798
   Kang GD, 2015, VACCINE, V33, P4093, DOI 10.1016/j.vaccine.2015.06.081
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   KINNEY JS, 1988, CLIN PERINATOL, V15, P727
   KORNAI J, 1979, ECONOMETRICA, V47, P801, DOI 10.2307/1914132
   Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796
   Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203
   Kravetz J., 2013, BMJ CLIN EVID, V2013, P1
   Kremer JR, 2006, VACCINE, V24, P2594, DOI 10.1016/j.vaccine.2005.12.015
   Kropp RY, 2006, PEDIATRICS, V117, P1955, DOI 10.1542/peds.2005-1778
   Kuznik A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127379
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5
   Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128
   Loto OM, 2012, J PREGNANCY, V2012, DOI DOI 10.1155/2012/379271
   Mack CL, 2012, J PEDIATR GASTR NUTR, V54, P838, DOI 10.1097/MPG.0b013e318258328d
   Manicklal S, 2014, CLIN INFECT DIS, V58, P1467, DOI 10.1093/cid/ciu096
   Mareri A, 2016, J MATERN-FETAL NEO M, V29, P1657, DOI 10.3109/14767058.2015.1058774
   Marin M, 2013, MMWR-MORBID MORTAL W, V63, P732
   Martinez-Quintana E, 2015, REV PANAM SALUD PUBL, V37, P179
   Martins-Melo FR, 2014, TROP MED INT HEALTH, V19, P943, DOI 10.1111/tmi.12328
   Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934
   Menendez C, 2007, SEMIN FETAL NEONAT M, V12, P207, DOI 10.1016/j.siny.2007.01.018
   Menendez C, 2015, LANCET GLOB HEALTH, V3, pE433, DOI 10.1016/S2214-109X(15)00041-8
   Lyall H., 2005, CURRENT PAEDIAT, V15, P163, DOI 10.1016/j.cupe.2004.12.004
   MRI, 2014, MEASL RUB ANN REP
   Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882
   Mussi-Pinhata MM, 2004, J PEDIATR-US, V145, P685, DOI 10.1016/j.jpeds.2004.07.025
   Mussi-Pinhata MM, 1998, J PEDIATR-US, V132, P285, DOI 10.1016/S0022-3476(98)70446-9
   Mwaanza N, 2014, CLIN INFECT DIS, V58, P728, DOI 10.1093/cid/cit766
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   NAHMIAS AJ, 1971, PEDIATR RES, V5, P405
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396
   Nigro G, 1996, AIDS, V10, P1127
   Nigro G, 2013, CLIN INFECT DIS, V57, pS193, DOI 10.1093/cid/cit586
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Okeke T C, 2012, Niger J Med, V21, P57
   OMS/OPS, 2006, EST CUANT ENF CHAG A
   Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790
   PAHO/WHO, 2016, EP UPD NEUR SYNDR CO
   PAHO/WHO, 2016, ZIK VIR INF
   Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749
   Pebody RG, 2004, SEX TRANSM INFECT, V80, P185, DOI 10.1136/sti.2003.005850
   Pembrey L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081881
   Phiske Meghana Madhukar, 2014, Indian J Sex Transm Dis, V35, P12, DOI 10.4103/0253-7184.132404
   Pinninti SG, 2014, CLIN PERINATOL, V41, P945, DOI 10.1016/j.clp.2014.08.012
   Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Rodriguez MDM, 2002, AIDS, V16, P451
   Lopes-Mori FMR, 2011, REV ASSOC MED BRAS, V57, P594, DOI 10.1590/S0104-42302011000500021
   Saloojee H, 2004, B WORLD HEALTH ORGAN, V82, P424
   Schillie S, 2015, PEDIATRICS, V135, pE1141, DOI 10.1542/peds.2014-3213
   Schleiss MR, 2009, AIDS, V23, P2215, DOI 10.1097/QAD.0b013e328331919c
   Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SCHULZ KF, 1987, GENITOURIN MED, V63, P320
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Shet A, 2011, INDIAN J PEDIATR, V78, P88, DOI 10.1007/s12098-010-0254-3
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sokal EM, 2000, ANTIMICROB AGENTS CH, V44, P590, DOI 10.1128/AAC.44.3.590-597.2000
   Stanaway Jeffrey D, 2015, Glob Heart, V10, P139, DOI 10.1016/j.gheart.2015.06.001
   Strick LB, 2006, CLIN INFECT DIS, V43, P347, DOI 10.1086/505496
   Study EC., 2005, CLIN INFECT DIS, V40, P458
   Talukder YS, 2007, EPIDEMIOL INFECT, V135, P1344, DOI 10.1017/S0950268807008497
   Tan MP, 2006, REPROD TOXICOL, V21, P410, DOI 10.1016/j.reprotox.2005.04.011
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Thiebaut R, 2007, LANCET, V369, P115
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   Uhanova J, 2012, J HEPATOL, V57, P736, DOI 10.1016/j.jhep.2012.05.018
   UNAIDS, 2014, CHILDR PREGN WOM LIV
   UNAIDS, 2015, AIDS NUMB
   UNICEF, 2012, OPT B B KEY CONS COU
   Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wallon M, 2013, CLIN INFECT DIS, V56, P1223, DOI 10.1093/cid/cit032
   Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085
   Waters A, 2014, J CLIN VIROL, V59, P156, DOI 10.1016/j.jcv.2013.12.007
   Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951
   WHO, 2015, HEP B SURV DOCD RESP
   WHO, 2011, WKLY EPIDEMIOL REC, V86, P180
   WHO, 2011, WKLY EPIDEMIOL REC, V86, P301
   WHO, 2007, GLOB EL CONG SYPH RA
   Organization WH, 1999, GUID SEX TRANSM INF
   WHO, 2015, GLOB IMM DAT
   WHO, 2010, VACCINE, V28, P589, DOI DOI 10.1016/J.VACCINE.2009.10.110
   WHO, 2014, WKLY EPIDEMIOL REC, V89, P265
   [Anonymous], 2015, GUID START ANT THER
   WHO, 2009, DENG GUID DIAGN TREA
   WHO, 2015, WKLY EPIDEMIOL REC, V90, P33
   WHO, 2010, STRENGTH HLTH SERV F
   WHO, 2014, PROGR REP GLOB PLAN
   WHO U UNAIDS, 2010, SCAL HIV SERV WOM CH
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Williams EJ, 2013, J PEDIATR-US, V163, P424, DOI 10.1016/j.jpeds.2013.02.004
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456
   Yahya-Malima KI, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-75
   Yamamoto AY, 2011, PEDIATR INFECT DIS J, V30, P1043, DOI 10.1097/INF.0b013e31822d9640
   Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840
   Zhang H, 2014, HEPATOLOGY, V60, P468, DOI 10.1002/hep.27034
   Zhang XW, 2007, J CLIN VIROL, V40, P180, DOI 10.1016/j.jcv.2007.08.018
NR 168
TC 0
Z9 0
U1 7
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PD SEP
PY 2016
VL 14
IS 9
BP 845
EP 861
DI 10.1080/14787210.2016.1215913
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DV7TJ
UT WOS:000383140000008
PM 27442227
ER

PT J
AU Govindarajan, M
   Vijayan, P
   Kadaikunnan, S
   Alharbi, NS
   Benelli, G
AF Govindarajan, Marimuthu
   Vijayan, Periasamy
   Kadaikunnan, Shine
   Alharbi, Naiyf S.
   Benelli, Giovanni
TI One-pot biogenic fabrication of silver nanocrystals using Quisqualis
   indica: Effectiveness on malaria and Zika virus mosquito vectors, and
   impact on non-target aquatic organisms
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Arbovirus; Mosquito-borne diseases; Green synthesis; Nanobiotechnology;
   AFM
ID AEGYPTI DIPTERA-CULICIDAE; CULEX-QUINQUEFASCIATUS; GREEN SYNTHESIS;
   AEDES-AEGYPTI; ANOPHELES-STEPHENSI; LEAF EXTRACT; PREDATION EFFICIENCY;
   VETERINARY IMPORTANCE; LARVICIDAL ACTIVITY; AZADIRACHTA-INDICA
AB Currently, mosquito vector control is facing a number of key challenges, including the rapid development of resistance to synthetic pesticides and the recent spread of aggressive arbovirus outbreaks. The biosynthesis of silver nanoparticles (AgNPs) is currently considered an environmental friendly alternative to the employ of pyrethroids, carbamates and microbial agents (e.g. Bacillus thuringiensis var. israelensis), since AgNPs are easy to produce, effective and stable in the aquatic environment. However, their biophysical features showed wide variations according to the botanical agent using for the green synthesis, outlining the importance of screening local floral resources used as reducing and stabilizing agents. In this study, we focused on the biophysical properties and the mosquitocidal action of Quisqualis indica-fabricated AgNPs. AgNPs were characterized using spectroscopic (UV, FTIR, XRD) and microscopic (AFM, SEM, TEM and EDX) techniques. AFM, SEM and TEM confirmed the synthesis of poly-dispersed AgNPs with spherical shape and size ranging from 1 to 30 nm. XRD shed light on the crystalline structure of these AgNPs. The acute toxicity of Quisqualis indica extract and AgNPs was evaluated against malaria, arbovirus, and filariasis vectors, Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus, as well as on three important non-target aquatic organisms. The Q. indica leaf extract showed moderate larvicidal effectiveness on Cx. quinquefasciatus (LC50 = 220.42), Ae. aegypti (LC50 = 203.63) and An. stephensi (LC50 = 185.98). Q indica-fabricated AgNPs showed high toxicity against Cx. quinquefasciatus (LC50 = 14.63), Ae. aegypti (LC50 = 13.55) and An. stephensi (LC50 = 1252), respectively. Notably, Q indica-synthesized AgNPs were moderately toxic to non-target aquatic mosquito predators Anisops bouvieri (LC50 = 653.05 mu g/mL), Diplonychus indicus (LC50 = 860.94 mu g/mL) and Gambusia affinis (LC50 = 2183.16 mu g/mL), if compared to the targeted mosquitoes. Overall, the proposed one-pot biogenic fabrication of AgNPs using Q. indica is a low-cost and eco-friendly tool in the fight against Zika virus, malaria and filariasis vectors, with little impact against non-target aquatic mosquito predators. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Govindarajan, Marimuthu; Vijayan, Periasamy] Annamalai Univ, Unit Vector Control Phytochem & Nanotechnol, Dept Zool, Annamalainagar 608002, Tamil Nadu, India.
   [Kadaikunnan, Shine; Alharbi, Naiyf S.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
RP Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.; Govindarajan, M (reprint author), Annamalai Univ, Unit Vector Biol Phytochem & Nanotechnol, Dept Zool, Annamalainagar 608002, Tamil Nadu, India.
EM drgovind1979@gmail.com; g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013
FU Deanship of Scientific Research at King Saud University [PRG-1437-36];
   PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX Prof. Matyus and three anonymous reviewers improved an earlier version
   of our manuscript. The authors extend their sincere appreciations to the
   Deanship of Scientific Research at King Saud University for its funding
   this Prolific Research Group (PRG-1437-36). G. Benelli is supported by
   PROAPI (PRAF 2015) and University of Pisa, Department of Agriculture,
   Food and Environment (grant ID: COFIN2015_22). Funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bar H, 2009, COLLOID SURFACE A, V348, P212, DOI 10.1016/j.colsurfa.2009.07.021
   Benelli G., 2016, PARASITOL RES MONOGR, P155
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2015, PARASITOL RES, V114, P1011, DOI 10.1007/s00436-014-4267-0
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli Giovanni, 2016, Asian Pacific Journal of Tropical Biomedicine, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, PARASITOL RES, V115, P2545, DOI 10.1007/s00436-016-5095-1
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Chandra G, 2008, INDIAN J MED RES, V127, P13
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   DEO P G, 1988, International Pest Control, V30, P118
   Efferth T, 2008, MOL CANCER THER, V7, P152, DOI 10.1158/1535-7163.MCT-07-0073
   Finney D.J., 1971, PROBIT ANAL
   Gardea-Torresdey JL, 2003, LANGMUIR, V19, P1357, DOI 10.1021/la020835i
   Govindarajan M., 2016, ENZYME MICROB TECHNO
   Govindarajan M., 2016, NAT PROD RES
   Govindarajan M., 2016, J CLUST SCI
   Govindarajan M, 2011, EUR REV MED PHARMACO, V15, P787
   Govindarajan M, 2016, PARASITOL RES MG, V8, P99, DOI 10.1007/978-3-319-25292-6_7
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Govindarajan M, 2016, PARASITOL RES, V115, P2685, DOI 10.1007/s00436-016-5038-x
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI [10.1016/j.rvsc.2015.11.011, 10.1016/j.rvsc.2016.05.017]
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Jhanan F. N., 2008, INT J ORIENT PHARM E, VI, P53
   Kannan P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/8/085602
   Kumar VP, 2006, J ETHNOPHARMACOL, V107, P182, DOI 10.1016/j.jep.2006.03.013
   Luo LB, 2005, J AM CHEM SOC, V127, P2822, DOI 10.1021/ja0428154
   Govindarajan Marimuthu, 2016, Journal of Asia-Pacific Entomology, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan Marimuthu, 2016, Journal of Asia-Pacific Entomology, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Mathivanan T, 2010, J VECTOR DIS, V47, P178
   Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003
   Murugan K, 2015, RES VET SCI, V102, P127, DOI 10.1016/j.rvsc.2015.08.001
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2016, ECOTOX ENVIRON SAFE, V132, P318, DOI 10.1016/j.ecoenv.2016.06.021
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Muthukumaran U, 2015, PARASITOL RES, V114, P4385, DOI 10.1007/s00436-015-4677-7
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Nair PMG, 2011, AQUAT TOXICOL, V101, P31, DOI 10.1016/j.aquatox.2010.08.013
   Nitu S., 2011, INT J RES PHARM SCI, V1, P88
   Pavela R., 2016, J PEST SCI
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Siddiqui BS, 2000, PHYTOCHEMISTRY, V53, P371, DOI 10.1016/S0031-9422(99)00548-8
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Subramaniam J., 2016, ENV SCI POLLUT RES
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Tavakoli F, 2015, MATER RES BULL, V63, P51, DOI 10.1016/j.materresbull.2014.11.045
   Thirunavoukkarasu M, 2013, SPECTROCHIM ACTA A, V116, P424, DOI 10.1016/j.saa.2013.07.033
   Tripathy A, 2010, J NANOPART RES, V12, P237, DOI 10.1007/s11051-009-9602-5
   Veerakumar K, 2014, PARASITOL RES, V113, P2363, DOI 10.1007/s00436-014-3895-8
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Velayutham K, 2013, ASIAN PAC J TROP MED, V6, P95, DOI 10.1016/S1995-7645(13)60002-4
   Vijayakumar M, 2013, IND CROP PROD, V41, P235, DOI 10.1016/j.indcrop.2012.04.017
   Vincent S., 2016, J CLUST SCI
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   Whiteman S C, 2008, Ther Adv Respir Dis, V2, P23, DOI 10.1177/1753465807087972
   World Health Organization, 2005, GUID LAB FIELD TEST
   Yugandhar P, 2016, APPL NANOSCI, V6, P223, DOI 10.1007/s13204-015-0428-4
   Zargar M, 2011, MOLECULES, V16, P6667, DOI 10.3390/molecules16086667
   Zhang WJ, 2011, COLLOID SURFACE B, V88, P196, DOI 10.1016/j.colsurfb.2011.06.031
NR 81
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD SEP
PY 2016
VL 162
BP 646
EP 655
DI 10.1016/j.jphotobiol.2016.07.036
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DV5XK
UT WOS:000383003800076
PM 27491031
ER

PT J
AU Kim, Y
AF Kim, Yoon
TI Healthcare reform after MERS outbreak: progress to date and next steps
SO JOURNAL OF THE KOREAN MEDICAL ASSOCIATION
LA Korean
DT Article
DE MERS outbreak; Health system; Reform; Evaluation
AB To avoid a future catastrophic event like the recent Middle East respiratory syndrome (MERS) outbreak, we must reform our health system based on an objective and thorough review of the outbreak. A little over a year after the outbreak, this paper aims to evaluate the current status of the government's effort to reform our health system across the three following areas: 1) infectious disease emergency preparedness and response; 2) an organized healthcare system for infectious diseases; and 3) hospital preparedness for healthcare-associated infections. In spite of the substantial organizational changes of the Korea Centers for Disease Control (CDC) responsible for infectious disease emergency preparedness and response, the Korea CDC has not shown significant improvement in its competence and organizational commitment in the face of recent infectious disease threats such as Zika virus and cholera. So far, the Korean government has not announced an implementation plan for establishing an organized healthcare system for infectious diseases. To reduce healthcare associated infections, the Korean government implemented major changes in the hospital infection control system, emergency medical service system, and enhanced nursing system. Because the most extensive reform occurred around reducing healthcare-associated infections in hospitals, we need to evaluate the impact of the entire reform effort in a near future. Because the effort to reform our health system remains ongoing, we also need to continue to observe the progress of reform to ensure the avoidance of a future catastrophic event like the recent MERS outbreak.
C1 [Kim, Yoon] Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea.
RP Kim, Y (reprint author), Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea.
EM yoonkim@snu.ac.kr
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN MEDICAL ASSOC
PI SEOUL
PA 302-75 INCHON-1 DONG, YONGSAN-GU, SEOUL, 140-721, SOUTH KOREA
SN 1975-8456
EI 2093-5951
J9 J KOREAN MED ASSOC
JI J. Korean Med. Assoc.
PD SEP
PY 2016
VL 59
IS 9
BP 668
EP 671
DI 10.5124/jkma.2016.59.9.668
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW0OZ
UT WOS:000383341400001
ER

PT J
AU de Sa, TH
   Reis-Santos, B
   Rodrigues, LC
AF de Sa, Thiago Herick
   Reis-Santos, Barbara
   Rodrigues, Laura C.
TI Zika outbreak, mega-events, and urban reform
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID VIRUS
C1 [de Sa, Thiago Herick] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.
   [Reis-Santos, Barbara] Univ Espirito Santo, LabEpi Lab Epidemiol, BR-29040091 Vitoria, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, London, England.
RP Reis-Santos, B (reprint author), Univ Espirito Santo, LabEpi Lab Epidemiol, BR-29040091 Vitoria, Brazil.
EM reissantos.barbara@gmail.com
FU Brazilian Science without Borders Scheme [200358/2014-6]; Sao Paulo
   Research Foundation [2012/08565-4]; International Clinical, Operational
   and Health Services Research Training Award (ICOHRTA grant) from the
   National Institutes of Health (Bethesda, Maryland, United States) [5 U2R
   TW006883-02]
FX We declare no competing interests. THdS was supported by the Brazilian
   Science without Borders Scheme (process number: 200358/2014-6) and the
   Sao Paulo Research Foundation (process number: 2012/08565-4). BR-S was
   supported by International Clinical, Operational and Health Services
   Research Training Award (ICOHRTA grant: 5 U2R TW006883-02) from the
   National Institutes of Health (Bethesda, Maryland, United States).
CR Comite Popular Rio Copa e Olimpiadas, 2013, MEG VIOL DIR HUM RIO
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Paula MD, 2014, COPA QUEM QUE OLHAR
   The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427
NR 5
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD SEP
PY 2016
VL 4
IS 9
BP E603
EP E603
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DU4VV
UT WOS:000382211700013
PM 27539802
ER

PT J
AU Samy, AM
   Thomas, SM
   Abd El Wahed, A
   Cohoon, KP
   Peterson, AT
AF Samy, Abdallah M.
   Thomas, Stephanie M.
   Abd El Wahed, Ahmed
   Cohoon, Kevin P.
   Peterson, A. Townsend
TI Mapping the global geographic potential of Zika virus spread
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; global distribution; risk; Aedes; Brazil; climate;
   socioeconomic; accessibility
AB The Americas are presently experiencing the most serious known outbreak of Zika virus (ZIKV). Here, we present a novel set of analyses using environmental characteristics, vector mosquito distributions, and socioeconomic risk factors to develop the first map to detail global ZIKV transmission risk in multiple dimensions based on ecological niche models. Our model predictions were tested against independent evaluation data sets, and all models had predictive ability significantly better than random expectations. The study addresses urgent knowledge gaps regarding (1) the potential geographic scope of the current ZIKV epidemic, (2) the global potential for spread of ZIKV, and (3) drivers of ZIKV transmission. Our analysis of potential drivers of ZIKV distributions globally identified areas vulnerable in terms of some drivers, but not for others. The results of these analyses can guide regional education and preparedness efforts, such that medical personnel will be better prepared for diagnosis of potential ZIKV cases as they appear.
C1 [Samy, Abdallah M.] Ain Shams Univ, Fac Sci, Cairo, Egypt.
   [Samy, Abdallah M.; Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.
   [Thomas, Stephanie M.] Univ Bayreuth, Dept Biogeog, Bayreuth, Germany.
   [Abd El Wahed, Ahmed] Univ Gottingen, Div Microbiol & Anim Hyg, Gottingen, Germany.
   [Cohoon, Kevin P.] Mayo Clin, Rochester, MN USA.
RP Samy, AM (reprint author), Ain Shams Univ, Fac Sci, Cairo, Egypt.; Samy, AM (reprint author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.
EM asamy.ku@hotmail.com
FU Research and Training Center on Vectors of Diseases; Department of
   Entomology of Ain Shams University; Egyptian Fulbright Mission Program
   (EFMP)
FX To the Egyptian Fulbright Mission Program (EFMP), for supporting AMS,
   Ian Mackay who provided enormously useful discussion and suggestions on
   the manuscript, KU ENM group and the Research and Training Center on
   Vectors of Diseases and the Department of Entomology of Ain Shams
   University for their support, Abdelghafar Alkishe and Katie Allen, for
   their continuous support during the study, and Omama Ali, for her
   support during the whole work.
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Koenig KL, 2016, DISASTER MED PUBLIC, V1, P1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan AJ, PLOS CURR, V8, DOI [10.1371/cur-rents.outbreaks.50dfc7f46798675fc63e7d7da563da76, DOI 10.1371/CURRENTS.OUTBREAKS.50DFC7F46798675FC63E7D7DA563DA76]
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19
   Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 9
TC 0
Z9 0
U1 5
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2016
VL 111
IS 9
BP 559
EP 560
DI 10.1590/0074-02760160149
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DW0NC
UT WOS:000383336100004
PM 27653360
ER

PT J
AU Safadi, MAP
AF Palazzi Safadi, Marco Aurelio
TI Zika Virus: What Have We Learned?
SO AMERICAN JOURNAL OF PERINATOLOGY
LA English
DT Editorial Material
ID BRAZIL; INFECTION; OUTBREAK
C1 [Palazzi Safadi, Marco Aurelio] Santa Casa de Sao Paulo Sch Med Sci, Dept Pediat, Div Pediat Infect Dis, Sao Paulo, Brazil.
RP Safadi, MAP (reprint author), Alameda Indigenas 228, BR-04059060 Sao Paulo, Brazil.
EM masafadi@uol.com.br
CR Brasil P, 2016, NEW ENGL J MED, V16, P742
   Brazilian Ministry of Health, B EPIDEMIOLOGICO
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, DIAGN TEST
   Delvecchio R, 2016, BIORXIV, DOI [10.1101/051268, DOI 10.1101/051268]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gubler D, 2007, FIELDS VIROLOGY, P1153
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 1998, J VIROL, V72, P73
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, ZIK SIT REP
   World Health Organization, GUILL BARR SYNDR BRA
   World Health Organization, GUILL BARR SYNDR COL
   World Health Organization, ZIK VIR MICR GUILL B
NR 25
TC 0
Z9 0
U1 13
U2 13
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0735-1631
EI 1098-8785
J9 AM J PERINAT
JI Am. J. Perinatol.
PD SEP
PY 2016
VL 33
IS 11
BP 1029
EP 1031
DI 10.1055/s-0036-1586116
PG 3
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA DU7TZ
UT WOS:000382418800001
PM 27603528
ER

PT J
AU Dar, H
   Zaheer, T
   Rehman, MT
   Ali, A
   Javed, A
   Khan, GA
   Babar, MM
   Waheed, Y
AF Dar, Hamza
   Zaheer, Tahreem
   Rehman, Muhammad Talha
   Ali, Amjad
   Javed, Aneela
   Khan, Gohar Ayub
   Babar, Mustafeez Mujtaba
   Waheed, Yasir
TI Prediction of promiscuous T-cell epitopes in the Zika virus polyprotein:
   An in silico approach
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika Virus; B-Cell Epitopes; T-Cell Epitopes; Vaccine; Antigenicity
ID TICK-BORNE ENCEPHALITIS; BINDING-SITES; VACCINATION; PATHOGEN; DATABASE;
   ANTIGEN
AB Objective: To predict immunogenic promiscuous T-cell epitopes from the polyprotein of the Zika virus using a range of bioinformatics tools. To date, no epitope data are available for the Zika virus in the IEDB database. Methods: We retrieved nearly 54 full length polyprotein sequences of the Zika virus from the NCBI database belonging to different outbreaks. A consensus sequence was then used to predict the promiscuous T-cell epitopes that bind MHC 1 and MHC II alleles using Propred1 and Propred immunoinformatic algorithms respectively. The antigencity predicted score was also calculated for each predicted epitope using the VaxiJen 2.0 tool. Results: By using ProPred1, 23 antigenic epitopes for HLA class I and 48 antigenic epitopes for HLA class II were predicted from the consensus polyprotein sequence of Zika virus. The greatest number of MHC class I binding epitopes were projected within the NS5 (21%), followed by Envelope (17%). For MHC class II, greatest number of predicted epitopes were in NS5 (19%) followed by the Envelope, NS1 and NS2 (17% each). A variety of epitopes with good binding affinity, promiscuity and antigenicity were predicted for both the HLA classes. Conclusion: The predicted conserved promiscuous T-cell epitopes examined in this study were reported for the first time and will contribute to the imminent design of Zika virus vaccine candidates, which will be able to induce a broad range of immune responses in a heterogeneous HLA population. However, our results can be verified and employed in future efficacious vaccine formulations only after successful experimental studies.
C1 [Dar, Hamza; Zaheer, Tahreem; Rehman, Muhammad Talha; Ali, Amjad; Javed, Aneela; Khan, Gohar Ayub] Natl Univ Sci & Technol, Atta ur Rahman Sch Appl Biosci ASAB, Islamabad 44000, Pakistan.
   [Babar, Mustafeez Mujtaba] Shifa Tameer e Millat Univ, Shifa Coll Pharmaceut Sci, Islamabad, Pakistan.
   [Waheed, Yasir] Fdn Univ Islamabad, DHA I, Fdn Univ Med Coll, Islamabad 44000, Pakistan.
RP Waheed, Y (reprint author), Fdn Univ Islamabad, DHA I, Fdn Univ Med Coll, Islamabad 44000, Pakistan.
EM darhamza000@gmail.com; javedaneela@gmail.com;
   yasir_waheed_199@hotmail.com
CR Adhisivam B, 2013, RECENT ADV PEDIAT, V22
   Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   Almanzar Giovanni, 2007, Wien Med Wochenschr, V157, P116, DOI 10.1007/s10354-007-0393-y
   Amin N, 2013, ISRN VIROL, V2013
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Awasthi S., 2016, J ANTIVIR ANTIRETROV, V8, DOI [10.4172/jaa.1000e130, DOI 10.4172/JAA.1000E130]
   Bashyam HS, 2006, J IMMUNOL, V176, P2817
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hafner C, 2005, J INVEST DERMATOL, V124, P125, DOI 10.1111/j.0022-202X.2004.23515.x
   Hari A, 2015, EUR J IMMUNOL, V45, P383, DOI 10.1002/eji.201445156
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HEINZ FX, 1983, VIROLOGY, V126, P525, DOI 10.1016/S0042-6822(83)80010-5
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Kollaritsch H, 2012, EXPERT REV VACCINES, V11, P1103, DOI [10.1586/erv.12.86, 10.1586/ERV.12.86]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lucchese G, 2016, AUTOIMMUN REV, V16, P53
   Macstrc AM, 2016, EBIO MED, V5, P2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Olsen AW, 2000, EUR J IMMUNOL, V30, P1724
   Oyarzun P, 2016, HUM VACC IMMUNOTHER, V12, P763, DOI 10.1080/21645515.2015.1094595
   Oyarzun P, 2015, VACCINE, V33, P1267, DOI 10.1016/j.vaccine.2015.01.040
   Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139
   Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, P1
   Saxena SK, 2016, VIRUS DIS, P1
   Scully C, 2016, BRIT DENT J, V220, P265, DOI 10.1038/sj.bdj.2016.182
   Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236
   Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108
   Slifka MK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00196
   Steward MW, 2001, BIOLOGICALS, V29, P215, DOI 10.1006/biol.2001.0291
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
NR 43
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD SEP
PY 2016
VL 9
IS 9
BP 822
EP 828
DI 10.1016/j.apjtm.2016.07.004
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DU1HD
UT WOS:000381957900004
PM 27633296
ER

PT J
AU Schmidt, CW
AF Schmidt, Charles W.
TI Zika in the United States How Are We Preparing?
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Editorial Material
ID VIRUS TRANSMISSION; EXPOSURE; DENGUE; BRAZIL
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   ATSDR, 2003, PUBL HLTH STAT PYR P
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Butler D, 2016, NATURE NEWS     0321
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, AR ZIK CAS COUNTS US
   CDC, TRAV HLTH NOT CURR N
   CDC, MOSQ LIF CYCL AED AE
   CDC, CLIN GUID HEALTHC PR
   CDC, ZIK SEX TRANSM BAS Z
   CDC, ADV PEOPL LIV TRAV W
   CDC, 2016, INT CDC ZIK IN PRESS
   CDC, SPEC BIRTH DEF MICR
   CDC, 2016, TRAV HLTH ZIK VIR PU
   Codeco F, BIORXIV, DOI [10.1101/055459, DOI 10.1101/055459]
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Engel SM, 2011, ENVIRON HEALTH PERSP, V119, P1182, DOI 10.1289/ehp.1003183
   Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Ferguson NM, 2016, COUNTERING ZIKA LATI, DOI [10.1126/science.aag0219, DOI 10.1126/SCIENCE.AAG0219]
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   FloridaHealth, ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Kathy Keatley Garvey, 2016, AR CUL MOSQ POT VECT
   Griffin S, 2016, LIVE UPDATES WHAT YO
   Guerbois Mathilde, J INFECT DIS, DOI [10.1093/infdis/jiw302, DOI 10.1093/INFDIS/JIW302]
   Gunier RB, ENV HLTH PERSPECT, DOI [10.1289/EHP504, DOI 10.1289/EHP504]
   Johansson MA, 2016, NEW ENGL J MED, V375
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Mallet HP, 2015, BISES B INFORM SANIT
   Mississippi State Department of Health, 2016, ZIK VIR
   Monaghan AJ, 2016, PLOS CURRENTS OUTBRE, DOI [10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76, DOI 10.1371/CURRENTS.0UTBREAKS.50DFC7F467]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   National Birth Defect Prevention Network, BIRTH DEFECTS RES A, V97
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   [Anonymous], 2016, DENGUE
   PAHO/WHO, 2016, ZIK EP UPD
   Pan American Health Organization, 1997, REV PANAM SALUD PUBL, V1, P1, DOI [10.1590/S1020-49891997000100023, DOI 10.1590/S1020-49891997000100023]
   Paul LM, 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sena BF, 2016, WAR ZIKA PERSISTENT
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48
   World Health Organization, 2016, PREV SEX TRANSM ZIK
   WHO, 2016, HIST ZIK VIR
   Zettel C, YELLOW FEVER MOSQUIT
NR 49
TC 0
Z9 0
U1 7
U2 7
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD SEP
PY 2016
VL 124
IS 9
BP A157
EP A165
DI 10.1289/ehp.124-A157
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA DU9IM
UT WOS:000382530200004
PM 27581255
ER

PT J
AU Tripp, RA
   Ross, TM
AF Tripp, Ralph A.
   Ross, Ted M.
TI Development of a Zika vaccine
SO EXPERT REVIEW OF VACCINES
LA English
DT Editorial Material
DE Zika; vaccine; virus; countermeasures; immunity
ID UNITED-STATES; VIRUS; TRANSMISSION; OUTBREAK
C1 [Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Anim Hlth Res Ctr, Athens, GA 30602 USA.
   [Ross, Ted M.] Univ Georgia, Dept Infect Dis, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
RP Ross, TM (reprint author), Univ Georgia, Dept Infect Dis, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
EM tedross@uga.edu
CR Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Durbin AP, 2016, J INFECT DIS
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rossi SL, 2012, VIROLOGY, V423, P58, DOI 10.1016/j.virol.2011.11.018
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Thomas SJ, 2011, CURR OPIN INFECT DIS, V24, P442, DOI 10.1097/QCO.0b013e32834a1b0b
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
NR 20
TC 0
Z9 0
U1 5
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD SEP
PY 2016
VL 15
IS 9
SI SI
BP 1083
EP 1085
DI 10.1080/14760584.2016.1192474
PG 3
WC Immunology
SC Immunology
GA DV2TX
UT WOS:000382775700003
PM 27212079
ER

PT J
AU De Groot, AS
   Moise, L
   Olive, D
   Einck, L
   Martin, W
AF De Groot, Anne S.
   Moise, Leonard
   Olive, David
   Einck, Leo
   Martin, William
TI Agility in adversity: Vaccines on Demand
SO EXPERT REVIEW OF VACCINES
LA English
DT Article
DE Vaccine; biodefense; Zika virus; smallpox; anthrax; influenza; avian
   influenza; pandemic; bioterror; cancer vaccine; computational
   vaccinology; immunoinformatics; genome; personalized vaccine; FDA; IND;
   BLA; platform; T cell; T-cell assay; iVAX system; genome-to-vaccine;
   epitope-driven vaccine
ID DESIGN; FEVER
AB Is the US ready for a biological attack using Ebola virus or Anthrax? Will vaccine developers be able to produce a Zika virus vaccine, before the epidemic spreads around the world? A recent report by The Blue Ribbon Study Panel on Biodefense argues that the US is not ready for these challenges, however, technologies and capabilities that could address these deficiencies are within reach. Vaccine technologies have advanced and readiness has improved in recent years, due to advances in sequencing technology and computational power making the vaccines on demand' concept a reality. Building a robust strategy to design effective biodefense vaccines from genome sequences harvested by real-time biosurveillance will benefit from technologies that are being brought to bear on the cancer cure moonshot'. When combined with flexible vaccine production platforms, vaccines on demand will relegate expensive and, in some cases, insufficiently effective vaccine stockpiles to the dust heap of history.
C1 [De Groot, Anne S.; Moise, Leonard; Martin, William] EpiVax Inc, Providence, RI 02903 USA.
   [De Groot, Anne S.; Moise, Leonard] Univ Rhode Isl, Inst Immunol & Informat, 825 Chalkstone Ave, Providence, RI 02908 USA.
   [Olive, David] Catalyst Partners, Washington, DC USA.
   [Einck, Leo] Sequella, Rockville, MD USA.
RP De Groot, AS (reprint author), EpiVax Inc, Providence, RI 02903 USA.; De Groot, AS (reprint author), Univ Rhode Isl, Inst Immunol & Informat, 825 Chalkstone Ave, Providence, RI 02908 USA.
EM annied@epivax.com
CR Bresciani A, 2016, IMMUNOLOGY, V148, P34, DOI 10.1111/imm.12585
   De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P1877, DOI 10.4161/hv.25611
   De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P950, DOI 10.4161/hv.24939
   Gardner Shea N, 2015, BMC Res Notes, V8, P682, DOI 10.1186/s13104-015-1530-0
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gilchrist CA, 2015, CLIN MICROBIOL REV, V28, P541, DOI 10.1128/CMR.00075-13
   Graham B, 2010, PREVENTION WMD PROLI
   Graham B, 2008, WORLD RISK REPORT CO
   Higbee RG, 2009, ATLA-ALTERN LAB ANIM, V37, P19
   Katoski SE, 2015, J MED VIROL, V87, P1616, DOI 10.1002/jmv.24196
   Leblanc P, 2014, HUM VACC IMMUNOTHER, V10, P3022, DOI 10.4161/hv.34413
   Liu R, 2015, HUM VACC IMMUNOTHER, V11, P2241, DOI 10.1080/21645515.2015.1052197
   Losikoff PT, 2015, J HEPATOL, V62, P48, DOI 10.1016/j.jhep.2014.08.026
   Moise L, 2015, HUM VACC IMMUNOTHER, V11, P2312, DOI 10.1080/21645515.2015.1061159
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Reardon S, 2014, NATURE, V509, P16, DOI 10.1038/509016a
   Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348
   Seib KL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000612
   Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003
   Wullner D, 2010, CLIN IMMUNOL, V137, P5, DOI 10.1016/j.clim.2010.06.018
   [Anonymous], 2015, BIPARTISAN REPORT BL
NR 21
TC 0
Z9 0
U1 5
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD SEP
PY 2016
VL 15
IS 9
SI SI
BP 1087
EP 1091
DI 10.1080/14760584.2016.1205951
PG 5
WC Immunology
SC Immunology
GA DV2TX
UT WOS:000382775700004
PM 27389971
ER

PT J
AU Maya, WDC
   Du Plessis, SS
   Velilla, PA
AF Cardona Maya, Walter D.
   Du Plessis, Stefan S.
   Velilla, Paula A.
TI Semen as virus reservoir?
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Letter
ID HUMAN-IMMUNODEFICIENCY-VIRUS; ZIKA VIRUS; EBOLA-VIRUS; SEXUAL
   TRANSMISSION; MANNOSE RECEPTOR; HIV-1; SPERMATOZOA; INFECTION; SPERM;
   DNA
C1 [Cardona Maya, Walter D.] Univ Antioquia, Fac Med, Dept Microbiol & Parasitol, Grp Reproducc, Medellin, Colombia.
   [Du Plessis, Stefan S.] Univ Stellenbosch, Div Med Physiol, Fac Med & Hlth Sci, Tygerberg, South Africa.
   [Velilla, Paula A.] Univ Antioquia, Fac Med, Dept Microbiol & Parasitol, Grp Inmunovirol, Medellin, Colombia.
RP Maya, WDC (reprint author), Univ Antioquia, Fac Med, Dept Microbiol & Parasitol, Grp Reproducc, Medellin, Colombia.
EM wdario.cardona@udea.edu.co
CR BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903
   BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005
   Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545
   Maya WC, 2009, ACTAS UROL ESP, V33, P223
   Cardona-Maya W, 2006, AM J REPROD IMMUNOL, V55, P241, DOI 10.1111/j.1600-0897.2005.00340.x
   Cardona-Maya W, 2009, CURR HIV RES, V7, P418
   Cardona-Maya W, 2011, J REPROD IMMUNOL, V92, P1, DOI 10.1016/j.jri.2011.09.002
   Cardona-Maya WD, 2014, REPROD SCI
   Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579
   Christianson HC, 2014, MATRIX BIOL, V35, P51, DOI 10.1016/j.matbio.2013.10.004
   Deen GF, 2015, NEW ENGLAND J MED
   EMOND RTD, 1977, BRIT MED J, V2, P541
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Houzet L, 2014, J INFECT DIS, V210, pS622, DOI 10.1093/infdis/jiu328
   Lu W, 2010, J ACQ IMMUN DEF SYND, V55, P232, DOI DOI 10.1097/QAI.0B013E3181E9B6B7
   Mate SE, 2015, NEW ENGLAND J MED
   McCarthy M, 2016, BMJ CLIN RES ED, V352, pi1813
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NUOVO GJ, 1994, AM J PATHOL, V144, P1142
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Snchez Jurany Andrea, 2013, Rev Cubana Obstet Ginecol, V39, P249
   Sturmer M, 2008, ANTIVIR THER, V13, P729
   Zea-Mazo JW, 2010, ACTAS UROL ESP, V34, P845, DOI 10.1016/j.acuro.2010.07.002
NR 25
TC 0
Z9 0
U1 7
U2 7
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD SEP
PY 2016
VL 33
IS 9
BP 1255
EP 1256
DI 10.1007/s10815-016-0747-8
PG 2
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA DV1LD
UT WOS:000382681700019
ER

PT J
AU Brown, WC
   Akey, DL
   Konwerski, JR
   Tarrasch, JT
   Skiniotis, G
   Kuhn, RJ
   Smith, JL
AF Brown, W. Clay
   Akey, David L.
   Konwerski, Jamie R.
   Tarrasch, Jeffrey T.
   Skiniotis, Georgios
   Kuhn, Richard J.
   Smith, Janet L.
TI Extended surface for membrane association in Zika virus NS1 structure
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
AB The Zika virus, which has been implicated in an increase in neonatal microcephaly and Guillain-Barre syndrome, has spread rapidly through tropical regions of the world. The virulence protein NS1 functions in genome replication and host immune-system modulation. Here, we report the crystal structure of full-length Zika virus NS1, revealing an elongated hydrophobic surface for membrane association and a polar surface that varies substantially among flaviviruses.
C1 [Brown, W. Clay; Akey, David L.; Konwerski, Jamie R.; Tarrasch, Jeffrey T.; Skiniotis, Georgios; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.
   [Skiniotis, Georgios; Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.
   [Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Kuhn, Richard J.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
RP Smith, JL (reprint author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.; Smith, JL (reprint author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.
EM janetsmith@umich.edu
FU Margaret J. Hunter Collegiate Professorship in the Life Sciences;
   University of Michigan Life Sciences Institute; NIH National Institute
   of General Medical Sciences [AGM-12006]; National Cancer Institute
   [ACB-12002];  [DE-AC02-06CH11357]
FX The work described in this report was supported by a Margaret J. Hunter
   Collegiate Professorship in the Life Sciences to J.L.S. and by the
   University of Michigan Life Sciences Institute. GM/CA@APS is supported
   by the NIH National Institute of General Medical Sciences (AGM-12006)
   and the National Cancer Institute (ACB-12002). The Advanced Photon
   Source is a US Department of Energy (DOE) Office of Science User
   Facility operated by Argonne National Laboratory under contract no.
   DE-AC02-06CH11357.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0
   Pierson TC, 2013, FIELDS VIROLOGY, V2, P747
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
NR 20
TC 0
Z9 0
U1 7
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD SEP
PY 2016
VL 23
IS 9
BP 865
EP 867
DI 10.1038/nsmb.3268
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DV1WL
UT WOS:000382712700016
PM 27455458
ER

PT J
AU Singh, RK
   Dhama, K
   Malik, YS
   Ramakrishnan, MA
   Karthik, K
   Tiwari, R
   Saurabh, S
   Sachan, S
   Joshi, SK
AF Singh, Raj Kumar
   Dhama, Kuldeep
   Malik, Yashpal Singh
   Ramakrishnan, Muthannan Andavar
   Karthik, Kumaragurubaran
   Tiwari, Ruchi
   Saurabh, Sharad
   Sachan, Swati
   Joshi, Sunil Kumar
TI Zika virus - emergence, evolution, pathology, diagnosis, and control:
   current global scenario and future perspectives - a comprehensive review
SO VETERINARY QUARTERLY
LA English
DT Review
DE Zika virus; flavivirus; global warming; zoonosis; review
ID MOSQUITOS DIPTERA-CULICIDAE; PUBLIC-HEALTH PREPAREDNESS; AEDES-AEGYPTI
   MOSQUITOS; YELLOW-FEVER; SEROLOGICAL SURVEY; UNITED-STATES; INTERIM
   GUIDELINES; FRENCH-POLYNESIA; LATIN-AMERICA; SOUTH-PACIFIC
AB This review converses the Zika virus which has attained global concern due to its rapid pandemic potential and impact on humans. Though Zika virus was first isolated in 1947, till the recent large-scale outbreak which occurred in Micronesia, in 2007, the virus was placed into the innocuous pathogen category. The World Health Organization on 1 February 2016 declared it as a Public Health Emergency of International Concern.' Of the note, American as well as Pacific Island strains/isolates is relatively closer to Asian lineage strains. The African and American strains share more than 87.5% and 95% homologies with Asian strains/isolates, respectively. Asian strains form independent clusters, except those isolated from China, suggesting relatively more diversity than African strains. Prevention and control are mainly aimed at the vector population (mosquitoes) with Aedes aegypti being the main species. Surveys in Africa and Asia indicated seropositivity in various animal species. However, so far its natural reservoir is unknown. There is an urgent need to understand why Zika virus has shifted from being a virus that caused mild illness to unforeseen birth defects as well as autoimmune-neurological problems. Unfortunately, an effective vaccine is not available yet. Availability of cryo-electron microscopy based on 3.8 angstrom resolution revealing mature Zika virus structure and the probable virus attachment site to host cell would provide critical insights into the development of antiviral treatments and vaccines.
C1 [Singh, Raj Kumar] ICAR Indian Vet Res Inst, Bareilly, Uttar Pradesh, India.
   [Dhama, Kuldeep] ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India.
   [Malik, Yashpal Singh; Saurabh, Sharad] ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
   [Ramakrishnan, Muthannan Andavar] ICAR Indian Vet Res Inst, Div Virol, Mukteswar Campus, Bareilly, Uttarakhand, India.
   [Karthik, Kumaragurubaran] ICAR Indian Vet Res Inst, Div Bacteriol & Mycol, Bareilly, Uttar Pradesh, India.
   [Tiwari, Ruchi] Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwa, Coll Vet Sci, Dept Vet Microbiol & Immunol, Mathura, India.
   [Sachan, Swati] ICAR Indian Vet Res Inst, Immunol Sect, Bareilly, Uttar Pradesh, India.
   [Joshi, Sunil Kumar] Old Dominion Univ, Sch Med Diagnost & Translat Sci, Frank Reidy Res Ctr Bioelect, Cellular Immunol Lab, Norfolk, VA USA.
RP Malik, YS (reprint author), ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
EM malikyps@ivri.res.in
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Araujo Helena R. C., 2015, Insects, V6, P576, DOI 10.3390/insects6020576
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C., 2014, GENOME ANNOUNC, V2, P2, DOI DOI 10.1128/GENOMEA.00500-14
   Barrera-Cruz Antonio, 2016, Rev Med Inst Mex Seguro Soc, V54, P211
   Barzon L, 2016, EUROSURVEILLANCE, V21, P1
   Basarab M, 2016, BMJ-BRIT MED J, V352, P1
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bergquist R, 2011, MEM I OSWALDO CRUZ, V106, P892, DOI 10.1590/S0074-02762011000700016
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Blecher K, 2011, VIRULENCE, V2, P395, DOI 10.4161/viru.2.5.17035
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Borchardt RA, 2016, JAAPA-J AM ACAD PHYS, V29, P48, DOI 10.1097/01.JAA.0000481413.11539.b1
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Brelsfoard C.L., 2009, ASIA PAC J MOL BIOL, V17, P55
   Brown C, 2015, CMAJ, V188, P1
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   Burt A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0432
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos R. de M., 2016, Journal of Clinical Virology, V77, P69
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Carvalho DO, 2014, ACTA TROP, V132, pS170, DOI 10.1016/j.actatropica.2013.09.023
   CDC, 2016, MED STAT CDC ADDS 4
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chastel C, 2012, Bull Soc Pathol Exot, V105, P251, DOI 10.1007/s13149-012-0255-8
   Chattopadhyay Shiladitya, 2010, Bioinformation, V4, P448
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Chong L, 2013, BIOMED CHROMATOGR, V27, P825, DOI 10.1002/bmc.2866
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   Citrome L, 2016, INT J CLIN PRACT, V70, P181, DOI 10.1111/ijcp.12793
   Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Delany I, 2014, EMBO MOL MED, V6, P708, DOI 10.1002/emmm.201403876
   [ Deng Yichu], 2016, [, Chinese Critical Care Medicine], V28, P106
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Dhama K, 2013, PAKISTAN J BIOL SCI, V16, P1
   Dhama K., 2013, INT J CURR RES, V5, P1942
   Dhama K, 2008, VET RES COMMUN, V32, P341, DOI 10.1007/s11259-008-9040-3
   Dhama K, 2015, J INFECT DEV COUNTR, V9, P441, DOI 10.3855/jidc.6197
   Dhama K, 2015, INT J PHARMACOL, V11, P253, DOI 10.3923/ijp.2015.253.290
   Dhama Kuldeep, 2014, Pak J Biol Sci, V17, P151, DOI 10.3923/pjbs.2014.151.166
   Dhiman RC, 2010, PARASITOL RES, V106, P763, DOI 10.1007/s00436-010-1767-4
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Driggers RW, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824., DOI 10.1056/NEJMOA1601824, 10.1056/NEJMoa1601824]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O., 2016, BMJ-BRIT MED J, V352, P1
   Dyer O., 2015, BMJ-BRIT MED J, V351, P1
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   European CDC, 2014, RAP RISK ASS ZIK VIR
   Faccini-Martinez AA, 2016, J INFECT PUBLIC HEAL, V9, P687, DOI 10.1016/j.jiph.2016.01.001
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Finco O, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00012
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Goeijenbier M, 2016, NETH J MED, V74, P104
   GOMA LKH, 1965, B ENTOMOL RES, V56, P17
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Gulland A., 2016, BMJ-BRIT MED J, V352, pi595, DOI DOI 10.1136/BMJ.I595
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I1739
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Hanada K, 2004, MOL BIOL EVOL, V21, P1074, DOI 10.1093/molbev/msh109
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jacob JA, 2016, JAMA-J AM MED ASSOC, V315, P1097, DOI 10.1001/jama.2016.1219
   Jain KK, 2007, CLIN CHEM, V53, P2002, DOI 10.1373/clinchem.2007.090795
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Junquera Elena C, 2014, Recent Pat Antiinfect Drug Discov, V9, P14
   Kant R, 2013, J VECTOR DIS, V50, P1
   Kapoor S, 2014, INSIGHT INFLUENZA VI
   Karwowski MP, 2016, PEDIATRICS
   Kawadkar J, 2011, J PHARM CLIN RES, V4, P23
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kelvin AA, 2016, J INFECT DEV COUNTR, V10, P113, DOI 10.3855/jidc.8248
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73
   Kim M.-G., 2014, ASIAN J PHARM SCI, V9, P227
   Kindhauser MK, 2016, B WHO
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kline MW, 2016, JAMA PEDIATR, V170, P309, DOI 10.1001/jamapediatrics.2016.0429
   Knust B, 2013, EMERG INFECT DIS, V19, P1934, DOI 10.3201/eid1912.131217
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuldeep Dhama, 2013, Journal of Experimental Biology and Agricultural Sciences, V1, P1
   Kuldeep Dhama, 2014, Research Opinions in Animal and Veterinary Sciences, V4, P353
   Kumar S, 2014, FRONT PUBLIC HLTH, V2, P1
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Loriere SE, 2011, NAT REV MICROBIOL, V9, P617
   Lucchese G, 2016, AUTOIMMUN REV
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   MacNamara F., 1952, ANN REPORT, P1951
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mahima, 2012, Pak J Biol Sci, V15, P754, DOI 10.3923/pjbs.2012.754.774
   Malik Y. S., 2013, South Asian Journal of Experimental Biology, V3, P207
   Marano G, 2015, BLOOD TRANSFUS, V5, P1, DOI DOI 10.2450/2015.0066-15.[
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez Miguel J, 2015, Infect Dis Ther, V4, P365, DOI 10.1007/s40121-015-0079-5
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi1042
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi306, DOI DOI 10.1136/BMJ.I306
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Mlakar J, 2016, NEW ENGL J MED, V352, pi855
   MONATH TP, 1980, AM J TROP MED HYG, V29, P624
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nereida V., 2015, INVEST CLIN, V56, P241
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nunes-Alves C, 2016, NAT REV MICROBIOL, V14, P130, DOI [10.1038/nrmicro.2016.9, 10.1038/nrmicro.2016.16]
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I875
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Ong KC, 2015, BRAIN PATHOL, V25, P605, DOI 10.1111/bpa.12278
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Palacios R, 2016, VACCINE, V34, P2291, DOI 10.1016/j.vaccine.2016.03.059
   Pany SS, 2015, ADV ANIMAL VET SCI, V3, P1
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0377
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Perkasa A, 2016, EMERG INFECT DIS, P22
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.1440-1711.2004.01272.x
   Picard-Jean F, 2013, CURRENT ISSUES MOL V
   Pierre DYS, 2014, J VECTOR DIS, V51, P216
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pyke AT, 2014, PLOS CURR, V2, P6, DOI DOI 10.1371/CURRENTS
   Rafiei N, 2016, MED J AUSTRALIA, V204, P186, DOI 10.5694/mja15.01275
   Ramkumar G, 2015, PARASITOL RES, V114, P167, DOI 10.1007/s00436-014-4173-5
   Rasmussen SA, 2011, AM J OBSTET GYNECOL, V204, pS13, DOI 10.1016/j.ajog.2011.01.048
   Ratcliff RM, 2007, CURR ISSUES MOL BIOL, V9, P87
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Reis-Castro L, 2012, CROAT MED J, V53, P635, DOI 10.3325/cmj.2012.53.635
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Ryan MD, 1998, J GEN VIROL, V79, P947
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Sadovsky Y, 2016, PLACENTA, V40, pA1, DOI 10.1016/j.placenta.2016.03.008
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Shiryaev SA, 2010, FUTURE VIROL, V5, P593, DOI 10.2217/FVL.10.39
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh RK, 2015, CURRENT TRENDS FUTUR, P1
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SMFM Publications Committee, 2016, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2016.02.043, DOI 10.1016/J.AJOG.2016.02.043]
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tetro JA, 2016, MICROBES INFECT
   Teurlai M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004211
   Tiwari Ruchi, 2014, Pak J Biol Sci, V17, P316, DOI 10.3923/pjbs.2014.316.328
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torjesen I, 2016, BMJ-BRIT MED J, V352, pi500
   Ulmer JB, 2015, EXPERT OPIN DRUG DIS, V10, P101, DOI 10.1517/17460441.2015.996128
   van den Hurk R, 2015, SENSORS-BASEL, V15, P14045, DOI 10.3390/s150614045
   van Panhuis WG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003063
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vest KG, 2016, DISASTER MED PUBLIC, V29, P1
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez W E, 2016, J INFECT PUBLIC HLTH, DOI S1876-0341(15)00221-X
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, DIS OUTBR NEWS ZIK V
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Xiao XW, 2013, J ASIAN NAT PROD RES, V15, P809, DOI 10.1080/10286020.2013.803473
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhou Yan, 2014, Medicinal Plant, V5, P57
NR 293
TC 0
Z9 0
U1 52
U2 52
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0165-2176
EI 1875-5941
J9 VET QUART
JI Vet. Q.
PD SEP
PY 2016
VL 36
IS 3
BP 150
EP 175
DI 10.1080/01652176.2016.1188333
PG 26
WC Veterinary Sciences
SC Veterinary Sciences
GA DT5HK
UT WOS:000381512700006
PM 27158761
ER

PT J
AU Landry, ML
   Ko, AI
   Kramer, LD
   Vasilakis, N
AF Landry, Marie Louise
   Ko, Albert I.
   Kramer, Laura D.
   Vasilakis, Nikolaos
TI Zika Virus: From Obscurity to Potentially Devastating International
   Threat
SO CLINICAL CHEMISTRY
LA English
DT Editorial Material
C1 [Landry, Marie Louise] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.
   [Landry, Marie Louise] Yale Univ, Sch Med, Dept Med Infect Dis, New Haven, CT 06510 USA.
   [Landry, Marie Louise] Yale New Haven Med Ctr, Clin Virol Lab, 20 York St, New Haven, CT 06504 USA.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.] Yale Univ, Sch Med, Med Infect Dis, New Haven, CT USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Arbovirus Lab, New York State Dept Hlth,Wadsworth Ctr, Albany, NY 12222 USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Biomed Sci, Albany, NY 12222 USA.
   [Vasilakis, Nikolaos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikolaos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikolaos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Ko, AI (reprint author), Yale Univ, Sch Med, POB 208035, New Haven, CT 06520 USA.
EM marie.landry@yale.edu
NR 0
TC 0
Z9 0
U1 25
U2 25
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD SEP
PY 2016
VL 62
IS 9
BP 1175
EP 1180
DI 10.1373/clinchem.2016.261917
PG 6
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA DU7VH
UT WOS:000382422200003
PM 27551005
ER

PT J
AU Taylor, TJ
   Diaz, F
   Colgrove, RC
   Bernard, KA
   DeLuca, NA
   Whelan, SPJ
   Knipe, DM
AF Taylor, Travis J.
   Diaz, Fernando
   Colgrove, Robert C.
   Bernard, Kristen A.
   DeLuca, Neal A.
   Whelan, Sean P. J.
   Knipe, David M.
TI Production of immunogenic West Nile virus-like particles using a herpes
   simplex virus 1 recombinant vector
SO VIROLOGY
LA English
DT Article
DE West Nile virus; Vaccine vector; Flavivirus; Zika virus; HSV recombinant
   vector
ID REPLICATION-DEFECTIVE MUTANT; SIMIAN IMMUNODEFICIENCY VIRUS; CD8(+)
   T-CELLS; IMMUNE-RESPONSES; ENCEPHALITIS-VIRUS; DISSEMINATED INFECTION;
   JAPANESE ENCEPHALITIS; INTERFERON-PRODUCTION; PROTECTIVE EFFICACY;
   GENITAL HERPES
AB West Nile virus (WNV) is a flavivirus that swept rapidly across North America in 1999, declined in prevalence, and then resurged in 2012. To date, no vaccine is available to prevent infection in the human population. Herpes simplex virus (HSV) replication-defective vaccine vectors induce a durable immunity characterized by strong antibody and CD8(+) T cell responses even in HSV-immune animals. In this study, a WNV protein expression cassette was optimized for virus-like. particle (VLP) production in transfection studies, and the cassette was recombined into an HSV-1 d106-WNV virus vector, which produced extracellular VLPs, as confirmed by immunoelectron microscopy. Immunization of mice with the d106-WNV recombinant vector elicited a specific anti-WNV IgG response. This study highlights the flavivirus coding sequences needed for efficient assembly of virus-like particles. This information will facilitate generation of additional vaccine vectors against other flaviviruses including the recently emerged Zika virus. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Taylor, Travis J.; Diaz, Fernando; Colgrove, Robert C.; Whelan, Sean P. J.; Knipe, David M.] Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
   [Bernard, Kristen A.] New York State Dept Hlth, Wadsworth Ctr, POB 509, Albany, NY 12201 USA.
   [DeLuca, Neal A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, 523 Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15261 USA.
   [Diaz, Fernando] Sanofi Pasteur, Cambridge, MA USA.
   [Colgrove, Robert C.] Mt Auburn Hosp, Cambridge, MA USA.
   [Bernard, Kristen A.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, 2015 Linden Dr, Madison, WI 53706 USA.
RP Knipe, DM (reprint author), Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM david_knipe@hms.harvard.edu
FU NIAID [U54-AI057159, U54-AI057158, R01 AI057552, U19-AI109740]
FX We thank Kim Appler for her technical assistance with the antibody
   analysis, Maria Ericsson for her assistance with electron microscopy,
   Gus Kousoulis for plasmids, and Patrick T. Waters for assistance with
   preparation of the manuscript. This research was supported by NIAID
   grants U54-AI057159 (New England Regional Center for Excellence in
   Biodefense and Emerging Infections) and U54-AI057158 (Northeast
   Biodefense Center) and R01 AI057552 to DMK and U19-AI109740 to SPJW.
CR ALLISON SL, 1995, J VIROL, V69, P5816
   Allison SL, 1999, J VIROL, V73, P5605
   Brehm M, 1999, VIROLOGY, V256, P258, DOI 10.1006/viro.1999.9653
   Brehm MA, 1997, J VIROL, V71, P3534
   Brockman MA, 2002, J VIROL, V76, P3678, DOI 10.1128/JVI.76.8.3678-3687.2002
   Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033
   Brubaker JO, 1996, J IMMUNOL, V157, P1598
   Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313
   Centers for Disease Control and Prevention, 2013, MMWR-MORBID MORTAL W, V62, P513
   Chang GJJ, 2000, J VIROL, V74, P4244, DOI 10.1128/JVI.74.9.4244-4252.2000
   Chu JHJ, 2007, J IMMUNOL, V178, P2699
   Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08
   Cruz L, 2005, AM J TROP MED HYG, V72, P612
   Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000
   Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994
   DaCosta XJ, 1997, VIROLOGY, V232, P1, DOI 10.1006/viro.1997.8564
   Dauphin G, 2004, COMP IMMUNOL MICROB, V27, P343, DOI 10.1016/j.cimid.2004.03.009
   Dayan GH, 2012, VACCINE, V30, P6656, DOI 10.1016/j.vaccine.2012.08.063
   DESMYTER J, 1968, J VIROL, V2, P955
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020
   Estrada-Franco JG, 2003, EMERG INFECT DIS, V9, P1604
   FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022
   Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837
   Ishikawa T, 2007, MICROBES INFECT, V9, P1089, DOI 10.1016/j.micinf.2007.05.013
   Jones CA, 2000, VIROLOGY, V278, P137, DOI 10.1006/viro.2000.0628
   Kaur A., UNPUB
   Kaur A, 2007, VIROLOGY, V357, P199, DOI 10.1016/j.virol.2006.08.007
   Kojima A, 2003, J VIROL, V77, P8745, DOI 10.1128/JVI.77.16.8745-8755.2003
   Komar Nicholas, 2003, Adv Virus Res, V61, P185
   Konishi E, 2000, VACCINE, V18, P1133, DOI 10.1016/S0264-410X(99)00376-X
   Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722
   Lee J.S., 2016, MBIO, V7
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920
   Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005
   Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028
   Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004
   Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103
   Morrison LA, 1997, VIROLOGY, V239, P315, DOI 10.1006/viro.1997.8884
   Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047
   MOSCA JD, 1986, MOL CELL BIOL, V6, P2279
   Murphy CG, 2000, J VIROL, V74, P7745, DOI 10.1128/JVI.74.17.7745-7754.2000
   NGUYEN L, 1994, J IMMUNOL, V152, P478
   Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109
   Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070
   Qiao M, 2004, J INFECT DIS, V190, P2104, DOI 10.1086/425933
   Reisen W, 2004, EMERG INFECT DIS, V10, P1369
   RICE SA, 1989, J VIROL, V63, P3399
   Samaniego LA, 1998, J VIROL, V72, P3307
   Samina I, 2005, VACCINE, V23, P4955, DOI 10.1016/j.vaccine.2005.03.052
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Siger L, 2006, VET THER, V7, P249
   Song BW, 2001, VIROLOGY, V290, P320, DOI 10.1006/viro.2001.1175
   Takahashi H, 2009, MICROBES INFECT, V11, P1019, DOI 10.1016/j.micinf.2009.07.009
   Volz A, 2016, VACCINE, V34, P1915, DOI 10.1016/j.vaccine.2016.02.042
   WALBOOMERS JMM, 1976, VIROLOGY, V74, P256, DOI 10.1016/0042-6822(76)90151-3
   Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003
   Watanabe D, 2007, VIROLOGY, V357, P186, DOI 10.1016/j.virol.2006.08.015
   Watts DM, 2007, VACCINE, V25, P2913, DOI 10.1016/j.vaccine.2006.08.008
   Yang JS, 2001, J INFECT DIS, V184, P809, DOI 10.1086/323395
   Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109
NR 66
TC 0
Z9 0
U1 7
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD SEP
PY 2016
VL 496
BP 186
EP 193
DI 10.1016/j.virol.2016.06.006
PG 8
WC Virology
SC Virology
GA DT1IU
UT WOS:000381235700021
PM 27336950
ER

PT J
AU Carneiro, BM
   Batista, MN
   Braga, ACS
   Nogueira, ML
   Rahal, P
AF Carneiro, Bruno M.
   Batista, Mariana N.
   Braga, Ana Claudia S.
   Nogueira, Mauricio L.
   Rahal, Paula
TI The green tea molecule EGCG inhibits Zika virus entry
SO VIROLOGY
LA English
DT Article
DE Zika virus; (-)-Epigallocatechin gallate; Antiviral; Green-tea
ID EPIGALLOCATECHIN GALLATE; HIV-1 THERAPY; POLYPHENOL; CATECHINS; AMERICA;
   SAFETY; RATS
AB During ZIKV the outbreak in Brazil it was observed an increase of almost 20 times the number of reported cases of microcephaly in newborn babies. There is no vaccine or approved drug available for the treatment and prevention of infections by this virus. EGCG, a polyphenol present in green tea has been shown to have an antiviral activity for many viruses. In view of the need for the development of a drug against a Brazilian strain of ZIKV, we assessed the effect of EGCG on ZIKV entry in Vero E6 cells. The drug was capable of inhibiting the virus entry by at least 1-log ( > 90%) at higher concentrations ( > 100 mu M). The pre-treatment of cells with EGCG did not show any effect on virus attachment. This is the first study to demonstrate the effect of EGCG on ZIKV indicating that this drug might be possibility to be used for prevention of Zika virus infections. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Carneiro, Bruno M.; Batista, Mariana N.; Braga, Ana Claudia S.; Rahal, Paula] Sao Paulo State Univ UNESP, Lab Genom Studies, Sao Jose Do Rio Preto, SP, Brazil.
   [Nogueira, Mauricio L.] FAMERP, Dept Doencas Infecciosas & Parasitarias, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP Carneiro, BM (reprint author), Sao Paulo State Univ UNESP, Lab Genom Studies, Sao Jose Do Rio Preto, SP, Brazil.
EM brunocopo@yahoo.com.br
FU Sao Paulo Research Foundation (FAPESP), Brazil [2013/21719-3,
   2014/22199-6, 2014/22198-0]
FX This work was supported by the Sao Paulo Research Foundation (FAPESP),
   Brazil. Grant numbers 2013/21719-3, 2014/22199-6 and 2014/22198-0.
CR Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chow HHS, 2003, CLIN CANCER RES, V9, P3312
   Chu KO, 2007, HUM REPROD, V22, P280, DOI 10.1093/humrep/del353
   Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fangueiro JF, 2016, INT J PHARMACEUT, V502, P161, DOI 10.1016/j.ijpharm.2016.02.039
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07
   Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P651, DOI 10.1016/j.fct.2005.11.002
   Lambert JD, 2006, DRUG METAB DISPOS, V34, P2111, DOI 10.1124/dmd.106.011460
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nance CL, 2009, J ALLERGY CLIN IMMUN, V123, P459, DOI 10.1016/j.jaci.2008.12.024
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009
   Weisburg JH, 2004, BASIC CLIN PHARMACOL, V95, P191
   Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016
   Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 0
Z9 0
U1 22
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD SEP
PY 2016
VL 496
BP 215
EP 218
DI 10.1016/j.virol.2016.06.012
PG 4
WC Virology
SC Virology
GA DT1IU
UT WOS:000381235700024
PM 27344138
ER

PT J
AU Muller, JA
   Harms, M
   Schubert, A
   Jansen, S
   Michel, D
   Mertens, T
   Schmidt-Chanasit, J
   Munch, J
AF Mueller, Janis A.
   Harms, Mirja
   Schubert, Axel
   Jansen, Stephanie
   Michel, Detlef
   Mertens, Thomas
   Schmidt-Chanasit, Jonas
   Muench, Jan
TI Inactivation and Environmental Stability of Zika Virus
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Mueller, Janis A.; Harms, Mirja; Schubert, Axel; Michel, Detlef; Mertens, Thomas; Muench, Jan] Univ Ulm, Med Ctr, Ulm, Germany.
   [Jansen, Stephanie; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, World Hlth Org Collaborating Ctr Arbovirus & Hemo, Hamburg, Germany.
   [Jansen, Stephanie; Schmidt-Chanasit, Jonas] German Ctr Infect Res Partner Sites, Hamburg Luebeck Borstel, Germany.
RP Munch, J (reprint author), Univ Ulm, Med Ctr, Inst Mol Virol, Meyerhofstr 1, D-89081 Ulm, Germany.
EM jan.muench@uni-ulm.de
CR Charrel RN, B WHO
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Zammarchi L, 2015, EURO SURVEILL, V20
NR 10
TC 0
Z9 0
U1 33
U2 33
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2016
VL 22
IS 9
BP 1685
EP 1687
DI 10.3201/eid2209.160664
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DU1GJ
UT WOS:000381955900039
PM 27367466
ER

PT J
AU Matheus, S
   Boukhari, R
   Labeau, B
   Ernault, V
   Bremand, L
   Kazanji, M
   Rousset, D
AF Matheus, Severine
   Boukhari, Rachida
   Labeau, Bhety
   Ernault, Valerie
   Bremand, Laetitia
   Kazanji, Mirdad
   Rousset, Dominique
TI Specificity of Dengue NS1 Antigen in Differential Diagnosis of Dengue
   and Zika Virus Infection
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Matheus, Severine; Labeau, Bhety; Bremand, Laetitia; Kazanji, Mirdad; Rousset, Dominique] Inst Pasteur, Cayenne, French Guiana.
   [Boukhari, Rachida; Ernault, Valerie] Ctr Hosp Ouest Guyanais, St Laurent Du Maroni, French Guiana.
RP Matheus, S (reprint author), Inst Pasteur, Ctr Natl Reference Arbovirus, Lab Associe, 23 Ave Pasteur,BP 6010-97306, Cayenne, French Guiana.
EM smatheus@pasteur-cayenne.fr
CR Chung SJ, 2015, AM J TROP MED HYG, V92, P367, DOI 10.4269/ajtmh.14-0247
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Pierson T.C., 2013, FIELDS VIROLOGY, P747
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   Wang SM, 2010, J CLIN MICROBIOL, V48, P2793, DOI 10.1128/JCM.02142-09
NR 7
TC 1
Z9 1
U1 19
U2 19
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2016
VL 22
IS 9
BP 1691
EP 1693
DI 10.3201/eid2209.160725
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DU1GJ
UT WOS:000381955900042
PM 27347853
ER

PT J
AU Harrison, SC
AF Harrison, Stephen C.
TI Immunogenic cross-talk between dengue and Zika viruses
SO NATURE IMMUNOLOGY
LA English
DT Editorial Material
ID ANTIBODIES; INFECTION
AB At least five recent papers have shown an unexpected antigenic relationship between Zika and dengue viruses, with potential implications for vaccines and therapeutics.
C1 [Harrison, Stephen C.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA.
   [Harrison, Stephen C.] Howard Hughes Med Inst, Boston, MA 02115 USA.
RP Harrison, SC (reprint author), Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA.; Harrison, SC (reprint author), Howard Hughes Med Inst, Boston, MA 02115 USA.
EM harrison@crystal.harvard.edu
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom J.A., 2016, MBIO, DOI [10.1128/mBio.01123-16, DOI 10.1128/MBIO.01123-16]
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 14
TC 0
Z9 0
U1 28
U2 28
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD SEP
PY 2016
VL 17
IS 9
BP 1010
EP 1012
PG 3
WC Immunology
SC Immunology
GA DT9OO
UT WOS:000381832000003
PM 27540984
ER

PT J
AU Dejnirattisai, W
   Supasa, P
   Wongwiwat, W
   Rouvinski, A
   Barba-Spaeth, G
   Duangchinda, T
   Sakuntabhai, A
   Cao-Lormeau, VM
   Malasit, P
   Rey, FA
   Mongkolsapaya, J
   Screaton, GR
AF Dejnirattisai, Wanwisa
   Supasa, Piyada
   Wongwiwat, Wiyada
   Rouvinski, Alexander
   Barba-Spaeth, Giovanna
   Duangchinda, Thaneeya
   Sakuntabhai, Anavaj
   Cao-Lormeau, Van-Mai
   Malasit, Prida
   Rey, Felix A.
   Mongkolsapaya, Juthathip
   Screaton, Gavin R.
TI Dengue virus sero-cross-reactivity drives antibody-dependent enhancement
   of infection with zika virus
SO NATURE IMMUNOLOGY
LA English
DT Article
ID CHIKUNGUNYA VIRUS; NEUTRALIZING ANTIBODIES; BRAZIL; OUTBREAK;
   DETERMINANTS; MODELS; BRAIN
AB Zika virus (ZIKV) was discovered in 1947 and was thought to lead to relatively mild disease. The recent explosive outbreak of ZIKV in South America has led to widespread concern, with reports of neurological sequelae ranging from Guillain Barre syndrome to microcephaly. ZIKV infection has occurred in areas previously exposed to dengue virus (DENV), a flavivirus closely related to ZIKV. Here we investigated the serological cross-reaction between the two viruses. Plasma immune to DENV showed substantial cross-reaction to ZIKV and was able to drive antibody-dependent enhancement (ADE) of ZIKV infection. Using a panel of human monoclonal antibodies (mAbs) to DENV, we showed that most antibodies that reacted to DENV envelope protein also reacted to ZIKV. Antibodies to linear epitopes, including the immunodominant fusion-loop epitope, were able to bind ZIKV but were unable to neutralize the virus and instead promoted ADE. Our data indicate that immunity to DENV might drive greater ZIKV replication and have clear implications for disease pathogenesis and future vaccine programs for ZIKV and DENV.
C1 [Dejnirattisai, Wanwisa; Supasa, Piyada; Wongwiwat, Wiyada; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England.
   [Supasa, Piyada; Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand.
   [Supasa, Piyada] Mahidol Univ, Siriraj Hosp, Dept Immunol, Fac Med,Grad Program Immunol, Bangkok, Thailand.
   [Rouvinski, Alexander; Barba-Spaeth, Giovanna; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, Paris, France.
   [Rouvinski, Alexander; Barba-Spaeth, Giovanna; Rey, Felix A.] CNRS UMR 3569 Virol, Paris, France.
   [Duangchinda, Thaneeya; Malasit, Prida] Natl Sci & Technol Dev Agcy, Med Biotechnol Unit, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand.
   [Sakuntabhai, Anavaj] Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France.
   [Sakuntabhai, Anavaj] CNRS URA3012, Paris, France.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Fr Polynesia.
RP Mongkolsapaya, J; Screaton, GR (reprint author), Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London, England.; Mongkolsapaya, J (reprint author), Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand.
EM j.mongkolsapaya@imperial.ac.uk; g.screaton@imperial.ac.uk
FU Medical Research Council, UK; Wellcome Trust, UK; National Institute for
   Health Research Biomedical Research Centre; European Commission [282
   378]; Laboratory of Excellence Integrative Biology of Emerging
   Infectious Diseases [ANR-10-LABX-62-IBEID]; Agence Nationale de la
   Recherche [FlaviStem/I1378]; Thailand Research Fund through the Royal
   Golden Jubilee PhD
FX We thank Armed Forces Research Institute of Medical Sciences, Thailand
   for Vero cells, C6/36 cells, mAb 4G2 to DENV envelope protein, and
   viruses DENV-1, DENV-2 and DENV-3; and M. Nguyen-De Bernon for technical
   assistance. Supported by the Medical Research Council, UK, the Wellcome
   Trust, UK (G.R.S.), the National Institute for Health Research
   Biomedical Research Centre, Funding Scheme, European Commission Seventh
   Framework Programme (FP7/2007-2013) for the DENFREE project (under grant
   agreement 282 378), Laboratory of Excellence Integrative Biology of
   Emerging Infectious Diseases (ANR-10-LABX-62-IBEID to F.A.R.), Agence
   Nationale de la Recherche (FlaviStem/I1378 to F.A.R.) and the Thailand
   Research Fund through the Royal Golden Jubilee PhD (P.S. and J.M.).
CR Barba-Spaeth G., NATURE IN PRESS
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   BRANDT WE, 1982, INFECT IMMUN, V36, P1036
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Brathwaite DO, 2012, AM TROP MED HYG, V87, P584, DOI DOI 10.4269/AJTMH.2012.11-0770
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J., 2016, CELL STEM CELL, DOI [10.1016/jstem.2016.04.014, DOI 10.1016/JSTEM.2016.04.014]
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2007, EMERG INFECT DIS, V13, P282
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paul LM, 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sarno M., 2016, PLOS NEGL TROP DIS, V10
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organization, 2016, ZIK EM
   World Health Organization, 2016, ZIK VIR FACT SHEET
   World Health Organization (WHO), 2016, DENG VACC
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 47
TC 7
Z9 7
U1 37
U2 37
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD SEP
PY 2016
VL 17
IS 9
BP 1102
EP 1108
DI 10.1038/ni.3515
PG 7
WC Immunology
SC Immunology
GA DT9OO
UT WOS:000381832000014
PM 27339099
ER

PT J
AU Tang, BL
AF Tang, Bor Luen
TI Zika virus as a causative agent for primary microencephaly: the evidence
   so far
SO ARCHIVES OF MICROBIOLOGY
LA English
DT Review
DE Microcephaly; Neuroprogenitor cells; Zika virus
ID CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; CEREBRAL-CORTEX; INFECTION;
   BRAIN; ENCEPHALITIS; BRAZIL; MICE; REPLICATION; FLAVIVIRUS
AB Zika virus (ZIKV) infection has been associated with congenital microcephaly and peripheral neuropathy. The ongoing epidemic has triggered swift responses in the scientific community, and a number of recent reports have now confirmed a causal relationship between ZIKV infection and birth defect. In particular, ZIKV has been shown to be capable of compromising and crossing the placental barrier and infect the developing fetal brain, resulting in the demise and functional impairment of neuroprogenitor cells critical for fetal cortex development. Here, the evidence for ZIKV as a teratogenic agent that causes microcephaly is reviewed, and its association with other disorders is discussed.
C1 [Tang, Bor Luen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD7,8 Med Dr, Singapore 117597, Singapore.
   [Tang, Bor Luen] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, 28 Med Dr, Singapore 117456, Singapore.
RP Tang, BL (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD7,8 Med Dr, Singapore 117597, Singapore.; Tang, BL (reprint author), Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, 28 Med Dr, Singapore 117456, Singapore.
EM bchtbl@nus.edu.sg
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chae Teresa H, 2007, Novartis Found Symp, V288, P79
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Corno C, 2016, CURR MED CHEM, V23, P1496, DOI 10.2174/0929867323666160405112954
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Johansson MA, 2016, NEW ENGL J MED, DOI [10.1056/NEJMp1605367, DOI 10.1056/NEJMP1605367]
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rakic P, 2007, BRAIN RES REV, V55, P204, DOI 10.1016/j.brainresrev.2007.02.010
   Rao S, 2013, BMJ CASE REP, P2013, DOI [10.1136/bcr-2012-008229, DOI 10.1136/BCR-2012-008229]
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang BL, 2016, J CELL PHYSIOL, V231, P1417, DOI 10.1002/jcp.25261
   Tang BL, 2006, BIOCHEM BIOPH RES CO, V345, P911, DOI 10.1016/j.bbrc.2006.05.040
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Turtle L, 2012, QJM-INT J MED, V105, P219, DOI 10.1093/qjmed/hcs013
   Tyler KL, 2014, CURR OPIN NEUROL, V27, P342, DOI 10.1097/WCO.0000000000000088
   Vargas JE, 2001, J PEDIATR-US, V139, P210, DOI 10.1067/mpd.2001.115314
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.1784, DOI 10.1001/JAMAOPHTHALMOL.2016.1784]
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 68
TC 0
Z9 0
U1 109
U2 109
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-8933
EI 1432-072X
J9 ARCH MICROBIOL
JI Arch. Microbiol.
PD SEP
PY 2016
VL 198
IS 7
BP 595
EP 601
DI 10.1007/s00203-016-1268-7
PG 7
WC Microbiology
SC Microbiology
GA DS3FI
UT WOS:000380668100001
PM 27412681
ER

PT J
AU Goubert, C
   Minard, G
   Vieira, C
   Boulesteix, M
AF Goubert, C.
   Minard, G.
   Vieira, C.
   Boulesteix, M.
TI Population genetics of the Asian tiger mosquito Aedes albopictus, an
   invasive vector of human diseases
SO HEREDITY
LA English
DT Review
ID YELLOW-FEVER MOSQUITO; DIPTERA-CULICIDAE; UNITED-STATES;
   MITOCHONDRIAL-DNA; REUNION ISLAND; 1ST RECORD; INSECTICIDE RESISTANCE;
   MICROSATELLITE MARKERS; ADAPTIVE EVOLUTION; BREEDING STRUCTURE
AB The Asian tiger mosquito Aedes albopictus is currently one of the most threatening invasive species in the world. Native to Southeast Asia, the species has spread throughout the world in the past 30 years and is now present in every continent but Antarctica. Because it was the main vector of recent Dengue and Chikungunya outbreaks, and because of its competency for numerous other viruses and pathogens such as the Zika virus, A. albopictus stands out as a model species for invasive diseases vector studies. A synthesis of the current knowledge about the genetic diversity of A. albopictus is needed, knowing the interplays between the vector, the pathogens, the environment and their epidemiological consequences. Such resources are also valuable for assessing the role of genetic diversity in the invasive success. We review here the large but sometimes dispersed literature about the population genetics of A. albopictus. We first debate about the experimental design of these studies and present an up-to-date assessment of the available molecular markers. We then summarize the main genetic characteristics of natural populations and synthesize the available data regarding the worldwide structuring of the vector. Finally, we pinpoint the gaps that remain to be addressed and suggest possible research directions.
C1 [Goubert, C.; Vieira, C.; Boulesteix, M.] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR5558, Villeurbanne, France.
   [Minard, G.] Univ Lyon 1, Microbial Ecol, UMR CNRS 5557, UMR INRA 1418,VetAgro Sup,BioEnvironm & Hlth FR41, Villeurbanne, France.
   [Minard, G.] Univ Helsinki, Metapopulat Res Ctr, Dept Biosci, Helsinki, Finland.
RP Boulesteix, M (reprint author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR CNRS 5558, 43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France.
EM matthieu.boulesteix@univ-lyon1.fr
FU French Ministry of Superior Education
FX We are grateful to Marie Fablet, who provided insightful comments, as
   well as three anonymous referees who contributed to improve the
   manuscript. We also thank Celine Toty (MIVEGEC Montpellier) for
   providing the A. albopictus individuals from La Reunion Island used in
   the pilot RAD-seq experiment and Helene Henri for the libraries
   construction. CG received a grant from the French Ministry of Superior
   Education.
CR Adhami J., 1987, REV MJEKESORE, V1, P13
   Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356
   Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276
   Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x
   Ayres C, 2002, MEM I OSWALDO CRUZ, V97, P871, DOI 10.1590/S0074-02762002000600022
   Barrett LG, 2008, TRENDS ECOL EVOL, V23, P678, DOI 10.1016/j.tree.2008.06.017
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Behura SK, 2014, FUNCT INTEGR GENOMIC, V14, P581, DOI 10.1007/s10142-014-0376-1
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   BLACK WC, 1988, HEREDITY, V61, P439, DOI 10.1038/hdy.1988.136
   BLACK WC, 1988, HEREDITY, V60, P173, DOI 10.1038/hdy.1988.29
   Bock DG, 2015, MOL ECOL, V24, P2277, DOI 10.1111/mec.13032
   Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Boulesteix M, 2007, MOL ECOL, V16, P441, DOI 10.1111/j.1365-294X.2006.03150.x
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   CAPRIO MA, 1992, J ECON ENTOMOL, V85, P611
   Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240
   Chareonviriyaphap T, 2004, J MED ENTOMOL, V41, P657, DOI 10.1603/0022-2585-41.4.657
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088
   Coffinet T, 2007, J AM MOSQUITO CONTR, V23, P471, DOI 10.2987/5636.1
   Cristescu ME, 2015, MOL ECOL, V24, P2212, DOI 10.1111/mec.13117
   da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x
   Damal K, 2013, AM J TROP MED HYG, V89, P482, DOI 10.4269/ajtmh.13-0102
   Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084
   de Albuquerque AL, 2011, MEM I OSWALDO CRUZ, V106, P773, DOI 10.1590/S0074-02762011000600021
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105
   Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016
   Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111
   Diallo M, 2010, TROP MED INT HEALTH, V15, P1185, DOI 10.1111/j.1365-3156.2010.02594.x
   Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x
   Dritsou V, 2015, PATHOG GLOB HEALTH, V109, P207, DOI 10.1179/2047773215Y.0000000031
   Esnault C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001968
   Excoffier L, 2004, HDB STAT GENETICS
   Fernandez Z, 2004, J MED ENTOMOL, V41, P961
   Fontenille D, 2001, EMERG INFECT DIS, V7, P1066
   Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244
   Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x
   Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089
   Goubert C, 2015, GENOME BIOL EVOL, V7, P1192, DOI 10.1093/gbe/evv050
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Gupta S, 2014, PARASITOL RES, V113, P2137, DOI 10.1007/s00436-014-3864-2
   Haddad N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-300
   Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2
   Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Henri H, 2015, GENETICA, V143, P139, DOI 10.1007/s10709-015-9828-3
   Higa Y, 2010, JPN J INFECT DIS, V63, P312
   Huber K, 2001, MOL ECOL NOTES, V1, P219, DOI 10.1046/j.1471-8278 .2001.00077.x
   Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056
   Isabel N, 1999, MOL ECOL, V8, P477, DOI 10.1046/j.1365-294X.1999.00597.x
   Ismail NA, 2015, J AM MOSQUITO CONTR, V31, P305, DOI 10.2987/moco-31-04-305-312.1
   Jones CJ, 1997, MOL BREEDING, V3, P381, DOI 10.1023/A:1009612517139
   KAMBHAMPATI S, 1990, HEREDITY, V64, P281, DOI 10.1038/hdy.1990.34
   KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67
   Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kittayapong P, 2002, AM J TROP MED HYG, V66, P108
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519
   Lenormand T, 1999, NATURE, V400, P861, DOI 10.1038/23685
   Liew C, 2004, MED VET ENTOMOL, V18, P351, DOI 10.1111/j.0269-283X.2004.00517.x
   Lowe A, 2004, ECOLOGICAL GENETICS
   Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624
   Manni M, 2015, AEDES ALBOPICTUS PAR, V8, P188
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Mccoy KD, 2008, PARASITE, V15, P444
   Medley KA, 2015, MOL ECOL, V24, P284, DOI 10.1111/mec.12925
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970
   Moore CG, 1999, J AM MOSQUITO CONTR, V15, P221
   Morales V. R. E., 2013, INFECT GENET EVOL, V13, P242
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Mutebi JP, 1997, J HERED, V88, P489
   O'Donnell D, 2010, INFECT GENET EVOL, V10, P669, DOI 10.1016/j.meegid.2010.03.011
   Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Perez T, 1998, MOL ECOL, V7, P1347, DOI 10.1046/j.1365-294x.1998.00484.x
   Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135
   Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143
   Pongsiri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092971
   Porretta D, 2006, MOL ECOL NOTES, V6, P880, DOI 10.1111/j.1471-8286.2006.01384.x
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Raharimalala FN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-56
   Rasic G, 2015, EVOL APPL, V8, P901, DOI 10.1111/eva.12301
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600
   SAVAGE HM, 1992, J AM MOSQUITO CONTR, V8, P101
   Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249
   Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x
   Shaikevich E, 2013, ISRN ENTOMOL, V2013, P1
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002
   Teixeira MG, 2009, CAD SAUDE PUBLICA, V25, pS7
   Toto JC, 2003, MED VET ENTOMOL, V17, P343, DOI 10.1046/j.1365-2915.2003.00447.x
   Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x
   Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709
   Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116
   van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x
   Vazeille M, 2001, AM J TROP MED HYG, V65, P491
   WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117
   White VL, 2015, INSECT SCI, V22, P409, DOI 10.1111/1744-7917.12145
   Zawani MKN, 2014, GENET MOL RES, V13, P8184, DOI 10.4238/2014.October.7.13
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
   Zitko T, 2011, EUR J ENTOMOL, V108, P501
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
   Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x
NR 114
TC 0
Z9 0
U1 55
U2 55
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0018-067X
EI 1365-2540
J9 HEREDITY
JI Heredity
PD SEP
PY 2016
VL 117
IS 3
BP 125
EP 134
DI 10.1038/hdy.2016.35
PG 10
WC Ecology; Evolutionary Biology; Genetics & Heredity
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity
GA DT2LR
UT WOS:000381312300001
PM 27273325
ER

PT J
AU Panchaud, A
   Vouga, M
   Musso, D
   Baud, D
AF Panchaud, Alice
   Vouga, Manon
   Musso, Didier
   Baud, David
TI An international registry for women exposed to Zika virus during
   pregnancy: time for answers
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID INFECTION; BRAZIL
C1 [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Sch Pharmaceut Sci, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Swiss Teratogen Informat Serv, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland.
   [Panchaud, Alice] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Vouga, Manon; Baud, David] Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Hosp, Lausanne, Switzerland.
   [Baud, David] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
   [Baud, David] CHU Vaudois, Dept Obstet & Gynecol, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
RP Baud, D (reprint author), Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.; Baud, D (reprint author), Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.; Baud, D (reprint author), Univ Hosp, Lausanne, Switzerland.; Baud, D (reprint author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.; Baud, D (reprint author), CHU Vaudois, Dept Obstet & Gynecol, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
EM david.baud@chuv.ch
CR Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 9
TC 0
Z9 0
U1 29
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2016
VL 16
IS 9
BP 995
EP 996
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DT7GN
UT WOS:000381655200011
PM 27684333
ER

PT J
AU Prisant, N
   Bujan, L
   Benichou, H
   Hayot, PH
   Pavili, L
   Lurel, S
   Herrmann, C
   Janky, E
   Joguet, G
AF Prisant, Nadia
   Bujan, Louis
   Benichou, Helene
   Hayot, Pierre-Humbert
   Pavili, Lynda
   Lurel, Sylvia
   Herrmann, Cecile
   Janky, Eustase
   Joguet, Guillaume
TI Zika virus in the female genital tract
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Prisant, Nadia; Benichou, Helene; Hayot, Pierre-Humbert; Pavili, Lynda; Lurel, Sylvia; Janky, Eustase; Joguet, Guillaume] Ctr Hosp Univ Pointe A Pitre, Pole Parents Enfant, Ctr Caribeen Med Reprod, CECOS Caraibes, Pointe A Pitre 97159, Guadeloupe.
   [Bujan, Louis] Univ Toulouse 3, Human Fertil Res Grp, Toulouse, France.
   [Bujan, Louis] Ctr Hosp Univ Paule de Viguier, CECOS, Toulouse, France.
   [Herrmann, Cecile] Ctr Hosp Univ Pointe A Pitre, Lab Microbiol Clin & Environm, Pointe A Pitre, Guadeloupe.
RP Prisant, N (reprint author), Ctr Hosp Univ Pointe A Pitre, Pole Parents Enfant, Ctr Caribeen Med Reprod, CECOS Caraibes, Pointe A Pitre 97159, Guadeloupe.
EM nadia.mutaftschiev@chu-guadeloupe.fr
CR Agence de la Biomedecine, 2016, REC PROF PRIS CHARG
   Calvet G., 2016, LANCET INFECT DIS
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
NR 5
TC 1
Z9 1
U1 20
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2016
VL 16
IS 9
BP 1000
EP 1001
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DT7GN
UT WOS:000381655200017
PM 27427201
ER

PT J
AU Attaran, A
AF Attaran, Amir
TI Zika virus and the 2016 Olympic Games
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Attaran, Amir] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada.
   [Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.
RP Attaran, A (reprint author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada.; Attaran, A (reprint author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.
EM aattaran@uottawa.ca
CR Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grills A, 2016, MMWR MORB MORTAL WKL, DOI 10.15585/mmwr.mm6528e1.
   International Research Institute for Climate and Society, IRI MULT PROB FOR TE
   The Lancet Infectious, 2016, LANCET INFECT DIS, V16, P619
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2016, MON CAS DENG FEBR CH, V21
   WHO, 1947, MAP COUNTR TERR SHOW
   WHO, 2016, ZIK VIR OL PAR GAM R
NR 7
TC 0
Z9 0
U1 24
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2016
VL 16
IS 9
BP 1001
EP 1003
DI 10.1016/S1473-3099(16)30230-4
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DT7GN
UT WOS:000381655200018
PM 27460685
ER

PT J
AU McConnell, J
   de Ambrogi, M
   Cleghorn, S
   Sekkides, O
AF McConnell, John
   de Ambrogi, Marco
   Cleghorn, Sean
   Sekkides, Onisillos
TI Zika virus and the 2016 Olympic Games reply
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID RIO-DE-JANEIRO
C1 [McConnell, John; de Ambrogi, Marco; Cleghorn, Sean; Sekkides, Onisillos] Lancet Infect Dis, 125 London Wall, London EC2Y 5AS, England.
RP McConnell, J (reprint author), Lancet Infect Dis, 125 London Wall, London EC2Y 5AS, England.
CR Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Grills A, 2016, MMWR MORB MORTAL WKL, DOI 10.15585/mmwr.mm6528e1.
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Ministerio da Saude Brazil, MIN SAUD CONF 1 656
   [Anonymous], 2016, LANCET INFECT DIS
NR 5
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD SEP
PY 2016
VL 16
IS 9
BP 1003
EP 1004
DI 10.1016/S1473-3099(16)30266-3
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DT7GN
UT WOS:000381655200019
PM 27460686
ER

PT J
AU Ye, Q
   Liu, ZY
   Han, JF
   Jiang, T
   Li, XF
   Qin, CF
AF Ye, Qing
   Liu, Zhong-Yu
   Han, Jian-Feng
   Jiang, Tao
   Li, Xiao-Feng
   Qin, Cheng-Feng
TI Genomic characterization and phylogenetic analysis of Zika virus
   circulating in the Americas
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Review
DE Zika virus; Genomic characterization; Phylogenetics; Flavivirus
ID JAPANESE ENCEPHALITIS-VIRUS; VACCINE STRAIN SA14-14-2; RNA SECONDARY
   STRUCTURES; DENGUE VIRUS; WEST-NILE; ATTENUATED VACCINE; GLYCOSYLATION
   SITE; ENVELOPE PROTEIN; N-GLYCOSYLATION; FLAVIVIRUS RNA
AB The rapid spread and potential link with birth defects have made Zika virus (ZIKV) a global public health problem. The virus was discovered 70 years ago, yet the knowledge about its genomic structure and the genetic variations associated with current ZIKV explosive epidemics remains not fully understood. In this review, the genome organization, especially conserved terminal structures of ZIKV genome were characterized and compared with other mosquito-borne flaviviruses. It is suggested that major viral proteins of ZIKV share high structural and functional similarity with other known flaviviruses as shown by sequence comparison and prediction of functional motifs in viral proteins. Phylogenetic analysis demonstrated that all ZIKV strains circulating in the America form a unique clade within the Asian lineage. Furthermore, we identified a series of conserved amino acid residues that differentiate the Asian strains including the current circulating American strains from the ancient African strains. Overall, our findings provide an overview of ZIKV genome characterization and evolutionary dynamics in the Americas and point out critical clues for future virological and epidemiological studies. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ye, Qing; Liu, Zhong-Yu; Han, Jian-Feng; Jiang, Tao; Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.
   [Jiang, Tao; Li, Xiao-Feng; Qin, Cheng-Feng] State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
RP Qin, CF (reprint author), Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.
EM qincf@bmi.ac.cn
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU State Key Laboratory of Pathogen and Biosecurity, China; National Basic
   Research Project [2012CB518904]; National Natural Science Foundation of
   China [31270974, 81522025]; National Major Special Program of Science
   and Technology of China [2013ZX10004001]; Newton Advanced Fellowship
   from the Academy of Medical Sciences, UK; NSFC of China [81661130162]
FX This work was supported by the State Key Laboratory of Pathogen and
   Biosecurity, China, the National Basic Research Project (No.
   2012CB518904), the National Natural Science Foundation of China (No.
   31270974) and the National Major Special Program of Science and
   Technology of China (2013ZX10004001). C.F. Qin was supported by the
   National Natural Science Foundation of China (81522025) and the Newton
   Advanced Fellowship from the Academy of Medical Sciences, UK and the
   NSFC of China (No. 81661130162).
CR Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EURO SURVEILL, V19
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chen LK, 1996, VIROLOGY, V217, P220, DOI 10.1006/viro.1996.0109
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Davis WG, 2013, J VIROL, V87, P7622, DOI 10.1128/JVI.00212-13
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci A.S., 2016, N ENGL J MED
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Li J, 2006, J GEN VIROL, V87, P613, DOI 10.1099/vir.0.81320-0
   Li XF, 2013, J GEN VIROL, V94, P2700, DOI 10.1099/vir.0.059436-0
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Lin SR, 2011, J VIROL, V85, P5159, DOI 10.1128/JVI.02099-10
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Maurice J, 2016, LANCET, V387, P1147, DOI 10.1016/S0140-6736(16)30012-5
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Torresi J, 2010, VACCINE, V28, P7993, DOI 10.1016/j.vaccine.2010.09.035
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Wang HJ, 2014, VACCINE, V32, P949, DOI 10.1016/j.vaccine.2013.12.050
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Waugh A, 2002, RNA, V8, P707, DOI 10.1017/S1355838202028017
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeng LL, 1998, J VIROL, V72, P7510
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 60
TC 3
Z9 3
U1 233
U2 233
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD SEP
PY 2016
VL 43
BP 43
EP 49
DI 10.1016/j.meegid.2016.05.004
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DR1YP
UT WOS:000379701100007
PM 27156653
ER

PT J
AU Hodak, H
AF Hodak, Helene
TI Down to the Molecular Mechanisms of Host-Pathogen Interactions
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Editorial Material
ID EBOLA-VIRUS DISEASE; ZIKA VIRUS
C1 [Hodak, Helene] Elsevier Inc, Journal Mol Biol, 50 Hampshire St, Cambridge, MA 02139 USA.
RP Hodak, H (reprint author), Elsevier Inc, Journal Mol Biol, 50 Hampshire St, Cambridge, MA 02139 USA.
EM h.hodak@elsevier.com
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Bajaj S, 2016, J MOL BIOL, V428, P3540, DOI 10.1016/j.jmb.2016.06.006
   Banadyga L, 2016, J MOL BIOL, V428, P3449, DOI 10.1016/j.jmb.2016.05.008
   Bishop BM, 2015, ANN PHARMACOTHER, V49, P196, DOI 10.1177/1060028014561227
   Blevins SM, 2010, INT J INFECT DIS, V14, pE744, DOI 10.1016/j.ijid.2009.12.003
   Bouzidi MS, 2016, J MOL BIOL, V428, P3514, DOI 10.1016/j.jmb.2016.05.022
   Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0
   Brown CS, 2014, J MOL BIOL, V426, P2045, DOI 10.1016/j.jmb.2014.01.010
   Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chatterjee S, 2016, J MOL BIOL, V428, P3467, DOI 10.1016/j.jmb.2016.07.017
   Choby JE, 2016, J MOL BIOL, V428, P3408, DOI 10.1016/j.jmb.2016.03.018
   Connor MJ, 2015, J AM SOC NEPHROL, V26, P31, DOI 10.1681/ASN.2014111057
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Furniss RCD, 2016, J MOL BIOL, V428, P3399, DOI 10.1016/j.jmb.2016.05.023
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024
   Johnson B, 2016, J MOL BIOL, V428, P3483, DOI 10.1016/j.jmb.2016.07.020
   Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960
   Koch R., 1987, ESSAYS R KOCH, P83
   Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841
   Miller C, 2016, J MOL BIOL, V428, P3387, DOI 10.1016/j.jmb.2016.07.007
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Olagnier D., 2016, J MOL BIOL, V428, P3429
   Patrick KL, 2016, J MOL BIOL, V428, P3372, DOI 10.1016/j.jmb.2016.04.030
   Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   RAZUMOV A. S., 1932, MIKROBIOLOGIIA [MICROBIOLOGY], V1, P131
   Rivers TM, 1937, J BACTERIOL, V33, P1
   Tay WH, 2016, J MOL BIOL, V428, P3355, DOI 10.1016/j.jmb.2016.05.006
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Turner T, 2016, J MOL BIOL, V428, P3529, DOI 10.1016/j.jmb.2016.05.029
   Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   [Anonymous], 2016, B WHO
NR 39
TC 0
Z9 0
U1 1
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 28
PY 2016
VL 428
IS 17
SI SI
BP 3353
EP 3354
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DW0FD
UT WOS:000383315400001
PM 27484029
ER

PT J
AU Olagnier, D
   Amatore, D
   Castiello, L
   Ferrari, M
   Palermo, E
   Diamond, MS
   Palamara, AT
   Hiscott, J
AF Olagnier, David
   Amatore, Donatella
   Castiello, Luciano
   Ferrari, Matteo
   Palermo, Enrico
   Diamond, Michael S.
   Palamara, Anna Teresa
   Hiscott, John
TI Dengue Virus Immunopathogenesis: Lessons Applicable to the Emergence of
   Zika Virus
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Review
DE dengue; Zika; innate immunity; oxidative stress; pathogenesis
ID ANTIBODY-DEPENDENT ENHANCEMENT; NITRIC-OXIDE SYNTHASE; HUMAN DENDRITIC
   CELLS; NF-KAPPA-B; INTERFERON ANTIVIRAL RESPONSE; HEPATITIS-C VIRUS;
   OXIDATIVE STRESS; RIG-I; RNA VIRUSES; DC-SIGN
AB Dengue is the leading mosquito-transmitted viral infection in the world. There are more than 390 million new infections annually; while the majority of infected individuals are asymptomatic or develop a self-limited dengue fever, up to 1 million clinical cases develop severe manifestations, including dengue hemorrhagic fever and shock syndrome, resulting in similar to 25,000 deaths annually, mainly in children. Gaps in our understanding of the mechanisms that contribute to dengue infection and immunopathogenesis have hampered the development of vaccines and antiviral agents. Some of these limitations are highlighted by the explosive re-emergence of another arthropod-borne flavivirus Zika virus spread by the same vector, the Aedes aegypti mosquito, that also carries dengue, yellow fever and chikungunya viruses. This review will discuss the early virus-host interactions in dengue infection, with emphasis on the interrelationship between oxidative stress and innate immune pathways, and will provide insight as to how lessons learned from dengue research may expedite therapeutic strategies for Zika virus. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Olagnier, David] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3A 2T5, Canada.
   [Amatore, Donatella; Palamara, Anna Teresa] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.
   [Castiello, Luciano; Ferrari, Matteo; Palermo, Enrico; Palamara, Anna Teresa; Hiscott, John] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy.
   [Diamond, Michael S.] Washington Univ, Dept Med, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Dept Pathol, St Louis, MO 63130 USA.
   [Diamond, Michael S.] Washington Univ, Dept Immunol, St Louis, MO USA.
RP Hiscott, J (reprint author), Ist Pasteur Fdn Cenci Bolognetti, Lab Pasteur, Viale Regina Elena 291, I-00161 Rome, Italy.
EM john.hiscott@istitutopasteur.it
FU National Institutes of Health [AI108861]; Italian Association for Cancer
   Research; Pasteur GPF Vaccinologie program; PRIN MIUR; Burroughs
   Wellcome Fund; NIH [R01 AI073755]; Peter Quinlan McGill postdoctoral
   fellowship
FX This research was supported by grants from the National Institutes of
   Health (AI108861), the Italian Association for Cancer Research and the
   Pasteur GPF Vaccinologie program to J.H.; by grants from PRIN MIUR to
   A.T.P.; and grants from the Burroughs Wellcome Fund and NIH (R01
   AI073755) to M.S.D. David Olagnier was supported by a Peter Quinlan
   McGill postdoctoral fellowship. The authors would like to acknowledge
   all the contributions in the field that could not be included in the
   review. The figures of the review were illustrated by David Olagnier
   with the Servier Medical Art software
   http://www.servier.fr/smart/banque-dimages-powerpoint.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448
   Al-alimi AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002711
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6
   Amatore D, 2015, CELL MICROBIOL, V17, P131, DOI 10.1111/cmi.12343
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012
   Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001
   Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009
   Beljanski V, 2015, J VIROL, V89, P10612, DOI 10.1128/JVI.01526-15
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI [10.4049/jimmunol.1203052, 10.4049/j.immunol.1203052]
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brien JD, 2013, J VIROL, V87, P7747, DOI 10.1128/JVI.00327-13
   Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016
   Butthep P, 2006, PEDIATR INFECT DIS J, V25, P894, DOI 10.1097/01.inf.0000237918.85330.b9
   Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6
   Callaway JB, 2015, J BIOL CHEM, V290, P17306, DOI 10.1074/jbc.M115.664136
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Cardier JE, 2006, CYTOKINE, V34, P155, DOI 10.1016/j.cyto.2006.04.002
   Castro R, 2015, COLOMB MEDICA, V46, P135
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0
   Chiang C, 2015, J VIROL, V89, P8011, DOI 10.1128/JVI.00845-15
   Ciriolo MR, 1997, J BIOL CHEM, V272, P2700
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Driggers R.W., 2016, N ENGL J MED
   Droge W, 2002, EXP GERONTOL, V37, P1333, DOI 10.1016/S0531-5565(02)00175-4
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Engering A, 2002, J IMMUNOL, V168, P2118
   Escalera-Cueto M, 2015, VIRUS RES, V196, P105, DOI 10.1016/j.virusres.2014.11.010
   Fang YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110655
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x
   Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   GARACI E, 1992, BIOCHEM BIOPH RES CO, V188, P1090, DOI 10.1016/0006-291X(92)91343-O
   Garaci E, 1997, J LEUKOCYTE BIOL, V62, P54
   Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172
   Ghezzi P, 2013, BBA-GEN SUBJECTS, V1830, P3165, DOI 10.1016/j.bbagen.2013.02.009
   Gil L, 2004, AM J TROP MED HYG, V71, P652
   Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011
   Goulet ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003298
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680
   Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3<329::AID-JMV12>3.3.CO;2-7
   Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858
   Gutteridge J M, 1989, Baillieres Clin Haematol, V2, P195, DOI 10.1016/S0950-3536(89)80017-4
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002
   Ho LJ, 2005, J IMMUNOL, V174, P8163
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957
   Jaiyen Y, 2009, MICROBIOL IMMUNOL, V53, P442, DOI 10.1111/j.1348-0421.2009.00148.x
   Jan JT, 2000, J VIROL, V74, P8680, DOI 10.1128/JVI.74.18.8680-8691.2000
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Ke PY, 2012, VIRUSES-BASEL, V4, P2251, DOI 10.3390/v4102251
   Kelser E.A., 2015, MICROBES INFECT
   Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11
   Lazear HM, 2016, CELL HOST MICROBE
   Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Lin YL, 2000, VIROLOGY, V276, P114, DOI 10.1006/viro.2000.0524
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Loke H, 2002, AM J TROP MED HYG, V67, P102
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Ma Q, 2012, PHARMACOL REV, V64, P1055, DOI 10.1124/pr.110.004333
   Malkki Hemi, 2016, Nat Rev Neurol, V12, P187, DOI 10.1038/nrneurol.2016.30
   Marianneau P, 1999, J VIROL, V73, P5201
   Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   MCCORD JM, 1968, J BIOL CHEM, V243, P5753
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Mlakar J., 2016, N ENGL J MED
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178
   Mufson S., 1 8 BILLION FIGHT ZI
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508-fje
   Neves-Souza PCF, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-64
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   Nickel A, 2014, J MOL CELL CARDIOL, V73, P26, DOI 10.1016/j.yjmcc.2014.03.011
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6
   PALAMARA AT, 1995, ANTIVIR RES, V27, P237, DOI 10.1016/0166-3542(95)00008-A
   Palamara AT, 1996, AIDS RES HUM RETROV, V12, P1373, DOI 10.1089/aid.1996.12.1373
   Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
   Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Richards AL, 2013, J VIROL, V87, P9966, DOI 10.1128/JVI.00460-13
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11
   Rodrigo WWSI, 2009, VIROLOGY, V394, P175, DOI 10.1016/j.virol.2009.09.024
   Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10
   Rossi S.L., 2016, AM J TROP MED HYG
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Sariol CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019323
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035
   Sgarbanti R, 2011, ANTIOXID REDOX SIGN, V15, P593, DOI 10.1089/ars.2010.3512
   Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748
   Silva RLA, 2008, VIRUS RES, V135, P320, DOI 10.1016/j.virusres.2008.03.007
   Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soundravally R, 2008, PLATELETS, V19, P447, DOI 10.1080/09537100802155284
   Soundravally R, 2014, INT J INFECT DIS, V18, P68, DOI 10.1016/j.ijid.2013.09.022
   Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013
   Sun PF, 2013, SCI WORLD J, DOI 10.1155/2013/843469
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D., 2015, MED MICROBIOL IMMUNO
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Teets F.D., 2013, VIROL REP, V1-2, P2
   Tian YP, 2010, BIOCHEM BIOPH RES CO, V397, P420, DOI 10.1016/j.bbrc.2010.05.108
   Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vlahos R, 2012, TRENDS PHARMACOL SCI, V33, P3, DOI 10.1016/j.tips.2011.09.001
   Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271
   Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055407
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wu MF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-36
   Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zhou Y, 2006, J GEN VIROL, V87, P2595, DOI 10.1099/vir.0.81994-0
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
   Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13
NR 182
TC 2
Z9 2
U1 2
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 28
PY 2016
VL 428
IS 17
SI SI
BP 3429
EP 3448
DI 10.1016/j.jmb.2016.04.024
PG 20
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DW0FD
UT WOS:000383315400007
PM 27130436
ER

PT J
AU Heukelbach, J
   Werneck, GL
AF Heukelbach, Joerg
   Werneck, Guilherme Loureiro
TI Surveillance of Zika virus infection and microcephaly in Brazil
SO LANCET
LA English
DT Editorial Material
C1 [Heukelbach, Joerg] Univ Fed Ceara, Sch Med, Dept Community Hlth, BR-60430140 Fortaleza, CE, Brazil.
   [Heukelbach, Joerg] James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld, Australia.
   [Heukelbach, Joerg] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia.
   [Werneck, Guilherme Loureiro] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, RJ, Brazil.
RP Heukelbach, J (reprint author), Univ Fed Ceara, Sch Med, Dept Community Hlth, BR-60430140 Fortaleza, CE, Brazil.; Heukelbach, J (reprint author), James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld, Australia.; Heukelbach, J (reprint author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia.
EM heukelbach@web.de
CR Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GV, 2016, LANCET, V2016
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
NR 8
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 846
EP 847
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800006
PM 27372396
ER

PT J
AU Roberts, DJ
   Frosch, MP
AF Roberts, Drucilla J.
   Frosch, Matthew P.
TI Zika and histopathology in first trimester infections
SO LANCET
LA English
DT Editorial Material
ID CRANIOSYNOSTOSIS; INTERVILLOSITIS; PREGNANCY; PLACENTA; VIRUS
C1 [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
   [Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA.
   [Frosch, Matthew P.] Harvard Med Sch, Boston, MA 02115 USA.
RP Roberts, DJ (reprint author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
EM djroberts@mgh.harvard.edu
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Boyd TK, 2000, HUM PATHOL, V31, P1389, DOI 10.1016/S0046-8177(00)80009-X
   Cohen MM, 2006, BIRTH DEFECTS RES A, V76, P658, DOI 10.1002/bdra.20295
   Flaherty K, 2016, WIRES DEV BIOL, V5, P429, DOI 10.1002/wdev.227
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Hazin Adriano N, 2016, N Engl J Med, V374, P2193, DOI 10.1056/NEJMc1603617
   Hyde SR, 1997, MODERN PATHOL, V10, P602
   Martines RB, 2016, LANCET
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011
   Raam MS, 2010, AM J MED GENET C, V154C, P176, DOI 10.1002/ajmg.c.30234
   Ribeiro CF, 2012, INT J INFECT DIS, V16, pE72, DOI 10.1016/j.ijid.2011.09.005
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   US Centers for Disease Control and Prevention, 2016, CDC CONCL ZIK CAUS M
NR 15
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 847
EP 849
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800007
PM 27372399
ER

PT J
AU de Laval, F
   Matheus, S
   Maquart, M
   Yvrard, E
   Barthes, N
   Combes, C
   Rousset, D
   Leparc-Goffart, I
   Briolant, S
AF de laval, Franck
   Matheus, Severine
   Maquart, Marianne
   Yvrard, Emmanuel
   Barthes, Nicolas
   Combes, Cedric
   Rousset, Dominique
   Leparc-Goffart, Isabelle
   Briolant, Sebastien
TI Prospective Zika virus disease cohort: systematic screening
SO LANCET
LA English
DT Letter
ID MICRONESIA; EPIDEMIC; URINE
C1 [de laval, Franck] Mil Ctr Epidemiol & Publ Hlth, Marseille, France.
   [de laval, Franck; Barthes, Nicolas; Combes, Cedric; Briolant, Sebastien] French Armed Forces Hlth Serv French Guiana, BP 6019, Cayenne 97306, French Guiana.
   [Rousset, Dominique; Briolant, Sebastien] Natl Reference Ctr Arboviruses, Inst Pasteur French Guiana, Virol Lab, Cayenne, French Guiana.
   [Briolant, Sebastien] Unit Med Entomol, Cayenne, French Guiana.
   [Maquart, Marianne; Yvrard, Emmanuel; Leparc-Goffart, Isabelle] Natl Reference Ctr Arboviruses, French Armed Forces Biomed Res Inst, Marseille, France.
   [Briolant, Sebastien] Hop Instruct Armees Laveran, Unit Parasitol & Med Entomol, Marseille, France.
   [Briolant, Sebastien] Aix Marseille Univ, Fac Med La Timone, Res Unit Emerging Infect & Trop Dis, UM 63,CNRS 7278,IRD 198, Marseille, France.
   [Briolant, Sebastien] Aix Marseille Univ, Fac Med La Timone, INSERM 1095, Marseille, France.
RP Briolant, S (reprint author), French Armed Forces Hlth Serv French Guiana, BP 6019, Cayenne 97306, French Guiana.; Briolant, S (reprint author), Natl Reference Ctr Arboviruses, Inst Pasteur French Guiana, Virol Lab, Cayenne, French Guiana.; Briolant, S (reprint author), Unit Med Entomol, Cayenne, French Guiana.; Briolant, S (reprint author), Hop Instruct Armees Laveran, Unit Parasitol & Med Entomol, Marseille, France.; Briolant, S (reprint author), Aix Marseille Univ, Fac Med La Timone, Res Unit Emerging Infect & Trop Dis, UM 63,CNRS 7278,IRD 198, Marseille, France.; Briolant, S (reprint author), Aix Marseille Univ, Fac Med La Timone, INSERM 1095, Marseille, France.
EM sbriolant@wanadoo.fr
CR Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
NR 5
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 868
EP 868
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800021
PM 27597462
ER

PT J
AU Franca, GVA
   Schuler-Faccini, L
   Oliveira, WK
   Henriques, CMP
   Carmo, EH
   Pedi, VD
   Nunes, ML
   Castro, MC
   Serruya, S
   Silveira, MF
   Barros, FC
   Victora, CG
AF Franca, Giovanny V. A.
   Schuler-Faccini, Lavinia
   Oliveira, Wanderson K.
   Henriques, Claudio M. P.
   Carmo, Eduardo H.
   Pedi, Vaneide D.
   Nunes, Marilia L.
   Castro, Marcia C.
   Serruya, Suzanne
   Silveira, Mariangela F.
   Barros, Fernando C.
   Victora, Cesar G.
TI Congenital Zika virus syndrome in Brazil: a case series of the first
   1501 livebirths with complete investigation
SO LANCET
LA English
DT Article
ID INFECTION; OUTBREAK
AB Background In November, 2015, an epidemic of microcephaly was reported in Brazil, which was later attributed to congenital Zika virus infection. 7830 suspected cases had been reported to the Brazilian Ministry of Health by June 4, 2016, but little is known about their characteristics. We aimed to describe these newborn babies in terms of clinical findings, anthropometry, and survival.
   Methods We reviewed all 1501 liveborn infants for whom investigation by medical teams at State level had been completed as of Feb 27, 2016, and classified suspected cases into five categories based on neuroimaging and laboratory results for Zika virus and other relevant infections. Definite cases had laboratory evidence of Zika virus infection; highly probable cases presented specific neuroimaging findings, and negative laboratory results for other congenital infections; moderately probable cases had specific imaging findings but other infections could not be ruled out; somewhat probable cases had imaging findings, but these were not reported in detail by the local teams; all other newborn babies were classified as discarded cases. Head circumference by gestational age was assessed with InterGrowth standards. First week mortality and history of rash were provided by the State medical teams.
   Findings Between Nov 19, 2015, and Feb 27, 2015, investigations were completed for 1501 suspected cases reported to the Brazilian Ministry of Health, of whom 899 were discarded. Of the remainder 602 cases, 76 were definite, 54 highly probable, 181 moderately probable, and 291 somewhat probable of congenital Zika virus syndrome. Clinical, anthropometric, and survival differences were small among the four groups. Compared with these four groups, the 899 discarded cases had larger head circumferences (mean Z scores -1.54 vs -3.13, difference 1.58 [95% CI 1.45-1.72]); lower first-week mortality (14 per 1000 vs 51 per 1000; rate ratio 0.28 [95% CI 0.14-0.56]); and were less likely to have a history of rash during pregnancy (20.7% vs 61.4%, ratio 0.34 [95% CI 0.27-0.42]). Rashes in the third trimester of pregnancy were associated with brain abnormalities despite normal sized heads. One in five definite or probable cases presented head circumferences in the normal range (above -2 SD below the median of the InterGrowth standard) and for one third of definite and probable cases there was no history of a rash during pregnancy. The peak of the epidemic occurred in late November, 2015.
   Interpretation Zika virus congenital syndrome is a new teratogenic disease. Because many definite or probable cases present normal head circumference values and their mothers do not report having a rash, screening criteria must be revised in order to detect all affected newborn babies. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
C1 [Franca, Giovanny V. A.; Oliveira, Wanderson K.; Henriques, Claudio M. P.; Carmo, Eduardo H.; Pedi, Vaneide D.; Nunes, Marilia L.] Secretariat Hlth Surveillance Minist Hlth, Brasilia, DF, Brazil.
   [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Castro, Marcia C.] Harvard T H Chan Sch Publ Hlth, Boston, MA USA.
   [Serruya, Suzanne] Latin Amer Ctr Perinatol Women & Reprod Hlth, Montevideo, Uruguay.
   [Silveira, Mariangela F.; Barros, Fernando C.; Victora, Cesar G.] Univ Fed Pelotas, Programa Posgrad Epidemiol, BR-96020220 Pelotas, RS, Brazil.
   [Barros, Fernando C.] Univ Catolica Pelotas, Pelotas, RS, Brazil.
RP Victora, CG (reprint author), Univ Fed Pelotas, Programa Posgrad Epidemiol, BR-96020220 Pelotas, RS, Brazil.
EM cvictora@equidade.org
RI Oliveira, Wanderson/D-7140-2016
OI Oliveira, Wanderson/0000-0002-9662-1930
FU Wellcome Trust
FX CGV holds a Wellcome Trust Senior Investigator Award. We thank the
   Health Secretaries of the Brazilian states and municipalities; the state
   Central Laboratories Network National Reference Laboratories; the
   General Coordination of National Dengue Control Program (CGPNCD/MS); the
   General Coordination of Surveillance and Response (CGVR/MS); the General
   Coordination of Public Health Laboratories (CGLAB/MS); the General
   Coordination of Information and Epidemiological Analysis (CGIAE/MS); the
   Brazilian Society of Medical Genetics; the Latin American Center for
   Perinatology, Women and Reproductive Health (CLAP/WR-PAHO/WHO); and the
   Pan American Health Organization in Washington and the national office
   in Brazil. Pablo Duran and Andres de Francisco provided inputs in an
   earlier version of the manuscript; Jose Villar and Eric Ohuma provided
   advice on the calculations of head circumference Z scores; Dacio de Lyra
   Rabello Neto, Roberto Carlos Reyes Lecca, Marli Montenegro Silva, and
   Anthony Stevens carried out the linkage between the microcephaly
   surveillance system and the National Birth Registration System (SINASC);
   and Aluisio J D Barros provided statistical analysis advice. The views
   and opinions expressed herein are those of the authors and do not
   necessarily reflect those of the Brazilian Ministry of Health or of the
   Pan American Health Organization.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI 10.32032/eid2206.160062
   Brasil. Ministerio da Saude, 2016, REG EV SAUD PUBL RES
   Brasil Ministerio da Saude, 2016, INF EP 25
   [DATASUS Brasil. Ministerio da Saude], IND MORT TEX MORT NE
   [DATASUS Brasil. Ministerio da Saude], 2016, SIST NAC NASC VIV
   [Secretaria de Vigilancia em Saude Departamento de Vigilancia das Doencas Transmissiveis Brasil. Ministerio da Saude], 2016, PROT VIG RESP OC MIC
   Brasil. Ministerio da Saude, 2016, INF EP 15
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, CDC CONCL ZIK CAUS M
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin Adriano N, 2016, N Engl J Med, V374, P2193, DOI 10.1056/NEJMc1603617
   Matijasevich A, 2013, EPIDEMIOL SERV SAUDE, V22, P557
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Organizacion Panamericana de la Salud, 2016, GUIA VIG ENF VIR ZIK
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   [Anonymous], 2016, ZIK VIR MICR GUILL B
NR 26
TC 0
Z9 0
U1 19
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 891
EP 897
DI 10.1016/S0140-6736(16)30902-3
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800027
PM 27372398
ER

PT J
AU Martines, RB
   Bhatnagar, J
   Ramos, AMD
   Davi, HPF
   Iglezias, SD
   Kanamura, CT
   Keating, MK
   Hale, G
   Silva-Flannery, L
   Muehlenbachs, A
   Ritter, J
   Gary, J
   Rollin, D
   Goldsmith, CS
   Reagan-Steiner, S
   Ermias, Y
   Suzuki, T
   Luz, KG
   de Oliveira, WK
   Lanciotti, R
   Lambert, A
   Shieh, WJ
   Zaki, SR
AF Martines, Roosecelis Brasil
   Bhatnagar, Julu
   de Oliveira Ramos, Ana Maria
   Freire Davi, Helaine Pompeia
   Iglezias, Silvia D'Andretta
   Kanamura, Cristina Takami
   Keating, M. Kelly
   Hale, Gillian
   Silva-Flannery, Luciana
   Muehlenbachs, Atis
   Ritter, Jana
   Gary, Joy
   Rollin, Dominique
   Goldsmith, Cynthia S.
   Reagan-Steiner, Sarah
   Ermias, Yokabed
   Suzuki, Tadaki
   Luz, Kleber G.
   de Oliveira, Wanderson Kleber
   Lanciotti, Robert
   Lambert, Amy
   Shieh, Wun-Ju
   Zaki, Sherif R.
TI Pathology of congenital Zika syndrome in Brazil: a case series
SO LANCET
LA English
DT Article
ID VIRUS-INFECTION; ARTHROGRYPOSIS; PREGNANCY; ETIOLOGY; TISSUES; UPDATE;
   STATES; BRAIN; PCR
AB Background Zika virus is an arthropod-borne virus that is a member of the family Flaviviridae transmitted mainly by mosquitoes of the genus Aedes. Although usually asymptomatic, infection can result in a mild and self-limiting illness characterised by fever, rash, arthralgia, and conjunctivitis. An increase in the number of children born with microcephaly was noted in 2015 in regions of Brazil with high transmission of Zika virus. More recently, evidence has been accumulating supporting a link between Zika virus and microcephaly. Here, we describe findings from three fatal cases and two spontaneous abortions associated with Zika virus infection.
   Methods In this case series, formalin-fixed paraffin-embedded tissue samples from five cases, including two newborn babies with microcephaly and severe arthrogryposis who died shortly after birth, one 2-month-old baby, and two placentas from spontaneous abortions, from Brazil were submitted to the Infectious Diseases Pathology Branch at the US Centers for Disease Control and Prevention (Atlanta, GA, USA) between December, 2015, and March, 2016. Specimens were assessed by histopathological examination, immunohistochemical assays using a mouse anti-Zika virus antibody, and RT-PCR assays targeting the NS5 and envelope genes. Amplicons of RT-PCR positive cases were sequenced for characterisation of strains.
   Findings Viral antigens were localised to glial cells and neurons and associated with microcalcifications in all three fatal cases with microcephaly. Antigens were also seen in chorionic villi of one of the first trimester placentas. Tissues from all five cases were positive for Zika virus RNA by RT-PCR, and sequence analyses showed highest identities with Zika virus strains isolated from Brazil during 2015.
   Interpretation These findings provide strong evidence of a link between Zika virus infection and different congenital central nervous system malformations, including microcephaly as well as arthrogryposis and spontaneous abortions.
C1 [Martines, Roosecelis Brasil; Bhatnagar, Julu; Keating, M. Kelly; Hale, Gillian; Silva-Flannery, Luciana; Muehlenbachs, Atis; Ritter, Jana; Gary, Joy; Rollin, Dominique; Goldsmith, Cynthia S.; Ermias, Yokabed; Shieh, Wun-Ju; Zaki, Sherif R.] NCEZID, Div High Consequence Pathogens & Pathol, Infect Dis Pathol Branch, Atlanta, GA USA.
   [Reagan-Steiner, Sarah] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Immunizat Serv Div, Atlanta, GA USA.
   [de Oliveira Ramos, Ana Maria] Univ Fed Rio Grande do Norte, Dept Pathol, Natal, RN, Brazil.
   [de Oliveira Ramos, Ana Maria; Freire Davi, Helaine Pompeia] Serv Ascertaining Death State Rio Grande Norte SV, Natal, RN, Brazil.
   [Iglezias, Silvia D'Andretta; Kanamura, Cristina Takami] Adolfo Lutz Inst, Sao Paulo, Brazil.
   [Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan.
   [Luz, Kleber G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, Natal, RN, Brazil.
   [de Oliveira, Wanderson Kleber] Minist Hlth, Brasilia, DF, Brazil.
   [Lanciotti, Robert; Lambert, Amy] Ctr Dis Control & Prevent, NCEZID, Div Vector Borne Dis, Arboviral Dis Branch, Ft Collins, CO USA.
RP Zaki, SR (reprint author), Ctr Dis Control & Prevent, NCEZID, Div High Consequence Pathogens & Pathol, Infect Dis Pathol Branch, Atlanta, GA 30329 USA.
EM szaki@cdc.gov
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bhatnagar J, 2016, 32 CLIN VIR S
   Bhatnagar J, 2012, AM J TROP MED HYG, V86, P335, DOI 10.4269/ajtmh.2012.11-0346
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GV, 2016, LANCET, V2016
   FRASER SH, 1994, J PAEDIATR CHILD H, V30, P450, DOI 10.1111/j.1440-1754.1994.tb00701.x
   Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hall JG, 2014, EUR J MED GENET, V57, P464, DOI 10.1016/j.ejmg.2014.03.008
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kowalczyk B, 2016, ARCH MED SCI, V12, P10, DOI 10.5114/aoms.2016.57578
   Lazar M, 2016, EBIOMEDICINE, V3, P86, DOI 10.1016/j.ebiom.2015.11.050
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 29
TC 0
Z9 0
U1 25
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 27
PY 2016
VL 388
IS 10047
BP 898
EP 904
DI 10.1016/S0140-6736(16)30883-2
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU0RI
UT WOS:000381911800028
PM 27372395
ER

PT J
AU Russell, K
   Oliver, SE
   Lewis, L
   Barfield, WD
   Cragan, J
   Meaney-Delman, D
   Staples, JE
   Fischer, M
   Peacock, G
   Oduyebo, T
   Petersen, EE
   Zaki, S
   Moore, CA
   Rasmussen, SA
AF Russell, Kate
   Oliver, Sara E.
   Lewis, Lillianne
   Barfield, Wanda D.
   Cragan, Janet
   Meaney-Delman, Dana
   Staples, J. Erin
   Fischer, Marc
   Peacock, Georgina
   Oduyebo, Titilope
   Petersen, Emily E.
   Zaki, Sherif
   Moore, Cynthia A.
   Rasmussen, Sonja A.
TI Update: Interim Guidance for the Evaluation and Management of Infants
   with Possible Congenital Zika Virus Infection - United States, August
   2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID CYTOMEGALOVIRUS-INFECTION; TRANSMISSION; CHILDREN; RUBELLA; BRAZIL;
   LABOR
C1 [Russell, Kate; Oliver, Sara E.; Lewis, Lillianne] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Oliver, Sara E.] CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Lewis, Lillianne] CDC, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.
   [Barfield, Wanda D.; Oduyebo, Titilope; Petersen, Emily E.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Cragan, Janet; Moore, Cynthia A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Staples, J. Erin; Fischer, Marc] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Peacock, Georgina] CDC, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Zaki, Sherif] CDC, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Rasmussen, Sonja A.] CDC, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
RP Russell, K; Oliver, SE (reprint author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Russell, K (reprint author), CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.; Oliver, SE (reprint author), CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
EM kerussell@cdc.gov; seoliver@cdc.gov
CR American Academy of Pediatrics, 2016, HLTH CHILDR
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Birkebaek NH, 2003, J CLIN ENDOCR METAB, V88, P5281, DOI 10.1210/jc.2003-030527
   Cannon MJ, 2011, REV MED VIROL, V21, P240, DOI 10.1002/rmv.695
   Committee on Practice and Ambulatory Medicine and Bright Futures Periodicity Schedule Workgroup, 2016, PEDIATRICS, V137, P1
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Franca GV, 2016, LANCET, V2016
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin Adriano N, 2016, N Engl J Med, V374, P2193, DOI 10.1056/NEJMc1603617
   Kuo DZ, 2012, MATERN CHILD HLTH J, V16, P297, DOI 10.1007/s10995-011-0751-7
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Marcin JP, 2016, PEDIATR RES, V79, P169, DOI 10.1038/pr.2015.192
   Masuzaki H, 2004, CLIN CHEM, V50, P1709, DOI 10.1373/chnchem.2004.036517
   Miranda Homero Augusto de 2nd, 2016, Ophthalmology, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Oduyebo Titilope, 2016, MMWR Morb Mortal Wkly Rep, V65, P739, DOI 10.15585/mmwr.mm6529e1
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RAWLS WE, 1967, ARCH OPHTHALMOL-CHIC, V77, P430
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SEVER JL, 1985, REV INFECT DIS, V7, pS164
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 30
TC 1
Z9 1
U1 1
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD AUG 26
PY 2016
VL 65
IS 33
BP 870
EP 878
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DU3TO
UT WOS:000382135300007
PM 27559830
ER

PT J
AU Larocca, RA
   Abbink, P
   Peron, JPS
   Zanotto, PMD
   Iampietro, MJ
   Badamchi-Zadeh, A
   Boyd, M
   Ng'ang'a, D
   Kirilova, M
   Nityanandam, R
   Mercado, NB
   Li, ZF
   Moseley, ET
   Bricault, CA
   Borducchi, EN
   Giglio, PB
   Jetton, D
   Neubauer, G
   Nkolola, JP
   Maxfield, LF
   De La Barrera, RA
   Jarman, RG
   Eckels, KH
   Michael, NL
   Thomas, SJ
   Barouch, DH
AF Larocca, Rafael A.
   Abbink, Peter
   Peron, Jean Pierre S.
   Zanotto, Paolo M. de A.
   Iampietro, M. Justin
   Badamchi-Zadeh, Alexander
   Boyd, Michael
   Ng'ang'a, David
   Kirilova, Marinela
   Nityanandam, Ramya
   Mercado, Noe B.
   Li, Zhenfeng
   Moseley, Edward T.
   Bricault, Christine A.
   Borducchi, Erica N.
   Giglio, Patricia B.
   Jetton, David
   Neubauer, George
   Nkolola, Joseph P.
   Maxfield, Lori F.
   De La Barrera, Rafael A.
   Jarman, Richard G.
   Eckels, Kenneth H.
   Michael, Nelson L.
   Thomas, Stephen J.
   Barouch, Dan H.
TI Vaccine protection against Zika virus from Brazil
SO NATURE
LA English
DT Article
ID PHASE-1 CLINICAL-TRIAL; HEALTHY-ADULTS; NEUTRALIZING ANTIBODY; JAPANESE
   ENCEPHALITIS; CHALLENGE; MICE; IMMUNOGENICITY; ORGANOIDS; INFECTION;
   AMERICA
AB Zika virus (ZIKV) is a flavivirus that is responsible for the current epidemic in Brazil and the Americas(1,2). ZIKV has been causally associated with fetal microcephaly, intrauterine growth restriction, and other birth defects in both humans(3-8) and mice(9-11). The rapid development of a safe and effective ZIKV vaccine is a global health priority(1,2), but very little is currently known about ZIKV immunology and mechanisms of immune protection. Here we show that a single immunization with a plasmid DNA vaccine or a purified inactivated virus vaccine provides complete protection in susceptible mice against challenge with a strain of ZIKV involved in the outbreak in northeast Brazil. This ZIKV strain has recently been shown to cross the placenta and to induce fetal microcephaly and other congenital malformations in mice(11). We produced DNA vaccines expressing ZIKV pre-membrane and envelope (prM-Env), as well as a series of deletion mutants. The prM-Env DNA vaccine, but not the deletion mutants, afforded complete protection against ZIKV, as measured by absence of detectable viraemia following challenge, and protective efficacy correlated with Env-specific antibody titers. Adoptive transfer of purified IgG from vaccinated mice conferred passive protection, and depletion of CD4 and CD8 T lymphocytes in vaccinated mice did not abrogate this protection. These data demonstrate that protection against ZIKV challenge can be achieved by single-shot subunit and inactivated virus vaccines in mice and that Env-specific antibody titers represent key immunologic correlates of protection. Our findings suggest that the development of a ZIKV vaccine for humans is likely to be achievable.
C1 [Larocca, Rafael A.; Abbink, Peter; Iampietro, M. Justin; Badamchi-Zadeh, Alexander; Boyd, Michael; Ng'ang'a, David; Kirilova, Marinela; Nityanandam, Ramya; Mercado, Noe B.; Li, Zhenfeng; Moseley, Edward T.; Bricault, Christine A.; Borducchi, Erica N.; Giglio, Patricia B.; Jetton, David; Neubauer, George; Nkolola, Joseph P.; Maxfield, Lori F.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Peron, Jean Pierre S.; Zanotto, Paolo M. de A.] Univ Sao Paulo, BR-05508000 Sao Paulo, Brazil.
   [De La Barrera, Rafael A.; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Barouch, DH (reprint author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (reprint author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
FU Ragon Institute of MGH, MIT, and Harvard; National Institutes of Health
   [AI095985, AI096040, AI100663, AI124377]; Sao Paulo Research Foundation
   [FAPESP 2011/18703-2, 2014/17766-9]
FX We thank P. Vasconcelos, K. Modjarrad, R. Olson, K. Kabra, C. Kannadka,
   C. Springer, G. Ballarini, G. Alter, K. Stephenson, F. Stephens, B. Lee,
   J. Jimenez, A. Chandrashekar, P. Penaloza and C. Cabral for generous
   advice, assistance and reagents. We acknowledge support from the Ragon
   Institute of MGH, MIT, and Harvard, the National Institutes of Health
   (AI095985, AI096040, AI100663, AI124377), and the Sao Paulo Research
   Foundation (FAPESP 2011/18703-2, 2014/17766-9). The views expressed in
   this manuscript are those of the authors and do not represent the
   official views of the Department of the Army or the Department of
   Defense.
CR Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Demicheli V., 2000, COCHRANE DB SYST REV
   Demicheli V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000977.pub2
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2005.07.002
   Johansson MA, 2016, NEW ENGL J MED, V375
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819
   MASON RA, 1973, APPL MICROBIOL, V25, P539
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tartaglia LJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005431
   Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361
NR 30
TC 3
Z9 3
U1 7
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD AUG 25
PY 2016
VL 536
IS 7617
BP 474
EP +
DI 10.1038/nature18952
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV0YL
UT WOS:000382646600045
PM 27355570
ER

PT J
AU Yockey, LJ
   Varela, L
   Rakib, T
   Khoury-Hanold, W
   Fink, SL
   Stutz, B
   Szigeti-Buck, K
   Van den Pol, A
   Lindenbach, BD
   Horvath, TL
   Iwasaki, A
AF Yockey, Laura J.
   Varela, Luis
   Rakib, Tasfia
   Khoury-Hanold, William
   Fink, Susan L.
   Stutz, Bernardo
   Szigeti-Buck, Klara
   Van den Pol, Anthony
   Lindenbach, Brett D.
   Horvath, Tamas L.
   Iwasaki, Akiko
TI Vaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain
   Infection
SO CELL
LA English
DT Article
ID TOLL-LIKE RECEPTORS; INNATE IMMUNITY; SEXUAL TRANSMISSION;
   UNITED-STATES; MOUSE MODEL; RIG-I; CELLS; RECOGNITION; ENCEPHALITIS;
   REPLICATION
AB Zika virus (ZIKV) can be transmitted sexually between humans. However, it is unknown whether ZIKV replicates in the vagina and impacts the unborn fetus. Here, we establish a mouse model of vaginal ZIKV infection and demonstrate that, unlike other routes, ZIKV replicates within the genital mucosa even in wild-type (WT) mice. Mice lacking RNA sensors or transcription factors IRF3 and IRF7 resulted in higher levels of local viral replication. Furthermore, mice lacking the type I interferon (IFN) receptor (IFNAR) became viremic and died of infection after a high-dose vaginal ZIKV challenge. Notably, vaginal infection of pregnant dams during early pregnancy led to fetal growth restriction and infection of the fetal brain in WT mice. This was exacerbated in mice deficient in IFN pathways, leading to abortion. Our study highlights the vaginal tract as a highly susceptible site of ZIKV replication and illustrates the dire disease consequences during pregnancy.
C1 [Yockey, Laura J.; Rakib, Tasfia; Khoury-Hanold, William; Fink, Susan L.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.
   [Varela, Luis; Stutz, Bernardo; Szigeti-Buck, Klara; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA.
   [Fink, Susan L.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA.
   [Van den Pol, Anthony] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.
   [Lindenbach, Brett D.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.
   [Iwasaki, Akiko] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.
RP Iwasaki, A (reprint author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Iwasaki, A (reprint author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.
EM akiko.iwasaki@yale.edu
FU Howard Hughes Medical Institute; National Institutes of Health (NIH)
   [R01 AI054359]; NIH Medical Scientist Training Program Training Grant
   [T32 GM007205];  [K08 AI119142]
FX We thank Huiping Dong for technical support and the members of the Erol
   Fikrig laboratory for helpful discussions. We thank Dr. Marie Flamand at
   the Institut Pasteur in Paris for providing us the antibody to NS1. This
   work was supported by the Howard Hughes Medical Institute, and National
   Institutes of Health (NIH) grants R01 AI054359 (A.I.). L.J.Y. is
   supported by NIH Medical Scientist Training Program Training Grant T32
   GM007205. S.L.F. is supported by K08 AI119142.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bruni D, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1552
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CROOKS AJ, 1994, J GEN VIROL, V75, P3453, DOI 10.1099/0022-1317-75-12-3453
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Flamand M, 1999, J VIROL, V73, P6104
   Foxman EF, 2015, P NATL ACAD SCI USA, V112, P827, DOI 10.1073/pnas.1411030112
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009
   JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1
   Ko MSH, 2001, TRENDS BIOTECHNOL, V19, P511, DOI 10.1016/S0167-7799(01)01806-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036
   PARR MB, 1994, LAB INVEST, V70, P369
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Pillai PS, 2016, SCIENCE, V352, P463, DOI 10.1126/science.aaf3926
   Prisant N., 2016, LANCET INFECT DIS
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x
   Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012
   Venturi G, 2016, EURO SURVEILL, V21
   Wang JP, 2006, J IMMUNOL, V177, P7114
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Welte T, 2009, J GEN VIROL, V90, P2660, DOI 10.1099/vir.0.011783-0
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 53
TC 0
Z9 0
U1 22
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD AUG 25
PY 2016
VL 166
IS 5
BP 1247
EP +
DI 10.1016/j.cell.2016.08.004
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DU5NW
UT WOS:000382259500020
PM 27565347
ER

PT J
AU Valadao, ALC
   Aguiar, RS
   de Arruda, LB
AF Valadao, Ana L. C.
   Aguiar, Renato S.
   de Arruda, Luciana B.
TI Interplay between Inflammation and Cellular Stress Triggered by
   Flaviviridae Viruses
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE flavivirus; innate immune response; ER stress; reactive oxygen species;
   stress granules
ID HEPATITIS-C VIRUS; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN
   RESPONSE; NF-KAPPA-B; TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA;
   PATTERN-RECOGNITION RECEPTORS; IRF3 TRANSCRIPTION FACTOR; INNATE
   IMMUNE-RESPONSES; BETA GENE-EXPRESSION
AB The Flaviviridae family comprises several human pathogens, including Dengue, Zika, Yellow Fever, West Nile, Japanese Encephalitis viruses, and Hepatitis C Virus. Those are enveloped, single-stranded positive sense RNA viruses, which replicate mostly in intracellular compartments associated to endoplasmic reticulum (ER) and Golgi complex. Virus replication results in abundant viral RNAs and proteins, which are recognized by cellular mechanisms evolved to prevent virus infection, resulting in inflammation and stress responses. Virus RNA molecules are sensed by Toll-like receptors (TLRs), RIG-I-like receptors (RIG-I and MDA5) and RNA-dependent protein kinases (PKR), inducing the production of inflammatory mediators and interferons. Simultaneously, the synthesis of virus RNA and proteins are distinguished in different compartments such as mitochondria, ER and cytoplasmic granules, triggering intracellular stress pathways, including oxidative stress, unfolded protein response pathway, and stress granules assembly. Here, we review the new findings that connect the inflammatory pathways to cellular stress sensors and the strategies of Flaviviridae members to counteract these cellular mechanisms and escape immune response.
C1 [Valadao, Ana L. C.; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [de Arruda, Luciana B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.
RP de Arruda, LB (reprint author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.
EM arruda@micro.ufrj.br
FU CAPES; CAPES/PVE-Program; CNPq; FAPERJ
FX This work was supported by CAPES, CAPES/PVE-Program, CNPq, and FAPERJ.
   AV is the recipient of a FAPERJ fellowship.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082
   Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694
   Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10
   Asdonk T, 2012, BIOCHEM BIOPH RES CO, V420, P66, DOI 10.1016/j.bbrc.2012.02.116
   Asehnoune K, 2004, J IMMUNOL, V172, P2522
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888
   Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005
   Banerjee S, 2014, MBIO, V5, DOI 10.1128/mBio.00856-14
   Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613
   Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004
   Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673
   Bergqvist A, 2003, J BIOL CHEM, V278, P18877, DOI 10.1074/jbc.M300185200
   Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   Boo KH, 2010, YONSEI MED J, V51, P9, DOI 10.3349/ymj.2010.51.1.9
   Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020
   Chakrabarti A, 2012, J VIROL, V86, P11311, DOI 10.1128/JVI.00270-12
   Chan YK, 2015, CURR OPIN VIROL, V12, P7, DOI 10.1016/j.coviro.2015.01.004
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082
   Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50
   Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084953
   Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001
   da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI [10.1016/j.virol.2012.09.038, 10.1016/j.viro1.2012.09.038]
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Daito T, 2014, GASTROENTEROLOGY, V147, P463, DOI 10.1053/j.gastro.2014.04.035
   Dang SS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-424
   Decembre E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004434
   Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004
   Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948
   Eksioglu EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021186
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pna.0703348104
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Finnen RL, 2012, J VIROL, V86, P8119, DOI 10.1128/JVI.00313-12
   Fulda S., 2010, INT J CELL BIOL, V2010, DOI DOI 10.1155/2010/214074
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004
   Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11
   Garcia-Mediavilla MV, 2005, J HEPATOL, V43, P606, DOI 10.1016/j.jhep.2005.04.019
   Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010
   Gil L, 2004, AM J TROP MED HYG, V71, P652
   Gilfoy FD, 2007, J VIROL, V81, P11148, DOI 10.1128/JVI.00446-07
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harijith A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00352
   He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833
   He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108
   Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758
   Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Iglesias NG, 2009, VIRAL GENOME REPLICATION, P41, DOI 10.1007/b135974_3
   Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086
   Ishikawa H, 2008, NATURE, V456, P274, DOI 10.1038/nature07432
   Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957
   Ivanov AV, 2015, VIRUSES-BASEL, V7, P2745, DOI 10.3390/v7062745
   Ivanov AV, 2013, VIRUSES-BASEL, V5, P439, DOI 10.3390/v5020439
   Jain B, 2014, MICROB PATHOGENESIS, V69-70, P45, DOI 10.1016/j.micpath.2014.03.004
   Jiang X, 2013, IMMUNOL LETT, V152, P8, DOI 10.1016/j.imlet.2013.03.006
   Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461
   Ke PY, 2012, VIRUSES-BASEL, V4, P2251, DOI 10.3390/v4102251
   Kedersha N, 2005, J CELL BIOL, V169, P871
   Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   Kim HJ, 2015, AM J RESP CELL MOL, V53, P525, DOI 10.1165/rcmb.2014-0334OC
   Kim S. K., 2013, PUBLIC MANAG REV, P1
   Klassen P, 2004, NUTRITION, V20, P542, DOI 10.1016/j.nut.2004.03.016
   Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010
   Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   Labbe K, 2011, PROG INFLAMM RES SER, P17, DOI 10.1007/978-3-0348-0148-5_2
   Langereis MA, 2013, J VIROL, V87, P6314, DOI 10.1128/JVI.03213-12
   Lavut A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002527
   Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007
   Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200
   Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Li YP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0051701, 10.1371/journal.pone.0071180]
   Liao SL, 2002, NEUROSCI LETT, V324, P133, DOI 10.1016/S0304-3940(02)00236-7
   Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121
   Lin YL, 2000, VIROLOGY, V276, P114, DOI 10.1006/viro.2000.0524
   Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690
   Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008
   Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Lucas K, 2013, MOL NEUROBIOL, V48, P190, DOI 10.1007/s12035-013-8425-7
   Lupfer C, 2015, CURR OPIN VIROL, V12, P38, DOI 10.1016/j.coviro.2015.02.007
   Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108
   Malathi K, 2010, RNA, V16, P2108, DOI 10.1261/rna.2244210
   Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782
   Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132
   Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x
   Ming-Ju Hsieh, 2011, J Cell Biochem, V112, P233, DOI 10.1002/jcb.22926
   Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007
   Montero H, 2011, VIRUSES-BASEL, V3, P2328, DOI 10.3390/v3112328
   Motani K, 2011, J BIOL CHEM, V286, P33963, DOI 10.1074/jbc.M111.286823
   Mottola G, 2002, VIROLOGY, V293, P31, DOI 10.1006/viro.2001.1229
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nazmi A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00347
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761
   Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330
   O'Leary DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044176
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031
   Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006
   Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200
   Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008
   Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027
   Pahl HL, 1997, TRENDS CELL BIOL, V7, P50, DOI 10.1016/S0962-8924(96)10050-7
   Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x
   Paracha UZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-251
   Park HS, 2004, J IMMUNOL, V173, P3589
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Pene Veronique, 2015, J Virol, V89, P5462, DOI 10.1128/JVI.03197-14
   Perera-Lecoin M, 2013, VIRUSES, V6, P69
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415
   Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09
   Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824
   Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256
   Qin CF, 2011, MOL BIOL REP, V38, P3867, DOI 10.1007/s11033-010-0502-7
   Rahman MM, 2011, J VIROL, V85, P12505, DOI 10.1128/JVI.00410-11
   Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017
   RESHI ML, 2014, INT J CELL BIOL, V2014, DOI DOI 10.1155/2014/467452
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Ruggieri A, 2012, CELL HOST MICROBE, V12, P71, DOI 10.1016/j.chom.2012.05.013
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0
   SANTOLINI E, 1994, J VIROL, V68, P3631
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Savic S, 2014, J AUTOIMMUN, V50, P59, DOI 10.1016/j.jaut.2013.11.002
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515
   SCHRECK R, 1991, EMBO J, V10, P2247
   Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035
   Sen D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00260
   Seronello S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027436
   Shen JS, 2005, MOL CELL BIOL, V25, P921, DOI 10.1128/MCB.25.3.921-932.2005
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Smith JA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00222
   Sou SN, 2012, BIOCHEM BIOPH RES CO, V420, P473, DOI 10.1016/j.bbrc.2012.03.030
   Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930
   Soundravally R, 2008, ACTA TROP, V106, P156, DOI 10.1016/j.actatropica.2008.03.001
   Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054
   Sumpter Rhea Jr, 2005, Journal of Virology, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005
   Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022
   Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106
   Szretter KJ, 2010, J VIROL, V84, P12125, DOI 10.1128/JVI.01026-10
   Takahashi K, 2006, J IMMUNOL, V176, P4520
   Takemura N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4492
   Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078
   Tardif KD, 2002, J VIROL, V76, P7453, DOI 10.1128/JVI.76.15.7453-7459.2002
   Thepparit Chutima, 2013, BMC Res Notes, V6, P372, DOI 10.1186/1756-0500-6-372
   Thoren F, 2004, J LEUKOCYTE BIOL, V76, P1180, DOI 10.1189/jlb.0704387
   Tsai WC, 2014, ANN REV VIROL, V1, P147, DOI 10.1146/annurev-virology-031413-085505
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Valiente-Echeverria F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5819
   Valiente-Echeverria F, 2012, VIRUS RES, V169, P430, DOI 10.1016/j.virusres.2012.06.004
   Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009
   Vasallo C, 2015, VIRUS RES, V209, P100, DOI 10.1016/j.virusres.2015.03.013
   von Bernuth H, 2012, EUR J IMMUNOL, V42, P3126, DOI 10.1002/eji.201242683
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x
   White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001
   Williams KL, 2009, ANN NY ACAD SCI, V1171, pE12, DOI 10.1111/j.1749-6632.2009.05057.x
   Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090
   Wu SY, 1997, J BIOL CHEM, V272, P1291
   Xu Z, 1998, J INTERF CYTOK RES, V18, P609, DOI 10.1089/jir.1998.18.609
   Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1
   Yang DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027552
   Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012
   Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200
   Yu CY, 2010, J VIROL, V84, P2421, DOI 10.1128/JVI.02174-09
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052
   Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203
   Zhang LR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00293
   Zhang PF, 2014, J CELL SCI, V127, P2471, DOI 10.1242/jcs.139626
   Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003
   Zhou H, 2013, EMBO J, V32, P583, DOI 10.1038/emboj.2013.2
   Zhou RB, 2011, NATURE, V475, DOI 10.1038/nature10156
   Zhu B, 2015, J IMMUNOL, V195, P2251, DOI 10.4049/jimmunol.1500370
   Zou J, 2013, IMMUNITY, V38, P717, DOI 10.1016/j.immuni.2012.12.007
NR 209
TC 0
Z9 0
U1 8
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 25
PY 2016
VL 7
AR 1233
DI 10.3389/fmicb.2016.01233
PG 19
WC Microbiology
SC Microbiology
GA DT9VS
UT WOS:000381851000001
PM 27610098
ER

PT J
AU Chan, JFW
   Yip, CCY
   Tsang, JOL
   Tee, KM
   Cai, JP
   Chik, KKH
   Zhu, Z
   Chan, CCS
   Choi, GKY
   Sridhar, S
   Zhang, AJ
   Lu, G
   Chiu, K
   Lo, ACY
   Tsao, SW
   Kok, KH
   Jin, DY
   Chan, KH
   Yuen, KY
AF Chan, Jasper Fuk-Woo
   Yip, Cyril Chik-Yan
   Tsang, Jessica Oi-Ling
   Tee, Kah-Meng
   Cai, Jian-Piao
   Chik, Kenn Ka-Heng
   Zhu, Zheng
   Chan, Chris Chung-Sing
   Choi, Garnet Kwan-Yue
   Sridhar, Siddharth
   Zhang, Anna Jinxia
   Lu, Gang
   Chiu, Kin
   Lo, Amy Cheuk-Yin
   Tsao, Sai-Wah
   Kok, Kin-Hang
   Jin, Dong-Yan
   Chan, Kwok-Hung
   Yuen, Kwok-Yung
TI Differential cell line susceptibility to the emerging Zika virus:
   implications for disease pathogenesis, non-vector-borne human
   transmission and animal reservoirs
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE animal; cell line; flavivirus; placenta; transmission; tropism; virus;
   Zika
ID INFECTION; EPIDEMIC; DENGUE; URINE; MICRONESIA; ORGANOIDS; EMERGENCE;
   MODELS; BRAZIL; FEVER
AB Zika virus (ZIKV) is unique among human-pathogenic flaviviruses by its association with congenital anomalies and trans-placental and sexual human-to-human transmission. Although the pathogenesis of ZIKV-associated neurological complications has been reported in recent studies, key questions on the pathogenesis of the other clinical manifestations, non-vector-borne transmission and potential animal reservoirs of ZIKV remain unanswered. We systematically characterized the differential cell line susceptibility of 18 human and 15 nonhuman cell lines to two ZIKV isolates (human and primate) and dengue virus type 2 (DENV-2). Productive ZIKV replication (>= 2 log increase in viral load, ZIKV nonstructural protein-1 (NS1) protein expression and cytopathic effects (CPE)) was found in the placental (JEG-3), neuronal (SF268), muscle (RD), retinal (ARPE19), pulmonary (Hep-2 and HFL), colonic (Caco-2), and hepatic (Huh-7) cell lines. These findings helped to explain the trans-placental transmission and other clinical manifestations of ZIKV. Notably, the prostatic (LNCaP), testicular (833KE) and renal (HEK) cell lines showed increased ZIKV load and/or NS1 protein expression without inducing CPE, suggesting their potential roles in sexual transmission with persistent viral replication at these anatomical sites. Comparatively, none of the placental and genital tract cell lines allowed efficient DENV-2 replication. Among the nonhuman cell lines, nonhuman primate (Vero and LLC-MK2), pig (PK-15), rabbit (RK-13), hamster (BHK21) and chicken (DF-1) cell lines supported productive ZIKV replication. These animal species may be important reservoirs and/or potential animal models for ZIKV. The findings in our study help to explain the viral shedding pattern, transmission and pathogenesis of the rapidly disseminating ZIKV, and are useful for optimizing laboratory diagnostics and studies on the pathogenesis and counter-measures of ZIKV.
C1 [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yip, Cyril Chik-Yan; Tsang, Jessica Oi-Ling; Tee, Kah-Meng; Cai, Jian-Piao; Chik, Kenn Ka-Heng; Zhu, Zheng; Chan, Chris Chung-Sing; Choi, Garnet Kwan-Yue; Sridhar, Siddharth; Zhang, Anna Jinxia; Kok, Kin-Hang; Chan, Kwok-Hung; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Kok, Kin-Hang; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.
   [Lu, Gang] Hainan Med Univ, Dept Pathogen Biol, Haikou 571101, Hainan, Peoples R China.
   [Chiu, Kin; Lo, Amy Cheuk-Yin] Univ Hong Kong, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China.
   [Chiu, Kin; Lo, Amy Cheuk-Yin] Univ Hong Kong, Resarch Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.
   [Chiu, Kin] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.
   [Tsao, Sai-Wah; Jin, Dong-Yan] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Hong Kong, Peoples R China.
RP Chan, JFW; Yuen, KY (reprint author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW; Yuen, KY (reprint author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW; Yuen, KY (reprint author), Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.; Chan, JFW; Yuen, KY (reprint author), Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.; Yuen, KY (reprint author), Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; kyyuen@hku.hk
FU Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Diseases of the Department of Health, Hong Kong Special
   Administrative Region; Seed Funding Programme for Basic Research, the
   University Research Committee, The University of Hong Kong;
   Collaborative Innovation Center for Diagnosis and Treatment of
   Infectious Diseases, the Ministry of Education of China; European Union
   [653316]
FX We thank Tony Schountz (Colorado State University, Fort Collins, CO,
   USA), Kwok-Fai So (The University of Hong Kong, Hong Kong Special
   Administrative Region, China), Stephen Yuen-Wing Shiu (The University of
   Hong Kong, Hong Kong Special Administrative Region, China) and Annie
   Nga-Yin Cheung (The University of Hong Kong, Hong Kong Special
   Administrative Region, China) for facilitation of the study. This work
   was partly supported by the donations of Larry Chi-Kin Yung, and Hui Hoy
   and Chow Sin Lan Charity Fund Limited; and funding from the Consultancy
   Service for Enhancing Laboratory Surveillance of Emerging Infectious
   Diseases of the Department of Health, Hong Kong Special Administrative
   Region; the Seed Funding Programme for Basic Research, the University
   Research Committee, The University of Hong Kong; the Collaborative
   Innovation Center for Diagnosis and Treatment of Infectious Diseases,
   the Ministry of Education of China; and the European Virus Archive goes
   Global (EVAg) project that has received funding from the European
   Union's Horizon 2020 research and innovation programme under grant
   agreement NO 653316.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bean AGD, 2013, NAT REV IMMUNOL, V13, P851, DOI 10.1038/nri3551
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2013, J INFECT DIS, V207, P1743, DOI 10.1093/infdis/jit123
   Chan JFW, 2015, CURR OPIN VIROL, V10, P63, DOI 10.1016/j.coviro.2015.01.006
   Chan JFW, 2015, J CLIN MICROBIOL, V53, P2722, DOI 10.1128/JCM.01224-15
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Poloni Telma Regina, 2016, J Med Virol, V88, P1711, DOI 10.1002/jmv.24533
   Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS S, VS1473-3099, P30006
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, 2016, EM ZIK SIT REP WHO
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yip CCY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-222
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 54
TC 0
Z9 0
U1 9
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD AUG 24
PY 2016
VL 5
AR e93
DI 10.1038/emi.2016.99
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DW1KK
UT WOS:000383401900001
PM 27553173
ER

PT J
AU Acharya, D
   Bastola, P
   Le, LD
   Paul, AM
   Fernandez, E
   Diamond, MS
   Miao, WJ
   Bai, FW
AF Acharya, Dhiraj
   Bastola, Pradip
   Le, Linda
   Paul, Amber M.
   Fernandez, Estefania
   Diamond, Michael S.
   Miao, Wujian
   Bai, Fengwei
TI An ultrasensitive electrogenerated chemiluminescence-based immunoassay
   for specific detection of Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ELECTROCHEMILUMINESCENCE DETECTION; SENSITIVE DETERMINATION;
   CAPILLARY-ELECTROPHORESIS; HIGH AMPLIFICATION; BLOOD-TRANSFUSION; GLOBAL
   RISK; HUMAN SERUM; INFECTION; DENGUE; MICROSPHERES
AB Zika virus (ZIKV) is a globally emerging mosquito-transmitted flavivirus that can cause severe fetal abnormalities, including microcephaly. As such, highly sensitive, specific, and cost-effective diagnostic methods are urgently needed. Here, we report a novel electrogenerated chemiluminescence (ECL)-based immunoassay for ultrasensitive and specific detection of ZIKV in human biological fluids. We loaded polystyrene beads (PSB) with a large number of ECL labels and conjugated them with anti-ZIKV monoclonal antibodies to generate anti-ZIKV-PSBs. These anti-ZIKV-PSBs efficiently captured ZIKV in solution forming ZIKV-anti-ZIKV-PSB complexes, which were subjected to measurement of ECL intensity after further magnetic beads separation. Our results show that the anti-ZIKV-PSBs can capture as little as 1 PFU of ZIKV in 100 mu l of saline, human plasma, or human urine. This platform has the potential for development as a cost-effective, rapid and ultrasensitive assay for the detection of ZIKV and possibly other viruses in clinical diagnosis, epidemiologic and vector surveillance, and laboratory research.
C1 [Acharya, Dhiraj; Le, Linda; Paul, Amber M.; Bai, Fengwei] Univ Southern Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.
   [Bastola, Pradip; Miao, Wujian] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.
   [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
RP Bai, FW (reprint author), Univ Southern Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.; Miao, WJ (reprint author), Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.
EM wujian.miao@usm.edu; fengwei.bai@usm.edu
FU National Science Foundation CAREER award [CHE-0955878]; National
   Institute of Allergy and Infectious Diseases of the National Institutes
   of Health [R15AI113706, R01 AI073755]
FX We thank Dr. Barbara W. Johnson (CDC Arbovirus Branch, Fort Collins CO)
   for providing ZIKV, Dr. Robert B. Tesh (University of Texas Medical
   Branch) for providing CHIKV, and Dr. John F. Anderson at the Connecticut
   Agricultural Experiment Station for providing WNV and dengue viruses. We
   thank Dr. Jennifer Givero and Derek Platt for technical help with
   generating antibodies. We also thank Mississippi-IDeA Network of
   Biomedical Research Excellence (MS-INBRE) for the use of research
   facility. This work was supported in part by financial support from the
   National Science Foundation CAREER award (CHE-0955878, W.M.) and
   National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (R15AI113706 to F.B. and R01 AI073755 to M.S.D.).
CR Acharya D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004139
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002
   de MCR, 2016, J CLIN VIROL, V77, P69
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Doeven EH, 2014, ANAL CHEM, V86, P2727, DOI 10.1021/ac404135f
   D'Ortenzio E., 2016, NEW ENGL J MED, DOI [10.1056/nejmc1604449, DOI 10.1056/NEJMC1604449, 10.1056/NEJMc1604449]
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hao N, 2016, ANAL BIOANAL CHEM, V408, P7035, DOI 10.1007/s00216-016-9548-2
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kilianski Andy, 2016, Emerg Infect Dis, V22, P1448, DOI 10.3201/eid2208.160270
   Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li J., 2016, EMERG INFECT DIS, V22, P22, DOI DOI 10.3201/EID2206.160273
   Li Y, 2008, ELECTROCHEM COMMUN, V10, P1322, DOI 10.1016/j.elecom.2008.06.027
   Liu X, 2008, ANAL CHEM, V80, P5377, DOI 10.1021/ac8003715
   Liu YM, 2008, J SEP SCI, V31, P2463, DOI 10.1002/jssc.200800034
   Liu YM, 2008, ELECTROPHORESIS, V29, P3207, DOI 10.1002/elps.200800048
   Ma F, 2012, BIOSENS BIOELECTRON, V32, P37, DOI 10.1016/j.bios.2011.11.011
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I1914
   Miao W., 2004, ELECTROGENERATED CHE, P213
   Miao WJ, 2004, ANAL CHEM, V76, P5379, DOI 10.1021/ac0495236
   Miao WJ, 2004, ANAL CHEM, V76, P7109, DOI 10.1021/ac048782s
   Miao WJ, 2008, CHEM REV, V108, P2506, DOI 10.1021/cr068083a
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Parajuli S, 2009, ANAL CHEM, V81, P5267, DOI 10.1021/ac900489a
   Parajuli S, 2013, ANAL CHEM, V85, P8008, DOI 10.1021/ac401962b
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Paty MC, 2013, TRANSFUS CLIN BIOL, V20, P165, DOI 10.1016/j.tracli.2013.03.008
   Paul AM, 2014, J GEN VIROL, V95, P1712, DOI 10.1099/vir.0.066084-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pittman TL, 2009, ANAL CHIM ACTA, V632, P197, DOI 10.1016/j.aca.2008.11.032
   Rabenau HF, 2007, J CLIN VIROL, V40, P93, DOI 10.1016/j.jcv.2007.07.009
   Rivera VR, 2006, ANAL BIOCHEM, V353, P248, DOI 10.1016/j.ab.2006.02.030
   Rougeron V, 2015, J CLIN VIROL, V64, P144, DOI 10.1016/j.jcv.2014.08.032
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Sun B, 2010, ANAL CHEM, V82, P5046, DOI 10.1021/ac9029289
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Toedter G, 2008, CLIN VACCINE IMMUNOL, V15, P42, DOI 10.1128/CVI.00211-07
   Wang SJ, 2010, PHYS CHEM CHEM PHYS, V12, P10073, DOI 10.1039/c0cp00545b
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Xu SJ, 2010, ANAL CHEM, V82, P9566, DOI 10.1021/ac102296g
NR 59
TC 0
Z9 0
U1 25
U2 25
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 24
PY 2016
VL 6
AR 32227
DI 10.1038/srep32227
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT9WC
UT WOS:000381852000001
PM 27554037
ER

PT J
AU Alvarado-Socarras, JL
   Sepulveda-Arias, JC
   Zambrano, LI
   Rodriguez-Morales, AJ
AF Alvarado-Socarras, Jorge L.
   Sepulveda-Arias, Juan C.
   Zambrano, Lysien I.
   Rodriguez-Morales, Alfonso J.
TI Relevance of laboratory diagnosis of Zika during pregnancy and its
   possible association with Guillain-Barre syndrome
SO MEDICINA CLINICA
LA English
DT Letter
ID POLYMORPHISMS; VIRUS
C1 [Alvarado-Socarras, Jorge L.; Sepulveda-Arias, Juan C.; Zambrano, Lysien I.; Rodriguez-Morales, Alfonso J.] Red Colombiana Colaborac Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Alvarado-Socarras, Jorge L.; Rodriguez-Morales, Alfonso J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Alvarado-Socarras, Jorge L.] Fdn Cardiovasc Colombia, Dept Pediat, Unidad Neonatol, Floridablanca, Santander, Colombia.
   [Sepulveda-Arias, Juan C.; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Infecc & Inmunidad, Pereira, Risaralda, Colombia.
   [Zambrano, Lysien I.] Univ Nacl Autonoma Honduras, Fac Ciencias Med, Tegucigalpa, Honduras.
   [Zambrano, Lysien I.] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med EPM, Sao Paulo, Brazil.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Salud Publ & Infecc, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (reprint author), Red Colombiana Colaborac Zika RECOLZIKA, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (reprint author), OLFIS, Bucaramanga, Santander, Colombia.; Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Infecc & Inmunidad, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Fac Ciencias Salud, Grp Invest Salud Publ & Infecc, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Fekih-Mrissa N, 2014, CLIN NEUROL NEUROSUR, V121, P19, DOI 10.1016/j.clineuro.2014.03.014
   Reyna-Villasmil E, 2016, MED CLIN-BARCELONA, V146, P331, DOI 10.1016/j.medcli.2016.02.002
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Wu LY, 2012, J NEUROIMMUNOL, V243, P18, DOI 10.1016/j.jneuroim.2011.12.003
   Zafar Mir Sadaqat Hassan, 2013, J Family Med Prim Care, V2, P90, DOI 10.4103/2249-4863.109965
NR 6
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER DOYMA SL
PI BARCELONA
PA TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN
SN 0025-7753
EI 1578-8989
J9 MED CLIN-BARCELONA
JI Med. Clin.
PD AUG 19
PY 2016
VL 147
IS 4
BP 182
EP 183
DI 10.1016/j.medcli.2016.03.044
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU9CA
UT WOS:000382512600011
PM 27236614
ER

PT J
AU Speer, SD
   Pierson, TC
AF Speer, Scott D.
   Pierson, Theodore C.
TI Diagnostics for Zika virus on the horizon
SO SCIENCE
LA English
DT Editorial Material
ID WEST-NILE-VIRUS; INFECTION; ANTIBODY
C1 [Speer, Scott D.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Bethesda, MD 20892 USA.
RP Pierson, TC (reprint author), NIAID, Viral Pathogenesis Sect, Bethesda, MD 20892 USA.
EM piersontc@niaid.nih.gov
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd K. A., 2016, CELL REP, DOI [10.1016/j.celrep.2016.07.049, DOI 10.1016/J.CELREP.2016.07.049]
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Lessler J, 2016, SCIENCE, V353, P663, DOI 10.1126/science.aaf8160
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Watterson D., 2016, ANTIVIRAL RES, V130
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 15
TC 0
Z9 0
U1 22
U2 22
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 19
PY 2016
VL 353
IS 6301
BP 750
EP 751
DI 10.1126/science.aah6187
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5ZE
UT WOS:000381561400020
PM 27540152
ER

PT J
AU Stettler, K
   Beltramello, M
   Espinosa, DA
   Graham, V
   Cassotta, A
   Bianchi, S
   Vanzetta, F
   Minola, A
   Jaconi, S
   Mele, F
   Foglierini, M
   Pedotti, M
   Simonelli, L
   Dowall, S
   Atkinson, B
   Percivalle, E
   Simmons, CP
   Varani, L
   Blum, J
   Baldanti, F
   Cameroni, E
   Hewson, R
   Harris, E
   Lanzavecchia, A
   Sallusto, F
   Corti, D
AF Stettler, Karin
   Beltramello, Martina
   Espinosa, Diego A.
   Graham, Victoria
   Cassotta, Antonino
   Bianchi, Siro
   Vanzetta, Fabrizia
   Minola, Andrea
   Jaconi, Stefano
   Mele, Federico
   Foglierini, Mathilde
   Pedotti, Mattia
   Simonelli, Luca
   Dowall, Stuart
   Atkinson, Barry
   Percivalle, Elena
   Simmons, Cameron P.
   Varani, Luca
   Blum, Johannes
   Baldanti, Fausto
   Cameroni, Elisabetta
   Hewson, Roger
   Harris, Eva
   Lanzavecchia, Antonio
   Sallusto, Federica
   Corti, Davide
TI Specificity, cross-reactivity, and function of antibodies elicited by
   Zika virus infection
SO SCIENCE
LA English
DT Article
ID DENGUE VIRUS; MONOCLONAL-ANTIBODIES; ENVELOPE GLYCOPROTEIN;
   DETERMINANTS; PATHOGENESIS; ENHANCEMENT; EPITOPES; RECEPTOR; BINDING;
   FEVER
AB Zika virus (ZIKV), a mosquito-borne flavivirus with homology to Dengue virus (DENV), has become a public health emergency. By characterizing memory lymphocytes from ZIKV-infected patients, we dissected ZIKV-specific and DENV-cross-reactive immune responses. Antibodies to nonstructural protein 1 (NS1) were largely ZIKV-specific and were used to develop a serological diagnostic tool. In contrast, antibodies against E protein domain I/II (EDI/II) were cross-reactive and, although poorly neutralizing, potently enhanced ZIKV and DENV infection in vitro and lethally enhanced DENV disease in mice. Memory T cells against NS1 or E proteins were poorly cross-reactive, even in donors preexposed to DENV. The most potent neutralizing antibodies were ZIKV-specific and targeted EDIII or quaternary epitopes on infectious virus. An EDIII-specific antibody protected mice from lethal ZIKV infection, illustrating the potential for antibody-based therapy.
C1 [Stettler, Karin; Beltramello, Martina; Bianchi, Siro; Vanzetta, Fabrizia; Minola, Andrea; Jaconi, Stefano; Cameroni, Elisabetta; Corti, Davide] Humabs BioMed SA, Via Mirasole 1, CH-6500 Bellinzona, Switzerland.
   [Espinosa, Diego A.; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA USA.
   [Graham, Victoria; Dowall, Stuart; Atkinson, Barry] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
   [Cassotta, Antonino; Foglierini, Mathilde; Pedotti, Mattia; Simonelli, Luca; Varani, Luca; Lanzavecchia, Antonio; Sallusto, Federica] Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.
   [Cassotta, Antonino; Lanzavecchia, Antonio] ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
   [Percivalle, Elena; Baldanti, Fausto] Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy.
   [Simmons, Cameron P.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX1 2JD, England.
   [Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Ctr Trop Med, Ho Chi Minh City, Vietnam.
   [Simmons, Cameron P.] Univ Melbourne, Peter Doherty Inst, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3000, Australia.
   [Blum, Johannes] Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4002 Basel, Switzerland.
   [Blum, Johannes] Univ Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
RP Corti, D (reprint author), Humabs BioMed SA, Via Mirasole 1, CH-6500 Bellinzona, Switzerland.; Sallusto, F (reprint author), Univ Svizzera Italiana, Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.
EM federica.sallusto@irb.usi.ch; davide.corti@humabs.ch
FU European Union [HEALTH-F3-2011-281803]; European Research Council
   [323183 PREDICT]; Swiss National Science Foundation [160279]; U.S.
   National Institutes of Health [R01 AI24493]; Ministero della Salute,
   Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente [8020615];
   Helmut Horten Foundation; SNF [310030_166445]; Lions Club Monteceneri
FX The data presented in this manuscript are tabulated in the main paper
   and in the supplementary materials. The views expressed are those of the
   authors and not necessarily those of the funding bodies. This work was
   supported by grants from the European Union
   (HEALTH-F3-2011-281803-Project IDAMS, "International Research Consortium
   on Dengue Risk Assessment, Management, and Surveillance" to F.S.), the
   European Research Council (grant 323183 PREDICT to F.S.), the Swiss
   National Science Foundation (grant 160279 to A.L.), the U.S. National
   Institutes of Health (grant R01 AI24493 to E.H.), and the Ministero
   della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente
   grant 8020615 (to E.P. and F.B.). A.L. is supported by the Helmut Horten
   Foundation. A.L. is the scientific founder of Humabs BioMed. D.C., A.L.,
   and F.S. hold shares in Humabs BioMed. F.S. and F.B. are a scientific
   advisor and a consultant at Humabs BioMed, respectively. The MAbs
   described in this study are available under a materials transfer
   agreement with Humabs BioMed SA. L.V. is grateful for financial support
   by SNF grant 310030_166445 and Lions Club Monteceneri. A.L. is an
   inventor on a patent related to DENV mAbs described in this study:
   PCT/IB2009/007372 (Dengue virus neutralizing antibodies and uses
   thereof). D.C. is an inventor on a patent application held by Humabs
   BioMed SA related to ZIKV mAbs described in this study:
   PCT/EP2016/066684 (Novel antibodies specifically binding to Zika virus
   epitopes and uses thereof). Antibody nucleotide and amino acid sequences
   for the 68 mAbs described in table S2 have been deposited in GenBank
   (accession nos. KX496807 to KX496874).
CR Aliota M. T., 2016, PLOS NEGLECT TROP D, V10
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowall S. D., 2016, PLOS NEGLECT TROP D, V10
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Halstead S. B., 2014, MICROBIOL SPECTR, V2, P249
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Johansson Michael A, 2016, N Engl J Med, V375, P1, DOI 10.1056/NEJMp1605367
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   MONATH TP, 1984, AM J TROP MED HYG, V33, P695
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen Thanh Hung, 2004, Journal of Infectious Diseases, V189, P221
   Ohana B., 2000, CLIN DIAGN LAB IMMUN, V7, P904
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI200421512
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teoh E. P., 2012, SCI TRANSL MED, V4
   Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453
NR 38
TC 4
Z9 4
U1 23
U2 23
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 19
PY 2016
VL 353
IS 6301
BP 823
EP 826
DI 10.1126/science.aaf8505
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5ZE
UT WOS:000381561400046
PM 27417494
ER

PT J
AU Paz-Soldan, VA
   Yukich, J
   Soonthorndhada, A
   Giron, M
   Apperson, CS
   Ponnusamy, L
   Schal, C
   Morrison, AC
   Keating, J
   Wesson, DM
AF Paz-Soldan, Valerie A.
   Yukich, Josh
   Soonthorndhada, Amara
   Giron, Maziel
   Apperson, Charles S.
   Ponnusamy, Loganathan
   Schal, Coby
   Morrison, Amy C.
   Keating, Joseph
   Wesson, Dawn M.
TI Design and Testing of Novel Lethal Ovitrap to Reduce Populations of
   Aedes Mosquitoes: Community-Based Participatory Research between
   Industry, Academia and Communities in Peru and Thailand
SO PLOS ONE
LA English
DT Article
ID TREATED-BED NETS; AEGYPTI DIPTERA; CONTROL STRATEGIES; MALARIA CONTROL;
   PUERTO-RICO; ZIKA VIRUS; CHIKUNGUNYA; CULICIDAE; DENGUE; PREFERENCES
AB Background
   Dengue virus (and Chikungunya and Zika viruses) is transmitted by Aedes aegypti and Aedes albopictus mosquitoes and causes considerable human morbidity and mortality. As there is currently no vaccine or chemoprophylaxis to protect people from dengue virus infection, vector control is the only viable option for disease prevention. The purpose of this paper is to illustrate the design and placement process for an attractive lethal ovitrap to reduce vector populations and to describe lessons learned in the development of the trap.
   Methods
   This study was conducted in 2010 in Iquitos, Peru and Lopburi Province, Thailand and used an iterative community-based participatory approach to adjust design specifications of the trap, based on community members' perceptions and feedback, entomological findings in the lab, and design and research team observations. Multiple focus group discussions (FGD) were held over a 6 month period, stratified by age, sex and motherhood status, to inform the design process. Trap testing transitioned from the lab to within households.
   Results
   Through an iterative process of working with specifications from the research team, findings from the laboratory testing, and feedback from FGD, the design team narrowed trap design options from 22 to 6. Comments from the FGD centered on safety for children and pets interacting with traps, durability, maintenance issues, and aesthetics. Testing in the laboratory involved releasing groups of 50 gravid Ae. aegypti in walk-in rooms and assessing what percentage were caught in traps of different colors, with different trap cover sizes, and placed under lighter or darker locations. Two final trap models were mocked up and tested in homes for a week; one model was the top choice in both Iquitos and Lopburi.
   Discussion
   The community-based participatory process was essential for the development of novel traps that provided effective vector control, but also met the needs and concerns of community members.
C1 [Paz-Soldan, Valerie A.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, 1440 Canal St, New Orleans, LA 70112 USA.
   [Paz-Soldan, Valerie A.] Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm, Ave Honorio Delgado 430, Lima, Peru.
   [Paz-Soldan, Valerie A.; Yukich, Josh; Keating, Joseph] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Appl Malaria Res & Evaluat, 1440 Canal St, New Orleans, LA 70112 USA.
   [Yukich, Josh; Keating, Joseph; Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, 1440 Canal St, New Orleans, LA 70112 USA.
   [Soonthorndhada, Amara] Mahidol Univ, Inst Populat & Social Res, Phuthamontol 73170, Nakornpathom, Thailand.
   [Giron, Maziel] San Jose State Univ, Dept Hlth Sci & Recreat, 1 Washington Sq, San Jose, CA 95192 USA.
   [Apperson, Charles S.; Ponnusamy, Loganathan; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.
   [Morrison, Amy C.] Univ Calif Davis, Dept Entomol & Nematol, One Shields Ave, Davis, CA 95616 USA.
   [Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, Vector Borne Infect Dis Res Ctr, 1440 Canal St, New Orleans, LA 70112 USA.
RP Paz-Soldan, VA (reprint author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, 1440 Canal St, New Orleans, LA 70112 USA.; Paz-Soldan, VA (reprint author), Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm, Ave Honorio Delgado 430, Lima, Peru.; Paz-Soldan, VA (reprint author), Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Appl Malaria Res & Evaluat, 1440 Canal St, New Orleans, LA 70112 USA.
EM vpazsold@tulane.edu
FU Bill and Melinda Gates Foundation [50025]; National Institute of Allergy
   and Infectious Diseases (NIAID) [5 U01 AI 58303-05]; National Institutes
   of Health Fogarty International Center [K01TW008414-01A1]
FX This study was made possible by the generous support of Bill and Melinda
   Gates Foundation Grant #50025 (PI: DMW), the National Institute of
   Allergy and Infectious Diseases (NIAID) Grant # 5 U01 AI 58303-05, and
   the National Institutes of Health Fogarty International Center Grant
   K01TW008414-01A1 (to VPS). The contents are the responsibility of the
   authors and do not necessarily reflect the views of either institution.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   AIKINS MK, 1994, J TROP MED HYG, V97, P81
   ALLAN SA, 1994, J AM MOSQUITO CONTR, V10, P266
   ALONSO PL, 1993, T ROY SOC TROP MED H, V87, P37, DOI 10.1016/0035-9203(93)90174-O
   Apperson C, 2007, AM J TROP MED HYG, V77, P254
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Bernard HR, 2006, RES METHODS ANTHR QU
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CHOI HW, 1995, AM J TROP MED HYG, V52, P377
   D'Alessandro U, 2001, BRIT MED J, V322, P249, DOI 10.1136/bmj.322.7281.249
   Das ML, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000100
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601
   Forshey BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004398
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gyapong M, 1996, TROP MED INT HEALTH, V1, P328, DOI 10.1046/j.1365-3156.1996.d01-41.x
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Instituto Nacional de Estadistica e Informatica Peru, 2009, EST PROYECC POBL TOT
   Lengeler C, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000363.pub2, DOI 10.1002/14651858.CD000363.PUB2]
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Lover AA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-199
   MACCORMACK CP, 1986, J TROP MED HYG, V89, P295
   Maketa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084314
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   National Statistical Office, 2010, 2010 POP HOUS CENS
   Ndeffo-Mbah ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep23997
   Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105
   Ponnusamy L, 2010, MICROB ECOL, V59, P158, DOI 10.1007/s00248-009-9565-1
   Ponnusamy L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1068-y
   Ponnusamy L, 2010, J CHEM ECOL, V36, P709, DOI 10.1007/s10886-010-9806-2
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wesson DM, 2013, AM J TROP MED HYG  S, V89
   World Health Organization, 2008, WKLY EPIDEMIOL REC, V83, P450
   Wiseman V, 2007, AM J TROP MED HYG, V76, P830
NR 41
TC 0
Z9 0
U1 6
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 17
PY 2016
VL 11
IS 8
AR e0160386
DI 10.1371/journal.pone.0160386
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT4YN
UT WOS:000381487600028
ER

PT J
AU Robert, MA
   Christofferson, RC
   Silva, NJB
   Vasquez, C
   Mores, CN
   Wearing, HJ
AF Robert, Michael A.
   Christofferson, Rebecca C.
   Silva, Noah J. B.
   Vasquez, Chalmers
   Mores, Christopher N.
   Wearing, Helen J.
TI Modeling Mosquito-Borne Disease Spread in US Urbanized Areas: The Case
   of Dengue in Miami
SO PLOS ONE
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; HUMAN MOVEMENT; HABITAT SEGREGATION; CHIKUNGUNYA
   VIRUS; ACQUIRED DENGUE; PERUVIAN AMAZON; SOUTH FLORIDA; AIR-TRAVEL;
   KEY-WEST; ALBOPICTUS
AB Expansion of mosquito-borne pathogens into more temperate regions of the world necessitates tools such as mathematical models for understanding the factors that contribute to the introduction and emergence of a disease in populations naive to the disease. Often, these models are not developed and analyzed until after a pathogen is detected in a population. In this study, we develop a spatially explicit stochastic model parameterized with publicly available U.S. Census data for studying the potential for disease spread in Urbanized Areas of the United States. To illustrate the utility of the model, we specifically study the potential for introductions of dengue to lead to autochthonous transmission and outbreaks in a population representative of the Miami Urbanized Area, where introductions of dengue have occurred frequently in recent years. We describe seasonal fluctuations in mosquito populations by fitting a population model to trap data provided by the Miami-Dade Mosquito Control Division. We show that the timing and location of introduced cases could play an important role in determining both the probability that local transmission occurs as well as the total number of cases throughout the entire region following introduction. We show that at low rates of clinical presentation, small outbreaks of dengue could go completely undetected during a season, which may confound mitigation efforts that rely upon detection. We discuss the sensitivity of the model to several critical parameter values that are currently poorly characterized and motivate the collection of additional data to strengthen the predictive power of this and similar models. Finally, we emphasize the utility of the general structure of this model in studying mosquito-borne diseases such as chikungunya and Zika virus in other regions.
C1 [Robert, Michael A.; Silva, Noah J. B.; Wearing, Helen J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.
   [Robert, Michael A.; Wearing, Helen J.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA.
   [Christofferson, Rebecca C.; Mores, Christopher N.] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
   [Vasquez, Chalmers] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
RP Robert, MA (reprint author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.; Robert, MA (reprint author), Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA.
EM marobert@unm.edu
FU National Institutes of Health/NIGMS program for Models of Infectious
   Disease Agent Study (MIDAS) [U01GM097661]
FX This project was supported by the National Institutes of Health/NIGMS
   program for Models of Infectious Disease Agent Study (MIDAS) grant
   U01GM097661. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR ABBEY HELEN, 1952, HUMAN BIOL, V24, P201
   Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   Anderson R. M., 1991, INFECT DIS HUMANS
   Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9
   Becker B, 2014, INT J ENV RES PUB HE, V11, P3256, DOI 10.3390/ijerph110303256
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   The Bureau of Transportation Statistics, 2015, STATE TRANSPORTATION
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15
   Christofferson RC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-282
   De Jong Mart C. M., 1995, P84
   Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250
   Drake JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002056
   Erlander S, 1990, GRAVITY MODEL TRANSP
   Feldstein LR, 2015, T ROY SOC TROP MED H, P1
   Florida Department of Health, 2015, WEEKL SURV INF MOSQ
   Fouque F, 2006, J VECTOR ECOL, V31, P390, DOI 10.3376/1081-1710(2006)31[390:AASADT]2.0.CO;2
   Guagliardo SA, 2015, J MED ENTOMOL, V52, P726, DOI 10.1093/jme/tjv048
   Guagliardo SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003648
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Gubler DJ, 2011, ASIA PAC J MOL BIOL, V19, P111
   Gubler DJ, 2009, REV SCI TECH OIE, V28, P583
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209
   Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2006.10.013
   Hennessey M, 2015, MMWR-MORBID MORTAL W, P65
   Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101
   Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022151
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   MACDONALD G, 1952, Trop Dis Bull, V49, P813
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665
   Miami-Dade Aviation Department, 2013, 2013 ANN REP MIAM IN
   Muir LE, 1998, AM J TROP MED HYG, V58, P277
   Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI [10.3201/eid2008.140333, 10.3201/eid2008.130333]
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Read JM, 2003, P ROY SOC B-BIOL SCI, V270, P699, DOI 10.1098/rspb.2002.2305
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Ross R, 1911, NATURE, V87, P466, DOI 10.1038/087466a0
   Ross R., 1910, PREVENTION MALARIA
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, pe1918, DOI DOI 10.1371/
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Suk JE, 2014, EUR J PUBLIC HEALTH, V24, P531, DOI 10.1093/eurpub/cku041
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263
   U. S. Census Bureau, 2010, 2010 CENS POP HOUS T
   U. S. Census Bureau, 2010, TIG LIN SHAP TIG LIN
   U. S. Centers for Disease Control and Prevention, 2014, CHIK VIR US 2014
   U. S. Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   U. S. Department of Transportation Bureau of Transportation Statistics, 2012, CRUIS SHIP STAT
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802
   Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   World Health Organization, 2015, DENG SEV DENG FACT S
   Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341
NR 78
TC 0
Z9 0
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 17
PY 2016
VL 11
IS 8
AR e0161365
DI 10.1371/journal.pone.0161365
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT4YN
UT WOS:000381487600088
ER

PT J
AU Lewnard, JA
   Gonsalves, G
   Ko, AI
AF Lewnard, Joseph A.
   Gonsalves, Gregg
   Ko, Albert I.
TI Low Risk of International Zika Virus Spread due to the 2016 Olympics in
   Brazil
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID RIO-DE-JANEIRO; GAMES
C1 Global Hlth Justice Partnership, Yale Sch Publ Hlth, New Haven, CT USA.
   Yale Univ, Yale Law Sch, New Haven, CT USA.
   Minist Saude, Salvador, BA, Brazil.
   [Lewnard, Joseph A.; Ko, Albert I.] Yale Sch Publ Hlth, 60 Coll St,Suite 710, New Haven, CT 06520 USA.
   [Gonsalves, Gregg] Yale Global Hlth Justice Partnership, POB 208215, New Haven, CT 06520 USA.
RP Lewnard, JA (reprint author), Yale Sch Publ Hlth, 60 Coll St,Suite 710, New Haven, CT 06520 USA.
EM joseph.lewnard@yale.edu
CR Attaran A, COMMUNICATION
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Eberhardt KA, 2016, TRAVEL MED INFECT DI, V14, P212, DOI 10.1016/j.tmaid.2016.05.014
   Lessler J, 2016, B WORLD HEALTH ORGAN, P1
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Secretaria Nacional de Politicas de Turismo, 2015, AN EST TUR 2015
   Secretaria de Vigilancia em Saude-Ministerio da Saude, 2015, B EPIDEMIOL, V46, P1
   Secretaria de Vigilancia em Saude-Ministerio da Saude, PROT VIG RESP OC MIC
NR 9
TC 2
Z9 2
U1 7
U2 7
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD AUG 16
PY 2016
VL 165
IS 4
BP 286
EP +
DI 10.7326/M16-1628
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1UI
UT WOS:000381267200019
PM 27454521
ER

PT J
AU Zhang, Y
   Zhao, B
   Roy, S
   Saha, TT
   Kokoza, VA
   Li, M
   Raikhel, AS
AF Zhang, Yang
   Zhao, Bo
   Roy, Sourav
   Saha, Tusar T.
   Kokoza, Vladimir A.
   Li, Ming
   Raikhel, Alexander S.
TI microRNA-309 targets the Homeobox gene SIX4 and controls ovarian
   development in the mosquito Aedes aegypti
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Homeobox protein gene; microRNA; CRISPR/Cas9; ovary; fast evolution
ID FAT-BODY; INSECT OOCYTES; WOLBACHIA USES; ZIKA VIRUS; DROSOPHILA;
   VECTOR; DRIVE; TRANSMISSION; REPRODUCTION; CRISPR-CAS9
AB Obligatory blood-triggered reproductive strategy is an evolutionary adaptation of mosquitoes for rapid egg development. It contributes to the vectorial capacity of these insects. Therefore, understanding the molecular mechanisms underlying reproductive processes is of particular importance. Here, we report that microRNA-309 (miR-309) plays a critical role in mosquito reproduction. A spatiotemporal expression profile of miR-309 displayed its blood feeding-dependent onset and ovary-specific manifestation in female Aedes aegypti mosquitoes. Antagomir silencing of miR-309 impaired ovarian development and resulted in nonsynchronized follicle growth. Furthermore, the genetic disruption of miR-309 by CRISPR/Cas9 system led to the developmental failure of primary follicle formation. Examination of genomic responses to miR-309 depletion revealed that several pathways associated with ovarian development are down-regulated. Comparative analysis of genes obtained from the high-throughput RNA sequencing of ovarian tissue from the miR-309 antagomirsilenced mosquitoes with those from the in silico computation target prediction identified that the gene-encoding SIX homeobox 4 protein (SIX4) is a putative target of miR-309. Reporter assay and RNA immunoprecipitation confirmed that SIX4 is a direct target of miR-309. RNA interference of SIX4 was able to rescue phenotypic manifestations caused by miR-309 depletion. Thus, miR-309 plays a critical role in mosquito reproduction by targeting SIX4 in the ovary and serves as a regulatory switch permitting a stage-specific degradation of the ovarian SIX4 mRNA. In turn, this microRNA (miRNA)targeted degradation is required for appropriate initiation of a blood feeding-triggered phase of ovarian development, highlighting involvement of this miRNA in mosquito reproduction.
C1 [Zhang, Yang; Zhao, Bo; Roy, Sourav; Saha, Tusar T.; Kokoza, Vladimir A.; Li, Ming; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Zhang, Yang] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China.
   [Zhao, Bo; Roy, Sourav; Saha, Tusar T.; Kokoza, Vladimir A.; Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA.
RP Raikhel, AS (reprint author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Raikhel, AS (reprint author), Univ Calif Riverside, Inst Integrat Genom Biol, Riverside, CA 92521 USA.
EM alexander.raikhel@ucr.edu
FU NIH Grant [R01 AI113729]; China Scholarship Council of Chinese Ministry
   of Education Scholar Fellowship [201408440009]
FX This work was supported by NIH Grant R01 AI113729 (to A.S.R.) and China
   Scholarship Council of Chinese Ministry of Education Scholar Fellowship
   201408440009.
CR Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932
   Allen AK, 2008, DEVELOPMENT, V135, P311, DOI 10.1242/dev.015156
   Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Berry S J, 1985, Dev Biol (N Y 1985), V1, P351
   Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107
   Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031
   Clark IBN, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-52
   Eggers S, 2014, NAT REV ENDOCRINOL, V10, P673, DOI 10.1038/nrendo.2014.163
   Enright AJ, 2004, GENOME BIOL, V5
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fujimoto Y, 2013, DEV CELL, V26, P416, DOI 10.1016/j.devcel.2013.06.018
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hansen IA, 2007, INSECT BIOCHEM MOLEC, V37, P985, DOI 10.1016/j.ibmb.2007.05.008
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005
   Huynh JR, 2000, DEVELOPMENT, V127, P2785
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107
   Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243
   Kwak H, 2013, ANNU REV GENET, V47, P483, DOI 10.1146/annurev-genet-110711-155440
   Langmead B, 2009, GENOME BIOL, V10, DOI [10.1186/gb-2009-10-3-r25, 10.1186/gb-2009-10-11-r134]
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Liu SP, 2014, P NATL ACAD SCI USA, V111, P14460, DOI 10.1073/pnas.1416278111
   Lucas KJ, 2015, CURR OPIN INSECT SCI, V11, P1, DOI 10.1016/j.cois.2015.06.004
   Lucas KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/j.pt.2013.04.003
   Lucas KJ, 2015, P NATL ACAD SCI USA, V112, P1440, DOI 10.1073/pnas.1424408112
   Ninova M, 2014, RNA, V20, P360, DOI 10.1261/rna.041657.113
   RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217
   Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111
   Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021
   Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Ziegler R, 1997, EUR J ENTOMOL, V94, P385
   Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014
NR 46
TC 0
Z9 0
U1 19
U2 19
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 16
PY 2016
VL 113
IS 33
BP E4828
EP E4836
DI 10.1073/pnas.1609792113
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3RS
UT WOS:000381399200012
PM 27489347
ER

PT J
AU Friedrich, MJ
AF Friedrich, M. J.
TI More Insights Into Zika Virus Infection and Birth Outcomes
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
CR Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Pacheco O., 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJMOA1604037]
NR 2
TC 0
Z9 0
U1 12
U2 12
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD AUG 16
PY 2016
VL 316
IS 7
BP 702
EP 702
DI 10.1001/jama.2016.10895
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT5IA
UT WOS:000381514800006
ER

PT J
AU Attaran, A
   Caplan, A
   Igel, L
AF Attaran, Amir
   Caplan, Arthur
   Igel, Lee
TI The olympically mismeasured risk of Zika virus in Rio de Janeiro
SO LANCET
LA English
DT Letter
ID VISITORS; GAMES
C1 [Attaran, Amir] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada.
   [Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.
   [Igel, Lee] NYU, Tisch Inst, Sports & Soc Program, New York, NY USA.
   [Caplan, Arthur] NYU, Div Med Eth, Langone Med Ctr, New York, NY USA.
RP Attaran, A (reprint author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON K1N 6N5, Canada.; Attaran, A (reprint author), Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada.
EM aattaran@uottawa.ca
CR Bastgos L, 2016, BIORXIV, DOI [10.1101/055475, DOI 10.1101/055475]
   International Research Institute for Climate and Society, 2016, IRI MULT PROB FOR TE
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Ministerio da Saude, 2016, B EPIDEMIOLOGICO, V47, P1
   Watts Jonathan, 2016, GUARDIAN
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 13
PY 2016
VL 388
IS 10045
BP 657
EP 658
DI 10.1016/S0140-6736(16)31227-2
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1UX
UT WOS:000381268700022
PM 27480044
ER

PT J
AU Massad, E
   Coutinho, FAB
   Wilder-Smith, A
AF Massad, Eduardo
   Bezerra Coutinho, Francisco Antonio
   Wilder-Smith, Annelies
TI The olympically mismeasured risk of Zika virus in Rio de Janeiro Reply
SO LANCET
LA English
DT Letter
ID VISITORS; DENGUE; GAMES
C1 [Massad, Eduardo; Bezerra Coutinho, Francisco Antonio] Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.
   [Massad, Eduardo] London Sch Hyg & Trop Med, London, England.
   [Wilder-Smith, Annelies] Lee Kong Chian Sch Med, Singapore, Singapore.
RP Massad, E (reprint author), Univ Sao Paulo, Sch Med, BR-01246903 Sao Paulo, Brazil.; Massad, E (reprint author), London Sch Hyg & Trop Med, London, England.
EM edmassad@usp.br
CR Bastgos L, 2016, BIORXIV, DOI [10.1101/055475, DOI 10.1101/055475]
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 7
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 13
PY 2016
VL 388
IS 10045
BP 658
EP 659
DI 10.1016/S0140-6736(16)31228-4
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1UX
UT WOS:000381268700023
PM 27480043
ER

PT J
AU Manrique, PD
   Xu, C
   Hui, PM
   Johnson, NF
AF Manrique, Pedro D.
   Xu, Chen
   Hui, Pak Ming
   Johnson, Neil F.
TI Atypical viral dynamics from transport through popular places
SO PHYSICAL REVIEW E
LA English
DT Article
ID NETWORKS; DISEASE; MODEL
AB The flux of visitors through popular places undoubtedly influences viral spreading-from H1N1 and Zika viruses spreading through physical spaces such as airports, to rumors and ideas spreading through online spaces such as chat rooms and social media. However, there is a lack of understanding of the types of viral dynamics that can result. Here we present a minimal dynamical model that focuses on the time-dependent interplay between the mobility through and the occupancy of such spaces. Our generic model permits analytic analysis while producing a rich diversity of infection profiles in terms of their shapes, durations, and intensities. The general features of these theoretical profiles compare well to real-world data of recent social contagion phenomena.
C1 [Manrique, Pedro D.; Johnson, Neil F.] Univ Miami, Dept Phys, Coral Gables, FL 33126 USA.
   [Xu, Chen] Soochow Univ, Coll Phys Optoelect & Energy, Suzhou 215006, Peoples R China.
   [Hui, Pak Ming] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China.
RP Manrique, PD (reprint author), Univ Miami, Dept Phys, Coral Gables, FL 33126 USA.
FU National Science Foundation (NSF) [CNS1522693]; Air Force (AFOSR)
   [16RT0367]
FX N.F.J. is grateful to the National Science Foundation (NSF) for funding
   under Grant No. CNS1522693 and to the Air Force (AFOSR) for Grant No.
   16RT0367.
CR Report by The American Academy of Pediatrics (AAP), 2007, PAND INFL WARN CHILD
   Zuzek LGA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12151
   Aoki T, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.040301
   Bajardi P, 2009, Emerg Health Threats J, V2, pe11, DOI 10.3134/ehtj.09.011
   Bajardi P, 2012, J R SOC INTERFACE, V9, P2814, DOI 10.1098/rsif.2012.0289
   Ball F, 1997, ANN APPL PROBAB, V7, P46, DOI [10.1214/aoap/1034625252, DOI 10.1214/A0AP/1034625252]
   Barrat A., 2008, DYNAMICAL PROCESSES
   Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701
   Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105
   Dodds PS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218701
   Estrada E., 2011, STRUCTURE COMPLEX NE
   Feng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126090
   Fernandez J. Gracia, ARXIV150408343
   Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701
   Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001
   Jo HH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011041
   Johnson N. F., 2008, MANAGING COMPLEXITY, P303, DOI 10.1007/978-3-540-75261-5_14
   Johnson N. F., 2003, FINANCIAL MARKET COM
   Karsai M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00397
   Karsai M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04001
   Keeling MJ, 2007, MODELING INFECT DIS
   Koopman J. S., 2007, BIOL NETWORKS
   Liu SY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032805
   Lyall S., 2009, NY TIMES
   Manore CA, 2015, J BIOL DYNAM, V9, P52, DOI 10.1080/17513758.2015.1005698
   Manrique P, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON INTELLIGENCE AND SECURITY INFORMATICS: BIG DATA, EMERGENT THREATS, AND DECISION-MAKING IN SECURITY INFORMATICS, P169, DOI 10.1109/ISI.2013.6578812
   Matheny J., 2013, TEST EVALUATION ACE
   May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112
   McNeil D. G., 2009, NY TIMES
   Murase Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052810
   Murray J. D., 2007, MATH BIOL
   Palchykov V, 2014, CONDENS MATTER PHYS, V17, DOI 10.5488/CMP.17.33802
   Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Perra N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023084
   Scholtes I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6024
   Shao J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018701
   Shaw LB, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066101
   Sornette D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.228701
   Stepanova E., 2011, 159 PONARS EUR
   Stopczynski A., ARXIV150906530V1
   Tomasello MV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05679
   Valdano E, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021005
   Valdez LD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12172
   Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102
   Zhao ZY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056107
NR 46
TC 0
Z9 0
U1 0
U2 0
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2470-0045
EI 2470-0053
J9 PHYS REV E
JI Phys. Rev. E
PD AUG 12
PY 2016
VL 94
IS 2
AR 022304
DI 10.1103/PhysRevE.94.022304
PG 13
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA DT3YW
UT WOS:000381418100007
PM 27627314
ER

PT J
AU Lessler, J
   Chaisson, LH
   Kucirka, LM
   Bi, QF
   Grantz, K
   Salje, H
   Carcelen, AC
   Ott, CT
   Sheffield, JS
   Ferguson, NM
   Cummings, DAT
   Metcalf, CJE
   Rodriguez-Barraquer, I
AF Lessler, Justin
   Chaisson, Lelia H.
   Kucirka, Lauren M.
   Bi, Qifang
   Grantz, Kyra
   Salje, Henrik
   Carcelen, Andrea C.
   Ott, Cassandra T.
   Sheffield, Jeanne S.
   Ferguson, Neil M.
   Cummings, Derek A. T.
   Metcalf, C. Jessica E.
   Rodriguez-Barraquer, Isabel
TI Assessing the global threat from Zika virus
SO SCIENCE
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; AEDES-AEGYPTI; DENGUE VIRUS; YELLOW-FEVER;
   FRENCH-POLYNESIA; ARBOVIRUS INFECTIONS; SEXUAL TRANSMISSION; SEROLOGICAL
   SURVEY; JAPANESE ENCEPHALITIS; VECTOR CONTROL
AB First discovered in 1947, Zika virus (ZIKV) infection remained a little-known tropical disease until 2015, when its apparent association with a considerable increase in the incidence of microcephaly in Brazil raised alarms worldwide. There is limited information on the key factors that determine the extent of the global threat from ZIKV infection and resulting complications. Here, we review what is known about the epidemiology, natural history, and public health effects of ZIKV infection, the empirical basis for this knowledge, and the critical knowledge gaps that need to be filled.
C1 [Lessler, Justin; Chaisson, Lelia H.; Kucirka, Lauren M.; Bi, Qifang; Salje, Henrik; Ott, Cassandra T.; Rodriguez-Barraquer, Isabel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   [Kucirka, Lauren M.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.
   [Grantz, Kyra; Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Dept Biol, Gainesville, FL USA.
   [Salje, Henrik] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.
   [Carcelen, Andrea C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Sheffield, Jeanne S.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA.
   [Ferguson, Neil M.] Imperial Coll London, Sch Publ Hlth, Dept Med, London, England.
   [Metcalf, C. Jessica E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.
   [Metcalf, C. Jessica E.] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.
RP Lessler, J (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
EM justin@jhu.edu
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4
   Althouse B., 2016, POTENTIAL ZIKA VIRUS
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   Anderson R.M., 1991, INFECT DIS HUMANS DY
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Bastos L., 2016, ZIKA RIO DE JANEIRO
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carlson C., 2016, ECOLOGICAL ASSESSMEN
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Diaz M. E., 2016, NY TIMES
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, ALL COUNTR TERR ACT
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Climate Prediction Center, ENSO DIAGN DISC
   Cornet M., 1979, ORSTOM SERIE ENTOMOL, V17, P47
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Fatima Vasco Aragao Maria, 2016, BMJ, V353, pi1901, DOI 10.1136/bmj.i1901
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Barbeiro FMD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005568
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   R. Editorial, 2016, REUTERS
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fajardo Alvaro, 2016, J Med Virol, V88, P1672, DOI 10.1002/jmv.24596
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Favoretto S, 2016, 1 DETECTION ZIKA VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   de Melo Freire C. C., 2015, SPREAD PANDEMIC ZIKA
   Funk S., 2016, COMP ANAL DENGUE ZIK
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638
   Hill AVS, 2012, PHILOS T R SOC B, V367, P840, DOI 10.1098/rstb.2011.0275
   Johansson MA, 2016, NEW ENGL J MED, V375
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73
   Kliegman R. M., 2015, NELSON TXB PEDIAT
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Kouri G, 1998, EMERG INFECT DIS, V4, P89
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423
   Lessler J., 2016, BIORXIV
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McIntosh B. M., 1961, T R SOC TROP MED HYG, V55, P192, DOI [10.1016/0035-9203(61)90025-6, DOI 10.1016/0035-9203(61)90025-6]
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan A. J., 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks, DOI 10.1371/CURRENTS.OUTBREAKS]
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Moreno-Mayar JV, 2014, CURR BIOL, V24, P2518, DOI 10.1016/j.cub.2014.09.057
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887
   Pacheco O., 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJMOA1604037]
   PATTERSON R, 1989, CAN MED ASSOC J, V141, P596
   Paul L. M., 2016, DENGUE VIRUS ANTIBOD
   Perkins A., 2016, MODEL BASED PROJECTI
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rios-Velasquez CM, 2007, MEM I OSWALDO CRUZ, V102, P617, DOI 10.1590/S0074-02762007005000076
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Rojas D. P., 2016, EPIDEMIOLOGY TRANSMI
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roze B., 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.9.30154, DOI 10.2807/1560-7917.ES.2016.21.9.30154]
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Samy AM, 2016, MEM I O CRUZ, DOI [10.1590/0074-02760160149, DOI 10.1590/0074-02760160149]
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vogel G, 2016, SCIENCE, V352, P1152, DOI 10.1126/science.352.6290.1152
   WAITZMAN NJ, 1994, INQUIRY-J HEALTH CAR, V31, P188
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, CURR ZIK PROD PIP
   WHO, 1995, MAT ANTHR PREGN OUTC
   Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   [Anonymous], 1997, SALUD PUBLICA, V1, P68, DOI [10.1590/ S1020- 49891997000100023, DOI 10.1590/S1020-49891997000100023]
NR 161
TC 2
Z9 2
U1 47
U2 47
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD AUG 12
PY 2016
VL 353
IS 6300
BP 663
EP +
DI 10.1126/science.aaf8160
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT5ZC
UT WOS:000381561200031
ER

PT J
AU Zhao, HY
   Fernandez, E
   Dowd, KA
   Speer, SD
   Platt, DJ
   Gorman, MJ
   Govero, J
   Nelson, CA
   Pierson, TC
   Diamond, MS
   Fremont, DH
AF Zhao, Haiyan
   Fernandez, Estefania
   Dowd, Kimberly A.
   Speer, Scott D.
   Platt, Derek J.
   Gorman, Matthew J.
   Govero, Jennifer
   Nelson, Christopher A.
   Pierson, Theodore C.
   Diamond, Michael S.
   Fremont, Daved H.
TI Structural Basis of Zika Virus-Specific Antibody Protection
SO CELL
LA English
DT Article
ID WEST-NILE-VIRUS; CROSS-REACTIVE ANTIBODIES; TICK-BORNE ENCEPHALITIS;
   DENGUE VIRUS; MONOCLONAL-ANTIBODY; ENVELOPE PROTEIN; DOMAIN-III;
   FUSION-LOOP; NEUTRALIZATION; INFECTION
AB Zika virus (ZIKV) infection during pregnancy has emerged as a global public health problem because of its ability to cause severe congenital disease. Here, we developed six mouse monoclonal antibodies (mAbs) against ZIKV including four (ZV-48, ZV-54, ZV-64, and ZV-67) that were ZIKV specific and neutralized infection of African, Asian, and American strains to varying degrees. X-ray crystallographic and competition binding analyses of Fab fragments and scFvs defined three spatially distinct epitopes in DIII of the envelope protein corresponding to the lateral ridge (ZV-54 and ZV-67), C-C' loop (ZV-48 and ZV-64), and ABDE sheet (ZV-2) regions. In vivo passive transfer studies revealed protective activity of DIII-lateral ridge specific neutralizing mAbs in a mouse model of ZIKV infection. Our results suggest that DIII is targeted by multiple type-specific antibodies with distinct neutralizing activity, which provides a path for developing prophylactic antibodies for use in pregnancy or designing epitope-specific vaccines against ZIKV.
C1 [Zhao, Haiyan; Gorman, Matthew J.; Nelson, Christopher A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Platt, Derek J.; Govero, Jennifer; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Fremont, Daved H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.
   [Nelson, Christopher A.; Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Dowd, Kimberly A.; Speer, Scott D.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, Bethesda, MD 20892 USA.
RP Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS; Fremont, DH (reprint author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Fremont, DH (reprint author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Diamond, MS; Fremont, DH (reprint author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@borcim.wustl.edu; fremont@wustl.edu
FU NIH [R01 AI073755, R01 AI104972, T32 AI007163]; NIAID
   [HHSN272201400018C, HHSN272201200026C]; NIH Research Education Program
   [R25 HG006687]; NIAID
FX This work was supported by NIH grants R01 AI073755 (to M.S.D. and D.H.F)
   and R01 AI104972 (to M.S.D.), and NIAID contracts HHSN272201400018C (to
   D.H.F. and M.S.D) and HHSN272201200026C (CSGID; to D.H.F.). E.F. and
   D.J.P. were supported by an NIH Pre-doctoral training grant award (T32
   AI007163) and the NIH Research Education Program (R25 HG006687),
   respectively. K.A.D., S.D.S., and T.C.P. were funded by the intramural
   program of NIAID. We acknowledge Jay Nix (MBC 4.2.2 beamline at ALS
   Berkeley) for aid in remote data collection. M.S.D. consults for Inbios,
   Visterra, Sanofi, and Takeda Pharmaceuticals, is on the Scientific
   Advisory Boards of Moderna and OraGene, and has received research grants
   from Moderna, Sanofi, and Visterra.
CR Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Barba-Spaeth G., 2016, NATURE
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Brien J.D., 2013, CURR PROTOC MICROBIO, V31
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca R.A., 2016, NATURE
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201
   Pierson T.C., 2013, FIELDS VIROLOGY, P747
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116
   Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith S.A., 2013, MBIO, V4, pe13
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
NR 53
TC 1
Z9 1
U1 9
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD AUG 11
PY 2016
VL 166
IS 4
BP 1016
EP 1027
DI 10.1016/j.cell.2016.07.020
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DU5NO
UT WOS:000382258700022
PM 27475895
ER

PT J
AU Barzon, L
   Pacenti, M
   Franchin, E
   Lavezzo, E
   Trevisan, M
   Sgarabotto, D
   Palu, G
AF Barzon, L.
   Pacenti, M.
   Franchin, E.
   Lavezzo, E.
   Trevisan, M.
   Sgarabotto, D.
   Palu, G.
TI Infection dynamics in a traveller with persistent shedding of Zika virus
   RNA in semen for six months after returning from Haiti to Italy, January
   2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION
AB We describe the dynamics of Zika virus (ZIKV) infection in a man in his early 40s who developed fever and rash after returning from Haiti to Italy, in January 2016. Follow-up laboratory testing demonstrated detectable ZIKV RNA in plasma up to day 9 after symptom onset and in urine and saliva up to days 15 and 47, respectively. Notably, persistent shedding of ZIKV RNA was demonstrated in semen, still detectable at 181 days after onset.
C1 [Barzon, L.; Franchin, E.; Lavezzo, E.; Trevisan, M.; Palu, G.] Univ Padua, Dept Mol Med, Padua, Italy.
   [Barzon, L.; Pacenti, M.; Franchin, E.; Palu, G.] Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
   [Sgarabotto, D.] Padova Univ Hosp, Transplant Infect Dis Unit, Padua, Italy.
RP Barzon, L (reprint author), Univ Padua, Dept Mol Med, Padua, Italy.; Barzon, L (reprint author), Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
EM luisa.barzon@unipd.it
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   World Health Organization (WHO), 2016, WHOZIKVMOC161
   [Anonymous], 2016, WKLY EPIDEMIOL REC, V91, P73
NR 17
TC 0
Z9 0
U1 8
U2 8
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD AUG 11
PY 2016
VL 21
IS 32
BP 2
EP 5
AR 30316
DI 10.2807/1560-7917.ES.2016.21.32.30316
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DU5CE
UT WOS:000382228800001
ER

PT J
AU Nicastri, E
   Castilletti, C
   Liuzzi, G
   Iannetta, M
   Capobianchi, MR
   Ippolito, G
AF Nicastri, E.
   Castilletti, C.
   Liuzzi, G.
   Iannetta, M.
   Capobianchi, M. R.
   Ippolito, G.
TI Persistent detection of Zika virus RNA in semen for six months after
   symptom onset in a traveller returning from Haiti to Italy, February
   2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION
AB A man in his early 30s reported in January 2016 a history of fever, asthenia and erythematous rash during a stay in Haiti. On his return to Italy, ZIKV RNA was detected in his urine and saliva 91 days after symptom onset, and in his semen on day 188, six months after symptom onset. Our findings support the possibility of sexual transmission of ZIKV and highlight the importance of continuing to investigate non-vector-borne ZIKV infection.
C1 [Nicastri, E.; Castilletti, C.; Liuzzi, G.; Iannetta, M.; Capobianchi, M. R.; Ippolito, G.] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
RP Castilletti, C (reprint author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
EM concetta.castilletti@inmi.it
FU Ricerca Corrente of the Italian Ministry of Health
FX This study was funded by Ricerca Corrente of the Italian Ministry of
   Health.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Deen GF, 2015, NEW ENGL J MED, V14, DOI [10.1056/NEJMoa1511410, DOI 10.1056/NEJMOA1511410, 10.1056/NEJMoa1511410.]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS ZIK VIR
   Fourcade Camille, 2016, J Clin Virol, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V9
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Huits RMHG, 2016, B WHO
   Liuzzi G, 2016, EUR J INTERN MED
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Papa A, 2010, VECTOR-BORNE ZOONOT, V10, P655, DOI 10.1089/vbz.2010.0042
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Turmel JM, 2016, LANCET, V18, P387
   World Health Organization (WHO), 2016, WHOZIKVMOC161
NR 20
TC 0
Z9 0
U1 6
U2 6
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD AUG 11
PY 2016
VL 21
IS 32
BP 6
EP 9
AR 30314
DI 10.2807/1560-7917.ES.2016.21.32.30314
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DU5CE
UT WOS:000382228800002
ER

PT J
AU Septfons, A
   Leparc-Goffart, I
   Couturier, E
   Franke, F
   Deniau, J
   Balestier, A
   Guinard, A
   Heuze, G
   Liebert, AH
   Mailles, A
   Ndong, J
   Poujol, I
   Raguet, S
   Rousseau, C
   Saidouni-Oulebsir, A
   Six, C
   Subiros, M
   Servas, V
   Terrien, E
   Tillaut, H
   Viriot, D
   Watrin, M
   Wyndels, K
   Noel, H
   Paty, M
   De Valk, H
AF Septfons, A.
   Leparc-Goffart, I.
   Couturier, E.
   Franke, F.
   Deniau, J.
   Balestier, A.
   Guinard, A.
   Heuze, G.
   Liebert, A. H.
   Mailles, A.
   Ndong, J.
   Poujol, I.
   Raguet, S.
   Rousseau, C.
   Saidouni-Oulebsir, A.
   Six, C.
   Subiros, M.
   Servas, V.
   Terrien, E.
   Tillaut, H.
   Viriot, D.
   Watrin, M.
   Wyndels, K.
   Noel, H.
   Paty, M.
   De Valk, H.
CA Zika Surveillance Working Grp
TI Travel-associated and autochthonous Zika virus infection in mainland
   France, 1 January to 15 July 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION
AB During summer 2016, all the conditions for local mosquito-borne transmission of Zika virus (ZIKV) are met in mainland France: a competent vector, Aedes albopictus, a large number of travellers returning from ZIKV-affected areas, and an immunologically naive population. From 1 January to 15 July 2016, 625 persons with evidence of recent ZIKV infection were reported in mainland France. We describe the surveillance system in place and control measures implemented to reduce the risk of infection.
C1 [Septfons, A.; Couturier, E.; Balestier, A.; Mailles, A.; Subiros, M.; Viriot, D.; Noel, H.; Paty, M.; De Valk, H.] French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France.
   [Septfons, A.] ECDC, European Ctr Dis Prevent & Control, EPIET, Stockholm, Sweden.
   [Leparc-Goffart, I.] Inst Rech Biomed Armees, Natl Reference Lab Arboviruses, Marseille, France.
   [Franke, F.; Deniau, J.; Heuze, G.; Six, C.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Provence Alpes Cotes dAzur, St Maurice, France.
   [Guinard, A.; Rousseau, C.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Languedoc Roussillon Midi Pyrenees, St Maurice, France.
   [Liebert, A. H.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Pays de la Loire, St Maurice, France.
   [Ndong, J.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Ctr Val de Loire, St Maurice, France.
   [Poujol, I.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Auvergne Rhone Alpes, St Maurice, France.
   [Raguet, S.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Alsace Lorraine Champagne Ardenne, St Maurice, France.
   [Saidouni-Oulebsir, A.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Ile de France, St Maurice, France.
   [Servas, V.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Aquitaine Limousin Poitou Charenes, St Maurice, France.
   [Terrien, E.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Bourgogne Franche Comte, St Maurice, France.
   [Tillaut, H.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Bretagne, St Maurice, France.
   [Watrin, M.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Normandie, St Maurice, France.
   [Wyndels, K.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Nord Pas de Calais, St Maurice, France.
RP Septfons, A (reprint author), French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France.; Septfons, A (reprint author), ECDC, European Ctr Dis Prevent & Control, EPIET, Stockholm, Sweden.
EM alexandra.septfons@santepubliquefrance.fr
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Codego Coelho F, 2016, SEXUAL TRANSMISSION
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), CURR ZIK TRANSM
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Jupille H, 2016, BIORXIV
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Marchand E., 2013, EURO SURVEILL, V201
   Ministere des Affaires Sociales et de la Sante, 2014, GUID REL MOD MIS OEU
   Ministere de l'Environnement de l'Energie et de la mer, B STAT TRAFF AER COM
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization/World Health Organization, 2016, GEOGR DISTR CONF CAS
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   WHO, 2016, ZIK SIT REP
   WHO World Health Organization, 2005, SAF PYR PUBL HLTH US
NR 27
TC 0
Z9 0
U1 3
U2 3
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD AUG 11
PY 2016
VL 21
IS 32
BP 10
EP 16
AR 30315
DI 10.2807/1560-7917.ES.2016.21.32.30315
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DU5CE
UT WOS:000382228800003
ER

PT J
AU Tabata, T
   Petitt, M
   Puerta-Guardo, H
   Michlmayr, D
   Wang, C
   Fang-Hoover, J
   Harris, E
   Pereira, L
AF Tabata, Takako
   Petitt, Matthew
   Puerta-Guardo, Henry
   Michlmayr, Daniela
   Wang, Chunling
   Fang-Hoover, June
   Harris, Eva
   Pereira, Lenore
TI Zika Virus Targets Different Primary Human Placental Cells, Suggesting
   Two Routes for Vertical Transmission
SO CELL HOST & MICROBE
LA English
DT Article
ID HUMAN CYTOMEGALOVIRUS-INFECTION; TROPHOBLAST PROGENITOR CELLS; DENGUE
   VIRUS; LANGERHANS CELLS; PHOSPHATIDYLSERINE RECEPTORS; TAM RECEPTORS;
   IN-VITRO; CYTOTROPHOBLASTS; ANTIBODIES; PATTERNS
AB Zika virus (ZIKV) infection during pregnancy is linked to severe birth defects, but mother-to-fetus transmission routes are unknown. We infected different primary cell types from mid- and late-gestation placentas and explants from first-trimester chorionic villi with the prototype Ugandan and a recently isolated Nicaraguan ZIKV strain. ZIKV infects primary human placental cells and explants-cytotropho-blasts, endothelial cells, fibroblasts, and Hofbauer cells in chorionic villi and amniotic epithelial cells and trophoblast progenitors in amniochorionic membranes-that express Axl, Tyro3, and/or TIM1 viral entry cofactors. ZIKV produced NS3 and E proteins and generated higher viral titers in amniotic epithelial cells from mid-gestation compared to late-gestation placentas. Duramycin, a peptide that binds phosphatidylethanolamine in enveloped virions and precludes TIM1 binding, reduced ZIKV infection in placental cells and explants. Our results suggest that ZIKV spreads from basal and parietal decidua to chorionic villi and amniochorionic membranes and that targeting TIM1 could suppress infection at the uterine-placental interface.
C1 [Tabata, Takako; Petitt, Matthew; Fang-Hoover, June; Pereira, Lenore] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
   [Puerta-Guardo, Henry; Michlmayr, Daniela; Wang, Chunling; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Pereira, L (reprint author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.; Harris, E (reprint author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu; lenore.pereira@ucsf.edu
FU NIH Institute for Allergy and Infectious Diseases [R01AI046657,
   P01AI106695, R01AI124493]
FX We thank Saira Saborio and Dr. Angel Balmaseda at the National Virology
   Laboratory of the Nicaraguan Ministry of Health and the entire study
   team of the Nicaraguan Pediatric Dengue Cohort Study. We are grateful to
   Magelda Montoya and Alejandro Ramirez for their technical assistance.
   This work was supported by grants from the NIH Institute for Allergy and
   Infectious Diseases: R01AI046657 (L.P.), P01AI106695 (E.H.), and
   R01AI124493 (E.H.).
CR Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Benirschke K, 2000, PATHOLOGY HUMAN PLAC
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x
   FUJITA M, 1991, J INVEST DERMATOL, V97, P65, DOI 10.1111/1523-1747.ep12478115
   Gao PS, 2005, J ALLERGY CLIN IMMUN, V115, P982, DOI 10.1016/j.jaci.2005.01.035
   Genbacev O, 2015, PLACENTA, V36, P716, DOI 10.1016/j.placenta.2015.05.002
   Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Kim HY, 2011, J CLIN INVEST, V121, P1111, DOI 10.1172/JCI44182
   Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108
   Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050483
   Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06
   McDonagh S, 2006, J CLIN VIROL, V35, P210, DOI 10.1016/j.jcv.2005.08.011
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019
   Perera-Lecoin M, 2013, VIRUSES, V6, P69
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Tabata T, 2007, PLACENTA, V28, P527, DOI 10.1016/j.placenta.2006.05.006
   Tabata T, 2012, AM J PATHOL, V181, P1540, DOI 10.1016/j.ajpath.2012.08.003
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Wu SJL, 2000, NAT MED, V6, P816
   Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004
   Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387
   Zydek M, 2014, VIRUSES-BASEL, V6, P1346, DOI 10.3390/v6031346
NR 51
TC 1
Z9 1
U1 41
U2 41
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD AUG 10
PY 2016
VL 20
IS 2
BP 155
EP 166
DI 10.1016/j.chom.2016.07.002
PG 12
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DT6II
UT WOS:000381587500008
PM 27443522
ER

PT J
AU Mounce, BC
   Poirier, EZ
   Passoni, G
   Simon-Loriere, E
   Cesaro, T
   Prot, M
   Stapleford, KA
   Moratorio, G
   Sakuntabhai, A
   Levraud, JP
   Vignuzzi, M
AF Mounce, Bryan C.
   Poirier, Enzo Z.
   Passoni, Gabriella
   Simon-Loriere, Etienne
   Cesaro, Teresa
   Prot, Matthieu
   Stapleford, Kenneth A.
   Moratorio, Gonzalo
   Sakuntabhai, Anavaj
   Levraud, Jean-Pierre
   Vignuzzi, Marco
TI Interferon-Induced Spermidine-Spermine Acetyltransferase and Polyamine
   Depletion Restrict Zika and Chikungunya Viruses
SO CELL HOST & MICROBE
LA English
DT Article
ID GAMBIENSE SLEEPING SICKNESS; SEMLIKI-FOREST VIRUS; HAMSTER-KIDNEY-CELLS;
   T7 RNA-POLYMERASE; ORNITHINE-DECARBOXYLASE; CHEMOPREVENTION TRIAL;
   MAMMALIAN-CELLS; VACCINIA VIRUS; DIFLUOROMETHYLORNITHINE; ANTIZYME
AB Polyamines are small, positively charged molecules derived from ornithine and synthesized through an intricately regulated enzymatic pathway. Within cells, they are abundant and play several roles in diverse processes. We find that polyamines are required for the life cycle of the RNA viruses chikungunya virus (CHIKV) and Zika virus (ZIKV). Depletion of spermidine and spermine via type I interferon signaling-mediated induction of spermidine/spermine N1-ace-tyltransferase (SAT1), a key catabolic enzyme in the polyamine pathway, restricts CHIKV and ZIKV replication. Polyamine depletion restricts these viruses in vitro and in vivo, due to impairment of viral translation and RNA replication. The restriction is released by exogenous replenishment of polyamines, further supporting a role for these molecules in virus replication. Thus, SAT1 and, more broadly, polyamine depletion restrict viral replication and suggest promising avenues for antiviral therapies.
C1 [Mounce, Bryan C.; Poirier, Enzo Z.; Cesaro, Teresa; Stapleford, Kenneth A.; Moratorio, Gonzalo; Vignuzzi, Marco] Inst Pasteur, Viral Populat & Pathogenesis Unit, CNRS, UMR 3569, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
   [Poirier, Enzo Z.] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, F-75013 Paris, France.
   [Passoni, Gabriella] INRA, Virol & Immunol Mol, F-78352 Jouy En Josas, France.
   [Passoni, Gabriella; Levraud, Jean-Pierre] Inst Pasteur, Macrophages & Dev Immun, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
   [Passoni, Gabriella; Levraud, Jean-Pierre] CNRS, URA2578, F-75724 Paris 15, France.
   [Simon-Loriere, Etienne; Prot, Matthieu; Sakuntabhai, Anavaj] Inst Pasteur, Unite Genet Fonct Malad Infect, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
RP Vignuzzi, M (reprint author), Inst Pasteur, Viral Populat & Pathogenesis Unit, CNRS, UMR 3569, 25-28 Rue Dr Roux, F-75724 Paris 15, France.
EM marco.vignuzzi@pasteur.fr
FU French Government's Investissement d'Avenir program; Laboratoire
   d'Excellence "Integrative Biology of Emerging Infectious Diseases''
   [ANR-10-LABX-62-IBEID]; French Fondation pour la Recherche Medicale
   [Equipe FRM DEQ20150331759]; DENFREE program; Defeat Dengue Program;
   Marie-Curie Initial Training Network FishForPharma
   [PITN-GA-2011-289209]; Erasmus+ Unipharma-Graduates Program
FX This work was supported by the French Government's Investissement
   d'Avenir program, Laboratoire d'Excellence "Integrative Biology of
   Emerging Infectious Diseases'' (grant noANR-10-LABX-62-IBEID) (B.C.M.
   and M.V.), the grant "Equipe FRM DEQ20150331759'' from the French
   Fondation pour la Recherche Medicale (M.V.), the DENFREE program
   (E.S.-L., M.P., and A.S.), the Defeat Dengue Program (B.C.M. and M.V.),
   PITN-GA-2011-289209 (G.P.) from Marie-Curie Initial Training Network
   FishForPharma, and the Erasmus+ Unipharma-Graduates Program (T.C.). We
   thank Benjamin tenOever, Britt Glaunsinger, Vera Tarakanova, and Carla
   Saleh for scientific discussions.
CR BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372
   BARDOCZ S, 1995, TRENDS FOOD SCI TECH, V6, P341, DOI 10.1016/S0924-2244(00)89169-4
   de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667
   Fabian CJ, 2002, CLIN CANCER RES, V8, P3105
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FONG WF, 1976, BIOCHIM BIOPHYS ACTA, V428, P456, DOI 10.1016/0304-4165(76)90054-4
   FRUGIER M, 1994, NUCLEIC ACIDS RES, V22, P2784, DOI 10.1093/nar/22.14.2784
   FUJITA K, 1982, BIOCHEM J, V204, P647
   FUKUMA I, 1975, J VIROL, V16, P222
   Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454
   GIBSON W, 1984, J VIROL, V50, P145
   GIBSON W, 1971, P NATL ACAD SCI USA, V68, P2818, DOI 10.1073/pnas.68.11.2818
   Goyal L, 2013, CANCER CHEMOTH PHARM, V72, P1305, DOI 10.1007/s00280-013-2293-8
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Henig N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062366
   HODGSON J, 1975, BIOCHEM BIOPH RES CO, V63, P308, DOI 10.1016/S0006-291X(75)80044-1
   Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601
   Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363
   Indraccolo S, 2007, J IMMUNOL, V178, P1122
   ISOM HC, 1979, J GEN VIROL, V42, P265, DOI 10.1099/0022-1317-42-2-265
   Iwata M, 2000, BIOORGAN MED CHEM, V8, P2185, DOI 10.1016/S0968-0896(00)00156-5
   Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822
   Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419
   LANZER W, 1975, J VIROL, V16, P1254
   Law GL, 2001, J BIOL CHEM, V276, P38036
   Lee SB, 2010, J BIOL CHEM, V285, P15548, DOI 10.1074/jbc.M109.092007
   Lightfoot HL, 2014, NUCLEIC ACIDS RES, V42, P11275, DOI 10.1093/nar/gku837
   Madhubala R, 1998, Methods Mol Biol, V79, P131
   Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110
   MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6
   METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050
   MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   MOUSSATCHE N, 1985, BIOCHIM BIOPHYS ACTA, V826, P113, DOI 10.1016/0167-4781(85)90116-2
   Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008
   Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133
   PEPIN J, 1987, LANCET, V2, P1431
   POHJANPELTO P, 1988, LIFE SCI, V42, P2011, DOI 10.1016/0024-3205(88)90501-2
   RAINA A, 1981, MED BIOL, V59, P428
   Rozen-Gagnon K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003877
   Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215
   Schipper RG, 2000, SEMIN CANCER BIOL, V10, P55, DOI 10.1006/scbi.2000.0308
   Simoneau AR, 2008, CANCER EPIDEM BIOMAR, V17, P292, DOI 10.1158/1055-9965.EPI-07-0658
   Svoboda KR, 2001, DEVELOPMENT, V128, P3511
   THOMAS T, 1995, J STEROID BIOCHEM, V54, P89, DOI 10.1016/0960-0760(95)00126-K
   TUOMI K, 1983, MED BIOL, V61, P199
   TUOMI K, 1982, BIOCHEM J, V206, P113
   Uimari A, 2009, BIOCHEM J, V422, P101, DOI 10.1042/BJ20090411
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Williams K, 1997, BIOCHEM J, V325, P289
   Wolff JC, 2003, CLIN CANCER RES, V9, P5922
   Yordanova MM, 2015, J BIOL CHEM, V290, P17863, DOI 10.1074/jbc.M115.647065
NR 52
TC 1
Z9 1
U1 7
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD AUG 10
PY 2016
VL 20
IS 2
BP 167
EP 177
DI 10.1016/j.chom.2016.06.011
PG 11
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DT6II
UT WOS:000381587500009
PM 27427208
ER

PT J
AU Barrows, NJ
   Campos, RK
   Powell, ST
   Prasanth, KR
   Schott-Lerner, G
   Soto-Acosta, R
   Galarza-Munoz, G
   McGrath, EL
   Urrabaz-Garza, R
   Gao, JL
   Wu, P
   Menon, R
   Saade, G
   Fernandez-Salas, I
   Rossi, SL
   Vasilakis, N
   Routh, A
   Bradrick, SS
   Garcia-Blanco, MA
AF Barrows, Nicholas J.
   Campos, Rafael K.
   Powell, Steven T.
   Prasanth, K. Reddisiva
   Schott-Lerner, Geraldine
   Soto-Acosta, Ruben
   Galarza-Munoz, Gaddiel
   McGrath, Erica L.
   Urrabaz-Garza, Rheanna
   Gao, Junling
   Wu, Ping
   Menon, Ramkumar
   Saade, George
   Fernandez-Salas, Ildefonso
   Rossi, Shannan L.
   Vasilakis, Nikos
   Routh, Andrew
   Bradrick, Shelton S.
   Garcia-Blanco, Mariano A.
TI A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
SO CELL HOST & MICROBE
LA English
DT Article
ID DENGUE VIRUS; CLINICAL PHARMACOKINETICS; FLAVIVIRUS REPLICATION;
   MYCOPHENOLIC-ACID; NUCLEAR IMPORT; HOST FACTORS; LONG-TERM; IVERMECTIN;
   DISCOVERY; CELLS
AB Currently there are no approved vaccines or specific therapies to prevent or treat Zika virus (ZIKV) infection. We interrogated a library of FDA-approved drugs for their ability to block infection of human HuH-7 cells by a newly isolated ZIKV strain (ZIKV MEX_I_7). More than 20 out of 774 tested compounds decreased ZIKV infection in our in vitro screening assay. Selected compounds were further validated for inhibition of ZIKV infection in human cervical, placental, and neural stem cell lines, as well as primary human amnion cells. Established anti-flaviviral drugs (e.g., bortezomib and mycophenolic acid) and others that had no previously known antiviral activity (e.g., daptomycin) were identified as inhibitors of ZIKV infection. Several drugs reduced ZIKV infection across multiple cell types. This study identifies drugs that could be tested in clinical studies of ZIKV infection and provides a resource of small molecules to study ZIKV pathogenesis.
C1 [Barrows, Nicholas J.; Campos, Rafael K.; Powell, Steven T.; Prasanth, K. Reddisiva; Schott-Lerner, Geraldine; Soto-Acosta, Ruben; Galarza-Munoz, Gaddiel; Routh, Andrew; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Barrows, Nicholas J.; Campos, Rafael K.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
   [McGrath, Erica L.; Gao, Junling; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Urrabaz-Garza, Rheanna; Menon, Ramkumar; Saade, George] Univ Texas Med Branch, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Fernandez-Salas, Ildefonso] Ctr Reg Invest Salud Publ INSP, 19 Poniente Esquina 4a Norte S-N, Tapachula 30700, Chiapas, Mexico.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Routh, Andrew] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
RP Bradrick, SS; Garcia-Blanco, MA (reprint author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.; Garcia-Blanco, MA (reprint author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
EM ssbradri@utmb.edu; maragarc@utmb.edu
FU University of Texas Medical Branch; University of Texas System Faculty
   STARs Award; NIH [R01-AI089526, R01-AI101431, R24-AI120942]; NIH-NINDS
   postdoctoral fellowship [F32-NS087899]; Chief Research Office at the
   University of Texas Medical Branch; John S. Dunn Foundation
FX This work was supported by start-up funds from the University of Texas
   Medical Branch (S.S.B and M.A.G.-B.), University of Texas System Faculty
   STARs Award (M.A.G.-B.), and NIH grants R01-AI089526 and R01-AI101431
   (M.A.G.-B.) and R24-AI120942 (N.V.). G.G.M was funded by NIH-NINDS
   postdoctoral fellowship F32-NS087899. P.W. was funded by the Chief
   Research Office at the University of Texas Medical Branch and the John
   S. Dunn Foundation. R.K. Campos, S. Powell, K. R. Prasanth, G.
   Schott-Lerner, and R. Soto-Acosta are listed in alphabetical order.
CR Adams J, 1999, CANCER RES, V59, P2615
   Araujo Helena R. C., 2015, Insects, V6, P576, DOI 10.3390/insects6020576
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benvenuto M, 2006, ANTIMICROB AGENTS CH, V50, P3245, DOI 10.1128/AAC.00247-06
   Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Bullingham RES, 1998, CLIN PHARMACOKINET, V34, P429, DOI 10.2165/00003088-199834060-00002
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   Fontes C. A., 2016, NEURORADIOLOGY
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048
   Guerbois M., 2016, J INFECT DIS
   Guzzo CA, 2002, J CLIN PHARMACOL, V42, P1122, DOI 10.1177/009127002237994
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830
   HERTEL LW, 1990, CANCER RES, V50, P4417
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   KARBWANG J, 1990, CLIN PHARMACOKINET, V19, P264, DOI 10.2165/00003088-199019040-00002
   KOE BK, 1983, J PHARMACOL EXP THER, V226, P686
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Ladner J. T., 2016, GENOME ANNOUNC, V4, P4
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   LENNARD L, 1992, EUR J CLIN PHARMACOL, V43, P329, DOI 10.1007/BF02220605
   Barrows N. J., 2012, PLOS NEGL TROP DIS, V6
   Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004
   Madeira J. M., 2012, Inflammopharmacology, V20, P297, DOI 10.1007/s10787-012-0149-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, pIV, DOI 10.1016/j.coviro.2014.08.002
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Navari RM, 2015, BBA-BIOMEMBRANES, V1848, P2738, DOI 10.1016/j.bbamem.2015.03.020
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665
   Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A., 2014, EURO SURVEILL, V19
   SCHWEITZER BI, 1990, FASEB J, V4, P2441
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328
   Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974
   Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5
   Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130
   Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
NR 73
TC 1
Z9 1
U1 17
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD AUG 10
PY 2016
VL 20
IS 2
BP 259
EP 270
DI 10.1016/j.chom.2016.07.004
PG 12
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DT6II
UT WOS:000381587500017
PM 27476412
ER

PT J
AU Dowd, KA
   DeMaso, CR
   Pelc, RS
   Speer, SD
   Smith, ARY
   Goo, L
   Platt, DJ
   Mascola, JR
   Graham, BS
   Mulligan, MJ
   Diamond, MS
   Ledgerwood, JE
   Pierson, TC
AF Dowd, Kimberly A.
   DeMaso, Christina R.
   Pelc, Rebecca S.
   Speer, Scott D.
   Smith, Alexander R. Y.
   Goo, Leslie
   Platt, Derek J.
   Mascola, John R.
   Graham, Barney S.
   Mulligan, Mark J.
   Diamond, Michael S.
   Ledgerwood, Julie E.
   Pierson, Theodore C.
TI Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a
   Single Viral Serotype
SO CELL REPORTS
LA English
DT Article
ID ANTIBODY-MEDIATED NEUTRALIZATION; DENGUE VIRUS; CLINICAL-TRIAL;
   DOUBLE-BLIND; PHASE-III; INFECTION; FLAVIVIRUSES; VACCINES;
   IMMUNOGENICITY; ENHANCEMENT
AB Recent epidemics of Zika virus (ZIKV) have been associated with congenital malformation during pregnancy and Guillain-Barre syndrome. There are two ZIKV lineages (African and Asian) that share >95% amino acid identity. Little is known regarding the ability of neutralizing antibodies elicited against one lineage to protect against the other. We investigated the breadth of the neutralizing antibody response following ZIKV infection by measuring the sensitivity of six ZIKV strains to neutralization by ZIKV-confirmed convalescent human serum or plasma samples. Contemporary Asian and early African ZIKV strains were similarly sensitive to neutralization regardless of the cellular source of virus. Furthermore, mouse immune serum generated after infection with African or Asian ZIKV strains was capable of neutralizing homologous and heterologous ZIKV strains equivalently. Because our study only defines a single ZIKV serotype, vaccine candidates eliciting robust neutralizing antibody responses should inhibit infection of both ZIKV lineages, including strains circulating in the Americas.
C1 [Dowd, Kimberly A.; DeMaso, Christina R.; Pelc, Rebecca S.; Speer, Scott D.; Smith, Alexander R. Y.; Goo, Leslie; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, Bethesda, MD 20892 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol, St Louis, MO 63110 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA.
   [Mascola, John R.; Graham, Barney S.; Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.
   [Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Hope Clin,Emory Vaccine Ctr,Div Infect Dis, Decatur, GA 30030 USA.
RP Pierson, TC (reprint author), NIAID, Viral Pathogenesis Sect, NIH, Bethesda, MD 20892 USA.
EM piersontc@mail.nih.gov
FU National Institute of Allergy and Infectious Disease; Emory University
   School of Medicine; Georgia Research Alliance; Moderna; Sanofi;
   Visterra;  [R01AI073755]
FX This work was funded by the intramural program of the National Institute
   of Allergy and Infectious Disease to the Division of Intramural Research
   and the Vaccine Research Center and extramural grant R01AI073755 to
   M.S.D. M.J.M. was supported by funds from the Emory University School of
   Medicine and the Georgia Research Alliance. We thank X. de Lamballerie
   (Emergence des Pathologies Virales, Aix-Marseille Universite) and the
   European Virus Archive Goes Global (EVAg) for providing the H/PF/2013
   ZIKV strain and Stephen S. Whitehead (NIAID) for the Brazil Paraiba/2015
   virus. We are grateful to the subjects for providing research samples
   and to Ingelise Gordon (VRC), Pamela Costner (VRC), Adam Dezure (VRC),
   Lilin Lai (Emory), Natalie Thornburg (Emory), Henry Wu (Emory), Srilatha
   Edupuganti (Emory), Allison Beck, (Emory), Sree Aramgam (Emory), and
   Pamela Lankford-Turner (Emory) for assistance with ZIKV patients and the
   collection of samples. We also thank Amanda Feldpausch (Georgia
   Department of Health), Jennifer Govero (Washington University), and
   Estefania Fernandez (Washington University) for their help with these
   studies. M.S.D. is a consultant for Inbios, Visterra, Sanofi, and Takeda
   Pharmaceuticals, is on the Scientific Advisory Boards of Moderna and
   OraGene, and is a recipient of research grants from Moderna, Sanofi, and
   Visterra.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Baronti C., 2014, GENOME ANNOUNC, V2, P2
   Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Guy B, 2016, ANNU REV MED, V67, P387, DOI 10.1146/annurev-med-091014-090848
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hazin Adriano N, 2016, N Engl J Med, V374, P2193, DOI 10.1056/NEJMc1603617
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   MASON RA, 1973, APPL MICROBIOL, V25, P539
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Monath TP, 2002, AM J TROP MED HYG, V66, P533
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson Theodore C, 2015, Prog Mol Biol Transl Sci, V129, P141, DOI 10.1016/bs.pmbts.2014.10.005
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   VanBlargan LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003761
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wang CL, 2016, J INFECT DIS, V213, P975, DOI 10.1093/infdis/jiv536
NR 39
TC 0
Z9 0
U1 9
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD AUG 9
PY 2016
VL 16
IS 6
BP 1485
EP 1491
DI 10.1016/j.celrep.2016.07.049
PG 7
WC Cell Biology
SC Cell Biology
GA DT3ID
UT WOS:000381373400001
PM 27481466
ER

PT J
AU van der Linden, V
   Rolim, EL
   Lins, OG
   van der Linden, A
   Aragao, MDVV
   Brainer-Lima, AM
   Cruz, DDS
   Rocha, MAW
   da Silva, PFS
   Carvalho, MDCG
   do Amaral, FJ
   Gomes, JA
   de Medeiros, ICR
   Ventura, CV
   Ramos, RC
AF van der Linden, Vanessa
   Rolim Filho, Epitacio Leite
   Lins, Otavio Gomes
   van der Linden, Ana
   Viana Vasco Aragao, Maria de Fatima
   Brainer-Lima, Alessandra Mertens
   Sousa Cruz, Danielle Di Cavalcanti
   Wanderley Rocha, Maria Angela
   Sobral da Silva, Paula Fabiana
   Costa Gomes Carvalho, Maria Durce
   do Amaral, Fernando Jose
   Gomes, Joelma Arruda
   Ribeiro de Medeiros, Igor Colaco
   Ventura, Camila V.
   Ramos, Regina Coeli
TI Congenital Zika syndrome with arthrogryposis: retrospective case series
   study
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID VIRUS-INFECTION; BRAZIL; OUTBREAK
AB OBJECTIVE
   To describe the clinical, radiological, and electromyographic features in a series of children with joint contractures (arthrogryposis) associated with congenital infection presumably caused by Zika virus.
   DESIGN
   Retrospective case series study.
   SETTING
   Association for Assistance of Disabled Children, Pernambuco state, Brazil.
   PARTICIPANTS
   Seven children with arthrogryposis and a diagnosis of congenital infection presumably caused by Zika virus during the Brazilian microcephaly epidemic.
   MAIN OUTCOME MEASURES
   Main clinical, radiological, and electromyographic findings, and likely correlation between clinical and primary neurological abnormalities.
   RESULTS
   The brain images of all seven children were characteristic of congenital infection and arthrogryposis. Two children tested positive for IgM to Zika virus in the cerebrospinal fluid. Arthrogryposis was present in the arms and legs of six children (86%) and the legs of one child (14%). Hip radiographs showed bilateral dislocation in seven children, subluxation of the knee associated with genu valgus in three children (43%), which was bilateral in two (29%). All the children underwent high definition ultrasonography of the joints, and there was no evidence of abnormalities. Moderate signs of remodeling of the motor units and a reduced recruitment pattern were found on needle electromyography (monopolar). Five of the children underwent brain computed tomography (CT) and magnetic resonance imaging (MRI) and the remaining two CT only. All presented malformations of cortical development, calcifications predominantly in the cortex and subcortical white matter (especially in the junction between the cortex and white matter), reduction in brain volume, ventriculomegaly, and hypoplasia of the brainstem and cerebellum. MRI of the spine in four children showed apparent thinning of the cord and reduced ventral roots.
   CONCLUSIONS
   Congenital Zika syndrome should be added to the differential diagnosis of congenital infections and arthrogryposis. The arthrogryposis was unrelated to the abnormalities of the joints themselves, but was possibly of neurogenic origin, with chronic involvement of central and peripheral motor neurones leading to deformities as a result of fixed postures in utero. Based on the neurophysiological observations, we suggest two possible mechanisms: tropism of neurones, with involvement of peripheral and central motor neurones, or a relation with vascular disorders.
C1 [van der Linden, Vanessa; Rolim Filho, Epitacio Leite] AACD, Recife, PE, Brazil.
   [van der Linden, Vanessa; do Amaral, Fernando Jose; Gomes, Joelma Arruda] HBL, Recife, PE, Brazil.
   [Rolim Filho, Epitacio Leite; Lins, Otavio Gomes] Univ Fed Pernambuco, Recife, PE, Brazil.
   [van der Linden, Ana; Sousa Cruz, Danielle Di Cavalcanti] Inst Materno Infantil Pernambuco, Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
   [Viana Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Recife, PE, Brazil.
   [Viana Vasco Aragao, Maria de Fatima; Brainer-Lima, Alessandra Mertens] Mauricio de Nassau Univ, Recife, PE, Brazil.
   [Brainer-Lima, Alessandra Mertens] Univ Pernambuco, Recife, PE, Brazil.
   [Wanderley Rocha, Maria Angela; Sobral da Silva, Paula Fabiana; Costa Gomes Carvalho, Maria Durce; Ramos, Regina Coeli] HUOC, Recife, PE, Brazil.
   [Ribeiro de Medeiros, Igor Colaco] Hosp Infantil Jorge de Medeiros, Recife, PE, Brazil.
   [Ventura, Camila V.] FAV, Recife, PE, Brazil.
   [Ventura, Camila V.] Pernambucos Eye Hosp, Recife, PE, Brazil.
RP van der Linden, V (reprint author), AACD, Recife, PE, Brazil.; van der Linden, V (reprint author), HBL, Recife, PE, Brazil.
EM vanessavdlinden@hotmail.com
CR Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281
   Besnard M, 2014, EUROSURVEILLANCE, V3
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FEDRIZZI E, 1993, PEDIATR NEUROL, V9, P343, DOI 10.1016/0887-8994(93)90102-I
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Kalampokas E, 2012, ISRN OBSTET GYNECOL, V2012, DOI [DOI 10.5402/2012/264918, 10.5402/2012/264918]
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Moller-Madsen B, 1999, THESIS, V9, P425
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moller-Madsen Bjarne, 2015, J Child Orthop, V9, P425, DOI 10.1007/s11832-015-0688-2
   Mussi-Pinhata M, 1999, J PEDIAT RIO J, V75, P15
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Poduri A, 2010, BRAIN DEV-JPN, V32, P550, DOI 10.1016/j.braindev.2009.08.005
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tavernise S, 2016, ZIKA VIRUS GLOBAL HL
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Volpe JJ, 2008, NEUROLOGY NEWBORN
   World Health Organization, 2016, ASS INF MICR CONT ZI
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 0
Z9 0
U1 2
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD AUG 9
PY 2016
VL 354
AR i3899
DI 10.1136/bmj.i3899
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT4TU
UT WOS:000381474800002
PM 27509902
ER

PT J
AU Kumar, A
   Singh, HN
   Pareek, V
   Raza, K
   Dantham, S
   Kumar, P
   Mochan, S
   Faiq, MA
AF Kumar, Ashutosh
   Singh, Himanshu N.
   Pareek, Vikas
   Raza, Khursheed
   Dantham, Subrahamanyam
   Kumar, Pavan
   Mochan, Sankat
   Faiq, Muneeb A.
TI A Possible Mechanism of Zika Virus Associated Microcephaly: Imperative
   Role of Retinoic Acid Response Element (RARE) Consensus Sequence Repeats
   in the Viral Genome
SO FRONTIERS IN HUMAN NEUROSCIENCE
LA English
DT Article
DE fetal brain malformation; microcephaly; neurotropism; retinoic acid
   response element (RARE); zika virus (ZIKV)
ID CENTRAL-NERVOUS-SYSTEM; EXPRESSION; INFECTION; BRAIN; NEUROTROPISM;
   RECEPTOR; FEVER; CELL; MALFORMATIONS; CORONAVIRUS
AB Owing to the reports of microcephaly as a consistent outcome in the fetuses of pregnant women infected with ZIKV in Brazil, Zika virus (ZIKV) microcephaly etiomechanistic relationship has recently been implicated. Researchers, however, are still struggling to establish an embryological basis for this interesting causal handcuff. The present study reveals robust evidence in favor of a plausible ZIKV-microcephaly cause-effect liaison. The rationale is based on: (1) sequence homology between ZIKV genome and the response element of an early neural tube developmental marker "retinoic acid" in human DNA and (2) comprehensive similarities between the details of brain defects in ZIKV-microcephaly and retinoic acid embryopathy. Retinoic acid is considered as the earliest factor for regulating anteroposterior axis of neural tube and positioning of structures in developing brain through retinoic acid response elements (RARE) consensus sequence (5'-AGGTCA-3') in promoter regions of retinoic acid-dependent genes. We screened genomic sequences of already reported virulent ZIKV strains (including those linked to microcephaly) and other viruses available in National Institute of Health genetic sequence database (GenBank) for the RARE consensus repeats and obtained results strongly bolstering our hypothesis that ZIKV strains associated with microcephaly may act through precipitation of dysregulation in retinoic acid-dependent genes by introducing extra stretches of RARE consensus sequence repeats in the genome of developing brain cells. Additional support to our hypothesis comes from our findings that screening of other viruses for RARE consensus sequence repeats is positive only for those known to display neurotropism and cause fetal brain defects (for which maternal-fetal transmission during developing stage may be required). The numbers of RARE sequence repeats appeared to match with the virulence of screened positive viruses. Although, bioinformatic evidence and embryological features are in favor of our hypothesis, additional studies including animal models are warranted to validate our proposition. Such studies are likely to unfold ZIKV-microcephaly association and may help in devising methods to combat it.
C1 [Kumar, Ashutosh; Raza, Khursheed; Kumar, Pavan; Mochan, Sankat] All India Inst Med Sci, Dept Anat, New Delhi, India.
   [Singh, Himanshu N.; Dantham, Subrahamanyam] All India Inst Med Sci, Dept Biochem, New Delhi, India.
   [Pareek, Vikas] Natl Brain Res Ctr, Computat Neurosci & Neuroimaging Div, Manesar, India.
   [Faiq, Muneeb A.] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.
   [Faiq, Muneeb A.] All India Inst Med Sci, Dept Anat, Lab Mol Reprod & Genet, New Delhi, India.
   [Faiq, Muneeb A.] Univ Delhi, Dr BP Ambedkar Ctr Biomed Res, Med Biotechnol Lab, New Delhi, India.
RP Faiq, MA (reprint author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.; Faiq, MA (reprint author), All India Inst Med Sci, Dept Anat, Lab Mol Reprod & Genet, New Delhi, India.; Faiq, MA (reprint author), Univ Delhi, Dr BP Ambedkar Ctr Biomed Res, Med Biotechnol Lab, New Delhi, India.
EM muneeb1983@gmail.com
CR Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.RI00015-JLR200
   Baronti C., 2014, GENOME ANNOUNC, V2, P2, DOI DOI 10.1128/GENOMEA.00500-14
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carty M, 2014, TRENDS IMMUNOL, V35, P79, DOI 10.1016/j.it.2013.10.012
   Cipriano R., 2016, REV EPIDEMIOL CONTRO, V6, DOI 10.17058/reci.v6i1.6959
   CIVITELLO LA, 1992, PEDIATR NEUROSURG, V17, P104
   Crandall JE, 2011, J NEUROCHEM, V119, P723, DOI 10.1111/j.1471-4159.2011.07471.x
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, V134, P529, DOI DOI 10.1001/JAMA0PHTHALM0L.2016.0267
   DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0
   Findlay GM, 1935, J PATHOL BACTERIOL, V41, P431, DOI 10.1002/path.1700410307
   Forton DM, 2001, LANCET, V358, P38, DOI 10.1016/S0140-6736(00)05270-3
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Grapin-Botton A, 1998, DEVELOPMENT, V125, P1173
   Grover VPB, 2012, J VIRAL HEPATITIS, V19, pE89, DOI 10.1111/j.1365-2893.2011.01510.x
   Guimard T, 2009, AM J TROP MED HYG, V81, P1141, DOI 10.4269/ajtmh.2009.09-0295
   Gupta S, 2015, DEVELOPMENT, V142, P1293, DOI 10.1242/dev.122390
   Halilagic A, 2007, DEV BIOL, V303, P362, DOI 10.1016/j.ydbio.2006.11.021
   Harrison-Uy SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058219
   Hazin Adriano N, 2016, N Engl J Med, V374, P2193, DOI 10.1056/NEJMc1603617
   Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702
   IRVING DW, 1986, TERATOLOGY, V34, P141, DOI 10.1002/tera.1420340203
   Jain Shobhit, 2011, Int J Pediatr Endocrinol, V2011, P11, DOI 10.1186/1687-9856-2011-11
   Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11
   KIMURAKURODA J, 1993, ARCH VIROL, V130, P477, DOI 10.1007/BF01309676
   Konig R, 2012, J CHEM NEUROANAT, V43, P120, DOI 10.1016/j.jchemneu.2012.01.002
   Kot-Leibovich H, 2009, DIS MODEL MECH, V2, P295, DOI 10.1242/dmm.001420
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401
   Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05
   Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Martinez-Morales PL, 2011, J CELL BIOL, V194, P489, DOI 10.1083/jcb.201011077
   Mic FA, 2004, DEV DYNAM, V231, P270, DOI 10.1002/dvdy.20128
   Micucci JA, 2014, HUM MOL GENET, V23, P434, DOI 10.1093/hmg/ddt435
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003
   Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289
   Okuda D. T., 2009, BMJ CASE REP, V2009, DOI [10.1136/bcr.05.2009.1908, DOI 10.1136/BCR.05.2009.1908]
   Paganelli A, 2010, CHEM RES TOXICOL, V23, P1586, DOI 10.1021/tx1001749
   Rajaii F, 2008, DEV BIOL, V316, P371, DOI 10.1016/j.ydbio.2008.01.041
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938
   Rubin SA, 2003, J VIROL, V77, P11616, DOI 10.1128/JVI.77.21.11616-11624.2003
   Salazar M. I., 2013, THESCIENTIFICWORLDJO, V2013, DOI 10.1155/2013/904067
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Sauerbrei A, 2000, J Perinatol, V20, P548, DOI 10.1038/sj.jp.7200457
   SCHEFFER IE, 1991, DEV MED CHILD NEUROL, V33, P916
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037
   Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004
   Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178
   Straface G., 2012, INFECT DIS OBSTET GY, V2012, DOI [10.1155/2012/385697, DOI 10.1155/2012/385697]
   Takano T, 1999, NEUROREPORT, V10, P2215, DOI 10.1097/00001756-199908020-00001
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI [10.1097/NEN.0000000000000038, 10.1097/NEN.0000000000000036]
   TSIANG H, 1983, J NEUROPATH EXP NEUR, V42, P439, DOI 10.1097/00005072-198307000-00006
   Tuiskunen A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-398
   VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   WHO, 2016, ZIK SIT REP
   Wilson LJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-138
   Wood BR, 2012, AIDS PATIENT CARE ST, V26, P383, DOI 10.1089/apc.2012.0048
   Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461
   Yamamoto M, 2003, MECH DEVELOP, V120, P701, DOI 10.1016/S0925-4773(03)00047-9
   Yazigi A., 2016, J MATERN-FETAL NEO M, DOI [10.3109/14767058.2016.1169526, DOI 10.3109/14767058.2016.1169526]
NR 72
TC 0
Z9 0
U1 37
U2 37
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1662-5161
J9 FRONT HUM NEUROSCI
JI Front. Hum. Neurosci.
PD AUG 9
PY 2016
VL 10
AR 403
DI 10.3389/fnhum.2016.00403
PG 11
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA DS7YT
UT WOS:000381000000001
PM 27555815
ER

PT J
AU Kao, JH
   Chen, CD
   Li, ZRT
   Chan, TC
   Tung, TH
   Chu, YH
   Cheng, HY
   Liu, JW
   Shih, FY
   Shu, PY
   Lin, CC
   Tsai, WH
   Ku, CC
   Ho, CK
   King, CC
AF Kao, Jui-Hung
   Chen, Chaur-Dong
   Li, Zheng-Rong Tiger
   Chan, Ta-Chien
   Tung, Tsung-Hwa
   Chu, Yin-Hsia
   Cheng, Hau-Yuan
   Liu, Jien-Wei
   Shih, Fuh-Yuan
   Shu, Pei-Yun
   Lin, Chien-Chou
   Tsai, Wu-Hsiung
   Ku, Chia-Chi
   Ho, Chi-Kung
   King, Chwan-Chuen
TI The Critical Role of Early Dengue Surveillance and Limitations of
   Clinical Reporting - Implications for Non-Endemic Countries
SO PLOS ONE
LA English
DT Article
ID GLOBAL DISTRIBUTION; DIFFUSION PATTERNS; TAIWAN; POPULATION; DISEASE;
   ADULTS; FEVER; TRANSMISSION; CHALLENGES; KAOHSIUNG
AB The increasing dengue burden and epidemic severity worldwide have highlighted the need to improve surveillance. In non-endemic areas such as Taiwan, where outbreaks start mostly with imported cases from Southeast Asia, a closer examination of surveillance dynamics to detect cases early is necessary. To evaluate problems with dengue surveillance and investigate the involvement of different factors at various epidemic stages, we investigated 632 laboratory-confirmed indigenous dengue cases in Kaohsiung City, Taiwan during 2009-2010. The estimated sensitivity of clinical surveillance was 82.4% (521/632). Initially, the modified serological surveillance (targeting only the contacts of laboratory-confirmed dengue cases) identified clinically unrecognized afebrile cases in younger patients who visited private clinics and accounted for 30.4% (35/115) of the early-stage cases. Multivariate regression indicated that hospital/medical center visits [Adjusted Odds Ratio (aOR): 11.6, 95% confidence interval (CI): 6.3-21.4], middle epidemic stage [aOR: 2.4 (1.2-4.7)], fever [aOR: 2.3 (2.3-12.9)], and musculo-articular pain [aOR: 1.9 (1.05-3.3)] were significantly associated with clinical reporting. However, cases with pruritus/rash [aOR: 0.47 (0.26-0.83)] and diarrhea [aOR: 0.47 (0.26-0.85)] were underreported. In conclusion, multiple factors contributed to dengue surveillance problems. To prevent a large-scale epidemic and minimize severe dengue cases, there is a need for integrated surveillance incorporating entomological, clinical, serological, and virological surveillance systems to detect early cases, followed by immediate prevention and control measures and continuous evaluation to ensure effectiveness. This effort will be particularly important for an arbovirus, such as Zika virus, with a high asymptomatic infection ratio. For dengue-non-endemic countries, we recommend serological surveillance be implemented in areas with high Aedes mosquito indices or many breeding sites. Syndromic surveillance, spatial analysis and monitoring changes in epidemiological characteristics using a geographical information system, as well as epidemic prediction models involving epidemiological, meteorological and environmental variables will be helpful for early risk communication to increase awareness.
C1 [Kao, Jui-Hung] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 100, Taiwan.
   [Chen, Chaur-Dong; Tsai, Wu-Hsiung; Ho, Chi-Kung] Kaohsiung City Govt, Dept Hlth, Kaohsiung 802, Taiwan.
   [Li, Zheng-Rong Tiger; Tung, Tsung-Hwa; King, Chwan-Chuen] NTU, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan.
   [Chan, Ta-Chien] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan.
   [Cheng, Hau-Yuan] NTU Hosp, Dept Pediat, Taipei 100, Taiwan.
   [Liu, Jien-Wei] Chang Gung Univ Med Coll, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung 833, Taiwan.
   [Shih, Fuh-Yuan] NTU Hosp, Dept Emergency Med, Taipei 100, Taiwan.
   [Shu, Pei-Yun; Lin, Chien-Chou] Taiwan Ctr Dis Control, Dept Hlth, Taipei 100, Taiwan.
   [Ho, Chi-Kung] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung 807, Taiwan.
   [Ho, Chi-Kung] Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung 807, Taiwan.
   [Ku, Chia-Chi] NTU, Coll Med, Inst Immunol, Taipei 100, Taiwan.
RP Ho, CK (reprint author), Kaohsiung City Govt, Dept Hlth, Kaohsiung 802, Taiwan.; King, CC (reprint author), NTU, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan.; Ho, CK (reprint author), Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung 807, Taiwan.; Ho, CK (reprint author), Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung 807, Taiwan.; Ku, CC (reprint author), NTU, Coll Med, Inst Immunol, Taipei 100, Taiwan.
EM chiachiku@ntu.edu.tw; hochikung@yahoo.com; chwanchuen@gmail.com
FU Ministry of Science and Technology (MOST) in Taiwan
   [MOST104-2314-B002-025, NSC102-2621-M002-002, 101-2923-B-002-006-MY3,
   102-2815-C-002-183-B]
FX The authors greatly appreciate financial support from the Ministry of
   Science and Technology (MOST) in Taiwan [formerly the National Science
   Council] Grant numbers MOST104-2314-B002-025, NSC102-2621-M002-002,
   101-2923-B-002-006-MY3, and 102-2815-C-002-183-B. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Rios M, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/678645, DOI 10.1155/2013/678645]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carvalho A, 2016, EXPERT REV VACCINES, V15, P539, DOI 10.1586/14760584.2016.1152187
   Chang SF, 2012, J FORMOS MED ASSOC, V111, P297, DOI 10.1016/j.jfma.2011.12.001
   Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070
   Chu HJ, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-42
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Hanna JN, 2006, AUST NZ J PUBL HEAL, V30, P220, DOI 10.1111/j.1467-842X.2006.tb00861.x
   Huang JH, 2007, AM J TROP MED HYG, V77, P903
   Huang JH, 2012, AM J TROP MED HYG, V87, P349, DOI 10.4269/ajtmh.2012.11-0666
   Jelinek T, 2009, EUROSURVEILLANCE B E, V14
   Kan CC, 2008, AM J TROP MED HYG, V79, P344
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103/141662, 10.3201/eid2103.141662]
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Li Z-RT, 2012, IMPACT ENV FACTORS M
   Lin CH, 2012, EMERG INFECT DIS, V18, P1603, DOI 10.3201/eid1810.111929
   Lin CC, 2010, AM J TROP MED HYG, V82, P731, DOI 10.4269/ajtmh.2010.09-0549
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775
   Shu PY, 2005, EMERG INFECT DIS, V11, P460
   Shu PY, 2001, VACCINE, V19, P1753, DOI 10.1016/S0264-410X(00)00391-1
   Tan HF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-11
   Wen TH, 2012, ANN ASSOC AM GEOGR, V102, P1026, DOI 10.1080/00045608.2012.671130
   Wen TH, 2010, INT J INFECT DIS, V14, pE334, DOI 10.1016/j.ijid.2009.06.006
   World Health Organization-European Union supported DSG, 1997, DENG HAEM FEV DIAGN
   WHO, 2009, DENG GUID DIAGN TREA
   Wu HH, 2013, J MED ENTOMOL, V50, P261, DOI 10.1603/ME11263
   Yap G, 2013, AM J TROP MED HYG, V88, P1065, DOI 10.4269/ajtmh.12-0150
NR 36
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 8
PY 2016
VL 11
IS 8
AR e0160230
DI 10.1371/journal.pone.0160230
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3IE
UT WOS:000381373500015
PM 27501302
ER

PT J
AU Trilla, A
   Trilla-Aymerich, G
AF Trilla, Antoni
   Trilla-Aymerich, Guillem
TI Zika virus: travel, mosquitoes and Olympic Games
SO MEDICINA CLINICA
LA Spanish
DT Editorial Material
ID FIFA WORLD CUP; RIO-DE-JANEIRO; BRAZIL; DENGUE
C1 [Trilla, Antoni] Univ Barcelona, Inst Salud Global Barcelona ISGlobal, Hosp Clin, Serv Med Prevent & Epidemiol, Barcelona, Spain.
   [Trilla-Aymerich, Guillem] CAP St Ildefons, Barcelona, Spain.
RP Trilla, A (reprint author), Univ Barcelona, Inst Salud Global Barcelona ISGlobal, Hosp Clin, Serv Med Prevent & Epidemiol, Barcelona, Spain.
EM atrilla@clinic.cat
CR Aguiar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08462
   Aguiar M, 2015, LANCET INFECT DIS, V15, P765, DOI 10.1016/S1473-3099(15)00073-0
   Alvarez R, 2016, MIL VECES MAS POSIBL
   Attaran A, 2016, PODIUM WHY PUBLIC HL
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Burattini MN, 2016, EPIDEMIOL INFECT, V144, P1904, DOI 10.1017/S0950268816000649
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   ECDC, 2016, PUBL HLTH RISKS REL
   European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS ZIK VIR
   Gasol P, 2016, SUENO OLIMPICO PESAD
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   ISGlobal y Hospital Clinic de Barcelona, 2016, COM RED RIESG CONTR
   Johansson MA, 2016, N ENGL J MED
   Massad E, 2016, LANCET
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Pacheco O, 2016, NEW ENGL J MED
   Rocklov J, 2016, EBIOMEDICINE
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   The Economist, 2016, ECONOMIST
   WHO, 2016, ZIK VIR TECHN REP IN
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   [Anonymous], 2016, LANCET INFECT DIS, V16, P619
NR 24
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER DOYMA SL
PI BARCELONA
PA TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN
SN 0025-7753
EI 1578-8989
J9 MED CLIN-BARCELONA
JI Med. Clin.
PD AUG 5
PY 2016
VL 147
IS 3
BP 113
EP 115
DI 10.1016/j.medcli.2016.06.021
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU1GZ
UT WOS:000381957500004
PM 27435517
ER

PT J
AU Mysorekar, IU
   Diamond, MS
AF Mysorekar, Indira U.
   Diamond, Michael S.
TI Modeling Zika Virus Infection in Pregnancy
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID TRANSMISSION; MICE
C1 [Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med & Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Mysorekar, IU; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mysorekar, IU (reprint author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Med & Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Li C, 2016, CELL STEM CELL
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Quicke KM, 2016, CELL HOST MICROBE
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 14
TC 1
Z9 1
U1 17
U2 17
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD AUG 4
PY 2016
VL 375
IS 5
BP 481
EP 484
DI 10.1056/NEJMcibr1605445
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS7AN
UT WOS:000380934900015
PM 27433842
ER

PT J
AU Dang, J
   Tiwari, SK
   Lichinchi, G
   Qin, Y
   Patil, VS
   Eroshkin, AM
   Rana, TM
AF Dang, Jason
   Tiwari, Shashi Kant
   Lichinchi, Gianluigi
   Qin, Yue
   Patil, Veena S.
   Eroshkin, Alexey M.
   Rana, Tariq M.
TI Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids
   through Activation of the Innate Immune Receptor TLR3
SO CELL STEM CELL
LA English
DT Article
ID TOLL-LIKE RECEPTOR-3; HIPPOCAMPAL NEUROGENESIS; NEGATIVE REGULATOR;
   CELL-PROLIFERATION; HUMAN BRAIN; NETRIN-1
AB Emerging evidence from the current outbreak of Zika virus (ZIKV) indicates a strong causal link between Zika and microcephaly. To investigate how ZIKV infection leads to microcephaly, we used human embryonic stem cell-derived cerebral organoids to recapitulate early stage, first trimester fetal brain development. Here we show that a prototype strain of ZIKV, MR766, efficiently infects organoids and causes a decrease in overall organoid size that correlates with the kinetics of viral copy number. The innate immune receptor Toll-like-Receptor 3 (TLR3) was upregulated after ZIKV infection of human organoids and mouse neurospheres and TLR3 inhibition reduced the phenotypic effects of ZIKV infection. Pathway analysis of gene expression changes during TLR3 activation highlighted 41 genes also related to neuronal development, suggesting a mechanistic connection to disrupted neurogenesis. Together, therefore, our findings identify a link between ZIKV-mediated TLR3 activation, perturbed cell fate, and a reduction in organoid volume reminiscent of microcephaly.
C1 [Dang, Jason; Tiwari, Shashi Kant; Lichinchi, Gianluigi; Qin, Yue; Patil, Veena S.; Rana, Tariq M.] Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Dang, Jason] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Lichinchi, Gianluigi] Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Eroshkin, Alexey M.] Sanford Burnham Prebys Med Discovery Inst, Bioinformat Core, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Rana, Tariq M.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
RP Rana, TM (reprint author), Univ Calif San Diego, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.; Rana, TM (reprint author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
EM trana@ucsd.edu
FU NIH
FX We thank Steve Head and the staff of the Next Generation Sequencing core
   facility at The Scripps Research Institute for help with the HT-seq and
   data analysis, and we thank members of the Rana laboratory for helpful
   discussions and advice. This work was supported in part by grants from
   the NIH.
CR Bin JM, 2015, CELL REP, V12, P1099, DOI 10.1016/j.celrep.2015.07.028
   Calvet G., 2016, LANCET INFE IN PRESS
   Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007
   De Miranda J, 2010, MBIO, V1, DOI 10.1128/mBio.00176-10
   Driggers RW, 2016, N ENGL J ME IN PRESS
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Furne C, 2008, P NATL ACAD SCI USA, V105, P14465, DOI 10.1073/pnas.0803645105
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523
   Katakowski M, 2005, NEUROSCI LETT, V385, P204, DOI 10.1016/j.neulet.2005.05.060
   Koehler KR, 2014, NAT PROTOC, V9, P1229, DOI 10.1038/nprot.2014.100
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Lazear H.M., 2016, CELL HOST M IN PRESS
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107
   Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005
   Ozmadenci D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8398
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Poliak S, 2015, ELIFE, V4, DOI 10.7554/eLife.10841
   Rossi S.L., 2016, AM J TROP M IN PRESS
   Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Yaddanapudi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026766
   Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005
NR 32
TC 7
Z9 7
U1 28
U2 28
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD AUG 4
PY 2016
VL 19
IS 2
BP 258
EP 265
DI 10.1016/j.stem.2016.04.014
PG 8
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DT6VG
UT WOS:000381622000018
PM 27162029
ER

PT J
AU Boeuf, P
   Drummer, HE
   Richards, JS
   Scoullar, MJL
   Beeson, JG
AF Boeuf, Phillipe
   Drummer, Heidi E.
   Richards, Jack S.
   Scoullar, Michelle J. L.
   Beeson, James G.
TI The global threat of Zika virus to pregnancy: epidemiology, clinical
   perspectives, mechanisms, and impact
SO BMC Medicine
LA English
DT Review
DE Biology; Pregnancy; Microcephaly; Placenta; Epidemiology; Economic cost;
   Pathogenesis; Public health
ID SEXUAL TRANSMISSION; BIRTH-DEFECTS; DENGUE VIRUS; INFECTION; BRAZIL;
   MICRONESIA; PARTICLES; OUTBREAK; EXPOSURE; STATES
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has newly emerged as a significant global threat, especially to pregnancy. Recent major outbreaks in the Pacific and in Central and South America have been associated with an increased incidence of microcephaly and other abnormalities of the central nervous system in neonates. The causal link between ZIKV infection during pregnancy and microcephaly is now strongly supported. Over 2 billion people live in regions conducive to ZIKV transmission, with similar to 4 million infections in the Americas predicted for 2016. Given the scale of the current pandemic and the serious and long-term consequences of infection during pregnancy, the impact of ZIKV on health services and affected communities could be enormous. This further highlights the need for a rapid global public health and research response to ZIKV to limit and prevent its impact through the development of therapeutics, vaccines, and improved diagnostics. Here we review the epidemiology of ZIKV; the threat to pregnancy; the clinical consequences and broader impact of ZIKV infections; and the virus biology underpinning new interventions, diagnostics, and insights into the mechanisms of disease.
C1 [Boeuf, Phillipe; Drummer, Heidi E.; Richards, Jack S.; Scoullar, Michelle J. L.; Beeson, James G.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia.
   [Boeuf, Phillipe; Richards, Jack S.; Scoullar, Michelle J. L.; Beeson, James G.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   [Drummer, Heidi E.; Richards, Jack S.; Beeson, James G.] Monash Univ, Dept Microbiol, Clayton, Vic, Australia.
   [Drummer, Heidi E.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.
RP Boeuf, P; Beeson, JG (reprint author), Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia.; Boeuf, P; Beeson, JG (reprint author), Univ Melbourne, Dept Med, Melbourne, Vic, Australia.; Beeson, JG (reprint author), Monash Univ, Dept Microbiol, Clayton, Vic, Australia.
EM philippe.boeuf@burnet.edu.au; beeson@burnet.edu.au
FU National Health and Medical Research Council (NHMRC) of Australia; NHMRC
   Independent Research Institutes Infrastructure Support Scheme; Victoria
   State Government Operational Infrastructure Support grant
FX Funding was provided by the National Health and Medical Research Council
   (NHMRC) of Australia (Early Career Fellowship to JSR, Senior Research
   Fellowships and Project Grants to JGB and HED). The Burnet Institute is
   supported by the NHMRC Independent Research Institutes Infrastructure
   Support Scheme, and a Victoria State Government Operational
   Infrastructure Support grant. Funding bodies had no role in the design
   of the study or collection, analysis, and interpretation of data or in
   writing the manuscript.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   de Fatima Vasco Aragao M, 2016, BMJ-BRIT MED J, p[353, i1901]
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   da Silva SR, 2016, J MED VIROL
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Delorme-Axford E, 2013, AUTOPHAGY, V9, P2173, DOI 10.4161/auto.26558
   Dick GW, 1953, T R SOC TROP MED HYG, V47, P1348
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Feldman DM, 2016, CLIN LAB MED, V36, P407, DOI 10.1016/j.cll.2016.01.011
   Feldman HS, 2012, ALCOHOL CLIN EXP RES, V36, P670, DOI 10.1111/j.1530-0277.2011.01664.x
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hazin Adriano N, 2016, N Engl J Med, V374, P2193, DOI 10.1056/NEJMc1603617
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kliegman RM, 2016, NELSON TXB PEDIAT
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marcdante K, 2014, NELSON ESSENTIALS PE
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M., 2016, BMJ-BRIT MED J, V352, P855
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONATH TP, 1980, AM J TROP MED HYG, V29, P624
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pyke AT, 2014, PLOS CURR, V6
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rios A, 1996, Pediatr Rev, V17, P386
   Roth A., 2014, EURO SURVEILL, V19
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Society for Maternal-Fetal Medicine Publications Committee, 2016, AM J OBSTET GYNECOL, p[214, B2]
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   Watts J, 2016, LANCET, V387, P1603, DOI 10.1016/S0140-6736(16)30249-5
   WHO, 2011, WORLD REPORT ON DISABILITY, P1
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5
   Yazigi A, 2016, J MATERN FETAL NEONA
   Zhang W, 2013, J STRUCT BIOL, V183, P86, DOI 10.1016/j.jsb.2013.04.005
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 82
TC 0
Z9 0
U1 101
U2 101
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD AUG 3
PY 2016
VL 14
AR 112
DI 10.1186/s12916-016-0660-0
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS5NT
UT WOS:000380829700001
PM 27487767
ER

PT J
AU Anderson, KB
   Thomas, SJ
   Endy, TP
AF Anderson, Kathryn B.
   Thomas, Stephen J.
   Endy, Timothy P.
TI The Emergence of Zika Virus A Narrative Review
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; ENROLLING PREGNANT-WOMEN; SEXUAL TRANSMISSION;
   CLINICAL-RESEARCH; POTENTIAL VECTOR; UNITED-STATES; DENGUE-FEVER;
   INFECTION; BRAZIL; MOSQUITOS
AB Zika virus (ZIKV) is yet another arbovirus that is rapidly emerging on a global scale, on the heels of a chikungunya epidemic in the Americas that began in 2013. A ZIKV epidemic that began in Brazil in 2015 has now spread rapidly to more than 30 countries in the Americas and the Caribbean, infecting more than 2 million inhabitants. This epidemic currently continues unabated. The explosive nature of recent outbreaks and concerning links to Guillain-Barre syndrome and microcephaly are incompletely understood. Also unknown is the relative importance of sexual transmission of ZIKV and asymptomatic ZIKV infections to the overall burden of transmission. The limited understanding of ZIKV presents an enormous challenge for responses to this rapidly emerging threat to human health. This article reviews the existing literature on ZIKV and proposes critical questions for vaccine development and other areas of needed research.
C1 Univ Minnesota, Minneapolis, MN USA.
   Walter Reed Army Inst Res, US Army Med Directorate, Armed Forces Res Inst Med Sci, Bangkok, Thailand.
   [Thomas, Stephen J.] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.
   SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Anderson, Kathryn B.] Univ Minnesota, Dept Med, MMC 741,Mayo Bldg, Minneapolis, MN 55455 USA.
   [Endy, Timothy P.] SUNY Upstate Med Univ, Div Infect Dis, 750 East Adams St,CPOB Suite 304, Syracuse, NY 13210 USA.
RP Anderson, KB (reprint author), Univ Minnesota, Dept Med, MMC 741,Mayo Bldg, Minneapolis, MN 55455 USA.
EM ande7622@umn.edu
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Afifi A K, 1994, J Family Community Med, V1, P30
   Ahmed S, 2000, NEUROLOGY, V55, P144
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B HP, 2016, EMERG INFECT DIS
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Besnard M, 2014, EURO SURVEILL, V19
   Blehar MC, 2013, WOMEN HEALTH ISS, V23, pE39, DOI 10.1016/j.whi.2012.10.003
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, N ENGL J MED
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   Centers for Disease Control and Prevention, 2016, TRAV HLTH CDC ISS IN
   Centers for Disease Control and Prevention, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention (CDC), 2003, MMWR-MORBID MORTAL W, V52, P769
   Cornblath DR, 2009, ANN NEUROL, V66, P569, DOI 10.1002/ana.21816
   Dallas County Department of Health and Human Services, 2016, HLTH ADV SEX TRANSM
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   EPPS RE, 1995, SEMIN DERMATOL, V14, P179
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foulkes MA, 2011, J WOMENS HEALTH, V20, P1429, DOI 10.1089/jwh.2011.3118
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Iacobucci G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1155
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, EP UPD ZIK VIR INF
   Pan American Health Organization, 2016, EP AL REP INCR CONG
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Roth A., 2014, EURO SURVEILL, V19
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, 2015, WEEKLY EPIDEMIOLOGIC, P609
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 76
TC 0
Z9 0
U1 59
U2 59
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD AUG 2
PY 2016
VL 165
IS 3
BP 175
EP +
DI 10.7326/M16-0617
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS2HA
UT WOS:000380583300006
PM 27135717
ER

PT J
AU Schmutzhard, E
   Pfausler, B
AF Schmutzhard, E.
   Pfausler, B.
TI Zika Virus and the Nervous System
SO AKTUELLE NEUROLOGIE
LA German
DT Article
DE zika virus; nervous system; encephalitis; microcephaly; Guillain-Barre
   syndrome
ID FRENCH-POLYNESIA; OUTBREAK; BRAZIL; INFECTION; AMERICA; TRANSMISSION;
   ARBOVIRUSES; CHIKUNGUNYA; EMERGENCE; DISEASE
AB In the past few months, Zika virus has been the subject of intense discussion both in the media and scientific circles. Recently, the WHO declared this viral infection to be a global public health emergency. 4 major reasons warrant a detailed discussion of this disease, as has been done in this journal, in the interest of both the public and neurologists. 1. Rapid worldwide spread in view of mass events, e.g. Olympic Summer Games in Rio de Janeiro, Brazil 2. Association of Zika virus epidemic with severe congenital malformations, e.g. microcephaly 3. In patients with severe encephalopathy (encephalitis?) the Zika virus has been detected 4. Association of Zika virus infection with Guillain-Barre syndrome.
C1 [Schmutzhard, E.; Pfausler, B.] Med Univ Innsbruck, Univ Klin Neurol, Anichstr 35, A-6020 Innsbruck, Austria.
RP Schmutzhard, E (reprint author), Med Univ Innsbruck, Univ Klin Neurol, Anichstr 35, A-6020 Innsbruck, Austria.
EM Erich.Schmutzhard@i-med.ac.at
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barreiro P, 2016, AIDS REV, V18, P54
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   Bogoch II, 2016, LANCET
   Campos R. de M., 2016, Journal of Clinical Virology, V77, P69
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30317-8
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paploski Igor A D, 2016, Emerg Infect Dis, V22, P1438, DOI 10.3201/eid2208.160496
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Ribeiro GS, 2016, REV SOC BRAS MED TRO, V49, P1, DOI 10.1590/0037-8682-0036-2016
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Roze B, 2016, EURO SURVEILL, V21
   Roze B, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.21.16.30205, DOI 10.2807/1560-7917.ES.2016.21.16.30205]
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Singh RK, 2016, VET Q, V9, P1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Cao-Lormeau VM, 2016, EMERG INFECT DIS, V22, P913, DOI 10.3201/eid2205.150547
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, BMJ-BRIT MED J, V352, pi657
   World Health Organisation, 2016, SIT REP 19 MAY 2016
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 65
TC 0
Z9 0
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0302-4350
EI 1438-9428
J9 AKTUEL NEUROL
JI Aktuelle Neurol.
PD AUG
PY 2016
VL 43
IS 6
BP 352
EP 357
DI 10.1055/s-0042-109974
PG 6
WC Clinical Neurology
SC Neurosciences & Neurology
GA DW7CZ
UT WOS:000383810100016
ER

PT J
AU Wahid, B
   Ali, A
   Rafique, S
   Idrees, M
AF Wahid, Braira
   Ali, Amjad
   Rafique, Shazia
   Idrees, Muhammad
TI Zika: As an emergent epidemic
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Review
DE ZIKV; Neurological complications; Pathogenesis; Future prospects
ID VIRUS-INFECTION; YELLOW-FEVER; AEDES-ALBOPICTUS; 1ST REPORT; BRAZIL;
   TRANSMISSION; CULICIDAE; MOSQUITOS; OUTBREAK; AMERICA
AB Zika virus is a new global threat for 2016 that has been swept to almost all Americas and is now posing serious threats to the entire globe. This deadly virus is playing havoc to unborn lives because of its reported association with upsurge of fetal deformation called microcephaly and neuropathic disorders including Guillain-Barre syndrome. Till today, there is no vaccine prospect, antiviral therapy or licensed medical countermeasures to curb the teratogenic outcomes of this destructive viral infection. Diagnosis, treatment, chronicity and pathogenesis are still vague and unsettled. Therefore, this review article addresses all the aspects related to this disease to mitigate the explosive rise in Zika virus infection.
C1 [Wahid, Braira; Ali, Amjad; Rafique, Shazia; Idrees, Muhammad] Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan.
RP Idrees, M (reprint author), Univ Punjab, Ctr Appl Mol Biol, Div Mol Virol, Lahore 53700, Pakistan.
EM idrees.khan96@yahoo.com
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Besnard M, 2014, EURO SURVEILL, V19
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   Cadu R, 2015, HEALTH, V386, P243
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Centers for Disease Control and Prevention, ZIK VIR SYMPT DIAGN
   Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761
   Corsica F, 2015, EMERG INFECT DIS, V21, P1887, DOI [10.3201/eid2010.151125, DOI 10.3201/EID2010.151125]
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   Dibo MR, 2011, REV SOC BRAS MED TRO, V44, P496, DOI 10.1590/S0037-86822011000400019
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontanet A, 2016, LANCET, V387, P2600, DOI 10.1016/S0140-6736(16)30773-5
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Getachew D, 2015, INTERDISCIP PERSPECT, V2015
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Halstead SB, 2014, MICROBIOL SPECTR, V2, P6
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joshi V, 2006, J MED ENTOMOL, V43, P330, DOI 10.1603/0022-2585(2006)043[0330:IOSSAT]2.0.CO;2
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050483
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   Muller GA, 2010, ENTOMOL NEWS, V121, P102, DOI 10.3157/021.121.0102
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shayama G, 2016, ZIKA LINK BIRTH DEFE
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Talan J., 2016, NEUROL TODAY, V16, P1
   Tappe D, 2014, EURO SURVEILL, V19
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Vasconcelos PFC, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   virus Zika, 2016, NURS STAND, V30, P17
   von Eije Karin J, 2015, Ned Tijdschr Geneeskd, V160, pD153
   Wang S, 2014, PROTEINS, V82, P2620, DOI 10.1002/prot.24626
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wise J., 2016, BMJ-BRIT MED J, V352, pi1242
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 73
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD AUG
PY 2016
VL 9
IS 8
BP 723
EP 729
DI 10.1016/j.apjtm.2016.06.019
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DV9EH
UT WOS:000383242400001
PM 27569879
ER

PT J
AU da Silva, SR
   Gao, SJ
AF da Silva, Suzane Ramos
   Gao, Shou-Jiang
TI Zika Virus: An Update on Epidemiology, Pathology, Molecular Biology, and
   Animal Model
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Review
DE Zika virus; epidemiology; pathology; transmission; animal model
ID SEXUAL CONTACT; DENGUE VIRUSES; BRAZIL; OUTBREAK; TRANSMISSION;
   INFECTION; GLYCOSYLATION; CHIKUNGUNYA; COLOMBIA; ILLNESS
AB Zika virus (ZIKV) was first described in 1947, and became a health emergency problem in 2016 when its association with fetal microcephaly cases was confirmed by Centers for Disease Control and Prevention (CDC) in the United States. To date, ZIKV infection has been documented in 66 countries. ZIKV is recognized as a neurotropic virus and numerous diseases manifested in multiple neurological disorders have been described, mainly in countries that have been exposed to ZIKV after the 2007 outbreak in the Federated States of Micronesia. The most dramatic consequence of ZIKV infection documented is the abrupt increase in fetal microcephaly cases in Brazil. Here, we present an update of the published research progress in the past few months. (C) 2016 Wiley Periodicals, Inc.
C1 [da Silva, Suzane Ramos; Gao, Shou-Jiang] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
RP da Silva, SR; Gao, SJ (reprint author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
EM ramosdas@usc.edu; shoujiag@usc.edu
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Baronti C., 2014, GENOME ANNOUNC, V2, P2
   Bayer A, 2016, CELL HOST MICROBE
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V3099, pS1473
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cordeiro MT, 2016, LANCET
   Cunha MS, 2016, GENOME ANNOUNC, P4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   D'Ortenzio E, 2016, N ENGL J ME IN PRESS
   Driggers RW, 2016, N ENGL J ME IN PRESS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S, 2016, 1 DETECTION ZIKA VIR
   Ferreira MLB, 2016, AAN 68 ANN M
   Garcez PP, 2016, SCIENCE
   Giovanetti M, 2016, INFECT GENET EVOL
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481
   Kostyuchenko VA, 2016, NATURE IN PRESS
   Lazear HM, 2016, CELL HOST MICROBE
   Lazear HM, 2016, J VIROL
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malkki Hemi, 2016, Nat Rev Neurol, V12, P187, DOI 10.1038/nrneurol.2016.30
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nowakowski TJ, 2016, CELL STEM CELL
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian X., 2016, CELL, V165, P1
   Rasmussen SA, 2016, N ENGL J ME IN PRESS
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI
   Roze B, 2016, EUROSURVEILLANCE, P21
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Song H, 2016, NAT STRUCT IN PRESS
   Tang H, 2016, CELL STEM CELL
   Venturi G, 2016, EURO SURVEILL, V21
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wang L, 2016, CELL HOST MICROBE
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, ZIK SIT REP ZIK VIR
   Willison HJ, 2016, LANCET
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 74
TC 1
Z9 1
U1 2
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2016
VL 88
IS 8
BP 1291
EP 1296
DI 10.1002/jmv.24563
PG 6
WC Virology
SC Virology
GA DW5FU
UT WOS:000383669500002
ER

PT J
AU Al-Abdely, HM
AF Al-Abdely, Hail M.
TI Zika An emerging teratogenic virus
SO SAUDI MEDICAL JOURNAL
LA English
DT Editorial Material
ID OUTBREAK
C1 [Al-Abdely, Hail M.] Minist Hlth, Gen Directorate Infect Prevent & Control, Riyadh, Saudi Arabia.
RP Al-Abdely, HM (reprint author), Minist Hlth, Gen Directorate Infect Prevent & Control, Riyadh, Saudi Arabia.
EM halabdely@moh.gov.sa
CR Baronti C., 2014, Genome Announcements, V2, pe00500
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 12
TC 0
Z9 0
U1 0
U2 0
PU SAUDI MED J
PI RIYADH
PA ARMED FORCES HOSPITAL, PO BOX 7897,, RIYADH 11159, SAUDI ARABIA
SN 0379-5284
J9 SAUDI MED J
JI Saudi Med. J.
PD AUG
PY 2016
VL 37
IS 8
BP 831
EP 833
DI 10.15537/smj.2016.8.15676
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DW6SR
UT WOS:000383782000001
PM 27464857
ER

PT J
AU Araujo, AQC
   Silva, MTT
   Araujo, APQC
AF Araujo, Abelardo Q. C.
   Silva, Marcus Tulius T.
   Araujo, Alexandra P. Q. C.
TI Zika virus-associated neurological disorders: a review
SO BRAIN
LA English
DT Review
DE Zika virus; arbovirus; microcephaly; Guillain-Barr; syndrome;
   neurological complications
ID GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS; VERTICAL TRANSMISSION;
   ENCEPHALITIS-VIRUS; FRENCH-POLYNESIA; FEBRUARY 2014; INFECTION; BRAZIL;
   MICE; BRAIN
AB Zika virus is spreading rapidly throughout the Americas. A number of neurological manifestations, in particular microcephaly and Guillain-Barr, syndrome, have been associated with infection. Araujo et al. discuss the role of Zika infection in the pathogenesis of these disorders, and highlight the remaining questions and uncertainties.Zika virus is spreading rapidly throughout the Americas. A number of neurological manifestations, in particular microcephaly and Guillain-Barr, syndrome, have been associated with infection. Araujo et al. discuss the role of Zika infection in the pathogenesis of these disorders, and highlight the remaining questions and uncertainties.Zika virus, an arbovirus transmitted by mosquitoes of the Aedes species, is now rapidly disseminating throughout the Americas and the ongoing Brazilian outbreak is the largest Zika virus epidemic so far described. In addition to being associated with a non-specific acute febrile illness, a number of neurological manifestations, mainly microcephaly and Guillain-Barr, syndrome, have been associated with infection. These with other rarer neurological conditions suggest that Zika virus, similar to other flaviviruses, is neuropathogenic. The surge of Zika virus-related microcephaly cases in Brazil has received much attention and the role of the virus in this and in other neurological manifestations is growing. Zika virus has been shown to be transmitted perinatally and the virus can be detected in amniotic fluid, placenta and foetus brain tissue. A significant increase in Guillain-Barr, syndrome incidence has also been reported during this, as well as in previous outbreaks. More recently, meningoencephalitis and myelitis have also been reported following Zika virus infection. In summary, while preliminary studies have suggested a clear relationship between Zika virus infection and certain neurological conditions, only longitudinal studies in this epidemic, as well as experimental studies either in animal models or in vitro, will help to better understand the role of the virus and the pathogenesis of these disorders.
C1 [Araujo, Abelardo Q. C.; Silva, Marcus Tulius T.] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis INI, Lab Clin Res Neuroinfect Lapclin Neuro, Ave Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Araujo, Abelardo Q. C.] Fed Univ Rio de Janeiro UFRJ, Deolindo Couto Inst Neurol INDC, Ave Venceslau Bras 95, BR-21941901 Rio De Janeiro, RJ, Brazil.
   [Araujo, Alexandra P. Q. C.] Fed Univ Rio de Janeiro UFRJ, Martagao Gesteira Inst Child Hlth & Paediat IPPMG, Neuropaediat Unit, Rua Bruno Lobo 50, BR-21941901 Rio De Janeiro, RJ, Brazil.
RP Araujo, AQC (reprint author), Brazilian Minist Hlth, FIOCRUZ, Evandro Chagas Natl Inst Infect Dis INI, Lab Clin Res Neuroinfect Lapclin Neuro, Ave Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM abelardo@ufrj.br
CR ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173
   Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Bahia SdS, 2015, PAN BAH DENG CHIK ZI
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brasil MdSd, 2016, B EPIDEMIOLOGICO, V47, P1
   Brasil MdSd, 2015, B EPIDEMIOL, V46, P1
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDC, 2016, EM PREP RESP ZIK VIR
   CDC, 2016, AR WITH ZIK
   CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Vieira MACES, 2015, REV INST MED TROP SP, V57, P276, DOI 10.1590/S0036-46652015000300017
   Sante Ddl, 2016, SURVEILLANCE DENGUE
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   E.C.D.C, 2015, RAP RISK ASS ZIK VIR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MATHUR A, 1982, J GEN VIROL, V59, P213, DOI 10.1099/0022-1317-59-1-213
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharma Chandra Mohan, 2011, J Indian Med Assoc, V109, P682
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119
   WHO, 2016, GUILL BARR SYNDR BRA
   WHO, 2016, ZIK POT COMPL 2016
   WHO, 2016, NEUR SYNDR CONG ABN
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 63
TC 2
Z9 2
U1 8
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD AUG
PY 2016
VL 139
BP 2122
EP 2130
DI 10.1093/brain/aww158
PN 8
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DV8NM
UT WOS:000383193700014
PM 27357348
ER

PT J
AU Zhou, HD
   Eaton, B
   Hu, ZH
   Arif, B
AF Zhou, Hedi
   Eaton, Bryan
   Hu, Zhihong
   Arif, Basil
TI Accidental discovery and isolation of Zika virus in Uganda and the
   relentless epidemiologist behind the investigations
SO VIROLOGICA SINICA
LA English
DT Editorial Material
ID CHIKUNGUNYA; INFECTION; SPECIFICITY; OUTBREAK; BRAZIL
C1 [Zhou, Hedi; Hu, Zhihong] Chinese Acad Sci, Wuhan Inst Virol, Wuhan 430071, Peoples R China.
   [Eaton, Bryan] 6 Belvedere Terrace, Ocean Grove, Vic 3226, Australia.
   [Arif, Basil] GLFC, Mol Virol Lab, Sault Ste Marie, ON P6A 2E5, Canada.
RP Arif, B (reprint author), GLFC, Mol Virol Lab, Sault Ste Marie, ON P6A 2E5, Canada.
EM basil.arif@canada.ca
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Ai JW, 2016, MICROB INFECT, V5, pe21
   Angusti A, 2008, CHEM PHARM BULL, V56, P423, DOI 10.1248/cpb.56.423
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chastel Claude, 2005, Bull Acad Natl Med, V189, P1827
   Citterio P, 2007, EXPERT OPIN INV DRUG, V16, P11, DOI 10.1517/13543784.16.1.11
   Cooke J, 2016, LANCET INFECT DIS, V16, P406, DOI 10.1016/S1473-3099(16)00123-7
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enserink M, 2006, SCIENCE, V311, P1085
   Haddow A. J., 1965, Transactions of the Royal Entomological Society of London, V117, P215
   [Anonymous], 1964, B WORLD HEALTH ORGAN
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P99, DOI 10.1053/j.spid.2006.04.009
   Lopes R J., 2016, NATURE NEWS, DOI [10.1038/nature.2016.19804, DOI 10.1038/NATURE.2016.19804]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Ravi V, 2006, Indian J Med Microbiol, V24, P83
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2016, CELL HOST MICROBE, V19, P1
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD.0b013e31806010a5
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tang H, 2016, CELL STEM CELL, V18, P1
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
NR 39
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD AUG
PY 2016
VL 31
IS 4
BP 357
EP 361
DI 10.1007/s12250-016-3821-6
PG 5
WC Virology
SC Virology
GA DU1YN
UT WOS:000382007000013
PM 27438084
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Guillain-Barre syndrome and Zika virus infection
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Editorial Material
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (reprint author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Wiwanitkit Somsri, 2016, Asian Pac J Trop Med, V9, P513, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 2
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD AUG
PY 2016
VL 74
IS 8
BP 692
EP 692
DI 10.1590/0004-282X20160089
PG 1
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA DU7UJ
UT WOS:000382419800017
PM 27556383
ER

PT J
AU Saumell, CR
   Diaz, LS
AF Roca Saumell, Carme
   Solsona Diaz, Luis
TI Zika virus. Excessive alarm or real risk?
SO ATENCION PRIMARIA
LA Spanish
DT Editorial Material
C1 [Roca Saumell, Carme] Univ Barcelona, Inst Catala Salut, EAP el Clot, Med Familia, Barcelona, Spain.
   [Roca Saumell, Carme; Solsona Diaz, Luis] Soc Catalana Med Familiar & Comunitaria, Comissio Cooperacio & Salut Int Cocoopsi, Barcelona, Spain.
   [Solsona Diaz, Luis] ABS Florida Nord, Med Familia, Unitat Docent Multiprofes Med Familia & Comunitar, Barcelona, Spain.
RP Saumell, CR (reprint author), Univ Barcelona, Inst Catala Salut, EAP el Clot, Med Familia, Barcelona, Spain.; Saumell, CR (reprint author), Soc Catalana Med Familiar & Comunitaria, Comissio Cooperacio & Salut Int Cocoopsi, Barcelona, Spain.
EM croca.bcn.ics@gencat.cat
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gil-Tarragato S, 2016, REV ENF EMERG, V15, P13
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Lopes MH, 2016, REV ASSOC MED BRAS, V62, P4, DOI 10.1590/1806-9282.62.01.4
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Organizacion Mundial de la Salud, 2016, EM INF SIT VIR ZIK M
   Soria FS, 2016, ENFERM INFEC MICR CL, V34, P219, DOI 10.1016/j.eimc.2016.03.002
   Valerio L, 2016, MED CLIN-BARCELONA, V146, P305, DOI 10.1016/j.medcli.2015.10.018
   World Health Organization, COUNTR TERR SHOW HIS
NR 11
TC 0
Z9 0
U1 4
U2 4
PU EDICIONES DOYMA S A
PI BARCELONA
PA TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN
SN 0212-6567
EI 1578-1275
J9 ATEN PRIM
JI Aten. Prim.
PD AUG-SEP
PY 2016
VL 48
IS 7
BP 429
EP 431
DI 10.1016/j.aprim.2016.05.005
PG 3
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA DU9BZ
UT WOS:000382512500002
ER

PT J
AU Muller, M
   Terry, SF
AF Muller, Marion
   Terry, Sharon F.
TI Rising Concern Regarding Pregnant Women and Zika Virus
SO GENETIC TESTING AND MOLECULAR BIOMARKERS
LA English
DT Editorial Material
C1 [Muller, Marion] Emory Univ, Atlanta, GA 30322 USA.
   [Terry, Sharon F.] Genet Alliance, 4301 Connecticut Ave,NW Suite 404, Washington, DC 20008 USA.
RP Terry, SF (reprint author), Genet Alliance, 4301 Connecticut Ave,NW Suite 404, Washington, DC 20008 USA.
EM sterry@geneticalliance.org
CR Center for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Center for Disease Control and Prevention, 2016, ZIK VIR SYMPT DIAGN
   Herszenhorn DM, 2016, NY TIMES
   Jernej M, 2016, NEW ENGL J MED, V374, P951
   Ordonez Franco, 2016, LACK ZIKA SPECIFIC T
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   WHO, 2016, HIST ZIK VIR
NR 7
TC 0
Z9 0
U1 4
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1945-0265
EI 1945-0257
J9 GENET TEST MOL BIOMA
JI Genet. Test. Mol. Biomark.
PD AUG
PY 2016
VL 20
IS 8
BP 411
EP 412
DI 10.1089/gtmb.2016.29018.sjt
PG 2
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DT2AL
UT WOS:000381283100001
PM 27414192
ER

PT J
AU Mansuy, JM
   Pasquier, C
   Daudin, M
   Chapuy-Regaud, S
   Moinard, N
   Chevreau, C
   Izopet, J
   Mengelle, C
   Bujan, L
AF Mansuy, Jean Michel
   Pasquier, Christophe
   Daudin, Myriam
   Chapuy-Regaud, Sabine
   Moinard, Nathalie
   Chevreau, Christine
   Izopet, Jacques
   Mengelle, Catherine
   Bujan, Louis
TI Zika virus in semen of a patient returning from a non-epidemic area
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Mansuy, Jean Michel; Pasquier, Christophe; Chapuy-Regaud, Sabine; Izopet, Jacques; Mengelle, Catherine] Ctr Hosp Univ Toulouse, F-31059 Toulouse, France.
   [Pasquier, Christophe; Chapuy-Regaud, Sabine; Izopet, Jacques] Univ Toulouse, UPS, Ctr Physiopathol Toulouse Purpan, INSERM U1043, Toulouse, France.
   [Daudin, Myriam; Moinard, Nathalie; Bujan, Louis] Univ Toulouse, UPS, Grp Rech Fertilite Humaine, Toulouse, France.
   [Daudin, Myriam; Moinard, Nathalie; Bujan, Louis] Ctr Hosp Univ Paule de Viguier, Ctr Etud & Conservat Oeufs & Sperme, Toulouse, France.
   [Chevreau, Christine] Inst Claudius Regaud, Inst Univ Canc Toulouse Oncopole, Med Oncol Serv, Toulouse, France.
RP Mansuy, JM (reprint author), Ctr Hosp Univ Toulouse, F-31059 Toulouse, France.
EM mansuy.jm@chu-toulouse.fr
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
NR 5
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD AUG
PY 2016
VL 16
IS 8
BP 894
EP 895
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DU4XH
UT WOS:000382215700031
PM 27477981
ER

PT J
AU Morrison, C
AF Morrison, Chris
TI DNA vaccines against Zika virus speed into clinical trials
SO NATURE REVIEWS DRUG DISCOVERY
LA English
DT News Item
AB Less than 6 months after Zika infection was declared a public health emergency, the first clinical trials of DNA vaccines against the virus are beginning.
NR 0
TC 0
Z9 0
U1 4
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1776
EI 1474-1784
J9 NAT REV DRUG DISCOV
JI Nat. Rev. Drug Discov.
PD AUG
PY 2016
VL 15
IS 8
BP 521
EP 522
DI 10.1038/nrd.2016.159
PG 2
WC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
SC Biotechnology & Applied Microbiology; Pharmacology & Pharmacy
GA DU9IT
UT WOS:000382531000003
PM 27469223
ER

PT J
AU Fontes, CAP
   dos Santos, AASMD
   Marchiori, E
AF Pantaleao Fontes, Cristina Asvolinsque
   Damas dos Santos, Alair Augusto S. M.
   Marchiori, Edson
TI Magnetic resonance imaging findings in Guillain-Barr, syndrome caused by
   Zika virus infection
SO NEURORADIOLOGY
LA English
DT Letter
C1 [Pantaleao Fontes, Cristina Asvolinsque; Damas dos Santos, Alair Augusto S. M.] Univ Fed Fluminense, Dept Radiol, Rio De Janeiro, Brazil.
   [Marchiori, Edson] Univ Fed Rio de Janeiro, Dept Radiol, Rua Thomaz Cameron 438, BR-25685120 Valparaiso, Brazil.
RP Marchiori, E (reprint author), Univ Fed Rio de Janeiro, Dept Radiol, Rua Thomaz Cameron 438, BR-25685120 Valparaiso, Brazil.
EM edmarchiori@gmail.com
CR Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Yardimci N, 2009, NEUROL SCI, V30, P431, DOI 10.1007/s10072-009-0120-0
NR 5
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-3940
EI 1432-1920
J9 NEURORADIOLOGY
JI Neuroradiology
PD AUG
PY 2016
VL 58
IS 8
BP 837
EP 838
DI 10.1007/s00234-016-1687-9
PG 2
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA DV2NN
UT WOS:000382757400012
PM 27067205
ER

PT J
AU Norton, ME
AF Norton, Mary E.
TI Guillain-Barre Syndrome Outbreak Associated With Zika Virus Infection in
   French Polynesia: A Case- Control Study EDITORIAL COMMENT
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 2
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD AUG
PY 2016
VL 71
IS 8
BP 451
EP 452
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DT2KK
UT WOS:000381309000003
ER

PT J
AU Tian, HL
   Ji, XY
   Yang, XY
   Zhang, ZX
   Lu, ZK
   Yang, KL
   Chen, C
   Zhao, Q
   Chi, H
   Mu, ZY
   Xie, W
   Wang, ZF
   Lou, HQ
   Yang, HT
   Rao, ZH
AF Tian, Hongliang
   Ji, Xiaoyun
   Yang, Xiaoyun
   Zhang, Zhongxin
   Lu, Zuokun
   Yang, Kailin
   Chen, Cheng
   Zhao, Qi
   Chi, Heng
   Mu, Zhongyu
   Xie, Wei
   Wang, Zefang
   Lou, Huiqiang
   Yang, Haitao
   Rao, Zihe
TI Structural basis of Zika virus helicase in recognizing its substrates
SO PROTEIN & CELL
LA English
DT Article
DE Zika virus; helicase; ATP; crystal structure; flavivirus
ID SOFTWARE; PROTEIN
AB The recent explosive outbreak of Zika virus (ZIKV) infection has been reported in South and Central America and the Caribbean. Neonatal microcephaly associated with ZIKV infection has already caused a public health emergency of international concern. No specific vaccines or drugs are currently available to treat ZIKV infection. The ZIKV helicase, which plays a pivotal role in viral RNA replication, is an attractive target for therapy. We determined the crystal structures of ZIKV helicase-ATP-Mn2+ and ZIKV helicase-RNA. This is the first structure of any flavivirus helicase bound to ATP. Comparisons with related flavivirus helicases have shown that although the critical P-loop in the active site has variable conformations among different species, it adopts an identical mode to recognize ATP/Mn2+. The structure of ZIKV helicase-RNA has revealed that upon RNA binding, rotations of the motor domains can cause significant conformational changes. Strikingly, although ZIKV and dengue virus (DENV) apo-helicases share conserved residues for RNA binding, their different manners of motor domain rotations result in distinct individual modes for RNA recognition. It suggests that flavivirus helicases could have evolved a conserved engine to convert chemical energy from nucleoside triphosphate to mechanical energy for RNA unwinding, but different motor domain rotations result in variable RNA recognition modes to adapt to individual viral replication.
C1 [Tian, Hongliang; Yang, Xiaoyun; Chen, Cheng; Chi, Heng; Mu, Zhongyu; Xie, Wei; Wang, Zefang; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.
   [Tian, Hongliang; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
   [Ji, Xiaoyun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.
   [Zhang, Zhongxin; Lou, Huiqiang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.
   [Lu, Zuokun; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.
   [Yang, Kailin] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44195 USA.
   [Zhao, Qi] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.
RP Yang, HT (reprint author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Yang, HT (reprint author), Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
EM yanght@tju.edu.cn
FU National Basic Research program of China (973 program) [2015CB859800,
   2014CB542800]; National Natural Science Foundation of China [31528006,
   31271331]
FX We would like to thank the staff at beamLine BL18U1 and BL19U1 of the
   Shanghai Synchrotron Radiation Facility (SSRF) for data collection;
   Henry C. Nguyen and Lanfeng Wang for discussion and advice. This work
   was supported by the National Basic Research program of China (973
   program) (Nos. 2015CB859800 and 2014CB542800) and the National Natural
   Science Foundation of China (Grant Nos. 31528006 and 31271331).
CR Brasil P, 2016, N ENGL J MED
   Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lindenbach BD, 2001, FUNDAMENTAL VIROLOGY
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Minor W, 1997, METHODS ENZYMOLOGY A, P307
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Pierson TC, 2013, FLAVIVIRUSES, V2
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 22
TC 0
Z9 0
U1 7
U2 7
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 1674-800X
EI 1674-8018
J9 PROTEIN CELL
JI Protein Cell
PD AUG
PY 2016
VL 7
IS 8
BP 562
EP 570
DI 10.1007/s13238-016-0293-2
PG 9
WC Cell Biology
SC Cell Biology
GA DT6GZ
UT WOS:000381583800003
PM 27430951
ER

PT J
AU Govindarajan, M
   Khater, HF
   Panneerselvam, C
   Benelli, G
AF Govindarajan, Marimuthu
   Khater, Hanem F.
   Panneerselvam, Chellasamy
   Benelli, Giovanni
TI One-pot fabrication of silver nanocrystals using Nicandra physalodes: A
   novel route for mosquito vector control with moderate toxicity on
   non-target water bugs
SO RESEARCH IN VETERINARY SCIENCE
LA English
DT Article
DE Biosafety; Dengue; Filariasis; Malaria; Green-synthesis; Zika virus
ID AEGYPTI DIPTERA-CULICIDAE; LEAF EXTRACT; ANOPHELES-STEPHENSI; GREEN
   SYNTHESIS; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; VETERINARY IMPORTANCE;
   LABORATORY EVALUATION; AQUATIC ORGANISMS; BORNE DISEASES
AB Mosquitoes (Diptera: Culicidae) as vectors for important diseases and parasites causing millions of deaths every year. The use of synthetic pesticides against Culicidae leads to resistance and environmental concerns. Therefore, eco-friendly control tools are a priority. In this research, Nicandra physalodes-mediated synthesis of silver nano particles (Ag NPs) was conducted, in order to control larval populations of three important mosquito vectors, Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus. Biofabricated Ag NPs were characterized using UV-vis spectrophotometry, XRD, FTIR spectroscopy, SEM, and TEM analyses. Ag NPs were highly toxic against the three mosquito vectors. Maximum efficacy was detected against A. stephensi (LC50 = 1239 mu g/mL), followed by Ae. aegypti (LC50 = 13.61 mu g/mL) and Cx. quinquefasciatus (LC50 = 14.79 mu g/mL). Interestingly, Ag NPs were safer for the non-target aquatic organism Diplonychus indicus sharing the same aquatic habitats of mosquito larvae. LC50 and LC90 values were 1032.81 and 19,076.59 mu g/mL, respectively. Overall, our results highlight that N. physalodes-fabricated Ag NPs are a promising for development of eco-friendly larvicides against mosquito vectors, with negligible toxicity against non-target aquatic water bugs. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Khater, Hanem F.] Benha Univ, Fac Vet Med, Dept Parasitol, Moshtohor 13736, Toukh, Egypt.
   [Panneerselvam, Chellasamy] Univ Tabuk, Dept Biol, Fac Sci, Tabuk 71491, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (reprint author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013
CR Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Ankamwar B, 2005, SYNTH REACT INORG ME, V35, P19, DOI 10.1081/SIM-200047527
   Benelli G., 2016, PARASITOL RES
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Benelli G, 2016, PARASITOL RES, V115, P2545, DOI 10.1007/s00436-016-5095-1
   Chopra R. N., 1986, GLOSSARY INDIAN MED
   DEO P G, 1988, International Pest Control, V30, P118
   Finney D.J., 1971, PROBIT ANAL
   Dobhal M. P., 2010, INT J ENG SCI TECHNO, V59, P15
   [Anonymous], 2016, PARASITOLOGY RES MON
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2015, PARASITOL RES, V114, P601, DOI 10.1007/s00436-014-4222-0
   Govindarajan M, 2016, PARASITOL RES, V115, P2685, DOI 10.1007/s00436-016-5038-x
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Kathiresan K, 2009, COLLOID SURFACE B, V71, P133, DOI 10.1016/j.colsurfb.2009.01.016
   KIRSON I, 1972, J CHEM SOC PERK T 1, P2109, DOI 10.1039/p19720002109
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Govindarajan Marimuthu, 2016, Journal of Asia-Pacific Entomology, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan Marimuthu, 2016, Journal of Asia-Pacific Entomology, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Oberdorster Gunter, 2005, Part Fibre Toxicol, V2, P8, DOI 10.1186/1743-8977-2-8
   Olga N., 1964, J AGR FOOD CHEM, V12, P55
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Saxena A, 2010, DIG J NANOMATER BIOS, V5, P427
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shanmugam N., 2014, APPL NANOSCI, V4, P881, DOI DOI 10.1007/S13204-013-0271-4
   Singh BP, 2010, J ENVIRON QUAL, V39, P1
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Thirunavoukkarasu M, 2013, SPECTROCHIM ACTA A, V116, P424, DOI 10.1016/j.saa.2013.07.033
   Veerakumar K, 2014, PARASITOL RES, V113, P4567, DOI 10.1007/s00436-014-4147-7
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   World Health Organization, 2005, GUID LAB FIELD TEST, P13
   Zaheer Z, 2013, COLLOID SURFACE B, V108, P90, DOI 10.1016/j.colsurfb.2013.02.023
   Zargar M, 2011, MOLECULES, V16, P6667, DOI 10.3390/molecules16086667
NR 47
TC 6
Z9 6
U1 9
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0034-5288
EI 1532-2661
J9 RES VET SCI
JI Res. Vet. Sci.
PD AUG
PY 2016
VL 107
BP 95
EP 101
DI 10.1016/j.rvsc.2016.05.017
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA DT5RZ
UT WOS:000381541600015
PM 26850541
ER

PT J
AU Hickman, HD
   Pierson, TC
AF Hickman, Heather D.
   Pierson, Theodore C.
TI Zika in the Brain: New Models Shed Light on Viral Infection
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Editorial Material
AB The current Zika virus (ZIKV) outbreak is associated with high numbers of human congenital birth defects, yet it has been unclear how ZIKV infection during pregnancy causes these abnormalities. Three new mouse models now show that ZIKV crosses the placenta and replicates in the brains of fetal mice.
C1 [Hickman, Heather D.; Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
RP Pierson, TC (reprint author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
EM piersontc@mail.nih.gov
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Chastain E.M., 2015, MBLO, V6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Hsu TH, 2012, MBIO, V3, DOI 10.1128/mBio.00131-12
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 10
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD AUG
PY 2016
VL 22
IS 8
BP 639
EP 641
DI 10.1016/j.molmed.2016.06.004
PG 3
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DT5NR
UT WOS:000381530400005
PM 27345865
ER

PT J
AU Charrel, RN
   Leparc-Goffart, I
   Pas, S
   de Lamballerie, X
   Koopmans, M
   Reusken, C
AF Charrel, Remi N.
   Leparc-Goffart, Isabelle
   Pas, Suzan
   de Lamballerie, Xavier
   Koopmans, Marion
   Reusken, Chantal
TI Background review for diagnostic test development for Zika virus
   infection
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID FRENCH-POLYNESIA; DECEMBER 2013; WEST NILE; RT-PCR; PREGNANT-WOMEN;
   YELLOW-FEVER; TRANSMISSION; OUTBREAK; FLAVIVIRUSES; BRAZIL
AB Objective To review the state of knowledge about diagnostic testing for Zika virus infection and identify areas of research needed to. address the current gaps in knowledge.
   Methods We made a non-systematic review of the published literkure about Zika virus and supplemented this with information from commercial diagnostic test kits and personal communications with researchers in European preparedness networks. The review covered current knowledge about the geographical spread, pathogen characteristics, life cycle and infection kinetics of the virus. The available molecular and serological tests and biosafety issues are described and discussed in the context of the current outbreak strain.
   Findings We identified the following areas of research to address current knowledge gaps: (i) an urgent assessment of the laboratory capacity and capability of countries to detect Zika virus; (ii) rapid and extensive field validation of the available molecular and serological tests in areas with and without Zika virus transmission, with a focus on pregnant women; (iii) monitoring the genomic diversity of circulating Zika virus strains; (iv) prospective studies into the virus infection kinetics, focusing on diagnostic sampling (specimen types, combinations and timings); and (v) developing external quality assessments for molecular and serological. testing, including differential diagnosis for similar viruses and symptom clusters. The availability of reagents for diagnostic development (virus strains and antigens, quantified viral ribonucleic acid) needs to be facilitated.
   Conclusion An international laboratory response is needed, including preparation of protocols for prospective studies to address the most pressing information needs.
C1 [Charrel, Remi N.; de Lamballerie, Xavier] Aix Marseille Univ, UMR EPV Emergence Pathol Virales, Marseille, France.
   [Leparc-Goffart, Isabelle] Armed Forces Biomed Res Inst, French Natl Reference Ctr Arbovirus, Marseille, France.
   [Pas, Suzan; Koopmans, Marion; Reusken, Chantal] Erasmus MC, WHO Collaborating Ctr Arboviruses & Viral Haemorr, Dept Virosci, Wytemaweg 80,Room EE 17-26, NL-3015 CN Rotterdam, Netherlands.
RP Reusken, C (reprint author), Erasmus MC, WHO Collaborating Ctr Arboviruses & Viral Haemorr, Dept Virosci, Wytemaweg 80,Room EE 17-26, NL-3015 CN Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
FU European Union under PREPARE [602525]; European Union under project
   European Virus Archive goes global [653316]; European Union under
   PRE-DEMICS [278433]; European Union under EDENext FP7 [261504]
FX This work received funding from the European Union under the following
   projects: PREPARE (grant agreement no. 602525), European Virus Archive
   goes global (no. 653316), PRE-DEMICS FP7/2007-2013 (no. 278433) and
   EDENext FP7 (no. 261504). This paper is catalogued by the EDENext
   Steering Committee as EDENext 444. The work of Remi N. Charrel was done
   under the framework of EurNegVec COST Action TD1303.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009
   Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   [Anonymous], 2016, DEV ZIK ANT RAP TEST
   Blow JA, 2004, J VIROL METHODS, V119, P195, DOI 10.1016/j.jviromet.2004.03.015
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Burke DS, 2001, FLAVIVIRUSES
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   [Anonymous], 2016, BRAZ CONF BLOOD TRAN
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   [Anonymous], 2016, EPID UPD OUBR ZIK VI
   Fang Y, 2009, AM J TROP MED HYG, V80, P862
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fornara C, 2015, J CLIN VIROL, V64, P45, DOI 10.1016/j.jcv.2015.01.004
   GOLLINS SW, 1986, J GEN VIROL, V67, P1941, DOI 10.1099/0022-1317-67-9-1941
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827
   Kindhauser MK, B WHO
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuno G, 1998, J VIROL, V72, P73
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pyke AT, 2014, PLOS CURR, V6, P6
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   [Anonymous], 2016, WHO SIT REP ZIK VIR
   [Anonymous], 2016, WHO SIT REP NEUR SYN
   Zika virus disease, 2016, WHOZIKVSUR161
   [Anonymous], 2016, EP UPD NEUR SYNDR CO
   [Anonymous], 2016, COUNTR TERR ZIK AUT
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 71
TC 1
Z9 1
U1 11
U2 11
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD AUG
PY 2016
VL 94
IS 8
BP 574
EP 584
DI 10.2471/BLT.16.171207
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DU3HM
UT WOS:000382101400013
PM 27516635
ER

PT J
AU Barr, KL
   Anderson, BD
   Prakoso, D
   Long, MT
AF Barr, Kelli L.
   Anderson, Benjamin D.
   Prakoso, Dhani
   Long, Maureen T.
TI Working with Zika and Usutu Viruses In Vitro
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; AEDES-ALBOPICTUS DIPTERA; BLOOD-FEEDING PATTERNS;
   CULEX-PIPIENS DIPTERA; SENTINEL CHICKENS; YELLOW-FEVER; CULICIDAE;
   TRANSMISSION; AEGYPTI; HOSTS
AB Usutu (USUV) and Zika (ZIKV) viruses are emerging arboviruses of significant medical and veterinary importance. These viruses have not been studied as well as other medically important arboviruses such as West Nile (WNV), dengue (DENV), or chikungunya (CHIKV) viruses. As such, information regarding the behavior of ZIKV and USUV viruses in the laboratory is dated. Usutu virus re-emerged in Austria in 2001 and has since spread throughout the European and Asian continents causing significant mortality among birds. Zika virus has recently appeared in the Western Hemisphere and has exhibited high rates of birth defects and sexual transmission. Information about the characteristics of USUV and ZIKV viruses are needed to better understand the transmission, dispersal, and adaptation of these viruses in new environments. Since their initial characterization in the middle of last century, technologies and reagents have been developed that could enhance our abilities to study these pathogens. Currently, standard laboratory methods for these viruses are limited to 2-3 cell lines and many assays take several days to generate meaningful data. The goal of this study was to characterize these viruses in cells from multiple diverse species. Cell lines from 17 species were permissive to both ZIKV and USUV. These viruses were able to replicate to significant titers in most of the cell lines tested. Moreover, cytopathic effects were observed in 8 of the cell lines tested. These data indicate that a variety of cell lines can be used to study ZIKV and USUV infection and may provide an updated foundation for the study of host-pathogen interactions, model development, and the development of therapeutics.
C1 [Barr, Kelli L.; Prakoso, Dhani; Long, Maureen T.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.
   [Anderson, Benjamin D.] Duke Univ, Sch Med, Div Infect Dis, Durham, NC USA.
   [Anderson, Benjamin D.] Duke Univ, Global Hlth Inst, Durham, NC USA.
RP Barr, KL (reprint author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.
EM kellilbarr@ufl.edu
CR Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P298
   Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005
   Bakonyi T, 2007, J CLIN MICROBIOL, V45, P3870, DOI 10.1128/JCM.01390-07
   Barr KL, 2012, VIRUS ADAPTATION TRE, V4, P65
   Barr KL, 2013, VIRUS ADAPTATION TRE, V5, P1
   Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   Ben Hassine T, 2014, TRANSBOUND EMERG DIS, V61, P385, DOI 10.1111/tbed.12259
   Buckley A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-71
   Burke DS, 2001, FIELDS VIROLOGY, VI, P1043
   Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809
   Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577
   Cadar D, 2014, EMERG INFECT DIS, V20, P1771, DOI 10.3201/eid2010.140909
   Cavrini F., 2009, EUROSURVEILLANCE, V14, P50
   Chambers TJ, 1998, J GEN VIROL, V79, P2375
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaibani P, 2010, J CLIN MICROBIOL, V48, P3338, DOI 10.1128/JCM.02501-09
   Gaibani P, 2012, VECTOR-BORNE ZOONOT, V12, P431, DOI 10.1089/vbz.2011.0813
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V., 2010, EMERG INFECT DIS, V18, P349, DOI DOI 10.3201/EID1802.111224
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   Hubalek Z, 2008, VIRAL IMMUNOL, V21, P247, DOI 10.1089/vim.2007.0111
   Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248
   Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005
   Lupulovic D, 2011, VECTOR-BORNE ZOONOT, V11, P1303, DOI 10.1089/vbz.2010.0249
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McIntosh BM, 1985, INT CATALOGUE ARBOVI, V3, P1059
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P447
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Pan American Health Organization (PAHO), 2015, NEUR SYNDR CONG MALF
   Pecorari M, 2009, EURO SURVEILL, V14
   Peletto S, 2012, NEW MICROBIOL, V35, P167
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Rizzoli A, 2007, VECTOR-BORNE ZOONOT, V7, P411, DOI 10.1089/vbz.2006.0626
   SAVAGE HM, 1993, J MED ENTOMOL, V30, P27
   SCHECHTER EM, 1988, J GEN VIROL, V69, P1591, DOI 10.1099/0022-1317-69-7-1591
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1
   Thaisomboonsuk BK, 2005, AM J TROP MED HYG, V72, P375
   Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 54
TC 0
Z9 0
U1 6
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004931
DI 10.1371/journal.pntd.0004931
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800066
PM 27541001
ER

PT J
AU Carlson, CJ
   Dougherty, ER
   Getz, W
AF Carlson, Colin J.
   Dougherty, Eric R.
   Getz, Wayne
TI An Ecological Assessment of the Pandemic Threat of Zika Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SPECIES DISTRIBUTION MODELS; SAMPLE-SIZE; DENGUE; TRANSMISSION; VECTOR;
   PERFORMANCE; EMERGENCE; INFECTION; TRAVELER; AMERICA
AB The current outbreak of Zika virus poses a severe threat to human health. While the range of the virus has been cataloged growing slowly over the last 50 years, the recent explosive expansion in the Americas indicates that the full potential distribution of Zika remains uncertain. Moreover, many studies rely on its similarity to dengue fever, a phylogenetically closely related disease of unknown ecological comparability. Here we compile a comprehensive spatially-explicit occurrence dataset from Zika viral surveillance and serological surveys based in its native range, and construct ecological niche models to test basic hypotheses about its spread and potential establishment. The hypothesis that the outbreak of cases in Mexico and North America are anomalous and outside the native ecological niche of the disease, and may be linked to either genetic shifts between strains, or El Nino or similar climatic events, remains plausible at this time. Comparison of the Zika niche against the known distribution of dengue fever suggests that Zika is more constrained by the seasonality of precipitation and diurnal temperature fluctuations, likely confining autochthonous nonsexual transmission to the tropics without significant evolutionary change. Projecting the range of the diseases in conjunction with three major vector species (Aedes africanus, Ae. aegypti, and Ae. albopictus) that transmit the pathogens, under climate change, suggests that Zika has potential for northward expansion; but, based on current knowledge, our models indicate Zika is unlikely to fill the full range its vectors occupy, and public fear of a vector-borne Zika epidemic in the mainland United States is potentially informed by biased or limited scientific knowledge. With recent sexual transmission of the virus globally, we caution that our results only apply to the vector-borne transmission route of the pathogen, and while the threat of a mosquito-carried Zika pandemic may be overstated in the media, other transmission modes of the virus may emerge and facilitate naturalization worldwide.
C1 [Carlson, Colin J.; Dougherty, Eric R.; Getz, Wayne] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.
   [Getz, Wayne] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa.
RP Carlson, CJ (reprint author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.
EM cjcarlson@berkeley.edu
CR Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Broenniman O., 2014, ECOSPAT SPATIAL ECOL
   Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x
   Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254
   Christofferson Rebecca C, 2016, Am J Trop Med Hyg, V95, P15, DOI 10.4269/ajtmh.15-0866
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hennessey M, 2015, MMWR-MORBID MORTAL W, P65
   Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168
   Jones C, 2013, J CLIMATE, V26, P4398, DOI 10.1175/JCLI-D-12-00554.1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MU, 2015, SCI DATA, V2, DOI [DOI 10.1038/SDATA.2015.35, 10.1038/sdata.2015.35]
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2015, SCI DATA, V1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Peterson AT, 2006, EMERG INFECT DIS, V12, P1822
   Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004
   Pigott DM, 2014, ELIFE, V3, DOI 10.7554/eLife.04395
   Ritchie SA, 2001, EMERG INFECT DIS, V7, P900
   Samy AM, 2016, MEM I O CRUZ, DOI [10.1590/0074-02760160149, DOI 10.1590/0074-02760160149]
   Shapshak P, GLOBAL VIROLOGY, DOI [10.1007/978-1-4939-2410-3_18, DOI 10.1007/978-1-4939-2410-3_18]
   Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
NR 48
TC 0
Z9 0
U1 25
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004968
DI 10.1371/journal.pntd.0004968
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800081
PM 27564232
ER

PT J
AU Jupille, H
   Seixas, G
   Mousson, L
   Sousa, CA
   Failloux, AB
AF Jupille, Henri
   Seixas, Goncalo
   Mousson, Laurence
   Sousa, Carla A.
   Failloux, Anna-Bella
TI Zika Virus, a New Threat for Europe?
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID STEGOMYIA ALBOPICTUS SKUSE; CHIKUNGUNYA; OUTBREAK; DENGUE; VECTOR;
   BRAZIL
AB Background
   Since its emergence in 2007 in Micronesia and Polynesia, the arthropod-borne flavivirus Zika virus) ZIKV) has spread in the Americas and the Caribbean, following first detection in Brazil in May 2015. The risk of ZIKV emergence in Europe increases as imported cases are repeatedly reported. Together with chikungunya virus) CHIKV) and dengue virus) DENV), ZIKV is transmitted by Aedes mosquitoes. Any countries where these mosquitoes are present could be potential sites for future ZIKV outbreak. We assessed the vector competence of European Aedes mosquitoes)Aedes aegypti and Aedes albopictus) for the currently circulating Asian genotype of ZIKV.
   Methodology/Principal Findings
   Two populations of Ae. aegypti from the island of Madeira) Funchal and Paul do Mar) and two populations of Ae. albopictus from France) Nice and Bar-sur-Loup) were challenged with an Asian genotype of ZIKV isolated from a patient in April 2014 in New Caledonia. Fully engorged mosquitoes were then maintained in insectary conditions (28 degrees +/- 1 degrees C, 16h:8h light: dark cycle and 80% humidity). 16-24 mosquitoes from each population were examined at 3, 6, 9 and 14 days post-infection to estimate the infection rate, disseminated infection rate and transmission efficiency. Based on these experimental infections, we demonstrated that Ae. albopictus from France were not very susceptible to ZIKV.
   Conclusions/Significance
   In combination with the restricted distribution of European Ae. albopictus, our results on vector competence corroborate the low risk for ZIKV to expand into most parts of Europe with the possible exception of the warmest regions bordering the Mediterranean coastline.
C1 [Jupille, Henri; Mousson, Laurence; Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors, Dept Virol, Paris, France.
   [Seixas, Goncalo; Sousa, Carla A.] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Parasitol Med, P-1200 Lisbon, Portugal.
   [Seixas, Goncalo; Sousa, Carla A.] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, P-1200 Lisbon, Portugal.
RP Failloux, AB (reprint author), Inst Pasteur, Arboviruses & Insect Vectors, Dept Virol, Paris, France.
EM anna-bella.failloux@pasteur.fr
RI Seixas, Goncalo/F-9282-2014
OI Seixas, Goncalo/0000-0001-5745-2153
FU FP7-HEALTH "Dengue research Framework for resisting epidemics in Europe"
   (DENFREE) [HEALTH.2011.2.3.3-2, 282378]; Institut Pasteur (ACIP grant)
   [A15-2014]
FX The work was supported by a grant FP7-HEALTH HEALTH.2011.2.3.3-2 (grant
   number: 282378) "Dengue research Framework for resisting epidemics in
   Europe" (DENFREE) and the Institut Pasteur (ACIP grant A15-2014). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Antoine Enfissi JC, 2015, LANCET
   Grard G, 2007, PLOS NEGLECT TROP D, V8, pe2681, DOI DOI 10.1371/J0URNAL.PNTD.0002681
   Levre E, 2002, Ann Ig, V14, P153
   Margarita Y, 2006, ACTA PARASITOL PORT, V13, P59
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   ROSEN L, 1986, AM J TROP MED HYG, V35, P642
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Tappe D, 2013, EURO SURVEILL, P19
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, EUROSURVEILLANCE, V20
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 0
Z9 0
U1 9
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004901
DI 10.1371/journal.pntd.0004901
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800043
PM 27505002
ER

PT J
AU Klase, ZA
   Khakhina, S
   Schneider, AD
   Callahan, MV
   Glasspool-Malone, J
   Malone, R
AF Klase, Zachary A.
   Khakhina, Svetlana
   Schneider, Adriano De Bernardi
   Callahan, Michael V.
   Glasspool-Malone, Jill
   Malone, Robert
TI Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID HERPES-SIMPLEX-VIRUS; WEST-NILE-VIRUS; HUMAN DENDRITIC CELLS;
   AICARDI-GOUTIERES SYNDROME; CENTRAL-NERVOUS-SYSTEM; HEPATITIS-C VIRUS;
   HUMAN CYTOMEGALOVIRUS-INFECTION; ANTIBODY-DEPENDENT ENHANCEMENT;
   CONGENITAL-RUBELLA SYNDROME; RECEPTOR TYROSINE KINASES
AB The ongoing Zika virus epidemic in the Americas and the observed association with both fetal abnormalities (primary microcephaly) and adult autoimmune pathology (Guillain-Barre syndrome) has brought attention to this neglected pathogen. While initial case studies generated significant interest in the Zika virus outbreak, larger prospective epidemiology and basic virology studies examining the mechanisms of Zika viral infection and associated pathophysiology are only now starting to be published. In this review, we analyze Zika fetal neuropathogenesis from a comparative pathology perspective, using the historic metaphor of "TORCH" viral pathogenesis to provide context. By drawing parallels to other viral infections of the fetus, we identify common themes and mechanisms that may illuminate the observed pathology. The existing data on the susceptibility of various cells to both Zika and other flavivirus infections are summarized. Finally, we highlight relevant aspects of the known molecular mechanisms of flavivirus replication.
C1 [Klase, Zachary A.; Khakhina, Svetlana] Univ Sci, Dept Biol Sci, Philadelphia, PA USA.
   [Schneider, Adriano De Bernardi] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC USA.
   [Callahan, Michael V.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA.
   [Callahan, Michael V.] Zika Fdn, College Stn, TX USA.
   [Glasspool-Malone, Jill; Malone, Robert] Ather Pharmaceut, Scottsville, VA 24590 USA.
   [Glasspool-Malone, Jill; Malone, Robert] Harvard Med Sch, Global Clin Scholars Res Training Program, Boston, MA 02115 USA.
RP Malone, R (reprint author), Ather Pharmaceut, Scottsville, VA 24590 USA.; Malone, R (reprint author), Harvard Med Sch, Global Clin Scholars Res Training Program, Boston, MA 02115 USA.
EM RWMaloneMD@gmail.com
FU UNC Research Opportunities Initiative grant
FX The authors received no specific funding for this work. Research
   reported in this publication was supported by a UNC Research
   Opportunities Initiative grant to UNC Charlotte, NC State University,
   and UNC-Chapel Hill. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Ahn HM, 2012, NEONATOLOGY, V102, P259, DOI 10.1159/000339577
   ALFORD CA, 1990, REV INFECT DIS, V12, pS745
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694
   Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003
   Atreya CD, 2004, ARCH VIROL, V149, P779, DOI 10.1007/s00705-003-0267-6
   Baldwin C, 2016, CLIN EXP RHEUMATOL, V34, P172
   BANATVALA JE, 1971, J GEN VIROL, V13, P193, DOI 10.1099/0022-1317-13-2-193
   Barefoot Katharine H, 2002, J Perinatol, V22, P86, DOI 10.1038/sj.jp.7210584
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   Barrett PN, 1996, J MED VIROL, V49, P1, DOI 10.1002/(SICI)1096-9071(199605)49:1<1::AID-JMV1>3.0.CO;2-A
   Bar-Yam Y ED, 2016, IS ZIKA CAUSE MICROC
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2013, EUROSURVEILLANCE, V2016, P21, DOI [10.2807/1560-7917.ES.2016.21.13.30181, DOI 10.2807/1560-7917]
   Bobryshev YV, 2010, DIS ESOPHAGUS, V23, P580, DOI 10.1111/j.1442-2050.2010.01061.x
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Boyle KA, 1998, J VIROL, V72, P1826
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Buers I, 2016, CYTOKINE GROWTH F R, V29, P101, DOI 10.1016/j.cytogfr.2016.03.005
   Bullerdiek J, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0240-1
   Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carpenter JE, 2016, J VIROL, V90, P379, DOI 10.1128/JVI.02389-15
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   CDC, 2016, REV DIAGN TEST ZIK C
   CHAMBERLIN TC, 1965, SCIENCE, V148, P754, DOI 10.1126/science.148.3671.754
   Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112
   Ciesek S, 2010, J INFECT DIS, V201, P1859, DOI 10.1086/652803
   Collantes-Fernandez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032123
   Compton T, 2004, TRENDS CELL BIOL, V14, P5, DOI 10.1016/j.tcb.2003.10.009
   COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192
   Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11
   Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548
   COOPER LZ, 1985, REV INFECT DIS, V7, pS2
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Coutinho R., CULEX DEVE MODIFICAR
   Crow YJ, 2014, CLIN EXP IMMUNOL, V175, P1, DOI 10.1111/cei.12115
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha Sergio Souza da, 2015, Rev Inst Med Trop Sao Paulo, V57, P481, DOI 10.1590/S0036-46652015000600004
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Delvecchio R, 2016, PREPRINT, DOI [10.1101/051268, DOI 10.1101/051268]
   Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Doerrbecker J, 2011, J INFECT DIS, V204, P1830, DOI 10.1093/infdis/jir535
   Dollner H, 2002, BJOG-INT J OBSTET GY, V109, P534, DOI 10.1111/j.1471-0528.2002.01028.x
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dube M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004530
   DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741
   DUDGEON JA, 1967, ARCH DIS CHILD, V42, P110
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pna.0703348104
   ENDERS AC, 1989, AM J ANAT, V186, P85, DOI 10.1002/aja.1001860107
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Finger-Jardim F, 2014, J MED VIROL, V86, P519, DOI 10.1002/jmv.23817
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Fujimori T, 2015, MUCOSAL IMMUNOL, V8, P1021, DOI 10.1038/mi.2014.129
   Funakoshi H, 2002, J NEUROSCI RES, V68, P150, DOI 10.1002/jnr.10211
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Huerta P, 2016, BRAIN RESEARCH IN PR, DOI [10.1016/j.brainres.2016.02.052, DOI 10.1016/J.BRAINRES.2016.02.052]
   George IO, 2009, WORLD J PEDIATR, V5, P287, DOI 10.1007/s12519-009-0054-x
   Gitlin D, 1971, IMMUNOLOGIC INCOMPET, P3
   GITLIN D, 1969, J CLIN INVEST, V48, P1433, DOI 10.1172/JCI106109
   Glass RBJ, 2004, RADIOGRAPHICS, V24, P507, DOI 10.1148/rg.242035105
   Good P, 1998, GENOMICS, V52, P382, DOI 10.1006/geno.1998.5456
   Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902
   Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132
   Halstead SB, 2014, MICROBIOLOGY SPECTRU, V2, DOI [10.1128/microbiolspec.AID-0022-2014, DOI 10.1128/MICROBIOLSPEC.AID-0022-2014]
   Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamilton ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052899
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Homan J, 2016, PREPRINT, DOI [10.1101/044834, DOI 10.1101/044834]
   Ishikawa T, 2015, INT J MOL MED, V35, P1273, DOI 10.3892/ijmm.2015.2141
   ISTAS AS, 1995, CLIN INFECT DIS, V20, P665
   Johnson EL, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19385
   Kabra NS, 2004, OBSTET GYNECOL, V103, P1004, DOI 10.1097/01.AOG.0000126180.25221.c5
   Kaewpoowat Q, 2016, INFECTION, V44, P337, DOI 10.1007/s15010-015-0867-6
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Katz Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03915
   Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6
   Kayama M, 2010, OPHTHAL RES, V43, P79, DOI 10.1159/000247592
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Kimberlin DW, 2001, PEDIATRICS, V108, P223, DOI 10.1542/peds.108.2.223
   Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325
   Kopp SJ, 2009, P NATL ACAD SCI USA, V106, P17916, DOI 10.1073/pnas.0908892106
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Kylat RI, 2006, EUR J PEDIATR, V165, P773, DOI 10.1007/s00431-006-0172-6
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledger WJ, 2008, CURR OPIN OBSTET GYN, V20, P120, DOI 10.1097/GCO.0b013e3282f734db
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Lopper M, 2004, J VIROL, V78, P8333, DOI 10.1128/jvi.78.15.8333-8341.2004
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Vianna FSL, 2015, REPROD TOXICOL, V53, P63, DOI 10.1016/j.reprotox.2015.03.007
   Luo SS, 2012, J R SOC INTERFACE, V9, P2603, DOI 10.1098/rsif.2012.0180
   Lyden TW, 2001, J IMMUNOL, V166, P3882
   Mackenzie JM, 1999, J VIROL, V73, P9555
   Mackenzie JM, 1996, J VIROL METHODS, V56, P67, DOI 10.1016/0166-0934(95)01916-2
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388
   Madani TA, 2014, ARCH VIROL, V159, P2687, DOI 10.1007/s00705-014-2134-z
   Magro-Checa C, 2016, DRUGS, V76, P459, DOI 10.1007/s40265-015-0534-3
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050483
   Maidji E, 2002, VIROLOGY, V304, P53, DOI 10.1006/viro.2002.1661
   Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MASTROMARINO P, 1990, MED MICROBIOL IMMUN, V179, P105
   McAdams RM, 2012, NEUROL RES INT, V2012, DOI [DOI 10.1155/2012/561494), 10.1155/2012/561494]
   Mejia C, 2015, FASEB J S, V29
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mis MSC, 2016, MOL CELL NEUROSCI, V72, P84, DOI 10.1016/j.mcn.2016.01.012
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moffitt KB, 2016, BIRTH DEFECTS RES A, V106, P155, DOI 10.1002/bdra.23470
   Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511
   Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015
   Musso D, 2014, EURO SURVEILL, V19
   Nandy A, 2016, CURR COMPUT-AID DRUG, V12, P87, DOI 10.2174/1573409912666160401115812
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nguyen Thong Van, 2015, EBioMedicine, V2, P59, DOI 10.1016/j.ebiom.2014.10.021
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   PAHO, 2016, ZIK EP UPD, P10
   Paploski Igor A D, 2016, Emerg Infect Dis, V22, P1438, DOI 10.3201/eid2208.160496
   Paul LM, 2016, PREPRINT, DOI [10.1101/050112, DOI 10.1101/050112]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierce AM, 2014, BRAIN RES, V1542, P206, DOI 10.1016/j.brainres.2013.10.049
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   PORTERFIELD JS, 1986, ADV VIRUS RES, V31, P335, DOI 10.1016/S0065-3527(08)60268-7
   Prada P., 2016, REUTERS
   Prasad VM, 2013, P NATL ACAD SCI USA, V110, P20105, DOI 10.1073/pnas.1316681110
   Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047
   Prieto AL, 2000, J COMP NEUROL, V425, P295
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991
   Reveiz L, 2009, REV PANAM SALUD PUBL, V26, P341, DOI 10.1590/S1020-49892009001000009
   Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417
   Rojas DP, 2016, PREPRINT, DOI [10.1101/049957, DOI 10.1101/049957]
   Paumgartten FJR, 2013, CIENC SAUDE COLETIVA, V18, P3401, DOI 10.1590/S1413-81232013001100029
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Saji F, 1999, REV REPROD, V4, P81, DOI 10.1530/ror.0.0040081
   Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Scollard DM, 2015, AM J TROP MED HYG, V92, P108, DOI 10.4269/ajtmh.13-0221
   Scutera S, 2009, J IMMUNOL, V183, P3004, DOI 10.4049/jimmunol.0804384
   Seitz HM, 2007, J IMMUNOL, V178, P5635
   SELLER MJ, 1975, ARCH DIS CHILD, V50, P484
   Shet A, 2011, INDIAN J PEDIATR, V78, P88, DOI 10.1007/s12098-010-0254-3
   Song HS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-40
   Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Steinlin MI, 1996, PEDIATR NEUROL, V15, P249, DOI 10.1016/S0887-8994(96)00170-1
   Sutherland JM, 2015, ASIAN J ANDROL, V17, P529, DOI 10.4103/1008-682X.151397
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thorbinson C, 2016, PEDIATR DRUGS, V18, P181, DOI 10.1007/s40272-016-0170-8
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Tonduti D, 2016, EUR J PAEDIATR NEURO, V20, P604, DOI 10.1016/j.ejpn.2016.03.009
   TOTH FD, 1994, CLIN EXP IMMUNOL, V96, P389
   Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115
   Ueda K, 2016, VACCINE, V34, P1971, DOI 10.1016/j.vaccine.2015.10.010
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182
   Vargesson N, 2015, BIRTH DEFECTS RES C, V105, P140, DOI 10.1002/bdrc.21096
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vianna FSL, 2013, CLIN DYSMORPHOL, V22, P59, DOI 10.1097/MCD.0b013e32835ffc58
   Vogel G., 2016, SCIENCE, DOI [10.1126/science.aaf5757, DOI 10.1126/SCIENCE.AAF5757]
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818
   Ward C, 2016, BBA-MOL CELL BIOL L, V1861, P269, DOI 10.1016/j.bbalip.2016.01.006
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650
   WHO, 2016, ON YEAR ZIK OUTBR OB
   Woo SJ, 2012, GRAEF ARCH CLIN EXP, V250, P915, DOI 10.1007/s00417-011-1648-2
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   YONEDA T, 1986, J CLIN INVEST, V77, P1613, DOI 10.1172/JCI112477
   Young OM, 2015, AM J REPROD IMMUNOL, V73, P22, DOI 10.1111/aji.12336
   Zearfoss NR, 2014, J BIOL CHEM, V289, P35530, DOI 10.1074/jbc.M114.597112
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 234
TC 0
Z9 0
U1 15
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004877
DI 10.1371/journal.pntd.0004877
PG 32
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800024
PM 27560129
ER

PT J
AU Sung, C
   Wei, Y
   Watanabe, S
   Lee, HS
   Khoo, YM
   Fan, L
   Rathore, APS
   Chan, KWK
   Choy, MM
   Kamaraj, US
   Sessions, OM
   Aw, P
   de Sessions, PF
   Lee, B
   Connolly, JE
   Hibberd, ML
   Vijaykrishna, D
   Wijaya, L
   Ooi, EE
   Low, JGH
   Vasudevan, SG
AF Sung, Cynthia
   Wei, Yuan
   Watanabe, Satoru
   Lee, How Sung
   Khoo, Yok Moi
   Fan, Lu
   Rathore, Abhay P. S.
   Chan, Kitti Wing-Ki
   Choy, Milly M.
   Kamaraj, Uma S.
   Sessions, October M.
   Aw, Pauline
   de Sessions, Paola F.
   Lee, Bernett
   Connolly, John E.
   Hibberd, Martin L.
   Vijaykrishna, Dhanasekaran
   Wijaya, Limin
   Ooi, Eng Eong
   Low, Jenny Guek-Hong
   Vasudevan, Subhash G.
TI Extended Evaluation of Virological, Immunological and Pharmacokinetic
   Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of
   Celgosivir in Dengue Fever Patients
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS-INFECTION; DOUBLE-BLIND; MOUSE MODEL; EFFICACY; INHIBITOR;
   VIREMIA; DIVERSITY; ALIGNMENT; SEVERITY; SEROTYPE
AB CELADEN was a randomized placebo-controlled trial of 50 patients with confirmed dengue fever to evaluate the efficacy and safety of celgosivir (A study registered at ClinicalTrials.gov, number NCT01619969). Celgosivir was given as a 400 mg loading dose and 200 mg bid (twice a day) over 5 days. Replication competent virus was measured by plaque assay and compared to reverse transcription quantitative PCR (qPCR) of viral RNA. Pharmacokinetics (PK) correlations with viremia, immunological profiling, next generation sequence (NGS) analysis and hematological data were evaluated as exploratory endpoints here to identify possible signals of pharmacological activity. Viremia by plaque assay strongly correlated with qPCR during the first four days. Immunological profiling demonstrated a qualitative shift in T helper cell profile during the course of infection. NGS analysis did not reveal any prominent signature that could be associated with drug treatment; however the phylogenetic spread of patients' isolates underlines the importance of strain variability that may potentially confound interpretation of dengue drug trials conducted during different outbreaks and in different countries. Celgosivir rapidly converted to castanospermine (Cast) with mean peak and trough concentrations of 5727 ng/mL (30.2 mu M) and 430 ng/mL (2.3 mu M), respectively and cleared with a half-life of 2.5 (+/- 0.6) hr. Mean viral log reduction between day 2 and 4 (VLR2-4) was significantly greater in secondary dengue than primary dengue (p = 0.002). VLR2-4 did not correlate with drug AUC but showed a trend of greater response with increasing Cmin. PK modeling identified dosing regimens predicted to achieve 2.4 to 4.5 times higher Cmin. than in the CELADEN trial for only 13% to 33% increase in overall dose. A small, non-statistical trend towards better outcome on platelet nadir and difference between maximum and minimum hematocrit was observed in celgosivir-treated patients with secondary dengue infection. Optimization of the dosing regimen and patient stratification may enhance the ability of a clinical trial to demonstrate celgosivir activity in treating dengue fever based on hematological endpoints. A new clinical trial with a revised dosing regimen is slated to start in 2016 (NCT02569827). Furthermore celgosivir's potential value for treatment of other flaviruses such as Zika virus should be investigated urgently.
C1 [Sung, Cynthia; Watanabe, Satoru; Rathore, Abhay P. S.; Chan, Kitti Wing-Ki; Kamaraj, Uma S.; Sessions, October M.; Vijaykrishna, Dhanasekaran; Ooi, Eng Eong; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
   [Sung, Cynthia] Hlth Sci Author, Vigilance & Compliance Branch, Singapore, Singapore.
   [Wei, Yuan] Singapore Clin Res Inst, Singapore, Singapore.
   [Lee, How Sung; Khoo, Yok Moi; Fan, Lu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore.
   [Choy, Milly M.; Aw, Pauline; de Sessions, Paola F.; Hibberd, Martin L.] ASTAR, Biopolis, Genome Inst Singapore, Singapore, Singapore.
   [Lee, Bernett; Connolly, John E.] ASTAR, Inst Mol & Cellular Biol, Biopolis, Singapore, Singapore.
   [Wijaya, Limin; Low, Jenny Guek-Hong] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore.
RP Vasudevan, SG (reprint author), Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
EM subhash.vasudevan@duke-nus.edu.sg
FU National Medical Research Council STOP Dengue TCR; Duke-NUS Start-up
   funds; National Medical Research Council Industry Alliance grant
   [NMRC/MOHIAFCat1/0008/2014]
FX CELADEN clinical trial was funded by "National Medical Research Council
   STOP Dengue TCR, Duke-NUS Start-up funds and National Medical Research
   Council Industry Alliance grant NMRC/MOHIAFCat1/0008/2014. The funders
   had no role in role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316
   Durantel D, 2009, CURR OPIN INVEST DR, V10, P860
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Kang WZ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-102
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Keller Thomas H, 2006, Novartis Found Symp, V277, P102, DOI 10.1002/0470058005.ch8
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Manokaran G, 2016, MICROBIOLOGY AUSTR
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524
   Sessions OM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004044
   Sim S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004052
   Sorbera LA, 2005, DRUG FUTURE, V30, P545, DOI 10.1358/dof.2005.030.06.914820
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Thai KTD, 2012, J VIROL, V86, P835, DOI 10.1128/JVI.05985-11
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Warfield KL, 2016, ANTIVIR RES, V129, P93, DOI 10.1016/j.antiviral.2016.03.001
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   WHO, 2009, DENG GUID DIAGN TREA
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918
   [Anonymous], 2010, PHARMACOKIN IN PRESS
   Liu PS, 1991, US Patent, Patent No. [5,017,563, 5017563]
NR 43
TC 0
Z9 0
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2016
VL 10
IS 8
AR e0004851
DI 10.1371/journal.pntd.0004851
PG 23
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DU7JR
UT WOS:000382390800012
ER

PT J
AU Garcia, GD
   dos Santos, LMB
   Villela, DAM
   Maciel-de-Freitas, R
AF Garcia, Gabriela de Azambuja
   Barbosa dos Santos, Lilha Maria
   Maciel Villela, Daniel Antunes
   Maciel-de-Freitas, Rafael
TI Using Wolbachia Releases to Estimate Aedes aegypti (Diptera: Culicidae)
   Population Size and Survival
SO PLOS ONE
LA English
DT Article
ID RIO-DE-JANEIRO; ZIKA VIRUS; CONTAINER PRODUCTIVITY; FIELD-EVALUATION;
   BG-SENTINEL; DENGUE; BRAZIL; MOSQUITOS; RATES; DISPERSAL
AB Mosquitoes carrying the endosymbiont bacterium Wolbachia have been deployed in field trials as a biological control intervention due to Wolbachia effects on reducing transmission of arboviruses. We performed mark, release and recapture (MRR) experiments using Wolbachia as an internal marker with daily collections with BG-Traps during the first two weeks of releases in Rio de Janeiro, Brazil. The MRR design allowed us to investigate two critical parameters that determine whether Wolbachia would successful invade a field population: the probability of daily survival (PDS) of Wolbachia-infected Aedes aegypti females, and the wild population density during releases. Released females had a PDS of 0.82 and 0.89 in the first and second weeks, respectively, immediately after releases, which is well within the range of previous estimates of survivorship of wild mosquitoes in Rio de Janeiro. Abundance estimation of wild population varied up to 10-fold higher depending on the estimation method used (634-3565 females on the average-difference model to 6365-16188 females according to Lincoln-Petersen). Wolbachia-released mosquitoes were lower than the density estimation of their wild counterparts, irrespectively of the model used. Individually screening mosquitoes for the presence of Wolbachia reduced uncertainty on abundance estimations due to fluctuation in capturing per week. A successful invasion into local population requires Ae. aegypti fitness is unaffected by Wolbachia presence, but also reliable estimates on the population size of wild mosquitoes.
C1 [Garcia, Gabriela de Azambuja; Barbosa dos Santos, Lilha Maria; Maciel-de-Freitas, Rafael] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz IOC FIOCRUZ, Lab Transmissao Hematozoarios, Rio De Janeiro, Brazil.
   [Maciel Villela, Daniel Antunes] Fundacao Oswaldo Cruz PROCC, Programa Computacao Cient, Rio De Janeiro, Brazil.
RP Maciel-de-Freitas, R (reprint author), Inst Oswaldo Cruz, Fundacao Oswaldo Cruz IOC FIOCRUZ, Lab Transmissao Hematozoarios, Rio De Janeiro, Brazil.
EM freitas@ioc.fiocruz.br
FU FAPERJ [E-26/110.168/2014]; CNPq; Brazilian Ministry of Health
   (DECIT/SVS); Foundation for the National Institutes of Health through
   the Vector-Based Transmission of Control: Discovery Research (VCTR)
   program of the Grand Challenges in Global Health Initiatives of the Bill
   and Melinda Gates Foundation
FX This work was partially supported by FAPERJ (E-26/110.168/2014), CNPq,
   the Brazilian Ministry of Health (DECIT/SVS) as well as a grant to
   Monash University from the Foundation for the National Institutes of
   Health through the Vector-Based Transmission of Control: Discovery
   Research (VCTR) program of the Grand Challenges in Global Health
   Initiatives of the Bill and Melinda Gates Foundation. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875
   Cattand P, 2006, DIS CONTROL PRIORITI
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   de Oliveira CD, 2015, B ENTOMOL RES, V105, P305, DOI 10.1017/S0007485315000085
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   Fares RCG, 2015, BIOMED RES INT, DOI 10.1155/2015/321873
   Focks DA, 2000, AM J TROP MED HYG, V62, P11
   Focks DA, 1997, AM J TROP MED HYG, V56, P159
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   GILLIES M. T., 1961, BULL ENT RES, V52, P99
   Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2
   Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Johnson PH, 2012, J MED ENTOMOL, V49, P29, DOI 10.1603/ME11116
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003
   Maciel-de-Freitas R, 2014, B WORLD HEALTH ORGAN, V92, P685, DOI 10.2471/BLT.13.119081
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659
   Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Muir LE, 1998, AM J TROP MED HYG, V58, P277
   Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913
   PAHO/WHO, 2016, NUMB REP CAS DENG SE
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201
   Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030
   SHEPPARD PM, 1969, B WORLD HEALTH ORGAN, V40, P467
   Silver JB, 2008, MOSQUITO ECOLOGY FIE
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   TRPIS M, 1995, J MED ENTOMOL, V32, P27
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   Villela DAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123794
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 54
TC 0
Z9 0
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 1
PY 2016
VL 11
IS 8
AR e0160196
DI 10.1371/journal.pone.0160196
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS9NO
UT WOS:000381110300031
ER

PT J
AU Jayakumar, P
   Bache, K
   Lippmann, S
AF Jayakumar, Priyanga
   Bache, Kendall
   Lippmann, Steven
TI How Is Zika Transmitted?
SO SOUTHERN MEDICAL JOURNAL
LA English
DT Letter
ID VIRUS; TRANSMISSION
C1 [Jayakumar, Priyanga; Bache, Kendall; Lippmann, Steven] Univ Louisville, Sch Med, Louisville, KY 40292 USA.
RP Jayakumar, P (reprint author), Univ Louisville, Sch Med, Louisville, KY 40292 USA.
CR Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, N ENGL J MED
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
NR 5
TC 0
Z9 0
U1 8
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0038-4348
EI 1541-8243
J9 SOUTH MED J
JI South.Med.J.
PD AUG
PY 2016
VL 109
IS 8
BP 492
EP 492
DI 10.14423/SMJ.0000000000000494
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU8RD
UT WOS:000382480500014
PM 27490661
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Neonatal neuroradiological aspects in Zika virus infection
SO CHILDS NERVOUS SYSTEM
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (reprint author), Surindra Rajabhat Univ, Surin, Thailand.
EM wviroj@yahoo.com
CR Cavalheiro S, 2016, CHILDS NERV SYST
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 2
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD AUG
PY 2016
VL 32
IS 8
BP 1349
EP 1349
DI 10.1007/s00381-016-3102-6
PG 1
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA DS3FB
UT WOS:000380667400002
PM 27138556
ER

PT J
AU Hotez, PJ
AF Hotez, Peter J.
TI What Does Zika Virus Mean for the Children of the Americas?
SO JAMA PEDIATRICS
LA English
DT Review
ID BRAIN DISRUPTION SEQUENCE; FETAL; INFECTION
C1 [Hotez, Peter J.] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Coll Med, Dept Mol Virol & Microbiol, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Hotez, Peter J.] Sabin Vaccine Inst, Houston, TX USA.
   [Hotez, Peter J.] Texas Childrens Hosp, Ctr Vaccine Dev, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
   [Hotez, Peter J.] Rice Univ, James Baker Inst Publ Policy 3, Houston, TX USA.
RP Hotez, PJ (reprint author), Baylor Coll Med, Natl Sch Trop Med, 1 Baylor Plaza,MS 320, Houston, TX 77030 USA.
EM hotez@bcm.edu
CR de Fatima Vasco Aragao M, 2016, BMJ-BRIT MED J, p[353, i1901]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hotez PJ, 2014, JAMA PSYCHIAT, V71, P1099, DOI 10.1001/jamapsychiatry.2014.1045
   Hotez PJ., 2016, NY TIMES, pA19
   HUGHES HE, 1986, PEDIATRICS, V78, P85
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 19
TC 1
Z9 1
U1 4
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD AUG
PY 2016
VL 170
IS 8
BP 787
EP 789
DI 10.1001/jamapediatrics.2016.1465
PG 3
WC Pediatrics
SC Pediatrics
GA DS9XW
UT WOS:000381137800017
PM 27322491
ER

PT J
AU Hotez, PJ
AF Hotez, P. J.
TI What does Zika virus mean for the children of the Americas? (vol 170, pg
   787, 2016)
SO JAMA PEDIATRICS
LA English
DT Correction
CR Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
NR 1
TC 0
Z9 0
U1 4
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD AUG
PY 2016
VL 170
IS 8
BP 811
EP 811
PG 1
WC Pediatrics
SC Pediatrics
GA DS9XW
UT WOS:000381137800030
ER

PT J
AU Martinez-Palomo, A
AF Martinez-Palomo, Adolfo
TI Revisiting Zika (and Rubella)
SO JOURNAL OF PUBLIC HEALTH POLICY
LA English
DT Article
DE Zika virus; dengue; chikungunya; rubella vaccine; microcephaly
AB Three months after the World Health Organization declared the epidemic of Zika virus infections to be a Public Health Emergency of International Concern, we can look back at what we have learned and prospects for controlling the disease. Although Zika virus infections may explain many cases of brain damage in newborns, it may not be the only cause. We need a clear association between confirmed cases of Zika infections in pregnant women and microcephaly in newborns. Until we reach a firm conclusion, past experience with another virus that causes damage to newborns offers some hope. The development and almost universal use of rubella vaccine has all but eliminated the congenital rubella syndrome in the world. Rapid development of Zika virus vaccine might well do the same for this epidemic.
C1 [Martinez-Palomo, Adolfo] Ctr Adv Studies, Mol Pathogenesis, Ave IPN 2508, Mexico City 01030, DF, Mexico.
RP Martinez-Palomo, A (reprint author), Ctr Adv Studies, Mol Pathogenesis, Ave IPN 2508, Mexico City 01030, DF, Mexico.
EM amartine@cinvestav.mx
CR Brasil P., 2016, NEW ENGL J MED, DOI [10.1056/NEJMoax6oz412, DOI 10.1056/NEJMOA16OZ412]
   Martinez-Palomo A, 2016, J PUBLIC HLTH POLICY, V2016, P133, DOI [10.ioj7/jphp.2016.11, DOI 10.1057/JPHP.2016.11]
NR 2
TC 0
Z9 0
U1 14
U2 14
PU PALGRAVE MACMILLAN LTD
PI BASINGSTOKE
PA BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND
SN 0197-5897
EI 1745-655X
J9 J PUBLIC HEALTH POL
JI J. Public Health Policy
PD AUG
PY 2016
VL 37
IS 3
BP 273
EP 276
DI 10.1057/s41271-016-0001-8
PG 4
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA DT9SH
UT WOS:000381842100001
ER

PT J
AU de Miranda, HA
   Costa, MC
   Frazao, MAM
   Simao, N
   Franchischini, S
   Moshfeghi, DM
AF de Miranda, Homero Augusto, II
   Costa, Marcelo Cavalcante
   Monteiro Frazao, Maria Auxiliadora
   Simao, Natalia
   Franchischini, Sandra
   Moshfeghi, Darius M.
TI Expanded Spectrum of Congenital Ocular Findings in Microcephaly with
   Presumed Zika Infection
SO OPHTHALMOLOGY
LA English
DT Article
ID TORPEDO MACULOPATHY; DENGUE; CHORIORETINOPATHY; BRAZIL
AB Purpose: To describe the ocular findings of 3 cases of suspected congenital Zika viral infection with microcephaly and maculopathy.
   Design: Retrospective, consecutive case series.
   Participants: Three male infants born in northern Brazil whose mothers demonstrated a viral syndrome during the first trimester and who subsequently were born with microcephaly.
   Methods: Observational report of macular findings.
   Main Outcome Measures: Continued observation.
   Results: Three male infants were born with microcephaly to mothers who had a viral syndrome during the first trimester of gestation in an area that subsequently has demonstrated epidemic Zika infection, a flavivirus related to Dengue. Ocular examination was performed. All 6 eyes demonstrated a pigmentary maculopathy ranging from mild to pronounced. In 4 eyes, well-delineated macular chorioretinal atrophy with a hyperpigmented ring developed. Three eyes demonstrated vascular tortuosity and 2 eyes demonstrated a pronounced early termination of the retinal vasculature on photographic evaluation. Two eyes demonstrated a washed out peripheral retina with a hypolucent spot. One eye had scattered subretinal hemorrhages external to the macula. Finally, 1 eye demonstrated peripheral pigmentary changes and clustered atrophic lesions resembling grouped congenital albinotic spots (polar bear tracks).
   Conclusions: Zika virus has been linked to microcephaly in children of mothers with a viral syndrome during the first trimester of pregnancy. Ocular findings previously described a pigmentary retinopathy and atrophy that now can be expanded to include torpedo maculopathy, vascular changes, and hemorrhagic retinopathy. Ophthalmologic screening guidelines need to be defined to determine which children would benefit from newborn screening in affected regions. (C) 2016 by the American Academy of Ophthalmology.
C1 [de Miranda, Homero Augusto, II; Costa, Marcelo Cavalcante; Monteiro Frazao, Maria Auxiliadora] Ophthalm Telemed Santa Casa Sao Paulo, Sao Paulo, Brazil.
   [Simao, Natalia] Univ Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
   [Franchischini, Sandra] Univ Santo Amaro, Dept Ophthalmol, Sao Paulo, Brazil.
   [Moshfeghi, Darius M.] Stanford Univ, Sch Med, Dept Ophthalmol, Horngren Family Vitreoretinal Ctr,Byers Eye Inst, Palo Alto, CA 94303 USA.
RP Moshfeghi, DM (reprint author), Stanford Univ, Horngren Family Vitreoretinal Ctr, Div Pediat Vitreoretinal Dis & Surg, Dept Ophthalmol,Byers Eye Inst, Palo Alto, CA 94303 USA.
EM dariusm@stanford.edu
FU Claire Giannini Foundation (San Francisco, CA); Clarity Medical Systems,
   Inc. (Pleasanton, CA)
FX The author(s) have made the following disclosure(s): D.M.M.: Consultant
   - Genentech (South San Francisco, CA); Alcon (Fort Worth, TX);
   Synergetics, Inc. (O'Fallon, MO); Iconic Therapeutics, Inc. (South San
   Francisco, CA); Intrexon (Germantown, MD); Oraya Therapeutics (Newark,
   CA); Thrombogenics (Leuven, Belgium); Visunex Medical Systems Co. Ltd
   (Grand Cayman, Cayman Islands); Financial support - Claire Giannini
   Foundation (San Francisco, CA); Clarity Medical Systems, Inc.
   (Pleasanton, CA); Board membership - Promisight, Inc. (Palo Alto, CA);
   Versl, Inc. (Palo Alto, CA); Patents - InSitu Therapeutics (Mill Valley,
   CA); Equity owner - Promisight; Versl; Visnuex; Krypton Vision (Fremont,
   CA)
CR Aggarwal Anju, 2013, J Neurosci Rural Pract, V4, P288, DOI 10.4103/0976-3147.118781
   Atchaneeyasakul LO, 1998, OPHTHALMIC GENET, V19, P39, DOI 10.1076/opge.19.1.39.2178
   Braithwaite T, 2013, BMJ CASE REP
   CANTU JM, 1977, HUM GENET, V36, P243, DOI 10.1007/BF00273265
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Fierson WM, 2013, PEDIATRICS, V131, P189, DOI 10.1542/peds.2012-2996
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Rosa RFM, 2015, SAO PAULO MED J, V133, P377, DOI 10.1590/1516-3180.2013.7930003
   MCKUSICK VA, 1966, ARCH OPHTHALMOL-CHIC, V75, P597
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   NELLHAUS G, 1968, PEDIATRICS, V41, P106
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Pastora N, 2012, OPHTHALMIC GENET, V33, P116, DOI 10.3109/13816810.2011.626012
   Richez F, 2010, J FR OPHTALMOL, V33, P296, DOI 10.1016/j.jfo.2009.12.013
   ROSEMAN RL, 1992, ARCH OPHTHALMOL-CHIC, V110, P1358
   Shields CL, 2010, ARCH OPHTHALMOL-CHIC, V128, P499, DOI 10.1001/archophthalmol.2010.29
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Su DHW, 2007, OPHTHALMOLOGY, V114, P1743, DOI 10.1016/j.ophtha.2007.03.054
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villegas VM, 2014, OSLI RETINA, V45, P222, DOI 10.3928/23258160-20140410-01
   Yzer S, 2013, JAMA OPHTHALMOL, V131, P1324, DOI 10.1001/jamaophthalmol.2013.4349
NR 25
TC 0
Z9 0
U1 47
U2 47
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD AUG
PY 2016
VL 123
IS 8
BP 1788
EP 1794
DI 10.1016/j.ophtha.2016.05.001
PG 7
WC Ophthalmology
SC Ophthalmology
GA DS4MC
UT WOS:000380754200038
ER

PT J
AU Werner, H
   Sodre, D
   Hygino, C
   Guedes, B
   Fazecas, T
   Nogueira, R
   Daltro, P
   Tonni, G
   Lopes, J
   Araujo, E
AF Werner, Heron
   Sodre, Danielle
   Hygino, Celso
   Guedes, Bianca
   Fazecas, Tatiana
   Nogueira, Renata
   Daltro, Pedro
   Tonni, Gabriele
   Lopes, Jorge
   Araujo Junior, Edward
TI First-trimester intrauterine Zika virus infection and brain pathology:
   prenatal and postnatal neuroimaging findings
SO PRENATAL DIAGNOSIS
LA English
DT Article
ID BRAZIL
C1 [Werner, Heron; Hygino, Celso; Guedes, Bianca; Fazecas, Tatiana; Nogueira, Renata; Daltro, Pedro] Clin Diagnost Imagem CDPI, Dept Radiol, Rio De Janeiro, RJ, Brazil.
   [Sodre, Danielle] Rio de Janeiro State Univ UERJ, Dept Obstet & Gynecol, Rio De Janeiro, RJ, Brazil.
   [Tonni, Gabriele] Guastalla Civil Hosp, Dept Obstet & Gynecol, AUSL Reggio Emilia, Reggio Emilia, Italy.
   [Lopes, Jorge] Pontificia Univ Catolica PUC Rio, Dept Arts & Design, Rio De Janeiro, RJ, Brazil.
   [Araujo Junior, Edward] Fed Univ Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Sao Paulo, SP, Brazil.
RP Araujo, E (reprint author), Fed Univ Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Sao Paulo, SP, Brazil.
EM araujojred@terra.com.br
OI Araujo Junior, Edward/0000-0002-6145-2532
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Araujo E, 2014, J ULTRAS MED, V33, P1185, DOI 10.7863/ultra.33.7.1185
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Driggers R. W., 2016, NEW ENGL J MED, DOI DOI 10.1056/NEJMOA1601824
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   Werner H, 2014, ULTRASOUND Q, V30, P69, DOI 10.1097/RUQ.0000000000000048
NR 12
TC 0
Z9 0
U1 8
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD AUG
PY 2016
VL 36
IS 8
BP 785
EP 789
DI 10.1002/pd.4860
PG 5
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA DS9LO
UT WOS:000381104800013
PM 27316349
ER

PT J
AU Lucchese, G
   Kanduc, D
AF Lucchese, Guglielmo
   Kanduc, Darja
TI Zika virus and autoimmunity: From microcephaly to Guillain-Barre
   syndrome, and beyond
SO AUTOIMMUNITY REVIEWS
LA English
DT Review
DE Zika virus infection; Microcephaly; Centriolar and centrosomal proteins;
   Ocular anomalies; Brain calcification; Aicardi-Goutieres syndromes;
   Guillain-Barre-like syndromes; Peptide sharing; Crossreactivity;
   Autoimmunity
ID AICARDI-GOUTIERES-SYNDROME; L-SERINE BIOSYNTHESIS; 3-PHOSPHOGLYCERATE
   DEHYDROGENASE; PONTOCEREBELLAR HYPOPLASIA; INTELLECTUAL DISABILITY;
   MUTATIONS; BRAIN; GENE; ANTIBODIES; PHENOTYPE
AB Zika virus (ZIKV) infection during, pregnancy may be linked to fetal neurological complications that include brain damage and microcephaly. How the viral infection relates to fetal brain malformations is unknown. This study analyzes ZIKV polyprotein for peptide sharing with human proteins that, when altered, associate with microcephaly and brain calcifications. Results highlight a vast viral versus human peptide commonality that, in particular, involves centriolar and centrosomal components canonically cataloged as microcephaly proteins, i.e., C2CD3, CASC5, CP131, GCP4, KIF2A, STIL, and TBG. Likewise, a search for ZIKV peptide occurrences in human proteins linked to Guillain-Barre-like syndromes also show a high, unexpected level of peptide sharing. Of note, further analyses using the Immune Epitope DataBase (IEDB) resource show that many of the shared peptides are endowed with immunological potential. The data indicate that immune reactions following ZIKV infection might be a considerable source of crossreactions with brain-specific proteins and might contribute to the ZIKV-associated neuropathologic sequelae. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lucchese, Guglielmo] Free Univ Berlin, Brain & Language Lab, D-14195 Berlin, Germany.
   [Kanduc, Darja] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.
RP Kanduc, D (reprint author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.
EM darja.kanduc@uniba.it
FU Deutscher Akademischer Austauschdienst (DAAD); Deutsche
   Forschungsgemeinschaft (DFG); Freie Universitat Berlin, Germany
FX GL gratefully acknowledges support by the Deutscher Akademischer
   Austauschdienst (DAAD), the Deutsche Forschungsgemeinschaft (DFG), and
   the Freie Universitat Berlin, Germany.
CR Ahmed I, 2015, HUM MOL GENET, V24, P3172, DOI 10.1093/hmg/ddv069
   Ahmed MY, 2015, NEUROLOGY, V84, P1745, DOI 10.1212/WNL.0000000000001523
   ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001
   Balestra FR, 2013, DEV CELL, V25, P555, DOI 10.1016/j.devcel.2013.05.016
   Beltran-Valero D, 2002, AM J HUM GENET, V71, P165
   Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995
   Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   Celato A, 2013, BRAIN DEV-JPN, V35, P675, DOI 10.1016/j.braindev.2012.10.014
   Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Devaux JJ, 2012, J PERIPHER NERV SYST, V17, P62, DOI 10.1111/j.1529-8027.2012.00372.x
   Devisme L, 2012, BRAIN, V135, P469, DOI 10.1093/brain/awr357
   Frank A, 2002, IMMUNOLOGY EVOLUTION
   Gurling HMD, 2006, ARCH GEN PSYCHIAT, V63, P844, DOI 10.1001/archpsyc.63.8.844
   Ito H, 2015, MOL PSYCHIATR, V20, P459, DOI 10.1038/mp.2014.69
   Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283
   Jampol LM, 2016, JAMA OPHTHALMOL
   Kanduc D, 2010, SELF NONSELF, V1, P255, DOI 10.4161/self.1.3.11897
   Kanduc D, 2007, AUTOIMMUN REV, V6, P290, DOI 10.1016/j.autrev.2006.09.004
   Kanduc D, 2013, CURR PROTEIN PEPT SC, V14, P111
   Kanduc Darja, 2012, Front Biosci (Schol Ed), V4, P1393
   Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886
   Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519
   KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997
   Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee-Kirsch MA, 2014, CLIN EXP IMMUNOL, V175, P17, DOI 10.1111/cei.12160
   Lucchese G, 2014, EPILEPSY RES TREAT, V2014
   Lucchese G, 2016, CURR DRUG DISCOV TEC
   Lucchese G, 2014, SCHIZOPHRENIA BULL, V40, P362, DOI 10.1093/schbul/sbs197
   MacFadden DR, 2016, CMAJ            0208
   Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198
   Martinez-Garay I, 2007, EUR J HUM GENET, V15, P29, DOI 10.1038/sj.ejhg.5201717
   MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402
   Mlakar J, 2016, N ENGL J MED     FEB, P10
   Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015
   Nigg EA, 2014, FEBS LETT, V588, P2366, DOI 10.1016/j.febslet.2014.06.030
   Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091
   Pillai-Kastoori L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004491
   Qi YL, 2005, EUR J NEUROSCI, V22, P1277, DOI 10.1111/j.1460-9568.2005.04339.x
   Querol L, 2015, CURR OPIN NEUROL, V28, P474, DOI 10.1097/WCO.0000000000000233
   Querol L, 2013, ANN NEUROL, V73, P370, DOI 10.1002/ana.23794
   Rex M, 1998, MOL BRAIN RES, V55, P28, DOI 10.1016/S0169-328X(97)00354-9
   Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373
   Rosch RE, 2014, J PERIPHER NERV SYST, V19, P246, DOI 10.1111/jns.12089
   Rubin EJ, 2016, N ENGL J MED     FEB, P10
   Sawai S, 2014, NEUROLOGY, V83, P113, DOI 10.1212/WNL.0000000000000566
   Scheidecker S, 2015, AM J HUM GENET, V96, P666, DOI 10.1016/j.ajhg.2015.02.011
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971
   Smith DW, 2016, LANCET, P29
   Stathopoulos P, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.260
   Tsurusaki Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5011
   UniProt Consortium, 2009, Nucleic Acids Res, V37, pD169, DOI 10.1093/nar/gkn664
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wang QQ, 2013, GENE DEV, V27, P615, DOI 10.1101/gad.212308.112
   Wanschitz J, 2008, J NEUROL, V255, P917, DOI 10.1007/s00415-008-0815-9
   Wurm A, 2008, EXP EYE RES, V86, P895, DOI 10.1016/j.exer.2008.03.004
   Yamasaki M, 2001, J NEUROSCI, V21, P7691
   Yonekura K, 2004, J NEUROIMMUNOL, V156, P204, DOI 10.1016/j.jneuroim.2004.07.017
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 63
TC 4
Z9 4
U1 21
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD AUG
PY 2016
VL 15
IS 8
BP 801
EP 808
DI 10.1016/j.autrev.2016.03.020
PG 8
WC Immunology
SC Immunology
GA DS2KL
UT WOS:000380598300004
PM 27019049
ER

PT J
AU Lucchese, G
   Kanduc, D
AF Lucchese, Guglielmo
   Kanduc, Darja
TI Reply concerning the article "Zika virus and autoimmunity: From
   microcephaly to Guillain-Barre syndrome, and beyond"
SO AUTOIMMUNITY REVIEWS
LA English
DT Letter
C1 [Lucchese, Guglielmo] Free Univ Berlin, Brain & Language Lab, D-14195 Berlin, Germany.
   [Kanduc, Darja] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.
RP Kanduc, D (reprint author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70126 Bari, Italy.
EM dkanduc@gmail.com
CR Kanduc D, 2012, J PEPT SCI, V18, P487, DOI 10.1002/psc.2419
NR 1
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD AUG
PY 2016
VL 15
IS 8
BP 854
EP 854
DI 10.1016/j.autrev.2016.04.003
PG 1
WC Immunology
SC Immunology
GA DS2KL
UT WOS:000380598300010
PM 27060380
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus, autoimmunity and microcephaly: Other things for
   consideration
SO AUTOIMMUNITY REVIEWS
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Wiwanitkit House, Bangkok, Thailand.
RP Wiwanitkit, V (reprint author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Lucchese G, 2016, AUTOIMMUN REV, V24, P801
   Wiwanitkit V, 2005, CLIN APPL THROMB-HEM, V11, P112, DOI 10.1177/107602960501100116
   Wiwanitkit Viroj, 2006, J Ayub Med Coll Abbottabad, V18, P13
   Wiwanitkit Viroj, 2005, Nanomedicine, V1, P239, DOI 10.1016/j.nano.2005.06.002
NR 4
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-9972
EI 1873-0183
J9 AUTOIMMUN REV
JI Autoimmun. Rev.
PD AUG
PY 2016
VL 15
IS 8
BP 855
EP 855
DI 10.1016/j.autrev.2016.04.002
PG 1
WC Immunology
SC Immunology
GA DS2KL
UT WOS:000380598300011
PM 27060381
ER

PT J
AU Olagnier, D
   Muscolini, M
   Coyne, CB
   Diamond, MS
   Hiscott, J
AF Olagnier, David
   Muscolini, Michela
   Coyne, Carolyn B.
   Diamond, Michael S.
   Hiscott, John
TI Mechanisms of Zika Virus Infection and Neuropathogenesis
SO DNA AND CELL BIOLOGY
LA English
DT Article
ID CAUSES BIRTH-DEFECTS; CELLS; TRANSMISSION; ORGANOIDS; MODELS; MICE
AB A spotlight has been focused on the mosquito-borne Zika virus (ZIKV) because of its epidemic outbreak in Brazil and Latin America, as well as the severe neurological manifestations of microcephaly and Guillain Barre syndrome associated with infection. In this review, we discuss the recent literature on ZIKV-host interactions, including new mechanistic insight concerning the basis of ZIKV-induced neuropathogenesis.
C1 [Olagnier, David] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada.
   [Muscolini, Michela; Hiscott, John] Fdn Cenci Bolognetti, Ist Pasteur, Viale Regina Elena 291, I-00161 Rome, Italy.
   [Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA.
RP Hiscott, J (reprint author), Fdn Cenci Bolognetti, Ist Pasteur, Viale Regina Elena 291, I-00161 Rome, Italy.
EM john.hiscott@istitutopasteur.it
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Quicke Kendra M., 2016, CELL HOST MICROBE, DOI [10.1016/j.chom.2016.05.015, DOI 10.1016/J.CHOM.2016.05.015]
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 44
TC 0
Z9 0
U1 53
U2 53
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD AUG
PY 2016
VL 35
IS 8
BP 367
EP 372
DI 10.1089/dna.2016.3404
PG 6
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA DS5JH
UT WOS:000380817500001
PM 27348136
ER

PT J
AU Ventura, CV
   Maia, M
   Travassos, SB
   Martins, TT
   Patriota, F
   Nunes, ME
   Agra, C
   Torres, VL
   van der Linden, V
   Ramos, RC
   Rocha, MAW
   Silva, PS
   Ventura, LO
   Belfort, R
AF Ventura, Camila V.
   Maia, Mauricio
   Travassos, Simone B.
   Martins, Thayze T.
   Patriota, Felipe
   Nunes, Marcos Eugenio
   Agra, Cristiana
   Torres, Virginia L.
   van der Linden, Vanessa
   Ramos, Regina C.
   Rocha, Maria Angela W.
   Silva, Paula S.
   Ventura, Liana O.
   Belfort, Rubens, Jr.
TI Risk Factors Associated With the Ophthalmoscopic Findings Identified in
   Infants With Presumed Zika Virus Congenital Infection
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID TRANSMISSION; CHILD
AB IMPORTANCE The Zika virus (ZIKV) might cause microcephaly and ophthalmoscopic findings in infants of mothers infected during pregnancy.
   OBJECTIVE To assess and identify possible risk factors for ophthalmoscopic findings in infants born with microcephaly and a presumed clinical diagnosis of ZIKV intrauterine infection.
   DESIGN, SETTING, AND PARTICIPANTS We conducted a cross-sectional study at the Altino Ventura Foundation in Recife, Brazil, that included 40 infants with microcephaly born in Pernambuco state, Brazil, between May and December 2015. Toxoplasmosis, rubella, cytomegalovirus, syphilis, and human immunodeficiency virus were ruled out in all of them. Testing of cerebrospinal fluid for ZIKV using IgM antibody-capture enzyme-linked immunosorbent assay was performed in 24 of 40 infants (60.0%). The infants and mothers underwent ocular examinations. The infants were divided into 2 groups, those with and without ophthalmoscopic alterations, for comparison.
   MAIN OUTCOMES AND MEASURES Identification of risk factors for ophthalmoscopic findings in infants born with microcephaly and ZIKV intrauterine infection.
   RESULTS Among the 40 infants, the mean (SD) age was 2.2 (1.2) months (range, 0.1-7.3 months). Of the 24 infants tested, 100% had positive results for ZIKV infection: 14 of 22 infants (63.6%) from the group with ophthalmoscopic findings and 10 of 18 infants (55.6%) from the group without ophthalmoscopic findings. The major symptoms reported in both groups were rash by 26 mothers (65.0%), fever by 9 mothers (22.5%), headache by 9 mothers (22.5%), and arthralgia by 8 mothers (20.0%). No mothers reported conjunctivitis or other ocular symptoms during pregnancy or presented signs of uveitis at the time of examination. Thirty-seven eyes (46.3%) of 22 infants (55.0%) had ophthalmoscopic alterations. Ten mothers (71.4%) of infants with ocular findings reported symptoms during the first trimester (frequency, 0.48; 95% CI, 0.02-0.67; P = .04). A difference was also observed between the groups of infants with and without ocular findings regarding the cephalic perimeter: mean (SD) of 28.8 (1.7) and 30.3 (1.5), respectively (frequency, -1.50; 95% CI, -2.56 to -0.51; P = .004).
   CONCLUSIONS AND RELEVANCE Ocular involvement in infants with presumed ZIKV congenital infection were more often seen in infants with smaller cephalic diameter at birth and in infants whose mothers reported symptoms during the first trimester.
C1 [Ventura, Camila V.; Travassos, Simone B.; Martins, Thayze T.; Patriota, Felipe; Nunes, Marcos Eugenio; Torres, Virginia L.; Ventura, Liana O.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.; Travassos, Simone B.; Martins, Thayze T.; Patriota, Felipe; Nunes, Marcos Eugenio; Agra, Cristiana; Torres, Virginia L.; Ventura, Liana O.] Pernambucos Eye Hosp HOPE, Recife, PE, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Sao Paulo, Brazil.
   [Ventura, Camila V.; Maia, Mauricio; Belfort, Rubens, Jr.] Vis Inst, Sao Paulo, Brazil.
   [van der Linden, Vanessa] Barao de Lucena Hosp, Recife, PE, Brazil.
   [Ramos, Regina C.; Rocha, Maria Angela W.; Silva, Paula S.] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
RP Belfort, R (reprint author), Escola Paulista Med, Dept Oftalmol, Rua Botucatu 831, BR-04023062 Sao Paulo, Brazil.
EM clinbelf@uol.com.br
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brasil Ministerio da Saude, PROT VIG RESP OC MIC
   Brasil - Ministerio da Saude, SAUD CONF 1 113 CAS
   Centers for Disease Control and Prevention, TRAV HLTH NOT
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8
   European Centre for Disease Prevention and Control, MICR BRAZ POT LINK Z
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Kaur Savleen, 2013, Oman J Ophthalmol, V6, P77, DOI 10.4103/0974-620X.116622
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, N ENGL J MED
   Teixeira MG, 2013, PLOS NEGL TROP DIS, V7, pe2520
   Ventura CV, 2014, ARQ BRAS OFTALMOL, V77, P300, DOI 10.5935/0004-2749.20140076
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, EP AL NEUR SYNDR CON
   World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053
NR 26
TC 2
Z9 2
U1 49
U2 49
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 912
EP 918
DI 10.1001/jamaophthalmol.2016.1784
PG 7
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200015
PM 27228275
ER

PT J
AU Moshfeghi, DM
   de Miranda, HA
   Costa, MC
AF Moshfeghi, Darius M.
   de Miranda, Homero Augusto, II
   Costa, Marcelo Cavalcante
TI Zika Virus, Microcephaly, and Ocular Findings
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Moshfeghi, Darius M.] Stanford Univ, Sch Med, Horngren Family Vitreoretinal Ctr, Byers Eye Inst,Dept Ophthalmol, 2452Watson Ct,Room 2277, Palo Alto, CA 94303 USA.
   [de Miranda, Homero Augusto, II; Costa, Marcelo Cavalcante] Ophthalm Telemed Santa Casa Sao Paulo, Sao Paulo, Brazil.
RP Moshfeghi, DM (reprint author), Stanford Univ, Sch Med, Horngren Family Vitreoretinal Ctr, Byers Eye Inst,Dept Ophthalmol, 2452Watson Ct,Room 2277, Palo Alto, CA 94303 USA.
EM dariusm@stanford.edu
CR Atchaneeyasakul LO, 1998, OPHTHALMIC GENET, V19, P39, DOI 10.1076/opge.19.1.39.2178
   de Paula Freitas B, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   MCKUSICK VA, 1966, ARCH OPHTHALMOL-CHIC, V75, P597
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 0
Z9 0
U1 9
U2 9
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 945
EP 945
DI 10.1001/jamaophthalmol.2016.1303
PG 1
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200024
PM 27254835
ER

PT J
AU Belfort, R
   Freitas, BD
   Dias, JRD
AF Belfort, Rubens, Jr.
   Freitas, Bruno de Paula
   de Oliveira Dias, Joao Rafael
TI Zika Virus, Microcephaly, and Ocular Findings Reply
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Belfort, Rubens, Jr.; de Oliveira Dias, Joao Rafael] Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Paulista Med Sch, Rua Botucatu,821,First Floor, BR-04023062 Sao Paulo, Brazil.
   [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
RP Belfort, R (reprint author), Univ Fed Sao Paulo, Dept Ophthalmol, Vis Inst, Paulista Med Sch, Rua Botucatu,821,First Floor, BR-04023062 Sao Paulo, Brazil.
EM prof.belfort@clinicabelfort.com.br
CR Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
NR 2
TC 0
Z9 0
U1 4
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 946
EP 947
DI 10.1001/jamaophthalmol.2016.1305
PG 2
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200026
PM 27253365
ER

PT J
AU Vasconcelos-Santos, DV
   Andrade, GMQ
   Caiaffa, WT
AF Vasconcelos-Santos, Daniel Vitor
   Queiroz Andrade, Glaucia Manzan
   Caiaffa, Waleska Teixeira
TI Zika Virus, Microcephaly, and Ocular Findings
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Vasconcelos-Santos, Daniel Vitor] Univ Fed Minas Gerais, Sch Med, Dept Ophthalmol, Av Alfredo Balena 190,Sala 199, BR-30130100 Belo Horizonte, MG, Brazil.
   [Vasconcelos-Santos, Daniel Vitor; Queiroz Andrade, Glaucia Manzan; Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Sch Med, Nucleo Acoes Pesquisa & Apoio Diagnost, Belo Horizonte, MG, Brazil.
   [Queiroz Andrade, Glaucia Manzan] Univ Fed Minas Gerais, Sch Med, Dept Pediat, Belo Horizonte, MG, Brazil.
   [Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Sch Med, Dept Prevent & Social Med Observ Urban Hlth, Belo Horizonte, MG, Brazil.
RP Vasconcelos-Santos, DV (reprint author), Univ Fed Minas Gerais, Sch Med, Dept Ophthalmol, Av Alfredo Balena 190,Sala 199, BR-30130100 Belo Horizonte, MG, Brazil.
EM dvitorvs@gmail.com
CR de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Peyron F, 2016, REMINGTON KLEINS INF, P949
   Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042
NR 5
TC 0
Z9 0
U1 2
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD AUG
PY 2016
VL 134
IS 8
BP 946
EP 946
DI 10.1001/jamaophthalmol.2016.1313
PG 1
WC Ophthalmology
SC Ophthalmology
GA DT1AD
UT WOS:000381213200025
PM 27253205
ER

PT J
AU Govindarajan, M
   Rajeswary, M
   Muthukumaran, U
   Hoti, SL
   Khater, HF
   Benelli, G
AF Govindarajan, Marimuthu
   Rajeswary, Mohan
   Muthukumaran, Udaiyan
   Hoti, S. L.
   Khater, Hanem F.
   Benelli, Giovanni
TI Single-step biosynthesis and characterization of silver nanoparticles
   using Zornia diphylla leaves: A potent eco-friendly tool against malaria
   and arbovirus vectors
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Aedes albopictus; Anopheles subpictus; Culex tritaeniorhynchus;
   Nanomosquitocidals; Plant-borne larvicides; Non-target effects
ID AEGYPTI DIPTERA-CULICIDAE; AEDES-AEGYPTI; ANOPHELES-STEPHENSI;
   CULEX-QUINQUEFASCIATUS; GOLD NANOPARTICLES; LEAF EXTRACT; ENGINEERED
   NANOPARTICLES; INTRODUCED MOSQUITOFISH; PREDATION EFFICIENCY; LARVICIDAL
   ACTIVITY
AB Mosquitoes (Diptera: Culicidae) are vectors of important pathogens and parasites, including malaria, dengue, chikungunya, Japanese encephalitis, lymphatic filariasis and Zika virus. The application of synthetic insecticides causes development of resistance, biological magnification of toxic substances through the food chain, and adverse effects on the environment and human health. In this scenario, eco-friendly control tools of mosquito vectors are a priority. Here single-step fabrication of silver nanoparticles (AgNP) using a cheap aqueous leaf extract of Zornia diphylla as reducing and capping agent pf Ag+ ions has been carried out. Biosynthesized AgNP were characterized by UV visible spectrophotometry, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), transmission electron microscopy (TEM), energy-dispersive spectroscopy (EDX) and X-ray diffraction analysis (XRD). The acute toxicity of Z. diphylla leaf extract and biosynthesized AgNP was evaluated against larvae of the malaria vector Anopheles subpictus, the dengue vector Aedes albopictus and the Japanese encephalitis vector Culex tritaeniorhynchus. Both the Z. diphylla leaf extract and Ag NP showed dose dependent larvicidal effect against all tested mosquito species. Compared to the leaf aqueous extract, biosynthesized Ag NP showed higher toxicity against An. subpictus, Ae. albopictus, and C chi. tritaeniorhynchus with LC50 values of 12.53, 13.42 and 14.61 mu g/ml, respectively. Biosynthesized AgNP were found safer to non-target organisms Chironomus circumdatus, Anisops bouvieri and Gambusia affinis, with the respective LC50 values ranging from 613.11 to 6903.93 mu g/ml, if compared to target mosquitoes. Overall, our results highlight that Z. diphylla-fabricated Ag NP are a promising and eco-friendly tool against larval populations of mosquito vectors of medical and veterinary importance, with negligible toxicity against other non-target organisms. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Govindarajan, Marimuthu; Rajeswary, Mohan; Muthukumaran, Udaiyan] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Hoti, S. L.] Reg Med Res Ctr, Belgaum 590010, Karnataka, India.
   [Khater, Hanem F.] Benha Univ, Fac Vet Med, Dept Parasitol, Moshtohor 13736, Toukh, Egypt.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (reprint author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013
CR Ankamwar B, 2005, SYNTH REACT INORG ME, V35, P19, DOI 10.1081/SIM-200047527
   Ankanna S, 2010, DIG J NANOMATER BIOS, V5, P369
   Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y
   Benelli G., 2015, NANOPARTICL IN PRESS, P2192
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2015, PARASITOL RES, V114, P1011, DOI 10.1007/s00436-014-4267-0
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Chandra G, 2008, INDIAN J MED RES, V127, P13
   DEO P G, 1988, International Pest Control, V30, P118
   Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Feynman R, 1991, SCIENCE, V254, P1300, DOI DOI 10.1126/SCIENCE.254.5036.1300
   Finney D.J., 1971, PROBIT ANAL
   Dobhal M. P., 2010, INT J ENG SCI TECHNO, V59, P15
   Gillespie GR, 2001, BIOL CONSERV, V100, P187, DOI 10.1016/S0006-3207(01)00021-0
   Gnanadesigan M, 2011, ASIAN PAC J TROP MED, V4, P799, DOI 10.1016/S1995-7645(11)60197-1
   Gong P., 2007, NANOTECHNOLOGY, V18, P285
   GOODSELL D.S., 2004, BIONANOTECHNOLOGY LE
   Goodsell JA, 1999, CONSERV BIOL, V13, P921, DOI 10.1046/j.1523-1739.1999.98237.x
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Jayaseelan C, 2012, PARASITOL RES, V111, P921, DOI 10.1007/s00436-011-2473-6
   Juvekar M., 2009, PLANTA MED, V75, P168
   Kasthuri J, 2009, J NANOPART RES, V11, P1075, DOI 10.1007/s11051-008-9494-9
   Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x
   Kavitha R, 2011, J CHEM PHARM RES, V3, P115
   Khare C.P., 2004, INDIAN MED PLANTS IL
   Komak S, 2000, WILDLIFE RES, V27, P185, DOI 10.1071/WR99028
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Morgan L. A., 1996, Australian Zoologist, V30, P143
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Murugan K., 2015, NAT PROD RES
   Murugan K., 2015, ENV SCI POLLUT RES
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Oberdorster E, 2006, CARBON, V44, P1112, DOI 10.1016/j.carbon.2005.11.008
   Park J, 2014, MAR POLLUT BULL, V85, P526, DOI 10.1016/j.marpolbul.2014.04.038
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Raghavendra K, 2008, INDIAN J MED RES, V128, P22
   Rai A, 2006, LANGMUIR, V22, P736, DOI 10.1021/la052055q
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Siddiqui BS, 2000, PHYTOCHEMISTRY, V53, P371, DOI 10.1016/S0031-9422(99)00548-8
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6
   Soni N, 2012, PARASITOL RES, V110, P175, DOI 10.1007/s00436-011-2467-4
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Webb Cameron, 1997, Australian Zoologist, V30, P316
   World Health Organization, 2005, WHOCDSWHOPESGCDPP201
NR 65
TC 1
Z9 1
U1 10
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD AUG
PY 2016
VL 161
BP 482
EP 489
DI 10.1016/j.jphotobiol.2016.06.016
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DT7FZ
UT WOS:000381653800057
PM 27318605
ER

PT J
AU Oladapo, OT
   Souza, JP
   De Mucio, B
   de Leon, RGP
   Perea, W
   Gulmezoglu, AM
AF Oladapo, Olufemi T.
   Souza, Joao Paulo
   De Mucio, Bremen
   de Leon, Rodolfo Gomez Ponce
   Perea, William
   Gulmezoglu, A. Metin
CA WHO Guideline Dev Grp
TI WHO interim guidance on pregnancy management in the context of Zika
   virus infection
SO LANCET GLOBAL HEALTH
LA English
DT Editorial Material
C1 [Oladapo, Olufemi T.; Souza, Joao Paulo; Gulmezoglu, A. Metin] WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA,UNICEF, CH-1211 Geneva 27, Switzerland.
   [De Mucio, Bremen; de Leon, Rodolfo Gomez Ponce] Pan Amer Hlth Org, Latin Amer Ctr Perinatol, Montevideo, Uruguay.
   [Perea, William] WHO, Dept Pandem & Epidem Dis, Geneva, Switzerland.
RP Oladapo, OT (reprint author), WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA,UNICEF, CH-1211 Geneva 27, Switzerland.
EM oladapoo@who.int
CR Brasil P, 2016, N ENGL J MED
   Erdman JN, 2012, INT J GYNECOL OBSTET, V118, P83, DOI 10.1016/j.ijgo.2012.04.002
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   World Health Organization, 2016, PSYCH SUPP PREGN WOM
   World Health Organization, 2016, PREGN MAN CONT ZIK V
NR 5
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD AUG
PY 2016
VL 4
IS 8
BP E510
EP E511
DI 10.1016/S2214-109X(16)30098-5
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS3RI
UT WOS:000380700000006
PM 27211476
ER

PT J
AU Barreto-Vieira, DF
   Barth, OM
   da Silva, MAN
   Santos, CC
   Santos, ADS
   Batista, FJ
   de Filippis, AMB
AF Barreto-Vieira, Debora Ferreira
   Barth, Ortrud Monika
   da Silva, Marcos Alexandre Nunes
   Santos, Carolina Cardoso
   Santos, Aline da Silva
   Joaquim Batista, F. Filho
   Bispo de Filippis, Ana Maria
TI Ultrastructure of Zika virus particles in cell cultures
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; virus particles; cell culture; transmission electron
   microscopy
AB Zika virus (ZIKV) has infected thousands of Brazilian people and spread to other American countries since 2015. The introduction of ZIKV brought a strong impact to public health in Brazil. It is of utmost importance to identify a susceptible cell line that will enable the isolation and identification of the virus from patient samples, viral mass production, and testing of drug and vaccine candidates. Besides real-time reverse transcriptase polymerase chain reaction diagnosis for detecting the viral genome, virus isolation in cell lines was useful in order to study the structure of the viral particle and its behaviour inside cells. Analysis of ZIKV infected cell lines was achieved using transmission electron microscopy (TEM). Blood was obtained from a Brazilian patient during the first days after presenting with signs of the disease, and ZIKV from the patient's blood was isolated in the C6/36 mosquito cell line. Afterwards, Vero cells were inoculated with the viral suspension, fixed six days after inoculation, embedded in polymers, and ultra-thin cut. Like dengue viruses, this flavivirus showed numerous virus particles present inside cellular vesicles thereby confirming the susceptibility of the Vero cell line to ZIKV replication. TEM is a unique technique available to make the virus visible.
C1 [Barreto-Vieira, Debora Ferreira; Barth, Ortrud Monika; da Silva, Marcos Alexandre Nunes] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Morfol & Morfogenese Viral, Rio De Janeiro, RJ, Brazil.
   [Santos, Carolina Cardoso; Santos, Aline da Silva; Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Havivirus, Rio De Janeiro, RJ, Brazil.
   [Joaquim Batista, F. Filho] Lab Cent Saude Publ Espirito Santo Virol, Vitoria, ES, Spain.
RP Barreto-Vieira, DF (reprint author), Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Morfol & Morfogenese Viral, Rio De Janeiro, RJ, Brazil.
EM barreto@ioc.fiocruz.br
FU CNPq [304067/2012-0]
FX CNPq (304067/2012-0).
CR Barreto-Vieira DF, 2015, INDIAN J APPL RES, V5, P44
   Barreto-Vieira DF, 2010, MODELO ANIMAL EXPT E
   Barth OM, 2000, ATLAS DENGUE VIRUSES
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MS - Ministerio da Saude. Dengue chikungunya e Zika, 2016, DENG CHIK ZIK INF EP
   PAHO/WHO - Pan American Health Organization/World Health Organization, 2015, EP AL INCR MICR NE B
   Schatzmayr HG, 2009, PESQUISA VET BRASIL, V29, P509, DOI 10.1590/S0100-736X2009000700004
   Sesso A, 2007, MANUAL TECNICAS BASI, VI, P13
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   TAKATA CS, 1994, REV SAUDE PUBL, V28, P209
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 0
Z9 0
U1 23
U2 23
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2016
VL 111
IS 8
BP 532
EP 534
DI 10.1590/0074-02760160104
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DS5OM
UT WOS:000380831600008
PM 27581122
ER

PT J
AU Jain, R
   Coloma, J
   Garcia-Sastre, A
   Aggarwal, AK
AF Jain, Rinku
   Coloma, Javier
   Garcia-Sastre, Adolfo
   Aggarwal, Aneel K.
TI Structure of the NS3 helicase from Zika virus
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID CRYSTAL-STRUCTURE; CATALYTIC-ACTIVITY; PROTEIN; REPLICATION; RESOLUTION;
   DOMAIN
AB Zika virus has emerged as a pathogen of major health concern. Here, we present a high-resolution (1.62-angstrom) crystal structure of the RNA helicase from the French Polynesia strain. The structure is similar to that of the RNA helicase from Dengue virus, with variability in the conformations of loops typically involved in binding ATP and RNA. We identify druggable 'hotspots' that are well suited for in silico and/or fragment-based high-throughput drug discovery.
C1 [Jain, Rinku; Coloma, Javier; Aggarwal, Aneel K.] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
RP Aggarwal, AK (reprint author), Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY 10029 USA.
EM aneel.aggarwal@mssm.edu
FU  [U19AI118610]
FX We thank K. Rajashankar and the staff at NECAT-24ID (APS) for
   facilitating data collection. These studies were partly funded by a
   supplement to the NIAID NIH grant U19AI118610 (to A.G.-S.).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147
   Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043
   KUKKO E, 1982, EUR J BIOCHEM, V127, P347, DOI 10.1111/j.1432-1033.1982.tb06878.x
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Mancini EJ, 2007, PROTEIN SCI, V16, P2294, DOI 10.1110/ps.072843107
   Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.imb.2007.06.055
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467
   Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Speroni S, 2008, PROTEINS, V70, P1120, DOI 10.1002/prot.21812
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yadav S, 2015, J STRUCT BIOL, V192, P100, DOI 10.1016/j.jsb.2015.08.004
NR 24
TC 0
Z9 0
U1 8
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD AUG
PY 2016
VL 23
IS 8
BP 752
EP +
DI 10.1038/nsmb.3258
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DS8CL
UT WOS:000381010300010
PM 27399257
ER

PT J
AU Gerdts, C
   Fuentes, L
   Wahlin, B
   Blanchard, K
AF Gerdts, Caitlin
   Fuentes, Liza
   Wahlin, Britt
   Blanchard, Kelly
TI Zika Virus and Pregnancy: What Obstetric Health Care Providers Need to
   Know
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
C1 [Gerdts, Caitlin; Fuentes, Liza] Ibis Reprod Hlth, Oakland, CA 94612 USA.
   [Wahlin, Britt; Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA USA.
RP Gerdts, C (reprint author), Ibis Reprod Hlth, Oakland, CA 94612 USA.
CR Asplin N, 2013, SEX REPROD HEALTHC, V4, P79, DOI 10.1016/j.srhc.2013.02.001
   Center for Reproductive Rights, 2015, WORLDS ABORTION LAWS
   Mansfield C, 1999, PRENATAL DIAG, V19, P808, DOI 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.3.CO;2-2
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Winikoff B, 2012, INT PERSPECT SEX R H, V38, P164
NR 5
TC 0
Z9 0
U1 6
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD AUG
PY 2016
VL 128
IS 2
BP 405
EP 405
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DS6UO
UT WOS:000380918500033
PM 27454712
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika Virus Infection and Surgery: What Should We Be Concerned About?
SO SURGICAL INFECTIONS
LA English
DT Letter
ID DENGUE-FEVER
C1 [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
   [Wiwanitkit, Viroj] Chulalongkorn Univ, Bangkok 10330, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Wiwanitkit, V (reprint author), Wiwanitkit House, Bangkok, Thailand.
EM wviroj@yahoo.com
CR Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Fry DE, 2016, SURG INFECT, V17, P123, DOI 10.1089/sur.2016.29004.df
   Shamim M, 2010, ASIAN J SURG, V33, P107, DOI 10.1016/S1015-9584(10)60019-X
   Wiwanitkit S., 2015, Journal of Acute Disease, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2010, J INFECT DEV COUNTR, V4, P51
   Wiwanitkit V, 2010, EXPERT REV ANTI-INFE, V8, P841, DOI [10.1586/eri.10.53, 10.1586/ERI.10.53]
NR 6
TC 0
Z9 0
U1 3
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-2964
EI 1557-8674
J9 SURG INFECT
JI Surg. Infect.
PD AUG
PY 2016
VL 17
IS 4
BP 498
EP 498
DI 10.1089/sur.2016.060
PG 1
WC Infectious Diseases; Surgery
SC Infectious Diseases; Surgery
GA DS5FH
UT WOS:000380806200018
PM 27249094
ER

PT J
AU Kim, K
   Shresta, S
AF Kim, Kenneth
   Shresta, Sujan
TI Neuroteratogenic Viruses anc Lessons for Zika Virus Vodels
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID JAPANESE ENCEPHALITIS-VIRUS; CENTRAL-NERVOUS-SYSTEM; VIRAL DIARRHEA
   VIRUS; BLOOD-BRAIN-BARRIER; CACHE VALLEY VIRUS; AKABANE VIRUS;
   CYTOMEGALOVIRUS-INFECTION; BLUETONGUE VIRUS; MURINE CYTOMEGALOVIRUS;
   VERTICAL TRANSMISSION
AB The Centers for Disease Control and Prevention has confirmed that Zika virus (ZIKV) causes congenital microcephaly. ZIKV now joins five other neuroteratogenic (NT) viruses in humans and ZIKV research is in its infancy. In addition, there is only one other NT human arbovirus (Venezuelan equine encephalitis virus), which is also poorly understood. But further insight into ZIKV can be found by evaluating arboviruses in domestic animals, of which there are at least seven NT viruses, three of which have been well studied. Here we review two key anatomical structures involved in modeling transplacental NT virus transmission: the placenta and the fetal blood-brain barrier. We then survey major research findings regarding transmission of NT viruses for guidance in establishing a mouse model of Zika disease that is crucial for a better understanding of ZIKV transmission and pathogenesis.
C1 [Kim, Kenneth; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.
RP Shresta, S (reprint author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.
EM sujan@lji.org
CR Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   Akashi H, 1999, ARCH VIROL, V144, P2101, DOI 10.1007/s007050050625
   ANDERSEN AA, 1978, AM J VET RES, V39, P301
   Authority E.F.S., 2014, EFSA J, V12, P54
   Baba S. S., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P343
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Berges BK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-65
   Bielefeldt-Ohmann H, 2008, J COMP PATHOL, V138, P72, DOI 10.1016/j.jcpa.2007.10.006
   Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606
   Burgos JS, 2006, J VIROL, V80, P2823, DOI 10.1128/JVI.80.6.2823-2831.2006
   Cantlle C., 2015, JUBB KENNEDY PALMERS, P280
   CHANTLER JK, 1979, J GEN VIROL, V42, P621, DOI 10.1099/0022-1317-42-3-621
   Coetzee P, 2014, VIRUS RES, V182, P21, DOI 10.1016/j.virusres.2013.12.044
   COETZER JAW, 1977, ONDERSTEPOORT J VET, V44, P205
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dilworth MR, 2013, PLACENTA, V34, pS34, DOI 10.1016/j.placenta.2012.10.011
   Donald KA, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-014-0042-7
   Doran KS, 2013, COLD SPRING HARB PER, V3, P1
   Edwards JF, 1998, J MED ENTOMOL, V35, P261
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fineberg AM, 2013, BIOL PSYCHIAT, V73, P951, DOI 10.1016/j.biopsych.2013.01.001
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ftaich N, 2015, J VIROL, V89, P10467, DOI 10.1128/JVI.01541-15
   FUCCILLO DA, 1973, BACTERIOL REV, V37, P19
   FUJISAKI Y, 1982, NATL I ANIM HEALTH Q, V22, P95
   Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI [10.1293/tox.2013-0060, 10.1293/tox.27.2013-0060]
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gilbert-Barness E, 2010, ANN CLIN LAB SCI, V40, P99
   Go Yun Young, 2014, Clin Exp Vaccine Res, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003776
   Habu A, 1977, Uirusu, V27, P21
   Halstead S.B., 2015, F1000RES, V4, P1353
   HARTLEY WJ, 1977, AUST VET J, V53, P319, DOI 10.1111/j.1751-0813.1977.tb00240.x
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoffmann AR, 2012, J VIROL, V86, P4793, DOI 10.1128/JVI.06858-11
   Kelling CL, 2013, BIOLOGICALS, V41, P20, DOI 10.1016/j.biologicals.2012.09.006
   KIRKLAND PD, 1988, VET REC, V122, P582
   Kosmac K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003200
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Ku CC, 2005, J VIROL, V79, P2651, DOI 10.1128/JVI.79.5.2651-2658.2005
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li RY, 2000, TERATOLOGY, V62, P79
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Liu TH, 2008, J NEUROVIROL, V14, P514, DOI 10.1080/13550280802339643
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Maclachlan NJ, 2015, REV SCI TECH OIE, V34, P329
   MacLachlan NJ, 2000, ANIM REPROD SCI, V60, P643, DOI 10.1016/S0378-4320(00)00105-6
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050483
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MATHUR A, 1986, J GEN VIROL, V67, P945, DOI 10.1099/0022-1317-67-5-945
   MATHUR A, 1982, J GEN VIROL, V59, P213, DOI 10.1099/0022-1317-59-1-213
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mishra MK, 2009, NEUROCHEM INT, V55, P717, DOI 10.1016/j.neuint.2009.07.006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murata Y, 2015, J COMP PATHOL, V153, P140, DOI 10.1016/j.jcpa.2015.06.003
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   OBERST RD, 1993, VET CLIN N AM-FOOD A, V9, P23
   D'Ortenzlo E, 2016, N ENGL J MED
   Pereira L, 2005, TRENDS MICROBIOL, V13, P164, DOI 10.1016/j.tim.2005.02.009
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Redwine JM, 2002, CURR TOP MICROBIOL, V265, P119
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saunders NR, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00046
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Seong G, 2015, ARCH VIROL, V160, P1565, DOI 10.1007/s00705-015-2412-4
   Sever J.L., 1983, TERATOGENESIS REPROD, P65
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Sison A.V., 2008, HDB CLIN OBSTET FETU, P94
   Slavuljica I, 2015, CELL MOL IMMUNOL, V12, P180, DOI 10.1038/cmi.2014.51
   SPERTZEL RO, 1972, INFECT IMMUN, V6, P339
   Straface G., 2012, INFECT DIS OBSTET GY, V2012, DOI [10.1155/2012/385697, DOI 10.1155/2012/385697]
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI [10.1097/NEN.0000000000000038, 10.1097/NEN.0000000000000036]
   Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   Tsuda T, 2004, VET RES, V35, P531, DOI 10.1051/vetres:2004029
   Varela M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003133
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   WALDVOGEL AS, 1987, VET PATHOL, V24, P404
   Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024744
   Wang ZY, 2003, INTERVIROLOGY, V46, P79, DOI 10.1159/000069742
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Wemike K., 2012, PLOS ONE, V7
   Woolf NK, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-26
   YUILL TM, 1970, AM J TROP MED HYG, V19, P513
NR 96
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD AUG
PY 2016
VL 24
IS 8
BP 622
EP 636
DI 10.1016/j.tim.2016.06.002
PG 15
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA DS7OQ
UT WOS:000380973200005
PM 27387029
ER

PT J
AU Phillips, JA
   Neyland, A
AF Phillips, Jennan A.
   Neyland, Anavernyel
TI Zika Virus
SO WORKPLACE HEALTH & SAFETY
LA English
DT Editorial Material
DE disease prevention; communicable diseases; global occupational health;
   women's health; emergency response
AB Zika virus (ZIKV) infections are the latest global public health emergency. Occupational health nurses can protect society by educating workers, women of childbearing age, and others traveling in ZIKV-infected areas about prevention strategies.
C1 [Phillips, Jennan A.; Neyland, Anavernyel] Univ Alabama Birmingham, Birmingham, AL USA.
RP Phillips, JA (reprint author), Univ Alabama Birmingham, Occupat Hlth Nursing Specialty, 1701 Univ Blvd,NB 316, Birmingham, AL 35244 USA.
EM japhil@uab.edu
CR Pan American Health Organization, ZIK VIR INF
   World Health Organization, 2016, ZIK VIR COMPL
NR 2
TC 0
Z9 0
U1 4
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2165-0799
EI 2165-0969
J9 WORKPLACE HEALTH SAF
JI Workplace Health Saf.
PD AUG
PY 2016
VL 64
IS 8
BP 396
EP 396
DI 10.1177/2165079916657109
PG 1
WC Nursing
SC Nursing
GA DS7KC
UT WOS:000380961400007
PM 27411846
ER

PT J
AU Shuaib, W
   Stanazai, H
   Abazid, AG
   Mattar, AA
AF Shuaib, Waqas
   Stanazai, Hashim
   Abazid, Ahmad G.
   Mattar, Ahmed A.
TI Re-Emergence of Zika Virus: A Review on Pathogenesis, Clinical
   Manifestations, Diagnosis, Treatment, and Prevention
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Review
DE Brazil; Chikungunya; Dengue; Microcephaly; Zika
ID TRANSMISSION; OUTBREAK; STATES; BRAZIL
AB Zika virus (ZKV) is an arbovirus of the Flaviviridae family, which includes West Nile, dengue fever, yellow fever, and Japanese encephalitis virus. It is transmitted by the Aedes genus of mosquitoes. Before 2015, ZKV outbreaks occurred in areas of Africa, the Pacific Islands, and Southeast Asia. The current large outbreak, which began in Brazil, has also emerged throughout a large part of South/Central America, a number of islands in the Caribbean, including Puerto Rico, the Virgin Islands, and Mexico. A sudden rise in the numbers of infants reported born with microcephaly in Brazil, and the detection of the single-stranded positive RNA virus in the amniotic fluid of affected newborns, has captured medical, mainstream media, and global political attention, causing considerable concern in a post-Ebola global community considerably more focused on the threat of internationally transmissible diseases. The goal of this article is to provide an overview of ZKV for clinicians, with the emphasis on pathogenesis, clinical manifestations, diagnosis, and treatment/preventive measures. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Shuaib, Waqas] Auburn Community Hosp, Dept Med, 17 Lansing St, Auburn, NY 13021 USA.
   [Stanazai, Hashim; Abazid, Ahmad G.; Mattar, Ahmed A.] Wichita Falls Family Practice Residency Program, Witchita Falls, TX USA.
RP Shuaib, W (reprint author), Auburn Community Hosp, Dept Med, 17 Lansing St, Auburn, NY 13021 USA.
EM waqas1184@hotmail.com
CR Besnard M, 2014, EURO SURVEILL, V19
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grenoble R, 2016, WHO DECLARES PUBLIC
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Marcondes CB, 2015, REV SOC BRA IN PRESS
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Royal College of Obstetricians and Gynaecologists, 2016, INT ALG ASS PREGN WO
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
NR 20
TC 1
Z9 1
U1 79
U2 79
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9343
EI 1555-7162
J9 AM J MED
JI Am. J. Med.
PD AUG
PY 2016
VL 129
IS 8
AR 879.e7
DI 10.1016/j.amjmed.2016.02.027
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR9YU
UT WOS:000380253000047
PM 26994509
ER

PT J
AU Vasconcelos, PFC
   Monath, TP
AF Vasconcelos, Pedro F. C.
   Monath, Thomas P.
TI Yellow Fever Remains a Potential Threat to Public Health
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Aedes aegypti mosquitoes; Epidemic; Underreporting; Vaccine; Yellow
   fever; Zika virus
ID VIRUS
AB Yellow fever (YF) remains a serious public health threat in endemic countries. The recent re-emergence in Africa, initiating in Angola and spreading to Democratic Republic of Congo and Uganda, with imported cases in China and Kenya is of concern. There is such a shortage of YF vaccine in the world that the World Health Organization has proposed the use of reduced doses (1/5) during emergencies. In this short communication, we discuss these and other problems including the risk of spread of YF to areas free of YF for decades or never before affected by this arbovirus disease.
C1 [Vasconcelos, Pedro F. C.] Minist Hlth, Evandro Chagas Inst, Rodovia BR-316,Km 7, BR-67030000 Ananindeua, Brazil.
   [Monath, Thomas P.] NewLink Genet Corp, Div Infect Dis, Devens, MA USA.
RP Vasconcelos, PFC (reprint author), Minist Hlth, Evandro Chagas Inst, Rodovia BR-316,Km 7, BR-67030000 Ananindeua, Brazil.
EM pedrovasconcelos@iec.pa.gov.br
CR Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Monath TP, 2016, LANCET, V387, P1816
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7
   Reed W, 1901, AM MED 2, V1, P15
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   WHO, 2016, 2 TEL WHO GEN APR 28
   World Health Organization, 2013, WKLY EPIDEMIOL REC, V88, P269
NR 8
TC 1
Z9 1
U1 37
U2 37
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD AUG
PY 2016
VL 16
IS 8
BP 566
EP 567
DI 10.1089/vbz.2016.2031
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DR7VR
UT WOS:000380108300011
PM 27400066
ER

PT J
AU Suter, MA
   Aagaard, KM
AF Suter, Melissa A.
   Aagaard, Kjersti M.
TI DISEASE WATCH Zika virus - placental passage and permissivity for
   infection
SO NATURE REVIEWS ENDOCRINOLOGY
LA English
DT Editorial Material
C1 [Suter, Melissa A.; Aagaard, Kjersti M.] Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, 1 Baylor Plza, Houston, TX 77030 USA.
RP Aagaard, KM (reprint author), Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, 1 Baylor Plza, Houston, TX 77030 USA.
EM aagaardt@bcm.tmc.edu
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bialas KM, 2015, CLIN PERINATOL, V42, P61, DOI 10.1016/j.clp.2014.10.006
   Brasil P, 2016, N ENGL J MED
   Center for Disease Control and Prevention, 2016, AR WITH ZIK
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Quicke KM, 2016, CELL HOST MICROBE
   Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005
NR 10
TC 0
Z9 0
U1 32
U2 32
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-5029
EI 1759-5037
J9 NAT REV ENDOCRINOL
JI Nat. Rev. Endocrinol.
PD AUG
PY 2016
VL 12
IS 8
BP 437
EP U14
DI 10.1038/nrendo.2016.101
PG 2
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DR8WB
UT WOS:000380178000001
PM 27339887
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Placenta, Zika Virus Infection and Fetal Brain Abnormality
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Letter
ID TRANSMISSION
C1 [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Maharashtra, India.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeki Arakeji, Niger.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (reprint author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Calvet G, 2016, LANCET INFECT DIS, V3099, pS1473
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Sadovsky Y, 2016, PLACENTA, V40, pA1, DOI 10.1016/j.placenta.2016.03.008
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Wiwanitkit V, 2005, AUST NZ J OBSTET GYN, V45, P539, DOI 10.1111/j.1479-828X.2005.00500.x
NR 10
TC 0
Z9 0
U1 56
U2 56
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD AUG
PY 2016
VL 76
IS 2
BP 97
EP 98
DI 10.1111/aji.12521
PG 2
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA DR6TH
UT WOS:000380033700001
PM 27207189
ER

PT J
AU Vasquez, AM
   Sapiano, MRP
   Basavaraju, SV
   Kuehnert, MJ
   Rivera-Garcia, B
AF Vasquez, Amber M.
   Sapiano, Mathew R. P.
   Basavaraju, Sridhar V.
   Kuehnert, Matthew J.
   Rivera-Garcia, Brenda
TI Survey of Blood Collection Centers and Implementation of Guidance for
   Prevention of Transfusion-Transmitted Zika Virus Infection Puerto Rico,
   2016
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Editorial Material
ID TRANSMISSION; OUTBREAK
AB This report details current guidance for managing blood donation in Puerto Rico, where Zika has been identified and there is the potential for transmission from asymptomatic blood donors.
C1 [Vasquez, Amber M.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Vasquez, Amber M.; Sapiano, Mathew R. P.; Basavaraju, Sridhar V.; Kuehnert, Matthew J.] CDC, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
RP Vasquez, AM (reprint author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
EM avasquez@cdc.gov
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, ZIK VIR TRANSM RISKS
   Chung Koo-Whang, 2016, Transfusion, V56, P2184, DOI 10.1111/trf.13644
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Reuters, 2016, BRAZ REP ZIK INF BLO
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   US Department of Health and Human Services, 2016, HHS SHIPS BLOOD PROD
NR 9
TC 0
Z9 0
U1 20
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD AUG
PY 2016
VL 16
IS 8
BP 2487
EP 2490
DI 10.1111/ajt.13941
PG 4
WC Surgery; Transplantation
SC Surgery; Transplantation
GA DR6QR
UT WOS:000380026900033
PM 27441778
ER

PT J
AU Diniz, D
AF Diniz, Debora
TI Zika virus, women and ethics
SO DEVELOPING WORLD BIOETHICS
LA English
DT Editorial Material
ID ABORTION
CR Ballantyne A, 2009, AM J BIOETHICS, V9, P48, DOI 10.1080/15265160902984996
   Brasil. Ministerio da Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, INF EP 19 SEM EP SE
   Broutet N, 2016, NEW ENGL J MED, P1
   Diniz D, 2016, NY TIMES MAGAZINE, P23
   Editorial, 2016, NAT MICROBIOL, P1
   Frank C, 2016, EMBO MOL MED, P1
   Jesudason S, 2011, CONTRACEPTION, V84, P541, DOI 10.1016/j.contraception.2011.08.022
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P2016
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
NR 10
TC 0
Z9 0
U1 27
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1471-8731
EI 1471-8847
J9 DEV WORLD BIOETH
JI Dev. World Bioeth.
PD AUG
PY 2016
VL 16
IS 2
BP 62
EP 63
DI 10.1111/dewb.12119
PG 2
WC Ethics; Medical Ethics
SC Social Sciences - Other Topics; Medical Ethics
GA DR5HY
UT WOS:000379935300001
PM 27378033
ER

PT J
AU Pavela, R
   Benelli, G
AF Pavela, Roman
   Benelli, Giovanni
TI Ethnobotanical knowledge on botanical repellents employed in the African
   region against mosquito vectors - A review
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Review
DE Aedes; Anopheles; Culex; Arbovirus; Dengue; Filariasis; Malaria; Zika
   virus; Mosquito-borne diseases; Insect repellents
ID STERILE INSECT TECHNIQUE; ESSENTIAL OILS; VETERINARY IMPORTANCE;
   ANOPHELES-ARABIENSIS; MALARIA VECTOR; USAGE CUSTOM; ZIKA VIRUS; PLANTS;
   AEDES; CULICIDAE
AB Mosquitoes (Diptera: Culicidae) represent a huge threat for millions of humans and animals worldwide, since they act as vectors for important parasites and pathogens, including malaria, filariasis and important arboviruses, such as dengue, West Nile and Zika virus. No vaccines or other specific treatments are available against the arboviruses transmitted by mosquitoes, and avoidance of mosquito bites remains the best strategy. African regions are usually hit most whose inhabitants are poor, and the use of repellent plants is the only efficient protection against vectors they have. Ethnobotanical knowledge of such plants and their use is usually passed on orally from one generation to another. However, it is also important to preserve this information in a written form, as well. Ethnobotanical research projects carried out in the regions of today's Ethiopia, South Africa, Nigeria, Kenya, and Tanzania indicate that the native inhabitants of the African study regions traditionally use 64 plant species, belonging to 30 families. Aromatic plants (i.e., Citrus spp., Eucalyptus spp., Lantana camara, Ocimum spp. and Lippia javanica) the most commonly used in all the study regions. Native people know three major methods of using repellent plants: (i) production of repellent smoke from burning plants, (ii) hanging plants inside the house or sprinkling leaves on the floor, (iii) the use of plant oils, juices from crushed fresh parts of the plants, or various prepared extracts applied on uncovered body parts. Overall, this review covers studies conducted only in a limited part of the African continent, highlighting the importance to undertake further research efforts to preserve the unique knowledge and traditions of the native tribes. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106 6, Czech Republic.
   [Benelli, Giovanni] Univ Pisa, Insect Behav Grp, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (reprint author), Univ Pisa, Insect Behav Grp, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013
FU Ministry of Agriculture of the Czech Republic [MZE RO0415]; PROAPI
   (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX R. Pavela would like to thank the Ministry of Agriculture of the Czech
   Republic for its financial support of botanical pesticide research
   (Project No. MZE RO0415). G. Benelli is supported by PROAPI (PRAF 2015)
   and University of Pisa, Department of Agriculture, Food and Environment
   (Grant ID: COFIN2015_22). Funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P3041, DOI 10.1007/s00436-015-4506-z
   Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Benelli G., 2016, PARASITOL RES
   Benelli G., 2016, ASIA PACIF J TROP DI, P253
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli Giovanni, 2016, Asian Pacific Journal of Tropical Biomedicine, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli Giovanni, 2016, Asian Pacific Journal of Tropical Biomedicine, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006
   Dugassa S, 2009, ACTA TROP, V112, P38, DOI 10.1016/j.actatropica.2009.06.002
   Edwin-Wosu N. L., 2013, Journal of Biopesticides, V6, P104
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   HWANG YS, 1985, J CHEM ECOL, V11, P1297, DOI 10.1007/BF01024117
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Karunamoorthi K, 2009, J ETHNOPHARMACOL, V121, P49, DOI 10.1016/j.jep.2008.09.027
   Karunamoorthi K, 2008, PARASITOL RES, V103, P529, DOI 10.1007/s00436-008-1001-9
   Karunamoorthi K, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-22
   Karunamoorthi K, 2009, J ETHNOPHARMACOL, V125, P224, DOI 10.1016/j.jep.2009.07.008
   [Anonymous], 2013, SCI RES ESSAYS, DOI DOI 10.5897/SRE11.1216
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Mavundza EJ, 2011, J ETHNOPHARMACOL, V137, P1516, DOI 10.1016/j.jep.2011.08.040
   Mehlhorn H, 2016, PARASITOL RES MG, V8, P1, DOI 10.1007/978-3-319-25292-6
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   MIKOLAJCZAK KL, 1988, J NAT PROD, V51, P606, DOI 10.1021/np50057a033
   MULHOLLAND DA, 1980, PHYTOCHEMISTRY, V19, P2421, DOI 10.1016/S0031-9422(00)91040-9
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nathan SS, 2005, ACTA TROP, V96, P47, DOI 10.1016/j.actatropica.2005.07.002
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2011, PARASITOL RES, V109, P1547, DOI 10.1007/s00436-011-2395-3
   Pavela R, 2014, IND CROP PROD, V60, P247, DOI 10.1016/j.indcrop.2014.06.030
   Pohlit AM, 2011, PLANTA MED, V77, P598, DOI 10.1055/s-0030-1270723
   Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008
   Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554
   Rehman JU, 2014, FITOTERAPIA, V95, P65, DOI 10.1016/j.fitote.2014.03.002
   SCHMUTTERER H, 1990, ANNU REV ENTOMOL, V35, P271, DOI 10.1146/annurev.en.35.010190.001415
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   Seyoum A, 2002, T ROY SOC TROP MED H, V96, P225, DOI 10.1016/S0035-9203(02)90084-2
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   WEISS EA, 1979, ECON BOT, V33, P35, DOI 10.1007/BF02858210
NR 52
TC 2
Z9 2
U1 33
U2 33
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
EI 1090-2449
J9 EXP PARASITOL
JI Exp. Parasitol.
PD AUG
PY 2016
VL 167
BP 103
EP 108
DI 10.1016/j.exppara.2016.05.010
PG 6
WC Parasitology
SC Parasitology
GA DR3IS
UT WOS:000379797500014
PM 27260568
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus transmission: What should we be concerned about apart from
   mosquito control
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Dept Biol Sci, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Coll Med, Pune, Maharashtra, India.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Publ Hlth Curriculum, Surin, Thailand.
RP Wiwanitkit, V (reprint author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Wiwanitkit S., 2015, Journal of Acute Disease, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
NR 7
TC 1
Z9 1
U1 46
U2 46
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD AUG
PY 2016
VL 115
IS 8
BP 684
EP 684
DI 10.1016/j.jfma.2016.03.008
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR5YX
UT WOS:000379979400017
PM 27265325
ER

PT J
AU Wong, SSY
AF Wong, Samson Sai-Yin
TI Reply to comments on "Zika virus transmission: What to concern on its
   transmission apart from mosquito control" by Viroj Wiwanitkit
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Wong, Samson Sai-Yin] Univ Hong Kong, Fac Med, Res Ctr Infect & Immunol, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
RP Wong, SSY (reprint author), Univ Hong Kong, Queen Mary Hosp, Fac Med, Dept Microbiol,Res Ctr Infect & Immunol, LG-1 Block K,102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.
EM samsonsy@hku.hk
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Campos R. de M., 2016, Journal of Clinical Virology, V77, P69
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS, V387, P405
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Suk Jonathan E, 2014, Glob Health Action, V7, P25287, DOI 10.3402/gha.v7.25287
   Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wiwanitkit V, 2016, J FORMOS MED ASSOC, V115, P684, DOI 10.1016/j.jfma.2016.03.008
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Wong SSY, 2015, J FORMOS MED ASSOC, V114, P384, DOI 10.1016/j.jfma.2015.01.012
NR 15
TC 0
Z9 0
U1 15
U2 15
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD AUG
PY 2016
VL 115
IS 8
BP 685
EP 686
DI 10.1016/j.jfma.2016.03.007
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR5YX
UT WOS:000379979400018
PM 27174386
ER

PT J
AU Shah, A
   Kumar, A
AF Shah, Ankit
   Kumar, Anil
TI Zika Virus Infection and Development of a Murine Model
SO NEUROTOXICITY RESEARCH
LA English
DT Editorial Material
DE ZIKV; Mouse model; Neurodegeneration; IFN-alpha/beta
ID GENOME
AB In view of the recent outbreak of Zika virus (ZIKV), there is an urgent need to investigate the pathogenesis of the symptoms associated with ZIKV infection. Since the first identification of the virus in 1947, the pathologies associated with ZIKV infection were thought to be limited with mild illness that presented fever, rashes, muscle aches, and weakness. However, ZIKV infection has been shown to cause Guillain-Barr, Syndrome, and numerous cases of congenital microcephaly in children have been reported when pregnant females were exposed to the virus. The severity and the rate of spread of ZIKV in the last year has drawn alarming interest among researchers to investigate murine models to study viral pathogenesis and develop candidate vaccines. A recent study by Lazear and colleagues, in the May 2016 issue of cell host and microbe, is an effort to study the pathogenesis of contemporary and historical virus strains in various mouse models.
C1 [Shah, Ankit; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, 2464 Charlotte St, Kansas City, MO 64108 USA.
RP Kumar, A (reprint author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, 2464 Charlotte St, Kansas City, MO 64108 USA.
EM kumaran@umkc.edu
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, GENOME ANNOUNC, V4, DOI DOI 10.1128/GENOMEA.00032-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison DW, 2016, GENOME ANNOUNC, V4, DOI [10.1128/genomeA.00359-16, DOI 10.1128/GENOMEA.00359-16]
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Ladner JT, 2016, GENOME ANNOUNC, V4, DOI [10.1128/genomeA.00377-16, DOI 10.1128/GENOMEA.00377-16]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu L, 2016, GENOME ANNOUNC, V4, DOI [10.1128/genomeA.00291-16, DOI 10.1128/GENOMEA.00291-16]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nandy A, 2016, CURR COMPUT AIDED DR
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 27
TC 0
Z9 0
U1 36
U2 36
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1029-8428
EI 1476-3524
J9 NEUROTOX RES
JI Neurotox. Res.
PD AUG
PY 2016
VL 30
IS 2
BP 131
EP 134
DI 10.1007/s12640-016-9635-3
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA DR6AU
UT WOS:000379984300001
PM 27260223
ER

PT J
AU Estofolete, CF
   Terzian, ACB
   Parreira, R
   Esteves, A
   Hardman, L
   Greque, GV
   Rahal, P
   Nogueira, ML
AF Estofolete, Cassia Fernanda
   Bernardes Terzian, Ana Carolina
   Parreira, Ricardo
   Esteves, Aida
   Hardman, Lucas
   Greque, Gilmar Valdir
   Rahal, Paula
   Nogueira, Mauricio Lacerda
TI Clinical and laboratory profile of Zika virus infection in dengue
   suspected patients: A case series
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Dengue virus; Chikungunya virus; NS1; Arbovirus
ID CHIKUNGUNYA-VIRUS; NS1 ANTIGEN; BRAZIL; OUTBREAK; FLAVIVIRUSES;
   TRANSMISSION; INDONESIA; ANTIBODY; VECTOR; TRAVEL
AB Background: The Zika virus (ZIKV) is an emerging arthropod-borne virus related to the dengue virus (DENV), and shows a similar clinical profile as other arboviral diseases, such as dengue and chikungunya virus (CHIKV). Historically, ZIKV has been associated with sporadic cases of human infection, but is now responsible for outbreaks worldwide. In Brazil, cases have been reported since 2015, with some cases causing severe disease.
   Objective: To identify clinical symptoms of Zika in patients in Dengue suspected patients.
   Study design: Description of a series of cases, wherein we analyzed 100 clinical samples collected from patients who exhibited acute febrile disease for <= 5 days, from January to February 2016.
   Results: In this study, we report 13 cases of ZIKV infection in adults presenting dengue-like symptoms in a DENV endemic area. All patients presented with fever, with myalgia being the second most frequently observed symptom. Two patients had rashes, but none of them had conjunctivitis. Other less frequent manifestations included headache, arthralgia, diarrhea, and nausea.
   Conclusion: The co-circulation of ZIKV and DENV is a serious public health concern, since it represents both a clinical and diagnostic challenge in endemic areas, as well as in the field of travel medicine. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Estofolete, Cassia Fernanda; Bernardes Terzian, Ana Carolina; Hardman, Lucas; Nogueira, Mauricio Lacerda] Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, Brazil.
   [Parreira, Ricardo; Esteves, Aida] Univ Nova Lisboa, Global Hlth & Trop Med GHTM, Rua Junqueira 100, P-1349008 Lisbon, Portugal.
   [Greque, Gilmar Valdir] Sao Jose do Rio Preto Reg Sch Med Fdn FUNFARME, Ave Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Rahal, Paula] Sao Paulo State Univ, Sao Jose do Rio Preto IBILCE UNESP, Inst Biosci Letters & Exact Sci, Dept Biol, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (reprint author), Ave Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM cassiafestofolete@gmail.com; anacarolinaterzian@gmail.com;
   ricardo@ihmt.unl.pt; aidaesteves@ihmt.unl.pt; lucashardman@hotmail.com;
   greque@terra.com.br; rahalp@yahoo.com.br; mnogueira@famerp.br
FU Sao Paulo State Research Foundation (FAPESP) [2013/21719-3,
   2015/12295-0]; FAPESP Zika Network
FX This work was supported by the Sao Paulo State Research Foundation
   (FAPESP) under Grant # 2013/21719-3 to MLN and the 2015/12295-0
   fellowship to ACBT. The FAPESP Zika Network supported this work. MLN is
   a CNPq fellow.
CR Arshad I., 2011, PROF MED J, V18, P7
   Banerjee M., 2008, MJAF, V64, P4
   Bashir A. B., 2015, J INFECT DIS IMMUN, V7, P7
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P2095, DOI 10.1128/CVI.05285-11
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chung SJ, 2015, AM J TROP MED HYG, V92, P367, DOI 10.4269/ajtmh.14-0247
   [Anonymous], 2016, RAP RISK ASS ZIK VIR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ., 1998, RELEVE EPIDEMIOLOGIQ, V73, P182
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   [Anonymous], 2009, DENG NO BRAS INF EP
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013
   Kuno G, 1998, J VIROL, V72, P72
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764
   Lanciotti RS, 2008, EMERG INFECT DIS, V8, P1232
   Mallet H., 2014, 15 JOURN NAT INF BOR, P28
   Mondini A, 2007, EMERG INFECT DIS, V13, P176
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nhan T. X. M. D., 2015, VIROLOGIE, V19, P11
   [Anonymous], 2014, EURO SURVEILLANCE B
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pierson T. C. D. M., 2013, FIELDS VIROLOGY
   Roth A., 2014, EURO SURVEILLANCE B, V19
   [Anonymous], 2015, PAIN MON IND 2014, P32
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 0
Z9 0
U1 46
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD AUG
PY 2016
VL 81
BP 25
EP 30
DI 10.1016/j.jcv.2016.05.012
PG 6
WC Virology
SC Virology
GA DR1EE
UT WOS:000379648000005
ER

PT J
AU Tavares, MP
   Foster, AM
AF Tavares, Marilia P.
   Foster, Angel M.
TI Emergency contraception in a public health emergency: exploring pharmacy
   availability in Brazil
SO CONTRACEPTION
LA English
DT Article
DE EC; ECPs; Postcoital contraception; Zika virus; Latin America
ID ABORTION; ACCESS; ZIKA
AB Introduction: Dedicated progestin-only emergency contraceptive pills (ECPs) have been available with a prescription in Brazil since 1999. However, utilization of emergency contraception has been limited. We conducted a mystery client study at retail pharmacies in three regions to assess current availability.
   Methods: Using a predetermined client profile, we approached a random sample of chain and independent pharmacies in urban areas in the southeastern, northeastern and central-west regions. We documented product availability, price and the client-pharmacy representative interaction at each site. We analyzed these data with descriptive statistics and for content and themes.
   Results: We visited 122 pharmacies in early 2016. All but three pharmacies (97.5%) had ECPs in stock at the time of the interaction and offered our client the medication without a prescription. In general, pharmacy representatives did not ask questions or provide our client with information about emergency contraception. When prompted, over one third of the pharmacy representatives (37.7%) inaccurately reported that levonorgestrel ECPs could only be used immediately or within 12, 24 or 48 h from the time of intercourse.
   Conclusion: Despite the current regulatory status, our findings suggest that progestin-only ECPs are widely available without a prescription. Additional efforts to ensure that women have up-to-date and medically accurate information about progestin-only ECPs appear warranted. Our findings suggest that more work needs to be done to align national regulatory policies with international standards and evidence-based practices.
   Implications: The Zika virus epidemic has shined a spotlight on the importance of providing timely access to emergency contraception in Latin America. This public health emergency offers a window of opportunity to advance national policies and practices to ensure that Brazilian women have access to a full range of reproductive health services. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Tavares, Marilia P.; Foster, Angel M.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada.
   [Foster, Angel M.] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada.
RP Foster, AM (reprint author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada.; Foster, AM (reprint author), Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada.
EM angel.foster@uottawa.ca
OI Foster, Angel/0000-0001-8848-203X
FU Ministry of Health and Long-Term Care in Ontario
FX Dr. Foster's Endowed Chair in Women's Health Research is funded by the
   Ministry of Health and Long-Term Care in Ontario and we appreciate the
   general support for her time that made this project possible. We thank
   Drs. Sanni Yaya and Raywat Deonandan for their input on early phases of
   this project. The conclusions and opinions expressed in this article are
   those of the authors and do not necessarily represent the views of the
   organizations with which the authors are affiliated or the funders.
CR Alano GM, 2012, CIENC SAUDE COLETIVA, V17, P2397, DOI 10.1590/S1413-81232012000900020
   Arajo Maria Suely Peixoto de, 2009, Cad. Sade Pblica, V25, P551
   Camargo RS, 2011, INT J GYNECOL OBSTET, V112, P88, DOI 10.1016/j.ijgo.2010.08.013
   Chin-Quee DS, 2006, STUD FAMILY PLANN, V37, P99, DOI 10.1111/j.1728-4465.2006.00089.x
   Cleland K, ACCESS EMER IN PRESS
   Deniz N, 2005, SAGE HDB QUALITATIVE
   Daz Soledad, 2003, Cad. Sade Pblica, V19, P1507, DOI 10.1590/S0102-311X2003000500029
   Daz Soledad, 2003, Cad. Sade Pblica, V19, P1729, DOI 10.1590/S0102-311X2003000600017
   Faundes A, 2015, EUR J CONTRACEP REPR, V2015, P1
   Faundes A, 2007, REPROD HEALTH MATTER, V15, P130, DOI 10.1016/S0968-8080(07)29300-0
   GBI Source, BRAZ GOV EV REIMB CO
   Hardy E, 2001, Cad Saude Publica, V17, P1031, DOI 10.1590/S0102-311X2001000400038
   Higgins SJ, 2013, RES SOC ADMIN PHARM, V9, P114, DOI 10.1016/j.sapharm.2012.03.004
   International Consortium for Emergency Contraception, STAT AV DAT
   International Consortium for Emergency Contraception, 2012, EM CONTR PILLS MED S
   Leon FR, 2005, STUD FAMILY PLANN, V36, P117, DOI 10.1111/j.1728-4465.2005.00049.x
   McNeil Jr DG, 2016, NY TIMES
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Trussell J, 2012, EMERGENCY CONTRACEPTION: THE STORY OF A GLOBAL REPRODUCTIVE HEALTH TECHNOLOGY, P19
   Borges ALV, 2016, HEALTH CARE WOMEN IN, V37, P170, DOI 10.1080/07399332.2015.1055746
   Borges ALV, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0087-7
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, PREV POT SEX TRANSM
   World Bank, BRAZ WORLD DEV IND
   Wynn LL, 2012, EMERGENCY CONTRACEPTION: THE STORY OF A GLOBAL REPRODUCTIVE HEALTH TECHNOLOGY, P3
   [Anonymous], 2014, ECONOMIST
NR 27
TC 0
Z9 0
U1 34
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0010-7824
EI 1879-0518
J9 CONTRACEPTION
JI Contraception
PD AUG
PY 2016
VL 94
IS 2
BP 109
EP 114
DI 10.1016/j.contraception.2016.04.006
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DQ1SV
UT WOS:000378981600003
PM 27091724
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Halting the Olympics-Zika virus bandwagon
SO LANCET
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 30
PY 2016
VL 388
IS 10043
BP 437
EP 437
AR PII S1473-3099(16)30230-4
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS2EK
UT WOS:000380559400001
ER

PT J
AU Maurice, J
AF Maurice, John
TI The Zika virus public health emergency: 6 months on
SO LANCET
LA English
DT Editorial Material
AB This year, the global health community has given top priority ranking on many research and public health fronts to its battle against the spreading Zika virus epidemic. John Maurice reports.
NR 0
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 30
PY 2016
VL 388
IS 10043
BP 449
EP 450
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS2EK
UT WOS:000380559400010
PM 27507747
ER

PT J
AU Rastogi, M
   Sharma, N
   Singh, SK
AF Rastogi, Meghana
   Sharma, Nikhil
   Singh, Sunit Kumar
TI Flavivirus NS1: a multifaceted enigmatic viral protein
SO VIROLOGY JOURNAL
LA English
DT Review
DE Flavivirus; Non-structural proteins; Arboviruses; NS1 protein
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; NONSTRUCTURAL GLYCOPROTEIN
   NS1; N-LINKED GLYCOSYLATION; TOLL-LIKE RECEPTOR-3; SIGNAL-TRANSDUCTION;
   PROTECTIVE IMMUNITY; RNA REPLICATION; DENGUE TYPE-2; CELL APOPTOSIS
AB Flaviviruses are emerging arthropod-borne viruses representing an immense global health problem. The prominent viruses of this group include dengue virus, yellow fever virus, Japanese encephalitis virus, West Nile virus tick borne encephalitis virus and Zika Virus. These are endemic in many parts of the world. They are responsible for the illness ranging from mild flu like symptoms to severe hemorrhagic, neurologic and cognitive manifestations leading to death. NS1 is a highly conserved non-structural protein among flaviviruses, which exist in diverse forms. The intracellular dimer form of NS1 plays role in genome replication, whereas, the secreted hexamer plays role in immune evasion. The secreted NS1 has been identified as a potential diagnostic marker for early detection of the infections caused by flaviviruses. In addition to the diagnostic marker, the importance of NS1 has been reported in the development of therapeutics. NS1 based subunit vaccines are at various stages of development. The structural details and diverse functions of NS1 have been discussed in detail in this review.
C1 [Rastogi, Meghana; Singh, Sunit Kumar] Banaras Hindu Univ, Fac Med, Mol Biol Unit, IMS,Lab Human Mol Virol & Immunol, Varanasi 221005, Uttar Pradesh, India.
   [Sharma, Nikhil] CSIR, Lab Neurovirol & Inflammat Biol, CCMB, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.
RP Singh, SK (reprint author), Banaras Hindu Univ, Fac Med, Mol Biol Unit, IMS,Lab Human Mol Virol & Immunol, Varanasi 221005, Uttar Pradesh, India.
EM sunitsingh2000@gmail.com
FU Department of Biotechnology, Govt. of India, New Delhi
   [BT/PR8706/AGR/36/767/2013]
FX The support through the Department of Biotechnology, Govt. of India, New
   Delhi, Grant no: BT/PR8706/AGR/36/767/2013 is highly acknowledged.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034
   Antunes P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16145
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Baronti C, 2010, VIROLOGY, V404, P319, DOI 10.1016/j.virol.2010.05.020
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Brooks SA, 2006, EXPERT REV PROTEOMIC, V3, P345, DOI 10.1586/14789450.3.3.345
   Cervantes-Salazar M, 2015, VIROLOGY, V484, P113, DOI 10.1016/j.virol.2015.05.017
   Chang HH, 2002, J INFECT DIS, V186, P743, DOI 10.1086/342600
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033
   Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025
   Chuang YC, 2013, THROMB HAEMOSTASIS, V110, P358, DOI 10.1160/TH13-02-0149
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   Crook KR, 2014, VIROLOGY, V458, P172, DOI 10.1016/j.virol.2014.04.036
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Dechtawewat T, 2016, BIOCH BIOPHYS ACTA
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   FALGOUT B, 1989, J VIROL, V63, P1852
   [Anonymous], 2014, VIROL SIN, DOI 10.1007/s12250-014-3459-1
   Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14
   Gubler D, 2007, FIELDS VIROLOGY, P1153
   HORI H, 1990, J VIROL, V64, P4573
   Hu Dongmei, 2013, Biosensors (Basel), V3, P297, DOI 10.3390/bios3030297
   Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0438, 10.1160/TH07-08-0483]
   Hukkanen RR, 2006, COMPARATIVE MED, V56, P46
   Ishikawa T, 2011, VACCINE, V29, P7444, DOI 10.1016/j.vaccine.2011.07.058
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Kanlaya R, 2010, MOL BIOSYST, V6, P795, DOI 10.1039/b923864f
   Khromykh AA, 1999, J VIROL, V73, P10272
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kneller ELP, 2009, J VIROL, V83, P770, DOI 10.1128/JVI.01279-08
   Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08
   Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137
   Lee HH, 2004, J CELL SCI, V117, P5579, DOI 10.1242/jcs.01482
   Lin CF, 2002, J IMMUNOL, V169, P657
   Lin TS, 2010, MICROB PATHOGENESIS, V49, P67, DOI 10.1016/j.micpath.2010.04.002
   Lin YL, 1998, J VIROL, V72, P191
   Linares EM, 2013, BIOSENS BIOELECTRON, V41, P180, DOI 10.1016/j.bios.2012.08.005
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 1997, J VIROL, V71, P9608
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Noisakran S, 2008, BIOCHEM BIOPH RES CO, V372, P67, DOI 10.1016/j.bbrc.2008.04.165
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Robinson PJ, 1997, ADV EXP MED BIOL, V419, P365
   Satchidanandam V, 2006, NOVART FDN SYMP, V277, P45
   Satchidanandam V, 2006, NOVART FDN SYMP, V277, P251
   Satchidanandam Vijaya, 2006, Novartis Found Symp, V277, P136, DOI 10.1002/0470058005.ch10
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   Scholle F, 2005, VIROLOGY, V342, P77, DOI 10.1016/j.virol.2005.07.021
   Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Sinawang PD, 2016, BIOSENS BIOELECTRON, V77, P400, DOI 10.1016/j.bios.2015.09.048
   SMITH GW, 1985, J GEN VIROL, V66, P559, DOI 10.1099/0022-1317-66-3-559
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   SRIVASTAVA AK, 1995, VACCINE, V13, P1251, DOI 10.1016/0264-410X(94)00059-V
   Sun EC, 2013, VET MICROBIOL, V166, P145, DOI 10.1016/j.vetmic.2013.05.026
   Sun J, 2012, MICROBES INFECT, V14, P930, DOI 10.1016/j.micinf.2012.03.007
   Tajima S, 2008, VIRUS GENES, V36, P323, DOI 10.1007/s11262-008-0211-7
   Takamatsu Y, 2014, J GEN VIROL, V95, P373, DOI 10.1099/vir.0.057968-0
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Vazquez S, 2007, J CLIN VIROL, V39, P194, DOI 10.1016/j.jcv.2007.04.003
   Wallis TP, 2004, J BIOL CHEM, V279, P20729, DOI 10.1074/jbc.M312907200
   Wan SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092495
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   Winkelmann ER, 2011, VIROLOGY, V421, P96, DOI 10.1016/j.virol.2011.09.007
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Yen LC, 2016, J VIROL, V90, P1178, DOI 10.1128/JVI.02057-15
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Young LB, 2015, J GEN VIROL, V96, P1042, DOI 10.1099/vir.0.000053
   Young LB, 2013, J VIROL, V87, P9384, DOI 10.1128/JVI.01101-13
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053
   Zheng Q, 2011, VACCINE, V29, P763, DOI 10.1016/j.vaccine.2010.11.014
   Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3
NR 96
TC 0
Z9 0
U1 5
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUL 29
PY 2016
VL 13
AR 131
DI 10.1186/s12985-016-0590-7
PG 10
WC Virology
SC Virology
GA DS6DF
UT WOS:000380871200001
PM 27473856
ER

PT J
AU Lei, J
   Hansen, G
   Nitsche, C
   Klein, CD
   Zhang, LL
   Hilgenfeld, R
AF Lei, Jian
   Hansen, Guido
   Nitsche, Christoph
   Klein, Christian D.
   Zhang, Linlin
   Hilgenfeld, Rolf
TI Crystal structure of Zika virus NS2B-NS3 protease in complex with a
   boronate inhibitor
SO SCIENCE
LA English
DT Article
ID NS3 PROTEASE; DENGUE
AB The ongoing Zika virus (ZIKV) outbreak is linked to severe neurological disorders. ZIKV relies on its NS2B/NS3 protease for polyprotein processing; hence, this enzyme is an attractive drug target. The 2.7 angstrom crystal structure of ZIKV protease in complex with a peptidomimetic boronic acid inhibitor reveals a cyclic diester between the boronic acid and glycerol. The P2 4-aminomethylphenylalanine moiety of the inhibitor forms a salt-bridge with the nonconserved Asp(83) of NS2B; ion-pairing between Asp(83) and the P2 residue of the substrate likely accounts for the enzyme's high catalytic efficiency. The unusual dimer of the ZIKV protease: inhibitor complex seen in the crystal may provide a model for assemblies formed at high local concentrations of protease at the endoplasmatic reticulum membrane, the site of polyprotein processing.
C1 [Lei, Jian; Hansen, Guido; Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, Ratzeburger Allee 160, D-23562 Lubeck, Germany.
   [Lei, Jian; Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany.
   [Nitsche, Christoph; Klein, Christian D.] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Med Chem, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [Nitsche, Christoph] Australian Natl Univ, Sch Chem, Canberra, ACT 2601, Australia.
RP Hilgenfeld, R (reprint author), Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, Ratzeburger Allee 160, D-23562 Lubeck, Germany.; Hilgenfeld, R (reprint author), Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany.
EM hilgenfeld@biochem.uni-luebeck.de
FU German Center for Infection Research [DZIF-TTU01, 8011801911]; Deutsche
   Forschungsgemeinschaft [KL-1356/3-1]
FX We thank S. Zoske and Y. Gul for assistance, S. Anemuller for recording
   the mass spectra, L. Weigel for the synthesis of precursors of cn-716,
   and D. Graf for testing this compound for cytotoxicity. We are indebted
   to the staff of synchrotron beamlines BL 14.1 (BESSY, Berlin) and P11
   (DESY, Hamburg) for support. The corresponding coordinates and structure
   factors are available from the PDB under accession code 5LC0. Funding
   from the German Center for Infection Research (DZIF-TTU01, grant
   8011801911) is gratefully acknowledged. C.D.K. thanks the Deutsche
   Forschungsgemeinschaft for financial support (KL-1356/3-1).
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kuroda Daisuke, 2016, Bioinformatics, V32, P2451, DOI 10.1093/bioinformatics/btw197
   LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445
   Turker L, 2006, INDIAN J CHEM A, V45, P1339
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI [10.1016/j.bmcl.2005.09.062, 10.1016/j.bmcl.2005.09.004]
NR 16
TC 0
Z9 0
U1 15
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 29
PY 2016
VL 353
IS 6298
BP 503
EP 505
DI 10.1126/science.aag2419
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS2HC
UT WOS:000380583600045
PM 27386922
ER

PT J
AU Pessoa, R
   Patriota, JV
   de Souza, MD
   Abd El Wahed, A
   Sanabani, SS
AF Pessoa, R.
   Patriota, J. V.
   de Souza, M. dL
   Abd El Wahed, A.
   Sanabani, S. S.
TI Detection of Zika virus in Brazilian patients during the first five days
   of infection - urine versus plasma
SO Eurosurveillance
LA English
DT Article
ID OUTBREAK; DENGUE; CHIKUNGUNYA; ILLNESS
AB Advantages of testing for Zika virus (ZIKV) in urine have been reported, such as the persistence of ZIKV in this type of specimen for up to 20 days after ZIKV disease onset. We investigate 61 patients in the first 5 days post-symptom onset and find more patients testing positive for ZIKV in plasma samples (n=46),than in corresponding urine samples (n=37). For patients respectively testing positive in both plasma and urine (n=28), respective viral loads appeared similar.
   Results of recent studies have suggested that after Zika virus (ZIKV) disease onset, the virus persists at higher levels and for a longer period in urine (up to ca 20 days) than in serum (up to ca 5 days) [1,2]. To provide further data, we tested for the presence of ZIKV in the urine and corresponding plasma specimens of 61 patients presenting symptoms of ZIKV disease in Brazil. The samples were collected between 1 and 5 days after symptom onset. During this phase of infection, the proportion of patients testing positive in plasma samples (46/61) appeared to be higher than those testing positive in urine samples (37/61).
C1 [Pessoa, R.; Sanabani, S. S.] Univ Sao Paulo, Sch Med, Hosp Clin, Dept Pathol, Sao Paulo, Brazil.
   [Patriota, J. V.; de Souza, M. dL] Municipal Hosp Tuparetama, Pernambuco, Brazil.
   [Abd El Wahed, A.] Univ Gottingen, Div Microbiol & Anim Hyg, Gottingen, Germany.
RP Sanabani, SS (reprint author), Univ Sao Paulo, Sch Med, Hosp Clin, Dept Pathol, Sao Paulo, Brazil.
EM sabyem_63@yahoo.com
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/24596-2]
FX This work was partially supported by grants 2014/24596-2 from the
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no
   role in design of the study, data collection and analysis, decision to
   publish, or preparation of the manuscript. We would like to acknowledge
   our colleague Shereen Petersen, DPZ, for English proofreading of the
   manuscript.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention (CDC), TRAV NOT
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P254, DOI 10.1016/0035-9203(77)90020-7
   Lan Nguyen Thi Phuong, 2011, Trop Med Health, V39, P73, DOI 10.2149/tmh.2011-S08
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
NR 13
TC 0
Z9 0
U1 16
U2 16
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUL 28
PY 2016
VL 21
IS 30
BP 2
EP 5
DI 10.2807/1560-7917.ES.2016.21.30.30302
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DS4NW
UT WOS:000380758800001
ER

PT J
AU Furtado, JM
   Esposito, DL
   Klein, TM
   Teixeira-Pinto, T
   da Fonseca, BA
AF Furtado, Joao M.
   Esposito, Danillo L.
   Klein, Taline M.
   Teixeira-Pinto, Tomas
   da Fonseca, Benedito A.
TI Uveitis Associated with Zika Virus Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Furtado, Joao M.; Esposito, Danillo L.; Klein, Taline M.; Teixeira-Pinto, Tomas; da Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, Brazil.
RP Furtado, JM (reprint author), Univ Sao Paulo, Ribeirao Preto, Brazil.
EM furtadojm@gmail.com
RI Furtado, Joao/D-4436-2012
CR Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
   Kuno G, 1998, J VIROL, V72, P73
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
NR 5
TC 1
Z9 1
U1 16
U2 16
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 28
PY 2016
VL 375
IS 4
BP 394
EP 396
DI 10.1056/NEJMc1603618
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0UV
UT WOS:000380313200030
PM 27332784
ER

PT J
AU Aiken, ARA
   Scott, JG
   Gomperts, R
   Trussell, J
   Worrell, M
   Aiken, CE
AF Aiken, Abigail R. A.
   Scott, James G.
   Gomperts, Rebecca
   Trussell, James
   Worrell, Marc
   Aiken, Catherine E.
TI Requests for Abortion in Latin America Related to Concern about Zika
   Virus Exposure
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Aiken, Abigail R. A.; Scott, James G.] Univ Texas Austin, Austin, TX 78712 USA.
   [Gomperts, Rebecca; Worrell, Marc] Women Web, Amsterdam, Netherlands.
   [Trussell, James] Princeton Univ, Princeton, NJ 08544 USA.
   [Aiken, Catherine E.] Univ Cambridge, Cambridge, England.
RP Aiken, ARA (reprint author), Univ Texas Austin, Austin, TX 78712 USA.
EM araa2@utexas.edu
CR Gerdts C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053346
   Gomperts RJ, 2008, BJOG-INT J OBSTET GY, V115, P1171, DOI 10.1111/j.1471-0528.2008.01787.x
   [Anonymous], 2015, FACT SHEET AB LAT AM
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2015, EP AL INCR MICR NE B
   Post C, 2016, PERU REPORTS    0125
NR 5
TC 1
Z9 1
U1 7
U2 7
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 28
PY 2016
VL 375
IS 4
BP 396
EP 398
DI 10.1056/NEJMc1605389
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0UV
UT WOS:000380313200031
PM 27331661
ER

PT J
AU Paploski, IAD
   Rodrigues, MS
   Mugabe, VA
   Kikuti, M
   Tavares, AS
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Dexheimer Paploski, Igor Adolfo
   Rodrigues, Moreno S.
   Mugabe, Vanio Andre
   Kikuti, Mariana
   Tavares, Aline S.
   Reis, Mitermayer Galvao
   Kitron, Uriel
   Ribeiro, Guilherme Sousa
TI Storm drains as larval development and adult resting sites for Aedes
   aegypti and Aedes albopictus in Salvador, Brazil
SO PARASITES & VECTORS
LA English
DT Article
DE Epidemiology; Entomology; Arboviruses; Insect vectors; Disease vectors
ID CATCH BASINS; ZIKA VIRUS; BREEDING SITES; VECTOR CONTROL; DRY SEASON;
   URBAN AREA; DENGUE; CULICIDAE; DIPTERA; CULEX
AB Background: Dengue (DENV), Chikungunya (CHIKV), Zika (ZIKV), as well as yellow fever (YFV) viruses are transmitted to humans by Aedes spp. females. In Salvador, the largest urban center in north-eastern Brazil, the four DENV types have been circulating, and more recently, CHIKV and ZIKV have also become common. We studied the role of storm drains as Aedes larval development and adult resting sites in four neighbourhoods of Salvador, representing different socioeconomic, infrastructure and topographic conditions.
   Results: A sample of 122 storm drains in the four study sites were surveyed twice during a 4-month period in 2015; in 49.0 % of the visits, the storm drains contained water. Adults and immatures of Aedes aegypti were captured in two of the four sites, and adults and immatures of Aedes albopictus were captured in one of these two sites. A total of 468 specimens were collected: 148 Ae. aegypti (38 adults and 110 immatures), 79 Ae. albopictus (48 adults and 31 immatures), and 241 non-Aedes (mainly Culex spp.) mosquitoes (42 adults and 199 immatures). The presence of adults or immatures of Ae. aegypti in storm drains was independently associated with the presence of non-Aedes mosquitoes and with rainfall of <= 50 mm during the preceding week.
   Conclusions: We found that in Salvador, one of the epicentres of the 2015 ZIKV outbreak, storm drains often accumulate water and serve as larval development sites and adult resting areas for both Ae. aegypti and Ae. albopictus. Vector control campaigns usually overlook storm drains, as most of the effort to prevent Ae. agypti reproduction is directed towards containers in the domicile environment. While further studies are needed to determine the added contribution of storm drains for the maintenance of Aedes spp. populations, we advocate that vector control programs incorporate actions directed at storm drains, including regular inspections and use of larvicides, and that human and capital resources are mobilized to modify storm drains, so that they do not serves as larval development sites for Aedes (and other) mosquitoes.
C1 [Dexheimer Paploski, Igor Adolfo; Rodrigues, Moreno S.; Mugabe, Vanio Andre; Kikuti, Mariana; Tavares, Aline S.; Reis, Mitermayer Galvao; Kitron, Uriel; Ribeiro, Guilherme Sousa] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Dexheimer Paploski, Igor Adolfo; Rodrigues, Moreno S.; Mugabe, Vanio Andre; Kikuti, Mariana; Ribeiro, Guilherme Sousa] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Mugabe, Vanio Andre] Univ Pedag Quelimane, Quelimane, ZB, Mozambique.
   [Reis, Mitermayer Galvao] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (reprint author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.; Ribeiro, GS (reprint author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
FU National Council for Scientific and Technological Development
   [400830/2013-2]; Coordination for the Improvement of Higher Education
   Personnel - Brazilian Ministry of Education
FX This study was supported by the National Council for Scientific and
   Technological Development (grant 400830/2013-2 and scholarships to IADP,
   MSR, VAM, UK, MGR and GSR); and the Coordination for the Improvement of
   Higher Education Personnel - Brazilian Ministry of Education
   (scholarship to MK).
CR Anderson JF, 2011, J AM MOSQUITO CONTR, V27, P45, DOI 10.2987/10-6079.1
   Arana-Guardia R, 2014, ACTA TROP, V134, P33, DOI 10.1016/j.actatropica.2014.01.011
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Braga IA, 2005, J MED ENTOMOL, V42, P830, DOI 10.1603/0022-2585(2005)042[0830:EOMAIG]2.0.CO;2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chang MS, 2011, W PACIFIC SURVEILL R, V2, pe1
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   GEERY PR, 1989, J AM MOSQUITO CONTR, V5, P537
   GOLDBERG LJ, 1977, MOSQ NEWS, V37, P355
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Instituto Nacional de Metereologia, 2016, EST MET OBS SUP AUT
   Instituto Nacional de Metereologia, 2009, NORM CLIM BRAS 1961
   Kay BH, 2000, J MED ENTOMOL, V37, P846, DOI 10.1603/0022-2585-37.6.846
   Kean Joy, 2015, Insects, V6, P236, DOI 10.3390/insects6010236
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Manrique-Saide P, 2013, J AM MOSQUITO CONTR, V29, P164, DOI 10.2987/12-6320R.1
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Ministerio da Saude, 2013, LEV RAP IND AED AEG
   Montgomery BL, 2004, J AM MOSQUITO CONTR, V20, P365
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Ocampo CB, 2014, ACTA TROP, V132, P15, DOI 10.1016/j.actatropica.2013.12.019
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887
   Rey JR, 2006, J VECTOR ECOL, V31, P334, DOI 10.3376/1081-1710(2006)31[334:FAMPFS]2.0.CO;2
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   Russell BM, 2002, J MED ENTOMOL, V39, P143, DOI 10.1603/0022-2585-39.1.143
   Rydzanicz K, 2016, PARASITOL RES, V115, P1711, DOI 10.1007/s00436-016-4912-x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   StataCorp, 2015, STAT STAT SOFTW REL
   Tauil Pedro Luiz, 2002, Cad. Sade Pblica, V18, P867, DOI [10.1590/S0102-311X2002000300035, 10.1590/S0102-311X2002000300030]
   Troyo A, 2008, J VECTOR ECOL, V33, P76, DOI 10.3376/1081-1710(2008)33[76:SPOAAD]2.0.CO;2
   TunLin W, 1995, AM J TROP MED HYG, V53, P595
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   WHO, 2009, DENG GUID DIAGN TREA
NR 36
TC 0
Z9 0
U1 13
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 27
PY 2016
VL 9
AR 419
DI 10.1186/s13071-016-1705-0
PG 8
WC Parasitology
SC Parasitology
GA DS1DL
UT WOS:000380335900001
PM 27464886
ER

PT J
AU Meda, N
   Salinas, S
   Kagone, T
   Simonin, Y
   Van de Perre, P
AF Meda, Nicolas
   Salinas, Sara
   Kagone, Therese
   Simonin, Yannick
   Van de Perre, Philippe
TI Zika virus epidemic: Africa should not be neglected
SO LANCET
LA English
DT Letter
C1 [Meda, Nicolas; Kagone, Therese] Ctr Muraz, Bobo Dioulasso, Burkina Faso.
   [Salinas, Sara; Simonin, Yannick; Van de Perre, Philippe] Univ Montpellier, Etab Francais Sang, INSERM, UMR 1058,Pathogenesis & Control Chron Infect, Montpellier, France.
   [Van de Perre, Philippe] CHU Montpellier, Dept Bacterioloy Virol, Montpellier, France.
RP Van de Perre, P (reprint author), Univ Montpellier, Etab Francais Sang, INSERM, UMR 1058,Pathogenesis & Control Chron Infect, Montpellier, France.; Van de Perre, P (reprint author), CHU Montpellier, Dept Bacterioloy Virol, Montpellier, France.
EM p-van_de_perre@chu-montpellier.fr
RI Salinas, Sara/O-1856-2013
OI Salinas, Sara/0000-0003-4492-2093
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Meda N, 2016, LANCET, V387, P2196, DOI 10.1016/S0140-6736(16)30015-0
   Olusanya BO, 2012, INT HEALTH, V4, P128, DOI 10.1016/j.inhe.2011.12.006
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
NR 6
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 23
PY 2016
VL 388
IS 10042
BP 337
EP 338
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR6MV
UT WOS:000380016900026
PM 27477155
ER

PT J
AU Cauchemez, S
   Besnard, M
   Garel, C
   Fontanet, A
   Mallet, HP
AF Cauchemez, Simon
   Besnard, Marianne
   Garel, Catherine
   Fontanet, Arnaud
   Mallet, Henri-Pierre
TI Could clinical symptoms be a predictor of complications in Zika virus
   infection? reply
SO LANCET
LA English
DT Letter
C1 [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis, F-75015 Paris, France.
   [Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France.
   [Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, F-75015 Paris, France.
   [Fontanet, Arnaud] Inst Pasteur, Ctr Global Hlth, F-75015 Paris, France.
   [Cauchemez, Simon] CNRS, URA3012, Paris, France.
   [Besnard, Marianne] French Polynesia Hosp Ctr, Neonatal Care Dept, Pirae, Tahiti, French Guiana.
   [Garel, Catherine] Hop Enfants Armand Trousseau, Dept Pediat Radiol, Paris, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France.
   [Mallet, Henri-Pierre] Direct Sante, Bur Veille Sanitaire, Papeete, Tahiti, French Guiana.
RP Cauchemez, S (reprint author), Inst Pasteur, Math Modelling Infect Dis, F-75015 Paris, France.; Cauchemez, S (reprint author), Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France.; Cauchemez, S (reprint author), CNRS, URA3012, Paris, France.
EM simon.cauchemez@pasteur.fr
CR Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   COES-Microcefalias, INF EP N15 SEM EP 08
   COES-Microcefalias, INF EP N31 SEM EP 24
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 6
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 23
PY 2016
VL 388
IS 10042
BP 338
EP 339
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR6MV
UT WOS:000380016900028
PM 27477157
ER

PT J
AU Freitas, ARR
   Napimoga, MH
   Donalisio, MR
AF Ribas Freitas, Andre Ricardo
   Napimoga, Marcelo Henrique
   Donalisio, Maria Rita
TI Could clinical symptoms be a predictor of complications in Zika virus
   infection?
SO LANCET
LA English
DT Letter
ID OUTBREAK; STATES
C1 [Ribas Freitas, Andre Ricardo; Napimoga, Marcelo Henrique] Sao Leopoldo Mand Inst & Res Ctr, Lab Immunol & Mol Biol, BR-13015904 Sao Paulo, Brazil.
   [Donalisio, Maria Rita] Univ Estadual Campinas, Sch Med Sci, Lab Spatial Anal Epidemiol Data, Sao Paulo, Brazil.
   [Ribas Freitas, Andre Ricardo] Campinas Dept Hlth, Div Hlth Surveillance, Sao Paulo, Brazil.
RP Freitas, ARR (reprint author), Sao Leopoldo Mand Inst & Res Ctr, Lab Immunol & Mol Biol, BR-13015904 Sao Paulo, Brazil.; Freitas, ARR (reprint author), Campinas Dept Hlth, Div Hlth Surveillance, Sao Paulo, Brazil.
EM arrfreitas2010@gmail.com
CR [Anonymous], 2016, NEW ENGL J MED, DOI DOI 10.1056/NEJM0A1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
NR 5
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 23
PY 2016
VL 388
IS 10042
BP 338
EP 338
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR6MV
UT WOS:000380016900027
PM 27477156
ER

PT J
AU Grills, A
   Morrison, S
   Nelson, B
   Miniota, J
   Watts, A
   Cetron, MS
AF Grills, Ardath
   Morrison, Stephanie
   Nelson, Bradley
   Miniota, Jennifer
   Watts, Alexander
   Cetron, Martin S.
TI Projected Zika Virus Importation and Subsequent Ongoing Transmission
   after Travel to the 2016 Olympic and Paralympic Games - Country-Specific
   Assessment, July 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Grills, Ardath; Morrison, Stephanie; Nelson, Bradley; Cetron, Martin S.] CDC, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.
   [Morrison, Stephanie] Eagle Med Serv, Atlanta, GA USA.
   [Miniota, Jennifer; Watts, Alexander] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
RP Cetron, MS (reprint author), CDC, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.
EM mcetron@cdc.gov
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CDC, 2016, TRAV HLTH
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Sports Reference, 2016, OL SPORTS
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan American Health Organization, 2016, GEOGR DISTR CONF AUT
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   World Health Organization, 2016, ZIK VIR OL PAR GAM 2
NR 9
TC 1
Z9 1
U1 1
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUL 22
PY 2016
VL 65
IS 28
BP 711
EP 715
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DR7AD
UT WOS:000380051500003
PM 27442184
ER

PT J
AU Davidson, A
   Slavinski, S
   Komoto, K
   Rakeman, J
   Weiss, D
AF Davidson, Alexander
   Slavinski, Sally
   Komoto, Kendra
   Rakeman, Jennifer
   Weiss, Don
TI Suspected Female-to-Male Sexual Transmission of Zika Virus - New York
   City, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES
C1 [Davidson, Alexander; Slavinski, Sally; Komoto, Kendra; Rakeman, Jennifer; Weiss, Don] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.
RP Slavinski, S (reprint author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.
EM sslavins@health.nyc.gov
CR CDC, 2016, ZIK MAC ELISA INSTR
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Prisant N, 2016, LANCET INFECT DIS
NR 6
TC 4
Z9 4
U1 4
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUL 22
PY 2016
VL 65
IS 28
BP 716
EP 717
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DR7AD
UT WOS:000380051500004
PM 27442327
ER

PT J
AU Nah, K
   Otsuki, S
   Chowell, G
   Nishiura, H
AF Nah, Kyeongah
   Otsuki, Shiori
   Chowell, Gerardo
   Nishiura, Hiroshi
TI Predicting the international spread of Middle East respiratory syndrome
   (MERS)
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Middle East respiratory syndrome; Airline transportation network;
   Infectious disease; Risk assessment; Importation
ID ZIKA VIRUS-INFECTION; REPUBLIC-OF-KOREA; EBOLA-VIRUS; CORONAVIRUS;
   TRANSMISSION; OUTBREAK; RISK; ANTIBODIES; LIKELIHOOD; NETWORK
AB Background: The Middle East respiratory syndrome (MERS) associated coronavirus has been imported via travelers into multiple countries around the world. In order to support risk assessment practice, the present study aimed to devise a novel statistical model to quantify the country-level risk of experiencing an importation of MERS case.
   Methods: We analyzed the arrival time of each reported MERS importation around the world, i.e., the date on which imported cases entered a specific country, which was modeled as a dependent variable in our analysis. We also used openly accessible data including the airline transportation network to parameterize a hazard-based risk prediction model. The hazard was assumed to follow an inverse function of the effective distance (i.e., the minimum effective length of a path from origin to destination), which was calculated from the airline transportation data, from Saudi Arabia to each country. Both country-specific religion and the incidence data of MERS in Saudi Arabia were used to improve our model prediction.
   Results: Our estimates of the risk of MERS importation appeared to be right skewed, which facilitated the visual identification of countries at highest risk of MERS importations in the right tail of the distribution. The simplest model that relied solely on the effective distance yielded the best predictive performance (Area under the curve (AUC) = 0. 943) with 100 % sensitivity and 79.6 % specificity. Out of the 30 countries estimated to be at highest risk of MERS case importation, 17 countries (56.7 %) have already reported at least one importation of MERS. Although model fit measured by Akaike Information Criterion (AIC) was improved by including country-specific religion (i.e. Muslim majority country), the predictive performance as measured by AUC was not improved after accounting for this covariate.
   Conclusions: Our relatively simple statistical model based on the effective distance derived from the airline transportation network data was found to help predicting the risk of importing MERS at the country level. The successful application of the effective distance model to predict MERS importations, particularly when computationally intensive large-scale transmission models may not be immediately applicable could have been benefited from the particularly low transmissibility of the MERS coronavirus.
C1 [Nah, Kyeongah] Univ Szeged, Bolyai Inst, Aradi Vertanuk Tere 1, H-6720 Szeged, Hungary.
   [Nah, Kyeongah; Otsuki, Shiori; Nishiura, Hiroshi] Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
   [Otsuki, Shiori; Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
   [Chowell, Gerardo] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA.
   [Chowell, Gerardo] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Nah, Kyeongah; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
RP Nishiura, H (reprint author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.; Nishiura, H (reprint author), Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.; Nishiura, H (reprint author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
EM nishiurah@m.u-tokyo.ac.jp
FU Japan Society for the Promotion of Science (JSPS) KAKENHI Grant
   [26670308, 26700028]; Japan Agency for Medical Research and Development;
   Japan Science and Technology Agency (JST) CREST program; RISTEX program
   for Science of Science, Technology and Innovation Policy; Division of
   International Epidemiology and Population Studies, The Fogarty
   International Center, United States National Institutes of Health -
   Office of Pandemics and Emerging Threats at the United States Department
   of Health and Human Services; NSF, joint NSF-NIH-USDA Ecology and
   Evolution of Infectious Diseases program [1414374]; United Kingdom
   Biotechnology and Biological Sciences Research Council [BB/M008894/1];
   NSF-IIS [1518939]
FX HN received funding support from the Japan Society for the Promotion of
   Science (JSPS) KAKENHI Grant Numbers 26670308 and 26700028, Japan Agency
   for Medical Research and Development, the Japan Science and Technology
   Agency (JST) CREST program and RISTEX program for Science of Science,
   Technology and Innovation Policy. GC acknowledge financial support from
   the Division of International Epidemiology and Population Studies, The
   Fogarty International Center, United States National Institutes of
   Health, funded in part by the Office of Pandemics and Emerging Threats
   at the United States Department of Health and Human Services, as well as
   support from grants NSF grant 1414374 as part of the joint NSF-NIH-USDA
   Ecology and Evolution of Infectious Diseases program, United Kingdom
   Biotechnology and Biological Sciences Research Council grant
   BB/M008894/1 and NSF-IIS Grant#1518939. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3
   Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742
   Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Buchholz U, 2013, EURO SURVEILL, V18
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   Chowell G, 2014, EPIDEMICS-NETH, V9, P40, DOI 10.1016/j.epidem.2014.09.011
   Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103
   Contentshare, OP DAT
   Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7
   European Centres for Disease Prevention and Control (ECDC), 2015, SEV RESP DIS ASS MID
   Gomes MFC, 2014, PLOS CURR OUTBREAKS, DOI [10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5, DOI 10.1371/CURRENTS.OUTBREAKS.CD818F63D40E24AEF769DDA7DF9E0DA5]
   Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X
   Hackett C, 2012, GLOBAL RELIG LANDSCA
   Hui DS, 2015, LANCET RESP MED, V3, P509, DOI 10.1016/S2213-2600(15)00238-6
   Khan K, 2013, PLOS CURR, DOI [10.1371/currents.outbreaks.a7b70897ac2fa4f79b59f90d24c860b8, DOI 10.1371/CURRENTS.OUTBREAKS.A7B70897AC2FA4F79B59F90D24C860B8]
   Nishiura H, 2016, BMJ OPEN, V6, DOI [10.1136/bmjopen-2015-009928, 10.1136/bmjopen-2015-009936]
   Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14
   Lessler J, 2014, PLOS CURR, P6, DOI [DOI 10.1371/CURRENTS.OUTBREAKS.C5C9C9ABD636164A9B6FD4DBDA974369, 10.1371/currents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369]
   Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6
   Meyer B, 2014, EMERG INFECT DIS, V20, P552, DOI 10.3201/eid2004.131746
   Mizumoto K, 2015, INT J INFECT DIS, V39, P7, DOI 10.1016/j.ijid.2015.08.005
   Mizumoto K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0468-3
   Muller MA, 2015, LANCET INFECT DIS, V15, P559, DOI 10.1016/S1473-3099(15)70090-3
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Nishiura H, 2015, EUROSURVEILLANCE, V20, P27, DOI [10.2807/1560-7917.ES201520.27.21181, DOI 10.2807/1560-7917.ES2015.20.27.21181]
   Nishiura H, 2016, EMERG INFECT DIS, V22, P146, DOI 10.3201/eid2201.151383
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Pebody RG, 2012, EUROSURVEILLANCE, V17, P2
   [Anonymous], 2012, GLOB RELIG LANDSC
   Poletto C, 2014, EURO SURVEILL, V19
   Reuss A, 2014, EMERG INFECT DIS, V20, P620, DOI 10.3201/eid2004.131375
   Visualizing.org, GLOB FLIGHTS NETW
   Wesolowski A, 2014, PLOS CURR OUTBREAKS, P6, DOI [10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e, DOI 10.1371/CURRENTS.OUTBREAKS.0177E7FCF52217B8B634376E2F3EFC5E, 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e.]
   World Health Organization (WHO), 2015, IHR EM COMM MIDDL E
   [Anonymous], 2015, MIDDL E RESP SYNDR C
   World Health Organization (WHO), 2015, DIS OUTBR NEW DONS G
   Yavarian J, 2015, EMERG INFECT DIS, V21, P362, DOI 10.3201/eid2102.141405
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 42
TC 0
Z9 0
U1 4
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUL 22
PY 2016
VL 16
AR 356
DI 10.1186/s12879-016-1675-z
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DS6IA
UT WOS:000380884300001
PM 27449387
ER

PT J
AU Ferguson, NM
   Cucunuba, ZM
   Dorigatti, I
   Nedjati-Gilani, GL
   Donnelly, CA
   Basanez, MG
   Nouvellet, P
   Lessler, J
AF Ferguson, Neil M.
   Cucunuba, Zulma M.
   Dorigatti, Ilaria
   Nedjati-Gilani, Gemma L.
   Donnelly, Christl A.
   Basanez, Maria-Gloria
   Nouvellet, Pierre
   Lessler, Justin
TI Countering the Zika epidemic in Latin America
SO SCIENCE
LA English
DT Editorial Material
ID PUERTO-RICO; VIRUS
C1 [Ferguson, Neil M.; Cucunuba, Zulma M.; Dorigatti, Ilaria; Nedjati-Gilani, Gemma L.; Donnelly, Christl A.; Basanez, Maria-Gloria; Nouvellet, Pierre] Imperial Coll London, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.
   [Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
RP Ferguson, NM (reprint author), Imperial Coll London, Sch Publ Hlth, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.
EM neil.ferguson@imperial.ac.uk
RI Cucunuba, Zulma/L-4076-2016
OI Cucunuba, Zulma/0000-0002-8165-3198
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dejnirattisai W., 2016, NAT IMMUNOL, DOI [10.1038/ni.3515, DOI 10.1038/NI.3515]
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Lessler J, 2016, SCIENCE, V353, P663, DOI 10.1126/science.aaf8160
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Schuck-Paim C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041918
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   World Health Organization (WHO), 2016, MOSQ VECT CONTR EM R
NR 11
TC 2
Z9 2
U1 15
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 22
PY 2016
VL 353
IS 6297
BP 353
EP 354
DI 10.1126/science.aag0219
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS2HB
UT WOS:000380583400024
PM 27417493
ER

PT J
AU Paniz-Mondolfi, AE
   Rodriguez-Morales, AJ
   Blohm, G
   Marquez, M
   Villamil-Gomez, WE
AF Paniz-Mondolfi, Alberto E.
   Rodriguez-Morales, Alfonso J.
   Blohm, Gabriela
   Marquez, Marilianna
   Villamil-Gomez, Wilmer E.
TI ChikDenMaZika Syndrome: the challenge of diagnosing arboviral infections
   in the midst of concurrent epidemics
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Editorial Material
ID INFORMATION-SYSTEM GIS; ZIKA VIRUS-INFECTION; OUTBREAK IMPLICATIONS;
   LATIN-AMERICA; TRAVEL ADVICE; CLIMATE VARIABILITY; CHIKUNGUNYA FEVER;
   DENGUE INCIDENCE; PUBLIC-HEALTH; YELLOW-FEVER
C1 [Paniz-Mondolfi, Alberto E.; Marquez, Marilianna] Hosp Int, Dept Pathol & Lab Med, Barquisimeto, Venezuela.
   [Paniz-Mondolfi, Alberto E.] Inst Biomed IVSS, Biochem Lab, Caracas, Venezuela.
   [Rodriguez-Morales, Alfonso J.; Villamil-Gomez, Wilmer E.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Rodriguez-Morales, Alfonso J.; Villamil-Gomez, Wilmer E.] Asociac Colombiana Infectol ACIN, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
   [Blohm, Gabriela] Univ Florida, Dept Biol, Gainesville, FL USA.
   [Villamil-Gomez, Wilmer E.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Programa Doctorado Med Trop, Barranquilla, Atlantico, Colombia.
RP Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Andrade Elisa H P, 2016, Am J Trop Med Hyg, V94, P1080, DOI 10.4269/ajtmh.15-0892
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Barreiro P, 2016, AIDS REV, V18, P54
   Benitez JA, 2013, J INFECT DEV COUNTR, V7, P638, DOI 10.3855/jidc.3620
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Gomez PC, 2014, OPEN FORUM INFECT DI, V1
   Herrera-Martinez AD, 2010, TROP BIOMED, V27, P280
   Kasper D., 2015, HARRISONS PRINCIPLES
   Kreuder Johnson C, 2015, SCI REP, V5, P14830
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Ling Y, 2016, EMERG INFECT DIS, V22, P1317, DOI 10.3201/eid2207.160469
   Mattar S, 2013, INT J INFECT DIS, V17, pE358, DOI 10.1016/j.ijid.2012.11.021
   McFarlane R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028374
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   Navarro Juan-Carlos, 2016, Am J Trop Med Hyg, V95, P328, DOI 10.4269/ajtmh.15-0679
   Noel H, 2014, EUROSURVEILLANCE, V19, P2
   Parreira R, 2014, EUROSURVEILLANCE, V19, DOI [10.2807/1560-7917.ES2014.19.10.20730, DOI 10.2807/1560-7917.ES2014.19.10.20730]
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Patino-Barbosa AM, 2016, J INFECT PUBLIC HEAL, V9, P532, DOI 10.1016/j.jiph.2015.10.001
   Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124
   Raut CG, 2015, EMERG INFECT DIS, V21, P908, DOI 10.3201/eid2105.141804
   Rifakis PM, 2006, ANN NY ACAD SCI, V1081, P57, DOI 10.1196/annals.1373.005
   Rifakis PM, 2008, J TRAVEL MED, V15, P119, DOI 10.1111/j.1708-8305.2007.00178.x
   Rodriguez-Morales Alfonso J, 2006, Am J Med, V119, pe9, DOI 10.1016/j.amjmed.2005.08.014
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, TRAVEL MED INFECT DI, V13, P256, DOI 10.1016/j.tmaid.2015.05.007
   Rodriguez-Morales Alfonso J, 2008, Travel Med Infect Dis, V6, P162, DOI 10.1016/j.tmaid.2008.02.009
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, ARCH MED, V11, pe3
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   [Anonymous], 2016, J INFECT PUBLIC HEAL, DOI DOI 10.1016/J.JIPH.2015.12.002
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, DOI [10.1016/j.jiph.2016.05.002, DOI 10.1016/J.JIPH.2016.05.002]
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Zambrano LI, 2012, TROP BIOMED, V29, P499
NR 44
TC 0
Z9 0
U1 16
U2 16
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD JUL 22
PY 2016
VL 15
AR 42
DI 10.1186/s12941-016-0157-x
PG 4
WC Microbiology
SC Microbiology
GA DR7QV
UT WOS:000380095700001
PM 27449770
ER

PT J
AU FitzSimmons, J
   Shah, S
AF FitzSimmons, Jack
   Shah, Shailen
TI Zika Virus
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [FitzSimmons, Jack; Shah, Shailen] Virtua Hlth, Voorhees, NJ 08043 USA.
RP FitzSimmons, J (reprint author), Virtua Hlth, Voorhees, NJ 08043 USA.
CR Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pilu G, 2003, DIAGNOSTIC IMAGING F, P275
   Society for Maternal-Fetal Medicine (SMFM) Publications Committee, 2016, AM J OBSTET GYNECOL, V214, pB2
   Woodward PJ, 2008, DIAGNOSTIC IMAGING O, P2
NR 4
TC 0
Z9 0
U1 8
U2 8
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 21
PY 2016
VL 375
IS 3
BP 293
EP 294
DI 10.1056/NEJMc1606769
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0ZL
UT WOS:000380325400031
PM 27482562
ER

PT J
AU Kass, DE
   Merlino, M
AF Kass, Daniel E.
   Merlino, Mario
TI Zika Virus
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Kass, Daniel E.; Merlino, Mario] New York City Dept Hlth & Mental Hyg, New York, NY USA.
RP Kass, DE (reprint author), New York City Dept Hlth & Mental Hyg, New York, NY USA.
EM dkass@health.nyc.gov
CR Monaghan A.J., 2016, PLOS CURR, V8
NR 1
TC 0
Z9 0
U1 2
U2 2
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 21
PY 2016
VL 375
IS 3
BP 294
EP 294
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0ZL
UT WOS:000380325400032
PM 27355411
ER

PT J
AU Petersen, LR
   Jamieson, DJ
   Honein, MA
AF Petersen, Lyle R.
   Jamieson, Denise J.
   Honein, Margaret A.
TI Zika Virus REPLY
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Petersen, Lyle R.] Ctr Dis Control & Prevent, Ft Collins, CO 80521 USA.
   [Jamieson, Denise J.; Honein, Margaret A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Petersen, LR (reprint author), Ctr Dis Control & Prevent, Ft Collins, CO 80521 USA.
EM lxp2@cdc.gov
CR Darsie R, 2005, IDENTIFICATION GEOGR
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Hahn MB, 2016, J MED ENTOMOL
   [Anonymous], 2013, HLTH COMM REP DENG V
NR 4
TC 1
Z9 1
U1 0
U2 0
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 21
PY 2016
VL 375
IS 3
BP 294
EP 295
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0ZL
UT WOS:000380325400033
PM 27355409
ER

PT J
AU Song, JZ
   Mauk, MG
   Hackett, BA
   Cherry, S
   Bau, HH
   Liu, CC
AF Song, Jinzhao
   Mauk, Michael G.
   Hackett, Brent A.
   Cherry, Sara
   Bau, Haim H.
   Liu, Changchun
TI Instrument-Free Point-of-Care Molecular Detection of Zika Virus
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID MEDIATED ISOTHERMAL AMPLIFICATION; HYDROXYNAPHTHOL BLUE-DYE; VISUAL
   DETECTION; DIAGNOSTICS; PCR; DENGUE; LAMP
AB The recent outbreak of Zika virus (ZIKV) infection in the Americas and its devastating impact on fetal development have prompted the World Health Organization (WHO) to declare the ZIKV pandemic as a Public Health Emergency of International Concern. Rapid and reliable diagnostics for ZIKV are vital because ZIKV-infected individuals display no symptoms or nonspecific symptoms similar to other viral infections. Because immunoassays lack adequate sensitivity and selectivity and are unable to identify active state of infection, molecular diagnostics are an effective means to detect ZIKV soon after infection and throughout pregnancy. We report on a highly sensitive reverse-transcription loop-mediated, isothermal amplification (RT-LAMP) assay for rapid detection of ZIKV and its implementation in a simple, easy-to-use, inexpensive, point-of-care (POC) disposable cassette that carries out all the unit operations from sample introduction to detection. For thermal control of the cassette, we use a chemically heated cup without a need for electrical power. Amplification products are detected with leuco crystal violet (LCV) dye by eye without a need for instrumentation. We demonstrated the utility of our POC diagnostic system by detecting ZIKV in oral samples with sensitivity of 5 plaque-forming units (PFU) in less than 40 min. Our system is particularly suitable for resource-poor settings, where centralized laboratory facilities, funds, and trained personnel are in short supply, and for use in doctors' offices, clinics, and at home.
C1 [Song, Jinzhao; Mauk, Michael G.; Bau, Haim H.; Liu, Changchun] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.
   [Hackett, Brent A.; Cherry, Sara] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
RP Liu, CC (reprint author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.
EM lchangc@seas.upenn.edu
FU NIH [K25AI099160, R21-AI-112713-01]; Penn CFAR Pilot Grant [AI045008]
FX Viruses were provided by the NIH NIAID WRCEVA. The work was supported,
   in part, by NIH Grants K25AI099160 and R21-AI-112713-01, and Penn CFAR
   Pilot Grant AI045008.
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso TC, 2010, MOL CELL PROBE, V24, P415, DOI 10.1016/j.mcp.2010.08.003
   Charrel R. N., STATE KNOWLEDGE ZIKA
   Driggers R. W., 2016, ENGL J MED, V374, P2142
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hart RW, 2011, ORAL DIS, V17, P745, DOI 10.1111/j.1601-0825.2011.01808.x
   Kim J, 2009, LAB CHIP, V9, P606, DOI 10.1039/b807915c
   Liao SC, 2016, SENSOR ACTUAT B-CHEM, V229, P232, DOI 10.1016/j.snb.2016.01.073
   Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a
   Liu CC, 2009, LAB CHIP, V9, P768, DOI 10.1039/b814322f
   Liu CC, 2013, ANAL CHEM, V85, P10463, DOI 10.1021/ac402459h
   Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b
   Luo L, 2011, J CLIN MICROBIOL, V49, P3545, DOI 10.1128/JCM.00930-11
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miyamoto S, 2015, ANAL BIOCHEM, V473, P28, DOI 10.1016/j.ab.2014.12.016
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nie K, 2011, J VIROL METHODS, V175, P283, DOI 10.1016/j.jviromet.2011.05.020
   Ocwieja KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117852
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Qiu XB, 2009, BIOMED MICRODEVICES, V11, P1175, DOI 10.1007/s10544-009-9334-4
   Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693
   Song JZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004318
   Tambo E, 2016, J INFECT PUBLIC HEAL, V9, P240, DOI 10.1016/j.jiph.2016.02.005
   Teoh BT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-387
   Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   World Health Organization, 2016, CURR ZIK PROD PIP
   Wong DT, 2006, J AM DENT ASSOC, V137, P313
NR 35
TC 1
Z9 1
U1 21
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD JUL 19
PY 2016
VL 88
IS 14
BP 7289
EP 7294
DI 10.1021/acs.analchem.6b01632
PG 6
WC Chemistry, Analytical
SC Chemistry
GA DS0OO
UT WOS:000380296800046
PM 27306491
ER

PT J
AU Martins, KAO
   Dye, JM
   Bavari, S
AF Martins, K. A. O.
   Dye, J. M.
   Bavari, S.
TI Considerations for the development of Zika virus vaccines
SO VACCINE
LA English
DT Editorial Material
ID ORIGINAL ANTIGENIC SIN; INFECTION; DENGUE
C1 [Martins, K. A. O.; Dye, J. M.; Bavari, S.] US Army, Med Res Inst Infect Dis, Frederick, MD 21702 USA.
   [Martins, K. A. O.] Ke Aki Technol, 5301 Buckeystown Pike,Suite 460, Frederick, MD 21704 USA.
RP Martins, KAO (reprint author), Ke Aki Technol, USAMRIID, 1425 Porter St, Frederick, MD 21704 USA.
EM karen.a.martins2.ctr@mail.mil
CR Beck C, 2013, INT J ENV RES PUB HE, V10, P6049, DOI 10.3390/ijerph10116049
   Dyer O., 2016, BMJ-BRIT MED J, V352, pi630
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   FRANCIS T, 1953, ANN INTERN MED, V39, P203
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Izurieta Ricardo O, 2009, J Glob Infect Dis, V1, P111, DOI 10.4103/0974-777X.56257
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mizumoto K, 2014, J VECTOR DIS, V51, P153
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Paul LM, 2016, BIORXIV
NR 13
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUL 19
PY 2016
VL 34
IS 33
BP 3711
EP 3712
DI 10.1016/j.vaccine.2016.06.012
PG 2
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DS1XN
UT WOS:000380418600001
PM 27318417
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI US Congress fails to agree Zika virus funding before summer break
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUL 19
PY 2016
VL 354
AR i3991
DI 10.1136/bmj.i3991
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DS0VP
UT WOS:000380315200011
PM 27435990
ER

PT J
AU Buekens, P
   Alger, J
   Althabe, F
   Bergel, E
   Berrueta, AM
   Bustillo, C
   Cafferata, ML
   Harville, E
   Rosales, K
   Wesson, DM
   Zuniga, C
AF Buekens, Pierre
   Alger, Jackeline
   Althabe, Fernando
   Bergel, Eduardo
   Berrueta, Amanda M.
   Bustillo, Carolina
   Cafferata, Maria-Luisa
   Harville, Emily
   Rosales, Karla
   Wesson, Dawn M.
   Zuniga, Concepcion
CA ZIPH Working Grp
TI Zika virus infection in pregnant women in Honduras: study protocol
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Honduras; Microcephaly; Pregnancy; Zika virus
ID GESTATIONAL-AGE
AB Background: Although there is increasing evidence for a relationship between symptomatic Zika virus (ZIKV) maternal infection, and microcephaly, a firm causal relation has yet to be established by epidemiologic studies. Studies also need to be conducted in recently infected settings. Our objectives are to assess the frequency of ZIKV infection during pregnancy in Honduras and the association of microcephaly with ZIKV infection.
   Methods/Design: We will perform a prospective study enrolling pregnant women at their first antenatal visit and following them up until delivery. At the time of enrollment, women will be interviewed to collect socio-demographic data, data needed to locate them for potential additional follow-up, and data about ZIKV symptoms during pregnancy. We will also collect maternal blood as soon as possible after enrollment. A probable maternal ZIKV infection will be defined as positive for maternal ZIKV IgM. A confirmed maternal ZIKV infection will be defined as positive for ZIKV IgM confirmed by plaque reduction neutralization test. Microcephaly at birth will be defined as an occipito-frontal circumference <2SD for sex and gestational age. Our objective is to enroll 2000 pregnant women. In a first step, we will follow a case cohort design and only analyze blood samples for cases and a sub-cohort of 200 women randomly selected. Blood samples for the entire population will be analyzed at a later stage if funds are available.
   Discussion: This protocol was designed to be implemented with minimal resources. It allows a cohort to be built, which could be a foundation for future in-depth and follow-up studies.
C1 [Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, 1440 Canal St,Ste 2430, New Orleans, LA 70112 USA.
   [Alger, Jackeline] UNAH, Hosp Escuela Univ, Fac Ciencias Med, Inst Enfermedades Infecciosas & Parasitol Antonio, Calle Salud,Blvd Suyapa,Colonia Quezada, Tegucigalpa, Honduras.
   [Althabe, Fernando; Bergel, Eduardo; Berrueta, Amanda M.] IECS, Dr Emilio Ravignani 2024,C1414CPV, Buenos Aires, DF, Argentina.
   [Bustillo, Carolina] Hosp Escuela Tegucigalpa, Dept Ginecol & Obstet, Calle Salud,Blvd Suyapa,Colonia Quezada, Tegucigalpa, Honduras.
   [Cafferata, Maria-Luisa] Hosp Clin Montevideo, Unidad Invest Clin & Epidemiol Montevideo UNICEM, Ave Italia S-N,Piso 4, Montevideo 11600, Uruguay.
   [Harville, Emily] Tulane Univ, Dept Epidemiol, Tulane Sch Publ Hlth & Trop Med, Ste 2012,1440 Canal St, New Orleans, LA 70112 USA.
   [Rosales, Karla] Reg Sanit Metropolitana Dist Cent Francisco Moraz, Tegucigalpa, Honduras.
   [Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, 1324 Tulane Ave,JBJ Bldg,Room 509, New Orleans, LA 70112 USA.
   [Zuniga, Concepcion] Hosp Escuela Univ, Inst Enfermedades Infecciosas & Parasitol Antonio, Calle Salud,Blvd Suyapa,Colonia Quezada, Tegucigalpa, Honduras.
RP Buekens, P (reprint author), Tulane Univ, Sch Publ Hlth & Trop Med, 1440 Canal St,Ste 2430, New Orleans, LA 70112 USA.
EM pbuekens@tulane.edu
FU Tulane University
FX This study is funded by Tulane University. The funding body had no role
   in the design of the study and in writing the manuscript.
CR Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Secretaria de Salud, 2016, B EPIDEMIOLOGICO
   Sharp SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101176
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, 1993, INT STAT CLASS DIS R, V2
   World Health Organization, 2016, WHO STAT 2 M IHR EM
   World Health Organization, 2016, WKLY EPIDEMIOL REC, V91, P73
   Zambrano LI, 2012, TROP BIOMED, V29, P499
NR 17
TC 0
Z9 0
U1 18
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD JUL 16
PY 2016
VL 13
AR 82
DI 10.1186/s12978-016-0200-6
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DR9UW
UT WOS:000380242600002
PM 27423687
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Quest Diagnostics Says Its Zika Virus Test Gets US Approval
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 15
PY 2016
VL 63
IS 2
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DT1FT
UT WOS:000381227800002
ER

PT J
AU Focosi, D
   Maggi, F
   Pistello, M
AF Focosi, Daniele
   Maggi, Fabrizio
   Pistello, Mauro
TI Zika Virus: Implications for Public Health
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus; ZIKAV; microcephaly; Aedes aegypti; Aedes albopictus
ID WEST NILE VIRUS; RT-PCR; AEDES-ALBOPICTUS; VIRAL-INFECTIONS;
   TRANSMISSION; CHIKUNGUNYA; BRAZIL; FLAVIVIRUSES; INACTIVATION;
   ISOLATIONS
AB The World Health Organization has declared the current Zika virus (ZIKV) epidemic a public health emergency of international concern. Lack of vaccines and reliable diagnostic tests, broad geographical distribution of mosquito species that can transmit the virus, and absence of population immunity in newly affected countries are causes for concern. Although most infected persons are asymptomatic, ZIKV has been associated with a rise in cases of neurological complications and fetal central nervous system malformations. This defines such an arbovirus as something whose transmission should be prevented. This review summarizes the current understanding of ZIKV biology and epidemiology, as well as possible interventions to prevent contagion and transmission.
C1 [Focosi, Daniele] Pisa Univ Hosp, North Western Tuscany Blood Bank, Via Paradisa 2, I-56124 Pisa, Italy.
   [Maggi, Fabrizio; Pistello, Mauro] Pisa Univ Hosp, Virol Unit, Pisa, Italy.
   [Pistello, Mauro] Univ Pisa, Dept Translat Res, Retrovirus Ctr, I-56100 Pisa, Italy.
   [Pistello, Mauro] Univ Pisa, Virol Sect, I-56100 Pisa, Italy.
RP Focosi, D (reprint author), Pisa Univ Hosp, North Western Tuscany Blood Bank, Via Paradisa 2, I-56124 Pisa, Italy.
EM d.focosi@ao-pisa.toscana.it
FU FAS Salute Regione Toscana "UNAVIR: Malattie virali rare: una strategia
   innovativa per combatterle con un unico agente antivirale"
FX This study was supported in part by grants of FAS Salute 2014 Regione
   Toscana "UNAVIR: Malattie virali rare: una strategia innovativa per
   combatterle con un unico agente antivirale".
CR Amnesty International, SALV TOT AB BAN SENT
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Barry A, 2016, EMERG INFECT DIS, DOI [10.3201/eid2205.160107, DOI 10.3201/EID2205.160107]
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EURO SURVEILL, V19
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caragata EP, 2015, TRENDS PARASITOL, V32, P207
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Centers for Disease Control and Prevention, TRANSCR CDC TEL ZIK
   CNN, ZIK VIR SPREAD ALL 2
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Center for Infectious Disease Research and Policy, BRAZ CONF BLOOD TRAN
   Dallas County Department of Health and Human Services, DCHHS REP 1 ZIK VIR
   Regis C, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.170639, DOI 10.2471/BLT.16.170639]
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Faddy HM, 2016, TRANSFUSION, V56, P1503, DOI 10.1111/trf.13443
   Faddy HM, 2015, TRANSFUSION, V55, P824, DOI 10.1111/trf.12899
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Iamarino A, 2015, SOREAD PANDEMIC ZIKA, DOI [10.1101/032839, DOI 10.1101/032839]
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Higgs S, 2016, VECTOR-BORNE ZOONOT, V16, P75, DOI 10.1089/vbz.2016.29001.hig
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   International Agency for Research on Cancer (IARC), IARC MALATH
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/50140-6736(16)00502-X]
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maurice J, 2016, LANCET, V387, P1147, DOI 10.1016/S0140-6736(16)30012-5
   Ministry of Health Brazil, INF SYST DIS COMP DE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19
   Office of the United Nations High Commissioner for Human Rights, UPH WOM HUM RIGHTS E
   Paty MC, 2013, TRANSFUS CLIN BIOL, V20, P165, DOI 10.1016/j.tracli.2013.03.008
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pozzetto Bruno, 2015, World J Virol, V4, P113, DOI 10.5501/wjv.v4.i2.113
   Pyke AT, 2014, PLOS CURR, V6
   Robert SL, 2016, EMERG INFECT DIS J, V22
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Saude A., MICROCEFALIA MINISTE
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EURO SURVEILL, V19
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Weselak M, 2007, J TOXICOL ENV HEAL B, V10, P41, DOI 10.1080/10937400601034571
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization, DIS OUTBR NEWS ZIK V
   World Health Organization, WHOZIKVHS161
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 92
TC 3
Z9 3
U1 16
U2 16
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 15
PY 2016
VL 63
IS 2
BP 227
EP 233
DI 10.1093/cid/ciw210
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DT1FT
UT WOS:000381227800016
PM 27048745
ER

PT J
AU Larrieu, S
   Filleul, L
   Reilhes, O
   Jaffar-Bandjee, M
   Dumont, C
   Abossolo, T
   Thebault, H
   Brottet, E
   Pages, F
   Vilain, P
   Leparc-Goffart, I
   Antok, E
   Vandroux, D
   Poubeau, P
   Moiton, M
   Von Theobald, P
   Chieze, F
   Gallay, A
   De Valk, H
   Bourdillon, F
AF Larrieu, S.
   Filleul, L.
   Reilhes, O.
   Jaffar-Bandjee, M.
   Dumont, C.
   Abossolo, T.
   Thebault, H.
   Brottet, E.
   Pages, F.
   Vilain, P.
   Leparc-Goffart, I.
   Antok, E.
   Vandroux, D.
   Poubeau, P.
   Moiton, M.
   Von Theobald, P.
   Chieze, F.
   Gallay, A.
   De Valk, H.
   Bourdillon, F.
TI Reunion Island prepared for possible Zika virus emergence, 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID ALBOPICTUS SKUSE; AEDES-ALBOPICTUS; SURVEILLANCE; INFECTION; OUTBREAK;
   SPREADS; AMERICA; VECTOR
AB Zika virus (ZIKV) has recently spread widely and turned into a major international public health threat. Reunion appears to offer conditions particularly favourable to its emergence and therefore prepared to face possible introduction of the virus. We designed a scaled surveillance and response system with specific objectives, methods and measures for various epidemiological phases including a potential epidemic. Several tools were developed in order to (i) detect individual cases (including a large information campaign on the disease and suspicion criteria), (ii) monitor an outbreak through several complementary systems allowing to monitor trends in disease occurrence and geographic spread and (iii) detect severe forms of the disease in collaboration with hospital clinicians. We put the emphasis on detecting the first cases in order to contain the spread of the virus as much as possible and try to avoid progress towards an epidemic. Our two main strengths are a powerful vector control team, and a close collaboration between clinicians, virologists, epidemiologists, entomologists and public health authorities. Our planned surveillance system could be relevant to Europe and island settings threatened by Zika virus all over the world.
C1 [Larrieu, S.; Filleul, L.; Brottet, E.; Pages, F.; Vilain, P.] Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Ocean Indien, St Maurice, Reunion.
   [Reilhes, O.; Thebault, H.; Chieze, F.] Agence Sante Ocean Indien, St Denis, Reunion.
   [Jaffar-Bandjee, M.] CHU Reunion, Ctr Natl Reference Arbovirus, Allee Des Topazes, Reunion.
   [Dumont, C.; Abossolo, T.; Von Theobald, P.] CHU Reunion, Ctr Diagnost Prenatal, Allee Des Topazes, Reunion.
   [Leparc-Goffart, I.] Ctr Natl Reference Arbovirus, Irba, Marseille, France.
   [Antok, E.; Vandroux, D.] CHU Reunion, Serv Reanimat, Allee Des Topazes, Reunion.
   [Poubeau, P.; Moiton, M.] CHU Reunion, Serv Malad Infect, Allee Des Topazes, Reunion.
   [Gallay, A.; De Valk, H.; Bourdillon, F.] Sante Publ France, French Natl Publ Hlth Agcy, St Maurice, France.
RP Larrieu, S (reprint author), Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Ocean Indien, St Maurice, Reunion.
EM sophie.larrieu@ars.sante.fr
CR [Anonymous], 2016, LANCET
   Brottet E, 2015, MED MALADIES INFECT, V45, P21, DOI 10.1016/j.medmal.2014.11.004
   Caillere N, 2013, EUROSURVEILLANCE, V18, P8
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x
   Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701
   D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   [Anonymous], 1964, T R SOC TROP MED HYG, DOI DOI 10.1016/0035-9203(64)90201-9
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marguerite N, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.26.30271
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   [Anonymous], 2014, EURO SURVEILLANCE B
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
   World Health Organization, 2011, INT STAT CLASS DIS R, V2
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 26
TC 1
Z9 1
U1 1
U2 1
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUL 14
PY 2016
VL 21
IS 28
BP 4
EP 10
AR 30281
DI 10.2807/1560-7917.ES.2016.21.28.30281
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA DS1VG
UT WOS:000380389700002
ER

PT J
AU Daudens-Vaysse, E
   Ledrans, M
   Gay, N
   Ardillon, V
   Cassadou, S
   Najioullah, F
   Leparc-Goffart, I
   Rousset, D
   Herrmann, C
   Cesaire, R
   Maquart, M
   Flusin, O
   Matheus, S
   Huc-Anais, P
   Jaubert, J
   Criquet-Hayot, A
   Hoen, B
   Djossou, F
   Locatelli-Jouans, C
   Blateau, A
   McKenzie, A
   Melin, M
   Saint-Martin, P
   Dorleans, F
   Suivant, C
   Carvalho, L
   Petit-Sinturel, M
   Andrieu, A
   Noel, H
   Septfons, A
   Gallay, A
   Paty, M
   Filleul, L
   Cabie, A
AF Daudens-Vaysse, E.
   Ledrans, M.
   Gay, N.
   Ardillon, V.
   Cassadou, S.
   Najioullah, F.
   Leparc-Goffart, I.
   Rousset, D.
   Herrmann, C.
   Cesaire, R.
   Maquart, M.
   Flusin, O.
   Matheus, S.
   Huc-Anais, P.
   Jaubert, J.
   Criquet-Hayot, A.
   Hoen, B.
   Djossou, F.
   Locatelli-Jouans, C.
   Blateau, A.
   McKenzie, A.
   Melin, M.
   Saint-Martin, P.
   Dorleans, F.
   Suivant, C.
   Carvalho, L.
   Petit-Sinturel, M.
   Andrieu, A.
   Noel, H.
   Septfons, A.
   Gallay, A.
   Paty, M.
   Filleul, L.
   Cabie, A.
CA Zika Surveillance Working Grp
TI Zika emergence in the French Territories of America and description of
   first confirmed cases of Zika virus infection on Martinique, November
   2015 to February 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID OUTBREAK; REGION
AB Following of the emergence of Zika virus in Brazil in 2015, an epidemiological surveillance system was quickly implemented in the French overseas Territories of America (FTA) according to previous experience with dengue and chikungunya and has detected first cases of Zika. General practitioners and medical microbiologists were invited to report all clinically suspected cases of Zika, laboratory investigations were systematically conducted (RT-PCR). On 18 December, the first autochthonous case of Zika virus infection was confirmed by RT-PCR on French Guiana and Martinique, indicating introduction of Zika virus in FTA. The viral circulation of Zika virus was then also confirmed on Guadeloupe and Saint-Martin. We report here early findings on 203 confirmed cases of Zika virus infection identified by RT- PCR or seroneutralisation on Martinique Island between 24 November 2015 and 20 January 2016. All cases were investigated. Common clinical signs were observed (maculopapular rash, arthralgia, fever, myalgia and conjunctival hyperaemia) among these patients, but the rash, the foundation of our case definition, may be absent in a significant proportion of patients (16%). These results are important for the implementation of a suspected case definition, the main tool for epidemiological surveillance, in territories that may be affected by ZIKV emergence, including Europe.
C1 [Daudens-Vaysse, E.; Ledrans, M.; Gay, N.; Ardillon, V.; Cassadou, S.; Dorleans, F.; Suivant, C.; Carvalho, L.; Petit-Sinturel, M.; Andrieu, A.] Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Antilles Guyane, St Maurice, France.
   [Najioullah, F.; Cesaire, R.] Univ Hosp Martin, Virol Lab, Fort De France, France.
   [Leparc-Goffart, I.; Maquart, M.; Flusin, O.] Natl Reference Ctr Arboviruses, Inst Rech Biomed Armees, Marseille, France.
   [Rousset, D.; Huc-Anais, P.] Inst Pasteur Guyane, Natl Reference Ctr Arboviruses Influenza Virus &, Cayenne, France.
   [Herrmann, C.] Univ Hosp Guadeloupe, Microbiol Lab, Pointe a Pitre, Guadeloupe.
   [Huc-Anais, P.] Lab Lepers, St Martin Dheres, France.
   [Jaubert, J.] Private Hosp St Paul, Fort De France, France.
   [Criquet-Hayot, A.] Reg Union Independent Med Practitioners Martin, Fort De France, France.
   [Hoen, B.] Univ Hosp Guadeloupe, Infect & Trop Dis Unit, Pointe a Pitre, Guadeloupe.
   [Djossou, F.] Univ Hosp Andree Rosemon, Infect & Trop Dis Unit, Cayenne, France.
   [Locatelli-Jouans, C.; Blateau, A.] Reg Hlth Agcy ARS Martin, Fort De France, France.
   [McKenzie, A.] Reg Hlth Agcy ARS French Guiana, Cayenne, France.
   [Saint-Martin, P.] Reg Hlth Agcy ARS Guadeloupe, St Martin Dheres, Gourbeyre, France.
   [Saint-Martin, P.] Reg Hlth Agcy ARS Guadeloupe, St Barthelemy, Gourbeyre, France.
   [Noel, H.; Septfons, A.; Gallay, A.; Paty, M.] Sante Publ France, French Natl Publ Hlth Agcy, St Maurice, France.
   [Filleul, L.] Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Ocean Indien, St Maurice, France.
   [Cabie, A.] Univ Hosp Martin, Infect & Trop Dis Unit, Fort De France, France.
RP Daudens-Vaysse, E (reprint author), Sante Publ France, French Natl Publ Hlth Agcy, Reg Unit Cire Antilles Guyane, St Maurice, France.
EM elise.daudens-vaysse@ars.sante.fr
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Garcia E., 2016, Weekly Epidemiological Record, V91, P73
   Gardner LM, 2016, LANCET INFECT DIS
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 2
Z9 2
U1 3
U2 3
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUL 14
PY 2016
VL 21
IS 28
BP 11
EP 16
AR 30285
DI 10.2807/1560-7917.ES.2016.21.28.30285
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DS1VG
UT WOS:000380389700003
ER

PT J
AU Rojas, DP
   Dean, NE
   Yang, Y
   Kenah, E
   Quintero, J
   Tomasi, S
   Ramirez, EL
   Kelly, Y
   Castro, C
   Carrasquilla, G
   Halloran, ME
   Longini, IM
AF Rojas, D. P.
   Dean, N. E.
   Yang, Y.
   Kenah, E.
   Quintero, J.
   Tomasi, S.
   Ramirez, E. L.
   Kelly, Y.
   Castro, C.
   Carrasquilla, G.
   Halloran, M. E.
   Longini, I. M.
TI The epidemiology and transmissibility of Zika virus in Girardot and San
   Andres island, Colombia, September 2015 to January 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; INTERIM GUIDELINES; SOUTH-PACIFIC;
   UNITED-STATES; OUTBREAK; BRAZIL; INFECTION; DIPTERA; URINE
AB Transmission of Zika virus (ZIKV) was first detected in Colombia in September 2015. As of April 2016, Colombia had reported over 65,000 cases of Zika virus disease (ZVD). We analysed daily surveillance data of ZVD cases reported to the health authorities of San Andres and Girardot, Colombia, between September 2015 and January 2016. ZVD was laboratory-confirmed by reverse transcription-polymerase chain reaction (RT-PCR) in the serum of acute cases within five days of symptom onset. We use daily incidence data to estimate the basic reproductive number (R-o) in each population. We identified 928 and 1,936 reported ZVD cases from San Andres and Girardot, respectively. The overall attack rate for reported ZVD was 12.13 cases per 1,000 residents of San Andres and 18.43 cases per 1,000 residents of Girardot. Attack rates were significantly higher in females in both municipalities (p < 0.001). Cases occurred in all age groups with highest rates in 20 to 49 year-olds. The estimated R 0 for the Zika outbreak was 1.41 (95% confidence interval (CI): 1.15-1.74) in San Andres and 4.61 (95% CI: 4.11-5.16) in Girardot. Transmission of ZIKV is ongoing in the Americas. The estimated R-o from Colombia supports the observed rapid spread.
C1 [Rojas, D. P.] Univ Florida, Dept Epidemiol, Gainesville, FL 32611 USA.
   [Dean, N. E.; Yang, Y.; Kenah, E.; Longini, I. M.] Univ Florida, Dept Biostat, Gainesville, FL USA.
   [Quintero, J.; Tomasi, S.; Carrasquilla, G.] Fdn Santa Fe Bogota, Ctr Estudios & Invest Salud, Bogota, Colombia.
   [Ramirez, E. L.] Secretaria Municipal Salud, Girardot, Colombia.
   [Kelly, Y.] IPS Univ, San Andres, Colombia.
   [Castro, C.] Secretaria Dept Salud, San Andres, Colombia.
   [Halloran, M. E.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Halloran, M. E.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
RP Rojas, DP (reprint author), Univ Florida, Dept Epidemiol, Gainesville, FL 32611 USA.
EM dprojas@ufl.edu
FU National Institutes of Health (NIH) [U54GM111274]; NIH [R37 AI032042];
   Colombian Department of Science and Technology (Fulbright-Colciencias
   scholarship)
FX This work was supported by National Institutes of Health (NIH)
   U54GM111274, NIH R37 AI032042 and the Colombian Department of Science
   and Technology (Fulbright-Colciencias scholarship to D.P.R).
CR Alcala L, 2015, BIOMEDICA, V35, P258, DOI [10.1590/S0120-41572015000200014, 10.7705/biomedica.v35i2.2567]
   Bastgos L, 2016, BIORXIV, DOI [10.1101/055475, DOI 10.1101/055475]
   [Anonymous], 2016, NEW ENGL J MED, DOI DOI 10.1056/NEJM0A1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   [Anonymous], 2016, EST PROYECC PROBL NA
   DAY JF, 1994, J MED ENTOMOL, V31, P611
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   [Anonymous], 2014, RAP RISK ASS ZIK VIR
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   Garcia-Betancourt T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129054
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   [Anonymous], 2016, VIG INT SINDR NEUR G
   [Anonymous], 2016, B EP SEM SEM EP 08 2
   [Anonymous], 2016, 007 INS
   [Anonymous], 2016, 004 INS
   [Anonymous], 2015, 061 MINSAD INS
   [Anonymous], 2015, REP ZIKK ILLN COL
   [Anonymous], 2015, CHIK WEEK 52 2015
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   [Anonymous], 2011, AN SIT SAL ASIS ARCH
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   [Anonymous], 2016, NEW ENGL J MED, DOI DOI 10.1056/NEJM0A1604037
   [Anonymous], 2012, DENGUE COLOMBIA EPID
   [Anonymous], GEOGR DISTR CONF CAS
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   R Core Team, 2016, R LANG ENV STAT COMP
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   [Anonymous], 2014, INFORME FINAL EVENTO
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Styer LM, 2007, AM J TROP MED HYG, V76, P111
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   [Anonymous], 2016, J INFECT PUBLIC HEAL, DOI DOI 10.1016/J.JIPH.2015.12.002
   WHO, 2016, GUILL BARR SYNDR BRA
   WHO, 2016, ZIK SIT REP
   [Anonymous], CAS DEF ZIK
   Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 49
TC 1
Z9 1
U1 11
U2 11
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUL 14
PY 2016
VL 21
IS 28
BP 26
EP 35
AR 30283
DI 10.2807/1560-7917.ES.2016.21.28.30283
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA DS1VG
UT WOS:000380389700005
ER

PT J
AU Dalla Bona, AC
   Chitolina, RF
   Fermino, ML
   Poncio, LD
   Weiss, A
   Lima, JBP
   Paldi, N
   Bernardes, ES
   Henen, J
   Maori, E
AF Dalla Bona, Ana Caroline
   Chitolina, Rodrigo Faitta
   Fermino, Marise Lopes
   Poncio, Lisiane de Castro
   Weiss, Avital
   Pereira Lima, Jose Bento
   Paldi, Nitzan
   Bernardes, Emerson Soares
   Henen, Jonathan
   Maori, Eyal
TI Larval application of sodium channel homologous dsRNA restores
   pyrethroid insecticide susceptibility in a resistant adult mosquito
   population
SO PARASITES & VECTORS
LA English
DT Article
DE Insecticide resistance; Pyrethroids; Voltage-gated sodium channel; RNAi;
   Aedes aegypti; Mosquitoes
ID AEDES-AEGYPTI POPULATIONS; RNA INTERFERENCE; ZIKA VIRUS; KNOCKDOWN
   RESISTANCE; BORNE DISEASES; GENE; MUTATION; MECHANISMS; VECTOR;
   EXPRESSION
AB Background: Mosquitoes host and pass on to humans a variety of disease-causing pathogens such as infectious viruses and other parasitic microorganisms. The emergence and spread of insecticide resistance is threatening the effectiveness of current control measures for common mosquito vector borne diseases, such as malaria, dengue and Zika. Therefore, the emerging resistance to the widely used pyrethroid insecticides is an alarming problem for public health. Herein we demonstrated the use of RNA interference (RNAi) to increase susceptibility of adult mosquitoes to a widely used pyrethroid insecticide.
   Methods: Experiments were performed on a field-collected pyrethroid resistant strain of Ae. aegypti (Rio de Janeiro; RJ). Larvae from the resistant Ae. aegypti population were soaked with double-stranded RNAs (dsRNAs) that correspond either to voltage-gate sodium channel (VGSC), P-glycoprotein, or P450 detoxification genes and reared to adulthood. Adult mortality rates in the presence of various Deltamethrin pyrethroid concentrations were used to assess mosquito insecticide susceptibility.
   Results: We characterized the RJ Ae. aegypti strain with regard to its level of resistance to a pyrethroid insecticide and found that it was approximately 6 times more resistant to Deltamethrin compared to the laboratory Rockefeller strain. The RJ strain displayed a higher frequency of Val1016Ile and Phe1534Cys substitutions of the VGSC gene. The resistant strain also displayed a higher basal expression level of VGSC compared to the Rockefeller strain. When dsRNA-treated mosquitoes were subjected to a standard pyrethroid contact bioassay, only dsRNA targeting VGSC increased the adult mortality of the pyrethroid resistant strain. The dsRNA treatment proved effective in increasing adult mosquito susceptibility over a range of pyrethroid concentrations and these results were associated with dsRNA-specific small interfering RNAs in treated adults, and the corresponding specific down regulation of VGSC gene expression level. Finally, we demonstrated that the efficiency of our approach was further improved by 'tiling' along the VGSC gene in order to identify the most potent dsRNA sequences.
   Conclusions: These results demonstrate that dsRNA applied to mosquito larvae retains its biological activity into adulthood. Thus, the RNAi system reported here could be a useful approach to control the widespread insecticide resistance in mosquitoes and other insect vectors of human diseases.
C1 [Dalla Bona, Ana Caroline; Chitolina, Rodrigo Faitta; Fermino, Marise Lopes; Poncio, Lisiane de Castro; Bernardes, Emerson Soares] Forrest Brasil Tecnol Ltda, Curitiba, Parana, Brazil.
   [Weiss, Avital; Paldi, Nitzan; Henen, Jonathan; Maori, Eyal] Forrest Innovat Ltd, Caesarea, Israel.
   [Pereira Lima, Jose Bento] Inst Oswaldo Cruz, FIOCRUZ, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, RJ, Brazil.
   [Bernardes, Emerson Soares] Inst Nucl Energy Res, Radiopharm Ctr, Sao Paulo, Brazil.
RP Maori, E (reprint author), Forrest Innovat Ltd, Caesarea, Israel.
EM Eyal@forrestinnovations.com
FU Forrest Innovations' internal resources
FX The study was supported by Forrest Innovations' internal resources.
   Forrest Innovations' funders had no role in the design of the study and
   collection, analysis, and interpretation of data as well as in writing
   the manuscript.
CR Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bing ZS, 2016, EXP PARASITOL, V162, P35
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brogdon W, 2010, METHODS ANOPHELES RE
   Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159
   Butler D, 2011, NATURE, V475, P19, DOI 10.1038/475019a
   Coy MR, 2012, J APPL ENTOMOL, V136, P741, DOI 10.1111/j.1439-0418.2012.01713.x
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429
   Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x
   Davies TGE, 2008, PEST MANAG SCI, V64, P1126, DOI 10.1002/ps.1617
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9
   Figueira-Mansur J, 2013, INSECT MOL BIOL, V22, P648, DOI 10.1111/imb.12052
   Garbian Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003035
   [Anonymous], 2014, DEADLIEST ANIMAL WOR
   Hoa NT, 2003, INSECT BIOCHEM MOLEC, V33, P949, DOI 10.1016/S0965-1748(03)00101-2
   Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160
   Katoch R, 2013, APPL BIOCHEM BIOTECH, V169, P1579, DOI 10.1007/s12010-012-0046-5
   Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024323
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kim DH, 2008, BIOTECHNIQUES, V44, P613, DOI 10.2144/000112792
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Montella IR, 2007, AM J TROP MED HYG, V77, P467
   Mysore K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004213
   Paldi N, 2010, APPL ENVIRON MICROB, V76, P5960, DOI 10.1128/AEM.01067-10
   Pan ZH, 2015, GENE, V565, P56, DOI 10.1016/j.gene.2015.03.069
   Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P414, DOI 10.1603/0022-2585(2008)45[414:TAADRK]2.0.CO;2
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785
   Sarkies P, 2014, NAT REV MOL CELL BIO, V15, P525, DOI 10.1038/nrm3840
   Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014
   Silva APB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-450
   SOPER FL, 1965, AM J TROP MED HYG, V14, P887
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   World Health Organization, 1998, WHOCDSCPCMAL9812
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Zhang X, 2016, CELL, V165, P683
NR 57
TC 0
Z9 0
U1 8
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 14
PY 2016
VL 9
AR 397
DI 10.1186/s13071-016-1634-y
PG 14
WC Parasitology
SC Parasitology
GA DS0ZU
UT WOS:000380326300001
ER

PT J
AU Adibi, JJ
   Zhao, YQ
   Cartus, AR
   Gupta, P
   Davidson, LA
AF Adibi, Jennifer J.
   Zhao, Yaqi
   Cartus, Abigail R.
   Gupta, Phalguni
   Davidson, Lance A.
TI Placental Mechanics in the Zika-Microcephaly Relationship
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID VIRUS-INFECTION
AB How the Zika virus (ZIKV) accesses the embryo remains unknown. In this issue, Quicke et al. (2016) use an in vitro model of the human placenta to show that placental macrophages are more permissive to ZIKV infection than trophoblasts, which may be refractory to infection (Bayer et al., 2016).
C1 [Adibi, Jennifer J.; Zhao, Yaqi; Cartus, Abigail R.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.
   [Adibi, Jennifer J.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15261 USA.
   [Gupta, Phalguni] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.
   [Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Davidson, Lance A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15261 USA.
   [Davidson, Lance A.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA.
RP Adibi, JJ (reprint author), Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.
EM adibij@pitt.edu
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, N ENGL J MED
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Jaenisch T., 2016, B WHO
   Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 9
TC 0
Z9 0
U1 23
U2 23
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUL 13
PY 2016
VL 20
IS 1
BP 9
EP 11
DI 10.1016/j.chom.2016.06.013
PG 3
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DS3UC
UT WOS:000380707200005
PM 27414496
ER

PT J
AU Quicke, KM
   Bowen, JR
   Johnson, EL
   McDonald, CE
   Ma, HL
   O'Neal, JT
   Rajakumar, A
   Wrammert, J
   Rimawi, BH
   Pulendran, B
   Schinazi, RF
   Chakraborty, R
   Suthar, MS
AF Quicke, Kendra M.
   Bowen, James R.
   Johnson, Erica L.
   McDonald, Circe E.
   Ma, Huailiang
   O'Neal, Justin T.
   Rajakumar, Augustine
   Wrammert, Jens
   Rimawi, Bassam H.
   Pulendran, Bali
   Schinazi, Raymond F.
   Chakraborty, Rana
   Suthar, Mehul S.
TI Zika Virus Infects Human Placental Macrophages
SO CELL HOST & MICROBE
LA English
DT Article
ID HOFBAUER CELLS; IMMUNITY; REPLICATION; VACCINE; BIOLOGY; BRAIN; HIV-1
AB The recent Zika virus (ZIKV) outbreak in Brazil has been directly linked to increased cases of microcephaly in newborns. Current evidence indicates that ZIKV is transmitted vertically from mother to fetus. However, the mechanism of intrauterine transmission and the cell types involved remain unknown. We demonstrate that the contemporary ZIKV strain PRVABC59 (PR 2015) infects and replicates in primary human placental macrophages, called Hofbauer cells, and to a lesser extent in cytotrophoblasts, isolated from villous tissue of full-term placentae. Viral replication coincides with induction of type I interferon (IFN), pro-inflammatory cytokines, and antiviral gene expression, but with minimal cell death. Our results suggest a mechanism for intrauterine transmission in which ZIKV gains access to the fetal compartment by directly infecting placental cells and disrupting the placental barrier.
C1 [Quicke, Kendra M.; Bowen, James R.; Johnson, Erica L.; McDonald, Circe E.; O'Neal, Justin T.; Wrammert, Jens; Schinazi, Raymond F.; Chakraborty, Rana; Suthar, Mehul S.] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.
   [Quicke, Kendra M.; Bowen, James R.; McDonald, Circe E.; Ma, Huailiang; O'Neal, Justin T.; Wrammert, Jens; Pulendran, Bali; Suthar, Mehul S.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Ma, Huailiang; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Rajakumar, Augustine; Rimawi, Bassam H.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med & Reprod Infect Dis, Atlanta, GA 30329 USA.
   [Schinazi, Raymond F.] Emory Univ, Sch Med, Ctr AIDS Res, Biochem Pharmacol Lab, Atlanta, GA 30322 USA.
RP Suthar, MS (reprint author), Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.; Suthar, MS (reprint author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
EM msuthar@emory.edu
FU NIH [U19AI083019, R56AI110516, R21AI113485, 2U19AI090023, 5R37DK057665,
   5R37AI048638, 2U19AI057266]; Children's Healthcare of Atlanta; Emory
   Vaccine Center; Georgia Research Alliance; Multi-Center NICHD
   International Maternal Pediatric Adolescent AIDS Clinical Trials
   Network; Center for AIDS Research at Emory University [P30AI050409]
FX We thank A. Price for the OAS1 qRT-PCR reagents. This work was funded in
   part by NIH grants U19AI083019 (M.S.S), R56AI110516 (M.S.S), R21AI113485
   (M.S.S.), 2U19AI090023 (B.P), 5R37DK057665 (B.P), 5R37AI048638 (B.P),
   and 2U19AI057266 (B.P); Children's Healthcare of Atlanta (M.S.S); Emory
   Vaccine Center (M.S.S); The Georgia Research Alliance (M.S.S);
   Multi-Center NICHD International Maternal Pediatric Adolescent AIDS
   Clinical Trials Network (R.C); and P30AI050409 Center for AIDS Research
   at Emory University (R.F.S).
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Calvet G., 2016, LANCET INFECT DIS
   Chiuppesi F, 2015, J VIROL, V89, P11884, DOI 10.1128/JVI.01701-15
   Cordeiro MT, 2016, LANCET
   Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Driggers R.W., 2016, N ENGL J MED
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Johnson EL, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-101
   Koi H, 2001, ANN NY ACAD SCI, V943, P148
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   LEWIS SH, 1990, LANCET, V335, P565, DOI 10.1016/0140-6736(90)90349-A
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Noronha L., 2016, MEM I O CRUZ
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thio CL, 2008, CLIN LIVER DIS, V12, P713, DOI 10.1016/j.cld.2008.03.002
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
NR 28
TC 5
Z9 5
U1 48
U2 48
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUL 13
PY 2016
VL 20
IS 1
BP 83
EP 90
DI 10.1016/j.chom.2016.05.015
PG 8
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DS3UC
UT WOS:000380707200012
PM 27247001
ER

PT J
AU Priyamvada, L
   Quicke, KM
   Hudson, WH
   Onlamoon, N
   Sewatanon, J
   Edupuganti, S
   Pattanapanyasat, K
   Chokephaibulkit, K
   Mulligan, MJ
   Wilson, PC
   Ahmed, R
   Suthar, MS
   Wrammert, J
AF Priyamvada, Lalita
   Quicke, Kendra M.
   Hudson, William H.
   Onlamoon, Nattawat
   Sewatanon, Jaturong
   Edupuganti, Srilatha
   Pattanapanyasat, Kovit
   Chokephaibulkit, Kulkanya
   Mulligan, Mark J.
   Wilson, Patrick C.
   Ahmed, Rafi
   Suthar, Mehul S.
   Wrammert, Jens
TI Human antibody responses after dengue virus infection are highly
   cross-reactive to Zika virus
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; cross-reactivity; antibodies; B-cell responses
ID FUSION LOOP; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; DEPENDENT
   ENHANCEMENT; DISEASE SEVERITY; GLYCOPROTEIN; MICRONESIA; EPITOPES;
   BURDEN; STATES
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus of significant public health concern. ZIKV shares a high degree of sequence and structural homology compared with other flaviviruses, including dengue virus (DENV), resulting in immunological cross-reactivity. Improving our current understanding of the extent and characteristics of this immunological cross-reactivity is important, as ZIKV is presently circulating in areas that are highly endemic for dengue. To assess the magnitude and functional quality of cross-reactive immune responses between these closely related viruses, we tested acute and convalescent sera from nine Thai patients with PCR-confirmed DENV infection against ZIKV. All of the sera tested were cross-reactive with ZIKV, both in binding and in neutralization. To deconstruct the observed serum cross-reactivity in depth, we also characterized a panel of DENV-specific plasmablast-derived monoclonal antibodies (mAbs) for activity against ZIKV. Nearly half of the 47 DENV-reactive mAbs studied bound to both whole ZIKV virion and ZIKV lysate, of which a subset also neutralized ZIKV. In addition, both sera and mAbs from the dengue-infected patients enhanced ZIKV infection of Fc gamma receptor (Fc gamma R)-bearing cells in vitro. Taken together, these findings suggest that preexisting immunity to DENV may impact protective immune responses against ZIKV. In addition, the extensive cross-reactivity may have implications for ZIKV virulence and disease severity in DENV-experienced populations.
C1 [Priyamvada, Lalita; Quicke, Kendra M.; Hudson, William H.; Sewatanon, Jaturong; Ahmed, Rafi; Suthar, Mehul S.; Wrammert, Jens] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Priyamvada, Lalita; Quicke, Kendra M.; Suthar, Mehul S.; Wrammert, Jens] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.
   [Hudson, William H.; Sewatanon, Jaturong; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Onlamoon, Nattawat; Pattanapanyasat, Kovit] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Res & Dev, Bangkok 10700, Thailand.
   [Sewatanon, Jaturong] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand.
   [Edupuganti, Srilatha; Mulligan, Mark J.] Emory Univ, Sch Med, Emory Vaccine Ctr, Hope Clin, Atlanta, GA 30322 USA.
   [Edupuganti, Srilatha; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Chokephaibulkit, Kulkanya] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pediat, Bangkok 10700, Thailand.
   [Wilson, Patrick C.] Univ Chicago, Dept Med, Knapp Ctr Lupus & Immunol Res, Rheumatol Sect, Chicago, IL 60637 USA.
RP Ahmed, R; Wrammert, J (reprint author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Wrammert, J (reprint author), Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.; Ahmed, R (reprint author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
EM rahmed@emory.edu; jwramme@emory.edu
FU NIH/National Institute of Allergy and Infectious Diseases (NIAID)
   [U19AI057266, 1U01AI115651, U19AI083019, R56AI110516]; NIH
   [1R01AI099385-01]; Faculty of Medicine Siriraj Hospital; Faculty of
   Medicine Siriraj Hospital, Mahidol University [R015636002]
FX This work was funded in part by NIH/National Institute of Allergy and
   Infectious Diseases (NIAID) Grants U19AI057266 (to R.A., P.C.W., and
   J.W.), 1U01AI115651 (to R.A. and J.W.), U19AI083019 (to M.S.S.), and
   R56AI110516 (to M.S.S.). K.P. is supported by NIH Grant 1R01AI099385-01.
   K.P. and N.O. are supported by a Chalermphrakiat Grant from the Faculty
   of Medicine Siriraj Hospital. N.O. is also supported by Grant R015636002
   from the Faculty of Medicine Siriraj Hospital, Mahidol University.
CR Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Butrapet S, 2011, VIROLOGY, V413, P118, DOI 10.1016/j.virol.2011.01.030
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2006, HUM VACCINES, V2, P255
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gallichotte EN, 2015, MBIO, V6
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Hsieh SC, 2010, J VIROL, V84, P4782, DOI 10.1128/JVI.01963-09
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Priyamvada L, 2016, J VIROL
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Xu MH, 2012, J IMMUNOL, V189, P5877, DOI 10.4049/jimmunol.1201688
   Yenchitsomanus Pa-Thai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P228
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 40
TC 2
Z9 2
U1 38
U2 38
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 12
PY 2016
VL 113
IS 28
BP 7852
EP 7857
DI 10.1073/pnas.1607931113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR1VX
UT WOS:000379694100052
PM 27354515
ER

PT J
AU Rossi, SL
   Vasilakis, N
AF Rossi, Shannan L.
   Vasilakis, Nikos
TI Modeling Zika Virus Infection in Mice
SO CELL STEM CELL
LA English
DT Editorial Material
ID ORGANOIDS
C1 [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Rossi, SL; Vasilakis, N (reprint author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Rossi, SL; Vasilakis, N (reprint author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.; Rossi, SL; Vasilakis, N (reprint author), Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.; Rossi, SL; Vasilakis, N (reprint author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM slrossi@utmb.edu; nivasila@utmb.edu
CR Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 10
TC 0
Z9 0
U1 12
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD JUL 7
PY 2016
VL 19
IS 1
BP 4
EP 6
DI 10.1016/j.stem.2016.06.009
PG 4
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DT6UT
UT WOS:000381620500003
PM 27392219
ER

PT J
AU Li, C
   Xu, D
   Ye, Q
   Hong, S
   Jiang, YS
   Liu, XY
   Zhang, N
   Shi, L
   Qin, CF
   Xu, ZH
AF Li, Cui
   Xu, Dan
   Ye, Qing
   Hong, Shuai
   Jiang, Yisheng
   Liu, Xinyi
   Zhang, Nana
   Shi, Lei
   Qin, Cheng-Feng
   Xu, Zhiheng
TI Zika Virus Disrupts Neural Progenitor Development and Leads to
   Microcephaly in Mice
SO CELL STEM CELL
LA English
DT Article
ID CELLS; STEM
AB The link between Zika virus (ZIKV) infection and microcephaly has raised urgent global alarm. The historical African ZIKV MR766 was recently shown to infect cultured human neural precursor cells (NPCs), but unlike the contemporary ZIKV strains, it is not believed to cause microcephaly. Here we investigated whether the Asian ZIKV strain SZ01 could infect NPCs in vivo and affect brain development. We found that SZ01 replicates efficiently in embryonic mouse brain by directly targeting different neuronal linages. ZIKV infection leads to cell-cycle arrest, apoptosis, and inhibition of NPC differentiation, resulting in cortical thinning and microcephaly. Global gene expression analysis of infected brains reveals upregulation of candidate flavirus entry receptors and dysregulation of genes associated with immune response, apoptosis, and microcephaly. Our model provides evidence for a direct link between Zika virus infection and microcephaly, with potential for further exploration of the underlying mechanisms and management of ZIKV-related pathological effects during brain development.
C1 [Li, Cui; Hong, Shuai; Jiang, Yisheng; Liu, Xinyi; Shi, Lei; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Li, Cui; Ye, Qing; Jiang, Yisheng] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Ye, Qing; Zhang, Nana; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
   [Xu, Dan] Fuzhou Univ, Inst Life Sci, Fuzhou 350116, Peoples R China.
   [Zhang, Nana] Guangxi Med Univ, Nanning 530021, Peoples R China.
RP Xu, ZH (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Qin, CF (reprint author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Xu, ZH (reprint author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
EM qincf@bmi.ac.cn; zhxu@genetics.ac.cn
FU NSF (China) [31430037/31271156/81522025/8151101191]; MOST (China) "973"
   program [2014CB942801/2013DFA31990/2012YQ03026006]
FX We thank Drs. Fu Gao, Xia Jin, Weixiang Guo, Lloyd Greene, and Feng
   Zhang for valuable advice, and we thank Fu-Chun Zhang for serum from the
   ZIKV patient. This work was supported by grants from NSF (China)
   (31430037/31271156/81522025/8151101191) and the MOST (China) "973"
   program (2014CB942801/2013DFA31990/2012YQ03026006).
CR Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155
   Calvet G., 2016, LANCET INFECT DIS
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Driggers R.W., 2016, N ENGL J MED
   Garcez P.P., 2016, SCIENCE
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006
   Marrs C., 2016, AM J PERINATOL
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL
   iQian X., 2016, CELL IN PRESS
   Tang H, 2016, CELL STEM CELL
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016
   Zhang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6815
NR 19
TC 16
Z9 16
U1 26
U2 26
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD JUL 7
PY 2016
VL 19
IS 1
BP 120
EP 126
PG 7
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DT6UT
UT WOS:000381620500016
PM 27179424
ER

PT J
AU Marceau, CD
   Puschnik, AS
   Majzoub, K
   Ooi, YS
   Brewer, SM
   Fuchs, G
   Swaminathan, K
   Mata, MA
   Elias, JE
   Sarnow, P
   Carette, JE
AF Marceau, Caleb D.
   Puschnik, Andreas S.
   Majzoub, Karim
   Ooi, Yaw Shin
   Brewer, Susan M.
   Fuchs, Gabriele
   Swaminathan, Kavya
   Mata, Miguel A.
   Elias, Joshua E.
   Sarnow, Peter
   Carette, Jan E.
TI Genetic dissection of Flaviviridae host factors through genome-scale
   CRISPR screens
SO NATURE
LA English
DT Article
ID HEPATITIS-C VIRUS; HUMAN-CELLS; N-GLYCOSYLATION; DENGUE VIRUS;
   REPLICATION; INFECTION; PROTEIN; HUR; OLIGOSACCHARYLTRANSFERASE;
   MEMBRANE
AB The Flaviviridae are a family of viruses that cause severe human diseases. For example, dengue virus (DENV) is a rapidly emerging pathogen causing an estimated 100 million symptomatic infections annually worldwide(1). No approved antivirals are available to date, and clinical trials with a tetravalent dengue vaccine showed disappointingly low protection rates(2). Hepatitis C virus (HCV) also remains a major medical problem, with 160 million chronically infected patients worldwide and only expensive treatments available(3). Despite distinct differences in their pathogenesis and modes of transmission, the two viruses share common replication strategies(4). A detailed understanding of the host functions that determine viral infection is lacking. Here we use a pooled CRISPR genetic screening strategy(5,6) to comprehensively dissect host factors required for these two highly important Flaviviridae members. For DENV, we identified endoplasmic-reticulum (ER)-associated multi-protein complexes involved in signal sequence recognition, N-linked glycosylation and ER-associated degradation. DENV replication was nearly completely abrogated in cells deficient in the oligosaccharyltransferase (OST) complex. Mechanistic studies pinpointed viral RNA replication and not entry or translation as the crucial step requiring the OST complex. Moreover, we show that viral non-structural proteins bind to the OST complex. The identified ER-associated protein complexes were also important for infection by other mosquito-borne flaviviruses including Zika virus, an emerging pathogen causing severe birth defects(7). By contrast, the most significant genes identified in the HCV screen were distinct and included viral receptors, RNA-binding proteins and enzymes involved in metabolism. We found an unexpected link between intracellular flavin adenine dinucleotide (FAD) levels and HCV replication. This study shows notable divergence in host-dependency factors between DENV and HCV, and illuminates new host targets for antiviral therapy.
C1 [Marceau, Caleb D.; Puschnik, Andreas S.; Majzoub, Karim; Ooi, Yaw Shin; Brewer, Susan M.; Fuchs, Gabriele; Mata, Miguel A.; Sarnow, Peter; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
   [Swaminathan, Kavya; Elias, Joshua E.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.
RP Carette, JE (reprint author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.
EM carette@stanford.edu
FU National Institutes of Health (NIH) [DP2 AI104557]; NIH [AI109662];
   David and Lucile Packard Foundation; Stanford Graduate Fellowship;
   Boehringer Ingelheim Fonds; NSF-GFRP
FX The authors thank T. Brummelkamp, J. Idoyaga and S. Einav for critically
   reading the manuscript and discussions; X. Ji and the Stanford
   Functional Genomics Facility; The Stanford Transmission Electron
   Microscope Facility; The Stanford Shared FACS Facility, and members of
   the Carette laboratory for discussions and support. S. Einav, K.
   Kirkegaard, F. Chisari, J. F. Anderson, C. Rice, H. Ploegh, R. Kopito,
   E. Harris, M. Ivessa, S. Weaver, R. Tesh and E. Campeau are acknowledged
   for providing materials. The work was funded in part by National
   Institutes of Health (NIH) DP2 AI104557 (J. E. C.), NIH AI109662 (J. E.
   C.), David and Lucile Packard Foundation (J. E. C.), Stanford Graduate
   Fellowship (A.S.P.), Boehringer Ingelheim Fonds (A.S.P.) and NSF-GFRP
   (C.D.M.).
CR Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854
   Canver MC, 2014, J BIOL CHEM, V289, P21312, DOI 10.1074/jbc.M114.564625
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955
   Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095
   Fuchs G, 2015, P NATL ACAD SCI USA, V112, P319, DOI 10.1073/pnas.1421328111
   Fujimura M, 2010, J NUTR, V140, P1722, DOI 10.3945/jn.110.128330
   Hasan M, 2015, IMMUNITY, V43, P463, DOI 10.1016/j.immuni.2015.07.022
   Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513
   Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179
   Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x
   Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106
   Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020
   Lindenbach BD, 1997, J VIROL, V71, P9608
   Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151
   Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375
   Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Ramage HR, 2015, MOL CELL, V57, P329, DOI 10.1016/j.molcel.2014.12.028
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005
   Shwetha S, 2015, J VIROL, V89, P11356, DOI 10.1128/JVI.01714-15
   Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003
   Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001
   Thomas SJ, 2015, AM J PREV MED, V49, pS334, DOI 10.1016/j.amepre.2015.09.006
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
NR 42
TC 1
Z9 1
U1 33
U2 33
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 7
PY 2016
VL 535
IS 7610
BP 159
EP +
DI 10.1038/nature18631
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ2EU
UT WOS:000379015600044
PM 27383987
ER

PT J
AU Zhang, R
   Miner, JJ
   Gorman, MJ
   Rausch, K
   Ramage, H
   White, JP
   Zuiani, A
   Zhang, P
   Fernandez, E
   Zhang, Q
   Dowd, KA
   Pierson, TC
   Cherry, S
   Diamond, MS
AF Zhang, Rong
   Miner, Jonathan J.
   Gorman, Matthew J.
   Rausch, Keiko
   Ramage, Holly
   White, James P.
   Zuiani, Adam
   Zhang, Ping
   Fernandez, Estefania
   Zhang, Qiang
   Dowd, Kimberly A.
   Pierson, Theodore C.
   Cherry, Sara
   Diamond, Michael S.
TI A CRISPR screen defines a signal peptide processing pathway required by
   flaviviruses
SO NATURE
LA English
DT Article
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; HEPATITIS-C VIRUS;
   MONOCLONAL-ANTIBODIES; ENVELOPE PROTEIN; HUMAN-CELLS; INFECTION; GENES;
   NEUTRALIZATION; IDENTIFICATION
AB Flaviviruses infect hundreds of millions of people annually, and no antiviral therapy is available(1,2). We performed a genome-wide CRISPR/Cas9-based screen to identify host genes that, when edited, resulted in reduced flavivirus infection. Here, we validated nine human genes required for flavivirus infectivity, and these were associated with endoplasmic reticulum functions including translocation, protein degradation, and N-linked glycosylation. In particular, a subset of endoplasmic reticulum-associated signal peptidase complex (SPCS) proteins was necessary for proper cleavage of the flavivirus structural proteins (prM and E) and secretion of viral particles. Loss of SPCS1 expression resulted in markedly reduced yield of all Flaviviridae family members tested (West Nile, dengue, Zika, yellow fever, Japanese encephalitis, and hepatitis C viruses), but had little impact on alphavirus, bunyavirus, or rhabdovirus infection or the surface expression or secretion of diverse host proteins. We found that SPCS1 dependence could be bypassed by replacing the native prM protein leader sequences with a class I major histocompatibility complex (MHC) antigen leader sequence. Thus, SPCS1, either directly or indirectly via its interactions with host proteins, preferentially promotes the processing of specific protein cargo, and Flaviviridae have a unique dependence on this signal peptide processing pathway. SPCS1 and other signal processing pathway members could represent pharmacological targets for inhibiting infection by the expanding number of flaviviruses of medical concern.
C1 [Zhang, Rong; Miner, Jonathan J.; Gorman, Matthew J.; White, James P.; Zuiani, Adam; Zhang, Ping; Fernandez, Estefania; Zhang, Qiang; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Rausch, Keiko; Ramage, Holly; Cherry, Sara] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Zhang, Ping] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Dept Immunol, Guangzhou 510080, Guangdong, Peoples R China.
   [Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@borcim.wustl.edu
FU NIH [U19 AI083019, U19 AI106772, R01 AI104972, T32 AI007163]; Washington
   University Institute of Clinical and Translational Sciences from the
   National Center for Advancing Translational Sciences [UL1 TR000448];
   Washington University Institute of Clinical and Translational Sciences
   from the National Institute of General Medical Sciences [P41
   GM103422-35]; NIAID
FX This work was supported by NIH grants U19 AI083019 (M.S.D.), U19
   AI106772 (M.S.D.), R01 AI104972 (M.S.D.), and T32 AI007163 (E.F.) and by
   the Washington University Institute of Clinical and Translational
   Sciences (UL1 TR000448 from the National Center for Advancing
   Translational Sciences and P41 GM103422-35 from the National Institute
   of General Medical Sciences). T.C.P and K.A.D are supported by the
   intramural program of NIAID. We thank R. Kuhn, A. Garcia-Sastre, H.
   Zhao, D. Fremont, X. Wang, and R. Townsend for reagents, experimental
   advice, and data analysis; P. Erdmann-Gilmore, R. Connors, Y. Mi, and H.
   Lin for expert technical assistance; and X. de Lamballerie and the
   European Virus Archive goes Global (EVAg) for consenting to the use of
   H/PF/2013 ZIKV strain for this study under a material transfer agreement
   with the EVAg parter, Aix-Marseille Universite.
CR BARTH BU, 1995, J CELL BIOL, V128, P283, DOI 10.1083/jcb.128.3.283
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266
   Brien J. D., 2013, CURR PROTOC MICROBIO, V31
   CHAMBERS TJ, 1991, J VIROL, V65, P6042
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581
   FALGOUT B, 1991, J VIROL, V65, P2467
   Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003
   Gowen BG, 2015, ELIFE, V4, DOI 10.7554/eLife.08474
   Hackett BA, 2015, P NATL ACAD SCI USA, V112, P7797, DOI 10.1073/pnas.1424098112
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113
   Khromykh AA, 1998, J VIROL, V72, P7270
   Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Lin TY, 2012, J VIROL, V86, P3501, DOI 10.1128/JVI.06435-11
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lober C, 2001, VIROLOGY, V289, P224, DOI 10.1006/viro.2001.1171
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159
   Miner JJ, 2011, J BIOL CHEM, V286, P9577, DOI 10.1074/jbc.M110.208777
   Mishin VP, 2001, VIRUS RES, V81, P113, DOI 10.1016/S0168-1702(01)00371-9
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Rose PP, 2011, CELL HOST MICROBE, V10, P97, DOI 10.1016/j.chom.2011.06.009
   Sabo MC, 2011, J VIROL, V85, P7005, DOI 10.1128/JVI.00586-11
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Schalich J, 1996, J VIROL, V70, P4549
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Suzuki R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003589
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
NR 49
TC 2
Z9 2
U1 39
U2 39
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 7
PY 2016
VL 535
IS 7610
BP 164
EP +
DI 10.1038/nature18625
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ2EU
UT WOS:000379015600045
PM 27383988
ER

PT J
AU Shi, WF
   Zhang, ZJ
   Ling, C
   Carr, MJ
   Tong, YG
   Gao, GF
AF Shi, Weifeng
   Zhang, Zhenjie
   Ling, Cheng
   Carr, Michael J.
   Tong, Yigang
   Gao, George F.
TI Increasing genetic diversity of Zika virus in the Latin American
   outbreak
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
C1 [Shi, Weifeng; Zhang, Zhenjie] Taishan Med Coll, Inst Pathogen Biol, Tai An 271000, Shandong, Peoples R China.
   [Ling, Cheng] Beijing Univ Chem Technol, Coll Informat Sci & Technol, Beijing 100029, Peoples R China.
   [Carr, Michael J.] Hokkaido Univ, Global Stn Zoonosis Control, Global Inst Collaborat Res & Educ, Sapporo, Hokkaido 0010020, Japan.
   [Carr, Michael J.] Univ Coll Dublin, Natl Virus Reference Lab, Dublin 4, Ireland.
   [Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100101, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China.
   [Gao, George F.] Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China.
RP Shi, WF (reprint author), Taishan Med Coll, Inst Pathogen Biol, Tai An 271000, Shandong, Peoples R China.
EM shiwf@ioz.ac.cn
CR Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 10
TC 1
Z9 1
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JUL 6
PY 2016
VL 5
AR e68
DI 10.1038/emi.2016.68
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DT7IB
UT WOS:000381659200003
PM 27381219
ER

PT J
AU Horovitz, DDG
   Pone, MVD
   Pone, SM
   Salles, TRDS
   Boechat, MCB
AF Gandelman Horovitz, Dafne Dain
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Dias Saad Salles, Tania Regina
   Bastos Boechat, Marcia Cristina
TI Cranial bone collapse in microcephalic infants prenatally exposed to
   Zika virus infection
SO NEUROLOGY
LA English
DT Editorial Material
AB Brazil has been experiencing an outbreak of Zika virus, a flavivirus transmitted by Aedes mosquitoes. Since October 2015, more than 4,000 infants,(1) born to mothers suspected to have contracted this infection during pregnancy, have microcephaly(1,2) and CNS malformations (figure 1), including parenchymal and periventricular calcifications, ventriculomegaly, and cortical migration anomalies.(2) This suggests marked viral neurotropism. Upon performing CT, cranial malformations (figure 2) with a pointed occiput are also observed.
C1 [Gandelman Horovitz, Dafne Dain; da Silva Pone, Marcos Vinicius; Pone, Sheila Moura; Dias Saad Salles, Tania Regina; Bastos Boechat, Marcia Cristina] Fundacao Oswaldo Cruz Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil.
RP Horovitz, DDG (reprint author), Fundacao Oswaldo Cruz Fiocruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, Brazil.
EM dafne@iff.fiocruz.br
CR Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 1
TC 0
Z9 0
U1 9
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JUL 5
PY 2016
VL 87
IS 1
BP 118
EP 119
DI 10.1212/WNL.0000000000002814
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA DR7VH
UT WOS:000380107300026
ER

PT J
AU Lazarus, C
   Guichard, M
   Philippe, JM
   Paux, T
   Vallet, B
AF Lazarus, Clement
   Guichard, Marie
   Philippe, Jean-Marc
   Paux, Thierry
   Vallet, Benoit
TI The French experience of the threat posed by Zika virus
SO LANCET
LA English
DT Editorial Material
C1 [Lazarus, Clement; Guichard, Marie; Philippe, Jean-Marc] Gen Directorate Hlth, Publ Hlth Emergency Operat Ctr, F-75007 Paris, France.
   [Paux, Thierry] Gen Directorate Hlth, Monitoring & Hlth Safety Dept, F-75007 Paris, France.
   [Lazarus, Clement; Guichard, Marie; Philippe, Jean-Marc; Paux, Thierry; Vallet, Benoit] Gen Directorate Hlth, Minist Hlth, F-75007 Paris, France.
RP Vallet, B (reprint author), Gen Directorate Hlth, Minist Hlth, F-75007 Paris, France.
EM benoit.vallet@sante.gouv.fr
CR Altona Diagnostics EN, REALSTAR ZIK VIR RT
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Conseil National Professionnel de Gynecologie et Obstetrique, ZIK GROSS
   Delfraissy JF, 2016, LANCET, V387, P2183, DOI 10.1016/S0140-6736(16)30059-9
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Haut Conseil de la Sante Publique, 2016, PERS ATT VIR ZIK ACT
   Haut Conseil de la Sante Publique, 2016, INF VIR ZIK PRIS CHA
   Haut Conseil de la Sante Publique, 2016, INF VIR ZIK INSCR LI
   Haut Conseil de la Sante Publique, 2016, MES GEST UT DELT DEP
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ministere des Aff aires etrangeres et du Developpement international, 2016, CONS VOYAG
   Ministere des Aff aires Sociales et de la Sante, 2015, MAL VIR ZIK MAL INF
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUL 2
PY 2016
VL 388
IS 10039
BP 9
EP 11
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP9PM
UT WOS:000378828400008
PM 27397775
ER

PT J
AU Graul, A
   Tremosa, L
   Dulsat, C
AF Graul, A.
   Tremosa, L.
   Dulsat, C.
TI ZIKA TESTING: ANIMAL MODELS AND ASSAYS
SO DRUGS OF THE FUTURE
LA English
DT Article
DE Zika virus; Animal models; Assays; Tests
ID VIRUS
AB The abrupt appearance last year of Zika virus disease and its rapid spread throughout the American continent caught scientists unprepared, with a pipeline devoid of any effective drugs and vaccines. Recent publications and reports concerning novel animal models of Zika-essential for the preclinical testing of new drugs and biologics-as well as diagnostic tests for use in research and in the field indicate early progress in facing this new viral threat, although much work remains to be done.
C1 [Graul, A.; Tremosa, L.; Dulsat, C.] Thomson Reuters, Barcelona, Spain.
RP Graul, A (reprint author), Thomson Reuters, Barcelona, Spain.
EM ann.graul@thomsonreuters.com
CR Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Julander J., 2016, 29 INT C ANT RES ICA
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   [Anonymous], 2016, DON SCREEN REC RED R
NR 6
TC 0
Z9 0
U1 1
U2 1
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 0377-8282
EI 2013-0368
J9 DRUG FUTURE
JI Drug Future
PD JUL
PY 2016
VL 41
IS 7
BP 423
EP 427
DI 10.1358/dof.2016.041.07.2516438
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DV8EJ
UT WOS:000383170000004
ER

PT J
AU Frazer, C
   Hussey, LC
   Whitworth, BS
   Paleo, N
AF Frazer, Christine
   Hussey, Leslie C.
   Whitworth, Bobbie Sue
   Paleo, Nicole
TI In the Midst of Zika: The Role of Childbirth Professionals
SO INTERNATIONAL JOURNAL OF CHILDBIRTH EDUCATION
LA English
DT Article
DE Zika virus; Aedes mosquitos; Aedes aegypti mosquito; microcephaly; fetal
   outcomes; childbirth professional role
ID INTERIM GUIDELINES; UNITED-STATES; VIRUS; OUTBREAK
AB The rapid spread of Zika virus presents a public health crisis. Zika is a mosquito-borne virus transmitted through the bite of infected Aedes mosquitoes. Symptoms of Zika virus develop 2 to 12 days after the bite and range from no symptoms to maculopapular rash, fever, arthralgia, muscle pain, headache, and conjunctivitis. Zika virus is especially dangerous to pregnant women as it can cause fetal brain defects, hearing loss, ocular abnormalities, and central nervous system defects. Because there is no vaccine or specific treatment, it is imperative for childbirth professionals to arm themselves with the most up-to-date information. This article aims to provide childbirth professionals with an overview of Zika virus, the recommended prevention measures, and their role in preventing the spread of Zika virus and its consequences.
C1 [Frazer, Christine; Hussey, Leslie C.] Walden Univ, Minneapolis, MN 55401 USA.
   [Hussey, Leslie C.] Walden Univ, Nursing Program, Minneapolis, MN USA.
   [Whitworth, Bobbie Sue] Walden Univ, Core Acad Program, Minneapolis, MN USA.
   [Whitworth, Bobbie Sue] Walden Univ, MSN Program, Minneapolis, MN USA.
RP Frazer, C (reprint author), Walden Univ, Minneapolis, MN 55401 USA.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baden L. R., 2016, NEW ENGL J MED, V374, P1552, DOI [10.1056/NEJMra1602113, DOI 10.1056/NEJMRA1602113]
   Barzon L, 2016, EUROSURVEILLANCE, V21, P1
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Center for Disease Control and Prevention, 2016, TRANSM RISKS
   Center for Disease Control and Prevention, 2016, AR WITH ZIK
   Center for Disease Control and Prevention, 2016, ZIK VIR DIS US 2016
   Center for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Centers for Disease Control and Prevention, 2016, PREVENTION
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   D'Ortenzio E., 2016, NEW ENGL J MED, DOI [10.1056/nejmc1604449, DOI 10.1056/NEJMC1604449, 10.1056/NEJMc1604449]
   Driggers RW, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824., DOI 10.1056/NEJMOA1601824, 10.1056/NEJMoa1601824]
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Lafrance A., 2016, ATLANTIC
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCabe E. R. B., 2016, ZIKA VIRUS INFECT EV
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   World Health Organization, 2016, BREASTF CONT ZIK VIR
   World Health Organization, 2016, ZIK VIR FACT SHEET
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   WHO, 2016, ZIK SIT REP
   World Health Organization, 2016, NEUR SYNDR CONG AN
   World Health Organization, 2016, PREGN MAN CONT ZIK V
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 27
TC 0
Z9 0
U1 2
U2 2
PU INT CHILDBIRTH EDUCATION ASSOC
PI RALEIGH
PA 1500 SUNDAY DR, STE 102, RALEIGH, NC 27607 USA
SN 0887-8625
J9 INT J CHILDBIRTH EDU
JI Int. J. Childbirth Educ.
PD JUL
PY 2016
VL 31
IS 3
BP 7
EP 12
PG 6
WC Nursing
SC Nursing
GA DV3TF
UT WOS:000382845700004
ER

PT J
AU Swanstrom, JA
   Plante, JA
   Plante, KS
   Young, EF
   McGowan, E
   Gallichotte, EN
   Widman, DG
   Heise, MT
   de Silva, AM
   Baric, RS
AF Swanstrom, J. A.
   Plante, J. A.
   Plante, K. S.
   Young, E. F.
   McGowan, E.
   Gallichotte, E. N.
   Widman, D. G.
   Heise, M. T.
   de Silva, A. M.
   Baric, R. S.
TI Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from
   Dengue Patients Are Protective against Zika Virus
SO MBIO
LA English
DT Article
ID CONGENITAL CYTOMEGALOVIRUS; NEUTRALIZING ANTIBODIES; HIGHLY POTENT;
   SEROTYPE 3; INFECTION; VACCINE; DETERMINANTS; PREGNANCY; CHILDREN;
   BRAZIL
AB Zika virus (ZIKV) is a mosquito-borne flavivirus responsible for thousands of cases of severe fetal malformations and neurological disease since its introduction to Brazil in 2013. Antibodies to flaviviruses can be protective, resulting in lifelong immunity to reinfection by homologous virus. However, cross-reactive antibodies can complicate flavivirus diagnostics and promote more severe disease, as noted after serial dengue virus (DENV) infections. The endemic circulation of DENV in South America and elsewhere raises concerns that preexisting flavivirus immunity may modulate ZIKV disease and transmission potential. Here, we report on the ability of human monoclonal antibodies and immune sera derived from dengue patients to neutralize contemporary epidemic ZIKV strains. We demonstrate that a class of human monoclonal antibodies isolated from DENV patients neutralizes ZIKV in cell culture and is protective in a lethal murine model. We also tested a large panel of convalescent-phase immune sera from humans exposed to primary and repeat DENV infection. Although ZIKV is most closely related to DENV compared to other human-pathogenic flaviviruses, most DENV immune sera (73%) failed to neutralize ZIKV, while others had low (50% effective concentration [EC50],<1:100 serum dilution; 18%) or moderate to high (EC50,>1:100 serum dilution; 9%) levels of cross-neutralizing antibodies. Our results establish that ZIKV and DENV share epitopes that are targeted by neutralizing, protective human antibodies. The availability of potently neutralizing human monoclonal antibodies provides an immunotherapeutic approach to control life-threatening ZIKV infection and also points to the possibility of repurposing DENV vaccines to induce cross-protective immunity to ZIKV.
   IMPORTANCE ZIKV is an emerging arbovirus that has been associated with severe neurological birth defects and fetal loss in pregnant women and Guillain-Barre syndrome in adults. Currently, there is no vaccine or therapeutic for ZIKV. The identification of a class of antibodies (envelope dimer epitope 1 [EDE1]) that potently neutralizes ZIKV in addition to all four DENV serotypes points to a potential immunotherapeutic to combat ZIKV. This is especially salient given the precedent of antibody therapy to treat pregnant women infected with other viruses associated with microcephaly, such as cytomegalovirus and rubella virus. Furthermore, the identification of a functionally conserved epitope between ZIKV and DENV raises the possibility that a vaccine may be able to elicit neutralizing antibodies against both viruses.
C1 [Swanstrom, J. A.; Plante, J. A.; Young, E. F.; Gallichotte, E. N.; Widman, D. G.; Baric, R. S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.
   [Plante, K. S.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA.
   [Young, E. F.; McGowan, E.; Gallichotte, E. N.; Heise, M. T.; de Silva, A. M.; Baric, R. S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
RP Baric, RS (reprint author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.; Baric, RS (reprint author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
EM rbaric@email.unc.edu
FU HHS \ National Institutes of Health (NIH) [R01 AI 107731, U19 AI 100625,
   T32 AI 007151-36A1]; Bill and Melinda Gates Foundation (Bill & Melinda
   Gates Foundation)
FX This work, including the efforts of Eileen McGowan, Jesica A. Swanstrom,
   Ellen F. Young, Emily N. Gallichotte, Aravinda de Silva, and Ralph S.
   Baric, was funded by HHS vertical bar National Institutes of Health
   (NIH) (R01 AI 107731). This work, including the efforts of Mark T.
   Heise, Ralph S. Baric, and Kenneth S. Plante, was funded by HHS vertical
   bar National Institutes of Health (NIH) (U19 AI 100625). This work,
   including the efforts of Kenneth S. Plante, was funded by HHS vertical
   bar National Institutes of Health (NIH) (T32 AI 007151-36A1). This work,
   including the efforts of Jessica Plante, Eileen McGowan, Aravinda de
   Silva, Ralph S. Baric, Jesica A. Swanstrom, Ellen F. Young, Emily N.
   Gallichotte, and Doug G. Widman, was funded by Bill and Melinda Gates
   Foundation (Bill & Melinda Gates Foundation) (Idea Grant).
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Beckham JD, 2016, JAMA NEUROL
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lindesmith LC, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001807
   Lindesmith LC, 2014, J VIROL, V88, P8826, DOI 10.1128/JVI.01192-14
   Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031
   Messer WB, 2016, J VIROL, V90, P5090, DOI 10.1128/JVI.00155-16
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   Nigro G, 2012, J INFECT DIS, V205, P215, DOI 10.1093/infdis/jir718
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Pitisuttithum P, 2016, EXPERT REV VACCINES, V15, P795, DOI 10.1080/14760584.2016.1189331
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sirivichayakul C, 2016, J INFECT DIS, V213, P1562, DOI 10.1093/infdis/jiv762
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Young MK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010586.pub2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 44
TC 1
Z9 1
U1 3
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2016
VL 7
IS 4
AR e01123
DI 10.1128/mBio.01123-16
PG 8
WC Microbiology
SC Microbiology
GA DW1YQ
UT WOS:000383440500061
ER

PT J
AU Tsetsarkin, KA
   Kenney, H
   Chen, RB
   Liu, GP
   Manukyan, H
   Whitehead, SS
   Laassri, M
   Chumakov, K
   Pletnev, AG
AF Tsetsarkin, Konstantin A.
   Kenney, Heather
   Chen, Rubing
   Liu, Guangping
   Manukyan, Hasmik
   Whitehead, Stephen S.
   Laassri, Majid
   Chumakov, Konstantin
   Pletnev, Alexander G.
TI A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic
   in Brazil as a Genetic Platform for Studies of Virus-Host Interactions
   and Vaccine Development
SO MBIO
LA English
DT Article
ID JAPANESE-ENCEPHALITIS-VIRUS; COOPERATIVE INTERACTIONS; RT-PCR; RNA; DNA;
   ROBUSTNESS; EVOLUTION; AMERICA; AMPLIFICATION; TRANSMISSION
AB An arthropod-borne virus, Zika virus (ZIKV), has recently emerged as a major human pathogen. Associated with complications during perinatal development and Guillain-Barr syndrome in adults, ZIKV raises new challenges for understanding the molecular determinants of flavivirus pathogenesis. This underscores the necessity for the development of a reverse genetic system based on an epidemic ZIKV strain. Here, we describe the generation and characterization in cell cultures of an infectious cDNA clone of ZIKV isolated from the 2015 epidemic in Brazil. The cDNA-derived ZIKV replicated efficiently in a variety of cell lines, including those of both neuronal and placental origin. We observed that the growth of cDNA-derived virus was attenuated compared to the growth of the parental isolate in most cell lines, which correlates with substantial differences in sequence heterogeneity between these viruses that were determined by deep-sequencing analysis. Our findings support the role of genetic diversity in maintaining the replicative fitness of viral populations under changing conditions. Moreover, these results indicate that caution should be exercised when interpreting the results of reverse-genetics experiments in attempts to accurately predict the biology of natural viruses. Finally, a Vero cell-adapted cDNA clone of ZIKV was generated that can be used as a convenient platform for studies aimed at the development of ZIKV vaccines and therapeutics.
   IMPORTANCE The availability of genetic tools and laboratory models determines the progress in understanding mechanisms of virus emergence and pathogenesis. Recent large-scale outbreaks of Zika virus (ZIKV) that were linked to complications during perinatal development and Guillain-Barre syndrome in adults emphasize the urgency for the development of a reverse-genetics system based on an epidemic ZIKV strain. Here, we report a stable infectious cDNA clone for ZIKV isolated during the 2015 epidemic in Brazil, as well as a Vero cell-adapted version of it, which will be used for virus-host interaction studies and vaccine development.
C1 [Tsetsarkin, Konstantin A.; Kenney, Heather; Liu, Guangping; Whitehead, Stephen S.; Pletnev, Alexander G.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Chen, Rubing] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Manukyan, Hasmik; Laassri, Majid; Chumakov, Konstantin] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
RP Pletnev, AG (reprint author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
EM apletnev@niaid.nih.gov
FU Division of Intramural Research Program of the National Institute of
   Allergy and Infectious Diseases, National Institutes of Health
FX This work was supported by the Division of Intramural Research Program
   of the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health
CR Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI [10.1586/erv.09.19, 10.1586/ERV.09.19]
   Blaney JE, 2004, AM J TROP MED HYG, V71, P811
   Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Ciota AT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-58
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12
   Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636
   Engel AR, 2010, VIROLOGY, V405, P243, DOI 10.1016/j.virol.2010.06.014
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gritsun TS, 1995, VIROLOGY, V214, P611, DOI 10.1006/viro.1995.0072
   Grubaugh ND, 2013, AM J TROP MED HYG, V88, P245, DOI 10.4269/ajtmh.2012.12-0048
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255
   Jerzak GVS, 2007, VIROLOGY, V360, P469, DOI 10.1016/j.virol.2006.10.029
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Polo S, 1997, J VIROL, V71, P5366
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13
   SUMIYOSHI H, 1992, J VIROL, V66, P5425
   Swofford DL, 1998, PAUP PHYLOGENETIC AN
   Tsetsarkin KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004852
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   WHO, 2016, ZIK SIT REP
   Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793
   Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003
   Zhang FQ, 2001, J VIROL METHODS, V96, P171, DOI 10.1016/S0166-0934(01)00331-7
   Zhao ZJ, 2005, J GEN VIROL, V86, P2209, DOI 10.1099/vir.0.80638-0
NR 44
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2016
VL 7
IS 4
AR e01114
DI 10.1128/mBio.01114-16
PG 8
WC Microbiology
SC Microbiology
GA DW1YQ
UT WOS:000383440500060
ER

PT J
AU Grischott, F
   Puhan, M
   Hatz, C
   Schlagenhauf, P
AF Grischott, Franca
   Puhan, Milo
   Hatz, Christoph
   Schlagenhauf, Patricia
TI Non-vector-borne transmission of Zika virus: A systematic review
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Review
DE Zika virus; Non-vector-borne transmission; Sexual transmission;
   Transfusion; Microcephaly
ID FRENCH-POLYNESIA; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; SEXUAL
   TRANSMISSION; 2015-FEBRUARY 2016; UNITED-STATES; YELLOW-FEVER;
   BREAST-MILK; INFECTION; BRAZIL
AB Background: Increasing numbers of confirmed cases of Zika virus (ZIKV) infection resulting from non-mosquito-borne transmission have been reported.
   Methods: We performed a systematic literature review (PRISMA guidelines) on intrauterine, intrapartum, sexual and animal bite ZIKV transmission. The presence of the virus in breast milk, urine, saliva and blood transfusions was also reviewed.
   Results: The search resulted in 285 papers of possible relevance, of which we included 53 in the systematic review. Mother-to-child transmission was most frequently described with adverse infant outcomes including microcephaly, intracranial calcification and fetal death. Zika virus RNA has been detected in amniotic fluid, breast milk, seminal fluid, saliva, urine and blood. Semen and blood products have proved to be infectious. Male-to-female and male-to-male ZIKV transmission is documented. There are contradictory results concerning the infectiousness of breast milk and urine and data on saliva, animal bites, transplantation, needlestick injury and laboratory work are inconclusive.
   Conclusions: Our systematic analysis shows that non-vector-borne ZIKV transmission plays a role in the spread of ZIKV and has great societal impact. It has important public health implications for the prevention and control of ZIKV globally and will be a basis for policy and further research. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Grischott, Franca; Puhan, Milo; Hatz, Christoph; Schlagenhauf, Patricia] Univ Zurich, Inst Epidemiol Biostat & Prevent, WHO Collaborating Ctr Travellers Hlth, Ctr Travel Med, Hirschengraben 84, CH-8001 Zurich, Switzerland.
   [Hatz, Christoph] Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Med & Diagnost, Socinstr 57, CH-4051 Basel, Switzerland.
RP Schlagenhauf, P (reprint author), Univ Zurich, Inst Epidemiol Biostat & Prevent, WHO Collaborating Ctr Travellers Hlth, Ctr Travel Med, Hirschengraben 84, CH-8001 Zurich, Switzerland.
EM patricia.schlagenhauf@uzh.ch
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Baron S, 1999, ARCH INTERN MED, V159, P303, DOI 10.1001/archinte.159.3.303
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILL B EUR S, V21
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Boadle A, BRAZIL REPORTS ZIKA
   Brasil P, 2016, N ENGL J MED
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Calvet G., 2016, LANCET INFECT DIS
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cauchemez S, 2016, LANCET
   Centers for Disease Control and Prevention, VECT SURV CONTR
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, MON CAS MICR BRAS
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   D'Ortenzio E, 2016, N ENGL J MED
   Driggers R.W., 2016, N ENGL J MED
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faria NR, 2016, SCIENCE
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   de Paula Freitas B, 2016, BRAZ JAMA OPHTHALMOL
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Habu A, 1977, Uirusu, V27, P21
   Hearn PT, 2014, AM J TROP MED HYG S1, V91, P62
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Korhonen EM, 2016, EUROSURVEILL B EUR S, V21
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Liuzzi G, 1996, AIDS, V10, pF51
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maria AT, 2016, EUROSURVEILL B EUR S, V21
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi720
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerioda Saude Secretaria de Vigilancia em Saude, 2016, PROT VIG RESP OC MIC, P16
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J., 2016, N ENGL J MED
   Moher D, 2009, ANN INTERN MED, V151, P264
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Rasmussen SA, 2016, N ENGL J MED
   Roze B, 2016, EUROSURVEILL B EUR S, V21
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stewart RD, 2013, CASE REP INFECT DIS, V2013
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tang H, 2016, CELL STEM CELL
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILL B EUR S, V21
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Werner H, 2016, ULTRASOUND OBSTET GY
   [Anonymous], 2010, EMERGING INFECT DIS, V16
   [Anonymous], 2002, MMWR MORB MORTAL WKL
NR 83
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2016
VL 14
IS 4
BP 313
EP 330
DI 10.1016/j.tmaid.2016.07.002
PG 18
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DU5EM
UT WOS:000382235000004
PM 27425793
ER

PT J
AU Castro, MC
AF Castro, Marcia C.
TI Zika virus and the 2016 Olympic Games - Evidence-based projections
   derived from dengue do not support cancellation
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
ID FIFA WORLD CUP; RIO-DE-JANEIRO; HEALTH-RISKS; TRAVELERS
C1 [Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave,Bldg 1,Room 1113, Boston, MA 02115 USA.
RP Castro, MC (reprint author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave,Bldg 1,Room 1113, Boston, MA 02115 USA.
EM mcastro@hsph.harvard.edu
CR Attaran A., 2016, HARVARD PUBLIC H MAY
   Brasil. Ministerio da Saude. Boletim Epidemiologico, 2016, B EPIDEMIOLOGICO
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Eberhardt KA, 2016, TRAVEL MED INFECT DI, V14, P212, DOI 10.1016/j.tmaid.2016.05.014
   European Centre for Disease Prevention and Control, 2016, POT RISKS PUBL HLTH
   The Lancet Infectious, 2016, LANCET INFECT DIS, V16, P619
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Secretaria de Estado de Saude do Rio de Janeiro, 2016, MON EM SAUD PUBL SIN
   Secretaria de Saude do Estado de Pernambuco, MICR OUTR ALT SIST N
   Wilson ME, 2016, TRAVEL MED INFECT DI, V14, P1, DOI 10.1016/j.tmaid.2016.01.010
   Wilson ME, 2014, TRAVEL MED INFECT DI, V12, P205, DOI 10.1016/j.tmaid.2014.04.001
NR 12
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2016
VL 14
IS 4
BP 384
EP 388
DI 10.1016/j.tmaid.2016.06.007
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DU5EM
UT WOS:000382235000010
PM 27363326
ER

PT J
AU Venkatraman, A
   Mukhija, D
   Kumar, N
   Nagpal, SJS
AF Venkatraman, Anand
   Mukhija, Dhruvika
   Kumar, Nilay
   Nagpal, Sajan Jiv Singh
TI Zika virus misinformation on the internet
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika; Internet; Misinformation
ID EBOLA
C1 [Venkatraman, Anand] Univ Alabama Birmingham, Dept Neurol, 401 20th St South,Unit 216, Birmingham, AL 35233 USA.
   [Mukhija, Dhruvika; Nagpal, Sajan Jiv Singh] Cleveland Clin, Dept Internal Med, Cleveland, OH 44106 USA.
   [Kumar, Nilay] Harvard Med Sch, Cambridge Hlth Alliance, Dept Internal Med, Boston, MA USA.
RP Venkatraman, A (reprint author), Univ Alabama Birmingham, Dept Neurol, 401 20th St South,Unit 216, Birmingham, AL 35233 USA.
EM anandv123@gmail.com
CR Fox S.D., 2013, MAEVE INFORM TRIAGE
   Nagpal SJS, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1251-9
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   Venkatraman A, 2015, VACCINE, V33, P1422, DOI 10.1016/j.vaccine.2015.01.078
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2016
VL 14
IS 4
BP 421
EP 422
DI 10.1016/j.tmaid.2016.05.018
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DU5EM
UT WOS:000382235000017
PM 27267799
ER

PT J
AU Lyra, PPR
   Campos, GS
   Bandeira, ID
   Sardi, SI
   Costa, LFD
   Santos, FR
   Ribeiro, CAS
   Jardim, AMB
   Santiago, ACT
   de Oliveira, PMR
   Moreira, LMO
AF Ribeiro Lyra, Priscila Pinheiro
   Campos, Gubio Soares
   Bandeira, Igor Dorea
   Sardi, Silvia Ines
   de Moura Costa, Lilian Ferreira
   Santos, Flavia Rocha
   Santos Ribeiro, Carlos Alexandre
   Barreto Jardim, Alena Maria
   Travassos Santiago, Ana Cecilia
   Ribeiro de Oliveira, Patricia Maria
   Oliveira Moreira, Licia Maria
TI Congenital Chikungunya Virus Infection after an Outbreak in Salvador,
   Bahia, Brazil
SO AJP REPORTS
LA English
DT Article
DE newborn; chikungunya; congenital; infection
ID TRANSMISSION
AB There is little information about the congenital chikungunya virus (CHIKV) transmission. We describe two cases of well-documented congenital CHIKV infection in Salvador-Brazil, where CHIKV has been identified since 2014. The outbreak in the city led to the clinical CHIKV diagnoses of both pregnant women 2 days before delivery. Urine and blood samples from the mothers and newborns were collected and tested for reverse transcription-polymerase chain reaction (PCR) analysis for Zika, dengue, and CHIKV. Both neonates and mothers had positive urine and serum PCR results for CHIKV. The newborns had significant perinatal complications and were admitted to the neonatal intensive care unit. The purpose of our case report is to show how severe congenital CHIKV infection can be and the importance to include CHIKV infection in the differential diagnosis of neonatal sepsis when mothers have clinical signs of the disease and live in an affected area.
C1 [Ribeiro Lyra, Priscila Pinheiro; Bandeira, Igor Dorea; Santos Ribeiro, Carlos Alexandre; Barreto Jardim, Alena Maria; Travassos Santiago, Ana Cecilia; Ribeiro de Oliveira, Patricia Maria; Oliveira Moreira, Licia Maria] Univ Fed Bahia, Sch Med, Climerio Oliveira Matern, Dept Pediat, Salvador, BA, Brazil.
   [Campos, Gubio Soares; Sardi, Silvia Ines; de Moura Costa, Lilian Ferreira; Santos, Flavia Rocha] Univ Fed Bahia, Hlth Sci Inst, Virol Lab, Salvador, BA, Brazil.
RP Lyra, PPR (reprint author), Univ Fed Bahia, Dept Pediat, Ave Reitor Miguel Calmon S-N, BR-40110060 Salvador, Bahia, Brazil.
EM priscilalyra@yahoo.com
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ramful D, 2014, J INFECT DIS, V209, P1726, DOI 10.1093/infdis/jit814
   Ritz N, 2015, PEDIATR INFECT DIS J, V34, P789, DOI 10.1097/INF.0000000000000716
   Vasani R, 2016, PEDIATR DERMATOL, V33, P209, DOI 10.1111/pde.12650
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
NR 11
TC 0
Z9 0
U1 0
U2 0
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 2157-6998
EI 2157-7005
J9 AJP REP
JI AJP Rep.
PD JUL
PY 2016
VL 6
IS 3
BP E299
EP E300
DI 10.1055/s-0036-1587323
PG 2
WC Pediatrics
SC Pediatrics
GA DU9IV
UT WOS:000382531200008
PM 27555980
ER

PT J
AU Panchaud, A
   Stojanov, M
   Ammerdorffer, A
   Vouga, M
   Baud, D
AF Panchaud, Alice
   Stojanov, Milos
   Ammerdorffer, Anne
   Vouga, Manon
   Baud, David
TI Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes
SO CLINICAL MICROBIOLOGY REVIEWS
LA English
DT Review
ID WEST-NILE-VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CONGENITAL
   CYTOMEGALOVIRUS-INFECTION; YELLOW-FEVER VACCINE; REAFFIRMATION
   RECOMMENDATION STATEMENT; PROSPECTIVE INSECT REPELLENT; JAPANESE
   ENCEPHALITIS-VIRUS; NORTHEASTERN UNITED-STATES; UPDATE INTERIM GUIDANCE;
   CHAIN-REACTION ANALYSIS
AB The rapid spread of the Zika virus (ZIKV) in the Americas and its potential association with thousands of suspected cases of microcephaly in Brazil and higher rates of Guillain-Barre syndrome meet the conditions for a Public Health Emergency of International Concern, as stated by the World Health Organization in February 2016. Two months later, the Centers for Disease Control and Prevention (CDC) announced that the current available evidence supports the existence of a causal relationship between prenatal Zika virus infection and microcephaly and other serious brain anomalies. Microcephaly can be caused by several factors, and its clinical course and prognosis are difficult to predict. Other pathogens with proven teratogenicity have been identified long before the current ZIKV epidemic. Despite the growing number of cases with maternal signs of infection and/or presence of ZIKV in tissues of affected newborns or fetuses, it is currently difficult to assess the magnitude of increase of microcephaly prevalence in Brazil, as well as the role of other factors in the development of congenital neurological conditions. Meanwhile, health agencies and medical organizations have issued cautious guidelines advising health care practitioners and expectant couples traveling to, returning from, or living in affected areas. Analogous to dengue virus (DENV) epidemics, ZIKV has the potential to become endemic in all countries infested by Aedes mosquitoes, while new mutations could impact viral replication in humans, leading to increased virulence and consequently heightened chances of viral transmission to additional naive mosquito vectors. Studies are urgently needed to answer the questions surrounding ZIKV and its role in congenital neurological conditions.
C1 [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Geneva, Switzerland.
   [Panchaud, Alice] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Panchaud, Alice] Univ Lausanne, Swiss Teratogen Informat Serv, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Div Clin Pharmacol, Lausanne, Switzerland.
   [Panchaud, Alice; Stojanov, Milos; Ammerdorffer, Anne; Vouga, Manon; Baud, David] Univ Lausanne Hosp, Lausanne, Switzerland.
   [Stojanov, Milos; Ammerdorffer, Anne; Vouga, Manon; Baud, David] Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.
   [Stojanov, Milos; Ammerdorffer, Anne; Vouga, Manon; Baud, David] Univ Lausanne, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
RP Baud, D (reprint author), Univ Lausanne Hosp, Lausanne, Switzerland.; Baud, D (reprint author), Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.; Baud, D (reprint author), Univ Lausanne, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
EM david.baud@chuv.ch
FU Swiss National Science Foundation (SNSF) [P3SMP3-158808/1]; SNSF
   [323530_158123, 310030_156169/1]; Department Femme-Mere-Enfant;
   Fondation Leenaards through the Bourse pour la releve academique
FX The contribution of Alice Panchaud was supported by a grant of the Swiss
   National Science Foundation (SNSF P3SMP3-158808/1). Manon Vouga is
   funded through an M.D.-Ph.D. grant from the SNSF (323530_158123). David
   Baud is supported by the Department Femme-Mere-Enfant, by the Fondation
   Leenaards through the Bourse pour la releve academique, and by the SNSF
   (310030_156169/1).
CR Aaskov J, 2007, J GEN VIROL, V88, P3334, DOI 10.1099/vir.0.83122-0
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   American Congress of Obstetricians and Gynecologists, 2016, PRACT ADV UPD INT GU
   American Congress of Obstetricians and Gynecologists, 2016, INT GUID CAR OBST PA
   American Congress of Obstetricians and Gynecologists, 2015, OBSTET GYNECOL, P1510, DOI DOI 10.1097/01.AOG.0000466430.19823.53
   Anderson JL, 2014, J CHILD NEUROL, V29, P837, DOI 10.1177/0883073813486295
   Andrews WW, 2000, AM J OBSTET GYNECOL, V183, P662, DOI 10.1067/mob.2000.106556
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Astroff AB, 1999, REPROD TOXICOL, V13, P223, DOI 10.1016/S0890-6238(99)00008-8
   Astroff AB, 2000, TERATOLOGY, V61, P222, DOI 10.1002/(SICI)1096-9926(200003)61:3<222::AID-TERA10>3.0.CO;2-M
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Banu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16105
   Barr DB, 2010, SCI TOTAL ENVIRON, V408, P790, DOI 10.1016/j.scitotenv.2009.10.007
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barton LL, 2001, CLIN INFECT DIS, V33, P370, DOI 10.1086/321897
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Baud D, 2015, New Microbes New Infect, V3, P41, DOI 10.1016/j.nmni.2014.11.004
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Bayer A, 2016, CELL HOST MICROBE
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Benoist G, 2013, FETAL DIAGN THER, V33, P203, DOI 10.1159/000342752
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Beral L, 2008, OPHTHALMOLOGY, V115, P1524
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biesbroeck L, 2013, DERMATOL THER, V26, P433, DOI 10.1111/dth.12107
   Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009
   Bocanegra C, 2016, CLIN MICROBIOL INFEC
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   Bonthius DJ, 2007, PLOS PATHOG, V3, P1541, DOI 10.1371/journal.ppat.0030149
   Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227
   Boussemart T, 2001, J Perinatol, V21, P255, DOI 10.1038/sj.jp.7200530
   Bouthry E, 2014, PRENATAL DIAG, V34, P1246, DOI 10.1002/pd.4467
   Bowen V, 2015, MMWR-MORBID MORTAL W, V64, P1241, DOI 10.15585/mmwr.mm6444a3
   Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brazil Ministry of Health, 2015, MIN HLTH REL EP B
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   BURNS KF, 1950, P SOC EXP BIOL MED, V75, P621
   Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   Callaghan WM, 2015, OBSTET GYNECOL, V126, P486, DOI 10.1097/AOG.0000000000000996
   Calonge N, 2009, ANN INTERN MED, V150, P705
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Canada Society of Obstetricians and Gynecologists, 2016, SOGC REC ZIKA VIR EX
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caragata EP, 2015, TRENDS PARASITOL, V32, P207
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcanti DP, 2007, TROP MED INT HEALTH, V12, P833, DOI 10.1111/j.1365-3156.2007.01851.x
   Centers for Disease Control and Prevention, 2016, TRANSCR CDC TEL ZIK
   Centers for Disease Control Prevention, 2015, INS REP US SAF
   Centers for Disease Control Prevention, 2016, LYMPH CHOR LCM
   Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P1135
   Centers for Disease Control Prevention, 2015, CONTR EFF AR BIRTH C
   Centers for Disease Control Prevention, 2002, MMWR-MORBID MORTAL W, V51, P877
   Centers for Disease Control Prevention, 2016, AV BUG BIT
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712
   Chretien JP, 2015, PLOS CURR
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   Cire Antilles Guyane, 2016, EM VIR ZIK ANT GUYAN
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   College National des Gynecologues et Obstetriciens Francais, 2016, VIR ZIK FEMM ENC AG
   Conseil National Professionnel de Gynecologie et Obstetrique, 2016, VIR ZIKA FEMM ENC AG
   Cordoba L, 2007, J GEN VIROL, V88, P476, DOI 10.1099/vir.0.82439-0
   Cortina-Borja M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000351
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   Crans WJ, 2004, J VECTOR ECOL, V29, P1
   Centre de Reference sur les Agents Teratogenes, 2016, REP GROSS ALL
   Carneiro SCD, 2007, CLIN DERMATOL, V25, P212, DOI 10.1016/j.clindermatol.2006.05.009
   Ministry of Health of Jamaica, 2016, NOT MIN HLTH H DALL
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deloison B, 2012, PRENATAL DIAG, V32, P869, DOI 10.1002/pd.3923
   Department of Health of Australia, 2016, ZIK VIR INF CLIN PUB
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Direction de la Sante Centre d'hygiene et de salubrite publique, 2015, NOT INV AUT MALF CER
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   D'Ortenzio E, 2016, N ENGL J MED
   Driggers R. W., 2016, NEW ENGL J MED, DOI DOI 10.1056/NEJMOA1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dugas J, 2010, OCCUP ENVIRON MED, V67, P196, DOI 10.1136/oem.2009.047373
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dyer O., 2016, BMJ-BRIT MED J, V352, pi630
   Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   Ergaz Z, 2006, REPROD TOXICOL, V21, P421, DOI 10.1016/j.reprotox.2005.01.006
   European Centre for Disease Prevention and Control, 2016, UPD RAP RISK ASS ZIK
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   EUROCAT, 2016, CAS PREV PER 10000 B
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FDA Center for Biologics Evaluation and Research, 2016, REC DON SCREEN DEF P
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Ferreira MC, 2014, GEOSPATIAL HEALTH, V9, P141, DOI 10.4081/gh.2014.12
   Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416
   FIUMARA N J, 1975, Clinical Obstetrics and Gynecology, V18, P183, DOI 10.1097/00003081-197503000-00016
   FIUMARA NJ, 1970, ARCH DERMATOL, V102, P78, DOI 10.1001/archderm.102.1.78
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foulon W, 1999, AM J OBSTET GYNECOL, V180, P410, DOI 10.1016/S0002-9378(99)70224-3
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18
   Freeman K, 2005, BJOG-INT J OBSTET GY, V112, P31, DOI 10.1111/j.1471-0528.2004.00299.x
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031
   Gambotto M, 2011, FETOLOGY DIAGNOSIS M
   Garcez PP, 2016, SCIENCE
   Gay-Andrieu F, 2003, PRENATAL DIAG, V23, P558, DOI 10.1002/pd.632
   Gaytant MA, 2003, EUR J PEDIATR, V162, P248, DOI 10.1007/s00431-002-1115-3
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gilbert R, 2003, BJOG-INT J OBSTET GY, V110, P112
   Gilbert RE, 2002, J MED SCREEN, V9, P135, DOI 10.1136/jms.9.3.135
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Gostin LO, 2016, JAMA-J AM MED ASSOC, V315, P1451, DOI 10.1001/jama.2016.1964
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Government of Canada, 2016, CAN REC PREC TREATM
   Government of the Commonwealth of Dominica, 2016, ZIK VIR THREAT DOM
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Gubler DJ, 2001, ANN NY ACAD SCI, V951, P13
   Guerra B, 2007, AM J OBSTET GYNECOL, V196, P221, DOI 10.1016/j.ajog.2006.08.039
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I1322
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Haute Autorite de Sante, 2009, SURV SER PREV TOX RU
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heffernan C, 2015, LANCET INFECT DIS, V15, P143, DOI 10.1016/S1473-3099(14)71077-1
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hindiyeh M, 2001, EMERG INFECT DIS, V7, P748
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hodge JG, 2016, DISASTER MED PUBLIC, V34, P1
   Hohlfeld P, 2012, LIVRE INTERNE OBSTET
   HOHLFELD P, 1991, ULTRASOUND OBST GYN, V1, P241, DOI 10.1046/j.1469-0705.1991.01040241.x
   Hollier LM, 2001, OBSTET GYNECOL, V97, P947, DOI 10.1016/S0029-7844(01)01367-9
   Horton MK, 2011, PEDIATRICS, V127, pE699, DOI 10.1542/peds.2010-0133
   Huang XH, 2014, SCI WORLD J, DOI 10.1155/2014/954849
   Hutton J, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.046
   Instituto Fernandes Figueira da Fiocruz and Centro de Referencia da Rede de Banco de Leite Humano, 2015, COM INF
   Instituto Nacional de Salud Colombia, 2016, B EP SEM
   International Committee on Taxonomy of Viruses, 2015, VIR TAX 2014 REL
   Jacquemard F, 2007, BJOG-INT J OBSTET GY, V114, P1113, DOI 10.1111/j.1471-0528.2007.01308.x
   Jampol LM, 2016, JAMA OPHTHALMOL
   Jin J, 2016, JAMA
   Jones JL, 2012, CLIN INFECT DIS, V55, P845, DOI 10.1093/cid/cis508
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Khairallah M, 2013, CURR OPIN OPHTHALMOL, V24, P574, DOI 10.1097/ICU.0b013e3283654e09
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   KOMROWER GM, 1955, LANCET, V1, P697
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Latin American Colaborative Study of Congenital Malformations, 2015, ECLAMC FIN DOC
   Lazear HM, 2016, CELL HOST MICROBE
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Leibovitz Z, 2015, ULTRASOUND OBSTET GY
   Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740
   Lim WK, 2004, OPHTHALMOLOGY, V111, P2057, DOI 10.1016/j.ophtha.2004.03.038
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   MacNeil A, 2012, EMERG INFECT DIS, V18, P1256, DOI 10.3201/eid1808.120212
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Mandelbrot L, 2012, PRENATAL DIAG, V32, P511, DOI 10.1002/pd.3843
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MATHUR A, 1981, INFECT IMMUN, V34, P26
   Mayor S., 2016, BMJ-BRIT MED J, V352, pi1362, DOI [10.1136/bmj.i1362., DOI 10.1136/BMJ]
   Mbizvo MT, 2014, BEST PRACT RES CL OB, V28, P931, DOI 10.1016/j.bpobgyn.2014.04.014
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I1813
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I786
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   McGee CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023247
   McGready R, 2001, T ROY SOC TROP MED H, V95, P137, DOI 10.1016/S0035-9203(01)90137-3
   McGready R, 2001, AM J TROP MED HYG, V65, P285
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mehta Vandana, 2008, Dermatol Online J, V14, P8
   Meritet JF, 2009, PRENATAL DIAG, V29, P626, DOI 10.1002/pd.2240
   Meroni V, 2009, CLIN VACCINE IMMUNOL, V16, P1517, DOI 10.1128/CVI.00253-09
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Ministere Francais des affaires sociales de la sante et des droit des femmes, 2016, VIR ZIK DEB EP MART
   Ministry of Health State of Israel, 2015, REC PERS TRAV ABR VI
   Ministry of Health of Mexico, 2016, ZIK VIR RIS GLOB HEA
   Ministry of health of New Zealand, 2016, ZIK VIR
   Ministry of Health of Samoa, 2016, SIT REP ZIK VIR
   Ministry of Health of Singapore, 2016, ZIK VIR
   Ministere de la Sante Publique et de la Population de Haiti, 2016, FICH INF VIR ZIK
   Miranda-Filho DDB, 2016, INITIAL DESCRIPTION
   Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003
   Monaghan AJ, 2016, PLOS CURR
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Mosti M, 2013, EPIDEMIOL INFECT, V141, P2192, DOI 10.1017/S0950268812002841
   MotherToBaby: a service of the Organization of Teratology Information Specialists, 2016, ZIK VIR PREGN ANSW
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, LANCET INFECT DIS
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Mytton OT, 2007, BJOG-INT J OBSTET GY, V114, P582, DOI 10.1111/j.1471-0528.2007.01290.x
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Oliveira RR, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0141852
   Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Paisley JE, 2006, PEDIATRICS, V117, P814, DOI 10.1542/peds.2005-1187
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0377
   Patz JA, 2001, TRENDS IMMUNOL, V22, P171, DOI 10.1016/S1471-4906(01)01867-1
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Peterman T., 2008, Morbidity and Mortality Weekly Report, V57, P872
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Platt KB, 2004, 02118 NAT PORK BOARD
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378
   Porat S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0204-7
   Public Health Agency of Canada, 2016, ZIK VIR INF AM
   Public Health England, 2016, GUID VIR RASH PREGN
   Public Health England, 2016, NHS INF DIS PREGN SC
   Pulla P, WIRE
   Rac MW, 2014, AM J OBSTET GYNECOL, V211, P426
   Ramful D, 2014, J INFECT DIS, V209, P1726, DOI 10.1093/infdis/jit814
   Rashid U, 2015, JCPSP-J COLL PHYSICI, V25, pS137
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002
   Rios A, 1996, Pediatr Rev, V17, P386
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Robert E, 1999, VACCINE, V17, P283, DOI 10.1016/S0264-410X(98)00051-6
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rodriguez SD, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev125
   Ross SA, 2014, J INFECT DIS, V210, P1415, DOI 10.1093/infdis/jiu263
   Rossi S.L., 2016, AM J TROP MED HYG
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roth-Harer A, 2001, ENVIRON TOXICOL PHAR, V9, P103, DOI 10.1016/S1382-6689(00)00069-7
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Royal College of Obstetricians and Gynaecologists, 2016, INT CLIN GUID ZIK VI
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Rudin C, 2008, SWISS MED WKLY, V138, P1
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sauerbrei A, 2007, MED MICROBIOL IMMUN, V196, P89, DOI 10.1007/s00430-006-0031-0
   Sauerbrei A, 2000, J Perinatol, V20, P548, DOI 10.1038/sj.jp.7200457
   SCHEFFER IE, 1991, DEV MED CHILD NEUROL, V33, P916
   SCHOENIG GP, 1994, FUND APPL TOXICOL, V23, P63, DOI 10.1006/faat.1994.1079
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SEVER JL, 1988, PEDIATRICS, V82, P181
   Shimizu T, 1954, JAP J EXP MED, V24, P363
   Simon-Loriere E, 2011, RNA BIOL, V8, P280, DOI 10.4161/rna.8.2.15193
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sint Maarten Ministry of Public Health Social Development and Labour, 2016, MULT GROUP MEETS PRE
   SKINNER HH, 1976, J HYG-CAMBRIDGE, V76, P299
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1
   TABOR A, 1986, LANCET, V1, P1287
   Tan MP, 2006, REPROD TOXICOL, V21, P410, DOI 10.1016/j.reprotox.2005.04.011
   Tappe D, 2014, EURO SURVEILL, V19
   Teratology Information Service UK, 2014, CHEM INS REP
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   THAITHUMYANON P, 1994, CLIN INFECT DIS, V18, P248
   Thalib L, 2005, BJOG-INT J OBSTET GY, V112, P567, DOI 10.1111/j.1471-0528.2005.00486.x
   Thiebaut R, 2007, LANCET, V369, P115
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   TSAI TF, 1993, J INFECT DIS, V168, P1520
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P29, DOI 10.2807/1560-7917.ES.2016.21.10.30163
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Ville Y, 2014, CURR OPIN INFECT DIS, V27, P251, DOI [10.1097/QCO.0000000000000066, 10.1097/QCO.0000000000000064]
   Villena I, 2003, PRENATAL DIAG, V23, P1098, DOI 10.1002/pd.754
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2013, J VIROL, V87, P9365, DOI 10.1128/JVI.00567-13
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Walker DG, 2002, LANCET INFECT DIS, V2, P432, DOI 10.1016/S1473-3099(02)00319-5
   Watemberg N, 2002, J CHILD NEUROL, V17, P117
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WELLER TH, 1957, P SOC EXP BIOL MED, V94, P4
   Werner H, 2016, ULTRASOUND OBST GYN, V47, P657, DOI 10.1002/uog.15901
   World Health Organization, 2016, ZIK VIR INF
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   World Health Organization, 2016, IHR PROC PUBL HLTH E
   World Health Organization, 2015, ZIK VIR OUTBR AM
   WHO, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, ZIK VIR
   World Health Organization-Pan American Health Organisation, 2016, PREL GUID SURV MICR
   World Health Organization-Pan American Health Organisation, 2016, DOC HLTH CAR PROF
   World Health Organization-Pan American Health Organisation, 2015, NEUR SYNDR CONG MALF
   Wickerham EL, 2012, ENVIRON INT, V47, P80, DOI 10.1016/j.envint.2012.06.007
   Wilcken B, 2015, J PAEDIATR CHILD H, V51, P103, DOI 10.1111/jpc.12817
   Wilson AL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-446
   Wolff T, 2009, ANN INTERN MED, V150, P710
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yamada M, 2004, VET PATHOL, V41, P62, DOI 10.1354/vp.41-1-62
   Yamamoto AY, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.018
   Yinon Y, 2010, OBSTET GYNECOL SURV, V65, P736, DOI 10.1097/OGX.0b013e31821102b4
   Yoon JK, 2015, J PARASITOL RES, V2015
   Youn S, 2010, J VIROL, V84, P9516, DOI 10.1128/JVI.00775-10
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zimmerman JJ, 2012, DIS SWINE
   [Anonymous], 2016, NATURE, V530, P5
NR 348
TC 2
Z9 2
U1 11
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0893-8512
EI 1098-6618
J9 CLIN MICROBIOL REV
JI Clin. Microbiol. Rev.
PD JUL
PY 2016
VL 29
IS 3
BP 659
EP 694
DI 10.1128/CMR.00014-16
PG 36
WC Microbiology
SC Microbiology
GA DU7MH
UT WOS:000382397800004
PM 27281741
ER

PT J
AU Bocanegra, C
   Sulleiro, E
   Soriano-Arandes, A
   Pou, D
   Suy, A
   Llurba, E
   Rodo, C
   Espasa, M
   Campins, M
   Martin, A
   Rodrigo, C
   Vazquez, A
   De Ory, F
   Sanchez-Seco, MP
   Pumarola, T
   Carreras, E
   Molina, I
AF Bocanegra, C.
   Sulleiro, E.
   Soriano-Arandes, A.
   Pou, D.
   Suy, A.
   Llurba, E.
   Rodo, C.
   Espasa, M.
   Campins, M.
   Martin, A.
   Rodrigo, C.
   Vazquez, A.
   De Ory, F.
   Sanchez-Seco, M. P.
   Pumarola, T.
   Carreras, E.
   Molina, I.
TI Zika virus infection in pregnant women in Barcelona, Spain
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Bocanegra, C.; Pou, D.] PROSICS Barcelona, Trop Med & Int Hlth Unit, Vall dHebron Drassanes, Barcelona, Spain.
   [Sulleiro, E.; Espasa, M.] PROSICS Barcelona, Dept Microbiol, Univ Hosp Vall dHebron, Barcelona, Spain.
   [Soriano-Arandes, A.] PROSICS Barcelona, Dept Pediat, Trop Med & Int Hlth Unit, Vall dHebron Drassanes, Barcelona, Spain.
   [Suy, A.; Llurba, E.; Rodo, C.; Carreras, E.] Univ Hosp Vall dHebron, Dept Gynecol & Obstet, Barcelona, Spain.
   [Campins, M.] Vall dHebron Univ Hosp, Prevent Med & Epidemiol Dept, Barcelona, Spain.
   [Martin, A.; Rodrigo, C.] Vall dHebron Univ Hosp, Dept Pediat, Barcelona, Spain.
   [Vazquez, A.; De Ory, F.; Sanchez-Seco, M. P.] Inst Salud Carlos III, Natl Microbiol Ctr, Madrid, Spain.
   [Pumarola, T.] Vall dHebron Univ Hosp, Dept Microbiol, Barcelona, Spain.
   [Molina, I.] PROSICS Barcelona, Vall dHebron Univ Hosp, Dept Infect Dis, Barcelona, Spain.
RP Bocanegra, C (reprint author), PROSICS Barcelona, Trop Med & Int Hlth Unit, Vall dHebron Drassanes, Barcelona, Spain.
EM cristinabocanegra@gmail.com
RI Carreras, Elena/N-7698-2016
OI Carreras, Elena/0000-0003-3471-7248
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
NR 4
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUL
PY 2016
VL 21
IS 7
BP 648
EP 650
DI 10.1016/j.cmi.2016.03.025
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DU5SS
UT WOS:000382272200013
PM 27063354
ER

PT J
AU Miller, A
   Yeskey, K
   Garantziotis, S
   Arnesen, S
   Bennett, A
   O'Fallon, L
   Thompson, C
   Reinlib, L
   Masten, S
   Remington, J
   Love, C
   Ramsey, S
   Rosselli, R
   Galluzzo, B
   Lee, J
   Kwok, R
   Hughes, J
AF Miller, Aubrey
   Yeskey, Kevin
   Garantziotis, Stavros
   Arnesen, Stacey
   Bennett, April
   O'Fallon, Liam
   Thompson, Claudia
   Reinlib, Les
   Masten, Scott
   Remington, James
   Love, Cindy
   Ramsey, Steve
   Rosselli, Richard
   Galluzzo, Betsy
   Lee, Joy
   Kwok, Richard
   Hughes, Joseph
TI Integrating Health Research into Disaster Response: The New NIH Disaster
   Research Response Program
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Editorial Material
DE disasters; disaster research; disaster epidemiology; environmental
   health; science preparedness; disaster risk reduction; strategic science
ID COMMUNITY; EPIDEMIOLOGY; TOOL
AB The need for high quality and timely disaster research has been a topic of great discussion over the past several years. Recent high profile incidents have exposed gaps in knowledge about the health impacts of disasters or the benefits of specific interventions-such was the case with the 2010 Gulf Oil Spill and recent events associated with lead-contaminated drinking water in Flint, Michigan, and the evolving health crisis related to Zika virus disease. Our inability to perform timely research to inform the community about health and safety risks or address specific concerns further heightens anxiety and distrust. Since nearly all disasters, whether natural or man-made, have an environmental health component, it is critical that specialized research tools and trained researchers be readily available to evaluate complex exposures and health effects, especially for vulnerable sub-populations such as the elderly, children, pregnant women, and those with socioeconomic and environmental disparities. In response, the National Institute of Environmental Health Science has initiated a Disaster Research Response Program to create new tools, protocols, networks of researchers, training exercises, and outreach involving diverse groups of stakeholders to help overcome the challenges of disaster research and to improve our ability to collect vital information to reduce the adverse health impacts and improve future preparedness.
C1 [Miller, Aubrey; Bennett, April] NIEHS, Bethesda, MD 20892 USA.
   [Yeskey, Kevin; Galluzzo, Betsy; Lee, Joy] MDB Inc, Washington, DC 20036 USA.
   [Garantziotis, Stavros; O'Fallon, Liam; Thompson, Claudia; Reinlib, Les; Masten, Scott; Remington, James; Kwok, Richard; Hughes, Joseph] NIEHS, Res Triangle Pk, NC 27709 USA.
   [Arnesen, Stacey; Love, Cindy] Natl Lib Med, Bethesda, MD 20892 USA.
   [Ramsey, Steve; Rosselli, Richard] Social & Sci Syst Inc, Durham, NC 27703 USA.
RP Miller, A (reprint author), NIEHS, Bethesda, MD 20892 USA.
EM miller.aubrey@nih.gov; kyeskey@michaeldbaker.com;
   garantziotis@niehs.nih.gov; arneses@mail.nlm.nih.gov;
   april.bennett@nih.gov; ofallon@niehs.nih.gov; thompso1@niehs.nih.gov;
   reinlib@niehs.nih.gov; masten@niehs.nih.gov; remingtonj@niehs.nih.gov;
   lovec@mail.nlm.nih.gov; SRamsey@s-3.com; RRosselli@s-3.com;
   beagin@michaeldbaker.com; jlee@michaeldbaker.com; Richard.Kwok@nih.gov;
   hughes3@niehs.nih.gov
CR Abara W, 2014, INT J ENV RES PUB HE, V11, P5684, DOI 10.3390/ijerph110605684
   Decker John A, 2013, Am J Disaster Med, V8, P25, DOI 10.5055/ajdm.2013.0108
   Institute of Medicine, 2014, EN RAP SUST PUBL HLT
   LECHAT MF, 1976, P ROY SOC MED, V69, P421
   Lurie N, 2013, NEW ENGL J MED, V368, P1251, DOI 10.1056/NEJMsb1209510
   Malilay J, 2014, AM J PUBLIC HEALTH, V104, P2092, DOI 10.2105/AJPH.2014.302010
   McNutt M, 2015, SCIENCE, V348, P11, DOI 10.1126/science.aab2091
   National Biodefense Science Board, 2011, CALL ACT INCL SCI IN
   National Institute of Environmental Health Sciences (NIEHS), MECH TIM SENS RES OP
   O'Fallon LR, 2002, ENVIRON HEALTH PERSP, V110, P155
   Schoch-Spana M, 2007, BIOSECUR BIOTERROR, V5, P8, DOI 10.1089/bsp.2006.0036
   US Department of Homeland Security, 2011, NAT DIS REC FRAM
   US Department of Homeland Security, 2016, NAT RESP FRAM
   Yeskey K., 2015, J DISASTER MED PUBLI, V9, P444
NR 14
TC 0
Z9 0
U1 10
U2 10
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2016
VL 13
IS 7
AR 676
DI 10.3390/ijerph13070676
PG 12
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DS4OG
UT WOS:000380759800052
ER

PT J
AU Eickmann, SH
   Carvalho, MDCG
   Ramos, RCF
   Rocha, MAW
   van der Linden, V
   da Silva, PFS
AF Eickmann, Sophie Helena
   Costa Gomes Carvalho, Maria Durce
   Ferreira Ramos, Regina Coeli
   Wanderley Rocha, Maria Angela
   van der Linden, Vanessa
   Sobral da Silva, Paula Fabiana
TI Zika virus congenital syndrome
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
ID INFECTION
C1 [Eickmann, Sophie Helena] Univ Fed Pernambuco, Ctr Ciencias Saude, Recife, PE, Brazil.
   [Costa Gomes Carvalho, Maria Durce; Ferreira Ramos, Regina Coeli; Wanderley Rocha, Maria Angela; Sobral da Silva, Paula Fabiana] Univ Pernambuco, Recife, PE, Brazil.
   [van der Linden, Vanessa] Hosp Barao Lucena, Recife, PE, Brazil.
RP Eickmann, SH (reprint author), Univ Fed Pernambuco, Ctr Ciencias Saude, Dept Materno Infantil, Av Prof Morais Rego S-N, BR-50670420 Recife, PE, Brazil.
EM sophie.eickmann@gmail.com
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680
   Miranda-Filho DB, 2016, AM J PUBLIC HEALTH, V4, P598
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Tang H, 2016, CELL STEM CELL, V18, P1
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   World Health Organization, 2016, WHOZIKVMOC163
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
NR 13
TC 0
Z9 0
U1 3
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JUL
PY 2016
VL 32
IS 7
AR e00047716
DI 10.1590/0102-311X00047716
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS5IT
UT WOS:000380815700007
ER

PT J
AU Paul, RE
AF Paul, Richard E.
TI The When and the Where of Zika Epidemic Potential in Europe - An
   Evidence Base for Public Health Preparedness
SO EBIOMEDICINE
LA English
DT Editorial Material
DE Zika; Flavivirus; Aedes; Mosquitoes
ID VIRUS
C1 [Paul, Richard E.] Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France.
RP Paul, RE (reprint author), Inst Pasteur, Funct Genet Infect Dis Unit, Paris, France.
CR Alves MJ, 2013, EUROSURVEILLANCE, V18, P2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau V. M., 2016, LANCET, V387
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP PREP
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 10
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUL
PY 2016
VL 9
BP 17
EP 18
DI 10.1016/j.ebiom.2016.06.020
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT6VL
UT WOS:000381622500009
PM 27333025
ER

PT J
AU Rocklov, J
   Quam, MB
   Sudre, B
   German, M
   Kraemer, MUG
   Brady, O
   Bogoch, II
   Liu-Helmersson, J
   Wilder-Smith, A
   Semenza, JC
   Ong, M
   Aaslav, KK
   Khan, K
AF Rocklov, Joacim
   Quam, Mikkel Brandon
   Sudre, Bertrand
   German, Matthew
   Kraemer, Moritz U. G.
   Brady, Oliver
   Bogoch, Isaac I.
   Liu-Helmersson, Jing
   Wilder-Smith, Annelies
   Semenza, Jan C.
   Ong, Mark
   Aaslav, Kaja Kaasik
   Khan, Kamran
TI Assessing Seasonal Risks for the Introduction and Mosquito-borne Spread
   of Zika Virus in Europe
SO EBIOMEDICINE
LA English
DT Article
DE ZIKV; Zika; Air travel; Globalization, mosquito; Climate; Aedes
ID UPDATE INTERIM GUIDANCE; AEDES-ALBOPICTUS; DENGUE VIRUS; UNITED-STATES;
   TRANSMISSION; AEGYPTI; SUSCEPTIBILITY; SINGAPORE; VECTOR; TEXAS
AB The explosive Zika virus epidemic in the Americas is amplifying spread of this emerging pathogen into previously unaffected regions of the world, including Europe (Gulland, 2016), where local populations are immunologically naive. As summertime approaches in the northern hemisphere, Aedes mosquitoes in Europe may find suitable climatic conditions to acquire and subsequently transmit Zika virus from viremic travellers to local populations. While Aedes albopictus has proven to be a vector for the transmission of dengue and chikungunya viruses in Europe (Delisle et al., 2015; ECDC, n.d.) there is growing experimental and ecological evidence to suggest that it may also be competent for Zika virus(Chouin-Carneiro et al., 2016; Grard et al., 2014; Li et al., 2012; Wong et al., 2013). Here we analyze and overlay the monthly flows of airline travellers arriving into European cities from Zika affected areas across the Americas, the predicted monthly estimates of the basic reproduction number of Zika virus in areas where Aedes mosquito populations reside in Europe (Aedes aegypti in Madeira, Portugal and Ae. albopictus in continental Europe), and human populations living within areas where mosquito-borne transmission of Zika virus may be possible. We highlight specific geographic areas and timing of risk for Zika virus introduction and possible spread within Europe to inform the efficient use of human disease surveillance, vector surveillance and control, and public education resources. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Rocklov, Joacim; Quam, Mikkel Brandon; Liu-Helmersson, Jing; Wilder-Smith, Annelies] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, S-90187 Umea, Sweden.
   [Sudre, Bertrand; Semenza, Jan C.; Aaslav, Kaja Kaasik] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden.
   [German, Matthew; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England.
   [Brady, Oliver] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Bogoch, Isaac I.] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Ong, Mark] Univ Waterloo, Geomat Program, Waterloo, ON, Canada.
RP Rocklov, J (reprint author), Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, S-90187 Umea, Sweden.
EM joacim.rocklov@umu.se
CR Anderson R.M., 1991, INFECT DIS HUMANS DY
   Angelini R., 2007, EURO SURVEILL, V12
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bellini R, 1996, J AM MOSQUITO CONTR, V12, P632
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET
   Chouin-Carneiro T., 2016, PLOS NEGL TROP DIS, V10
   Christofferson R. C., 2016, AM J TROP MED HYG
   Clark GG, 2008, AM J TROP MED HYG, V78, P361
   Delisle E, 2015, EURO SURVEILL, V20
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Dobson J. E., 2000, PHOTOGRAMM ENG REMOT, V66, P9
   [Anonymous], 2016, MOSQ MAPS
   ECDC, AED ALB
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP PREP
   Faria NR, 2016, SCIENCE
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funk S., 2016, BIORXIV
   Gil JF, 2016, ACTA TROP, V158, P24, DOI 10.1016/j.actatropica.2016.02.003
   Grard G., 2014, PLOS NEGL TROP DIS, V8
   Gulland A., 2016, BMJ-BRIT MED J, V352, pi753
   Guzzetta G., 2016, EURO SURVEILL, V21
   [Anonymous], 2008, J GEOPHYS RES-ATMOS, DOI DOI 10.1029/2008JD010100
   Jupille H, 2016, BIORXIV
   Kraemer M. U., 2015, ELIFE, V4
   Kucharski A. J., 2016, PLOS NEGL TROP DIS, V10
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lessler J. T., 2016, B WHO, V9, P250
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Majumder M. S., 2016, B WHO UNPUB
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maria A. T., 2016, EURO SURVEILL, V21
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen L. R., 2016, N ENGL J MED
   Promed, 2015, ZIKA VIR BRAZIL CONF
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Wallinga J. L. M., 2007, P R SOC B, V274
   WHO, 2016, ZIK VIR TECHN REP IN
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 52
TC 1
Z9 1
U1 8
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUL
PY 2016
VL 9
BP 250
EP 256
DI 10.1016/j.ebiom.2016.06.009
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT6VL
UT WOS:000381622500036
PM 27344225
ER

PT J
AU Engel, J
AF Engel, Jeffrey
TI Of Mosquito Nets and Condoms: The Zika Virus Challenge
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Editorial Material
ID UNITED-STATES; TRANSMISSION; DENGUE
C1 [Engel, Jeffrey] Council State & Terr Epidemiologists, 2872 Woodcock Blvd,Ste 250, Atlanta, GA 30341 USA.
RP Engel, J (reprint author), Council State & Terr Epidemiologists, 2872 Woodcock Blvd,Ste 250, Atlanta, GA 30341 USA.
EM jengel@cste.org
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
NR 9
TC 0
Z9 0
U1 11
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD JUL-AUG
PY 2016
VL 22
IS 4
BP 323
EP 325
DI 10.1097/PHH.0000000000000431
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS5PA
UT WOS:000380833100005
PM 27223311
ER

PT J
AU Allen, M
   Blumenstock, JS
AF Allen, Meredith
   Blumenstock, James S.
TI State of Public Health Public Health Acts to Detect, Respond to, and
   Prevent the Latest Public Health Threat-Zika Virus Disease
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Editorial Material
C1 [Allen, Meredith; Blumenstock, James S.] Assoc State & Terr Hlth Officials, 2231 Crystal Dr,Ste 450, Arlington, VA 22202 USA.
RP Blumenstock, JS (reprint author), Assoc State & Terr Hlth Officials, 2231 Crystal Dr,Ste 450, Arlington, VA 22202 USA.
EM jblumenstock@astho.org
CR Hadler JL, 2014, MMWR-MORBID MORTAL W, V63, P281
NR 1
TC 0
Z9 0
U1 8
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD JUL-AUG
PY 2016
VL 22
IS 4
BP 424
EP 426
DI 10.1097/PHH.0000000000000432
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DS5PA
UT WOS:000380833100020
PM 27223315
ER

PT J
AU Anderson, MR
   Kashanchi, F
   Jacobson, S
AF Anderson, Monique R.
   Kashanchi, Fatah
   Jacobson, Steven
TI Exosomes in Viral Disease
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Exosomes; microvesicles; multivesicular bodies; "back fusion"; ESCRT
ID CELL-DERIVED EXOSOMES; MATURE DENDRITIC CELLS; STRUCTURES L-PARTICLES;
   HEPATITIS-C VIRUS; EXTRACELLULAR VESICLES; T-CELLS; SECRETE EXOSOMES;
   EBOLA-VIRUS; DC-SIGN; PHOSPHATIDYLSERINE RECEPTOR
AB Viruses have evolved many mechanisms by which to evade and subvert the immune system to ensure survival and persistence. However, for each method undertaken by the immune system for pathogen removal, there is a counteracting mechanism utilized by pathogens. The new and emerging role of microvesicles in immune intercellular communication and function is no different. Viruses across many different families have evolved to insert viral components in exosomes, a subtype of microvesicle, with many varying downstream effects. When assessed cumulatively, viral antigens in exosomes increase persistence through cloaking viral genomes, decoying the immune system, and even by increasing viral infection in uninfected cells. Exosomes therefore represent a source of viral antigen that can be used as a biomarker for disease and targeted for therapy in the control and eradication of these disorders. With the rise in the persistence of new and reemerging viruses like Ebola and Zika, exploring the role of exosomes become more important than ever.
C1 [Anderson, Monique R.; Jacobson, Steven] NINDS, NIH, Neuroimmunol Branch, Viral Immunol Sect, Bethesda, MD 20892 USA.
   [Anderson, Monique R.] Univ Virginia, Sch Med, Dept Pathol, Mol & Cellular Basis Dis Grad Program, Charlottesville, VA 22903 USA.
   [Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Mol Virol Lab, Manassas, VA 20110 USA.
RP Anderson, MR (reprint author), NINDS, NIH, Neuroimmunol Branch, Viral Immunol Sect, Bethesda, MD 20892 USA.; Anderson, MR (reprint author), Univ Virginia, Sch Med, Dept Pathol, Mol & Cellular Basis Dis Grad Program, Charlottesville, VA 22903 USA.
EM andersonmr2@mail.nih.gov
CR Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615
   Ahsan Noor A, 2016, Front Microbiol, V7, P139, DOI 10.3389/fmicb.2016.00139
   Alefantis T, 2005, J BIOMED SCI, V12, P961, DOI 10.1007/s11373-005-9026-x
   Alefantis T, 2005, J BIOL CHEM, V280, P17353, DOI 10.1074/jbc.M409851200
   Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862
   Ali SA, 2010, AIDS RES HUM RETROV, V26, P173, DOI 10.1089/aid.2009.0068
   Ansari MA, 2013, J VIROL, V87, P8606, DOI 10.1128/JVI.00805-13
   Arenaccio C, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0216-y
   Arenaccio C, 2014, J VIROL, V88, P11529, DOI 10.1128/JVI.01712-14
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baglio SR, 2016, P NATL ACAD SCI USA, V113, pE587, DOI 10.1073/pnas.1518130113
   Basso M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00127
   Bello-Morales R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-265
   Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009
   Blanchard N, 2002, J IMMUNOL, V168, P3235
   Boukouris S, 2015, PROTEOM CLIN APPL, V9, P358, DOI 10.1002/prca.201400114
   Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10
   Campbell PE, 2012, J MOL MODEL, V18, P4603, DOI 10.1007/s00894-012-1452-x
   Campbell Tamika D, 2008, Ethn Dis, V18, pS2
   Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770
   Chai N, 2008, J VIROL, V82, P7812, DOI 10.1128/JVI.00561-08
   Chugh PE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003484
   Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326
   Comelli L, 2014, MOL BIOSYST, V10, P1146, DOI 10.1039/c3mb70544g
   Cowan EP, 1997, J VIROL, V71, P6982
   Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406
   de Carvalho JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113691
   DHIBJALBUT S, 1994, ANN NEUROL, V36, P787, DOI 10.1002/ana.410360516
   Dukers DF, 2000, J IMMUNOL, V165, P663
   EL Andaloussi S, 2013, ADV DRUG DELIVER REV, V65, P391, DOI 10.1016/j.addr.2012.08.008
   Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121
   Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003
   Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x
   Feng ZD, 2015, J CLIN INVEST, V125, P169, DOI 10.1172/JCI77527
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Flanagan J, 2003, J GEN VIROL, V84, P1871, DOI 10.1099/vir.0.18944-0
   Fraile-Ramos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015318
   Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.183143100
   Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han ZY, 2015, J INFECT DIS, V212, pS138, DOI 10.1093/infdis/jiu838
   Heilingloh CS, 2015, J VIROL, V89, P11046, DOI 10.1128/JVI.01517-15
   Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712
   Irish BP, 2009, AM J INFECT DIS, V5, P231, DOI DOI 10.3844/AJIDSP.2009.231.258
   Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740
   Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778
   Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659
   JOHNSTONE RM, 1989, BLOOD, V74, P1844
   Kalamvoki M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0518-2
   Kalamvoki M, 2014, P NATL ACAD SCI USA, V111, pE4991, DOI 10.1073/pnas.1419338111
   Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450
   Kim DK, 2013, J EXTRACELL VESICLES, V2
   Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596
   Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522
   Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10
   Kubota R, 2000, AIDS RES HUM RETROV, V16, P1705, DOI 10.1089/08892220050193182
   Kuo HT, 2010, TRANSPLANTATION, V90, P1091, DOI 10.1097/TP.0b013e3181f7c053
   Lagana Alessandro, 2013, Frontiers in Genetics, V4, P120, DOI 10.3389/fgene.2013.00120
   Lai FW, 2015, J LEUKOCYTE BIOL, V97, P237, DOI 10.1189/jlb.3RU0513-292RR
   Lee CC, 2012, CLIN CHEM LAB MED, V1, P1
   Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x
   Lepoutre V, 2009, FRONT BIOSCI, V14, P1152, DOI 10.2741/3300
   Levin MC, 2002, J INFECT DIS, V186, P1514, DOI 10.1086/344734
   Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x
   Longatti A, 2015, J VIROL, V89, P2956, DOI 10.1128/JVI.02721-14
   Longatti A, 2015, VIRUSES-BASEL, V7, P6707, DOI 10.3390/v7122967
   Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007
   Luo XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124436
   Madison MN, 2015, VIRUSES-BASEL, V7, P4093, DOI 10.3390/v7072810
   Malkki Hemi, 2016, Nat Rev Neurol, V12, P187, DOI 10.1038/nrneurol.2016.30
   Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011
   Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425
   McDevitt LM, 2006, AM J HEALTH-SYST PH, V63, pS3, DOI 10.2146/ajhp060377
   MCLAUCHLAN J, 1992, VIROLOGY, V190, P682, DOI 10.1016/0042-6822(92)90906-6
   MCLAUCHLAN J, 1992, J GEN VIROL, V73, P269, DOI 10.1099/0022-1317-73-2-269
   Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107
   Meckes DG, 2015, J VIROL, V89, P5200, DOI 10.1128/JVI.02470-14
   Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110
   Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11
   Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005
   Meng B, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0197-x
   Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824
   Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x
   Mulcahy LA, 2014, J EXTRACELL VESICLES, V3
   Murk JL, 2002, SEMIN CELL DEV BIOL, V13, P303, DOI 10.1016/S1084-9521(02)00060-5
   Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13
   Naranatt PP, 2004, CANCER RES, V64, P72, DOI 10.1158/0008-5472.CAN-03-2767
   Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Nour AM, 2014, TRENDS CELL BIOL, V24, P449, DOI 10.1016/j.tcb.2014.03.006
   Okoye IS, 2014, IMMUNITY, V41, P89, DOI 10.1016/j.immuni.2014.05.019
   Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000
   Ota M, 2014, MICROBIOL IMMUNOL, V58, P119, DOI 10.1111/1348-0421.12121
   Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002
   Gerber PP, 2015, J CELL BIOL, V209, P435, DOI 10.1083/jcb.201409082
   Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304
   Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010
   Plazolles N, 2011, J LEUKOCYTE BIOL, V89, P329, DOI 10.1189/jlb.0710386
   Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110
   Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161
   Rhein BA, 2016, J VIROL
   RIXON FJ, 1992, J GEN VIROL, V73, P277, DOI 10.1099/0022-1317-73-2-277
   Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622
   Romanelli MG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00271
   Roux A, 2013, CLIN IMMUNOL, V148, P16, DOI 10.1016/j.clim.2013.03.012
   Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021
   Sampey GC, 2016, J BIOL CHEM, V291, P1251, DOI 10.1074/jbc.M115.662171
   Sampey GC, 2014, J NEUROVIROL, V20, P199, DOI 10.1007/s13365-014-0238-6
   Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x
   Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363
   Schwab A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01132
   Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909
   Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220
   Segura E, 2007, J IMMUNOL, V179, P1489
   Shembade Noula, 2010, World J Biol Chem, V1, P13, DOI 10.4331/wjbc.v1.i1.13
   Silvas JA, 2016, J VIROL, V90, P873, DOI 10.1128/JVI.02490-15
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x
   Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083
   Temme S, 2010, J IMMUNOL, V184, P236, DOI 10.4049/jimmunol.0902192
   Thebaud B, 2012, CIRCULATION, V126, P2553, DOI 10.1161/CIRCULATIONAHA.112.146738
   Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599
   Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854
   Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124
   TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5
   Utley TJ, 2008, P NATL ACAD SCI USA, V105, P10209, DOI 10.1073/pnas.0712144105
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983
   van Dongen HM, 2016, MICROBIOL MOL BIOL R, V80, P369, DOI 10.1128/MMBR.00063-15
   van Niel G, 2011, DEV CELL, V21, P708, DOI 10.1016/j.devcel.2011.08.019
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Vincent-Schneider H, 2002, INT IMMUNOL, V14, P713, DOI 10.1093/intimm/dxf048
   Walker JD, 2009, J IMMUNOL, V182, P1548
   Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513
   Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111
   Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103
   Williamson PR, 2016, LANCET NEUROL, V15, P17, DOI 10.1016/S1474-4422(15)00359-2
   Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438
   Woodward CL, 2015, J VIROL, V89, P1267, DOI [10.1128/JVI.02997-14, 10.1128/JVI02997-14]
   Wurdinger Thomas, 2012, Adv Virol, V2012, P767694, DOI 10.1155/2012/767694
   Yandrapalli N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00220
   Yang TZ, 2015, PHARM RES-DORDR, V32, P2003, DOI 10.1007/s11095-014-1593-y
   Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013
   [Anonymous], BIOPHYS J
   [Anonymous], J IMMUNOL
NR 149
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD JUL
PY 2016
VL 13
IS 3
BP 535
EP 546
DI 10.1007/s13311-016-0450-6
PG 12
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA DS3JP
UT WOS:000380679400010
PM 27324390
ER

PT J
AU Leibovitch, EC
   Jacobson, S
AF Leibovitch, Emily C.
   Jacobson, Steven
TI Vaccinations for Neuroinfectious Disease: A Global Health Priority
SO NEUROTHERAPEUTICS
LA English
DT Review
DE Vaccines; Neuroinfectious; Neuroinvasive; Meningitis; Encephalitis; CNS
   infections
ID CENTRAL-NERVOUS-SYSTEM; TICK-BORNE ENCEPHALITIS; VENEZUELAN EQUINE
   ENCEPHALITIS; JAPANESE ENCEPHALITIS; VIRUS-INFECTION; VACCINE STRAIN;
   DENGUE VACCINE; ZIKA VIRUS; COMPLICATIONS; MICE
AB Vaccines for neuroinfectious diseases are becoming an ever-increasing global health priority, as neurologic manifestations and sequelae from existing and emerging central nervous system infections account for significant worldwide morbidity and mortality. The prevention of neurotropic infections can be achieved through globally coordinated vaccination campaigns, which have successfully eradicated nonzoonotic agents such as the variola viruses and, hopefully soon, poliovirus. This review discusses vaccines that are currently available or under development for zoonotic flaviviruses and alphaviruses, including Japanese and tick-borne encephalitis, yellow fever, West Nile, dengue, Zika, encephalitic equine viruses, and chikungunya. Also discussed are nonzoonotic agents, including measles and human herpesviruses, as well as select bacterial, fungal, and protozoal pathogens. While therapeutic vaccines will be required to treat a multitude of ongoing infections of the nervous system, the ideal vaccination strategy is pre-exposure vaccination, with the ultimate goals of minimizing disease associated with zoonotic viruses and the total eradication of nonzoonotic agents.
C1 [Leibovitch, Emily C.; Jacobson, Steven] NINDS, Viral Immunol Sect, NIH, Bethesda, MD 20892 USA.
   [Leibovitch, Emily C.] George Washington Univ, Sch Med, Inst Biomed Sci, Washington, DC 20037 USA.
RP Jacobson, S (reprint author), NINDS, Viral Immunol Sect, NIH, Bethesda, MD 20892 USA.
EM jacobsons@ninds.nih.gov
CR Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089
   Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI [10.1586/erv.09.19, 10.1586/ERV.09.19]
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Broutet N, 2016, N ENGL J MED
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Campbell H, 2007, INT J EPIDEMIOL, V36, P1334, DOI 10.1093/ije/dym207
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G., 2016, N ENGL J MED
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Cohen JI, 2013, VACCINE, V31, pB194, DOI 10.1016/j.vaccine.2012.09.041
   CONNELLY KP, 1994, PEDIATR NEUROL, V10, P181, DOI 10.1016/0887-8994(94)90021-3
   De Benedictis P., 2016, EMBO MOL MED
   Dieye Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1965
   Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608
   Gagliardi AM, 2016, COCHRANE DB SYST REV, V3
   George B.P., 2000, PLOS ONE, V9
   Gianchecchi E, 2015, EXPERT REV ANTI-INFE, V13, P1249, DOI 10.1586/14787210.2015.1070096
   Go Yun Young, 2014, Clin Exp Vaccine Res, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Gosling R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001994
   Guerbois M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002197
   Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709
   Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458
   Hora R, 2016, METAB BRAIN DIS, V31, P225, DOI 10.1007/s11011-015-9787-5
   Hotez P. J., 1969, PLOS NEGLECT TROP D, V10
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Johnston C, 2016, VACCINE
   Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148
   Kalita J, 2014, NEUROL INDIA, V62, P662, DOI 10.4103/0028-3886.149394
   Kardani K, 2016, VACCINE, V34, P413, DOI 10.1016/j.vaccine.2015.11.062
   Karunamoorthi K., 2013, YELLOW FEVER ENCEPHA, P41
   Kunze U, 2015, CENT EUR J PUBL HEAL, V23, P223
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Liang HB, 2016, CELL MOL IMMUNOL, V13, P36, DOI 10.1038/cmi.2015.76
   Lobigs M, 2012, EXPERT REV VACCINES, V11, P177, DOI [10.1586/erv.11.180, 10.1586/ERV.11.180]
   Long CA, 2016, CURR OPIN MICROBIOL, V32, P96, DOI 10.1016/j.mib.2016.04.006
   Malkki Hemi, 2016, Nat Rev Neurol, V12, P187, DOI 10.1038/nrneurol.2016.30
   Mecharles S., 2016, LANCET
   Molina OM, 1999, REV NEUROLOGIA, V29, P296
   Morrison C, 2015, NAT BIOTECHNOL, V33, P1015, DOI 10.1038/nbt1015-1015
   Nanjappa SG, 2014, CURR OPIN IMMUNOL, V28, P27, DOI 10.1016/j.coi.2014.01.014
   Nath A, 2013, ANN NEUROL, V74, P412, DOI 10.1002/ana.23988
   Ogata M, 2015, BONE MARROW TRANSPL, V50, P1030, DOI 10.1038/bmt.2015.76
   Paessler S, 2003, J VIROL, V77, P9278, DOI 10.1128/JVI.77.17.9278-9286.2003
   Palacios R., 2016, VACCINE
   Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac
   Tripp R.A., 2016, J NEUROVIROL, P1
   Petersen L. R., 2016, N ENGL J MED
   Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13
   Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353
   Phillips AT, 2014, J VIROL, V88, P1771, DOI 10.1128/JVI.02297-13
   Rella A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00836
   Sanders BP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005483
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Science M, 2014, J PEDIATR-US, V165, P779, DOI 10.1016/j.jpeds.2014.06.014
   Smalley C., 2016, VACCINE
   Smith C, 2015, CURR TOP MICROBIOL, V391, P455, DOI 10.1007/978-3-319-22834-1_16
   Gualberto FAS, 2013, J CLIN VIROL, V58, P737, DOI 10.1016/j.jcv.2013.10.016
   Tesini BL, 2014, CURR OPIN VIROL, V9, P91, DOI 10.1016/j.coviro.2014.09.013
   Tracey J., 2015, SYNDROMIC APPROACH N, P28
   Broutet N., 2016, EXPERT REV VACCINES
   Veje M, 2016, ACTA NEUROL SCAND
   Weinberg A, 2002, ANN NEUROL, V52, P543, DOI 10.1002/ana.10321
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Wilder-Smith A, 2016, EXPERT REV VACCINES, V15, P433, DOI 10.1586/14760584.2016.1154459
   Wilson J.W., 2015, FUNGAL INFECTIONS CE
   Wozniak KL, 2011, CLIN VACCINE IMMUNOL, V18, P717, DOI 10.1128/CVI.00036-11
   Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023
   Zajkowska J, 2011, NEUROL NEUROCHIR POL, V45, P402
   [Anonymous], 2015, VACCINE PREVENTABLE
   [Anonymous], 2013, WKLY EPIDEMIOL REC, V88, P201
   [Anonymous], 2006, WKLY EPIDEMIOL REC
   [Anonymous], 2016, WKLY EPIDEMIOL REC, V91, P33
NR 74
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1933-7213
EI 1878-7479
J9 NEUROTHERAPEUTICS
JI Neurotherapeutics
PD JUL
PY 2016
VL 13
IS 3
BP 562
EP 570
DI 10.1007/s13311-016-0453-3
PG 9
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA DS3JP
UT WOS:000380679400013
PM 27365085
ER

PT J
AU Ulrich, JN
   Beier, JC
   Devine, GJ
   Hugo, LE
AF Ulrich, Jill N.
   Beier, John C.
   Devine, Gregor J.
   Hugo, Leon E.
TI Heat Sensitivity of wMelWolbachia during Aedes aegypti Development
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CYTOPLASMIC INCOMPATIBILITY; DROSOPHILA-SIMULANS; BACTERIAL DENSITY;
   WOLBACHIA INFECTION; ANOPHELES-STEPHENSI; DENGUE TRANSMISSION;
   ENDOSYMBIONT WOLBACHIA; BLOCKS DENGUE; POPULATIONS; CULICIDAE
AB The wMel strain of Wolbachia bacteria is known to prevent dengue and Zika virus transmission in the mosquito vector Aedes aegypti. Accordingly, the release of wMel-infected A. aegypti in endemic regions has been recommended by the World Health Organization as a potential strategy for controlling dengue and Zika outbreaks. However, the utility of this approach could be limited if high temperatures in the aquatic habitats where A. aegypti develop are detrimental to Wolbachia. We exposed wMel-infected A. aegypti eggs and larvae to fluctuating daily temperatures of 30-40 degrees C for three, five, or seven days during their development. We found that Wolbachia levels in females emerging from heat treatments were significantly lower than in the controls that had developed at 20-30 degrees C. Notably, seven days of high temperatures starting at the egg stage reduced Wolbachia levels in emerging females to less than 0.1% of the wMel control levels. However, after adult females returned to 20-30 degrees C for 4-7 days, they experienced differing degrees of Wolbachia recovery. Our findings suggest that the spread of Wolbachia in wild A. aegypti populations and any consequent protection from dengue and Zika viruses might be limited in ecosystems that experience periods of extreme heat, but Wolbachia levels recover partially after temperatures return to normal.
C1 [Ulrich, Jill N.; Devine, Gregor J.; Hugo, Leon E.] Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Ulrich, Jill N.] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA.
   [Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
RP Ulrich, JN (reprint author), Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Ulrich, JN (reprint author), Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA.
EM j.ulrich1@umiami.edu
FU Leonard and Jayne Abess Center for Ecosystem Science and Policy at the
   University of Miami, Florida; Australian Infectious Diseases Research
   Centre; National Science Foundation Graduate Research Fellowship Program
   [2015178889]
FX This study was supported by the Leonard and Jayne Abess Center for
   Ecosystem Science and Policy at the University of Miami, Florida, the
   Australian Infectious Diseases Research Centre
   (http://www.aidrc.org.au/), and by the National Science Foundation
   Graduate Research Fellowship Program (https://www.nsfgrfp.org/) under
   Grant No. 2015178889. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Achee NL, 2015, PLOS NEGL TROP DIS, V9
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Bhatt S, 2013, NATURE
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bourtzis K, 1996, GENETICS, V144, P1063
   Bourtzis K, 2016, ACTA TROP, V78, DOI [10.1016/j.cell.2009.11.042, DOI 10.1016/J.CELL.2009.11.042]
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587
   Braig HR, 1998, J BACTERIOL, V180, P2373
   BREEUWER JAJ, 1993, GENETICS, V135, P565
   Bull James J, 2013, Evol Med Public Health, V2013, P197, DOI 10.1093/emph/eot018
   Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813
   CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P629
   Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1046/j.1570-7458.1998.00261.x
   Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096
   Dutra HLC, 2016, CELL HOST MICROBE
   Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Eliminate Dengue, PROGR 2016
   Feder ME, 1999, AM ZOOL, V39, P363
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gubler DJ, 2011, ASIA PAC J MOL BIOL, V19, P111
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1990, GENETICS, V126, P933
   HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.2307/2408456
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hoffmann AA, 2014, AUSTRAL ENTOMOL, V53, P125, DOI 10.1111/aen.12068
   Hugo LE, 2010, J MED ENTOMOL, V47, P1044, DOI 10.1603/ME10030
   Hurst GDD, 2000, GENETICS, V156, P699
   Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x
   Jeyaprakash A, 2010, FLA ENTOMOL, V93, P464, DOI 10.1653/024.093.0326
   Kessler S, 2008, J VECTOR ECOL, V33, P145, DOI 10.3376/1081-1710(2008)33[145:ROAGAS]2.0.CO;2
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Martinez J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005021
   McCall P, 2006, CONTROL DENGUE VECTO, P110
   MERCOT H, 1995, GENETICS, V141, P1015
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Mouton L, 2007, BIOL LETT-UK, V3, P210, DOI 10.1098/rsbl.2006.0590
   Nairn J. R., 2013, DEFINING HEATWAVES H
   NASCI RS, 1990, J MED ENTOMOL, V27, P716
   Nguyen HT, 2009, J AM MOSQUITO CONTR, V25, P74, DOI 10.2987/08-5752.1
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   PARTON WJ, 1981, AGR METEOROL, V23, P205, DOI 10.1016/0002-1571(81)90105-9
   Patil NS, 1996, MED VET ENTOMOL, V10, P277, DOI 10.1111/j.1365-2915.1996.tb00743.x
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Pettit WJ, 2010, J AM MOSQUITO CONTR, V26, P387, DOI 10.2987/09-5962.1
   R Development Core Team, 2010, R A LANGUAGE AND ENV
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157
   Sinkins SP, 1995, EXP PARASITOL, V81, P284, DOI 10.1006/expr.1995.1119
   SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461
   STEVENS L, 1989, J INVERTEBR PATHOL, V53, P78, DOI 10.1016/0022-2011(89)90076-1
   Sugimoto TN, 2015, J INSECT PHYSIOL, V81, P48, DOI 10.1016/j.jinsphys.2015.06.016
   TRPIS M, 1981, J HERED, V72, P313
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Turley AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-36
   Van Opijnen T, 1999, EXP APPL ACAROL, V23, P871, DOI 10.1023/A:1006363604916
   Van den Hurk F, 2012, PLOS NEGL TROP DIS, V6
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004
   Veneti Z, 2003, GENETICS, V164, P545
   Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   WHO, 2012, GLOB STRAT DENG PREV
   World Health Organization, 2013, FACTSH DENG SERV DEN
   World Health Organization Pesticide Evaluation Scheme (WHOPES), 2006, PEST THEIR APPL CONT
   World Health Organization, 2016, QUEST ANS DENG VACC
   WHO Vector Control Advisory Group, 2016, MOSQ VECT CONTR EM R
   Wiwatanaratanabutr I, 2009, J INVERTEBR PATHOL, V102, P220, DOI 10.1016/j.jip.2009.08.009
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1
   Yixin HY, 2016, AM J TROP MED HYG
   Zhukova M. V., 2008, Cell and Tissue Biology, V2, P546, DOI 10.1134/S1990519X08050131
   Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 91
TC 0
Z9 0
U1 3
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2016
VL 10
IS 7
AR e0004873
DI 10.1371/journal.pntd.0004873
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DS8FC
UT WOS:000381017800062
PM 27459519
ER

PT J
AU Porrino, P
AF Porrino, Pedro
TI Zika virus infection and once again the risk from other neglected
   diseases
SO TROPICAL DOCTOR
LA English
DT Article
DE Zika; neglected diseases; dengue; uutbreaks; epidemiological
   surveillance
ID AFRICA; DENGUE
AB Since the first cases of Zika were identified and reported in Brazil, the magnitude and consequences of the outbreak in the Americas have increased tremendously, leading the World Health Organization to consider Zika and its link with clusters of microcephaly a Public Health Emergency of International Concern. Only a previous large outbreak in French Polynesia was known and no neurological anomalies have been reported. Differences in African and Asian lineage and differences in genetic evolution of the Zika virus may possibly provide an explanation for the development of the recent outbreaks and their variable presentation. However, the similar clinical presentation between Zika and other diseases like Dengue and Chikungunya can support that Zika has been circulating and spreading inadvertently. This hypothesis gains strength when rates of laboratory confirmation diagnosis for Dengue are observed in Brazil and Colombia, two of the most affected countries by Zika virus (ZIKV) infection. The lack of attention and resources on neglected diseases supposes a huge risk that new lethal pathogens camouflage themselves to spread into large areas and populations.
C1 [Porrino, Pedro] The World, Trop Med, London, England.
   [Porrino, Pedro] The World, Mission, London, England.
RP Porrino, P (reprint author), The World, Trop Med, London, England.; Porrino, P (reprint author), The World, Mission, London, England.
EM pedro.porrino@gmail.com
CR Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2015, ARB DIS NEUR NONN 20
   Centers for Disease Control and Prevention, 2015, DENG VIR INF 2015 CA
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franco L, 2015, TROP MED INT HEALTH, V20, P107
   Instituto Nacional de Salud de Colombia Direccion de Vigilancia y Analisis del Riesgo en Salud Publica, 2015, B EP SEM SEM EP
   Jaenisch T, 2014, EMERG INFECT DIS, V20
   Johansson MA, RISK ESTIMATES MICRO
   Kindhauser MK, 2016, B WHO
   Ministerio da Saude (Brazil), 2015, CONF ZIK VIR BRAS
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2015, ZIK VIR INF
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   WHO, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, CHIK FACT SHEET
NR 20
TC 0
Z9 0
U1 5
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0049-4755
EI 1758-1133
J9 TROP DOCT
JI Trop. Dr.
PD JUL
PY 2016
VL 46
IS 3
BP 159
EP 165
DI 10.1177/0049475516656101
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DS0LO
UT WOS:000380287300012
PM 27390166
ER

PT J
AU Martinez, ME
AF Martinez, Micaela Elvira
TI Preventing Zika Virus Infection during Pregnancy Using a Seasonal Window
   of Opportunity for Conception
SO PLOS BIOLOGY
LA English
DT Article
ID AEDES-AEGYPTI; DYNAMICS; AMERICA; EPIDEMIOLOGY; DISEASES; TRANSMISSION;
   DENGUE
AB It has come to light that Zika virus (ZIKV) infection during pregnancy can result in trans-placental transmission to the fetus along with fetal death, congenital microcephaly, and/or Central Nervous System (CNS) malformations. There are projected to be >9,200,000 births annually in countries with ongoing ZIKV transmission. In response to the ZIKV threat, the World Health Organization (WHO) is strategically targeting prevention of infection in pregnant women and funding contraception in epidemic regions. I propose that the damaging effects of ZIKV can be reduced using a seasonal window of opportunity for conception that may minimize maternal exposure. Like other acute viral infections-including the related flavivirus, dengue virus (DENV)-the transmission of ZIKV is anticipated to be seasonal. By seasonally planning pregnancy, this aspect of pathogen ecology can be leveraged to align sensitive periods of gestation with the low-transmission season.
C1 [Martinez, Micaela Elvira] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.
   [Martinez, Micaela Elvira] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Global Hlth Program, Princeton, NJ 08544 USA.
RP Martinez, ME (reprint author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.; Martinez, ME (reprint author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Global Hlth Program, Princeton, NJ 08544 USA.
EM micaelam@princeton.edu
FU US National Science Foundation [1523757]
FX MEM is supported by a US National Science Foundation Postdoctoral
   Fellowship in Biology Award Number 1523757. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   [National Center for Emerging and Zoonotic Infectious Diseases Division of Vector-Borne Diseases Centers for Disease Control and Prevention], ZIK VIR WOM THEIR PA
   Centers for Disease Control and Prevention, MORBIDITY MORTALITY
   Cugola FR, 2016, NATURE, P1
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dowell SF, 2012, EPIDEMIOL INFECT, V140, P87, DOI 10.1017/S0950268811001695
   Dowell SF, 2001, EMERG INFECT DIS, V7, P369
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128
   Frieden T., 2016, ZIK ACT PLAN SUMM AP
   Gareez P, 2016, SCIENCE, V352, P816
   Grassly NC, 2006, P R SOC B, V273, P2541, DOI 10.1098/rspb.2006.3604
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167
   Hazin A, 2016, NEW ENGL J MED, P1
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   King AA, 2015, J STAT SOFT IN PRESS
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez-Bakker M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002172
   Martinez-Bakker M, 2015, TRENDS ECOL EVOL, V30, P314, DOI 10.1016/j.tree.2015.03.012
   Martinez-Bakker M, 2014, P ROYAL SOC B, V281
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   McNeil Jr DG, 2016, NY TIMES
   Miner J, 2016, CELL, P1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Obama B., 2016, COMMUNICATION
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rasmussen SA, 2016, NEW ENGL J MED, P1
   ROENNEBERG T, 1990, J BIOL RHYTHM, V5, P195, DOI 10.1177/074873049000500303
   Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, P1, DOI DOI 10.1371/J0URNAL.PNTD.0001918
   Sauerbrei A, 2007, MED MICROBIOL IMMUN, V196, P89, DOI 10.1007/s00430-006-0031-0
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   SEVER J, 1968, ANNU REV MED, V19, P471, DOI 10.1146/annurev.me.19.020168.002351
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P536
   Stevenson TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1453
   Tavernise S, 2016, NY TIMES
   United Nations Statistics Division: Demographics Statistics, 2016, DEM STAT LIV BIRTHS
   US Central Intelligence Agency, 2016, WORLD FACTB 2016
   World Health Organization, 2016, WHO ZIK Q A
   World Health Organization, 2016, ZIK STRAT RESP FRAM
NR 47
TC 0
Z9 0
U1 16
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD JUL
PY 2016
VL 14
IS 7
AR e1002520
DI 10.1371/journal.pbio.1002520
PG 11
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA DS4RN
UT WOS:000380768700016
PM 27467271
ER

PT J
AU Kuehnert, MJ
   Epstein, JS
AF Kuehnert, Matthew J.
   Epstein, Jay S.
TI Assuring blood safety and availability: Zika virus, the latest emerging
   infectious disease battlefront
SO TRANSFUSION
LA English
DT Editorial Material
C1 [Kuehnert, Matthew J.] Ctr Dis Control & Prevent, Off Blood Organ & Other Tissue Safety, Div Healthcare Qual Promot, Natl Ctr Zoonot & Infect Dis, Atlanta, GA 30333 USA.
   [Epstein, Jay S.] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
RP Kuehnert, MJ (reprint author), Ctr Dis Control & Prevent, Off Blood Organ & Other Tissue Safety, Div Healthcare Qual Promot, Natl Ctr Zoonot & Infect Dis, Atlanta, GA 30333 USA.
EM mkuehnert@cdc.gov
NR 0
TC 0
Z9 0
U1 2
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2016
VL 56
IS 7
BP 1669
EP 1672
DI 10.1111/trf.13673
PG 4
WC Hematology
SC Hematology
GA DS1NG
UT WOS:000380362100001
PM 27389990
ER

PT J
AU Barjas-Castro, ML
   Angerami, RN
   Cunha, MS
   Suzuki, A
   Nogueira, JS
   Rocco, IM
   Maeda, AY
   Vasami, FGS
   Katz, G
   Boin, IFSF
   Stucchi, RSB
   Resende, MR
   Esposito, DLA
   de Souza, RP
   da Fonseca, BA
   Addas-Carvalho, M
AF Barjas-Castro, Maria L.
   Angerami, Rodrigo N.
   Cunha, Mariana S.
   Suzuki, Akemi
   Nogueira, Juliana S.
   Rocco, Iray M.
   Maeda, Adriana Y.
   Vasami, Fernanda G. S.
   Katz, Gizelda
   Boin, Ilka F. S. F.
   Stucchi, Raquel S. B.
   Resende, Mariangela R.
   Esposito, Danillo L. A.
   de Souza, Renato P.
   da Fonseca, Benedito A.
   Addas-Carvalho, Marcelo
TI Probable transfusion-transmitted Zika virus in Brazil
SO TRANSFUSION
LA English
DT Article
ID WEST NILE VIRUS; BLOOD-TRANSFUSION; FRENCH-POLYNESIA; FEBRUARY 2014;
   TRANSMISSION; DENGUE; CHIKUNGUNYA; OUTBREAK
AB BACKGROUNDZika virus (ZIKV) is an emerging arthropod-borne flavivirus transmitted by Aedes mosquitoes. Recent commentaries regarding ZIKV routes of transmission describe a potential transmission by transfusion. Herein, we report a probable case of transfusion-transmitted ZIKV infection through a platelet transfusion that was detected from postdonation information.
   CASE REPORTA blood donor made a voluntary telephone report to the blood donor facility 3 days after donation and informed the facility of a febrile illness (fever, malaise, and headaches). Due to the ongoing dengue epidemic, the initial clinical investigation included dengue among other possible diagnoses. The serology and molecular laboratory results excluded dengue infection. However, stored samples from the donation were positive for ZIKV on reverse transcription-polymerase chain reaction (RT-PCR) analysis. A retrospective investigation demonstrated that the platelet concentrate, which was part of a pool, had been transfused after a liver transplantation. A physician had evaluated the patient 4 days after surgery. Laboratory investigation showed enzyme-linked immunosorbent assay results that were negative for dengue immunoglobulin M antibodies; however, the results were positive for hemagglutination inhibition antibodies against flavivirus. ZIKV RT-PCR and virus isolation analyses in cell cultures from recipient serum were both positive. The sequencing confirmed ZIKV in the donor and patient samples. Ten partial nucleotide sequences from the ZIKV strain that were detected in the donor were aligned and compared with the ZIKV genome detected in the recipient, revealing a 99.8% homology between the two strains.
   CONCLUSIONSThis is a case of probable transmission of ZIKV through blood transfusion. The patient had been transfused with the blood product from an infected donor, most likely in the incubation period after ZIKV infection but prior to clinical disease onset. This report emphasizes the importance of postdonation information and recipient investigations during outbreaks of potentially blood-borne infections.
C1 [Barjas-Castro, Maria L.; Addas-Carvalho, Marcelo] Univ Estadual Campinas UNICAMP, Hematol & Transfus Ctr, Campinas, SP, Brazil.
   [Angerami, Rodrigo N.; Resende, Mariangela R.] Univ Estadual Campinas UNICAMP, Hosp Clin, Sect Hosp Epidemiol, Campinas, SP, Brazil.
   [Cunha, Mariana S.; Suzuki, Akemi; Nogueira, Juliana S.; Rocco, Iray M.; Maeda, Adriana Y.; Vasami, Fernanda G. S.; de Souza, Renato P.] Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
   [Katz, Gizelda] Infect Dis Surveillance Ctr Prof Alexandre Vranja, Sao Paulo, SP, Brazil.
   [Boin, Ilka F. S. F.; Stucchi, Raquel S. B.; Resende, Mariangela R.] Univ Estadual Campinas UNICAMP, Dept Clin Med, Fac Med Sci, Campinas, SP, Brazil.
   [Esposito, Danillo L. A.; da Fonseca, Benedito A.] Univ Estadual Sao Paulo, Fac Ciencias Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RP Barjas-Castro, ML (reprint author), Univ Estadual Campinas UNICAMP, Hemoctr Unicamp, Rua Carlos Chagas 480,Cidade Univ Zeferino Vaz, Campinas, SP, Brazil.
EM maluz@unicamp.br
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   Cunha MS, 2016, GENOME ANNOUNC, V4, DOI DOI 10.1128/GENOMEA.00032-16
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lederman E., 2010, Morbidity and Mortality Weekly Report, V59, P34
   [Anonymous], 2015, B EPIDEMIOLOGICO, V46
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Healthcare Safety Network [NHSN], 2016, NHSN BIOV COMP HEM M
   Paty MC, 2013, TRANSFUS CLIN BIOL, V20, P165, DOI 10.1016/j.tracli.2013.03.008
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   US Food and Drug Administration (FDA), 2016, FDA GUID REC DON SCR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 0
Z9 0
U1 3
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2016
VL 56
IS 7
BP 1684
EP 1688
DI 10.1111/trf.13681
PG 5
WC Hematology
SC Hematology
GA DS1NG
UT WOS:000380362100006
PM 27329551
ER

PT J
AU Lanteri, MC
   Kleinman, SH
   Glynn, SA
   Musso, D
   Hoots, WK
   Custer, BS
   Sabino, EC
   Busch, MP
AF Lanteri, Marion C.
   Kleinman, Steven H.
   Glynn, Simone A.
   Musso, Didier
   Hoots, W. Keith
   Custer, Brian S.
   Sabino, Ester C.
   Busch, Michael P.
TI Zika virus: a new threat to the safety of the blood supply with
   worldwide impact and implications
SO TRANSFUSION
LA English
DT Editorial Material
ID FRENCH-POLYNESIA; EMERGING PATHOGENS; FEBRUARY 2014; TRANSMISSION;
   OUTBREAK; DENGUE; BRAZIL; INFECTION; AMERICA; DONORS
C1 [Lanteri, Marion C.; Custer, Brian S.; Busch, Michael P.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.
   [Lanteri, Marion C.; Custer, Brian S.; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Kleinman, Steven H.] Univ British Columbia, Vancouver, BC, Canada.
   [Glynn, Simone A.; Hoots, W. Keith] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
   [Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil.
RP Busch, MP (reprint author), Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
EM mbusch@bloodsystems.org
CR [Anonymous], 2016, ASS B, V#16-04
   [Anonymous], 2016, ASS B, V#16-03
   AFP, 2016, WHO SOUNDS ZIKA BLOO
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Atreya Chintamani, 2011, Transfusion, V51, P1855, DOI 10.1111/j.1537-2995.2011.03084.x
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brasil P, 2016, N ENGL J MED
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Busch MP, 2014, ISBT SCI SER, V9, P276
   Calvet GA, 2015, BRAZIL J CLIN VIROL, V74, P1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodd RY, 2014, TRANSFUSION, V54, P1693, DOI 10.1111/trf.12705
   Dodd RY, 2003, NEW ENGL J MED, V349, P1205, DOI 10.1056/NEJMp038138
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   [Anonymous], 2016, ZIKA VIRUS DISEASE E
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 2006, FLAVIVIRUSES FIELDS
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kindhauser MK, 2016, B WHO
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2015, B INFORM SANITAIRES
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marks PW, 2016, J INFECT DIS, V213, P1676, DOI 10.1093/infdis/jiw089
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreno-Sanchez R, 2006, HEALTH PLACE, V12, P715, DOI 10.1016/j.healthplace.2005.10.001
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, BLOOD TRANSFUS, DOI [10.2450/2016.0003-16., DOI 10.2450/2016.0003-16]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nett RJ, 2012, TRANSPL INFECT DIS, V14, P268, DOI 10.1111/j.1399-3062.2012.00743.x
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Stein J, 2011, VOX SANG, V101, P277, DOI 10.1111/j.1423-0410.2011.01526.x
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   [Anonymous], 2016, REC DON SCREEN DEF P
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   [Anonymous], 2016, ZIK VIR SIT REP
   [Anonymous], 2016, MAINT SAF AD BLOOD S
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 85
TC 0
Z9 0
U1 8
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUL
PY 2016
VL 56
IS 7
BP 1907
EP 1914
DI 10.1111/trf.13677
PG 8
WC Hematology
SC Hematology
GA DS1NG
UT WOS:000380362100034
PM 27282638
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh RamBihariLal
   Shrivastava, Prateek Saurabh
   Ramasamy, Jegadeesh
TI Standardized management of Zika virus infection during pregnancy
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Shrivastava, Saurabh RamBihariLal; Shrivastava, Prateek Saurabh; Ramasamy, Jegadeesh] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvancherry Main Rd, Kancheepuram 603108, Tamil Nadu, India.
RP Shrivastava, SR (reprint author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvancherry Main Rd, Kancheepuram 603108, Tamil Nadu, India.
EM drshrishri2008@gmail.com
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization, 2016, PAED EM TRIAG ASS TR, P1
NR 5
TC 0
Z9 0
U1 2
U2 2
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JUL-AUG
PY 2016
VL 9
IS 4
BP 217
EP 218
DI 10.4103/1755-6783.184814
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA DR9VP
UT WOS:000380244500002
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Coinfection between dengue virus and Zika virus: A complex situation
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Med Sci, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayo Babalola Univ, Dept Biol Sci, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Dept Community Med, Pune, Maharashtra, India.
RP Wiwanitkit, S (reprint author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
   Wiwanitkit S., 2015, Journal of Acute Disease, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 0
Z9 0
U1 2
U2 2
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD JUL-AUG
PY 2016
VL 9
IS 4
BP 302
EP 303
DI 10.4103/1755-6783.184810
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA DR9VP
UT WOS:000380244500033
ER

PT J
AU Beckham, JD
   Pastula, DM
   Massey, A
   Tyler, KL
AF Beckham, J. David
   Pastula, Daniel M.
   Massey, Aaron
   Tyler, Kenneth L.
TI Zika Virus as an Emerging Global Pathogen Neurological Complications of
   Zika Virus
SO JAMA NEUROLOGY
LA English
DT Review
ID WEST-NILE-VIRUS; FRENCH-POLYNESIA; TRANSMISSION; BRAZIL; INFECTION;
   ARBOVIRUSES; OUTBREAK; MICRONESIA; STATES; FEVER
AB IMPORTANCE Zika virus (ZIKV) is an emerging arthropod-borne virus (arbovirus) in the genus Flavivirus that has caused a widespread outbreak of febrile illness, is associated with neurological disease, and has spread across the Pacific to the Americas in a short period.
   OBSERVATIONS In this review, we discuss what is currently known about ZIKV, neuroimmunologic complications, and the impact on global human health. Zika virus spread across Africa and Asia in part owing to unique genomic evolutionary conditions and pressures resulting in specific human disease manifestations, complications, and pathogenesis. Recent data suggest that acute ZIKV infection in pregnant women may result in acute infection of fetal tissue and brain tissue, causing microcephaly and potentially severe debilitation of the infant or even death of the fetus. Cases of acute ZIKV are also associated with Guillain-Barre syndrome. With the increased number of cases, new complications such as ocular involvement and sexual transmission have been reported.
   CONCLUSIONS AND RELEVANCE Zika virus is an emerging viral pathogen with significant consequences on human health throughout the world. Ongoing research into this pathogen is urgently needed to produce viable vaccine and therapeutic options.
C1 [Beckham, J. David; Pastula, Daniel M.; Tyler, Kenneth L.] Univ Colorado, Sch Med, Dept Neurol, Neuroinfect Dis Grp, Aurora, CO USA.
   [Beckham, J. David; Massey, Aaron] Univ Colorado, Sch Med, Dept Med, Div Infect Dis, 12700 E 19th Ave,B168, Aurora, CO 80045 USA.
RP Beckham, JD (reprint author), Univ Colorado, Sch Med, Dept Med, Div Infect Dis, 12700 E 19th Ave,B168, Aurora, CO 80045 USA.
EM david.beckham@ucdenver.edu
CR Baronti C., 2014, GENOME ANNOUNC, V2, P2, DOI DOI 10.1128/GENOMEA.00500-14
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   Centers for Disease Control and Prevention, AR WITH ZIK
   Centers for Disease Control and Prevention, ZIK VIR PREGN WOM
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHALMOL.2016.0267]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization; World Health Organization, ZIK VIR INF
   Petersen LR, 2001, EMERG INFECT DIS, V7, P611
   REAGAN RL, 1953, TEX REP BIOL MED, V11, P347
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shives KD, 2014, J VIROL, V88, P9458, DOI 10.1128/JVI.01323-14
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 46
TC 1
Z9 1
U1 22
U2 22
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD JUL
PY 2016
VL 73
IS 7
BP 875
EP 879
DI 10.1001/jamaneurol.2016.0800
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA DQ7XC
UT WOS:000379420500021
PM 27183312
ER

PT J
AU Jin, J
   Simmons, G
AF Jin, Jing
   Simmons, Graham
TI Inhibitory Antibodies Targeting Emerging Viruses: Advancements and
   Mechanisms
SO CLINICAL AND VACCINE IMMUNOLOGY
LA English
DT Article
ID DENGUE VIRUS; NONNEUTRALIZING ANTIBODIES; NEUTRALIZING ANTIBODIES;
   MONOCLONAL-ANTIBODIES; HIGHLY POTENT; GLYCOPROTEIN; INFECTION; EPITOPE;
   ENTRY; NEURAMINIDASE
AB From Ebola virus outbreaks in Western Africa to the introduction of chikungunya and Zika viruses in the Americas, new and neglected viruses continue to emerge and spread around the world. Due to a lack of existing vaccines or specific therapeutics, little other than supportive care and attempts to interrupt transmission can be provided during initial outbreaks. This has prompted a shift in vaccine design and development to identify novel epitopes and mechanisms of protection that may offer a broader range of protection against groups or whole families of viruses. Receptor-binding domains and other motifs within viral envelope proteins represent one excellent opportunity to target communal epitopes shared by related viruses. Similarly, for viruses where envelope participates in driving viral egress from infected cells, shared epitopes need to be identified to guide the development of broadly protective antibodies and vaccines. Here, we discuss recent advances in our understanding of broadly protective humoral responses for emerging viruses.
C1 [Simmons, Graham] Blood Syst Res Inst, San Francisco, CA 94118 USA.
   Univ Calif San Francisco, San Francisco, CA 94143 USA.
RP Simmons, G (reprint author), Blood Syst Res Inst, San Francisco, CA 94118 USA.
EM gsimmons@bloodsystems.org
FU HHS \ NIH \ National Institute of Allergy and Infectious Diseases
   (NIAID) [R01 AI119056]
FX This work, including the efforts of Jing Jin and Graham Simmons, was
   funded by HHS vertical bar NIH vertical bar National Institute of
   Allergy and Infectious Diseases (NIAID) (R01 AI119056).
CR Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bornholdt ZA, 2015, MBIO, V7
   Dai L, 2016, CELL HOST MICROBE
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Furuyama W, 2016, SCI REP-UK, V6, DOI 10.1038/srep20514
   Halbherr SJ, 2015, J VIROL, V89, P1550, DOI 10.1128/JVI.02949-14
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Kajihara M, 2012, J VIROL, V86, P13467, DOI 10.1128/JVI.01896-12
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Long F, 2015, P NATL ACAD SCI USA, V112, P13898, DOI 10.1073/pnas.1515558112
   Masrinoul P, 2014, VIROLOGY, V464, P111, DOI 10.1016/j.virol.2014.05.038
   McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283
   Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534
   Porta J, 2014, J VIROL, V88, P9616, DOI 10.1128/JVI.01286-14
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Simmons G, 2013, ADV EXP MED BIOL, V790, P83, DOI 10.1007/978-1-4614-7651-1_5
   Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435
   Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044
NR 24
TC 0
Z9 0
U1 9
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1556-6811
EI 1556-679X
J9 CLIN VACCINE IMMUNOL
JI Clin. Vaccine Immunol.
PD JUL
PY 2016
VL 23
IS 7
BP 535
EP 539
DI 10.1128/CVI.00136-16
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DQ9GB
UT WOS:000379517300002
PM 27226280
ER

PT J
AU Shadgan, B
   Pakravan, A
   Zaeimkohan, H
   Shahpar, FM
   Khodaee, M
AF Shadgan, Babak
   Pakravan, Amir
   Zaeimkohan, Hamid
   Shahpar, Farhad Moradi
   Khodaee, Morteza
TI Zika and Rio Olympic Games
SO CURRENT SPORTS MEDICINE REPORTS
LA English
DT Review
ID REPRODUCTIVE AGE; VIRUS EXPOSURE; UNITED-STATES; OUTBREAK; WOMEN
AB Zika virus (ZIKV) is an arthropod-borne virus that is mainly transmitted via a bite from a female mosquito of the Aedes species. However, ZIKV can be transmitted sexually or via blood. Due to the recent ZIKV outbreak in South and Central America, many national and international organizations are concerned about the safety of athletes, coaches, staff, and spectators during the Olympic and Paralympic Games. Infected individuals are generally asymptomatic or have mild symptoms. However, ZIKV infection can potentially cause serious complications such as Guillain-Barre syndrome and congenital defects. Preferred diagnosis is based on real-time reverse-transcription polymerase chain reaction from blood and urine. Currently, there is no treatment or immunization available for ZIKV infection, and disease control is limited to preventing mosquito bites.
C1 [Shadgan, Babak] Med & Anti Doping Commiss, UWW, Vancouver, BC, Canada.
   [Pakravan, Amir] ECOSEP, London, England.
   [Zaeimkohan, Hamid] Med & Anti Doping Commiss, WKF, Madrid, Spain.
   [Shahpar, Farhad Moradi] Federat Int Natat FINA, Sports Med Comm, Tehran, Iran.
   [Khodaee, Morteza] Univ Colorado, Sch Med, Dept Family Med, Denver, CO USA.
RP Khodaee, M (reprint author), AFW Clin, 3055 Roslyn St, Denver, CO 80238 USA.
EM morteza.khodaee@ucdenver.edu
CR Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   CDC, 2016, ZIK VIR
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Hayden EC, NATURE NEWS
   Interim Guidance for Zika Virus Testing of Urine MMWR Morb, 2016, MMWR-MORBID MORTAL W, V65, P474
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Paploski Igor A D, 2016, Emerg Infect Dis, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   WHO, ZIK VIR
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 12
TC 0
Z9 0
U1 13
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1537-890X
EI 1537-8918
J9 CURR SPORT MED REP
JI Curr. Sport. Med. Rep.
PD JUL-AUG
PY 2016
VL 15
IS 4
BP 298
EP 300
PG 3
WC Sport Sciences
SC Sport Sciences
GA DR2SH
UT WOS:000379753700014
PM 27399828
ER

PT J
AU Gioula, G
   Nunes, ML
   Zafeiriou, DI
AF Gioula, Georgia
   Nunes, Magda Lahorgue
   Zafeiriou, Dimitrios I.
TI An emerging cause of concern in Europe: Zika virus, the developing CNS
   and the pediatric neurologist
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Editorial Material
ID BRAZIL
C1 [Gioula, Georgia] Aristotle Univ Thessaloniki, Dept Microbiol 2, Thessaloniki, Greece.
   [Nunes, Magda Lahorgue] Pontificia Univ Catolica Rio Grande do Sul, Div Neurol, Porto Alegre, RS, Brazil.
   [Nunes, Magda Lahorgue; Zafeiriou, Dimitrios I.] Brain Inst Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Zafeiriou, Dimitrios I.] Aristotle Univ Thessaloniki, Dept Pediat 1, Thessaloniki, Greece.
RP Zafeiriou, DI (reprint author), Aristotle Univ Thessaloniki, Dept Pediat 1, Thessaloniki, Greece.
EM jeff@med.auth.gr
CR Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Basarab M, 2016, BMJ-BRIT MED J, V26, P352
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nunes ML, 2016, J PEDIAT RIO J
   Salvador FS, 2014, TRAVEL MED INFECT DI, VS1477-8939
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shuaib W, 2016, AM J MED
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
NR 12
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD JUL
PY 2016
VL 20
IS 4
BP 497
EP 499
DI 10.1016/j.ejpn.2016.04.017
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA DQ3MP
UT WOS:000379106700001
PM 27160366
ER

PT J
AU Caragata, EP
   Dutra, HLC
   Moreira, LA
AF Caragata, Eric Pearce
   Carneiro Dutra, Heverton Leandro
   Moreira, Luciano Andrade
TI Inhibition of Zika virus by Wolbachia in Aedes aegypti
SO MICROBIAL CELL
LA English
DT Article
DE Zika virus; mosquito-transmitted disease; Aedes aegypti; Wolbachia
AB Through association with cases of microcephaly in 2015, Zika virus (ZIKV) has transitioned from a relatively unknown mosquito-transmitted pathogen to a global health emergency, emphasizing the need to improve existing mosquito control programs to prevent future disease outbreaks. The response to Zika must involve a paradigm shift from traditional to novel methods of mosquito control, and according to the World Health Organization should incorporate the release of mosquitoes infected with the bacterial endosymbiont Wolbachia pipientis. In our recent paper [Dutra, HLC et al., Cell Host & Microbe 2016] we investigated the potential of Wolbachia infections in Aedes aegypti to restrict infection and transmission of Zika virus recently isolated in Brazil. Wolbachia is now well known for its ability to block or reduce infection with a variety of pathogens in different mosquito species including the dengue (DENV), yellow fever, and chikungunya viruses, and malaria-causing Plasmodium, and consequently has great potential to control mosquito- transmitted diseases across the globe. Our results demonstrated that the wMel Wolbachia strain in Brazilian Ae. aegypti is a strong inhibitor of ZIKV infection, and furthermore appears to prevent transmission of infectious viral particles in mosquito saliva, which highlights the bacterium's suitability for more widespread use in Zika control.
C1 [Caragata, Eric Pearce; Carneiro Dutra, Heverton Leandro; Moreira, Luciano Andrade] Ctr Pesquisas Rene Rachou Fiocruz, Mosquitos Vetores Endossimbiontes & Interacao Pat, Belo Horizonte, MG, Brazil.
RP Moreira, LA (reprint author), 1715 Ave Augusto de Lima, BR-30190002 Belo Horizonte, MG, Brazil.
EM luciano@cpqrr.fiocruz.br
NR 0
TC 0
Z9 0
U1 31
U2 31
PU SHARED SCIENCE PUBLISHERS OG
PI GRAZ
PA AM BLUMENHAG 25-4, GRAZ, 8010, AUSTRIA
SN 2311-2638
J9 MICROB CELL
JI Microb. Cell
PD JUL
PY 2016
VL 3
IS 7
BP 293
EP 295
DI 10.15698/mic2016.07.513
PG 3
WC Cell Biology
SC Cell Biology
GA DR4LE
UT WOS:000379872200004
ER

PT J
AU Nguyen, HN
   Qian, XY
   Song, HJ
   Ming, GL
AF Ha Nam Nguyen
   Qian, Xuyu
   Song, Hongjun
   Ming, Guo-li
TI Neural stem cells attacked by Zika virus
SO CELL RESEARCH
LA English
DT Editorial Material
ID MICE
AB The current outbreak of Zika virus-associated diseases in South America and its threat to spread to other parts of the world has emerged as a global health emergency. Insights from cell and animal models to understand how Zika virus causes severe birth defects may lead to treatments and prevention of these diseases.
C1 [Ha Nam Nguyen; Qian, Xuyu; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Ha Nam Nguyen; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Qian, Xuyu] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
RP Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
EM gming1@jhmi.edu
CR Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 10
TC 0
Z9 0
U1 20
U2 20
PU INST BIOCHEMISTRY & CELL BIOLOGY
PI SHANGHAI
PA SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD JUL
PY 2016
VL 26
IS 7
BP 753
EP 754
DI 10.1038/cr.2016.68
PG 2
WC Cell Biology
SC Cell Biology
GA DQ8XP
UT WOS:000379495300002
PM 27283801
ER

PT J
AU Kallas, EG
   O'Connor, DH
AF Kallas, Esper G.
   O'Connor, David H.
TI Real-Time Sharing of Zika Virus Data in an Interconnected World
SO JAMA PEDIATRICS
LA English
DT Editorial Material
C1 [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.
   [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil.
   [O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53711 USA.
   [O'Connor, David H.] Wisconsin Natl Primate Res Ctr, Madison, WI USA.
RP O'Connor, DH (reprint author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, 555 Sci Dr, Madison, WI 53711 USA.
EM doconnor@primate.wisc.edu
CR Athavaley A, ZIKA VIRUS TRENDING
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Francis DP, 2012, J PUBLIC HEALTH POL, V33, P290, DOI 10.1057/jphp.2012.14
   Google Trends, WORLD SEARCH ZIK VIR
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nelson EK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-71
   Wellcome Trust, DAT SHAR PUBL HLTH E
NR 10
TC 0
Z9 0
U1 5
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD JUL
PY 2016
VL 170
IS 7
BP 633
EP 634
DI 10.1001/jamapediatrics.2016.0857
PG 2
WC Pediatrics
SC Pediatrics
GA DQ2OK
UT WOS:000379041800003
PM 27031608
ER

PT J
AU Han, JF
   Jiang, T
   Ye, Q
   Li, XF
   Liu, ZY
   Qin, CF
AF Han, Jian-Feng
   Jiang, Tao
   Ye, Qing
   Li, Xiao-Feng
   Liu, Zhong-Yu
   Qin, Cheng-Feng
TI Homologous recombination of Zika viruses in the Americas
SO JOURNAL OF INFECTION
LA English
DT Letter
ID BRAZIL
C1 [Han, Jian-Feng; Jiang, Tao; Ye, Qing; Li, Xiao-Feng; Liu, Zhong-Yu; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
RP Qin, CF (reprint author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, 20 Dongda St, Beijing 100071, Peoples R China.
EM qincf@bmi.ac.cn
OI Qin, Cheng-Feng/0000-0002-0632-2807
CR Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Haddow AD, 2016, PLOS NEGLECT TROP D, V6, pe1477
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
NR 10
TC 0
Z9 0
U1 10
U2 10
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JUL
PY 2016
VL 73
IS 1
BP 87
EP 88
DI 10.1016/j.jinf.2016.04.011
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DQ3RC
UT WOS:000379118700012
PM 27105655
ER

PT J
AU Unlu, I
   Faraji, A
   Indelicato, N
   Rochlin, I
AF Unlu, Isik
   Faraji, Ary
   Indelicato, Nicholas
   Rochlin, Ilia
TI TrapTech R-Octenol Lure Does Not Improve the Capture Rates of Aedes
   albopictus (Diptera: Culicidae) and Other Container-Inhabiting Species
   in Biogents Sentinel Traps
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito surveillance; trap evaluation; BGS trap; olfactory kairomone;
   New Jersey
ID NORTH CENTRAL FLORIDA; CARBON-DIOXIDE; FIELD-EVALUATION; MOSQUITO TRAPS;
   LACTIC-ACID; SURVEILLANCE; 1-OCTEN-3-OL; ATTRACTANTS; CHIKUNGUNYA;
   JAPONICUS
AB Aedes albopictus (Skuse) and other container-inhabiting species have become important public health concerns due to the transmission of dengue, chikungunya, and Zika viruses. Effective surveillance is dependent on the ability to collect a sufficient number of mosquitoes for population monitoring and pathogen isolation. The Biogents Sentinel (BGS) trap supplied with a proprietary human skin lure has become the standard tool for container-inhabiting Aedes species collections worldwide. Recently, R-octenol, a single isomer of the well characterized mosquito attractant octenol, was shown to greatly improve the capture rate of some Aedes species when utilized with the Center for Disease Control and Prevention (CDC) light traps and Mosquito Magnet traps. This study evaluated the effectiveness of the TrapTech lure (TT lure), containing R-octenol, alone or in combination with the human skin lure in a BGS trap to capture Ae. albopictus and other species. BGS traps with human skin lures or a combination of the two lures collected approximately twice as many Ae. albopictus females compared to those with TT lures. Unlike previous studies, baiting BGS traps with TT lures did not result in increased diversity of mosquito species, or in higher numbers of other container-inhabiting Aedes species. Although human skin lures were clearly superior to TT R-octenol lures in BGS traps, R-octenol lures are more widely available and might still be used as an alternative lure, especially when Ae. albopictus populations are high.
C1 [Unlu, Isik; Faraji, Ary; Rochlin, Ilia] Rutgers State Univ, Ctr Vector Biol, 180 Jones Ave, New Brunswick, NJ 08901 USA.
   [Unlu, Isik; Indelicato, Nicholas] Mercer Cty Mosquito Control, 300 Scotch Rd, West Trenton, NJ 08628 USA.
   [Faraji, Ary] Salt Lake City Mosquito Abatement Dist, Salt Lake City, UT 84116 USA.
   [Rochlin, Ilia] Suffolk Cty Vector Control, 335 Yaphank Ave, Yaphank, NY 11980 USA.
RP Unlu, I (reprint author), Rutgers State Univ, Ctr Vector Biol, 180 Jones Ave, New Brunswick, NJ 08901 USA.; Unlu, I (reprint author), Mercer Cty Mosquito Control, 300 Scotch Rd, West Trenton, NJ 08628 USA.
EM iunlu@mercercounty.org; ary@slcmad.org; nindelicato@mercercounty.org;
   ilia.rochlin@suffolkcountyny.gov
CR Anderson JF, 2012, J AM MOSQUITO CONTR, V28, P184, DOI 10.2987/12-6260R.1
   Beals E. W, 1984, ADV ECOL RES, V14, P55
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221
   Hoel DF, 2007, J AM MOSQUITO CONTR, V23, P11, DOI 10.2987/8756-971X(2007)23[11:EOCDOA]2.0.CO;2
   HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661
   Kline DL, 2007, MED VET ENTOMOL, V21, P323
   Kline DL, 2002, J VECTOR ECOL, V27, P1
   KLINE DL, 1990, MED VET ENTOMOL, V4, P383, DOI 10.1111/j.1365-2915.1990.tb00455.x
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Luhken R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-268
   Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1
   Obenauer PJ, 2010, ENVIRON ENTOMOL, V39, P1608, DOI 10.1603/EN09322
   Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   R Development Core Team, 2015, R LANG ENV STAT COMP
   Rochlin I, 2016, J MED ENTOMOL, V53, P454, DOI 10.1093/jme/tjv171
   Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999
   Unlu I, 2014, J AM MOSQUITO CONTR, V30, P122, DOI 10.2987/14-6401.1
   Unlu Isik, 2012, Hacettepe Journal of Biology and Chemistry, V40, P23
NR 25
TC 0
Z9 0
U1 5
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2016
VL 53
IS 4
BP 982
EP 985
DI 10.1093/jme/tjw068
PG 4
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DQ4WL
UT WOS:000379204800035
ER

PT J
AU Killion, MM
AF Killion, Molly M.
TI Zika Virus Update
SO MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING
LA English
DT Editorial Material
C1 [Killion, Molly M.] Univ Calif San Francisco, Benioff Childrens Hosp, Birth Ctr, San Francisco, CA 94143 USA.
RP Killion, MM (reprint author), Univ Calif San Francisco, Benioff Childrens Hosp, Birth Ctr, San Francisco, CA 94143 USA.
EM molly.killion@ucsf.edu
CR Centers for Disease Control and Prevention, 2016, QUEST ANSW ZIK VIR I
   Centers for Disease Control and Prevention, 2016, UPD INT GUID HLTH CA
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   [American College of Obstetricians and Gynecologists Society for Maternal-Fetal Medicine], 2016, PRACT ADV INT GUID C
NR 4
TC 0
Z9 0
U1 3
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0361-929X
EI 1539-0683
J9 MCN-AM J MATERN-CHIL
JI MCN-Am. J. Matern.-Child Nurs.
PD JUL-AUG
PY 2016
VL 41
IS 4
BP 252
EP 252
DI 10.1097/NMC.0000000000000246
PG 1
WC Nursing
SC Nursing
GA DQ4ID
UT WOS:000379166500009
ER

PT J
AU Govindarajan, M
   Hoti, SL
   Rajeswary, M
   Benelli, G
AF Govindarajan, Marimuthu
   Hoti, S. L.
   Rajeswary, Mohan
   Benelli, Giovanni
TI One-step synthesis of polydispersed silver nanocrystals using Malva
   sylvestris: an eco-friendly mosquito larvicide with negligible impact on
   non-target aquatic organisms
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Biosafety; Biosynthesis; Mosquito-borne diseases; Nanotechnology; Zika
   virus
ID QUINQUEFASCIATUS DIPTERA-CULICIDAE; ANOPHELES-STEPHENSI; AEDES-AEGYPTI;
   CULEX-QUINQUEFASCIATUS; GREEN SYNTHESIS; VETERINARY IMPORTANCE; LEAF
   EXTRACT; PLANT LATEX; NANOPARTICLES; MALARIA
AB The synthesis of eco-friendly nanoparticles is evergreen branch of nanoscience with a growing number of biomedical implications. In this study, we investigated the synthesis of polydisperse and stable silver nanoparticles (AgNP) using a cheap leaf extract of Malva sylvestris (Malvaceae). Bio-reduced AgNP were characterized by UV-visible spectrophotometry, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD), atomic force microscopy (AFM), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The acute toxicity of M. sylvestris leaf extract and green-synthesized AgNP was evaluated against larvae of the malaria vector Anopheles stephensi, the dengue vector Aedes aegypti and the filariasis vector Culex quinquefasciatus. Compared to the leaf aqueous extract, AgNP showed higher toxicity against A. stephensi, A. aegypti, and C. quinquefasciatus with LC50 values of 10.33, 11.23, and 12.19 mu g/mL, respectively. Green-synthesized AgNP were found safer to non-target organisms Diplonychus indicus and Gambusia affinis, with respective LC50 values ranging from 813.16 to 1044.52 mu g/mL. Overall, this research firstly shed light on the mosquitocidal potential of M. sylvestris, a potential bio-resource for rapid, cheap and effective synthesis of polydisperse and highly stable silver nanocrystals.
C1 [Govindarajan, Marimuthu; Rajeswary, Mohan] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Hoti, S. L.] Reg Med Res Ctr, Nehru Nagar, Belgaum 590010, Karnataka, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (reprint author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovindzoo@yahoo.com; g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013
CR Barros L, 2010, FOOD CHEM TOXICOL, V48, P1466, DOI 10.1016/j.fct.2010.03.012
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2016, PARASITOL RES, V115, P2131, DOI 10.1007/s00436-016-5037-y
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   BILLETER M, 1991, PHYTOCHEMISTRY, V30, P987, DOI 10.1016/0031-9422(91)85292-8
   DEO P G, 1988, International Pest Control, V30, P118
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gardea-Torresdey JL, 2002, NANO LETT, V2, P397, DOI [10.1021/nl015673+, 10.1021/nl.015673+]
   Dobhal M. P., 2010, INT J ENG SCI TECHNO, V59, P15
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Howard AFV, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-199
   Huang J, 2007, NANOTECHNOLOGY, V18, P1
   Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018
   Lee HJ, 2003, J MATER SCI, V38, P2199, DOI 10.1023/A:1023736416361
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Murugan K, 2016, PARASITOL RES, V115, P1085, DOI 10.1007/s00436-015-4838-8
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Pavela R., 2015, IND CROP PROD, V30, P311
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pirbalouti AG, 2010, ACTA POL PHARM, V67, P511
   Raghvendra K, 2002, ICMR B, V32
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   [Anonymous], 2012, INT RES J BIOL SCI
   Sap-Iam N., 2010, Journal of Applied Sciences, V10, P3132
   Sarwar M, 2009, PAK J BOT, V41, P3047
   Shameli K, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-73
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Smith SL, 2008, SPECTROCHIM ACTA A, V71, P186, DOI 10.1016/j.saa.2007.12.002
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   TOMODA M, 1989, CHEM PHARM BULL, V37, P3029
   Veerakumar K, 2014, PARASITOL RES, V113, P2363, DOI 10.1007/s00436-014-3895-8
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Vignesh V, 2013, COLLOID SURFACE A, V439, P184, DOI 10.1016/j.colsurfa.2013.04.011
   World Health Organization, 2005, WHOCDSWHOPESGCDPP13
NR 47
TC 3
Z9 3
U1 10
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD JUL
PY 2016
VL 115
IS 7
BP 2685
EP 2695
DI 10.1007/s00436-016-5038-x
PG 11
WC Parasitology
SC Parasitology
GA DQ2MO
UT WOS:000379036600018
PM 27075309
ER

PT J
AU Qin, XF
AF Qin, Xiao-Feng
TI Understanding the pathogenic evolution of Zika virus
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Editorial Material
C1 [Qin, Xiao-Feng] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Qin, Xiao-Feng] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Qin, Xiao-Feng] Suzhou Inst Syst Med, Suzhou 215123, Peoples R China.
RP Qin, XF (reprint author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Qin, XF (reprint author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Qin, XF (reprint author), Suzhou Inst Syst Med, Suzhou 215123, Peoples R China.
EM fqin1@foxmail.com
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 5
TC 0
Z9 0
U1 11
U2 11
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD JUL
PY 2016
VL 59
IS 7
BP 737
EP 739
DI 10.1007/s11427-016-5069-7
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DQ2OX
UT WOS:000379043200013
PM 27207138
ER

PT J
AU Gong, Z
   Gao, YX
   Han, GZ
AF Gong, Zhen
   Gao, Yuxia
   Han, Guan-Zhu
TI Zika Virus: Two or Three Lineages?
SO TRENDS IN MICROBIOLOGY
LA English
DT Editorial Material
ID EVOLUTION
AB Zika virus (ZIKV) infection has become an emerging concern of global public health. Several recent studies provide new insights into the evolution and diversity of ZIKV, with important implications for ongoing surveillance and control measures.
C1 [Gong, Zhen; Gao, Yuxia; Han, Guan-Zhu] Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing 210046, Jiangsu, Peoples R China.
RP Han, GZ (reprint author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing 210046, Jiangsu, Peoples R China.
EM guanzhu@email.arizona.edu
RI Han, Guan-Zhu/A-6818-2011
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Worobey M, 2008, J VIROL, V82, P3769, DOI 10.1128/JVI.02207-07
NR 8
TC 0
Z9 0
U1 13
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD JUL
PY 2016
VL 24
IS 7
BP 521
EP 522
DI 10.1016/j.tim.2016.05.002
PG 2
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA DQ3KD
UT WOS:000379100300004
PM 27220937
ER

PT J
AU Meagher, RJ
   Negrete, OA
   Van Rompay, KK
AF Meagher, Robert J.
   Negrete, Oscar A.
   Van Rompay, Koen K.
TI Engineering Paper-Based Sensors for Zika Virus
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Editorial Material
ID AMPLIFICATION
AB The emergence of Zika virus (ZIKV) infections in Latin America and Southeast Asia has created an urgent need for new, simple, yet sensitive, diagnostic tests. We highlight recent work using paper-based sensors coupled with CRISPR/Cas9 to detect ZIKV RNA as a new approach to achieve rapid development and deployment of field-ready diagnostics for emerging infectious diseases.
C1 [Meagher, Robert J.; Negrete, Oscar A.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94551 USA.
   [Van Rompay, Koen K.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
RP Meagher, RJ (reprint author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94551 USA.
EM rmeaghe@sandia.gov
CR Ball CS, 2016, ANAL CHEM, V88, P3562, DOI 10.1021/acs.analchem.5b04054
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]
   Faye O, 2015, EUROSURVEILLANCE, V20, P10, DOI 10.2807/1560-7917.ES.2015.20.44.30053
   Klevits T., 1991, J VIROL METHODS, V35, P273
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Perkins MD, 2015, NAT BIOTECHNOL, V33, P464, DOI 10.1038/nbt.3215
NR 9
TC 1
Z9 1
U1 21
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD JUL
PY 2016
VL 22
IS 7
BP 529
EP 530
DI 10.1016/j.molmed.2016.05.009
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DQ3ID
UT WOS:000379095100001
PM 27255410
ER

PT J
AU dos Santos, CND
   Goldenberg, S
AF Duarte dos Santos, Claudia Nunes
   Goldenberg, Samuel
TI Zika Virus and Vicrocephaly: Challenges for a Long-Term Agenda
SO TRENDS IN PARASITOLOGY
LA English
DT Editorial Material
ID TRANSMISSION; INFECTION; BRAZIL
AB Since its introduction in Brazil in 2015, Zika virus (ZIKV) has begun to spread worldwide. One of the major infection outcomes is related to congenital malformations, but little is known about the pathogenicity of ZIKV. Here we discuss concerns about the ongoing ZIKV epidemic in the context of academic research, politics, and society.
C1 [Duarte dos Santos, Claudia Nunes] Flocruz PR, Inst Carlos Chagas, Lab Virol Mol, Curitiba, PR, Brazil.
   [Goldenberg, Samuel] Flocruz PR, Inst Carlos Chagas, Lab Regulacao Expressao Genica, Curitiba, PR, Brazil.
RP dos Santos, CND (reprint author), Flocruz PR, Inst Carlos Chagas, Lab Virol Mol, Curitiba, PR, Brazil.
EM clsantos@fiocruz.br
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Noronha L., 2016, MEM I O CRUZ, V85, P5
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Zanluca C., 2016, MICROBES INFECT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD JUL
PY 2016
VL 32
IS 7
BP 508
EP 511
DI 10.1016/j.pt.2016.03.008
PG 4
WC Parasitology
SC Parasitology
GA DQ3IE
UT WOS:000379095200002
ER

PT J
AU Vahlne, A
AF Vahlne, Anders
TI How Zika virus made the transition from being a virtually unknown virus
   to a high-profile public health threat
SO ACTA PAEDIATRICA
LA English
DT Editorial Material
ID AMERICA
C1 [Vahlne, Anders] Karolinska Univ Hosp, Karolinska Inst, Div Clin Microbiol, Stockholm, Sweden.
RP Vahlne, A (reprint author), Karolinska Univ Hosp, Karolinska Inst, Div Clin Microbiol, Stockholm, Sweden.
EM anders.vahlne@ki.se
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Driggers RW, 2016, N ENGL J ME IN PRESS
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Tang H, 2016, CELL STEM C IN PRESS
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Willison HJ, 2016, LANCET IN PRESS
NR 8
TC 0
Z9 0
U1 11
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD JUL
PY 2016
VL 105
IS 7
BP 728
EP 729
DI 10.1111/apa.13436
PG 2
WC Pediatrics
SC Pediatrics
GA DP5VC
UT WOS:000378565100008
PM 27272625
ER

PT J
AU Dasti, JI
AF Dasti, Javid Iqbal
TI Zika virus infections: an overview of current scenario
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Neurological complications; microcephaly; Guillain-Barre
   syndrome; Aedes aegypti; Aedes albopictus
ID AEDES-AEGYPTI; DENGUE VIRUS; YELLOW-FEVER; TRANSMISSION; BRAZIL;
   CHIKUNGUNYA; MOSQUITOS; OUTBREAK; ORGANIZATION; TEMPERATURE
AB Zika virus (ZIKV) was discovered more than half a century ago, recently it has gained unprecedented attention by the global health community. Until 2007, only 14 cases of human ZIKV infections were reported around the globe, while during the current outbreak, estimated cases mounted to approximately 1.5 million in Brazil alone, the virus was disseminated to wider South-American territories and travel-associated ZIKV infections were reported in USA, Europe and recently in China. ZIKV infections remain asymptomatic in approximately 80% of the individuals, and no anti-viral treatments were recommended. Yet, neurological complications associated with the infections, such as infant microcephaly and Guillain-Barre syndrome are major cause of the concern. Although, based on small numbers of cases, existing evidence strongly supports an exclusive link of viral infection and observed neurological complications. However, much work remains to assign exact numbers of complications caused by ZIKV. Regarding its structural attributes ZIKV shows remarkable resemblance with dengue virus and West-Nile virus. Despite, genomes of different ZIKV strains have already been decoded; role of the viral components in infection process and particularly pathogenesis of the disease remain widely unclear. In vulnerable areas, most viable strategy to ensure public health safety is vector control and enhanced public awareness about the transmission of the disease.
C1 [Dasti, Javid Iqbal] Qauid I Azam Univ, Dept Microbiol, Islamabad, Pakistan.
RP Dasti, JI (reprint author), Qauid I Azam Univ, Dept Microbiol, Islamabad, Pakistan.
EM iqba178@hushmail.com
FU Higher Education Commission of Pakistan
FX The author would like to acknowledge Higher Education Commission of
   Pakistan for supporting this study.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   D'Ortenzio E, 2016, NEW ENGL J MED, DOI [10.1056/NEJMc1604449, DOI 10.1056/NEJMC160/1119]
   Du Toit A, 2016, NAT REV MICROBIOL, V14, P267, DOI [10.1038/nrmicro.2016.54, 10.1038/nrmicro.2016.55]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Finlay C, 1937, Yale J Biol Med, V9, P589
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376
   Jan C, 1977, B SOC PATHOL EXOT, V71, P140
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Kindhauser MK, 2016, B WHO UNPUB
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 2013, FIELDS VIROLOGY
   Logan IS, 2016, BIORXIV
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Monath TP, 1989, ARBOVIRUSES EPIDEMIO, VV
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2014, EUROSURVEILLANCE, V19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pierson T.C., 2013, FIELDS VIROLOGY, P747
   Robin Y, 1974, B SOC PATHOL EXOT, V68, P249
   Saluzzo JF, 1980, B SOC PATHOL EXOT, V74, P490
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P1
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 53
TC 0
Z9 0
U1 37
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2016
VL 9
IS 7
BP 601
EP 605
DI 10.1016/j.apjtm.2016.05.010
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500001
PM 27393087
ER

PT J
AU Jamil, Z
   Waheed, Y
   Durrani, TZ
AF Jamil, Zubia
   Waheed, Yasir
   Durrani, Taimoor Zeb
TI Zika virus, a pathway to new challenges
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Public health emergency; Microcephaly; Guillian-Barre
   syndrome; Mosquito bites
ID INFECTION; OUTBREAK; BRAZIL; AMERICA
AB The current Zika outbreak is largest of its kind with 1.4 million cases in Brazil alone. World Health Organization declared the current outbreak as the public health emergency of international concerns. The major route of Zika virus transmission is mosquito bites. Sexual transmission and monkey bites are also observed in few cases. There is dire need to evaluate the other routes of transmission like blood transfusion, lactation and contact with body fluids. Zika virus is infecting infants, not only causing microcephaly but also creating number of complications resulting in bad outcomes of pregnancy. In Brazil alone, 4 000 cases of microcephaly have observed during the current outbreak. The incidence of Guillian-Barre (GB) syndrome is also observed during the current Zika virus outbreak. GB syndrome is acute medical condition leading the patients to death due to weakness of respiratory muscles or can cause the life time disability. There is no anti-viral drug or vaccine available for Zika virus. Zika infection can be prevented by using mosquito repellents, mosquito nets, cooling rooms by air conditions and wearing full sleeves or permethrin treated clothes. The current outbreak of Zika has not only affected the health care but also caused great economic loss. Estimated loss in Latin America and Caribbean is US$3.5 billion. United Nation's sustainable development goal 3.d stresses the strengthening of early warning, risk reduction and management of national and global health risks. The world will keep on facing new challenges in the form of Ebola or Zika; there is strong need to prepare ourselves for any disease outbreak.
C1 [Jamil, Zubia] Fauji Fdn Hosp, Rawalpindi 46000, Pakistan.
   [Waheed, Yasir] Fdn Univ Islamabad, Fdn Univ Med Coll, DHA Phase 1, Islamabad 44000, Pakistan.
   [Durrani, Taimoor Zeb] Illikhar Eye Hosp, Liver Clin, Mayo Rd, Islamabad 44000, Pakistan.
RP Waheed, Y (reprint author), Fdn Univ Islamabad, Fdn Univ Med Coll, DHA Phase 1, Islamabad 44000, Pakistan.
EM yasir_waheed_199@hotmail.com
FU University Medical College; Foundation University Islamabad, DHA-I
   Islamabad, Pakistan
FX University Medical College. Foundation University Islamabad, DHA-I
   Islamabad (44000), Pakistan.
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Duhaime-Ross A, 2016, THE VERGE
   Elgot J, 2016, GUARDIAN
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gubio SC, 2015, EMERG INFECT DIS, V21, P1885
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Korte G, 2016, US TODAY
   Lawder D, 2016, REUTERS
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Maurice J, 2016, LANCET INFECT DIS
   Musso D, 2015, EMERG INFEC IN PRESS, V21, P552
   Palmer KM, 2016, CDC SEES BIRTH DEFEC
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Reuters, 2016, REUTERS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stewart A, 2016, VACCINE ZIKA VIRUS M
   Tozzi J, 9 PREGNANT AM TOURIS
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 23
TC 0
Z9 0
U1 34
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2016
VL 9
IS 7
BP 606
EP 609
DI 10.1016/j.apjtm.2016.05.020
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500002
PM 27393088
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Predicted pattern of Zika virus infection distribution with reference to
   rainfall in Thailand
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Infection; Rainfall
AB Zika virus infection is the present global medical problem. The disease appears in several countries around the world. The relationship between rainfall and occurrence of Zika virus infection was previously mentioned. Here, the authors use the mathematical modeling technique to reappraise on the previous data on immunoreactivity rate of Zika virus, dengue virus and Ckikungunya virus in Thailand and the reported interrelationship between arboviral infections and rainfall in Thailand for constructing of the predicted pattern of Zika virus distribution in Thailand. This data can be a useful tool for further disease surveillance in this area.
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou 571199, Hainan, Peoples R China.
RP Wiwanitkit, S (reprint author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S., 2015, Journal of Acute Disease, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit S, 2013, J ARTHROPOD-BORNE DI, V7, P185
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit Viroj, 2006, Journal of Vector Borne Diseases, V43, P73
NR 7
TC 0
Z9 0
U1 16
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2016
VL 9
IS 7
BP 698
EP 699
DI 10.1016/j.apjtm.2016.05.014
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500019
PM 27393105
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Humidity that is appropriate for Zika virus infection: A summary from
   Thai cases
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Letter
DE Zika virus; Humidity; Infection
ID CLIMATE
AB In the present day, Zika virus infection is a big problem in medicine. As a mosquito borne infectious disease, the climate parameters including humidity can affect the disease suitability. However, there is no previous data on the appropriate humidity level that can promote Zika virus infection. Here, the authors analyze the data on humidity where the Zika infections are detected in Thailand and found that the average humidity is equal to (66.14%+/- 19.86%), which is the level that can be seen in several areas of the world including to non-tropical countries. This implies that there is a possible risk of Zika virus infection in the non-tropical country with appropriate humidity level.
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pune, Maharashtra, India.
RP Joob, B (reprint author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
   SHOPE R, 1991, ENVIRON HEALTH PERSP, V96, P171, DOI 10.2307/3431227
   Wiwanitkit S., 2015, Journal of Acute Disease, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 7
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2016
VL 9
IS 7
BP 700
EP 700
DI 10.1016/j.apjtm.2016.05.016
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DP5ZU
UT WOS:000378577500020
PM 27393106
ER

PT J
AU Witkin, SS
AF Witkin, S. S.
TI The Zika virus epidemic: professionals and the public search for answers
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
C1 [Witkin, S. S.] Weill Cornell Med Obstet & Gynecol, Infect & Immunol Ob Gyn, New York, NY 10065 USA.
RP Witkin, SS (reprint author), Weill Cornell Med Obstet & Gynecol, Infect & Immunol Ob Gyn, New York, NY 10065 USA.
EM switkin@med.cornell.edu
NR 0
TC 0
Z9 0
U1 9
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1255
EP 1255
DI 10.1111/1471-0528.14076
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500002
PM 27151254
ER

PT J
AU Lissauer, D
   Smit, E
   Kilby, MD
AF Lissauer, D.
   Smit, E.
   Kilby, M. D.
TI Zika virus and pregnancy
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
ID CHIKUNGUNYA
C1 [Lissauer, D.; Kilby, M. D.] Univ Birmingham, Inst Metab & Syst Res, Coll Med & Dent Sci, Ctr Womens & Newborn Hlth, Birmingham, W Midlands, England.
   [Lissauer, D.; Kilby, M. D.] Birmingham Womens Fdn Trust Birmingham Hlth Partn, Fetal Med Ctr, Birmingham, W Midlands, England.
   [Smit, E.] Heart England NHS Fdn Trust, Publ Hlth England, West Midlands Publ Hlth Lab, Birmingham, W Midlands, England.
RP Kilby, MD (reprint author), Birmingham Womens Fdn Trust, Acad Unit, Third Floor, Birmingham B15 2TG, W Midlands, England.
EM m.d.kilby@bham.ac.uk
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   CDC, 2016, CDC HLTH ADV REC MAN
   CDC, 2016, ZIK VIR
   European Centre for Disease Prevention and Control, 2016, ZIK INF EP SIT
   Freire CCM, 2015, BIORXIV
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   [Anonymous], INT RCOG RCM PHE HPS
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Pan American Health Organisations, NEUR SYNDR CONG MALF
   Teixeira MG, 2000, PLOS NEGLECT TROP D, V7, pe2520, DOI [DOI 10.1371/JOURNAL.PNTD.0002520, 10.1371/journal.pntd.0002520]
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Vouga M, 2016, LANCET
   Wicks E, 2004, MED LAW REV, V12, P285, DOI 10.1093/medlaw/12.3.285
   [Anonymous], 2016, CTR DIS CONTROL PREV, V65, P59
NR 19
TC 0
Z9 0
U1 16
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1258
EP 1263
DI 10.1111/1471-0528.14071
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500003
PM 27150456
ER

PT J
AU Burke, RM
   Candfield, S
   Gothard, P
AF Burke, R. M.
   Candfield, S.
   Gothard, P.
TI Zika virus and microcephaly - more questions than answers?
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
C1 [Burke, R. M.; Candfield, S.; Gothard, P.] Univ Coll London Hosp FT, Hosp Trop Dis, Infect Div, London, England.
RP Burke, RM (reprint author), Univ Coll London Hosp FT, Hosp Trop Dis, Infect Div, London, England.
OI Candfield, Sophie/0000-0002-6543-7276
CR DUFFY, 2009, NEW ENGL J MED, V360, P2536
   GOURINAT, 2015, EMERG INFECT DIS, V21, P84
   HILLS, 2016, MMWR-MORBID MORTAL W, V8, P215
   LISSAUER S, 2016, BJOG, V123, P1258
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
NR 5
TC 0
Z9 0
U1 17
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1264
EP 1264
DI 10.1111/1471-0528.14073
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500004
PM 27150736
ER

PT J
AU Moron, AF
   Cavalheiro, S
   Milani, HJF
   Sarmento, SGP
   Tanuri, C
   de Souza, FF
   Richtmann, R
   Witkin, SS
AF Moron, A. F.
   Cavalheiro, S.
   Milani, H. J. F.
   Sarmento, S. G. P.
   Tanuri, C.
   de Souza, F. F.
   Richtmann, R.
   Witkin, S. S.
TI Microcephaly associated with maternal Zika virus infection
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Article
ID BRAZIL
C1 [Moron, A. F.; Milani, H. J. F.; Sarmento, S. G. P.] Hosp & Maternidade Santa Joana, Dept Fetal Med, Rua Leandro Dupret,334 Apto 81, BR-04025011 Sao Paulo, Brazil.
   [Cavalheiro, S.] Hosp & Maternidade Santa Joana, Dept Paediat Neurosurg, Sao Paulo, Brazil.
   [Tanuri, C.] Hosp & Maternidade Santa Joana, Neonatal Intens Care Unit, Sao Paulo, Brazil.
   [de Souza, F. F.] Hosp & Maternidade Santa Joana, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [Richtmann, R.] Hosp & Maternidade Santa Joana, Dept Infect Dis, Sao Paulo, Brazil.
   [Witkin, S. S.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA.
RP Moron, AF (reprint author), Hosp & Maternidade Santa Joana, Dept Fetal Med, Rua Leandro Dupret,334 Apto 81, BR-04025011 Sao Paulo, Brazil.
EM doutormoron.consultorio@gmail.com
CR [Anonymous], 2016, NEW ENGL J MED, DOI DOI 10.1056/NEJM0A1602412
   Brazil Ministry of Health, 15 BRAZ MIN HLTH
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SMFM Statement, 2016, AM J OBSTET GYNECOL
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 0
Z9 0
U1 26
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1265
EP 1269
DI 10.1111/1471-0528.14072
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500005
ER

PT J
AU Saade, GR
AF Saade, George R.
TI Asymptomatic pregnant women returning to the United States from
   countries experiencing a Zika virus outbreak should be tested for Zika
   virus : FOR: Importance of identification in ALL pregnant women
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
CR DASGUPTA, 2016, MMWR-MORBID MORTAL W, V65, P395
   FLEMINGDUTRA, 2016, MMWR-MORBID MORTAL W, V65, P182
   ODUYEBO, 2016, MMWR-MORBID MORTAL W, V65, P122
   SMFM Publications Committee, 2016, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2016.02.043, DOI 10.1016/J.AJOG.2016.02.043]
NR 4
TC 0
Z9 0
U1 3
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1272
EP 1272
DI 10.1111/1471-0528.14069
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500010
PM 27149896
ER

PT J
AU Sheffield, JS
AF Sheffield, Jeanne S.
TI Asymptomatic pregnant women returning to the United States from
   countries experiencing a Zika virus outbreak should be tested for Zika
   virus: AGAINST: Not so fast
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Editorial Material
C1 [Sheffield, Jeanne S.] Johns Hopkins Med, Maternal Fetal Med, Baltimore, MD 21287 USA.
RP Sheffield, JS (reprint author), Johns Hopkins Med, Maternal Fetal Med, Baltimore, MD 21287 USA.
CR ODUYEBO, 2016, MMWR-MORBID MORTAL W, V65, P122
   SCHULERFACCINI, 2016, MMWR-MORBID MORTAL W, V65, P59
NR 2
TC 0
Z9 0
U1 3
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD JUL
PY 2016
VL 123
IS 8
BP 1272
EP 1272
DI 10.1111/1471-0528.14068
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP5AN
UT WOS:000378508500009
PM 27150136
ER

PT J
AU Plourde, AR
   Bloch, EM
AF Plourde, Anna R.
   Bloch, Evan M.
TI A Literature Review of Zika Virus
SO EMERGING INFECTIOUS DISEASES
LA English
DT Review
ID TRANSMISSION; INFECTION; OUTBREAK; AMERICA; MICRONESIA; INDONESIA;
   SPREADS; THREAT; VECTOR; ISLAND
AB Zika virus is a mosquitoborne flavivirus that is the focus of an ongoing pandemic and public health emergency. Previously limited to sporadic cases in Africa and Asia, the emergence of Zika virus in Brazil in 2015 heralded rapid spread throughout the Americas. Although most Zika virus infections are characterized by subclinical or mild influenza-like illness, severe manifestations have been described, including Guillain-Barre syndrome in adults and microcephaly in babies born to infected mothers. Neither an effective treatment nor a vaccine is available for Zika virus; therefore, the public health response primarily focuses on preventing infection, particularly in pregnant women. Despite growing knowledge about this virus, questions remain regarding the virus's vectors and reservoirs, pathogenesis, genetic diversity, and potential synergistic effects of co-infection with other circulating viruses. These questions highlight the need for research to optimize surveillance, patient management, and public health intervention in the current Zika virus epidemic.
C1 [Plourde, Anna R.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Bloch, Evan M.] Johns Hopkins Univ, Baltimore, MD USA.
   [Bloch, Evan M.] Blood Syst Res Inst, San Francisco, CA USA.
RP Plourde, AR (reprint author), Univ Calif San Francisco, Dept Pathol & Lab Med, 505 Parnassus Ave, San Francisco, CA 94143 USA.
EM anna.plourde@ucsf.edu
CR Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Centers for Disease Control and Prevention, 2016, ZIKA VIRUS DISEASE I
   Dallas County Health and Human Services, 2016, DCHHS REPORTS FIRST
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2016, ZIKA VIRUS DISEASE E
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaffigan TVWR, 2016, SYSTEMATIC CATALOG O
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kraemer MU, 2015, SCI DATA, V2, DOI [DOI 10.1038/SDATA.2015.35, 10.1038/sdata.2015.35]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lastere S, 2014, EUROSURVEILLANCE, V19, P20751
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   MacNamara FN, 1954, T R SOC TROP MED HYG, V48, P139
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Roth A, 2012, EUROSURVEILLANCE, V19, P20929
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   US Food and Drug Administration, 2016, RECOMMENDATIONS FOR
NR 40
TC 2
Z9 2
U1 74
U2 74
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2016
VL 22
IS 7
BP 1185
EP 1192
DI 10.3201/eid2207.151990
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DP5UR
UT WOS:000378563900006
PM 27070380
ER

PT J
AU Waggoner, JJ
   Gresh, L
   Mohamed-Hadley, A
   Ballesteros, G
   Davila, MJV
   Tellez, Y
   Sahoo, MK
   Balmaseda, A
   Harris, E
   Pinsky, BA
AF Waggoner, Jesse J.
   Gresh, Lionel
   Mohamed-Hadley, Alisha
   Ballesteros, Gabriela
   Vargas Davila, Maria Jose
   Tellez, Yolanda
   Sahoo, Malaya K.
   Balmaseda, Angel
   Harris, Eva
   Pinsky, Benjamin A.
TI Single-Reaction Multiplex Reverse Transcription PCR for Detection of
   Zika, Chikungunya, and Dengue Viruses
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID TIME RT-PCR; PAN-DENGUE; MICRONESIA; ASSAYS
AB Clinical manifestations of Zika virus, chikungunya virus, and dengue virus infections can be similar. To improve virus detection, streamline molecular workflow, and decrease test costs, we developed and evaluated a multiplex real-time reverse transcription PCR for these viruses.
C1 [Waggoner, Jesse J.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Mohamed-Hadley, Alisha; Sahoo, Malaya K.; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
   [Gresh, Lionel] Sustainable Sci Inst, Managua, Nicaragua.
   [Ballesteros, Gabriela; Vargas Davila, Maria Jose; Tellez, Yolanda; Balmaseda, Angel] Minist Hlth, Lab Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
RP Pinsky, BA (reprint author), 3375 Hillview Ave,Room 2913, Palo Alto, CA 94304 USA.
EM bpinsky@stanford.edu
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH) [K08AI110528]; American Society of Tropical
   Medicine and Hygiene; NIH [R01AI099631, U54AI65359, HHSN2722001000026C];
   Pediatric Dengue Vaccine Initiative [VE-1]
FX This research was supported by National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health (NIH) grant
   K08AI110528 (to J.J.W.) and the Robert E. Shope International Fellowship
   in Infectious Diseases from the American Society of Tropical Medicine
   and Hygiene. Studies in Nicaragua were supported by NIH grants
   R01AI099631 (to A.B.) and U54AI65359 (to A.B.), NIH contract
   HHSN2722001000026C (to E.H. and A.B.), and VE-1 (to E.H.) from the
   Pediatric Dengue Vaccine Initiative. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09
   Diario El Nuevo, CONF CAS POS ZIK NIC
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Waggoner JJ, 2016, J CLIN VIROL, V78, P57, DOI 10.1016/j.jcv.2016.01.007
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 2
Z9 2
U1 21
U2 21
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2016
VL 22
IS 7
BP 1295
EP 1297
DI 10.3201/eid2207.160326
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DP5UR
UT WOS:000378563900030
PM 27184629
ER

PT J
AU Cerbino-Neto, J
   Mesquita, EC
   Souza, TML
   Parreira, V
   Wittlin, BB
   Durovni, B
   Lemos, MCF
   Vizzoni, A
   de Filippis, AMB
   Sampaio, SA
   Goncalves, BD
   Bozza, FA
AF Cerbino-Neto, Jose
   Mesquita, Emersom Cicilini
   Souza, Thiago Moreno L.
   Parreira, Viviane
   Wittlin, Bernardo Bastos
   Durovni, Betina
   Ferreira Lemos, Maria Cristina
   Vizzoni, Alexandre
   Bispo de Filippis, Ana Maria
   Sampaio, Simone Alves
   Goncalves, Bianca de Santis
   Bozza, Fernando A.
TI Clinical Manifestations of Zika Virus Infection, Rio de Janeiro, Brazil,
   2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION; MICRONESIA; OUTBREAK
C1 [Cerbino-Neto, Jose; Mesquita, Emersom Cicilini; Souza, Thiago Moreno L.; Parreira, Viviane; Vizzoni, Alexandre; Bispo de Filippis, Ana Maria; Sampaio, Simone Alves; Goncalves, Bianca de Santis; Bozza, Fernando A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Wittlin, Bernardo Bastos; Durovni, Betina; Ferreira Lemos, Maria Cristina] Secretaria Municipal Saude Estado Rio de Janeiro, Rio De Janeiro, Brazil.
RP Cerbino-Neto, J (reprint author), Inst Nacl Infectol Evandro Chagas INI Fiocruz, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM cerbino@fiocruz.br
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Martinez de Salazar P, 2016, ENFERM INFE IN PRESS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   WHO, 2016, ZIK SIT REP
   World Health Organization, 2015, ZIK VIR DIS
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 2
Z9 3
U1 9
U2 9
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2016
VL 22
IS 7
BP 1318
EP 1320
DI 10.3201/eid2207.160375
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DP5UR
UT WOS:000378563900041
PM 27070847
ER

PT J
AU Southwell, BG
   Dolina, S
   Jimenez-Magdaleno, K
   Squiers, LB
   Kelly, BJ
AF Southwell, Brian G.
   Dolina, Suzanne
   Jimenez-Magdaleno, Karla
   Squiers, Linda B.
   Kelly, Bridget J.
TI Zika Virus-Related News Coverage and Online Behavior, United States,
   Guatemala, and Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID AVIAN INFLUENZA
C1 [Southwell, Brian G.; Dolina, Suzanne; Jimenez-Magdaleno, Karla; Squiers, Linda B.; Kelly, Bridget J.] RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.
RP Southwell, BG (reprint author), RTI Int, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.
EM bsouthwell@rti.org
OI Southwell, Brian/0000-0001-5091-8782
CR Dudo AD, 2007, SCI COMMUN, V28, P429, DOI 10.1177/1075547007302211
   Kelly B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2441-7
   Prue C, 2015, NAT C HLTH COMM MARK
   Rowan KE, 2015, SPECTRA, V51, P13
   Southwell Brian, 2003, Minn Med, V86, P14
   Southwell BG, 2006, EMERG INFECT DIS, V12, P1797
   Southwell BG, 2013, INFECTIOUS DISEASE SURVEILLANCE, 2ND EDITION, P607
   Tavernise S, 2016, NY TIMES
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Weeks BE, 2012, HEALTH COMMUN, V27, P158, DOI 10.1080/10410236.2011.571757
NR 10
TC 1
Z9 1
U1 6
U2 6
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2016
VL 22
IS 7
BP 1320
EP 1321
DI 10.3201/eid2207.160415
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DP5UR
UT WOS:000378563900042
PM 27100826
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus infection: Control and prevention
SO JOURNAL OF THE CHINESE MEDICAL ASSOCIATION
LA English
DT Letter
ID PUBLIC-HEALTH
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Dept Publ Hlth Curriculum, Mueang Surin Dist, Surin, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Dept Community Med, Pune, Maharashtra, India.
RP Wiwanitkit, V (reprint author), Wiwanitkit House,140 Bangkhae 7, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Burd I, 2016, J ASSIST REPROD GEN, V33, P439, DOI 10.1007/s10815-016-0687-3
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Wiwanitkit S, 2016, ASIAN PAC J IN PRESS
NR 5
TC 1
Z9 1
U1 11
U2 11
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1726-4901
EI 1728-7731
J9 J CHIN MED ASSOC
JI J. Chin. Med. Assoc.
PD JUL
PY 2016
VL 79
IS 7
BP 409
EP 409
DI 10.1016/j.jcma.2016.04.002
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP6BY
UT WOS:000378583100011
PM 27221543
ER

PT J
AU Chen, HL
   Tang, RB
AF Chen, Hui-Lan
   Tang, Ren-Bin
TI Zika virus infection: Control and prevention Reply
SO JOURNAL OF THE CHINESE MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Chen, Hui-Lan] Minist Hlth & Welf, Keelung Hosp, Dept Pediat, Keelung, Taiwan.
   [Tang, Ren-Bin] Cheng Hsin Gen Hosp, Div Pediat, 45 Cheng Hsin St, Taipei 112, Taiwan.
RP Tang, RB (reprint author), Cheng Hsin Gen Hosp, Div Pediat, 45 Cheng Hsin St, Taipei 112, Taiwan.
EM ch9406@chgh.org.com.tw
CR Centers for Disease Control R.O.C (Taiwan), 2016, US TAIW COORG INT TR
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Wiwanitkit V, 2016, J CHIN MED ASSOC, V79, P409, DOI 10.1016/j.jcma.2016.04.002
NR 6
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1726-4901
EI 1728-7731
J9 J CHIN MED ASSOC
JI J. Chin. Med. Assoc.
PD JUL
PY 2016
VL 79
IS 7
BP 410
EP 410
DI 10.1016/j.jcma.2016.04.004
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP6BY
UT WOS:000378583100012
PM 27238558
ER

PT J
AU Hamel, R
   Liegeois, F
   Wichit, S
   Pompon, J
   Diop, F
   Talignani, L
   Thomas, F
   Despres, P
   Yssel, H
   Misse, D
AF Hamel, Rodolphe
   Liegeois, Florian
   Wichit, Sineewanlaya
   Pompon, Julien
   Diop, Fode
   Talignani, Loic
   Thomas, Frederic
   Despres, Philippe
   Yssel, Hans
   Misse, Dorothee
TI Zika virus: epidemiology, clinical features and host-virus interactions
SO MICROBES AND INFECTION
LA English
DT Review
DE ZIKA; Arbovirus; Innate immunity; Epidemiology; Host-pathogen
   interactions; Vector
ID HUMAN DENDRITIC CELLS; DENGUE-VIRUS; HUMAN SKIN; RIG-I; INFECTION;
   TRANSMISSION; FLAVIVIRUSES; REPLICATION; RECEPTORS; OUTBREAK
AB Very recently, Zika virus (ZIKV) has gained a medical importance following the large-scale epidemics in South Pacific and Latin America. This paper reviews information on the epidemiology and clinical features of Zika disease with a particular emphasis on the host-virus interactions that contribute to the pathogenicity of ZIKV in humans. (C) 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Hamel, Rodolphe; Liegeois, Florian; Wichit, Sineewanlaya; Pompon, Julien; Diop, Fode; Talignani, Loic; Thomas, Frederic; Misse, Dorothee] CNRS, UM1, Lab MIVEGEC, UMR IRD 224, Montpellier, France.
   [Pompon, Julien] Duke NUS Med Sch, Programme Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
   [Despres, Philippe] Univ La Reunion, GIP CYROI, CNRS 9192, UM PIMIT 134,Inserm U1187,IRD 249, St Clotilde 97491, Reunion.
   [Yssel, Hans] UPMC, Univ Paris 04, Hop Pitie Salpetriere, AP HP,Ctr Immunol & Malad Infect,Inserm,U1135, Paris, France.
RP Misse, D (reprint author), CNRS, UM1, Lab MIVEGEC, UMR IRD 224, Montpellier, France.
EM dorothee.misse@ird.fr
RI Liegeois, Florian/D-3798-2013
OI Liegeois, Florian/0000-0003-1048-0661
FU French Research Agency "Agence Nationale de la Recherche"
   [ANR-12-BSV3-0004-01, ANR-14-CE14-0029]
FX This work was supported by grants from the French Research Agency
   "Agence Nationale de la Recherche" (ANR-12-BSV3-0004-01;
   ANR-14-CE14-0029).
CR Besnard M, 2014, EUROSURVEILLANCE, P19
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2013, EMERG INFECT DIS, V2014, P1084
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P446, DOI 10.1016/0035-9203(83)90108-6
   Diallo M, 1999, AM J TROP MED HYG, V60, P281
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2014, EMERG INFECT DIS, V2015, P381
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2010, EMERG INFECT DIS, V2012, P349
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Ivory MO, 2015, J INVEST DERMATOL, V135, P1711, DOI 10.1038/jid.2014.544
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, P19
   LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X
   Lanciotti R.S., 2007, EMERG INFECT DIS, V2008, P1232
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu Wen Jun, 2004, Journal of Virology, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2015, BISES B INFORM SANIT, P1
   Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pyke AT, 2014, PLOS CURR, V6
   Roth A, 2014, EUROSURVEILLANCE, V19
   Salazar M. I., 2013, THESCIENTIFICWORLDJO, V2013, DOI 10.1155/2013/904067
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Shipley JG, 2012, VIROLOGY, V432, P232, DOI 10.1016/j.virol.2012.06.009
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 70
TC 2
Z9 2
U1 29
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD JUL-AUG
PY 2016
VL 18
IS 7-8
DI 10.1016/j.micinf.2016.03.009
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DP9WK
UT WOS:000378848400001
ER

PT J
AU Aliota, MT
   Peinado, SA
   Velez, ID
   Osorio, JE
AF Aliota, Matthew T.
   Peinado, Stephen A.
   Dario Velez, Ivan
   Osorio, Jorge E.
TI The wMel strain of Wolbachia Reduces Transmission of Zika virus by Aedes
   aegypti
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUSES; YELLOW-FEVER; GEOGRAPHIC STRAINS; CHIKUNGUNYA VIRUS;
   MOSQUITO VECTOR; INFECTION; SUSCEPTIBILITY; ALBOPICTUS; OUTBREAK;
   ESTABLISHMENT
AB Zika virus (ZIKV) is causing an explosive outbreak of febrile disease in the Americas. There are no effective antiviral therapies or licensed vaccines for this virus, and mosquito control strategies have not been adequate to contain the virus. A promising candidate for arbovirus control and prevention relies on the introduction of the intracellular bacterium Wolbachia into Aedes aegypti mosquitoes. This primarily has been proposed as a tool to control dengue virus (DENV) transmission; however, evidence suggests Wolbachia infections confer protection for Ae. aegypti against other arboviruses. At present, it is unknown whether or not ZIKV can infect, disseminate, and be transmitted by Wolbachia-infected Ae. aegypti. Using Ae. aegypti infected with the wMel strain of Wolbachia that are being released in Medellin, Colombia, we report that these mosquitoes have reduced vector competence for ZIKV. These results support the use of Wolbachia biocontrol as a multivalent strategy against Ae. aegypti-transmitted viruses.
C1 [Aliota, Matthew T.; Peinado, Stephen A.; Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Dario Velez, Ivan] Univ Antioquia, PECET, Medellin 1226, Colombia.
RP Aliota, MT (reprint author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
EM mtaliota@wisc.edu
FU National Institutes of Health [R21 AI117413-01]
FX The authors thank Emma Walker and Katrina Larkin for time spent rearing
   mosquitoes. We also thank the Eliminate Dengue Program for sharing
   Wolbachia-infected mosquitoes. This work was partially funded by
   National Institutes of Health Grant # R21 AI117413-01.
CR Aliota MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039387
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CHRISTENSEN BM, 1984, T AM MICROSC SOC, V103, P423, DOI 10.2307/3226478
   Cornet M., CAH ORSTOM EMP, V27, P47
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers R.W., 2016, N ENGL J MED
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Mlakar J., 2016, N ENGL J MED
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Rasgon JL, 2004, INSECT BIOCHEM MOLEC, V34, P707, DOI 10.1016/j.ibmb.2004.03.023
   Rasmussen SA, 2016, N ENGL J MED
   Reiczigel J, 2008, COMPUT STAT DATA AN, V52, P5046, DOI 10.1016/j.csda.2008.04.032
   RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weger-Lucarelli J, 2016, J VIROL, V90, P2418, DOI 10.1128/JVI.02792-15
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 47
TC 1
Z9 1
U1 33
U2 33
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 1
PY 2016
VL 6
AR 28792
DI 10.1038/srep28792
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ0JB
UT WOS:000378884100001
PM 27364935
ER

PT J
AU Ladhani, SN
   O'Connor, C
   Kirkbride, H
   Brooks, T
   Morgan, D
AF Ladhani, Shamez N.
   O'Connor, Catherine
   Kirkbride, Hilary
   Brooks, Tim
   Morgan, Dilys
TI Outbreak of Zika virus disease in the Americas and the association with
   microcephaly, congenital malformations and Guillain-Barre syndrome
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Article
ID TRANSMISSION
C1 [Ladhani, Shamez N.; O'Connor, Catherine; Kirkbride, Hilary; Morgan, Dilys] Publ Hlth England, Natl Infect Serv, 61 Colindale Ave, London NW9 5EQ, England.
   [Ladhani, Shamez N.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England.
   [Brooks, Tim] Publ Hlth England, Rare & Imported Pathogens Lab, Salisbury, Wilts, England.
RP Ladhani, SN (reprint author), Publ Hlth England, Immunisat Dept, 61 Colindale Ave, London NW9 5EQ, England.
EM shamez.ladhani@phe.gov.uk
CR Arzusa-Ortega L, 2016, EMERGING INFECT DIS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 5
TC 0
Z9 0
U1 40
U2 40
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 1468-2044
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD JUL
PY 2016
VL 101
IS 7
BP 600
EP 602
DI 10.1136/archdischild-2016-310590
PG 3
WC Pediatrics
SC Pediatrics
GA DO8WF
UT WOS:000378065400004
PM 26998633
ER

PT J
AU O'Malley, PA
AF O'Malley, Patricia Anne
TI Zika Virus What We Know and Do Not Know
SO CLINICAL NURSE SPECIALIST
LA English
DT Article
ID UNITED-STATES
C1 [O'Malley, Patricia Anne] Premier Hlth Miami Valley Hosp, Ctr Nursing Excellence, Dayton, OH 45409 USA.
RP O'Malley, PA (reprint author), Premier Hlth Miami Valley Hosp, 1 Wyoming St, Dayton, OH 45409 USA.
EM pomalley@premierhealth.com
CR Centers forDisease Control, 2016, ZIK VIR AR ZIK
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Tang H, CELL STEM CELL
   World Health Organization, 2016, ZIK VIR ZIK VIR FACT
   World Health Organization, MICR FACT SHEET
   World Health Organization, 2016, GUILL BARR SYNDR FAC
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P352
NR 10
TC 0
Z9 0
U1 17
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0887-6274
EI 1538-9782
J9 CLIN NURSE SPEC
JI Clin. Nurse Spec.
PD JUL-AUG
PY 2016
VL 30
IS 4
BP 194
EP 197
DI 10.1097/NUR.0000000000000218
PG 4
WC Nursing
SC Nursing
GA DO8TA
UT WOS:000378055500005
PM 27309781
ER

PT J
AU Steele, RW
AF Steele, Russell W.
TI Zika Virus: An Explosive Pandemic and a New TORCH Agent
SO CLINICAL PEDIATRICS
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES
C1 [Steele, Russell W.] Univ Queensland, Sch Med, Herston, Qld, Australia.
   [Steele, Russell W.] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.
   [Steele, Russell W.] Ochsner Childrens Hlth Ctr, 1315 Jefferson Highway, New Orleans, LA 70121 USA.
RP Steele, RW (reprint author), Ochsner Childrens Hlth Ctr, 1315 Jefferson Highway, New Orleans, LA 70121 USA.
EM RWSteele@aol.com
CR Centers for Disease Control and Prevention, 2016, EM PREP RESP REC MAN
   Centers for Disease Control and Prevention, ZIK VIR DIAGN TEST
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Ministry of Health-Manuatu Hauora, ZIK VIR
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization, ZIK VIR INF
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
NR 10
TC 0
Z9 0
U1 7
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0009-9228
EI 1938-2707
J9 CLIN PEDIATR
JI Clin. Pediatr.
PD JUL
PY 2016
VL 55
IS 8
BP 698
EP 700
DI 10.1177/0009922816638660
PG 3
WC Pediatrics
SC Pediatrics
GA DP3NV
UT WOS:000378402500002
PM 27000068
ER

PT J
AU Vorou, R
AF Vorou, Rengina
TI Zika virus, vectors, reservoirs, amplifying hosts, and their potential
   to spread worldwide: what we know and what we should investigate
   urgently
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus infection; Vector; Animal; Aedes; Anopheles; Migrants
ID STEGOMYIA ALBOPICTUS SKUSE; AEDES-ALBOPICTUS; YELLOW-FEVER;
   DIPTERA-CULICIDAE; TRANSMISSION; INFECTION; MOSQUITOS; BRAZIL;
   ARBOVIRUSES; CHIKUNGUNYA
AB Objectives: The widespread epidemic of Zika virus infection in South and Central America and the Caribbean in 2015, along with the increased incidence of microcephaly in fetuses born to mothers infected with Zika virus and the potential for worldwide spread, indicate the need to review the current literature regarding vectors, reservoirs, and amplification hosts.
   Vectors: The virus has been isolated in Africa in mosquitoes of the genera Aedes, Anopheles, and Mansonia, and in Southeast Asia and the Pacific area in mosquitoes of the genus Aedes. Aedes albopictus has invaded several countries in Central Africa and all Mediterranean countries, and continues to spread throughout Central and Northern Europe. The wide distribution of the virus in animal hosts and vectors favors the emergence of recombinants.
   Animal hosts: The virus has been isolated in monkeys, and antibodies have been detected in domestic sheep, goats, horses, cows, ducks, rodents, bats, orangutans, and carabaos.
   Conclusions: It is a public health imperative to define the domestic and wild animal reservoirs, amplification hosts, and vector capacity of the genera Aedes, Anopheles, and Mansonia. These variables will define the geographic distribution of Zika virus along with the indicated timing and scale of the environmental public health interventions worldwide. (C) 2016 The Author. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Vorou, Rengina] Hellen Ctr Dis Control & Prevent, 3-5 Agrafon Str, Athens 15123, Greece.
RP Vorou, R (reprint author), Hellen Ctr Dis Control & Prevent, 3-5 Agrafon Str, Athens 15123, Greece.
EM vorou@keelpno.gr
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Boukraa S, 2015, J VECTOR ECOL, V40, P398, DOI 10.1111/jvec.12180
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   CDC, 2016, REV DIAGN TEST ZIK C
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erguler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149282
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2013, VIROL J, V10, P311, DOI DOI 10.1186/1743-422X-10-311
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kampango A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1361-4
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marcondes CB, 2015, REV SOC BRAS MED TRO, V49, P4
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Prata A, 2000, MEM I OSWALDO CRUZ, V95, P183, DOI 10.1590/S0074-02762000000700031
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roze B, 2016, EURO SURVEILL, V21
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Valerio L, 2015, TRAVEL MED INFECT DI, V13, P415, DOI 10.1016/j.tmaid.2015.06.008
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vorou R, 2016, EURO SURVEILL, V21
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Werner D, 2015, PARASITOL RES, V115, P1331
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 0
Z9 0
U1 50
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2016
VL 48
BP 85
EP 90
DI 10.1016/j.ijid.2016.05.014
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DO8PW
UT WOS:000378046700022
PM 27208633
ER

PT J
AU Wasserman, S
   Tambyah, PA
   Lim, PL
AF Wasserman, Sean
   Tambyah, Paul Anantharajah
   Lim, Poh Lian
TI Yellow fever cases in Asia: primed for an epidemic
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Yellow fever; Aedes aegypti; Arboviruses; Flaviviruses; Emerging
   infectious diseases
ID AEDES-AEGYPTI; CHANGING EPIDEMIOLOGY; ZIKA VIRUS; DENGUE; RISK; AFRICA;
   SPREAD; EVOLUTIONARY; REEMERGENCE; CHIKUNGUNYA
AB There is currently an emerging outbreak of yellow fever in Angola. Cases in infected travellers have been reported in a number of other African countries, as well as in China, representing the first ever documented cases of yellow fever in Asia. There is a large Chinese workforce in Angola, many of whom may be unvaccinated, increasing the risk of ongoing importation of yellow fever into Asia via busy commercial airline routes. Large parts of the region are hyperendemic for the related Flavivirus dengue and are widely infested by Aedes aegypti, the primary mosquito vector of urban yellow fever transmission. The combination of sustained introduction of viraemic travellers, an ecology conducive to local transmission, and an unimmunized population raises the possibility of a yellow fever epidemic in Asia. This represents a major global health threat, particularly in the context of a depleted emergency vaccine stockpile and untested surveillance systems in the region. In this review, the potential for a yellow fever outbreak in Asia is discussed with reference to the ecological and historical forces that have shaped global yellow fever epidemiology. The limitations of surveillance and vector control in the region are highlighted, and priorities for outbreak preparedness and response are suggested. (C) 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Wasserman, Sean] Univ Cape Town, Dept Med, Div Infect Dis, ZA-7925 Cape Town, South Africa.
   [Wasserman, Sean] Univ Cape Town, Dept Med, HIV Med, ZA-7925 Cape Town, South Africa.
   [Tambyah, Paul Anantharajah] Natl Univ Singapore, Div Infect Dis, Singapore 117548, Singapore.
   [Lim, Poh Lian] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Dept Infect Dis, Singapore, Singapore.
   [Lim, Poh Lian] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
RP Wasserman, S (reprint author), Univ Cape Town, Dept Med, Div Infect Dis, ZA-7925 Cape Town, South Africa.; Wasserman, S (reprint author), Univ Cape Town, Dept Med, HIV Med, ZA-7925 Cape Town, South Africa.
EM sean.wasserman@gmail.com
CR Abrao E, 2007, 26 ANN M AM SOC VIR, P273
   Abrao E, 2006, VIRUS REV RES, V2006, P130
   Amaku M, 2011, BIOSYSTEMS, V106, P111, DOI 10.1016/j.biosystems.2011.07.004
   Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   BEATY BJ, 1979, MOSQ NEWS, V39, P232
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   BRES PLJ, 1986, B WORLD HEALTH ORGAN, V64, P775
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Carrington CVF, 2013, INFECT GENET EVOL, V13, P198, DOI 10.1016/j.meegid.2012.08.015
   Cathey JT, 2014, T ROY SOC TROP MED H, V108, P252, DOI 10.1093/trstmh/tru043
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Lim PL, 2013, J TRAVEL MED, V20, P211, DOI 10.1111/jtm.12031
   MAHAFFY A. F., 1941, ANN TROP MED AND PARASITOL, V35, P141
   Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Monath T P, 2006, Bull Soc Pathol Exot, V99, P341
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7
   MONATH TP, 1991, AM J TROP MED HYG, V45, P1
   Monath TP, 1999, LANCET, V353, P1541, DOI 10.1016/S0140-6736(99)00155-5
   Monath TP, 2002, CLIN INFECT DIS, V34, P1369, DOI 10.1086/340104
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Mutebi JP, 2002, MICROBES INFECT, V4, P1459, DOI 10.1016/S1286-4579(02)00028-X
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   NASIDI A, 1993, T ROY SOC TROP MED H, V87, P337, DOI 10.1016/0035-9203(93)90156-K
   Pan American Health Organization, 2013, TECHN REP REC SCI EV
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   ProMED, 2016, YELL FEV AFR 02 ANG
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Sanders EJ, 1998, AM J TROP MED HYG, V59, P644
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P879
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   THEILER M, 1975, AM J TROP MED HYG, V24, P115
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   Tomori Oyewale, 2002, Biomedica, V22, P178
   Van der Stuyft P, 1999, LANCET, V353, P1558, DOI 10.1016/S0140-6736(99)03291-2
   World Health Organization, 2008, WKLY EPIDEMIOL REC, V83, P105
   World Health Organization, 2015, GLOB REG IMM PROF AF
   WHO, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, YELL FEV DEM REP CON
   World Health Organization, 2014, RISK ASS YELL FEV VI
   World Health Organization, 2016, YELL FEV KEN 6 APR 2
   Xiao SY, 2003, AM J TROP MED HYG, V68, P695
NR 58
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2016
VL 48
BP 98
EP 103
DI 10.1016/j.ijid.2016.04.025
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA DO8PW
UT WOS:000378046700025
PM 27156836
ER

PT J
AU Nawas, ZY
   Tong, Y
   Kollipara, R
   Peranteau, AJ
   Woc-Colburn, L
   Yan, AC
   Lupi, O
   Tyring, SK
AF Nawas, Zeena Y.
   Tong, Yun
   Kollipara, Ramya
   Peranteau, Andrew J.
   Woc-Colburn, Laila
   Yan, Albert C.
   Lupi, Omar
   Tyring, Stephen K.
TI Emerging infectious diseases with cutaneous manifestations Viral and
   bacterial infections
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Article
DE Acinetobacter baumannii; Chikungunya; dengue; Ebola; emerging
   infections; HFMD; Lyme; measles; melioidosis; rickettsia;
   trichodysplasia spinulosa; Zika
ID MOUNTAIN-SPOTTED-FEVER; ZIKA VIRUS OUTBREAK; RESISTANT
   STAPHYLOCOCCUS-AUREUS; TICK-BORNE LYMPHADENOPATHY; RICKETTSIA-FELIS
   INFECTION; UPDATE INTERIM GUIDANCE; OF-THE-LITERATURE; UNITED-STATES;
   MOUTH-DISEASE; TRICHODYSPLASIA-SPINULOSA
AB Given increased international travel, immigration, and climate change, bacterial and viral infections that were once unrecognized or uncommon are being seen more frequently in the Western Hemisphere. A delay in diagnosis and treatment of these diseases can lead to significant patient morbidity and mortality. However, the diagnosis and management of these infections is fraught with a lack of consistency because there is a dearth of dermatology literature on the cutaneous manifestations of these infections. We review the epidemiology, cutaneous manifestations, diagnosis, and management of these emerging bacterial and viral diseases.
C1 [Nawas, Zeena Y.; Tong, Yun; Peranteau, Andrew J.; Tyring, Stephen K.] Ctr Clin Studies, Houston, TX USA.
   [Kollipara, Ramya] Texas Tech Hlth Sci Ctr, Dept Dermatol, Lubbock, TX USA.
   [Woc-Colburn, Laila] Baylor Coll Med, Natl Sch Trop Med, Dept Med, Houston, TX 77030 USA.
   [Yan, Albert C.] Childrens Hosp Philadelphia, Dermatol Sect, Philadelphia, PA USA.
   [Lupi, Omar] Fed Univ State Rio de Janeiro, Rio De Janeiro, Brazil.
   [Lupi, Omar] Policlin Geral Rio Janeiro, Rio De Janeiro, Brazil.
   [Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA.
RP Nawas, ZY (reprint author), Dermatol Assoc, 1401 Binz St,Ste 200, Houston, TX 77030 USA.
EM znawas@ccstexas.com
CR Abarca K, 2014, REV CHIL INFECTOL, V31, P569, DOI 10.4067/S0716-10182014000500009
   [Anonymous], 2015, ABCS BACT SURV 2012
   Abdullah S, 2015, EUR REV MED PHARMACO, V19, P2983
   Abrao EP, 2015, REV SAUDE PUBL, P49
   Adler BL, 2014, JAMA DERMATOL, V150, P905, DOI 10.1001/jamadermatol.2013.8855
   Allegue F, 2009, CLIN EXP DERMATOL, V34, pe246, DOI 10.1111/j.1365-2230.2008.03115.x
   Arroyo-Avila M, 2015, P R HEALTH SCI J, V34, P71
   Atkinson B, 2016, EMERG INFECT DIS J, V22
   Bachmeyer C, 2005, CLIN EXP DERMATOL, V30, P256, DOI 10.1111/j.1365-2230.2005.01743.x
   Bandyopadhyay Debabrata, 2010, Indian J Dermatol, V55, P64, DOI 10.4103/0019-5154.60356
   Benoit TJ, 2015, AM J TROP MED HYG, V93, P1134, DOI 10.4269/ajtmh.15-0405
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bitam I, 2010, INT J INFECT DIS, V14, pE667, DOI 10.1016/j.ijid.2009.11.011
   Blattner CM, 2015, DERMATOL ONLINE J, P21
   Campbell Ross M, 2006, Arch Dermatol, V142, P1643, DOI 10.1001/archderm.142.12.1643-d
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, ROCK MOUNT SPOTT FEV
   [Anonymous], MEASL HEALTHC PROF
   CDC, HAND FOOT MOUTH DIS
   [Anonymous], STAT EHRL
   [Anonymous], ZIK VIR S AM AL LEV
   [Anonymous], CHIK VIR US CHIK VIR
   [Anonymous], TRANSM MEL
   [Anonymous], 2014 FIN DAT US CHIK
   [Anonymous], SIGNS SYMPT LYM DIS
   [Anonymous], GEOGR DISTR ZIK VIR
   [Anonymous], ZIK VIR CENTR AM AL
   [Anonymous], MAN PEOPL GET LYM DI
   [Anonymous], 2015 PROV DAT US CHI
   [Anonymous], ZIK VIR CAR AL LEV 2
   [Anonymous], ZI9K VIR US ZIK VIR
   [Anonymous], SYMPT DIAGN TREATM Z
   [Anonymous], REP CAS LYM DIS STAT
   [Anonymous], ZIK VIR PUERT RIC AL
   CDC, INT MAPS LYM DIS
   [Anonymous], SIGNS SYMPT MEL
   [Anonymous], MEL C
   [Anonymous], ZIK VIR MEX AL LEV 2
   [Anonymous], AR ZIK ZIK VIR
   [Anonymous], TRENDS TUB US
   [Anonymous], CLIN EV DIS ZIK VIR
   Centers for Disease Control and Prevention website, EB HEM FEV
   Centers for Disease Control and Prevention website, DIAGN EB HEM FEV
   Centers for Disease Control and Prevention website, DENG CHAPT 3 2016 YE
   Centers for Disease Control and Prevention website, CAS DEF DENG
   Centers for Disease Control and Prevention website, DENGUE
   Chen SM, 2015, ASIA-PAC J PUBLIC HE, V27, P715, DOI 10.1177/1010539515579123
   Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221
   Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900
   Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6
   David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09
   Demma LJ, 2005, NEW ENGL J MED, V353, P587, DOI 10.1056/NEJMoa050043
   Downing C, 2014, J CLIN VIROL, V60, P381, DOI 10.1016/j.jcv.2014.04.023
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2014, ZIK VIR INF OUTBR FR
   Edouard S, 2014, EMERG INFECT DIS, V20, P1780, DOI 10.3201/eid2010.140905
   Eliopoulos G. M., 2008, CLIN INFECT DIS, V46, P1254
   Elston D, WHATS EATING YOUR 1
   Essackjee K, 2013, POSTGRAD MED J, V89, P440, DOI 10.1136/postgradmedj-2012-131477
   Fischer MK, 2012, ARCH DERMATOL, V148, P726, DOI 10.1001/archdermatol.2011.3298
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Foldvari G, 2013, DIAGN MICR INFEC DIS, V76, P387, DOI 10.1016/j.diagmicrobio.2013.03.005
   Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202
   Gan ZK, 2015, HUM VACC IMMUNOTHER, V11, P2400, DOI 10.1080/21645515.2015.1059980
   Garnacho-Montero J, 2015, INTENS CARE MED, V41, P2057, DOI 10.1007/s00134-015-4079-4
   Gerardin P, 2013, ARTHRITIS RES THER, V15, P1
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HALSTEAD SB, 1984, REV INFECT DIS, V6, P251
   Haycox CL, 1999, J INVEST DERM SYMP P, V4, P268, DOI 10.1038/sj.jidsp.5640227
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HELMICK CG, 1984, J INFECT DIS, V150, P480
   Holzer AM, 2009, J AM ACAD DERMATOL, V60, P169, DOI 10.1016/j.jaad.2008.07.051
   Ibarra V, 2006, ANN NY ACAD SCI, V1078, P206, DOI 10.1196/annals.1374.040
   Ibarra V, 2005, ANN NY ACAD SCI, V1063, P257, DOI 10.1196/annals.1355.040
   Inamadar AC, 2008, INT J DERMATOL, V47, P154, DOI 10.1111/j.1365-4632.2008.03478.x
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Jawad A, 1996, J CLIN MICROBIOL, V34, P2881
   KAPLAN JE, 1986, AM J TROP MED HYG, V35, P840
   Kazem S, 2013, APMIS, V121, P770, DOI 10.1111/apm.12092
   KIRKLAND KB, 1995, CLIN INFECT DIS, V20, P1118
   Kumsa B, 2014, AM J TROP MED HYG, V90, P457, DOI 10.4269/ajtmh.13-0010
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007
   Lupi O, 2011, DERMATOL CLIN, V29, P33, DOI 10.1016/j.det.2010.09.009
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marimoutou C, 2012, MEDICINE, V91, P212, DOI 10.1097/MD.0b013e318260b604
   Mathes EF, 2013, PEDIATRICS, V132, pE149, DOI 10.1542/peds.2012-3175
   Mediannikov O, 2014, AM J TROP MED HYG, V91, P1015, DOI 10.4269/ajtmh.13-0629
   Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Nassef C, 2015, CURR OPIN PEDIATR, V26, P486
   Ng Geraldine, 2004, J Perinatol, V24, P526, DOI 10.1038/sj.jp.7211133
   Nkoghe Dieudonne, 2012, Infect Dis Rep, V4, pe5, DOI 10.4081/idr.2012.e5
   Nkoghe D, 2012, INT J DERMATOL, V51, P1037, DOI 10.1111/j.1365-4632.2011.05379.x
   Olano JP, 2006, TROPICAL DERMATOLOGY, P297, DOI 10.1016/B978-0-443-06790-7.50028-4
   Openshaw JJ, 2010, AM J TROP MED HYG, V83, P174, DOI 10.4269/ajtmh.2010.09-0752
   Osswald SS, 2007, J CUTAN PATHOL, V34, P721, DOI 10.1111/j.1600-0560.2006.00693.x
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oteo JA, 2012, TICKS TICK-BORNE DIS, V3, P270, DOI 10.1016/j.ttbdis.2012.10.035
   PAHO WHO, EP AL NEUR SYNDR CON
   Pal Gautam, 2011, J Indian Med Assoc, V109, P666
   Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13
   Passi D, 2015, J CLIN DIAGN RES JCD, V9, pLE01
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Portillo A, 2015, MICROBES INFECT, V17, P834, DOI 10.1016/j.micinf.2015.09.009
   Prashant Soma, 2009, Indian J Dermatol, V54, P128, DOI 10.4103/0019-5154.53186
   Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8
   Procop GW, 1997, ARCH PATHOL LAB MED, V121, P894
   Raoult D, 1997, CLIN MICROBIOL REV, V10, P694
   Rieg S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-167
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sadler GM, 2007, AUSTRALAS J DERMATOL, V48, P110, DOI 10.1111/j.1440-0960.2007.00348.x
   Saidani N, 2015, TRAVEL MED INFECT DI, V13, P367, DOI 10.1016/j.tmaid.2015.08.007
   Sarma N, 2013, INDIAN J DERMATOL VE, V79, P165, DOI 10.4103/0378-6323.107631
   Schweizer HP, 2014, EMERG INFECT DIS, V20
   Schwieger-Briel A, 2010, PEDIATR DERMATOL, V27, P509, DOI 10.1111/j.1525-1470.2010.01278.x
   Sebeny PJ, 2008, CLIN INFECT DIS, V47, P444, DOI 10.1086/590568
   Silva-Pinto A, 2014, TICKS TICK-BORNE DIS, V5, P656, DOI 10.1016/j.ttbdis.2014.04.016
   Sinha N, 2014, CASE REP INFECT DIS, V2014
   Sperling CLC, 2004, J AM ACAD DERMATOL, V50, P318, DOI 10.1016/S0190-9622(03)01490-7
   Stewart CL, 2013, JAMA DERMATOL, V149, P1419, DOI 10.1001/jamadermatol.2013.6777
   Sueblinvong V, 2015, CRIT CARE MED, V43, P2066, DOI 10.1097/CCM.0000000000001197
   Sulis G, 2015, J TRAVEL MED, V22, P276, DOI 10.1111/jtm.12207
   Tay ST, 2014, MED VET ENTOMOL, V28, P104, DOI 10.1111/mve.12075
   van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024
   Ventarola D, 2015, CLIN DERMATOL, V33, P340, DOI 10.1016/j.clindermatol.2014.12.011
   WALKER DH, 1995, CLIN INFECT DIS, V20, P1111
   Wanat KA, 2012, ARCH DERMATOL, V148, P219, DOI 10.1001/archdermatol.2011.1413
   World Health Organization website, LAT EB OUTBR LIB W A
   WHO, EB VIR DIS
   World Health Organization, EB SIT REP
   World Health Organization, 2015, 2015 GLOB TUB REP
   World Health Organization, EB VACC THER DIAGN
   Wormser GP, 2015, INFECT DIS CLIN N AM, V29, P371, DOI 10.1016/j.idc.2015.02.009
   Yao X, 2015, J MED VIROL, V87, P2009, DOI 10.1002/jmv.24275
   Zhao YY, 2015, EPIDEMIOL INFECT, V143, P3094, DOI 10.1017/S095026881500028X
   [Anonymous], 2008, MEL CAS SEL REP OCC
   [Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P351
NR 144
TC 0
Z9 0
U1 22
U2 22
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD JUL
PY 2016
VL 75
IS 1
BP 1
EP +
DI 10.1016/j.jaad.2016.04.033
PG 19
WC Dermatology
SC Dermatology
GA DO9GN
UT WOS:000378093300018
PM 27317512
ER

PT J
AU Schuler-Faccini, L
   Sanseverino, MTV
   Vianna, FSL
   da Silva, AA
   Larrandaburu, M
   Marcolongo-Pereira, C
   Abeche, AM
AF Schuler-Faccini, L.
   Sanseverino, M. T. V.
   Vianna, F. S. L.
   da Silva, A. A.
   Larrandaburu, M.
   Marcolongo-Pereira, C.
   Abeche, A. M.
TI Zika Virus: A New Human Teratogen? Implications for Women of
   Reproductive Age
SO CLINICAL PHARMACOLOGY & THERAPEUTICS
LA English
DT Editorial Material
AB In 2015 an unprecedented increase of reports of newborns with microcephaly in Brazil made news headlines around the world. A possible etiological association with prenatal maternal infection by Zika virus (ZIKV) was suggested based on temporal and geographic distribution of ZIKV infection and the subsequent increase in the reports of microcephaly cases. Here we discuss ZIKV as a new human teratogen, with comments on potential treatment options.
C1 [Schuler-Faccini, L.; Sanseverino, M. T. V.; Vianna, F. S. L.; da Silva, A. A.; Larrandaburu, M.; Abeche, A. M.] Hosp Clin Porto Alegre, Med Genet Serv, Brazilian Teratogen Informat Serv, SIAT, Porto Alegre, RS, Brazil.
   [Schuler-Faccini, L.; Sanseverino, M. T. V.; Vianna, F. S. L.; Larrandaburu, M.] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, BR-90046900 Porto Alegre, RS, Brazil.
   [da Silva, A. A.] UNIVATES Univ, Lajeado, RS, Brazil.
   [Marcolongo-Pereira, C.] UniRitter Laureate Int Univ, Vet Sci Fac, Porto Alegre, RS, Brazil.
   [Abeche, A. M.] Univ Fed Rio Grande do Sul, Obstet & Gynecol Dept, BR-90046900 Porto Alegre, RS, Brazil.
RP Schuler-Faccini, L (reprint author), Hosp Clin Porto Alegre, Med Genet Serv, Brazilian Teratogen Informat Serv, SIAT, Porto Alegre, RS, Brazil.; Schuler-Faccini, L (reprint author), Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, BR-90046900 Porto Alegre, RS, Brazil.
EM lavinia.faccini@ufrgs.br
RI SCHULER-FACCINI, LAVINIA/K-2927-2016
OI SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460
CR Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira W.K., 2016, MMWR-MORBID MORTAL W, V65, P242
   Petersen E.E., 2016, MMWR MORB MORTAL WKL
   Schuler-Faccini L., 2015, MMWR-MORBID MORTAL W, V65, P59
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103
   Tang H, 2016, CELL STEM CELL
NR 10
TC 1
Z9 1
U1 17
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9236
EI 1532-6535
J9 CLIN PHARMACOL THER
JI Clin. Pharmacol. Ther.
PD JUL
PY 2016
VL 100
IS 1
BP 28
EP 30
DI 10.1002/cpt.386
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DO3UK
UT WOS:000377707200020
PM 27090438
ER

PT J
AU Burattini, MN
   Coutinho, FAB
   Lopez, LF
   Ximenes, R
   Quam, M
   Wilder-Smith, A
   Massad, E
AF Burattini, M. N.
   Coutinho, F. A. B.
   Lopez, L. F.
   Ximenes, R.
   Quam, M.
   Wilder-Smith, A.
   Massad, E.
TI Potential exposure to Zika virus for foreign tourists during the 2016
   Carnival and Olympic Games in Rio de Janeiro, Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
C1 [Burattini, M. N.; Coutinho, F. A. B.; Lopez, L. F.; Ximenes, R.; Massad, E.] Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.
   [Burattini, M. N.] Hosp Sao Paulo, Escola Paulista Med, Sao Paulo, SP, Brazil.
   [Lopez, L. F.] Florida Int Univ, CIARA, Miami, FL 33199 USA.
   [Quam, M.] Umea Univ, Epidemiol & Global Hlth, Umea, Sweden.
   [Wilder-Smith, A.] Lee Kong Chian Sch Med, Nanyang, Singapore.
   [Wilder-Smith, A.] Nanyang Technol Univ, Singapore 639798, Singapore.
   [Massad, E.] London Sch Hyg & Trop Med, London WC1, England.
RP Massad, E (reprint author), Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.
EM edmassad@usp.br
RI Ximenes, Raphael/G-2881-2014
OI Ximenes, Raphael/0000-0003-2536-951X
FU HSP/ UNIFESP; CNPq; FAPESP [2012/18463-4]; Ministry of Health (Fundo
   Nacional de Saude) [27835/2012]; DengueTools under Health theme of
   Seventh Framework Programme of the European Community [282589];
   DengueTools: innovative tools and strategies for the surveillance and
   control of dengue;  [LIM01-HCFMUSP]
FX This study received partial funding from LIM01-HCFMUSP, HSP/ UNIFESP,
   CNPq, FAPESP (grant no. 2012/18463-4), Ministry of Health (Fundo
   Nacional de Saude, grant no. 27835/2012), and was also partially funded
   by DengueTools under the Health theme of the Seventh Framework Programme
   of the European Community (grant agreement no. 282589), DengueTools:
   innovative tools and strategies for the surveillance and control of
   dengue.
CR Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   World Health Organization, DENGUE
   WHO, ZIK VIR POT COMPL
NR 7
TC 3
Z9 3
U1 22
U2 22
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUL
PY 2016
VL 144
IS 9
BP 1904
EP 1906
DI 10.1017/S0950268816000649
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO5JV
UT WOS:000377820300013
PM 27040593
ER

PT J
AU Nicastri, E
   Castilletti, C
   Di Caro, A
   Capobianchi, MR
   Ippolito, G
AF Nicastri, Emanuele
   Castilletti, Concetta
   Di Caro, Antonino
   Capobianchi, Maria R.
   Ippolito, Giuseppe
TI Diagnosis of Zika virus infection in pregnant women travelling to or
   residing in endemic areas
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Nicastri, Emanuele; Castilletti, Concetta; Di Caro, Antonino; Capobianchi, Maria R.; Ippolito, Giuseppe] Natl Inst Infect Dis INMI Lazzaro Spallanzani IRC, I-00149 Rome, Italy.
RP Nicastri, E (reprint author), Natl Inst Infect Dis INMI Lazzaro Spallanzani IRC, I-00149 Rome, Italy.
EM emanuele.nicastri@inmi.it
RI Di Caro, Antonino/K-6854-2016; 
OI Di Caro, Antonino/0000-0001-6027-3009; Capobianchi, Maria
   Rosaria/0000-0003-3465-0071
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CDC, DIV VECT BORN DIS SU
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
NR 4
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP 771
EP 772
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600020
PM 27352748
ER

PT J
AU Vouga, M
   Musso, D
   Panchaud, A
   Baud, D
AF Vouga, Manon
   Musso, Didier
   Panchaud, Alice
   Baud, David
TI Clinical management of pregnant women exposed to Zika virus
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Vouga, Manon; Baud, David] Univ Lausanne Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Swiss Teratogen Informat Serv, CH-1011 Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne Hosp, Div Clin Pharmacol, CH-1011 Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Vouga, Manon; Baud, David] Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland.
   [Panchaud, Alice] Univ Geneva & Lausanne, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
RP Baud, D (reprint author), Univ Lausanne Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.; Baud, D (reprint author), Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.; Baud, D (reprint author), Univ Lausanne Hosp, CH-1011 Lausanne, Switzerland.
EM david.baud@chuv.ch
CR Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Driggers RW, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824., DOI 10.1056/NEJMOA1601824, 10.1056/NEJMoa1601824]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
NR 5
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP 773
EP 773
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600022
PM 27352750
ER

PT J
AU Brasil, P
   Calvet, GA
   de Souza, RV
   Siqueira, AM
AF Brasil, Patricia
   Calvet, Guilherme A.
   de Souza, Rogerio V.
   Siqueira, Andre M.
TI Exanthema associated with Zika virus infection
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Brasil, Patricia; Calvet, Guilherme A.; de Souza, Rogerio V.; Siqueira, Andre M.] Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
RP Brasil, P (reprint author), Oswaldo Cruz Fdn Fiocruz, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
NR 0
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP 866
EP 866
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600043
PM 27352763
ER

PT J
AU Wikan, N
   Smith, DR
AF Wikan, Nitwara
   Smith, Duncan R.
TI Zika virus: history of a newly emerging arbovirus
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID FRENCH-POLYNESIA; YELLOW-FEVER; SEXUAL TRANSMISSION; SEROLOGICAL SURVEY;
   FEDERATED STATES; HUMAN-POPULATION; DENGUE VIRUSES; AEDES-HENSILLI;
   SOUTH-PACIFIC; YAP STATE
AB Zika virus was originally identified in a sentinel rhesus monkey in the Zika Forest of Uganda in 1947. The virus is a member of the family Flaviviridae, genus Flavivirus, and is transmitted to humans by Aedes species mosquitoes. The first report of Zika virus outside Africa and Asia was in 2007 when the virus was associated with a small outbreak in Yap State, part of the Federated States of Micronesia. Since then, Zika virus infections have been reported around the world, including in southeast Asia; French Polynesia and other islands in the Pacific Ocean; and parts of South, Central, and North America. Symptomatic infection in human beings normally results in a mild and self-limiting febrile disease, although recent reports have suggested a possible association with more serious sequelae such as Guillain-Barre syndrome, and microcephaly in newborn infants of mothers infected with Zika virus during pregnancy. In this Review, we summarise the history of Zika virus from its first detection to its current worldwide distribution.
C1 [Wikan, Nitwara; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya 73170, Nakhon Pathom, Thailand.
   [Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya 73170, Nakhon Pathom, Thailand.
RP Smith, DR (reprint author), Mahidol Univ, Mol Pathol Lab, Inst Mol Biosci, Salaya 73170, Nakhon Pathom, Thailand.
EM duncan.smi@mahidol.ac.th
RI Smith, Duncan /C-6891-2011
OI Smith, Duncan /0000-0002-6592-9852
FU Mahidol University; Thailand Research Fund [IRG5780009, RTA5780009];
   Office of the Higher Education Commission; Mahidol University under the
   National Research Universities Initiative; Cluster and Program
   Management Office, National Science and Technology Development Agency
FX We are supported by Mahidol University, The Thailand Research Fund
   (IRG5780009 and RTA5780009), the Office of the Higher Education
   Commission and Mahidol University under the National Research
   Universities Initiative and by the Cluster and Program Management
   Office, National Science and Technology Development Agency.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699
   Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Durand Mark A, 2005, Pac Health Dialog, V12, P99
   Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   ECDC, 2016, ZIK VIR DIS EP POT A
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi306, DOI DOI 10.1136/BMJ.I306
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pyke AT, 2014, PLOS CURR, V2, P6, DOI DOI 10.1371/CURRENTS
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Savage HM, 1998, AM J TROP MED HYG, V58, P519
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torjesen I, 2016, BMJ-BRIT MED J, V352, pi500
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, 1 M INT HLTH REG IHR
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 97
TC 3
Z9 3
U1 45
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2016
VL 16
IS 7
BP E119
EP E126
DI 10.1016/S1473-3099(16)30010-X
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DP2LH
UT WOS:000378319600002
PM 27282424
ER

PT J
AU Hofer, U
AF Hofer, Ursula
TI Tracing the steps of Zika virus
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 14
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD JUL
PY 2016
VL 14
IS 7
BP 401
EP 401
DI 10.1038/nrmicro.2016.80
PG 1
WC Microbiology
SC Microbiology
GA DO8ZD
UT WOS:000378073200001
PM 27211788
ER

PT J
AU De Smet, B
   Van den Bossche, D
   van de Werve, C
   Mairesse, J
   Schmidt-Chanasitd, J
   Michiels, J
   Arien, KK
   Van Esbroeck, M
   Cnops, L
AF De Smet, Birgit
   Van den Bossche, Dorien
   van de Werve, Charlotte
   Mairesse, Jacques
   Schmidt-Chanasitd, Jonas
   Michiels, Jo
   Arien, Kevin K.
   Van Esbroeck, Marjan
   Cnops, Lieselotte
TI Confirmed Zika virus infection in a Belgian traveler returning from
   Guatemala, and the diagnostic challenges of imported cases into Europe
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Import; Europe; Real-time RT-PCR
ID STATES
AB We report the first laboratory-confirmed Zika virus (ZIKV) infection in a Belgian traveler after a three week holiday in Guatemala, December 2015. This case along with other imported cases into Europe emphases once again the need for accurate diagnostic tools for this rapidly emerging virus. The challenge is to diagnose patients in the acute phase, which appears short, as serological testing is complicated by cross-reactivity, vaccination status and scarce availability of specific ZIKV tests. (C) 2016 Elsevier B.V. All rights reserved.
C1 [De Smet, Birgit; Van den Bossche, Dorien; Van Esbroeck, Marjan; Cnops, Lieselotte] Inst Trop Med, Dept Clin Sci, Natl Reference Ctr Arboviruses, B-2000 Antwerp, Belgium.
   [van de Werve, Charlotte] Clin St Pierre, Travel Clin, Ottignies, Belgium.
   [Mairesse, Jacques] Clin St Pierre, Biol Clin, Ottignies, Belgium.
   [Schmidt-Chanasitd, Jonas] Inst Trop Med, Natl Reference Ctr Trop Infect Dis, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht, Hamburg, Germany.
   [Schmidt-Chanasitd, Jonas] Partner Site Hamburg Lubeck Borstel, German Ctr Infect Res DZIF, Hamburg, Germany.
   [Michiels, Jo; Arien, Kevin K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, B-2000 Antwerp, Belgium.
RP Cnops, L (reprint author), Inst Trop Med, Kronenburgstr 43-3, B-2000 Antwerp, Belgium.
EM lcnops@itg.be
FU Belgian Ministry of Social Affairs through Health Insurance System
FX The National Reference Center of arboviruses (ITM) is partially
   supported by the Belgian Ministry of Social Affairs through a fund
   within the Health Insurance System. LC holds an innovation mandate from
   the Flanders Innovation & Entrepreneurship.
CR Barzon L, 2012, Euro Surveill, V17, P20260
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   CDC, 1999, MMWR-MORBID MORTAL W, V48, P845
   Charrel R. N., 2016, B WHO, V10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci A.S., 2016, N ENGL J MED, V13
   Ginier M., 2016, TRAVEL MED INFECT DI, V1
   Goutinal A.C., 2015, EMERG INFECT DIS, V21, P84
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Korhonen E.M., 2015, EUROSURVEILL, V21
   Maria A. T., 2016, EURO SURVEILL, V21
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Shinohara K, 2016, J TRAVEL MED, V23
   Tappe D, 2014, EURO SURVEILL, V19
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Van den Bossche D, 2015, EUR J CLIN MICROBIOL, V34, P1361, DOI 10.1007/s10096-015-2359-0
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Lecuit M., 2015, NEW ENGL J MED, V372, P13
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 20
TC 0
Z9 0
U1 18
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JUL
PY 2016
VL 80
BP 8
EP 11
DI 10.1016/j.jcv.2016.04.009
PG 4
WC Virology
SC Virology
GA DN9HW
UT WOS:000377391100002
PM 27128355
ER

PT J
AU Jang, HC
   Park, WB
   Kim, UJ
   Chun, JY
   Choi, SJ
   Choe, PG
   Jung, SI
   Jee, Y
   Kim, NJ
   Choi, EH
   Oh, MD
AF Jang, Hee-Chang
   Park, Wan Beom
   Kim, Uh Jin
   Chun, June Young
   Choi, Su-Jin
   Choe, Pyoeng Gyun
   Jung, Sook-In
   Jee, Youngmee
   Kim, Nam-Joong
   Choi, Eun Hwa
   Oh, Myoung-don
TI First Imported Case of Zika Virus Infection into Korea
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE Zika Virus; Travel; Virus Shedding; Brazil; Korea
ID MICRONESIA; OUTBREAK; BRAZIL; CELLS
AB Since Zika virus has been spreading rapidly in the Americas from 2015, the outbreak of Zika virus infection becomes a global health emergency because it can cause neurological complications and adverse fetal outcome including microcephaly. Here, we report clinical manifestations and virus isolation findings from a case of Zika virus infection imported from Brazil. The patient, 43-year-old Korean man, developed fever, myalgia, eyeball pain, and maculopapular rash, but not neurological manifestations. Zika virus was isolated from his semen, and reverse-transcriptase PCR was positive for the virus in the blood, urine, and saliva on the 7th day of the illness but was negative on the 21st day. He recovered spontaneously without any neurological complications. He is the first case of Zika virus infection in Korea imported from Brazil.
C1 [Jang, Hee-Chang; Kim, Uh Jin; Jung, Sook-In] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Gwangju, South Korea.
   [Park, Wan Beom; Chun, June Young; Choi, Su-Jin; Choe, Pyoeng Gyun; Kim, Nam-Joong; Oh, Myoung-don] Seoul Natl Univ, Coll Med, Dept Internal Med, 103 Daehak Ro, Seoul 03080, South Korea.
   [Jee, Youngmee] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Ctr Pathol & Immunol, Osong, South Korea.
   [Choi, Eun Hwa] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul 03080, South Korea.
RP Oh, MD (reprint author), Seoul Natl Univ, Coll Med, Dept Internal Med, 103 Daehak Ro, Seoul 03080, South Korea.
EM mdohmd@snu.ac.kr
FU Korea Centers for Disease Control and Prevention [2016P2400100]
FX Eun Hwa Choi and Nam-Joong Kim are participating investigators of the
   research program funded by the Korea Centers for Disease Control and
   Prevention (2016P2400100).
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, N ENGL J ME IN PRESS
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, N ENGL J ME IN PRESS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, ZIK VIR INF OUTBR FR
   Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   World Health Organization, ZIK SIT REP
   [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P474
NR 20
TC 0
Z9 0
U1 34
U2 34
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
EI 1598-6357
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD JUL
PY 2016
VL 31
IS 7
BP 1173
EP 1177
DI 10.3346/jkms.2016.31.7.1173
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DN6GA
UT WOS:000377169700027
PM 27366020
ER

PT J
AU Giovanetti, M
   Faria, NR
   Nunes, MRT
   de Vasconcelos, JM
   Lourenco, J
   Rodrigues, SG
   Vianez, JL
   da Silva, SP
   Lemos, PS
   Tavares, FN
   Martin, DP
   do Rosario, MS
   Siqueira, IC
   Ciccozzi, M
   Pybus, OG
   de Oliveira, T
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Teixeira Nunes, Marcio Roberto
   de Vasconcelos, Janaina Mota
   Lourenco, Jose
   Rodrigues, Sueli Guerreiro
   Vianez, Joao Lidio, Jr.
   da Silva, Sandro Patroca
   Lemos, Poliana Silva
   Tavares, Fernando Neto
   Martin, Darren Patrick
   do Rosario, Mateus Santana
   Siqueira, Isadora Cristina
   Ciccozzi, Massimo
   Pybus, Oliver G.
   de Oliveira, Tulio
   Alcantara Junior, Luiz Carlos
TI Zika virus complete genome from Salvador, Bahia, Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; Full-length sequence; Phylogeny
ID PHYLOGENIES; MICRONESIA; LIKELIHOOD
AB In May 2015 the first autochthonous Zika virus infection was reported in Brazil. Rapid and urgent measures are needed to contain the ongoing outbreak. Here we report the full-length ZIKV coding sequence from Bahia. Genetic analysis of outbreak sequences will be essential for characterizing the diversity of circulating strains, identifying hotspots of virus transmission and guiding public health control. Rapid and urgent measures are needed to contain the ongoing outbreak. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Giovanetti, Marta; do Rosario, Mateus Santana; Siqueira, Isadora Cristina; Alcantara Junior, Luiz Carlos] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Rome, Italy.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 2JD, England.
   [Teixeira Nunes, Marcio Roberto; de Vasconcelos, Janaina Mota; Rodrigues, Sueli Guerreiro; Vianez, Joao Lidio, Jr.; Lemos, Poliana Silva; Tavares, Fernando Neto] Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Martin, Darren Patrick] Univ Cape Town, Fac Hlth Sci, Div Computat Biol, ZA-7925 Cape Town, South Africa.
   [do Rosario, Mateus Santana] Hosp Santa Isabel, Salvador, BA, Brazil.
   [Ciccozzi, Massimo] Natl Inst Hlth, Rome, Italy.
   [de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr, Durban, South Africa.
RP Giovanetti, M (reprint author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Hematol Genet & Biol Computac, BR-42296710 Salvador, BA, Brazil.
EM giovanetti.marta@gmail.com
RI CICCOZZI, MASSIMO/C-6484-2016; 
OI CICCOZZI, MASSIMO/0000-0003-3866-9239; Lourenco,
   Jose/0000-0002-9318-2581
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A., 2016, LANCET, V10015, P227
   Faye O., 2014, PLOS NEGLECT TROP D, V9, P8
   Grard G., 2014, PLOS NEGLECT TROP D, P8
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hall T. A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J., 2016, N ENGL J MED
   Mourao M. P., 2012, VECTOR-BORNE ZOONOT, V2012, P12
   Oehler E., 2014, EUROSURVEILLANCE, V19, P9
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304
   Rodrigues Faria N., 2016, PLOS CURR OUTBREAKS
   Ventura C. V., 2016, LANCET, V16
   Zamree I, 2005, Trop Biomed, V22, P217
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 3
Z9 3
U1 101
U2 101
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2016
VL 41
BP 142
EP 145
DI 10.1016/j.meegid.2016.03.030
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DL5BU
UT WOS:000375652800020
PM 27071531
ER

PT J
AU Musso, D
   Gubler, DJ
AF Musso, Didier
   Gubler, Duane J.
TI Zika Virus
SO CLINICAL MICROBIOLOGY REVIEWS
LA English
DT Review
ID WEST-NILE-VIRUS; POLYMERASE-CHAIN-REACTION; DENGUE HEMORRHAGIC-FEVER;
   GUILLAIN-BARRE-SYNDROME; ARTHROPOD-BORNE VIRUSES; ROSS RIVER VIRUS;
   REDUCTION NEUTRALIZATION TESTS; ALBOPICTUS DIPTERA-CULICIDAE;
   LINKED-IMMUNOSORBENT-ASSAY; GENOTYPE CHIKUNGUNYA VIRUS
AB Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the genus Flavivirus and the family Flaviviridae. ZIKV was first isolated from a nonhuman primate in 1947 and from mosquitoes in 1948 in Africa, and ZIKV infections in humans were sporadic for half a century before emerging in the Pacific and the Americas. ZIKV is usually transmitted by the bite of infected mosquitoes. The clinical presentation of Zika fever is nonspecific and can be misdiagnosed as other infectious diseases, especially those due to arboviruses such as dengue and chikungunya. ZIKV infection was associated with only mild illness prior to the large French Polynesian outbreak in 2013 and 2014, when severe neurological complications were reported, and the emergence in Brazil of a dramatic increase in severe congenital malformations (microcephaly) suspected to be associated with ZIKV. Laboratory diagnosis of Zika fever relies on virus isolation or detection of ZIKV-specific RNA. Serological diagnosis is complicated by cross-reactivity among members of the Flavivirus genus. The adaptation of ZIKV to an urban cycle involving humans and domestic mosquito vectors in tropical areas where dengue is endemic suggests that the incidence of ZIKV infections may be underestimated. There is a high potential for ZIKV emergence in urban centers in the tropics that are infested with competent mosquito vectors such as Aedes aegypti and Aedes albopictus.
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Tahiti, Fr Polynesia.
   [Gubler, Duane J.] Duke NUS Med Sch, Program Emerging Infect Dis, Signature Res, Singapore, Singapore.
   [Gubler, Duane J.] Partnership Dengue Control, Lyon, France.
RP Musso, D (reprint author), Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Tahiti, Fr Polynesia.; Gubler, DJ (reprint author), Duke NUS Med Sch, Program Emerging Infect Dis, Signature Res, Singapore, Singapore.; Gubler, DJ (reprint author), Partnership Dengue Control, Lyon, France.
EM dmusso@ilm.pf; duane.gubler@duke-nus.edu.sg
CR Aaskov J, 2007, J GEN VIROL, V88, P3334, DOI 10.1099/vir.0.83122-0
   Abraham Alon, 2011, J Clin Neuromuscul Dis, V12, P113, DOI 10.1097/CND.0b013e318209ef9a
   ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Ahmed S, 2000, NEUROLOGY, V55, P144
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005
   Ameline M, 2014, ANN DERMATOL VENER, V141, pS447
   ANDRAL L, 1968, B WORLD HEALTH ORGAN, V38, P855
   Angelini R, 2007, EUROSURVEILLANCE, V12, P3260
   Arzuza-Ortega L, 2016, EMERG INFECT DIS LET
   Atkinson B HP, 2016, EMERG INFECT DIS
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Aubry A, 2015, 64 ANN M AM SOC TROP
   Aubry M, 2012, J CLIN VIROL, V55, P23, DOI 10.1016/j.jcv.2012.05.010
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barber B, 2009, AUST FAM PHYSICIAN, V38, P586
   Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Barzon L, 2009, EUROSURVEILLANCE, V14, P22
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   BEARCROFT WGC, 1957, J PATHOL BACTERIOL, V74, P295, DOI 10.1002/path.1700740207
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/milbev/msg182
   Berge TO, 1975, INT CATALOG ARBOVIRU
   Berthet FX, 1997, J GEN VIROL, V78, P2293
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   BRES P., 1963, BULL SOC PATHOL EXOTIQUE, V56, P384
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Brust Karen B, 2014, IDCases, V1, P95, DOI 10.1016/j.idcr.2014.10.009
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Calisher CH, 2001, EMERG INFECT DIS, V7, P756
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   CALISHER CH, 1980, INTERVIROLOGY, V14, P229, DOI 10.1159/000149190
   Calvet G., 2016, LANCET INFECT DIS
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Camacho E, 2016, EMERG INFECT DIS LET
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Canals M, 2012, REV CHIL INFECTOL, V29, P388, DOI 10.4067/S0716-10182012000400004
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-35
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cao-Lormeau V-M, 2016, EMERG INFECT DIS
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   CAREY DE, 1972, B WORLD HEALTH ORGAN, V46, P645
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Casals J., 1971, COMPARATIVE VIROLOGY, P307
   CASALS J, 1963, AM J TROP MED HYG, V12, P587
   Casals J., 1966, 9 P S INT C MICR MOS, P441
   CASALS JORDI, 1957, TRANS NEW YORK ACAD SCI, V19, P219
   Centers for Disease Control and Prevention, 2009, BIOS MICR BIOM LAB
   Centers for Disease Control Prevention, 2002, MMWR-MORBID MORTAL W, V51, P877
   Chambers T., 2008, ENCY VIROLOGY, P241
   Champion Samantha R, 2014, Environ Health Insights, V8, P35, DOI 10.4137/EHI.S16004
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   CHANG GJJ, 1994, J CLIN MICROBIOL, V32, P477
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chen LH, 2016, ANN INTERN MED
   CHIPPAUX.C, 1966, B WORLD HEALTH ORGAN, V34, P105
   Chippaux-Hyppolite C, 1965, Bull Soc Pathol Exot Filiales, V58, P812
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   Chretien JP, 2007, AM J TROP MED HYG, V76, P405
   Clark BM, 2012, J CLIN VIROL, V54, P376, DOI 10.1016/j.jcv.2012.04.012
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561
   Coelho GE, 2012, REV INST MED TROP SP, V54, pS13, DOI 10.1590/S0036-46652012000700006
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   Cornet M, 1979, CAH ORSTOM EMP, V27, P47
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Delaunay P, 2009, ARCH PEDIATRIE, V16, pS66, DOI 10.1016/S0929-693X(09)75304-7
   Delbue S, 2014, J NEUROVIROL, V20, P437, DOI 10.1007/s13365-014-0276-0
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dickinson D B, 1965, S Afr J Med Sci, V30, P11
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Di Sabatino D, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/907852
   Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Durand Mark A, 2005, Pac Health Dialog, V12, P99
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006
   European Centre for Disease Prevention and Control, 2014, ZIK VIR INF OUTBR FR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   European Centre for Disease Prevention and Control, 2014, MON CURR THREATS ECD
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   FAGBAMI AH, 1977, T ROY SOC TROP MED H, V71, P60, DOI 10.1016/0035-9203(77)90210-3
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   FILIPE AR, 1975, AM J TROP MED HYG, V24, P516
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franchini M, 2015, BLOOD TRANSFUS
   Franco L, 2010, EUROSURVEILLANCE, V15, P5
   Fratti C, 2014, TRANSFUS CLIN BIOL, V21, P234
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaunt MW, 2001, J GEN VIROL, V82, P1867
   Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Gerardin Patrick, 2008, PLoS Med, V5, pe60, DOI 10.1371/journal.pmed.0050060
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Giordano BV, 2015, J AM MOSQUITO CONTR, V31, P101, DOI 10.2987/14-6456R.1
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   GONZALEZ JP, 1979, B SOC PATHOL EXOT, V72, P416
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubbler DJ, 1997, DENGUE DENGUE HEMORR, P1
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442
   Gubler DJ, 2012, HUNTERS TROPICAL MED, P1012
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045
   Gubler DJ, 2007, FIELDS VIROLOGY, P1155
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HADDOW A. J., 1961, BULL ENTOMOL RES, V52, P317
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P271
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HAMMON WM, 1956, P SOC EXP BIOL MED, V91, P521
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323
   Hanley KA, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P351, DOI 10.1016/B978-0-12-374153-0.00016-3
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P787
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   HENDERSON BE, 1968, B WORLD HEALTH ORGAN, V38, P229
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Himeidan Yousif E, 2014, Front Public Health, V2, P169, DOI 10.3389/fpubh.2014.00169
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hoad VC, 2015, MED J AUSTRALIA, V202, P267, DOI 10.5694/mja14.01522
   Holder P, 2010, J MED ENTOMOL, V47, P600
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827
   Johnson BW, 2009, CLIN VACCINE IMMUNOL, V16, P1052, DOI 10.1128/CVI.00095-09
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1
   KERR JA, 1952, J IMMUNOL, V68, P461
   Kiedrzynski T., 1998, Pacific Health Dialog, V5, P129
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kimura R., 1944, NIPPON IGAKKU, V3379, P629
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177
   Kojima G, 2015, EMERG INFECT DIS, V21, P182, DOI 10.3201/eid2101.141581
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MU, 2015, SCI DATA, V2, DOI [DOI 10.1038/SDATA.2015.35, 10.1038/sdata.2015.35]
   Kuno G, 2001, ACTA VIROL, V45, P139
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Laigret J, 1964, B SOC PATHOL EXOT, V60, P339
   Laird Marshall, 1994, New Zealand Entomologist, V17, P14
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti Robert S, 2003, Adv Virus Res, V61, P67, DOI 10.1016/S0065-3527(03)61002-X
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   Lanciotti RS L.A., 2016, EMERG INFECT DIS
   Lardeux F, 2002, ANN TROP MED PARASIT, V96, pS105, DOI 10.1179/000349802125002455
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397
   Lucey DR, 2016, JAMA
   Macesic Nenad, 2015, Clin Infect Dis, V61, P1485, DOI 10.1093/cid/civ408
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Malkinson M, 2002, EMERG INFECT DIS, V8, P392
   Mallet H., 2014, 15 JOURN NAT INF BOR, P28
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Marano G, 2015, BLOOD TRANSFUS
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi306, DOI DOI 10.1136/BMJ.I306
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Meiyu Fang, 1997, Microbiology and Immunology, V41, P209
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   METTLER NE, 1971, APPL MICROBIOL, V22, P377
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Moore CG, 1997, EMERG INFECT DIS, V3, P329
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365
   Murray KO, 2013, VECTOR-BORNE ZOONOT, V13, P835, DOI 10.1089/vbz.2013.1413
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, C BRAS HEM HEM TER C
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2016, LANCET INFECT DIS
   Musso D, 2014, INT J INFECT DIS, V20, P74, DOI 10.1016/j.ijid.2013.12.002
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Nemes Z, 2004, EMERG INFECT DIS, V10, P1880
   Nhan T X, 2015, Clin Microbiol Infect, V21, pe47, DOI 10.1016/j.cmi.2015.02.018
   Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622
   Nhan T-X, 2014, REV FRANCOPH LAB, V467, P45
   Nicholson J, 2014, J MED ENTOMOL, V51, P661, DOI 10.1603/ME13204
   Noel Martine, 2005, Pac Health Dialog, V12, P39
   Novella IS, 2011, J MOL MICROB BIOTECH, V21, P71, DOI 10.1159/000332752
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oki M, 2013, EPIDEMIOL INFECT, V141, P2612, DOI 10.1017/S0950268813000447
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2015, ZIK VIR ZIKV SURV LA
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization, 2015, EP AL ZIK VIR INF
   Pan American Health Organization, 2015, EP UPD ZIK VIR INF
   Pan American Health Organization, 2015, EPIDEMIOLOGICAL ALER
   Paquet C, 2006, EUROSURVEILLANCE, V11
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Perret C, 2003, EMERG INFECT DIS, V9, P1465
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2004, NEW ENGL J MED, V351, P2257, DOI 10.1056/NEJMp048261
   Petersen LR, 2001, EMERG INFECT DIS, V7, P611
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   PINTO MR, 1967, B WORLD HEALTH ORGAN, V37, P101
   Platonov AE, 2001, EMERG INFECT DIS, V7, P128
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Porter KR, 2005, AM J TROP MED HYG, V72, P60
   PORTERFIELD JS, 1978, INTERVIROLOGY, V9, P129, DOI 10.1159/000148930
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Powers AM, 2009, FUTURE VIROL, V4, P391, DOI 10.2217/FVL.09.19
   Prado I, 2005, J VIROL METHODS, V125, P75, DOI 10.1016/j.jviromet.2005.01.001
   ProMED-mail, 2014, ZIK VIR PAC 03 NEW C
   ProMED-mail, 2015, ZIK VIR SUR
   ProMED-mail, 2014, ZIK VIR PAC 07 CHIL
   ProMED-mail, 2015, UND ILLN BRAZ 02 ZIK
   ProMED-mail, 2015, ZIK VIR PAC VAN
   ProMED-mail, 2015, UND ILLN BRAZ NE RIO
   Pulmanausahakul R, 2011, INT J INFECT DIS, V15, pE671, DOI 10.1016/j.ijid.2011.06.002
   Pyke AT, 2014, PLOS CURR, V2, P6, DOI DOI 10.1371/CURRENTS
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Richard V, 2015, 64 ANN M AM SOC TROP
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   Robin Y, 1967, 7 C TECHN ORG COORD
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   ROBIN Y, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P833
   Robinson MC., 1955, T R SOC TROP MED HYG, V49, P28
   RODHAIN F, 1989, T ROY SOC TROP MED H, V83, P851, DOI 10.1016/0035-9203(89)90352-0
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   SALAUN JJ, 1967, B WORLD HEALTH ORGAN, V37, P343
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sambiri V, 2008, NEW MICROBIOL, V31, P303
   Savage HM, 1998, AM J TROP MED HYG, V58, P519
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P843
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Simmonds P, 2011, 9 INT COMM TAX VIR, P1003
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN K. C, 1941, AMER JOUR TROP MED, V21, P75
   SMITHBURN K. C, 1959, S AFRICAN MED JOUR, V33, P555
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1946, AM J TROP MED, V26, P189
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, AM J HYG, V59, P157
   Smithburn KC, 1944, J IMMUNOL, V49, P141
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74
   Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   Stewart RD, 2013, CASE REP INFECT DIS, V2013
   Stramer SL, 2005, NEW ENGL J MED, V353, P451, DOI 10.1056/NEJMoa044333
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tan FLS, 2005, NEPHROL DIAL TRANSPL, V20, P447, DOI 10.1093/ndt/gfh601
   Tappe D., 2015, MED MICROBIOL IMMUNO
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   TAYLOR RM, 1952, J IMMUNOL, V68, P473
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   THEILER M, 1958, AM J TROP MED HYG, V7, P585
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tomashek KM, 2011, TRANSFUSION, V51, P1654, DOI 10.1111/j.1537-2995.2011.03269.x
   Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tukei P., 1974, YELLOW FEVER INFECT
   van den Hurk AF, 2010, VECTOR-BORNE ZOONOT, V10, P489, DOI 10.1089/vbz.2009.0106
   Vandenbogaert M, 2014, 63 AM SOC TROP MED H
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vasilakis N, 2007, VIROLOGY, V358, P402, DOI 10.1016/j.virol.2006.08.049
   Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06
   Vasilakis V, 2016, ARBOVIRUSES MOL BIOL
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Viennet E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-379
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Villamil-Gomez W E, 2016, J INFECT PUBLIC HLTH, DOI S1876-0341(15)00221-X
   Ville Y, 2014, CURR OPIN INFECT DIS, V27, P251, DOI [10.1097/QCO.0000000000000066, 10.1097/QCO.0000000000000064]
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wagner D, 2004, EMERG INFECT DIS, V10, P1872
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Way J H, 1976, J Gen Virol, V30, P123
   Weaver SC, 2005, ARCH VIROL, P33
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   [Anonymous], 1985, FLAVIVIRIDAE INTERVI
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
   World Health Organization, 2007, GUID PLAQ RED NEUTR
   World Health Organization, 2014, AS PAC STRAT EM DIS
   World Health Organization, 2014, GUID REG TRANSP INF
   World Health Organization, 1961, WHO TECH REP SER, V219, P1
   WHO, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2014, DENG PAC SIT UPD 26
   World Health Organization, 2014, PAC SYNDR SURV REP W
   World Health Organization, 1967, WHO TECHN REP SER, V369, P1
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548
NR 437
TC 32
Z9 32
U1 249
U2 258
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0893-8512
EI 1098-6618
J9 CLIN MICROBIOL REV
JI Clin. Microbiol. Rev.
PD JUL
PY 2016
VL 29
IS 3
BP 487
EP 524
DI 10.1128/CMR.00072-15
PG 38
WC Microbiology
SC Microbiology
GA DK6TI
UT WOS:000375057900003
PM 27029595
ER

PT J
AU O'Connor, DH
   Osorio, JE
   Tanuri, A
   Kallas, EG
AF O'Connor, David H.
   Osorio, Jorge E.
   Tanuri, Amilcar
   Kallas, Esper G.
TI Forging Collaborative Relationships in Brazil: From AIDS to ZIKV
SO CELL
LA English
DT Editorial Material
AB The Zika virus (ZIKV) outbreak has stimulated collaborations between Brazilians, researchers from other South American countries, and scientists from around the world. The Brazilian response to the HIV/AIDS epidemic demonstrates capabilities that can be applied to the study of ZIKV and provides lessons for developing effective international infectious disease research collaborations.
C1 [O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53705 USA.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, BR-2194190 Rio De Janeiro, Brazil.
   [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246903 Sao Paulo, Brazil.
   [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-01246903 Sao Paulo, Brazil.
RP O'Connor, DH (reprint author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.; Kallas, EG (reprint author), Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-01246903 Sao Paulo, Brazil.; Kallas, EG (reprint author), Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-01246903 Sao Paulo, Brazil.
EM dhoconno@wisc.edu; esper.kallas@usp.br
CR Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Central Intelligence Agency, 2016, WORLD FACTBOOK
   Gao GF, 2014, SCIENCE, V346, P666, DOI 10.1126/science.346.6209.666
   Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205
   Merson MH, 2014, NEW ENGL J MED, V370, P1676, DOI 10.1056/NEJMp1401124
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   Scimago Journal & Country Rank, 2016, COUNTR RANK
   Sistema Unico de Saude, 2016, PORT DA SAUD
   Office of the United Nations Special Envoy on Ebola, 2016, RES RES 5
   World Health Organization, 2016, SIT REP ZIK VIR DIS
   World Health Organization, 2016, WORLD HLTH ORG COUNT
   The World Bank, 2016, WORLD DEV IND REPR H
   The World Bank, 2016, RES DEV EXP GDP
   The World Bank, 2016, COUNTR LEND GROUPS
NR 14
TC 0
Z9 0
U1 6
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JUN 30
PY 2016
VL 166
IS 1
BP 2
EP 4
DI 10.1016/j.cell.2016.06.023
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DR9ZH
UT WOS:000380254400002
PM 27368092
ER

PT J
AU Lustig, Y
   Mendelson, E
   Paran, N
   Melamed, S
   Schwartz, E
AF Lustig, Y.
   Mendelson, E.
   Paran, N.
   Melamed, S.
   Schwartz, E.
TI Detection of Zika virus RNA in whole blood of imported Zika virus
   disease cases up to 2 months after symptom onset, Israel, December 2015
   to April 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION; SALIVA; URINE
AB Zika virus RNA presence in serum, whole-blood and urine samples from six Israeli travellers symptomatic for Zika virus disease was examined. Whole-blood samples were positive for as late as 2 months (58 days) post-symptom onset, longer than for urine (26 days) and serum (3 days). These findings suggest the utility of whole blood in Zika infection diagnosis.
C1 [Lustig, Y.; Mendelson, E.] Minist Hlth, Cent Virol Lab, Tel Hashomer, Israel.
   [Mendelson, E.] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, IL-69978 Tel Aviv, Israel.
   [Paran, N.; Melamed, S.] Israel Inst Biol Res, Ness Ziona, Israel.
   [Schwartz, E.] Sheba Med Ctr, Inst Trop Med, Tel Hashomer, Israel.
RP Lustig, Y (reprint author), Minist Hlth, Cent Virol Lab, Tel Hashomer, Israel.
EM yaniv.lustig@sheba.health.gov.il
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lai L, 2012, TRANSFUSION, V52, P447, DOI 10.1111/j.1537-2995.2011.03289.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, J CLIN MICROBIOL, DOI [10.1128/JCM.01283-16, DOI 10.1128/JCM.01283-16]
   Meltzer E, 2016, AM J MED
   Meltzer E, 2016, EMERG INFECT DIS, V22, DOI [10.3201/eid2208.160480, DOI 10.3201/EID2208.160480]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Shulman LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039455
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
NR 18
TC 0
Z9 0
U1 13
U2 13
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 30
PY 2016
VL 21
IS 26
BP 7
EP 10
AR 30269
DI 10.2807/1560-7917.ES.2016.21.26.30269
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DQ5KP
UT WOS:000379244400002
ER

PT J
AU Savidis, G
   McDougall, WM
   Meraner, P
   Perreira, JM
   Portmann, JM
   Trincucci, G
   John, SP
   Aker, AM
   Renzette, N
   Robbins, DR
   Guo, ZR
   Green, S
   Kowalik, TF
   Brass, AL
AF Savidis, George
   McDougall, William M.
   Meraner, Paul
   Perreira, Jill M.
   Portmann, Jocelyn M.
   Trincucci, Gaia
   John, Sinu P.
   Aker, Aaron M.
   Renzette, Nicholas
   Robbins, Douglas R.
   Guo, Zhiru
   Green, Sharone
   Kowalik, Timothy F.
   Brass, Abraham L.
TI Identification of Zika Virus and Dengue Virus Dependency Factors using
   Functional Genomics
SO CELL REPORTS
LA English
DT Article
ID PHOSPHATIDYLSERINE RECEPTORS; ENDOPLASMIC-RETICULUM; GENES; CELLS;
   REPLICATION; INFECTION; CRISPR-CAS9; SCREEN; ENTRY; RNAI
AB The flaviviruses dengue virus (DENV) and Zika virus (ZIKV) are severe health threats with rapidly expanding ranges. To identify the host cell dependencies of DENV and ZIKV, we completed orthologous functional genomic screens using RNAi and CRISPR/Cas9 approaches. The screens recovered the ZIKV entry factor AXL as well as multiple host factors involved in endocytosis (RAB5C and RABGEF), heparin sulfation (NDST1 and EXT1), and transmembrane protein processing and maturation, including the endoplasmic reticulum membrane complex (EMC). We find that both flaviviruses require the EMC for their early stages of infection. Together, these studies generate a high-confidence, systems-wide view of human-flavivirus interactions and provide insights into the role of the EMC in flavivirus replication.
C1 [Savidis, George; McDougall, William M.; Meraner, Paul; Perreira, Jill M.; Portmann, Jocelyn M.; Trincucci, Gaia; Aker, Aaron M.; Renzette, Nicholas; Robbins, Douglas R.; Kowalik, Timothy F.; Brass, Abraham L.] Univ Massachusetts Med, Dept Microbiol & Physiol Syst MaPS, Worcester, MA 01655 USA.
   [John, Sinu P.] NIAID, Signaling Syst Unit, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Guo, Zhiru; Green, Sharone] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA.
   [Brass, Abraham L.] Univ Massachusetts, Sch Med, Dept Med, Div Gastroenterol, Worcester, MA 01655 USA.
RP Brass, AL (reprint author), Univ Massachusetts Med, Dept Microbiol & Physiol Syst MaPS, Worcester, MA 01655 USA.; Brass, AL (reprint author), Univ Massachusetts, Sch Med, Dept Med, Div Gastroenterol, Worcester, MA 01655 USA.
EM abraham.brass@umassmed.edu
FU Burroughs Wellcome Foundation; NIAID, NIH [HHSN272200900041C]; UMMS
   Center for Clinical and Translational Science; Bill and Melinda Gates
   Foundation
FX We thank R.H. Scheuermann and B. Pickett (J. Craig Venter Institute),
   the University of Maryland Medical System (UMMS; R. Fish, L. Benson, and
   J. Barrett), ICCB-L (C. Shamu, J. Smith, S. Rudnicki, S. Johnston, K.
   Rudnicki, and D. Wrobel), and T. Soellner of Heidelberg University for
   help and inspiration. This work was supported by an Investigators in the
   Pathogenesis of Infectious Disease award from the Burroughs Wellcome
   Foundation to A. L. B. and a subcontract to A. L. B. from contract
   HHSN272200900041C to Northrup Grumman Corporation from NIAID, NIH.
   A.L.B. is grateful to the UMMS Center for Clinical and Translational
   Science and to the Bill and Melinda Gates Foundation for their support.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00266
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588
   Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fernandez-Garcia M.D., 2016, MBIO, V7
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kwon YJ, 2014, ANTIVIR RES, V110, P20, DOI 10.1016/j.antiviral.2014.07.006
   Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Li C., 2016, CELL STEM CELL, V19
   Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   [Anonymous], 2016, ZIKA VIRUS CLIN MICR
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076
   Perreira JM, 2016, ADV VIRUS RES, V94, P1, DOI 10.1016/bs.aivir.2015.11.001
   Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richard A.S., 2015, P NATL ACAD SCI USA, V112, P14682
   Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Satoh T., 2015, ELIFE, V4, P4
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031
NR 48
TC 1
Z9 1
U1 14
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN 28
PY 2016
VL 16
IS 1
BP 232
EP 246
DI 10.1016/j.celrep.2016.06.028
PG 15
WC Cell Biology
SC Cell Biology
GA DQ1GY
UT WOS:000378950700021
PM 27342126
ER

PT J
AU Craig, AT
   Paterson, BJ
   Durrheim, DN
AF Craig, Adam T.
   Paterson, Beverley J.
   Durrheim, David N.
TI Commentary: Zika Virus: the Latest Newcomer
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Editorial Material
DE epidemiology; surveillance; disease surveillance; Zika virus (ZIKV);
   outbreaks; communicable diseases; emerging; communicable disease
   epidemiology
C1 [Craig, Adam T.; Paterson, Beverley J.; Durrheim, David N.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia.
RP Craig, AT (reprint author), Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia.
EM adam.craig@uon.edu.au
CR Craig A. T., 2016, B WHO
   Global Polio Eradication Initiative, 2016, AC FLACC PAR AFP SUR
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olive JA, 1997, J INFECT DIS, V175, pS160
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   World Health Organization, 2016, ZIK SIT REP 19 MAY 2
   World Health Organization, 2014, WEEKLY EPIDEMIOL REC, V17, P165
   World Health Organization, 2016, WEEKLY EPIDEMIOL REC, V15, P193
NR 8
TC 1
Z9 1
U1 4
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 28
PY 2016
VL 7
AR 1028
DI 10.3389/fmicb.2016.01028
PG 2
WC Microbiology
SC Microbiology
GA DP7NS
UT WOS:000378686700001
PM 27443350
ER

PT J
AU Turtle, L
   Bali, T
   Buxton, G
   Chib, S
   Chan, S
   Soni, M
   Hussain, M
   Isenman, H
   Fadnis, P
   Venkataswamy, MM
   Satishkumar, V
   Lewthwaite, P
   Kurioka, A
   Krishna, S
   Shankar, MV
   Ahmed, R
   Begum, A
   Ravi, V
   Desai, A
   Yoksan, S
   Fernandez, S
   Willberg, CB
   Kloverpris, HN
   Conlon, C
   Klenerman, P
   Satchidanandam, V
   Solomon, T
AF Turtle, Lance
   Bali, Tanushka
   Buxton, Gemma
   Chib, Savita
   Chan, Sajesh
   Soni, Mohammed
   Hussain, Mohammed
   Isenman, Heather
   Fadnis, Prachi
   Venkataswamy, Manjunatha M.
   Satishkumar, Vishali
   Lewthwaite, Penny
   Kurioka, Ayako
   Krishna, Srinivasa
   Shankar, M. Veera
   Ahmed, Riyaz
   Begum, Ashia
   Ravi, Vasanthapuram
   Desai, Anita
   Yoksan, Sutee
   Fernandez, Stefan
   Willberg, Christian B.
   Kloverpris, Henrik N.
   Conlon, Christopher
   Klenerman, Paul
   Satchidanandam, Vijaya
   Solomon, Tom
TI Human T cell responses to Japanese encephalitis virus in health and
   disease
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID DENGUE HEMORRHAGIC-FEVER; CROSS-REACTIVITY; NEUTRALIZING ANTIBODIES;
   INFECTION; PROTECTION; LYMPHOCYTES; CD4(+); CHALLENGE; SEQUENCE;
   IMMUNITY
AB Japanese encephalitis (JE) virus (JEV) is an important cause of encephalitis in children of South and Southeast Asia. However, the majority of individuals exposed to JEV only develop mild symptoms associated with long-lasting adaptive immunity. The related flavivirus dengue virus (DENV) cocirculates in many JEV-endemic areas, and clinical data suggest cross-protection between DENV and JEV. To address the role of T cell responses in protection against JEV, we conducted the first full-breadth analysis of the human memory T cell response using a synthetic peptide library. Ex vivo interferon-gamma (IFN-gamma) responses to JEV in healthy JEV-exposed donors were mostly CD8(+) and targeted nonstructural (NS) proteins, whereas IFN-gamma responses in recovered JE patients were mostly CD4(+) and targeted structural proteins and the secreted protein NS1. Among patients, a high quality, polyfunctional CD4(+) T cell response was associated with complete recovery from JE. T cell responses from healthy donors showed a high degree of cross-reactivity to DENV that was less apparent in recovered JE patients despite equal exposure. These data reveal divergent functional CD4(+) and CD8(+) T cell responses linked to different clinical outcomes of JEV infection, associated with distinct targeting and broad flavivirus cross-reactivity including epitopes from DENV, West Nile, and Zika virus.
C1 [Turtle, Lance; Buxton, Gemma; Isenman, Heather; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
   [Turtle, Lance; Solomon, Tom] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 7BE, Merseyside, England.
   [Turtle, Lance] Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool L7 8XP, Merseyside, England.
   [Bali, Tanushka; Chib, Savita; Chan, Sajesh; Soni, Mohammed; Satchidanandam, Vijaya] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.
   [Hussain, Mohammed; Satishkumar, Vishali; Krishna, Srinivasa; Begum, Ashia] Vijayanagar Inst Med Sci, Coll Med, Dept Microbiol, Bellary 583104, India.
   [Satishkumar, Vishali; Shankar, M. Veera; Ahmed, Riyaz; Begum, Ashia] Vijayanagar Inst Med Sci, Coll Med, Dept Paediat, Bellary 583104, India.
   [Fadnis, Prachi; Venkataswamy, Manjunatha M.; Ravi, Vasanthapuram; Desai, Anita] Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bangalore 560029, Karnataka, India.
   [Lewthwaite, Penny] Natl Hlth Serv Trust, St James Univ Hosp, Leeds Teaching Hosp, Dept Infect & Travel Med, Leeds LS9 7TF, W Yorkshire, England.
   [Kurioka, Ayako; Willberg, Christian B.; Kloverpris, Henrik N.; Conlon, Christopher; Klenerman, Paul] Univ Oxford, Peter Medawar Bldg Pathogen Res, Nuffield Dept Med, Oxford OX1 3SY, England.
   [Yoksan, Sutee] Mahidol Univ Salaya, Inst Mol Biosci, Ctr Vaccine Dev, Bangkok 73170, Thailand.
   [Fernandez, Stefan] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand.
   [Solomon, Tom] Walton Ctr Natl Hlth Serv Fdn Trust, Liverpool L9 7LJ, Merseyside, England.
   [Chib, Savita] Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Kloverpris, Henrik N.] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, ZA-4001 Durban, South Africa.
   [Kloverpris, Henrik N.] Univ Copenhagen, Dept Immunol & Microbiol, DK-2200 Copenhagen, Denmark.
RP Turtle, L (reprint author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.; Turtle, L (reprint author), Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 7BE, Merseyside, England.; Turtle, L (reprint author), Royal Liverpool Univ Hosp, Trop & Infect Dis Unit, Liverpool L7 8XP, Merseyside, England.; Satchidanandam, V (reprint author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.; Klenerman, P (reprint author), Univ Oxford, Peter Medawar Bldg Pathogen Res, Nuffield Dept Med, Oxford OX1 3SY, England.
EM lturtle@liverpool.ac.uk; paul.klenerman@medawar.ox.ac.uk;
   vijaya@mcbl.iisc.ernet.in
FU National Institutes of Health Tetramer Core Facility
   [HHSN272201300006C]; National Institute of Allergy and Infectious
   Diseases, National Institutes of Health, and Department of Health and
   Human Services [HHSN272201400028C]; Wellcome Trust [087757/Z/08/Z];
   National Institute for Health Research, UK; Wellcome Trust the National
   Institute for Health Research biomedical research center, Oxford
   [WT091663MA]; Oxford Martin School; Health Protection Research Unit in
   Emerging Infections and Zoonoses of the National Institute for Health
   Research [HPRU-2012-10117]
FX We acknowledge the National Institutes of Health Tetramer Core Facility
   (contract HHSN272201300006C) for provision of MHC class I tetramers and
   the Biodefense and Emerging Infections Research Resources Repository and
   the National Institute of Allergy and Infectious Diseases for provision
   of DENV and WNV peptide libraries. The Virus Pathogen Database and
   Analysis Resource has been wholly funded with federal funds from the
   National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, and Department of Health and Human Services under
   contract HHSN272201400028C. We thank Prof. Phillip Goulder for the gift
   of B cell lines. We thank the director, patients, relatives, and staff
   at VIMS Medical College Hospital and all the volunteers who took part.;
   This work was funded by a Wellcome Trust fellowship (087757/Z/08/Z) to
   L. Turtle (currently funded by the National Institute for Health
   Research, UK). P. Klenerman is a Wellcome Trust Senior Clinical Fellow
   (WT091663MA) funded through the National Institute for Health Research
   biomedical research center, Oxford, and the Oxford Martin School. T.
   Solomon is supported by the Health Protection Research Unit in Emerging
   Infections and Zoonoses of the National Institute for Health Research
   (HPRU-2012-10117).
CR Aihara H, 1998, J VIROL, V72, P8032
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07
   Ashok MS, 1999, VACCINE, V18, P68, DOI 10.1016/S0264-410X(99)00180-2
   Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155
   Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5
   Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   CHATURVEDI UC, 1979, CLIN EXP IMMUNOL, V38, P492
   Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0
   Draenert R, 2004, AIDS, V18, P871, DOI 10.1097/01.aids.0000111400.02002.db
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   EDELMAN R, 1975, Southeast Asian Journal of Tropical Medicine and Public Health, V6, P308
   Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051
   Friberg H, 2011, IMMUNOL CELL BIOL, V89, P122, DOI 10.1038/icb.2010.61
   Gao N, 2010, IMMUNOL LETT, V129, P23, DOI 10.1016/j.imlet.2009.12.023
   Garcia-Boronat M, 2008, NUCLEIC ACIDS RES, V36, pW35, DOI 10.1093/nar/gkn211
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   HALSTEAD SB, 1962, AM J HYG, V75, P190
   Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   Konishi E, 1999, J VIROL, V73, P5527
   KONISHI E, 1995, AM J TROP MED HYG, V53, P278
   Konishi E, 1998, VACCINE, V16, P842, DOI 10.1016/S0264-410X(97)00265-X
   Kumar P, 2004, J INFECT DIS, V189, P880, DOI 10.1086/381768
   Kumar P, 2004, J GEN VIROL, V85, P471, DOI 10.1099/vir.0.19531-0
   Kumar P, 2004, J GEN VIROL, V85, P1131, DOI 10.1099/vir.0.19698-0
   KURANE I, 1991, J VIROL, V65, P1823
   Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81
   Larena M, 2013, EUR J IMMUNOL, V43, P1789, DOI 10.1002/eji.201243152
   Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5
   Lewthwaite P, 2010, EMERG INFECT DIS, V16, P1780, DOI 10.3201/eid1611.100672
   Lewthwaite P, 2010, B WORLD HEALTH ORGAN, V88, P584, DOI 10.2471/BLT.09.071357
   Lewthwaite P, 2010, TROP MED INT HEALTH, V15, P811, DOI 10.1111/j.1365-3156.2010.02537.x
   Libraty DH, 2002, T ROY SOC TROP MED H, V96, P173, DOI 10.1016/S0035-9203(02)90294-4
   LUBINIECKI AS, 1973, AM J TROP MED HYG, V22, P535
   MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   MURALIKRISHNA K, 1994, J GEN VIROL, V75, P799, DOI 10.1099/0022-1317-75-4-799
   MuraliKrishna K, 1996, J GEN VIROL, V77, P705, DOI 10.1099/0022-1317-77-4-705
   Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115
   PARKER KC, 1994, J IMMUNOL, V152, P163
   Parsons R, 2008, J IMMUNOL, V181, P1563
   Piazza P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015343
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015
   Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274
   Solomon T, 2002, BRAIN, V125, P1084, DOI 10.1093/brain/awf116
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   Watt G, 2003, AM J TROP MED HYG, V68, P704
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
NR 64
TC 0
Z9 0
U1 4
U2 4
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD JUN 27
PY 2016
VL 213
IS 7
BP 1331
EP 1352
DI 10.1084/jem.20151517
PG 22
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DS5VA
UT WOS:000380849800018
PM 27242166
ER

PT J
AU Avelino-Silva, VI
   Martin, JRN
AF Avelino-Silva, Vivian I.
   Martin, Jeff Rey N.
TI Association between Guillain-Barre syndrome and Zika virus infection
SO LANCET
LA English
DT Letter
C1 [Avelino-Silva, Vivian I.] Univ Sao Paulo, Sch Med, Hosp Sirio Libanes, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, Brazil.
   [Avelino-Silva, Vivian I.] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, Brazil.
   [Martin, Jeff Rey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
RP Avelino-Silva, VI (reprint author), Univ Sao Paulo, Sch Med, Hosp Sirio Libanes, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, Brazil.; Avelino-Silva, VI (reprint author), Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, Brazil.
EM viviansilva87@gmail.com
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019
NR 2
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 25
PY 2016
VL 387
IS 10038
BP 2599
EP 2599
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP3JX
UT WOS:000378390500019
PM 27353814
ER

PT J
AU Bautista, LE
   Sethi, AK
AF Bautista, Leonelo E.
   Sethi, Ajay K.
TI Association between Guillain-Barre syndrome and Zika virus infection
SO LANCET
LA English
DT Letter
C1 [Bautista, Leonelo E.; Sethi, Ajay K.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53726 USA.
RP Bautista, LE (reprint author), Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53726 USA.
EM lebautista@wisc.edu
CR Aubry M, 2015, 64 ANN M AM SOC TROP
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Nickerson Raymond S., 1998, REV GEN PSYCHOL, V2, P175, DOI DOI 10.1037/1089-2680.2.2.175
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
NR 6
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 25
PY 2016
VL 387
IS 10038
BP 2599
EP 2600
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP3JX
UT WOS:000378390500020
PM 27353815
ER

PT J
AU Fontanet, A
   Cao-Lormeau, VM
   Dub, T
   Mallet, HP
   Ghawche, F
AF Fontanet, Arnaud
   Cao-Lormeau, Van-Mai
   Dub, Timothee
   Mallet, Henri-Pierre
   Ghawche, Frederic
TI Association between Guillain-Barre syndrome and Zika virus infection
   Reply
SO LANCET
LA English
DT Letter
C1 [Fontanet, Arnaud; Dub, Timothee] Inst Pasteur, Emerging Dis Epidemiol Unit, 25-28 Rue Dr Roux, F-75015 Paris, France.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, Tahiti, Fr Polynesia.
   [Mallet, Henri-Pierre] Bur Veille Sanit, Direct Sante, Papeete, Fr Polynesia.
   [Ghawche, Frederic] Ctr Hosp Polynesie Francaise, Serv Neurol, Tahiti, Fr Polynesia.
RP Fontanet, A (reprint author), Inst Pasteur, Emerging Dis Epidemiol Unit, 25-28 Rue Dr Roux, F-75015 Paris, France.
EM fontanet@pasteur.fr
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
NR 1
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 25
PY 2016
VL 387
IS 10038
BP 2600
EP 2600
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP3JX
UT WOS:000378390500021
PM 27353817
ER

PT J
AU Kuehnert, MJ
   Basavaraju, SV
   Moseley, RR
   Pate, LL
   Galel, SA
   Williamson, PC
   Busch, MP
   Alsina, JO
   Climent-Peris, C
   Marks, PW
   Epstein, JS
   Nakhasi, HL
   Hobson, JP
   Leiby, DA
   Akolkar, PN
   Petersen, LR
   Rivera-Garcia, B
AF Kuehnert, Matthew J.
   Basavaraju, Sridhar V.
   Moseley, Robin R.
   Pate, Lisa L.
   Galel, Susan A.
   Williamson, Phillip C.
   Busch, Michael P.
   Alsina, Jose O.
   Climent-Peris, Consuelo
   Marks, Peter W.
   Epstein, Jay S.
   Nakhasi, Hira L.
   Hobson, J. Peyton
   Leiby, David A.
   Akolkar, Pradip N.
   Petersen, Lyle R.
   Rivera-Garcia, Brenda
TI Screening of Blood Donations for Zika Virus Infection - Puerto Rico,
   April 3-June 11, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Kuehnert, Matthew J.; Basavaraju, Sridhar V.; Moseley, Robin R.; Petersen, Lyle R.] CDC, Zika Virus Response Blood Safety Team, Atlanta, GA 30333 USA.
   [Pate, Lisa L.; Galel, Susan A.] Roche Mol Syst Inc, Pleasanton, CA USA.
   [Williamson, Phillip C.] Creat Testing Solut, Tempe, AZ USA.
   [Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA.
   [Alsina, Jose O.] Banco Sangre Serv Mutuos, San Juan, PR USA.
   [Climent-Peris, Consuelo] Banco Sangre Puerto Rico, San Juan, PR USA.
   [Marks, Peter W.; Epstein, Jay S.; Nakhasi, Hira L.; Hobson, J. Peyton; Leiby, David A.; Akolkar, Pradip N.] US FDA, Silver Spring, MD USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
RP Kuehnert, MJ (reprint author), CDC, Zika Virus Response Blood Safety Team, Atlanta, GA 30333 USA.
EM eocevent281@cdc.gov
CR Barjas-Castro ML, 2016, TRANSFUSION IN PRESS
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Lanteri MC, 2016, TRANSFUSION, V9
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
NR 6
TC 0
Z9 0
U1 7
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 24
PY 2016
VL 65
IS 24
BP 627
EP 628
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP2UX
UT WOS:000378349900005
PM 27337368
ER

PT J
AU Lee, CT
   Vora, NM
   Bajwa, W
   Boyd, L
   Harper, S
   Kass, D
   Langston, A
   McGibbon, E
   Merlino, M
   Rakeman, JL
   Raphael, M
   Slavinski, S
   Tran, A
   Wong, R
   Varma, JK
AF Lee, Christopher T.
   Vora, Neil M.
   Bajwa, Waheed
   Boyd, Lorraine
   Harper, Scott
   Kass, Daniel
   Langston, Aileen
   McGibbon, Emily
   Merlino, Mario
   Rakeman, Jennifer L.
   Raphael, Marisa
   Slavinski, Sally
   Tran, Anthony
   Wong, Ricky
   Varma, Jay K.
CA NYC Zika Response Team
TI Zika Virus Surveillance and Preparedness - New York City, 2015-2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES
C1 [Lee, Christopher T.] New York City Dept Hlth & Mental Hyg, Div Epidemiol, New York, NY 10013 USA.
   [Lee, Christopher T.] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Vora, Neil M.; Harper, Scott; McGibbon, Emily; Slavinski, Sally; Varma, Jay K.] New York City Dept Hlth & Mental Hyg, Div Dis Control, New York, NY USA.
   [Vora, Neil M.; Harper, Scott] CDC, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Bajwa, Waheed; Kass, Daniel; Merlino, Mario] New York City Dept Hlth & Mental Hyg, Div Environm Hlth, New York, NY USA.
   [Boyd, Lorraine; Langston, Aileen] New York City Dept Hlth & Mental Hyg, Div Family & Child Hlth, New York, NY USA.
   [Rakeman, Jennifer L.; Tran, Anthony] New York City Dept Hlth & Mental Hyg, Publ Hlth Lab, New York, NY USA.
   [Raphael, Marisa] New York City Dept Hlth & Mental Hyg, Off Emergency Preparedness & Response, New York, NY USA.
   [Wong, Ricky] New York City Dept Hlth & Mental Hyg, Off External Affairs, New York, NY USA.
   [Varma, Jay K.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Lee, CT (reprint author), New York City Dept Hlth & Mental Hyg, Div Epidemiol, New York, NY 10013 USA.; Lee, CT (reprint author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
EM klq5@cdc.gov
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Millman AJ, 2016, MMWR-MORBID MORTAL W, V65, P51, DOI 10.15585/mmwr.mm6503a3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 7
TC 0
Z9 0
U1 7
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 24
PY 2016
VL 65
IS 24
BP 629
EP 635
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP2UX
UT WOS:000378349900006
PM 27337505
ER

PT J
AU Meepagala, KM
   Estep, AS
   Becnel, JJ
AF Meepagala, Kumudini M.
   Estep, Alden S.
   Becnel, James J.
TI Larvicidal and Adulticidal Activity of Chroman and Chromene Analogues
   against Susceptible and Permethrin-Resistant Mosquito Strains
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE mosquitoes; larvicide; repellents; chromenes; chromans; insecticide
   resistance
ID BTI RESISTANCE; FEVER MOSQUITO; PESTICIDES; TOXICITY
AB Mosquitoes play a major role as vectors that transmit parasitic and viral diseases worldwide, especially in tropical and subtropical countries. Mosquito borne diseases not only affect humans but they also affect livestock in many parts of the world. They carry diseases that are lethal to dogs and horses. Dog heartworm disease (Dirofilaria immitis) is a parasitic disease spread through mosquitoes. This disease is not limited to dogs, but it can affect other animals and humans as well. Eastern equine encephalitis (EEE) and West Nile virus (WNV) are also mosquito borne diseases that affect the central nervous system of horses and cause severe complications and death. Emergence of resistance among mosquitoes to current pesticides has increased the importance of the search for alternate compounds that are effective and environmentally benign with diverse modes of actions than those that are commercially available. Aedes aegypti mosquitoes are the primary vector for transmission of Zika viral fever, yellow fever, dengue fever, and chikungunya. Mosquito control is currently the best strategy to prevent mosquito borne diseases. There are numerous approaches for control of potentially dangerous mosquito populations. These approaches include the use of adulticides (insecticides), larvicides, and, to a limited extent, the use of repellents. Our previous studies have shown the mosquito repellent activity of chromenes. In the present study, we demonstrate larvicidal and adulticidal activity of chroman and chromene analogues against a permethrin susceptible laboratory strain as well as activity against a permethrin-resistant strain of Aedes aegypti.
C1 [Meepagala, Kumudini M.] ARS, NPURU, USDA, POB 8048, University, MS 38677 USA.
   [Estep, Alden S.; Becnel, James J.] ARS, CMAVE, USDA, MFRU1600-1700 SW 23rd Dr, Gainesville, FL 32608 USA.
   [Estep, Alden S.] NASJAX, Navy Entomol Ctr Excellence NECE, 937 Child St, Jacksonville, FL 32212 USA.
RP Meepagala, KM (reprint author), ARS, NPURU, USDA, POB 8048, University, MS 38677 USA.
EM kmeepaga@olemiss.edu
FU Deployed War Fighter Protection (DWFP) Research Program of the U.S.
   Department of Defense through the Armed Forces Pest Management Board
FX This study was partly supported by the Deployed War Fighter Protection
   (DWFP) Research Program of the U.S. Department of Defense through the
   Armed Forces Pest Management Board.
CR Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9
   Chuaycharoensuk T, 2012, PARASITE, V19, P427
   Cupp EW, 2003, AM J TROP MED HYG, V68, P495
   FAGOONEE I, 1981, INSECT SCI APPL, V1, P373
   Ghosh A., 2012, INDIAN J MED RES, V135, P581
   ISMAN MB, 1986, NATURWISSENSCHAFTEN, V73, P500, DOI 10.1007/BF00367198
   ISMAN MB, 1986, PLANTA MED, P558
   Kitchen LW, 2009, J VECTOR ECOL, V34, P50, DOI [10.1111/j.1948-7134.2009.00007.x, 10.3376/038.034.0107]
   Manguin S., 2011, IMPORTANCE BIOL INTE, P27
   Meepagala KM, 2010, J AGR FOOD CHEM, V58, P9476, DOI 10.1021/jf101626g
   Meepagala KM, 2011, PEST MANAG SCI, V67, P1446, DOI 10.1002/ps.2196
   Meepagala KM, 2013, J AGR FOOD CHEM, V61, P9293, DOI 10.1021/jf402635z
   Pridgeon JW, 2009, J MED ENTOMOL, V46, P335, DOI 10.1603/033.046.0219
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   PROKSCH P, 1983, J NAT PROD, V46, P331, DOI 10.1021/np50027a006
   Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2
   Tetreau G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-248
   Tetreau G, 2013, ARCH INSECT BIOCHEM, V82, P71, DOI 10.1002/arch.21076
   WISDOM CS, 1983, J ECON ENTOMOL, V76, P993
   Yang YY, 2010, J INSECT PHYSIOL, V56, P1219, DOI 10.1016/j.jinsphys.2010.03.028
NR 20
TC 0
Z9 0
U1 9
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUN 22
PY 2016
VL 64
IS 24
BP 4914
EP 4920
DI 10.1021/acs.jafc.6b01299
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA DP6CK
UT WOS:000378584300012
PM 27249182
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Thousands of pregnant women in Puerto Rico are at risk of Zika virus
   infection, CDC warns
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Kuehnert MJ, 2016, MORB MORTAL WKLY REP, V2016
NR 1
TC 0
Z9 0
U1 4
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 21
PY 2016
VL 353
AR i3462
DI 10.1136/bmj.i3462
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP8BP
UT WOS:000378723200006
PM 27328974
ER

PT J
AU Pingen, M
   Bryden, SR
   Pondeville, E
   Schnettler, E
   Kohl, A
   Merits, A
   Fazakerley, JK
   Graham, GJ
   McKimmie, CS
AF Pingen, Marieke
   Bryden, Steven R.
   Pondeville, Emilie
   Schnettler, Esther
   Kohl, Alain
   Merits, Andres
   Fazakerley, John K.
   Graham, Gerard J.
   McKimmie, Clive S.
TI Host Inflammatory Response to Mosquito Bites Enhances the Severity of
   Arbovirus Infection
SO IMMUNITY
LA English
DT Article
ID DENGUE VIRUS-INFECTION; SEMLIKI-FOREST-VIRUS; BONE-MARROW; IN-VIVO;
   MICE; SALIVA; ENCEPHALITIS; POTENTIATION; PATHOGENESIS; MACROPHAGES
AB Aedes aegypti mosquitoes are responsible for transmitting many medically important viruses such as those that cause Zika and dengue. The inoculation of viruses into mosquito bite sites is an important and common stage of all mosquito-borne virus infections. We show, using Semliki Forest virus and Bunyamwera virus, that these viruses use this inflammatory niche to aid their replication and dissemination in vivo. Mosquito bites were characterized by an edema that retained virus at the inoculation site and an inflammatory influx of neutrophils that coordinated a localized innate immune program that inadvertently facilitated virus infection by encouraging the entry and infection of virus-permissive myeloid cells. Neutrophil depletion and therapeutic blockade of inflammasome activity suppressed inflammation and abrogated the ability of the bite to promote infection. This study identifies facets of mosquito bite inflammation that are important determinants of the subsequent systemic course and clinical outcome of virus infection.
C1 [Pingen, Marieke; Bryden, Steven R.; McKimmie, Clive S.] Univ Leeds, Leeds Inst Canc & Pathol, Sect Infect & Immun, Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England.
   [Bryden, Steven R.; Graham, Gerard J.] Univ Glasgow, Inst Infect Immunol & Inflammat, Glasgow G12 8TA, Lanark, Scotland.
   [Pondeville, Emilie; Schnettler, Esther; Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Merits, Andres] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia.
   [Fazakerley, John K.] Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England.
RP McKimmie, CS (reprint author), Univ Leeds, Leeds Inst Canc & Pathol, Sect Infect & Immun, Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England.
EM c.s.mckimmie@leeds.ac.uk
RI Institute, Pirbright/K-4476-2014; McKimmie, Clive/C-9208-2013
OI McKimmie, Clive/0000-0002-7694-9509
FU MRC [G1001724]; BBSRC PhD studentship
FX We acknowledge the kind assistance of Melanie McFarlane and Stephanie
   Rainey for the provision of virus stocks and insect cell culture; Ryan
   Ritchie for help with IVIS; Margaret McFadyen and Joy Kean for culture
   of mosquitoes; Prof. Eileen Devaney for her detailed editing of the
   manuscript; and the Institute of Infection, Immunity and Inflammation
   Flow Cytometry Facility, all based at the University of Glasgow. This
   work was funded by the MRC (G1001724) and a BBSRC PhD studentship to
   S.R.B.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Charmoy M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000755
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689
   Dessens JT, 1998, J VIROL, V72, P8362
   Edwards JF, 1998, J MED ENTOMOL, V35, P261
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   Ferguson MC, 2015, J VIROL, V89, P7536, DOI 10.1128/JVI.03645-14
   Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Jabir MS, 2014, CELL HOST MICROBE, V15, P214, DOI 10.1016/j.chom.2014.01.010
   King JG, 2011, J BIOL CHEM, V286, P40824, DOI 10.1074/jbc.M111.280552
   Le Coupanec A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002237
   Limesand KH, 2000, PARASITE IMMUNOL, V22, P461, DOI 10.1046/j.1365-3024.2000.00326.x
   McCracken MK, 2014, J VIROL, V88, P1881, DOI 10.1128/JVI.01218-13
   Michlmayr D, 2014, J VIROL, V88, P9553, DOI 10.1128/JVI.03421-13
   Moser L.A., 2015, J VIROL, V90, P292
   Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179
   Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194
   Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935
   Rodriguez-Andres J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002977
   Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x
   Schaeffer E, 2015, J INVEST DERMATOL, V135, P1743, DOI 10.1038/jid.2014.525
   Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171
   Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565
   Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Supajatura V, 2002, J CLIN INVEST, V109, P1351, DOI 10.1172/JCI200214704
   Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004
   Ulper L, 2008, J VIROL METHODS, V148, P265, DOI 10.1016/j.jviromet.2007.10.007
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WEDMORE CV, 1981, NATURE, V289, P646, DOI 10.1038/289646a0
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 43
TC 2
Z9 2
U1 14
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD JUN 21
PY 2016
VL 44
IS 6
BP 1455
EP 1469
DI 10.1016/j.immuni.2016.06.002
PG 15
WC Immunology
SC Immunology
GA DP2SE
UT WOS:000378341200022
PM 27332734
ER

PT J
AU Camara, DCP
   Codeo, CT
   Juliano, SA
   Lounibos, LP
   Riback, TIS
   Pereira, GR
   Honorio, NA
AF Portela Camara, Daniel Cardoso
   Codeo, Claudia Torres
   Juliano, Steven A.
   Lounibos, L. Philip
   Souza Riback, Thais Irene
   Pereira, Glaucio Rocha
   Honorio, Nildimar Alves
TI Seasonal Differences in Density But Similar Competitive Impact of Aedes
   albopictus (Skuse) on Aedes aegypti (L.) in Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID LARVAL COMPETITION; CONTAINER MOSQUITOS; DENGUE VECTORS; INTERSPECIFIC
   COMPETITION; CHIKUNGUNYA VIRUS; SOUTH FLORIDA; UNITED-STATES; URBAN
   FOREST; CULICIDAE; DIPTERA
AB Previous studies have shown that the negative effects of density of Ae. albopictus on Ae. aegypti exceed those of Ae. aegypti on Ae. albopictus for population growth, adult size, survivorship, and developmental rate. This competitive superiority has been invoked to explain the displacement of Ae. aegypti by Ae. albopictus in the southeastern USA. In Brazil, these species coexist in many vegetated suburban and rural areas. We investigated a related, but less-well-studied question: do effects of Ae. albopictus on Ae. aegypti larval development and survival occur under field conditions at realistic densities across multiple seasons in Brazil? We conducted additive competition experiments in a vegetated area of Rio de Janeiro where these species coexist. We tested the hypothesis that Ae. aegypti (the focal species, at a fixed density) suffers negative effects on development and survivorship across a gradient of increasing densities of Ae. albopictus (the associate species) in three seasons. The results showed statistically significant effects of both season and larval density on Ae. aegypti survivorship, and significant effects of season on development rate, with no significant season-density interactions. Densities of Aedes larvae in these habitats differed among seasons by a factor of up to 7x. Overall, Spring was the most favorable season for Ae. aegypti survivorship and development. Results showed that under natural conditions the negative competitive effects of Ae. albopictus on Ae. aegypti were expressed primarily as lower survivorship. Coexistence between Ae. aegypti and Ae. albopictus in vegetated areas is likely affected by seasonal environmental differences, such as detrital resource levels or egg desiccation, which can influence competition between these species. Interactions between these Aedes are important in Brazil, where both species are well established and widely distributed and vector dengue, Zika and chikungunya viruses.
C1 [Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios LATHEMA, Rio De Janeiro, Brazil.
   [Portela Camara, Daniel Cardoso; Pereira, Glaucio Rocha; Honorio, Nildimar Alves] Fundacao Oswaldo Cruz, DIRAC IOC VPAAPS, Nucleo Operac Sentinela Mosquitos Vetores NOSMOVE, Rio De Janeiro, Brazil.
   [Codeo, Claudia Torres; Souza Riback, Thais Irene] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil.
   [Juliano, Steven A.] Illinois State Univ, Sch Biol Sci, Behav Ecol Evolut & Systemat Sect, Normal, IL 61761 USA.
   [Lounibos, L. Philip] Univ Florida, Florida Med Entomol Lab, Vero Beach, FL USA.
RP Camara, DCP (reprint author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Transmissores Hematozoarios LATHEMA, Rio De Janeiro, Brazil.; Camara, DCP (reprint author), Fundacao Oswaldo Cruz, DIRAC IOC VPAAPS, Nucleo Operac Sentinela Mosquitos Vetores NOSMOVE, Rio De Janeiro, Brazil.
EM dcpcamara.ioc@gmail.com
FU US National Institutes of Health Fogarty International Center FIRCA
   grant [R03TW007446-01A1]; INCT-EM/CNPq - PAPES V grant, Rede Dengue
   FIOCRUZ [407744/2012-6]; Instituto Oswaldo Cruz, Brazil
FX This research was funded by US National Institutes of Health Fogarty
   International Center FIRCA grant R03TW007446-01A1 - received by LPL and
   SAJ, by INCT-EM/CNPq - PAPES V grant 407744/2012-6, Rede Dengue FIOCRUZ
   and funds from Instituto Oswaldo Cruz, Brazil, received by NAH. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aguiar Ducineia Barros, 2008, Acta Amaz., V38, P357, DOI 10.1590/S0044-59672008000200021
   Alto BW, 2008, P R SOC B, V275, P463, DOI 10.1098/rspb.2007.1497
   Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209
   Bargielowski IE, 2015, INFECT GENET EVOL, V36, P456, DOI 10.1016/j.meegid.2015.08.016
   Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110
   Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   [Anonymous], 2004, ANN ENTOMOL SOC AM, DOI DOI 10.1603/0013-8746
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christophers SR, 1960, AEDES AEGYPTI L YELL
   Costanzo KS, 2005, ECOLOGY, V86, P3289, DOI 10.1890/05-0583
   Daugherty MP, 2000, J MED ENTOMOL, V37, P364, DOI 10.1603/0022-2585(2000)037[0364:ICAARF]2.0.CO;2
   Patton DJ, 1985, WATER RESOURCES ATLA
   Fox J., 2011, R COMPANION APPL REG
   GILOTRA SK, 1967, B WORLD HEALTH ORGAN, V37, P437
   Goldberg DE, 2001, DESIGN ANAL ECOLOGIC, P77
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Honorio NA, 2006, MEM I OSWALDO CRUZ, V101, P225, DOI 10.1590/S0074-02762006000200017
   Honorio NA, 2001, REV SAUDE PUBL, V35, P385, DOI 10.1590/S0034-89102001000400009
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   HORNBY JA, 1994, J AM MOSQUITO CONTR, V10, P397
   Juliano S. A, 2014, MEM I O CRUZ, V109, P96
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.2307/176880
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611
   Juliano SA, 2010, ISR J ECOL EVOL, V56, P325, DOI 10.1560/IJEE.55.3-4.325
   Lima-Camara TN, 2013, MEM I OSWALDO CRUZ, V108, P18, DOI 10.1590/0074-0276130381
   Lima-Camara TN, 2006, CAD SAUDE PUBLICA, V22, P2079
   Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lounibos LP, 2002, J VECTOR ECOL, V27, P86
   Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Maciel-De-Freitas R, 2006, J MED ENTOMOL, V43, P1112, DOI 10.1603/0022-2585(2006)43[1112:MODVBT]2.0.CO;2
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Moore CG, 1999, J AM MOSQUITO CONTR, V15, P221
   Moraes R. M., 1999, REV BRAS BOT, V22, P9
   Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x
   MORELLATO LPC, 1992, J TROP ECOL, V8, P205
   Murrell EG, 2008, J MED ENTOMOL, V45, P375, DOI 10.1603/0022-2585(2008)45[375:DTATOO]2.0.CO;2
   Murrell EG, 2011, ANN ENTOMOL SOC AM, V104, P688, DOI 10.1603/AN10158
   Nazni WA, 2009, SE ASIAN J TROP MED, V40, P40
   O'Neal PA, 2013, J ANIM ECOL, V82, P256, DOI 10.1111/j.1365-2656.2012.02017.x
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554
   Bloch EM, 2016, EMERG INFEC IN PRESS
   R Core Team, 2014, R LANG ENV STAT COMP
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   RStudio Team, 2012, RSTUDIO INT DEV R
   SOTA T, 1992, ENTOMOL EXP APPL, V63, P155
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Teixeira MG, 2000, PLOS NEGLECT TROP D, V7, pe2520, DOI [DOI 10.1371/JOURNAL.PNTD.0002520, 10.1371/journal.pntd.0002520]
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Williamson M., 1996, BIOL INVASIONS
NR 62
TC 0
Z9 0
U1 12
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 20
PY 2016
VL 11
IS 6
AR e0157120
DI 10.1371/journal.pone.0157120
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP0WR
UT WOS:000378212000009
PM 27322537
ER

PT J
AU Turmel, JM
   Abgueguen, P
   Hubert, B
   Vandamme, YM
   Maquart, M
   Le Guillou-Guillemette, H
   Leparc-Goffart, I
AF Turmel, Jean Marie
   Abgueguen, Pierre
   Hubert, Bruno
   Vandamme, Yves Marie
   Maquart, Marianne
   Le Guillou-Guillemette, Helene
   Leparc-Goffart, Isabelle
TI Late sexual transmission of Zika virus related to persistence in the
   semen
SO LANCET
LA English
DT Letter
C1 [Turmel, Jean Marie; Abgueguen, Pierre; Vandamme, Yves Marie] CHU Angers, Dept Infect Dis, F-49933 Angers, France.
   [Le Guillou-Guillemette, Helene] CHU Angers, Virol Lab, F-49933 Angers, France.
   [Hubert, Bruno] French Publ Hlth Agcy, Reg Off, Nantes, France.
   [Maquart, Marianne; Leparc-Goffart, Isabelle] French Armed Forces Biomed Res Inst, Marseille, France.
RP Turmel, JM (reprint author), CHU Angers, Dept Infect Dis, F-49933 Angers, France.
EM jeanmarie.turmel@chu-angers.fr
CR D'Ortenzio E., 2016, NEW ENGL J MED, DOI [10.1056/nejmc1604449, DOI 10.1056/NEJMC1604449, 10.1056/NEJMc1604449]
   European Centre for Disease Prevention and Control, RAP RISK ASS ZIK VIR
   Lessler JT, 2016, B WORLD HEALTH ORGAN, V1, DOI [10.2471/BLT.16.174540, DOI 10.2471/BLT.16.174540]
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   WHO, 2016, TRAV HLTH ADV ZIK VI
NR 5
TC 4
Z9 4
U1 11
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 18
PY 2016
VL 387
IS 10037
BP 2501
EP 2501
DI 10.1016/S0140-6736(16)30775-9
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO7FG
UT WOS:000377947200017
PM 27287833
ER

PT J
AU Ventura, CV
   Maia, M
   Dias, N
   Ventura, LO
   Belfort, R
AF Ventura, Camila V.
   Maia, Mauricio
   Dias, Natalia
   Ventura, Liana O.
   Belfort, Rubens, Jr.
TI Zika: neurological and ocular findings in infant without microcephaly
SO LANCET
LA English
DT Letter
ID VIRUS
C1 [Ventura, Camila V.; Dias, Natalia; Ventura, Liana O.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Maia, Mauricio; Belfort, Rubens, Jr.] HOPE Eye Hosp, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Sao Paulo, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.] Vis Inst, Sao Paulo, Brazil.
RP Belfort, R (reprint author), HOPE Eye Hosp, Recife, PE, Brazil.
EM clinbelf@uol.com.br
CR Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2015, EP AL NEUR SYNDR CON
NR 5
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD JUN 18
PY 2016
VL 387
IS 10037
BP 2502
EP 2502
DI 10.1016/S0140-6736(16)30776-0
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO7FG
UT WOS:000377947200018
PM 27287830
ER

PT J
AU Perez, S
   Tato, R
   Cabrera, JJ
   Lopez, A
   Robles, O
   Paz, E
   Coira, A
   Sanchez-Seco, MP
   Vazquez, A
   Carballo, R
   Quintas, C
   Pousa, A
AF Perez, S.
   Tato, R.
   Cabrera, J. J.
   Lopez, A.
   Robles, O.
   Paz, E.
   Coira, A.
   Sanchez-Seco, M. P.
   Vazquez, A.
   Carballo, R.
   Quintas, C.
   Pousa, A.
TI Confirmed case of Zika virus congenital infection, Spain, March 2016
SO EUROSURVEILLANCE
LA English
DT Article
AB We describe Zika virus (ZIKV) vertical transmission in an imported case in Spain, in a 17-week pregnant woman. ZIKV IgG, IgM and RNA were detected in serum in week 17. At 19 weeks, ultrasound scan revealed fetal malformations and ZIKV was detected in the amniotic fluid. Pregnancy was terminated at week 21; autopsy of the fetus revealed bilateral hydrocephalus, brain microcalcifications and arthrogryposis multiplex congenita. ZIKV was detected in the umbilical cord and brain tissue.
C1 [Perez, S.; Cabrera, J. J.; Carballo, R.] Univ Hosp Vigo, Dept Microbiol, Vigo, Spain.
   [Tato, R.] Univ Hosp Pontevedra, Dept Microbiol, Pontevedra, Spain.
   [Lopez, A.; Paz, E.] Lucus Augusti Hosp, Dept Gynecol, Lugo, Spain.
   [Robles, O.] Lucus Augusti Hosp, Dept Pathol, Lugo, Spain.
   [Coira, A.] Lucus Augusti Hosp, Dept Microbiol, Lugo, Spain.
   [Sanchez-Seco, M. P.; Vazquez, A.] Carlos III Hlth Inst ISCIII, Natl Ctr Microbiol CNM, Virol Area, Arbovirus & Imported Viral Dis, Madrid, Spain.
   [Quintas, C.] Lucus Augusti Hosp, Dept Prevent Med, Lugo, Spain.
   [Pousa, A.] Conselleria Sanidade, Gen Direct Publ Hlth, Gen Subdirect Epidemiol & Informat Syst, Santiago De Compostela, Spain.
RP Perez, S (reprint author), Univ Hosp Vigo, Dept Microbiol, Vigo, Spain.
EM sonia.perez.castro@sergas.es
OI PEREZ, SONIA/0000-0003-1734-1904; Lopez, Alberto/0000-0003-1879-354X
CR Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bocanegra C, 2016, CLIN MICROBIOL INFEC, V21, P648, DOI 10.1016/j.cmi.2016.03.025
   Brasil P, 2016, N ENGL J MED
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Johansson MA, 2016, NEW ENGL J MED, DOI [10.1056/NEJMp1605367, DOI 10.1056/NEJMP1605367]
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pan American Health Organization (PAHO) / World Health Organization (WHO), TIM EM ZIK VIR AM
   Pan American Health Organization (PAHO) / World Health Organization (WHO), 2016, EP AL ZIK VIR INF
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waggoner Jesse J, 2016, J Clin Microbiol, V54, P860, DOI 10.1128/JCM.00279-16
   World Health Organization, GUILL BARR SYNDR COL
   World Health Organization (WHO), SIT REP ZIK VIR MICR
NR 21
TC 0
Z9 0
U1 10
U2 10
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 16
PY 2016
VL 21
IS 24
BP 1
EP 4
AR 30261
DI 10.2807/1560-7917.ES.2016.21.24.30261
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DP5KP
UT WOS:000378535500001
ER

PT J
AU Musso, D
   Teissier, A
   Rouault, E
   Teururai, S
   de Pina, JJ
   Nhan, TX
AF Musso, Didier
   Teissier, Anita
   Rouault, Eline
   Teururai, Sylviane
   de Pina, Jean-Jacques
   Tu-Xuan Nhan
TI Detection of chikungunya virus in saliva and urine
SO VIROLOGY JOURNAL
LA English
DT Article
DE Chikungunya; CHIKV; PCR; Saliva; French Polynesia; Arbovirus; Urine
ID WEST-NILE-VIRUS; ZIKA VIRUS; FRENCH-POLYNESIA; INFECTION; DENGUE;
   TRANSMISSION; GENOME; PCR
AB Background: Saliva and urine have been used for arthropod-borne viruses molecular detection but not yet for chikungunya virus (CHIKV). We investigated the use of saliva and urine for molecular detection of CHIKV during the French Polynesian outbreak.
   Methods: During the French Polynesian chikungunya outbreak (2014-2015), we collected the same day blood and saliva samples from 60 patients with probable chikungunya (47 during the 1st week post symptoms onset and 13 after), urine was available for 39 of them. All samples were tested using a CHIKV reverse-transcription PCR.
   Results: Forty eight patients had confirmed chikungunya. For confirmed chikungunya presenting during the 1st week post symptoms onset, CHIKV RNA was detected from 86.1 % (31/36) of blood, 58.3 % (21/36) of saliva and 8. 3 % (2/24) of urine. Detection rate of CHIKV RNA was significantly higher in blood compared to saliva. For confirmed chikungunya presenting after the 1st week post symptoms onset, CHIKV RNA was detected from 8.3 % (1/12) of blood, 8.3 % (1/12) of saliva and 0 % (0/8) of urine.
   Conclusions: In contrast to Zika virus (ZIKV), saliva did not increased the detection rate of CHIKV RNA during the 1st week post symptoms onset. In contrast to ZIKV, dengue virus and West Nile virus, urine did not enlarged the window of detection of CHIKV RNA after the 1st week post symptoms onset. Saliva can be used for molecular detection of CHIKV during the 1st week post symptoms onset only if blood is impossible to collect but with a lower sensitivity compared to blood.
C1 [Musso, Didier; Rouault, Eline; Teururai, Sylviane; de Pina, Jean-Jacques; Tu-Xuan Nhan] Inst Louis Malarde, Med Biol Lab, POB 3098713, Papeete, Tahiti, Fr Polynesia.
   [Musso, Didier; Teissier, Anita] Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, Fr Polynesia.
RP Musso, D (reprint author), Inst Louis Malarde, Med Biol Lab, POB 3098713, Papeete, Tahiti, Fr Polynesia.; Musso, D (reprint author), Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   de Campos RM, 2016, J CLIN VIROL, V77, P69
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   European Centre for Disease Prevention and Control, 2007, INF HLTH PRACT
   Gardner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139481
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haute Autorite de la Sante, 2013, DIAGN BIOL DIR PREC, V95
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Jones PH, 2015, J INFECT DIS THER, V3, DOI [10.4172/2332-0877.1000226, DOI 10.4172/2332-0877.1000226]
   Kondo M, 2016, J DERMATOL, DOI [10.1111/1346-8138.13253, DOI 10.1111/1346-8138.13253]
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Laigret J, 1967, Bull Soc Pathol Exot Filiales, V60, P339
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Mardekian SK, 2015, BIOMED RES INT, DOI 10.1155/2015/834371
   MATHUR A, 1995, INT J EXP PATHOL, V76, P103
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nhan T X, 2015, Clin Microbiol Infect, V21, pe47, DOI 10.1016/j.cmi.2015.02.018
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294
   Regional office for South-East Asia, 2008, GUID CLIN MAN CHIK F
NR 29
TC 1
Z9 1
U1 9
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUN 16
PY 2016
VL 13
AR 102
DI 10.1186/s12985-016-0556-9
PG 4
WC Virology
SC Virology
GA DO7DN
UT WOS:000377942500001
PM 27306056
ER

PT J
AU Hanners, NW
   Eitson, JL
   Usui, N
   Richardson, RB
   Wexler, EM
   Konopka, G
   Schoggins, JW
AF Hanners, Natasha W.
   Eitson, Jennifer L.
   Usui, Noriyoshi
   Richardson, R. Blake
   Wexler, Eric M.
   Konopka, Genevieve
   Schoggins, John W.
TI Western Zika Virus in Human Fetal Neural Progenitors Persists Long Term
   with Partial Cytopathic and Limited Immunogenic Effects
SO CELL REPORTS
LA English
DT Article
ID 3-DIMENSIONAL ARCHITECTURE; INFECTION; CELLS; REPLICATION; ORGANOIDS;
   BRAZIL; SITES
AB The recent Zika virus (ZIKV) outbreak in the Western hemisphere is associated with severe pathology in newborns, including microcephaly and braindamage. The mechanisms underlying these outcomes are under intense investigation. Here, we show that a 2015 ZIKV isolate replicates in multiple cell types, including primary human fetal neural progenitors (hNPs). In immortalized cells, ZIKV is cytopathic and grossly rearranges endoplasmic reticulum membranes similar to other flaviviruses. In hNPs, ZIKV infection has a partial cytopathic phase characterized by cell rounding, pyknosis, and activation of caspase 3. Despite notable cell death, ZIKV did not activate a cytokine response in hNPs. This lack of cell intrinsic immunity to ZIKV is consistent with our observation that virus replication persists in hNPs for at least 28 days. These findings, supported by published fetal neuropathology, establish a proof-of-concept that neural progenitors in the developing human fetus can be direct targets of detrimental ZIKV-induced pathology.
C1 [Hanners, Natasha W.; Eitson, Jennifer L.; Richardson, R. Blake; Schoggins, John W.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
   [Hanners, Natasha W.] Univ Texas SW Med Ctr Dallas, Div Infect Dis, Dept Pediat, Dallas, TX 75390 USA.
   [Usui, Noriyoshi; Konopka, Genevieve] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.
   [Wexler, Eric M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA.
RP Schoggins, JW (reprint author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.
EM john.schoggins@utsouthwestern.edu
FU NIH [DK095031, AI117922, MH102603]; Rita Allen Foundation
FX We thank Katrina Mar for technical advice and the UT Southwestern
   Electron Microscopy Core Facility for technical support. This work was
   supported in part by NIH grants DK095031 (J.W.S.), AI117922 (J.W.S.),
   MH102603 (G.K.), and a grant from the Rita Allen Foundation (J.W.S.).
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the NIH or the other
   funders.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010
   Cugola F.R., 2016, NATURE
   Dang J, 2016, CELL STEM CELL
   Driggers R.W., 2016, N ENGL J MED
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kindhauser MK, 2016, B WHO
   Konopka G, 2012, MOL PSYCHIATR, V17, P202, DOI 10.1038/mp.2011.60
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL
   Limatola C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00229
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi S.L., 2016, AM J TROP MED HYG, P16
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu K.Y., 2016, CELL RES
NR 30
TC 4
Z9 4
U1 11
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN 14
PY 2016
VL 15
IS 11
BP 2315
EP 2322
DI 10.1016/j.celrep.2016.05.075
PG 8
WC Cell Biology
SC Cell Biology
GA DO4TG
UT WOS:000377776400001
PM 27268504
ER

PT J
AU Savidis, G
   Perreira, JM
   Portmann, JM
   Meraner, P
   Guo, ZR
   Green, S
   Brass, AL
AF Savidis, George
   Perreira, Jill M.
   Portmann, Jocelyn M.
   Meraner, Paul
   Guo, Zhiru
   Green, Sharone
   Brass, Abraham L.
TI The IFITMs Inhibit Zika Virus Replication
SO CELL REPORTS
LA English
DT Article
ID INFLUENZA-A VIRUS; DENGUE VIRUS; PROTEINS; INFECTION; LINE
AB Zika virus has emerged as a severe health threat with a rapidly expanding range. The IFITM family of restriction factors inhibits the replication of a broad range of viruses, including the closely related flaviruses West Nile virus and dengue virus. Here, we show that IFITM1 and IFITM3 inhibit Zika virus infection early in the viral life cycle. Moreover, IFITM3 can prevent Zika-virus-induced cell death. These results suggest that strategies to boost the actions and/or levels of the IFITMs might be useful for inhibiting a broad range of emerging viruses.
C1 [Savidis, George; Perreira, Jill M.; Portmann, Jocelyn M.; Meraner, Paul; Brass, Abraham L.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst MaPS, Worcester, MA 01655 USA.
   [Guo, Zhiru; Green, Sharone] Univ Massachusetts, Div Infect Dis & Immunol, Dept Med, Sch Med, Worcester, MA 01655 USA.
   [Brass, Abraham L.] Univ Massachusetts, Div Gastroenterol, Dept Med, Sch Med, Worcester, MA 01655 USA.
RP Brass, AL (reprint author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst MaPS, Worcester, MA 01655 USA.; Brass, AL (reprint author), Univ Massachusetts, Div Gastroenterol, Dept Med, Sch Med, Worcester, MA 01655 USA.
EM abraham.brass@umassmed.edu
FU NIH National Institute of Allergy and Infectious Diseases
   [1R01AI091786]; Burroughs Wellcome Foundation; UMMS Center for Clinical
   and Translational Science; Bill and Melinda Gates Foundation
FX We thank University of Massachusetts Medical School (UMMS) colleagues R.
   Fish, L. Benson, and J. Barrett. We thank Thomas Soellner of Heidelberg
   University for inspiration. This work was supported by grant
   1R01AI091786 from the NIH National Institute of Allergy and Infectious
   Diseases and by the Investigators in the Pathogenesis of Infectious
   Disease Award from the Burroughs Wellcome Foundation, both to A.L.B.
   A.L.B. is grateful to the UMMS Center for Clinical and Translational
   Science and to the Bill and Melinda Gates Foundation for their support.
CR Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909
   Bailey CC, 2014, ANN REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/fmb.14.65, 10.2217/FMB.14.65]
   Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694
   Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   D'Ortenzio E, 2016, N ENGL J MED
   Driggers R.W., 2016, N ENGL J MED
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262
   John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13
   Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tartour K, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0103-y
   Way J H, 1976, J Gen Virol, V30, P123
   Yang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124985
   Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433
NR 31
TC 2
Z9 2
U1 10
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN 14
PY 2016
VL 15
IS 11
BP 2323
EP 2330
DI 10.1016/j.celrep.2016.05.074
PG 8
WC Cell Biology
SC Cell Biology
GA DO4TG
UT WOS:000377776400002
PM 27268505
ER

PT J
AU Gostin, LO
   Hodge, JG
AF Gostin, Lawrence O.
   Hodge, James G., Jr.
TI Is the United States Prepared for a Major Zika Virus Outbreak?
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
C1 [Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, Washington, DC 20001 USA.
   [Hodge, James G., Jr.] Arizona State Univ, Publ Hlth Law & Policy Program, Sandra Day OConnor Coll Law, Tempe, AZ USA.
RP Gostin, LO (reprint author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.
EM gostin@law.georgetown.edu
CR Boodman E, CHRISTIE CALLS QUARA
   Kim M, MOSQUITOES SELF DEST
   McNeil Jr DG, PUERTO RICO BRACES I
   Pollack A, NEW WEAPON FIGHT ZIK
   Sullivan P, GOP SKEPTICAL NEW FU
   Tavernise S, CDC OFFERS GUIDELINE
   The White House, FACT SHEET PREP RESP
   World Health Organization, WHO DIR GEN BRIEFS M
   [Anonymous], 2016, FED REG, V81, P10878
NR 9
TC 0
Z9 0
U1 5
U2 5
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD JUN 14
PY 2016
VL 315
IS 22
BP 2395
EP 2396
DI 10.1001/jama.2016.4919
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO3CE
UT WOS:000377656900012
PM 27074330
ER

PT J
AU Ahmad, N
   White, J
AF Ahmad, Nina
   White, Jennifer
CA Zika Pregnancy Working Grp
TI Possible Zika Virus Infection Among Pregnant Women - United States and
   Territories, May 2016 (vol 65, pg 514, 2016)
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Correction
C1 [Ahmad, Nina; White, Jennifer; Zika Pregnancy Working Grp] New York State Dept Hlth, New York, NY USA.
RP Ahmad, N (reprint author), New York State Dept Hlth, New York, NY USA.
CR Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
NR 1
TC 0
Z9 0
U1 5
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 10
PY 2016
VL 65
IS 22
BP 587
EP 587
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP2EH
UT WOS:000378300400006
ER

PT J
AU Rolfe, AJ
   Bosco, DB
   Wang, JY
   Nowakowski, RS
   Fan, JQ
   Ren, Y
AF Rolfe, Alyssa J.
   Bosco, Dale B.
   Wang, Jingying
   Nowakowski, Richard S.
   Fan, Jianqing
   Ren, Yi
TI Bioinformatic analysis reveals the expression of unique transcriptomic
   signatures in Zika virus infected human neural stem cells
SO CELL AND BIOSCIENCE
LA English
DT Article
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; DENGUE VIRUS; MECHANISMS;
   CYTOSCAPE; NETWORKS; DISEASE; PROTEIN; FEVER
AB Background: The single-stranded RNA Flavivirus, Zika virus (ZIKV), has recently re-emerged and spread rapidly across the western hemisphere's equatorial countries, primarily through Aedes mosquito transmission. While symptoms in adult infections appear to be self-limiting and mild, severe birth defects, such as microcephaly, have been linked to infection during early pregnancy. Recently, Tang et al. (Cell Stem Cell 2016, doi: 10.1016/j.stem.2016.02.016) demonstrated that ZIKV efficiently infects induced pluripotent stem cell (iPSC) derived human neural progenitor cells (hNPCs), resulting in cell cycle abnormalities and apoptosis. Consequently, hNPCs are a suggested ZIKV target.
   Methods: We analyzed the transcriptomic sequencing (RNA-seq) data (GEO: GSE78711) of ZIKV (Strain: MR766) infected hNPCs. For comparison to the ZIKV-infected hNPCs, the expression data from hNPCs infected with human cytomegalovirus (CMV) (Strain: AD169) was used (GEO: GSE35295). Utilizing a combination of Gene Ontology, database of human diseases, and pathway analysis, we generated a putative systemic model of infection supported by known molecular pathways of other highly related viruses.
   Results: We analyzed RNA-sequencing data for transcript expression alterations in ZIKV-infected hNPCs, and then compared them to expression patterns of iPSC-derived hNPCs infected with CMV, a virus that can also induce severe congenital neurological defects in developing fetuses. We demonstrate for the first time that many of cellular pathways correlate with clinical pathologies following ZIKV infection such as microcephaly, congenital nervous system disorders and epilepsy. Furthermore, ZIKV activates several inflammatory signals within infected hNPCs that are implicated in innate and acquired immune responses, while CMV-infected hNPCs showed limited representation of these pathways. Moreover, several genes related to pathogen responses are significantly upregulated upon ZIKV infection, but not perturbed in CMV-infected hNPCs.
   Conclusion: The presented study is the first to report enrichment of numerous pro-inflammatory pathways in ZIKV-infected hNPCs, indicating that hNPCs are capable of signaling through canonical pro-inflammatory pathways following viral infection. By defining gene expression profiles, new factors in the pathogenesis of ZIKV were identified which could help develop new therapeutic strategies.
C1 [Rolfe, Alyssa J.; Bosco, Dale B.; Wang, Jingying; Nowakowski, Richard S.; Ren, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, 1115 West St, Tallahassee, FL 32306 USA.
   [Fan, Jianqing] Princeton Univ, Stat Lab, Princeton, NJ 08540 USA.
RP Ren, Y (reprint author), Florida State Univ, Coll Med, Dept Biomed Sci, 1115 West St, Tallahassee, FL 32306 USA.
EM yi.ren@med.fsu.edu
FU National Institutes of Health [R01GM100474, R01GM072611]
FX Thanks to Stephanie Hurwitz for review of the manuscript. This work was
   supported by the National Institutes of Health (R01GM100474 and
   R01GM072611).
CR Aggarwal Anju, 2013, J Neurosci Rural Pract, V4, P288, DOI 10.4103/0976-3147.118781
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16
   Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   D'Aiuto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049700
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Kelley JF, 2011, VIROLOGY, V418, P27, DOI 10.1016/j.virol.2011.07.006
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LARUSSA VF, 1995, BAILLIERE CLIN HAEM, V8, P249, DOI 10.1016/S0950-3536(05)80240-9
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09
   Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39
   MARTIN EM, 1961, BIOCHEM J, V80, P585
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   NAKAO S, 1989, BLOOD, V74, P1235
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515
   R Core Team, 2015, R LANG ENV STAT COMP
   Rappaport N., 2013, DATABASE-OXFORD, V2013, P18, DOI DOI 10.1093/DATABASE/BAT018
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zuguang G, 2015, COMPLEXHEATMAP MAKIN
NR 36
TC 0
Z9 0
U1 23
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD JUN 10
PY 2016
VL 6
AR 42
DI 10.1186/s13578-016-0110-x
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DO4VI
UT WOS:000377782600004
PM 27293547
ER

PT J
AU Zambon, M
AF Zambon, M.
TI Zika virus, the new kid on the block
SO EUROSURVEILLANCE
LA English
DT Editorial Material
C1 [Zambon, M.] Publ Hlth England, London, England.
RP Zambon, M (reprint author), Publ Hlth England, London, England.
EM Maria.Zambon@phe.gov.uk
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bastgos L, 2016, BIORXIV, DOI [10.1101/055475, DOI 10.1101/055475]
   Coelho FC, 2016, BIORXIV, V26, DOI [10.1101/055459, DOI 10.1101/055459]
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Deen GF, 2015, NEW ENGL J MED, DOI [10. 1056/ NEJMoa1511410, DOI 10.1056/NEJM0A1511410, 10.1056/NEJMoa1511410]
   European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS ZIK VIR
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Niedrig M, 2005, J CLIN VIROL, V34, P22, DOI 10.1016/j.jcv.2005.01.004
   Public Health England (PHE), ZIK VIR INT ALG ASS
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rezza G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.21.30238
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   United Nations Development Group (UNDG)-Western and Central Africa, 2015, SOC IMP EB VIR DIS W
   WHO, 2016, ZIK SIT REP
NR 15
TC 0
Z9 0
U1 7
U2 7
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 9
PY 2016
VL 21
IS 23
BP 2
EP 5
AR 30255
DI 10.2807/1560-7917.ES.2016.21.23.30255
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DO6MS
UT WOS:000377898200001
ER

PT J
AU Reusken, C
   Pas, S
   GeurtsvanKessel, C
   Mogling, R
   van Kampen, J
   Langerak, T
   Koopmans, M
   van der Eijk, A
   van Gorp, E
AF Reusken, C.
   Pas, S.
   GeurtsvanKessel, C.
   Mogling, R.
   van Kampen, J.
   Langerak, T.
   Koopmans, M.
   van der Eijk, A.
   van Gorp, E.
TI Longitudinal follow-up of Zika virus RNA in semen of a traveller
   returning from Barbados to the Netherlands with Zika virus disease,
   March 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID SEXUAL TRANSMISSION; UNITED-STATES
AB We report the longitudinal follow-up of Zika virus (ZIKV) RNA in semen of a traveller who developed ZIKV disease after return to the Netherlands from Barbados, March 2016. Persistence of ZIKV RNA in blood, urine, saliva and semen was followed until the loads reached undetectable levels. RNA levels were higher in semen than in other sample types and declined to undetectable level at day 62 post onset of symptoms.
C1 [Reusken, C.; Pas, S.; GeurtsvanKessel, C.; Mogling, R.; van Kampen, J.; Langerak, T.; Koopmans, M.; van der Eijk, A.; van Gorp, E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Reusken, C.; Pas, S.; GeurtsvanKessel, C.; Mogling, R.; van Kampen, J.; Langerak, T.; Koopmans, M.; van der Eijk, A.; van Gorp, E.] Erasmus MC, WHO Collaborating Ctr Arbovirus & Viral Hemorrhag, Rotterdam, Netherlands.
RP Reusken, C (reprint author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.; Reusken, C (reprint author), Erasmus MC, WHO Collaborating Ctr Arbovirus & Viral Hemorrhag, Rotterdam, Netherlands.
EM c.reusken@erasmusmc.nl
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Charrel RN, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171207, DOI 10.2471/BLT.16.171207]
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR OUTBR AM PAC
   European Centre for Disease Prevention and Control (ECDC), 2016, RAP RISK ASS ZIK VIR
   Federal public service, WAARSCHUWING IN VERB
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   National Coordination Centre for Communicable Disease Control (LCI), LCI RICHTL ZIK
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pan American Health Organization (PAHO), 2016, CUM ZIK SUSP CONF CA
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization (WHO), 2016, DIS OUTBREAK NE 0120
NR 18
TC 4
Z9 4
U1 8
U2 8
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 9
PY 2016
VL 21
IS 23
BP 6
EP 9
AR 30251
DI 10.2807/1560-7917.ES.2016.21.23.30251
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DO6MS
UT WOS:000377898200002
ER

PT J
AU Freour, T
   Mirallie, S
   Hubert, B
   Splingart, C
   Barriere, P
   Maquart, M
   Leparc-Goffart, I
AF Freour, T.
   Mirallie, S.
   Hubert, B.
   Splingart, C.
   Barriere, P.
   Maquart, M.
   Leparc-Goffart, I.
TI Sexual transmission of Zika virus in an entirely asymptomatic couple
   returning from a Zika epidemic area, France, April 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID STATES
AB The current Zika virus outbreak and its potential severe health consequences, especially congenital fetal syndrome, have led to increased concern about sexual transmission, especially in pregnant women and women of reproductive age. Here we report a case of Zika virus sexual transmission, likely male-to-female, in a totally asymptomatic couple.
C1 [Freour, T.; Mirallie, S.; Splingart, C.; Barriere, P.] CHU Nantes, Serv Med Reprod, Nantes, France.
   [Hubert, B.] French Natl Publ Hlth Agcy, Sante Publ France, Reg Unit Cire Pays de la Loire, St Maurice, France.
   [Maquart, M.; Leparc-Goffart, I.] French Armed Forces Biomed Res Inst, Marseille, France.
RP Leparc-Goffart, I (reprint author), French Armed Forces Biomed Res Inst, Marseille, France.
EM isabelle.leparcgoffart@gmail.com
CR Agence de la Biomedecine, REC PROF CADR EP VIR
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Coelho FC, SEXUAL TRANSMISSION
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), CURR ZIK TRANSM
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haneche F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.18.30222
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lessler JT, 2016, B WORLD HEALTH ORGAN, V1, DOI [10.2471/BLT.16.174540, DOI 10.2471/BLT.16.174540]
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Sow MS, 2016, J INFECT DIS, DOI [10.1093/infdis/jiw078, DOI 10.1093/INFDIS/JIW078]
   Turmel JM, 2016, LANCET
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 15
TC 8
Z9 8
U1 9
U2 9
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 9
PY 2016
VL 21
IS 23
BP 10
EP 12
AR 30254
DI 10.2807/1560-7917.ES.2016.21.23.30254
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DO6MS
UT WOS:000377898200003
ER

PT J
AU Frank, C
   Cadar, D
   Schlaphof, A
   Neddersen, N
   Gunther, S
   Schmidt-Chanasit, J
   Tappe, D
AF Frank, C.
   Cadar, D.
   Schlaphof, A.
   Neddersen, N.
   Guenther, S.
   Schmidt-Chanasit, J.
   Tappe, D.
TI Sexual transmission of Zika virus in Germany, April 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID TRAVELERS
AB Zika virus (ZIKV), an emerging mosquito-borne flavivirus, causes a mild dengue fever-like illness but has recently been associated with neurological disease and severe birth defects. The virus is currently causing a large epidemic in the Americas. Here, we report a male-to-female sexual transmission of ZIKV in Germany in April 2016, following travel to Puerto Rico of the male patient, demonstrated by subsequent seroconversions and molecular identification of identical virus sequences from both patients.
C1 [Frank, C.] Robert Koch Inst, Dept Infect Dis Epidemiol, Div Gastrointestinal Infect Zoonoses & Trop Infec, Berlin, Germany.
   [Cadar, D.; Schlaphof, A.; Neddersen, N.; Guenther, S.; Schmidt-Chanasit, J.; Tappe, D.] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Schmidt-Chanasit, J.; Tappe, D.] German Ctr Infect Res DZIF, Site Hamburg Luebeck Borstel, Hamburg, Germany.
RP Schmidt-Chanasit, J (reprint author), Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.; Schmidt-Chanasit, J (reprint author), German Ctr Infect Res DZIF, Site Hamburg Luebeck Borstel, Hamburg, Germany.
EM jonassi@gmx.de
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Campos R. de M., 2016, Journal of Clinical Virology, V77, P69
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   D'Ortenzio Eric, 2016, N Engl J Med, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dirlikov E, 2015, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   European Centre for Disease Prevention and Control (ECDC), RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization, 2016, PREV SEX TRANSM ZIK
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
NR 20
TC 4
Z9 4
U1 12
U2 12
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 9
PY 2016
VL 21
IS 23
BP 13
EP 16
AR 30252
DI 10.2807/1560-7917.ES.2016.21.23.30252
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DO6MS
UT WOS:000377898200004
ER

PT J
AU Cugola, FR
   Fernandes, IR
   Russo, FB
   Freitas, BC
   Dias, JLM
   Guimaraes, KP
   Benazzato, C
   Almeida, N
   Pignatari, GC
   Romero, S
   Polonio, CM
   Cunha, I
   Freitas, CL
   Brandao, WN
   Rossato, C
   Andrade, DG
   Faria, DD
   Garcez, AT
   Buchpigel, CA
   Braconi, CT
   Mendes, E
   Sall, AA
   Zanotto, PMD
   Peron, JPS
   Muotri, AR
   Beltrao-Braga, PCB
AF Cugola, Fernanda R.
   Fernandes, Isabella R.
   Russo, Fabiele B.
   Freitas, Beatriz C.
   Dias, Joao L. M.
   Guimaraes, Katia P.
   Benazzato, Cecilia
   Almeida, Nathalia
   Pignatari, Graciela C.
   Romero, Sarah
   Polonio, Carolina M.
   Cunha, Isabela
   Freitas, Carla L.
   Brandao, Wesley N.
   Rossato, Cristiano
   Andrade, David G.
   Faria, Daniele de P.
   Garcez, Alexandre T.
   Buchpigel, Carlos A.
   Braconi, Carla T.
   Mendes, Erica
   Sall, Amadou A.
   Zanotto, Paolo M. de A.
   Peron, Jean Pierre S.
   Muotri, Alysson R.
   Beltrao-Braga, Patricia C. B.
TI The Brazilian Zika virus strain causes birth defects in experimental
   models
SO NATURE
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; INFECTION; BRAIN; ORGANOIDS; GROWTH
AB Zika virus (ZIKV) is an arbovirus belonging to the genus Flavivirus (family Flaviviridae) and was first described in 1947 in Uganda following blood analyses of sentinel rhesus monkeys(1). Until the twentieth century, the African and Asian lineages of the virus did not cause meaningful infections in humans. However, in 2007, vectored by Aedes aegypti mosquitoes, ZIKV caused the first noteworthy epidemic on Yap Island in Micronesia(2). Patients experienced fever, skin rash, arthralgia and conjunctivitis(2). From 2013 to 2015, the Asian lineage of the virus caused further massive outbreaks in New Caledonia and French Polynesia. In 2013, ZIKV reached Brazil, later spreading to other countries in South and Central America3. In Brazil, the virus has been linked to congenital malformations, including microcephaly and other severe neurological diseases, such as Guillain-Barre syndrome(4,5). Despite clinical evidence, direct experimental evidence showing that the Brazilian ZIKV (ZIKVBR) strain causes birth defects remains absent(6). Here we demonstrate that ZIKVBR infects fetuses, causing intrauterine growth restriction, including signs of microcephaly, in mice. Moreover, the virus infects human cortical progenitor cells in vitro, leading to an increase in cell death. We also report that the infection of human brain organoids results in a reduction of proliferative zones and disrupted cortical layers. These results indicate that ZIKVBR crosses the placenta and causes microcephaly by targeting cortical progenitor cells, inducing cell death by apoptosis and autophagy, and impairing neurodevelopment. Our data reinforce the growing body of evidence linking the ZIKVBR outbreak to the alarming number of cases of congenital brain malformations. Our model can be used to determine the efficiency of therapeutic approaches to counteracting the harmful impact of ZIKVBR in human neurodevelopment.
C1 [Cugola, Fernanda R.; Fernandes, Isabella R.; Russo, Fabiele B.; Dias, Joao L. M.; Guimaraes, Katia P.; Benazzato, Cecilia; Almeida, Nathalia; Pignatari, Graciela C.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.
   [Fernandes, Isabella R.; Freitas, Beatriz C.; Romero, Sarah; Muotri, Alysson R.] Univ Calif San Diego, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego, Sch Med,Dept Pediat,Stem Cell Program, La Jolla, CA 92037 USA.
   [Russo, Fabiele B.; Pignatari, Graciela C.] Tismoo, BR-01401000 Sao Paulo, Brazil.
   [Polonio, Carolina M.; Cunha, Isabela; Freitas, Carla L.; Brandao, Wesley N.; Rossato, Cristiano; Andrade, David G.; Peron, Jean Pierre S.] Univ Sao Paulo, Dept Immunol, Neuroimmune Interact Lab, BR-05508000 Sao Paulo, Brazil.
   [Faria, Daniele de P.; Garcez, Alexandre T.; Buchpigel, Carlos A.] Univ Sao Paulo, USP Sch Med, Dept Radiol & Oncol, BR-05403010 Sao Paulo, Brazil.
   [Braconi, Carla T.; Mendes, Erica; Zanotto, Paolo M. de A.] Univ Sao Paulo, Inst Microbiol Sci, Dept Microbiol, Lab Mol Evolut & Bioinformat, BR-05508000 Sao Paulo, Brazil.
   [Sall, Amadou A.] Inst Pasteur, Dakar 220, Senegal.
   [Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, Brazil.
RP Beltrao-Braga, PCB (reprint author), Univ Sao Paulo, Dept Surg, Stem Cell Lab, BR-05508270 Sao Paulo, Brazil.; Muotri, AR (reprint author), Univ Calif San Diego, Dept Cellular & Mol Med, Rady Childrens Hosp San Diego, Sch Med,Dept Pediat,Stem Cell Program, La Jolla, CA 92037 USA.; Peron, JPS (reprint author), Univ Sao Paulo, Dept Immunol, Neuroimmune Interact Lab, BR-05508000 Sao Paulo, Brazil.; Beltrao-Braga, PCB (reprint author), Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, Brazil.
EM jeanpierre@usp.br; muotri@ucsd.edu; patriciacbbbraga@usp.br
RI Buchpiguel, Carlos/C-3774-2012
OI Buchpiguel, Carlos/0000-0003-0956-2790
FU Zika Network FAPESP [2011/18703-2, 2014/17766-9]; NGO 'The Tooth Fairy
   Project'; National Institutes of Health [U19MH107367, R01MH094753];
   NARSAD Independent Investigator Grant
FX This work was supported by grants from the Zika Network FAPESP projects
   2011/18703-2 and 2014/17766-9, the NGO 'The Tooth Fairy Project', the
   National Institutes of Health through the U19MH107367, R01MH094753 and
   an NARSAD Independent Investigator Grant to A.R.M. We would like to
   thank M. Goncalves and M. A. Miglino for scientific discussions, G.
   Amarante-Mendes for the FITC-Annexin V reagent, M. Zatz for the SJL
   mice, E. Durigon and his group for the ZIKV<SUP>BR</SUP> aliquots, P.
   Vasconcelos for providing a lyophilized ZIKV<SUP>BR</SUP> seed, N. Olsen
   for reagent and equipment support, D. Candido for analysis support, F.
   Mastrantonio for drawings and R. E. Grassi for electron and confocal
   microscopy support.
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O., 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI DOI 10.1371/J0URNAL.PNTD.0002636
   Freire C. C. d. M., 2015, PREPRINT
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Jang EA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00176
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Qian X., 2016, CELL, V165, P1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi S.L., 2016, AM J TROP MED HYG
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Stock NK, 2013, J VIROL, V87, P2895, DOI 10.1128/JVI.01116-12
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 36
TC 29
Z9 29
U1 63
U2 63
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 9
PY 2016
VL 534
IS 7606
BP 267
EP +
DI 10.1038/nature18296
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO0NH
UT WOS:000377475100045
PM 27279226
ER

PT J
AU van Hemert, F
   Berkhout, B
AF van Hemert, Formijn
   Berkhout, Ben
TI Nucleotide composition of the Zika virus RNA genome and its codon usage
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; ZIKV; Viral RNA genome; Nucleotide composition; Nucleotide
   bias; Purine-rich; Codon usage; RNA structure; Flavivirus
ID MOLECULAR CHARACTERIZATION; FEVER-VIRUS; WEB SERVER; SELECTION; BIAS;
   TRANSMISSION; EVOLUTION; RECOMBINATION; RECOGNITION; SEQUENCES
AB Background: RNA viruses have genomes with a distinct nucleotide composition and codon usage. We present the global characteristics of the RNA genome of Zika virus (ZIKV), an emerging pathogen within the Flavivirus genus. ZIKV was first isolated in 1947 in Uganda, caused a widespread epidemic in South and Central America and the Caribbean in 2015 and has recently been associated with microcephaly in newborns.
   Methods: The nearly 11 kb positive-stranded RNA genome of ZIKV was analyzed for its nucleotide composition, also in the context of the folded RNA molecule. Nucleotide trends were investigated along the genome length by skew analyses and we analyzed the codons used for translation of the ZIKV proteins.
   Results: ZIKV RNA has a biased nucleotide composition in being purine-rich and pyrimidine-poor. This preference for purines is a general characteristic of the mosquito-borne and tick-borne flaviviruses. The virus-specific nucleotide bias is further enriched in the unpaired, single-stranded regions of the structured ZIKV RNA genome, thus further imposing this ZIKV-specific signature. The codons used for translation of the ZIKV proteins is also unusual, but we show that it is the underlying bias in nucleotide composition of the viral RNA that largely dictates these codon preferences.
   Conclusions: The ZIKV RNA genome has a biased nucleotide composition that dictates the codon usage of this flavivirus. We discuss the evolutionary scenarios and molecular mechanisms that may be responsible for these distinctive ZIKV RNA genome features.
C1 [van Hemert, Formijn; Berkhout, Ben] Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,Ctr Infect & Immun Amsterdam C, NL-1105 AZ Amsterdam, Netherlands.
RP Berkhout, B (reprint author), Univ Amsterdam, Acad Med Ctr, Lab Expt Virol, Dept Med Microbiol,Ctr Infect & Immun Amsterdam C, NL-1105 AZ Amsterdam, Netherlands.
EM b.berkhout@amc.uva.nl
FU NWO-Chemical Sciences (TOP grant)
FX We thank Alexander Pasternak and Tonja van der Kuyl for critical reading
   of the manuscript. RNA research in the BB laboratory is sponsored by
   NWO-Chemical Sciences (TOP grant).
CR Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498
   Behura SK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-37
   BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026
   BERKHOUT B, 1994, NUCLEIC ACIDS RES, V22, P1705, DOI 10.1093/nar/22.9.1705
   Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674
   Berkhout B, 2015, VIRUS RES, V202, P41, DOI 10.1016/j.virusres.2014.11.031
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dorn A, 2008, CURR OPIN MOL THER, V10, P10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE
   Francino M P, 1999, Nature, V400, P30, DOI 10.1038/21804
   Freire CCM, 2015, BIORXIV
   Girardin SE, 2002, TRENDS MICROBIOL, V10, P193, DOI 10.1016/S0966-842X(02)02334-X
   Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286
   Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   Jenkins GM, 2001, J MOL EVOL, V52, P383
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   KARLIN S, 1994, J VIROL, V68, P2889
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057
   Lara-Ramirez EE, 2014, BIOMED RES INT, DOI 10.1155/2014/851425
   Leifer I, 2013, VIROLOGY, V438, P51, DOI 10.1016/j.virol.2013.01.013
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Mlakar J., 2016, N ENGL J MED
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292
   ROTHBERG PG, 1981, NUCLEIC ACIDS RES, V9, P6221, DOI 10.1093/nar/9.23.6221
   Schubert AM, 2010, INFECT GENET EVOL, V10, P129, DOI 10.1016/j.meegid.2009.11.004
   SHARP PM, 1993, BIOCHEM SOC T, V21, P835
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tang H, 2016, CELL STEM CELL
   Vabret N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033502
   van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-92
   van Hemert F, 2014, VIRUS RES, V193, P16, DOI 10.1016/j.virusres.2014.03.019
   van Hemert FJ, 2013, RNA BIOL, V10, P211, DOI 10.4161/rna.22896
   VANHEMERT FJ, 1995, J MOL EVOL, V41, P132
   von Lindern JJ, 2006, J GEN VIROL, V87, P895, DOI 10.1099/vir.0.81536-0
   WATTERSON GA, 1992, MOL BIOL EVOL, V9, P666
   Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237
   WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Zheng H, 2013, J VET SCI, V14, P27, DOI 10.4142/jvs.2013.14.1.27
   Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077239
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 56
TC 0
Z9 0
U1 12
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUN 8
PY 2016
VL 13
AR 95
DI 10.1186/s12985-016-0551-1
PG 9
WC Virology
SC Virology
GA DO0ZK
UT WOS:000377507600001
PM 27278486
ER

PT J
AU Hall, RA
   Macdonald, J
AF Hall, Roy A.
   Macdonald, Joanne
TI Synthetic Biology Provides a Toehold in the Fight against Zika
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID VIRUS; AMPLIFICATION
AB The World Health Organization has identified the development of a rapid point-of-care diagnostic test for Zika virus as a top research priority. In a recent Cell paper, Pardee et al. (2016) have exploited recent advances in synthetic biology and molecular engineering to deliver a sensitive, affordable, and field-ready Zika test.
C1 [Hall, Roy A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.
   [Macdonald, Joanne] Univ Sunshine Coast, Sch Sci & Engn, Genecol Res Ctr, Inflammat & Healing Res Cluster, Maroochydore, Qld 4558, Australia.
   [Macdonald, Joanne] Columbia Univ, Div Expt Therapeut, New York, NY 10027 USA.
RP Hall, RA (reprint author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.
EM roy.hall@uq.edu.au
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   James A, 2015, EXPERT REV MOL DIAGN, V15, P1475, DOI 10.1586/14737159.2015.1090877
   Li J, 2015, BIOSENS BIOELECTRON, V64, P196, DOI 10.1016/j.bios.2014.08.069
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Poje JE, 2014, ANGEW CHEM INT EDIT, V53, P9222, DOI 10.1002/anie.201402698
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   2014, TOEHOLD SWITCH RNA S
NR 11
TC 0
Z9 0
U1 14
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 8
PY 2016
VL 19
IS 6
BP 752
EP 754
DI 10.1016/j.chom.2016.05.020
PG 3
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DO0CM
UT WOS:000377447000005
PM 27281566
ER

PT J
AU Dutra, HLC
   Rocha, MN
   Dias, FBS
   Mansur, SB
   Caragata, EP
   Moreira, LA
AF Carneiro Dutra, Heverton Leandro
   Neves Rocha, Marcele
   Stehling Dias, Fernando Braga
   Mansur, Simone Brutman
   Caragata, Eric Pearce
   Moreira, Luciano Andrade
TI Wolbachia Blocks Currently Circulating Zika Virus Isolates in Brazilian
   Aedes aegypti Mosquitoes
SO CELL HOST & MICROBE
LA English
DT Article
ID DENGUE; POPULATIONS; INFECTION; CHIKUNGUNYA; PLASMODIUM
AB The recent association of Zika virus with cases of microcephaly has sparked a global health crisis and highlighted the need for mechanisms to combat the Zika vector, Aedes aegypti mosquitoes. Wolbachia pipientis, a bacterial endosymbiont of insect, has recently garnered attention as a mechanism for arbovirus control. Here we report that Aedes aegypti harboring Wolbachia are highly resistant to infection with two currently circulating Zika virus isolates from the recent Brazilian epidemic. Wolbachia-harboring mosquitoes displayed lower viral prevalence and intensity and decreased disseminated infection and, critically, did not carry infectious virus in the saliva, suggesting that viral transmission was blocked. Our data indicate that the use of Wolbachia-harboring mosquitoes could represent an effective mechanism to reduce Zika virus transmission and should be included as part of Zika control strategies.
C1 [Carneiro Dutra, Heverton Leandro; Neves Rocha, Marcele; Stehling Dias, Fernando Braga; Mansur, Simone Brutman; Caragata, Eric Pearce; Moreira, Luciano Andrade] Ctr Pesquisas Rene Rachou Fiocruz, Mosquitos Vetores Endossimbiontes & Interacao Pat, BR-30190002 Belo Horizonte, MG, Brazil.
   [Stehling Dias, Fernando Braga] Plataforma Vetores Doencas Fiocruz, BR-60190800 Fortaleza, Ceara, Brazil.
RP Moreira, LA (reprint author), Ctr Pesquisas Rene Rachou Fiocruz, Mosquitos Vetores Endossimbiontes & Interacao Pat, BR-30190002 Belo Horizonte, MG, Brazil.
EM luciano@cpqrr.fiocruz.br
FU FAPEMIG; CNPq; CAPES; Brazilian Ministry of Health (DECIT/SVS);
   Foundation for National Institutes of Health through Vector-Based
   Transmission of Control: Discovery Research (VCTR) program of Grand
   Challenges in Global Health Initiatives of Bill and Melinda Gates
   Foundation
FX We are grateful to all members of the Mosquitos Vetores Group
   (MV-CPqRR/FIOCRUZ), particularly Jessica Silva, who helped to develop
   the salivation assay. We thank Dr. Luis Villegas for helpful discussion
   on statistics and Dr. Alexandre Machado for assistance with viral
   cultures. The Zika virus isolates were kindly provided by the Department
   of Virology and Experimental Therapy (Aggeu Magalhaes Research
   Center/FIOCRUZ) and by the Laboratory of Viral Isolation (Evandro Chagas
   Institute). We thank INCT-EM for the Real-Time PCR machine, and the
   Brazilian and Australian teams of the Eliminate Dengue program,
   particularly Prof. Scott L. O'Neill for donating the original wMel line
   and the Entomology team for providing field mosquito eggs. This work was
   supported by FAPEMIG, CNPq, CAPES, the Brazilian Ministry of Health
   (DECIT/SVS), and a grant to Monash University from the Foundation for
   the National Institutes of Health through the Vector-Based Transmission
   of Control: Discovery Research (VCTR) program of the Grand Challenges in
   Global Health Initiatives of the Bill and Melinda Gates Foundation.
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Caragata Eric P, 2016, Trends Parasitol, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Nam VS, 2005, AM J TROP MED HYG, V72, P67
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 28
TC 3
Z9 3
U1 24
U2 24
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 8
PY 2016
VL 19
IS 6
BP 771
EP 774
DI 10.1016/j.chom.2016.04.021
PG 4
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DO0CM
UT WOS:000377447000008
PM 27156023
ER

PT J
AU Grant, A
   Ponia, SS
   Tripathi, S
   Balasubramaniam, V
   Miorin, L
   Sourisseau, M
   Schwarz, MC
   Sanchez-Seco, MP
   Evans, MJ
   Best, SM
   Garcia-Sastre, A
AF Grant, Alesha
   Ponia, Sanket S.
   Tripathi, Shashank
   Balasubramaniam, Vinod
   Miorin, Lisa
   Sourisseau, Marion
   Schwarz, Megan C.
   Paz Sanchez-Seco, Mari
   Evans, Matthew J.
   Best, Sonja M.
   Garcia-Sastre, Adolfo
TI Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling
SO CELL HOST & MICROBE
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; NS5 PROTEIN; ANTAGONIST; FLAVIVIRUS;
   IDENTIFICATION; ACTIVATION; MECHANISMS; HEMISPHERE; EMERGENCE
AB The ongoing epidemic of Zika virus (ZIKV) illustrates the importance of flaviviruses as emerging human pathogens. All vector-borne flaviviruses studied thus far have to overcome type I interferon (IFN) to replicate and cause disease in vertebrates. The mechanism(s) by which ZIKV antagonizes IFN signaling is unknown. Here, we report that the nonstructural protein NS5 of ZIKV and other flaviviruses examined could suppress IFN signaling, but through different mechanisms. ZIKV NS5 expression resulted in proteasomal degradation of the IFN-regulated transcriptional activator STAT2 from humans, but not mice, which may explain the requirement for IFN deficiency to observe ZIKV-induced disease in mice. The mechanism of ZIKV NS5 resembles dengue virus (DENV) NS5 and not its closer relative, Spondweni virus (SPOV). However, unlike DENV, ZIKV did not require the E3 ubiquitin ligase UBR4 to induce STAT2 degradation. Hence, flavivirus NS5 proteins exhibit a remarkable functional convergence in IFN antagonism, albeit by virus-specific mechanisms.
C1 [Grant, Alesha; Tripathi, Shashank; Balasubramaniam, Vinod; Miorin, Lisa; Sourisseau, Marion; Schwarz, Megan C.; Evans, Matthew J.; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Grant, Alesha; Tripathi, Shashank; Balasubramaniam, Vinod; Miorin, Lisa; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Ponia, Sanket S.; Best, Sonja M.] NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
   [Paz Sanchez-Seco, Mari] Inst Hlth Carlos III, Natl Ctr Microbiol, Lab Arbovirus & Imported Viral Dis, Madrid 28029, Spain.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
RP Garcia-Sastre, A (reprint author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Garcia-Sastre, A (reprint author), Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.; Garcia-Sastre, A (reprint author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.
EM adolfo.garcia-sastre@mssm.edu
FU Intramural Research Program of the NIH, National Institute of Allergy
   and Infectious Diseases;  [U19AI118610]
FX We thank Barbara W. Johnson, Ana Fernandez-Sesma, and Steve Whitehead
   for kindly providing the 2015 PR ZIKV, 16881 DENV2, and 2015 Fortaleza
   ZIKV strains, respectively. We thank Genhong Cheng for
   IFNAR1<SUP>-/-</SUP> MEFs. We thank the microscopy and FACS SRF at Icahn
   School of Medicine for their support and Richard Cadagan for excellent
   technical assistance. This work was supported in part by the Intramural
   Research Program of the NIH, National Institute of Allergy and
   Infectious Diseases. These studies were also partly supported by a
   supplement to NIAID grant U19AI118610.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Bayer A, 2016, CELL HOST MICROBE
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/fmb.12.139, 10.2217/FMB.12.139]
   COIMBRA TLM, 1993, INTERVIROLOGY, V36, P144
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Engel D., 2016, MBIO, V7
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Kroczynska B, 2014, J INTERF CYTOK RES, V34, P289, DOI 10.1089/jir.2013.0148
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, CELL HOST MICROBE
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Liu Wen Jun, 2004, Journal of Virology, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Ouyang J, 2014, CELL HOST MICROBE, V16, P616, DOI 10.1016/j.chom.2014.10.001
   Rajsbaum R, 2014, IMMUNITY, V40, P880, DOI 10.1016/j.immuni.2014.04.018
   Rasmussen SA, 2016, N ENGL J MED
   Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.878.10.5358-5367.2004
   Rossi S.L., 2016, AM J TROP MED HYG
   Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005
   Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002
   Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009
   WOLFE MS, 1982, LANCET, V2, P1306
NR 44
TC 5
Z9 5
U1 26
U2 26
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 8
PY 2016
VL 19
IS 6
BP 882
EP 890
DI 10.1016/j.chom.2016.05.009
PG 9
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DO0CM
UT WOS:000377447000018
PM 27212660
ER

PT J
AU Shan, C
   Xie, XP
   Muruato, AE
   Rossi, SL
   Roundy, CM
   Azar, SR
   Yang, YJ
   Tesh, RB
   Boume, N
   Barrett, AD
   Vasilakis, N
   Weaver, SC
   Shi, PY
AF Shan, Chao
   Xie, Xuping
   Muruato, Antonio E.
   Rossi, Shannan L.
   Roundy, Christopher M.
   Azar, Sasha R.
   Yang, Yujiao
   Tesh, Robert B.
   Boume, Nigel
   Barrett, Alan D.
   Vasilakis, Nikos
   Weaver, Scott C.
   Shi, Pei-Yong
TI An Infectious cDNA Clone of Zika Virus to Study Viral Virulence,
   Mosquito Transmission, and Antiviral Inhibitors
SO CELL HOST & MICROBE
LA English
DT Article
ID FULL-LENGTH CDNA; WEST NILE VIRUS; DENGUE VIRUS; RNA; FLAVIVIRUS;
   VACCINE; THROUGHPUT; EPIDEMIC; RECOVERY; AMERICA
AB The Asian lineage of Zika virus (ZIKV) has recently caused epidemics and severe disease. Unraveling the mechanisms causing increased viral transmissibility and disease severity requires experimental systems. We report an infectious cDNA clone of ZIKV that was generated using a clinical isolate of the Asian lineage. The cDNA clone-derived RNA is infectious in cells, generating recombinant ZIKV. The recombinant virus is virulent in established ZIKV mouse models, leading to neurological signs relevant to human disease. Additionally, recombinant ZIKV is infectious for Aedes aegypti and thus provides a means to examine virus transmission. The infectious cDNA clone was further used to generate a luciferase ZIKV that exhibited sensitivity to a panflavivirus inhibitor, highlighting its potential utility for antiviral screening. This ZIKV reverse genetic system, together with mouse and mosquito infection models, may help identify viral determinants of human virulence and mosquito transmission as well as inform vaccine and therapeutic strategies.
C1 [Shan, Chao; Xie, Xuping; Yang, Yujiao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Rossi, Shannan L.; Roundy, Christopher M.; Azar, Sasha R.; Tesh, Robert B.; Barrett, Alan D.; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Muruato, Antonio E.; Roundy, Christopher M.; Azar, Sasha R.; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Tesh, Robert B.; Barrett, Alan D.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Tesh, Robert B.; Barrett, Alan D.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Boume, Nigel; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Boume, Nigel; Barrett, Alan D.; Weaver, Scott C.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Boume, Nigel] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Shi, PY (reprint author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (reprint author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (reprint author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Weaver, Scott/D-6490-2011
FU NIH [AI120942, AI087856]
FX We are grateful to Mariano A. Garcia-Blanco, Shelton S. Brarick, and
   their lab members for providing lab space, equipment, and helpful
   discussions during the course of this work. We thank James C. Lee,
   Shirley J. Broz, Lisa M. Pipper, and Julia K. Melchor for their support
   during the establishment of P.-Y.S.'s lab at UTMB. This research was
   supported by NIH grants AI120942 and AI087856.
CR Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Calvet G., 2016, LANCET INFECT DIS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DUDLEY D., 2016, BIORXIV
   Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fitzpatrick KA, 2010, VIROLOGY, V404, P89, DOI 10.1016/j.virol.2010.04.029
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   KHROMYKH AA, 1994, J VIROL, V68, P4580
   LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Li XD, 2014, J GEN VIROL, V95, P806, DOI 10.1099/vir.0.061838-0
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Mandl CW, 1997, J GEN VIROL, V78, P1049
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   RICE C M, 1989, New Biologist, V1, P285
   Rossi S.L., 2016, AM J TROP MED HYG
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Shustov AV, 2007, J VIROL, V81, P11737, DOI 10.1128/JVI.01112-07
   Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13
   SUMIYOSHI H, 1992, J VIROL, V66, P5425
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI [10.1016/j.bmcl.2005.09.062, 10.1016/j.bmcl.2005.09.004]
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zmurko J., 2016, BIORXIV
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 39
TC 1
Z9 1
U1 22
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 8
PY 2016
VL 19
IS 6
BP 891
EP 900
DI 10.1016/j.chom.2016.05.004
PG 10
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DO0CM
UT WOS:000377447000019
PM 27198478
ER

PT J
AU Spong, CY
AF Spong, Catherine Y.
TI Understanding Zika virus pathogenesis: an interview with Catherine Spong
SO BMC MEDICINE
LA English
DT Editorial Material
DE Zika; Infants; Pregnancy; Neurology; Microcephaly; Miscarriage;
   Stillbirth; Infectious disease; Cohort; Fetal anomaly
AB A recent outbreak of Zika virus has been linked to fetal abnormalities in pregnant women who have been infected. The scientific community is working toward understanding Zika virus pathogenesis to better manage affected women and children. In an interview with Dr. Catherine Spong, we discuss the aims and challenges of a forthcoming longitudinal study of a cohort of pregnant women in areas of current active Zika virus transmission.
C1 [Spong, Catherine Y.] NICHHD, Eunice Kennedy Shriver, NIH, Bethesda, MD 20892 USA.
RP Spong, CY (reprint author), NICHHD, Eunice Kennedy Shriver, NIH, Bethesda, MD 20892 USA.
EM spongc@mail.nih.gov
CR Besnard M, 2013, EUROSURVEILLANCE, V2016, P21, DOI [10.2807/1560-7917.ES.2016.21.13.30181, DOI 10.2807/1560-7917]
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Driggers RW, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824., DOI 10.1056/NEJMOA1601824, 10.1056/NEJMoa1601824]
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin AN, 2016, NEW ENGL J MED, DOI [10.1056/NEJMc1603617, DOI 10.1056/NEJMC1603617]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 9
TC 0
Z9 0
U1 14
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD JUN 6
PY 2016
VL 14
AR 84
DI 10.1186/s12916-016-0628-0
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO2DA
UT WOS:000377588700001
PM 27268016
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Clinical features and neuroimaging (CT and MRI) findings in presumed
   Zika virus related congenital infection and microcephaly: retrospective
   case series study (vol 353, pg i1901, 2016)
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Correction
CR Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 1
TC 0
Z9 0
U1 7
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD JUN 6
PY 2016
VL 353
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO5YA
UT WOS:000377857800014
ER

PT J
AU Rabe, IB
   Staples, JE
   Villanueva, J
   Hummel, KB
   Johnson, JA
   Rose, L
   Hills, S
   Wasley, A
   Fischer, M
   Powers, AM
AF Rabe, Ingrid B.
   Staples, J. Erin
   Villanueva, Julie
   Hummel, Kimberly B.
   Johnson, Jeffrey A.
   Rose, Laura
   Hills, Susan
   Wasley, Annemarie
   Fischer, Marc
   Powers, Ann M.
TI Interim Guidance for Interpretation of Zika Virus Antibody Test Results
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES; PERSISTENCE; INFECTION; MICRONESIA; OUTBREAK; VACCINE;
   YELLOW; DENGUE; WOMEN
C1 [Rabe, Ingrid B.; Staples, J. Erin; Villanueva, Julie; Hummel, Kimberly B.; Johnson, Jeffrey A.; Rose, Laura; Hills, Susan; Wasley, Annemarie; Fischer, Marc; Powers, Ann M.] CDC, Zika Virus Response Epidemiol & Lab Teams, Atlanta, GA 30333 USA.
RP Rabe, IB (reprint author), CDC, Zika Virus Response Epidemiol & Lab Teams, Atlanta, GA 30333 USA.
EM irabe@cdc.gov
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   CDC, REV DIAGN TEST ZIK C
   CDC, 2016, MMWR-MORBID MORTAL W, V65, P474
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH S
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   WHO, 2009, DENG GUID DIAGN TREA
NR 23
TC 3
Z9 3
U1 16
U2 16
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD JUN 3
PY 2016
VL 65
IS 21
BP 543
EP 546
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DN4IL
UT WOS:000377028200004
PM 27254248
ER

PT J
AU Duran, N
   Islan, GA
   Duran, M
   Castro, GR
AF Duran, Nelson
   Islan, German A.
   Duran, Marcela
   Castro, Guillermo R.
TI Nanobiotechnology Solutions against Aedes aegypti
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Review
DE Aedes aegypti; mosquitoes; nanostructures; nanobiotechnology; antiviral;
   nanobiosensors; nanoinsecticides
ID STEPHENSI LISTON DIPTERA; VIRUS NS1 PROTEIN; OF-THE-ART; SILVER
   NANOPARTICLES; DENGUE VIRUS; ANOPHELES-STEPHENSI; GREEN SYNTHESIS; LEAF
   EXTRACT; CULEX-QUINQUEFASCIATUS; LARVICIDAL ACTIVITY
AB United Nations Children's Fund (UNICEF)/United Nations Development Programme (UNDP)/World Bank/ World Health Organization (WHO) implemented the Training in Tropical Diseases (TDR) program with excellent results; however, due to current challenges, this active program requires new and innovative solutions. Nowadays, Aedes aegyptis-borne diseases can be added among neglected diseases. Surveillance and control must be considered owing to a great risk of infection with dengue, chikungunya and zika viruses. Although investigations on several vaccines are in progress, new insights in term of development of drugs that evade from resistance are of paramount importance. Nanobiotechnology appears as one of the most innovative strategy in the search of new uses for old pharmaceuticals or in the development of innovative and intelligent nanomedicines for neglected diseases. Liposomes, solid lipid nanoparticles, nanoemulsions, polymeric nanoparticles, metallic nanoparticles, quantum dots, carbon dots and carbon nanotubes were the focus of the current advances. In this direction, we have focused this overview on new advances in diagnostic assays as nanobiosensors, antivirus and nanoinsecticides on Aedes aegyptis control.
C1 [Duran, Nelson] Univ Estadual Campinas Unicamp, Inst Quim, Lab Quim Biol, BR-13083970 Campinas, SP, Brazil.
   [Duran, Nelson] Univ Estadual Campinas Unicamp, Inst Quim, Lab NanoBioss, BR-13083970 Campinas, SP, Brazil.
   [Duran, Nelson; Duran, Marcela] LNNano CNPEM, BR-13083100 Campinas, SP, Brazil.
   [Islan, German A.; Castro, Guillermo R.] Univ Nacl La Plata, Sch Sci, UNLP CONICET CCT La Plata, Appl Biotechnol Inst CINDEFI,Nanobiomat Lab, La Plata, Buenos Aires, Argentina.
   [Duran, Marcela] Univ Estadual Campinas Unicamp, Inst Biol, Lab Carcinogenese Urogenital & Imunoterapia, BR-13083970 Campinas, SP, Brazil.
RP Duran, N (reprint author), Univ Estadual Campinas Unicamp, Inst Quim, Lab Quim Biol, BR-13083970 Campinas, SP, Brazil.; Duran, N (reprint author), Univ Estadual Campinas Unicamp, Inst Quim, Lab NanoBioss, BR-13083970 Campinas, SP, Brazil.; Duran, N; Duran, M (reprint author), LNNano CNPEM, BR-13083100 Campinas, SP, Brazil.; Duran, M (reprint author), Univ Estadual Campinas Unicamp, Inst Biol, Lab Carcinogenese Urogenital & Imunoterapia, BR-13083970 Campinas, SP, Brazil.
EM duran@iqm.unicamp.br; marceladuranduran@gmail.com
FU INOMAT (CNPq); Brazilian Network on Nanotechnology (MCTI/CNPq);
   NanoBioss (MCTI); FAPESP
FX Support from INOMAT (CNPq), Brazilian Network on Nanotechnology
   (MCTI/CNPq), NanoBioss (MCTI) and FAPESP are acknowledged. The authors
   also thank Mauricio Ramalho Custodio for the design art photography of
   the cover image.
CR Alex MRA, 2011, EUR J PHARM SCI, V42, P11, DOI 10.1016/j.ejps.2010.10.002
   Araujo Helena R. C., 2015, Insects, V6, P576, DOI 10.3390/insects6020576
   Arjunan NK, 2012, VECTOR-BORNE ZOONOT, V12, P262, DOI 10.1089/vbz.2011.0661
   Baeumner AJ, 2002, ANAL CHEM, V74, P1442, DOI 10.1021/ac015675e
   Banu AN, 2014, PARASITOL RES, V113, P311, DOI 10.1007/s00436-013-3656-0
   Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890
   Bender AR, 1996, ANTIMICROB AGENTS CH, V40, P1467
   Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013
   Borase P. H., 2013, NANOMED BIOTHER DISC, V3, P111
   Bowman MC, 2008, J AM CHEM SOC, V130, P6896, DOI 10.1021/ja710321g
   Carvalho DO, 2014, JOVE-J VIS EXP, V83, pe3579, DOI [10.3791/3579, DOI 10.3791/3579]
   Center of Diseases Control and Prevention (CDC), SURV CONTR AED AEG A
   Clayton R, 2009, ANTIVIR RES, V84, P142, DOI 10.1016/j.antiviral.2009.08.003
   Das S, 2015, ACS APPL MATER INTER, V7, P19530, DOI 10.1021/acsami.5b05232
   De Jaeghere F, 2000, J CONTROL RELEASE, V68, P291, DOI 10.1016/S0168-3659(00)00272-8
   de Mareuil J, 2002, ANTIVIR RES, V54, P175, DOI 10.1016/S0166-3542(02)00002-5
   Deda DK, 2015, J BRAZIL CHEM SOC, V26, P2448, DOI 10.5935/0103-5053.20150316
   Dembri A, 2001, PHARM RES-DORDR, V18, P467, DOI 10.1023/A:1011050209986
   Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768
   Dias ACMS, 2013, BIOSENS BIOELECTRON, V44, P216, DOI 10.1016/j.bios.2012.12.033
   Duarte JL, 2015, REV BRAS FARMACOGN, V25, P189, DOI [10.1016/j.bjp.2015.02.2010, 10.1016/j.bjp.2015.02.010]
   Duran N., 2015, NANOMED-NANOTECHNOL, V12, P789
   Duran N, 2010, J BRAZIL CHEM SOC, V21, P949, DOI 10.1590/S0103-50532010000600002
   Duran N, 2009, CURR NANOSCI, V5, P396
   Duran N, 2010, QUIM NOVA, V33, P151, DOI 10.1590/S0100-40422010000100028
   Duran N, 2016, NANOMED-NANOTECHNOL, V12, P789, DOI 10.1016/j.nano.2015.11.016
   Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6, DOI 10.1186/1477-3155-3-6
   Gaikwad SC, 2013, J BRAZIL CHEM SOC, V24, P1974, DOI 10.5935/0103-5053.20130247
   Ghosh V, 2013, ASIAN J CHEM, V25, pS321
   Gnanadesigan M, 2011, ASIAN PAC J TROP MED, V4, P799, DOI 10.1016/S1995-7645(11)60197-1
   Gong TT, 2014, AIDS RES HUM RETROV, V30, pA143
   Gunaseelan S, 2010, ADV DRUG DELIVER REV, V62, P518, DOI 10.1016/j.addr.2009.11.021
   Hajra A., 2015, INT J SCI RES ENV SC, V3, P47
   Ham AS, 2009, PHARM RES-DORD, V26, P502, DOI 10.1007/s11095-008-9765-2
   Hunsawong T, 2015, VACCINE, V33, P1702, DOI 10.1016/j.vaccine.2015.02.016
   Hussain A, 2014, J ANIM PLANT SCI, V24, P1110
   Idrees Sobia, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P232, DOI 10.1016/S2221-1691(13)60057-X
   Jahanshahi P, 2014, SCI REP-UK, V4, DOI 10.1038/srep03851
   Jhaveri A, 2016, EXPERT OPIN DRUG DEL, V13, P49, DOI 10.1517/17425247.2015.1086745
   Kalimuthu K., 2013, Journal of Entomological and Acarological Research, V45, P57, DOI 10.4081/jear.2013.e11
   Kuo YC, 2006, INT J PHARM, V327, P160, DOI 10.1016/j.ijpharm.2006.07.044
   Lembo David, 2010, Antiviral Chemistry & Chemotherapy, V21, P53, DOI 10.3851/IMP1684
   LEROUX JC, 1995, J PHARM SCI, V84, P1387, DOI 10.1002/jps.2600841202
   Lobenberg R, 1998, J CONTROL RELEASE, V50, P21, DOI 10.1016/S0168-3659(97)00105-3
   Mashwani ZUR, 2015, APPL MICROBIOL BIOT, V99, P9923, DOI 10.1007/s00253-015-6987-1
   Miller JL, 2012, ANTIMICROB AGENTS CH, V56, P6379, DOI 10.1128/AAC.01554-12
   Mungrue K., 2014, ADV LAB MED INT, V4, P1
   Olliaro PL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003379
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Peh A. E., 2010, FRONT BIOSCI SCHOLAR, V3, P806
   Pollock S, 2010, P NATL ACAD SCI USA, V107, P17176, DOI 10.1073/pnas.1009445107
   Poopathi S, 2015, ENVIRON SCI POLLUT R, V22, P2956, DOI 10.1007/s11356-014-3560-x
   Prabhu RH, 2015, INT J NANOMED, V10, P1001, DOI 10.2147/IJN.S56932
   Priyadarshini KA, 2012, PARASITOL RES, V111, P997, DOI 10.1007/s00436-012-2924-8
   Rai M., 2015, NANOTECHNOLOGY DIAGN
   Rai M, 2012, J BRAZIL CHEM SOC, V23, P14, DOI 10.1590/S0103-50532012000100004
   Rossi-Bergmann B, 2012, J NANO RES-SW, V20, P89, DOI 10.4028/www.scientific.net/JNanoR.20.89
   Salunkhe RB, 2011, PARASITOL RES, V109, P823, DOI 10.1007/s00436-011-2328-1
   Sareen Sarah J, 2012, RES J RECENT SCI, V1, P52
   Sathishkumar M, 2009, COLLOID SURFACE B, V73, P332, DOI 10.1016/j.colsurfb.2009.06.005
   Saxena M, 2013, RSC ADV, V3, P22504, DOI 10.1039/c3ra44100h
   Sayce AC, 2010, TRENDS MICROBIOL, V18, P323, DOI 10.1016/j.tim.2010.04.003
   Serizawa T, 2013, BIOMACROMOLECULES, V14, P613, DOI 10.1021/bm4000822
   Shah LK, 2006, PHARM RES, V23, P2638, DOI 10.1007/s11095-006-9101-7
   Shegokar R, 2010, INT J PHARMACEUT, V399, P129, DOI 10.1016/j.ijpharm.2010.07.044
   Silva EF, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-13
   Silva MMS, 2015, J CHEM TECHNOL BIOT, V90, P194, DOI 10.1002/jctb.4305
   Silveira CP, 2015, RSC ADV, V5, P81348, DOI 10.1039/c5ra15006j
   Smith AJ, 2011, MOL PHARMACEUT, V8, P1867, DOI 10.1021/mp200209j
   Soni N, 2012, ASIAN PAC J TROP DIS, V2, pS356, DOI DOI 10.1016/S2222-1808(12)60181-9
   [Anonymous], 2012, REP PARASITOL, DOI DOI 10.2147/RIP.S29033
   Soni N, 2013, ADV NANOPART, V2, P125
   Soni N, 2012, PARASITOL RES, V111, P2091, DOI 10.1007/s00436-012-3056-x
   Soni N, 2012, PARASITOL RES, V110, P175, DOI 10.1007/s00436-011-2467-4
   Suganya A, 2013, PARASITOL RES, V112, P1385, DOI 10.1007/s00436-012-3269-z
   Sundaravadivelan C, 2013, PARASITOL RES, V112, P303, DOI [10.1007/s00436-012-3138-9, 10.100]
   Teles FRR, 2005, REV MED VIROL, V15, P287, DOI 10.1002/rmv.461
   Tsai MJ, 2012, INT J PHARMACEUT, V423, P461, DOI 10.1016/j.ijpharm.2011.12.009
   Veerakumar K, 2014, PARASITOL RES, V113, P2363, DOI 10.1007/s00436-014-3895-8
   Veerakumar K, 2014, PARASITOL RES, V113, P4567, DOI 10.1007/s00436-014-4147-7
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Yumei L., 2009, PRACT PHARM CLIN REM, V12, P104
   Zandi K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-214
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zhang GJ, 2010, SENSOR ACTUAT B-CHEM, V146, P138, DOI 10.1016/j.snb.2010.02.021
   Zhang Y, 2015, LAB CHIP, V15, P1465, DOI 10.1039/c4lc01127a
   Zoppe JO, 2014, BIOMACROMOLECULES, V15, P1534, DOI 10.1021/bm500229d
NR 88
TC 0
Z9 0
U1 2
U2 2
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PD JUN
PY 2016
VL 27
IS 7
BP 1139
EP 1149
DI 10.5935/0103-5053.20160122
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA DV7FF
UT WOS:000383101000002
ER

PT J
AU Nebbia, G
   Douthwaite, ST
AF Nebbia, Gaia
   Douthwaite, Samuel Thomas
TI Zika infection: From obscurity to public health emergency
SO OBSTETRIC MEDICINE
LA English
DT Editorial Material
ID BRAZIL; VIRUS
C1 [Nebbia, Gaia; Douthwaite, Samuel Thomas] St Thomas Hosp, London, England.
RP Douthwaite, ST (reprint author), St Thomas Hosp, London, England.
EM sam.douthwaite@gstt.nhs.uk
CR Brasil P, N ENGL J MED
   Calvet G, LANCET INFECT DIS
   Cauchemez S, LANCET
   Driggers RW, N ENGL J MED
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Tang H, CELL STEM CELL
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 9
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1753-495X
EI 1753-4968
J9 OBSTET MED
JI Obstet. Med.
PD JUN
PY 2016
VL 9
IS 2
BP 53
EP 54
DI 10.1177/1753495X16648078
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DV7MI
UT WOS:000383119800001
PM 27512493
ER

PT J
AU Ribeiro, LS
   Marques, RE
   de Jesus, AMR
   de Almeida, RP
   Teixeira, MM
AF Ribeiro, Lucas Secchim
   Marques, Rafael Elias
   Ribeiro de Jesus, Amelia Maria
   de Almeida, Roque Pacheco
   Teixeira, Mauro Martins
TI Zika crisis in Brazil: challenges in research and development
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID VIRUS-INFECTION; DENGUE VIRUS; TRANSMISSION; REPLICATION; MICRONESIA;
   INHIBITORS; PREGNANCY; EPIDEMIC; MODEL; MICE
AB Infection with the Zika virus (ZIKV) usually causes a mild acute illness, but two major severe syndromes have been described during the epidemic in Brazil: microcephaly and the Guillain-Barre Syndrome. There is now much evidence to show that ZIKV can infect and damage neuronal cells in vitro. In experimental animals, ZIKV has significant neurotropism and can cause brain damage. At present, diagnosis is still a challenge in the field and there is no treatment available. Another major challenge is that one must devise therapies for pregnant women, at all stages of pregnancy. Devising adequate treatment for ZIKV infections represents a challenge that will only be met by the joint effort of the research community.
C1 [Ribeiro, Lucas Secchim] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Ribeiro, Lucas Secchim; Marques, Rafael Elias; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Immunopharmacol, Belo Horizonte, MG, Brazil.
   [Ribeiro de Jesus, Amelia Maria; de Almeida, Roque Pacheco] Univ Fed Sergipe, Lab Biol Mol, Univ Hosp, Aracaju, Brazil.
   [Ribeiro de Jesus, Amelia Maria; de Almeida, Roque Pacheco] Univ Fed Sergipe, Programa Pos Grad Ciencias Saude, Univ Hosp, Aracaju, Brazil.
RP Teixeira, MM (reprint author), Univ Fed Minas Gerais, Immunopharmacol, Belo Horizonte, MG, Brazil.
EM mmtex@icb.ufmg.br
FU CNPq; FAPEMIG
FX We would like to thank CNPq and FAPEMIG for their financial support.
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Brazilian Health Ministry BR, 2016, MON MICR CAS BRAZ
   Brazilian Health Ministry BR, 2015, MIN SAUD DIV B EP
   Brazilian Health Ministry BR, 2016, EPIDEMIOL WEEK, V2016, P5
   Calvet G., 2016, LANCET INFECT DIS
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Faria NR, 2016, SCIENCE
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Garcez PPLE, 2016, PEERJ PREPRINTS, V4
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08
   Kourtis AP, 2014, NEW ENGL J MED, V371, P1077, DOI 10.1056/NEJMc1408436
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL
   Lazear H M, 2016, JAMA
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison J, 2014, JAK STAT, V3
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E, 2014, EUROSURVEILLANCE, P19
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Roberts SS, 2010, BIRTH DEFECTS RES A, V88, P551, DOI 10.1002/bdra.20682
   Rossi S.L., 2016, AM J TROP MED HYG
   Roze B, 2016, EUROSURVEILLANCE, P21
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tang H, 2016, CELL STEM CELL
   Thorne C, 2007, DRUG SAFETY, V30, P203, DOI 10.2165/00002018-200730030-00004
   Villamil-Gomez W E, 2016, J INFECT PUBLIC HLTH, DOI S1876-0341(15)00221-X
   Vogel G, 2016, SCIENCE, V351, P1377, DOI 10.1126/science.351.6280.1377
   Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2016, LANCET INFECT DIS, V16, P265
NR 52
TC 3
Z9 3
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD JUN
PY 2016
VL 18
BP 76
EP 81
DI 10.1016/j.coviro.2016.04.002
PG 6
WC Virology
SC Virology
GA DU5TC
UT WOS:000382273200014
PM 27179929
ER

PT J
AU Slenczka, W
AF Slenczka, Werner
TI Zika Virus Disease
SO MICROBIOLOGY SPECTRUM
LA English
DT Article
ID INTERIM GUIDELINES; DENGUE VIRUSES; UNITED-STATES; YELLOW-FEVER;
   INFECTION; TRANSMISSION; OUTBREAK; ARBOVIRUSES; MOSQUITOS; NIGERIA
AB The history of Zika virus disease serves as a paradigm of a typical emerging viral infection. Zika virus disease, a mosquito-borne flavivirus, was first isolated in 1947 in the Zika forest of Uganda. The same virus was also isolated from jungle-dwelling mosquitoes (Aedes [Stegomyia] africanus). In many areas of Africa and South Asia human infections with Zika virus were detected by both serology and virus isolation. About 80% of infections are asymptomatic, and in 20% a mostly mild disease with fever, rash, arthralgia, and conjunctivitis may occur. Fetal infections with malformations were not recorded in Africa or Asia. Zika virus was imported to northern Brazil possibly during the world soccer championship that was hosted by Brazil in June through July 2014. A cluster of severe fetal malformations with microcephaly and ocular defects was noted in 2015 in the northeast of Brazil, and intrauterine infections with Zika virus were confirmed. The dramatic change in Zika virus pathogenicity upon its introduction to Brazil has remained an enigma.
C1 [Slenczka, Werner] Univ Marburg, Inst Virol, D-35037 Marburg, Germany.
RP Slenczka, W (reprint author), Univ Marburg, Inst Virol, D-35037 Marburg, Germany.
EM slenczka-marburg@t-online.de
OI Khan, Yawar/0000-0003-1964-591X
CR Baeten JM, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1506110, DOI 10.1056/NEJMOA1506110, 10.1056/NEJMoa1506110.]
   Bhattacharya A, 2015, IMMUNITY, V43, P974, DOI 10.1016/j.immuni.2015.10.013
   Bielefeldt-Ohmann H, 2012, INT J EXP PATHOL, V93, P24, DOI 10.1111/j.1365-2613.2011.00795.x
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2016, UPD INT GUID PREV SE
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Da Paula Freitas B, 2016, JAMA OPHTHALMOL, V2016, DOI [10.1001 / jamaophthalmol., DOI 10.1001/JAMAOPHTHALM0L]
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gubler D, 2007, FIELDS VIROLOGY, P1153
   [Anonymous], 1964, B WORLD HEALTH ORGAN
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasci RS, 2015, CDC HLTH INFORM INT, P94
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Slenczka W, 1968, Ger Med Mon, V13, P524
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   WHO, 2009, DENG GUID DIAGN TREA
   World Health Organization/ PAN American Health Organization, 2016, ZIK VIR MICR GUILL B
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 51
TC 0
Z9 0
U1 6
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
EI 2165-0497
J9 MICROBIOL SPECTR
JI Microbiol. Spectr.
PD JUN
PY 2016
VL 4
IS 3
AR UNSP EI10-0019-2016
DI 10.1128/microbiolspec.EI10-0019-2016
PG 8
WC Microbiology
SC Microbiology
GA DT9GD
UT WOS:000381803300023
ER

PT J
AU Al-Tawfiq, JA
   Gautret, P
   Benkouiten, S
   Memish, ZA
AF Al-Tawfiq, Jaffar A.
   Gautret, Philippe
   Benkouiten, Samir
   Memish, Ziad A.
TI Mass Gatherings and the Spread of Respiratory Infections Lessons from
   the Hajj
SO ANNALS OF THE AMERICAN THORACIC SOCIETY
LA English
DT Article
AB The mass gathering of people is a potential source for developing, propagating, and disseminating infectious diseases on a global scale. Of the illnesses associated with mass gatherings, respiratory tract infections are the most common, the most easily transmitted, and the most likely to be spread widely beyond the site of the meeting by attendees returning home. Many factors contribute to the spread of these infections during mass gatherings, including crowding, the health of the attendees, and the type and location of meetings. The annual Hajj in the Kingdom of Saudi Arabia is the largest recurring single mass gathering in the world. Every year more than 10 million pilgrims attend the annual Hajj and Umrah. Attendees assemble in confined areas for several days. People with a wide range of age, health, susceptibility to illness, and hygiene sophistication come in close contact, creating an enormous public health challenge. Controlling respiratory infections at the Hajj requires surveillance, rapid diagnostic testing, and containment strategies. Although the Hajj is without equal, other mass gatherings can generate similar hazards. The geographic colocalization of the Zika virus epidemic and the 2016 Summer Olympic Games in Brazil is a current example of great concern. The potential of international mass gatherings for local and global calamity calls for greater global attention and research.
C1 [Al-Tawfiq, Jaffar A.] Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
   [Al-Tawfiq, Jaffar A.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA.
   [Gautret, Philippe; Benkouiten, Samir] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, INSERM 1095, UM63,CNRS 7278,IRD 198, Marseille, France.
   [Gautret, Philippe; Benkouiten, Samir] Inst Hosp Univ Mediterranee Infect, F-13005 Marseille, France.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, POB 54146, Riyadh 11514, Saudi Arabia.
   [Memish, Ziad A.] Minist Hlth, Riyadh, Saudi Arabia.
RP Memish, ZA (reprint author), Alfaisal Univ, Coll Med, POB 54146, Riyadh 11514, Saudi Arabia.; Memish, ZA (reprint author), Alfaisal Univ, Minist Hlth, POB 54146, Riyadh 11514, Saudi Arabia.
EM zmemish@yahoo.com
NR 0
TC 0
Z9 0
U1 2
U2 2
PU AMER THORACIC SOC
PI NEW YORK
PA 25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA
SN 1546-3222
EI 2325-6621
J9 ANN AM THORAC SOC
JI Ann. Am. Thoracic Society
PD JUN
PY 2016
VL 13
IS 6
BP 759
EP 765
DI 10.1513/AnnalsATS.201511-772FR
PG 7
WC Respiratory System
SC Respiratory System
GA DR7WD
UT WOS:000380109500001
PM 27088298
ER

PT J
AU Stamm, LV
AF Stamm, Lola V.
TI Zika Virus in the Americas An Obscure Arbovirus Comes Calling
SO JAMA DERMATOLOGY
LA English
DT Editorial Material
C1 [Stamm, Lola V.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Program Infect Dis, Chapel Hill, NC USA.
RP Stamm, LV (reprint author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Program Infect Dis,Hooker Res Ctr 3302, S Columbia St, Chapel Hill, NC 27599 USA.
EM lstamm@email.unc.edu
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Monaghan AJ, PLOS CURR, V8, DOI [10.1371/cur-rents.outbreaks.50dfc7f46798675fc63e7d7da563da76, DOI 10.1371/CURRENTS.OUTBREAKS.50DFC7F46798675FC63E7D7DA563DA76]
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   [Anonymous], 2016, GENETIC ENG BIOTECHN
NR 9
TC 0
Z9 0
U1 6
U2 6
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6068
EI 2168-6084
J9 JAMA DERMATOL
JI JAMA Dermatol.
PD JUN
PY 2016
VL 152
IS 6
BP 621
EP 622
DI 10.1001/jamadermatol.2016.1499
PG 2
WC Dermatology
SC Dermatology
GA DR0HM
UT WOS:000379588600001
PM 27167249
ER

PT J
AU Derrington, SM
   Cellura, P
   McDermott, LE
   Gubitosi, T
   Sonstegard, AM
   Chen, S
   Garg, A
AF Derrington, Sarah M.
   Cellura, Paul
   McDermott, Laura E.
   Gubitosi, Taylor
   Sonstegard, Anna Marie
   Chen, Sheng
   Garg, Amit
TI Mucocutaneous Findings and Course in an Adult With Zika Virus Infection
SO JAMA DERMATOLOGY
LA English
DT Article
AB IMPORTANCE The Zika virus epidemic has been declared a public health emergency of international concern by the World Health Organization. We describe the mucocutaneous features and histologic correlation in a patient with the acute Zika virus infection.
   OBSERVATIONS We observed the presence of a diffuse papular descending eruption, petechiae on the palate, and hyperemic sclerae in a 44-year-old man returning from Puerto Rico with confirmatory testing for the Zika virus.
   CONCLUSIONS AND RELEVANCE A detailed awareness of mucocutaneous findings associated with Zika virus infection will support its early recognition and will facilitate elimination of Zika infection from consideration for concerned patients who present with other, more common erythematous eruptions.
C1 [Derrington, Sarah M.; Cellura, Paul; McDermott, Laura E.; Gubitosi, Taylor; Sonstegard, Anna Marie; Chen, Sheng; Garg, Amit] Hofstra Northwell Sch Med, Dept Dermatol, 1991 Marcus Ave,Ste 300,New Hyde Pk, Hempstead, NY 11042 USA.
RP Garg, A (reprint author), Hofstra Northwell Sch Med, Dept Dermatol, 1991 Marcus Ave,Ste 300,New Hyde Pk, Hempstead, NY 11042 USA.
EM amgarg@northwell.edu
CR Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garcia E., 2016, Weekly Epidemiological Record, V91, P73
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
NR 6
TC 1
Z9 1
U1 4
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6068
EI 2168-6084
J9 JAMA DERMATOL
JI JAMA Dermatol.
PD JUN
PY 2016
VL 152
IS 6
BP 691
EP 693
DI 10.1001/jamadermatol.2016.1433
PG 3
WC Dermatology
SC Dermatology
GA DR0HM
UT WOS:000379588600017
PM 27168495
ER

PT J
AU Robinson, JK
AF Robinson, June K.
TI Zika Virus
SO JAMA DERMATOLOGY
LA English
DT Editorial Material
CR Derrington SM, 2016, JAMA DERMATOL, V152, P691, DOI 10.1001/jamadermatol.2016.1433
   Jin Jill, 2016, JAMA, V315, P2482, DOI 10.1001/jama.2016.4741
NR 2
TC 0
Z9 0
U1 7
U2 7
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6068
EI 2168-6084
J9 JAMA DERMATOL
JI JAMA Dermatol.
PD JUN
PY 2016
VL 152
IS 6
BP 693
EP 693
PG 1
WC Dermatology
SC Dermatology
GA DR0HM
UT WOS:000379588600018
PM 27166755
ER

PT J
AU Cavalcanti, LPD
   Tauil, PL
   Alencar, CH
   Oliveira, W
   Teixeira, MM
   Heukelbach, J
AF de Goes Cavalcanti, Luciano Pamplona
   Tauil, Pedro Luiz
   Alencar, Carlos Henrique
   Oliveira, Wanderson
   Teixeira, Mauro Martins
   Heukelbach, Jorg
TI Zika virus infection, associated microcephaly, and low yellow fever
   vaccination coverage in Brazil: is there any causal link?
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Zika; Brazil; epidemiology
AB Introduction: Since the end of 2014, Zika virus (ZIKV) infection has been rapidly spreading in Brazil.
   Methodology: To analyze the possible association of yellow fever vaccine with a protective effect against ZIKV-related microcephaly, the following spatial analyses were performed, using Brazilian municipalities as units: i) yellow fever vaccination coverage in Brazilian municipalities in individuals aged 15-49; ii) reported cases of microcephaly by municipality; and iii) confirmed cases of microcephaly related to ZIKV, by municipality. SaTScan software was used to identify clusters of municipalities for high risk of microcephaly.
   Results: There were seven significant high risk clusters of confirmed microcephaly cases, with four of them located in the Northeast where yellow fever vaccination rates were the lowest. The clusters harbored only 2.9% of the total population of Brazil, but 15.2% of confirmed cases of microcephaly.
   Conclusion: We hypothesize that pregnant women in regions with high yellow fever vaccination coverage may pose their offspring to lower risk for development of microcephaly. There is an urgent need for systematic studies to confirm the possible link between low yellow fever vaccination coverage, Zika virus infection and microcephaly.
C1 [de Goes Cavalcanti, Luciano Pamplona; Alencar, Carlos Henrique; Heukelbach, Jorg] Univ Fed Ceara, Sch Med, Dept Community Hlth, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, Ceara, Brazil.
   [Oliveira, Wanderson] Minist Saude Brasil, Coordenacao Geral Vigilancia & Resposta Emergenci, Brasilia, DF, Brazil.
   [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Heukelbach, Jorg] James Cook Univ, Anton Breinl Ctr Publ Hlth, Townsville, Qld, Australia.
   [Heukelbach, Jorg] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Div Trop Hlth & Med, Townsville, Qld, Australia.
   [Tauil, Pedro Luiz] Univ Brasilia UnB, Fac Med, Brasilia, DF, Brazil.
RP Cavalcanti, LPD (reprint author), Univ Fed Ceara, Sch Med, Dept Community Hlth, Rua Prof Costa Mendes 1608,5 Andar, BR-60430140 Fortaleza, Ceara, Brazil.
EM pamplona.luciano@gmail.com
RI Oliveira, Wanderson/D-7140-2016
OI Oliveira, Wanderson/0000-0002-9662-1930
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cavalcante Karina Ribeiro Leite Jardim, 2016, Epidemiol. Serv. Sade, V25, P11, DOI 10.5123/S1679-49742016000100002
   Chan M, 2016, LANCET, DOI [10.1016/S0140-6736(16)30620-1, DOI 10.1016/S0140-6736(16)30620-1.]
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Brasil, 2015, PROT VIG RESP OC MIC
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Brasil. Secretaria de Vigilancia em Saude. Departamento de Vigilancia em Saude, 2005, MAN VIG EP PRIM NAO
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 0
Z9 0
U1 15
U2 15
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD JUN
PY 2016
VL 10
IS 6
BP 563
EP 566
DI 10.3855/jidc.8575
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DQ5SY
UT WOS:000379266500003
ER

PT J
AU Bonaldo, MC
   Ribeiro, IP
   Lima, NS
   dos Santos, AAC
   Menezes, LSR
   da Cruz, SOD
   de Mello, IS
   Furtado, ND
   de Moura, EE
   Damasceno, L
   da Silva, KAB
   de Castro, MG
   Gerber, AL
   de Almeida, LGP
   Lourenco-de-Oliveira, R
   Vasconcelos, ATR
   Brasil, P
AF Bonaldo, Myrna C.
   Ribeiro, Ieda P.
   Lima, Noemia S.
   dos Santos, Alexandre A. C.
   Menezes, Lidiane S. R.
   da Cruz, Stephanie O. D.
   de Mello, Iasmim S.
   Furtado, Nathalia D.
   de Moura, Elaine E.
   Damasceno, Luana
   da Silva, Kely A. B.
   de Castro, Marcia G.
   Gerber, Alexandra L.
   de Almeida, Luiz G. P.
   Lourenco-de-Oliveira, Ricardo
   Vasconcelos, Ana Tereza R.
   Brasil, Patricia
TI Isolation of Infective Zika Virus from Urine and Saliva of Patients in
   Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; WEST-NILE-VIRUS; TRANSMISSION; ENCEPHALITIS;
   DENGUE; FLAVIVIRUS; OUTBREAK; SAMPLES
AB Background
   Zika virus (ZIKV) is an emergent threat provoking a worldwide explosive outbreak. Since January 2015, 41 countries reported autochthonous cases. In Brazil, an increase in Guillain-Barre syndrome and microcephaly cases was linked to ZIKV infections. A recent report describing low experimental transmission efficiency of its main putative vector, Ae. aegypti, in conjunction with apparent sexual transmission notifications, prompted the investigation of other potential sources of viral dissemination. Urine and saliva have been previously established as useful tools in ZIKV diagnosis. Here, we described the presence and isolation of infectious ZIKV particles from saliva and urine of acute phase patients in the Rio de Janeiro state, Brazil.
   Methodology/Principal Findings
   Nine urine and five saliva samples from nine patients from Rio de Janeiro presenting rash and other typical Zika acute phase symptoms were inoculated in Vero cell culture and submitted to specific ZIKV RNA detection and quantification through, respectively, NAT-Zika, RT-PCR and RT-qPCR. Two ZIKV isolates were achieved, one from urine and one from saliva specimens. ZIKV nucleic acid was identified by all methods in four patients. Whenever both urine and saliva samples were available from the same patient, urine viral loads were higher, corroborating the general sense that it is a better source for ZIKV molecular diagnostic. In spite of this, from the two isolated strains, each from one patient, only one derived from urine, suggesting that other factors, like the acidic nature of this fluid, might interfere with virion infectivity. The complete genome of both ZIKV isolates was obtained. Phylogenetic analysis revealed similarity with strains previously isolated during the South America outbreak.
   Conclusions/Significance
   The detection of infectious ZIKV particles in urine and saliva of patients during the acute phase may represent a critical factor in the spread of virus. The epidemiological relevance of this finding, regarding the contribution of alternative non-vectorial ZIKV transmission routes, needs further investigation.
C1 [Bonaldo, Myrna C.; Ribeiro, Ieda P.; Lima, Noemia S.; dos Santos, Alexandre A. C.; Menezes, Lidiane S. R.; da Cruz, Stephanie O. D.; de Mello, Iasmim S.; Furtado, Nathalia D.; de Moura, Elaine E.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
   [Damasceno, Luana; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.
   [da Silva, Kely A. B.; de Castro, Marcia G.; Lourenco-de-Oliveira, Ricardo] Fiocruz MS, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.
   [Gerber, Alexandra L.; de Almeida, Luiz G. P.; Vasconcelos, Ana Tereza R.] Petropolis, Lab Nacl Comp Cient, Rio De Janeiro, Brazil.
RP Bonaldo, MC (reprint author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, Brazil.
EM mbonaldo@ioc.fiocruz.br
OI Bonaldo, Myrna/0000-0001-9899-3386
CR Anders KL, 2012, AM J TROP MED HYG, V87, P165, DOI 10.4269/ajtmh.2012.11-0713
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Barzon L., 2016, EURO SURVEILL, V21
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, N ENGL J MED
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2013, EMERG INFECT DIS, V20, P1085, DOI DOI 10.3201/EID2006.140138
   CDC, 2016, ZIKA VIRUS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M., 2016, LANCET
   Faye O, 2013, VIROL J, V10, P311, DOI DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2007, PLOS NEGLECT TROP D, V8, pe2681, DOI DOI 10.1371/J0URNAL.PNTD.0002681
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Kumar S., 2016, MOL BIOL EVOL
   Kuno G, 1998, J VIROL, V72, P73
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545
   Lanciotti RS L.A., 2016, EMERG INFECT DIS
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   LUBY JP, 1980, AM J TROP MED HYG, V29, P265
   Nei M.a.K. S, 2000, MOL EVOLUTION PHYLOG, P352
   Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MATHUR A, 1995, INT J EXP PATHOL, V76, P103
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Mlakar J., 2016, N ENGL J MED
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Roze B, 2016, EURO SURVEILL, V21
   Saude M.d., 2016, INFORME EPIDEMIOLOGI
   Shugars DC, 1999, J INFECT DIS, V179, pS431, DOI 10.1086/314799
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Sufiawati I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088803
   Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109
   Tonry JH, 2005, EMERG INFECT DIS, V11, P1294
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, WKLY EPIDEMIOL REC, V91, P73
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 2
Z9 2
U1 26
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004816
DI 10.1371/journal.pntd.0004816
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200055
PM 27341420
ER

PT J
AU Franca, RFO
   Neves, MHL
   Ayres, CFJ
   Melo-Neto, OP
   Brandao, SP
AF Franca, Rafael F. O.
   Neves, Maria Helena L.
   Junqueira Ayres, Constancia F.
   Melo-Neto, Osvaldo P.
   Brandao Filho, Sinval P.
TI First International Workshop on Zika Virus Held by Oswaldo Cruz
   Foundation FIOCRUZ in Northeast Brazil March 2016-A Meeting Report
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SEXUAL CONTACT; TRANSMISSION
C1 [Franca, Rafael F. O.; Neves, Maria Helena L.; Junqueira Ayres, Constancia F.; Melo-Neto, Osvaldo P.; Brandao Filho, Sinval P.] Fundacao Oswaldo Cruz Fiocruz, IAM, Recife, PE, Brazil.
RP Franca, RFO; Brandao, SP (reprint author), Fundacao Oswaldo Cruz Fiocruz, IAM, Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br; sinval@cpqam.fiocruz.br
CR Barreto ML, 2016, LANCET
   Besnard M, 2014, EUROSURVEILLANCE, P19
   Brasil P, 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Christofferson RC, 2016, AM J TROP MED HYG
   Cohen J, 2016, Q A SCOTT HALSTEAD Z, DOI [10.1126/science.aaf4154, DOI 10.1126/SCIENCE.AAF4154]
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
NR 14
TC 1
Z9 1
U1 4
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004760
DI 10.1371/journal.pntd.0004760
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200026
PM 27258065
ER

PT J
AU Guzzetta, G
   Montarsi, F
   Baldacchino, FA
   Metz, M
   Capelli, G
   Rizzoli, A
   Pugliese, A
   Rosa, R
   Poletti, P
   Merler, S
AF Guzzetta, Giorgio
   Montarsi, Fabrizio
   Baldacchino, Frederic Alexandre
   Metz, Markus
   Capelli, Gioia
   Rizzoli, Annapaola
   Pugliese, Andrea
   Rosa, Roberto
   Poletti, Piero
   Merler, Stefano
TI Potential Risk of Dengue and Chikungunya Outbreaks in Northern Italy
   Based on a Population Model of Aedes albopictus (Diptera: Culicidae)
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID KOREICUS HULECOETEOMYIA-KOREICA; INVASIVE MOSQUITO; ZIKA VIRUS;
   COLD-ACCLIMATION; VECTOR; AEGYPTI; TEMPERATURE; OVIPOSITION; EUROPE;
   EPIDEMIOLOGY
AB The rapid invasion and spread of Aedes albopictus (Skuse, 1894) within new continents and climatic ranges has created favorable conditions for the emergence of tropical arboviral diseases in the invaded areas. We used mosquito abundance data from 2014 collected across ten sites in northern Italy to calibrate a population model for Aedes albopictus and estimate the potential of imported human cases of chikungunya or dengue to generate the condition for their autochthonous transmission in the absence of control interventions. The model captured intra-year seasonality and heterogeneity across sites in mosquito abundance, based on local temperature patterns and the estimated site-specific mosquito habitat suitability. A robust negative correlation was found between the latter and local late spring precipitations, indicating a possible washout effect on larval breeding sites. The model predicts a significant risk of chikungunya outbreaks in most sites if a case is imported between the beginning of summer and up to mid-November, with an average outbreak probability between 4.9% and 25%, depending on the site. A lower risk is predicted for dengue, with an average probability between 4.2% and 10.8% for cases imported between mid-July and mid-September. This study shows the importance of an integrated entomological and medical surveillance for the evaluation of arboviral disease risk, which is a precondition for designing cost-effective vector control programs.
C1 [Guzzetta, Giorgio; Poletti, Piero; Merler, Stefano] Fdn Bruno Kessler, Trento, Italy.
   [Montarsi, Fabrizio; Capelli, Gioia] Ist Zooprofilatt Sperimentale Venezie, Parasitol Lab, Padua, Italy.
   [Baldacchino, Frederic Alexandre; Metz, Markus; Rizzoli, Annapaola; Rosa, Roberto] Fdn Edmund Mach, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy.
   [Pugliese, Andrea] Univ Trento, Dept Math, Trento, Italy.
   [Poletti, Piero] Bocconi Univ, Dondena Ctr Res Social Dynam & Publ Policy, Milan, Italy.
RP Guzzetta, G (reprint author), Fdn Bruno Kessler, Trento, Italy.
EM guzzetta@fbk.eu
RI Rizzoli, Annapaola/J-2439-2012; Rosa, Roberto/B-8562-2011; 
OI Rizzoli, Annapaola/0000-0003-3997-6783; Rosa,
   Roberto/0000-0002-8655-2230; Guzzetta, Giorgio/0000-0002-9296-9470
FU Autonomous Province of Trento, Research fund "Grandi Progetti", project
   LExEM (Laboratory of excellence for epidemiology and modelling)
FX This study was funded by the Autonomous Province of Trento, Research
   fund "Grandi Progetti 2012", project LExEM (Laboratory of excellence for
   epidemiology and modelling) awarded to AP. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Angelini P, 2010, EURO SURVEILL, V15
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Capelli G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-188
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8
   Dieng H, 2012, INT J BIOMETEOROL, V56, P113, DOI 10.1007/s00484-011-0402-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FOCKS DA, 1995, AM J TROP MED HYG, V53, P489
   Fortuna C, 2015, MED VET ENTOMOL, V29, P430, DOI 10.1111/mve.12133
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   HANSON SM, 1994, J MED ENTOMOL, V31, P192
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MU, 2015, SCI DATA, V2, DOI [DOI 10.1038/SDATA.2015.35, 10.1038/sdata.2015.35]
   Lacour G, 2014, J INSECT PHYSIOL, V71, P87, DOI 10.1016/j.jinsphys.2014.10.008
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Metz M, 2014, REMOTE SENS-BASEL, V6, P3822, DOI 10.3390/rs6053822
   Ministero della Salute, 2015, SORV CAS UM CHIK DEN
   Montarsi F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-292
   Montarsi F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1208-4
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Napoli C, 2012, J TRAVEL MED, V19, P294, DOI 10.1111/j.1708-8305.2012.00640.x
   Neteler M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-49
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Reiner RC, 2013, J R SOC INTERFACE, V10
   Reiskind MH, 2012, J MED ENTOMOL, V49, P71, DOI 10.1603/ME10270
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098
   Aznar VR, 2013, ECOL MODEL, V253, P44, DOI 10.1016/j.ecolmodel.2012.12.004
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   Tappe D, 2013, EUROSURVEILLANCE, V19, P20685
   Toma L, 2003, J AM MOSQUITO CONTR, V19, P19
   Tomasello D, 2007, TRAVEL MED INFECT DI, V11, P274, DOI DOI 10.1016/J.TMAID.2013.07.006
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Trexler JD, 1998, J MED ENTOMOL, V35, P967
   Tsunoda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095606
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yee DA, 2012, J MED ENTOMOL, V49, P825, DOI 10.1603/ME11132
NR 60
TC 0
Z9 0
U1 14
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004762
DI 10.1371/journal.pntd.0004762
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200028
PM 27304211
ER

PT J
AU Pylro, VS
   Oliveira, FS
   Morais, DK
   Cuadros-Orellana, S
   Pais, FSM
   Medeiros, JD
   Geraldo, JA
   Gilbert, J
   Volpini, AC
   Fernandes, GR
AF Pylro, Victor Satler
   Oliveira, Francislon Silva
   Morais, Daniel Kumazawa
   Cuadros-Orellana, Sara
   Pais, Fabiano Sviatopolk-Mirsky
   Medeiros, Julliane Dutra
   Geraldo, Juliana Assis
   Gilbert, Jack
   Volpini, Angela Cristina
   Fernandes, Gabriel Rocha
TI ZIKV - CDB: A Collaborative Database to Guide Research Linking SncRNAs
   and ZIKA Virus Disease Symptoms
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MICRORNAS; PREDICTION; TARGETS; FAMILY; RNAS
AB Background
   In early 2015, a ZIKA Virus (ZIKV) infection outbreak was recognized in northeast Brazil, where concerns over its possible links with infant microcephaly have been discussed. Providing a causal link between ZIKV infection and birth defects is still a challenge. MicroRNAs (miRNAs) are small noncoding RNAs (sncRNAs) that regulate post-transcriptional gene expression by translational repression, and play important roles in viral pathogenesis and brain development. The potential for flavivirus-mediated miRNA signalling dysfunction in brain-tissue development provides a compelling hypothesis to test the perceived link between ZIKV and microcephaly.
   Methodology/Principal Findings
   Here, we applied in silico analyses to provide novel insights to understand how Congenital ZIKA Syndrome symptoms may be related to an imbalance in miRNAs function. Moreover, following World Health Organization (WHO) recommendations, we have assembled a database to help target investigations of the possible relationship between ZIKV symptoms and miRNA-mediated human gene expression.
   Conclusions/Significance
   We have computationally predicted both miRNAs encoded by ZIKV able to target genes in the human genome and cellular (human) miRNAs capable of interacting with ZIKV genomes. Our results represent a step forward in the ZIKV studies, providing new insights to support research in this field and identify potential targets for therapy.
C1 [Pylro, Victor Satler; Oliveira, Francislon Silva; Morais, Daniel Kumazawa; Cuadros-Orellana, Sara; Pais, Fabiano Sviatopolk-Mirsky; Medeiros, Julliane Dutra; Geraldo, Juliana Assis; Volpini, Angela Cristina; Fernandes, Gabriel Rocha] Fiocruz MS, Biosyst Informat & Genom Grp, Rene Rachou Res Ctr, CPqRR, Belo Horizonte, MG, Brazil.
   [Gilbert, Jack] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.
   [Gilbert, Jack] Argonne Natl Lab, Inst Genom & Syst Biol, 9700 S Cass Ave, Argonne, IL 60439 USA.
   [Gilbert, Jack] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.
RP Pylro, VS; Fernandes, GR (reprint author), Fiocruz MS, Biosyst Informat & Genom Grp, Rene Rachou Res Ctr, CPqRR, Belo Horizonte, MG, Brazil.
EM victor.pylro@cpqrr.fiocruz.br; gabriel.fernandes@cpqrr.fiocruz.br
FU FAPEMIG; CNPq [168223/2014-7]; CAPES
FX FAPEMIG, CNPq and CAPES funded this work. FSMP received research
   fellowship from the CNPq (process number 168223/2014-7). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ahmed F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S14-S9
   Berger J., 2015, BIOCHIM BIOPHYS ACTA, V4889, P426
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Enright AJ, 2004, GENOME BIOL, V5
   Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Garcez PP, 2016, SCIENCE
   Gupta M, 2013, J BIOL CHEM, V288, P14522, DOI 10.1074/jbc.M112.430371
   Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Kadri S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S35
   Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018
   Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109
   Klase Z. A., 2013, RETROVIROLOGY, V10, P1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290
   Lorenz R., 2011, ALGORITHM MOL BIOL, V6, P26
   Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2015, EMERG INFECT DIS, V21, P1897
   Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030
   Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243
   Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010
   Tang H, 2016, CELL STEM CELL
   Teng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09912
   Whitty CJM, 2015, LANCET, V386, P1797, DOI 10.1016/S0140-6736(15)00758-8
   Witkos TM, 2011, CURR MOL MED, V11, P93
   Xuecai G, 2010, NEURON, V65, P191, DOI [10.1016/j.neuron.2010.01.011, DOI 10.1016/J.NEURON.2010.01.011]
NR 29
TC 1
Z9 1
U1 7
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2016
VL 10
IS 6
AR e0004817
DI 10.1371/journal.pntd.0004817
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DQ6WL
UT WOS:000379346200056
PM 27332714
ER

PT J
AU Mawson, AR
AF Mawson, Anthony R.
TI Pathogenesis of Zika Virus-Associated Embryopathy
SO BIORESEARCH OPEN ACCESS
LA English
DT Article
DE embryopathy; Guillain-Barre syndrome; hypervitaminosis A; liver;
   microcephaly; pregnancy; retinoids; virus; Zika
ID GUILLAIN-BARRE-SYNDROME; RETINOIC ACID; VITAMIN-A; LIVER; ISOTRETINOIN;
   TOXICITY; CELLS; CALCIFICATION; REPLICATION; TERATOLOGY
AB A strong causal association has become evident between Zika virus (ZIKV) infection during pregnancy and the occurrence of fetal growth restriction, microcephaly and eye defects. Circumstantial evidence is presented in this paper in support of the hypothesis that these effects, as well as the Guillain-Barre syndrome, are due to an endogenous form of hypervitaminosis A resulting from ZIKV infection-induced damage to the liver and the spillage of stored vitamin A compounds ("retinoids") into the maternal and fetal circulation in toxic concentrations. Retinoids are mainly stored in the liver (about 80%) and are essential for numerous biological functions. In higher concentration, retinoids are potentially cytotoxic, pro-oxidant, mutagenic and teratogenic, especially if sudden shifts occur in their bodily distribution. Although liver involvement has not been mentioned specifically in recent reports, conventional liver enzyme tests underestimate the true extent of liver dysfunction. The proposed model could be tested by comparing retinoid concentration and expression profiles in microcephalic newborns of ZIKV-infected mothers and nonmicrocephalic newborn controls, and by correlating these profiles with measures of clinical severity.
C1 [Mawson, Anthony R.] Jackson State Univ, Sch Publ Hlth Initiat, Dept Epidemiol & Biostat, 350 West Woodrow Wilson Ave,Room 229, Jackson, MS 39213 USA.
RP Mawson, AR (reprint author), Jackson State Univ, Sch Publ Hlth Initiat, Dept Epidemiol & Biostat, 350 West Woodrow Wilson Ave,Room 229, Jackson, MS 39213 USA.
EM anthony.r.mawson@jsums.edu
CR ADAMS J, 1993, REPROD TOXICOL, V7, P175, DOI 10.1016/0890-6238(93)90273-A
   Allen LH, 2002, J NUTR, V132, p2907S
   ANGULO A, 1995, J VIROL, V69, P3831
   Barbero P, 2004, BIRTH DEFECTS RES A, V70, P831, DOI 10.1002/bdra.20078
   Bell TM, 1971, ARCH GES VIRUSFORSCH, V35
   BENKE PJ, 1984, JAMA-J AM MED ASSOC, V251, P3267, DOI 10.1001/jama.251.24.3267
   Binkley N, 2000, NUTR REV, V58, P138
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Brun PJ, 2013, BIOFACTORS, V39, P151, DOI 10.1002/biof.1056
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Collins MD, 1999, ANNU REV PHARMACOL, V39, P399, DOI 10.1146/annurev.pharmtox.39.1.399
   Dan Z, 2005, FASEB J, V19, P845, DOI 10.1096/fj.04-2809fje
   DE LUCA LM, 1986, PROG LIVER DIS, V8, P81
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   de Oliveira MR, 2015, OXID MED CELL LONGEV, V2015
   Dick GW, 1952, T R SOC TROP MED HYG, V46
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ganguly J., 1989, BIOCH VITAMIN A
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   HUAN BF, 1992, P NATL ACAD SCI USA, V89, P9059, DOI 10.1073/pnas.89.19.9059
   Huk DJ, 2013, ARTERIOSCL THROM VAS, V33, P285, DOI 10.1161/ATVBAHA.112.300388
   Ihara H, 1998, J NUTR SCI VITAMINOL, V44, P329
   KURTZ PJ, 1984, TOXICOLOGY, V30, P115, DOI 10.1016/0300-483X(84)90122-7
   LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401
   Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002
   Laroche ML, 2007, ANN PHARMACOTHER, V41, P1073, DOI 10.1345/aph.1K028
   LEE MO, 1994, P NATL ACAD SCI USA, V91, P5632, DOI 10.1073/pnas.91.12.5632
   Lee SA, 2007, J BIOL CHEM, V282, P35621, DOI 10.1074/jbc.M706372200
   LEO MA, 1985, J BIOL CHEM, V260, P5228
   Litwak G, 2007, VITAMIN A VITAMINS H, V75
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963
   Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200
   Fernandez-Real JM, 2008, DIABETES, V57, P1918, DOI 10.2337/db08-0041
   Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002
   Masuda E, 2015, BIOTECHNIQUES, V58, P318, DOI 10.2144/000114300
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nau H, 2012, BIOCH MOL BAS VIT A, P465
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   PAHO WHO, 2016, CAS DEF ZIK RES
   Patatanian E, 2008, J CLIN PHARM THER, V33, P331, DOI 10.1111/j.1365-2710.2008.00935.x
   Penniston KL, 2006, AM J CLIN NUTR, V83, P191
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Popper H, 1985, GASTROENTEROLOGY, V5, P2697
   Pritchard J, 2004, BRIT MED J, V328, P1537, DOI 10.1136/bmj.328.7455.1537
   Rodahl K, 1943, BIOCHEM J, V37, P166
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sim W, 1989, CELLS HEPATIC SINUSO, P91
   Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, p1e3
   World Health Organization, 2016, ZIK SIT REP NEUR SY
NR 58
TC 0
Z9 0
U1 21
U2 21
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2164-7844
EI 2164-7860
J9 BIORESEARCH OPEN ACC
JI BioResearch Open Access
PD JUN
PY 2016
VL 5
IS 1
BP 171
EP 176
DI 10.1089/biores.2016.0004
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DQ4FE
UT WOS:000379158500001
PM 27403405
ER

PT J
AU Goulet, V
   Septfons, A
   Leparc-Goffart, I
   Benachi, A
   Couturier, E
   Mailles, A
   Noel, H
   De Valk, H
   Paty, MC
AF Goulet, V.
   Septfons, A.
   Leparc-Goffart, I.
   Benachi, A.
   Couturier, E.
   Mailles, A.
   Noel, H.
   De Valk, H.
   Paty, M. C.
TI Epidemiological surveillance of fetal diseases related to Zika virus,
   mainland France, 2016
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 4
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD JUN
PY 2016
VL 106
IS 6
SI SI
BP 504
EP 504
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HM
UT WOS:000379023400015
ER

PT J
AU Musso, D
   Baud, D
   Gubler, DJ
AF Musso, D.
   Baud, D.
   Gubler, D. J.
TI Zika virus: what do we know?
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Editorial Material
ID UNITED-STATES; TRANSMISSION; HEALTH
C1 [Musso, D.] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete 98713, Tahiti, Fr Polynesia.
   [Baud, D.] Univ Hosp, Maternofetal & Obstet Res Unit, Dept Femme Mere Enfant, Matern, Lausanne, Switzerland.
   [Gubler, D. J.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
RP Musso, D (reprint author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR Baud D, 2016, LANCET INFECT DIS
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Faria NR, 2016, SCIENCE
   Food and Drug Administration, 2016, REC DON SCREEN DEF P
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   International Federation of Red Cross and Red Crescent Societies World Health Organization UNICEF, 2016, RISK COMM COMM ENG Z
   Korhonen EM, 2016, EURO SURVEILL, V21
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, EUROSURVEILLANCE, V19, P20771, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917.ES2014.19.14.20761]
   Musso D, 2016, LANCET INFECT DIS, V3099
   Musso D, 2016, CLIN MICROBIOL REV, V29
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shakir R, 2016, LANCET NEUROL, V15, P353, DOI 10.1016/S1474-4422(16)00072-7
   Vouga M, 2016, LANCET, V287, P843
   World Health Organization, 2016, ZIK SIT REP WHO
NR 23
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUN
PY 2016
VL 22
IS 6
BP 494
EP 496
DI 10.1016/j.cmi.2016.03.032
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DQ5NM
UT WOS:000379252100005
PM 27067096
ER

PT J
AU Dudley, DM
   Aliota, MT
   Mohr, EL
   Weiler, AM
   Lehrer-Brey, G
   Weisgrau, KL
   Mohns, MS
   Breitbach, ME
   Rasheed, MN
   Newman, CM
   Gellerup, DD
   Moncla, LH
   Post, J
   Schultz-Darken, N
   Schotzko, ML
   Hayes, JM
   Eudailey, JA
   Moody, MA
   Permar, SR
   O'Connor, SL
   Rakasz, EG
   Simmons, HA
   Capuano, S
   Golos, TG
   Osorio, JE
   Friedrich, TC
   O'Connor, DH
AF Dudley, Dawn M.
   Aliota, Matthew T.
   Mohr, Emma L.
   Weiler, Andrea M.
   Lehrer-Brey, Gabrielle
   Weisgrau, Kim L.
   Mohns, Mariel S.
   Breitbach, Meghan E.
   Rasheed, Mustafa N.
   Newman, Christina M.
   Gellerup, Dane D.
   Moncla, Louise H.
   Post, Jennifer
   Schultz-Darken, Nancy
   Schotzko, Michele L.
   Hayes, Jennifer M.
   Eudailey, Josh A.
   Moody, M. Anthony
   Permar, Sallie R.
   O'Connor, Shelby L.
   Rakasz, Eva G.
   Simmons, Heather A.
   Capuano, Saverio
   Golos, Thaddeus G.
   Osorio, Jorge E.
   Friedrich, Thomas C.
   O'Connor, David H.
TI A rhesus macaque model of Asian-lineage Zika virus infection
SO NATURE COMMUNICATIONS
LA English
DT Article
ID MONOCLONAL-ANTIBODIES; PATHOGENESIS; MOSQUITOS; HEALTH; MICE
AB Infection with Asian-lineage Zika virus (ZIKV) has been associated with Guillain-Barre syndrome and fetal abnormalities, but the underlying mechanisms remain poorly understood. Animal models of infection are thus urgently needed. Here we show that rhesus macaques are susceptible to infection by an Asian-lineage ZIKV closely related to strains currently circulating in the Americas. Following subcutaneous inoculation, ZIKV RNA is detected in plasma 1 day post infection (d.p.i.) in all animals (N = 8, including 2 pregnant animals), and is also present in saliva, urine and cerebrospinal fluid. Non-pregnant and pregnant animals remain viremic for 21 days and for up to at least 57 days, respectively. Neutralizing antibodies are detected by 21 d.p.i. Rechallenge 10 weeks after the initial challenge results in no detectable virus replication, indicating protective immunity against homologous strains. Therefore, Asian-lineage ZIKV infection of rhesus macaques provides a relevant animal model for studying pathogenesis and evaluating potential interventions against human infection, including during pregnancy.
C1 [Dudley, Dawn M.; Mohns, Mariel S.; Breitbach, Meghan E.; Rasheed, Mustafa N.; Newman, Christina M.; Moncla, Louise H.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.
   [Aliota, Matthew T.; Moncla, Louise H.; Osorio, Jorge E.; Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53705 USA.
   [Weiler, Andrea M.; Lehrer-Brey, Gabrielle; Weisgrau, Kim L.; Gellerup, Dane D.; Post, Jennifer; Schultz-Darken, Nancy; Schotzko, Michele L.; Hayes, Jennifer M.; Rakasz, Eva G.; Simmons, Heather A.; Capuano, Saverio; Golos, Thaddeus G.; Friedrich, Thomas C.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.
   [Eudailey, Josh A.; Moody, M. Anthony; Permar, Sallie R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.
   [Eudailey, Josh A.; Moody, M. Anthony; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Obstet & Gynecol, Madison, WI 53706 USA.
RP O'Connor, DH (reprint author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.; O'Connor, DH (reprint author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.
EM dhoconno@wisc.edu
FU DHHS/PHS/NIH [R01Al116382-01A1, R01Al107157-01A1, DP2HD075699]; Research
   Facilities Improvement Program [RR15459-01, RR020141-01];  [P51OD011106]
FX We thank the Veterinary, Animal Care, Scientific Protocol Implementation
   and the Pathology staff at the WNPRC for their contribution to this
   study. We thank the DHHS/PHS/NIH (R01Al116382-01A1 to D.H.O'C.),
   (R01Al107157-01A1 to T.G.G.) and (DP2HD075699 to S.R.P.) for funding. We
   also thank the P51OD011106 awarded to the WNPRC, Madison-Wisconsin. This
   research was conducted in part at a facility constructed with support
   from Research Facilities Improvement Program grants RR15459-01 and
   RR020141-01.
CR Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160
   Brasil P, 2016, N ENGL J MED
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lauck M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-107
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Lugo-Roman LA, 2010, J MED PRIMATOL, V39, P41, DOI 10.1111/j.1600-0684.2009.00394.x
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pomplun N, 2015, CYTOM PART A, V87A, P890, DOI 10.1002/cyto.a.22727
   Rossi Shannan L, 2016, Am J Trop Med Hyg, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Silveira ELV, 2015, J IMMUNOL METHODS, V416, P69, DOI 10.1016/j.jim.2014.11.003
   Staprans SI, 1999, J VIROL, V73, P4829
   Stockham S. L., 2002, FUNDAMENTALS VET CLI
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 24
TC 4
Z9 4
U1 9
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN
PY 2016
VL 7
AR 12204
DI 10.1038/ncomms12204
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ3PV
UT WOS:000379115100001
PM 27352279
ER

PT J
AU Tian, HL
   Ji, XY
   Yang, XY
   Xie, W
   Yang, KL
   Chen, C
   Wu, C
   Chi, H
   Mu, ZY
   Wang, ZF
   Yang, HT
AF Tian, Hongliang
   Ji, Xiaoyun
   Yang, Xiaoyun
   Xie, Wei
   Yang, Kailin
   Chen, Cheng
   Wu, Chen
   Chi, Heng
   Mu, Zhongyu
   Wang, Zefang
   Yang, Haitao
TI The crystal structure of Zika virus helicase: basis for antiviral drug
   design
SO PROTEIN & CELL
LA English
DT Letter
ID RESOLUTION
C1 [Tian, Hongliang; Yang, Xiaoyun; Xie, Wei; Chen, Cheng; Wu, Chen; Chi, Heng; Mu, Zhongyu; Wang, Zefang; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.
   [Tian, Hongliang; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
   [Ji, Xiaoyun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.
   [Yang, Kailin] Case Western Reserve Univ, Lerner Coll, Cleveland Clin, Cleveland, OH 44195 USA.
RP Yang, HT (reprint author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Yang, HT (reprint author), Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
EM yanght@tju.edu.cn
CR Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1
   Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lindenbach BD, 2001, FUNDAMENTAL VIROLOGY
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pierson TC, 2013, FLAVIVIRUSES, V2
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
NR 14
TC 4
Z9 4
U1 11
U2 11
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 1674-800X
EI 1674-8018
J9 PROTEIN CELL
JI Protein Cell
PD JUN
PY 2016
VL 7
IS 6
BP 450
EP 454
DI 10.1007/s13238-016-0275-4
PG 5
WC Cell Biology
SC Cell Biology
GA DQ4NN
UT WOS:000379180700007
PM 27172988
ER

PT J
AU Zhang, YJ
   Chen, WX
   Wong, G
   Bi, YH
   Yan, JY
   Sun, Y
   Chen, EF
   Yan, H
   Lou, XY
   Mao, HY
   Xia, SC
   Gao, GF
   Shi, WF
   Chen, ZP
AF Zhang, Yanjun
   Chen, Wenxian
   Wong, Gary
   Bi, Yuhai
   Yan, Juying
   Sun, Yi
   Chen, Enfu
   Yan, Hao
   Lou, Xiuyu
   Mao, Haiyan
   Xia, Shichang
   Gao, George F.
   Shi, Weifeng
   Chen, Zhiping
TI Highly diversified Zika viruses imported to China, 2016
SO PROTEIN & CELL
LA English
DT Letter
ID OUTBREAK; AMERICA; STATES; BRAZIL
C1 [Zhang, Yanjun; Yan, Juying; Sun, Yi; Chen, Enfu; Yan, Hao; Lou, Xiuyu; Mao, Haiyan; Xia, Shichang; Chen, Zhiping] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China.
   [Chen, Wenxian] Yiwu Ctr Dis Control & Prevent, Yiwu 322000, Peoples R China.
   [Wong, Gary; Bi, Yuhai; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing 100101, Peoples R China.
   [Shi, Weifeng] Taishan Med Coll, Inst Pathogen Biol, Tai An 271000, Shandong, Peoples R China.
   [Bi, Yuhai; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing 100101, Peoples R China.
   [Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Off Director Gen, Beijing 102206, Peoples R China.
RP Chen, ZP (reprint author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China.; Shi, WF (reprint author), Taishan Med Coll, Inst Pathogen Biol, Tai An 271000, Shandong, Peoples R China.
EM shiwf@ioz.ac.cn; zhpchen@cdc.zj.cn
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 16
TC 2
Z9 2
U1 5
U2 5
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 1674-800X
EI 1674-8018
J9 PROTEIN CELL
JI Protein Cell
PD JUN
PY 2016
VL 7
IS 6
BP 461
EP 464
DI 10.1007/s13238-016-0274-5
PG 4
WC Cell Biology
SC Cell Biology
GA DQ4NN
UT WOS:000379180700009
PM 27209301
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI FDA Issues Recommendations to Reduce the Risk of Zika Virus Transmission
   by Human Cell and Tissue Products
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 5
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 1
PY 2016
VL 62
IS 11
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DP3YX
UT WOS:000378433400002
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Revision to CDC's Zika Travel Notices: Minimal Likelihood for
   Mosquito-Borne Zika Virus Transmission at Elevations Above 2000 Meters
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 1
PY 2016
VL 62
IS 11
BP I
EP II
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DP3YX
UT WOS:000378433400003
ER

PT J
AU Khurshid, Z
   Zohaib, S
   Najeeb, S
   Zafar, MS
   Slowey, PD
   Almas, K
AF Khurshid, Zohaib
   Zohaib, Sana
   Najeeb, Shariq
   Zafar, Muhammad Sohail
   Slowey, Paul D.
   Almas, Khalid
TI Human Saliva Collection Devices for Proteomics: An Update
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE omics; salivaomics; proteomics; salivary biomarkers; saliva collection
   devices
ID SPECTROMETRY-BASED PROTEOMICS; MASS-SPECTROMETRY; HUMAN WHOLE; ZIKA
   VIRUS; HEALTH; BIOMARKERS; DISEASE; CANCER; FLUID; PERIODONTITIS
AB There has been a rapid growth in the interest and adaptation of saliva as a diagnostic specimen over the last decade, and in the last few years in particular, there have been major developments involving the application of saliva as a clinically relevant specimen. Saliva provides a "window" into the oral and systemic health of an individual, and like other bodily fluids, saliva can be analyzed and studied to diagnose diseases. With the advent of new, more sensitive technologies to detect smaller concentrations of analytes in saliva relative to blood levels, there have been a number of critical developments in the field that we will describe. In particular, recent advances in standardized saliva collection devices that were not available three to four years ago, have made it easy for safe, simple, and non-invasive collection of samples to be carried out from patients. With the availability of these new technologies, we believe that in the next decade salivary proteomics will make it possible to predict and diagnose oral as well as systemic diseases, cancer, and infectious diseases, among others. The aim of this article is to review recent developments and advances in the area of saliva specimen collection devices and applications that will advance the field of proteomics.
C1 [Khurshid, Zohaib] King Faisal Univ, Coll Dent, Al Hufuf 31982, Al Ahsa, Saudi Arabia.
   [Zohaib, Sana] King Faisal Univ, Sch Engn, Dept Biomed Engn, Al Hufuf 31982, Al Ahsa, Saudi Arabia.
   [Najeeb, Shariq] Al Farabi Coll, Restorat Dent Sci, Riyadh 361724, Saudi Arabia.
   [Zafar, Muhammad Sohail] Taibah Univ, Dept Restorat Dent, Coll Dent, Al Madinah 41311, Al Munawwarah, Saudi Arabia.
   [Slowey, Paul D.] Oasis Diagnost Corp, 15720 NE 31st Ave, Vancouver, WA 98686 USA.
   [Almas, Khalid] Univ Dammam, Div Periodontol, Coll Dent, Dammam 31441, Saudi Arabia.
RP Zafar, MS (reprint author), Taibah Univ, Dept Restorat Dent, Coll Dent, Al Madinah 41311, Al Munawwarah, Saudi Arabia.
EM drzohaibkhurshid@gmail.com; szohaib@kfu.edu.sa; shariqnajeeb@gmail.com;
   MZAFAR@taibahu.edu.sa; pds@4saliva.com; Kalmas@uod.edu.sa
OI Najeeb, Shariq/0000-0002-3803-6055
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Ai J., 2010, BMC BIOINFORM, V11
   Amado FML, 2013, CLIN BIOCHEM, V46, P506, DOI 10.1016/j.clinbiochem.2012.10.024
   Aps JKM, 2005, FORENSIC SCI INT, V150, P119, DOI 10.1016/j.forsciint.2004.10.026
   Bassim CW, 2012, J CLIN IMMUNOL, V32, P1390, DOI 10.1007/s10875-012-9738-4
   Besnard M., 2014, EUROSURVEILLANCE, V19
   Broadhurst M. J., 2015, LANCET, V386
   Crittenden A. L., 1909, EXP BIOL MED, V7, P52
   Caswell S. V., 2015, ADV SALIVARY DIAGNOS, P121
   Chiappin S, 2007, CLIN CHIM ACTA, V383, P30, DOI 10.1016/j.cca.2007.04.011
   Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009
   EDGAR WM, 1992, BRIT DENT J, V172, P305
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Farnaud SJC, 2010, THESCIENTIFICWORLDJO, V10, P434, DOI 10.1100/tsw.2010.38
   Garg K, 2015, IRAN J BASIC MED SCI, V18, P529
   Groschl M, 2008, J PHARMACEUT BIOMED, V47, P478, DOI 10.1016/j.jpba.2008.01.033
   Groschl M, 2006, STEROIDS, V71, P1097, DOI 10.1016/j.steroids.2006.09.007
   Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633
   Henson BS, 2010, METHODS MOL BIOL, V666, P21, DOI 10.1007/978-1-60761-820-1_2
   Horgan RP, 2011, OBSTET GYNECOL, V13, P189, DOI DOI 10.1576/T0AG.13.3.189.27672
   Huang CM, 2004, ARCH ORAL BIOL, V49, P951, DOI 10.1016/j.archoralbio.2004.06.003
   Huynh AHS, 2015, J PERIODONTAL RES, V50, P637, DOI 10.1111/jre.12244
   Khurshid Z., 2015, DENT SCI, V2, P260
   Khurshid Z., 2016, OPEN DENT J, V10
   Khurshid Z., 2016, INT J MOL SCI, V17
   Khurshid Z., 2015, SAUDI PHARM J
   Khurshid Z., 2016, SAUDI PHARM J
   KUTSCHER AH, 1967, J ORAL THER PHARMACO, V3, P391
   Latterich M, 2008, EUR J CANCER, V44, P2737, DOI 10.1016/j.ejca.2008.09.007
   Lee YH, 2012, J MOL MED, V90, P427, DOI 10.1007/s00109-011-0829-0
   Li Y, 2004, J DENT RES, V83, P199
   Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004
   Michishige Fumiko, 2006, J Med Invest, V53, P140, DOI 10.2152/jmi.53.140
   Mohamed Roslinda, 2012, Clin Transl Med, V1, P19, DOI 10.1186/2001-1326-1-19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Neyraud E, 2006, J PROTEOME RES, V5, P2474, DOI 10.1021/pr060189z
   Slowey P. D., 2012, NANOBIOMATER CLIN DE, P453
   Range H, 2012, J CLIN PERIODONTOL, V39, P799, DOI 10.1111/j.1600-051X.2012.01913.x
   Thongboonkerd V., 2008, PROTEOMICS HUMAN BOD, V2
   Sheikh Z., 2014, HDB ORAL BIOMATERIAL, V6, P605
   Shirtcliff EA, 2015, CLIN THER, V37, P505, DOI 10.1016/j.clinthera.2015.02.014
   Siqueira W. L., 2016, BRAZ ORAL RES, V30
   Slowey P., 2015, P 2 N AM SAL S SEATT
   Sorsa T, 2016, PERIODONTOL 2000, V70, P142, DOI 10.1111/prd.12101
   Speicher DJ, 2015, DIAGN MICR INFEC DIS, V82, P120, DOI 10.1016/j.diagmicrobio.2015.02.013
   Sreebny LM, 2000, INT DENT J, V50, P140
   Streckfus CF, 2002, ORAL DIS, V8, P69, DOI 10.1034/j.1601-0825.2002.1o834.x
   Streckfus CF, 2015, ADV SALIVARY DIAGNOS
   Su S.-B., 2013, BIOMED RES INT, V2013, P2
   Topkas E, 2012, CLIN CHIM ACTA, V413, P1066, DOI 10.1016/j.cca.2012.02.020
   TRUELOVE EL, 1967, J DENT RES, V46, P1400, DOI 10.1177/00220345670460064301
   Viet CT, 2008, CANCER EPIDEM BIOMAR, V17, P3603, DOI 10.1158/1055-9965.EPI-08-0507
   Wainwright W. W., 1934, J DENT RES, V14, P425, DOI 10.1177/00220345340140060101
   Wang QH, 2014, TALANTA, V119, P299, DOI 10.1016/j.talanta.2013.11.008
   Wang QH, 2015, CLIN CHIM ACTA, V438, P214, DOI 10.1016/j.cca.2014.08.037
   Wang QH, 2014, CLIN CHIM ACTA, V427, P79, DOI 10.1016/j.cca.2013.10.004
   Yakob M, 2014, CURR ORAL HLTH REP, V1, P133
   Zafar MS, 2015, TISSUE ENG REGEN MED, V12, P387, DOI 10.1007/s13770-015-0030-6
   Zhang L, 2012, CELL MOL LIFE SCI, V69, P3341, DOI 10.1007/s00018-012-1027-0
   Zhang Y, 2016, PERIODONTOL 2000, V70, P38, DOI 10.1111/prd.12099
NR 60
TC 0
Z9 0
U1 7
U2 7
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2016
VL 17
IS 6
AR 846
DI 10.3390/ijms17060846
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DP9EK
UT WOS:000378799300060
ER

PT J
AU Yoon, HJ
AF Yoon, Hee Jung
TI Advanced understandings for Zika virus
SO JOURNAL OF THE KOREAN MEDICAL ASSOCIATION
LA Korean
DT Article
DE Zika virus; Flavivirus; Arboviruses; Disease outbreaks
ID TRANSMISSION; BRAZIL; MICRONESIA; OUTBREAK
AB Zika virus (ZIKV) is an arthropod-borne member of the genus Flavivirus, closely related to the dengue, West Nile, Japanese encephalitis, and yellow fever viruses and is transmitted by Aedes spp. mosquitoes. It has emerged explosively since 2007 to cause a series of epidemics in Micronesia, the South Pacific, and most recently the Americas. Following the first detection of ZIKV on the American continent, autochthonous ZIKV transmission has been confirmed throughout Central and South America. The unprecedented numbers of people infected during recent outbreaks in the South Pacific and the Americas may have resulted in enough ZIKV infections to notice patterns of the associated incidence of congenital microcephaly, Gillain-Barre symdrome, and acute diffuse encephalomyelitis. Here we review the history, emergence, biology, transmission, and control strategies for the ongoing outbreak through vector-centric approaches on ZIKV to date.
C1 [Yoon, Hee Jung] Seoul Metropolitan Govt Seobuk Hosp, Div Infect Dis, Seoul, South Korea.
RP Yoon, HJ (reprint author), Seoul Metropolitan Govt Seobuk Hosp, Div Infect Dis, Seoul, South Korea.
EM yhj822@naver.com
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Brasil P, 2016, N ENGL J MED
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   CDC, 2016, REV DIAGN TEST ZIK C
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fang J, 2010, NATURE, V466, P432, DOI 10.1038/466432a
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   International Committee on Taxonomy of Viruses, 2014, VIR TAX 2014 REL
   Kim JS, 2016, MONEY TODAY     0427
   Korea Centers for Disease Control and Prevention, 2016, IMP CAS ZIK VIR INF
   Korea Centers for Disease Control and Prevention, 2016, SIT REP ZIK VIR
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Leftwich PT, 2015, EVOL APPL, V9, P212
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Mubarqui RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103077
   Oehler E, 2014, EURO SURVEILL
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization; World Health Organization, 2016, 17 FEBR 2016 EP UPD
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson T.C., 2013, FIELDS VIROLOGY, P747
   Rasmussen SA, 2016, ENGL J MED, V374, P1981
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2016, SHANGHAI DAILY
   [Anonymous], 2016, FOX NEWS
   [Anonymous], 2014, EMERG INFECT DIS, V20, P1090
NR 35
TC 0
Z9 0
U1 6
U2 6
PU KOREAN MEDICAL ASSOC
PI SEOUL
PA 302-75 INCHON-1 DONG, YONGSAN-GU, SEOUL, 140-721, SOUTH KOREA
SN 1975-8456
EI 2093-5951
J9 J KOREAN MED ASSOC
JI J. Korean Med. Assoc.
PD JUN
PY 2016
VL 59
IS 6
BP 443
EP 451
DI 10.5124/jkma.2016.59.6.443
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DP9JW
UT WOS:000378813500007
ER

PT J
AU Codeco, C
   Villela, D
   Gomes, MF
   Bastos, L
   Cruz, O
   Struchiner, C
   Carvalho, LM
   Coelho, F
AF Codeco, Claudia
   Villela, Daniel
   Gomes, Marcelo F.
   Bastos, Leonardo
   Cruz, Oswaldo
   Struchiner, Claudio
   Carvalho, Luis Max
   Coelho, Flavio
TI Zika is not a reason for missing the Olympic Games in Rio de Janeiro:
   response to the open letter of Dr Attaran and colleagues to Dr Margaret
   Chan, Director - General, WHO, on the Zika threat to the Olympic and
   Paralympic Games
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Editorial Material
DE Zika; Olympic Games
ID FOREIGN VISITORS; DENGUE; BRAZIL; VIRUS; RISK
AB Attaran and colleagues in an open letter to WHO expressed their concern about the upcoming Olympic and Paralympic Games in Rio de Janeiro and the threat posed by the Zika epidemic (Attaran 2016). We agree that Zika virus is of great public health concern and much remains to be known about this disease. Care should be taken to reduce the risk of infection, especially to pregnant women. However, we argue that this is not sufficient reason for changing the original plans for the Games, in particular because of the time of the year when they will take place. The present article outlines several scientific results related to Zika and mosquito-borne infectious diseases dynamics that we believe ratify the current position of WHO in not endorsing the postponing or relocation of the 2016 Olympic and Paralympic Games (WHO 2016).
C1 [Codeco, Claudia; Villela, Daniel; Gomes, Marcelo F.; Bastos, Leonardo; Cruz, Oswaldo; Struchiner, Claudio; Carvalho, Luis Max] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.
   [Coelho, Flavio] Fundacao Getulio Vargas, Rio De Janeiro, RJ, Brazil.
RP Codeco, C (reprint author), Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, RJ, Brazil.
EM codeco@fiocruz.br
CR Attaran A., 2016, HARVARD PUBLIC HLTH
   Bastos L, 2016, BIORXIV
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Codeco C, 2016, BIORXIV
   Coelho FC, 2016, BIORXIV
   Gautret P, 2015, TRAVEL MED INFECT DI, V14, P7
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Massad E, 2014, MEM I OSWALDO CRUZ, V109, P394, DOI 10.1590/0074-0276140133
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143
   WHO, 2016, ZIK VIR OL PAR GAM R
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 12
TC 3
Z9 4
U1 2
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2016
VL 111
IS 6
BP 414
EP 415
DI 10.1590/0074-02760160003
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ0LC
UT WOS:000378889800011
PM 27304097
ER

PT J
AU Gostin, LO
   Katz, R
AF Gostin, Lawrence O.
   Katz, Rebecca
TI The International Health Regulations: The Governing Framework for Global
   Health Security
SO MILBANK QUARTERLY
LA English
DT Article
DE International Health Regulations; global health security; World Health
   Organization reform; crisis management; emergency response
ID ZIKA VIRUS; OUTBREAK; EBOLA; SARS; EPIDEMIC
AB The International Health Regulations (IHR) are the governing framework for global health security yet require textual and operational reforms to remain effective, particularly as parallel initiatives are developed. The World Health Organization (WHO) is the agency charged with oversight of the IHR, and its leadership and efficient functioning are prerequisites for the effective implementation of the IHR. We reviewed the historical origins of the IHR and their performance over the past 10 years and analyzed all of the ongoing reform panel efforts to provide a series of politically feasible recommendations for fundamental reform. This article offers proposals for fundamental reformwith politically feasible pathwaysof the IHR, their operations and implementation, WHO oversight, and State Party conformance.
   ContextThe International Health Regulations (IHR) have been the governing framework for global health security for the past decade and are a nearly universally recognized World Health Organization (WHO) treaty, with 196 States Parties. In the wake of the Ebola epidemic, major global commissions have cast doubt on the future effectiveness of the IHR and the leadership of the WHO.
   MethodsWe conducted a review of the historical origins of the IHR and their performance over the past 10 years and analyzed all of the ongoing reform panel efforts to provide a series of politically feasible recommendations for fundamental reform.
   FindingsWe propose a series of recommendations with realistic pathways for change. These recommendations focus on the development and strengthening of IHR core capacities; independently assessed metrics; new financing mechanisms; harmonization with the Global Health Security Agenda, Performance of Veterinary Services (PVS) Pathways, the Pandemic Influenza Preparedness Framework, and One Health strategies; public health and clinical workforce development; Emergency Committee transparency and governance; tiered public health emergency of international concern (PHEIC) processes; enhanced compliance mechanisms; and an enhanced role for civil society.
   ConclusionsEmpowering the WHO and realizing the IHR's potential will shore up global health securitya vital investment in human and animal healthwhile reducing the vast economic consequences of the next global health emergency.
C1 [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW,McDonough 574, Washington, DC 20001 USA.
   [Katz, Rebecca] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.
RP Gostin, LO (reprint author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW,McDonough 574, Washington, DC 20001 USA.
EM gostin@law.georgetown.edu
CR Boateng L., 2015, PERSPECTIVES GLOBAL
   Buse K, 2014, CURRENT LEGAL ISSUES, V16
   Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fidler DP, 2011, JAMA-J AM MED ASSOC, V306, P200, DOI 10.1001/jama.2011.960
   Fleck F, 2003, B WORLD HEALTH ORGAN, V81, P625
   Gostin LO, 2014, LANCET, V384, P1323, DOI 10.1016/S0140-6736(14)61791-8
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   [Anonymous], 2014, GLOBAL HLTH LAW
   Gostin LO, 2015, JAMA
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Heymann DL, 2013, LANCET, V381, P779, DOI 10.1016/S0140-6736(13)60185-3
   Heymann DL, 2004, PHILOS T ROY SOC B, V359, P1127, DOI 10.1098/rstb.2004.1484
   Horton R, 2015, LANCET, V386, P103
   Howard-Jones N, 1975, SCI BACKGR INT SAN C
   [Anonymous], 2016, BMJ-BRIT MED J, DOI DOI 10.1136/BMJ.I409
   Katz R, 2009, EMERG INFECT DIS, V15, P1165, DOI 10.3201/eid1508.090665
   Lescano AG, 2007, SCIENCE, V318, P574, DOI 10.1126/science.1146837
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Lucey DR, 2015, MERS KOREA WHY THIS
   McNeil D.G., 2013, NY TIMES
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Standley CJ, 2015, SCIENCE, V348, P762, DOI 10.1126/science.aaa5521
   The Lancet, 2014, LANCET, V384, P1321
   Phu TD, 2014, MMWR-MORBID MORTAL W, V63, P77
   United Nations Development Group (UNDG)-Western and Central Africa, 2015, SOC IMP EB VIR DIS W
   WHA, 2001, WHA5414
   WHA, 1995, WHA487
   WHA, 2002, WHA5516
   White House, 2015, FACT SHEET US COMM G
   White House, 2014, GLOB HLTH SEC AG WOR
   WHO, 2015, 2014 EB VIR DIS OUTB
   WHO, 2016, DIR GEN EX BOARD ITS
   WHO, 2005, STAT PART INT HLTH R
   WHO, 2015, REP RB INT ASS PAN
   WHO, 2015, EM COMM 9 M SUMM BRI
   WHO, EB VIR DIS OUTBR
   [Anonymous], 2013, IHR COR CAP MON FRAM
   WHO, 2013, EM RESP FRAM, P19
   World Health Organization, 2005, INT HLTH REG
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   WHO, 2015, MIDDL E RESP SYNDR S
   WHO, ADV GROUP REF WHOS W
   WHO, 2015, IMPL INT HLTH REG 20
   WHO, CURR WHO PHAS PAND A
   WHO, 2016, DIR GEN SUMM OUTC EM
   [Anonymous], 2015, NY TIMES
NR 48
TC 0
Z9 0
U1 7
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-378X
EI 1468-0009
J9 MILBANK Q
JI Milbank Q.
PD JUN
PY 2016
VL 94
IS 2
BP 264
EP 313
DI 10.1111/1468-0009.12186
PG 50
WC Health Care Sciences & Services; Health Policy & Services
SC Health Care Sciences & Services
GA DP5OX
UT WOS:000378548000008
PM 27166578
ER

PT J
AU Brasil, P
   Pereira, JP
   Gabaglia, CR
   Damasceno, L
   Wakimoto, M
   Nogueira, RMR
   de Sequeira, PC
   Siqueira, AM
   de Carvalho, LMA
   da Cunha, DC
   Calvet, GA
   Neves, ES
   Moreira, ME
   Baiao, AER
   de Carvalho, PRN
   Janzen, C
   Valderramos, SG
   Cherry, JD
   de Filippis, AMB
   Nielsen-Saines, K
AF Brasil, Patricia
   Pereira, Jose P., Jr.
   Gabaglia, Claudia Raja
   Damasceno, Luana
   Wakimoto, Mayumi
   Ribeiro Nogueira, Rita M.
   de Sequeira, Patricia Carvalho
   Siqueira, Andre Machado
   Abreu de Carvalho, Liege M.
   da Cunha, Denise Cotrim
   Calvet, Guilherme A.
   Neves, Elizabeth S.
   Moreira, Maria E.
   Rodrigues Baiao, Ana E.
   Nassar de Carvalho, Paulo R.
   Janzen, Carla
   Valderramos, Stephanie G.
   Cherry, James D.
   Bispo de Filippis, Ana M.
   Nielsen-Saines, Karin
TI Zika Virus Infection in Pregnant Women in Rio de JaneiroPreliminary
   Report
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Meeting Abstract
C1 [Brasil, Patricia; Pereira, Jose P., Jr.; Damasceno, Luana; Wakimoto, Mayumi; Ribeiro Nogueira, Rita M.; de Sequeira, Patricia Carvalho; Siqueira, Andre Machado; Abreu de Carvalho, Liege M.; da Cunha, Denise Cotrim; Calvet, Guilherme A.; Neves, Elizabeth S.; Moreira, Maria E.; Rodrigues Baiao, Ana E.; Nassar de Carvalho, Paulo R.; Bispo de Filippis, Ana M.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Gabaglia, Claudia Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Janzen, Carla; Valderramos, Stephanie G.; Cherry, James D.; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA.
NR 0
TC 0
Z9 0
U1 4
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD JUN
PY 2016
VL 71
IS 6
BP 331
EP 333
DI 10.1097/01.ogx.0000483239.08585.8d
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DP3XL
UT WOS:000378429200006
ER

PT J
AU Deuschl, G
AF Deuschl, G.
TI Zika Virus Infections: an Emerging Neurological Disorder in Europe
SO AKTUELLE NEUROLOGIE
LA German
DT Editorial Material
C1 [Deuschl, G.] Univ Kiel, Univ Klinikum Schleswig Holstein, Neurol Klin, Campus Kiel,Schittenhelmstr 10, D-24105 Kiel, Germany.
RP Deuschl, G (reprint author), Univ Kiel, Univ Klinikum Schleswig Holstein, Neurol Klin, Campus Kiel,Schittenhelmstr 10, D-24105 Kiel, Germany.
EM g.deuschl@neurologie.uni-kiel.de
NR 0
TC 0
Z9 0
U1 1
U2 1
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0302-4350
EI 1438-9428
J9 AKTUEL NEUROL
JI Aktuelle Neurol.
PD JUN
PY 2016
VL 43
IS 5
BP 279
EP 279
DI 10.1055/s-0042-108911
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA DP2TU
UT WOS:000378346600010
ER

PT J
AU Costello, A
   Dua, T
   Duran, P
   Gulmezoglu, M
   Oladapo, OT
   Perea, W
   Pires, J
   Ramon-Pardo, P
   Rollins, N
   Saxena, S
AF Costello, Anthony
   Dua, Tarun
   Duran, Pablo
   Gulmezoglu, Metin
   Oladapo, Olufemi T.
   Perea, William
   Pires, Joao
   Ramon-Pardo, Pilar
   Rollins, Nigel
   Saxena, Shekhar
TI Defining the syndrome associated with congenital Zika virus infection
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Editorial Material
C1 [Costello, Anthony; Rollins, Nigel] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland.
   [Dua, Tarun; Saxena, Shekhar] WHO, Dept Mental Hlth & Subst Abuse, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
   [Duran, Pablo] WHO, Pan Amer Hlth Org, Ctr Perinatol Women & Reprod Hlth, Montevideo, Uruguay.
   [Gulmezoglu, Metin; Oladapo, Olufemi T.] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.
   [Perea, William] WHO, Dept Pandem & Epidem Dis, CH-1211 Geneva, Switzerland.
   [Pires, Joao] WHO, Reg Off Europe, Div Communicable Dis & Hlth Secur, DK-2100 Copenhagen, Denmark.
   [Ramon-Pardo, Pilar] WHO, Dept Communicable Dis & Hlth Anal, Pan Amer Hlth Org, Washington, DC USA.
RP Dua, T (reprint author), WHO, Dept Mental Hlth & Subst Abuse, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.
EM duat@who.int
NR 0
TC 2
Z9 2
U1 4
U2 4
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD JUN
PY 2016
VL 94
IS 6
BP 406
EP 406
DI 10.2471/BLT.16.176990
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DO9HT
UT WOS:000378096800001
PM 27274588
ER

PT J
AU Arora, N
   Banerjee, AK
   Narasu, ML
AF Arora, Neelima
   Banerjee, Amit K.
   Narasu, Mangamoori Lakshmi
TI Zika virus: an emerging arboviral disease
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE Aedes aegypti; Aedes albopictus; Flavivirus; mosquito-borne viral
   disease; transmission; Zika virus outbreak
ID TRANSMISSION; OUTBREAK; DENGUE; POPULATIONS; MICRONESIA; WOLBACHIA
C1 [Arora, Neelima; Narasu, Mangamoori Lakshmi] JawaharLal Nehru Technol Univ, Inst Sci & Technol Autonomous, Ctr Biotechnol, Hyderabad, Telangana, India.
   [Banerjee, Amit K.] Indian Inst Chem Technol, Uppal Rd, Hyderabad, Telangana, India.
RP Arora, N (reprint author), JawaharLal Nehru Technol Univ, Inst Sci & Technol Autonomous, Ctr Biotechnol, Hyderabad, Telangana, India.
EM neelimaiict@gmail.com
CR Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   Baronti C., 2014, GENOME ANNOUNC, V2, P2, DOI DOI 10.1128/GENOMEA.00500-14
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bull James J, 2013, Evol Med Public Health, V2013, P197, DOI 10.1093/emph/eot018
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Charrel RN, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171207, DOI 10.2471/BLT.16.171207]
   Craig AT, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171892, DOI 10.2471/BLT.16.171892]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, P311, DOI DOI 10.1186/1743-422X-10-311
   Ferguson N. M., 2015, SCI TRANSL MED, V7, DOI DOI 10.1126/SCITRANSLMED.3010370
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Kurosu Takeshi, 2011, Trop Med Health, V39, P29, DOI 10.2149/tmh.2011-S02
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zumla A, 2016, INT J INFECT DIS, V4, P92
   [Anonymous], 2016, ZIKA VIRUS MICROCEPH
NR 30
TC 0
Z9 0
U1 4
U2 4
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JUN
PY 2016
VL 11
IS 6
BP 395
EP 399
DI 10.2217/fvl-2016-0048
PG 5
WC Virology
SC Virology
GA DO9FW
UT WOS:000378091400001
ER

PT J
AU Hillebrandt, D
   Richards, P
   Clark, A
   Jean, D
AF Hillebrandt, David
   Richards, Paul
   Clark, Andy
   Jean, Dominique
TI Zika Virus Advice for Mountaineers: A UIAA Medcom Consensus Advice Sheet
SO HIGH ALTITUDE MEDICINE & BIOLOGY
LA English
DT Article
DE mountain travel; travel advice; Zika virus
AB With the current media coverage of the spread of Zika virus from Africa and Asia to Central and South America and its possible relationship with fetal abnormalities, UIAA Medcom has produced an advice sheet for mountaineers visiting risk areas.
C1 [Hillebrandt, David] UIAA, UIAA Med Commiss, Bern, Switzerland.
   [Richards, Paul] South Essex Travel Clin, Billericay, Essex, England.
   [Jean, Dominique] CHU Grenoble, Ctr Pluridisciplinaire Diagnost Prenatal, F-38043 Grenoble, France.
RP Hillebrandt, D (reprint author), Derriton House, Holsworthy EX22 6JX, Devon, England.
EM dh@hillebrandt.org.uk
NR 0
TC 0
Z9 0
U1 2
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1527-0297
EI 1557-8682
J9 HIGH ALT MED BIOL
JI High Alt. Med. Biol.
PD JUN
PY 2016
VL 17
IS 2
BP 70
EP 71
DI 10.1089/ham.2016.0013
PG 2
WC Biophysics; Public, Environmental & Occupational Health; Sport Sciences
SC Biophysics; Public, Environmental & Occupational Health; Sport Sciences
GA DO8PG
UT WOS:000378044900003
PM 27081746
ER

PT J
AU Ali, T
   Aziz, S
   Khan, M
AF Ali, Tayyaba
   Aziz, Sina
   Khan, Mahjabeen
TI Zika Virus - An International Public Health Emergency
SO ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE
LA English
DT Article
DE Aedes; Flavivirus; Guillain Barre Syndrome; microcephaly; Zika Virus
AB Zika Virus is a member of the virus family flaviviridae and the genus flavivirus. It is spread by day time active Aedes mosquitoes, such as A. aegypti and A. albopictus. This is the same mosquito that spread and causes dengue, chikungunya and yellow fever. The first known case of Zika fever was reported in a sentinel rhesus monkey stationed on a tree platform in the Zika Forest in Uganda in 1947. Sexual transmission of Zika virus from men to women has been witnessed in at least 4 cases. Zika virus has also been isolated from semen samples. Cases of vertical perinatal transmission, from mother to the baby during pregnancy have been reported. WHO declared the couple of microcephaly and Guillain-Barre syndrome (GBS) cases reported in Brazil are strongly suspected to be associated with the Zika virus outburst. Thus, World Health Organisation (WHO) declared that a coordinated and an organized international response is required to improve surveillance, identification of infections, congenital malformations, and neurological complications, to heighten the control of mosquito populations at risk, and to execute the development of diagnostic tests and vaccines to secure people from this international public health emergency.
C1 [Ali, Tayyaba] Abbasi Shaheed Hosp, Karachi Med & Dent Coll, Karachi, Pakistan.
   [Aziz, Sina] Abbasi Shaheed Hosp, Karachi Med & Dent Coll, Dept Paediat, Karachi, Pakistan.
   [Khan, Mahjabeen] Karachi Dow Univ Hlth Sci, Civil Hosp, Dept Gynaecol, Karachi, Pakistan.
RP Ali, T (reprint author), Karachi Med & Dent Coll, Karachi, Pakistan.
EM tayyabaali_388@hotmail.com
CR Centers for Disease Control and Prevention, 2015, HELP CONTR MOSQ SPRE
   Centers for Disease Control and Prevention, 2016, ZIKA VIRUS
   CDC, 2016, REV DIAGN TEST ZIK C
   Chen LH, 2016, ANN INTERN MED
   [Anonymous], 2016, OUTBR ZIK VIR COMPL
   Fauci AS, N ENGL J MED, V374, P601
   Gatherer D, 2015, J GEN VIROL, V97, P269
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McNeil DG, NY TIMES
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen EE, 2016, UPDATE INTERIM GUIDE
   [Anonymous], 2015, ZIK VIR
   Romero Simon, 2016, NY TIMES
   Romero S., 2015, NY TIMES
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3
   [Anonymous], 2016, TRANSCR CDC TEL ZIK
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 0
Z9 0
U1 15
U2 15
PU ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLL
PI KARACHI
PA BLOCK M, N NAZIMABAD, KARACHI, 74700, PAKISTAN
SN 1563-3241
J9 ANN ABBASI SHAHEED H
JI Ann. Abbasi Shaheed Hosp. Karachi Med. Dent. Coll.
PD JUN
PY 2016
VL 21
IS 2
BP 124
EP 127
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO2AC
UT WOS:000377580600010
ER

PT J
AU Nishiura, H
   Mizumoto, K
   Rock, KS
   Yasuda, Y
   Kinoshita, R
   Miyamatsu, Y
AF Nishiura, Hiroshi
   Mizumoto, Kenji
   Rock, Kat S.
   Yasuda, Yohei
   Kinoshita, Ryo
   Miyamatsu, Yuichiro
TI A theoretical estimate of the risk of microcephaly during pregnancy with
   Zika virus infection
SO EPIDEMICS
LA English
DT Article
DE Microcephaly; Zika infection; Gestation; Statistical estimation; Brazil
ID CONGENITAL-RUBELLA SYNDROME; BRAZIL
AB Objectives: There has been a growing concern over Zika virus (ZIKV) infection, particularly since a probable link between ZIKV infection during pregnancy and microcephaly in the baby was identified. The present study aimed to estimate a theoretical risk of microcephaly during pregnancy with ZIKV infection in Northeastern Brazil in 2015.
   Methods: Temporal distributions of microcephaly, reported dengue-like illness and dengue seropositive in Brazil were extracted from secondary data sources. Using an integral equation model and a back calculation technique, we estimated the risk of microcephaly during pregnancy with Zika virus infection.
   Results: If the fraction of Zika virus infections among a total of seronegative dengue-like illness cases is 30%, the risk of microcephaly following infection during the first trimester was estimated at 46.7% (95% CI: 9.1, 84.2), comparable to the risk of congenital rubella syndrome. However, the risk of microcephaly was shown to vary widely from 14.0% to 100%. The mean gestational age at delivery with microcephaly was estimated at 37.5 weeks (95% CI: 36.9, 39.3).
   Conclusions: The time interval between peaks of reported dengue-like illness and microcephaly was consistent with cause-outcome relationship. Our modeling framework predicts that the incidence of microcephaly is expected to steadily decline in early 2016, Brazil. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Nishiura, Hiroshi; Mizumoto, Kenji; Rock, Kat S.; Yasuda, Yohei; Kinoshita, Ryo; Miyamatsu, Yuichiro] Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
   [Nishiura, Hiroshi; Yasuda, Yohei; Kinoshita, Ryo; Miyamatsu, Yuichiro] Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
   [Mizumoto, Kenji] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.
   [Nishiura, Hiroshi; Mizumoto, Kenji; Kinoshita, Ryo; Miyamatsu, Yuichiro] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
RP Nishiura, H (reprint author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
EM nishiurah@gmail.com
FU JSPS KAKENHI [26670308, 26700028]; Japan Agency for Medical Research and
   Development; Japan Science and Technology Agency Agency (JST) CREST
   program; RISTEX program for Science of Science, Technology and
   Innovation Policy; JSPS Postdoctoral Fellowship; Japanese Society for
   the Promotion of Science (JSPS) KAKENHI [15K20936]
FX HN received funding support from the JSPS KAKENHI Grant Numbers 26670308
   and 26700028, Japan Agency for Medical Research and Development, the
   Japan Science and Technology Agency (JST) CREST program and RISTEX
   program for Science of Science, Technology and Innovation Policy. KSR
   was supported by the JSPS Postdoctoral Fellowship for Foreign
   Researchers. KM received funding support from the Japanese Society for
   the Promotion of Science (JSPS) KAKENHI Grant Number 15K20936.
CR Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176
   Regis C.T., 2016, B WHO IN PRESS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Prazeres J., 2016, JAMA OPHTHA IN PRESS
   Gao ZH, 2013, VACCINE, V31, P691, DOI 10.1016/j.vaccine.2012.11.043
   Ministerio da Saude, 2016, SIT EP DAD
   Ministerio da Saude, 2016, PERG RESP MICR
   Ministerio da Saude, 2009, GUIA VIGILANCIA EPID
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nishiura H., 2016, EPIDEMIOLOGICA UNPUB
   Nishiura H., 2016, INT J INFEC IN PRESS
   Pereira Ana Paula Esteves, 2013, BMC Res Notes, V6, P60, DOI 10.1186/1756-0500-6-60
   Pybus O., 2016, PLOS CURR OUTBREAKS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2016, MON CAS DENG FIBR CH
   United Nations Population Division, 2016, VIT STAT BRAZ
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 18
TC 2
Z9 2
U1 15
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD JUN
PY 2016
VL 15
BP 66
EP 70
DI 10.1016/j.epidem.2016.03.001
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA DO6CK
UT WOS:000377870200007
PM 27288540
ER

PT J
AU Long, D
   Long, B
   Koyfman, A
AF Long, Drew
   Long, Brit
   Koyfman, Alex
TI ZIKA VIRUS: WHAT DO EMERGENCY PHYSICIANS NEED TO KNOW?
SO JOURNAL OF EMERGENCY MEDICINE
LA English
DT Review
DE Zika virus; flavivirus; mosquito; Aedes; blood; microcephaly
ID AMERICA; SPREADS; MICRONESIA; INFECTION; OUTBREAK; STATES; CHILD
AB Background: Zika virus currently dominates headlines, creating public fear due to its complications. With the ease of worldwide travel, this disease has spread rapidly to the U.S. Objectives: To provide physicians with an updated clinical review of the epidemiology, pathogenesis, diagnosis, management, and mimics of zika virus. Discussion: This flavivirus is spread by the bite of the Aedes mosquito during daylight. The ease of worldwide travel has allowed the virus to spread to Mexico and the U.S. Main transmission route is via blood contact or sexual activity involving mucous membranes. Incubation ranges from 2 to 12 days, but only 20% of patients experience symptoms. Fever is low grade with conjunctivitis, arthralgias, myalgias, and a maculopapular rash. Chikungunya and Dengue Fever differ in that patients experience higher fever and no conjunctivitits. The dreaded complication of Zika virus is microcephaly in infants born to infected mothers. Guillain-Barre Syndrome is also linked to the virus. Historical factors including travel history are paramount, and diagnosis includes PCR or serology. No current treatment regimen exists beyond symptom control. The emergency physician must seek to rule out other similar diseases such as malaria, chikungunya, and dengue fever. Conclusion: Zika virus has created public fear due to complications, and this flavivirus spread by the Aedes mosquito presents similarly to Chikungunya and Dengue Fever. The dreaded complication of Zika virus is microcephaly in infants born to infected mothers. This review provides key information concerning the disease and management. (c) 2016 Elsevier Inc. All rights reserved.
C1 [Long, Drew] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.
   [Long, Brit] San Antonio Mil Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.
   [Koyfman, Alex] Univ Texas SW Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA.
RP Long, B (reprint author), San Antonio Mil Med Ctr, Dept Emergency Med, 3841 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Atkinson B, DETECTION ZIKA VIRUS
   Baombe J, 2016, BREAKING NEWS ZIKA V
   [Anonymous], 2014, EUROSURVEILLANCE, DOI DOI 10.2807/1560-7917.ES2014.19.13.20751
   [Anonymous], ZIK VIR
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Dehning M, 2016, BRIEF CLIN PRACTICE
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministry of Health-Manuatu Hauora, ZIK VIR
   [Anonymous], 2014, EUROSURVEILLANCE
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   O'Dowd A, 2016, BMJ-BRIT MED J, V352, pi875
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pan American Health Organization, ZIK VIR INF ZIK FEV
   Pan American Health Organization, QUEST ANSW ZIK PREGN
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization, ZIK VIR INF
   Pan American Health Organization/World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pike L, 2016, ZIKA VIRUS WHAT EMER
   U.S. Centers for Disease Control and Prevention, ZIK VIR
   U.S. Centers for Disease Control and Prevention, EM PREP RESP REC MAN
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, ZIK VIR INF
NR 38
TC 0
Z9 0
U1 14
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0736-4679
EI 1090-1280
J9 J EMERG MED
JI J. Emerg. Med.
PD JUN
PY 2016
VL 50
IS 6
BP 832
EP 838
DI 10.1016/j.jemermed.2016.03.033
PG 7
WC Emergency Medicine
SC Emergency Medicine
GA DO7VF
UT WOS:000377990400004
PM 27157106
ER

PT J
AU Ames, H
   Rodriguez, F
   Hill, D
   Ho, CY
AF Ames, Heather
   Rodriguez, Fausto
   Hill, D.
   Ho, Cheng-Ying
TI Early neuropathological findings in congenital Zika virus infection
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 92nd Annual Meeting of the American-Association-of-Neuropathologist-Inc
CY JUN 16-19, 2016
CL Baltimore, MD
SP Amer Assoc Neuropathologist Inc
C1 [Ames, Heather; Rodriguez, Fausto] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.
   [Hill, D.; Ho, Cheng-Ying] Childrens Natl Hlth Syst, Div Pathol, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 9
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2016
VL 75
IS 6
MA 1
BP 567
EP 567
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DO3FC
UT WOS:000377665000010
ER

PT J
AU Chimelli, L
   Melo, ASO
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Camacho, AHS
   Gomes, GC
   Melo, FO
   Batista, AGM
   Machado, HN
   Awad, E
   Ferreira, TA
   Andrade, RD
   Mello, RJV
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Camacho, Aline H. S.
   Gomes, Giovanna C.
   Melo, Fabiana O.
   Batista, Alba G. M.
   Machado, Heloisa N.
   Awad, Elizabeth
   Ferreira, Thales A.
   Andrade, Rodrigo D.
   Mello, Roberto J. V.
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Tanuri, Amilcar
TI Neuropathological aspects of congenital Zika virus infection in Brazil
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 92nd Annual Meeting of the American-Association-of-Neuropathologist-Inc
CY JUN 16-19, 2016
CL Baltimore, MD
SP Amer Assoc Neuropathologist Inc
C1 [Chimelli, Leila; Camacho, Aline H. S.; Gomes, Giovanna C.] State Inst Brain, Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Melo, Fabiana O.] Res Inst Prof Amorim Neto, Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.] Hlth Secretary Campina Grande, Campina Grande, PB, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Sao Paulo, SP, Brazil.
   [Machado, Heloisa N.; Awad, Elizabeth] Fiocruz MS, Fernandes Figueira Inst, BR-21045900 Rio De Janeiro, Brazil.
   [Ferreira, Thales A.] Univ Fed Pernambuco, Dept Pathol, Recife, PE, Brazil.
   [Andrade, Rodrigo D.] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Mello, Roberto J. V.] Hlth Inst Elpidio de Almeida, Campina Grande, PB, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Mol Virol Lab, Rio De Janeiro, RJ, Brazil.
NR 0
TC 0
Z9 0
U1 6
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUN
PY 2016
VL 75
IS 6
MA 2
BP 567
EP 567
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DO3FC
UT WOS:000377665000011
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI ZIka virus infection in Asia: Reappraisal on phylogenetic data of Asian
   lineage
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pune, Maharashtra, India.
RP Wiwanitkit, S (reprint author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cabrera-Gaytan David Alejandro, 2016, Rev Med Inst Mex Seguro Soc, V54, P225
   Chan JF, 2016, J INFECT
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
NR 6
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUN
PY 2016
VL 9
IS 6
BP 614
EP 615
DI 10.1016/j.apjtm.2016.04.017
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DN9UK
UT WOS:000377426000018
PM 27262078
ER

PT J
AU Ruiz-Lopez, F
   Gonzalez-Mazo, A
   Velez-Mira, A
   Gomez, GF
   Zuleta, L
   Uribe, S
   Velez-Bernal, ID
AF Ruiz-Lopez, Freddy
   Gonzalez-Mazo, Ana
   Velez-Mira, Andres
   Gomez, Giovan F.
   Zuleta, Luisa
   Uribe, Sandra
   Dario Velez-Bernal, Ivan
TI Presence of Aedes (Stegomyia) aegypti (Linnaeus, 1762) and its natural
   infection with dengue virus at unrecorded heights in Colombia
SO BIOMEDICA
LA Spanish
DT Article
DE Aedes aegypti; altitude; geographic locations; dengue; Colombia
ID GLOBAL DISTRIBUTION; MOSQUITO; FEVER; MEXICO
AB Introduction: Aedes aegypti is the main vector of urban yellow fever, dengue, chikungunya and Zika viruses. The biogeographical distribution of this species has expanded due to global warming, and socioeconomic and cultural factors. The changes in the altitudinal distribution patterns of this vector and its natural infection are priority fields of research to develop entomological, virological and public health surveillance strategies.
   Objective: To evaluate the presence of A. aegypti and its natural infection with dengue virus in altitudes above 1.800 meters above sea level in two peripheral municipalities of the Valle de Aburra, Antioquia, Colombia.
   Materials and methods: Twenty-one ovitraps were set in the municipalities of Bello and San Pedro de los Milagros, at altitudes ranging from 1.882 to 2.659 masl. Emerged adults caught in the ovitraps were tested by RT-PCR for dengue virus detection.
   Results: We collected 367 A. aegypti adults, seven of which were found as high as 2.302 masl in Tierradentro, Bello. We detected serotype 2 dengue infection in 12 A. aegypti specimens collected in the neighbourhood of Paris, in Bello, at 1.984 masl.
   Conclusion: We recorded A. aegypti at 2.302 masl, so far the highest altitudinal record in Colombia for this vector. Furthermore, mosquitoes collected at 1.984 masl were positive for dengue virus. These findings are significant as they identify regions in Colombia at risk of potential autochthonous transmission of dengue and other arboviruses by A. aegypti.
C1 [Ruiz-Lopez, Freddy; Gonzalez-Mazo, Ana; Velez-Mira, Andres; Gomez, Giovan F.; Zuleta, Luisa; Uribe, Sandra; Dario Velez-Bernal, Ivan] Univ Antioquia, PECET, Calle 62 52-59,Lab 632, Medellin, Colombia.
   [Zuleta, Luisa; Uribe, Sandra] Univ Nacl Colombia, Grp Invest Sistemat Mol, Medellin, Colombia.
RP Ruiz-Lopez, F (reprint author), Univ Antioquia, PECET, Calle 62 52-59,Lab 632, Medellin, Colombia.
EM fredyruiz9@gmail.com
CR Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Cassab Alexander, 2011, Rev. salud pblica, V13, P115, DOI [10.1590/S0124-00642011000100010, 10.1590/s0124-00642011000100010]
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   HERRERABASTO E, 1992, AM J TROP MED HYG, V46, P649
   Ibanez-Bernal S., 1987, Folia Entomologica Mexicana, V72, P163
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   Monath T. P., 1989, The arboviruses: epidemiology and ecology. Volume V., P139
   Navarro JC, 2010, REV BIOL TROP, V58, P245
   Padilla JC, 2012, DENGUE COLOMBIA EPID, P249
   Petersen JL, 1977, THESIS U NOTRE DAME
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rodrguez G. Hernn, 2005, Rev. salud pblica, V7, P1, DOI 10.1590/s0124-00642005000100001
   Ra Uribe Guillermo Len, 2012, Iatreia, V25, P314
   Rua-Uribe GL, 2013, BIOMEDICA, P142
   Ruiz-Lopez F, 2010, THESIS U KENT LONDON
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Suarez FM, 1981, BIOMEDICA, V1, P225
   TABACHNICK WJ, 1979, EVOLUTION, V33, P287, DOI 10.2307/2407619
NR 25
TC 1
Z9 1
U1 5
U2 5
PU INST NACIONAL SALUD
PI BOGOTA D C
PA AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C,
   00000, COLOMBIA
SN 0120-4157
J9 BIOMEDICA
JI Biomedica
PD JUN
PY 2016
VL 36
IS 2
BP 303
EP 308
DI 10.7705/biomedica.v36i2.3301
PG 6
WC Tropical Medicine
SC Tropical Medicine
GA DN7KI
UT WOS:000377253900017
PM 27622492
ER

PT J
AU Marks, PW
   Epstein, JS
   Borio, LL
AF Marks, Peter W.
   Epstein, Jay S.
   Borio, Luciana L.
TI Maintaining a Safe Blood Supply in an Era of Emerging Pathogens
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE blood safety; donor screening tests; emerging pathogens;
   pathogen-reduction; Zika virus
ID ZIKA VIRUS; TRANSMISSION; TRANSFUSION; STATES; BRAZIL
AB Coming shortly after outbreaks of dengue and chikungunya virus in related locations, the recent outbreak of Zika virus in the southern part of the western hemisphere is yet another reminder that infectious pathogens continue to emerge rapidly and can adversely affect public health, including the safety of the blood supply. In response to Zika virus, public health measures that rely largely on donor deferral and sourcing of blood from non-outbreak areas until a blood donor screening test becomes available have been implemented to address the safety of the blood supply in the United States. However, a more universal approach to ensuring blood safety in the setting of rapidly emerging infectious diseases is needed.
C1 [Marks, Peter W.; Epstein, Jay S.; Borio, Luciana L.] US FDA, 10903 New Hampshire Ave WO1-3317, Silver Spring, MD 20993 USA.
RP Borio, LL (reprint author), US FDA, 10903 New Hampshire Ave WO1-3317, Silver Spring, MD 20993 USA.
EM luciana.borio@fda.hhs.gov
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Centers for Disease Control and Prevention, AR ZIK COUNTR TERR A
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Food and Drug Administration, REC DON SCREEN DEF P
   Freedman J, 2014, TRANSFUS APHER SCI, V50, P5, DOI 10.1016/j.transci.2013.12.003
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hogshire L, 2013, CURR OPIN HEMATOL, V20, P546, DOI 10.1097/MOH.0b013e32836508bd
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Salunkhe V, 2015, TRANSFUS APHER SCI, V52, P19, DOI 10.1016/j.transci.2014.12.016
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 1
Z9 2
U1 5
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2016
VL 213
IS 11
BP 1676
EP 1677
DI 10.1093/infdis/jiw089
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DO0BC
UT WOS:000377443400002
PM 26962237
ER

PT J
AU Pastula, DM
   Smith, DE
   Beckham, JD
   Tyler, KL
AF Pastula, Daniel M.
   Smith, Daniel E.
   Beckham, J. David
   Tyler, Kenneth L.
TI Four emerging arboviral diseases in North America: Jamestown Canyon,
   Powassan, chikungunya, and Zika virus diseases
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Review
DE Arbovirus; Arboviral disease; Jamestown Canyon virus; Powassan virus;
   Chikungunya virus; Zika virus; North America
ID GUILLAIN-BARRE-SYNDROME; INFECTION; BUNYAVIRIDAE; CALIFORNIA; SEROGROUP;
   OUTBREAK; STATES; FEVER
AB Arthropod-borne viruses, or arboviruses, are viruses that are transmitted through the bites of mosquitoes, ticks, or sandflies. There are numerous arboviruses throughout the world capable of causing human disease spanning different viral families and genera. Recently, Jamestown Canyon, Powassan, chikungunya, and Zika viruses have emerged as increasingly important arboviruses that can cause human disease in North America. Unfortunately, there are currently no proven disease-modifying therapies for these arboviral diseases, so treatment is largely supportive. Given there are also no commercially available vaccines for these four arboviral infections, prevention is the key. To prevent mosquito or tick bites that might result in one of these arboviral diseases, people should wear long-sleeved shirts and pants while outside if feasible, apply insect repellant when going outdoors, using window screens or air conditioning to keep mosquitoes outside, and perform tick checks after being in wooded or brushy outdoor areas.
C1 [Pastula, Daniel M.] Univ Colorado Denver, Dept Neurol, Neuroinfect Dis Grp, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
   Univ Colorado Denver, Div Infect Dis, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
RP Pastula, DM (reprint author), Univ Colorado Denver, Dept Neurol, Neuroinfect Dis Grp, 12401 East 17th Ave,Mailstop L950,Room 486, Aurora, CO 80045 USA.
EM Daniel.Pastula@ucdenver.edu
CR AGUIRRE AA, 1992, J WILDLIFE DIS, V28, P435
   Anderson JF, 2015, AM J TROP MED HYG, V92, P377, DOI 10.4269/ajtmh.14-0291
   Andreadis TG, 2008, VECTOR-BORNE ZOONOT, V8, P175, DOI 10.1089/vbz.2007.0169
   Angelini R, 2007, EUROSURVEILLANCE, V12
   [Anonymous], ZIK VIR
   [Anonymous], CHIK VIR
   [Anonymous], POW VIR
   [Anonymous], PREV TICK BIT
   [Anonymous], ARB
   [Anonymous], PREV MOSQ BIT
   Deibel R, 1983, Prog Clin Biol Res, V123, P313
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Gatherer D., 2015, J GEN VIROL
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   GRIMSTAD PR, 1986, AM J TROP MED HYG, V35, P376
   Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022
   Johnson Diep K Hoang, 2010, WMJ, V109, P91
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Martines R, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6506E1ER
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Oehler E, 2013, EURO SURVEILL, V19
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Pastula DM, 2015, AM J TROP MED HYG, V93, P384, DOI 10.4269/ajtmh.15-0196
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Walters LL, 1999, AM J TROP MED HYG, V60, P806
NR 30
TC 1
Z9 1
U1 11
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD JUN
PY 2016
VL 22
IS 3
BP 257
EP 260
DI 10.1007/s13365-016-0428-5
PG 4
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA DO0JR
UT WOS:000377465700001
PM 26903031
ER

PT J
AU Bharucha, T
   Breuer, J
AF Bharucha, Tehmina
   Breuer, Judith
TI Review: A neglected Flavivirus: an update on Zika virus in 2016 and the
   future direction of research
SO NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
LA English
DT Review
DE arbovirus; emerging infection; Flavivirus; public health
ID GUILLAIN-BARRE-SYNDROME; JAPANESE ENCEPHALITIS; YELLOW-FEVER;
   NEUROLOGICAL MANIFESTATIONS; FRENCH-POLYNESIA; ENVELOPE PROTEIN;
   CONTROLLED-TRIAL; INFECTION; TRANSMISSION; DENGUE
AB The 2015-16 global emergence of Zika virus infection (ZIKV) and its link with Guillain-Barre Syndrome and microcephaly, at the tail-end of the Ebola epidemic, has provoked unease throughout the international community. The World Health Organisation declared ZIKV a public health emergency on 1st February 2016, but until the 31st March 2016 maintained that there was insufficient evidence that ZIKV was independently responsible for any serious complications. Our current understanding of this arthropod-borne flavivirus is still at an early stage. The first reported human infections were 60 years ago, and until the first outbreak in Micronesia in 2007, there were only 14 documented cases. Nonetheless, there are parallels that we can draw from our understanding of other related arbo-flaviviruses, such as dengue, Japanese encephalitis and West Nile viruses. This article provides a focussed review of the literature on ZIKV to date, with perspectives on the direction of future research.
C1 [Bharucha, Tehmina; Breuer, Judith] UCL, London WC1E 6BT, England.
   [Bharucha, Tehmina] Royal Free Hosp NHS Fdn Trust, Dept Virol, London, England.
RP Bharucha, T (reprint author), UCL, Div Infect & Immun, Cruciform Bldg,Gower St, London WC1E 6BT, England.
EM t.bharucha@doctors.org.uk
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, N ENGL J MED
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Carteaux G., 2016, N ENGL J MED
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Donadieu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084473
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hart J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-248
   Howard CR, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.37
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kariwa H, 2013, INT J ENV RES PUB HE, V10, P7144, DOI 10.3390/ijerph10127144
   Kindhausera MK, 2016, B WHO
   King AMQ, 2011, VIRUS TAXONOMY
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kumar R, 2009, CLIN INFECT DIS, V48, P400, DOI 10.1086/596309
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Majumder MS, 2016, B WHO
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martines RB, 2015, MEM I O CRUZ, V110, P569
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E., 2014, Eurosurveillance, V19, P20720
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Solomon T, 2003, CURR OPIN INFECT DIS, V16, P375, DOI 10.1097/01.qco.0000092807.64370.1e
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Solomon T, 2014, INFECT CENTRAL NERVO, P210
   Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2
   Tang H, 2016, CELL STEM CELL, V18, P1
   Tappe D., 2015, MED MICROBIOL IMMUNO
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   Velandia ML, 2012, FLAVIVIRUS NEUROTROP
   World Health Organisation, 2016, ZIK VIR DIS INT CAS
   WHO, 2016, ZIK SIT REP
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
   Zhang F, 2014, COCHRANE DATABASE SY
   Zuckerman AJ, 2009, PRINCIPLES PRACTICE
NR 66
TC 1
Z9 1
U1 17
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1846
EI 1365-2990
J9 NEUROPATH APPL NEURO
JI Neuropathol. Appl. Neurobiol.
PD JUN
PY 2016
VL 42
IS 4
BP 317
EP 325
DI 10.1111/nan.12326
PG 9
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA DO1BC
UT WOS:000377512300001
PM 27029817
ER

PT J
CA Soc Maternal-Fetal Med SMFM Public
TI Ultrasound screening for fetal microcephaly following Zika virus
   exposure
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Editorial Material
AB The practice of medicine continues to evolve, and individual circumstances will vary. This publication reflects information available at the time of its submission for publication and is neither designed nor intended to establish an exclusive standard of perinatal care. This publication is not expected to reflect the opinions of all members of the Society for Maternal-Fetal Medicine.
CR ACOG and SMFM, PRACT ADV UPD INT GU
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Leibovitz Z, 2015, ULTRASOUND OBSTET GY
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P1
   Persutte WH, 1998, ULTRASOUND OBST GYN, V11, P317, DOI 10.1046/j.1469-0705.1998.11050317.x
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   World Health Organization, ZIK SIT REP NEUR SYN
NR 10
TC 0
Z9 0
U1 7
U2 7
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JUN
PY 2016
VL 214
IS 6
BP B2
EP B4
DI 10.1016/j.ajog.2016.02.043
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DN6YP
UT WOS:000377222800001
ER

PT J
AU Wu, KY
   Zuo, GL
   Li, XF
   Ye, Q
   Deng, YQ
   Huang, XY
   Cao, WC
   Qin, CF
   Luo, ZG
AF Wu, Kong-Yan
   Zuo, Guo-Long
   Li, Xiao-Feng
   Ye, Qing
   Deng, Yong-Qiang
   Huang, Xing-Yao
   Cao, Wu-Chun
   Qin, Cheng-Feng
   Luo, Zhen-Ge
TI Vertical transmission of Zika virus targeting the radial glial cells
   affects cortex development of offspring mice
SO CELL RESEARCH
LA English
DT Article
DE Zika virus; vertical transmission; radial glial cells; cortical
   development
ID INFECTION; AUTISM; BRAZIL; BRAIN; PROGENITORS; NEOCORTEX; AMERICA
AB The recent Zika virus (ZIKV) epidemic in Latin America coincided with a marked increase in microcephaly in newborns. However, the causal link between maternal ZIKV infection and malformation of the fetal brain has not been firmly established. Here we show a vertical transmission of ZIKV in mice and a marked effect on fetal brain development. We found that intraperitoneal (i.p.) injection of a contemporary ZIKV strain in pregnant mice led to the infection of radial glia cells (RGs) of dorsal ventricular zone of the fetuses, the primary neural progenitors responsible for cortex development, and caused a marked reduction of these cortex founder cells in the fetuses. Interestingly, the infected fetal mice exhibited a reduced cavity of lateral ventricles and a discernable decrease in surface areas of the cortex. This study thus supports the conclusion that vertically transmitted ZIKV affects fetal brain development and provides a valuable animal model for the evaluation of potential therapeutic or preventative strategies.
C1 [Wu, Kong-Yan; Zuo, Guo-Long; Luo, Zhen-Ge] Chinese Acad Sci, Inst Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, State Key Lab Neurosci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.
   [Li, Xiao-Feng; Ye, Qing; Deng, Yong-Qiang; Huang, Xing-Yao; Cao, Wu-Chun; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zuo, Guo-Long; Luo, Zhen-Ge] Chinese Acad Sci Univ, Beijing, Peoples R China.
   [Luo, Zhen-Ge] ShanghaiTech Univ, Shanghai, Peoples R China.
RP Luo, ZG (reprint author), Chinese Acad Sci, Inst Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, State Key Lab Neurosci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.; Qin, CF (reprint author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Luo, ZG (reprint author), Chinese Acad Sci Univ, Beijing, Peoples R China.; Luo, ZG (reprint author), ShanghaiTech Univ, Shanghai, Peoples R China.
EM qincf@bmi.ac.cn; zgluo@ion.ac.cn
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU National Natural Science Foundation of China [31330032, 31490591,
   31321091, 61327902, 31371063, 81522025, 8151101191]; National Key Basic
   Research Program of China [2014CB910203]; Chinese Academy of Sciences
   [XDB02040003]; Youth Innovation Promotion Association CAS [2016247]; UK
   Academy of Medical Sciences
FX We thank Dr Fu-Chun Zhang at Guangzhou No. 8 People's hospital for
   providing the convalescent serum from the recovered patient. This study
   was partially supported by grants from, the National Natural Science
   Foundation of China (31330032, 31490591, 31321091, and 61327902 to ZGL,
   31371063 to KYW, 81522025 and 8151101191 to CFQ), the National Key Basic
   Research Program of China (2014CB910203), the Strategic Priority
   Research Program of the Chinese Academy of Sciences (XDB02040003), the
   Youth Innovation Promotion Association CAS (2016247 to KYW), and the
   Newton Advanced Fellowship from the UK Academy of Medical Sciences (to
   CFQ).
CR Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brown AS, 2014, MOL PSYCHIATR, V19, P259, DOI 10.1038/mp.2012.197
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824., DOI 10.1056/NEJMOA1601824, 10.1056/NEJMoa1601824]
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Hazin AN, 2016, NEW ENGL J MED, DOI [10.1056/NEJMc1603617, DOI 10.1056/NEJMC1603617]
   Lazear Helen M, 2016, CELL HOST MICROBE, DOI [10.1016/j.chom.2016.03.010, DOI 10.1016/J.CHOM.2016.03.010]
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rossi SL, 2016, AM J TROP MED HYG, DOI [10.4269/ajtmh.16-0111, DOI 10.4269/AJTMH.16-0111]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 38
TC 11
Z9 11
U1 23
U2 23
PU INST BIOCHEMISTRY & CELL BIOLOGY
PI SHANGHAI
PA SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD JUN
PY 2016
VL 26
IS 6
BP 645
EP 654
DI 10.1038/cr.2016.58
PG 10
WC Cell Biology
SC Cell Biology
GA DO0DL
UT WOS:000377449500005
PM 27174054
ER

PT J
AU Cavalheiro, S
   Lopez, A
   Serra, S
   Da Cunha, A
   da Costa, MDS
   Moron, A
   Lederman, HM
AF Cavalheiro, Sergio
   Lopez, Amanda
   Serra, Suzana
   Da Cunha, Arthur
   da Costa, Marcos Devanir S.
   Moron, Antonio
   Lederman, Henrique M.
TI Microcephaly and Zika virus: neonatal neuroradiological aspects
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Zika virus; Microcephaly; Ventriculomegaly; Lissencephaly; Intracranial
   calcifications; Aedes aegypti
ID INFECTION
AB The aim of this study is to describe some radiological features in the newborns with microcephaly caused by Zika virus infection during pregnancy.
   We radiologically analyzed 13 cases of newborns with microcephaly born to mothers who were infected by the Zika virus in the early stage of pregnancy.
   The most frequently observed radiological findings were microcephaly and decreased brain parenchymal volume associated with lissencephaly, ventriculomegaly secondary to the lack of brain tissue (not hypertensive), and coarse and anarchic calcifications mainly involving the subcortical cortical transition, and the basal ganglia.
   Although it cannot be concluded that there is a definitive pathognomonic radiographic pattern of microcephaly caused by Zika virus, gross calcifications and anarchic distribution involving the subcortical cortical transition and the basal ganglia, in association with lissencephaly and in the absence of hypertensive ventriculomegaly, are characteristic of this type of infection.
C1 [Cavalheiro, Sergio; da Costa, Marcos Devanir S.] Univ Fed Sao Paulo, Dept Neurosurg, Rua Botucatu 591,Conj 41, BR-04023062 Sao Paulo, SP, Brazil.
   [Lopez, Amanda; Serra, Suzana; Da Cunha, Arthur] Hosp Restauracao, Neurosurg Serv, Recife, PE, Brazil.
   [Moron, Antonio] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, SP, Brazil.
   [Lederman, Henrique M.] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, SP, Brazil.
RP Cavalheiro, S (reprint author), Univ Fed Sao Paulo, Dept Neurosurg, Rua Botucatu 591,Conj 41, BR-04023062 Sao Paulo, SP, Brazil.
EM sergiocavalheironeuro@gmail.com
CR Adibi JJ, 2016, LANCET
   Almeida G, 1964, ARQ NEURO-PSIQUIAT, V22, P1
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   CDC, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci A.S., 2016, N ENGL J MED
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morquio L, 1903, HIDROCEFALIA REV MED, V6, P4
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Swan C, 1943, MED J AUSTRALIA, V2, P1
   Swan C, 1946, J PATHOL, V56, P6
NR 11
TC 6
Z9 6
U1 14
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD JUN
PY 2016
VL 32
IS 6
BP 1057
EP 1060
DI 10.1007/s00381-016-3074-6
PG 4
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA DN3VD
UT WOS:000376991200010
PM 27080092
ER

PT J
AU Li, JD
   Xiong, Y
   Wu, W
   Liu, XQ
   Qu, J
   Zhao, X
   Zhang, S
   Li, JH
   Li, WH
   Liao, Y
   Gong, T
   Wang, LJ
   Shi, Y
   Xiong, YF
   Ni, DX
   Li, Q
   Liang, MF
   Hu, GL
   Li, DX
AF Li, Jiandong
   Xiong, Ying
   Wu, Wei
   Liu, Xiaoqing
   Qu, Jing
   Zhao, Xiang
   Zhang, Shuo
   Li, Jianhua
   Li, Weihong
   Liao, Yong
   Gong, Tian
   Wang, Lijing
   Shi, Yong
   Xiong, Yanfeng
   Ni, Daxin
   Li, Qun
   Liang, Mifang
   Hu, Guoliang
   Li, Dexin
TI Zika Virus in a Traveler Returning to China from Caracas, Venezuela,
   February 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID TRANSMISSION
C1 [Li, Jiandong; Wu, Wei; Qu, Jing; Zhao, Xiang; Zhang, Shuo; Wang, Lijing; Liang, Mifang; Li, Dexin] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Changbai Rd 155, Beijing 102206, Peoples R China.
   [Xiong, Ying; Liu, Xiaoqing; Gong, Tian; Shi, Yong; Hu, Guoliang] Jiangxi Prov Ctr Dis Control & Prevent, Beijingdong Rd 555, Nanchang 330029, Peoples R China.
   [Li, Jiandong; Liao, Yong; Xiong, Yanfeng] Ganzhou Municipal Ctr Dis Control & Prevent, Ganzhou, Peoples R China.
   [Ni, Daxin; Li, Qun] Chinese Ctr Dis Control & Prevent, Off Emergence Response, Beijing, Peoples R China.
   [Li, Weihong] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China.
RP Li, DX (reprint author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Changbai Rd 155, Beijing 102206, Peoples R China.; Hu, GL (reprint author), Jiangxi Prov Ctr Dis Control & Prevent, Beijingdong Rd 555, Nanchang 330029, Peoples R China.
EM jxcdchgl@163.com; lidx@chinacdc.cn
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization/World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095635
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Xu RM, 1990, VECTOR DENGUE FEVER, P51
NR 10
TC 0
Z9 0
U1 4
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2016
VL 22
IS 6
BP 1133
EP 1136
DI 10.3201/eid2206.160273
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DN0YY
UT WOS:000376794200038
PM 27070735
ER

PT J
AU Yusuf, M
   Hussain, HF
AF Yusuf, Muhammad
   Hussain, Hareem Fatima
TI Zika virus: Another alarming threat
SO JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Yusuf, Muhammad; Hussain, Hareem Fatima] Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan.
RP Yusuf, M (reprint author), Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan.
EM m.yusufhafiz17@gmail.com
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 3
TC 0
Z9 0
U1 3
U2 3
PU PAKISTAN MEDICAL ASSOC
PI KARACHI
PA PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN
SN 0030-9982
J9 J PAK MED ASSOC
JI J. Pak. Med. Assoc.
PD JUN
PY 2016
VL 66
IS 6
BP 789
EP 789
PG 1
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA DM9LF
UT WOS:000376687000036
PM 27339593
ER

PT J
AU Molnar, Z
   Kennedy, S
AF Molnar, Zoltan
   Kennedy, Stephen
TI Risks of Zika virus during the first trimester of pregnancy
SO NATURE REVIEWS NEUROLOGY
LA English
DT Editorial Material
AB The ongoing Zika virus (ZIKV) epidemic in the Americas raises urgent questions about the risks of microcephaly in the children of ZIKV-infected mothers. New research into the 2013-2014 ZIKV outbreak in French Polynesia supports a link between maternal ZIKV infection during the first trimester of pregnancy and microcephaly.
C1 [Molnar, Zoltan] Univ Oxford, Dept Physiol Anat & Genet, S Parks Rd, Oxford OX1 3QX, England.
   [Kennedy, Stephen] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.
RP Molnar, Z (reprint author), Univ Oxford, Dept Physiol Anat & Genet, S Parks Rd, Oxford OX1 3QX, England.
EM zoltan.molnar@dpag.ox.ac.uk
CR Brasil P, 2016, N ENGL J MED
   Cauchemez S, 2016, LANCET
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008
   Stolp Helen, 2012, Front Psychiatry, V3, P50, DOI 10.3389/fpsyt.2012.00050
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
NR 10
TC 0
Z9 0
U1 7
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4758
EI 1759-4766
J9 NAT REV NEUROL
JI Nat. Rev. Neurol.
PD JUN
PY 2016
VL 12
IS 6
BP 315
EP U13
DI 10.1038/nrneurol.2016.71
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA DN1LR
UT WOS:000376827800001
PM 27150532
ER

PT J
AU Guillemette-Artur, P
   Besnard, M
   Eyrolle-Guignot, D
   Jouannic, JM
   Garel, C
AF Guillemette-Artur, Prisca
   Besnard, Marianne
   Eyrolle-Guignot, Dominique
   Jouannic, Jean-Marie
   Garel, Catherine
TI Prenatal brain MRI of fetuses with Zika virus infection
SO PEDIATRIC RADIOLOGY
LA English
DT Article
DE Brain; Fetus; Intrauterine infection; Magnetic resonance imaging;
   Prenatal diagnosis; Ultrasound; Zika virus
ID FETAL; LESIONS
AB An outbreak of Zika virus was observed in French Polynesia in 2013-2014. Maternal Zika virus infection has been associated with fetal microcephaly and severe cerebral damage.
   To analyze the MRI cerebral findings in fetuses with intrauterine Zika virus infection.
   We retrospectively analyzed prospectively collected data. Inclusion criteria comprised cases with (1) estimated conception date between June 2013 and May 2014, (2) available US and MRI scans revealing severe fetal brain lesions and (3) positive polymerase chain reaction for Zika virus in the amniotic fluid. We recorded pregnancy history of Zika virus infection and analyzed US and MRI scans.
   Three out of 12 cases of severe cerebral lesions fulfilled all inclusion criteria. History of maternal Zika virus infection had been documented in two cases. Calcifications and ventriculomegaly were present at US in all cases. MRI showed micrencephaly (n = 3), low cerebellar biometry (n = 2), occipital subependymal pseudocysts (n = 2), polymicrogyria with laminar necrosis and opercular dysplasia (n = 3), absent (n = 1) or hypoplastic (n = 1) corpus callosum and hypoplastic brainstem (n = 1).
   Severe cerebral damage was observed in our series, with indirect findings suggesting that the germinal matrix is the principal target for Zika virus. The lesions are very similar to severe forms of congenital cytomegalovirus and lymphocytic choriomeningitis virus infections.
C1 [Guillemette-Artur, Prisca] Ctr Hosp Polynesie Francaise, Serv Radiol, Pirae, Tahiti, Fr Polynesia.
   [Besnard, Marianne] Ctr Hosp Polynesie Francaise, Serv Reanimat Neonatale, Pirae, Tahiti, Fr Polynesia.
   [Eyrolle-Guignot, Dominique] Ctr Hosp Polynesie Francaise, Serv Obstet, Pirae, Tahiti, Fr Polynesia.
   [Jouannic, Jean-Marie] Univ Paris 06, Hop Enfants Armand Trousseau, Serv Med Foetale, Paris, France.
   [Garel, Catherine] Hop Enfants Armand Trousseau, Dept Radiol, 26 Ave Dr Arnold Netter, Paris, France.
RP Garel, C (reprint author), Hop Enfants Armand Trousseau, Dept Radiol, 26 Ave Dr Arnold Netter, Paris, France.
EM catherine.garel@aphp.fr
CR Besnard M, 2014, EURO SURVEILL, V19
   Blondiaux E, 2013, ACTA RADIOL, V54, P1046, DOI 10.1258/ar.2012.120428
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   [Anonymous], 2016, NEW ENGL J MED, DOI DOI 10.1056/NEJM0A1602412
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duin LK, 2007, PRENATAL DIAG, V27, P81, DOI 10.1002/pd.1631
   Esteban H, 2015, ULTRASOUND OBST GYN, V46, P678, DOI 10.1002/uog.14820
   Garel C, 2004, AM J NEURORADIOL, V25, P1563
   Glenn OA, 2007, J MATERN-FETAL NEO M, V20, P769, DOI 10.1080/14767050701580960
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kucharski AJ, 2016, BIORXIV, DOI [10.1101/038588, DOI 10.1101/038588]
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Mandelbrot L, 2012, PRENATAL DIAG, V32, P511, DOI 10.1002/pd.3843
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mutnal MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016211
   Paladini D, 2009, ULTRASOUND OBST GYN, V33, P720, DOI 10.1002/uog.6393
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tilea B, 2009, ULTRASOUND OBST GYN, V33, P173, DOI 10.1002/uog.6276
   Werner H, 2016, ULTRASOUND OBST GYN, DOI [10.1002/uog.15901, DOI 10.1002/U0G.15901]
NR 23
TC 2
Z9 2
U1 12
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0301-0449
EI 1432-1998
J9 PEDIATR RADIOL
JI Pediatr. Radiol.
PD JUN
PY 2016
VL 46
IS 7
BP 1032
EP 1039
DI 10.1007/s00247-016-3619-6
PG 8
WC Pediatrics; Radiology, Nuclear Medicine & Medical Imaging
SC Pediatrics; Radiology, Nuclear Medicine & Medical Imaging
GA DN4FX
UT WOS:000377020100010
PM 27090801
ER

PT J
AU Marrs, C
   Olson, G
   Saade, G
   Hankins, G
   Wen, T
   Patel, J
   Weaver, S
AF Marrs, Caroline
   Olson, Gayle
   Saade, George
   Hankins, Gary
   Wen, Tony
   Patel, Janak
   Weaver, Scott
TI Zika Virus and Pregnancy: A Review of the Literature and Clinical
   Considerations
SO AMERICAN JOURNAL OF PERINATOLOGY
LA English
DT Review
DE Zika virus; pregnancy; fetus; transmission; microcephaly
ID UNITED-STATES; INTERIM GUIDELINES; DENGUE VIRUS; VERTICAL TRANSMISSION;
   SEXUAL TRANSMISSION; FRENCH-POLYNESIA; FEBRUARY 2014; INFECTION;
   OUTBREAK; BRAZIL
AB The latest Zika virus (ZIKV) outbreak has reached epidemic proportions as it spreads throughout South and Central America. In November 2015, the Brazilian Ministry of Health reported a 20-fold increase in the number of cases of neonatal microcephaly, which corresponds geographically and temporally to the ZIKV outbreak. Case reports have provided some evidence of a causal link between maternal ZIKV infection, fetal microcephaly, and intracranial calcifications. The sparse data regarding ZIKV in pregnancy come solely from case reports and personal communications, and recommendations for management of ZIKV exposure during pregnancy are rapidly evolving. Our objective is to review and synthesize the current literature regarding ZIKV as it pertains to pregnancy and provide some assistance to clinicians who may have to manage a pregnant patient with potential exposure to ZIKV. We will also explore certain aspects of related viruses in pregnancy in hopes to shed light on this little-known topic.
C1 [Marrs, Caroline; Olson, Gayle; Saade, George; Hankins, Gary; Wen, Tony] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, 301 Univ Blvd,JSA 3-400, Galveston, TX 77555 USA.
   [Patel, Janak] Univ Texas Med Branch, Dept Pediat, Div Pediat Infect Dis, Galveston, TX 77555 USA.
   [Weaver, Scott] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Weaver, Scott] Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA.
   [Weaver, Scott] Univ Texas Med Branch, Dept Immunol, Galveston, TX 77555 USA.
RP Marrs, C (reprint author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med, 301 Univ Blvd,JSA 3-400, Galveston, TX 77555 USA.
EM carolinemarrs@gmail.com
CR AABB, AABB ASS B
   Agencia Saude, 2015, MICR MIN SAUD DIV B
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bianchi DW, 2010, FETOLOGY DIAGNOSIS M, P166
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Center of Diseases Control and Prevention (CDC), SURV CONTR AED AEG A
   CDC, 2016, CDC EM OP CTR MOV HI
   Centers for Disease Control Prevention, 2002, MMWR-MORBID MORTAL W, V51, P877
   Centers for Disease Control and Prevention Division of Vector-Borne Diseases Arboviral Diseases and Dengue Branches, 2016, UPD DIAGN TEST ZIK C
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   CHERVENAK FA, 1984, AM J OBSTET GYNECOL, V149, P512
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dontigny Lorraine, 2008, J Obstet Gynaecol Can, V30, P152
   Dotters-Katz SK, 2015, OBSTET GYNECOL SURV, V70, P453, DOI 10.1097/OGX.0000000000000184
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2016, RAPID RISK ASS ZIK V
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Kuhn JH, 2015, HARRISONS PRINCIPLES
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kurmanavicius J, 1999, BRIT J OBSTET GYNAEC, V106, P126, DOI 10.1111/j.1471-0528.1999.tb08212.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Leite JM, 2008, ULTRASOUND OBST GYN, P133
   Lipitz S, 2013, ULTRASOUND OBST GYN, V41, P508, DOI 10.1002/uog.12377
   Buck Louis GM, 2015, AM J OBSTET GYNECOL, V213
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MORB MORTAL WKLY REP
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nasci RS, 2015, CDC HLTH INFORM INT, P94
   Nguyen Q., 2002, Morbidity and Mortality Weekly Report, V51, P1135
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, PREL GUID SURV MICR
   Pan American Health Organization, QUEST ANSW ZIK PREGN
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Passemard S, 2013, HDB CLIN NEUROLOGY, VIII, P129
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pilu G, 2008, ULTRASOUND OBST GYN, P382
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e
   SMFM, 2016, AM J OBSTET GYNECOL, DOI 10.1016/j.ajog.2016.02.043
   Society of Maternal Fetal Medicine, 2016, PRACT ADV UPD INT GU
   Spenser BR, 2015, AABB ANN M OCT 24 27
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 71
TC 2
Z9 3
U1 21
U2 21
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0735-1631
EI 1098-8785
J9 AM J PERINAT
JI Am. J. Perinatol.
PD JUN
PY 2016
VL 33
IS 7
BP 625
EP 639
DI 10.1055/s-0036-1580089
PG 15
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA DM7FE
UT WOS:000376521500001
PM 26939047
ER

PT J
AU Weaver, SC
   Costa, F
   Garcia-Blanco, MA
   Ko, AI
   Ribeiro, GS
   Saade, G
   Shi, PY
   Vasilakis, N
AF Weaver, Scott C.
   Costa, Federico
   Garcia-Blanco, Mariano A.
   Ko, Albert I.
   Ribeiro, Guilherme S.
   Saade, George
   Shi, Pei-Yong
   Vasilakis, Nikos
TI Zika virus: History, emergence, biology, and prospects for control
SO ANTIVIRAL RESEARCH
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; AEDES-AEGYPTI; POTENTIAL VECTOR; DENGUE VIRUS;
   YELLOW-FEVER; HOST FACTORS; PUERTO-RICO; INFECTION; BRAZIL; TRANSMISSION
AB Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cause a series of epidemics in Micronesia, the South Pacific, and most recently the Americas. After its putative evolution in sub-Saharan Africa, ZIKV spread in the distant past to Asia and has probably emerged on multiple occasions into urban transmission cycles involving Aedes (Stegomyia) spp. mosquitoes and human amplification hosts, accompanied by a relatively mild dengue-like illness. The unprecedented numbers of people infected during recent outbreaks in the South Pacific and the Americas may have resulted in enough ZIKV infections to notice relatively rare congenital microcephaly and Guillain-Barre syndromes. Another hypothesis is that phenotypic changes in Asian lineage ZIKV strains led to these disease outcomes. Here, we review potential strategies to control the ongoing outbreak through vector-centric approaches as well as the prospects for the development of vaccines and therapeutics. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Microbiol & Immunol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Costa, Federico; Ko, Albert I.; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Garcia-Blanco, Mariano A.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Saade, George] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Weaver, SC (reprint author), Univ Texas Med Branch, Dept Microbiol & Immunol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Weaver, Scott/D-6490-2011; Ko, Albert/P-2343-2015; 
OI Garcia-Blanco, Mariano/0000-0001-8538-1997
FU NIH [AI120942, AI093491, AI121207]
FX The authors' research on Zika virus is supported by NIH grants AI120942
   and AI093491 to SCW, and AI121207 to AIK.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Atkinson B., 2016, EMERG INFEC IN PRESS
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrows NJ, 2014, METHODS MOL BIOL, V1138, P285, DOI 10.1007/978-1-4939-0348-1_18
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Committee S. P., 2016, AM J OBSTET GYNECOL
   Cornet M., 1979, ORSTOM ENTOMOL MED P, V17, P149
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Costa F., 2016, ANN INT MED IN PRESS
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faria N. R., 2016, SCI ONLINE
   Faye O., 2014, PLOS NEGLECT TROP D, V8
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Freitas B.P, 2016, JAMA OPHTHALMOL BRAZ
   Garcia-Blanco MA, 2015, RNA, V21, P525, DOI 10.1261/rna.050138.115
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler D J, 1987, P R Health Sci J, V6, P107
   Gubler Duane J., 1997, P1
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanley K. A., 2013, INFECT GENET EVOL
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Horwood Paul, 2013, Western Pac Surveill Response J, V4, P8, DOI 10.5365/WPSAR.2013.4.2.003
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marrs C., 2016, AM J PERINATOL
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McGee CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023247
   Mlakar J., 2016, N ENGL J MED
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen E., 2016, INT J INFECT DIS IJI
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Tang H, 2016, CELL STEM CELL
   Taucher C, 2010, J VIROL, V84, P599, DOI 10.1128/JVI.01063-09
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Winch PJ, 2002, AM J TROP MED HYG, V67, P363
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 78
TC 13
Z9 13
U1 77
U2 77
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2016
VL 130
BP 69
EP 80
DI 10.1016/j.antiviral.2016.03.010
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA DM2ZW
UT WOS:000376217600009
PM 26996139
ER

PT J
AU McNeill, C
   Shreve, MD
   Jarrett, A
   Perry, C
AF McNeill, Charleen
   Shreve, Marilou D.
   Jarrett, Anna
   Perry, Cheryl
TI Zika: What Providers Need to Know
SO JNP-JOURNAL FOR NURSE PRACTITIONERS
LA English
DT Article
DE arboviruses; flaviviridae; infectious disease; treatment guidelines;
   Zika virus
ID HEALTH; VIRUS; TRANSMISSION; DEET
AB Emerging or reemerging infectious diseases (EIDs) are rapidly increasing. EIDs will remain a major cause of disease and death worldwide. One such EID is the Zika virus (ZIKV). ZIKV proves to be a global public health crisis. In January 2016, it became a notifiable condition in the United States. Providers must be knowledgeable regarding preventive measures as well as the proper diagnosis and treatment for it. The most current, evidence-based guidelines for managing ZIKV in the general population as well as specific recommendations for pregnant women are presented. (C) 2016 Elsevier Inc. All rights reserved.
C1 [McNeill, Charleen; Shreve, Marilou D.; Jarrett, Anna; Perry, Cheryl] Univ Arkansas, Eleanor Mann Sch Nursing, Fayetteville, AR 72701 USA.
RP McNeill, C (reprint author), Univ Arkansas, Eleanor Mann Sch Nursing, Fayetteville, AR 72701 USA.
EM cmcneill@uark.edu
CR Brown DM, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P519, DOI 10.1079/9781845939649.0519
   Center for Disease Control and Prevention, 2016, TRANSM RISKS
   [Anonymous], 2016, MOSQ BIT PREV US
   [Anonymous], 2016, EST RANG AED AEG AED
   [Anonymous], 2016, DIAGN TEST
   [Anonymous], 2016, TOOLS HLTH CAR PROV
   Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   [Anonymous], 2016, SYMPT DIAGN TREATM
   [Anonymous], 2016, CLIN EV DIS
   Cetron M., 2016, MMWR MORB MORTAL WKL
   Chen-Hussey V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-173
   Darsie R, 2005, IDENTIFICATION GEOGR
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   [Anonymous], 2016, SCI NEWSSH ZIK VIR I
   Kabasenche WP, 2013, ENV HLTH, V13, P1
   Kallen B., 2014, EPIDEMIOLOGY HUMAN C, P27
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kronen MR, 2007, FIELDS VIROLOGY, V2, P1102
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   MORSE SS, 1990, J INFECT DIS, V162, P1
   Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088
   Mosquera A, 2015, PUBLIC HEALTH NURS, V32, P550, DOI 10.1111/phn.12217
   [Anonymous], 2014, EUROSURVEILLANCE
   [Anonymous], 2016, ZIK VIR
   Nhan T, 2015, CLIN MICROBIOL, V4, P222
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P1
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   [Anonymous], 2015, EP UPD ZIK VIR INF
   Pullella P., 2016, POPE SIGNALS POSSIBL
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Tian JN, 2014, J ENVIRON HEALTH, V76, P162
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   [Anonymous], 2015, INF CONS ANT EM INF
   [Anonymous], 2016, ZIK VIR
   Zaccagnini M, 2014, DOCTOR NURSING PRACT
NR 39
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1555-4155
EI 1878-058X
J9 JNP-J NURSE PRACT
JI JNP-J. Nurse Pract.
PD JUN
PY 2016
VL 12
IS 6
BP 359
EP 370
DI 10.1016/j.nurpra.2016.04.009
PG 11
WC Nursing
SC Nursing
GA DM9FB
UT WOS:000376669300014
ER

PT J
AU Boete, C
   Reeves, RG
AF Boete, Christophe
   Reeves, R. Guy
TI Alternative vector control methods to manage the Zika virus outbreak:
   more haste, less speed
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID AMERICA
C1 [Boete, Christophe] Aix Marseille Univ, UMR Emergence Pathol Virales, Inserm 1207, EHESP,IRD 190, F-13385 Marseille, France.
   [Reeves, R. Guy] Max Planck Inst Evolutionary Biol, Dept Evolutionary Genet, Plon, Germany.
RP Boete, C (reprint author), Aix Marseille Univ, UMR Emergence Pathol Virales, Inserm 1207, EHESP,IRD 190, F-13385 Marseille, France.
EM cboete@gmail.com
CR Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   James S, 2011, SCIENCE, V334, P771, DOI 10.1126/science.1213798
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 5
TC 0
Z9 0
U1 14
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JUN
PY 2016
VL 4
IS 6
BP E363
EP E363
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM6LH
UT WOS:000376463200012
PM 27198836
ER

PT J
AU Bouyer, J
   Chandre, F
   Gilles, J
   Baldet, T
AF Bouyer, Jeremy
   Chandre, Fabrice
   Gilles, Jeremie
   Baldet, Thierry
TI Alternative vector control methods to manage the Zika virus outbreak:
   more haste, less speed
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID MOSQUITOS
C1 [Bouyer, Jeremy; Baldet, Thierry] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, F-34398 Montpellier, France.
   [Chandre, Fabrice] Inst Rech Dev, Unite Mixte Rech Malad infect & Vecteurs Ecol Gen, Montpellier, France.
   [Gilles, Jeremie] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.
RP Bouyer, J (reprint author), Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, F-34398 Montpellier, France.
EM bouyer@cirad.fr
FU European Research Council under the European Union [682387-REVOLINC]
FX We declare no competing interests. This project has been selected for
   funding from the European Research Council under the European Union's
   Horizon 2020 research and innovation programme (grant agreement No
   682387-REVOLINC). This Correspodence reflects only the authors' views
   and the Agency is not responsible for any use that may be made of the
   information it contains.
CR Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)38010-X
   Curtis Z, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003999
   Locatelli MAF, 2011, ARCH ENVIRON CON TOX, V60, P385, DOI 10.1007/s00244-010-9550-1
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 5
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JUN
PY 2016
VL 4
IS 6
BP E364
EP E364
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM6LH
UT WOS:000376463200013
PM 27198837
ER

PT J
AU Yakob, L
   Walker, T
AF Yakob, Laith
   Walker, Thomas
TI Alternative vector control methods to manage the Zika virus outbreak:
   more haste, less speed Reply
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID COMPETITION; SPACE
C1 [Yakob, Laith; Walker, Thomas] Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.
RP Yakob, L (reprint author), Univ London London Sch Hyg & Trop Med, Dept Dis Control, Keppel St, London WC1E 7HT, England.
EM laith.yakob@lshtm.ac.uk
CR Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887
   PAHO WHO, DENG PAHO WHO DAT MA
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   WHO, MOSQ CONTR CAN IT ST
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x
   Yakob L, 2009, J ECON ENTOMOL, V102, P50
NR 10
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JUN
PY 2016
VL 4
IS 6
BP E365
EP E366
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM6LH
UT WOS:000376463200014
PM 27198838
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika virus at the games: is it safe?
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 619
EP 619
DI 10.1016/S1473-3099(16)30069-X
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500001
ER

PT J
AU Musso, D
   Baud, D
AF Musso, Didier
   Baud, David
TI Zika virus: time to move from case reports to case control
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID INTERIM GUIDELINES; UNITED-STATES; INFECTION; PREGNANCY
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
   [Baud, David] Univ Lausanne Hosp, Maternofetal & Obstet Res Unit, Dept Femme Mere Enfant, Matern, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne Hosp, Lausanne, Switzerland.
RP Musso, D (reprint author), Inst Louis Malarde, Unit Emerging Infect Dis, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR Calvet G., 2016, LANCET INFECT DIS
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P1
   PAHO WHO, 2016, EP UPD NEUR SYNDR CO
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ville Y, 2014, CURR OPIN INFECT DIS, V27, P251, DOI [10.1097/QCO.0000000000000066, 10.1097/QCO.0000000000000064]
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 11
TC 5
Z9 5
U1 9
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 620
EP 621
DI 10.1016/S1473-3099(16)00096-7
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500002
PM 26897106
ER

PT J
AU Zhang, FC
   Li, XF
   Deng, YQ
   Tong, YG
   Qin, CF
AF Zhang, Fu-Chun
   Li, Xiao-Feng
   Deng, Yong-Qiang
   Tong, Yi-Gang
   Qin, Cheng-Feng
TI Excretion of infectious Zika virus in urine
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Zhang, Fu-Chun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Li, Xiao-Feng; Deng, Yong-Qiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.
   [Tong, Yi-Gang; Qin, Cheng-Feng] State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
RP Qin, CF (reprint author), Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.; Qin, CF (reprint author), State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
EM qincf@bmi.ac.cn
OI Qin, Cheng-Feng/0000-0002-0632-2807
CR Berzon L, 2016, EUROSURVEILLANCE, P21, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917]
   de MCR, 2016, J CLIN VIROL, V77, P69
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
NR 5
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 641
EP 642
DI 10.1016/S1473-3099(16)30070-6
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500020
PM 27184420
ER

PT J
AU Blonz, ER
AF Blonz, Edward R.
TI Zika virus and GLUT1
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Blonz, Edward R.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA.
RP Blonz, ER (reprint author), Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA.
EM er@blonz.com
CR Cauchemez S, 2016, LANCET
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernando WMADB, 2015, BRIT J NUTR, V114, P1, DOI 10.1017/S0007114515001452
   Noppakunmongkolchai W, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0494-6
   PAHWA S, 1986, JAMA-J AM MED ASSOC, V255, P2299, DOI 10.1001/jama.255.17.2299
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Wang DZ, 2002, HEBEI FORESTORY TECH, V30, P30
   Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10
NR 8
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 642
EP 642
DI 10.1016/S1473-3099(16)30062-7
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500021
PM 27184421
ER

PT J
AU Calvet, G
   Aguiar, RS
   Melo, ASO
   Sampaio, SA
   de Filippis, I
   Fabri, A
   Araujo, ESM
   de Sequeira, PC
   de Mendonca, MCL
   de Oliveira, L
   Tschoeke, DA
   Schrago, CG
   Thompson, FL
   Brasil, P
   dos Santos, FB
   Nogueira, RMR
   Tanurit, A
   Filippis, AMB
AF Calvet, Guilherme
   Aguiar, Renato S.
   Melo, Adriana S. O.
   Sampaio, Simone A.
   de Filippis, Ivano
   Fabri, Allison
   Araujo, Eliane S. M.
   de Sequeira, Patricia C.
   de Mendonca, Marcos C. L.
   de Oliveira, Louisi
   Tschoeke, Diogo A.
   Schrago, Carlos G.
   Thompson, Fabiano L.
   Brasil, Patricia
   dos Santos, Flavia B.
   Nogueira, Rita M. R.
   Tanurit, Amilcar
   de Filippis, Ana M. B.
TI Detection and sequencing of Zika virus from amniotic fluid of fetuses
   with microcephaly in Brazil: a case study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; CHIKUNGUNYA-VIRUS; MICRONESIA;
   OUTBREAK; UGANDA; ISLAND; FEVER; STATE
AB Background The incidence of microcephaly in Brazil in 2015 was 20 times higher than in previous years. Congenital microcephaly is associated with genetic factors and several causative agents. Epidemiological data suggest that microcephaly cases in Brazil might be associated with the introduction of Zika virus. We aimed to detect and sequence the Zika virus genome in amniotic fluid samples of two pregnant women in Brazil whose fetuses were diagnosed with microcephaly.
   Methods In this case study, amniotic fluid samples from two pregnant women from the state of Paraiba in Brazil whose fetuses had been diagnosed with microcephaly were obtained, on the recommendation of the Brazilian health authorities, by ultrasound-guided transabdominal amniocentesis at 28 weeks' gestation. The women had presented at 18 weeks' and 10 weeks' gestation, respectively, with clinical manifestations that could have been symptoms of Zika virus infection, including fever, myalgia, and rash. After the amniotic fluid samples were centrifuged, DNA and RNA were extracted from the purified virus particles before the viral genome was identified by quantitative reverse transcription PCR and viral metagenomic next-generation sequencing. Phylogenetic reconstruction and investigation of recombination events were done by comparing the Brazilian Zika virus genome with sequences from other Zika strains and from flaviviruses that occur in similar regions in Brazil.
   Findings We detected the Zika virus genome in the amniotic fluid of both pregnant women. The virus was not detected in their urine or serum. Tests for dengue virus, chikungunya virus, Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex virus, HIV, Treponema pallidum, and parvovirus B19 were all negative. After sequencing of the complete genome of the Brazilian Zika virus isolated from patient 1, phylogenetic analyses showed that the virus shares 97-100% of its genomic identity with lineages isolated during an outbreak in French Polynesia in 2013, and that in both envelope and NS 5 genomic regions, it clustered with sequences from North and South America, southeast Asia, and the Pacific. After assessing the possibility of recombination events between the Zika virus and other flaviviruses, we ruled out the hypothesis that the Brazilian Zika virus genome is a recombinant strain with other mosquito-borne flaviviruses.
   Interpretation These findings strengthen the putative association between Zika virus and cases of microcephaly in neonates in Brazil. Moreover, our results suggest that the virus can cross the placental barrier. As a result, Zika virus should be considered as a potential infectious agent for human fetuses. Pathogenesis studies that confirm the tropism of Zika virus for neuronal cells are warranted.
C1 [Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, BR-21040900 Rio De Janeiro, Brazil.
   [Sampaio, Simone A.; Fabri, Allison; Araujo, Eliane S. M.; de Sequeira, Patricia C.; de Mendonca, Marcos C. L.; dos Santos, Flavia B.; Nogueira, Rita M. R.; de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [de Filippis, Ana M. B.] Fundacao Oswaldo Cruz, Inst Nacl Controle & Qualidade, BR-21040900 Rio De Janeiro, Brazil.
   [Aguiar, Renato S.; de Oliveira, Louisi; Schrago, Carlos G.; Tanurit, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.
   [Tschoeke, Diogo A.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Melo, Adriana S. O.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Brazil.
   [Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Lab Sistemas Avancados Gestao Prod SAGE COPPE, Ctr Gestaotecnol CT2, Rio de Janeiro, Brazil.
RP Filippis, AMB (reprint author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
EM abispo@ioc.fiocruz.br
FU Consellho Nacional de Desenvolvimento e Pesquisa (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
FX Consellho Nacional de Desenvolvimento e Pesquisa (CNPq), Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P8
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brazilian Ministry of Health, MIN SAUD INV 3 852 C
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Onis M, 2008, LANCET, V371, P204, DOI 10.1016/S0140-6736(08)60131-2
   De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437
   Harris SR, 2013, DEV NEUROREHABIL, V16, P129, DOI 10.3109/17518423.2012.737040
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Lanari M, 2012, Early Hum Dev, V88 Suppl 2, pS3, DOI 10.1016/S0378-3782(12)70003-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Oehler E, 2014, EUROSURVEILLANCE, V19
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Sibley SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098569
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 49
Z9 51
U1 51
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUN
PY 2016
VL 16
IS 6
BP 653
EP 660
DI 10.1016/S1473-3099(16)00095-5
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DM6QC
UT WOS:000376476500044
PM 26897108
ER

PT J
AU Farahnik, B
   Beroukhim, K
   Blattner, CM
   Young, J
AF Farahnik, Benjamin
   Beroukhim, Kourosh
   Blattner, Collin M.
   Young, John, III
TI Cutaneous manifestations of the Zika virus
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
LA English
DT Editorial Material
DE disease prevention and control; microcephaly; public health concerns;
   viral exanthem; Zika virus
C1 [Farahnik, Benjamin] Univ Vermont, Coll Med, Burlington, VT 05405 USA.
   [Beroukhim, Kourosh] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Blattner, Collin M.] Good Samaritan Reg Med Ctr, Corvallis, OR USA.
   [Young, John, III] Silver Falls Dermatol, 1793 13th St SE, Salem, OR 97302 USA.
RP Young, J (reprint author), Silver Falls Dermatol, 1793 13th St SE, Salem, OR 97302 USA.
EM jyoung@silverfallsderm.net
CR CDC Division of Vector-Borne Diseases, 2016, REV DIAGN TEST ZIK C
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Mann D, 2016, PRACT DERMATOL, V13, P10
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   World Health Organization, 2016, ZIK VIR FACT SHEET
NR 6
TC 0
Z9 0
U1 13
U2 13
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0190-9622
J9 J AM ACAD DERMATOL
JI J. Am. Acad. Dermatol.
PD JUN
PY 2016
VL 74
IS 6
BP 1286
EP 1287
DI 10.1016/j.jaad.2016.02.1232
PG 2
WC Dermatology
SC Dermatology
GA DM2LV
UT WOS:000376179200056
PM 27016775
ER

PT J
AU Tappe, D
   Perez-Giron, JV
   Zammarchi, L
   Rissland, J
   Ferreira, DF
   Jaenisch, T
   Gomez-Medina, S
   Gunther, S
   Bartoloni, A
   Munoz-Fontela, C
   Schmidt-Chanasit, J
AF Tappe, Dennis
   Perez-Giron, Jose Vicente
   Zammarchi, Lorenzo
   Rissland, Juergen
   Ferreira, Davis F.
   Jaenisch, Thomas
   Gomez-Medina, Sergio
   Guenther, Stephan
   Bartoloni, Alessandro
   Munoz-Fontela, Cesar
   Schmidt-Chanasit, Jonas
TI Cytokine kinetics of Zika virus-infected patients from acute to
   reconvalescent phase
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE Zika virus; Arbovirus; Flavivirus; Zika fever; Outbreak; Cytokine
ID SERUM-LEVELS; DENGUE
AB Zika virus is an emerging mosquito-borne flavivirus currently causing large epidemics in the Pacific Ocean region and Brazil. Clinically, Zika fever resembles dengue fever, but is less severe. Whereas the clinical syndrome and laboratory diagnostic procedures have been described, little attention was paid to the immunology of the disease and its possible use for clinical follow-up of patients. Here, we investigate the role of cytokines in the pathogenesis of Zika fever in travelers returning from Asia, the Pacific, and Brazil. Polyfunctional T cell activation (Th1, Th2, Th9, and Th17 response) was seen during the acute phase characterized by respective cytokine level increases, followed by a decrease in the reconvalescent phase.
C1 [Tappe, Dennis; Guenther, Stephan; Munoz-Fontela, Cesar; Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Tappe, Dennis; Guenther, Stephan; Munoz-Fontela, Cesar; Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
   [Perez-Giron, Jose Vicente; Gomez-Medina, Sergio; Munoz-Fontela, Cesar] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.
   [Zammarchi, Lorenzo; Bartoloni, Alessandro] Univ Florence, Dipartimento Med Sperimentale & Clin, Clin Malattie Infett, Florence, Italy.
   [Rissland, Juergen] Univ Saarland, Med Ctr, Inst Virol, Homburg, Germany.
   [Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
RP Tappe, D (reprint author), Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.; Tappe, D (reprint author), German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, Hamburg, Germany.
EM tappe@bnitm.de
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Guabiraba R, 2014, IMMUNOLOGY, V141, P143, DOI 10.1111/imm.12188
   Guzman-Fulgencio M, 2012, J ANTIMICROB CHEMOTH, V67, P1238, DOI 10.1093/jac/dkr595
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Martina Byron E. E., 2014, Science Progress, V97, P197, DOI 10.3184/003685014X14049173153889
   McNamara PS, 2004, LANCET, V363, P1031, DOI 10.1016/S0140-6736(04)15838-8
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Restrepo BN, 2008, AM J TROP MED HYG, V79, P673
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 18
TC 3
Z9 3
U1 18
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0300-8584
EI 1432-1831
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PD JUN
PY 2016
VL 205
IS 3
BP 269
EP 273
DI 10.1007/s00430-015-0445-7
PG 5
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DM3QR
UT WOS:000376261700009
PM 26702627
ER

PT J
AU Benelli, G
   Lo Iacono, A
   Canale, A
   Mehlhorn, H
AF Benelli, Giovanni
   Lo Iacono, Annalisa
   Canale, Angelo
   Mehlhorn, Heinz
TI Mosquito vectors and the spread of cancer: an overlooked connection?
SO PARASITOLOGY RESEARCH
LA English
DT Review
DE Aedes; Anopheles; Arbovirus; Artesunate; Dengue; Epstein-Barr virus;
   Malaria; Nanosynthesis; Tumor biology; Zika virus
ID NECROSIS-FACTOR-ALPHA; DENGUE VIRUS; ZIKA VIRUS;
   HEPATOCELLULAR-CARCINOMA; VETERINARY IMPORTANCE; MEDIATED SYNTHESIS;
   DECLINING MALARIA; NANOPARTICLES; TRANSMISSION; ALLERGY
AB Mosquitoes (Diptera: Culicidae) represent a key threat for millions of humans and animals worldwide, vectoring important pathogens and parasites, including malaria, dengue, filariasis, and Zika virus. Besides mosquito-borne diseases, cancers figure among the leading causes of mortality worldwide. It is expected that annual cancer cases will rise from 14 million in 2012 to 22 million within the next two decades. Notably, there are few contrasting evidences of the relationship between cancer and mosquito-borne diseases, with special reference to malaria. However, analogies at the cellular level for the two diseases were reported. Recently, a significant association of malaria incidence with all cancer mortality in 50 USA states was highlighted and may be explained by the ability of Plasmodium to induce suppression of the immune system. However, it was hypothesized that Anopheles vectors may transmit obscure viruses linked with cancer development. The possible activation of cancer pathways by mosquito feeding events is not rare. For instance, the hamster reticulum cell sarcoma can be transmitted through the bites of Aedes aegypti by a transfer of tumor cells. Furthermore, mosquito bites may influence human metabolic pathways following different mechanisms, leading to other viral infections and/or oncogenesis. Hypersensitivity to mosquito bites is routed by a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy, and oncogenesis. During dengue virus infection, high viral titers, macrophage infiltration, and tumor necrosis factor alpha production in the local tissues are the three key important events that lead to hemorrhage. Overall, basic epidemiological knowledge on the relationships occurring between mosquito vector activity and the spread of cancer is urgently needed, as well as detailed information about the ability of Culicidae to transfer viruses or tumor cells among hosts over time. Current evidences on nanodrugs with multipotency against mosquito-borne diseases and cancers are reviewed, with peculiar attention to their mechanisms of action.
C1 [Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Lo Iacono, Annalisa] St Anna Sch Adv Studies, Piazza Martiri Liberta 33, I-56127 Pisa, Italy.
   [Mehlhorn, Heinz] Univ Dusseldorf, Dept Parasitol, Dusseldorf, Germany.
RP Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX We are grateful to M. Nicoletti and K. Murugan for helpful discussions
   on the topic. G. Benelli is supported by PROAPI (PRAF 2015) and
   University of Pisa, Department of Agriculture, Food and Environment
   (Grant ID COFIN2015_22). Funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Asada H, 2007, J DERMATOL SCI, V45, P153, DOI 10.1016/j.jdermsci.2006.11.002
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   BANFIELD WG, 1966, CANCER, V19, P1333, DOI 10.1002/1097-0142(196610)19:10<1333::AID-CNCR2820191002>3.0.CO;2-I
   BANFIELD WG, 1965, SCIENCE, V148, P1239, DOI 10.1126/science.148.3674.1239
   Bao SR, 2012, BIOMED ENVIRON SCI, V25, P495
   Barik TK, 2008, PARASITOL RES, V103, P253, DOI 10.1007/s00436-008-0975-7
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2016, PARASITOL RES, V115, P1747, DOI 10.1007/s00436-016-4971-z
   Benelli Giovanni, 2016, Asian Pacific Journal of Tropical Biomedicine, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   CBTRUS, 2008, STAT REP PRIM BRAIN, P1
   Chaturvedi D, 2010, CHEM SOC REV, V39, P435, DOI 10.1039/b816679j
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Dobler Gerhard, 2010, Denisia, P501
   Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412
   Efferth T, 2001, INT J ONCOL, V18, P767
   Espina LM, 2003, AM J TROP MED HYG, V68, P48
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gopinath P, 2010, COLLOID SURFACE B, V77, P240, DOI 10.1016/j.colsurfb.2010.01.033
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8
   Kawa K, 2001, BLOOD, V98, P3173, DOI 10.1182/blood.V98.10.3173
   Kilham L, 1955, AM J EPIDEMIOL, P6155
   KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960
   Lehrer S, 2010, MED HYPOTHESES, V74, P167, DOI 10.1016/j.mehy.2009.07.005
   Lehrer S, 2010, ANTICANCER RES, V30, P1371
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Majumder DD, 2006, IETE J RES, V52, P339
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Murugan K, 2016, PARASITOL RES, V115, P1085, DOI 10.1007/s00436-015-4838-8
   Oehler E., 2014, EUROSURVEILLANCE, V19, P9
   Pastula DM, 2016, J NEUROVIROL, DOI [10.1007/s13365-016-0428-5, DOI 10.1007/S13365-016-0428-5]
   Rajasekharreddy P, 2014, MAT SCI ENG C-MATER, V39, P203, DOI 10.1016/j.msec.2014.03.003
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Sanpui P, 2011, ACS APPL MATER INTER, V3, P218, DOI 10.1021/am100840c
   Saxena SK, 2016, VIRUS DIS, DOI [10.1007/s13337-016-0307-y, DOI 10.1007/S13337-016-0307-Y]
   Shanthi K, 2015, RSC ADV, V5, P44998, DOI 10.1039/c5ra05803a
   Skarbinski Jacek, 2006, Morbidity and Mortality Weekly Report, V55, P23
   Suffness M., 1991, METHODS PLANT BIOCH, P71
   Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001
   Tokura Y, 2001, J AM ACAD DERMATOL, V45, P569, DOI 10.1067/mjd.2001.114751
   Tsuge I, 1999, CLIN EXP IMMUNOL, V115, P385
   Usherwood EJ, 1996, J VIROL, V70, P6516
   WELSH JD, 1976, GASTROENTEROLOGY, V70, P392
   White NJ, 2015, NEW ENGL J MED, V373, P1670, DOI 10.1056/NEJMe1511278
   World Health Organization, 2015, FACT SHEET WORLD MAL
   Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08
NR 51
TC 8
Z9 8
U1 15
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD JUN
PY 2016
VL 115
IS 6
BP 2131
EP 2137
DI 10.1007/s00436-016-5037-y
PG 7
WC Parasitology
SC Parasitology
GA DM1JH
UT WOS:000376101000001
PM 27053131
ER

PT J
AU Frumence, E
   Roche, M
   Krejbich-Trotot, P
   El-Kalamouni, C
   Nativel, B
   Rondeau, P
   Misse, D
   Gadea, G
   Viranaicken, W
   Despres, P
AF Frumence, Etienne
   Roche, Marjolaine
   Krejbich-Trotot, Pascale
   El-Kalamouni, Chaker
   Nativel, Brice
   Rondeau, Philippe
   Misse, Dorothee
   Gadea, Gilles
   Viranaicken, Wildriss
   Despres, Philippe
TI The South Pacific epidemic strain of Zika virus replicates efficiently
   in human epithelial A549 cells leading to IFN-beta production and
   apoptosis induction
SO VIROLOGY
LA English
DT Article
DE Zika virus; Arbovirus; Emerging virus; Viral pathogenicity; Apoptosis;
   Oxidative stress; Innate immunity; Type-I interferon; Human epithelial
   cells
ID WEST NILE VIRUS; DENGUE VIRUS; PROINFLAMMATORY CYTOKINES; JAPANESE
   ENCEPHALITIS; INNATE IMMUNITY; I INTERFERON; INFECTION; PROTEIN; IRF-7;
   DEATH
AB Zika virus (ZIKV) is an emerging flavivirus since the first epidemics in South Pacific in 2007. The recent finding that ZIKV is now circulating in Western Hemisphere and can be associated to severe human diseases, warrants the need for its study. Here we evaluate the susceptibility of human lung epithelial A549 cells to South Pacific epidemic strain of ZIKV isolated in 2013. We showed that ZIKV growth in A549 cells is greatly efficient. ZIKV infection resulted in the secretion of IFN-beta followed by the expression of pro-inflammatory cytokines such as IL-1 beta, and transcriptional activity of IFIT genes. At the maximum of virus progeny production, ZIKV triggers mitochondrial apoptosis through activation of caspases-3 and -9. Whereas at early infection times, the rapid release of IFN-1 beta which exerts an antiviral effect against ZIKV might delay apoptosis in infected cells. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Frumence, Etienne; Roche, Marjolaine; Krejbich-Trotot, Pascale; El-Kalamouni, Chaker; Gadea, Gilles; Viranaicken, Wildriss; Despres, Philippe] Univ Reunion, UM Proc Infect Milieu Insulaire Trop PIMIT 13, INSERM, U1187,CNRS UMR9192,IRD UMR249,Plateforme Technol, F-97490 St Clotilde, Reunion.
   [Nativel, Brice; Rondeau, Philippe] Univ Reunion, UMR Diabet Atherothrombose Therapies Reunion Ocea, INSERM, U1188,Plateforme Technol CYROI, F-97490 St Clotilde, Reunion.
   [Misse, Dorothee] Lab MIVEGEC, UMR IRD CNRS UM 224, F-34394 Montpellier, France.
RP Viranaicken, W; Despres, P (reprint author), Univ Reunion, UM Proc Infect Milieu Insulaire Trop PIMIT 13, INSERM, U1187,CNRS UMR9192,IRD UMR249,Plateforme Technol, F-97490 St Clotilde, Reunion.
EM wildriss.viranaicken@univ-reunion.fr; philippe.despres@univ-reunion.fr
RI MISSE, DOROTHEE/A-7590-2012
FU Agence Nationale de la Recherche, France [ANR-12-BSV3-0004-01]; Conseil
   Regional de l'Ile de La Reunion, France [DIRED 20121399, DIRED 20131515]
FX We thank Patrick Mavingui, Pascale Guiraud, Olivier Meilhac and Philippe
   Gasque for helpful discussions. We would like to thank Mai-Lormeau and
   Didier Musso for kindly providing the ZIKV strain PF-25013-18. DM and PD
   were supported by the Grant ANR-12-BSV3-0004-01 (KerARBO) from the
   Agence Nationale de la Recherche, France. EF and BN were supported by
   grants DIRED 20121399 and DIRED 20131515, respectively, from the Conseil
   Regional de l'Ile de La Reunion, France.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EURO SURVEILL, V19
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Catteau A, 2004, PROG MOL SUBCELL BIO, V36, P171
   Courageot MP, 2003, ADV VIRUS RES, V60, P157, DOI 10.1016/S0065-3527(03)60005-9
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101
   Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martin-Acebes MA, 2015, AUTOPHAGY, V11, P861, DOI 10.1080/15548627.2015.1037062
   Martins SD, 2012, VIRUSES-BASEL, V4, P2736, DOI 10.3390/v4112736
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Miorin L, 2012, VIRUS RES, V163, P660, DOI 10.1016/j.virusres.2011.11.020
   Mizushima Noboru, 2007, Autophagy, V3, P542
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Nativel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076039
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Olagnier D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004566
   Reich NC, 2013, J INTERF CYTOK RES, V33, P199, DOI 10.1089/jir.2012.0159
   Ghosh Roy S., 2014, WORLD J BIOL CHEM, V5, P93
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381
   Suthar MS, 2012, J VIROL, V86, P7704, DOI 10.1128/JVI.00401-12
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4
   Tappe D., 2015, MED MICROBIOL IMMUN, P1
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Viranaicken W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022296
   Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 55
TC 4
Z9 4
U1 20
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JUN
PY 2016
VL 493
BP 217
EP 226
DI 10.1016/j.virol.2016.03.006
PG 10
WC Virology
SC Virology
GA DL7MH
UT WOS:000375824300021
PM 27060565
ER

PT J
AU Attaway, DF
   Jacobsen, KH
   Falconer, A
   Manca, G
   Waters, NM
AF Attaway, David F.
   Jacobsen, Kathryn H.
   Falconer, Allan
   Manca, Germana
   Waters, Nigel M.
TI Risk analysis for dengue suitability in Africa using the ArcGIS
   predictive analysis tools (PA tools)
SO ACTA TROPICA
LA English
DT Article
DE Dengue; Geographic information systems; Risk mapping; Developing
   countries; Medical geography; Africa
ID AEDES-AEGYPTI; VIRUS TRANSMISSION; FEVER; TEMPERATURE; MALARIA;
   VULNERABILITY; MOSQUITOS; COLOMBIA; MODELS; MEXICO
AB Background: Risk maps identifying suitable locations for infection transmission are important for public health planning. Data on dengue infection rates are not readily available in most places where the disease is known to occur.
   Methods: A newly available add-in to Esri's ArcGIS software package, the ArcGIS Predictive Analysis Toolset (PA Tools), was used to identify locations within Africa with environmental characteristics likely to be suitable for transmission of dengue virus.
   Results: A more accurate, robust, and localized (1 km x 1 km) dengue risk map for Africa was created based on bioclimatic layers, elevation data, high-resolution population data, and other environmental factors that a search of the peer-reviewed literature showed to be associated with dengue risk. Variables related to temperature, precipitation, elevation, and population density were identified as good predictors of dengue suitability. Areas of high dengue suitability occur primarily within West Africa and parts of Central Africa and East Africa, but even in these regions the suitability is not homogenous.
   Conclusion: This risk mapping technique for an infection transmitted by Aedes mosquitoes draws on entomological, epidemiological, and geographic data. The method could be applied to other infectious diseases (such as Zika) in order to provide new insights for public health officials and others making decisions about where to increase disease surveillance activities and implement infection prevention and control efforts. The ability to map threats to human and animal health is important for tracking vectorborne and other emerging infectious diseases and modeling the likely impacts of climate change. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Attaway, David F.; Falconer, Allan; Waters, Nigel M.] George Mason Univ, Dept Geog & GeoInformat Sci, 4400 Univ Dr,MS 6C3, Fairfax, VA 22030 USA.
   [Attaway, David F.] Esri, 8615 Westwood Ctr Dr, Vienna, VA 22182 USA.
   [Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, 4400 Univ Dr,MS 5B7, Fairfax, VA 22030 USA.
   [Manca, Germana] Penn State Univ, Dept Geog, Lab Geoinformat & Earth Observat, University Pk, PA 16802 USA.
   [Manca, Germana] Penn State Univ, Inst Cybersci, University Pk, PA 16802 USA.
   [Waters, Nigel M.] Univ Calgary, Inst Publ Hlth, Fac Med, 3280Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.
RP Attaway, DF (reprint author), Esri, 8615 Westwood Ctr Dr, Vienna, VA 22182 USA.
EM dattaway@esri.com
RI Jacobsen, Kathryn/B-5857-2008
OI Jacobsen, Kathryn/0000-0002-4198-6246
CR Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Arboleda S, 2009, INT J ENV RES PUB HE, V6, P3040, DOI 10.3390/ijerph6123040
   Battersby S. E., 2014, CARTOGRAPHICA INT J, V49, P85, DOI [10.3138/carto.49.2.2313, DOI 10.3138/CARTO.49.2.2313]
   Bhatt S., 2013, NATURE, V496, P1
   Bhatt S., 2013, NATURE, V496, P3
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bontemps S., 2010, GLOBCOVER 2009 PRODU
   Bontemps S., 2011, GLOBCOVER 2009 PRODU
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Bright E.A., 2011, LANDSCAN 2011
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164
   Collenberg E, 2006, J MED VIROL, V78, P683, DOI 10.1002/jmv.20593
   Conn JE, 2015, AM J TROP MED HYG, V93, P28, DOI 10.4269/ajtmh.15-0009
   Esri, 2014, GETT START ARCGIS PR
   Esri, 2014, ARCGIS PRED AN TOOLS
   Franco L, 2010, EUROSURVEILLANCE, V15, P5
   Gassert F., 2013, WORKING PAPER
   Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92
   Global Administrative Areas, 2012, GADM DAT GLOB ADM AR
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Halstead Scott B., 2008, V5, P75
   Hassan H, 2012, GEOSPATIAL HEALTH, V7, P21
   Heng B., 1998, DENGUE SINGAPORE TEC, V2, P139
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Hogland J.S., 2014, IMPR AN US FUNCT DAT, P1
   Hoogeveen J., 2000, INLAND WATER BODIES
   Jenness J., 2007, CIFA TECH, V33, P1
   Kienberger S, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-29
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Machado-Machado EA, 2012, APPL GEOGR, V33, P82, DOI 10.1016/j.apgeog.2011.06.011
   MCLEAN DM, 1975, MOSQ NEWS, V35, P322
   MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255
   Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824
   Pinto E, 2011, INT J ENVIRON HEAL R, V21, P415, DOI 10.1080/09603123.2011.572279
   Pollack A., 2015, 1 DENGUE FEVER VACCI
   Raheel U, 2011, J INFECT DEV COUNTR, V5, P239
   Rezayat M, 2000, COMPUT AIDED DESIGN, V32, P299, DOI 10.1016/S0010-4485(00)00013-0
   Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Sessions O.M., 2013, HLTH ACTION, V6, P21822
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stocker TF, 2013, CLIMATE CHANGE 2013
   [Anonymous], 2000, AUSTR MED VET ENTOMO
   TURELL MJ, 1990, AM J TROP MED HYG, V43, P543
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143
   WHO, 2012, GLOB STRAT DENG PREV
   Wiwanitkit Viroj, 2006, Journal of Vector Borne Diseases, V43, P73
NR 50
TC 0
Z9 0
U1 46
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUN
PY 2016
VL 158
BP 248
EP 257
DI 10.1016/j.actatropica.2016.02.018
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DK8GU
UT WOS:000375166000034
PM 26945482
ER

PT J
AU Imperato, PJ
AF Imperato, Pascal James
TI The Convergence of a Virus, Mosquitoes, and Human Travel in Globalizing
   the Zika Epidemic
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Review
DE Zika virus; Zika virus infection; Zika virus and travel; Microcephaly;
   Guillain-Barre syndrome; Zika Forest and Pascal James Imperato; Kisubi
   Catholic Mission; Aedes aegypti
ID SEXUAL TRANSMISSION; BRAZIL; INFECTIONS; ISOLATIONS; NIGERIA
AB The Zika virus was first identified in 1947 in the Zika Forest of Uganda. It was discovered in a rhesus monkey that had been placed in a cage on a sentinel platform in the forest by the Virus Research Institute. When this writer visited the institute and the Zika Forest in 1961, work was underway to identify mosquito species at various levels of the tree canopy. This was done through the placement of traps at various levels of a 120-foot-high steel tower which this writer climbed. At that time, researchers isolated 12 strains of Zika virus from traps on the tower. Over the next six decades, the virus spread slowly to other parts of Africa, and eventually appeared in Southeast Asia, transmitted by Aedes aegypti and other Aedes mosquito species. By 1981, only 14 cases of illness had been reported as due to the Zika virus. Since most infections with this virus are either mild or asymptomatic, its true geographic spread was not fully appreciated. The current globalization of the Zika epidemic began on the Pacific island of Yap in the Federated States of Polynesia in 2007. This was the first known presence of the Zika virus outside of Africa and Southeast Asia. It was estimated that 73 % of the island's population had been infected. In 2013, the virus spread to French Polynesia where an estimated 28,000 cases occurred in a population of 270,000. During that year and afterwards, microcephaly and other congenital abnormalities were observed in the infants of women who were pregnant when they contracted the virus. It is currently not known if cases of microcephaly have resulted from infection of pregnant women or from infection plus some other co-factor. The epidemic rapidly spread to the Cook Islands and Easter Island. In 2015, Zika virus infection was diagnosed in Brazil where it was associated with microcephaly in the infants of some women who were pregnant when they contracted the disease. Cases of the Guillain-Barr, syndrome were also found to be associated with Zika virus infection. How the disease entered Brazil is a matter of conjecture. However, the strain responsible for the epidemic in Brazil and elsewhere in South and Central America is phylogenetically identical to that which caused the epidemic in French Polynesia. The wide distribution of Aedes aegypti, a principal vector of the virus, and other Aedes species has greatly facilitated the spread of the disease. Aedes aegypti is an invasive species of mosquito in the Western Hemisphere that has adapted well to densely-populated urban environments. In addition, male-to-female human sexual transmission has increasingly been demonstrated in the US and elsewhere. In February 2016, the World Health Organization (WHO) declared the current Zika outbreak a Public Health Emergency of international concern. On the recommendation of its Emergency Committee on Zika Virus and Observed Increase in Neurological Disorders and Neonatal Malformations, WHO issued a group of recommendations to contain the epidemic. The globalization of the Zika virus was made possible by the widespread presence in various parts of the world of Aedes vectors and increased human travel that facilitated geographic spread. This globalization of Zika follows upon that of West Nile, Ebola, Dengue, and Chikungunya. Its ultimate spread is difficult to predict, but will hopefully be restricted through vigorous preventive measures.
C1 [Imperato, Pascal James] Suny Downstate Med Ctr, Sch Publ Hlth, 450 Clarkson Ave,MSC 43, Brooklyn, NY 11203 USA.
RP Imperato, PJ (reprint author), Suny Downstate Med Ctr, Sch Publ Hlth, 450 Clarkson Ave,MSC 43, Brooklyn, NY 11203 USA.
EM pascal.imperato@downstate.edu
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Saint Louis C., 2016, NY TIMES, VCLXV, pA5
   McNeil Jr D. G, 2016, NY TIMES, VCLXV, pA5
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D., 2014, EUROSURVEILLANCE, V19, P2077
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tavernise S., 2016, NY TIMES, VCLXV, pA14
   Tavernise S, 2016, NY TIMES, pA3
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WHO statement on the first meeting of the International Health Regulations, 2016, WHO 1 M INT HLTH REG
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 23
TC 5
Z9 7
U1 48
U2 48
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD JUN
PY 2016
VL 41
IS 3
BP 674
EP 679
DI 10.1007/s10900-016-0177-7
PG 6
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA DK3TB
UT WOS:000374839200029
PM 26969497
ER

PT J
AU Waddell, LA
   Greig, JD
AF Waddell, Lisa A.
   Greig, Judy D.
TI Y Scoping Review of the Zika Virus Literature
SO PLOS ONE
LA English
DT Review
ID POLYMERASE-CHAIN-REACTION; YELLOW-FEVER EPIDEMIC; GROUP-B ARBOVIRUSES;
   SEROLOGICAL SURVEY; SEXUAL TRANSMISSION; HUMAN-POPULATION; DENGUE
   VIRUSES; AEDES-AEGYPTI; INFECTION; BRAZIL
AB The global primary literature on Zika virus (ZIKV) (n = 233 studies and reports, up toMarch 1, 2016) has been compiled using a scoping review methodology to systematically identify and characterise the literature underpinning this broad topic using methods that are documented, updateable and reproducible. Our results indicate that more than half the primary literature on ZIKV has been published since 2011. The articles mainly covered three topic categories: epidemiology of ZIKV (surveillance and outbreak investigations) 56.6%(132/233), pathogenesis of ZIKV (case symptoms/outcomes and diagnosis) 38.2%(89/233) and ZIKV studies (molecular characterisation and in vitro evaluation of the virus) 18.5%(43/233). There has been little reported in the primary literature on ZIKV vectors (12/233), surveillance for ZIKV (13/233), diagnostic tests (12/233) and transmission (10/233). Three papers reported on ZIKV prevention/control strategies, one investigated knowledge and attitudes of health professionals and two vectormapping studies were reported. The majority of studies used observational study designs, 89.7%(209/233), of which 62/233 were case studies or case series, while fewer (24/233) used experimental study designs. Several knowledge gaps were identified by this review with respect to ZIKV epidemiology, the importance of potential non-human primates and other hosts in the transmission cycle, the burden of disease in humans, and complications related to human infection with ZIKV. Historically there has been little research on ZIKV; however, given its current spread through Australasia and the Americas, research resources are now being allocated to close many of the knowledge gaps identified in this scoping review. Future updates of this project will probably demonstrate enhanced evidence and understanding of ZIKV and its impact on public health.
C1 [Waddell, Lisa A.; Greig, Judy D.] Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada.
   [Waddell, Lisa A.] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada.
RP Waddell, LA (reprint author), Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada.; Waddell, LA (reprint author), Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada.
EM Lisa.Waddell@phac-aspc.gc.ca
FU Public Health Agency of Canada
FX This study was funded through the Public Health Agency of Canada
   (http://www.phac-aspc.gc.ca). The funder had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Agence Regionale de Sante, 2016, SIT EP POINT EP 21 J
   Agence Regionale de Sante, 2014, B VEILL SAN, V2
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Antonjaya, 2012, AM J TROP MED HYG, V87, P122
   Araujo J, B WHO
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, VOX SANG S1, V109, P189
   Baba S. S., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P343
   Babaniyi OA, 2015, INT J PUBLIC HLTH EP, V4, P110
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Bearcroft WGC, 1956, T R SOC TROP MED HYG, V50, P438, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M., 2014, EUROSURVEILLANCE, V19
   Boche R, 1974, Bull Soc Pathol Exot Filiales, V67, P126
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2
   Brooks Hearn, 2014, AM J TROP MED HYG, V91, P62
   Brust Karen B, 2014, IDCases, V1, P95, DOI 10.1016/j.idcr.2014.10.009
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G., 2016, LANCET INFECT DIS
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau Roche, 2014, AM J TROP MED HYG, V91, P588
   Cao-Lormeau VM, 2016, LANCET
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Center for Disease Control ROC (Taiwan), 2016, 1 IMP CAS ZIK VIR IN
   Center for Disease Control and Prevention, 2016, ZIK WEBP
   Center for Disease Control and Prevention, 2016, SUBJ REV DIAGN TEST
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Crabtree Crockett, 2011, AM J TROP MED HYG, V85, P374
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   De Araujo LJ, 2010, AM J TROP MED HYG, V83, P314
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, ZIKA VIRUS EMERGENCE, V9, pe10
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Direction de la Sante - Bureau de Veille sanitaire, 2014, SURV DENG ZIK POL FR
   Direction de la sante Bureau de veille sanitaire, 2016, SURV VEILL SAN POL F
   DOWNS W. G., 1965, CARIBBEAN MED J, V27, P39
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dupont-Rouzeyrol M., 2016, LANCET
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire CCM, 2015, BIORXIV
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Goorhuis A, 2015, PROMED MAIL
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Henerson B, 1970, AM J TROP MED HYG, V19, P110
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Institut de Veille Sanitaire, 2014, B HEBD INT, V442
   Institut de Veille Sanitaire, 2014, VIR ZIK POL 2013 201
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
   Jouannic JM, 2016, LANCET
   Karimi O, 2016, LANCET
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kucharski AJ, 2016, BIORXIV
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Traore Lamizana M, 1994, J MED ENTOMOL, V31, P623
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS L.A., 2016, EMERG INFECT DIS
   Ledermann Crockett, 2012, AM J TROP MED HYG, V87, P170
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Macesic N, 2015, CLIN INFECT DIS, V61, P1445, DOI 10.1093/cid/civ401
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mallet HP, 2014, C 15ES JNI BORD 11 1
   Mallet HP, 2015, B INFORM SANITAIRES
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Salim Mattar V, 2015, REV MVZ CORDOBA, V20, P4511
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, MMWR MORB MORTAL WKL, V65
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER BR, 1991, AM J TROP MED HYG, V45, P399
   Millon P, 2015, MED HUMAINE PATHOLOG
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Mossel Kading, 2014, AM J TROP MED HYG, V91, P260
   Musso D, 2014, EUROSURVEILLANCE, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622
   New Zealand Public Health, 2015, OUTBR MUMPS LIK ILLN, V13
   New Zealand Public Health, 2014, SUMM KEY TRENDS NOT, V13
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2015, EP AL ZIK VIR INF 7
   Pan American Health Organization, 2016, ZIK EP UPD 17 FEBR 2
   Pan American Health Organization, 2016, REP INCR CONG MICR O
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pham MT, 2014, SCOPING REV SCOPING, DOI [10.1002/jrsm.1123, DOI 10.1002/JRSM.1123]
   PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pyke AT, 2014, PLOS CURR, V2, P6, DOI DOI 10.1371/CURRENTS
   REAGAN R L, 1955, Tex Rep Biol Med, V13, P934
   REAGAN RL, 1953, TEX REP BIOL MED, V11, P347
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   ROBERT V, 1993, B SOC PATHOL EXOT, V86, P90
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Rockefeller Foundation, 1951, ROCK FDN ANN REP, P131
   RODHAIN F, 1987, B SOC PATHOL EXOT, V80, P155
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roth A, 2014, EUROSURVEILLANCE, V19
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SALUZZO JF, 1986, ANN INST PASTEUR VIR, V137E, P155, DOI 10.1016/S0769-2617(86)80201-5
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsegaye, 2014, AM J TROP MED HYG, V91, P53
   Tusevljak N, 2012, FOODBORNE PATHOG DIS, V9, P487, DOI 10.1089/fpd.2011.1063
   UK government, 2016, HLTH PROTECTION REPO, V10
   VANPEENEN PFD, 1975, ANN TROP MED PARASIT, V69, P475
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EURO SURVEILL, V21
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez W E, 2016, J INFECT PUBLIC HLTH, DOI S1876-0341(15)00221-X
   Vouga M, 2016, LANCET
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Weitzel T, 2016, AM J TROP MED HYG
   World Health Organization, 2016, ZIK POT COMPL
   World Health Organization (WHO), 2016, WHOZIKVMOC161
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   World Health Organization, 2014, PAC SYNDR SURV WEEK
   World Health Organisation, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2016, NEUR SYNDR CONG AN
   World Health Organization, 2015, PAC SYNDR SURV WEEK
   World Health Organization, 2016, ZIK SIT REP FEBR 16
   World Health Organization, 2016, PAC SYNDR SURV WEEK
   World Health Organization, 2015, PAC SYNDR SURV REP W
   World Health Organization, 2015, PAC SYNDR SURV REP
   World Health Organization, 2016, ZIK VIR MICR GULL BA
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2015, DIS OUTBREAK NE 1215
   World Health Organization, 2015, DIS OUTBREAK NE 1205
   World Health Organization, 2015, DIS OUTBREAK NE 1111
   World Health Organization, 2015, DIS OUTBREAK NE 1222
   World Health Organization, 2016, DIS OUTBREAK NE 1212
   World Health Organization, 2016, DIS OUTBREAK NE 0108
   World Health Organization, 2016, DIS OUTBREAK NE 0212
   World Health Organization, 2016, DIS OUTBREAK NE 0129
   World Health Organization, 2016, DIS OUTBREAK NE 0208
   World Health Organization, 2016, DIS OUTBREAK NE 0121
   World Health Organization, 2015, DIS OUTBREAK NE 1113
   World Health Organization, 2015, DIS OUTBREAK NE 1203
   World Health Organization, 2015, DIS OUTBREAK NE 1221
   World Health Organization, 2015, DIS OUTBREAK NE 1127
   World Health Organization, 2015, DIS OUTBREAK NE 1021
   World Health Organization, 2016, DIS OUTBREAK NE 0127
   World Health Organization (WHO), 2016, DIS OUTBREAK NE 0120
   Wurapa Ofula, 2013, AM J TROP MED HYG, V89, P278
   Wurapa Ofula, 2012, AM J TROP MED HYG, V87, P126
   Yasri S., 2015, Asian Pacific Journal of Tropical Disease, V5, P1007, DOI 10.1016/S2222-1808(15)60974-4
   Young I, 2014, PREV VET MED, V113, P339, DOI 10.1016/j.prevetmed.2013.11.009
   Zammarchi L, 2015, EUROSURVEILLANCE, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2016, CDC INVESTIGATING 14
NR 232
TC 0
Z9 0
U1 17
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 31
PY 2016
VL 11
IS 5
AR e0156376
DI 10.1371/journal.pone.0156376
PG 45
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN5XX
UT WOS:000377146100034
PM 27244249
ER

PT J
AU Simeone, RM
   Shapiro-Mendoza, CK
   Meaney-Delman, D
   Petersen, EE
   Galang, RR
   Oduyebo, T
   Rivera-Garcia, B
   Valencia-Prado, M
   Newsome, KB
   Perez-Padilla, J
   Williams, TR
   Biggerstaff, M
   Jamieson, DJ
   Honein, MA
AF Simeone, Regina M.
   Shapiro-Mendoza, Carrie K.
   Meaney-Delman, Dana
   Petersen, Emily E.
   Galang, Romeo R.
   Oduyebo, Titilope
   Rivera-Garcia, Brenda
   Valencia-Prado, Miguel
   Newsome, Kimberly B.
   Perez-Padilla, Janice
   Williams, Tonya R.
   Biggerstaff, Matthew
   Jamieson, Denise J.
   Honein, Margaret A.
CA Zika Pregnancy Working Grp
TI Possible Zika Virus Infection Among Pregnant Women - United States and
   Territories, May 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID REPRODUCTIVE AGE; TRAVELERS; EXPOSURE
C1 [Simeone, Regina M.; Newsome, Kimberly B.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Shapiro-Mendoza, Carrie K.; Petersen, Emily E.; Oduyebo, Titilope; Jamieson, Denise J.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Meaney-Delman, Dana] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Galang, Romeo R.; Oduyebo, Titilope] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Galang, Romeo R.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR USA.
   [Valencia-Prado, Miguel] Puerto Rico Dept Hlth, Puerto Rico Birth Defects Surveillance & Prevent, San Juan, PR USA.
   [Perez-Padilla, Janice] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Williams, Tonya R.] CDC, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Biggerstaff, Matthew] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
RP Simeone, RM (reprint author), CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM eocbirthdef@cdc.gov
CR Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   CDC, 2016, ZIK MAC ELISA US EM
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
NR 9
TC 3
Z9 3
U1 8
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 27
PY 2016
VL 65
IS 20
BP 514
EP 519
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DM8LI
UT WOS:000376614200003
PM 27248295
ER

PT J
AU Van Esbroeck, M
   Meersman, K
   Michiels, J
   Arien, KK
   Van den Bossche, D
AF Van Esbroeck, M.
   Meersman, K.
   Michiels, J.
   Arien, K. K.
   Van den Bossche, D.
TI Letter to the editor: Specificity of Zika virus ELISA: interference with
   malaria
SO EUROSURVEILLANCE
LA English
DT Letter
C1 [Van Esbroeck, M.; Meersman, K.; Van den Bossche, D.] Inst Trop Med, Natl Reference Ctr Arboviruses, Dept Clin Sci, B-2000 Antwerp, Belgium.
   [Michiels, J.; Arien, K. K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, B-2000 Antwerp, Belgium.
RP Van Esbroeck, M (reprint author), Inst Trop Med, Natl Reference Ctr Arboviruses, Dept Clin Sci, B-2000 Antwerp, Belgium.
EM mvesbroeck@itg.be
CR Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Messina JP, 2016, ELIFE, V5, DOI DOI 10.7554/ELIFE.15272
   Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002
NR 3
TC 1
Z9 1
U1 2
U2 2
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAY 26
PY 2016
VL 21
IS 21
BP 32
EP 33
AR 30237
DI 10.2807/1560-7917.ES.2016.21.21.30237
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DN0KD
UT WOS:000376751900005
ER

PT J
AU Kieny, MP
   Moorthy, V
   Bagozzi, D
AF Kieny, Marie-Paule
   Moorthy, Vasee
   Bagozzi, Daniela
TI Use open data to curb Zika virus
SO NATURE
LA English
DT Letter
C1 [Kieny, Marie-Paule; Moorthy, Vasee; Bagozzi, Daniela] WHO, CH-1211 Geneva, Switzerland.
RP Bagozzi, D (reprint author), WHO, CH-1211 Geneva, Switzerland.
EM bagozzid@who.int
CR Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
NR 1
TC 1
Z9 1
U1 4
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 26
PY 2016
VL 533
IS 7604
BP 469
EP 469
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM6EJ
UT WOS:000376443100019
PM 27225109
ER

PT J
AU Rodrigues, LC
AF Rodrigues, Laura C.
TI Microcephaly and Zika virus infection
SO LANCET
LA English
DT Editorial Material
ID BRAZIL
C1 [Rodrigues, Laura C.] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
   [Rodrigues, Laura C.] MERG, Recife, PE, Brazil.
RP Rodrigues, LC (reprint author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.; Rodrigues, LC (reprint author), MERG, Recife, PE, Brazil.
EM laura.rodrigues@lshtm.ac.uk
CR Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cauchemez S, 2016, LANCET
   Centre D'Hygiene et de Salubrite Publique, 2015, NOT INV AUT MALF CER
   Centro de Operacoes de Emergencias em Saude Publica Sobre Microcefalias, 2016, INF EP 15 SEM EP SE
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
NR 11
TC 5
Z9 5
U1 19
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 21
PY 2016
VL 387
IS 10033
BP 2070
EP 2072
DI 10.1016/S0140-6736(16)00742-X
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6HC
UT WOS:000376450800008
PM 26993880
ER

PT J
AU Cauchemez, S
   Besnard, M
   Bompard, P
   Dub, T
   Guillemette-Artur, P
   Eyrolle-Guignot, D
   Salje, H
   Van Kerkhove, MD
   Abadie, V
   Garel, C
   Fontanet, A
   Mallet, HP
AF Cauchemez, Simon
   Besnard, Marianne
   Bompard, Priscillia
   Dub, Timothee
   Guillemette-Artur, Prisca
   Eyrolle-Guignot, Dominique
   Salje, Henrik
   Van Kerkhove, Maria D.
   Abadie, VRonique
   Garel, Catherine
   Fontanet, Arnaud
   Mallet, Henri-Pierre
TI Association between Zika virus and microcephaly in French Polynesia,
   2013-15: a retrospective study
SO LANCET
LA English
DT Article
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; PREGNANT-WOMEN; UNITED-STATES;
   OUTBREAK; CHILDREN; MOTHER; ISLAND
AB Background The emergence of Zika virus in the Americas has coincided with increased reports of babies born with microcephaly. On Feb 1, 2016, WHO declared the suspected link between Zika virus and microcephaly to be a Public Health Emergency of International Concern. This association, however, has not been precisely quantified.
   Methods We retrospectively analysed data from a Zika virus outbreak in French Polynesia, which was the largest documented outbreak before that in the Americas. We used serological and surveillance data to estimate the probability of infection with Zika virus for each week of the epidemic and searched medical records to identify all cases of microcephaly from September, 2013, to July, 2015. Simple models were used to assess periods of risk in pregnancy when Zika virus might increase the risk of microcephaly and estimate the associated risk.
   Findings The Zika virus outbreak began in October, 2013, and ended in April, 2014, and 66% (95% CI 62-70) of the general population were infected. Of the eight microcephaly cases identified during the 23-month study period, seven (88%) occurred in the 4-month period March 1 to July 10, 2014. The timing of these cases was best explained by a period of risk in the first trimester of pregnancy. In this model, the baseline prevalence of microcephaly was two cases (95% CI 0-8) per 10 000 neonates, and the risk of microcephaly associated with Zika virus infection was 95 cases (34-191) per 10 000 women infected in the first trimester. We could not rule out an increased risk of microcephaly from infection in other trimesters, but models that excluded the first trimester were not supported by the data.
   Interpretation Our findings provide a quantitative estimate of the risk of microcephaly in fetuses and neonates whose mothers are infected with Zika virus.
C1 [Cauchemez, Simon; Salje, Henrik] Inst Pasteur, Math Modelling Infect Dis, Paris, France.
   [Dub, Timothee; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.
   [Van Kerkhove, Maria D.; Fontanet, Arnaud] Inst Pasteur, Ctr Global Hlth, Paris, France.
   [Besnard, Marianne] French Polynesia Hosp Ctr, Neonatal Care Dept, Pirae, Tahiti, Fr Polynesia.
   [Guillemette-Artur, Prisca] French Polynesia Hosp Ctr, Dept Med Imaging, Pirae, Tahiti, Fr Polynesia.
   [Eyrolle-Guignot, Dominique] French Polynesia Hosp Ctr, Dept Obstet Gynecol, Pirae, Tahiti, Fr Polynesia.
   [Bompard, Priscillia; Mallet, Henri-Pierre] Bur Veille Sanitaire, Direct Sante, Papeete, Tahiti, Fr Polynesia.
   [Salje, Henrik] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA.
   [Abadie, VRonique] Hop Necker Enfants Malad, Gen Paediat Dept, Paris, France.
   [Garel, Catherine] Hop Enfants Armand Trousseau, Dept Paediat Radiol, Paris, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France.
RP Cauchemez, S (reprint author), Inst Pasteur, Math Modelling Infect Dis Unit, 28 Rue Dr Roux, F-75015 Paris, France.
EM simon.cauchemez@pasteur.fr
FU Labex-IBEID; NIH-MIDAS; AXA Research fund; EU-PREDEMICS
FX Labex-IBEID, NIH-MIDAS, AXA Research fund, EU-PREDEMICS.
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Aubry M, 2015, 64 ANN M AM SOC TROP
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Burnham K.P., 2002, MODEL SELECTION MULT
   Butler D, 2016, NATURE, V530, P12
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   de Jong EP, 2011, PRENATAL DIAG, V31, P419, DOI 10.1002/pd.2714
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   Regis CT, MICROCEPHALY NE BRAZ
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Eurocat, 2003, EUR SURV CONG AN EUR
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gubler D, 2007, FIELDS VIROLOGY, P1153
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Institut de Statistique de Polynesie Francaise, 2014, GRANDS IND POP ISS E
   King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Liu J. S., 2001, MONTE CARLO STRATEGI
   Mallet HP, 2015, B INFORM SANITAIRES
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Olusanya BO, 2012, INT HEALTH, V4, P128, DOI 10.1016/j.inhe.2011.12.006
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x
   Vauloup-Fellous C, 2013, ANN BIOL CLIN-PARIS, V71, P5, DOI 10.1684/abc.2013.0897
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Whitehouse AJO, 2012, ARCH DIS CHILD, V97, P49, DOI 10.1136/adc.2009.180331
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   WHO, 2016, ZIK SIT REP
   WHO, 2005, WHO STAT 1 M INT HLT
   WHO, 2016, GUILL BARR SYNDR SAL
   [Anonymous], 2016, WASHINGTON POST
NR 44
TC 39
Z9 41
U1 37
U2 37
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 21
PY 2016
VL 387
IS 10033
BP 2125
EP 2132
DI 10.1016/S0140-6736(16)00651-6
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6HC
UT WOS:000376450800036
PM 26993883
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI WHO warns of risk of Zika virus in Europe
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 1
Z9 2
U1 6
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 20
PY 2016
VL 353
AR i2887
DI 10.1136/bmj.i2887
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM6GI
UT WOS:000376448200010
PM 27207768
ER

PT J
AU Miner, JJ
   Cao, B
   Govero, J
   Smith, AM
   Fernandez, E
   Cabrera, OH
   Garber, C
   Noll, M
   Klein, RS
   Noguchi, KK
   Mysorekar, IU
   Diamond, MS
AF Miner, Jonathan J.
   Cao, Bin
   Govero, Jennifer
   Smith, Amber M.
   Fernandez, Estefania
   Cabrera, Omar H.
   Garber, Charise
   Noll, Michelle
   Klein, Robyn S.
   Noguchi, Kevin K.
   Mysorekar, Indira U.
   Diamond, Michael S.
TI Zika Virus Infection during Pregnancy in Mice Causes Placental Damage
   and Fetal Demise
SO CELL
LA English
DT Article
ID ENCEPHALITIS-VIRUS; MOUSE PLACENTA; DETERMINANTS; TROPHOBLAST; BRAZIL;
   BRAIN
AB Zika virus (ZIKV) infection in pregnant women causes intrauterine growth restriction, spontaneous abortion, and microcephaly. Here, wedescribe two mouse models of placental and fetal disease associated with in utero transmission of ZIKV. Female mice lacking type I interferon signaling (Ifnar1(-/-)) crossed to wild-type (WT) males produced heterozygous fetuses resembling the immune status of human fetuses. Maternal inoculation at embryonic day 6.5 (E6.5) or E7.5 resulted in fetal demise that was associated with ZIKV infection of the placenta and fetal brain. We identified ZIKV within trophoblasts of the maternal and fetal placenta, consistent with a transplacental infection route. Antibody blockade of Ifnar1 signaling in WT pregnant mice enhanced ZIKV trans-placental infection although it did not result in fetal death. These models will facilitate the study of ZIKV pathogenesis, in utero transmission, and testing of therapies and vaccines to prevent congenital malformations.
C1 [Miner, Jonathan J.; Govero, Jennifer; Smith, Amber M.; Fernandez, Estefania; Garber, Charise; Noll, Michelle; Klein, Robyn S.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.
   [Klein, Robyn S.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Klein, Robyn S.; Mysorekar, Indira U.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Cabrera, Omar H.; Noguchi, Kevin K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Mysorekar, IU; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Mysorekar, IU (reprint author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM mysorekari@wudosis.wustl.edu; diamond@borcim.wustl.edu
FU NIH [R01 AI073755, R01 AI104972, R01 HD052664, R01 NS052632];
   Intellectual and Developmental Disabilities Research Center at
   Washington University (NIH/NICHD) [U54 HD087011]; Rheumatology Research
   Foundation Scientist Development Award; NIH Pre-doctoral training grant
   award [T32 AI007163]; NIH Research Education Program [R25 HG006687];
   Preventing Prematurity Initiative grant from the Burroughs Wellcome
   Fund; Prematurity Research Initiative Investigator award from the March
   of Dimes
FX This work was supported by grants from the NIH (R01 AI073755 and R01
   AI104972 to M.S.D., R01 HD052664 to K.K.N., and R01 NS052632 to R.S.K.)
   and the Intellectual and Developmental Disabilities Research Center at
   Washington University (NIH/NICHD U54 HD087011). J.J.M., E.F., and D.J.P.
   were supported by a Rheumatology Research Foundation Scientist
   Development Award, NIH Pre-doctoral training grant award (T32 AI007163),
   and the NIH Research Education Program (R25 HG006687), respectively. The
   work also was supported by a Preventing Prematurity Initiative grant
   from the Burroughs Wellcome Fund and a Prematurity Research Initiative
   Investigator award from the March of Dimes (to I.U.M). We thank Wandy
   Betty for her TEM assistance, Fredrik Kraus for his expertise in
   placental pathology, and Justin Richner for advice with establishing the
   RNA FISH assays. Finally, we acknowledge Xavier de Lamballerie
   (Emergence des Pathologies Virales, Aix-Marseille Universite, Marseille,
   France) and the European Virus Archive goes Global (EVAg) for consenting
   to the use of H/PF/2013 ZIKV strain for this study under a material
   transfer agreement with the EVAg parter, Aix-Marseille Universite.
   M.S.D. is a consultant for Inbios, Visterra, and Takeda Pharmaceuticals
   and on the Scientific Advisory Boards of Moderna and OraGene.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003
   ANDERSEN AA, 1975, INFECT IMMUN, V12, P1173
   Arechavaleta-Velasco F, 2002, J REPROD IMMUNOL, V55, P113, DOI 10.1016/S0165-0378(01)00143-7
   Baronti C., 2014, GENOME ANNOUNC, V2, P2, DOI DOI 10.1128/GENOMEA.00500-14
   Bayer A., 2016, CELL HOST MICROBE, V16, P30100
   Brasil P, 2016, N ENGL J MED
   Brien J. D., 2013, CURR PROTOC MICROBIO, V31
   Calvet G., 2016, LANCET INFECT DIS
   Cao B, 2014, PLACENTA, V35, P139, DOI 10.1016/j.placenta.2013.12.007
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712
   CHERVENAK FA, 1987, OBSTET GYNECOL, V69, P908
   Delorme-Axford E, 2014, ANN REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Edwards MS, 2015, PEDIATR DEVEL PATHOL, V18, P155, DOI 10.2350/14-09-1548-CR.1
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856
   HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lazear HM, 2016, CELL HOST MICROBE
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen Q., 2002, Morbidity and Mortality Weekly Report, V51, P1135
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pinto A. K., 2015, MBIO, V6
   Rasmussen SA, 2016, N ENGL J MED
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Rossi S.L., 2016, AM J TROP MED HYG
   Sarathy VV, 2015, J VIROL, V89, P1254, DOI [10.1128/JVI.01320-14, 10.1128/JVI01320-14]
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang H, 2016, CELL STEM CELL
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005
   Zeldovich VB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002804
NR 43
TC 30
Z9 30
U1 62
U2 62
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 19
PY 2016
VL 165
IS 5
BP 1080
EP 1090
DI 10.1016/j.cell.2016.05.008
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DM6QT
UT WOS:000376478200010
PM 27180225
ER

PT J
AU Qian, XY
   Nguyen, HN
   Song, MM
   Hadiono, C
   Ogden, SC
   Hammack, C
   Yao, B
   Hamersky, GR
   Jacob, F
   Zhong, C
   Yoon, KJ
   Jeang, W
   Lin, L
   Li, YJ
   Thakor, J
   Berg, DA
   Zhang, C
   Kang, E
   Chickering, M
   Nauen, D
   Ho, CY
   Wen, ZX
   Christian, KM
   Shi, PY
   Maher, BJ
   Wu, H
   Jin, P
   Tang, HL
   Song, HJ
   Ming, GL
AF Qian, Xuyu
   Ha Nam Nguyen
   Song, Mingxi M.
   Hadiono, Christopher
   Ogden, Sarah C.
   Hammack, Christy
   Yao, Bing
   Hamersky, Gregory R.
   Jacob, Fadi
   Zhong, Chun
   Yoon, Ki-Jun
   Jeang, William
   Lin, Li
   Li, Yujing
   Thakor, Jai
   Berg, Daniel A.
   Zhang, Ce
   Kang, Eunchai
   Chickering, Michael
   Nauen, David
   Ho, Cheng-Ying
   Wen, Zhexing
   Christian, Kimberly M.
   Shi, Pei-Yong
   Maher, Brady J.
   Wu, Hao
   Jin, Peng
   Tang, Hengli
   Song, Hongjun
   Ming, Guo-li
TI Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV
   Exposure
SO CELL
LA English
DT Article
ID SELF-ORGANIZATION; HUMAN NEOCORTEX; STEM-CELLS; DIFFERENTIATION;
   NEURONS; TISSUE; SCHIZOPHRENIA; DYSREGULATION; HYPOTHALAMUS;
   MICROGRAVITY
AB Cerebral organoids, three-dimensional cultures that model organogenesis, provide a new platform to investigatehuman brain development. High cost, variability, and tissue heterogeneity limit their broad applications. Here, we developed a miniaturized spinning bioreactor (Spin Omega) to generate forebrain-specific organoids from human iPSCs. These organoids recapitulate key features of human cortical development, including progenitor zone organization, neurogenesis, gene expression, and, notably, a distinct human-specific outer radial glia cell layer. We also developed protocols for midbrain and hypothalamic organoids. Finally, we employed the forebrain organoid platform to model Zika virus (ZIKV) exposure. Quantitative analyses revealed preferential, productive infection of neural progenitors with either African or Asian ZIKV strains. ZIKV infection leads to increased cell death and reduced proliferation, resulting in decreased neuronal cell-layer volume resembling microcephaly. Together, our brain-region-specific organoids and Spin Omega provide an accessible and versatile platform for modeling human brain development and disease and for compound testing, including potential ZIKV antiviral drugs.
C1 [Qian, Xuyu; Ha Nam Nguyen; Song, Mingxi M.; Hadiono, Christopher; Jacob, Fadi; Zhong, Chun; Yoon, Ki-Jun; Jeang, William; Thakor, Jai; Berg, Daniel A.; Zhang, Ce; Kang, Eunchai; Chickering, Michael; Nauen, David; Wen, Zhexing; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Qian, Xuyu] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA.
   [Ha Nam Nguyen; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA.
   [Zhong, Chun; Yoon, Ki-Jun; Zhang, Ce; Kang, Eunchai; Wen, Zhexing; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Hamersky, Gregory R.; Maher, Brady J.] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD 21205 USA.
   [Nauen, David] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Maher, Brady J.; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Song, Mingxi M.] Riverhill High Sch, Clarksville, MD 21029 USA.
   [Hadiono, Christopher] Byram Hills High Sch, Armonk, NY 10504 USA.
   [Ogden, Sarah C.; Hammack, Christy; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
   [Yao, Bing; Lin, Li; Li, Yujing; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.
   [Wu, Hao] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.
   [Jeang, William] Clear Lake High Sch, Harris, TX 77058 USA.
   [Ho, Cheng-Ying] Childrens Natl Med Ctr, Div Pathol, Washington, DC 20010 USA.
   [Ho, Cheng-Ying] George Washington Univ, Pathol & Pediat, Washington, DC 20010 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Song, HJ; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.
EM shongju1@jhmi.edu; gming1@jhmi.edu
RI Maher, Brady/L-8314-2016
OI Maher, Brady/0000-0001-5930-885X
FU NIH [NS048271, MH105128, NS095348, NS047344, ES021957, AI119530,
   AI111250, NS051630, NS079625, MH102690, MH104593]; MSCRF; SFARI [308988]
FX We thank Hopkins WSE machine shop and Nathaniel Leon for help of 3D
   printing and members of the Ming and Song laboratories for discussion;
   L. Liu and Y. Cai for technical support; and Robert B. Tesh at UTMB and
   the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
   for the Cambodian strain ZIKV<SUP>C</SUP>. This work was supported by
   grants from NIH (NS048271, MH105128, and NS095348 to G.L.M.; NS047344
   and ES021957 to H.S.; AI119530 and AI111250 to H.T.; NS051630, NS079625,
   and MH102690 to P.J.; and MH104593 to B.J.M.), MSCRF (to H.S.), and
   SFARI (308988 to H.S.).
CR Bayer A, 2016, CELL HOST MICROBE
   Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P361, DOI 10.1016/j.tins.2004.05.007
   Blackshaw S, 2010, J NEUROSCI, V30, P14925, DOI 10.1523/JNEUROSCI.4499-10.2010
   Calvet G., 2016, LANCET INFECT DIS
   Cauchemez S, 2016, LANCET
   Chung S, 2005, MOL CELL NEUROSCI, V28, P241, DOI 10.1016/j.mcn.2004.09.008
   Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011
   Driggers R.W., 2016, N ENGL J MED
   Faria NR, 2016, SCIENCE
   Garcez PP, 2016, SCIENCE
   GOODWIN TJ, 1993, P SOC EXP BIOL MED, V202, P181
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898
   JESSUP JM, 1993, J CELL BIOCHEM, V51, P290, DOI 10.1002/jcb.240510308
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazear HM, 2016, CELL HOST MICROBE
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Pasxca A.M., 2015, NAT METHODS, V12, P671
   Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078
   Roost MS, 2015, STEM CELL REP, V4, P1112, DOI 10.1016/j.stemcr.2015.05.002
   Tang H, 2016, CELL STEM CELL
   Thomsen E.R., 2015, NAT METHODS, V13, P87
   Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003
   Yu XJ, 2011, J NEUROSCI, V31, P2413, DOI 10.1523/JNEUROSCI.5249-10.2011
NR 36
TC 16
Z9 16
U1 24
U2 24
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 19
PY 2016
VL 165
IS 5
BP 1238
EP 1254
DI 10.1016/j.cell.2016.04.032
PG 17
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DM6QT
UT WOS:000376478200022
PM 27118425
ER

PT J
AU Pardee, K
   Green, AA
   Takahashi, MK
   Braff, D
   Lambert, G
   Lee, JW
   Ferrante, T
   Ma, D
   Donghia, N
   Fan, M
   Daringer, NM
   Bosch, I
   Dudley, DM
   O'Connor, DH
   Gehrke, L
   Collins, JJ
AF Pardee, Keith
   Green, Alexander A.
   Takahashi, Melissa K.
   Braff, Dana
   Lambert, Guillaume
   Lee, Jeong Wook
   Ferrante, Tom
   Ma, Duo
   Donghia, Nina
   Fan, Melina
   Daringer, Nichole M.
   Bosch, Irene
   Dudley, Dawn M.
   O'Connor, David H.
   Gehrke, Lee
   Collins, James J.
TI Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular
   Components
SO CELL
LA English
DT Article
ID EPIDEMIC; DENGUE; QUANTIFICATION; DIAGNOSTICS; BRAZIL; URINE
AB The recent Zika virus outbreak highlights the need for low-cost diagnostics that can be rapidly developed for distribution and use in pandemic regions. Here, we report a pipeline for the rapid design, assembly, and validation of cell-free, paper-based sensors for the detection of the Zika virus RNA genome. By linking isothermal RNA amplification to toehold switch RNA sensors, we detect clinically relevant concentrations of Zika virus sequences and demonstrate specificity against closely related Dengue virus sequences. When coupled with a novel CRISPR/Cas9-based module, our sensors can discriminate between viral strains with single-base resolution. We successfully demonstrate a simple, field-ready sample-processing workflow and detect Zika virus from the plasma of a viremic macaque. Our freeze-dried biomolecular platform resolves important practical limitations to the deployment of molecular diagnostics in the field and demonstrates how synthetic biology can be used to develop diagnostic tools for confronting global health crises.
C1 [Pardee, Keith] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada.
   [Green, Alexander A.; Ma, Duo] Arizona State Univ, Biodesign Ctr Mol Design & Biomimet, Tempe, AZ 85287 USA.
   [Green, Alexander A.; Ma, Duo] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.
   [Takahashi, Melissa K.; Braff, Dana; Daringer, Nichole M.; Bosch, Irene; Gehrke, Lee; Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Braff, Dana] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Braff, Dana; Lambert, Guillaume; Lee, Jeong Wook; Ferrante, Tom; Donghia, Nina; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Lambert, Guillaume] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.
   [Fan, Melina] Addgene, Cambridge, MA 02139 USA.
   [Dudley, Dawn M.; O'Connor, David H.] UW Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
   [Dudley, Dawn M.; O'Connor, David H.] UW Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Gehrke, Lee] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
   [Gehrke, Lee; Collins, James J.] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Collins, James J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Collins, James J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
RP Collins, JJ (reprint author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (reprint author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Collins, JJ (reprint author), Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA.; Collins, JJ (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (reprint author), MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (reprint author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
EM jimjc@mit.edu
FU Wyss Institute for Biologically Inspired Engineering; MIT's Center for
   Microbiome Informatics and Therapeutics; Defense Threat Reduction Agency
   [HDTRA1-14-1-0006]; Arizona State University; NIH [AI100190]
FX We would like to thank Marcelle Tuttle from the Church Lab (Wyss
   Institute) for the vectors used to produce the lentivirus. We would also
   like to thank Xiao Tan and Shimyn Slomovic for helpful comments on the
   manuscript, as well as Ewen Cameron, Andres Cubillos, James Niemi and
   Dionna Williams for assistance with project logistics. The work was
   supported by the Wyss Institute for Biologically Inspired Engineering,
   MIT's Center for Microbiome Informatics and Therapeutics, and the
   Defense Threat Reduction Agency grant HDTRA1-14-1-0006. A.A.G
   acknowledges startup funds provided by Arizona State University. L.G.
   acknowledges support from NIH AI100190.
CR Antunes P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16145
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Calvet G., 2016, LANCET INFECT DIS
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Casper ET, 2007, HARMFUL ALGAE, V6, P112, DOI 10.1016/j.hal.2006.11.001
   Cordray MS, 2012, AM J TROP MED HYG, V87, P223, DOI 10.4269/ajtmh.2012.11-0685
   Crannell ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112146
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/nmeth.1318, 10.1038/NMETH.1318]
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   GUATELLI JC, 1990, P NATL ACAD SCI USA, V87, P1874, DOI 10.1073/pnas.87.5.1874
   Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111
   Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lu TK, 2013, TRENDS BIOTECHNOL, V31, P325, DOI 10.1016/j.tibtech.2013.03.009
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Stefan CP, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0509-3
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Ulrich RM, 2010, HARMFUL ALGAE, V9, P116, DOI 10.1016/j.hal.2009.08.010
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WHO, 2016, WHO FAST TRACK AV DI
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zika Experimental Science Team, 2016, ZIKV 001 INF 3 RHES
NR 31
TC 5
Z9 5
U1 54
U2 54
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 19
PY 2016
VL 165
IS 5
BP 1255
EP 1266
DI 10.1016/j.cell.2016.04.059
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DM6QT
UT WOS:000376478200023
PM 27160350
ER

PT J
AU Kostyuchenko, VA
   Lim, EXY
   Zhang, SJ
   Fibriansah, G
   Ng, TS
   Ooi, JSG
   Shi, J
   Lok, SM
AF Kostyuchenko, Victor A.
   Lim, Elisa X. Y.
   Zhang, Shuijun
   Fibriansah, Guntur
   Ng, Thiam-Seng
   Ooi, Justin S. G.
   Shi, Jian
   Lok, Shee-Mei
TI Structure of the thermally stable Zika virus
SO NATURE
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; ENVELOPE GLYCOPROTEIN; CRYO-EM;
   ENCEPHALITIS-VIRUS; CRYSTAL-STRUCTURE; PROTEIN; RESOLUTION; MATURATION;
   INFECTION
AB Zika virus (ZIKV), formerly a neglected pathogen, has recently been associated with microcephaly in fetuses(1), and with Guillian-Barre syndrome in adults(2). Here we present the 3.7 angstrom resolution cryoelectron microscopy structure of ZIKV, and show that the overall architecture of the virus is similar to that of other flaviviruses. Sequence and structural comparisons of the ZIKV envelope (E) protein with other flaviviruses show that parts of the E protein closely resemble the neurovirulent West Nile and Japanese encephalitis viruses, while others are similar to dengue virus (DENV). However, the contribution of the E protein to flavivirus pathobiology is currently not understood. The virus particle was observed to be structurally stable even when incubated at 40 degrees C, in sharp contrast to the less thermally stable DENV3. This is also reflected in the infectivity of ZIKV compared to DENV serotypes 2 and 4 (DENV2 and DENV4) at different temperatures. The cryoelectron microscopy structure shows a virus with a more compact surface. This structural stability of the virus may help it to survive in the harsh conditions of semen(4), saliva(5) and urine(6). Antibodies or drugs that destabilize the structure may help to reduce the disease outcome or limit the spread of the virus.
C1 [Kostyuchenko, Victor A.; Lim, Elisa X. Y.; Zhang, Shuijun; Fibriansah, Guntur; Ng, Thiam-Seng; Ooi, Justin S. G.; Lok, Shee-Mei] Duke Natl Univ Singapore, Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore.
   [Kostyuchenko, Victor A.; Lim, Elisa X. Y.; Zhang, Shuijun; Fibriansah, Guntur; Ng, Thiam-Seng; Ooi, Justin S. G.; Shi, Jian; Lok, Shee-Mei] Natl Univ Singapore, Dept Biol Sci, Ctr BioImaging Sci, Singapore 117557, Singapore.
   [Shi, Jian] Natl Univ Singapore, Dept Biol Sci, CryoEM Unit, Singapore 117557, Singapore.
RP Lok, SM (reprint author), Duke Natl Univ Singapore, Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore.; Lok, SM (reprint author), Natl Univ Singapore, Dept Biol Sci, Ctr BioImaging Sci, Singapore 117557, Singapore.
EM sheemei.lok@duke-nus.edu.sg
FU Singapore Ministry of Education Tier 3 grant [MOE2012-T3-1-008];
   National Research Foundation [NRF-NRFI2016-01]; Duke-NUS Signature
   Research Programme - Ministry of Health, Singapore
FX We thank the European Virus Archive for providing us with the ZIKV
   H/PF/2013 strain. We thank S. Lambert for helping to edit the paper. The
   work is supported by Singapore Ministry of Education Tier 3 grant
   (MOE2012-T3-1-008), National Research Foundation Investigatorship award
   (NRF-NRFI2016-01) awarded to S.-M.L. and the Duke-NUS Signature Research
   Programme funded by the Ministry of Health, Singapore.
CR Baronti C, 2014, GENOME ANNOUNC, V2, DOI [DOI 10.1128/GENOMEA.00500-14, 10.1128/genomeA.00500-14]
   Barzon L, 2016, EUROSURVEILLANCE, V21, P1
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Liu XG, 2007, J STRUCT BIOL, V160, P11, DOI 10.1016/j.jsb.2007.06.009
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D., 2016, SCIENCE
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 29
TC 13
Z9 13
U1 42
U2 42
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 19
PY 2016
VL 533
IS 7603
BP 425
EP +
DI 10.1038/nature17994
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM0AH
UT WOS:000376004300055
PM 27093288
ER

PT J
AU Rasmussen, SA
   Jamieson, DJ
   Honein, MA
   Petersen, LR
AF Rasmussen, Sonja A.
   Jamieson, Denise J.
   Honein, Margaret A.
   Petersen, Lyle R.
TI Zika Virus and Birth Defects - Reviewing the Evidence for Causality
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Review
ID HUMAN TERATOGENICITY; INFECTION; BRAZIL; BRAIN; 21ST-CENTURY;
   ASSOCIATION; CAUSATION; SEQUENCE; OUTBREAK; UPDATE
C1 [Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Ctr Surveillance Epidemiol & Lab Serv, Div Publ Hlth Informat Disseminat, Atlanta, GA USA.
   [Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA.
   [Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Div Congenital & Dev Disorders, Atlanta, GA USA.
   [Petersen, Lyle R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
RP Rasmussen, SA (reprint author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-33, Atlanta, GA 30329 USA.
EM skr9@cdc.gov
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Associated Press-NORC Center for Public Affairs Research, 2016, ZIK VIR AM AW OP US
   Bale JF, 2009, CLIN PERINATOL, V36, P639, DOI 10.1016/j.clp.2009.06.005
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Byrd AL, 2016, SCIENCE, V351, P224, DOI 10.1126/science.aad6753
   Calvet G., 2016, LANCET INFECT DIS
   Carey JC, 2009, BIRTH DEFECTS RES A, V85, P63, DOI 10.1002/bdra.20533
   Cauchemez S, 2016, LANCET
   Chan JF, 2016, J INFECT
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664
   Costa F, 2016, ANN INTERN MED
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824., DOI 10.1056/NEJMOA1601824, 10.1056/NEJMoa1601824]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frank C, 2016, EMBO MOL MED
   Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18
   HILL AB, 1965, P ROY SOC MED, V58, P295
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Instituto Nacional de Salud, 2016, B EP SEM
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JONES KL, 1973, LANCET, V2, P999
   LAMMER EJ, 1987, TERATOLOGY, V35, P465, DOI 10.1002/tera.1420350319
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mitchell AA, 2010, NEW ENGL J MED, V363, P2161, DOI 10.1056/NEJMe1009631
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   National Birth Defects Prevention Network, 2013, MAJ BIRTH DEF DAT PO
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Oliveira W. K. de, 2016, Morbidity and Mortality Weekly Report, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Palacios R, 2016, VACCINE, DOI [10.1056/NEJMsr1604338, DOI 10.1056/NEJMSR1604338]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reefhuis J, EMERG INFEC IN PRESS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scialli AR, 2005, BIRTH DEFECTS RES A, V73, P421, DOI 10.1002/bdra.21039
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Tang H, 2016, CELL STEM CELL
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Webster WS, 1998, TERATOLOGY, V58, P13
   Williams JV, 2010, J INFECT DIS, V201, P1611, DOI 10.1086/652406
NR 44
TC 48
Z9 49
U1 42
U2 42
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAY 19
PY 2016
VL 374
IS 20
BP 1981
EP 1987
DI 10.1056/NEJMsr1604338
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DM1OX
UT WOS:000376116600014
PM 27074377
ER

PT J
AU Orsborne, J
   Banks, SD
   Hendy, A
   Gezan, SA
   Kaur, H
   Wilder-Smith, A
   Lindsay, SW
   Logan, JG
AF Orsborne, James
   Banks, Sarah DeRaedt
   Hendy, Adam
   Gezan, Salvador A.
   Kaur, Harparkash
   Wilder-Smith, Annelies
   Lindsay, Steve W.
   Logan, James G.
TI Personal Protection of Permethrin-Treated Clothing against Aedes
   aegypti, the Vector of Dengue and Zika Virus, in the Laboratory
SO PLOS ONE
LA English
DT Article
ID ANOPHELES-GAMBIAE; CONTROLLED-TRIAL; RISK-ASSESSMENT; INSECTICIDE;
   EFFICACY; MALARIA; NETS; RESISTANCE; UNIFORMS; REPELLENTS
AB Background
   The dengue and Zika viruses are primarily transmitted by Aedes aegypti mosquitoes, which are most active during day light hours and feed both in and outside of the household. Personal protection technologies such as insecticide-treated clothing could provide individual protection. Here we assessed the efficacy of permethrin-treated clothing on personal protection in the laboratory.
   Methods
   The effect of washing on treated clothing, skin coverage and protection against resistant and susceptible Ae. aegypti was assessed using modified WHO arm-in-cage assays. Coverage was further assessed using free-flight room tests to investigate the protective efficacy of unwashed factory-dipped permethrin-treated clothing. Clothing was worn as full coverage (long sleeves and trousers) and partial coverage (short sleeves and shorts). Residual permethrin on the skin and its effect on mosquitoes was measured using modified WHO cone assays and quantified using high-pressure liquid chromatography (HPLC) analysis.
   Results
   In the arm-in-cage assays, unwashed clothing reduced landing by 58.9% (95% CI 49.2-66.9) and biting by 28.5%(95% CI 22.5-34.0), but reduced to 18.5% (95% CI 14.7-22.3) and 11.1% (95% CI 8.5-13.8) respectively after 10 washes. Landing and biting for resistant and susceptible strains was not significantly different (p<0.05). In free-flight room tests, full coverage treated clothing reduced landing by 24.3% (95% CI 17.4-31.7) and biting by 91% (95% CI 82.2-95.9) with partial coverage reducing landing and biting by 26.4%(95% CI 20.3-31.2) and 49.3%(95% CI 42.1-59.1) respectively with coverage type having no significant difference on landing (p<0.05). Residual permethrin was present on the skin in low amounts (0.0041mg/cm(2)), but still produced a KD of >80% one hour after wearing treated clothing.
   Conclusion
   Whilst partially covering the body with permethrin-treated clothing provided some protection against biting, wearing treated clothing with long sleeves and trousers provided the highest form of protection. Washing treated clothing dramatically reduced protection provided. Permethrin-treated clothing could provide protection to individuals from Ae. aegypti that show permethrin resistance. Additionally, it could continue to provide protection even after the clothing has been worn. Field trials are urgently needed to determine whether clothing can protect against dengue and Zika.
C1 [Orsborne, James; Banks, Sarah DeRaedt; Hendy, Adam; Kaur, Harparkash; Logan, James G.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.
   [Gezan, Salvador A.] Univ Florida, SFRC, Gainesville, FL USA.
   [Wilder-Smith, Annelies] Umea Univ, Dept Global Hlth & Epidemiol, Umea, Sweden.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore.
   [Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England.
   [Orsborne, James; Logan, James G.] London Sch Hyg & Trop Med, Arctec, London WC1, England.
RP Logan, JG (reprint author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.; Logan, JG (reprint author), London Sch Hyg & Trop Med, Arctec, London WC1, England.
EM james.logan@lshtm.ac.uk
FU European Union [282589]
FX The authors have received funding from the European Union Seventh
   Framework Programme FP7/2007-2013 under grant agreement 282589. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164
   Ahmed S, 2015, EMERG INFECT DIS, V21, P909, DOI 10.3201/eid2105.141813
   Appel KE, 2008, INT J HYG ENVIR HEAL, V211, P88, DOI [10.1016/j.ijheh.2007.10.005, 10.1016/j.ijheb.2007.10.005]
   Asilian A, 2003, J CLIN PHARM THER, V28, P175, DOI 10.1046/j.1365-2710.2003.00476.x
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Banks SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004109
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, ANTICIPATING INT SPR
   Champion Samantha R, 2014, Environ Health Insights, V8, P35, DOI 10.4137/EHI.S16004
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x
   Chua K. B., 2005, SMJ Singapore Medical Journal, V46, P639
   Corbel V, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-22
   Corp. I, 2013, IBM SPSS STAT WIND V
   Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389
   Darriet F, 2000, B SOC PATHOL EXOT, V93, P131
   Darriet F, 1998, Med Trop (Mars), V58, P349
   Ditsuwan T, 2013, TROP MED INT HEALTH, V18, P230, DOI 10.1111/tmi.12030
   Dom NC, 2013, PROCD SOC BEHV, V85, P100, DOI 10.1016/j.sbspro.2013.08.342
   EAMSILA C, 1994, J AM MOSQUITO CONTR, V10, P515
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Etang J, 2007, T ROY SOC TROP MED H, V101, P881, DOI 10.1016/j.trstmh.2007.05.012
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008
   FINLEY EL, 1974, B ENVIRON CONTAM TOX, V12, P268
   Fulmali PV, 2008, INDIAN J MED RES, V127, P589
   Ghosh A, 2015, INDIAN J MED MICROBI, V33, P3, DOI 10.4103/0255-0857.148369
   Gonzalez JO, 2002, T ROY SOC TROP MED H, V96, P370, DOI 10.1016/S0035-9203(02)90363-9
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2015, MMWR-MORBID MORTAL W, P65
   Institute S, 2009, SAS SYST WIND REL 9, P486
   Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-208
   Kimani EW, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-63
   Kroeger A, 2006, BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   Lenhart A, 2008, TROP MED INT HEALTH, V13, P56, DOI 10.1111/j.1365-3156.2007.01966.x
   Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690
   LINDSAY SW, 1991, MED VET ENTOMOL, V5, P477, DOI 10.1111/j.1365-2915.1991.tb00576.x
   Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239
   Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252
   Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061
   MILLER JE, 1991, MED VET ENTOMOL, V5, P465, DOI 10.1111/j.1365-2915.1991.tb00575.x
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x
   Narahashi T, 1998, NEUROTOXICOLOGY, V19, P581
   Hung NT, 2012, PAEDIATR INT CHILD H, V32, P39, DOI 10.1179/2046904712Z.00000000051
   Pan American Health Organization, 1995, DENG DENG HEM FEV AM
   Pennetier C, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-81
   Platt KB, 1997, AM J TROP MED HYG, V57, P119
   Rafinejad J., 2008, Journal of Vector Borne Diseases, V45, P143
   Rajapakse Senaka, 2012, Infect Drug Resist, V5, P103, DOI 10.2147/IDR.S22613
   Rossbach B, 2010, TOXICOL LETT, V192, P50, DOI 10.1016/j.toxlet.2009.06.863
   SCHRECK CE, 1984, AM J TROP MED HYG, V33, P725
   SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P247
   SCHRECK CE, 1986, J MED ENTOMOL, V23, P396
   Schuler-Faccini L, 2015, MMWR-MORBID MORTAL W, P65, DOI 10.15585/mmwr.mm6503e2er
   Siler-Marinkovic S, 2006, CHEM IND CHEM ENG Q, V12, P58
   SNODGRASS HL, 1992, J TOXICOL ENV HEALTH, V35, P91
   Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8
   Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x
   Van Bortel W, 2013, EUROSURVEILLANCE, V19, P20759
   WHO, 2012, GLOB STRAT DENG PREV
   W.H.O, 2015, DENG HAEM FEV, V2, P25
   World Health Organization, 2009, GUID EFF TEST MOSQ R, P4
   WHO, 2009, DENG GUID DIAGN TREA
   Wilder-Smith A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-212
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
   Yao TT, 2015, MED VET ENTOMOL, V29, P37, DOI 10.1111/mve.12088
   Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x
   Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429
NR 71
TC 0
Z9 0
U1 12
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 17
PY 2016
VL 11
IS 5
AR e0152805
DI 10.1371/journal.pone.0152805
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM3YJ
UT WOS:000376282300002
PM 27187593
ER

PT J
AU Friedrich, MJ
AF Friedrich, M. J.
TI More Evidence Linking Zika Virus to Birth Defects
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 6
U2 6
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAY 17
PY 2016
VL 315
IS 19
BP 2056
EP 2056
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL9PN
UT WOS:000375975300006
ER

PT J
AU Costa, F
   Sarno, M
   Khouri, R
   Freitas, BD
   Siqueira, I
   Ribeiro, GS
   Ribeiro, HC
   Campos, GS
   Alcantara, LC
   Reis, MG
   Weaver, SC
   Vasilakis, N
   Ko, AI
   Almeida, AR
AF Costa, Federico
   Sarno, Manoel
   Khouri, Ricardo
   Freitas, Bruno de Paula
   Siqueira, Isadora
   Ribeiro, Guilherme S.
   Ribeiro, Hugo C.
   Campos, Gubio S.
   Alcantara, Luiz C.
   Reis, Mitermayer G.
   Weaver, Scott C.
   Vasilakis, Nikos
   Ko, Albert I.
   Almeida, Antonio Raimundo
TI Emergence of Congenital Zika Syndrome: Viewpoint From the Front Lines
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID VIRUS; CHIKUNGUNYA; DENGUE; BRAZIL
C1 [Khouri, Ricardo; Ribeiro, Guilherme S.; Alcantara, Luiz C.] Minist Saude, Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Freitas, Bruno de Paula; Ribeiro, Hugo C.] Secretaria Estadual Saude Bahia, Hosp Geral Roberto Santos, Ave Paulo 6,2240,Apt 1004, BR-41810001 Salvador, BA, Brazil.
   Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
   [Costa, Federico] Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.
   [Sarno, Manoel] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia & Maternidade Clime, Rua Limoeiro 137, BR-41055150 Salvador, BA, Brazil.
   [Siqueira, Isadora; Reis, Mitermayer G.] Funda, Ctr Pesquisas Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Campos, Gubio S.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Almeida, Antonio Raimundo] Univ Fed Bahia, Hosp Geral Roberto Santos, Secretaria Saude Estado Bahia, Ave Santa Luzia 149-302,Ed Bosque Italia, BR-40295050 Salvador, BA, Brazil.
RP Costa, F (reprint author), Inst Saude Colet, Rua Basilio da Gama S-N, BR-40110040 Salvador, BA, Brazil.
EM fcosta2001@gmail.com
RI Ko, Albert/P-2343-2015; Weaver, Scott/D-6490-2011
CR Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Martines R, 2015, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J., 2016, N ENGL J MED
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2014, EUROSURVEILLANCE, P19
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 9
TC 6
Z9 7
U1 10
U2 10
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAY 17
PY 2016
VL 164
IS 10
BP 689
EP +
DI 10.7326/M16-0332
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL8GF
UT WOS:000375878500019
PM 26914810
ER

PT J
AU Armstrong, C
AF Armstrong, Carrie
TI CDC Updates Interim Guidance on Caring for Women with Possible Exposure
   to Zika Virus
SO AMERICAN FAMILY PHYSICIAN
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 2
U2 2
PU AMER ACAD FAMILY PHYSICIANS
PI KANSAS CITY
PA 8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA
SN 0002-838X
EI 1532-0650
J9 AM FAM PHYSICIAN
JI Am. Fam. Physician
PD MAY 15
PY 2016
VL 93
IS 10
BP 874
EP +
PG 3
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA DL8KO
UT WOS:000375891100009
PM 27175724
ER

PT J
AU Machado-Alba, JE
   Machado-Duque, ME
   Gaviria-Mendoza, A
   Orozco-Giraldo, VA
AF Machado-Alba, Jorge E.
   Machado-Duque, Manuel E.
   Gaviria-Mendoza, Andres
   Orozco-Giraldo, Viviana A.
TI Hormonal contraceptive prescriptions in Colombia and Zika virus
SO LANCET
LA English
DT Letter
C1 [Machado-Alba, Jorge E.] Univ Tecnol Pereira, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Colombia.
   Audifarma SA, Pereira, Colombia.
RP Machado-Alba, JE (reprint author), Univ Tecnol Pereira, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Colombia.
EM machado@utp.edu.co
CR Ministry of Health and Social Protection (Colombia), VIR DEL ZIK
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Zwizwai R, 2016, LANCET INFECT DIS, V16, P299, DOI 10.1016/S1473-3099(16)00083-9
NR 4
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 14
PY 2016
VL 387
IS 10032
BP 1993
EP 1993
DI 10.1016/S0140-6736(16)30429-9
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL8HJ
UT WOS:000375881500017
PM 27156436
ER

PT J
AU Musso, D
   Stramer, SL
   Busch, MP
AF Musso, Didier
   Stramer, Susan L.
   Busch, Michael P.
CA AABB Transfusion-Transmitted Dis
   Int Soc Blood Transfusion Working
TI Zika virus: a new challenge for blood transfusion
SO LANCET
LA English
DT Letter
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
   [Stramer, Susan L.] Amer Red Cross, Gaithersburg, MD USA.
   [Busch, Michael P.] Blood Syst Res Inst, Int Soc Blood Transfus, San Francisco, CA USA.
RP Musso, D (reprint author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   [Anonymous], 2016, MAINT SAF AD BLOOD S
NR 5
TC 3
Z9 3
U1 9
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 14
PY 2016
VL 387
IS 10032
BP 1993
EP 1994
DI 10.1016/S0140-6736(16)30428-7
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL8HJ
UT WOS:000375881500018
PM 27156435
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Interim Guidance for Zika Virus Testing of Urine - United States, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
ID EPIDEMIC
OI Khan, Yawar/0000-0003-1964-591X
CR Bingham AM, 2016, MMWR MORB MORTAL WKL, V65
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   CDC, 2016, MEM REV DIAGN TEST Z
   CDC, 2016, COLL SUBM BOD FLUIDS
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH S
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
NR 9
TC 0
Z9 1
U1 4
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 13
PY 2016
VL 65
IS 18
BP 474
EP 474
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL9FQ
UT WOS:000375947600005
ER

PT J
AU Bingham, AM
   Cone, M
   Mock, V
   Heberlein-Larson, L
   Stanek, D
   Blackmore, C
   Likos, A
AF Bingham, Andrea M.
   Cone, Marshall
   Mock, Valerie
   Heberlein-Larson, Lea
   Stanek, Danielle
   Blackmore, Carina
   Likos, Anna
TI Comparison of Test Results for Zika Virus RNA in Urine, Serum, and
   Saliva Specimens from Persons with Travel-Associated Zika Virus Disease
   - Florida, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Bingham, Andrea M.; Cone, Marshall; Mock, Valerie; Heberlein-Larson, Lea; Stanek, Danielle; Blackmore, Carina; Likos, Anna] Florida Dept Health, Tampa, FL 33602 USA.
RP Bingham, AM (reprint author), Florida Dept Health, Tampa, FL 33602 USA.
EM Andrea.Bingham@flhealth.gov
OI Khan, Yawar/0000-0003-1964-591X
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Council of State and Territorial Epidemiologists, 2016, ZIK VIR DIS CONG ZIK
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH E
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
NR 9
TC 7
Z9 8
U1 9
U2 9
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 13
PY 2016
VL 65
IS 18
BP 475
EP 478
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL9FQ
UT WOS:000375947600006
PM 27171533
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Interim Guidance for Zika Virus Testing of Urine - United States, 2016
   (vol 65, pg 474, 2016)
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Correction
CR 2016, MMWR, V65, P474
NR 1
TC 0
Z9 0
U1 1
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 13
PY 2016
VL 65
IS 18
BP 484
EP 484
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL9FQ
UT WOS:000375947600012
ER

PT J
AU Garcez, PP
   Loiola, EC
   Da Costa, RM
   Higa, LM
   Trindade, P
   Delvecchio, R
   Nascimento, JM
   Brindeiro, R
   Tanuri, A
   Rehen, SK
AF Garcez, Patricia P.
   Loiola, Erick Correia
   da Costa, Rodrigo Madeiro
   Higa, Luiza M.
   Trindade, Pablo
   Delvecchio, Rodrigo
   Nascimento, Juliana Minardi
   Brindeiro, Rodrigo
   Tanuri, Amilcar
   Rehen, Stevens K.
TI Zika virus impairs growth in human neurospheres and brain organoids
SO SCIENCE
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; CEREBRAL ORGANOIDS; INFECTION; TRANSMISSION;
   BRAZIL; GENERATION; CELLS
AB Since the emergence of Zika virus (ZIKV), reports of microcephaly have increased considerably in Brazil; however, causality between the viral epidemic and malformations in fetal brains needs further confirmation. We examined the effects of ZIKV infection in human neural stem cells growing as neurospheres and brain organoids. Using immunocytochemistry and electron microscopy, we showed that ZIKV targets human brain cells, reducing their viability and growth as neurospheres and brain organoids. These results suggest that ZIKV abrogates neurogenesis during human brain development.
C1 [Garcez, Patricia P.; Loiola, Erick Correia; da Costa, Rodrigo Madeiro; Trindade, Pablo; Nascimento, Juliana Minardi; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Garcez, Patricia P.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Higa, Luiza M.; Delvecchio, Rodrigo; Brindeiro, Rodrigo; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Nascimento, Juliana Minardi] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil.
RP Garcez, PP; Rehen, SK (reprint author), DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.; Garcez, PP; Rehen, SK (reprint author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
EM ppgarcez@icb.ufrj.br; srehen@lance-ufrj.org
RI Loiola, Erick/I-4106-2016
OI Loiola, Erick/0000-0002-7926-795X
FU Brazilian Development Bank; Funding Authority for Studies and Projects;
   National Council of Scientific and Technological Development; Foundation
   for Research Support in the State of Rio de Janeiro; Sao Paulo Research
   Foundation [2014/21035-0]; Coordination for the Improvement of Higher
   Education Personnel
FX The authors thank the laboratory crew members M. Costa, I. Gomes, G.
   Vitoria, J. Sochacki, R. Maciel, and M. Alloati for providing technical
   support and cultures of human iPS cells and brain organoids. We
   acknowledge O. M. Barth for comments on the electron micrographs. We
   also thank F. Pamplona for assistance with the Mind the Graph science
   infographic maker and Centro Nacional de Biologia Estrutural e Bioimagem
   for the use of their electron microscopy facility. Funds (not
   specifically for Zika virus studies) were provided by the Brazilian
   Development Bank; the Funding Authority for Studies and Projects; the
   National Council of Scientific and Technological Development; the
   Foundation for Research Support in the State of Rio de Janeiro; and
   fellowships from the Sao Paulo Research Foundation (grant 2014/21035-0)
   and Coordination for the Improvement of Higher Education Personnel. All
   protocols and procedures were approved by the institutional research
   ethics committee of Hospital Copa D'Or under approved protocol no.
   727.269. The authors declare no competing financial interests.
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Grief C, 1997, ARCH VIROL, V142, P2347, DOI 10.1007/s007050050247
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Tang H, 2016, CELL STEM CELL, V18, P1
   Vasconcelos-Santos DV, 2009, OPHTHALMOLOGY, V116, P2199, DOI 10.1016/j.ophtha.2009.04.042
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 33
Z9 34
U1 40
U2 40
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAY 13
PY 2016
VL 352
IS 6287
BP 816
EP 818
DI 10.1126/science.aaf6116
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL5FP
UT WOS:000375663000038
PM 27064148
ER

PT J
AU Haug, CJ
   Kieny, MP
   Murgue, B
AF Haug, Charlotte J.
   Kieny, Marie Paule
   Murgue, Bernadette
TI The Zika Challenge
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID VIRUS
C1 [Haug, Charlotte J.] WHO, Geneva, Switzerland.
   [Kieny, Marie Paule] WHO, Hlth Syst & Innovat, Geneva, Switzerland.
   [Murgue, Bernadette] WHO, WHO R&D Blueprint, Geneva, Switzerland.
RP Haug, CJ (reprint author), WHO, Geneva, Switzerland.
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
NR 5
TC 6
Z9 7
U1 15
U2 15
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAY 12
PY 2016
VL 374
IS 19
BP 1801
EP 1803
DI 10.1056/NEJMp1603734
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL6JS
UT WOS:000375746100001
PM 27028782
ER

PT J
AU Dieng, H
   Yusop, NSBT
   Kamal, NNB
   Ahmad, AH
   Ghani, IA
   Abang, F
   Satho, T
   Ahmad, H
   Zuharah, WF
   Ab Majid, AH
   Morales, RE
   Morales, NP
   Hipolito, CN
   Noweg, GT
AF Dieng, Hamady
   Yusop, Nur Syafiqah Bt. Tan
   Kamal, Nurafidah Natasyah Bt.
   Ahmad, Abu Hassan
   Ghani, Idris Abd
   Abang, Fatimah
   Satho, Tomomitsu
   Ahmad, Hamdan
   Zuharah, Wan Fatma
   Ab Majid, Abdul Hafiz
   Morales, Ronald E.
   Morales, Noppawan P.
   Hipolito, Cirilo N.
   Noweg, Gabriel Tonga
TI Exposure of a Dengue Vector to Tea and Its Waste: Survival,
   Developmental Consequences, and Significance for Pest Management
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE dengue; tea; mosquito; Ae. albopictus
ID AEDES-ALBOPICTUS DIPTERA; INSECTICIDE RESISTANCE; AEGYPTI DIPTERA;
   LETHAL OVITRAP; MATING SUCCESS; COFFEE GROUNDS; BODY-SIZE; CULICIDAE;
   CAFFEINE; MOSQUITO
AB Dengue mosquitoes are evolving into a broader global public health menace, with relentless outbreaks and the rise in number of Zika virus disease cases as reminders of the continued hazard associated with Aedes vectors. The use of chemical insecticides-the principal strategy against mosquito vectors-has been greatly impeded due to the development of insecticide resistance and the shrinking spectrum of effective agents. Therefore, there is a pressing need for new chemistries for vector control. Tea contains hundreds of chemicals, and its waste, which has become a growing global environmental problem, is almost as rich in toxicants as green leaves. This paper presents the toxic and sublethal effects of different crude extracts of tea on Aedes albopictus. The survival rates of larvae exposed to tea extracts, especially fresh tea extract (FTE), were markedly lower than those in the control treatment group. In addition to this immediate toxicity against different developmental stages, the extracts tested caused a broad range of sublethal effects. The developmental time was clearly longer in containers with tea, especially in those with young larvae (YL) and FTE. Among the survivors, pupation success was reduced in containers with tea, which also produced low adult emergence rates with increasing tea concentration. The production of eggs tended to be reduced in females derived from the tea treatment groups. These indirect effects of tea extracts on Ae. albopictus exhibited different patterns according to the exposed larval stage. Taken together, these findings indicate that tea and its waste affect most key components of Ae. albopictus vectorial capacity and may be useful for dengue control. Reusing tea waste in vector control could also be a practical solution to the problems associated with its pollution.
C1 [Dieng, Hamady; Noweg, Gabriel Tonga] Univ Malaysia Sarawak, IBEC, Kuching, Kota Samarahan, Malaysia.
   [Yusop, Nur Syafiqah Bt. Tan; Kamal, Nurafidah Natasyah Bt.; Ahmad, Abu Hassan; Ahmad, Hamdan; Zuharah, Wan Fatma; Ab Majid, Abdul Hafiz] Univ Sains Malaysia, Sch Biol Sci, George Town, Penang, Malaysia.
   [Ghani, Idris Abd] Univ Kebangsaan Malaysia, Fac Sci & Technol, Bangi 43600, Malaysia.
   [Abang, Fatimah] Univ Malaysia Sarawak, Fac Resource Sci & Technol, Kota Samarahan, Malaysia.
   [Satho, Tomomitsu] Fukuoka Univ, Fac Pharmaceut Sci, 8-19-1 Nanakuma, Fukuoka 81401, Japan.
   [Morales, Ronald E.] Mahidol Univ, Fac Trop Med, Dept Med Entomol, Bangkok, Thailand.
   [Morales, Noppawan P.] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand.
   [Hipolito, Cirilo N.] Univ Malaysia, Fac Engn, Dept Chem Engn & Energy Sustainabil, Miri, Sarawak, Malaysia.
RP Dieng, H (reprint author), Univ Malaysia Sarawak, IBEC, Kuching, Kota Samarahan, Malaysia.
EM hamadydieng69@gmail.com
FU Ministry of Higher Education, Malaysia; USM (Universiti Sains Malaysia)
   [304/Pbiology/650575/U112]
FX This work was supported by a Long Term Research Grant (LRGS) for
   Infectious Diseases, 2011-2014, Ministry of Higher Education, Malaysia,
   and USM (Universiti Sains Malaysia) (304/Pbiology/650575/U112).
CR Aoyama N., 2013, ASAHI SHIMBUM GLOBE
   Azmat R, 2010, PAK J BOT, V42, P3065
   Briegel H, 2002, J INSECT PHYSIOL, V48, P547, DOI 10.1016/S0022-1910(02)00072-0
   Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566
   Brogdon WG, 1998, EMERG INFECT DIS, V4, P605
   Couret J., 2014, BMC ECOL, V4, P3
   Daniels S., 2005, TEA WASTE RICH EXTRA
   Derraik J. G. B., 2005, Annals of Medical Entomology, V14, P14
   Dieng H., 2013, PARASITE VECTOR, V6, P206
   Dieng H, 2015, ACTA TROP, V145, P68, DOI 10.1016/j.actatropica.2015.01.004
   Dieng H, 2011, J AM MOSQUITO CONTR, V27, P263, DOI 10.2987/11-6124.1
   Dieng H, 2014, ACTA TROP, V130, P123, DOI 10.1016/j.actatropica.2013.11.001
   Elango G., 2012, Journal of King Saud University Science, V24, P73, DOI 10.1016/j.jksus.2010.08.012
   EPPO, 2010, B OEPP EPPO B, V40, P313, DOI DOI 10.1111/J.1365-2338.2010.02418.X
   FAY R. W., 1965, MOSQUITO NEWS, V25, P276
   GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F
   [Anonymous], 2014, INT RES J BIOL SCI
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hare S. G., 1986, J AM MOSQUITO CONTR, V3, P325
   Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301
   Khan Mahfuza, 2007, Pakistan Journal of Biological Sciences, V10, P3656
   Laranja AT, 2003, GENET MOL BIOL, V26, P419, DOI 10.1590/S1415-47572003000400004
   Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131
   Li Min-Jing, 2014, World J Clin Oncol, V5, P520, DOI 10.5306/wjco.v5.i3.520
   Lu M, 2013, MOLECULES, V18, P2754, DOI 10.3390/molecules18032754
   Macchioni F., 2004, Annali della Facolta di Medicina Veterinaria di Pisa, V57, P215
   Magellan TM, 2013, HORTTECHNOLOGY, V23, P201
   Maiga H, 2014, ACTA TROP, V132, pS102, DOI 10.1016/j.actatropica.2013.08.018
   MITCHELL MJ, 1993, INSECT BIOCHEM MOLEC, V23, P65, DOI 10.1016/0965-1748(93)90083-5
   Montgomery B. L., 2005, ARBOVIRUS RES AUST, V9, P268
   Nandal M., 2014, INT J CURR ENG TECHN, V4, P244
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   NATHANSON JA, 1984, SCIENCE, V226, P184, DOI 10.1126/science.6207592
   Norizan SNM, 2013, SENSORS-BASEL, V13, P5117, DOI 10.3390/s130405117
   Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x
   Ponlawat A, 2009, AM J TROP MED HYG, V80, P395
   Primavesi L., 2014, POLYPHENOLS HUMAN HL, P849
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Ritchie S. A., 2005, ARBOVIRUS RES AUST, V9, P324
   Ritchie SA, 2008, J AM MOSQUITO CONTR, V24, P47, DOI 10.2987/5658.1
   Satho T, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0874-6
   Systat Software Inc, 2004, SYST WIND STAT
   Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862
   Thompson AG, 2004, ENVIRON MONIT ASSESS, V91, P87, DOI 10.1023/B:EMAS.0000009231.04123.2d
   Thomson Reuters/Zawya, 2013, LIPT JEB AL FACT ACH
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wasewar K. L., 2010, International Journal of Research and Reviews in Applied Sciences, V3, P303
   Wheeler D, 1996, ANNU REV ENTOMOL, V41, P407, DOI 10.1146/annurev.en.41.010196.002203
   World Health Organization (WHO), 2013, GLOB STRAT DENG PREV
   Wink M., 1992, INSECT PLANT INTERAC, V4
   Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222
   Yee DA, 2004, J VECTOR ECOL, V29, P315
   [Anonymous], 2014, GUARDIAN NEWS
NR 53
TC 0
Z9 0
U1 10
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 11
PY 2016
VL 64
IS 18
BP 3485
EP 3491
DI 10.1021/acs.jafc.6b01157
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA DL9ND
UT WOS:000375969100001
PM 27115536
ER

PT J
AU Wang, L
   Valderramos, SG
   Wu, AP
   Ouyang, SY
   Li, CF
   Brasil, P
   Bonaldo, M
   Coates, T
   Nielsen-Saines, K
   Jiang, TJ
   Aliyari, R
   Cheng, GH
AF Wang, Lulan
   Valderramos, Stephanie G.
   Wu, Aiping
   Ouyang, Songying
   Li, Chunfeng
   Brasil, Patricia
   Bonaldo, Myrna
   Coates, Thomas
   Nielsen-Saines, Karin
   Jiang, Taijiao
   Aliyari, Roghiyh
   Cheng, Genhong
TI From Mosquitos to Humans: Genetic Evolution of Zika Virus
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID STATES
AB Initially isolated in 1947, Zika virus (ZIKV) has recently emerged as a significant public health concern. Sequence analysis of all 41 known ZIKV RNA open reading frames to date indicates that ZIKV has undergone significant changes in both protein and nucleotide sequences during the past half century.
C1 [Wang, Lulan; Valderramos, Stephanie G.; Ouyang, Songying; Li, Chunfeng; Aliyari, Roghiyh; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Wang, Lulan; Wu, Aiping; Jiang, Taijiao; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Wang, Lulan; Wu, Aiping; Jiang, Taijiao; Cheng, Genhong] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Wang, Lulan; Wu, Aiping; Jiang, Taijiao; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Valderramos, Stephanie G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.
   [Ouyang, Songying] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.
   [Brasil, Patricia] Inst Oswaldo Cruz FIOCRUZ, Inst Nacl Infectol Evandro Chagas, BR-21040900 Rio De Janeiro, Brazil.
   [Bonaldo, Myrna] Inst Oswaldo Cruz FIOCRUZ, Lab Biol Mol Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [Coates, Thomas] Univ Calif Los Angeles, UCLA Ctr World Hlth, Los Angeles, CA 90024 USA.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Los Angeles, CA 90095 USA.
RP Aliyari, R; Cheng, GH (reprint author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Jiang, TJ; Cheng, GH (reprint author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Jiang, TJ; Cheng, GH (reprint author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Jiang, TJ; Cheng, GH (reprint author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
EM jtj@ism.cams.cn; aliyarirs@ucla.edu; gcheng@mednet.ucla.edu
CR Bonaldo M. C., 2016, BIORXIV
   Brasil P, 2016, N ENGL J MED
   Broutet N, 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Lazear HM, 2016, CELL HOST MICROBE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ramachandran S, 2011, J VIROL, V85, P6369, DOI 10.1128/JVI.02204-10
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446
NR 17
TC 13
Z9 13
U1 32
U2 32
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 561
EP 565
DI 10.1016/j.chom.2016.04.006
PG 5
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500001
PM 27091703
ER

PT J
AU Xie, XP
   Shan, C
   Shi, PY
AF Xie, Xuping
   Shan, Chao
   Shi, Pei-Yong
TI Restriction of Zika Virus by Host Innate Immunity
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID RESISTANCE; CELLS
AB Recent epidemics of Zika virus (ZIKV) have brought increasing concerns of heightened disease severity and neurotropism. In this issue of Cell Host & Microbe, Lazear et al. (2016) and Bayer et al. (2016) show that innate immunity can restrict ZIKV infection and disease development.
C1 [Xie, Xuping; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Xie, Xuping; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Xie, Xuping; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Shi, PY (reprint author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (reprint author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (reprint author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rossi S.L., 2016, AM J TROP MED HYG, P16
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shi PY, 2014, CELL HOST MICROBE, V16, P269, DOI 10.1016/j.chom.2014.08.011
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
NR 10
TC 0
Z9 0
U1 13
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 566
EP 567
DI 10.1016/j.chom.2016.04.019
PG 2
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500002
PM 27173920
ER

PT J
AU Rasmussen, AL
   Katze, MG
AF Rasmussen, Angela L.
   Katze, Michael G.
TI Genomic Signatures of Emerging Viruses: A New Era of Systems
   Epidemiology
SO CELL HOST & MICROBE
LA English
DT Review
ID REVERSE TRANSCRIPTION-PCR; POLYMERASE-CHAIN-REACTION; FIELD-EFFECT
   TRANSISTORS; CROSS FOUNDER MICE; HEPATITIS-C VIRUS; EBOLA-VIRUS; RAPID
   DETECTION; REAL-TIME; GENETIC DIVERSITY; VIRAL-INFECTIONS
AB Compared to classical epidemiologic methods, genomics can be used to precisely monitor virus evolution and transmission in real time across large, diverse populations. Integration of pathogen genomics with data about host genetics and global transcriptional responses to infection allows for comprehensive studies of population-level responses to infection and provides novel methods for predicting clinical outcomes. As genomic technologies become more accessible, these methods will redefine how emerging viruses are studied and outbreaks are contained. Here we review the existing and emerging genomic technologies that are enabling systems epidemiology and systems virology and making it possible to respond rapidly to emerging viruses such as Zika.
C1 [Rasmussen, Angela L.; Katze, Michael G.] Univ Washington, Dept Microbiol, 960 Republican St, Seattle, WA 98109 USA.
RP Katze, MG (reprint author), Univ Washington, Dept Microbiol, 960 Republican St, Seattle, WA 98109 USA.
EM honey@uw.edu
OI Rasmussen, Angela/0000-0001-9462-3169
CR Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861
   Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800
   Casas I, 1997, J VIROL METHODS, V66, P39, DOI 10.1016/S0166-0934(97)00035-9
   Dong H, 2015, GENOM DATA, V6, P1, DOI 10.1016/j.gdata.2015.07.018
   D'Ortenzio E, 2016, N ENGL J MED
   Driggers R. W., 2016, NEW ENGL J MED, DOI DOI 10.1056/NEJMOA1601824
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Edwards KM, 2014, EXPERT REV VACCINES, V13, P1183, DOI 10.1586/14760584.2014.946015
   Elbarbary RA, 2016, SCIENCE, V351, P678, DOI 10.1126/science.aac7247
   Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799
   Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196
   Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18
   Garcez PP, 2016, SCIENCE
   Gardeux V, 2015, J BIOMED INFORM, V55, P94, DOI 10.1016/j.jbi.2015.03.003
   Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Graham J. B., 2015, MBIO, V6
   Gralinski LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005504
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Haeussler M., 2014, PLOS CURR, V6, P6
   Haraksingh RR, 2013, J MOL BIOL, V425, P3970, DOI 10.1016/j.jmb.2013.07.015
   Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646
   Hoenen T., 2016, EMERG INFECT DIS, V22, P22
   Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001
   Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234
   Jansen L, 2015, LIVER INT, V35, P1824, DOI 10.1111/liv.12768
   Josset L, 2014, RNA BIOL, V11, P875, DOI 10.4161/rna.29442
   Katze M., 2016, VIRAL PATHOGENESIS E
   Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816
   Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522
   Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008
   Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551
   Luebke Robert W, 2004, J Immunotoxicol, V1, P15, DOI 10.1080/15476910490438342
   MacNeil A, 2014, VACCINE, V32, P4893, DOI 10.1016/j.vaccine.2014.07.005
   Madoui MA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1519-z
   Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953
   Martinez MT, 2009, NANO LETT, V9, P530, DOI 10.1021/nl8025604
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   McElhaney JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00041
   Nicholson TL, 2011, J CLIN MICROBIOL, V49, P1542, DOI 10.1128/JCM.01876-10
   Palacios G, 2006, EMERG INFECT DIS, V12, P692
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Quinones-Mateu ME, 2014, J CLIN VIROL, V61, P9, DOI 10.1016/j.jcv.2014.06.013
   Rasmussen AL, 2012, HEPATOLOGY, V56, P17, DOI 10.1002/hep.25612
   Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595
   Rasmussen SA, 2016, N ENGL J MED
   Renois F, 2010, J CLIN MICROBIOL, V48, P3836, DOI 10.1128/JCM.00733-10
   Sanghavi SK, 2012, J MED VIROL, V84, P162, DOI 10.1002/jmv.22186
   Scarpino SV, 2015, CLIN INFECT DIS, V60, P1079, DOI 10.1093/cid/ciu1131
   Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612
   Sloots TP, 2015, PATHOLOGY, V47, P191, DOI 10.1097/PAT.0000000000000241
   Sorgenfrei S, 2011, NAT NANOTECHNOL, V6, P125, DOI 10.1038/nnano.2010.275
   Stadler T., 2014, PLOS CURR, V6, P6
   Star A, 2006, P NATL ACAD SCI USA, V103, P921, DOI 10.1073/pnas.0504146103
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Tang H, 2016, CELL STEM CELL
   Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Valassina M, 1997, CLIN DIAGN VIROL, V8, P227, DOI 10.1016/S0928-0197(97)10001-0
   Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Xiong H, 2014, G3-GENES GENOM GENET, V4, P1429, DOI 10.1534/g3.114.011759
   Yao FJ, 2014, CHEM COMMUN, V50, P13853, DOI 10.1039/c4cc06135g
   Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280
NR 67
TC 0
Z9 0
U1 20
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 611
EP 618
DI 10.1016/j.chom.2016.04.016
PG 8
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500011
PM 27173929
ER

PT J
AU Dai, LP
   Song, J
   Lu, XS
   Deng, YQ
   Musyoki, AM
   Cheng, HJ
   Zhang, YF
   Yuan, Y
   Song, H
   Haywood, J
   Xiao, HX
   Yan, JH
   Shi, Y
   Qin, CF
   Qi, JX
   Gao, GF
AF Dai, Lianpan
   Song, Jian
   Lu, Xishan
   Deng, Yong-Qiang
   Musyoki, Abednego Moki
   Cheng, Huijun
   Zhang, Yanfang
   Yuan, Yuan
   Song, Hao
   Haywood, Joel
   Xiao, Haixia
   Yan, Jinghua
   Shi, Yi
   Qin, Cheng-Feng
   Qi, Jianxun
   Gao, George F.
TI Structures of the Zika Virus Envelope Protein and Its Complex with a
   Flavivirus Broadly Protective Antibody
SO CELL HOST & MICROBE
LA English
DT Article
ID WEST-NILE-VIRUS; CROSS-REACTIVE ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES;
   DENGUE VIRUS; FUSION-LOOP; NEUTRALIZING ANTIBODIES; EBOLA-VIRUS;
   ENCEPHALITIS-VIRUS; CRYSTAL-STRUCTURE; ASIAN LINEAGE
AB Zika virus (ZIKV), a mosquito-borne flavivirus, is a current global public health concern. The flavivirus envelope (E) glycoprotein is responsible for virus entry and represents a major target of neutralizing antibodies for other flaviviruses. Here, we report the structures of ZIKV E protein at 2.0 angstrom and in complex with a flavivirus broadly neutralizing murine antibody 2A10G6 at 3.0 angstrom. ZIKV-E resembles all the known flavivirus E structures but contains a unique, positively charged patch adjacent to the fusion loop region of the juxtaposed monomer, which may influence host attachment. The ZIKV-E-2A10G6 complex structure reveals antibody recognition of a highly conserved fusion loop. 2A10G6 binds to ZIKV-E with high affinity in vitro and neutralizes currently circulating ZIKV strains in vitro and in mice. The E protein fusion loop epitope represents a potential candidate for therapeutic antibodies against ZIKV.
C1 [Dai, Lianpan; Cheng, Huijun; Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth RNIH, Beijing 100101, Peoples R China.
   [Song, Jian; Musyoki, Abednego Moki; Yuan, Yuan; Song, Hao; Haywood, Joel; Yan, Jinghua; Shi, Yi; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100071, Peoples R China.
   [Song, Jian; Musyoki, Abednego Moki; Yuan, Yuan; Song, Hao; Haywood, Joel; Yan, Jinghua; Shi, Yi; Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.
   [Lu, Xishan; Zhang, Yanfang; Xiao, Haixia; Gao, George F.] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.
   [Deng, Yong-Qiang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100101, Peoples R China.
   [Yan, Jinghua; Shi, Yi; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.
   [Yan, Jinghua; Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing 100101, Peoples R China.
   [Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Engn, Beijing 100101, Peoples R China.
   [Gao, George F.] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
RP Gao, GF (reprint author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth RNIH, Beijing 100101, Peoples R China.; Qi, JX; Gao, GF (reprint author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100071, Peoples R China.; Gao, GF (reprint author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.; Gao, GF (reprint author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.; Qin, CF (reprint author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100101, Peoples R China.; Gao, GF (reprint author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.; Gao, GF (reprint author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing 100101, Peoples R China.; Gao, GF (reprint author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.; Gao, GF (reprint author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
EM qincf@bmi.ac.cn; jxqi@im.ac.cn; gaof@im.ac.cn
RI Haywood, Joel/G-8311-2016; 
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU Task-Force of Zika Virus Research from the Chinese Academy of Sciences
   (CAS); Emergency Task-Force Project of the National Natural Science
   Foundation of China (NSFC) [81641001]; Zika Special Project of the
   National Infectious Disease Control ST Grand Project; Strategic Priority
   Research Program of the Chinese Academy of Sciences [XDB08020100];
   Excellent Young Scientist Program of the Chinese Academy of Sciences;
   Youth Innovation Promotion Association CAS [2015078]; Excellent Young
   Scientist Program from the NSFC [81522025]; Academy of Medical Sciences,
   UK; NSFC; NSFC Innovative Research Group [81321063]
FX This work was supported by the Task-Force of Zika Virus Research from
   the Chinese Academy of Sciences (CAS), the Emergency Task-Force Project
   (Grant No. 81641001) of the National Natural Science Foundation of China
   (NSFC), Zika Special Project of the National Infectious Disease Control
   S&T Grand Project, and Strategic Priority Research Program of the
   Chinese Academy of Sciences (XDB08020100). We thank the staff of BL17U
   beamline at Shanghai Synchrotron Radiation Facility for assistance
   during data collection. Y.S. is supported by the Excellent Young
   Scientist Program of the Chinese Academy of Sciences and the Youth
   Innovation Promotion Association CAS (Grant No. 2015078). C.-F.Q. is
   supported by the Excellent Young Scientist Program from the NSFC (No.
   81522025) and the Newton Advanced Fellowship from the Academy of Medical
   Sciences, UK and NSFC. G.F.G. is a leading principal investigator of the
   NSFC Innovative Research Group (Grant No. 81321063). We thank Shihua Li,
   Gary Wong, Kefang Liu, and Helin Zhang for their technical support.
CR Aad G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.161801
   Audet J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06881
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DiLillo DJ, 2016, J CLIN INVEST, V126, P605, DOI 10.1172/JCI84428
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kostyuchenko V.A., 2016, NATURE
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Lai RPJ, 2014, J BIOL CHEM, V289, P29912, DOI 10.1074/jbc.M114.569566
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8
   Li J., 2016, EMERG INFECT DIS, V22, P22, DOI DOI 10.3201/EID2206.160273
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu J, 2011, J VIROL, V85, P7372, DOI 10.1128/JVI.00350-11
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07
   [Anonymous], 1997, ENZYMOLOGY, DOI DOI 10.1016/S0076-6879
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Qiu XG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001575
   Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Roberson JA, 2007, J CLIN MICROBIOL, V45, P3167, DOI 10.1128/JCM.01143-07
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith S.A., 2013, MBIO, V4
   Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093
   Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108
   Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 55
TC 9
Z9 9
U1 33
U2 33
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 696
EP 704
DI 10.1016/j.chom.2016.04.013
PG 9
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500019
PM 27158114
ER

PT J
AU Bayer, A
   Lennemann, NJ
   Ouyang, YS
   Bramley, JC
   Morosky, S
   Marques, ETD
   Cherry, S
   Sadovsky, Y
   Coyne, CB
AF Bayer, Avraham
   Lennemann, Nicholas J.
   Ouyang, Yingshi
   Bramley, John C.
   Morosky, Stefanie
   De Azeved Marques, Ernesto Torres, Jr.
   Cherry, Sara
   Sadovsky, Yoel
   Coyne, Carolyn B.
TI Type III Interferons Produced by Human Placental Trophoblasts Confer
   Protection against Zika Virus Infection
SO CELL HOST & MICROBE
LA English
DT Article
ID IN-VITRO; CELLS; DIFFERENTIATION; LAMBDA; BRAZIL; BRAIN; COMPLEX
AB During mammalian pregnancy, the placenta acts as a barrier between the maternal and fetal compartments. The recently observed association between Zika virus (ZIKV) infection during human pregnancy and fetal microcephaly and other anomalies suggests that ZIKV may bypass the placenta to reach the fetus. This led us to investigate ZIKV infection of primary human trophoblasts (PHTs), which are the barrier cells of the placenta. We discovered that PHT cells from full-term placentas are refractory to ZIKV infection. In addition, medium from uninfected PHT cells protects non-placental cells from ZIKV infection. PHT cells constitutively release the type III interferon (IFN) IFN lambda 1, which functions in both a paracrine and autocrine manner to protect trophoblast and non-trophoblast cells from ZIKV infection. Our data suggest that for ZIKV to access the fetal compartment, it must evade restriction by trophoblast- derived IFNl1 and other trophoblast-specific antiviral factors and/or use alternative strategies to cross the placental barrier.
C1 [Bayer, Avraham; Ouyang, Yingshi; Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.
   [Bayer, Avraham; Ouyang, Yingshi; Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.
   [Lennemann, Nicholas J.; Bramley, John C.; Morosky, Stefanie; Sadovsky, Yoel; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
   [De Azeved Marques, Ernesto Torres, Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
   [De Azeved Marques, Ernesto Torres, Jr.] Fundacao Osvaldo Cruz FIOCRUZ, BR-50670420 Recife, PE, Brazil.
   [Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
RP Sadovsky, Y; Coyne, CB (reprint author), Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.; Sadovsky, Y; Coyne, CB (reprint author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA.; Sadovsky, Y; Coyne, CB (reprint author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
EM ysadovsky@mwri.magee.edu; coynec2@pitt.edu
FU NIH [R01-AI081759, R01-HD075665, T32-AI049820]; Burroughs Wellcome
   Investigators in the Pathogenesis of Infectious Disease Awards
FX We thank Saumendra Sarkar and Donald Burke (University of Pittsburgh)
   for reagents and/or advice, Ted Pierson (NIH/NIAID) and Margaret Kielian
   (Albert Einstein College of Medicine) for DENV reagents, and Kwang Sik
   Kim (Johns Hopkins University) for the HBMECs used in the study. This
   project was supported by NIH R01-AI081759 (C.B.C.), NIH R01-HD075665
   (C.B.C. and Y.S.), and T32-AI049820 (N.J.L.). In addition, C.B.C. and
   S.C. are supported by Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease Awards.
CR Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Bazer FW, 1996, AM J REPROD IMMUNOL, V35, P297
   Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080
   Brasil P, 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Cauchemez S, 2016, LANCET
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   LEFEVRE F, 1993, J BIOL CHEM, V268, P19760
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MORRISH DW, 1987, J CLIN ENDOCR METAB, V65, P1282
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Shu Q, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005150
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
   Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406
   Thirkill TL, 1997, J CELL BIOCHEM, V65, P460, DOI 10.1002/(SICI)1097-4644(19970615)65:4<460::AID-JCB2>3.0.CO;2-M
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7
NR 34
TC 17
Z9 17
U1 32
U2 32
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 705
EP 712
DI 10.1016/j.chom.2016.03.008
PG 8
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500020
PM 27066743
ER

PT J
AU Lazear, HM
   Govero, J
   Smith, AM
   Platt, DJ
   Fernandez, E
   Miner, JJ
   Diamond, MS
AF Lazear, Helen M.
   Govero, Jennifer
   Smith, Amber M.
   Platt, Derek J.
   Fernandez, Estefania
   Miner, Jonathan J.
   Diamond, Michael S.
TI A Mouse Model of Zika Virus Pathogenesis
SO CELL HOST & MICROBE
LA English
DT Review
ID DENGUE VIRUS; GENE INDUCTION; UNITED-STATES; MICE; ALPHA/BETA;
   INFECTION; TRANSMISSION; ISOLATIONS; PROTEIN; RECEPTORS
AB The ongoing Zika virus (ZIKV) epidemic and unexpected clinical outcomes, including Guillain-Barre syndrome and birth defects, has brought an urgent need for animal models. We evaluated infection and pathogenesis with contemporary and historical ZIKV strains in immunocompetent mice and mice lacking components of the antiviral response. Four-to six-week-old Irf3(-/-) Irf5(-/-) Irf7(-/-) triple knockout mice, which produce little interferon alpha/beta, and mice lacking the interferon receptor (Ifnar1(-/-)) developed neurological disease and succumbed to ZIKV infection, whereas single Irf3(-/-), Irf5(-/-), and Mavs(-/-) knockout mice exhibited no overt illness. Ifnar1(-/-) mice sustained high viral loads in the brain and spinal cord, consistent with evidence that ZIKV causes neurodevelopmental defects in human fetuses. The testes of Ifnar1(-/-) mice had the highest viral loads, which is relevant to sexual transmission of ZIKV. This model of ZIKV pathogenesis will be valuable for evaluating vaccines and therapeutics as well as understanding disease pathogenesis.
C1 [Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Govero, Jennifer; Smith, Amber M.; Platt, Derek J.; Fernandez, Estefania; Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@borcim.wustl.edu
FU University of North Carolina Department of Microbiology and Immunology;
   Lineberger Comprehensive Cancer Center; NIH [R01 AI073755, R01
   AI104972]; Rheumatology Research Foundation Scientist Development Award;
   NIH Pre-Doctoral Training Grant award [T32 AI007163]; NIH Research
   Education Program [R25 HG006687]
FX This work was supported by start-up funds from the University of North
   Carolina Department of Microbiology and Immunology and the Lineberger
   Comprehensive Cancer Center (H.M.L.), as well as grants from the NIH
   (R01 AI073755 and R01 AI104972) (M.S.D.). J.J.M., E.F., and D.J.P. were
   supported by a Rheumatology Research Foundation Scientist Development
   Award, NIH Pre-Doctoral Training Grant award (T32 AI007163), and NIH
   Research Education Program (R25 HG006687), respectively. M.S.D. is a
   consultant for InBios and Visterra and a member of the Scientific
   Advisory Board of Moderna.
CR Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Ank N, 2008, J IMMUNOL, V180, P2474
   Atkinson BHP, 2016, EMERG INFECT DIS, P22
   Baronti C., 2014, GENOME ANNOUNC, V2, P2, DOI DOI 10.1128/GENOMEA.00500-14
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Brien J.D., 2013, CURR PROTOC MICROBIO, V31, P18
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET
   Cauchemez S, 2016, LANCET
   Daffis S, 2011, J VIROL, V85, P5664, DOI 10.1128/JVI.00232-11
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Fensterl V, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002712
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Lazear HM, 2016, J VIROL
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005
   Pagni S, 2012, IMMUNOL RES, V54, P152, DOI 10.1007/s12026-012-8334-2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pierson T.C., 2013, FIELDS VIROLOGY, P747
   Pinto A. K., 2015, MBIO, V6
   Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086
   Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407
   Rossi S.L., 2016, AM J TROP MED HYG
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sheehan KCF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128636
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308
   Tang H, 2016, CELL STEM CELL
   VANDENBROEK MF, 1995, J VIROL, V69, P4792
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EURO SURVEILL, V21
   Way J H, 1976, J Gen Virol, V30, P123
   Willison HJ, 2016, LANCET
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
NR 67
TC 30
Z9 30
U1 60
U2 60
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 11
PY 2016
VL 19
IS 5
BP 720
EP 730
DI 10.1016/j.chom.2016.03.010
PG 11
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA DL4HR
UT WOS:000375595500022
PM 27066744
ER

PT J
AU Behura, SK
   Sarro, J
   Li, P
   Mysore, K
   Severson, DW
   Emrich, SJ
   Duman-Scheel, M
AF Behura, Susanta K.
   Sarro, Joseph
   Li, Ping
   Mysore, Keshava
   Severson, David W.
   Emrich, Scott J.
   Duman-Scheel, Molly
TI High-throughput cis-regulatory element discovery in the vector mosquito
   Aedes aegypti
SO BMC GENOMICS
LA English
DT Article
DE Genome; FAIRE-seq; Dengue virus; Zika; Next generation sequencing;
   Drosophila
ID EUKARYOTIC MESSENGER-RNAS; MAJOR ARBOVIRUS VECTOR;
   DROSOPHILA-MELANOGASTER; UNTRANSLATED REGIONS; COMPARATIVE GENOMICS;
   MICRORNA EXPRESSION; GENE-EXPRESSION; OPEN CHROMATIN; SEQUENCE;
   TRANSCRIPTION
AB Background: Despite substantial progress in mosquito genomic and genetic research, few cis-regulatory elements (CREs), DNA sequences that control gene expression, have been identified in mosquitoes or other non-model insects. Formaldehyde-assisted isolation of regulatory elements paired with DNA sequencing, FAIRE-seq, is emerging as a powerful new high-throughput tool for global CRE discovery. FAIRE results in the preferential recovery of open chromatin DNA fragments that are not bound by nucleosomes, an evolutionarily conserved indicator of regulatory activity, which are then sequenced. Despite the power of the approach, FAIRE-seq has not yet been applied to the study of non-model insects. In this investigation, we utilized FAIRE-seq to profile open chromatin and identify likely regulatory elements throughout the genome of the human disease vector mosquito Aedes aegypti. We then assessed genetic variation in the regulatory elements of dengue virus susceptible (Moyo-S) and refractory (Moyo-R) mosquito strains.
   Results: Analysis of sequence data obtained through next generation sequencing of FAIRE DNA isolated from A. aegypti embryos revealed >121,000 FAIRE peaks (FPs), many of which clustered in the 1 kb 5' upstream flanking regions of genes known to be expressed at this stage. As expected, known transcription factor consensus binding sites were enriched in the FPs, and of these FoxA1, Hunchback, Gfi, Klf4, MYB/ph3 and Sox9 are most predominant. All of the elements tested in vivo were confirmed to drive gene expression in transgenic Drosophila reporter assays. Of the >13,000 single nucleotide polymorphisms (SNPs) recently identified in dengue virus-susceptible and refractory mosquito strains, 3365 were found to map to FPs.
   Conclusion: FAIRE-seq analysis of open chromatin in A. aegypti permitted genome-wide discovery of CREs. The results of this investigation indicate that FAIRE-seq is a powerful tool for identification of regulatory DNA in the genomes of non-model organisms, including human disease vector mosquitoes.
C1 [Behura, Susanta K.; Sarro, Joseph; Li, Ping; Mysore, Keshava; Severson, David W.; Emrich, Scott J.; Duman-Scheel, Molly] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Behura, Susanta K.; Sarro, Joseph; Severson, David W.; Emrich, Scott J.; Duman-Scheel, Molly] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Sarro, Joseph; Li, Ping; Mysore, Keshava; Severson, David W.; Duman-Scheel, Molly] Indiana Univ Sch Med, Dept Med & Mol Genet, 1234 Notre Dame Ave, South Bend, IN 46617 USA.
   [Emrich, Scott J.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.
RP Emrich, SJ; Duman-Scheel, M (reprint author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.; Emrich, SJ; Duman-Scheel, M (reprint author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Duman-Scheel, M (reprint author), Indiana Univ Sch Med, Dept Med & Mol Genet, 1234 Notre Dame Ave, South Bend, IN 46617 USA.
EM semrich@nd.edu; mscheel@nd.edu
FU National Institutes of Health, National Center for Advancing
   Translational Sciences, Clinical and Translational Sciences Award
   [UL1TR001108]; University of Notre Dame Genomics and Bioinformatics Core
   Facility
FX We are grateful to the staff of VectorBase and the University of Notre
   Dame Genomics and Bioinformatics Core Facility for their assistance.
   Thanks to Emily Andrews for assistance with the egg collections.
   Drosophila transgenics were generated by Rainbow Transgenic Flies, Inc.
   (Camarillo, CA). Open chromatin profiling was performed with a pilot
   grant to MDS from the Indiana Clinical and Translational Sciences
   Institute which is funded in part by Grant Number UL1TR001108 from the
   National Institutes of Health, National Center for Advancing
   Translational Sciences, Clinical and Translational Sciences Award. A
   Navari Family Foundation grant to MDS supported analysis of FP
   sequences. An NIH-NIAID R21AI117145-01 to MDS supported reporter
   generation and analysis. The University of Notre Dame Genomics and
   Bioinformatics Core Facility provided further support for this project.
   The funding bodies did not play roles in the experimental design,
   collection, analysis, or interpretation of data, writing of the
   manuscript or decision to submit it for publication.
CR Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   Behura SK, 2015, J MOL BIOL, V427, P521, DOI 10.1016/j.jmb.2014.11.008
   Behura SK, 2013, EVOL APPL, V6, P1079, DOI 10.1111/eva.12088
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonizzoni M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-739
   Borel C, 2011, GENOME RES, V21, P68, DOI 10.1101/gr.109371.110
   Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035
   Chavali PL, 2011, NUCLEIC ACIDS RES, V39, P6908, DOI 10.1093/nar/gkr303
   Clemons A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016730
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299
   Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530
   Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003
   Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506
   Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902
   GUNDERSON SI, 1990, GENE DEV, V4, P2048, DOI 10.1101/gad.4.12a.2048
   Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198
   Haugen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021694
   Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61
   Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Juneja P, 2014, PLOS NEGL TROP DIS, V8
   Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854
   Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021
   Kundaje A, ENCODE TF CHIP SEQ P
   Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466
   McKay DJ, 2013, DEV CELL, V27, P306, DOI 10.1016/j.devcel.2013.10.009
   Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089
   Meyer CG, 2014, SEMIN IMMUNOL, V26, P445, DOI 10.1016/j.smim.2014.09.005
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9
   Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003
   Pesole G, 1999, TRENDS GENET, V15, P378, DOI 10.1016/S0168-9525(99)01795-3
   Sarro J, 2013, DEV DYNAM, V242, P1466, DOI 10.1002/dvdy.24059
   Schneider JR, 2007, MED VET ENTOMOL, V21, P370
   SHARP SJ, 1988, MOL CELL BIOL, V8, P1266
   Sieglaff DH, 2009, P NATL ACAD SCI USA, V106, P3053, DOI 10.1073/pnas.0813264106
   Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444
   Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111
   THATHY V, 1994, J PARASITOL, V80, P705, DOI 10.2307/3283249
   Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3
   Zhang G, 2011, NUCLEIC ACIDS RES, V39, P3331, DOI 10.1093/nar/gkq1257
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 48
TC 0
Z9 0
U1 6
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD MAY 10
PY 2016
VL 17
AR 341
DI 10.1186/s12864-016-2468-x
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA DM4WP
UT WOS:000376348300001
PM 27161480
ER

PT J
AU Lazear, HM
   Stringer, EM
   de Silva, AM
AF Lazear, Helen M.
   Stringer, Elizabeth M.
   de Silva, Aravinda M.
TI The Emerging Zika Virus Epidemic in the Americas Research Priorities
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
C1 [Lazear, Helen M.; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Stringer, Elizabeth M.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chapel Hill, NC USA.
   [Stringer, Elizabeth M.; de Silva, Aravinda M.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA.
   [Lazear, Helen M.] Univ N Carolina, Sch Med, 160 Dent Circle,9021 Burnett Womack Bldg, Chapel Hill, NC 27599 USA.
RP Lazear, HM (reprint author), Univ N Carolina, Sch Med, 160 Dent Circle,9021 Burnett Womack Bldg, Chapel Hill, NC 27599 USA.
EM helen.lazear@med.unc.edu
CR Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gallichotte EN, 2015, MBIO, V6
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison AC, 2010, PLOSNEGL TROP DIS, V4, pe670
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
NR 8
TC 3
Z9 3
U1 4
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAY 10
PY 2016
VL 315
IS 18
BP 1945
EP 1946
DI 10.1001/jama.2016.2899
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL2JP
UT WOS:000375461100008
PM 26963564
ER

PT J
AU Dirlikov, E
   Ryff, KR
   Torres-Aponte, J
   Thomas, DL
   Perez-Padilla, J
   Munoz-Jordan, J
   Caraballo, EV
   Garcia, M
   Segarra, MO
   Malave, G
   Simeone, RM
   Shapiro-Mendoza, CK
   Reyes, LR
   Alvarado-Ramy, F
   Harris, AF
   Rivera, A
   Major, CG
   Mayshack, M
   Alvarado, LI
   Lenhart, A
   Valencia-Prado, M
   Waterman, S
   Sharp, TM
   Rivera-Garcia, B
AF Dirlikov, Emilio
   Ryff, Kyle R.
   Torres-Aponte, Jomil
   Thomas, Dana L.
   Perez-Padilla, Janice
   Munoz-Jordan, Jorge
   Caraballo, Elba V.
   Garcia, Myriam
   Segarra, Marangely Olivero
   Malave, Graciela
   Simeone, Regina M.
   Shapiro-Mendoza, Carrie K.
   Reyes, Lourdes Romero
   Alvarado-Ramy, Francisco
   Harris, Angela F.
   Rivera, Aidsa
   Major, Chelsea G.
   Mayshack, Marrielle
   Alvarado, Luisa I.
   Lenhart, Audrey
   Valencia-Prado, Miguel
   Waterman, Steve
   Sharp, Tyler M.
   Rivera-Garcia, Brenda
TI Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1,
   2015-April 14, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID INTERIM GUIDANCE; UNITED-STATES; PREVENTION
C1 [Dirlikov, Emilio; Ryff, Kyle R.; Torres-Aponte, Jomil; Thomas, Dana L.; Mayshack, Marrielle; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR 00936 USA.
   [Dirlikov, Emilio] CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Thomas, Dana L.] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Perez-Padilla, Janice; Munoz-Jordan, Jorge; Caraballo, Elba V.; Rivera, Aidsa; Major, Chelsea G.; Waterman, Steve; Sharp, Tyler M.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Off Publ Hlth Preparedness & Response, Biol & Chem Emergencies Lab, San Juan, PR USA.
   [Garcia, Myriam; Segarra, Marangely Olivero; Malave, Graciela] Puerto Rico Dept Hlth, Publ Hlth Lab, San Juan, PR USA.
   [Simeone, Regina M.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Shapiro-Mendoza, Carrie K.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Reyes, Lourdes Romero] Puerto Rico Women Infants & Children Program, San Juan, PR USA.
   [Alvarado-Ramy, Francisco] CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Harris, Angela F.] Bill & Melinda Gates Fdn, Seattle, WA USA.
   [Major, Chelsea G.; Mayshack, Marrielle] CDC, Off State Tribal Local & Terr Support, Atlanta, GA 30333 USA.
   [Alvarado, Luisa I.] Ponce Hlth Sci Univ, St Lukes Episcopal Hosp Consortium, San Juan, PR USA.
   [Lenhart, Audrey] CDC, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.
   [Valencia-Prado, Miguel] Puerto Rico Dept Hlth, Puerto Rico Birth Defects Surveillance & Preven S, San Juan, PR USA.
RP Dirlikov, E (reprint author), Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR 00936 USA.; Dirlikov, E (reprint author), CDC, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
EM Zika@salud.gov.pr
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, N ENGL J MED
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
NR 10
TC 3
Z9 3
U1 4
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD MAY 6
PY 2016
VL 65
IS 17
BP 451
EP 455
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DL1GP
UT WOS:000375380900005
PM 27149205
ER

PT J
AU Di Luca, M
   Severini, F
   Toma, L
   Boccolini, D
   Romi, R
   Remoli, ME
   Sabbatucci, M
   Rizzo, C
   Venturi, G
   Rezza, G
   Fortuna, C
AF Di Luca, M.
   Severini, F.
   Toma, L.
   Boccolini, D.
   Romi, R.
   Remoli, M. E.
   Sabbatucci, M.
   Rizzo, C.
   Venturi, G.
   Rezza, G.
   Fortuna, C.
TI Experimental studies of susceptibility of Italian Aedes albopictus to
   Zika virus
SO EUROSURVEILLANCE
LA English
DT Article
ID WEST-NILE-VIRUS; VECTOR COMPETENCE; CHIKUNGUNYA VIRUS; INFECTION;
   CULICIDAE; DIPTERA; FRANCE
AB We report a study on vector competence of an Italian population of Aedes albopictus for Zika virus (ZIKV). Ae. albopictus was susceptible to ZIKV infection (infection rate: 10%), and the virus could disseminate and was secreted in the mosquito's saliva (dissemination rate: 29%; transmission rate: 29%) after an extrinsic incubation period of 11 days. The observed vector competence was lower than that of an Ae. aegypti colony tested in parallel.
C1 [Di Luca, M.; Severini, F.; Toma, L.; Boccolini, D.; Romi, R.] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Unit Vector Borne Dis & Int Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Remoli, M. E.; Venturi, G.; Rezza, G.; Fortuna, C.] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Natl Reference Lab Arboviruses, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Sabbatucci, M.] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, European Programme Publ Hlth Microbiol Training E, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Rizzo, C.] Ist Super Sanita, Natl Ctr Epidemiol & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy.
RP Fortuna, C (reprint author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Natl Reference Lab Arboviruses, Viale Regina Elena 299, I-00161 Rome, Italy.
EM claudia.fortuna@iss.it
RI VENTURI, GIULIETTA/O-8123-2015; Remoli, Maria Elena/O-9447-2015;
   FORTUNA, CLAUDIA/O-9446-2015; 
OI VENTURI, GIULIETTA/0000-0002-9078-8350; Remoli, Maria
   Elena/0000-0003-3565-383X; Rizzo, Caterina/0000-0002-5583-7508
CR Barontti C., 2013, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00500-14, DOI 10.1128/GENOMEA.00500-14]
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Fortuna C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1067-z
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Powers AM, 2009, FUTURE VIROL, V4, P391, DOI 10.2217/FVL.09.19
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Richards SL, 2012, J MED ENTOMOL, V49, P132, DOI 10.1603/ME10280
   Richards SL, 2007, VECTOR-BORNE ZOONOT, V7, P629, DOI 10.1089/vbz.2007.0101
   Talbalaghi A, 2010, MED VET ENTOMOL, V24, P83, DOI 10.1111/j.1365-2915.2009.00853.x
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 18
TC 3
Z9 3
U1 14
U2 14
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAY 5
PY 2016
VL 21
IS 18
BP 6
EP 9
AR 30223
DI 10.2807/1560-7917.ES.2016.21.18.30223
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DM2EI
UT WOS:000376159000002
ER

PT J
AU Miner, JJ
   Diamond, MS
AF Miner, Jonathan J.
   Diamond, Michael S.
TI Understanding How Zika Virus Enters and Infects Neural Target Cells
SO CELL STEM CELL
LA English
DT Editorial Material
ID RECEPTORS; BRAIN
AB Zika virus is a mosquito-transmitted flavivirus that has become a public health concern because of its ability to cause microcephaly. In this issue of Cell Stem Cell, Tang et al. (2016) and Nowakowski et al. (2016) use human neural stem cell models and single-cell RNA sequencing to investigate Zika virus tropism and potential entry receptors.
C1 [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@borcim.wustl.edu
CR Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lazear H.M., 2016, CELL HOST M IN PRESS
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rossi S.L., 2016, AM J TROP M IN PRESS
NR 8
TC 5
Z9 5
U1 37
U2 37
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAY 5
PY 2016
VL 18
IS 5
BP 559
EP 560
DI 10.1016/j.stem.2016.04.009
PG 3
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DL4HE
UT WOS:000375594200002
PM 27152436
ER

PT J
AU Tang, HL
   Hammack, C
   Ogden, SC
   Wen, ZX
   Qian, XY
   Li, YJ
   Yao, B
   Shin, J
   Zhang, FR
   Lee, EM
   Christian, KM
   Didier, RA
   Jin, P
   Song, HJ
   Ming, GL
AF Tang, Hengli
   Hammack, Christy
   Ogden, Sarah C.
   Wen, Zhexing
   Qian, Xuyu
   Li, Yujing
   Yao, Bing
   Shin, Jaehoon
   Zhang, Feiran
   Lee, Emily M.
   Christian, Kimberly M.
   Didier, Ruth A.
   Jin, Peng
   Song, Hongjun
   Ming, Guo-li
TI Zika Virus Infects Human Cortical Neural Progenitors and Attenuates
   Their Growth
SO CELL STEM CELL
LA English
DT Article
ID CELLS
AB The suspected link between infection by Zika virus (ZIKV), a re-emerging flavivirus, and microcephaly is an urgent global health concern. The direct target cells of ZIKV in the developing human fetus are not clear. Here we show that a strain of the ZIKV, MR766, serially passaged in monkey and mosquito cells efficiently infects human neural progenitor cells (hNPCs) derived from induced pluripotent stem cells. Infected hNPCs further release infectious ZIKV particles. Importantly, ZIKV infection increases cell death and dysregulates cell-cycle progression, resulting in attenuated hNPC growth. Global gene expression analysis of infected hNPCs reveals transcriptional dysregulation, notably of cell-cycle-related pathways. Our results identify hNPCs as a direct ZIKV target. In addition, we establish a tractable experimental model system to investigate the impact and mechanism of ZIKV on human brain development and provide a platform to screen therapeutic compounds.
C1 [Tang, Hengli; Hammack, Christy; Ogden, Sarah C.; Lee, Emily M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.
   [Wen, Zhexing; Qian, Xuyu; Shin, Jaehoon; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Wen, Zhexing; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Qian, Xuyu] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA.
   [Shin, Jaehoon; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
   [Li, Yujing; Yao, Bing; Zhang, Feiran; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.
   [Didier, Ruth A.] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.
RP Tang, HL (reprint author), Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.; Song, HJ; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21205 USA.; Ming, GL (reprint author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
EM tang@bio.fsu.edu; shongju1@jhmi.edu; gming1@jhmi.edu
FU College of Arts and Sciences at Florida State University; Department of
   Biological Science at Florida State University; NIH [AI119530, AI111250,
   NS047344, NS048271, NS095348, NS051630, NS079625, MH102690]; MSCRF
FX We thank Yichen Cheng, Taylor Lee, and Jianshe Lang of the Tang
   laboratory, Lihong Liu and Yuan Cai of the Ming and Song laboratories,
   Luoxiu Huang of the Jin laboratory for technical assistance, Zhiheng Xu
   and additional laboratory members for suggestions, and Timothy Megraw
   for assistance with confocal imaging. H.T. thanks the College of Arts
   and Sciences and the Department of Biological Science at Florida State
   University for seed funding. This work was partially supported by NIH
   (AI119530/AI111250 to H.T., NS047344 to H.S., NS048271/NS095348 to
   G-I.M., and NS051630/NS079625/MH102690 to P.J.), MSCRF (to H.S.), and
   start-up funding (to H.S.).
CR BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003
   Calvet G., 2016, LANCET INFECT DIS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Mlakar J., 2016, N ENGL J MED
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465
   Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
NR 12
TC 46
Z9 47
U1 41
U2 41
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAY 5
PY 2016
VL 18
IS 5
BP 587
EP 590
DI 10.1016/j.stem.2016.02.016
PG 4
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DL4HE
UT WOS:000375594200009
PM 26952870
ER

PT J
AU Nowakowski, TJ
   Pollen, AA
   Di Lullo, E
   Sandoval-Espinosa, C
   Bershteyn, M
   Kriegstein, AR
AF Nowakowski, Tomasz J.
   Pollen, Alex A.
   Di Lullo, Elizabeth
   Sandoval-Espinosa, Carmen
   Bershteyn, Marina
   Kriegstein, Arnold R.
TI Expression Analysis Highlights AXL as a Candidate Zika Virus Entry
   Receptor in Neural Stem Cells
SO CELL STEM CELL
LA English
DT Article
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; TAM RECEPTORS; CORTICAL
   DEVELOPMENT; RADIAL GLIA; BRAIN; CHILDREN; MALFORMATIONS; PROGENITORS;
   NEOCORTEX; UPDATE
AB The recent outbreak of Zika virus (ZIKV) in Brazil has been linked to substantial increases in fetal abnormalities and microcephaly. However, information about the underlying molecular and cellular mechanisms connecting viral infection to these defects remains limited. In this study we have examined the expression of receptors implicated in cell entry of several enveloped viruses including ZIKV across diverse cell types in the developing brain. Using single-cell RNA-seq and immunohistochemistry, we found that the candidate viral entry receptor AXL is highly expressed by human radial glial cells, astrocytes, endothelial cells, and microglia in developing human cortex and by progenitor cells in developing retina. We also show that AXL expression in radial glia is conserved in developing mouse and ferret cortex and in human stem cell-derived cerebral organoids, highlighting multiple experimental systems that could be applied to study mechanisms of ZIKV infectivity and effects on brain development.
C1 [Nowakowski, Tomasz J.; Pollen, Alex A.; Di Lullo, Elizabeth; Sandoval-Espinosa, Carmen; Bershteyn, Marina; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.
   [Nowakowski, Tomasz J.; Pollen, Alex A.; Di Lullo, Elizabeth; Sandoval-Espinosa, Carmen; Bershteyn, Marina; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.
RP Kriegstein, AR (reprint author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Kriegstein, AR (reprint author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.
EM kriegsteina@stemcell.ucsf.edu
FU Damon Runyon Cancer Research Foundation [DRG-2166-13]; NIH [U01
   MH105989, R37 NS35710, R01NS075998]; CIRM [GCIR-06673-A]
FX We are grateful to Hanna Retallack, Shaohui Wang, Anne Leyrat, Joe
   Shuga, Aaron Diaz, Mercedes Paredes, Joseph LoTurco, Melanie Bedolli,
   Lillian Adame, Joe DeRisi, and Jeremy Reiter for helpful comments,
   suggestions, and technical help. A.A.P. is supported by a Damon Runyon
   Cancer Research Foundation postdoctoral fellowship (DRG-2166-13). This
   research was supported by NIH awards U01 MH105989, R37 NS35710, and
   R01NS075998 to A.R.K. and CIRM award GCIR-06673-A, and by gifts from
   Helen Ford and Bernard Osher. All work using human tissues and cells was
   conducted in strict observance of the protocols approved by the Human
   Gamete, Embryo, and Stem Cell Research Committee (institutional review
   board), and work involving animal tissues was performed in accordance
   with protocols approved by the University of California San Francisco
   Institutional Animal Care and Use Committee.
CR AHLFORS K, 1986, PEDIATRICS, V78, P1058
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J ME IN PRESS
   Calvet G., 2016, LANCET INFE IN PRESS
   Carteaux G., 2016, N ENGL J ME IN PRESS
   CONBOY TJ, 1986, PEDIATRICS, V77, P801
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   de Paula Freitas B., 2016, JAMA OPTHAL IN PRESS
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Kawasaki H, 2015, AM J PATHOL, V185, P1304, DOI 10.1016/j.ajpath.2015.01.032
   Lanari M, 2012, Early Hum Dev, V88 Suppl 2, pS3, DOI 10.1016/S0378-3782(12)70003-8
   Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S., 2016, LANCET IN PRESS
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   NAKAO T, 1970, PEDIATRICS, V46, P483
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Ostrem BEL, 2014, CELL REP, V8, P656, DOI 10.1016/j.celrep.2014.06.058
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Schuler-Faccini L., 2015, MMWR-MORBID MORTAL W, V65, P59
   SINHA SK, 1972, J MENT DEFIC RES, V16, P90
   Tang H, 2016, CELL STEM C IN PRESS
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI [10.1097/NEN.0000000000000038, 10.1097/NEN.0000000000000036]
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
NR 44
TC 18
Z9 18
U1 26
U2 26
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD MAY 5
PY 2016
VL 18
IS 5
BP 591
EP 596
DI 10.1016/j.stem.2016.03.012
PG 6
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA DL4HE
UT WOS:000375594200010
PM 27038591
ER

PT J
AU Chen, LH
   Hamer, DH
AF Chen, Lin H.
   Hamer, Davidson H.
TI Zika Virus: Rapid Spread in the Western Hemisphere
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID MICRONESIA
C1 [Chen, Lin H.] Mt Auburn Hosp, Div Infect Dis, 330 Mt Auburn St,South 2, Cambridge, MA 02138 USA.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, 801 Massachusetts Ave,Crosstown Third Floor, Boston, MA 02118 USA.
RP Chen, LH (reprint author), Mt Auburn Hosp, 330 Mt Auburn St, Cambridge, MA 02138 USA.
EM lchen@hms.harvard.edu
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Hennessey M, 2015, ZIK VIR SPREADS NEW
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pan American Health Organization, ZIK VIR INF
NR 10
TC 8
Z9 8
U1 3
U2 3
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAY 3
PY 2016
VL 164
IS 9
BP 613
EP +
DI 10.7326/M16-0150
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL6IX
UT WOS:000375744000021
PM 26832396
ER

PT J
AU Aragao, MDV
AF Vasco Aragao, Maria de Fatima
TI Zika virus study in The BMJ was different from the one reported in the
   New England Journal of Medicine
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Letter
C1 [Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Leite Recife Pernam, Brazil.
   [Vasco Aragao, Maria de Fatima] Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil.
RP Aragao, MDV (reprint author), Ctr Diagnost Multimagem, Rua Frei Matias Tevis 194, BR-52010450 Ilha Leite Recife Pernam, Brazil.; Aragao, MDV (reprint author), Mauricio de Nassau Univ, Sch Med, Recife, PE, Brazil.
EM fatima.vascoaragao@gmail.com
CR Hazin AN, 2016, NEW ENGL J MED, DOI [10.1056/NEJMc1603617, DOI 10.1056/NEJMC1603617]
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 2
TC 1
Z9 1
U1 7
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAY 3
PY 2016
VL 353
AR i2444
DI 10.1136/bmj.i2444
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DL4AE
UT WOS:000375574000009
ER

PT J
AU Byk, LA
   Iglesias, NG
   De Maio, FA
   Gebhard, LG
   Rossi, M
   Gamarnik, AV
AF Byk, Laura A.
   Iglesias, Nestor G.
   De Maio, Federico A.
   Gebhard, Leopoldo G.
   Rossi, Mario
   Gamarnik, Andrea V.
TI Dengue Virus Genome Uncoating Requires Ubiquitination
SO MBIO
LA English
DT Article
ID WEST-NILE-VIRUS; CAPSID PROTEIN; CORE PROTEIN; NUCLEAR-LOCALIZATION;
   MONOCLONAL-ANTIBODY; ENVELOPE PROTEIN; MEMBRANE-FUSION; INFECTION; RNA;
   PROTEASOME
AB The process of genome release or uncoating after viral entry is one of the least-studied steps in the flavivirus life cycle. Flaviviruses are mainly arthropod-borne viruses, including emerging and reemerging pathogens such as dengue, Zika, and West Nile viruses. Currently, dengue virus is one of the most significant human viral pathogens transmitted by mosquitoes and is responsible for about 390 million infections every year around the world. Here, we examined for the first time molecular aspects of dengue virus genome uncoating. We followed the fate of the capsid protein and RNA genome early during infection and found that capsid is degraded after viral internalization by the host ubiquitin-proteasome system. However, proteasome activity and capsid degradation were not necessary to free the genome for initial viral translation. Unexpectedly, genome uncoating was blocked by inhibiting ubiquitination. Using different assays to bypass entry and evaluate the first rounds of viral translation, a narrow window of time during infection that requires ubiquitination but not proteasome activity was identified. In this regard, ubiquitin E1-activating enzyme inhibition was sufficient to stabilize the incoming viral genome in the cytoplasm of infected cells, causing its retention in either endosomes or nucleocapsids. Our data support a model in which dengue virus genome uncoating requires a nondegradative ubiquitination step, providing new insights into this crucial but understudied viral process.
   IMPORTANCE Dengue is the most significant arthropod-borne viral infection in humans. Although the number of cases increases every year, there are no approved therapeutics available for the treatment of dengue infection, and many basic aspects of the viral biology remain elusive. After entry, the viral membrane must fuse with the endosomal membrane to deliver the viral genome into the cytoplasm for translation and replication. A great deal of information has been obtained in the last decade regarding molecular aspects of the fusion step, but little is known about the events that follow this process, which leads to viral RNA release from the nucleocapsid. Here, we investigated the fate of nucleocapsid components (capsid protein and viral genome) during the infection process and found that capsid is degraded by the ubiquitin-proteasome system. However, in contrast to that observed for other RNA and DNA viruses, dengue virus capsid degradation was not responsible for genome uncoating. Interestingly, we found that dengue virus genome release requires a nondegradative ubiquitination step. These results provide the first insights into dengue virus uncoating and present new opportunities for antiviral intervention.
C1 [Byk, Laura A.; Iglesias, Nestor G.; De Maio, Federico A.; Gebhard, Leopoldo G.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina.
   [Rossi, Mario] Consejo Nacl Invest Cient & Tecn, Inst Invest Biomed Buenos Aires IBioBA, Partner Inst Max Planck Soc, Polo Cient Tecnol, Buenos Aires, DF, Argentina.
RP Gamarnik, AV (reprint author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina.
EM agamarnik@leloir.org.ar
FU ANPCyT Argentina [PICT-2014-2111]; NIAID \ National Institutes of Health
   (NIH) [R01.AI095175]
FX This work, including the efforts of Andrea Gamarnik, was funded by
   ANPCyT Argentina (PICT-2014-2111). This work, including the efforts of
   Andrea Gamarnik, was funded by NIAID vertical bar National Institutes of
   Health (NIH) (R01.AI095175).
CR Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919
   Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10
   Greene W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002703
   Huotari J, 2012, P NATL ACAD SCI USA, V109, P823, DOI 10.1073/pnas.1118744109
   Iglesias NG, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P334, DOI 10.1079/9781845939649.0334
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Kanlaya R, 2010, J PROTEOME RES, V9, P4960, DOI 10.1021/pr100219y
   Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Klumpp K, 2014, CURR OPIN VIROL, V5, P63, DOI 10.1016/j.coviro.2014.02.002
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mateo R, 2015, MBIO, V6, DOI 10.1128/mBio.01960-15
   Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Piper R.C., 2014, COLD SPRING HARB PER, V6, P6, DOI DOI 10.1101/CSHPERSPECT.A016808
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   SINGH I, 1992, J VIROL, V66, P7049
   Su WC, 2013, P NATL ACAD SCI USA, V110, P17516, DOI 10.1073/pnas.1312374110
   TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409
   Wang SH, 2002, J GEN VIROL, V83, P3093
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhou HL, 2013, GENE DEV, V27, P1046, DOI 10.1101/gad.215681.113
NR 34
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2016
VL 7
IS 3
AR e00804-16
DI 10.1128/mBio.00804-16
PG 10
WC Microbiology
SC Microbiology
GA DW1YP
UT WOS:000383440300064
ER

PT J
AU Rodrigues, ML
   Morel, CM
AF Rodrigues, Marcio L.
   Morel, Carlos M.
TI The Brazilian Dilemma: Increased Scientific Production and High
   Publication Costs during a Global Health Crisis and Major Economic
   Downturn
SO MBIO
LA English
DT Editorial Material
ID ZIKA VIRUS; PAGE CHARGES; OUTBREAK
C1 [Rodrigues, Marcio L.; Morel, Carlos M.] Fundacao Oswaldo Cruz Fiocruz, Ctr Desenvolvimento Tecnol Saude CDTS, Rio De Janeiro, Brazil.
   [Rodrigues, Marcio L.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
RP Rodrigues, ML; Morel, CM (reprint author), Fundacao Oswaldo Cruz Fiocruz, Ctr Desenvolvimento Tecnol Saude CDTS, Rio De Janeiro, Brazil.; Rodrigues, ML (reprint author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
EM marciolrodrig@gmail.com; morel@cdts.fiocruz.br
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CNPq, 2016, ED UN CHAM MCTI CNPQ
   World Factbook, 2009, COUNTR COMP GROSS DO
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   GRUNDFEST H, 1969, SCIENCE, V164, P905, DOI 10.1126/science.164.3882.905-c
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kligfield P, 2005, J ELECTROCARDIOL, V38, P296, DOI 10.1016/j.jelectrocard.2005.05.004
   Petherick A, 2011, NAT MED, V17, P1173, DOI 10.1038/nm1011-1173
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   [Anonymous], 2011, NAT MED, V17, P1169
NR 12
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2016
VL 7
IS 3
AR e00907-16
DI 10.1128/mBio.00907-16
PG 2
WC Microbiology
SC Microbiology
GA DW1YP
UT WOS:000383440300075
ER

PT J
AU Giovanetti, M
   Milano, T
   Alcantara, LC
   Carcangiu, L
   Cella, E
   Lai, A
   Lo Presti, A
   Pascarella, S
   Zehender, G
   Angeletti, S
   Ciccozzi, M
AF Giovanetti, Marta
   Milano, Teresa
   Alcantara, Luiz Carlos
   Carcangiu, Laura
   Cella, Eleonora
   Lai, Alessia
   Lo Presti, Alessandra
   Pascarella, Stefano
   Zehender, Gianguglielmo
   Angeletti, Silvia
   Ciccozzi, Massimo
TI Zika virus spreading in South America: evolutionary analysis of emerging
   neutralizing resistant Phe279Ser strains
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Phylogeny; Evolution
ID AMINO-ACID SITES; ENVELOPE PROTEIN; MOLECULAR EVOLUTION; POSITIVE
   SELECTION; SEQUENCE ALIGNMENT; AEDES-AEGYPTI; GLYCOPROTEIN; MONTENEGRO;
   PREDICTION; RESOLUTION
AB Objective: To investigate the genetic diversity of Zika virus (ZIKV) and the relationships existing among these circulating viruses worldwide. To evaluate the genetic polymorphisms harboured from ZIKV that can have an influence on the virus circulation. Methods: Three different ZIKV dataset were built. The first dataset included 63 E gene sequences, the second one 22 NS3 sequences and the third dataset was composed of 108 NS5 gene sequences. Phylogenetic and selective pressure analysis was performed. The edited nucleic acid alignment from the Envelope dataset was used to generate a conceptual translation to the corresponding peptide sequences through UGene software. Results: The phylogeographic reconstruction was able to discriminate unambiguously that the Brazilian strains are belonged to the Asian lineage. The structural analysis reveals instead the presence of the Ser residue in the Brazilian sequences (however already observed in other previously reported ZIKV infections) that could suggest the presence of a neutralization-resistant population of viruses. Conclusions: Phylogenetic, evolutionary and selective pressure analysis contributed to improve the knowledge on the circulation of ZIKV.
C1 [Giovanetti, Marta; Carcangiu, Laura; Cella, Eleonora; Lo Presti, Alessandra; Ciccozzi, Massimo] Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Rome, Italy.
   [Giovanetti, Marta] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.
   [Giovanetti, Marta; Alcantara, Luiz Carlos] Oswaldo Cruz Fdn LHGB CPqGM FIOCRUZ, Goncalo Moniz Res Ctr, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil.
   [Milano, Teresa; Pascarella, Stefano] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.
   [Cella, Eleonora] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy.
   [Lai, Alessia; Zehender, Gianguglielmo] Univ Milan, Lab Infect Dis & Trop Med, I-20122 Milan, Italy.
   [Angeletti, Silvia] Univ Hosp Campus Biomed Rome, Clin Pathol & Microbiol Lab, Rome, Italy.
   [Ciccozzi, Massimo] Univ Campus Biomed, Rome, Italy.
RP Ciccozzi, M (reprint author), Natl Inst Hlth, Dept Infect Parasit & Immunomediated Dis, Epidemiol Unit, Reference Ctr Phylogeny Mol Epidemiol & Microbial, Rome, Italy.
EM ciccozzi@iss.it
RI Lo Presti, Alessandra/K-1451-2016; CICCOZZI, MASSIMO/C-6484-2016; Cella,
   Eleonora/J-9961-2016
OI Lo Presti, Alessandra/0000-0001-7611-5021; CICCOZZI,
   MASSIMO/0000-0003-3866-9239; Cella, Eleonora/0000-0002-7870-9744
CR Anisimova M, 2001, MOL BIOL EVOL, V18, P1585
   Anisimova M, 2002, MOL BIOL EVOL, V19, P950
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721
   Bisset J A, 2001, Rev Cubana Med Trop, V53, P37
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Ciccozzi M, 2012, AIDS RES HUM RETROV, V28, P1280, DOI 10.1089/aid.2011.0138
   Ciccozzi M, 2011, AIDS RES HUM RETROV, V27, P921, DOI [10.1089/AID.2010.0323, 10.1089/aid.2010.0323]
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Haddow AD, PLOS NEGL TROP DIS, V201
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008
   Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lcmey P, 2009, PLOS COMPUT BIOL, V5, P1
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Lo Presti A, 2012, INFECT GENET EVOL, V12, P392, DOI 10.1016/j.meegid.2011.12.015
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nielsen R, 1998, GENETICS, V148, P929
   Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rodriguez MM, 2001, J MED ENTOMOL, V38, P623, DOI 10.1603/0022-2585-38.5.623
   Salemi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001390
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schroedinger L., 2015, PYMOL MOL GRAPHICS S
   Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
   Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097
   Yang ZH, 2000, GENETICS, V155, P431
NR 47
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAY
PY 2016
VL 9
IS 5
BP 445
EP 452
DI 10.1016/j.apjtm.2016.03.028
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DL0YS
UT WOS:000375359100006
PM 27261852
ER

PT J
AU Zhang, JW
   Jin, X
   Zhu, ZY
   Huang, L
   Liang, SJ
   Xu, Y
   Liao, RY
   Zhou, LC
   Zhang, Y
   Wilder-Smith, A
AF Zhang, Jiwen
   Jin, Xia
   Zhu, Zhaoyin
   Huang, Li
   Liang, Shaojun
   Xu, Yuan
   Liao, Ruyan
   Zhou, Licheng
   Zhang, Yan
   Wilder-Smith, Annelies
TI Early detection of Zika virus infection among travellers from areas of
   ongoing transmission in China
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Zika virus; detection; imported case
AB Nine imported Zika virus (ZIKV) infections (four through temperature monitoring and epidemiological investigation at entry and five by active surveillance tracking of index case contacts during follow-up; from Venezuela [n = 5], Samoa [n = 3] and both Samoa and Fiji [n = 1]) were detected in mainland China from February 1 to 29, 2016. The minimal incubation period lasted 5.2 days, with mean lag time to diagnosis of 2.6 days. Diagnosis relied on positive real-time reverse transcriptase polymerase chain reaction for ZIKV RNA in serum (n = 7), urine (n = 4) or saliva (n = 3), respectively. All cases recovered rapidly without serious complications.
C1 [Zhang, Jiwen; Jin, Xia; Zhu, Zhaoyin] Gen Adm Qual Supervis Inspect & Quarantine PRC, Beijing, Peoples R China.
   [Huang, Li] Guangdong Entry & Exit Inspect & Quarantine Bur, Guangzhou, Guangdong, Peoples R China.
   [Liang, Shaojun] Guangdong Int Travel Hlth Care Ctr, Guangzhou, Guangdong, Peoples R China.
   [Xu, Yuan] Shenzhen Int Travel Hlth Care Ctr, Shenzhen, Guangdong, Peoples R China.
   [Liao, Ruyan] Guangzhou Entry & Exit Inspect & Quarantine Bur, Guangzhou, Guangdong, Peoples R China.
   [Zhou, Licheng] Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen, Guangdong, Peoples R China.
   [Zhang, Yan] Zhejiang Entry & Exit Inspect & Quarantine Bur, Hangzhou, Zhejiang, Peoples R China.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
RP Huang, L (reprint author), Guangdong Entry & Exit Inspect & Quarantine Bur, Guangzhou, Guangdong, Peoples R China.
EM 997843156@qq.com
CR Jiamu C, 2015, PORT HLTH CONTROL, V20, P14
   Kui Z, 2016, CHIN FRONT HLTH QUAR, V39, P1
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Qiyong L., 2016, CHIN J VECTOR BIOL C, V27, P93
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   WHO, WHO DIR GEN SUMM OUT
   [Anonymous], 2016, ZIK VIR MICR GUILL B
NR 8
TC 0
Z9 0
U1 2
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD MAY
PY 2016
VL 23
IS 5
AR taw047
DI 10.1093/jtm/taw047
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DV9MN
UT WOS:000383264700003
ER

PT J
AU Koenig, KL
   Almadhyan, A
   Burns, MJ
AF Koenig, Kristi L.
   Almadhyan, Abdulmajeed
   Burns, Michael J.
TI Identify-Isolate-Inform: A Tool for Initial Detection and Management of
   Zika Virus Patients in the Emergency Department
SO WESTERN JOURNAL OF EMERGENCY MEDICINE
LA English
DT Article
AB First isolated in 1947 from a monkey in the Zika forest in Uganda, and from mosquitoes in the same forest the following year, Zika virus has gained international attention due to concerns for infection in pregnant women potentially causing fetal microcephaly. More than one million people have been infected since the appearance of the virus in Brazil in 2015. Approximately 80% of infected patients are asymptomatic. An association with microcephaly and other birth defects as well as Guillain-Barre Syndrome has led to a World Health Organization declaration of Zika virus as a Public Health Emergency of International Concern in February 2016. Zika virus is a vector-borne disease transmitted primarily by the Aedes aegypti mosquito. Male to female sexual transmission has been reported and there is potential for transmission via blood transfusions. After an incubation period of 2-7 days, symptomatic patients develop rapid onset fever, maculopapular rash, arthralgia, and conjunctivitis, often associated with headache and myalgias. Emergency department (ED) personnel must be prepared to address concerns from patients presenting with symptoms consistent with acute Zika virus infection, especially those who are pregnant or planning travel to Zika-endemic regions, as well as those women planning to become pregnant and their partners. The identify-isolate-inform (3I) tool, originally conceived for initial detection and management of Ebola virus disease patients in the ED, and later adjusted for measles and Middle East Respiratory Syndrome, can be adapted for real-time use for any emerging infectious disease. This paper reports a modification of the 3I tool for initial detection and management of patients under investigation for Zika virus. Following an assessment of epidemiologic risk, including travel to countries with mosquitoes that transmit Zika virus, patients are further investigated if clinically indicated. If after a rapid evaluation, Zika or other arthropod-borne diseases are the only concern, isolation (contact, droplet, airborne) is unnecessary. Zika is a reportable disease and thus appropriate health authorities must be notified. The modified 3I tool will facilitate rapid analysis and triggering of appropriate actions for patients presenting to the ED at risk for Zika.
C1 [Koenig, Kristi L.; Almadhyan, Abdulmajeed] Univ Calif Irvine, Med Ctr, Dept Emergency Med, Ctr Disaster Med Sci, Orange, CA 92668 USA.
   [Burns, Michael J.] Univ Calif Irvine, Med Ctr, Dept Emergency Med, Orange, CA 92668 USA.
   [Burns, Michael J.] Univ Calif Irvine, Med Ctr, Dept Med, Div Infect Dis, Orange, CA 92668 USA.
   [Almadhyan, Abdulmajeed] Qassim Univ, Dept Emergency Med, Buraydah, Saudi Arabia.
RP Koenig, KL (reprint author), Univ Calif Irvine, Dept Emergency Med, Ctr Disaster Med Sci, 333 City Blvd West,Suite 640,Rt 128-01, Orange, CA 92868 USA.
EM kkoenig@uci.edu
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Barbisch D, 2015, DISASTER MED PUBLIC
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   Cauchemez S, LANCET
   CDC, 2016, DIV VECT BORN DIS ME
   Centers for Disease Control and Prevention, 2016, WEB UPD INT ZIK VIR
   Darlington S., CNN BRAZIL WARNS PRE
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Koenig KL, 2016, DISASTER MED PUBLIC
   Koenig KL, 2014, 2014 EBOLA VIRUS OUT
   Koenig KL, DISASTER MED PUBLIC
   Koenig KL, 2014, ANN EMERG MED
   Koenig KL, 2015, W J EMERG MED
   Koenig KL, 2014, W J EMERG MED
   Korte G, 2016, US TODAY
   Lucey DR, 2016, JAMA
   Maron DF, 2016, SCI AM
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   [Anonymous], 2016, POT ZIK VIR RISK EST
   WHO Emergency Preparedness and Response, 2015, ZIK VIR DIS INT CAS
   WHO statement on the first meeting of the International Health Regulations, 2005, 1 M INT HLTH REG IHR
   [Anonymous], 2016, WHO ZIKA STRATEGIC R
   [Anonymous], 2016, MMWR, V65, P122
   [Anonymous], 2016, FDA ISSUES RECOMMEND
NR 24
TC 0
Z9 0
U1 3
U2 3
PU WESTJEM
PI ORANGE
PA C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01,
   ORANGE, CA 92868 USA
SN 1936-900X
EI 1936-9018
J9 WEST J EMERG MED
JI West. J. Emerg. Med.
PD MAY
PY 2016
VL 17
IS 3
BP 238
EP 244
DI 10.5811/westjem.2016.3.30188
PG 7
WC Emergency Medicine
SC Emergency Medicine
GA DV3QH
UT WOS:000382837400001
PM 27330653
ER

PT J
AU Ottersen, T
   Hoffman, SJ
   Groux, G
AF Ottersen, Trygve
   Hoffman, Steven J.
   Groux, Gaelle
TI EBOLA AGAIN SHOWS THE INTERNATIONAL HEALTH REGULATIONS ARE BROKEN: WHAT
   CAN BE DONE DIFFERENTLY TO PREPARE FOR THE NEXT EPIDEMIC?
SO AMERICAN JOURNAL OF LAW & MEDICINE
LA English
DT Article
ID ADDRESSING ANTIBIOTIC-RESISTANCE; VIRUS DISEASE EPIDEMIC; GLOBAL HEALTH;
   PUBLIC-HEALTH; PANDEMIC PREPAREDNESS; GOVERNANCE CHALLENGES;
   ECONOMIC-IMPACT; LESSONS; INFLUENZA; FRAMEWORK
AB Epidemics are among the greatest threats to humanity, and the International Health Regulations are the world's key legal instrument for addressing this threat. Since their revision in 2005, the IHR have faced two big tests: the 2009 H1N1 influenza pandemic and the 2014 Ebola epidemic in West Africa. Both exposed major shortcomings of the IHR, and both offered profound lessons for the future. The objective of this Article is twofold. First, we seek to compare the lessons learned from H1N1 and Ebola for reforming the IHR in order to test the hypothesis that they are similar. Second, we seek to examine the barriers to implementing these lessons and to identify strategies for overcoming those barriers. We find that the lessons from H1N1 and Ebola are indeed similar, and that opportunities to act on lessons from H1N1 were woefully missed. We identify many political barriers to global collective action and implementation of lessons for the IHR. On that basis, we describe strategies to overcome these barriers, which will hopefully be deployed now to reform the IHR before the policy window following Ebola closes, and before the inevitable next epidemic comes. The emerging threat of the Zika virus underscores that we have no time to waste.
C1 [Ottersen, Trygve] Univ Oslo, Dept Community Med & Global Hlth, Oslo Grp Global Hlth Policy, Oslo, Norway.
   [Hoffman, Steven J.; Groux, Gaelle] Univ Ottawa, Fac Law, Global Strategy Lab, Ctr Hlth Law Policy & Eth, Ottawa, ON, Canada.
RP Ottersen, T (reprint author), Univ Oslo, Dept Community Med & Global Hlth, Oslo Grp Global Hlth Policy, Oslo, Norway.
EM trygve.ottersen@medisin.uio.no; steven.hoffman@globalstrategylab.org;
   gaelle.groux@globalstrategylab.org
FU Research Council of Norway's Global Health & Vaccination Programme
   (GLOBVAC) [234608]; Canadian Institutes of Health Research; Trudeau
   Foundation
FX Thank you to Benedikte Alveberg, Steinar Andresen, Frode Forland,
   Elizabeth Peacocke, and Jeremy Shiffman for providing feedback on
   earlier drafts of this manuscript, and to Tanner McInnis and Kelsey
   Vercammen for their research assistance. This work was completed as part
   of the International Collaboration for Capitalizing on Cost-Effective
   and Life-Saving Commodities (i4C) that is funded through the Research
   Council of Norway's Global Health & Vaccination Programme (GLOBVAC
   Project #234608). SJH is additionally funded by the Canadian Institutes
   of Health Research and the Trudeau Foundation.
CR Andresen S, 2015, J LAW MED ETHICS, V43, P46, DOI 10.1111/jlme.12274
   Anema A, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-1
   Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5
   BBC, 2009, BBC
   Behdinan A, 2015, J LAW MED ETHICS, V43, P68, DOI 10.1111/jlme.12277
   Bogich Tiffany L., 2012, PLOS MED, V9, P2
   Bogich Tiffany L., 2012, PLOS MED, V9, P1
   Browne Andrew, 2009, WALL ST J
   [Anonymous], 2009, OR 2009 H1N1 FLU SWI
   [Anonymous], 2010, 2009 H1N1 PAND
   [Anonymous], 2009, COMMUNICATION
   Chan Margaret, 2009, WORLD NOW START 2009
   Cheng Maria, 2015, BUSINESS INSIDER
   Clift Charles, 2015, IS YET ANOTHER EBOLA
   Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3513
   COMM'N ON A GLOBAL HEALTH RISK FRAMEWORK FOR THE FUTURE & NAT'L ACAD. OF MED, 2016, NEGL DIM GLOB SEC FR, P18
   Dahlberg Rasmus, 2016, DISASTER RES MULTIDI
   DAVIES SARA E., 2015, DIS DIPLOMACY INT NO
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   DECLICH S, 1994, B WORLD HEALTH ORGAN, V72, P285
   Feler Lane, 2015, COLUM J TRANSNATL L, V13, P28
   Feler Lane, 2015, COLUM J TRANSNATL L, V13, P13
   Fidler DP, 2006, J LAW MED ETHICS, V34, P85, DOI 10.1111/j.1748-720X.2006.00011.x
   Fidler DP, 2005, CHIN J INT LAW, V4, P325, DOI DOI 10.1093/CHINESEJIL/JMI029
   Fidler David P., 2015, EBOLA REPORT MISSES
   Fidler D.P., 2005, CHIN J INT LAW, Viv, P331
   FIDLER DAVID P., 1999, INT LAW INFECT DIS, P22
   Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802
   Fink Sheri, 2014, NY TIMES
   Flynn Daniel, 2014, REUTERS
   Flynn Paul, 2010, HANDLING H1N1 PANDEM, P17
   Foulkes Imogen, 2010, BBC
   Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339
   Garrett L, 2015, FOREIGN AFF, V94, P80
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Gopinathan U, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0128-6
   Gostin LO, 2014, LANCET, V384, pE49, DOI 10.1016/S0140-6736(14)61345-3
   Gostin LO, 2009, JAMA-J AM MED ASSOC, V301, P2376, DOI 10.1001/jama.2009.849
   Gostin LO, 2015, LANCET, V386, P2222, DOI 10.1016/S0140-6736(15)00948-4
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   GOSTIN LAWRENCE O., 2014, GLOBAL HLTH LAW, P202
   Gostin Lawrence O., 2014, LANCET, V384, pe50
   Hardiman MC, 2012, EMERG INFECT DIS, V18, P1041, DOI 10.3201/eid1807.120395
   Harrell Eben, 2010, TIME
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3
   Hodge Jr James G., 2010, MINN L J SCI TECH, V11, P607
   Hodge Jr JG, 2010, MINNESOTA J LAW SCI, V11, P599
   Hoffman Steven J., B WHO, V93, P867
   Hoffman Steven J., 2015, MAPPING GLOBAL HLTH, P5
   Hoffman S. J., 2016, SYSTEMATIC REVS, V5, P1
   Hoffman SJ, 2015, J LAW MED ETHICS, V43, P363, DOI 10.1111/jlme.12253
   Hoffman SJ, 2014, PUBLIC HEALTH, V128, P188, DOI 10.1016/j.puhe.2013.08.021
   Hoffman SJ, 2016, J CLIN EPIDEMIOL, V75, P47, DOI 10.1016/j.jclinepi.2015.12.010
   Hoffman SJ, 2015, ROUTLEDGE HANDBOOK OF GLOBAL HEALTH SECURITY, P239
   Hoffman SJ, 2015, B WORLD HEALTH ORGAN, V93, P66, DOI 10.2471/BLT.15.152710
   Hoffman SJ, 2015, J LAW MED ETHICS, V43, P53, DOI 10.1111/jlme.12275
   Hoffman SJ, 2015, J LAW MED ETHICS, V43, P65, DOI 10.1111/jlme.12276
   Hoffman SJ, 2010, HEALTH POLICY PLANN, V25, P510, DOI 10.1093/heapol/czq037
   Hoffman SJ, 2015, AM J PUBLIC HEALTH, V105, P26, DOI 10.2105/AJPH.2014.302085
   Hoffman SJ, 2015, AM J PUBLIC HEALTH, V105, P1523, DOI 10.2105/AJPH.2015.302726
   INST. FOR HEALTH METRICS & EVALUATION, 2014, FIN GLOB HLTH 2013 T, P19
   [Anonymous], 2015, INT CRISIS GRP  1028
   Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   Kamradt-Scott A, 2016, THIRD WORLD Q, V37, P401, DOI 10.1080/01436597.2015.1112232
   Kamradt-Scott Adam, 2013, HLTH DIPL MONITOR, V4, P15
   Kamradt-Scott Adam, 2013, HLTH DIPL MONITOR, V4, P14
   Kamradt-Scott Adam, 2010, HLTH DIPL MONITOR, V1, P11
   Kamradt-Scott Adam, 2010, HLTH DIPL MONITOR, V1, P10
   KATES, 2015, US RESPONSE EBOLA ST, P4
   Katz R., 2010, GLOBAL HLTH GOVERNAN, V3, P1
   Katz R, 2010, GLOB HLTH GOV, VIII, P2
   Katz R, 2015, LANCET GLOB HEALTH, V3, pE352, DOI 10.1016/S2214-109X(15)00025-X
   Keller Ann C., 2012, RISK HAZARDS CRISIS, V3, P15
   Keller A. C., 2012, RISKS HAZARDS CRISIS, V3, P1
   Keogh-Brown MR, 2008, HEALTH POLICY, V88, P110, DOI 10.1016/j.healthpol.2008.03.003
   Keogh-Brown Marcus Richard, 2008, HLTH POLY, V88, P117
   Keung Nicholas, 2014, TORONTO STAR
   Kickbusch I, 2010, J LAW MED ETHICS, V38, P550, DOI 10.1111/j.1748-720X.2010.00511.x
   Kingdon J. W., 1995, AGENDAS ALTERNATIVES
   Knobler Stacey, 2004, LEARNING SARS PREPAR, P4
   Kupferschmidt Kai, 2015, SCIENCE
   Lavis John N., 2012, PLOS MED, V9, P4
   Lavis John N., 2012, PLOS MED, V9, P1
   Liu B, 2015, INT J HEALTH POLICY, V4, P381, DOI 10.15171/ijhpm.2015.84
   Mackey TK, 2012, J PUBLIC HEALTH POL, V33, P119, DOI 10.1057/jphp.2011.51
   [Anonymous], 2015, LIMN            0710
   McKirdy Euan, 2014, CNN             1028
   MEDICINS SANS FRONTIERES, 2014, EB W AFR EP REQ MASS
   [Anonymous], 2015, PUSH LIM YEAR LARG E, P12
   Molenaar Bente, 2011, HLTH DIPLOMACY MONIT, V2, P20
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Nishtar Sania, 2007, HEARTFILE       0701
   Nuzzo Jennifer B., 2011, GLOBAL HLTH GOV, V4, P1
   Nuzzo Jennifer B., 2011, GLOBAL HLTH GOV, V4, P10
   Ooms Gorik, 2015, SAVE HUMANITY WHAT M, p[257, 258]
   Osborne James, 2009, FOX NEWS
   Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068
   Phu Tran Dac, 2013, MMWR-MORBID MORTAL W, V63, P77
   Piot Peter, 2010, ENSURING HLTH ALL NE
   PREVENT Project, 2011, PAND WHOL OF SOC APP, P69
   Rassy Dunia, 2013, HEALTH ECON, V22, P831
   Rassy D, 2013, HEALTH ECON, V22, P824, DOI 10.1002/hec.2862
   Rizvi Z, 2015, J LAW MED ETHICS, V43, P74, DOI 10.1111/jlme.12278
   Rodier G, 2007, EMERG INFECT DIS, V13, P1447, DOI 10.3201/eid1310.070732
   RUBIN HARVEY, 2011, FUTURE GLOBAL SHOCKS, P4
   Sack K, 2014, NY TIMES
   Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7
   Siedner Mark J., 2015, PLOS MED, V12, P6
   Siedner Mark J., 2015, PLOS MED, V12, P1
   Stephens David S., 2015, PLOS MED, V12, P1
   The Lancet, 2014, LANCET, V384, P1321
   Thompson Nick, 2014, CNN             1202
   UNITED NATIONS, 1945, CHART UN
   UNITED NATIONS, 2015, MAK DIFF PROG REP 20, P9
   JOINT UNITED NATIONS PROGRAMME ON HVI/AIDS [UNAIDS] & WHO, 2009, AIDS EP UPD DEC 2009, P7
   von Tigerstrom Barbara, 2005, Health Law J, V13, P35
   Wamala Joseph F., 2010, BMC PUBLIC HEALTH, V10, P1
   Wamala Joseph F., 2010, BMC PUBLIC HEALTH, V10, P4
   WATSON TOWERS, 2013, EXTREME RISKS INSURA, P3
   WORLD BANK GRP. [WBG], 2014, WORLD DEV REP 2014 R, P18
   [Anonymous], 2005, INT HLTH REG 2015
   WHO, 2011, STRENGTH RESP PAND O
   WHO, 2014, REP SECR EB VIR DIS, P2
   [Anonymous], 2016, GLOB HTLH OBS GHO DA
   [Anonymous], 2015, DIR GEN SPEC SESS EX
   WHO, 2009, WKLY EPIDEMIOL REC, V84, P173
   [Anonymous], WHO REF MIL
   WHO, 2015, EB SIT REP 30 DEC 20
   [Anonymous], 2016, STAT PART INT HLTH R
   [Anonymous], 2009, SWIN INFL UPD 3
   [Anonymous], 2016, GLOB HLTH OBS DAT RE
   [Anonymous], 2010, H1N1 POSTP PER
   [Anonymous], REV COMM ROL INT HLT
   WHO, 2013, CHECKL IND MON PROGR, P15
   WHO, 2016, EB SIT REP 20 JAN
   [Anonymous], IHR EM COMM REG EB
   World Health Organization, 2008, PROGR BUDG 2006 2007, P262
   [Anonymous], 2005, SUMM STAT PART 2013
   World Health Organization, 2015, ON YEAR EB EP DEADL
   WHO, 2015, PROV SUMM REC 8 M JU, P14
   World Health Organization, GLOB HLTH OBS DAT RE
   WHO, 2016, EB13820 WHO, P20
   [Anonymous], LIST MEMB ADV INT HL
   WHO, PROGR BUDG PERF ASS
   WHO, 2015, ADV GROUP REF WHOS W, p[4, 10]
   WHO, 2016, ADV GROUP REF WHOS W, p[10, 14]
   WHO, PROGR BUDG 2014 2015
   WHO, 2015, REP EB INT ASS PAN, P5
   [Anonymous], BIOGR MEMB ADV IHR E
   WHO, 2006, PATH GEN SKIN TUM, P13
   Wilson K, 2010, HEALTH POLICY PLANN, V25, P505, DOI 10.1093/heapol/czq026
   THE WORLD BANK, 2012, PEOPL PATH OUR PLAN, P23
   WORLD HEALTH ASSEMBLY, 2008, WORLD DEV REP 2008 A, P3
   THE WORLD BANK, 2010, PEOPL PATH OUR PLAN, P7
   [Anonymous], 2014, TRANSCR UN HLTH COV
   WRIGHT SIMON, 2015, WAKE CALL LESSONS EB, P1
   Zhang Ying, 2013, PLOS ONE, V8, P5
   Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056732
   [Anonymous], 2008, JAKARTA POST
   [Anonymous], 2014, BBC NEWS
   [Anonymous], 2016, PROTECTING HUMANITY, P11
NR 163
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0098-8588
EI 2375-835X
J9 AM J LAW MED
JI Am. J. Law Med.
PD MAY
PY 2016
VL 42
IS 2-3
BP 356
EP 392
DI 10.1177/0098858816658273
PG 37
WC Law
SC Government & Law
GA DS7KJ
UT WOS:000380962100006
ER

PT J
AU Mourya, DT
   Shil, P
   Sapkal, GN
   Yadav, PD
AF Mourya, Devendra T.
   Shil, Pratip
   Sapkal, Gajanan N.
   Yadav, Pragya D.
TI Zika virus: Indian perspectives
SO INDIAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Review
DE Aedes; microcephaly; mosquito; vector; vertical transmission; Zika virus
ID TRANSMISSION; INFECTIONS; NIGERIA; ARBOVIRUSES; FEVER
AB The emergence of Zika virus (ZiV), a mosquito borne Flavivirus like dengue (DEN) and chikungunya (CHIK), in Brazil in 2014 and its spread to various countries have led to a global health emergency. Aedes aegypti is the major vector for ZiV. Fast dissemination of this virus in different geographical areas posses a major threat especially to regions where the population lacks herd immunity against the ZiV and there is abundance of Aedes mosquitoes. In this review, we focus on current global scenario, epidemiology, biology, diagnostic challenges and remedial measures for ZiV considering the Indian perspective.
C1 [Mourya, Devendra T.; Shil, Pratip; Sapkal, Gajanan N.; Yadav, Pragya D.] ICMR Natl Inst Virol, 20-A,Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
RP Mourya, DT (reprint author), ICMR Natl Inst Virol, 20-A,Dr Ambedkar Rd, Pune 411001, Maharashtra, India.
EM dtmourya@gmail.com
CR BHATT PN, 1967, INDIAN J MED RES, V55, P1295
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Center for Disease Control Atlanta United States, REV TEST ALG ZIK CHI
   Centre for Disease Control Atlanta United States, ZIK GUILL BARR SYNDR
   Centers for Disease Control and Prevention, MORBIDITY MORTALITY
   Constancia FJA, 2016, LANCET INFECT DIS
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Enserink M, SCI NEWS
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Fields BN, 2007, FIELDS VIROLOGY, P1156
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire CCM, 2015, BIORXIV
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, pe2681, DOI [DOI 10.1371/J0URNAL.PNTD.0002681, 10.1371/journal.pntd.0002681]
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2010, EMERG INFECT DIS, V2012, P349
   Khan K, 2014, PLOS CURR, V6, P6, DOI DOI 10.1371/CURRENTS.OUTBREAKS.2134A0A7BF37FD8D388181539FEA2DA5
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2013, EUROSURVEILLANCE, V19, P20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lowes Linda, 2016, J Pediatr Rehabil Med, V9, P65, DOI 10.3233/PRM-160362
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maron DF, SCI AM
   McKenna M., ZIV NEW THREAT NEW K
   Oliveira Melo A S, ULTRASOUND OBSTET GY, V47, P6
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Mosquitocatalogue.org, 1963 WORLD WID MOSQ
   Mourya D. T., 2014, WHO South East Asia Journal of Public Health, V3, P8
   Mourya DT, 2015, EMERG INFECT DIS, V21, P1837, DOI 10.3201/eid2110.141961
   Mourya DT, 2012, J VIROL METHODS, V186, P49, DOI 10.1016/j.jviromet.2012.07.019
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan American Health Organization, 2015, EP AL ZIK VIR INF
   Roth A, 2012, EUROSURVEILLANCE, V19, P20929
   Shil Pratip, 2006, In Silico Biology, V6, P373
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Statnews, WHATS PRED 3 4 MILL
   WHO, WHO DIR GEN SUMM OUT
   World Health Organisation, ZIK VIR COMPL
   World Health Organization, DENG CONTR HUM
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 55
TC 0
Z9 0
U1 2
U2 2
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0971-5916
J9 INDIAN J MED RES
JI Indian J. Med. Res.
PD MAY
PY 2016
VL 143
BP 553
EP 564
DI 10.4103/0971-5916.187103
PG 12
WC Immunology; Medicine, General & Internal; Medicine, Research &
   Experimental
SC Immunology; General & Internal Medicine; Research & Experimental
   Medicine
GA DS9PH
UT WOS:000381115100005
PM 27487998
ER

PT J
AU Ong, CW
AF Ong, C. W.
TI Zika virus: an emerging infectious threat
SO INTERNAL MEDICINE JOURNAL
LA English
DT Editorial Material
ID UNITED-STATES; INTERIM GUIDELINES; SEXUAL TRANSMISSION; PREGNANT-WOMEN;
   BRAZIL; INDONESIA; TRAVELERS; OUTBREAK; BRAIN
C1 [Ong, C. W.] Canberra Hosp, Dept Microbiol, Canberra, ACT, Australia.
RP Ong, CW (reprint author), Canberra Hosp, Dept Microbiol, Canberra, ACT, Australia.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Australian Government Department of Health, 2016, ZIK VIR INF CLIN PUB
   Australian Government Department of Health, 2016, NAT NOT DIS SURV SYS
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, ZIK VIR HLTH CAR PRO
   Communicable Diseases Network Australia, 2016, INT REC RED RISK SEX
   Soares de Aracjo J, 2016, B WORLD HLT IN PRESS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF FACTSH H
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   King AMQ., 2012, VIRUS TAXONOMY CLASS
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lopez-Camelo JS, 2015, ECLAMC FINAL DOCUMEN
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   New Zealand Government Ministry of Health, 2016, ZIK VIR INT GUID INF
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Public Health England Royal College of Obstetricians and Gynaecologists Royal College of Midwives Health Protection Scotland NHS Scotland, 2016, ZIK VIR INT ALG ASS
   Pyke AT, 2014, PLOS CURR, V6
   Queensland Government Department of Health, 2014, ZIK VIR QUEENSL HLTH
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2016, CAR WOM CONF ZIK VIR
   Russell Richard C, 2005, Commun Dis Intell Q Rep, V29, P296
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 46
TC 0
Z9 0
U1 2
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1444-0903
EI 1445-5994
J9 INTERN MED J
JI Intern. Med. J.
PD MAY
PY 2016
VL 46
IS 5
BP 525
EP 530
DI 10.1111/imj.13059
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA DR6WL
UT WOS:000380041900001
PM 27170237
ER

PT J
AU da Silva, LRC
   de Souza, AM
AF Cangussu da Silva, Lucia Regina
   de Souza, Adriano Miranda
TI Zika virus: what do we know about the viral structure, mechanisms of
   transmission, and neurological outcomes?
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Zika virus; Transmission modes; Microcephaly; Guillain-Barre syndrome;
   Neurological disorders
ID FRENCH-POLYNESIA; DECEMBER 2013; INFECTION; BRAZIL; EPIDEMIC; DENGUE;
   ENCEPHALITIS; MICRONESIA; FLAVIVIRUS; OUTBREAK
AB The Zika virus epidemic that started in Brazil in 2014 has spread to >30 countries and territories in Latin America, leading to a rapid rise in the incidence of microcephalic newborns and adults with neurological complications. At the beginning of the outbreak, little was known about Zika virus morphology, genome structure, modes of transmission, and its potential to cause neurological malformations and disorders. With the advancement of basic science, discoveries of the mechanisms of strain variability, viral transfer to the fetus, and neurovirulence were published. These will certainly lead to the development of strategies to block vertical viral transmission, neuronal invasion, and pathogenesis in the near future. This paper reviews the current literature on Zika virus infections, with the aim of gaining a holistic insight into their etiology and pathogenesis. We discuss Zika virus history and epidemiology in Brazil, viral structure and taxonomy, old and newly identified transmission modes, and neurological consequences of infection.
C1 [Cangussu da Silva, Lucia Regina] Univ Salgado de Oliveira, Dept Ciencias Biomed, Juiz De Fora, MG, Brazil.
   [de Souza, Adriano Miranda] Univ Fed Juiz de Fora, Dept Farmacol, Juiz De Fora, MG, Brazil.
RP da Silva, LRC (reprint author), Univ Salgado de Oliveira, Dept Ciencias Biomed, Juiz De Fora, MG, Brazil.
EM Prof.luciacangussu@gmail.com
CR Adibi JJ, 2016, LANCET, V6736, P1
   Alves JAG, 2009, REV BRAS GINECOL OBS, V31, P89
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Escribano-Romero E, 2014, FRONT MICROBIOL, V5, P1
   Bonaldo MC, 2016, BIORXIV
   Brito CAA, 2007, REV SOC BRAS MED TRO, V40, P236, DOI 10.1590/S0037-86822007000200019
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V6736, P1
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, P4
   Driggers Rita W, 2016, N Engl J Med, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fauci AS, 2016, NEW ENGL J MED, V363, P1
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcez PP, 2016, COMBINED PROTEOME TR, DOI DOI 10.7287/PEERJ.PREPRINTS.2033V1
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [10.1371/journal.pntd.0001477.22389730, DOI 10.1371/JOURNAL.PNTD.0001477.22389730]
   Henry R, 2014, EMERG INFECT DIS, V20, P1090
   Heymann DL, 2016, LANCET, V6736, P1
   Koga M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124004
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, pe3188
   Stokic DS, 2012, FRONT NEUROL, V3, P1
   [Anonymous], 2015, J TROP MED PUBLIC HL
   Malkki Hemi, 2016, Nat Rev Neurol, V12, P187, DOI 10.1038/nrneurol.2016.30
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marcondes CB, 2015, REV SOC BRAS MED TRO, V49, P4
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V8, P6736
   Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0
   Ministerio da Saude. Brasil. Instituto Evandro Chagas (IEC), 2015, COMPR REL VIR ZIK CO
   Ministerio da Saude. Brasil. Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO, V47
   Brasil. Ministerio da Saude, 2015, B EPIDEMIOLOGICO, V46, P1
   Ministerio da Saude. Brasil. Secretaria de Vigilancia em Saude. Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, INF EP 25 SEM EP SE
   Ministerio da Saude. Brasil. Agencia Nacional de Vigilancia (ANVISA), 2016, 0012015 ANVISA CGSHG, P1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P14, DOI [10.2807/1560-7917.ES2014.19.14, DOI 10.2807/1560-7917.ES2014.19.14]
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D., 2016, EMERG INFECT DIS, V21, P1887
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Noronha Lucia de, 2016, Mem Inst Oswaldo Cruz, V111, P287, DOI 10.1590/0074-02760160085
   Nyati KK, 2014, MEDIAT INFLAMM, V2014, P1
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliveira Danilo Bretas de, 2016, Rev Soc Bras Med Trop, V49, P125, DOI 10.1590/0037-8682-0208-2015
   Pan American Health Organization (PAHO), 2015, EP AL ZIK VIR INF
   Perera-Lecoin M, 2013, VIRUSES, V6, P69
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Piorkowski G, 2016, GENOME ANNOUNC, V2
   Pyke AT, 2014, PLOS CURRENTS
   Ribeiro GS, 2016, REV SOC BRAS MED TRO, V49, P1, DOI 10.1590/0037-8682-0036-2016
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P582, DOI 10.2105/AJPH.2016.303114
   Roth A, 2014, EUROSURVEILLANCE, V19, P20929
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Sirohi D, 2016, SCIENCE, V5316, P1
   Sousa AM, 2014, TROP MED HLTH, V42, P115
   Tang ZH, 2011, ANN NY ACAD SCI, V1221, P103, DOI 10.1111/j.1749-6632.2010.05932.x
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Vasconcelos PFC, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   World Health Organization (WHO), 2016, ZIK VIR MICR GUILL B, V2016, P1
   World Health Organization (WHO), 2016, ASS INF MICR CONT ZI, P1
   World Health Organization (WHO), 2016, 31 WHO, P1
   Zammarchi L, 2015, EUROSURVEILLANCE, V20
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeinad Audrey K., 2004, Rev. Bras. Hematol. Hemoter., V26, P114, DOI 10.1590/S1516-84842004000200009
NR 86
TC 0
Z9 0
U1 20
U2 20
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2016
VL 49
IS 3
BP 267
EP 273
DI 10.1590/0037-8682-0150-2016
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ6YW
UT WOS:000379354400002
ER

PT J
AU Honein, M
   Jamieson, DJ
AF Honein, M.
   Jamieson, D. J.
TI Exploring the Link between Zika Virus and Adverse Pregnancy and Birth
   Outcomes
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Honein, M.; Jamieson, D. J.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 3
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2016
VL 106
IS 5
SI SI
MA SR2
BP 376
EP 376
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HT
UT WOS:000379024100057
ER

PT J
AU Schuler-Faccini, L
AF Schuler-Faccini, L.
TI Exploring the Link between Zika Virus and Microcephaly
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Schuler-Faccini, L.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
NR 0
TC 0
Z9 0
U1 4
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2016
VL 106
IS 5
SI SI
MA SR1
BP 376
EP 376
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HT
UT WOS:000379024100056
ER

PT J
AU Ventura, CV
   Ventura, LO
   Maia, M
   Belfort, JRR
AF Ventura, C. V.
   Ventura, L. O.
   Maia, M.
   Belfort, J. R. R.
TI Ocular Features and Limb Anomalies in Patients with Microcephaly and
   Presumed Zika Virus Congenital Infection in Pernambuco, Brazil
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Ventura, C. V.; Ventura, L. O.; Belfort, J. R. R.] Altino Ventura Fdn FAV, Recife, PE, Brazil.
   [Ventura, L. O.] HOPE Eye Hosp, Recife, PE, Brazil.
   [Ventura, C. V.; Maia, M.; Belfort, J. R. R.] Fed Univ Sao Paulo Unifesp, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 3
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2016
VL 106
IS 5
SI SI
MA 13
BP 391
EP 391
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HT
UT WOS:000379024100082
ER

PT J
AU Schuler-Faccini, L
   Ribeiro, E
   Pessoa, A
AF Schuler-Faccini, L.
   Ribeiro, E.
   Pessoa, A.
TI Zika Virus Infection in Brazil and Brain Anomalies Defects
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Meeting Abstract
C1 [Schuler-Faccini, L.] Univ Fed Rio Grande do Sul, Teratogen Informat Serv, Porto Alegre, RS, Brazil.
   [Ribeiro, E.; Pessoa, A.] Hosp Albert Sabin, Fortaleza, Ceara, Brazil.
NR 0
TC 0
Z9 0
U1 4
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD MAY
PY 2016
VL 106
IS 5
SI SI
MA 4
BP 443
EP 443
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA DQ2HT
UT WOS:000379024100154
ER

PT J
AU Nandy, A
   Basak, SC
AF Nandy, Ashesh
   Basak, Subhash C.
TI A Brief Review of Computer-Assisted Approaches to Rational Design of
   Peptide Vaccines
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE peptide vaccines; computer assisted vaccine development; epitopes;
   alignment-free analysis; web based approaches; sequence descriptors;
   rational peptide vaccine design; dengue; chikungunya; rotavirus; Zika
   virus
ID IN-VIVO; CORONAVIRUS PHYLOGENY; INFLUENZA VACCINES; DENDRITIC CELLS;
   VIRUS; PROTEIN; RESPONSES; EPITOPES; ANTIGENS; CANCER
AB The growing incidences of new viral diseases and increasingly frequent viral epidemics have strained therapeutic and preventive measures; the high mutability of viral genes puts additional strains on developmental efforts. Given the high cost and time requirements for new drugs development, vaccines remain as a viable alternative, but there too traditional techniques of live-attenuated or inactivated vaccines have the danger of allergenic reactions and others. Peptide vaccines have, over the last several years, begun to be looked on as more appropriate alternatives, which are economically affordable, require less time for development and hold the promise of multi-valent dosages. The developments in bioinformatics, proteomics, immunogenomics, structural biology and other sciences have spurred the growth of vaccinomics where computer assisted approaches serve to identify suitable peptide targets for eventual development of vaccines. In this mini-review we give a brief overview of some of the recent trends in computer assisted vaccine development with emphasis on the primary selection procedures of probable peptide candidates for vaccine development.
C1 [Nandy, Ashesh] Ctr Interdisciplinary Res & Educ, Jodhpur Pk, Kolkata 700068, India.
   [Basak, Subhash C.] Univ Minnesota, Duluth, MN 55811 USA.
RP Nandy, A (reprint author), Ctr Interdisciplinary Res & Educ, Jodhpur Pk, Kolkata 700068, India.
EM anandy43@yahoo.com; sbasak@nrri.umn.edu
OI Nandy, Ashesh/0000-0002-1649-7731
CR Almeida JPM, 2015, SMALL, V11, P1453, DOI 10.1002/smll.201402179
   Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065
   Basak S.C., 2016, CURR COMPUT-AID DRUG, V12, P1
   Basak SC, 2006, TOP HETEROCYCL CHEM, V3, P39, DOI 10.1007/7081_025
   Brossart P, 2000, BLOOD, V96, P3102
   Chakraborty Sajib, 2010, In Silico Biology, V10, P235, DOI 10.3233/ISB-2010-0435
   Chit A, 2014, VACCINE, V32, P3336, DOI 10.1016/j.vaccine.2013.06.055
   Chroboczek J, 2014, ACTA BIOCHIM POL, V61, P531
   Doytchinova I.A., 2007, BMC BIOINFORM, V8
   Ghosh A., 2010, BMC STRUCT BIOL, V10
   Ghosh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040749
   Ghosh A, 2009, J CHEM INF MODEL, V49, P2627, DOI 10.1021/ci9001662
   Gomase Virendra S, 2007, Curr Drug Discov Technol, V4, P117
   Gomase V.S., 2008, GENE THER MOL BIOL, V12, P83
   Gonzalez-Diaz H, 2009, J THEOR BIOL, V261, P136, DOI 10.1016/j.jtbi.2009.07.029
   Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638
   Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004
   Hardy L.W., 2003, CURR DRUG DISCOV, V11, P15
   Hawkins DM, 2006, J CHEM INF MODEL, V46, P9, DOI 10.1021/ci050252p
   Huber S.R., 2014, FRONT IMMUNOL, V5, P1
   Islam R, 2012, FUTURE VIROL, V7, P1029, DOI 10.2217/FVL.12.95
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   LANGEVELD JPM, 1994, J VIROL, V68, P4506
   Li Weidang, 2014, Vaccines (Basel), V2, P515, DOI 10.3390/vaccines2030515
   Liao B, 2006, CHEM PHYS LETT, V421, P313, DOI 10.1016/j.cplett.2006.01.030
   Liao SJ, 2013, J HUAZHONG U SCI-MED, V33, P735, DOI 10.1007/s11596-013-1189-5
   Ludewig B, 2000, VACCINE, V19, P23, DOI 10.1016/S0264-410X(00)00163-8
   Moisa A.A., 2012, INSIGHT CONTROL INFE
   Monso M, 2011, J PEPT SCI, V17, P24, DOI 10.1002/psc.1292
   Nandy A, 2015, CURR COMPUT-AID DRUG, V11, P110, DOI 10.2174/1573409911666150722122034
   Oany AR, 2014, DRUG DES DEV THER, V8, P1139, DOI [10.2147/DDDT.S67861, 10.2147/DDDT.567861]
   Oyarzun P., 2013, BMC BIOINFORM, V14
   Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344
   Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI [10.2217/pgs.09.25, 10.2217/PGS.09.25]
   Poland GA, 2016, CURR OPIN VIROL, V17, P116, DOI 10.1016/j.coviro.2016.03.003
   Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224
   Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5
   Rojas-Caraballo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105323
   Sarkar T, 2015, COMPUT BIOL CHEM, V59, P8, DOI 10.1016/j.compbiolchem.2015.08.003
   Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004
   Singluff C.L., 2011, CANCER J, V17, P343
   Sirskyj D, 2011, IMMUNOL CELL BIOL, V89, P81, DOI 10.1038/icb.2010.65
   Sobolev BN, 2005, CURR COMPUT-AID DRUG, V1, P207, DOI 10.2174/1573409053585681
   Stanaway JD, 2016, LANCET INFECT DIS
   Suzuki H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-97
   Tomar N, 2010, IMMUNOLOGY, V131, P153, DOI 10.1111/j.1365-2567.2010.03330.x
   Varghese JN, 1999, DRUG DEVELOP RES, V46, P176, DOI 10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6
   Vilar S., 2010, TOPOLOGICAL INDICES, P145
   Wang R., 1995, J IMMUNOL, V154, P2764
   World Health Organization, 2008, WKLY EPIDEMIOL REC, V83, P421
   [Anonymous], 2015, MIDDL E RESP SYNDR C
   World Health Organization, 2016, EB VIR DIS OUTBR
   Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12
NR 53
TC 0
Z9 0
U1 3
U2 3
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2016
VL 17
IS 5
AR 666
DI 10.3390/ijms17050666
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DP9BJ
UT WOS:000378791400060
ER

PT J
AU Diniz, D
AF Diniz, Debora
TI Zika virus and women
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Diniz, Debora] Univ Brasilia, Fac Direito, Brasilia, DF, Brazil.
   [Diniz, Debora] Anis Inst Bioet Direitos Humanos & Genero, BR-70673970 Brasilia, DF, Brazil.
RP Diniz, D (reprint author), Anis Inst Bioet Direitos Humanos & Genero, Setor Sudoeste, CP 8011, BR-70673970 Brasilia, DF, Brazil.
EM d.diniz@anis.org.br
CR Brasil P, 2016, N ENGL J MED
   Cavarero Adriana, 2007, Rev. Estud. Fem., V15, P650
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias Ministerio da Saude, 2016, MON CAS MICR BRAS
   Corte Interamericana de Derechos Humanos, 2015, DEM EST EC REL JUEZ
   LUGONES MARA, 2008, Tabula Rasa, P73
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sassaki RK, 2010, REACAO REV NACL REAB, VXIV, P14
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
NR 9
TC 2
Z9 2
U1 3
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR e00046316
DI 10.1590/0102-311X00046316
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900020
PM 27192024
ER

PT J
AU Pitanguy, J
AF Pitanguy, Jacqueline
TI Women's reproductive rights and the Zika virus epidemic
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
C1 [Pitanguy, Jacqueline] CEPIA, Rua Russel 694,Apto 201, BR-22210010 Rio De Janeiro, RJ, Brazil.
RP Pitanguy, J (reprint author), CEPIA, Rua Russel 694,Apto 201, BR-22210010 Rio De Janeiro, RJ, Brazil.
EM pitanguy@cepia.org.br
NR 0
TC 0
Z9 0
U1 4
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD MAY
PY 2016
VL 32
IS 5
AR e00066016
DI 10.1590/0102-311X00066016
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DP6RB
UT WOS:000378624900022
ER

PT J
AU Nunes, ML
   Carlini, CR
   Marinowic, D
   Neto, FK
   Fiori, HH
   Scotta, MC
   Zanella, PLA
   Soder, RB
   da Costa, JC
AF Nunes, Magda Lahorgue
   Carlini, Celia Regina
   Marinowic, Daniel
   Neto, Felipe Kalil
   Fiori, Humberto Holmer
   Scotta, Marcelo Comerlato
   Avila Zanella, Pedro Luis
   Soder, Ricardo Bernardi
   da Costa, Jaderson Costa
TI Microcephaly and Zika virus: a clinical and epidemiological analysis of
   the current outbreak in Brazil
SO JORNAL DE PEDIATRIA
LA English
DT Review
DE Zika virus; Microcephaly; Pregnancy; Cortical development; Neuroimaging
ID INTERIM GUIDELINES; HEAD CIRCUMFERENCE; NERVOUS-SYSTEM; REUNION ISLAND;
   UNITED-STATES; INDIAN-OCEAN; HUMAN BRAIN; CHIKUNGUNYA; INFECTION;
   DISORDERS
AB Objective: This study aimed to critically review the literature available regarding the Zika virus outbreak in Brazil and its possible association with microcephaly cases.
   Sources: Experts from Instituto do Cerebro do Rio Grande do Sul performed a critical (nonsystematic) literature review regarding different aspects of the Zika virus outbreak in Brazil, such as transmission, epidemiology, diagnostic criteria, and its possible association with the increase of microcephaly reports. The PubMed search using the key word "Zika virus'' in February 2016 yielded 151 articles. The manuscripts were reviewed, as well as all publications/guidelines from the Brazilian Ministry of Health, World Health Organization and Centers for Disease Control and Prevention (CDC - United States).
   Summary of findings: Epidemiological data suggest a temporal association between the increased number of microcephaly notifications in Brazil and outbreak of Zika virus, primarily in the Brazil's Northeast. It has been previously documented that many different viruses might cause congenital acquired microcephaly. Still there is no consensus on the best curve to measure cephalic circumference, specifically in preterm neonates. Conflicting opinions regarding the diagnosis of microcephaly (below 2 or 3 standard deviations) that should be used for the notifications were also found in the literature.
   Conclusion: The development of diagnostic techniques that confirm a cause-effect association and studies regarding the physiopathology of the central nervous system impairment should be prioritized. It is also necessary to strictly define the criteria for the diagnosis of microcephaly to identify cases that should undergo an etiological investigation. (C) 2016 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.
C1 [Nunes, Magda Lahorgue; Fiori, Humberto Holmer; Avila Zanella, Pedro Luis; da Costa, Jaderson Costa] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil.
   [Nunes, Magda Lahorgue; Carlini, Celia Regina; Marinowic, Daniel; Neto, Felipe Kalil; Fiori, Humberto Holmer; Scotta, Marcelo Comerlato; Avila Zanella, Pedro Luis; Soder, Ricardo Bernardi; da Costa, Jaderson Costa] Inst Cerebro Rio Grande Sul Inscer, Zika Team, Porto Alegre, RS, Brazil.
   [Carlini, Celia Regina; Marinowic, Daniel] Inst Cerebro Rio Grande Sul Inscer, Porto Alegre, RS, Brazil.
   [Neto, Felipe Kalil] Pontificia Univ Catolica Rio Grande Sul PUCRS, Postgrad Program Pediat & Child Hlth, Porto Alegre, RS, Brazil.
   [Scotta, Marcelo Comerlato] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Dept Pediat, Porto Alegre, RS, Brazil.
   [Soder, Ricardo Bernardi] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Dept Diagnost Methods, Porto Alegre, RS, Brazil.
RP Nunes, ML (reprint author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Med, Porto Alegre, RS, Brazil.; Nunes, ML (reprint author), Inst Cerebro Rio Grande Sul Inscer, Zika Team, Porto Alegre, RS, Brazil.
EM nunes@pucrs.br
FU CNPq
FX MLN, CRC, and JCC receive a research productivity grant from CNPq.
CR Arai A, 2012, BRAIN RES, V1470, P89, DOI 10.1016/j.brainres.2012.06.009
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Bae BI, 2013, SCIENCE, V342, P200, DOI 10.1126/science.1245812
   BECKER LE, 1992, AM J NEURORADIOL, V13, P537
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V9
   BHUSHAN V, 1991, J CLIN EPIDEMIOL, V44, P1027, DOI 10.1016/0895-4356(91)90004-S
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doenc as Transmissiveis, 2015, PROT VIG RESP OC MIC
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   COES, 2016, MICR AT ENTR COL MIC
   D'Aiuto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049700
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2015, RAP RISK ASS MICR BR, P1
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faye O, 2013, VIROL J, V10, P311, DOI DOI 10.1186/1743-422X-10-311
   Faye O, 2014, PLOS NEGLECT TROP D, V8, pe2636, DOI [DOI 10.1371/JOURNAL.PNTD.0002636, 10.1371/journal.pntd.0002636]
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Freire CCM, 2015, BIORXIV
   FRIES KM, 1994, CLIN IMMUNOL IMMUNOP, V72, P283, DOI 10.1006/clin.1994.1144
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Golden JA, 2001, NEUROPATH APPL NEURO, V27, P22, DOI 10.1046/j.0305-1846.2001.00307.x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586
   Gulland A, 2016, BMJ-BRIT MED J, V352, pi657
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Ichida JK, 2015, EMBO J, V34, P1456, DOI 10.15252/embj.201591267
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Javelle E, 2014, J CLIN VIROL, V59, P270, DOI 10.1016/j.jcv.2014.01.011
   Kularatne SAM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4661
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lucey DR, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i781
   Mardekian SK, 2015, BIOMED RES INT, V2015
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Brasil. Ministerio da Saude, 2015, PROT AT SAUD RESP OC
   [Anonymous], 2016, B EPIDEMIOLOGICO
   [Anonymous], 2015, PROT AT MULH ID FERT
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   [Anonymous], 2015, CLIN VIROL, DOI DOI 10.1016/J.JCV.2015.04.021
   Pan American Health Organization (PAHO), 2016, LIN PREL VIG MICR RE
   PAHO/WHO, 2015, NEUR SYNDR CONG MALF, P1
   Passemard S, 2013, HDB CLIN NEUROLOGY 1, P129
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rakic P, 1995, TRENDS NEUROSCI, V18, P338
   Rakic P., 1978, POSTGRAD MED J, V54, pS25
   RORKE LB, 1994, J NEUROPATH EXP NEUR, V53, P105, DOI 10.1097/00005072-199403000-00001
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seltzer LE, 2014, AM J MED GENET C, V166, P140, DOI 10.1002/ajmg.c.31400
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Teixeira MG, 2009, BMJ-BRIT MED J, V339, P1189
   Tetro JA, 2016, MICROBES INFECT
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Vargas JE, 2001, J PEDIATR-US, V139, P210, DOI 10.1067/mpd.2001.115314
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Volpe J, 2001, NEUROLOGY NEWBORN
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   World Health Organization (WHO), 2016, WHO CHILD GROWTH STA
   WHO, 2009, DENG GUID DIAGN TREA
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Zhang R, 2013, ACTA PHARMACOL SIN, V34, P765, DOI 10.1038/aps.2013.21
NR 78
TC 2
Z9 2
U1 10
U2 10
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD MAY-JUN
PY 2016
VL 92
IS 3
BP 230
EP 240
DI 10.1016/j.jped.2016.02.009
PG 11
WC Pediatrics
SC Pediatrics
GA DP9VP
UT WOS:000378846100004
PM 27049675
ER

PT J
AU Bajjou, T
   Elrhaffouli, H
   Sekhsokh, Y
AF Bajjou, Tahar
   Elrhaffouli, Hicham
   Sekhsokh, Yassine
TI Emergence of Zika virus: Is Morocco concerned?
SO VIROLOGIE
LA French
DT Editorial Material
C1 [Bajjou, Tahar; Elrhaffouli, Hicham; Sekhsokh, Yassine] Univ Mohammed V Rabat, Fac Med & Pharm Rabat, Maroc Hop Mil Instruct Mohammed V, Lab Rech & Biosecurite P3, Rabat, Morocco.
RP Bajjou, T (reprint author), Univ Mohammed V Rabat, Fac Med & Pharm Rabat, Maroc Hop Mil Instruct Mohammed V, Lab Rech & Biosecurite P3, Rabat, Morocco.
EM taharbajjou@gmail.com
CR BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Ministere de la Sante du Maroc, AUC CAS VIR ZIKA ET
   Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622
   World Heath Organization, ZIK VIR SIT REP
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 0
Z9 0
U1 4
U2 4
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1267-8694
J9 VIROLOGIE
JI Virologie
PD MAY-JUN
PY 2016
VL 20
IS 3
BP 144
EP 144
DI 10.1684/vir.2016.0654
PG 1
WC Virology
SC Virology
GA DP9AF
UT WOS:000378788400002
ER

PT J
AU Musso, D
AF Musso, Didier
TI Emergence of the virus Zika : do not mix up detection of antibody during
   ancient studies and actual circulation
SO VIROLOGIE
LA French
DT Editorial Material
C1 [Musso, Didier] Inst Louis Malarde, Lab Rech & Biol Med, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
RP Musso, D (reprint author), Inst Louis Malarde, Lab Rech & Biol Med, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM dmusso@ilm.pf
CR BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Dickinson D B, 1965, S Afr J Med Sci, V30, P11
   DORCHE G, 1961, Maroc Med, V40, P979
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622
   SMITHBURN K. C, 1959, S AFRICAN MED JOUR, V33, P555
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
NR 7
TC 0
Z9 0
U1 1
U2 1
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1267-8694
J9 VIROLOGIE
JI Virologie
PD MAY-JUN
PY 2016
VL 20
IS 3
BP 145
EP 146
DI 10.1684/vir.2016.0655
PG 2
WC Virology
SC Virology
GA DP9AF
UT WOS:000378788400003
ER

PT J
AU Eberhardt, KA
   Vinnemeier, CD
   Dehnerdt, J
   Rolling, T
   Steffen, R
   Cramer, JP
AF Eberhardt, Kirsten Alexandra
   Vinnemeier, Christof David
   Dehnerdt, Johanna
   Rolling, Thierry
   Steffen, Robert
   Cramer, Jakob Peter
TI Travelers to the FIFA world cup 2014 in Brazil: Health risks related to
   mass gatherings/sports events and implications for the Summer Olympic
   Games in Rio de Janeiro in 2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Mass gathering; Brazil; FIFA world cup 2014; Summer Olympic Games 2016
ID PARALYMPIC GAMES; ZIKA VIRUS; MEDICINE; VISITORS; DISEASES; DENGUE;
   ADVICE; AGENDA
AB Background: Health threats during mass gatherings, such as the FIFA world cup 2014 differ from traditional health risks. The influence of event type, demographics of attendees and environmental conditions are still not fully understood.
   Methods: An observational, prospective case-control survey conducted at the Frankfurt international airport in Germany on 544 travelers to the FIFA world cup 2014 and 432 regular travelers to Brazil departing after the end of the world cup.
   Results: Travelers to the FIFA world cup 2014 were predominantly male whereas the gender distribution in the control group was more balanced. The majority in both groups obtained insect bites and sunburns as environmental risk factors. Every third traveler suffered from diarheal complaints in both groups, whereas the proportion of travelers with flu-like symptoms was higher in the case group. Travelers to the FIFA world cup 2014 indicated alcohol intake and sexual contacts outside of a relationship more frequently than travelers in the control group.
   Conclusions: The additional health risks of travelers to sporting events as the FIFA world cup 2014 should be addressed in addition to traditional health threats in pre-travel counseling for the Summer Olympic Games 2016 in Brazil. (C) 2016 Published by Elsevier Ltd.
C1 [Eberhardt, Kirsten Alexandra; Vinnemeier, Christof David; Dehnerdt, Johanna; Rolling, Thierry; Cramer, Jakob Peter] Bernhard Nocht Inst Trop Med, Clin Res Unit, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
   [Vinnemeier, Christof David; Rolling, Thierry] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Sect Trop Med, Hamburg, Germany.
   [Steffen, Robert] Univ Zurich, Ctr Travel Med, WHO Collaborating Ctr Travelers Hlth, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland.
RP Cramer, JP (reprint author), Bernhard Nocht Inst Trop Med, Clin Res Unit, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.
EM cramer@bni-hamburg.de
FU Frankfurt international airport; airlines Lufthansa; TAP Portugal
FX We are grateful to the travelers participating in this study. We thank
   the Frankfurt international airport and the airlines Lufthansa and TAP
   Portugal for their support. JPC accepted a position at Takeda
   Pharmaceuticals International AG, Vaccine Business Unit, Zurich
   Switzerland.
CR Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8
   Aguiar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08462
   Aldea M, 2015, INT HEALTH, V7, P272, DOI 10.1093/inthealth/ihu076
   Alqahtani AS, 2015, VACCINE, V33, P6552, DOI 10.1016/j.vaccine.2015.09.076
   Alquthami Ahmed H, 2014, Prehosp Disaster Med, V29, P167, DOI 10.1017/S1049023X14000144
   Arbon P, 2001, Prehosp Disaster Med, V16, P150
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Botelho-Nevers E, 2013, EUROSURVEILLANCE, V18, P32
   Burton James O, 2012, Prehosp Disaster Med, V27, P458, DOI 10.1017/S1049023X12000830
   Ezzedine Khaled, 2007, Travel Med Infect Dis, V5, P176, DOI 10.1016/j.tmaid.2006.08.001
   Gaines J, 2014, JAMA INTERN MED, V174, P1383, DOI 10.1001/jamainternmed.2014.2227
   Gallego V, 2014, TRAVEL MED INFECT DI, V12, P208, DOI 10.1016/j.tmaid.2014.04.004
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Gocotano AE, 2015, B WORLD HEALTH ORGAN, V93, P810, DOI 10.2471/BLT.15.158089
   Hall V, 2015, SEX TRANSM INFECT, V91, P592, DOI 10.1136/sextrans-2014-051826
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heywood AE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-321
   Hopkins N, 2016, INT J INFECT DIS
   Hopkins N, 2016, J EPIDEMIOL GLOB HEA, V6, P49, DOI 10.1016/j.jegh.2015.06.001
   Hutton Alison, 2011, Prehosp Disaster Med, V26, P414, DOI 10.1017/S1049023X12000155
   Hutton A, 2015, AUST J PRIM HEALTH, V21, P249, DOI 10.1071/PY13094
   Iliaki E, 2014, J TRAVEL MED, V21, P214, DOI 10.1111/jtm.12117
   Jentes ES, 2010, AM J TROP MED HYG, V82, P466, DOI 10.4269/ajtmh.2010.09-0660
   Leder K, 2015, J TRAVEL MED, V22, P13, DOI 10.1111/jtm.12170
   Locoh-Donou S, 2013, AM J EMERG MED, V31, P843, DOI 10.1016/j.ajem.2013.01.016
   Locoh-Donou S, 2016, INTERN EMERG MED
   Lund Adam, 2014, Prehosp Disaster Med, V29, P648, DOI 10.1017/S1049023X14001216
   Lund A, 2015, PREHOSPITAL DISASTER, V30, P271, DOI 10.1017/S1049023X15004598
   Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1
   Rack J, 2005, J TRAVEL MED, V12, P248
   Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X
   Shoaf Kimberley, 2014, Prehosp Disaster Med, V29, P409, DOI 10.1017/S1049023X1400065X
   Sile B, 2015, SEX TRANSM DIS, V42, P710, DOI 10.1097/OLQ.0000000000000370
   Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006
   Steffen R, 2012, LANCET INFECT DIS, V12, P142, DOI 10.1016/S1473-3099(11)70293-6
   Tam JS, 2012, LANCET INFECT DIS, V12, P231, DOI 10.1016/S1473-3099(11)70353-X
   Turris SA, 2014, DISASTER MED PUBLIC, P1
   van Panhuis WG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003063
   World Health Organization, 2008, COMM DIS AL RESP MAS
   Wilson ME, 2014, CLIN INFECT DIS, V58, P1347, DOI 10.1093/cid/ciu122
   Wilson ME, 2014, TRAVEL MED INFECT DI, V12, P205, DOI 10.1016/j.tmaid.2014.04.001
   Wood Cate, 2013, Travel Med Infect Dis, V11, P438, DOI 10.1016/j.tmaid.2013.10.008
NR 42
TC 2
Z9 2
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2016
VL 14
IS 3
BP 212
EP 220
DI 10.1016/j.tmaid.2016.05.014
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO8TP
UT WOS:000378057000006
PM 27238909
ER

PT J
AU Nishiura, H
   Mizumoto, K
   Villamil-Gomez, WE
   Rodriguez-Morales, AJ
AF Nishiura, Hiroshi
   Mizumoto, Kenji
   Villamil-Gomez, Wilmer E.
   Rodriguez-Morales, Alfonso J.
TI Preliminary estimation of the basic reproduction number of Zika virus
   infection during Colombia epidemic, 2015-2016
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika; Transmission; Epidemiology; Colombia; Latin America
ID AMERICA
C1 [Nishiura, Hiroshi; Mizumoto, Kenji] Univ Tokyo, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
   [Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
   [Nishiura, Hiroshi; Mizumoto, Kenji] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Cartagena, Programa Doctorado Med Trop, Cartagena, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Barranquilla, Colombia.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Panamer Assoc Infect Dis, Comm Travel Med, Quito, Ecuador.
   [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Asociac Colombiana Infectol, Comm Zoonoses & Haemorrhag Fevers, Bogota, DC, Colombia.
   [Rodriguez-Morales, Alfonso J.] Int Soc Chemotherapy, Working Grp Zoonoses, Aberdeen, Scotland.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Incubator & Grp, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Fac Hlth Sci, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   Instituto Nacional de Salud de Bogota, 2016, ZIK SEM EP 10 2016
   Majumder MS, 2016, B WHO IN PRESS
   Nishiura H, 2016, EPIDEMICS IN PRESS
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127
   Villamil-Gomez WE, 2016, J INFECT PU IN PRESS
NR 8
TC 3
Z9 3
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2016
VL 14
IS 3
BP 274
EP 276
DI 10.1016/j.tmaid.2016.03.016
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO8TP
UT WOS:000378057000015
PM 27060613
ER

PT J
AU Tridane, A
   El Khajah, A
   Ali, BR
AF Tridane, Abdessamad
   El Khajah, Abdelmajid
   Ali, Bassam R.
TI The possible threat of Zika virus in the Middle East
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Letter
DE Zika virus; Middle East; Congenital microcephaly; Travel warning
ID TRANSMISSION
C1 [Tridane, Abdessamad] United Arab Emirates Univ, Coll Sci, Dept Math Sci, POB 15551, Al Ain, U Arab Emirates.
   [El Khajah, Abdelmajid] United Arab Emirates Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates.
   [Ali, Bassam R.] United Arab Emirates Univ, Dept Pathol, Coll Med & Hlth Sci, Al Ain, U Arab Emirates.
RP Tridane, A (reprint author), United Arab Emirates Univ, Coll Sci, Dept Math Sci, POB 15551, Al Ain, U Arab Emirates.
EM a-tridane@uaeu.ac.ae
OI Tridane, Abdessamad/0000-0001-8471-7807
CR Al-Gazali L, 2010, HUM MUTAT, V31, P505, DOI 10.1002/humu.21232
   Bastaki F, 2015, CONGENIT ANOM
   European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Korhonen EM, 2015, EUROSURVEILLANCE, V21, P2016
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Zain AA, 2016, KHALEEJ TIMES   0201
NR 9
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2016
VL 14
IS 3
BP 277
EP 278
DI 10.1016/j.tmaid.2016.03.003
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DO8TP
UT WOS:000378057000016
PM 26972490
ER

PT J
AU Picone, O
   Vauloup-Fellous, C
   D'Ortenzio, E
   Huissoud, C
   Carles, G
   Benachi, A
   Faye, A
   Luton, D
   Paty, MC
   Ayoubi, JM
   Yazdanpanah, Y
   Mandelbrot, L
   Matheron, S
AF Picone, O.
   Vauloup-Fellous, C.
   D'Ortenzio, E.
   Huissoud, C.
   Carles, G.
   Benachi, A.
   Faye, A.
   Luton, D.
   Paty, M. -C.
   Ayoubi, J. -M.
   Yazdanpanah, Y.
   Mandelbrot, L.
   Matheron, S.
TI Zika virus infection during pregnancy
SO JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION
LA French
DT Article
DE Zika virus; Congenital infection; Microcephaly; Prevention
ID UNITED-STATES; INTERIM GUIDELINES; TRANSMISSION; OUTBREAK; OUTCOMES;
   INFANTS; WOMEN
AB A Zika virus epidemic is currently ongoing in the Americas. This virus is linked to congenital infections with potential severe neurodevelopmental dysfunction. However, incidence of fetal infection and whether this virus is responsible of other fetal complications are still unknown. National and international public health authorities recommend caution and several prevention measures. Declaration of Zika virus infection is now mandatory in France. Given the available knowledge on Zika virus, we suggest here a review of the current recommendations for management of pregnancy in case of suspicious or infection by Zika virus in a pregnant woman. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Picone, O.; Ayoubi, J. -M.] Hop Foch, Dept Obstet & Gynecol, 40 Rue Worth, F-92151 Suresnes, France.
   [Vauloup-Fellous, C.] Univ Paris 11, Grp Hosp Univ Paris Sud, Hop Paul Brousse,Serv Virol,WHO Rubella NRL, AP HP,Inserm,U1193,Natl Reference Lab Maternofeta, F-94804 Villejuif, France.
   [Picone, O.; Ayoubi, J. -M.] Univ Versailles St Quentin En Yvelines, EA2493, UFR Sci Sante Simone Veil, F-78180 Montigny Le Bretonneux, France.
   [Yazdanpanah, Y.; Matheron, S.] Hop Bichat Claude Bernard, AP HP, HPNVS, Serv Malad Infect & Trop, 46 Rue Henri Huchard, F-75018 Paris, France.
   [Yazdanpanah, Y.; Matheron, S.] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, IAME,UMR 1137, Paris, France.
   [Luton, D.] Bichat Claude Bernard Hosp, AP HP, Dept Gynecol Obstet & Reprod, 46 Rue Henri Huchard, F-75018 Paris, France.
   [Luton, D.] Univ Paris 07, DHU Risque & Grossesse, Paris, France.
   [D'Ortenzio, E.] Univ Paris 07, Hop Bichat, AP HP, Serv Malad Infect & Trop,HPNVS, Paris, France.
   [D'Ortenzio, E.] Univ Paris 07, INSERM, IAME, UMR 1137, F-75018 Paris, France.
   [Huissoud, C.] Hosp Civils Lyon, Hop Croix Rousse, Serv Gynecol Obstet, 103 Grande Rue Croix Rousse, F-69317 Lyon 04, France.
   [Huissoud, C.] Univ Lyon 1, UER Lyon Est, 8 Ave Rockefeller, F-69008 Lyon, France.
   [Huissoud, C.] INSERM, U846, Stem Cell & Brain Res Inst, 18 Ave Doyen Lepine, F-69500 Bron, France.
   [Huissoud, C.] Univ Lyon 1, UMR S 846, F-69003 Lyon, France.
   [Carles, G.] Ctr Hosp Ouest Guyanais, St Laurent Du Maroni, French Guiana.
   [Benachi, A.] Univ Paris 11, Hop Antoine Beclere, AP HP, Dept Obstet Gynecol & Reprod Med,Ctr Malad Rares, F-92140 Clamart, France.
   [Faye, A.] Hop Robert Debre, AP HP, Serv Pediat Generate & Malad Infect, 48 Blvd Serrurier, F-75019 Paris, France.
   [Faye, A.] Univ Paris 07, Sorbonne Paris Cite, Inserm 1123, Paris, France.
   [Mandelbrot, L.] Risk Pregnancy Univ Dept, Paris, France.
   [Mandelbrot, L.] Hop Louis Mourier, AP HP, Serv Gynecol & Obstet, 178 Rue Renouillets, F-92700 Colombes, France.
   [Mandelbrot, L.] Univ Paris Diderot, Paris, France.
   [Mandelbrot, L.] Inserm CESP, F-1019 Le Kremlin Bicetre, France.
   [Paty, M. -C.] Inst Veille Sanit, Dept Malad Infect, Coordinat Surveillance Malad Vectorielles, F-94415 St Maurice, France.
RP Picone, O (reprint author), Hop Foch, Dept Obstet & Gynecol, 40 Rue Worth, F-92151 Suresnes, France.; Picone, O (reprint author), Univ Versailles St Quentin En Yvelines, EA2493, UFR Sci Sante Simone Veil, F-78180 Montigny Le Bretonneux, France.
EM o.picone@hopital-foch.org
CR Atkinson BHP, 2016, EMERG INFECT DIS, P22
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, N ENGL J MED
   Broutet N, 2016, N ENGL J MED
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, LANCET
   Carteaux G., 2016, N ENGL J MED
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M., 2016, LANCET
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jouannic JM, 2016, LANCET
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Mansuy JMDM, 2016, LANCET INFECT DIS
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi720
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   Mecharles S., 2016, LANCET
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J., 2016, N ENGL J MED
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E, 2014, EURO SURVEILL, P19
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang HHC, 2016, STEM CELLS, P1
   Tetro JA, 2016, MICROBES INFECT
   Ventura C. V., 2016, LANCET
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   [Anonymous], 2016, MICROBES IN IN PRESS
NR 39
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 0368-2315
EI 1773-0430
J9 J GYNECOL OBST BIO R
JI J. Gynecol. Obstet. Biol. Reprod.
PD MAY
PY 2016
VL 45
IS 5
BP 415
EP 423
DI 10.1016/j.jgyn.2016.03.005
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DO2WB
UT WOS:000377640600001
PM 27079865
ER

PT J
AU Abbate, JL
   Murall, CL
   Richner, H
   Althaus, CL
AF Abbate, Jessica L.
   Murall, Carmen Lia
   Richner, Heinz
   Althaus, Christian L.
TI Potential Impact of Sexual Transmission on Ebola Virus Epidemiology:
   Sierra Leone as a Case Study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID REALISTIC DISTRIBUTIONS; DISEASE TRANSMISSION; HIV-1 TRANSMISSION;
   INFECTIOUS PERIODS; ZIKA VIRUS; COITAL ACT; OUTBREAK; MODELS;
   PERSISTENCE; CONGO
AB Background
   Sexual transmission of Ebola virus disease (EVD) 6 months after onset of symptoms has been recently documented, and Ebola virus RNA has been detected in semen of survivors up to 9 months after onset of symptoms. As countries affected by the 2013-2015 epidemic in West Africa, by far the largest to date, are declared free of Ebola virus disease (EVD), it remains unclear what threat is posed by rare sexual transmission events that could arise from survivors.
   Methodology/Principal Findings
   We devised a compartmental mathematical model that includes sexual transmission from convalescent survivors: a SEICR (susceptible-exposed-infectious-convalescent-recovered) transmission model. We fitted the model to weekly incidence of EVD cases from the 2014-2015 epidemic in Sierra Leone. Sensitivity analyses and Monte Carlo simulations showed that a 0.1% per sex act transmission probability and a 3-month convalescent period (the two key unknown parameters of sexual transmission) create very few additional cases, but would extend the epidemic by 83 days [95% CI: 68-98 days] (p < 0.0001) on average. Strikingly, a 6-month convalescent period extended the average epidemic by 540 days (95% CI: 508-572 days), doubling the current length, despite an insignificant rise in the number of new cases generated.
   Conclusions/Significance
   Our results show that reductions in the per sex act transmission probability via abstinence and condom use should reduce the number of sporadic sexual transmission events, but will not significantly reduce the epidemic size and may only minimally shorten the length of time the public health community must maintain response preparedness. While the number of infectious survivors is expected to greatly decline over the coming months, our results show that transmission events may still be expected for quite some time as each event results in a new potential cluster of non-sexual transmission. Precise measurement of the convalescent period is thus important for planning ongoing surveillance efforts.
C1 [Abbate, Jessica L.; Richner, Heinz] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.
   [Abbate, Jessica L.] Univ Montpellier, Inst Dev Res, IRD 224, UMR MIVEGEC,UMR 5290,CNRS, F-34059 Montpellier, France.
   [Abbate, Jessica L.] UPMC, IRD, UMI 209, UMR UMMISCO, Bondy, France.
   [Murall, Carmen Lia] Max Planck Inst Dynam & Self Org, Gottingen, Germany.
   [Althaus, Christian L.] Univ Bern, ISPM, Bern, Switzerland.
RP Abbate, JL (reprint author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.; Abbate, JL (reprint author), Univ Montpellier, Inst Dev Res, IRD 224, UMR MIVEGEC,UMR 5290,CNRS, F-34059 Montpellier, France.; Abbate, JL (reprint author), UPMC, IRD, UMI 209, UMR UMMISCO, Bondy, France.
EM jessica.abbate@ird.fr
FU University of Bern; French National Research Agency (ANR JC "STORY");
   Ambizione grant from the Swiss National Science Foundation [136737]
FX JLA received post-doctoral support from the University of Bern and a
   grant from the French National Research Agency (ANR JC "STORY"). CLA
   received funding through an Ambizione grant from the Swiss National
   Science Foundation (project 136737). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alizon S, 2015, VIRULENCE, V5, P825
   Althaus CL, 2015, EPIDEMICS-NETH, V11, P80, DOI 10.1016/j.epidem.2015.03.001
   Althaus CL, 2015, PEERJ, V3, DOI 10.7717/peerj.1418
   Althaus CL, 2015, LANCET INFECT DIS, V15, P507, DOI 10.1016/S1473-3099(15)70135-0
   Althaus CL, 2014, PLOS CURR OUTBREAKS, P1
   Anderson R.M., 1991, INFECT DIS HUMANS DY
   Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545
   Bellan SE, 2014, LANCET, V384, P1499, DOI 10.1016/S0140-6736(14)61839-0
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Chalom A, 2012, ARXIV12106278
   Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006
   Clark D V, 2015, LANCET INFECT DIS, V3099, P1
   Davtyan M, 2014, GLOB HLTH ACTION, V7, P1
   Deen GF, 2015, N ENGL J MED
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   Diekmann O, 2000, MATH EPIDEMIOLOGY IN
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323
   Eggo RM, 2015, EUROSURVEILLANCE, V20, P15, DOI 10.2807/1560-7917.ES.2015.20.48.30083
   Ergonul O, 2014, JPN J INFECT DIS, V67, P137, DOI 10.7883/yoken.67.137
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garnett GP, 2002, SEX TRANSM INFECT, V78, P7, DOI 10.1136/sti.78.1.7
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2
   Johnson TL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004428
   Kucharski AJ, 2015, P NATL ACAD SCI USA, V112
   Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3
   Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599
   Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525
   Mate SE, 2015, N ENGL J MED
   Merler S, 2015, LANCET INFECT DIS, V3099, P1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Obilade TT, 2015, INT ARCH MED, V8, P1
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   R Core Team, 2014, R LANG ENV STAT COMP
   Rocha G, 2004, LANCET, V363, P247, DOI 10.1016/S0140-6736(03)15345-7
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135
   Rowe AK, 1999, J INFECT DIS, V179, P28
   Schuette MC, 2003, MATH BIOSCI, V182, P113, DOI 10.1016/S0025-5564(02)00219-5
   Slenczka W, 2007, J INFECT DIS, V196, pS131, DOI 10.1086/520551
   Smith J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088378
   Sprecher A, 2015, N ENGL J MED
   Stadler T, 2014, PLOS CURR OUTBREAKS, V1, P1, DOI DOI 10.1371/CURRENTS.OUTBREAKS.02BC6D927ECEE7BBD33532EC8BA6A25F
   SWENSON PD, 1995, J CLIN MICROBIOL, V33, P2728
   Thrall PH, 1997, P ROY SOC B-BIOL SCI, V264, P581
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Toth DJA, 2015, EMERG INFECT DIS, V21, P1402, DOI 10.3201/eid2108.150170
   Van Bortel T, 2016, B WORLD HEALTH ORGAN, V94, P210, DOI 10.2471/BLT.15.158543
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411
   World Health Organization, 2015, WHO EB SIT REP
   WHO, 2016, WHO EB SIT REP
   World Health Organization, 2015, EB DAT STAT DAT NEW
   WHO Ebola Response Team, 2014, ENGLAND J MED, V371, P1481
   The World Bank, 2015, SIERR LEON COUNTR GL
NR 57
TC 0
Z9 0
U1 10
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004676
DI 10.1371/journal.pntd.0004676
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300029
ER

PT J
AU Alfaro-Murillo, JA
   Parpia, AS
   Fitzpatrick, MC
   Tamagnan, JA
   Medlock, J
   Ndeffo-Mbah, ML
   Fish, D
   Avila-Aguero, ML
   Marin, R
   Ko, AI
   Galvani, AP
AF Alfaro-Murillo, Jorge A.
   Parpia, Alyssa S.
   Fitzpatrick, Meagan C.
   Tamagnan, Jules A.
   Medlock, Jan
   Ndeffo-Mbah, Martial L.
   Fish, Durland
   Avila-Aguero, Maria L.
   Marin, Rodrigo
   Ko, Albert I.
   Galvani, Alison P.
TI A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; OUTBREAK; STATES
AB Background
   As Zika virus continues to spread, decisions regarding resource allocations to control the outbreak underscore the need for a tool to weigh policies according to their cost and the health burden they could avert. For example, to combat the current Zika outbreak the US President requested the allocation of $1.8 billion from Congress in February 2016.
   Methodology/Principal Findings
   Illustrated through an interactive tool, we evaluated how the number of Zika cases averted, the period during pregnancy in which Zika infection poses a risk of microcephaly, and probabilities of microcephaly and Guillain-Barre Syndrome (GBS) impact the cost at which an intervention is cost-effective. From Northeast Brazilian microcephaly incidence data, we estimated the probability of microcephaly in infants born to Zika-infected women (0.49% to 2.10%). We also estimated the probability of GBS arising from Zika infections in Brazil (0.02% to 0.06%) and Colombia (0.08%). We calculated that each microcephaly and GBS case incurs the loss of 29.95 DALYs and 1.25 DALYs per case, as well as direct medical costs for Latin America and the Caribbean of $91,102 and $28,818, respectively. We demonstrated the utility of our cost-effectiveness tool with examples evaluating funding commitments by Costa Rica and Brazil, the US presidential proposal, and the novel approach of genetically modified mosquitoes. Our analyses indicate that the commitments and the proposal are likely to be cost-effective, whereas the cost-effectiveness of genetically modified mosquitoes depends on the country of implementation.
   Conclusions/Significance
   Current estimates from our tool suggest that the health burden from microcephaly and GBS warrants substantial expenditures focused on Zika virus control. Our results justify the funding committed in Costa Rica and Brazil and many aspects of the budget outlined in the US president's proposal. As data continue to be collected, new parameter estimates can be customized in real-time within our user-friendly tool to provide updated estimates on cost-effectiveness of interventions and inform policy decisions in country-specific settings.
C1 [Alfaro-Murillo, Jorge A.; Parpia, Alyssa S.; Fitzpatrick, Meagan C.; Tamagnan, Jules A.; Ndeffo-Mbah, Martial L.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.
   [Alfaro-Murillo, Jorge A.; Parpia, Alyssa S.; Fitzpatrick, Meagan C.; Ndeffo-Mbah, Martial L.; Fish, Durland; Ko, Albert I.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Medlock, Jan] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.
   [Avila-Aguero, Maria L.] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Pediat Infect Dis Dept, San Jose, Costa Rica.
   [Marin, Rodrigo] Minist Salud, Programa Control Vectores, San Jose, Costa Rica.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [Galvani, Alison P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
RP Galvani, AP (reprint author), Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.; Galvani, AP (reprint author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.; Galvani, AP (reprint author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
EM alison.galvani@yale.edu
RI Ko, Albert/P-2343-2015
FU National Institutes of Health [NIH U01 GM087719, U01 GM105627]
FX This research was supported by the National Institutes of Health (NIH
   U01 GM087719 and U01 GM105627). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Boadle A., 2016, BRAZILS BNDES PROVID
   Brasil P, 2016, N ENGL J MED MASS ME
   Cao-Lormeau VM, 2016, LANCET
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   [Anonymous], 2016, COUNTRIES TERRITORIE
   Centers for Disease Control and Prevention, 2016, ZIKA VIRUS IN THE UN
   Centers for Disease Control and Prevention, 2016, TRANSCRIPT FOR CDC T
   Centers for Disease Control and Prevention (CDC), 2004, MMWR-MORBID MORTAL W, V53, P57
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci A.S., 2016, N ENGL J MED
   Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1
   Instituto Brasileiro de Geografia e Estatistica, 2014, ESTIMATIVAS DA POPUL
   Instituto Nacional de Salud, 2016, CONTEO CASOS ZIKA MU
   Ministerio de Salud, 2016, ANALISIS DE SITUACIO
   Ministerio da Saude Brasil, 2016, PREVENCAO E COMBATE
   National Birth Defects Prevention Network, 2013, STATE BIRTH DEFECTS
   Nembhard WN, 2001, TERATOLOGY, V64, P267, DOI 10.1002/tera.1073
   Notimerica, 2015, MAS DE 10 MILLONES D
   Rasmussen SA, 2016, N ENGL J MED
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2015, MMWR-MORBID MORTAL W, V2016, P59, DOI DOI 10.15585/MMWR.MM6503E2
   Secretaria de Vigilancia em Saude, 2015, REPORT NO VERSAO 1 2
   Simmons G, 2014, EMERG INFECT DIS, V22, DOI [10.3201/eid2207.160116, DOI 10.3201/EID2207.160116]
   Stanaway JD, 2013, LANCET INFECT DIS
   Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X9801800209
   The White House Office of the Press Secretary, 2016, THE WHITE HOUSE OFFI
   UN Population Division, 2015, 2015 REVISION OF WOR
   United States Department of Labor: Bureau of Labor Statistics, DATABASES TABLES CAL
   World Health Organization, 2016, EMERGENCIES PREPARED
   World Health Organization, 2016, WHO DIRECTOR GENERAL
   World Health Organization, 2016, EMERGENCIES ZIKA VIR
   WHO, 2016, MICROCEPHALY PANAMA
   World Health Organization, 2010, CHOOSING INTERVENTIO
   The World Bank, 2014, PURCHASING POWER PAR
   World Development Indicators, 2013, BIRTH RATE CRUDE PER
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 39
TC 2
Z9 2
U1 19
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004743
DI 10.1371/journal.pntd.0004743
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300070
PM 27205899
ER

PT J
AU Aman, MJ
   Kashanchi, F
AF Aman, M. Javad
   Kashanchi, Fatah
TI Zika Virus: A New Animal Model for an Arbovirus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Editorial Material
ID ISOLATIONS
C1 [Aman, M. Javad] Integrated BioTherapeut Inc, Gaithersburg, MD USA.
   [Kashanchi, Fatah] George Mason Univ, Mol Virol Lab, Manassas, VA USA.
RP Aman, MJ (reprint author), Integrated BioTherapeut Inc, Gaithersburg, MD USA.
EM Jaman@integratedbiotherapeutics.com; fkashanc@gmu.edu
CR BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V5, pe4658
   Duvanel CB, 2001, J NEUROSCI RES, V65, P446
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Lambert ND, 2014, CLIN VACCINE IMMUNOL, V21, P340, DOI 10.1128/CVI.00681-13
   Lazear HM, 2016, CELL HOST MICROBE, V19, P1
   Petersen L. R., 2016, N ENGL J MED
   Plante KS, 2015, PLOS NEGLECTED TROPI, V9
   Rossi S.L., 2016, AM J TROP MED HYG, P16
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Zanluca C, 2016, ZIKA VIRUS OVERVIEW
NR 12
TC 0
Z9 0
U1 5
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004702
DI 10.1371/journal.pntd.0004702
PG 3
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300044
PM 27149628
ER

PT J
AU Dowall, SD
   Graham, VA
   Rayner, E
   Atkinson, B
   Hall, G
   Watson, RJ
   Bosworth, A
   Bonney, LC
   Kitchen, S
   Hewson, R
AF Dowall, Stuart D.
   Graham, Victoria A.
   Rayner, Emma
   Atkinson, Barry
   Hall, Graham
   Watson, Robert J.
   Bosworth, Andrew
   Bonney, Laura C.
   Kitchen, Samantha
   Hewson, Roger
TI A Susceptible Mouse Model for Zika Virus Infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; HEMORRHAGIC-FEVER VIRUS; RECEPTOR-KNOCKOUT
   MICE; WEST-NILE-VIRUS; BRAZIL; ADULT; TRANSMISSION; CHIKUNGUNYA;
   ISOLATIONS; OUTBREAK
AB Zika virus (ZIKV) is a mosquito-borne pathogen which has recently spread beyond Africa and into Pacific and South American regions. Despite first being detected in 1947, very little information is known about the virus, and its spread has been associated with increases in Guillain-Barre syndrome and microcephaly. There are currently no known vaccines or antivirals against ZIKV infection. Progress in assessing interventions will require the development of animal models to test efficacies; however, there are only limited reports on in vivo studies. The only susceptible murine models have involved intracerebral inoculations or juvenile animals, which do not replicate natural infection. Our report has studied the effect of ZIKV infection in type-I interferon receptor deficient (A129) mice and the parent strain (129Sv/Ev) after subcutaneous challenge in the lower leg to mimic a mosquito bite. A129 mice developed severe symptoms with widespread viral RNA detection in the blood, brain, spleen, liver and ovaries. Histological changes were also striking in these animals. 129Sv/Ev mice developed no clinical symptoms or histological changes, despite viral RNA being detectable in the blood, spleen and ovaries, albeit at lower levels than those seen in A129 mice. Our results identify A129 mice as being highly susceptible to ZIKV and thus A129 mice represent a suitable, and urgently required, small animal model for the testing of vaccines and antivirals.
C1 [Dowall, Stuart D.; Graham, Victoria A.; Rayner, Emma; Atkinson, Barry; Hall, Graham; Watson, Robert J.; Bosworth, Andrew; Bonney, Laura C.; Kitchen, Samantha; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
RP Dowall, SD (reprint author), Publ Hlth England, Natl Infect Serv, Salisbury, Wilts, England.
EM stuart.dowall@phe.gov.uk
FU Public Health England
FX This work was funded by a Public Health England Grant-In-Aid project.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aoki K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-105
   Atkinson B HP, 2016, EMERG INFECT DIS
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0
   [Anonymous], 2016, LANCET
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   Buttigieg KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091516
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V.M., 2013, EMERG INFECT DIS, V2014, P1085, DOI DOI 10.3201/EID2006.140138
   Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P1135
   Christofferson RC, 2016, AM J TROP MED HYG
   Cohen S, 2016, NEUROLOGY, V86, P19, DOI 10.1212/WNL.0000000000002209
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2012, J GEN VIROL, V93, P560, DOI 10.1099/vir.0.038455-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   (ECDC) E.C.f.D.p.a.C, 2016, RAP RISK ZIK VIR INF
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Holzer GW, 2011, VACCINE, V29, P4132, DOI 10.1016/j.vaccine.2011.03.089
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Inomata K., 1980, BRAIN DEV, V2
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   Jayasundara VK, 2008, B ENVIRON CONTAM TOX, V80, P374, DOI 10.1007/s00128-008-9392-y
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Milatovic D, 2002, J NEUROVIROL, V8, P295, DOI 10.1080/13550280290100743
   Mlakar J., 2016, N ENGL J MED
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nagel MA, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-015-0614-5
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Plante KS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004007
   PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N
   REAGAN R L, 1955, Tex Rep Biol Med, V13, P934
   Salvador F. S., 2015, TRAVEL MED INFECT DI
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Seymour RL, 2013, AM J TROP MED HYG, V88, P1170, DOI 10.4269/ajtmh.12-0674
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tetro JA, 2016, MICROBES INFECT
   Ventura C. V., 2016, LANCET
   Waggoner J. J., 2016, J CLIN MICROBIOL
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Way J H, 1976, J Gen Virol, V30, P123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, BRIEF ZIK VIR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 62
TC 10
Z9 10
U1 27
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004658
DI 10.1371/journal.pntd.0004658
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300025
PM 27149521
ER

PT J
AU Kucharski, AJ
   Funk, S
   Eggo, RM
   Mallet, HP
   Edmunds, WJ
   Nilles, EJ
AF Kucharski, Adam J.
   Funk, Sebastian
   Eggo, Rosalind M.
   Mallet, Henri-Pierre
   Edmunds, W. John
   Nilles, Eric J.
TI Transmission Dynamics of Zika Virus in Island Populations: A Modelling
   Analysis of the 2013-14 French Polynesia Outbreak
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHIKUNGUNYA OUTBREAK; COMMUNITY SIZE; DENGUE; AEGYPTI; MEASLES; VECTOR
AB Between October 2013 and April 2014, more than 30,000 cases of Zika virus (ZIKV) disease were estimated to have attended healthcare facilities in French Polynesia. ZIKV has also been reported in Africa and Asia, and in 2015 the virus spread to South America and the Caribbean. Infection with ZIKV has been associated with neurological complications including Guillain-Barre Syndrome (GBS) and microcephaly, which led the World Health Organization to declare a Public Health Emergency of International Concern in February 2015. To better understand the transmission dynamics of ZIKV, we used a mathematical model to examine the 2013-14 outbreak on the six major archipelagos of French Polynesia. Our median estimates for the basic reproduction number ranged from 2.6-4.8, with an estimated 11.5%(95% CI: 7.32-17.9%) of total infections reported. As a result, we estimated that 94% (95% CI: 91-97%) of the total population of the six archipelagos were infected during the outbreak. Based on the demography of French Polynesia, our results imply that if ZIKV infection provides complete protection against future infection, it would take 12-20 years before there are a sufficient number of susceptible individuals for ZIKV to re-emerge, which is on the same timescale as the circulation of dengue virus serotypes in the region. Our analysis suggests that ZIKV may exhibit similar dynamics to dengue virus in island populations, with transmission characterized by large, sporadic outbreaks with a high proportion of asymptomatic or unreported cases.
C1 [Kucharski, Adam J.; Funk, Sebastian; Eggo, Rosalind M.; Edmunds, W. John] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England.
   [Mallet, Henri-Pierre] Bur Veille Sanit, Direct Sante, Tahiti, Fr Polynesia.
   [Nilles, Eric J.] World Hlth Org, Suva, Fiji.
RP Kucharski, AJ (reprint author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England.
EM adam.kucharski@lshtm.ac.uk
FU Medical Research Council [MR/K021524/1, MR/K021680/1]
FX AJK and SF are supported by the Medical Research Council ( fellowships
   MR/K021524/1 and MR/K021680/1). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   BLACK FL, 1966, J THEOR BIOL, V11, P207, DOI 10.1016/0022-5193(66)90161-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brady OJ, 2013, PARASITE VECTOR, V6, P1
   Breto C, 2009, ANN APPL STAT, P319
   Camacho A, 2011, P ROY SOC B-BIOL SCI, V278, P3635, DOI 10.1098/rspb.2011.0300
   Camacho E, 2016, EMERG INFECT DIS, V22, DOI [10.3201/eid2205, DOI 10.3201/EID2205]
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cao-Lormeau V.M., 2013, EMERG INFECT DIS, V2014, P1085, DOI DOI 10.3201/EID2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centre d'hygiene et de salubrite publique, 2014, SURV DENG ZIK POL FR
   Centre d'hygiene et de salubrite publique, 2015, NOT INV AUT MALF CER
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290
   CIA, 2016, WORLD FACTBOOK
   Corsica F, 2015, EMERG INFECT DIS, V21, P1887, DOI [10.3201/eid2010.151125, DOI 10.3201/EID2010.151125]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Institut national de la statistique et des etudes economiques, 2012, POP SUBD ADM POL FRA
   Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65
   Lardeux F, 2001, MED VET ENTOMOL, V15, P167, DOI 10.1046/j.0269-283x.2001.00305.x
   Lessler J., 2016, BIORXIV
   Chau P.Y.K., 2009, PACIFIC ASIA J ASS I, V1, P1
   Mallet HP, 2015, B INFORM SANITAIRES
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007
   R Core Team, 2015, R LANG ENV STAT COMP
   Riviere F, 1988, THESIS
   Roth A., 2014, EURO SURVEILL, V19
   Schuler-Faccini L, 2015, MMWR-MORBID MORTAL W, P65, DOI 10.15585/mmwr.mm6503e2er
   Soetaert K, 2010, J STAT SOFTW, V33, P1
   The World Bank, 2016, CLIM CHANG KNOWL POR
NR 44
TC 2
Z9 2
U1 14
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004726
DI 10.1371/journal.pntd.0004726
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300064
PM 27186984
ER

PT J
AU Zmurko, J
   Marques, RE
   Schols, D
   Verbeken, E
   Kaptein, SJF
   Neyts, J
AF Zmurko, Joanna
   Marques, Rafael E.
   Schols, Dominique
   Verbeken, Erik
   Kaptein, Suzanne J. F.
   Neyts, Johan
TI The Viral Polymerase Inhibitor 7-Deaza-2 '-C-Methyladenosine Is a Potent
   Inhibitor of In Vitro Zika Virus Replication and Delays Disease
   Progression in a Robust Mouse Infection Model
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TRANSMISSION; ENCEPHALITIS; AMERICA; THREAT; BRAZIL
AB Zika virus (ZIKV) is an emerging flavivirus typically causing a dengue-like febrile illness, but neurological complications, such as microcephaly in newborns, have potentially been linked to this viral infection. We established a panel of in vitro assays to allow the identification of ZIKV inhibitors and demonstrate that the viral polymerase inhibitor 7-deaza-2'-C-methyladenosine (7DMA) efficiently inhibits replication. Infection of AG129 (IFN-alpha/beta and IFN-gamma receptor knock-out) mice with ZIKV resulted in acute neutrophilic encephalitis with viral antigens accumulating in neurons of the brain and spinal cord. Additionally, high levels of viral RNA were detected in the spleen, liver and kidney, and levels of IFN-gamma and IL-18 were systematically increased in serum of ZIKV-infected mice. Interestingly, the virus was also detected in testicles of infected mice. In line with its in vitro anti-ZIKV activity, 7DMA reduced viremia and delayed virus-induced morbidity and mortality in infected mice, which also validates this small animal model to assess the in vivo efficacy of novel ZIKV inhibitors. Since AG129 mice can generate an antibody response, and have been used in dengue vaccine studies, the model can also be used to assess the efficacy of ZIKV vaccines.
C1 [Zmurko, Joanna; Schols, Dominique; Kaptein, Suzanne J. F.; Neyts, Johan] KU Leuven Univ Leuven, Lab Virol & Chemotherapy, Leuven, Belgium.
   [Marques, Rafael E.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Verbeken, Erik] Univ Leuven, Dept Pathol, Leuven, Belgium.
   [Verbeken, Erik] Leuven Univ Hosp, Leuven, Belgium.
RP Neyts, J (reprint author), KU Leuven Univ Leuven, Lab Virol & Chemotherapy, Leuven, Belgium.
EM Johan.Neyts@rega.kuleuven.be
FU EU FP7 [264286]; Belgian Interuniversity Attraction Poles (IAP) [P7/45];
   Fondation Dormeur, Vaduz; Hercules Foundation [ZW13-02]; Rega
   Foundation, KU Leuven
FX JZ's work was supported by: EU FP7 [FP7/2007-2013] project EUVIRNA under
   grant agreement no [264286]
   http://cordis.europa.eu/result/rcn/176954_de.html, a grant from the
   Belgian Interuniversity Attraction Poles (IAP) phase VII - P7/45
   (BELVIR) and the Fondation Dormeur, Vaduz. Part of this research work
   was performed using the 'Caps-It' research infrastructure (project
   ZW13-02) that was financially supported by the Hercules Foundation and
   Rega Foundation, KU Leuven. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Bischoff K, 2012, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, 2ND EDITION, P443, DOI 10.1016/B978-0-12-385926-6.00028-4
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V.M., 2013, EMERG INFECT DIS, V2014, P1085, DOI DOI 10.3201/EID2006.140138
   Centers for Disease Control and Prevention, ZIK VIR SYMPT TREATM
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Fauci A.S., 2016, N ENGL J MED
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goorhuis A., 2015, PROMED
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, pe1477, DOI [DOI 10.1371/J0URNAL.PNTD.0001477, 10.1371/journal.pntd.0001477]
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Iversen PW, 2006, J BIOMOL SCREEN, V11, P247, DOI 10.1177/1087057105285610
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Leyssen P, 2003, BRAIN PATHOL, V13, P279
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i212
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030
   Pan American Health Organization /World Health Organization, 2015, NEUR SYDNDR CONG MAL
   Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sarathy VV, 2015, J VIROL, V89, P1254, DOI [10.1128/JVI.01320-14, 10.1128/JVI01320-14]
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Tappe D., 2015, MED MICROBIOL IMMUNO
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 38
TC 4
Z9 4
U1 13
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004695
DI 10.1371/journal.pntd.0004695
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300037
PM 27163257
ER

PT J
AU Schoffel, N
   Bendels, MHK
   Bauer, J
   Bruggmann, D
   Groneberg, DA
AF Schoeffel, N.
   Bendels, M. H. K.
   Bauer, J.
   Brueggmann, D.
   Groneberg, D. A.
TI Zika virus. Clinical implications regarding the current Zika virus
   outbreak
SO ZENTRALBLATT FUR ARBEITSMEDIZIN ARBEITSSCHUTZ UND ERGONOMIE
LA German
DT Article
DE Zika virus; Diagnosis, differential; Disease outbreaks; Prognosis;
   Flavivirus
ID AMERICA
AB The Zika virus is a flavivirus closely related to Dengue fever, Yellow fever and West Nile virus. In 1947, the virus was isolated in a rhesus monkey in the Zika Forest of Uganda. It is considered an emerging arbovirus transmitted by mosquitos of the genus Aedes. Only sporadic cases were detected in Africa and East Asia until the early 2000s. In 2007, epidemics were described on islands in the Pacific Ocean and more recently in Brazil. Clinical symptoms are unspecific and may be characterized as an influenza-like illness. Currently, no deaths caused by the virus have been reported. Diagnosis can be performed by RT-PCR and/or by IgG and IgM antibody detection. The spread of the virus and its epidemic potential are of particular interest in countries where other arboviruses circulate, which imposes difficulties in differential diagnosis. This review outlines the current knowledge in epidemiology, diagnosis, therapy and prognosis of the Zika virus outbreak.
C1 [Schoeffel, N.; Bendels, M. H. K.; Bauer, J.; Brueggmann, D.; Groneberg, D. A.] Goethe Univ Frankfurt, Inst Arbeitsmed Sozialmed & Umweltmed, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
RP Schoffel, N (reprint author), Goethe Univ Frankfurt, Inst Arbeitsmed Sozialmed & Umweltmed, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM Schoeffel@med.uni-frankfurt.de
CR Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Choumet V., 2015, Revue Scientifique et Technique - Office International des Epizooties, V34, P467
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gulland A, 2016, BMJ-BRIT MED J, V352, pi657
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torjesen I, 2016, BMJ-BRIT MED J, V352, pi500
   [Anonymous], 2016, LANCET, V387, P96, DOI [10.1016/S0140-6736(16)00014-3, DOI 10.1016/S0140-6736(16)00014-3]
NR 18
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-2502
EI 2198-0713
J9 ZENTRALBLATT ARB ARB
JI Zentralblatt Arb. Arb. Ergon.
PD MAY
PY 2016
VL 66
IS 3
BP 156
EP 158
DI 10.1007/s40664-016-0104-x
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DO2IL
UT WOS:000377603200005
ER

PT J
AU Silveira, FP
   Campos, SV
AF Silveira, Fernantla P.
   Campos, Silvia V.
TI The Zika epidemics and transplantation
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Article
DE Zika virus; transplantation; complications; microcephaly; Guillain-Barre
   syndrome; donor-derived infection
ID VIRUS; TRANSMISSION; STATES
AB In the last few months an epidemic of Zika virus (ZIKV) has affected several countries, and it continues to spread rapidly. This virus was initially thought to cause only a mild febrile illness; however, the current epidemic has shown that it is associated with serious complications. Increasing reports are linking ZIKV to devastating conditions such as microcephaly in newborns and important neurologic syndromes. Although ZIKV infection has not yet been reported in transplant recipients, it is likely that it will be reported soon because of the number of transplants performed in affected areas and global travel. We discuss the effect of ZIKV in transplantation and propose recommendations to prevent donor derived infections. (C) 2016 International Society for Heart and Lung Transplantation. All rights reserved.
C1 [Silveira, Fernantla P.] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA USA.
   [Campos, Silvia V.] Univ Sao Paulo, Lung Transplant Grp, Div Pulm, Heart Inst InCor, Sao Paulo, Brazil.
RP Silveira, FP (reprint author), 3601 Fifth Ave,Ste 3A, Pittsburgh, PA 15237 USA.
EM silveirafd@upmc.edu
CR Associacao Brasileira de Transplante de Orgaos, REG BRAS TRANSPL
   Brasil P, N ENGL J MED
   Calvet G, LANCET INFECT DIS
   Cao-Lormeau VM, LANCET
   Centers for Disease Control and Prevention, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, LANCET INFECT DIS
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   United Network for Organ Sharing, GUID ORG DON TRANSPL
   [Anonymous], 2016, MAINT SAF AD BLOOD S
NR 15
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
EI 1557-3117
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD MAY
PY 2016
VL 35
IS 5
BP 560
EP 563
DI 10.1016/j.healun.2016.03.010
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA DN3HB
UT WOS:000376951900003
PM 27197772
ER

PT J
AU de Noronha, L
   Zanluca, C
   Azevedo, MLV
   Luz, KG
   dos Santos, CND
AF de Noronha, Lucia
   Zanluca, Camila
   Viola Azevedo, Marina Luize
   Luz, Kleber Giovanni
   Duarte dos Santos, Claudia Nunes
TI Zika virus damages the human placental barrier and presents marked fetal
   neurotropism
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; transplacental transmission; Hofbauer cells; neurotropism
ID WEST-NILE VIRUS; INFECTIONS; TRANSMISSION; PATHOGENESIS; EMERGENCE
AB An unusually high incidence of microcephaly in newborns has recently been observed in Brazil. There is a temporal association between the increase in cases of microcephaly and the Zika virus (ZIKV) epidemic. Viral RNA has been detected in amniotic fluid samples, placental tissues and newborn and fetal brain tissues. However, much remains to be determined concerning the association between ZIKV infection and fetal malformations. In this study, we provide evidence of the transplacental transmission of ZIKV through the detection of viral proteins and viral RNA in placental tissue samples from expectant mothers infected at different stages of gestation. We observed chronic placentitis (TORCH type) with viral protein detection by immunohistochemistry in Hofbauer cells and some histiocytes in the intervillous spaces. We also demonstrated the neurotropism of the virus via the detection of viral proteins in glial cells and in some endothelial cells and the observation of scattered foci of microcalcifications in the brain tissues. Lesions were mainly located in the white matter. ZIKV RNA was also detected in these tissues by real-time-polymerase chain reaction. We believe that these findings will contribute to the body of knowledge of the mechanisms of ZIKV transmission, interactions between the virus and host cells and viral tropism.
C1 [de Noronha, Lucia; Viola Azevedo, Marina Luize] Pontificia Univ Catolica Parana, Curitiba, Parana, Brazil.
   [Zanluca, Camila; Duarte dos Santos, Claudia Nunes] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
   [Luz, Kleber Giovanni] Univ Fed Rio Grande do Norte, Inst Med Trop, BR-59072970 Natal, RN, Brazil.
RP dos Santos, CND (reprint author), Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
EM clsantos@fiocruz.br
FU FIOCRUZ; CNPq; CAPES; Fundacao Araucaria
FX FIOCRUZ, CNPq, CAPES, Fundacao Araucaria. LN and CZ contributed equally
   to this work.
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Baurakiades E, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-101
   Benirchke K, 2006, PATHOLOGY HUMAN PLAC, P502
   Boussemart T, 2001, J Perinatol, V21, P255, DOI 10.1038/sj.jp.7200530
   Brasil P, 2016, N ENGL J ME IN PRESS
   Calvet G., 2016, LANCET INFECT DIS
   Chong DC, 2009, PEDIATR DEVEL PATHOL, V12, P211, DOI 10.2350/07-02-0229.1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   EBC - Empresa Brasil de Comunicacao, 2016, CAS CONF MICR SOB PA
   GREENOUGH A, 1994, ARCH DIS CHILD, V70, pF163, DOI 10.1136/fn.70.3.F163
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Laszczyk Magdalena, 2007, Ginekol Pol, V78, P560
   Love S, 2002, GREENFIELDS NEUROPAT, P45
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823
   Martines R, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6506E1ER
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Oehler E, 2014, EUROSURVEILLANCE, V19
   PAHO - Pan American Health Organization, 2016, ZIK VIR INF
   Pierson T.C., 2013, FIELDS VIROLOGY, P747
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   TSAI TF, 1993, J INFECT DIS, V168, P1520
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 7
Z9 7
U1 12
U2 12
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2016
VL 111
IS 5
BP 287
EP +
DI 10.1590/0074-02760160085
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DN2EI
UT WOS:000376876500002
ER

PT J
AU Kotton, CN
AF Kotton, Camille Nelson
TI Zika Virus and Solid Organ Transplantation: Significant Pathogen or
   Harbinger of Things to Come?
SO TRANSPLANTATION
LA English
DT Editorial Material
ID TRANSMISSION; RECIPIENTS
C1 [Kotton, Camille Nelson] Harvard Univ, Massachusetts Gen Hosp, Transplant & Immunocompromised Host Infect Dis, Infect Dis Div,Med Sch, Boston, MA USA.
RP Kotton, CN (reprint author), Massachusetts Gen Hosp, 55 Fruit St,Cox 5, Boston, MA 02114 USA.
EM ckotton@partners.org
CR CDC, 2016, ALL COUNTR TERR ACT
   Prevention CfDCa, 2016, ZIK VIR DIAGN TEST C
   Costa SD, 2015, AM J TROP MED HYG, V93, P394, DOI 10.4269/ajtmh.15-0038
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Kaul DR, 2015, AM J TRANSPLANT, V15, P5, DOI 10.1111/ajt.13093
   Laffoon B., 2010, Morbidity and Mortality Weekly Report, V59, P1335
   Lieshout-Krikke RW, 2013, VOX SANG, V104, P12, DOI 10.1111/j.1423-0410.2012.01631.x
   Oehler E., 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Prevention CfDCa, 2016, ZIK VIR CLIN EV DIS
   Regan DM, 2016, ASS BLOOD BANKS AABB, V16-03
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P1
   [Anonymous], 2016, GUILLAIN BARRE SYNDR
   [Anonymous], 2016, GUIDANCE ORGAN DONAT
NR 15
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD MAY
PY 2016
VL 100
IS 5
BP 970
EP 972
DI 10.1097/TP.0000000000001179
PG 3
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA DN5QU
UT WOS:000377126000007
PM 27023395
ER

PT J
AU dos Santos, AG
   Stucchi, RSB
   Boin, IFSF
   Ataide, E
   Angerami, R
   Cunha, MS
   Souza, RP
   Fonseca, BAL
AF dos Santos, Andrea G.
   Stucchi, Raquel S. B.
   Boin, Ilka F. S. F.
   Ataide, Elaine
   Angerami, Rodrigo
   Cunha, Mariana S.
   Souza, Renato P.
   Fonseca, Benedito A. L.
TI First Reported Case: Zika Virus Infection in a Liver Transplant Patient
SO TRANSPLANTATION
LA English
DT Meeting Abstract
CT 22nd Annual International Congress of the
   International-Liver-Transplantation-Society (ILTS)
CY MAY 04-07, 2016
CL Seoul, SOUTH KOREA
SP Int Liver Transplantat Soc
C1 [dos Santos, Andrea G.; Stucchi, Raquel S. B.; Boin, Ilka F. S. F.; Ataide, Elaine] State Univ Campinas UNICAMP, Fac Med Sci, Unit Liver Transplantat, Campinas, SP, Brazil.
   [Angerami, Rodrigo] State Univ Campinas UNICAMP, Hosp Clin, Sect Hosp Epidemiol, Campinas, SP, Brazil.
   [Cunha, Mariana S.; Souza, Renato P.] Adolfo Lutz Inst, Div Vector Borne Dis, Sao Paulo, Brazil.
   [Fonseca, Benedito A. L.] Univ Sao Paulo, Sch Med Ribeirao Preto, Div Infect Dis, Dept Internal Med, BR-14049 Ribeirao Preto, SP, Brazil.
NR 0
TC 0
Z9 0
U1 3
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD MAY
PY 2016
VL 100
SU 5
MA LB-18
BP S166
EP S166
PG 1
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA DN5QY
UT WOS:000377126400278
ER

PT J
AU Campos, GC
   Sardi, SI
   Sarno, M
   Brites, C
AF Campos, Gubio C.
   Sardi, Silvia I.
   Sarno, Manoel
   Brites, Carlos
TI Zika virus infection, a new public health challenge
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
ID OUTBREAK
C1 [Campos, Gubio C.; Sardi, Silvia I.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Sarno, Manoel; Brites, Carlos] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
RP Brites, C (reprint author), Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
EM crbrites@gmail.com
CR Brasil P, 2016, NEW ENGL J MED, V4, P2016, DOI DOI 10.1056/NEJM0A1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   [Anonymous], 2016, B EP, V47, P3
   Mlakar L, 2016, NEW ENGL J MED, V374, P951
   WHO/CDC/ICBDSR, 2016, ASS INF MICR CONT ZI
NR 7
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD MAY-JUN
PY 2016
VL 20
IS 3
BP 227
EP 228
DI 10.1016/j.bjid.2016.05.001
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DM6ER
UT WOS:000376443900001
PM 27215946
ER

PT J
AU De Carvalho, NS
   De Carvalho, BF
   Fugaca, CA
   Doris, B
   Biscaia, ES
AF De Carvalho, Newton Sergio
   De Carvalho, Beatriz Freitas
   Fugaca, Cyllian Arias
   Doris, Bruna
   Biscaia, Evellyn Silverio
TI Zika virus infection during pregnancy and microcephaly occurrence: a
   review of literature and Brazilian data
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus; Microcephaly; Aedes mosquitoes; Pregnancy
ID TRANSMISSION; ISLAND; CHILD
AB In November of 2015, the Ministry of Health of Brazil published an announcement confirming the relationship between Zika virus and the microcephaly outbreak in the Northeast, suggesting that infected pregnant women might have transmitted the virus to their fetuses. The objectives of this study were to conduct a literature review about Zika virus infection and microcephaly, evaluate national and international epidemiological data, as well as the current recommendations for the health teams. Zika virus is an arbovirus, whose main vector is the Aedes sp. The main symptoms of the infection are maculopapular rash, fever, non-purulent conjunctivitis, and arthralgia. Transmission of this pathogen occurs mainly by mosquito bite, but there are also reports via the placenta. Microcephaly is defined as a measure of occipto-frontal circumference being more than two standard deviations below the mean for age and gender. The presence of microcephaly demands evaluation of the patient, in order to diagnose the etiology. Health authorities issued protocols, reports and notes concerning the management of microcephaly caused by Zika virus, but there is still controversy about managing the cases. The Ministry of Health advises notifying any suspected or confirmed cases of children with microcephaly related to the pathogen, which is confirmed by a positive specific laboratory test for the virus. The first choice for imaging exam in children with this malformation is transfontanellar ultrasound. The most effective way to control this outbreak of microcephaly probably caused by this virus is to combat the vector. Since there is still uncertainty about the period of vulnerability of transmission via placenta, the use of repellents is crucial throughout pregnancy. More investigations studying the consequences of this viral infection on the body of newborns and in their development are required. (C) 2016 Elsevier Editora Ltda.
C1 [De Carvalho, Newton Sergio] Univ Fed Parana UFPR, Dept Gynecol & Obstet, Infect Dis Gynecol & Obstet Sect, Clin Hosp, Curitiba, Parana, Brazil.
   [De Carvalho, Newton Sergio] Postgrad Educ Program Obstet, Curitiba, Parana, Brazil.
   [De Carvalho, Newton Sergio] Univ Fed Parana UFPR, Curitiba, Parana, Brazil.
   [De Carvalho, Beatriz Freitas; Fugaca, Cyllian Arias; Doris, Bruna; Biscaia, Evellyn Silverio] Pontificia Univ Catolica Parana PUC PR, Curitiba, Parana, Brazil.
RP De Carvalho, NS (reprint author), Univ Fed Parana UFPR, Dept Gynecol & Obstet, Infect Dis Gynecol & Obstet Sect, Clin Hosp, Curitiba, Parana, Brazil.; De Carvalho, NS (reprint author), Postgrad Educ Program Obstet, Curitiba, Parana, Brazil.; De Carvalho, NS (reprint author), Univ Fed Parana UFPR, Curitiba, Parana, Brazil.
EM newtonsdc@gmail.com
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Centers for Disease Control and Prevention, HLTH CAR PROV DIAGN
   Centers for Disease Control Prevention, 2002, MMWR-MORBID MORTAL W, V51, P877
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2015, MON CAS MICR BRAS IN, P46
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, 2016, MON CAS MICR BRAS IN, P52
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Faccini LS, 2016, MMWR-MORBID MORTAL W, V65, P59
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubio SC, 2015, EMERG INFECT DIS, V21, P1885
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   [Anonymous], 2014, REV PAN-AMAZ SAUDE, DOI DOI 10.5123/S2176-62232014000300007
   Brasil, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2009, NORM MAN TECN
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EURO SURVEILL, P2014
   Pan American Health Organization. World Health Organization, 2015, ZIK VIR ZIK SURV AM
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   PARSONSON IM, 1977, INFECT IMMUN, V15, P254
   Sadler TW, 1997, EMBRIOLOGIA MED LANG, P250
   Secretaria Estadual de Saude do Parana, 2015, 012015I SESA
   Secretaria Estadual de Saude do Parana. Superintendencia devigilancia em saude, 2015, PROT VIG RESP OC MIC
   Secretaria Estadual de Saude de Pernambuco. Secretaria Executiva de Vigilancia em Saude, 2015, PROT CLIN EP INV CAS
   Secretaria Estadual de Saude de Sao Paulo. Coordenadoria deControle de Doencas. Centro de Vigilancia Epidemiologica. Instituto Adolfo Lutz, 2015, 01 SECR EST SAUD SAO, V01
   Secretaria de Vigilancia em Saude-Ministerio da Saude, 2015, B EP, P48
   Sweet RL, 2009, INFECT DIS FEMALE GE, P266
   Vasconcelos PFC, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
   Wasay M, 2015, NEUROLOGY, V84, P421, DOI 10.1212/WNL.0000000000001177
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
NR 35
TC 1
Z9 1
U1 16
U2 16
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD MAY-JUN
PY 2016
VL 20
IS 3
BP 282
EP 289
DI 10.1016/j.bjid.2016.02.006
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DM6ER
UT WOS:000376443900011
PM 27102780
ER

PT J
AU Tambo, E
   Chuisseu, PD
   Ngogang, JY
   Khater, EIM
AF Tambo, Ernest
   Chuisseu, Pascal D.
   Ngogang, Jeanne Y.
   Khater, Emad I. M.
TI Deciphering emerging Zika and dengue viral epidemics: Implications for
   global maternal-child health burden
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article; Proceedings Paper
CT Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Research
   Initiative Workshop
CY SEP 09-10, 2015
CL Riyadh, SAUDI ARABIA
DE Zika virus; Epidemics; Health; Preparedness; Surveillance;
   Maternal-child
ID INFECTIOUS-DISEASES; INTERIM GUIDELINES; UNITED-STATES; VIRUS;
   ALBOPICTUS; TRAVELERS; OUTBREAK; VECTOR
AB Since its discovery in 1947 in Uganda and control and eradication efforts have aimed at its vectors (Aedes mosquitoes) in Latin America in the 1950s, an absolute neglect of Zika programs and interventions has been documented in Aedes endemic and epidemic-prone countries. The current unprecedented Zika viral epidemics and rapid spread in the Western hemisphere pose a substantial global threat, with associated anxiety and consequences. The lack of safe and effective drugs and vaccines against Zika or dengue epidemics further buttresses the realization from the West Africa Ebola outbreak that most emerging disease-prone countries are still poorly prepared for an emergency response. This paper examines knowledge gaps in both emerging and neglected arthropod-borne flavivirus infectious diseases associated with poverty and their implications for fostering local, national and regional emerging disease preparedness, effective and robust surveillance-response systems, sustained control and eventual elimination. Strengthening the regional and Global Health Flavivirus Surveillance-Response Network (GHFV-SRN) with other models of socio-economic, climatic, environmental and ecological mitigation and adaptation strategies will be necessary to improve evidence-based national and global maternal-child health agenda and action plans. (C) 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
C1 [Tambo, Ernest; Chuisseu, Pascal D.; Ngogang, Jeanne Y.] Univ Montagnes, Higher Inst Hlth Sci, Biochem & Pharmaceut Sci Dept, Bangangte, Cameroon.
   [Tambo, Ernest] Africa Intelligence & Surveillance Commun & Respo, Yaounde, Cameroon.
   [Ngogang, Jeanne Y.] CHU, Serv Biochim, Yaounde, Cameroon.
   [Khater, Emad I. M.] Jeddah Governate, Publ Hlth Pests Lab, Jeddah, Saudi Arabia.
RP Tambo, E (reprint author), Univ Montagnes, Higher Inst Hlth Sci, Biochem & Pharmaceut Sci Dept, Bangangte, Cameroon.; Khater, EIM (reprint author), Jeddah Governate, Publ Hlth Pests Lab, Jeddah, Saudi Arabia.
EM tambo0711@gmail.com
OI Tambo, Ernest/0000-0002-4799-3252
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   [Anonymous], 2016, LANCET
   Cristiane WC, 2015, EMERG INFECT DIS, V21, P2274
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536
   Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   Fauci AS, 2012, NEW ENGL J MED, V366, P454, DOI 10.1056/NEJMra1108296
   Fauci A.S., 2016, N ENGL J MED
   Faye O, 2014, PLOS NEGLECT TROP D, V8
   Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Korhonen EM, 2016, EURO SURVEILL, V21
   Li MI, 2012, PLOS NEGLECT TROP D, V6
   McCarthy M, 2016, BMJ-BRIT MED J, V352, pi306, DOI DOI 10.1136/BMJ.I306
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   [Anonymous], 2014, CLIN MICROBIOL INFEC, DOI DOI 10.1111/1469-0691.12707
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Roth A, 2014, EURO SURVEILLANCE, V19
   Shinohara K, 2016, J TRAVEL MED, V23
   Tambo E, 2015, INT J VACCINES VACCI, V1, P00011
   Tambo E, 2015, J PREV INFECT CONTRO, V1, P2
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-42
   Tappe D., 2015, MED MICROBIOL IMMUNO
   Tetro JA, 2016, MICROBES INFECT
   Ventura C. V., 2016, LANCET
   Villamil-Gomez W E, 2016, J INFECT PUBLIC HLTH, DOI S1876-0341(15)00221-X
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 35
TC 2
Z9 2
U1 14
U2 14
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAY-JUN
PY 2016
VL 9
IS 3
BP 240
EP 250
DI 10.1016/j.jiph.2016.02.005
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DM6LM
UT WOS:000376463900009
PM 27052794
ER

PT J
AU Zhang, HM
   Srinivas, S
   Li, DF
   Feng, YJ
AF Zhang, Huimin
   Srinivas, Swaminath
   Li, Defeng
   Feng, Youjun
TI Origin, dissemination and entry of the pandemic Zika viruses
SO SCIENCE BULLETIN
LA English
DT Article
DE Zika virus; Flavivirus; Dissemination; Entry; Origin
ID FRENCH-POLYNESIA; OUTBREAK; AMERICA
AB Zika virus (ZIKV) is a previously-neglected, but newly-emerging zoonotic pathogen that has swept most of the western hemisphere. The unexpected attention aroused worldwide lies in the explosive spread of ZIKV to Brazil and USA in 2015 and its rare correlation to microcephaly in newborns, raising a serious challenge to public health. We show the origin and fast dissemination of these epidemic ZIKA isolates. Phylogenetic analyses revealed that all the newly-emerging ZIKV isolates belong to the Asian-American Lineage. Structural analyses of the ZIKV E surface protein suggested that it might adopt a similar entry mechanism to that of other Flavi-viruses like Dengue Virus and West Nile Virus.
C1 [Zhang, Huimin; Feng, Youjun] Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Peoples R China.
   [Zhang, Huimin] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
   [Srinivas, Swaminath] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
   [Li, Defeng] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.
RP Feng, YJ (reprint author), Zhejiang Univ, Sch Med, Dept Med Microbiol & Parasitol, Hangzhou 310058, Peoples R China.
EM fengyj@zju.edu.cn
FU Zhejiang Provincial Natural Science Foundation for Distinguished Young
   Scholars [LR15H190001]; National Natural Science Foundation of China
   [31570027]; Zhejiang University; "Young 1000 Talents'' Award
FX This work was supported by Zhejiang Provincial Natural Science
   Foundation for Distinguished Young Scholars (LR15H190001), the National
   Natural Science Foundation of China (31570027), and the start-up package
   from Zhejiang University (Y.F.). Dr. Feng is a recipient of the "Young
   1000 Talents'' Award.
CR Besnard M, 2014, EUROSURVEILLANCE, P19
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2013, EMERG INFECT DIS, V20, P1085, DOI DOI 10.3201/EID2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2014, EMERG INFECT DIS, V21, P381, DOI DOI 10.3201/EID2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141380, 10.3201/eid2011.141253]
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 13
TC 0
Z9 0
U1 9
U2 9
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 2095-9273
EI 2095-9281
J9 SCI BULL
JI Sci. Bull.
PD MAY
PY 2016
VL 61
IS 10
BP 749
EP 751
DI 10.1007/s11434-016-1068-0
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM5SR
UT WOS:000376410900002
ER

PT J
AU Aldrich, CC
AF Aldrich, Courtney C.
TI The Known Unknowns of Emerging Viruses
SO ACS INFECTIOUS DISEASES
LA English
DT Editorial Material
ID EBOLA-VIRUS; ZIKA VIRUS
CR Calvet G., 2016, DETECTION SEQUENCING, DOI [10.1016/S1473-3099(16)00095-5., DOI 10.1016/S1473-3099(16)00095-5]
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Mendoza EJ, 2016, TRENDS MOL MED, V22, P164, DOI 10.1016/j.molmed.2015.12.005
   Messaoudi I, 2015, NAT REV MICROBIOL, V13, P663, DOI 10.1038/nrmicro3524
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Vetter P., 2016, LANCET INFECT DIS, DOI [10.1016/S1473-3099(16)00077-3, DOI 10.1016/S1473-3099(16)00077-3]
NR 7
TC 0
Z9 0
U1 7
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD MAY
PY 2016
VL 2
IS 5
BP 310
EP 311
DI 10.1021/acsinfecdis.6b00072
PG 2
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA DM1ZP
UT WOS:000376145700001
PM 27627199
ER

PT J
AU Shakib, K
AF Shakib, Kaveh
TI Epidemic of Zika virus and maxillofacial surgery
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Editorial Material
DE Zika virus; Microcephaly; Guillain Barre syndrome; Virus induced
   congenital malformation
AB Zika is a RNA virus spread by the ubiquitous Aedes mosquitoes. It was first discovered in Uganda in 1947, and arrived in south-east Asia by the middle of the 20th century. In 2014 the virus started to spread across the Pacific Islands to reach South America. Since then it has spread rapidly northwards, and reached Mexico and the Caribbean in November 2015. Clinically it presents as a self-limiting febrile illness. However, there is increasing evidence of a link between Zika virus and the Guillain-Barre syndrome, and maternal Zika virus infection and microcephaly of the fetus. (C) 2016 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Shakib, Kaveh] Univ London Royal Free Hosp, Dept Oral & Maxillofacial Surg, London, England.
RP Shakib, K (reprint author), Univ London Royal Free Hosp, Dept Oral & Maxillofacial Surg, London, England.
EM k.shakib@nhs.net
CR European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Gatherer D., 2015, J GEN VIROL
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Public Health England, ZIK VIR TRAV ADV PRE
   Ventura C. V., 2016, LANCET
   World Health Organization, ZIK VIR FACTSH
   World Health Organization, GUILL BARR SYNDR SAL
   [Anonymous], BBC NEWS
NR 10
TC 0
Z9 0
U1 6
U2 6
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
EI 1532-1940
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD MAY
PY 2016
VL 54
IS 4
BP 355
EP 357
DI 10.1016/j.bjoms.2016.02.001
PG 3
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA DL8GE
UT WOS:000375878400001
PM 26907929
ER

PT J
AU Granato, C
   Lazari, C
   Serafini, PC
AF Granato, Celso
   Lazari, Carolina
   Serafini, Paulo C.
TI New threat on the horizon: The Zika virus
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Editorial Material
ID BRAZIL; TRANSMISSION; OUTBREAK; INFECTION
C1 [Granato, Celso] Univ Fed Sao Paulo, Discipline Infect Dis, Sao Paulo, Brazil.
   [Granato, Celso; Lazari, Carolina] Fleury Med Grp, Sao Paulo, Brazil.
   [Lazari, Carolina] Univ Sao Paulo, Fac Med, Dept Infect Dis, BR-04501000 Sao Paulo, SP, Brazil.
   [Serafini, Paulo C.] Univ Sao Paulo, Discipline Gynecol, Dept Obstet & Gynecol, BR-04501000 Sao Paulo, SP, Brazil.
   [Serafini, Paulo C.] Huntington Reprod Med, Reprod Endocrinol, Sao Paulo, Brazil.
   [Serafini, Paulo C.] Univ Sao Paulo, Human Reprod Serv, BR-04501000 Sao Paulo, SP, Brazil.
RP Serafini, PC (reprint author), Univ Sao Paulo, Huntington Med Reprod, Disciplina Ginecol, Fac Med, Ave Republ Libano 529, BR-04501000 Sao Paulo, SP, Brazil.
EM pauloivf@aol.com
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Besnard M, 2014, EURO SURVEILL, V19
   Brazilian Ministry of Health, 2016, SE07201614A20022016
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mlakar J, N ENGL J MED
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E, 2015, EURO SURVEILL, V19
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Waggoner JJ, J CLIN MICROBIOL
   World Health Organization, 2016, PREV POT SEX TRANSM
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAY
PY 2016
VL 133
IS 2
BP 137
EP 138
DI 10.1016/j.ijgo.2016.03.006
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DL6HE
UT WOS:000375739500002
PM 27058990
ER

PT J
AU Werner, H
   Fazecas, T
   Guedes, B
   Dos Santos, JL
   Daltro, P
   Tonni, G
   Campbell, S
   Araujo, E
AF Werner, H.
   Fazecas, T.
   Guedes, B.
   Lopes Dos Santos, J.
   Daltro, P.
   Tonni, G.
   Campbell, S.
   Araujo Junior, E.
TI Intrauterine Zika virus infection and microcephaly: correlation of
   perinatal imaging and three-dimensional virtual physical models
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Article
ID SCAN DATA; BRAZIL; ULTRASOUND; RECONSTRUCTION
C1 [Werner, H.; Fazecas, T.; Guedes, B.; Daltro, P.] Clin Diagnost Imagem CPDI, Dept Radiol, Rio De Janeiro, Brazil.
   [Lopes Dos Santos, J.] Pontificia Univ Catolica PUC Rio, Dept Arts & Design, Rio De Janeiro, Brazil.
   [Tonni, G.] AUSL Reggio Emilia, Guastalla Civil Hosp, Dept Obstet & Gynecol, Reggio Emilia, Italy.
   [Campbell, S.] Create Hlth Clin, London, England.
   [Araujo Junior, E.] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Obstet, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, Brazil.
RP Araujo, E (reprint author), Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Dept Obstet, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, Brazil.
EM araujojred@terra.com.br
CR Araujo E, 2014, J ULTRAS MED, V33, P1185, DOI 10.7863/ultra.33.7.1185
   Besnard M, 2014, EURO SURVEILL, V19
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E, 2013, EURO SURVEILL, V19
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Werner H, 2015, J MATERN-FETAL NEO M, P1
   Werner H, 2015, CHILD NERV SYST, V31, P511, DOI 10.1007/s00381-015-2641-6
   Werner H, 2014, ULTRASOUND Q, V30, P69, DOI 10.1097/RUQ.0000000000000048
   Werner H, 2015, MED ULTRASON, V17, P252, DOI 10.11152/mu.2013.2066.172.tert
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 21
TC 4
Z9 4
U1 8
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD MAY
PY 2016
VL 47
IS 5
BP 657
EP 660
DI 10.1002/uog.15901
PG 4
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA DL9KI
UT WOS:000375961100024
PM 26923098
ER

PT J
AU Harris, LH
   Silverman, NS
   Marshall, MF
AF Harris, Lisa H.
   Silverman, Neil S.
   Marshall, Mary Faith
TI The Paradigm of the Paradox: Women, Pregnant Women, and the Unequal
   Burdens of the Zika Virus Pandemic
SO AMERICAN JOURNAL OF BIOETHICS
LA English
DT Editorial Material
C1 [Harris, Lisa H.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.
   [Silverman, Neil S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Marshall, Mary Faith] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
   [Marshall, Mary Faith] Univ Virginia, Sch Nursing, Charlottesville, VA 22908 USA.
RP Marshall, MF (reprint author), Univ Virginia, Sch Nursing, Charlottesville, VA 22908 USA.; Marshall, MF (reprint author), Univ Virginia, Sch Med, Ctr Biomed Eth & Humanities, POB 800758, Charlottesville, VA 22908 USA.
EM mfm@virginia.edu
CR Ahmed A., 2016, NY TIMES
   Boorstein M., 2016, WASHINGTON POST
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1602412, DOI 10.1056/NEJMOA1602412]
   Centers for Disease Control, 2016, MORBIDITY MORTALITY
   DeBruin D, 2012, AM J PUBLIC HEALTH, V102, P586, DOI 10.2105/AJPH.2011.300483
   Diniz D., 2016, NY TIMES
   Driggers RW, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1601824., DOI 10.1056/NEJMOA1601824, 10.1056/NEJMoa1601824]
   Farmer P., 1999, INFECT INEQUALITIES
   Guttmacher Institute, 2015, FACT SHEET CONTR US
   Guttmacher Institute, 2013, INT PERSP SEX REPR H, V39, P163
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   World Health Organization, 2016, ZIK VIR POT COMPL QU
   Zielinksi A., 2016, THINK PROGR
NR 15
TC 0
Z9 0
U1 6
U2 6
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND
SN 1526-5161
EI 1536-0075
J9 AM J BIOETHICS
JI Am. J. Bioeth.
PD MAY
PY 2016
VL 16
IS 5
BP 1
EP 4
DI 10.1080/15265161.2016.1177367
PG 4
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA DK4TA
UT WOS:000374911100002
PM 27111356
ER

PT J
AU Reefhuis, J
   Gilboa, SM
   Johansson, MA
   Valencia, D
   Simeone, RM
   Hills, SL
   Polen, K
   Jamieson, DJ
   Petersen, LR
   Honein, MA
AF Reefhuis, Jennita
   Gilboa, Suzanne M.
   Johansson, Michael A.
   Valencia, Diana
   Simeone, Regina M.
   Hills, Susan L.
   Polen, Kara
   Jamieson, Denise J.
   Petersen, Lyle R.
   Honein, Margaret A.
TI Projecting Month of Birth for At-Risk Infants after Zika Virus Disease
   Outbreaks
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UPDATE INTERIM GUIDELINES; UNITED-STATES; INFECTION; BRAZIL
AB The marked increase in infants born with microcephaly in Brazil after a 2015 outbreak of Zika virus disease suggests an association between maternal Zika virus infection and congenital microcephaly. To project the timing of delivery of infants born to mothers infected during early pregnancy in 1 city in Bahia State, Brazil, we incorporated data on reported Zika cases and microcephaly cases into a graphical schematic of weekly birth cohorts. We projected that these births would occur through February 2016. Applying similar projections to a hypothetical location at which Zika virus transmission started in November, we projected that full term infants at risk for Zika virus infection would be born during April September 2016. We also developed a modifiable spreadsheet tool that public health officials and researchers can use for their countries to plan for deliveries of infants to women who were infected with Zika virus during different pregnancy trimesters.
C1 [Reefhuis, Jennita; Gilboa, Suzanne M.; Johansson, Michael A.; Valencia, Diana; Simeone, Regina M.; Polen, Kara; Jamieson, Denise J.; Honein, Margaret A.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E86, Atlanta, GA 30329 USA.
   [Hills, Susan L.; Petersen, Lyle R.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RP Reefhuis, J (reprint author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E86, Atlanta, GA 30329 USA.
EM nzr5@cdc.gov
CR Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bodeus M, 2010, J CLIN VIROL, V47, P201, DOI 10.1016/j.jcv.2009.11.009
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cha AE, 2016, WASHINGTON POST
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, RAPID RISK ASSESSMEN
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MILLER E, 1982, LANCET, V2, P781
   Ministry of Health Brazil, MONITORAMENTO DOS CA
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Pan American Health Organization World Health Organization, COUNTRIES AND TERRIT
   Pan American Health Organization World Health Organization, 2015, EPIDEMIOLOGICAL ALER
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Live Birth Information System Brazil (SINASC), LIVE BIRTH DATA FOR
   Live Birth Information System Brazil (SINASC), MICROCEPHALY IN BRAZ
   Live Birth Information System Brazil (SINASC), PANEL, V3
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, 2016, IHR PROCEDURES CONCE
NR 23
TC 2
Z9 2
U1 26
U2 26
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 828
EP 832
DI 10.3201/eid2205.160290
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100008
PM 27088494
ER

PT J
AU Cao-Lormeau, VM
AF Van-Mai Cao-Lormeau
TI Tropical Islands as New Hubs for Emerging Arboviruses
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID CHIKUNGUNYA VIRUS; ZIKA VIRUS; TRANSMISSION; DENGUE
C1 [Van-Mai Cao-Lormeau] Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
RP Cao-Lormeau, VM (reprint author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, Fr Polynesia.
EM mlormeau@ilm.pf
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Coffey LL, 2014, VIRUSES-BASEL, V6, P4628, DOI 10.3390/v6114628
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Pan American Health Organization, EP AL NEUR SYNDR CON
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 10
TC 2
Z9 3
U1 9
U2 9
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 913
EP 915
DI 10.3201/eid2205.150547
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100027
PM 27088243
ER

PT J
AU Perkasa, A
   Yudhaputri, F
   Haryanto, S
   Hayati, RF
   Ma'roef, CN
   Antonjaya, U
   Yohan, B
   Myint, KSA
   Ledermann, JP
   Rosenberg, R
   Powers, AM
   Sasmono, RT
AF Perkasa, Aditya
   Yudhaputri, Frilasita
   Haryanto, Sotianingsih
   Hayati, Rahma F.
   Ma'roef, Chairin Nisa
   Antonjaya, Ungke
   Yohan, Benediktus
   Myint, Khin Saw Aye
   Ledermann, Jeremy P.
   Rosenberg, Ronald
   Powers, Ann M.
   Sasmono, R. Tedjo
TI Isolation of Zika Virus from Febrile Patient, Indonesia
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID INFECTION
C1 [Perkasa, Aditya; Yudhaputri, Frilasita; Hayati, Rahma F.; Ma'roef, Chairin Nisa; Yohan, Benediktus; Myint, Khin Saw Aye; Sasmono, R. Tedjo] Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia.
   [Haryanto, Sotianingsih] Siloam Hosp Jambi, Jambi, Indonesia.
   [Antonjaya, Ungke] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.
   [Ledermann, Jeremy P.; Rosenberg, Ronald; Powers, Ann M.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RP Sasmono, RT (reprint author), Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia.
EM sasmono@eijkman.go.id
OI Sasmono, R. Tedjo/0000-0003-0986-2590; Yohan,
   Benediktus/0000-0003-2378-2386
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 6
Z9 6
U1 14
U2 14
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 924
EP 925
DI 10.3201/eid2205.151915
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100033
PM 27088970
ER

PT J
AU Arzuza-Ortega, L
   Polo, A
   Perez-Tatis, G
   Lopez-Garcia, H
   Parra, E
   Pardo-Herrera, LC
   Rico-Turca, AM
   Villamil-Gomez, W
   Rodriguez-Morales, AJ
AF Arzuza-Ortega, Laura
   Polo, Arnulfo
   Perez-Tatis, Giamina
   Lopez-Garcia, Humberto
   Parra, Edgar
   Pardo-Herrera, Lissethe C.
   Rico-Turca, Angelica M.
   Villamil-Gomez, Wilmer
   Rodriguez-Morales, Alfonso J.
TI Fatal Sickle Cell Disease and Zika Virus Infection in Girl from Colombia
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID RISK-FACTORS; CHIKUNGUNYA; OUTBREAK; AMERICA; ANEMIA; DENGUE
C1 [Arzuza-Ortega, Laura] Entidades Promotoras Salud Barrios Unido Mutual, Quibdo, Colombia.
   [Polo, Arnulfo] Empresa Social Estado Hosp Malambo, Malambo, Colombia.
   [Perez-Tatis, Giamina; Lopez-Garcia, Humberto] Hosp Metropolitano, Barranquilla, Colombia.
   [Parra, Edgar; Pardo-Herrera, Lissethe C.; Rico-Turca, Angelica M.] Inst Nacl Salud, Bogota, Colombia.
   [Villamil-Gomez, Wilmer] Hosp Univ Sincelejo, Sincelejo, Colombia.
   [Villamil-Gomez, Wilmer] Univ Atlantico, Barranquilla, Colombia.
   [Villamil-Gomez, Wilmer] Univ Cartagena, Cartagena, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (reprint author), Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
EM arodriguezm@ufp.edu.co
CR Alfaro-Toloza P, 2015, LANCET INFECT DIS, V15, P510, DOI 10.1016/S1473-3099(15)70160-X
   BRAVO JR, 1987, T ROY SOC TROP MED H, V81, P816, DOI 10.1016/0035-9203(87)90041-1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Fong C, 2013, GENET MOL BIOL, V36, P494, DOI 10.1590/S1415-47572013000400005
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Moesker FM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002203
   Pan American Health Organisations, NEUR SYNDR CONG MALF
   Rankine-Mullings A, 2015, EBIOMEDICINE, V2, P935
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
NR 10
TC 6
Z9 7
U1 11
U2 11
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 925
EP 927
DI 10.3201/eid2205.151934
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100034
PM 27089120
ER

PT J
AU Camacho, E
   Paternina-Gomez, M
   Blanco, PJ
   Osorio, JE
   Aliota, MT
AF Camacho, Erwin
   Paternina-Gomez, Margaret
   Blanco, Pedro J.
   Osorio, Jorge E.
   Aliota, Matthew T.
TI Detection of Autochthonous Zika Virus Transmission in Sincelejo,
   Colombia
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID OUTBREAK; CHIKUNGUNYA; DENGUE; PCR
C1 [Camacho, Erwin; Osorio, Jorge E.; Aliota, Matthew T.] Univ Wisconsin, Madison, WI 53706 USA.
   [Paternina-Gomez, Margaret; Blanco, Pedro J.] Univ Sucre, Sincelejo, Colombia.
RP Aliota, MT (reprint author), Univ Wisconsin, Dept Pathobiol Sci, 1656 Linden Dr, Madison, WI 53706 USA.
EM mtaliota@wisc.edu
CR Baronti C, 2014, GENOME ANNOUNC, P2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Harris E, 1998, J CLIN MICROBIOL, V36, P2634
   Instituto Nacional de Salud, 2016, ZIK SEM EP 01 DE 201
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
NR 10
TC 4
Z9 4
U1 10
U2 10
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 927
EP 929
DI 10.3201/eid2205.160023
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100035
PM 27089253
ER

PT J
AU Lanciotti, RS
   Lambert, AJ
   Holodniy, M
   Saavedra, S
   Signor, LDC
AF Lanciotti, Robert S.
   Lambert, Amy J.
   Holodniy, Mark
   Saavedra, Sonia
   Castillo Signor, Leticia del Carmen
TI Phylogeny of Zika Virus in Western Hemisphere, 2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID CHIKUNGUNYA
C1 [Lanciotti, Robert S.; Lambert, Amy J.] Ctr Dis Control & Prevent, 3150 Rampart Rd, Ft Collins, CO 80521 USA.
   [Holodniy, Mark] Dept Vet Affairs, Palo Alto, CA USA.
   [Saavedra, Sonia] VA Caribbean Hlth Care Syst, San Juan, PR USA.
   [Castillo Signor, Leticia del Carmen] Lab Nacl Salud Guatemala, Villa Nueva, Guatemala.
RP Lanciotti, RS (reprint author), Ctr Dis Control & Prevent, 3150 Rampart Rd, Ft Collins, CO 80521 USA.
EM rsl2@cdc.gov
CR Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, AM J TROP M IN PRESS
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 10
TC 9
Z9 9
U1 18
U2 18
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 933
EP 935
DI 10.3201/eid2205.160065
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100038
PM 27088323
ER

PT J
AU Diaz-Quinonez, JA
   Escobar-Escamilla, N
   Wong-Arambula, C
   Vazquez-Pichardo, M
   Torres-Longoria, B
   Lopez-Martinez, I
   Ruiz-Matus, C
   Kuri-Morales, P
   Ramirez-Gonzalez, JE
AF Alberto Diaz-Quinonez, Jose
   Escobar-Escamilla, Noe
   Wong-Arambula, Claudia
   Vazquez-Pichardo, Mauricio
   Torres-Longoria, Belem
   Lopez-Martinez, Irma
   Ruiz-Matus, Cuitlahuac
   Kuri-Morales, Pablo
   Ernesto Ramirez-Gonzalez, Jose
TI Asian Genotype Zika Virus Detected in Traveler Returning to Mexico from
   Colombia, October 2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID CHIKUNGUNYA
C1 [Alberto Diaz-Quinonez, Jose] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico.
   [Alberto Diaz-Quinonez, Jose; Escobar-Escamilla, Noe; Wong-Arambula, Claudia; Vazquez-Pichardo, Mauricio; Torres-Longoria, Belem; Lopez-Martinez, Irma; Ernesto Ramirez-Gonzalez, Jose] Inst Diagnost & Referencia Epidemiol Dr Manuel Ma, Francisco de P Miranda 177, Mexico City 01480, DF, Mexico.
   [Ruiz-Matus, Cuitlahuac] Direcc Gen Epidemiol, Mexico City, DF, Mexico.
   [Kuri-Morales, Pablo] Subsecretaria Prevenc & Promoc Salud, Mexico City, DF, Mexico.
RP Diaz-Quinonez, JA (reprint author), Inst Diagnost & Referencia Epidemiol Dr Manuel Ma, Francisco de P Miranda 177, Mexico City 01480, DF, Mexico.
EM alberto.diaz@salud.gob.mx
CR Diaz-Quinonez JA, 2016, VIRUS GENES, V52, P127, DOI 10.1007/s11262-015-1275-9
   Centers for Disease Control and Prevention, ZIK VIR
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306
   World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P609
NR 9
TC 0
Z9 0
U1 9
U2 9
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 937
EP 939
DI 10.3201/eid2205.160190
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100040
PM 27088574
ER

PT J
AU Atkinson, B
   Hearn, P
   Afrough, B
   Lumley, S
   Carter, D
   Aarons, EJ
   Simpson, AJ
   Brooks, TJ
   Hewson, R
AF Atkinson, Barry
   Hearn, Pasco
   Afrough, Babak
   Lumley, Sarah
   Carter, Daniel
   Aarons, Emma J.
   Simpson, Andrew J.
   Brooks, Timothy J.
   Hewson, Roger
TI Detection of Zika Virus in Semen
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Atkinson, Barry; Hearn, Pasco; Afrough, Babak; Lumley, Sarah; Carter, Daniel; Aarons, Emma J.; Simpson, Andrew J.; Brooks, Timothy J.; Hewson, Roger] Publ Hlth England, Porton Down, England.
   [Brooks, Timothy J.; Hewson, Roger] Natl Inst Hlth Res, Liverpool, Merseyside, England.
RP Atkinson, B (reprint author), Publ Hlth England, Porton Manor Farm Rd, Salisbury SP4 0JG, Wilts, England.
EM barry.atkinson@phe.gov.uk
CR Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization, 2016, REP INCR CONG MICR O
NR 3
TC 28
Z9 29
U1 16
U2 16
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 940
EP 940
DI 10.3201/eid2205.160107
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100042
PM 27088817
ER

PT J
AU Freitas, BD
   Dias, JRD
   Prazeres, J
   Sacramento, GA
   Ko, AI
   Maia, M
   Belfort, R
AF Freitas, Bruno de Paula
   de Oliveira Dias, Joao Rafael
   Prazeres, Juliana
   Sacramento, Gielson Almeida
   Ko, Albert Icksang
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Ocular Findings in Infants With Microcephaly Associated With Presumed
   Zika Virus Congenital Infection in Salvador, Brazil
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID FRENCH-POLYNESIA; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION;
   DECEMBER 2013; DENGUE; MICRONESIA; PREGNANCY; OUTBREAK; OUTCOMES; FEVER
AB IMPORTANCE The Zika virus (ZIKV) has rapidly reached epidemic proportions, especially in northeastern Brazil, and has rapidly spread to other parts of the Americas. A recent increase in the prevalence of microcephaly in newborn infants and vision-threatening findings in these infants is likely associated with the rapid spread of ZIKV.
   OBJECTIVE To evaluate the ocular findings in infants with microcephaly associated with presumed intrauterine ZIKV infection in Salvador, Bahia, Brazil.
   DESIGN, SETTING, AND PARTICIPANTS Case series at a tertiary hospital. Twenty-nine infants with microcephaly (defined by a cephalic circumference of <= 32 cm) with a presumed diagnosis of congenital ZIKV were recruited through an active search and referrals from other hospitals and health unities. The study was conducted between December 1 and December 21, 2015.
   INTERVENTIONS All infants and mothers underwent systemic and ophthalmic examinations from December 1 through December 21, 2015, in the Roberto Santos General Hospital, Salvador, Brazil. Anterior segment and retinal, choroidal, and optic nerve abnormalities were documented using a wide-field digital imaging system. The differential diagnosis included toxoplasmosis, rubella, cytomegalovirus, herpes simplex virus, syphilis, and human immunodeficiency virus, which were ruled out through serologic and clinical examinations.
   MAIN OUTCOMES AND MEASURES Ocular abnormalities associated with ZIKV.
   RESULTS Twenty-three of 29 mothers (79.3%) reported suspected ZIKV infection signs and symptoms during pregnancy, 18 in the first trimester, 4 in the second trimester, and 1 in the third trimester. Of the 29 infants (58 eyes) examined (18 [62.1%] female), ocular abnormalities were present in 17 eyes (29.3%) of 10 children (34.5%). Bilateral findings were found in 7 of 10 patients presenting with ocular lesions, the most common of which were focal pigment mottling of the retina and chorioretinal atrophy in 11 of the 17 eyes with abnormalities (64.7%), followed by optic nerve abnormalities in 8 eyes (47.1%), bilateral iris coloboma in 1 patient (2 eyes [11.8%]), and lens subluxation in 1 eye (5.9%).
   CONCLUSIONS AND RELEVANCE Congenital infection due to presumed ZIKV exposure is associated with vision-threatening findings, which include bilateral macular and perimacular lesions as well as optic nerve abnormalities in most cases.
C1 [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [de Oliveira Dias, Joao Rafael; Prazeres, Juliana; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
   [Sacramento, Gielson Almeida; Ko, Albert Icksang] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert Icksang] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Belfort, R (reprint author), Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
EM clinbelf@uol.com.br
RI de Oliveira Dias, Joao/J-6735-2016; Ko, Albert/P-2343-2015
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Federal University of Sao Paulo (Paulista Medical School); Vision
   Institute (IPEPO)
FX Hospital Geral Roberto Santos provided the site and materials for
   ophthalmologic examination. Federal University of Sao Paulo (Paulista
   Medical School), Vision Institute (IPEPO), and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) provided funds for
   travel expenses as well as the materials necessary for the ocular
   examinations.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control Prevention, 2002, MMWR-MORBID MORTAL W, V51, P877
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, MON CAS MICR BRAS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin Patrick, 2008, PLoS Med, V5, pe60, DOI 10.1371/journal.pmed.0050060
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kelly JC, 2016, MEDSCAPE
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministerio da Saude Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Ministerio da Saude, NOT MED PER CEF DIAG
   Ministerio da Saude, MIN SAUD CONF REL EN
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2015, MIN SAUD B EP, V46, P1
   Ministerio da Saude, MICR 3174 CAS SAO IN
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Stewart RD, 2013, CASE REP INFECT DIS, V2013
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization, EP AL NEUR SYNDR CON
   World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 35
TC 21
Z9 21
U1 43
U2 43
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD MAY
PY 2016
VL 134
IS 5
BP 529
EP 535
DI 10.1001/jamaophthalmol.2016.0267
PG 7
WC Ophthalmology
SC Ophthalmology
GA DL7CB
UT WOS:000375796100014
ER

PT J
AU Jampol, LM
   Goldstein, DA
AF Jampol, Lee M.
   Goldstein, Debra A.
TI Zika Virus Infection and the Eye
SO JAMA OPHTHALMOLOGY
LA English
DT Editorial Material
C1 [Jampol, Lee M.; Goldstein, Debra A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, 645 N Michigan Ave,Ste 440, Chicago, IL 60611 USA.
RP Jampol, LM (reprint author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, 645 N Michigan Ave,Ste 440, Chicago, IL 60611 USA.
EM l-jampol@northwestern.edu
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Boze B; Vector Disease Control International, ZIKA VIRUS EMERGING
   Centers for Disease Control and Prevention, ZIK VIR
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 8
TC 5
Z9 5
U1 55
U2 55
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD MAY
PY 2016
VL 134
IS 5
BP 535
EP 536
DI 10.1001/jamaophthalmol.2016.0284
PG 3
WC Ophthalmology
SC Ophthalmology
GA DL7CB
UT WOS:000375796100015
ER

PT J
AU Wooton, AK
AF Wooton, Angela K.
TI Zika Virus: An Emerging Threat to Travelers
SO JNP-JOURNAL FOR NURSE PRACTITIONERS
LA English
DT Editorial Material
C1 [Wooton, Angela K.] Univ So Indiana, Nursing, 8600 Univ Blvd, Evansville, IN 47712 USA.
RP Wooton, AK (reprint author), Univ So Indiana, Nursing, 8600 Univ Blvd, Evansville, IN 47712 USA.
EM awooton57@gmail.com
OI Wooton, Angela/0000-0002-1992-2174
CR AccessScience Editors, 2016, SPREAD ZIK VIR DIS
   US Centers for Disease Control and Prevention, 2016, ZIK VIR
NR 2
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1555-4155
EI 1878-058X
J9 JNP-J NURSE PRACT
JI JNP-J. Nurse Pract.
PD MAY
PY 2016
VL 12
IS 5
BP E237
EP E238
DI 10.1016/j.nurpra.2016.02.016
PG 2
WC Nursing
SC Nursing
GA DL4LH
UT WOS:000375607100012
ER

PT J
AU Zanluca, C
   dos Santos, CND
AF Zanluca, Camila
   Duarte dos Santos, Claudia Nunes
TI Zika virus - an overview
SO MICROBES AND INFECTION
LA English
DT Review
DE Zika virus; Flavivirus; Arthropod-borne virus; Viral emergence
ID SEXUAL TRANSMISSION; INTERIM GUIDELINES; UNITED-STATES; YELLOW-FEVER;
   INFECTION; AEDES; MOSQUITOS; ARBOVIRUSES; BRAZIL; CHIKUNGUNYA
AB Zika virus (ZIKV) is currently one of the most important emerging viruses in the world. Recently, it has caused outbreaks and epidemics, and has been associated with severe clinical manifestations and congenital malformations. However to date, little is known about the pathogenicity of the virus and the consequences of ZIKV infection. In this paper, we provide an overview of the current knowledge on ZIKV. (C) 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Zanluca, Camila; Duarte dos Santos, Claudia Nunes] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Mol Virol Lab, Curitiba, Parana, Brazil.
RP dos Santos, CND (reprint author), Inst Carlos Chagas ICC Fiocruz, CIC, Rua Prof Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.
EM clsantos@fiocruz.br
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Alera MT, 2012, EMERG INFECT DIS, V2015, P722
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P8
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvet G, 2016, LANCET INFECT DIS, V3099, pS1473
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V.M., 2013, EMERG INFECT DIS, V2014, P1085, DOI DOI 10.3201/EID2006.140138
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire CCM, 2015, SPREAD PANDEMIC ZIKA, V2015, P1
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, P1
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2010, EMERG INFECT DIS, V2012, P349
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   ICTV, 2014, VIRUS TAXONOMY
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kutsuna S, 2014, EURO SURVEILL, P19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Martines R, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6506E1ER
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P7
   Oliveira M. A. S., 2016, ULTRASOUND OBST GYN, V47, P6, DOI DOI 10.1002/U0G.15831
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   PAHO - Pan American Health Organization, 2016, CHIK
   PAHO - Pan American Health Organization, 2016, ZIK VIR INF
   Pierson T.C., 2013, FIELDS VIROLOGY, P747
   Pond WL, 1963, T R SOC TROP MED HYG, V57, P364
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EURO SURVEILL, V19
   Tognarelli J, 2015, ARCH VIROL
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   [Anonymous], 2014, EMERG INFECT DIS, V20, P1090
   Waehre T, 2013, EMERG INFECT DIS, V2014, P1412
   [Anonymous], 2016, WHO DIR GEN SUMM OUT
   WHO, 2009, DENG GUID DIAGN TREA
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 79
TC 3
Z9 4
U1 23
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD MAY
PY 2016
VL 18
IS 5
BP 295
EP 301
DI 10.1016/j.micinf.2016.03.003
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DL3XY
UT WOS:000375568200001
PM 26993028
ER

PT J
AU Song, H
   Qi, JX
   Haywood, J
   Shi, Y
   Gao, GF
AF Song, Hao
   Qi, Jianxun
   Haywood, Joel
   Shi, Yi
   Gao, George F.
TI Zika virus NS1 structure reveals diversity of electrostatic surfaces
   among flaviviruses
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS1
AB The association of Zika virus (ZIKV) infections with microcephaly has resulted in an ongoing public-health emergency. Here we report the crystal structure of a C-terminal fragment of ZIKV nonstructural protein 1 (NS1), a major host-interaction molecule that functions in flaviviral replication, pathogenesis and immune evasion. Comparison with West Nile and dengue virus NS1 structures reveals conserved features but diverse electrostatic characteristics at host-interaction interfaces, thus possibly implying different modes of flavivirus pathogenesis.
C1 [Song, Hao; Qi, Jianxun; Haywood, Joel; Shi, Yi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Song, Hao; Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.
   [Shi, Yi; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
   [Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.
   [Shi, Yi; Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
RP Shi, Y; Gao, GF (reprint author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Shi, Y; Gao, GF (reprint author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.; Shi, Y; Gao, GF (reprint author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.; Shi, Y; Gao, GF (reprint author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.; Shi, Y; Gao, GF (reprint author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Gao, GF (reprint author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
EM shiyi@im.ac.cn; gaof@im.ac.cn
RI Haywood, Joel/G-8311-2016
FU Emergency Task-Force Project of the National Natural Science Foundation
   of China (NSFC) [81641001]; China Ministry of Science and Technology
   National 973 Project [2015CB910500]; Task Force of Zika Virus Research
   from the Chinese Academy of Sciences (CAS); Zika Special Project of the
   National Infectious Disease Control ST Grand Project; Strategic Priority
   Research Program of the CAS [XDB08020100]; Excellent Young Scientist
   Program of the CAS; Youth Innovation Promotion Association, CAS
   [2015078]; NSFC Innovative Research Group [81321063]
FX This work was supported by the Emergency Task-Force Project (grant no.
   81641001) of the National Natural Science Foundation of China (NSFC),
   the China Ministry of Science and Technology National 973 Project (grant
   no. 2015CB910500) and the Task Force of Zika Virus Research from the
   Chinese Academy of Sciences (CAS) and the Zika Special Project of the
   National Infectious Disease Control S&T Grand Project and Strategic
   Priority Research Program of the CAS (XDB08020100).; We thank the staff
   of the BL17U beamline at the Shanghai Synchrotron Radiation Facility for
   assistance during data collection. We thank X. Xu, H. Wang and Z. Su for
   assistance in protein preparation. Y.S. is supported by the Excellent
   Young Scientist Program of the CAS and the Youth Innovation Promotion
   Association, CAS (2015078). G.F.G. is supported partly as a leading
   principal investigator of the NSFC Innovative Research Group (grant no.
   81321063).
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Kuno G, 1998, J VIROL, V72, P73
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   Mansuy JMDM, 2016, LANCET INFECT DIS
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tang H, 2016, CELL STEM CELL
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053
NR 19
TC 5
Z9 5
U1 21
U2 21
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD MAY
PY 2016
VL 23
IS 5
BP 456
EP 458
DI 10.1038/nsmb.3213
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DL4UK
UT WOS:000375633100018
PM 27088990
ER

PT J
AU Ogden, SC
   Hammack, C
   Tang, HL
AF Ogden, Sarah C.
   Hammack, Christy
   Tang, Hengli
TI Zika virus and neural developmental defects: building a case for a cause
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Editorial Material
C1 [Ogden, Sarah C.; Hammack, Christy; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
RP Tang, HL (reprint author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
EM tang@bio.fsu.edu
CR Brasil P., 2016, NEW ENGL J MED, DOI [10.1056/NEIMoa1602412, DOI 10.1056/NEIMOA1602412]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617
NR 10
TC 0
Z9 0
U1 11
U2 11
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
PD MAY
PY 2016
VL 59
IS 5
BP 536
EP 538
DI 10.1007/s11427-016-5053-2
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DL8II
UT WOS:000375885300013
PM 27066795
ER

PT J
AU Waxman, MA
AF Waxman, Matthew A.
TI Update on Emerging Infections: News From the Centers for Disease Control
   and Prevention
SO ANNALS OF EMERGENCY MEDICINE
LA English
DT Editorial Material
ID ZIKA VIRUS OUTBREAK; MICRONESIA; STATES
C1 [Waxman, Matthew A.] Olive View UCLA Med Ctr, Dept Emergency Med, 14445 Olive View Dr, Sylmar, CA 91342 USA.
RP Waxman, MA (reprint author), Olive View UCLA Med Ctr, Dept Emergency Med, 14445 Olive View Dr, Sylmar, CA 91342 USA.
CR Centers for Disease Control and Prevention, 2015, CHIK VIR CLIN EV DIS
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D., 2014, CLIN MICROBIOL INFEC, V20, P595, DOI DOI 10.1111/1469-0691.12707
   Nasci RS, 2015, CDC HLTH INFORM INT
   Pan American Health Organization, 2016, ZIK VIR INF
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   WHO, 2009, DENG GUID DIAGN TREA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 0
Z9 0
U1 6
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-0644
J9 ANN EMERG MED
JI Ann. Emerg. Med.
PD MAY
PY 2016
VL 67
IS 5
BP 645
EP 647
DI 10.1016/j.annemergmed.2016.02.022
PG 3
WC Emergency Medicine
SC Emergency Medicine
GA DL1DU
UT WOS:000375373200019
ER

PT J
AU Molloy, JC
   Sommer, U
   Viant, MR
   Sinkins, SP
AF Molloy, Jennifer C.
   Sommer, Ulf
   Viant, Mark R.
   Sinkins, Steven P.
TI Wolbachia Modulates Lipid Metabolism in Aedes albopictus Mosquito Cells
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID DENGUE VIRUS; MASS-SPECTROMETRY; CHIKUNGUNYA VIRUS; PHOSPHOINOSITIDE
   METABOLISM; AEGYPTI POPULATIONS; AUTOPHAGY MACHINERY; BLOCKS DENGUE;
   INFECTION; PATHWAY; CHOLESTEROL
AB Certain strains of the intracellular endosymbiont Wolbachia can strongly inhibit or block the transmission of viruses such as dengue virus (DENV) by Aedes mosquitoes, and the mechanisms responsible are still not well understood. Direct infusion and liquid chromatography-Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry-based lipidomics analyses were conducted using Aedes albopictus Aa23 cells that were infected with the wMel and wMelPop strains of Wolbachia in comparison to uninfected Aa23-T cells. Substantial shifts in the cellular lipid profile were apparent in the presence of Wolbachia. Most significantly, almost all sphingolipid classes were depleted, and some reductions in diacylglycerols and phosphatidylcholines were also observed. These lipid classes have previously been shown to be selectively enriched in DENV-infected mosquito cells, suggesting that Wolbachia may produce a cellular lipid environment that is antagonistic to viral replication. The data improve our understanding of the intracellular interactions between Wolbachia and mosquitoes.
   IMPORTANCE
   Mosquitoes transmit a variety of important viruses to humans, such as dengue virus and Zika virus. Certain strains of the intracellular bacterial genus called Wolbachia found in or introduced into mosquitoes can block the transmission of viruses, including dengue virus, but the mechanisms responsible are not well understood. We found substantial shifts in the cellular lipid profiles in the presence of these bacteria. Some lipid classes previously shown to be enriched in dengue virus-infected mosquito cells were depleted in the presence of Wolbachia, suggesting that Wolbachia may produce a cellular lipid environment that inhibits mosquito-borne viruses.
C1 [Molloy, Jennifer C.; Sinkins, Steven P.] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Molloy, Jennifer C.; Sinkins, Steven P.] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.
   [Sommer, Ulf; Viant, Mark R.] Univ Birmingham, Sch Biosci, NERC Biomol Anal Facil Metab Node, Birmingham, W Midlands, England.
   [Sinkins, Steven P.] Univ Lancaster, Biomed & Life Sci, Lancaster, England.
RP Sinkins, SP (reprint author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Sinkins, SP (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.; Sinkins, SP (reprint author), Univ Lancaster, Biomed & Life Sci, Lancaster, England.
EM s.sinkins@lancaster.ac.uk
FU Wellcome Trust [WT095121]; Biotechnology and Biological Sciences
   Research Council (BBSRC) [BB/H016511/1]; Natural Environment Research
   Council (NERC) [R8-H10-61]
FX This work, including the efforts of Steven P. Sinkins, was funded by
   Wellcome Trust (WT095121). This work, including the efforts of Jennifer
   C. Molloy, was funded by Biotechnology and Biological Sciences Research
   Council (BBSRC) (BB/H016511/1). This work, including the efforts of Ulf
   Sommer and Mark Viant, was funded by Natural Environment Research
   Council (NERC) (R8-H10-61).
CR BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Carvalho M, 2010, DEVELOPMENT, V137, P3675, DOI 10.1242/dev.044560
   Cho KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022703
   Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185
   Dunn WB, 2008, J CHROMATOGR B, V871, P288, DOI 10.1016/j.jchromb.2008.03.021
   Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200
   Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gay B, 2012, INFECT GENET EVOL, V12, P1275, DOI 10.1016/j.meegid.2012.02.003
   Geiger O, 2013, BBA-MOL CELL BIOL L, V1831, P503, DOI 10.1016/j.bbalip.2012.08.009
   Glazov EA, 2005, GENOME RES, V15, P800, DOI 10.1101/gr.3545105
   Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007
   Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006
   Hilbi H, 2006, CELL MICROBIOL, V8, P1697, DOI 10.1111/j.1462-5822.2006.00793.x
   HOBSON RALPH PERCIVAL, 1935, BIOCHEM JOUR, V29, P2023
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hsu FF, 2002, J AM SOC MASS SPECTR, V13, P558, DOI 10.1016/S1044-0305(02)00358-6
   Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005
   Judith D, 2013, EMBO REP, V14, P534, DOI 10.1038/embor.2013.51
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Khoo CCH, 2013, B ENTOMOL RES, V103, P251, DOI 10.1017/S0007485312000648
   Kirwan J. A., 2014, SCI DATA, DOI [10.1038/sdata.2014.12, DOI 10.1038/SDATA.2014.12]
   Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630
   Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   MARQUARDT MT, 1993, J CELL BIOL, V123, P57, DOI 10.1083/jcb.123.1.57
   Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI [10.1016/j.antiviral.2011.11.014, 10.1016/j.antivira1.2011.11.014]
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Scheitz CJF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072726
   Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059
   Shi JY, 2012, ACTA BIOCH BIOPH SIN, V44, P375, DOI 10.1093/abbs/gms010
   Hoffmann AA, 1997, INFLUENTIAL PASSENGE, P42
   Sommer U, 2006, J LIPID RES, V47, P804, DOI 10.1194/jlr.M500506-JLR200
   Southam AD, 2007, ANAL CHEM, V79, P4595, DOI 10.1021/ac062446p
   Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Viant MR, 2013, METABOLOMICS, V9, pS144, DOI 10.1007/s11306-012-0412-x
   Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weber RJM, 2011, ANAL CHEM, V83, P3737, DOI 10.1021/ac2001803
   Weber RJM, 2010, CHEMOMETR INTELL LAB, V104, P75, DOI 10.1016/j.chemolab.2010.04.010
   Weber SS, 2009, MOL MICROBIOL, V71, P1341, DOI 10.1111/j.1365-2958.2009.06608.x
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zheng W, 2006, BIOCHIM BIOPHYS ACTA, V1758, P864
NR 69
TC 1
Z9 1
U1 12
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD MAY
PY 2016
VL 82
IS 10
BP 3109
EP 3120
DI 10.1128/AEM.00275-16
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA DK9EU
UT WOS:000375234400024
PM 26994075
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Afebrile, asymptomatic and non thrombocytopenic Zika virus infection:
   don't miss it!
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Letter
DE Afebrile; Asymptomatic; Thrombocytopenia; Zika virus; Infection
ID PREGNANT-WOMEN; NOVEMBER 2013; GUIDELINES; OUTBREAK
AB Zika virus infection is the present problematic arboviral disease. Classically, this disease cause febrile illness and can result in low platelet count. However, there are some new obervations on atypical clinical presentations of Zika virus infection that can make the diagnosis more difficult. The afebrile, asymptomatic and non-thrombocytopenic Zika virus infection can be seen in clinical practice and can lead to missed or delayed diagnosis.
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] DR DY Patil Med Univ, Delhi, India.
RP Wiwanitkit, S (reprint author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Chan JF, 2016, J INFECTION, V2
   [ Deng Yichu], 2016, [, Chinese Critical Care Medicine], V28, P106
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI DOI 10.4103/1755-6783.162402
   Kwong SC, 2013, AM J TROP MED HYG, V89, P516
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2013, ANN TROP MED PUBLIC, V6, P686
   Wiwanitkit S., 2015, Journal of Acute Disease, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 11
TC 1
Z9 1
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD MAY
PY 2016
VL 9
IS 5
BP 499
EP 500
DI 10.1016/j.apjtm.2016.03.036
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA DL0YS
UT WOS:000375359100019
ER

PT J
AU Chan, JFW
   Choi, GKY
   Yip, CCY
   Cheng, VCC
   Yuen, KY
AF Chan, Jasper F. W.
   Choi, Garnet K. Y.
   Yip, Cyril C. Y.
   Cheng, Vincent C. C.
   Yuen, Kwok-Yung
TI Zika fever and congenital Zika syndrome: An unexpected emerging
   arboviral disease
SO JOURNAL OF INFECTION
LA English
DT Review
DE Zika; Virus; Flavivirus; Arbovirus; Microcephaly; Aedes; Mosquito
ID WEST-NILE-VIRUS; RESPIRATORY SYNDROME CORONAVIRUS; BORNE
   VIRAL-INFECTIONS; INFLUENZA-A H5N1; RIO-DE-JANEIRO; YELLOW-FEVER;
   AEDES-ALBOPICTUS; DENGUE VIRUS; VERTICAL TRANSMISSION; INTERIM
   GUIDELINES
AB Unlike its mosquito-borne relatives, such as dengue, West Nile, and Japanese encephalitis viruses, which can cause severe human diseases, Zika virus (ZIKV) has emerged from obscurity by its association with a suspected "congenital Zika syndrome", while causing asymptomatic or mild exanthematous febrile infections which are dengue-or rubella-like in infected individuals. Despite having been discovered in Uganda for almost 60 years, <20 human cases were reported before 2007. The massive epidemics in the Pacific islands associated with the ZIKV Asian lineage in 2007 and 2013 were followed by explosive outbreaks in Latin America in 2015. Although increased mosquito breeding associated with the El Nino effect superimposed on global warming is suspected, genetic changes in its RNA virus genome may have led to better adaptation to mosquitoes, other animal reservoirs, and human. We reviewed the epidemiology, clinical manifestation, virology, pathogenesis, laboratory diagnosis, management, and prevention of this emerging infection. Laboratory diagnosis can be confounded by cross-reactivity with other circulating flaviviruses. Besides mosquito bite and transplacental transmission, the risk of other potential routes of transmission by transfusion, transplantation, sexual activity, breastfeeding, respiratory droplet, and animal bite is discussed. Epidemic control requires adequate clearance of mosquito breeding grounds, personal protection against mosquito bite, and hopefully a safe and effective vaccine. (C) 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
C1 [Chan, Jasper F. W.; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper F. W.; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper F. W.; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper F. W.; Choi, Garnet K. Y.; Yip, Cyril C. Y.; Cheng, Vincent C. C.; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
RP Yuen, KY (reprint author), Univ Hong Kong, Queen Mary Hosp, State Key Lab Emerging Infect Dis, Carol Yu Ctr Infect,Dept Microbiol, 102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.
EM kyyuen@hku.hk
RI Chan, Jasper Fuk-Woo/D-8007-2013
OI Chan, Jasper Fuk-Woo/0000-0001-6336-6657
FU Consultancy Service for Enhancing Laboratory Surveillance of Emerging
   Infectious Disease of the Department of Health, The Food and Health
   Bureau, Hong Kong Special Administrative Region, China
FX The study was partly supported by the Consultancy Service for Enhancing
   Laboratory Surveillance of Emerging Infectious Disease of the Department
   of Health, The Food and Health Bureau, Hong Kong Special Administrative
   Region, China; and by the donations of Hui Hoy and Chow Sin Lan Charity
   Fund Limited and Mr. Larry Chi-Kin Yung.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Arzuza-Ortega L, 2016, EMERG INFECT DIS
   Atkinson B HP, 2016, EMERG INFECT DIS
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   [Anonymous], 2016, BRIT BROADCASTING CO
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EURO SURVEILL, V19
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro LA, 2016, MICROBES INFECT
   Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P1133
   Centers for Disease Control and Prevention (CDC), 2004, MMWR-MORBID MORTAL W, V53, P738
   Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P877
   Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002
   Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
   Chan JFW, 2015, CURR OPIN VIROL, V10, P63, DOI 10.1016/j.coviro.2015.01.006
   Chan JFW, 2013, J FORMOS MED ASSOC, V112, P372, DOI 10.1016/j.jfma.2013.05.010
   Chan JFW, 2013, TRENDS MICROBIOL, V21, P544, DOI 10.1016/j.tim.2013.05.005
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11
   Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Melo Freire CC, 2015, BIORXIV
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2009, Med Trop (Mars), V69, P339
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2016, BMJ-BRIT MED J, V352, pi383
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   [Anonymous], 2014, RAP RISK ASS ZIK VIR
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836
   Gerardin Patrick, 2008, PLoS Med, V5, pe60, DOI 10.1371/journal.pmed.0050060
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73
   Korhonen EM, 2016, EURO SURVEILL, V21
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314
   Kuno G, 1998, J VIROL, V72, P73
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Marano G, 2015, BLOOD TRANSFUS, P1, DOI DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Marcondes CB, 2015, REV SOC BRAS MED TRO
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J., 2016, N ENGL J MED
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   NOGUEIRA RMR, 1992, RES VIROLOGY, V143, P423, DOI 10.1016/S0923-2516(06)80136-6
   Oehler E, 2014, EURO SURVEILL, P19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005
   Rigau-Perez Jose G., 2001, American Journal of Tropical Medicine and Hygiene, V64, P67
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376
   Roth A., 2014, EURO SURVEILL, V19
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shinohara K, 2016, J TRAVEL MED, V23
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Stewart RD, 2013, CASE REP INFECT DIS, V2013
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tappe D, 2014, EURO SURVEILL, V19
   Tappe D., 2015, MED MICROBIOL IMMUNO
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24
   To KKW, 2014, J INFECTION, V68, P205, DOI 10.1016/j.jinf.2013.12.014
   To KKW, 2015, MICROBES INFECT, V17, P84, DOI 10.1016/j.micinf.2014.11.007
   To KKW, 2013, J THORAC DIS, V5, pS103, DOI 10.3978/j.issn.2072-1439.2013.06.02
   To KKW, 2013, LANCET INFECT DIS, V13, P809, DOI 10.1016/S1473-3099(13)70167-1
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization (WHO), 2016, 1 M INT HLTH REG 200
   World Health Organization, 2016, ZIK SIT REP NEUR SYN
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zammarchi L, 2015, EURO SURVEILL, V20
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 153
TC 13
Z9 14
U1 54
U2 54
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD MAY
PY 2016
VL 72
IS 5
BP 507
EP 524
DI 10.1016/j.jinf.2016.02.011
PG 18
WC Infectious Diseases
SC Infectious Diseases
GA DK6BD
UT WOS:000375004900001
PM 26940504
ER

PT J
AU Palomo, AM
AF Martinez Palomo, Adolfo
TI Zika virus: An international emergency?
SO JOURNAL OF PUBLIC HEALTH POLICY
LA English
DT Editorial Material
DE Zika virus; public health emergency of international concern; women's
   health; microcephaly; mosquito
AB This Viewpoint discusses the World Health Organization's Declaration on 1 February 2016 that the epidemic infection caused by the Zika virus is a public health emergency of international concern - the basis of the decision and controversy surrounding it.
C1 [Martinez Palomo, Adolfo] Ctr Adv Studies, Mol Pathogenesis, Ave IPN 2508, Mexico City 01030, DF, Mexico.
RP Palomo, AM (reprint author), Ctr Adv Studies, Mol Pathogenesis, Ave IPN 2508, Mexico City 01030, DF, Mexico.
EM amartine@cinvestav.mx
NR 0
TC 0
Z9 0
U1 11
U2 11
PU PALGRAVE MACMILLAN LTD
PI BASINGSTOKE
PA BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND
SN 0197-5897
EI 1745-655X
J9 J PUBLIC HEALTH POL
JI J. Public Health Policy
PD MAY
PY 2016
VL 37
IS 2
BP 133
EP 135
DI 10.1057/jphp.2016.11
PG 3
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA DK7XS
UT WOS:000375140800002
PM 26911655
ER

PT J
AU Lazear, HM
   Diamond, MS
AF Lazear, Helen M.
   Diamond, Michael S.
TI Zika Virus: New Clinical Syndromes and Its Emergence in the Western
   Hemisphere
SO JOURNAL OF VIROLOGY
LA English
DT Review
ID ENVELOPE PROTEIN GLYCOSYLATION; JAPANESE ENCEPHALITIS-VIRUS;
   CENTRAL-NERVOUS-SYSTEM; NILE-VIRUS; DENGUE VIRUS; PREGNANT-WOMEN;
   UNITED-STATES; SEXUAL TRANSMISSION; INTERIM GUIDELINES; FRENCH-POLYNESIA
AB Zika virus (ZIKV) had remained a relatively obscure flavivirus until a recent series of outbreaks accompanied by unexpectedly severe clinical complications brought this virus into the spotlight as causing an infection of global public health concern. In this review, we discuss the history and epidemiology of ZIKV infection, recent outbreaks in Oceania and the emergence of ZIKV in the Western Hemisphere, newly ascribed complications of ZIKV infection, including Guillain-Barre syndrome and microcephaly, potential interactions between ZIKV and dengue virus, and the prospects for the development of antiviral agents and vaccines.
C1 [Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, Dept Mol Microbiol,Dept Pathol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA.
RP Lazear, HM (reprint author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Med, Dept Mol Microbiol,Dept Pathol, St Louis, MO 63110 USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA.; Diamond, MS (reprint author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA.
EM helen.lazear@med.unc.edu; diamond@borcim.wustl.edu
FU HHS \ NIH \ National Institute of Allergy and Infectious Diseases
   (NIAID) [R01 AI073755]; Burroughs Wellcome Fund (BWF)
FX This work, including the efforts of Michael S Diamond, was funded by HHS
   vertical bar NIH vertical bar National Institute of Allergy and
   Infectious Diseases (NIAID) (R01 AI073755). This work, including the
   efforts of Michael S Diamond, was funded by Burroughs Wellcome Fund
   (BWF).
CR Acosta EG, 2015, EXPERT REV VACCINES
   Agerholm JS, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0145-8
   Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Ansar V, 2015, PRIMARY CARE, V42, P189, DOI 10.1016/j.pop.2015.01.001
   Atkinson B HP, 2016, EMERG INFECT DIS
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Baronti C, 2014, GENOME ANNOUNC  0605
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   CALISHER CH, 1995, EMERG INFECT DIS, V1, P147
   Calvet G., 2016, LANCET INFECT DIS
   Camacho E, 2016, EMERG INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau V, 2016, LANCET, DOI [DOI 10.1016/S0140-6736(16)00562-6, 10.1016/S0140-6736(16)00562-6]
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P1135
   Centers for Disease Control Prevention, 2002, MMWR-MORBID MORTAL W, V51, P877
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chiou SS, 2008, CLIN VACCINE IMMUNOL, V15, P825, DOI 10.1128/CVI.00004-08
   C. Collaborative Cross, 2012, GENETICS, V190, P389, DOI DOI 10.1534/GENETICS.111.132639
   Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x
   Dallas County Health and Human Services, 2016, DCHHS PROV UPD ZIK V
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Soares de Araujo JS, 2016, B WHO
   Deen GF, 2015, N ENGL J MED
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Union Directorate-General for Health and Food Safety, 2012, W NIL VIR BLOOD SAF
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fleming-Dutra KE, 2016, MMWR MORB MORTAL WKL
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   de Paula Freitas B, 2016, JAMA OPHTHALMOL 0209
   Fuchs A, 2010, CELL HOST MICROBE, V8, P186, DOI 10.1016/j.chom.2010.07.007
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gralinski LE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005504
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR MORB MORTAL WKL
   JIANG WR, 1993, J GEN VIROL, V74, P931, DOI 10.1099/0022-1317-74-5-931
   Karimi O, 2016, LANCET
   Kelly S, 2013, MMWR-MORBID MORTAL W, V62, P622
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   Maria AT, 2016, EURO SURVEILL
   Martin JN, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P960
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Mateo R, 2015, MBIO, V6, DOI 10.1128/mBio.01960-15
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, MMWR MORB MORTAL WKL
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J., 2016, N ENGL J MED
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408
   O'Brien SF, 2010, TRANSFUSION, V50, P1118, DOI 10.1111/j.1537-2995.2009.02550.x
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Ortega LA, 2016, EMERG INFECT DIS
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Paisley JE, 2006, PEDIATRICS, V117, P814, DOI 10.1542/peds.2005-1187
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pierson TC, 2013, FIELDS VIROLOGY, V2, P747
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Prow NA, 2011, J GEN VIROL, V92, P2286, DOI 10.1099/vir.0.034793-0
   Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Stefanovic KB, 2009, AM FAM PHYSICIAN, V80, P1421
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI [10.1097/NEN.0000000000000038, 10.1097/NEN.0000000000000036]
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Ubogu EE, 2015, ACTA NEUROPATHOL, V130, P445, DOI 10.1007/s00401-015-1466-4
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waggoner J. J., 2016, J CLIN MICROBIOL
   Way J H, 1976, J Gen Virol, V30, P123
   Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310
   Yakob L, 2016, LANCET GLOB HLT 0201
   Yoshii K, 2013, J GEN VIROL, V94, P2249, DOI 10.1099/vir.0.055269-0
   Zammarchi L., 2015, Eurosurveillance, V20, P21153
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 144
TC 19
Z9 20
U1 23
U2 23
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAY
PY 2016
VL 90
IS 10
BP 4864
EP 4875
DI 10.1128/JVI.00252-16
PG 12
WC Virology
SC Virology
GA DK7SN
UT WOS:000375126100003
PM 26962217
ER

PT J
AU Benelli, G
   Mehlhorn, H
AF Benelli, Giovanni
   Mehlhorn, Heinz
TI Declining malaria, rising of dengue and Zika virus: insights for
   mosquito vector control
SO PARASITOLOGY RESEARCH
LA English
DT Review
DE Arbovirus; Artemisinin; Biological control; Boosted SIT; Nanosynthesis;
   Sex pheromones; Sterile insect technique; Sound traps; Swarming
   behaviour; Vaccine
ID STERILE INSECT TECHNIQUE; AEDES-AEGYPTI DIPTERA; ASIAN TIGER MOSQUITO;
   MATING-BEHAVIOR; ESSENTIAL OILS; VETERINARY IMPORTANCE; POLYGYNOUS
   MOSQUITO; SEXUAL PERFORMANCE; ANOPHELES-GAMBIAE; CURRENT KNOWLEDGE
AB The fight against mosquito-borne diseases is a challenge of huge public health importance. To our mind, 2015 was an extraordinary year for malaria control, due to three hot news: the Nobel Prize to Youyou Tu for the discovery of artemisinin, the development of the first vaccine against Plasmodium falciparum malaria [i.e. RTS,S/AS01 (RTS,S)], and the fall of malaria infection rates worldwide, with special reference to sub-Saharan Africa. However, there are major challenges that still deserve attention, in order to boost malaria prevention and control. Indeed, parasite strains resistant to artemisinin have been detected, and RTS,S vaccine does not offer protection against Plasmodium vivax malaria, which predominates in many countries outside of Africa. Furthermore, the recent outbreaks of Zika virus infections, occurring in South America, Central America and the Caribbean, represent the most recent of four arrivals of important arboviruses in the Western Hemisphere, over the last 20 years. Zika virus follows dengue (which slyly arrived in the hemisphere over decades and became more aggressive in the 1990s), West Nile virus (emerged in 1999) and chikungunya (emerged in 2013). Notably, there are no specific treatments for these arboviruses. The emerging scenario highlights that the effective and eco-friendly control of mosquito vectors, with special reference to highly invasive species such as Aedes aegypti and Aedes albopictus, is crucial. The concrete potential of screening plant species as sources of metabolites for parasitological purposes is worthy of attention, as elucidated by the Y. Tu's example. Notably, plant-borne molecules are often effective at few parts per million against Aedes, Ochlerotatus, Anopheles and Culex young instars, can be used for the rapid synthesis of mosquitocidal nanoformulations and even employed to prepare cheap repellents with low human toxicity. In addition, behaviour-based control tools relying to the employ of sound traps and the manipulation of swarming behaviour (i.e. "lure and kill" approach) are discussed. The importance of further research on the chemical cues routing mosquito swarming and mating dynamics is highlighted. Besides radiation, transgenic and symbiont-based mosquito control approaches, an effective option may be the employ of biological control agents of mosquito young instars, in the presence of ultra-low quantities of nanoformulated botanicals, which boost their predation rates.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Mehlhorn, Heinz] Univ Dusseldorf, Dept Parasitol, Dusseldorf, Germany.
RP Benelli, G (reprint author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM g.benelli@sssup.it
RI Benelli, Giovanni/A-9100-2013
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX We would like to thank A. Canale, M. Nicoletti and K. Murugan for
   helpful discussions on the topic. G. Benelli is supported by PROAPI
   (PRAF 2015) and University of Pisa, Department of Agriculture, Food and
   Environment (Grant ID: COFIN2015_22). Funders had no role in the study
   design, data collection and analysis, decision to publish or preparation
   of the manuscript.
CR Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P3041, DOI 10.1007/s00436-015-4506-z
   Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Attar Naomi, 2016, Nat Rev Microbiol, V14, P62, DOI 10.1038/nrmicro.2015.28
   Balestrino F, 2010, J MED ENTOMOL, V47, P581
   Becker N, 2012, PARASITOLOGY RES MON, V3, P31
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli Giovanni, 2016, Asian Pacific Journal of Tropical Biomedicine, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2014, J PEST SCI, V87, P385, DOI 10.1007/s10340-014-0577-3
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P887, DOI 10.1007/s00436-014-4252-7
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2
   Callaway E, 2015, NATURE, V526, P174, DOI 10.1038/nature.2015.18507
   Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327
   Carlton JM, 2008, TRENDS PARASITOL, V24, P545, DOI 10.1016/j.pt.2008.09.003
   Cator LJ, 2010, ANIM BEHAV, V82, P627
   Charlwood JD, 2002, MED VET ENTOMOL, V16, P109, DOI 10.1046/j.0269-283x.2002.00342.x
   Cohen J, 2011, PARASITOL RES MG, V2, P121, DOI 10.1007/978-3-642-21396-0_7
   Dabire KR, 2014, ACTA TROP, V132, pS35, DOI 10.1016/j.actatropica.2013.12.012
   Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8
   Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fawaz EY, 2014, J VECTOR ECOL, V39, P347, DOI 10.1111/jvec.12110
   Hamady D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-206
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   IKESHOJI T, 1981, Medical Entomology and Zoology, V32, P7
   Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8
   KAHN MC, 1949, AM J TROP MED, V29, P811
   KANDA T, 1988, Tropical Biomedicine, V5, P37
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Madakacherry O, 2014, ACTA TROP S, V132S, P124
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mehlhorn H, 2016, PARASITOL RES MG, V8, P1, DOI 10.1007/978-3-319-25292-6
   Mehlhorn H, 2005, PARASITOL RES, V95, P363, DOI 10.1007/s00436-004-1297-z
   Mehlhorn H, 2012, PARASITOL RES MONOGR, V3
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Melaun C, 2015, PARASITOL RES, V114, P1051, DOI 10.1007/s00436-014-4274-1
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Oehler E, 2014, EURO SURVEILL, P19
   Oliva CF, 2014, ACTA TROP S, V132S, pS512
   Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Philips KT, 1996, J INSECT BEHAV, V9, P739
   Pitts RJ, 2014, ACTA TROP, V132, pS26, DOI 10.1016/j.actatropica.2013.09.005
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   South SH, 2009, P R SOC B, V276, P3671, DOI 10.1098/rspb.2009.0991
   South SH, 2011, ANIM BEHAV, V81, P645, DOI 10.1016/j.anbehav.2010.12.014
   South SH, 2008, J INSECT BEHAV, V21, P451, DOI 10.1007/s10905-008-9137-0
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471
   White NJ, 2015, NEW ENGL J MED, V373, P1670, DOI 10.1056/NEJMe1511278
   WHO, 2015, BACKGR BRIEF MAL VAC
   World Health Organization, 2015, FACT SHEET WORLD MAL
   WHO, 2015, WHO UPD ART RES
   Wiwatanaratanabutr I, 2010, J AM MOSQUITO CONTR, V26, P265, DOI 10.2987/09-5937.1
   Zsemlye JL, 2005, MED VET ENTOMOL, V19, P276, DOI 10.1111/j.1365-2915.2005.00570.x
NR 81
TC 17
Z9 18
U1 57
U2 57
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD MAY
PY 2016
VL 115
IS 5
BP 1747
EP 1754
DI 10.1007/s00436-016-4971-z
PG 8
WC Parasitology
SC Parasitology
GA DK5RG
UT WOS:000374976900001
PM 26932263
ER

PT J
AU Karwowski, MP
   Nelson, JM
   Staples, JE
   Fischer, M
   Fleming-Dutra, KE
   Villanueva, J
   Powers, AM
   Mead, P
   Honein, MA
   Moore, CA
   Rasmussen, SA
AF Karwowski, Mateusz P.
   Nelson, Jennifer M.
   Staples, J. Erin
   Fischer, Marc
   Fleming-Dutra, Katherine E.
   Villanueva, Julie
   Powers, Ann M.
   Mead, Paul
   Honein, Margaret A.
   Moore, Cynthia A.
   Rasmussen, Sonja A.
TI Zika Virus Disease: A CDC Update for Pediatric Health Care Providers
SO PEDIATRICS
LA English
DT Article
ID INTERIM GUIDELINES; UNITED-STATES; FRENCH-POLYNESIA; FEBRUARY 2014;
   INFECTION; TRANSMISSION; BRAZIL; DENGUE; OUTBREAK; CHILDREN
AB Zika virus is a mosquito-borne flavivirus discovered in Africa in 1947. Most persons with Zika virus infection are asymptomatic; symptoms when present are generally mild and include fever, maculopapular rash, arthralgia, and conjunctivitis. Since early 2015, Zika virus has spread rapidly through the Americas, with local transmission identified in 31 countries and territories as of February 29, 2016, including several US territories. All age groups are susceptible to Zika virus infection, including children. Maternal-fetal transmission of Zika virus has been documented; evidence suggests that congenital Zika virus infection is associated with microcephaly and other adverse pregnancy and infant outcomes. Perinatal transmission has been reported in 2 cases; 1 was asymptomatic, and the other had thrombocytopenia and a rash. Based on limited information, Zika virus infection in children is mild, similar to that in adults. The long-term sequelae of congenital, perinatal, and pediatric Zika virus infection are largely unknown. No vaccine to prevent Zika virus infection is available, and treatment is supportive. The primary means of preventing Zika virus infection is prevention of mosquito bites in areas with local Zika virus transmission. Given the possibility of limited local transmission of Zika virus in the continental United States and frequent travel from affected countries to the United States, US pediatric health care providers need to be familiar with Zika virus infection. This article reviews the Zika virus, its epidemiologic characteristics, clinical presentation, laboratory testing, treatment, and prevention to assist providers in the evaluation and management of children with possible Zika virus infection.
C1 [Karwowski, Mateusz P.; Nelson, Jennifer M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Karwowski, Mateusz P.] Ctr Dis Control & Prevent, Div Environm Hazards & Hlth Effects, Natl Ctr Environm Hlth, Atlanta, GA USA.
   [Nelson, Jennifer M.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis & Hlth Promot, Atlanta, GA USA.
   [Staples, J. Erin; Fischer, Marc; Powers, Ann M.; Mead, Paul] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Fleming-Dutra, Katherine E.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Villanueva, Julie] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Honein, Margaret A.; Moore, Cynthia A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Div Publ Hlth Informat Disseminat, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA USA.
RP Rasmussen, SA (reprint author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-33, Atlanta, GA 30333 USA.
EM skr9@cdc.gov
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   American Academy of Pediatrics, 2015, RED BOOK ATL PED INF
   Araujo Helena R. C., 2015, Insects, V6, P576, DOI 10.3390/insects6020576
   Arzuza-Ortega L, EMERG INFECT DIS
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13
   Brazil Ministry of Health, 2016, PUBL HLTH EM OP CTR
   Brazil Ministry of Health, PUBL HLTH EM OP CTR
   Brazil Ministry of Health, 2015, PUBL HLTH EM OP CTR, V47
   Brazil Ministry of Health, PROT SURV RESP OCC M
   Brunette GW, 2016, HLTH INFORM INT TRAV, V2016
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet G, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, SURV CONTR AED AEG A
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Centers for Disease Control Prevention, 2002, MMWR-MORBID MORTAL W, V51, P877
   Centers for Disease Control and Prevention, MEM REV DIAGN TEST Z
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, RAP RISK ASS MICR BR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, P159
   Meaney-Delman D, MMWR MORB MORTAL WKL
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, N ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   O'Leary DR, 2006, PEDIATRICS, V117
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, EP AL NEUR SYNDR CON
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirois PA, 2014, BIRTH DEFECTS RES A, V100, P792, DOI 10.1002/bdra.23297
   Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852
   Ventura CV, ARQ BRAS OFTALMOL
   Ventura CV, LANCET
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   WESTAWAY EG, 1974, J IMMUNOL, V112, P656
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 63
TC 2
Z9 2
U1 17
U2 17
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD MAY
PY 2016
VL 137
IS 5
AR e20160621
DI 10.1542/peds.2016-0621
PG 13
WC Pediatrics
SC Pediatrics
GA DK8XZ
UT WOS:000375214300064
ER

PT J
AU Vasconcelos, PFC
   Calisher, CH
AF Vasconcelos, Pedro F. C.
   Calisher, Charles H.
TI Emergence of Human Arboviral Diseases in the Americas, 2000-2016
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Review
DE Arbovirus; Bourbon; Cache Valley; Chikungunya; Emerging; Heartland;
   Iquitos; Mayaro; Powassan; The Americas; Zika; Zoonoses
ID CACHE VALLEY VIRUS; BUNYAMWERA SEROGROUP VIRUSES; TICK-BORNE
   ENCEPHALITIS; CENTRAL-NERVOUS-SYSTEM; ZIKA VIRUS; UNITED-STATES;
   CHIKUNGUNYA VIRUS; OROPOUCHE VIRUS; FEBRILE ILLNESS; BRAZIL
AB In addition to individual or clusters of cases of human infections with arboviruses, the past 15 years has seen the emergence of newly recognized arboviruses and the re-emergence of others. Mentioned in this brief summary are Bourbon, Cache Valley, chikungunya, Heartland, Itaqui, Mayaro, Oropouche, Powassan, and Zika viruses, the latter being a remarkable occurrence.
C1 [Vasconcelos, Pedro F. C.] Brazilian Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.
   [Vasconcelos, Pedro F. C.] Univ Para State, Dept Pathol, Belem, Para, Brazil.
   [Calisher, Charles H.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, 3195 Rampart Rd,Delivery Code 1690, Ft Collins, CO 80523 USA.
RP Calisher, CH (reprint author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, 3195 Rampart Rd,Delivery Code 1690, Ft Collins, CO 80523 USA.
EM calisher@cybersafe.net
CR Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Anthony SJ, 2013, MBIO, V4
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Batista PM, 2013, REV SOC BRAS MED TRO, V46, P684, DOI 10.1590/0037-8682-0181-2013
   Calisher C H, 1974, Bull Pan Am Health Organ, V8, P243
   CALISHER CH, 1995, EMERG INFECT DIS, V1, P147
   CALISHER CH, 1986, AM J TROP MED HYG, V35, P429
   Campbell GL, 2006, EMERG INFECT DIS, V12, P854
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CHUMAKOV MP, 1963, ACTA VIROL, V7, P82
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EDWARDS JF, 1989, VET PATHOL, V26, P33
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022
   HOLDEN P, 1959, SCIENCE, V130, P1187, DOI 10.1126/science.130.3383.1187
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Kosoy OI, 2015, EMERG INFECT DIS, V21, P760, DOI 10.3201/eid2105.150150
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411
   McLEAN D M, 1959, Can Med Assoc J, V80, P708
   McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen NL, 2013, J CLIN MICROBIOL, V51, P1966, DOI 10.1128/JCM.00252-13
   Nunes Marcio Roberto Teixeira, 2005, Emerg Infect Dis, V11, P1610
   Pastula DM, 2014, MMWR-MORBID MORTAL W, V63, P270
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674
   Pinheiro FP, 1962, REV SERVICO ESPECIAL, V12, P15
   Powers AM, 2006, AM J TROP MED HYG, V75, P461
   Rodriguez-Roche R, 2016, J VIROL, DOI [10.1128/JVI.02647.15, DOI 10.1128/JVI.02647.15]
   Rothman Alan L, 2016, J Infect Dis, V214, P825, DOI 10.1093/infdis/jiw068
   Saeed MF, 2000, J GEN VIROL, V81, P743
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209
   Sexton DJ, 1997, NEW ENGL J MED, V336, P547, DOI 10.1056/NEJM199702203360804
   Tavakolipoor P, 2016, TRAVEL MED INFECT DI, V14, P39, DOI 10.1016/j.tmaid.2016.01.007
   Taylor LH, 2001, PHILOS T ROY SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Telford SR, 1997, EMERG INFECT DIS, V3, P165
   Tilston-Lunel NL, 2015, J GEN VIROL, V96, P1636, DOI 10.1099/vir.0.000108
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Vedovello D, 2015, ARCH VIROL, V160, P1189, DOI 10.1007/s00705-015-2378-2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wang LF, 2014, REV SCI TECH OIE, V33, P569
   World Health Organization Food and Agriculture Organization of the United Nations and World Organization for Animal Health, 2004, WHO FAO OIE JOINT CO
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
NR 51
TC 3
Z9 4
U1 28
U2 28
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD MAY
PY 2016
VL 16
IS 5
BP 295
EP 301
DI 10.1089/vbz.2016.1952
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DK3RZ
UT WOS:000374836400001
PM 26991057
ER

PT J
AU Gardner, LM
   Chen, N
   Sarkar, S
AF Gardner, Lauren M.
   Chen, Nan
   Sarkar, Sahotra
TI Global risk of Zika virus depends critically on vector status of Aedes
   albopictus
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Gardner, Lauren M.; Chen, Nan] Univ New South Wales Australia, Sydney, NSW, Australia.
   [Sarkar, Sahotra] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.
RP Gardner, LM (reprint author), Univ New South Wales Australia, Sydney, NSW, Australia.
EM l.gardner@unsw.edu.au
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Gardner LM, 2012, J TROP MED, V2012, DOI [DOI 10.1155/2012/103679, 10.1155/2012/103679]
   [Anonymous], 2016, WHO SIT REP ZIK VIR
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 6
TC 3
Z9 4
U1 48
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2016
VL 16
IS 5
BP 522
EP 523
DI 10.1016/S1473-3099(16)00176-6
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DJ5TL
UT WOS:000374272900014
PM 26997578
ER
